PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Costantino, MA; Bonati, M				Costantino, Maria Antonella; Bonati, Maurizio			A Scoping Review of Interventions to Supplement Spoken Communication for Children with Limited Speech or Language Skills	PLOS ONE			English	Review							RANDOMIZED CLINICAL-TRIALS; ALTERNATIVE COMMUNICATION; COMPLEX INTERVENTIONS; DEVELOPMENTAL DELAYS; SERVICE PROVISION; AAC TECHNOLOGIES; CEREBRAL-PALSY; HEALTH; PRESCHOOLERS; ADOLESCENTS	Background: Augmentative and Alternative Communication (AAC) is used for treating children with severe disorders of speech-language production and/or comprehension. Various strategies are used, but research and debate on their efficacy have remained limited to a specific area and have rarely reached the general medical community. Objective: To systematically evaluate outcomes of AAC interventions in children with limited speech or language skills. Methods: Searches were conducted (up to December 2012) in the MEDLINE, EMBASE, PsycINFO, CINAHL, DARE, and Cochrane Library databases. Furthermore, relevant journals were searched by hand. References from identified studies were examined. Only RCTs were considered. Trial quality was assessed according to a standardized and validated set of criteria. Results: Fourteen of 1661 retrieved papers met inclusion criteria. A total of 666 children were included in the review and 7 papers involved only children <5 years old. Papers were of average quality and all but one had been published during the previous 10 years by one of 8 research groups, 5 of which from the United States. Seven studies directly addressed AAC use by children with different disabilities. Seven studies enrolled typically developing children: 5 evaluated the use of AAC technologies by children without disabilities in order to obtain results that could be used to improve interventions in peers with disabilities, and 2 evaluated peers' attitudes towards children who used AAC. Both interventions and outcome measures varied widely between studies. Overall findings demonstrate the effectiveness of the AAC interventions considered, but the focus on RCTs alone appears too restrictive. Conclusions: Solid evidence of the positive effects of AAC interventions in children with severe communication disorders must be generated, and different methods are needed besides RCTs. Moreover, it is important that knowledge, research, and debate extend to the medical community in order to ensure clinically effective AAC provision for these children (and their parents).	[Costantino, Maria Antonella] Osped Maggiore Policlin, IRCCS Fdn Ca Granda, Child & Adolescent Neuropsychiat Unit, Milan, Italy; [Bonati, Maurizio] IRCCS Mario Negri Pharmacol Res Inst, Lab Mother & Child Hlth, Dept Publ Hlth, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Bonati, M (corresponding author), IRCCS Mario Negri Pharmacol Res Inst, Lab Mother & Child Hlth, Dept Publ Hlth, Milan, Italy.	mother_child@marionegri.it	de Jager, Aimee/AAL-1264-2021; Bonati, Maurizio/K-8980-2016	Bonati, Maurizio/0000-0003-3997-3726				Alant E, 2010, AUGMENT ALTERN COMM, V26, P41, DOI 10.3109/07434610903585422; American Speech Language Hearing Association, 2005, ROL RESP SPEECH LANG; Angelo DH., 2000, AUGMENTATIVE ALTERNA, V16, P37, DOI [DOI 10.1080/07434610012331278894, 10.1080/07434610012331278894]; Basson Magdel, 2005, S Afr J Commun Disord, V52, P4; Beck AR, 2010, J SPEECH LANG HEAR R, V53, P572, DOI 10.1044/1092-4388(2009/07-0140); Beck AR, 2003, AM J SPEECH-LANG PAT, V12, P51, DOI 10.1044/1058-0360(2003/052); Bedrosian J.L., 1995, AUGMENT ALTERN COMM, V11, P6, DOI [10.1080/07434619512331277089, DOI 10.1080/07434619512331277089]; Beukelman D, 2010, J PEDIATR REHAB MED, V3, P279, DOI 10.3233/PRM-2010-0139; Beukelman DR, 1986, AUGMENTATIVE COMMUNI, P423; BLOOMBERG K, 1990, AAC (Augmentative and Alternative Communication), V6, P50, DOI 10.1080/07434619012331275314; Bubbico L, 2007, Acta Otorhinolaryngol Ital, V27, P17; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Cress C.J., 2003, AUGMENTATIVE ALTERNA, V19, P254, DOI [DOI 10.1080/07434610310001598242, https://doi.org/10.1080/07434610310001598242]; Drager KDR, 2004, J SPEECH LANG HEAR R, V47, P1133, DOI 10.1044/1092-4388(2004/084); Fellinger J, 2012, LANCET, V379, P1037, DOI 10.1016/S0140-6736(11)61143-4; Geytenbeek J, 2010, DEV MED CHILD NEUROL, V52, pE267, DOI 10.1111/j.1469-8749.2010.03807.x; Hawe P, 2004, BMJ-BRIT MED J, V328, P1561, DOI 10.1136/bmj.328.7455.1561; Higginbotham D., 1995, AUGMENT ALTERN COMM, V11, P11, DOI [DOI 10.1080/07434619512331277099, 10.1080/07434619512331277099]; Higginbotham D.J., 1995, AAC AUGM ALT COMM, V11, P2, DOI [10.1080/07434619512331277079, DOI 10.1080/07434619512331277079]; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Law J, 2000, INT J LANG COMM DIS, V35, P165, DOI 10.1080/136828200247133; Lenker JA, 2005, ASSIST TECHNOL, V17, P7, DOI 10.1080/10400435.2005.10132092; Light J, 1999, AUGMENTATIVE ALTERNA, V15, P13, DOI [DOI 10.1080/07434619912331278535, 10.1080/07434619912331278535]; Light J, 2007, AUGMENT ALTERN COMM, V23, P204, DOI 10.1080/07434610701553635; Light JC, 2001, AUGMENT ALTERN COMM, V20, P137; Matas J., 1985, AUGMENTATIVE ALTERNA, V1, P17; McCarthy J, 2006, AUGMENT ALTERN COMM, V22, P269, DOI 10.1080/00498250600718621; Millar DC, 2006, J SPEECH LANG HEAR R, V49, P248, DOI 10.1044/1092-4388(2006/021); Mirenda P., 2009, AUTISM SPECTRUM DISO; Mitchell RE, 2006, J DEAF STUD DEAF EDU, V11, P112, DOI 10.1093/deafed/enj004; Mohler R, 2012, INT J NURS STUD, V49, P40, DOI 10.1016/j.ijnurstu.2011.08.003; Pennington L, 2004, INT J LANG COMM DIS, V39, P151, DOI 10.1080/13682820310001625598; Pennington L, 2004, COCHRANE DB SYST REV, V2; Romski M, 2011, AM J SPEECH-LANG PAT, V20, P111, DOI 10.1044/1058-0360(2011/09-0087); Romski M, 2010, J SPEECH LANG HEAR R, V53, P350, DOI 10.1044/1092-4388(2009/08-0156); Schlosser R., 2003, EFFICACY AUGMENTATIV, V1st, P472, DOI DOI 10.1044/1058-0360(2008/021); Schlosser R., 2000, AUGMENTATIVE ALTERNA, V16, P208, DOI DOI 10.1080/07434610012331279074; Schlosser R., 1999, AUGMENTATIVE ALTERNA, V15, P234, DOI [DOI 10.1080/07434619912331278775, 10.1080/07434619912331278775]; Schlosser R. W., 2007, EVIDENCE BASED COMMU, V1, P138, DOI [10.1080/17489530701560831, DOI 10.1080/17489530701560831]; Schlosser RW, 2008, AM J SPEECH-LANG PAT, V17, P212, DOI 10.1044/1058-0360(2008/021); Schlosser RW, 2007, J COMMUN DISORD, V40, P225, DOI 10.1016/j.jcomdis.2006.06.008; Schlosser RW, 2012, J SPEECH LANG HEAR R, V55, P342, DOI 10.1044/1092-4388(2011/10-0164); Schlosser RW, 2009, AUGMENT ALTERN COMM, V25, P225, DOI 10.3109/07434610903360649; SCHLOSSER RW, 2009, ROLE SINGLE SUBJECT; Schlosser RW., 2004, AUGMENTATIVE ALTERNA, V20, P1, DOI [10.1080/07434610310001621083, DOI 10.1080/07434610310001621083]; Sevcik RA, 1999, AUGMENTATIVE ALTERNA, V15, P38, DOI DOI 10.1080/07434619912331278555; Siu E, 2010, AUGMENT ALTERN COMM, V26, P289, DOI 10.3109/07434618.2010.521894; Sutherland DE, 2005, AUGMENT ALTERN COMM, V21, P295, DOI 10.1080/07434610500103483; Trembath D, 2009, J INTELLECT DEV DIS, V34, P173, DOI 10.1080/13668250902845210; Udwin O, 1987, CHILD LANG TEACH THE, V3, P18; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Weiss PL, 2005, AUGMENT ALTERN COMM, V21, P56, DOI 10.1080/07434610412331272910; Wilkinson KM, 2007, MENT RETARD DEV D R, V13, P58, DOI 10.1002/mrdd.20133; Wu CH, 2004, IEEE T NEUR SYS REH, V12, P441, DOI 10.1109/TNSRE.2003.819930; Yoder P, 2006, J SPEECH LANG HEAR R, V49, P698, DOI 10.1044/1092-4388(2006/051); Yoder P, 2006, J CONSULT CLIN PSYCH, V74, P426, DOI 10.1037/0022-006X.74.3.426; Yoder PJ, 2010, J AUTISM DEV DISORD, V40, P629, DOI 10.1007/s10803-009-0897-y; YODER PJ, 1988, J AUTISM DEV DISORD, V18, P217, DOI 10.1007/BF02211948	60	6	6	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90744	10.1371/journal.pone.0090744	http://dx.doi.org/10.1371/journal.pone.0090744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9JS	24625465	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300031
J	Lou, J; Blevins, M; Ruan, YH; Vermund, SH; Tang, SY; Webb, GF; Shepherd, BE; He, X; Lu, HY; Shao, YM; Qian, HZ				Lou, Jie; Blevins, Meridith; Ruan, Yuhua; Vermund, Sten H.; Tang, Sanyi; Webb, Glenn F.; Shepherd, Bryan E.; He, Xiong; Lu, Hongyan; Shao, Yiming; Qian, Han-Zhu			Modeling the Impact on HIV Incidence of Combination Prevention Strategies among Men Who Have Sex with Men in Beijing, China	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; TRANSMISSION RISK; INFECTION; EPIDEMIC; RESISTANCE; BEHAVIOR; DONORS; COHORT; CARE	Objective: To project the HIV/AIDS epidemics among men who have sex with men (MSM) under different combinations of HIV testing and linkage to care (TLC) interventions including antiretroviral therapy (ART) in Beijing, China. Design: Mathematical modeling. Methods: Using a mathematical model to fit prevalence estimates from 2000-2010, we projected trends in HIV prevalence and incidence during 2011-2020 under five scenarios: (S1) current intervention levels by averaging 2000-2010 coverage; (S2) increased ART coverage with current TLC; (S3) increased TLC/ART coverage; (S4) increased condom use; and (S5) increased TLC/ART plus increased condom use. Results: The basic reproduction number based upon the current level of interventions is significantly higher than 1 (R-0 = 2.09; 95% confidence interval (CI), 1.83-2.35), suggesting that the HIV epidemic will continue to increase to 2020. Compared to the 2010 prevalence of 7.8%, the projected HIV prevalence in 2020 for the five prevention scenarios will be: (S1) Current coverage: 21.4% (95% CI, 9.9-31.7%); (S2) Increased ART: 19.9% (95% CI, 9.9-28.4%); (S3) Increased TLC/ART: 14.5% (95% CI, 7.0-23.8%); (S4) Increased condom use: 13.0% (95% CI, 9.8-28.4%); and (S5) Increased TLC/ART and condom use: 8.7% (95% CI, 5.4-11.5%). HIV epidemic will continue to rise (R-0 > 1) for S1-S4 even with hyperbolic coverage in the sensitivity analysis, and is expected to decline (R-0 = 0.93) for S5. Conclusion: Our transmission model suggests that Beijing MSM will have a rapidly rising HIV epidemic. Even enhanced levels of TLC/ART will not interrupt epidemic expansion, despite optimistic assumptions for coverage. Promoting condom use is a crucial component of combination interventions.	[Lou, Jie] Shanghai Univ, Dept Math, Shanghai, Peoples R China; [Blevins, Meridith; Vermund, Sten H.; Shepherd, Bryan E.; Qian, Han-Zhu] Vanderbilt Univ, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA; [Blevins, Meridith; Shepherd, Bryan E.] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA; [Ruan, Yuhua; Shao, Yiming] Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Vermund, Sten H.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Tang, Sanyi] Shaanxi Normal Univ, Coll Math & Informat Sci, Xian, Shaanxi Provinc, Peoples R China; [Webb, Glenn F.] Vanderbilt Univ, Dept Math, Nashville, TN USA; [He, Xiong; Lu, Hongyan] Beijing Municipal Ctr Dis Control & Prevent, Inst AIDS STD Prevent & Control, Beijing, Peoples R China; [Qian, Han-Zhu] Vanderbilt Univ, Div Epidemiol, Dept Med, Nashville, TN USA	Shanghai University; Vanderbilt University; Vanderbilt University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Vanderbilt University; Shaanxi Normal University; Vanderbilt University; Vanderbilt University	Shao, YM (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China.	yshao08@gmail.com; han-zhu.qian@vanderbilt.edub	Webb, Glenn/AAW-7228-2021; Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698; Blevins, Meridith/0000-0002-3861-9859	National Institute Of Allergy And Infectious Diseases of the National Institutes of Health [R01AI094562, R34AI091446]; Natural Science Foundation of China [11271246, 11331009]; International Development Research Center of Canada [104519-010]; Chinese State Key Laboratory for Infectious Disease Develop Grant [2012SKLID103]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R34AI091446, R01AI094562] Funding Source: NIH RePORTER	National Institute Of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Development Research Center of Canada; Chinese State Key Laboratory for Infectious Disease Develop Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was mainly supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Numbers R01AI094562 and R34AI091446. This study was also in part sponsored by grants from the Natural Science Foundation of China (grants #11271246 & 11331009), the International Development Research Center of Canada (grant #104519-010) and Chinese State Key Laboratory for Infectious Disease Develop Grant (grant #2012SKLID103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusto FB, 2013, MATH BIOSCI, V243, P147, DOI 10.1016/j.mbs.2013.02.001; AHLGREN DJ, 1990, J ACQ IMMUN DEF SYND, V3, P631; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Buonomo B, 2012, J MATH ANAL APPL, V385, P709, DOI 10.1016/j.jmaa.2011.07.006; CDC C, 2010, ANN REP HIV AIDS BEI; Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P250; Chow EPF, 2012, AIDS BEHAV, V16, P653, DOI 10.1007/s10461-011-9935-9; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fan S, 2012, AIDS PATIENT CARE ST, V26, P148, DOI 10.1089/apc.2011.0277; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; HELTON JC, 1985, ECOL MODEL, V28, P243, DOI 10.1016/0304-3800(85)90077-8; Hoare A, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-4; JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169; Jia Z, 2012, LANCET; Johnson LF, 2006, DEMOGR RES, V14, P541, DOI 10.4054/DemRes.2006.14.22; Li D-I, 2008, J PREVENTIVE MED INF, V6; Li HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023431; Li XF, 2012, SEX TRANSM INFECT, V88, P187, DOI 10.1136/sextrans-2011-050248; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Liu H., 2001, CHIN J STD AIDS PREV, V7, P289; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Ma Y, 2010, INT J EPIDEMIOL, V39, P973, DOI 10.1093/ije/dyp233; Ministry of Health in People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; Muessig KE, 2012, AIDS, V26, P2267, DOI 10.1097/QAD.0b013e328355713d; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Qian HZ, 2006, AIDS, V20, P1429, DOI 10.1097/01.aids.0000233577.33973.fa; Qian ZH, 2005, SEX TRANSM INFECT, V81, P442, DOI 10.1136/sti.2004.014258; Rottingen JA, 2002, SEX TRANSM DIS, V29, P818, DOI 10.1097/00007435-200212000-00014; Ruan YH, 2009, AIDS BEHAV, V13, P663, DOI 10.1007/s10461-008-9503-0; Sullivan P, 2010, AIDS RES HUM RETROVI; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Supervie V, 2010, P NATL ACAD SCI USA, V107, P12381, DOI 10.1073/pnas.1006061107; Tan WY, 1999, J STAT PLAN INFER, V78, P71, DOI 10.1016/S0378-3758(98)00207-9; Tucker JD, 2012, SEX TRANSM INFECT, V88, P116, DOI 10.1136/sextrans-2011-050135; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; van Sighem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044819; Vardavas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000152; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Vernazza PL, 1997, AIDS, V11, P1249, DOI 10.1097/00002030-199710000-00008; Wang JJ, 2010, NONLINEAR ANAL-REAL, V11, P2390, DOI 10.1016/j.nonrwa.2009.07.012; Wang L, 2010, JAIDS-J ACQ IMM DEF, V55, P232, DOI 10.1097/QAI.0b013e3181e9b6b7; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Wilson DP, 2009, SEX HEALTH, V6, P19, DOI 10.1071/SH08081; Wirtz AL, 2013, INT J STD AIDS; Wu Z, 2013, HIV SYPHILIS PREVALE; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xu Juan, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P975; Ye SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050873; Yu M-R, 2011, CHINESE J PUBLIC HLT, V10; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang L, 2012, SEX HEALTH, V9, P261, DOI 10.1071/SH11104; Zhou Zhen-hai, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P273	60	29	29	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90985	10.1371/journal.pone.0090985	http://dx.doi.org/10.1371/journal.pone.0090985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626165	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300047
J	Steffener, J; Barulli, D; Habeck, C; O'Shea, D; Razlighi, Q; Stern, Y				Steffener, Jason; Barulli, Daniel; Habeck, Christian; O'Shea, Deirdre; Razlighi, Qolamreza; Stern, Yaakov			The Role of Education and Verbal Abilities in Altering the Effect of Age-Related Gray Matter Differences on Cognition	PLOS ONE			English	Article							BRAIN VOLUME DECLINE; MEDIATION ANALYSIS; RESERVE; MEMORY; INTELLIGENCE; MAINTENANCE; MODELS	Evidence suggests that individual variability in lifetime exposures influences how cognitive performance changes with advancing age. Brain maintenance and cognitive reserve are theories meant to account for preserved performance despite advancing age. These theories differ in their causal mechanisms. Brain maintenance predicts more advantageous lifetime exposures will reduce age-related neural differences. Cognitive reserve predicts that lifetime exposures will not directly reduce these differences but minimize their impact on cognitive performance. The present work used moderated-mediation modeling to investigate the contributions of these mechanisms at explaining variability in cognitive performance among a group of 39 healthy younger (mean age (standard deviation) 25.9 (2.92) and 45 healthy older adults (65.2 (2.79)). Cognitive scores were computed using composite measures from three separate domains (speed of processing, fluid reasoning, and memory), while their lifetime exposures were estimated using education and verbal IQ measures. T1-weighted MR images were used to measure cortical thickness and subcortical volumes. Results suggest a stronger role for cognitive reserve mechanisms in explaining age-related cognitive variability: even with age-related reduced gray matter, individuals with greater lifetime exposures could perform better given their quantity of brain measures.	[Steffener, Jason; Barulli, Daniel; Habeck, Christian; O'Shea, Deirdre; Razlighi, Qolamreza; Stern, Yaakov] Columbia Univ Coll Phys & Surg, Cognit Neurosci Div, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Steffener, Jason; Habeck, Christian; Razlighi, Qolamreza; Stern, Yaakov] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [Barulli, Daniel] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Stern, Yaakov] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Steffener, J (corresponding author), Columbia Univ Coll Phys & Surg, Cognit Neurosci Div, Taub Inst Res Alzheimers Dis & Aging Brain, 630 W 168th St, New York, NY 10032 USA.	js2746@columbia.edu		Stern, Yaakov/0000-0001-7542-3241	NIH [K01AG035061]; NATIONAL INSTITUTE ON AGING [K01AG044467, R01AG026158, R01AG038465, K01AG035061] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for this study was from NIH grant: K01AG035061, titled "Age-Related Structural and Functional Neural Changes on Cognitive Measures'' and awarded to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GE, 2008, J NEUROSCI, V28, P2710, DOI 10.1523/JNEUROSCI.1852-07.2008; Association A.P., 1994, DIAGN STAT MAN MENT, V4th; Bartres-Faz D, 2009, BIOL PSYCHOL, V80, P256, DOI 10.1016/j.biopsycho.2008.10.005; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Benjamini Y, 1995, J R STAT SOC B; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Clymo RS, 2013, MANY DIGITS MEAN ARE; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Fotenos AF, 2008, ARCH NEUROL-CHICAGO, V65, P113, DOI 10.1001/archneurol.2007.27; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Grieve SM, 2005, HUM BRAIN MAPP, V25, P391, DOI 10.1002/hbm.20115; Hayes AF, 2013, INTRO MEDIAITON MODE; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Johnson PO, 1936, STAT RES MEMOIRS, V1; MacDonald P.A., 2013, BRAIN IMAGING BEHAV; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; Mattis S, 1988, DEMENTIA RATING SCAL; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; Park Denise C, 2013, Dialogues Clin Neurosci, V15, P109; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Raven J.C., 1962, ADV PROGR MATRICES; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Reitan R.M., 1993, HALSTEAD REITAN NEUR; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Salthouse TA, 2004, CURR DIR PSYCHOL SCI, V13, P140, DOI 10.1111/j.0963-7214.2004.00293.x; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Salthouse TA, 2008, INTELLIGENCE, V36, P464, DOI 10.1016/j.intell.2007.10.003; Salthouse TA, 2011, PSYCHOL BULL, V137, P753, DOI 10.1037/a0023262; Samanez-Larkin GR, 2010, J NEUROSCI, V30, P1426, DOI 10.1523/JNEUROSCI.4902-09.2010; Siedlecki KL, 2009, J INT NEUROPSYCH SOC, V15, P558, DOI 10.1017/S1355617709090857; Steffener J, 2012, HUM BRAIN MAPP; Steffener J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044421; Steffener J, 2012, BBA-MOL BASIS DIS, V1822, P467, DOI 10.1016/j.bbadis.2011.09.012; Steffener J, 2011, BRAIN IMAGING BEHAV, V5, P212, DOI 10.1007/s11682-011-9125-4; STERN Y, 1992, ANN NEUROL, V32, P371, DOI 10.1002/ana.410320311; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird	48	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91196	10.1371/journal.pone.0091196	http://dx.doi.org/10.1371/journal.pone.0091196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9JS	24625888	gold, Green Published, Green Submitted			2022-12-27	WOS:000332851300062
J	Lim, SH; Wu, LX; Kiew, LV; Chung, LY; Burgess, K; Lee, HB				Lim, Siang Hui; Wu, Liangxing; Kiew, Lik Voon; Chung, Lip Yong; Burgess, Kevin; Lee, Hong Boon			Rosamines Targeting the Cancer Oxidative Phosphorylation Pathway	PLOS ONE			English	Article							DELOCALIZED LIPOPHILIC CATIONS; RAT-LIVER MITOCHONDRIA; CARDIAC TOXICITY; CARCINOMA-CELLS; INHIBITORS; DOXORUBICIN; RESISTANCE; ACIDOSIS; SCREEN; GROWTH	Reprogramming of energy metabolism is pivotal to cancer, so mitochondria are potential targets for anticancer therapy. A prior study has demonstrated the anti-proliferative activity of a new class of mitochondria-targeting rosamines. This present study describes in vitro cytotoxicity of second-generation rosamine analogs, their mode of action, and their in vivo efficacies in a tumor allografted mouse model. Here, we showed that these compounds exhibited potent cytotoxicity (average IC50<0.5 mu M), inhibited Complex II and ATP synthase activities of the mitochondrial oxidative phosphorylation pathway and induced loss of mitochondrial transmembrane potential. A NCI-60 cell lines screen further indicated that rosamine analogs 4 and 5 exhibited potent antiproliferative effects with Log(10)GI(50) = -7 (GI(50) = 0.1 mu M) and were more effective against a colorectal cancer sub-panel than other cell lines. Preliminary in vivo studies on 4T1 murine breast cancer-bearing female BALB/c mice indicated that treatment with analog 5 in a single dosing of 5 mg/kg or a schedule dosing of 3 mg/kg once every 2 days for 6 times (q2dx6) exhibited only minimal induction of tumor growth delay. Our results suggest that rosamine analogs may be further developed as mitochondrial targeting agents. Without a doubt proper strategies need to be devised to enhance tumor uptake of rosamines, i.e. by integration to carrier molecules for better therapeutic outcome.	[Lim, Siang Hui; Lee, Hong Boon] Canc Res Initiat Fdn CARIF, Drug Discovery Lab, Subang Jaya, Selangor, Malaysia; [Lim, Siang Hui; Chung, Lip Yong] Univ Malaya, Dept Pharm, Kuala Lumpur, Malaysia; [Wu, Liangxing; Burgess, Kevin] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Kiew, Lik Voon] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Texas A&M University System; Texas A&M University College Station; Universiti Malaya	Lee, HB (corresponding author), Canc Res Initiat Fdn CARIF, Drug Discovery Lab, Subang Jaya, Selangor, Malaysia.	hongboon.lee@carif.com.my	Burgess, Kevin/B-5372-2015; CHUNG, LIP YONG/B-7764-2010; Lim, Siang Hui/H-2804-2014; KIEW, LIK VOON/B-8789-2010	Burgess, Kevin/0000-0001-6597-1842; CHUNG, LIP YONG/0000-0002-3596-768X; KIEW, LIK VOON/0000-0002-6855-9631; , LEE/0000-0002-0768-2222	Cancer Research Initiatives Foundation; Malaysia Ministry of Higher Education's HIR-MOHE [UM.C/625/1/HIR/MOHE/MED/17, UM.C/625/1/HIR/MOHE/MED/33]; Universiti Malaya [PS204/2010B]; National Institutes of Health [GM087981]; Robert A. Welch Foundation [A-1121]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087981] Funding Source: NIH RePORTER	Cancer Research Initiatives Foundation; Malaysia Ministry of Higher Education's HIR-MOHE; Universiti Malaya(Universiti Malaya); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from Cancer Research Initiatives Foundation, Malaysia Ministry of Higher Education's HIR-MOHE grants (UM.C/625/1/HIR/MOHE/MED/17 and UM.C/625/1/HIR/MOHE/MED/33), Universiti Malaya Post Graduate Research Grant (PS204/2010B), and by grants to KB from The National Institutes of Health (GM087981) and The Robert A. Welch Foundation (A-1121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken MJ, 2009, CLIN NUCL MED, V34, P762, DOI 10.1097/RLU.0b013e3181b7d76f; Alcala AM, 2012, CLIN CANCER RES, V18, P33, DOI 10.1158/1078-0432.CCR-11-0997; Ayoola A, 2012, CANCER INVEST, V30, P433, DOI 10.3109/07357907.2012.666691; Biasutto L, 2010, MITOCHONDRION, V10, P670, DOI 10.1016/j.mito.2010.06.004; BOYD MR, 1995, DRUG DEVELOP RES, V34, P91, DOI 10.1002/ddr.430340203; Don AS, 2004, TRENDS MOL MED, V10, P372, DOI 10.1016/j.molmed.2004.06.005; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gerebtzoff G, 2004, CHEMBIOCHEM, V5, P676, DOI 10.1002/cbic.200400017; Hollingshead MG, 2008, JNCI-J NATL CANCER I, V100, DOI 10.1093/jnci/djn351; HUANG DP, 1980, INT J CANCER, V26, P127, DOI 10.1002/ijc.2910260202; Jin W, 2010, CARCINOGENESIS, V31, P1939, DOI 10.1093/carcin/bgq180; Kesterson JP, 2010, CHEMOTHERAPY, V56, P108, DOI 10.1159/000312644; Kowaltowski AJ, 1999, J BIOENERG BIOMEMBR, V31, P581, DOI 10.1023/A:1005421112345; Kraut JA, 2012, NAT REV NEPHROL, V8, P589, DOI 10.1038/nrneph.2012.186; Kurtoglu M, 2009, MOL NUTR FOOD RES, V53, P68, DOI 10.1002/mnfr.200700457; LAMPIDIS TJ, 1985, BIOMED PHARMACOTHER, V39, P220; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lim SH, 2009, ANTI-CANCER DRUG, V20, P461, DOI 10.1097/CAD.0b013e32832b7bee; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Modica-Napolitano JS, 2001, ADV DRUG DELIVER REV, V49, P63, DOI 10.1016/S0169-409X(01)00125-9; MODICANAPOLITANO JS, 1984, BIOCHEM BIOPH RES CO, V118, P717, DOI 10.1016/0006-291X(84)91453-0; MORENO SNJ, 1988, J BIOL CHEM, V263, P12493; Nadanaciva S, 2007, TOXICOL IN VITRO, V21, P902, DOI 10.1016/j.tiv.2007.01.011; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Plowman J, 1997, ANTICANCER DRUG DEV, P101; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Renda F, 2013, EUR REV MED PHARMACO, V17, P45; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Toogood PL, 2008, CURR OPIN CHEM BIOL, V12, P457, DOI 10.1016/j.cbpa.2008.06.002; Wang F, 2010, MOL ASPECTS MED, V31, P75, DOI 10.1016/j.mam.2009.12.003; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Wu LX, 2008, J ORG CHEM, V73, P8711, DOI 10.1021/jo800902j	32	13	19	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e82934	10.1371/journal.pone.0082934	http://dx.doi.org/10.1371/journal.pone.0082934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622277	Green Submitted, gold, Green Published			2022-12-27	WOS:000332845300002
J	Loneragan, GH; Thomson, DU; Scott, HM				Loneragan, Guy H.; Thomson, Daniel U.; Scott, H. Morgan			Increased Mortality in Groups of Cattle Administered the beta-Adrenergic Agonists Ractopamine Hydrochloride and Zilpaterol Hydrochloride	PLOS ONE			English	Article							CARCASS CHARACTERISTICS; GROWTH-PERFORMANCE; FINISHING PIGS; ASTHMA; STEERS; METAANALYSIS; BEHAVIOR; TENDERNESS; HEIFERS; IMPACT	The United States Food and Drug Administration (FDA) approved two beta-adrenergic agonists (beta AA) for in-feed administration to cattle fed in confinement for human consumption. Anecdotal reports have generated concern that administration of beta AA might be associated with an increased incidence of cattle deaths. Our objectives, therefore, were to a) quantify the association between beta AA administration and mortality in feedlot cattle, and b) explore those variables that may confound or modify this association. Three datasets were acquired for analysis: one included information from randomized and controlled clinical trials of the beta AA ractopamine hydrochloride, while the other two were observational data on zilpaterol hydrochloride administration to large numbers of cattle housed, fed, and cared for using routine commercial production practices in the U. S. Various population and time at-risk models were developed to explore potential beta AA relationships with mortality, as well as the extent of confounding and effect modification. Measures of effect were relatively consistent across datasets and models in that the cumulative risk and incidence rate of death was 75 to 90% greater in animals administered the beta AA compared to contemporaneous controls. During the exposure period, 40 to 50% of deaths among groups administered the beta AA were attributed to administration of the drug. None of the available covariates meaningfully confounded the relationship between beta AA and increased mortality. Only month of slaughter, presumably a proxy for climate, consistently modified the effect in that the biological association was generally greatest during the warmer months of the year. While death is a rare event in feedlot cattle, the data reported herein provide compelling evidence that mortality is nevertheless increased in response to administration of FDA-approved beta AA and represents a heretofore unquantified adverse drug event.	[Loneragan, Guy H.] Texas Tech Univ, Int Ctr Food Ind Excellence, Dept Anim & Food Sci, Coll Agr & Nat Resources, Lubbock, TX 79409 USA; [Thomson, Daniel U.] Kansas State Univ, Coll Vet Med, Dept Clin Sci, Manhattan, KS 66506 USA; [Scott, H. Morgan] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Texas Tech University System; Texas Tech University; Kansas State University; Kansas State University	Loneragan, GH (corresponding author), Texas Tech Univ, Int Ctr Food Ind Excellence, Dept Anim & Food Sci, Coll Agr & Nat Resources, Lubbock, TX 79409 USA.	Guy.Loneragan@TTU.edu	Scott, Harvey/ABC-9935-2020	Scott, Harvey/0000-0002-0538-5961	Elanco Animal Health, Greenfield, IN	Elanco Animal Health, Greenfield, IN	Initial funding for the evaluation of an association of ractopamine hydrochloride with death loss was provided by Elanco Animal Health, Greenfield, IN. In preparation for manuscript development, further analyses of ractopamine hydrochloride data and all analyses of zilpaterol hydrochloride data were performed solely in the service of the first author's employment at Texas Tech University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avendano-Reyes L, 2011, J ANIM SCI, V89, P4188, DOI 10.2527/jas.2011-3904; Babcock AH, 2013, PREV VET MED, V108, P38, DOI 10.1016/j.prevetmed.2012.07.008; Baszczak JA, 2006, J ANIM SCI, V84, P3410, DOI 10.2527/jas.2006-167; Beasley R, 2006, J ALLERGY CLIN IMMUN, V117, P225, DOI 10.1016/j.jaci.2005.10.029; Bohrer BM, 2013, J ANIM SCI, V91, P1015, DOI 10.2527/jas.2012-5647; Brown, 2006, APPL MIXED MODELS ME; Bryant TC, 2010, J ANIM SCI, V88, P4102, DOI 10.2527/jas.2010-2901; Capper JL, 2012, J ANIM SCI, V90, P3527, DOI 10.2527/jas.2011-4870; GUZY PM, 1977, WESTERN J MED, V127, P455; Health and Human Services Food and Drug Administration website, FREED INF SUMM OR NE; Hilton GG, 2009, J ANIM SCI, V87, P1394, DOI 10.2527/jas.2008-1170; Kononoff PJ, 2013, J ANIM SCI, V91, P5011, DOI 10.2527/jas.2012-5229; Loneragan GH, 2001, J AM VET MED ASSOC, V219, P1122, DOI 10.2460/javma.2001.219.1122; Marchant-Forde JN, 2003, J ANIM SCI, V81, P416; MCDERMOTT JJ, 1994, PREV VET MED, V18, P155, DOI 10.1016/0167-5877(94)90073-6; MCDERMOTT JJ, 1994, PREV VET MED, V18, P175, DOI 10.1016/0167-5877(94)90074-4; McMahon AW, 2011, PEDIATRICS, V128, pE1147, DOI 10.1542/peds.2010-1720; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Poletto R, 2009, J ANIM SCI, V87, P304, DOI 10.2527/jas.2008-1188; Poletto R, 2010, J ANIM SCI, V88, P1184, DOI 10.2527/jas.2008-1576; Rathmann RJ, 2012, J ANIM SCI, V90, P3301, DOI 10.2527/jas.2011-4375; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Salpeter SR, 2010, EXPERT OPIN DRUG SAF, V9, P407, DOI 10.1517/14740330903535852; Salpeter SR, 2004, CHEST, V125, P2309, DOI 10.1378/chest.125.6.2309; Scramlin SM, 2010, J ANIM SCI, V88, P1823, DOI 10.2527/jas.2009-2405; Stryhn H., 2009, VET EPIDEMIOLOGIC RE, V2nd; University of Bristol Centre for Multilevel Modeling website, US GUID MLWIN VERS 2; Wagner SA, 2008, J EQUINE VET SCI, V28, P238, DOI 10.1016/j.jevs.2008.02.006	28	33	34	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91177	10.1371/journal.pone.0091177	http://dx.doi.org/10.1371/journal.pone.0091177			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621596	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300057
J	Rasgon, NL; Geist, CL; Kenna, HA; Wroolie, TE; Williams, KE; Silverman, DHS				Rasgon, Natalie L.; Geist, Cheri L.; Kenna, Heather A.; Wroolie, Tonita E.; Williams, Katherine E.; Silverman, Daniel H. S.			Prospective Randomized Trial to Assess Effects of Continuing Hormone Therapy on Cerebral Function in Postmenopausal Women at Risk for Dementia	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE RELATION; HEALTH INITIATIVE MEMORY; BRAIN METABOLIC-CHANGE; OLDER-ADULTS; REPLACEMENT THERAPY; GLUCOSE-METABOLISM; ESTROGEN THERAPY; ELDERLY-PEOPLE	The objective of this study was to examine the effects of estrogen-based hormone therapy (HT) on regional cerebral metabolism in postmenopausal women (mean age = 58, SD = 5) at risk for development of dementia. The prospective clinical trial design included pre- and post-intervention neuroimaging of women randomized to continue (HT+) or discontinue (HT-) therapy following an average of 10 years of use. The primary outcome measure was change in brain metabolism during the subsequent two years, as assessed with fluorodeoxyglucose-18 positron emission tomography (FDG-PET). Longitudinal FDG-PET data were available for 45 study completers. Results showed that women randomized to continue HT experienced relative preservation of frontal and parietal cortical metabolism, compared with women randomized to discontinue HT. Women who discontinued 17-beta estradiol (17 beta E)-based HT, as well as women who continued conjugated equine estrogen (CEE)-based HT, exhibited significant decline in metabolism of the precuneus/posterior cingulate cortical (PCC) area. Significant decline in PCC metabolism was additionally seen in women taking concurrent progestins (with either 17 beta E or CEE). Together, these findings suggest that among postmenopausal subjects at risk for developing dementia, regional cerebral cortical metabolism is relatively preserved for at least two years in women randomized to continue HT, compared with women randomized to discontinue HT. In addition, continuing unopposed 17 beta E therapy is associated specifically with preservation of metabolism in PCC, known to undergo the most significant decline in the earliest stages of Alzheimer's disease.	[Rasgon, Natalie L.; Kenna, Heather A.; Wroolie, Tonita E.; Williams, Katherine E.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford Ctr Neurosci Womens Hlth, Stanford, CA 94305 USA; [Geist, Cheri L.; Silverman, Daniel H. S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Ahmanson Translat Imaging Div,Sch Med, Los Angeles, CA 90095 USA	Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Rasgon, NL (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford Ctr Neurosci Womens Hlth, Stanford, CA 94305 USA.	nrasgon@stanford.edu	Rasgon, Natalie/ABH-9813-2020		National Institute on Aging [R01 AG22008]; National Center for Research Resources, National Institutes of Health [M01 RR00070]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022008] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by a grant from the National Institute on Aging (R01 AG22008 to N. Rasgon) and supported in part by grant M01 RR00070 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes DE, 2012, ARCH GEN PSYCHIAT, V69, P493, DOI 10.1001/archgenpsychiatry.2011.1481; Bassett SS, 2006, BRAIN, V129, P1229, DOI 10.1093/brain/awl089; Boccardi M, 2006, MENOPAUSE, V13, P584, DOI 10.1097/01.gme.0000196811.88505.10; Bondi MW, 2005, NEUROLOGY, V64, P501, DOI 10.1212/01.WNL.0000150885.00929.7E; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Coker LH, 2010, J STEROID BIOCHEM, V118, P304, DOI 10.1016/j.jsbmb.2009.11.007; Drzezga A, 2003, EUR J NUCL MED MOL I, V30, P1104, DOI 10.1007/s00259-003-1194-1; DUARA R, 1986, NEUROLOGY, V36, P879, DOI 10.1212/WNL.36.7.879; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frick KM, 2012, BEHAV NEUROSCI, V126, P29, DOI 10.1037/a0026660; Friston KJ, 2005, NEUROIMAGE, V24, P244, DOI 10.1016/j.neuroimage.2004.08.055; Genon S, 2012, NEUROBIOL AGING; Gleason CE, 2005, ANN NY ACAD SCI, V1052, P93, DOI 10.1196/annals.1347.007; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Han SD, 2007, NEUROBIOL AGING, V28, P238, DOI 10.1016/j.neurobiolaging.2005.12.013; Harman SM, 2005, ANN NY ACAD SCI, V1052, P43, DOI 10.1196/annals.1347.004; Henderson VW, 2011, WOMENS HEALTH, V7, P81, DOI 10.2217/WHE.10.87; Henderson VW, 2006, NEUROSCIENCE, V138, P1031, DOI 10.1016/j.neuroscience.2005.06.017; HOM J, 1994, J CLIN EXP NEUROPSYC, V16, P568, DOI 10.1080/01688639408402668; Houston WS, 2005, J INT NEUROPSYCH SOC, V11, P863, DOI 10.1017/S1355617705051015; Hu Ling, 2006, Chinese Medical Sciences Journal, V21, P214; Jacobson MW, 2005, NEUROPSYCHOLOGY, V19, P822, DOI 10.1037/0894-4105.19.6.822; Jacobson MW, 2005, J CLIN EXP NEUROPSYC, V27, P240, DOI 10.1080/13803390490515441; Jarvik LF, 2005, J GERIATR PSYCH NEUR, V18, P187, DOI 10.1177/0891988705281862; Johnson SC, 2006, J NEUROSCI, V26, P6069, DOI 10.1523/JNEUROSCI.0959-06.2006; Kantarci K, 2000, NEUROLOGY, V55, P210, DOI 10.1212/WNL.55.2.210; Kordower JH, 2001, ANN NEUROL, V49, P202, DOI 10.1002/1531-8249(20010201)49:2<202::AID-ANA40>3.3.CO;2-V; LARUE A, 1995, J CLIN EXP NEUROPSYC, V17, P65, DOI 10.1080/13803399508406582; LARUE A, 1992, J CLIN EXP NEUROPSYC, V14, P533, DOI 10.1080/01688639208402842; Lehtovirta M, 1996, J NEUROL NEUROSUR PS, V60, P644, DOI 10.1136/jnnp.60.6.644; Lehtovirta M, 1996, NEUROLOGY, V46, P413, DOI 10.1212/WNL.46.2.413; Lord C, 2008, NEUROBIOL AGING, V29, P95, DOI 10.1016/j.neurobiolaging.2006.09.001; Maeshima H, 2012, J AFFECT DISORDERS, V143, P84, DOI 10.1016/j.jad.2012.05.033; Maki PM, 2000, NEUROBIOL AGING, V21, P373, DOI 10.1016/S0197-4580(00)00123-8; MAZZIOTTA JC, 1992, SEMIN NUCL MED, V22, P233, DOI 10.1016/S0001-2998(05)80118-7; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meguro K, 1999, BRAIN, V122, P1519, DOI 10.1093/brain/122.8.1519; Mielke R, 1996, ACTA NEUROPATHOL, V91, P174, DOI 10.1007/s004010050410; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; NEWMAN SK, 1994, J NEUROL NEUROSUR PS, V57, P967, DOI 10.1136/jnnp.57.8.967; Olazaran J., 2013, INT J ALZHEIMERS DIS, V2013; Pardo JV, 2007, NEUROIMAGE, V35, P1231, DOI 10.1016/j.neuroimage.2006.12.044; Phelps ME., 1986, POSITRON EMISSION TO; Polkowski K, 2000, Acta Pol Pharm, V57, P135; Rasgon N, 2008, REGIONAL CEREBRAL ME; Rasgon NL, 2005, NEUROBIOL AGING, V26, P229, DOI 10.1016/j.neurobiolaging.2004.03.003; Rasgon NL, 2001, PSYCHIAT RES-NEUROIM, V107, P11, DOI 10.1016/S0925-4927(01)00084-1; Raz N, 2004, NEUROREPORT, V15, P2531, DOI 10.1097/00001756-200411150-00020; Robertson D, 2009, CLIMACTERIC, V12, P301, DOI 10.1080/13697130902730742; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Silverman D., 2009, PET EVALUATION ALZHE; Silverman DHS, 2008, SEMIN NUCL MED, V38, P251, DOI 10.1053/j.semnuclmed.2008.02.006; Silverman DHS, 2007, BREAST CANCER RES TR, V103, P303, DOI 10.1007/s10549-006-9380-z; Silverman Daniel H.S., 1999, Clin Positron Imaging, V2, P119, DOI 10.1016/S1095-0397(99)00020-5; Silverman DHS, 2011, PSYCHONEUROENDOCRINO, V36, P502, DOI 10.1016/j.psyneuen.2010.08.002; SMALL GW, 1993, ARCH NEUROL-CHICAGO, V50, P209, DOI 10.1001/archneur.1993.00540020085022; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; SMALL GW, 1995, AM J PSYCHIAT, V152, P1757; SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942; Smith CD, 1999, NEUROLOGY, V53, P1391, DOI 10.1212/WNL.53.7.1391; Smith CD, 2002, NEUROLOGY, V58, P1197, DOI 10.1212/WNL.58.8.1197; Smith YR, 2006, J CLIN ENDOCR METAB, V91, P4476, DOI 10.1210/jc.2006-0907; Suzuki S, 2006, ENDOCRINE, V29, P209, DOI 10.1385/ENDO:29:2:209; Vincent A, 2000, MAYO CLIN PROC, V75, P1174, DOI 10.4065/75.11.1174; Wishart HA, 2006, AM J PSYCHIAT, V163, P1603, DOI 10.1176/appi.ajp.163.9.1603; Wolf H, 2003, ACTA NEUROL SCAND, V107, P52, DOI 10.1034/j.1600-0404.107.s179.10.x; Wroolie TE, 2011, AM J GERIAT PSYCHIAT, V19, P792, DOI 10.1097/JGP.0b013e3181ff678a	69	45	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e89095	10.1371/journal.pone.0089095	http://dx.doi.org/10.1371/journal.pone.0089095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622517	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300006
J	Frohlich, LF; Mrakovcic, M; Smole, C; Lahiri, P; Zatloukal, K				Froehlich, Leopold F.; Mrakovcic, Maria; Smole, Claudia; Lahiri, Pooja; Zatloukal, Kurt			Epigenetic Silencing of Apoptosis-Inducing Gene Expression Can Be Efficiently Overcome by Combined SAHA and TRAIL Treatment in Uterine Sarcoma Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; SUBEROYLANILIDE HYDROXAMIC ACID; BREAST-CANCER CELLS; HDAC INHIBITORS; COMMON HALLMARK; OVARIAN-CANCER; CASPASE 8; RESISTANCE; DEATH; APO2L/TRAIL	The lack of knowledge about molecular pathology of uterine sarcomas with a representation of 3-7% of all malignant uterine tumors prevents the establishment of effective therapy protocols. Here, we explored advanced therapeutic options to the previously discovered antitumorigenic effects of the histone deacetylase (HDAC) inhibitor suberoylanilide hydroxamic acid (SAHA) by combined treatment with the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo-2L). In addition, we investigated the uterine sarcoma cell lines, MES-SA and ESS-1, regarding the underlying molecular mechanisms of SAHA and TRAIL-induced apoptosis and their resistance towards TRAIL. Compared to single SAHA or TRAIL treatment, the combination of SAHA with TRAIL led to complete cell death of both tumor cell lines after 24 to 48 hours. In contrast to single SAHA treatment, apoptosis occured faster and was more pronounced in ESS-1 cells than in MES-SA cells. Induction of SAHA-and TRAIL-induced apoptosis was accompanied by upregulation of the intrinsic apoptotic pathway via reduction of mitochondrial membrane potential, caspase-3, -6, and -7 activation, and PARP cleavage, but was also found to be partially caspase-independent. Apoptosis resistance was caused by reduced expression of caspase-8 and DR 4/TRAIL-R1 in ESS-1 and MES-SA cells, respectively, due to epigenetic silencing by DNA hypermethylation of gene promoter sequences. Treatment with the demethylating agent 5-Aza-2'-deoxycytidine or gene transfer therefore restored gene expression and increased the sensitivity of both cell lines against TRAIL-induced apoptosis. Our data provide evidence that deregulation of epigenetic silencing by histone acetylation and DNA hypermethylation might play a fundamental role in the origin of uterine sarcomas. Therefore, tumor growth might be efficiently overcome by a cytotoxic combinatorial treatment of HDAC inhibitors with TRAIL.	[Froehlich, Leopold F.; Smole, Claudia; Lahiri, Pooja; Zatloukal, Kurt] Med Univ Graz, Mol Pathol Lab, Graz, Austria; [Mrakovcic, Maria] Med Univ Graz, Med Res Ctr, Graz, Austria	Medical University of Graz; Medical University of Graz	Frohlich, LF (corresponding author), Med Univ Graz, Mol Pathol Lab, Graz, Austria.	leopold.froehlich@medunigraz.at	Lahiri, Pooja/AAE-6663-2019	Lahiri, Pooja/0000-0002-6305-9451	Lore Saldow Research Fund	Lore Saldow Research Fund	This work was supported by the Lore Saldow Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SI, 2008, ONCOGENE, V27, P490, DOI 10.1038/sj.onc.1210655; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Butler LM, 2006, INT J CANCER, V119, P944, DOI 10.1002/ijc.21939; Carlisi D, 2009, EUR J CANCER, V45, P2425, DOI 10.1016/j.ejca.2009.06.024; Cichorek M, 2008, DERMATOLOGIA ESTETYC, V10, P1; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; D'Angelo E, 2010, GYNECOL ONCOL, V116, P131, DOI 10.1016/j.ygyno.2009.09.023; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Elias A, 2009, CLIN CANCER RES, V15, P5457, DOI 10.1158/1078-0432.CCR-09-1125; Fandy TE, 2005, NEOPLASIA, V7, P646, DOI 10.1593/neo.04655; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Frew AJ, 2008, P NATL ACAD SCI USA, V105, P11317, DOI 10.1073/pnas.0801868105; Frew AJ, 2009, CANCER LETT, V280, P125, DOI 10.1016/j.canlet.2009.02.042; Frohlich LF, 2007, ENDOCRINOLOGY, V148, P2925, DOI 10.1210/en.2006-1298; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fulda S, 2001, ONCOGENE, V20, P5865, DOI 10.1038/sj.onc.1204750; Fulda S, 2008, CURR CANCER DRUG TAR, V8, P132, DOI 10.2174/156800908783769355; Gillenwater AM, 2007, MOL CANCER THER, V6, P2967, DOI 10.1158/1535-7163.MCT-04-0344; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gunawan B, 1998, INT J CANCER, V77, P424, DOI 10.1002/(SICI)1097-0215(19980729)77:3<424::AID-IJC19>3.0.CO;2-7; Harada K, 2002, CANCER RES, V62, P5897; HARKER WG, 1983, CANCER RES, V43, P4943; Horak P, 2005, MOL CANCER RES, V3, P335, DOI 10.1158/1541-7786.MCR-04-0136; Hrzenjak A, 2008, J PATHOL, V216, P495, DOI 10.1002/path.2434; Hrzenjak A, 2006, MOL CANCER THER, V5, P2203, DOI 10.1158/1535-7163.MCT-05-0480; Hrzenjak A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-49; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kaminskyy VO, 2011, CARCINOGENESIS, V32, P1450, DOI 10.1093/carcin/bgr135; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Kubota T, 1997, NAT GENET, V16, P16, DOI 10.1038/ng0597-16; Lakshmikanthan V, 2006, INT J CANCER, V119, P221, DOI 10.1002/ijc.21824; Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Li H, 2007, P NATL ACAD SCI USA, V104, P20001, DOI 10.1073/pnas.0709986104; Lillehammer T, 2007, J GENE MED, V9, P440, DOI 10.1002/jgm.1036; Lin JQ, 2006, BIOCHEM BIOPH RES CO, V346, P1136, DOI 10.1016/j.bbrc.2006.05.209; Lubieniecka JM, 2008, CANCER RES, V68, P4303, DOI 10.1158/0008-5472.CAN-08-0092; MAJOR FJ, 1993, CANCER-AM CANCER SOC, V71, P1702, DOI 10.1002/cncr.2820710440; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Martinez R, 2007, CARCINOGENESIS, V28, P1264, DOI 10.1093/carcin/bgm014; Mrakovcic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056791; Nakata S, 2004, ONCOGENE, V23, P6261, DOI 10.1038/sj.onc.1207830; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Reichardt P, 2012, ANN ONCOL, V23, P151, DOI 10.1093/annonc/mds359; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Shivapurkar N, 2002, CANCER BIOL THER, V1, P65, DOI 10.4161/cbt.1.1.45; Sonnemann J, 2007, J CANCER RES CLIN, V133, P847, DOI 10.1007/s00432-007-0227-8; Sung ES, 2010, APOPTOSIS, V15, P1256, DOI 10.1007/s10495-010-0521-9; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tavassoli FA, 2003, WHO CLASSIFICATION P, P233; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Tomek S, 2004, GYNECOL ONCOL, V94, P107, DOI 10.1016/j.ygyno.2004.04.012; VALERIOTE F, 1975, CANCER CHEMOTH REP 1, V59, P895; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Wiegmans AP, 2011, CANCER RES, V71, P3603, DOI 10.1158/0008-5472.CAN-10-3289; Wu YY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-32; Yang P, 2007, INVEST OPHTH VIS SCI, V48, P3341, DOI 10.1167/iovs.06-1340	57	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91558	10.1371/journal.pone.0091558	http://dx.doi.org/10.1371/journal.pone.0091558			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618889	gold, Green Published, Green Submitted			2022-12-27	WOS:000332842400105
J	Tamaki, T; Hirata, M; Soeda, S; Nakajima, N; Saito, K; Nakazato, K; Okada, Y; Hashimoto, H; Uchiyama, Y; Mochida, J				Tamaki, Tetsuro; Hirata, Maki; Soeda, Shuichi; Nakajima, Nobuyuki; Saito, Kosuke; Nakazato, Kenei; Okada, Yoshinori; Hashimoto, Hiroyuki; Uchiyama, Yoshiyasu; Mochida, Joji			Preferential and Comprehensive Reconstitution of Severely Damaged Sciatic Nerve Using Murine Skeletal Muscle-Derived Multipotent Stem Cells	PLOS ONE			English	Article							PERIPHERAL-NERVES; PERINEURIAL CELLS; SCHWANN-CELLS; NEURITE OUTGROWTH; PROGENITOR CELLS; SILICONE TUBES; AXONAL GROWTH; IN-VITRO; REGENERATION; INJURY	Loss of vital functions in the somatic motor and sensory nervous systems can be induced by severe peripheral nerve transection with a long gap following trauma. In such cases, autologous nerve grafts have been used as the gold standard, with the expectation of activation and proliferation of graft-concomitant Schwann cells associated with their paracrine effects. However, there are a limited number of suitable sites available for harvesting of nerve autografts due to the unavoidable sacrifice of other healthy functions. To overcome this problem, the potential of skeletal muscle-derived multipotent stem cells (Sk-MSCs) was examined as a novel alternative cell source for peripheral nerve regeneration. Cultured/expanded Sk-MSCs were injected into severely crushed sciatic nerve corresponding to serious neurotmesis. After 4 weeks, engrafted Sk-MSCs preferentially differentiated into not only Schwann cells, but also perineurial/endoneurial cells, and formed myelin sheath and perineurium/endoneurium, encircling the regenerated axons. Increased vascular formation was also observed, leading to a favorable blood supply and waste product excretion. In addition, engrafted cells expressed key neurotrophic and nerve/vascular growth factor mRNAs; thus, endocrine/paracrine effects for the donor/recipient cells were also expected. Interestingly, skeletal myogenic capacity of expanded Sk-MSCs was clearly diminished in peripheral nerve niche. The same differentiation and tissue reconstitution capacity of Sk-MSCs was sufficiently exerted in the long nerve gap bridging the acellular conduit, which facilitated nerve regeneration/reconnection. These effects represent favorable functional recovery in Sk-MSC-treated mice, as demonstrated by good corduroy walking. We also demonstrated that these differentiation characteristics of the Sk-MSCs were comparable to native peripheral nerve-derived cells, whereas the therapeutic capacities were largely superior in Sk-MSCs. Therefore, Sk-MSCs can be a novel/suitable alternative cell source for healthy nerve autografts.	[Tamaki, Tetsuro; Hirata, Maki; Soeda, Shuichi; Nakajima, Nobuyuki; Saito, Kosuke; Nakazato, Kenei; Okada, Yoshinori; Hashimoto, Hiroyuki; Uchiyama, Yoshiyasu] Tokai Univ, Sch Med, Muscle Physiol & Cell Biol Unit, Hiratsuka, Kanagawa 25912, Japan; [Tamaki, Tetsuro; Hirata, Maki] Tokai Univ, Sch Med, Dept Regenerat Med, Div Basic Clin Sci, Hiratsuka, Kanagawa 25912, Japan; [Soeda, Shuichi; Nakajima, Nobuyuki] Tokai Univ, Sch Med, Dept Urol, Div Surg, Hiratsuka, Kanagawa 25912, Japan; [Saito, Kosuke] Tokai Univ, Sch Med, Dept Otolaryngol, Hiratsuka, Kanagawa 25912, Japan; [Nakazato, Kenei] Tokai Univ, Sch Med, Dept Resp Surg, Hiratsuka, Kanagawa 25912, Japan; [Hirata, Maki; Okada, Yoshinori] Tokai Univ, Sch Med, Teaching & Res Support Ctr, Hiratsuka, Kanagawa 25912, Japan; [Hashimoto, Hiroyuki; Uchiyama, Yoshiyasu; Mochida, Joji] Tokai Univ, Sch Med, Dept Orthoped, Div Surg, Hiratsuka, Kanagawa 25912, Japan	Tokai University; Tokai University; Tokai University; Tokai University; Tokai University; Tokai University; Tokai University	Tamaki, T (corresponding author), Tokai Univ, Sch Med, Muscle Physiol & Cell Biol Unit, Hiratsuka, Kanagawa 25912, Japan.	tamaki@is.icc.u-tokai.ac.jp	Tamaki, Tetsuro/I-2615-2019	Tamaki, Tetsuro/0000-0002-9071-049X; Nakajima, Nobuyuki/0000-0001-6307-032X	Tokai University School of Medicine	Tokai University School of Medicine	This work was supported by the grant 2013 Tokai University School of Medicine, Project Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102; Amoh Y, 2009, J CELL BIOCHEM, V107, P1016, DOI 10.1002/jcb.22204; Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Billings SD, 2004, MODERN PATHOL, V17, P141, DOI 10.1038/modpathol.3800042; Bremer M, 2011, GLIA, V59, P1022, DOI 10.1002/glia.21173; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Campbell WW, 2008, CLIN NEUROPHYSIOL, V119, P1951, DOI 10.1016/j.clinph.2008.03.018; Dezawa M, 2001, EUR J NEUROSCI, V14, P1771, DOI 10.1046/j.0953-816x.2001.01814.x; Dezawa Mari, 2005, Current Neuropharmacology, V3, P257, DOI 10.2174/157015905774322507; Dezawa Mari, 2002, Anatomical Science International, V77, P12, DOI 10.1046/j.0022-7722.2002.00012.x; Dubovy Petr, 2004, Anatomical Science International, V79, P198, DOI 10.1111/j.1447-073x.2004.00090.x; Dubovy P, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-58; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Gordon T, 2010, J COMMUN DISORD, V43, P265, DOI 10.1016/j.jcomdis.2010.04.003; Horie H, 1999, J NEUROSCI, V19, P9964; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pfister Bryan J., 2011, Critical Reviews in Biomedical Engineering, V39, P81, DOI 10.1615/CritRevBiomedEng.v39.i2.20; POPOVIC M, 1994, J NEUROPATH EXP NEUR, V53, P590, DOI 10.1097/00005072-199411000-00006; Popovic M, 2000, NEUROPATH APPL NEURO, V26, P221, DOI 10.1046/j.1365-2990.2000.00238.x; Pummi KP, 2006, J HISTOCHEM CYTOCHEM, V54, P53, DOI 10.1369/jhc.5A6671.2005; Radtke C, 2011, CELL TRANSPLANT, V20, P145, DOI 10.3727/096368910X522081; Robinson LR, 2000, MUSCLE NERVE, V23, P863, DOI 10.1002/(SICI)1097-4598(200006)23:6<863::AID-MUS4>3.0.CO;2-0; Robinson PP, 2004, J OROFAC PAIN, V18, P287; SCARAVILLI F, 1984, J ANAT, V139, P411; SCHRODER JM, 1993, CLIN NEUROL NEUROSUR, V95, pS78; Schroder K, 2011, ANTIOXID REDOX SIGN, V15, P915, DOI 10.1089/ars.2010.3533; Seddon HJ, 1943, J PHYSIOL-LONDON, V102, P191, DOI 10.1113/jphysiol.1943.sp004027; SUNDERLAND S, 1990, MUSCLE NERVE, V13, P771, DOI 10.1002/mus.880130903; Tamaki T, 2005, CIRCULATION, V112, P2857, DOI 10.1161/CIRCULATIONAHA.105.554832; Tamaki T, 2003, EXP CELL RES, V291, P83, DOI 10.1016/S0014-4827(03)00376-8; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Tamaki T, 2008, STEM CELLS DEV, V17, P653, DOI 10.1089/scd.2008.0070; Tamaki T, 2007, HISTOCHEM CELL BIOL, V128, P349, DOI 10.1007/s00418-007-0331-5; Tamaki T, 2007, STEM CELLS, V25, P2283, DOI 10.1634/stemcells.2006-0746; Tamaki T, 2010, CURR PHARM DESIGN, V16, P956, DOI 10.2174/138161210790883408; THOMAS PK, 1967, J ANAT, V101, P45; Tosaki T, 2008, EXP NEUROL, V213, P381, DOI 10.1016/j.expneurol.2008.06.017; Uemura T, 2012, BIOCHEM BIOPH RES CO, V419, P130, DOI 10.1016/j.bbrc.2012.01.154; Wang L, 2009, NEUROREPORT, V20, P663, DOI 10.1097/WNR.0b013e32832a09f8; Weerasuriya A, 2011, METHODS MOL BIOL, V686, P149, DOI 10.1007/978-1-60761-938-3_6; WEIS J, 1994, ACTA NEUROPATHOL, V88, P159; Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1046/j.1460-9568.2000.01312.x	45	31	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91257	10.1371/journal.pone.0091257	http://dx.doi.org/10.1371/journal.pone.0091257			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614849	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300102
J	Zhou, Y; Chen, LF; Fan, XZ; Bian, YB				Zhou, Yan; Chen, Lianfu; Fan, Xiuzhi; Bian, Yinbing			De Novo Assembly of Auricularia polytricha Transcriptome Using Illumina Sequencing for Gene Discovery and SSR Marker Identification	PLOS ONE			English	Article							COPRINUS-CINEREUS ENCODES; GENOME SEQUENCE; RNA-SEQ; MICROSATELLITE MARKERS; AGARICUS-BISPORUS; MUSHROOM; EXPRESSION; TOOL; PHOTORECEPTOR; EXPANSION	Auricularia polytricha (Mont.) Sacc., a type of edible black-brown mushroom with a gelatinous and modality-specific fruiting body, is in high demand in Asia due to its nutritional and medicinal properties. Illumina Solexa sequenceing technology was used to generate very large transcript sequences from the mycelium and the mature fruiting body of A. polytricha for gene discovery and molecular marker development. De novo assembly generated 36,483 ESTs with an N50 length of 636 bp. A total of 28,108 ESTs demonstrated significant hits with known proteins in the nr database, and 94.03% of the annotated ESTs showed the greatest similarity to A. delicata, a related species of A. polytricha. Functional categorization of the Gene Ontology (GO), Clusters of Orthologous Groups (COG) and Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathways revealed the conservation of genes involved in various biological processes in A. polytricha. Gene expression profile analysis indicated that a total of 2,057 ESTs were differentially expressed, including 1,020 ESTs that were up-regulated in the mycelium and 1,037 up-regulated in the fruiting body. Functional enrichment showed that the ESTs associated with biosynthesis, metabolism and assembly of proteins were more active in fruiting body development. The expression patterns of homologous transcription factors indicated that the molecular mechanisms of fruiting body formation and development were not exactly the same as for other agarics. Interestingly, an EST encoding tyrosinase was significantly up-regulated in the fruiting body, indicating that melanins accumulated during the processes of the formation of the black-brown color of the fruiting body in A. polytricha development. In addition, a total of 1,715 potential SSRs were detected in this transcriptome. The transcriptome analysis of A. polytricha provides valuable sequence resources and numerous molecular markers to facilitate further functional genomics studies and genetic researches on this fungus.	[Zhou, Yan; Chen, Lianfu; Fan, Xiuzhi; Bian, Yinbing] Huazhong Agr Univ, Inst Appl Mycol, Wuhan, Hubei, Peoples R China; [Zhou, Yan; Chen, Lianfu; Fan, Xiuzhi; Bian, Yinbing] Huazhong Agr Univ, Minist Agr, Key Lab Agromicrobial Resource Comprehens Utiliza, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Bian, YB (corresponding author), Huazhong Agr Univ, Inst Appl Mycol, Wuhan, Hubei, Peoples R China.	bianyinbinghzaucn@yahoo.com			National Natural Science Foundation of China [31200079]; Chinese Postdoctoral Research Fellowship [20110491164]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Research Fellowship	This work was supported by the National Natural Science Foundation of China (31200079) and the Chinese Postdoctoral Research Fellowship (20110491164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Razak DL, 2013, APPL MICROBIOL BIOT, V97, P3207, DOI 10.1007/s00253-012-4135-8; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Casselton LA, 1998, MICROBIOL MOL BIOL R, V62, P55, DOI 10.1128/MMBR.62.1.55-70.1998; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corrochano LM, 2011, IMA FUNGUS, V2, P25, DOI 10.5598/imafungus.2011.02.01.04; da Maia Luciano Carlos, 2008, Int J Plant Genomics, V2008, P412696, DOI 10.1155/2008/412696; ENDO H, 1994, GENE, V139, P117, DOI 10.1016/0378-1119(94)90533-9; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Gawlik-Dziki U, 2008, FOOD CHEM, V107, P129, DOI 10.1016/j.foodchem.2007.07.068; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kamada T, 2010, FUNGAL GENET BIOL, V47, P917, DOI 10.1016/j.fgb.2010.05.003; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KIRK PM, 2008, DICT FUNGI, P549; Kues U, 2000, MICROBIOL MOL BIOL R, V64, P316, DOI 10.1128/MMBR.64.2.316-353.2000; Linden H, 1997, EMBO J, V16, P98, DOI 10.1093/emboj/16.1.98; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Metzgar D, 2000, GENOME RES, V10, P72; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muraguchi H, 2008, FUNGAL GENET BIOL, V45, P890, DOI 10.1016/j.fgb.2007.11.004; Murata Y, 1998, GENETICS, V149, P1753; Ohm RA, 2011, MOL MICROBIOL, V81, P1433, DOI 10.1111/j.1365-2958.2011.07776.x; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Park J, 2008, BIOINFORMATICS, V24, P1024, DOI 10.1093/bioinformatics/btn058; Qian J, 2013, GENE, V512, P331, DOI 10.1016/j.gene.2012.09.127; RAPER CA, 1972, MYCOLOGIA, V64, P1088, DOI 10.2307/3758075; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Sano H, 2007, BIOSCI BIOTECH BIOCH, V71, P2206, DOI 10.1271/bbb.70170; Sano H, 2009, FUNGAL GENET BIOL, V46, P333, DOI 10.1016/j.fgb.2009.01.001; Soler-Rivas C, 2001, PHYSIOL MOL PLANT P, V58, P95, DOI 10.1006/pmpp.2000.0312; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Tang LH, 2013, APPL MICROBIOL BIOT, V97, P4977, DOI 10.1007/s00253-013-4832-y; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Terashima K, 2005, GENETICS, V171, P101, DOI 10.1534/genetics.104.040048; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056686; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wichers HJ, 2003, APPL MICROBIOL BIOT, V61, P336, DOI 10.1007/s00253-002-1194-2; Wu Q, 2010, INT J BIOL MACROMOL, V46, P284, DOI 10.1016/j.ijbiomac.2010.01.016; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038381, 10.1371/journal.pone.0051853]; Yu GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044031; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116; Zheng Y, 2008, FUNGAL GENET BIOL, V45, P1340, DOI 10.1016/j.fgb.2008.07.012; Zhong MT, 2013, BIOCHEM BIOPH RES CO, V431, P111, DOI 10.1016/j.bbrc.2012.12.065	53	34	43	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91740	10.1371/journal.pone.0091740	http://dx.doi.org/10.1371/journal.pone.0091740			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626227	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300131
J	Acosta, SA; Tajiri, N; Shinozuka, K; Ishikawa, H; Sanberg, PR; Sanchez-Ramos, J; Song, SJ; Kaneko, Y; Borlongan, CV				Acosta, Sandra A.; Tajiri, Naoki; Shinozuka, Kazutaka; Ishikawa, Hiroto; Sanberg, Paul R.; Sanchez-Ramos, Juan; Song, Shijie; Kaneko, Yuji; Borlongan, Cesar V.			Combination Therapy of Human Umbilical Cord Blood Cells and Granulocyte Colony Stimulating Factor Reduces Histopathological and Motor Impairments in an Experimental Model of Chronic Traumatic Brain Injury	PLOS ONE			English	Article							MARROW STROMAL CELLS; CEREBRAL-ARTERY OCCLUSION; ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; FACTOR G-CSF; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTORS; COLLAGEN SCAFFOLDS; MILD HYPOTHERMIA; PROGENITOR CELLS	Traumatic brain injury (TBI) is associated with neuro-inflammation, debilitating sensory-motor deficits, and learning and memory impairments. Cell-based therapies are currently being investigated in treating neurotrauma due to their ability to secrete neurotrophic factors and anti-inflammatory cytokines that can regulate the hostile milieu associated with chronic neuroinflammation found in TBI. In tandem, the stimulation and mobilization of endogenous stem/progenitor cells from the bone marrow through granulocyte colony stimulating factor (G-CSF) poses as an attractive therapeutic intervention for chronic TBI. Here, we tested the potential of a combined therapy of human umbilical cord blood cells (hUCB) and G-CSF at the acute stage of TBI to counteract the progressive secondary effects of chronic TBI using the controlled cortical impact model. Four different groups of adult Sprague Dawley rats were treated with saline alone, G-CSF+saline, hUCB+saline or hUCB+G-CSF, 7-days post CCI moderate TBI. Eight weeks after TBI, brains were harvested to analyze hippocampal cell loss, neuroinflammatory response, and neurogenesis by using immunohistochemical techniques. Results revealed that the rats exposed to TBI treated with saline exhibited widespread neuroinflammation, impaired endogenous neurogenesis in DG and SVZ, and severe hippocampal cell loss. hUCB monotherapy suppressed neuroinflammation, nearly normalized the neurogenesis, and reduced hippocampal cell loss compared to saline alone. G-CSF monotherapy produced partial and short-lived benefits characterized by low levels of neuroinflammation in striatum, DG, SVZ, and corpus callosum and fornix, a modest neurogenesis, and a moderate reduction of hippocampal cells loss. On the other hand, combined therapy of hUCB+G-CSF displayed synergistic effects that robustly dampened neuroinflammation, while enhancing endogenous neurogenesis and reducing hippocampal cell loss. Vigorous and long-lasting recovery of motor function accompanied the combined therapy, which was either moderately or short-lived in the monotherapy conditions. These results suggest that combined treatment rather than monotherapy appears optimal for abrogating histophalogical and motor impairments in chronic TBI.	[Acosta, Sandra A.; Tajiri, Naoki; Shinozuka, Kazutaka; Ishikawa, Hiroto; Sanberg, Paul R.; Kaneko, Yuji; Borlongan, Cesar V.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Sanberg, Paul R.] Univ S Florida, Off Res & Innovat, Tampa, FL USA; [Sanchez-Ramos, Juan; Song, Shijie] James Haley Vet Affairs Med Ctr, Tampa, FL USA; [Sanchez-Ramos, Juan; Song, Shijie] Univ S Florida, Dept Neurol, Tampa, FL 33620 USA; [Sanchez-Ramos, Juan; Song, Shijie] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Borlongan, CV (corresponding author), Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Sanchez-Ramos, Juan/O-7870-2014; Borlongan, Cesar/I-5696-2012; Tajiri, Naoki/K-1230-2012; Sanchez-Ramos, Juan/A-1188-2009	Borlongan, Cesar/0000-0002-2966-9782; Tajiri, Naoki/0000-0003-2189-662X; Sanberg, Paul/0000-0001-9130-4592; Sanchez-Ramos, Juan/0000-0002-3391-7857; Shinozuka, Kazutaka/0000-0002-6435-4460; Ishikawa, Hiroto/0000-0003-0760-7203	Department of Defense [W81XWH-11-1-0634]; University of South Florida Signature Interdisciplinary Program in Neuroscience funds; University of South Florida; Veterans Administration Reintegration Funds; University of South Florida Neuroscience Collaborative Program; National Institutes of Health [1R01NS071956-01A1]; James and Esther King Biomedical Research Foundation [1KG01-33966]; SanBio Inc.; KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071956] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001407] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); University of South Florida Signature Interdisciplinary Program in Neuroscience funds; University of South Florida; Veterans Administration Reintegration Funds; University of South Florida Neuroscience Collaborative Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James and Esther King Biomedical Research Foundation; SanBio Inc.; KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	Financial support for this study was provided by the Department of Defense W81XWH-11-1-0634, the University of South Florida Signature Interdisciplinary Program in Neuroscience funds, the University of South Florida and Veterans Administration Reintegration Funds, and the University of South Florida Neuroscience Collaborative Program. CVB and PRS serve as consultant and founder, respectively, of Saneron CCEL Therapeutics, Inc. CVB is funded by the National Institutes of Health 1R01NS071956-01A1, James and Esther King Biomedical Research Foundation 1KG01-33966, SanBio Inc., KMPHC and NeuralStem Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Bakhtiary Mehrdad, 2010, Iranian Biomedical Journal, V14, P142; Bath PMW, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005207.pub4; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Borlongan CV, 2011, LEUKEMIA, V25, P1674, DOI 10.1038/leu.2011.167; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Campbell K, 2013, BRAIN RES, V1502, P47, DOI 10.1016/j.brainres.2013.01.038; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Cui LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064684; Dasari VR, 2008, NEUROBIOL DIS, V32, P486, DOI 10.1016/j.nbd.2008.09.005; England TJ, 2012, STROKE, V43, P405, DOI 10.1161/STROKEAHA.111.636449; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Fabrizio KS, 2010, NURS CLIN N AM, V45, P569, DOI 10.1016/j.cnur.2010.06.003; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Guo XH, 2012, INT J NEUROSCI, V122, P723, DOI 10.3109/00207454.2012.716109; Hartung T, 1998, Curr Opin Hematol, V5, P221, DOI 10.1097/00062752-199805000-00013; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Imamura K, 2005, ACTA NEUROPATHOL, V109, P141, DOI 10.1007/s00401-004-0919-y; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Iskander A, 2013, STEM CELL TRANSL MED, V2, P703, DOI 10.5966/sctm.2013-0066; Joo YD, 2011, CYTOKINE, V54, P36, DOI 10.1016/j.cyto.2010.12.020; Jung KH, 2006, BRAIN RES, V1073, P190, DOI 10.1016/j.brainres.2005.12.037; Khatibi NH, 2011, ACTA NEUROCHIR SUPPL, V111, P265, DOI 10.1007/978-3-7091-0693-8_44; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Lewis FD, 2013, J SPEC OPER MED, V13, P56; Liu CY, 2008, NEUROSURGERY, V63, pN12, DOI 10.1227/01.NEU.0000339457.01711.3B; Lopes FRP, 2013, NEUROSCIENCE, V230, P184, DOI 10.1016/j.neuroscience.2012.10.025; Loving CL, 2013, BIOLOGICALS, V41, P368, DOI 10.1016/j.biologicals.2013.07.001; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Lyman GH, 2013, ANN ONCOL, V24, P2475, DOI 10.1093/annonc/mdt226; Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2013, J NEUROSURG, V118, P381, DOI 10.3171/2012.11.JNS12753; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; Maurer MH, 2008, CURR MED CHEM, V15, P1407, DOI 10.2174/092986708784567671; Minnerup Jens, 2009, Exp Transl Stroke Med, V1, P2, DOI 10.1186/2040-7378-1-2; Morita Y, 2007, NEUROSCI RES, V58, P356, DOI 10.1016/j.neures.2007.04.006; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Ozen LJ, 2012, ARCH CLIN NEUROPSYCH, V27, P85, DOI 10.1093/arclin/acr087; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Popa-Wagner A, 2010, STROKE, V41, P1027, DOI 10.1161/STROKEAHA.109.575621; Prakash A, 2013, PHARMACOL BIOCHEM BE, V110, P46, DOI 10.1016/j.pbb.2013.05.015; Sakowitz OW, 2006, ACTA NEUROCHIR SUPPL, V96, P139; Sanberg PR, 2012, PROG BRAIN RES, V201, P99, DOI 10.1016/B978-0-444-59544-7.00006-8; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Sasaki A, 2008, BRAIN RES, V1214, P159, DOI 10.1016/j.brainres.2008.02.084; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Shahaduzzaman M, 2013, AGE, V35, P2071, DOI 10.1007/s11357-012-9496-5; Sheibani N, 2004, CRIT CARE MED, V32, P2274, DOI 10.1097/01.CCM.0000145998.11686.ED; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Stachura DL, 2013, BLOOD; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Tajiri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043779; Takahashi K, 2008, BRAIN RES, V1234, P172, DOI 10.1016/j.brainres.2008.07.086; Toth ZE, 2008, BLOOD, V111, P5544, DOI 10.1182/blood-2007-10-119073; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Tsuji T, 1999, GROWTH FACTORS, V16, P225, DOI 10.3109/08977199909002132; Tu Y, 2012, J NEUROTRAUM, V29, P2393, DOI 10.1089/neu.2012.2374; Walker PA, 2012, SURGERY, V152, P790, DOI 10.1016/j.surg.2012.06.006; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Willing AE, 2003, CELL TRANSPLANT, V12, P449, DOI 10.3727/000000003108746885; Wong D, 2013, BRAIN INJURY, V27, P1377, DOI 10.3109/02699052.2013.823662; Yang DY, 2010, NEUROL RES, V32, P1041, DOI 10.1179/016164110X12807570510013; Yang M, 2010, CELL TRANSPLANT, V19, P1073, DOI 10.3727/096368910X503415; Yang YN, 2013, PEDIATR NEONATOL, V54, P380, DOI 10.1016/j.pedneo.2013.04.011; Yasuda Y, 2007, BRAIN RES, V1138, P196, DOI 10.1016/j.brainres.2006.12.054; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang C, 2006, NEUROSCIENCE, V141, P687, DOI 10.1016/j.neuroscience.2006.04.054; Zhao Li R, 2013, Recent Pat CNS Drug Discov, V8, P2; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001	83	72	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90953	10.1371/journal.pone.0090953	http://dx.doi.org/10.1371/journal.pone.0090953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621603	gold, Green Published, Green Submitted			2022-12-27	WOS:000332845300037
J	Arthanari, Y; Heintzen, C; Griffiths-Jones, S; Crosthwaite, SK				Arthanari, Yamini; Heintzen, Christian; Griffiths-Jones, Sam; Crosthwaite, Susan K.			Natural Antisense Transcripts and Long Non-Coding RNA in Neurospora crassa	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; FUNCTIONAL ANNOTATION; BUDDING YEAST; HUMAN GENOME; SEQUENCE; EXPRESSION; IDENTIFICATION; REVEALS; GENES; ARABIDOPSIS	The prevalence of long non-coding RNAs (lncRNA) and natural antisense transcripts (NATs) has been reported in a variety of organisms. While a consensus has yet to be reached on their global importance, an increasing number of examples have been shown to be functional, regulating gene expression at the transcriptional and post-transcriptional level. Here, we use RNA sequencing data from the ABI SOLiD platform to identify lncRNA and NATs obtained from samples of the filamentous fungus Neurospora crassa grown under different light and temperature conditions. We identify 939 novel lncRNAs, of which 477 are antisense to annotated genes. Across the whole dataset, the extent of overlap between sense and antisense transcripts is large: 371 sense/antisense transcripts are complementary over 500 nts or more and 236 overlap by more than 1000 nts. Most prevalent are 3' end overlaps between convergently transcribed sense/antisense pairs, but examples of divergently transcribed pairs and nested transcripts are also present. We confirm the expression of a subset of sense/antisense transcript pairs by qPCR. We examine the size, types of overlap and expression levels under the different environmental stimuli of light and temperature, and identify 11 lncRNAs that are up-regulated in response to light. We also find differences in transcript length and the position of introns between protein-coding transcripts that have antisense expression and transcripts with no antisense expression. These results demonstrate the ability of N. crassa lncRNAs and NATs to be regulated by different environmental stimuli and provide the scope for further investigation into the function of NATs.	[Arthanari, Yamini; Heintzen, Christian; Griffiths-Jones, Sam; Crosthwaite, Susan K.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Griffiths-Jones, S (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg, Manchester, Lancs, England.	sam.griffiths-jones@manchester.ac.uk; susan.crosthwaite@manchester.ac.uk	Griffiths-Jones, Sam/H-2998-2014	Griffiths-Jones, Sam/0000-0001-6043-807X	Leverhulme Trust [RPG-091]; BBSRC [BB/F012055/1]; Biotechnology and Biological Sciences Research Council [BB/F012055/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors would like to acknowledge the financial support of The Leverhulme Trust (RPG-091, to SKC and SG-J) and a BBSRC project grant awarded to CH (BB/F012055/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], NEUR CRASS SEQ PROJ; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; Belden WJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002166; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Dang YK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003761; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Davis RH, 2002, NAT REV GENET, V3, P397, DOI 10.1038/nrg797; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Donaldson ME, 2012, MOL MICROBIOL, V85, P405, DOI 10.1111/j.1365-2958.2012.08125.x; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Goodman AJ, 2013, MOL BIOL EVOL, V30, P409, DOI 10.1093/molbev/mss240; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hobson DJ, 2012, MOL CELL, V48, P365, DOI 10.1016/j.molcel.2012.08.027; Honda S, 2009, GENETICS, V182, P11, DOI 10.1534/genetics.108.098707; Jen CH, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r51; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kramer C, 2003, NATURE, V421, P948, DOI 10.1038/nature01427; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li KG, 2010, ONCOTARGET, V1, P447, DOI 10.18632/oncotarget.178; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McKinlay A, 2011, G3-GENES GENOM GENET, V1, P549, DOI 10.1534/g3.111.000810; Munroe SH, 2006, CELL MOL LIFE SCI, V63, P2102, DOI 10.1007/s00018-006-6070-2; Murray SC, 2012, NUCLEIC ACIDS RES, V40, P2432, DOI 10.1093/nar/gkr1121; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Ni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015271; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Osato N, 2007, GENETICS, V176, P1299, DOI 10.1534/genetics.106.069484; Palma-Guerrero J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003669; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Read ND., 1994, CELLULAR NATURE MULT, P254; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Salato VK, 2010, RNA BIOL, V7, P179, DOI 10.4161/rna.7.2.11182; Sasson A, 2010, BIOINFORMATICS, V26, P849, DOI 10.1093/bioinformatics/btq045; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Smith CA, 2008, CURR GENET, V54, P241, DOI 10.1007/s00294-008-0215-9; Steigele S, 2005, NUCLEIC ACIDS RES, V33, P5034, DOI 10.1093/nar/gki804; Sun M, 2005, NUCLEIC ACIDS RES, V33, P5533, DOI 10.1093/nar/gki852; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang DN, 2013, INT J MOL SCI, V14, P9018, DOI 10.3390/ijms14059018; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Yan B, 2012, DNA CELL BIOL, V31, pS34, DOI 10.1089/dna.2011.1544; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87; Young RS, 2013, ESSAYS BIOCHEM, V54, P113, DOI [10.1042/bse0540113, 10.1042/BSE0540113]; Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020	61	34	35	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91353	10.1371/journal.pone.0091353	http://dx.doi.org/10.1371/journal.pone.0091353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621812	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300080
J	Dessilly, G; Elens, L; Panin, N; Capron, A; Decottignies, A; Demoulin, JB; Haufroid, V				Dessilly, Geraldine; Elens, Laure; Panin, Nadtha; Capron, Arnaud; Decottignies, Anabelle; Demoulin, Jean-Baptiste; Haufroid, Vincent			ABCB1 1199G > A Genetic Polymorphism (Rs2229109) Influences the Intracellular Accumulation of Tacrolimus in HEK293 and K562 Recombinant Cell Lines	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; BINDING CASSETTE TRANSPORTERS; SOLID-ORGAN TRANSPLANTATION; MULTIDRUG-RESISTANCE GENE; BLOOD MONONUCLEAR-CELLS; HUMAN MDR1 GENE; P-GLYCOPROTEIN; DRUG DISPOSITION; EXPRESSION; IMPACT	Objective: ATP-binding cassette, subfamily B, member 1 (ABCB1) transporter, or P-glycoprotein, is an efflux protein implicated in the absorption and the distribution of various compounds, including tacrolimus and cyclosporine A. In vivo studies suggest an association between the ABCB1 1199G>A single nucleotide polymorphism (SNP) and tacrolimus intracellular accumulation. The aim of the present experimental study was to clarify in vitro the impact of the coding ABCB1 1199G>A SNP on ABCB1 transport activity towards both immunosuppressive drugs. Method: Two recombinant cell lines, i.e. Human Embryonic Kidney (HEK293) and Human Myelogenous Leukemia (K562) cells, overexpressing ABCB1 carrying either the wild-type allele (1199G) or its mutated counterpart (1199A), were generated. The impact of the 1199G>A SNP on ABCB1 activity towards rhodamine (Rh123), doxorubicin, vinblastine, tacrolimus and cyclosporine A was assessed by accumulation, cytotoxicity and/or kinetic experiments. Results: Tacrolimus accumulation was strongly decreased in cells overexpressing the wild-type protein (1199G) compared to control cells, confirming the ability of ABCB1 to transport tacrolimus. By contrast, overexpression of the variant protein (1199A) had nearly no effect on tacrolimus intracellular accumulation whatever the model used and the concentration tested. Unlike tacrolimus, our results also indicate that cyclosporine A, Rh123 and doxorubicin are transported in a similar extent by the wild-type and variant ABCB1 proteins while the variant protein seems to be more efficient for the transport of vinblastine. Conclusion: ABCB1 encoded by the 1199G wild-type allele transports more efficiently tacrolimus in comparison to the 1199A variant protein. This observation indicates that the amino-acid substitution (Ser400Asn) encoded by the 1199A allele drastically decreases the ability of ABCB1 to drive the efflux of tacrolimus in a substrate-specific manner, in agreement with our previously published clinical data. Our study emphasizes the importance of the ABCB1 1199G>A polymorphism for ABCB1 activity and its potential to explain differences in drug response.	[Dessilly, Geraldine; Panin, Nadtha; Haufroid, Vincent] Catholic Univ Louvain, Inst Rech Expt & Clin, Louvain Ctr Toxicol & Appl Pharmacol, B-1200 Brussels, Belgium; [Elens, Laure] Catholic Univ Louvain, Louvain Drug Res Inst, B-1200 Brussels, Belgium; [Capron, Arnaud; Haufroid, Vincent] Catholic Univ Louvain, Clin Univ St Luc, Dept Clin Chem, B-1200 Brussels, Belgium; [Decottignies, Anabelle; Demoulin, Jean-Baptiste] Catholic Univ Louvain, De Duve Inst, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain	Haufroid, V (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, Louvain Ctr Toxicol & Appl Pharmacol, B-1200 Brussels, Belgium.	vincent.haufroid@uclouvain.be		Demoulin, Jean-Baptiste/0000-0002-8016-6689; Elens, Laure/0000-0002-0039-3583	Fonds National de la Recherche Scientifique (FNRS)- Televie, Belgium [7.4539.13]	Fonds National de la Recherche Scientifique (FNRS)- Televie, Belgium(Fonds de la Recherche Scientifique - FNRS)	Geraldine Dessilly (GD) is a doctoral researcher with the Fonds National de la Recherche Scientifique (FNRS)- Televie, Belgium (credit no7.4539.13). Laure Elens (LE) is a post-doctoral researcher with the Fonds National de la Recherche Scientifique (FNRS, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beringer PM, 2005, ANN PHARMACOTHER, V39, P1097, DOI 10.1345/aph.1E614; Bodor M, 2005, AAPS J, V7, pE1, DOI 10.1208/aapsj070101; Callaghan R, 2008, J CLIN PHARMACOL, V48, P365, DOI 10.1177/0091270007311568; Capron A, 2010, PHARMACOGENOMICS, V11, P703, DOI [10.2217/pgs.10.43, 10.2217/PGS.10.43]; Capron A, 2009, THER DRUG MONIT, V31, P178, DOI 10.1097/FTD.0b013e3181905aaa; Cascorbi I, 2001, CLIN PHARMACOL THER, V69, P169, DOI 10.1067/mcp.2001.114164; Cascorbi I, 2006, PHARMACOL THERAPEUT, V112, P457, DOI 10.1016/j.pharmthera.2006.04.009; CHIN JE, 1989, MOL CELL BIOL, V9, P3808, DOI 10.1128/MCB.9.9.3808; Choudhuri S, 2006, INT J TOXICOL, V25, P231, DOI 10.1080/10915810600746023; CORNWELL MM, 1986, P NATL ACAD SCI USA, V83, P3847, DOI 10.1073/pnas.83.11.3847; Crettol S, 2008, PHARMACOGENET GENOM, V18, P307, DOI 10.1097/FPC.0b013e3282f7046f; Crouthamel MH, 2006, J PHARM SCI-US, V95, P2767, DOI 10.1002/jps.20743; Czyzewski K, 2009, NEOPLASMA, V56, P202; Elens L, 2011, PHARMACOGENET GENOM, V21, P884, DOI 10.1097/FPC.0b013e32834d672b; Fardel O, 1996, GEN PHARMACOL, V27, P1283, DOI 10.1016/S0306-3623(96)00081-X; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Haufroid V, 2011, CURR DRUG TARGETS, V12, P631, DOI 10.2174/138945011795378487; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; HORIO M, 1988, P NATL ACAD SCI USA, V85, P3580, DOI 10.1073/pnas.85.10.3580; JUSKO WJ, 1995, THER DRUG MONIT, V17, P606, DOI 10.1097/00007691-199512000-00011; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Lepper ER, 2005, PHARMACOGENOMICS, V6, P115, DOI 10.1517/14622416.6.2.115; Li Yan-Hong, 2006, Acta Genetica Sinica, V33, P93, DOI 10.1016/S0379-4172(06)60027-9; SAEKI T, 1993, J BIOL CHEM, V268, P6077; Sakaeda T, 2003, PHARMACOGENOMICS, V4, P397, DOI 10.1517/phgs.4.4.397.22747; Salama NN, 2006, J PHARM SCI-US, V95, P2293, DOI 10.1002/jps.20717; Schwab M, 2003, ANNU REV PHARMACOL, V43, P285, DOI 10.1146/annurev.pharmtox.43.100901.140233; Scott LJ, 2003, DRUGS, V63, P1247, DOI 10.2165/00003495-200363120-00006; Staatz CE, 2004, CLIN PHARMACOKINET, V43, P623, DOI 10.2165/00003088-200443100-00001; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; Vallet CM, 2011, INT J ANTIMICROB AG, V38, P249, DOI 10.1016/j.ijantimicag.2011.05.011; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; Wallemacq P, 2009, THER DRUG MONIT, V31, P139, DOI 10.1097/FTD.0b013e318198d092; Woodahl EL, 2005, AIDS, V19, P1617, DOI 10.1097/01.aids.0000183626.74299.77; Woodahl EL, 2004, J PHARMACOL EXP THER, V310, P1199, DOI 10.1124/jpet.104.065383; Woodahl EL, 2009, CANCER CHEMOTH PHARM, V64, P183, DOI 10.1007/s00280-008-0906-4; Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI 10.1080/00498250701867889 	38	35	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91555	10.1371/journal.pone.0091555	http://dx.doi.org/10.1371/journal.pone.0091555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621983	gold, Green Submitted, Green Published			2022-12-27	WOS:000332845300103
J	Han, DH; Yoo, HJ; Kim, BN; McMahon, W; Renshaw, PF				Han, Doug Hyun; Yoo, Hee Jeong; Kim, Bung Nyun; McMahon, William; Renshaw, Perry F.			Brain Activity of Adolescents with High Functioning Autism in Response to Emotional Words and Facial Emoticons	PLOS ONE			English	Article							FUSIFORM FACE AREA; COMPUTER-MEDIATED COMMUNICATION; NONVERBAL-COMMUNICATION; SPECTRUM DISORDERS; BIOLOGICAL MOTION; JOINT ATTENTION; PERCEPTION; CHILDREN; COMPREHENSION; LANGUAGE	Studies of social dysfunction in patients with autism spectrum disorder (ASD) have generally focused on the perception of emotional words and facial affect. Brain imaging studies have suggested that the fusiform gyrus is associated with both the comprehension of language and face recognition. We hypothesized that patients with ASD would have decreased ability to recognize affect via emotional words and facial emoticons, relative to healthy comparison subjects. In addition, we expected that this decreased ability would be associated with altered activity of the fusiform gyrus in patients with ASD. Ten male adolescents with ASDs and ten age and sex matched healthy comparison subjects were enrolled in this case-control study. The diagnosis of autism was further evaluated with the Autism Diagnostic Observation Schedule. Brain activity was assessed using functional magnetic resonance imaging (fMRI) in response to emotional words and facial emoticon presentation. Sixty emotional words (45 pleasant words +15 unpleasant words) were extracted from a report on Korean emotional terms and their underlying dimensions. Sixty emoticon faces (45 pleasant faces +15 unpleasant faces) were extracted and modified from on-line sites. Relative to healthy comparison subjects, patients with ASD have increased activation of fusiform gyrus in response to emotional aspects of words. In contrast, patients with ASD have decreased activation of fusiform gyrus in response to facial emoticons, relative to healthy comparison subjects. We suggest that patients with ASD are more familiar with word descriptions than facial expression as depictions of emotion.	[Han, Doug Hyun] Chung Ang Univ Hosp, Dept Psychiat, Seoul, South Korea; [Yoo, Hee Jeong] Seoul Natl Bundang Hosp, Dept Psychiat, Seoul, South Korea; [Kim, Bung Nyun] Seoul Natl Hosp, Dept Psychiat, Seoul, South Korea; [McMahon, William] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Renshaw, Perry F.] Univ Utah, Inst Brain, Salt Lake City, UT USA	Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University Hospital; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Han, DH (corresponding author), Chung Ang Univ Hosp, Dept Psychiat, Seoul, South Korea.	hduk@yahoo.com	Renshaw, Perry/O-1384-2018		Korean Game Culture Foundation; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A120013]; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA031247] Funding Source: NIH RePORTER	Korean Game Culture Foundation; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Korean Game Culture Foundation and a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2013, SOC COGN AFFECT NEUR; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Buchsbaum MS, 2007, AM J PSYCHIAT, V164, P1072, DOI 10.1176/appi.ajp.164.7.1072; Carper RA, 2005, BIOL PSYCHIAT, V57, P126, DOI 10.1016/j.biopsych.2004.11.005; Charman T, 2003, PHILOS T R SOC B, V358, P315, DOI 10.1098/rstb.2002.1199; Chugani DC, 1997, ANN NEUROL, V42, P666, DOI 10.1002/ana.410420420; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Derks D, 2008, CYBERPSYCHOL BEHAV, V11, P99, DOI 10.1089/cpb.2007.9926; Dichter GS, 2009, SOC COGN AFFECT NEUR, V4, P215, DOI 10.1093/scan/nsp017; Freitag CM, 2008, NEUROPSYCHOLOGIA, V46, P1480, DOI 10.1016/j.neuropsychologia.2007.12.025; Ghosh Shantanu, 2010, Indian J Radiol Imaging, V20, P182, DOI 10.4103/0971-3026.69352; Grelotti DJ, 2002, DEV PSYCHOBIOL, V40, P213, DOI 10.1002/dev.10028; HAPPE FGE, 1993, COGNITION, V48, P101, DOI 10.1016/0010-0277(93)90026-R; Hauck M, 1998, CHILD NEUROPSYCHOL, V4, P187, DOI 10.1076/chin.4.3.187.3174; Herrington JD, 2011, BRAIN COGNITION, V77, P372, DOI 10.1016/j.bandc.2011.09.001; HOBSON RP, 1988, BRIT J PSYCHOL, V79, P441, DOI 10.1111/j.2044-8295.1988.tb02745.x; HOBSON RP, 1986, J CHILD PSYCHOL PSYC, V27, P321, DOI 10.1111/j.1469-7610.1986.tb01836.x; Huang J, 2008, BRAIN LANG, V104, P10, DOI 10.1016/j.bandl.2007.01.003; Kaiser MD, 2010, AUTISM RES, V3, P191, DOI 10.1002/aur.137; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kikuchi Y, 2011, J AUTISM DEV DISORD, V41, P629, DOI 10.1007/s10803-010-1082-z; Kim YS, 2004, YONSEI MED J, V45, P81, DOI 10.3349/ymj.2004.45.1.81; Koldewyn K, 2011, DEVELOPMENTAL SCI, V14, P1075, DOI 10.1111/j.1467-7687.2011.01058.x; Lo SK, 2008, CYBERPSYCHOL BEHAV, V11, P595, DOI 10.1089/cpb.2007.0132; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Mason RA, 2008, NEUROPSYCHOLOGIA, V46, P269, DOI 10.1016/j.neuropsychologia.2007.07.018; 박인조, 2005, [Korean Journal of Social and Personality Psychology, 한국심리학회지: 사회및성격], V19, P109; Minshew NJ, 2010, CURR OPIN NEUROL, V23, P124, DOI 10.1097/WCO.0b013e32833782d4; MUNDY P, 1990, J AUTISM DEV DISORD, V20, P115, DOI 10.1007/BF02206861; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; Rosset DB, 2008, J AUTISM DEV DISORD, V38, P919, DOI 10.1007/s10803-007-0465-2; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Sahyoun CP, 2010, NEUROPSYCHOLOGIA, V48, P86, DOI 10.1016/j.neuropsychologia.2009.08.013; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; SCOTT DW, 1985, PSYCHOL MED, V15, P683, DOI 10.1017/S0033291700031548; Suzuki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020470; Tager-Flusberg H, 2003, PHILOS T R SOC B, V358, P303, DOI 10.1098/rstb.2002.1198; Talairach I., 1988, COPLANAR STEREOTACTI; Tesink CMJY, 2009, BRAIN, V132, P1941, DOI 10.1093/brain/awp103; van der Geest JN, 2002, J AUTISM DEV DISORD, V32, P69, DOI 10.1023/A:1014832420206; Wang AT, 2006, BRAIN, V129, P932, DOI 10.1093/brain/awl032; Yeom TH, 1992, KOREAN VERSION WECHS; Yoo H. J, 2008, SOCIAL COMMUNICATION; Yuasa M, 2007, IEEJ T ELECT INFORM, V127, P1865; Yuasa M, 2006, EMOTICONS CONVEY EMO; Yuasa M, 2011, ELECTR COMMUN JPN, V94, P17, DOI 10.1002/ecj.10311	52	11	12	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91214	10.1371/journal.pone.0091214	http://dx.doi.org/10.1371/journal.pone.0091214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621866	gold, Green Submitted, Green Published			2022-12-27	WOS:000332845300065
J	Lega, JC; Bertoletti, L; Gremillet, C; Chapelle, C; Mismetti, P; Cucherat, M; Vital-Durand, D; Laporte, S				Lega, Jean-Christophe; Bertoletti, Laurent; Gremillet, Cyrielle; Chapelle, Celine; Mismetti, Patrick; Cucherat, Michel; Vital-Durand, Denis; Laporte, Silvy		Meta-Embol Grp	Consistency of Safety and Efficacy of New Oral Anticoagulants across Subgroups of Patients with Atrial Fibrillation	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; OPTIMAL SEARCH STRATEGIES; RANDOMIZED EVALUATION; STROKE RISK; WARFARIN; DABIGATRAN; APIXABAN; PREVENTION; VALIDATION; GUIDELINES	Aims: The well-known limitations of vitamin K antagonists (VKA) led to development of new oral anticoagulants (NOAC) in non-valvular atrial fibrillation (NVAF). The aim of this meta-analysis was to determine the consistency of treatment effects of NOAC irrespective of age, comorbidities, or prior VKA exposure. Methods and Results: All randomized, controlled phase III trials comparing NOAC to VKA up to October 2012 were eligible provided their results (stroke/systemic embolism (SSE) and major bleeding (MB)) were reported according to age (<= or >75 years), renal function, CHADS2 score, presence of diabetes mellitus or heart failure, prior VKA use or previous cerebrovascular events. Interactions were considered significant at p<0.05. Three studies (50,578 patients) were included, respectively evaluating apixaban, rivaroxaban, and dabigatran versus warfarin. A trend towards interaction with heart failure (p = 0.08) was observed with respect to SSE reduction, this being greater in patients not presenting heart failure (RR = 0.76 [0.67-0.86]) than in those with heart failure (RR = 0.90 [0.78-1.04]); Significant interaction (p = 0.01) with CHADS2 score was observed, NOAC achieving a greater reduction in bleeding risk in patients with a score of 0-1 (RR 0.67 CI 0.57-0.79) than in those with a score >= 2 (RR 0.85 CI 0.74-0.98). Comparison of MB in patients with (RR 0.97 CI 0.79-1.18) and without (RR 0.76 CI 0.65-0.88) diabetes mellitus showed a similar trend (p = 0.06). No other interactions were found. All subgroups derived benefit from NOA in terms of SSE or MB reduction. Conclusions: NOAC appeared to be more effective and safer than VKA in reducing SSE or MB irrespective of patient comorbidities. Thromboembolism risk, evaluated by CHADS2 score and, to a lesser extent, diabetes mellitus modified the treatment effects of NOAC without complete loss of benefit with respect to MB reduction.	[Lega, Jean-Christophe; Vital-Durand, Denis] Univ Lyon 1, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Med Interne & Vasc, F-69365 Lyon, France; [Lega, Jean-Christophe; Bertoletti, Laurent; Mismetti, Patrick; Laporte, Silvy] Univ St Etienne, EA3065, Grp Rech Thrombose, St Etienne, France; [Bertoletti, Laurent; Gremillet, Cyrielle; Mismetti, Patrick] Hop Nord St Etienne, Ctr Hosp Univ St Etienne, Dept Med Therapeut, St Etienne, France; [Bertoletti, Laurent; Chapelle, Celine; Mismetti, Patrick] INSERM, CIE3, St Etienne, France; [Cucherat, Michel] Univ Lyon 1, CNRS, UMR Evaluat & Modelisat Effets Therapeut 5558, F-69365 Lyon, France; [Laporte, Silvy] Ctr Hosp Univ St Etienne, Unite Rech Clin, St Etienne, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Jean Monnet; CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU de St Etienne	Lega, JC (corresponding author), Univ Lyon 1, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Med Interne & Vasc, F-69365 Lyon, France.	jean-christophe.lega@chu-lyon.fr	Gueyffier, François/B-8545-2008; Cucherat, Michel/B-2343-2008; albaladejo, pierre/M-6901-2014; Bertoletti, Laurent/X-1319-2019	Gueyffier, François/0000-0002-9921-0977; Cucherat, Michel/0000-0003-2150-5932; Bertoletti, Laurent/0000-0001-8214-3010; Chapelle, Celine/0000-0003-3281-3666; Rosencher, Nadia/0000-0003-0615-4804; Couturaud, Francis/0000-0002-1855-8032	Programme Hospitalier de Recherche Clinique, MinistAre de la SantA(C), France	Programme Hospitalier de Recherche Clinique, MinistAre de la SantA(C), France	This work formed part of the META EMBOL project, supported by the Programme Hospitalier de Recherche Clinique 2008, MinistAre de la SantA (c), France. This work formed part of the META EMBOL project, supported by the Programme Hospitalier de Recherche Clinique 2008, MinistAre de la SantA (c), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens I, 2011, THROMB HAEMOSTASIS, V105, P574, DOI 10.1160/TH10-12-0808; Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; Albers GW, 2003, LANCET, V362, P1691; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dans AL, 2013, CIRCULATION, V127, P634, DOI 10.1161/CIRCULATIONAHA.112.115386; Darius H, 2012, AM HEART ASS SCI SES; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diener HC, 2010, LANCET NEUROL, V9, P1157, DOI 10.1016/S1474-4422(10)70274-X; Dulli DA, 2003, NEUROEPIDEMIOLOGY, V22, P118, DOI 10.1159/000068743; Easton JD, 2012, LANCET NEUROL, V11, P503, DOI 10.1016/S1474-4422(12)70092-3; Eikelboom JW, 2012, J STROKE CEREBROVASC, V21, P429, DOI 10.1016/j.jstrokecerebrovasdis.2012.05.007; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Ezekowitz MD, 2010, CIRCULATION, V122, P2246, DOI 10.1161/CIRCULATIONAHA.110.973735; Fox KAA, 2011, EUR HEART J, V32, P2387, DOI 10.1093/eurheartj/ehr342; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Garcia D, 2010, BLOOD, V115, P15, DOI 10.1182/blood-2009-09-241851; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hankey GJ, 2012, LANCET NEUROL, V11, P315, DOI 10.1016/S1474-4422(12)70042-X; Harenberg J, 2012, THROMB HAEMOSTASIS, V108, P407, DOI 10.1160/TH12-07-0463; Haynes RB, 2005, BMJ-BRIT MED J, V330, P1179, DOI 10.1136/bmj.38446.498542.8F; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hohnloser SH, 2012, EUR HEART J, V33, P2821, DOI 10.1093/eurheartj/ehs274; Holster I. L., 2013, GASTROENTEROLOGY; Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024; Lip GYH, 2010, STROKE, V41, P2731, DOI 10.1161/STROKEAHA.110.590257; Lopes RD, 2010, AM HEART J, V159, P331, DOI 10.1016/j.ahj.2009.07.035; Oldgren J, 2011, ANN INTERN MED, V155, P660, DOI 10.7326/0003-4819-155-10-201111150-00004; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Rupprecht HJ, 2010, DRUGS, V70, P2153, DOI 10.2165/11538030-000000000-00000; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Singer DE, 2008, CHEST, V133, p546S, DOI 10.1378/chest.08-0678; Slot KB, 2008, BRIT MED J, V336, P376, DOI 10.1136/bmj.39456.688333.BE; Team RC, 2012, R LANG ENV STAT COMP; Wong SSL, 2006, J MED LIBR ASSOC, V94, P41	42	36	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91398	10.1371/journal.pone.0091398	http://dx.doi.org/10.1371/journal.pone.0091398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622012	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300084
J	Li, MM; Li, GS; Zhu, LY; Yin, YS; Zhao, XL; Xiang, C; Yu, GL; Wang, X				Li, Miaomiao; Li, Guangsheng; Zhu, Liying; Yin, Yeshi; Zhao, Xiaoliang; Xiang, Charlie; Yu, Guangli; Wang, Xin			Isolation and Characterization of an Agaro-Oligosaccharide (AO)-Hydrolyzing Bacterium from the Gut Microflora of Chinese Individuals	PLOS ONE			English	Article							IN-VITRO; POLYSACCHARIDES; IDENTIFICATION; BACTEROIDES; DIVERSITY; BIFIDOBACTERIUM; FERMENTATION; POPULATIONS; MICROBIOME; HYDROLYSIS	Agarose (AP) from red algae has a long history as food ingredients in East Asia. Agaro-oligosaccharides (AO) derived from AP have shown potential prebiotic effects. However, the human gut microbes responsible for the degradation of AO and AP have not yet been fully investigated. Here, we reported that AO and AP can be degraded and utilized at various rates by fecal microbiota obtained from different individuals. Bacteroides uniformis L8 isolated from human feces showed a pronounced ability to degrade AO and generate D-galactose as its final end product. PCR-DGGE analysis showed B. uniformis to be common in the fecal samples, but only B. uniformis L8 had the ability to degrade AO. A synergistic strain, here classified as Escherichia coli B2, was also identified because it could utilize the D-galactose as the growth substrate. The cross-feeding interaction between B. uniformis L8 and E. coli B2 led to exhaustion of the AO supply. Bifidobacterium infantis and Bifidobacterium adolescentis can utilize one of the intermediates of AO hydrolysis, agarotriose. Growth curves indicated that AO was the substrate that most favorably sustained the growth of B. uniformis L8. In contrast, kappa-carrageenan oligosaccharides (KCO), guluronic acid oligosaccharides (GO), and mannuronic acid oligosaccharides (MO) were found to be unusable to B. uniformis L8. Current results indicate that B. uniformis L8 is a special degrader of AO in the gut microbiota. Because B. uniformis can mitigate high-fat-diet-induced metabolic disorders, further study is required to determine the potential applications of AO.	[Li, Miaomiao; Li, Guangsheng; Zhao, Xiaoliang; Yu, Guangli] Ocean Univ China, Shandong Prov Key Lab Glycosci & Glycotechnol, Qingdao, Shandong, Peoples R China; [Li, Miaomiao; Li, Guangsheng; Zhao, Xiaoliang; Yu, Guangli] Ocean Univ China, Minist Educ, Key Lab Marine Drugs, Qingdao, Shandong, Peoples R China; [Zhu, Liying; Yin, Yeshi; Wang, Xin] Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China; [Zhu, Liying; Yin, Yeshi; Wang, Xin] Zhejiang Acad Agr Sci, Key Lab Food Microbial Technol Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Xiang, Charlie] Zhejiang Univ, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	Ocean University of China; Ocean University of China; Zhejiang Academy of Agricultural Sciences; Zhejiang Academy of Agricultural Sciences; Zhejiang University	Yu, GL (corresponding author), Ocean Univ China, Shandong Prov Key Lab Glycosci & Glycotechnol, Qingdao, Shandong, Peoples R China.	glyu@ouc.edu.cn; xxww101@sina.com	Rui, Zhenhua/J-8195-2019	Rui, Zhenhua/0000-0001-6088-0845; Li, Miaomiao/0000-0003-4508-196X	 [31070724];  [31100097];  [2013BAB01B02];  [201005024];  [2013CB531404];  [2010R10095]	; ; ; ; ; 	1. 31070724, http://www.nsfc.gov.cn/, 2. 31100097, http://www.nsfc.gov.cn/, 3. 2013BAB01B02, http://program.most.gov.cn/, 4. 201005024, http://www.soa.gov.cn/, 5. 2013CB531404, http://program.most.gov.cn/, 6. 2010R10095, http://www.zjkjt.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; Candela M, 2010, INT J FOOD MICROBIOL, V140, P93, DOI 10.1016/j.ijfoodmicro.2010.04.017; Chen HM, 2005, BBA-GEN SUBJECTS, V1722, P103, DOI 10.1016/j.bbagen.2004.11.016; Child MW, 2006, FEMS MICROBIOL ECOL, V55, P299, DOI 10.1111/j.1574-6941.2005.00016.x; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Dolci P, 2008, INT J FOOD MICROBIOL, V122, P302, DOI 10.1016/j.ijfoodmicro.2007.12.018; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Enoki T, 2012, BIOL PHARM BULL, V35, P1145, DOI 10.1248/bpb.b12-00188; Enoki T, 2010, BIOSCI BIOTECH BIOCH, V74, P766, DOI 10.1271/bbb.90803; Fan W, 2013, WORLD J MICROBIOL BI; FISCHER FG, 1955, H-S Z PHYSIOL CHEM, V302, P186, DOI 10.1515/bchm2.1955.302.1-2.186; Fite A, 2004, GUT, V53, P523, DOI 10.1136/gut.2003.031245; Franco W, 2012, APPL ENVIRON MICROB, V78, P1273, DOI 10.1128/AEM.06605-11; Fu WD, 2008, J IND MICROBIOL BIOT, V35, P915, DOI 10.1007/s10295-008-0365-2; Cano PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041079; Hehemann JH, 2012, P NATL ACAD SCI USA, V109, P19786, DOI 10.1073/pnas.1211002109; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Higashimura Y, 2012, J GASTROENTEROL, P1; Higashimura Y, 2013, J GASTROENTEROL, V48, P897, DOI 10.1007/s00535-012-0719-4; Holben WE, 2004, APPL ENVIRON MICROB, V70, P2263, DOI 10.1128/AEM.70.4.2263-2270.2004; Hu B, 2006, ANAEROBE, V12, P260, DOI 10.1016/j.anaerobe.2006.07.005; Ishikawa E, 2013, J BIOSCI BIOENG, V116, P265, DOI 10.1016/j.jbiosc.2013.02.010; Jiao G, 2012, J OCEAN U CHINA ENGL, P1; Kim J, 2012, J MICROBIOL BIOTECHN, V22, P1621, DOI 10.4014/jmb.1209.08087; Lei F, 2012, APPL ENVIRON MICROB, V78, P5763, DOI 10.1128/AEM.00327-12; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Long MX, 2010, MAR BIOTECHNOL, V12, P62, DOI 10.1007/s10126-009-9200-7; Nakanishi H, 2013, FORENSIC SCI INT-GEN, V7, P176, DOI 10.1016/j.fsigen.2012.09.006; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ramnani P, 2012, ANAEROBE, V18, P1, DOI 10.1016/j.anaerobe.2011.08.003; Rantsiou K, 2005, APPL ENVIRON MICROB, V71, P1977, DOI 10.1128/AEM.71.4.1977-1986.2005; SALYERS AA, 1977, APPL ENVIRON MICROB, V33, P319, DOI 10.1128/AEM.33.2.319-322.1977; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Vera J, 1998, APPL ENVIRON MICROB, V64, P4378; Wang JX, 2006, APPL MICROBIOL BIOT, V71, P833, DOI 10.1007/s00253-005-0207-3; Wang PP, 2012, CARBOHYD POLYM, V89, P914, DOI 10.1016/j.carbpol.2012.04.034; Yang B, 2009, FEBS J, V276, P2125, DOI 10.1111/j.1742-4658.2009.06947.x; Yu GL, 2006, ANAL CHEM, V78, P8499, DOI 10.1021/ac061416j	39	59	63	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91106	10.1371/journal.pone.0091106	http://dx.doi.org/10.1371/journal.pone.0091106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622338	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300049
J	Lyver, PO; Barron, M; Barton, KJ; Ainley, DG; Pollard, A; Gordon, S; McNeill, S; Ballard, G; Wilson, PR				Lyver, Phil O'B.; Barron, Mandy; Barton, Kerry J.; Ainley, David G.; Pollard, Annie; Gordon, Shulamit; McNeill, Stephen; Ballard, Grant; Wilson, Peter R.			Trends in the Breeding Population of Adelie Penguins in the Ross Sea, 1981-2012: A Coincidence of Climate and Resource Extraction Effects	PLOS ONE			English	Article							PACIFIC SECTOR; SOUTHERN-OCEAN; ANTARCTICA; ECOSYSTEMS; COLONIES; IMPACTS; BIOMASS; SIZE	Measurements of the size of Adelie penguin (Pygoscelis adeliae) colonies of the southern Ross Sea are among the longest biologic time series in the Antarctic. We present an assessment of recent annual variation and trends in abundance and growth rates of these colonies, adding to the published record not updated for more than two decades. High angle oblique aerial photographic surveys of colonies were acquired and penguins counted for the breeding seasons 1981-2012. In the last four years the numbers of Adelie penguins in the Ross and Beaufort Island colonies (southern Ross Sea metapopulation) reached their highest levels since aerial counts began in 1981. Results indicated that 855,625 pairs of Adelie penguins established breeding territories in the western Ross Sea, with just over a quarter (28%) of those in the southern portion, constituting a semi-isolated metapopulation (three colonies on Ross Island, one on nearby Beaufort Island). The southern population had a negative per capita growth rate of -0.019 during 1981-2000, followed by a positive per capita growth rate of 0.067 for 2001-2012. Colony growth rates for this metapopulation showed striking synchrony through time, indicating that large-scale factors influenced their annual growth. In contrast to the increased colony sizes in the southern population, the patterns of change among colonies of the northern Ross Sea were difficult to characterize. Trends were similar to southern colonies until the mid-1990s, after which the signal was lost owing to significantly reduced frequency of surveys. Both climate factors and recovery of whale populations likely played roles in the trends among southern colonies until 2000, after which depletion of another trophic competitor, the Antarctic toothfish (Dissostichus mawsoni), may explain the sharp increasing trend evident since then.	[Lyver, Phil O'B.; Barron, Mandy; McNeill, Stephen] Landcare Res, Lincoln, New Zealand; [Barton, Kerry J.] Bartonk Solut, Nelson, New Zealand; [Ainley, David G.; Pollard, Annie] HT Harvey & Associates Ecol Consultants, Los Gatos, CA USA; [Gordon, Shulamit] Antarctica New Zealand, Christchurch, New Zealand; [Ballard, Grant] Point Blue Conservat Sci, Petaluma, CA USA	Landcare Research - New Zealand	Lyver, PO (corresponding author), Landcare Res, Lincoln, New Zealand.	lyverp@landcareresearch.co.nz	McNeill, Stephen JE/A-9939-2008	McNeill, Stephen JE/0000-0003-1288-4387	New Zealand's Foundation for Research, Science and Technology grants [C09527, C09X0510]; Ministry of Science and Innovation project [C01X1001, CONT-21216-BKBN]; National Science Foundation [OPP 0944411]; Office of Polar Programs (OPP) [0944141] Funding Source: National Science Foundation	New Zealand's Foundation for Research, Science and Technology grants; Ministry of Science and Innovation project; National Science Foundation(National Science Foundation (NSF)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was primarily funded by New Zealand's Foundation for Research, Science and Technology grants (C09527; C09X0510) and Ministry of Science and Innovation project (C01X1001; CONT-21216-BKBN). Funding for DA, AP, and GB came from the National Science Foundation (OPP 0944411). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D.G., 2002, ADELIE PENGUIN BELLW, DOI DOI 10.7312/AINL12306; Ainley D, 2007, ANTARCT SCI, V19, P283, DOI 10.1017/S095410200700051X; Ainley D, 2010, ECOL MONOGR, V80, P49, DOI 10.1890/08-2289.1; Ainley D, 2010, MAR MAMMAL SCI, V26, P482, DOI 10.1111/j.1748-7692.2009.00337.x; Ainley DG, 2006, ECOLOGY, V87, P2080, DOI 10.1890/0012-9658(2006)87[2080:CAPACR]2.0.CO;2; Ainley DG, 2013, FISH FISH, V14, P343, DOI 10.1111/j.1467-2979.2012.00474.x; Ainley DG, 2009, FISH FISH, V10, P13, DOI 10.1111/j.1467-2979.2008.00293.x; Ainley DG, 1995, AUK, V112, P171, DOI 10.2307/4088776; Ainley DG, 2005, ANTARCT SCI, V17, P171, DOI 10.1017/S0954102005002567; AINLEY DG, 1981, DEEP-SEA RES, V28, P1173, DOI 10.1016/0198-0149(81)90054-6; Ainley DG, 2003, CONDOR, V105, P95, DOI 10.1650/0010-5422(2003)105[95:SATVOD]2.0.CO;2; Antarctic Treaty Consultative Meeting (ATCM), 2010, MAN PLAN ANT SPEC PR; Arrigo KR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017721; Arrigo KR, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014160; Ballance LT, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P215; Ballance LT, 2009, J AVIAN BIOL, V40, P279, DOI 10.1111/j.1600-048X.2008.04538.x; Ballard G, 2010, THESIS; Ballard G, 2010, ECOLOGY, V91, P2056, DOI 10.1890/09-0688.1; Ballard G, 2010, MAR ECOL PROG SER, V405, P287, DOI 10.3354/meps08514; Barber-Meyer SM, 2008, ANTARCT SCI, V20, P3, DOI 10.1017/S0954102007000673; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; CCAMLR, 2004, CCAMLR EC MON PROGR; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Dugger KM, 2010, P NATL ACAD SCI USA, V107, P12375, DOI 10.1073/pnas.1000623107; EASTMAN JT, 1985, POLAR BIOL, V4, P155, DOI 10.1007/BF00263878; Emmerson L, 2008, ECOLOGY, V89, P2096, DOI 10.1890/08-0011.1; Emslie SD, 2007, GEOLOGY, V35, P61, DOI 10.1130/G23011A.1; HENTTONEN H, 1985, ANN ZOOL FENN, V22, P221; JACOBS SS, 1989, J GEOPHYS RES-OCEANS, V94, P18195, DOI 10.1029/JC094iC12p18195; Jenouvrier S, 2005, ECOLOGY, V86, P2889, DOI 10.1890/05-0514; Jenouvrier S, 2006, POLAR BIOL, V29, P413, DOI 10.1007/s00300-005-0073-6; Jenouvrier S, 2013, GLOBAL CHANGE BIOL, V19, P2036, DOI 10.1111/gcb.12195; Kooyman GL, 2007, ANTARCT SCI, V19, P31, DOI 10.1017/S0954102007000065; LaRue MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060568; Lescroel A, 2010, ECOLOGY, V91, P2044, DOI 10.1890/09-0766.1; Lynch HJ, 2012, ECOLOGY, V93, P1367; Lyver PO, 2011, POLAR BIOL, V34, P49, DOI 10.1007/s00300-010-0858-0; Marschoff ER, 2012, FISH RES, V125, P206, DOI 10.1016/j.fishres.2012.02.017; Martin S, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006700; McNeill S, 2011, INT GEOSCI REMOTE SE, P4312, DOI 10.1109/IGARSS.2011.6050185; Parkinson CL, 2002, ANN GLACIOL, V34, P435, DOI 10.3189/172756402781817482; R Development Core Team, 2012, R LANG ENV STAT COMP; Robinson NJ, 2012, ANTARCT SCI, V24, P514, DOI 10.1017/S0954102012000296; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; Seibel BA, 2003, BIOL BULL-US, V205, P93, DOI 10.2307/1543229; Siniff DB, 2008, ANTARCT SCI, V20, P425, DOI 10.1017/S0954102008001351; Smith RC, 1999, BIOSCIENCE, V49, P393, DOI 10.2307/1313632; Southwell C, 2013, ANTARCT SCI, V25, P531, DOI 10.1017/S0954102012001174; Stammerjohn S, 2012, REGIONS RAPID SEA IC; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; TAYLOR RH, 1990, NEW ZEAL J ECOL, V14, P25; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Williams TD, 1995, BIRD FAMILIES OF THE, V2; Wilson PR, 2001, MAR ECOL PROG SER, V213, P301, DOI 10.3354/meps213301; Woehler EJ, 1993, DISTRIBUTION ABUNDAN	56	73	75	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91188	10.1371/journal.pone.0091188	http://dx.doi.org/10.1371/journal.pone.0091188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621601	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300058
J	Odman, AM; Olsson, PA				Odman, Anja Madelen; Olsson, Pal Axel			Conservation of Sandy Calcareous Grassland: What Can Be Learned from the Land Use History?	PLOS ONE			English	Article							WIND EROSION; NEW-ENGLAND; VEGETATION; RESTORATION; ACIDIFICATION; BIODIVERSITY; DISTURBANCE; LANDSCAPES; DYNAMICS; PATTERNS	Understanding the land use history has proven crucial for the conservation of biodiversity in the agricultural landscape. In southern Sweden, very small and fragmented areas of the disturbance-dependent habitat xeric sand calcareous grassland support a large number of threatened and rare plants and animals. In order to find out if historical land use could explain variation in present-day habitat quality, the land use on eight such sites was traced back to the 18th century and compared with key factors such as the amount of bare sand, lime content and P availability. There was no support for the common explanation of the decline in xeric sand calcareous grassland being caused by abandonment of agricultural fields during the last century. Instead, fertilization history was the main explanation for the difference in depletion depth of CaCO3 seen between the sites. The decline in xeric sand calcareous grassland since the 18th century is most probably the result of the drastic changes in land use during the 19th century, which put an end to the extensive sand drift. Since cultivation was shown to have played an important role in the historical land use of xeric sand calcareous grassland, grazing alone may not be the optimal management option for these grasslands. Instead more drastic measures are needed to restore the high calcium content and maintain proper disturbance levels.	[Odman, Anja Madelen; Olsson, Pal Axel] Lund Univ, Dept Biol, Lund, Sweden	Lund University	Odman, AM (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Anja.Odman@biol.lu.se	Ödman, Anja/AGV-7196-2022; Zimmerman, Anja/CAA-7485-2022	Ödman, Anja/0000-0002-3556-7029; Zimmerman, Anja/0000-0002-3556-7029	County Administrative Board; Swedish Research Council; Gyllenstiernska Krapperup Foundation	County Administrative Board; Swedish Research Council(Swedish Research CouncilEuropean Commission); Gyllenstiernska Krapperup Foundation	Financial support from The County Administrative Board, The Swedish Research Council, and the Gyllenstiernska Krapperup Foundation made this study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antrop M, 2005, LANDSCAPE URBAN PLAN, V70, P21, DOI 10.1016/j.landurbplan.2003.10.002; Bahr A, 2012, FLORA, V207, P379, DOI 10.1016/j.flora.2012.03.003; Bateman MD, 2004, HOLOCENE, V14, P579, DOI 10.1191/0959683604hl735rp; Berglund B.E., 1991, CULTURAL LANDSCAPE 6, P425; Bjorkman L, 2003, VEG HIST ARCHAEOBOT, V12, P61, DOI 10.1007/s00334-003-0004-9; Bolan NS, 2003, ADV AGRON, V78, P215, DOI 10.1016/S0065-2113(02)78006-1; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Campbell A, 1929, THESIS UPPSALA U SWE; Carroll JA, 2003, ENVIRON POLLUT, V121, P363, DOI 10.1016/S0269-7491(02)00241-5; Dahl S, 1989, MEDDELANDE B, V69; Dahlstrom A., 2006, Environment and History, V12, P191, DOI 10.3197/096734006776680218; Eberhardt RW, 2003, ECOL APPL, V13, P68, DOI 10.1890/1051-0761(2003)013[0068:COCLVA]2.0.CO;2; Eichberg C, 2010, APPL VEG SCI, V13, P425, DOI 10.1111/j.1654-109X.2010.01082.x; Ellenberg H., 1992, SCRIPTA GEOBOT, V18, P1, DOI DOI 10.1002/FEDR.19931040323; Emanuelsson U., 2002, SKANSKA KULTURLANDSK; FOSTER DR, 1992, J ECOL, V80, P753, DOI 10.2307/2260864; Gazenbeek A, 2005, LIFE FOCUS; Jentsch A, 2009, RESTOR ECOL, V17, P107, DOI 10.1111/j.1526-100X.2007.00339.x; Johansson LJ, 2008, LANDSCAPE URBAN PLAN, V84, P200, DOI 10.1016/j.landurbplan.2007.08.001; Kent M, 2001, PROG PHYS GEOG, V25, P455, DOI 10.1177/030913330102500401; Kent Martin, 2003, Botanical Journal of Scotland, V55, P161; Ljungberg H, 1999, SKALBAGGAR ANDRA INS, P1; Ljungberg KO, 1994, 390254094 SWED ENV P; Lunt ID, 2005, J BIOGEOGR, V32, P1859, DOI 10.1111/j.1365-2699.2005.01296.x; Martensson LM, 2010, PLANT ECOL, V206, P127, DOI 10.1007/s11258-009-9629-9; Mattiasson G, 1974, MEDDELANDEN FRAN AVD, V2, P1; Motzkin G, 1996, ECOL MONOGR, V66, P345, DOI 10.2307/2963522; Odman AM, 2012, BIODIVERS CONSERV, V21, P1921, DOI 10.1007/s10531-012-0292-4; OENEMA O, 1990, FERT RES, V26, P217, DOI 10.1007/BF01048759; Olsson K-A, 1994, LUNDS BOT FORENING M, V2, P4; Olsson PA, 2014, RESTOR ECOL, V22, P49, DOI 10.1111/rec.12024; Olsson PA, 2010, FUNGAL ECOL, V3, P357, DOI 10.1016/j.funeco.2010.01.004; Olsson PA, 2009, APPL VEG SCI, V12, P350, DOI 10.1111/j.1654-109X.2009.01029.x; Owen NW, 2004, J VEG SCI, V15, P669, DOI 10.1111/j.1654-1103.2004.tb02309.x; Persson KM, 2000, DESCRIPTION QUATERNA; PIGOTT CD, 1954, J ECOL, V42, P95, DOI 10.2307/2256981; Poortinga A, 2011, AEOLIAN RES, V3, P81, DOI 10.1016/j.aeolia.2011.05.003; Poschlod P, 2002, BIOL CONSERV, V104, P361, DOI 10.1016/S0006-3207(01)00201-4; Poschlod P., 2009, GRASSLANDS EUROPE HI, P113; Poska A, 1999, VEG HIST ARCHAEOBOT, V8, P185, DOI 10.1007/BF02342719; Rehounkova K, 2008, RESTOR ECOL, V16, P305, DOI 10.1111/j.1526-100X.2007.00316.x; Riksen M, 2006, LANDSCAPE ECOL, V21, P431, DOI 10.1007/s10980-005-2895-6; Riksen M, 2008, J NAT CONSERV, V16, P26, DOI 10.1016/j.jnc.2007.07.002; Roem WJ, 2000, BIOL CONSERV, V92, P151, DOI 10.1016/S0006-3207(99)00049-X; Schnoor TK, 2010, AGR ECOSYST ENVIRON, V139, P714, DOI 10.1016/j.agee.2010.10.018; Smits NAC, 2008, APPL VEG SCI, V11, P279, DOI 10.3170/2008-7-18417; Snogerup S, 2000, FRAN SKANSKA RESA SK; Stroia C, 2011, SOIL SCI SOC AM J, V75, P112, DOI 10.2136/sssaj2009.0135; Tyler T., 2007, FLORAN SKANE ARTERNA; Tyler Torbjorn, 2003, Botaniska Notiser, V136, P1; Tyler Torbjorn, 2005, Lindbergia, V30, P11; VONLINNE C, 1751, C LINNAEI SKANSKA RE; Warren SD, 2007, RESTOR ECOL, V15, P606, DOI 10.1111/j.1526-100X.2007.00272.x; Wassen MJ, 2005, NATURE, V437, P547, DOI 10.1038/nature03950; WELLS TCE, 1976, J ECOL, V64, P589, DOI 10.2307/2258775	55	11	11	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90998	10.1371/journal.pone.0090998	http://dx.doi.org/10.1371/journal.pone.0090998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621928	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300044
J	Gou, WL; Wang, X; Peng, J; Lu, Q; Wang, Y; Wang, AY; Guo, QY; Gao, XP; Xu, WJ; Lu, SB				Gou, Wenlong; Wang, Xin; Peng, Jiang; Lu, Qiang; Wang, Yu; Wang, Aiyuan; Guo, Quanyi; Gao, Xupeng; Xu, Wenjing; Lu, Shibi			Controlled Delivery of Zoledronate Improved Bone Formation Locally In Vivo	PLOS ONE			English	Article							BISPHOSPHONATE-RELATED OSTEONECROSIS; OSTEOGENIC DIFFERENTIATION; PAMIDRONATE TREATMENT; OSTEOBLAST APOPTOSIS; MINERAL DENSITY; OSTEOCYTE; ALENDRONATE; MECHANISMS; INCREASES; CELLS	Bisphosphonates (BPs) have been widely used in clinical treatment of bone diseases with increased bone resorption because of their strong affinity for bone and their inhibition of bone resorption. Recently, there has been growing interest in their improvement of bone formation. However, the effect of local controlled delivery of BPs is unclear. We used polylactide acid-glycolic acid copolymer (PLGA) as a drug carrier to deliver various doses of the bisphosphonate zoledronate (Zol) into the distal femur of 8-week-old Sprague-Dawley rats. After 6 weeks, samples were harvested and analyzed by micro-CT and histology. The average bone mineral density and mineralized bone volume fraction were higher with medium-and high-dose PLGA-Zol (30 and 300 mu g Zol, respectively) than control and low-dose Zol (3 mu g PLGA-Zol; p<0.05). Local controlled delivery of Zol decreased the numbers of osteoclast and increased the numbers of osteoblast. Moreover, local controlled delivery of medium-and high-dose Zol accelerated the expression of bone-formation markers. PLGA used as a drug carrier for controlled delivery of Zol may promote local bone formation.	[Gou, Wenlong; Wang, Xin; Peng, Jiang; Lu, Qiang; Wang, Yu; Wang, Aiyuan; Guo, Quanyi; Gao, Xupeng; Xu, Wenjing; Lu, Shibi] Chinese Peoples Liberat Army Gen Hosp, Inst Orthopaed, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Peng, J (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Orthopaed, Beijing, Peoples R China.	pengjiang301@126.com			National Technology Research and Development Program of China [2012AA020502, 2012CB518106]; National Science Foundation of China [30930092, 30973047, 31240048];  [BWS11J025]	National Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This work was funded by a grant from the National Technology Research and Development Program of China (2012AA020502, 2012CB518106) and the National Science Foundation of China (30930092, 30973047, 31240048), and BWS11J025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aya-Ay J, 2007, J BONE MINER RES, V22, P93, DOI 10.1359/JBMR.060817; Belfrage O, 2011, ACTA ORTHOP, V82, P228, DOI 10.3109/17453674.2011.566138; Bellido T, 2011, BONE, V49, P50, DOI 10.1016/j.bone.2010.08.008; Bembi B, 1997, J PEDIATR-US, V131, P622, DOI 10.1016/S0022-3476(97)70074-X; Cenni E, 2008, BIOMATERIALS, V29, P1400, DOI 10.1016/j.biomaterials.2007.12.022; Dai RC, 2008, J BONE MINER METAB, V26, P342, DOI 10.1007/s00774-007-0830-4; EGGELMEIJER F, 1994, J RHEUMATOL, V21, P2016; Freiberg S, 2004, INT J PHARMACEUT, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013; Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3; Gourion-Arsiquaud S, 2010, BONE, V46, P666, DOI 10.1016/j.bone.2009.11.011; Green JR, 2003, CANCER, V97, P840, DOI 10.1002/cncr.11128; Greiner S, 2007, J BIOMED MATER RES A, V80A, P769, DOI 10.1002/jbm.a.30950; Idris AI, 2008, CALCIFIED TISSUE INT, V82, P191, DOI 10.1007/s00223-008-9104-y; Im GI, 2004, BIOMATERIALS, V25, P4105, DOI 10.1016/j.biomaterials.2003.11.024; Jeong HM, 2013, BIOCHEM BIOPH RES CO, V432, P152, DOI 10.1016/j.bbrc.2013.01.068; Kim HK, 2009, CLIN ORTHOP RELAT R, V467, P3121, DOI 10.1007/s11999-008-0409-y; Koch FP, 2011, J CRANIO MAXILL SURG, V39, P562, DOI 10.1016/j.jcms.2010.10.007; KOST J, 1992, TRENDS BIOTECHNOL, V10, P127, DOI 10.1016/0167-7799(92)90194-Z; Lala R, 2000, ACTA PAEDIATR, V89, P188, DOI 10.1080/080352500750028816; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Lu JG, 2011, J CANCER RES CLIN, V137, P1613, DOI 10.1007/s00432-011-1024-y; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Paccou J, 2010, JOINT BONE SPINE, V77, pS120, DOI 10.1016/S1297-319X(10)70007-5; Pan BQ, 2004, BONE, V34, P112, DOI 10.1016/j.bone.2003.08.013; Peter B, 2005, BONE, V36, P52, DOI 10.1016/j.bone.2004.10.004; Plotkin LI, 2011, BONE, V49, P122, DOI 10.1016/j.bone.2010.08.011; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Plotkin LI, 2008, J BONE MINER RES, V23, P1712, DOI [10.1359/jbmr.080617, 10.1359/JBMR.080617]; Ponader S, 2008, COLLOID SURFACE B, V64, P275, DOI 10.1016/j.colsurfb.2008.02.002; Pozzi S, 2009, CLIN CANCER RES, V15, P5829, DOI 10.1158/1078-0432.CCR-09-0426; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Roshan-Ghias A, 2011, CLIN BIOMECH, V26, P1039, DOI 10.1016/j.clinbiomech.2011.06.004; Ruggiero SL, 2009, AUST ENDOD J, V35, P119, DOI 10.1111/j.1747-4477.2009.00213.x; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; Schindeler A, 2011, J BONE JOINT SURG BR, V93B, P1134, DOI 10.1302/0301-620X.93B8.25940; Sharma D, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-1; Sinha VR, 2003, J CONTROL RELEASE, V90, P261, DOI 10.1016/S0168-3659(03)00194-9; TENENBAUM HC, 1992, BONE, V13, P249, DOI 10.1016/8756-3282(92)90205-B; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Wang CZ, 2010, BIOMATERIALS, V31, P8674, DOI 10.1016/j.biomaterials.2010.07.096; Xiong Y, 2009, J INT MED RES, V37, P407, DOI 10.1177/147323000903700216; Xu XL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-303	44	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91317	10.1371/journal.pone.0091317	http://dx.doi.org/10.1371/journal.pone.0091317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618585	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400073
J	Pozhitkov, AE; Noble, PA; Bryk, J; Tautz, D				Pozhitkov, Alex E.; Noble, Peter A.; Bryk, Jaroslaw; Tautz, Diethard			A Revised Design for Microarray Experiments to Account for Experimental Noise and Uncertainty of Probe Response	PLOS ONE			English	Article							NONEQUILIBRIUM THERMAL-DISSOCIATION; HYBRIDIZATION ISOTHERMS; GENE-EXPRESSION; MODEL; ADSORPTION; ARRAY	Background: Although microarrays are analysis tools in biomedical research, they are known to yield noisy output that usually requires experimental confirmation. To tackle this problem, many studies have developed rules for optimizing probe design and devised complex statistical tools to analyze the output. However, less emphasis has been placed on systematically identifying the noise component as part of the experimental procedure. One source of noise is the variance in probe binding, which can be assessed by replicating array probes. The second source is poor probe performance, which can be assessed by calibrating the array based on a dilution series of target molecules. Using model experiments for copy number variation and gene expression measurements, we investigate here a revised design for microarray experiments that addresses both of these sources of variance. Results: Two custom arrays were used to evaluate the revised design: one based on 25 mer probes from an Affymetrix design and the other based on 60 mer probes from an Agilent design. To assess experimental variance in probe binding, all probes were replicated ten times. To assess probe performance, the probes were calibrated using a dilution series of target molecules and the signal response was fitted to an adsorption model. We found that significant variance of the signal could be controlled by averaging across probes and removing probes that are nonresponsive or poorly responsive in the calibration experiment. Taking this into account, one can obtain a more reliable signal with the added option of obtaining absolute rather than relative measurements. Conclusion: The assessment of technical variance within the experiments, combined with the calibration of probes allows to remove poorly responding probes and yields more reliable signals for the remaining ones. Once an array is properly calibrated, absolute quantification of signals becomes straight forward, alleviating the need for normalization and reference hybridizations.	[Pozhitkov, Alex E.; Bryk, Jaroslaw; Tautz, Diethard] Max Planck Inst Evolut Biol, D-24306 Plon, Germany; [Pozhitkov, Alex E.; Noble, Peter A.] Univ Washington, Sch Dent, Dept Periodont, Seattle, WA 98195 USA; [Noble, Peter A.] Alabama State Univ, Dept Biol Sci, PhD Microbiol Program, Montgomery, AL 36101 USA; [Bryk, Jaroslaw] Univ Reading, Natl Ctr Biotechnol Educ, Reading, Berks, England	Max Planck Society; University of Washington; University of Washington Seattle; University of Reading	Tautz, D (corresponding author), Max Planck Inst Evolut Biol, D-24306 Plon, Germany.	tautz@evolbio.mpg.de	Tautz, Diethard/H-8436-2014; Noble, Peter/A-8117-2008	Tautz, Diethard/0000-0002-0460-5344; Noble, Peter/0000-0002-6013-2588; Bryk, Jaroslaw/0000-0002-2791-9709; Pozhitkov, Alexander/0000-0001-6566-6450	Max-Planck Society; NSF [DBI 1038671]	Max-Planck Society(Max Planck SocietyFoundation CELLEX); NSF(National Science Foundation (NSF))	This work was supported by institutional funds of the Max-Planck Society (www.mpg.de) and by NSF (www.nsf.gov) grant DBI 1038671. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barash Y, 2004, BIOINFORMATICS, V20, P839, DOI 10.1093/bioinformatics/btg487; Bryk J, 2013, ECOL EVOL, V3, P558, DOI 10.1002/ece3.447; Burden CJ, 2006, J PHYS-CONDENS MAT, V18, P5545, DOI 10.1088/0953-8984/18/23/024; Burden CJ, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/016004; Czypionka T, 2012, MOL ECOL, V21, P4797, DOI 10.1111/j.1365-294X.2012.05645.x; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Freundlich H, 1932, T FARADAY SOC, V28, P0195, DOI 10.1039/tf9322800195; Halperin A, 2004, BIOPHYS J, V86, P718, DOI 10.1016/S0006-3495(04)74150-8; Halperin A, 2006, J PHYS-CONDENS MAT, V18, pS463, DOI 10.1088/0953-8984/18/18/S01; Harrison A, 2013, NUCLEIC ACIDS RES, V41, P2779, DOI 10.1093/nar/gks1358; Heim T, 2006, J PHYS CHEM B, V110, P22786, DOI 10.1021/jp062889x; Hekstra D, 2003, NUCLEIC ACIDS RES, V31, P1962, DOI 10.1093/nar/gkg283; Held GA, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl122; Held GA, 2003, P NATL ACAD SCI USA, V100, P7575, DOI 10.1073/pnas.0832500100; Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809; Lang BE, 2007, BIOPHYS CHEM, V131, P96, DOI 10.1016/j.bpc.2007.09.007; Li SZ, 2008, NUCLEIC ACIDS RES, V36, P6585, DOI 10.1093/nar/gkn740; Matveeva OV, 2003, NUCLEIC ACIDS RES, V31, P4211, DOI 10.1093/nar/gkg476; Meyer S.L., 1975, DATA ANAL SCI ENG; Millenaar FF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-137; Miller M, 2004, FREUNDS MATH STAT AP; Mueckstein U, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-35; Ono N, 2008, BIOINFORMATICS, V24, P1278, DOI 10.1093/bioinformatics/btn109; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; Pozhitkov AE, 2010, NUCLEIC ACIDS RES, V8, pe2; Pozhitkov AE, 2008, J MICROBIOL METH, V74, P82, DOI 10.1016/j.mimet.2008.03.010; Pozhitkov AE, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm154; Seo J, 2004, BIOINFORMATICS, V20, P2534, DOI 10.1093/bioinformatics/bth280; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Steger D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023727; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]	32	15	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91295	10.1371/journal.pone.0091295	http://dx.doi.org/10.1371/journal.pone.0091295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618910	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000332842400068
J	Ardissone, AN; de la Cruz, DM; Davis-Richardson, AG; Rechcigl, KT; Li, N; Drew, JC; Murgas-Torrazza, R; Sharma, R; Hudak, ML; Triplett, EW; Neu, J				Ardissone, Alexandria N.; de la Cruz, Diomel M.; Davis-Richardson, Austin G.; Rechcigl, Kevin T.; Li, Nan; Drew, Jennifer C.; Murgas-Torrazza, Roberto; Sharma, Renu; Hudak, Mark L.; Triplett, Eric W.; Neu, Josef			Meconium Microbiome Analysis Identifies Bacteria Correlated with Premature Birth	PLOS ONE			English	Article							PRETERM BIRTH; LACTIC-ACID; INFLAMMATION; INFECTION; COLONIZATION; ASSOCIATION; MODE	Background: Preterm birth is the second leading cause of death in children under the age of five years worldwide, but the etiology of many cases remains enigmatic. The dogma that the fetus resides in a sterile environment is being challenged by recent findings and the question has arisen whether microbes that colonize the fetus may be related to preterm birth. It has been posited that meconium reflects the in-utero microbial environment. In this study, correlations between fetal intestinal bacteria from meconium and gestational age were examined in order to suggest underlying mechanisms that may contribute to preterm birth. Methods: Meconium from 52 infants ranging in gestational age from 23 to 41 weeks was collected, the DNA extracted, and 16S rRNA analysis performed. Resulting taxa of microbes were correlated to clinical variables and also compared to previous studies of amniotic fluid and other human microbiome niches. Findings: Increased detection of bacterial 16S rRNA in meconium of infants of,33 weeks gestational age was observed. Approximately 61.1% of reads sequenced were classified to genera that have been reported in amniotic fluid. Gestational age had the largest influence on microbial community structure (R = 0.161; p = 0.029), while mode of delivery (C-section versus vaginal delivery) had an effect as well (R = 0.100; p = 0.044). Enterobacter, Enterococcus, Lactobacillus, Photorhabdus, and Tannerella, were negatively correlated with gestational age and have been reported to incite inflammatory responses, suggesting a causative role in premature birth. Interpretation: This provides the first evidence to support the hypothesis that the fetal intestinal microbiome derived from swallowed amniotic fluid may be involved in the inflammatory response that leads to premature birth.	[Ardissone, Alexandria N.; Davis-Richardson, Austin G.; Rechcigl, Kevin T.; Drew, Jennifer C.; Triplett, Eric W.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [de la Cruz, Diomel M.; Li, Nan; Murgas-Torrazza, Roberto; Neu, Josef] Univ Florida, Dept Pediat, Gainesville, FL 32610 USA; [Sharma, Renu; Hudak, Mark L.] Univ Florida, Dept Pediat, Jacksonville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Neu, J (corresponding author), Univ Florida, Dept Pediat, Gainesville, FL 32610 USA.	neuj@peds.ufl.edu	Neu, Josef/AAI-2799-2020	Ardissone, Alexandria/0000-0003-3608-6486; Drew, Jennifer/0000-0002-4037-108X	United States National Institutes of Health [HD059153]	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was funded by United States National Institutes of Health grant #HD059153. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub4; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631; GILBERT WM, 1993, SEMIN PERINATOL, V17, P150; Goepfert AR, 2004, OBSTET GYNECOL, V104, P777, DOI 10.1097/01.AOG.0000139836.47777.6d; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gosalbes MJ, 2013, CLIN EXP ALLERGY, V43, P198, DOI 10.1111/cea.12063; Jarjoura K, 2005, AM J OBSTET GYNECOL, V192, P513, DOI 10.1016/j.ajog.2004.07.018; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Madan JC, 2012, ARCH DIS CHILD-FETAL, V97, pF456, DOI 10.1136/fetalneonatal-2011-301373; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Menon R, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.025; Miettinen M, 1996, INFECT IMMUN, V64, P5403, DOI 10.1128/IAI.64.12.5403-5405.1996; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Onderdonk AB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.068; Rautava S, 2012, NAT REV GASTRO HEPAT, V9, P565, DOI 10.1038/nrgastro.2012.144; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; SALAFIA CM, 1991, AM J OBSTET GYNECOL, V165, P934, DOI 10.1016/0002-9378(91)90443-U; Skogstrand K, 2008, OBSTET GYNECOL, V111, P1118, DOI 10.1097/AOG.0b013e31817057fb; Srinivasan U, 2009, MED HYPOTHESES, V73, P963, DOI 10.1016/j.mehy.2009.06.017; Stewart CJ, 2012, ACTA PAEDIATR, V101, P1121, DOI 10.1111/j.1651-2227.2012.02801.x; WATTS DH, 1992, OBSTET GYNECOL, V79, P351	28	254	275	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90784	10.1371/journal.pone.0090784	http://dx.doi.org/10.1371/journal.pone.0090784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614698	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300041
J	Koush, Y; Elliott, MA; Scharnowski, F; Mathiak, K				Koush, Yury; Elliott, Mark A.; Scharnowski, Frank; Mathiak, Klaus			Comparison of Real-Time Water Proton Spectroscopy and Echo-Planar Imaging Sensitivity to the BOLD Effect at 3 T and at 7 T	PLOS ONE			English	Article							HIGH MAGNETIC-FIELDS; HUMAN VISUAL-CORTEX; VIVO H-1-NMR SPECTROSCOPY; HUMAN BRAIN; SPIN-ECHO; FMRI NEUROFEEDBACK; GRADIENT-ECHO; SELF-REGULATION; FUNCTIONAL MRI; ACTIVATION	Gradient-echo echo-planar imaging (GE EPI) is the most commonly used approach to assess localized blood oxygen level dependent (BOLD) signal changes in real-time. Alternatively, real-time spin-echo single-voxel spectroscopy (SE SVS) has recently been introduced for spatially specific BOLD neurofeedback at 3 T and at 7 T. However, currently it is not known how neurofeedback based on real-time SE SVS compares to real-time GE EPI-based. We therefore compared both methods at high (3 T) and at ultra-high (7 T) magnetic field strengths. We evaluated standard quality measures of both methods for signals originating from the motor cortex, the visual cortex, and for a neurofeedback condition. At 3 T, the data quality of the real-time SE SVS and GE EPI R2* estimates were comparable. At 7 T, the data quality of the real-time GE EPI acquisitions was superior compared to those of the real-time SE SVS. Despite the somehow lower data quality of real-time SE SVS compared to GE EPI at 7 T, SE SVS acquisitions might still be an interesting alternative. Real-time SE SVS allows for a direct and subject-specific T2* estimation and thus for a physiologically more plausible neurofeedback signal.	[Koush, Yury; Scharnowski, Frank] Univ Geneva, Dept Radiol & Med Informat, Geneva, Switzerland; [Koush, Yury; Scharnowski, Frank] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland; [Koush, Yury; Mathiak, Klaus] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Elliott, Mark A.] Univ Penn, Dept Radiol, CMROI, Philadelphia, PA 19104 USA; [Mathiak, Klaus] JARA Translat Brain Med, Julich, Germany	University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; RWTH Aachen University; University of Pennsylvania	Koush, Y (corresponding author), Univ Geneva, Dept Radiol & Med Informat, Geneva, Switzerland.	yury.koush@unige.ch		Koush, Yury/0000-0002-3684-5641; Scharnowski, Frank/0000-0002-9973-2521	DFG [MA2631/4-1, IRTG1328]; NIH [P41 RR002305]; Swiss National Science Foundation; European Union; Center for Biomedical Imaging (CIBM); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002305] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); Center for Biomedical Imaging (CIBM); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the DFG (MA2631/4-1, IRTG1328), the NIH (P41 RR002305), the Swiss National Science Foundation, the European Union, and the Center for Biomedical Imaging (CIBM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger JR, 2010, MAGN RESON IMAGING, V21, P115; Bray S, 2007, J NEUROSCI, V27, P7498, DOI 10.1523/JNEUROSCI.2118-07.2007; Budde J, 2014, MAGN RESON MED, V71, P209, DOI 10.1002/mrm.24656; Caria A, 2007, NEUROIMAGE, V35, P1238, DOI 10.1016/j.neuroimage.2007.01.018; Chiew M, 2012, NEUROIMAGE, V61, P21, DOI 10.1016/j.neuroimage.2012.02.053; Decharms RC, 2008, NAT REV NEUROSCI, V9, P720, DOI 10.1038/nrn2414; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; DeCharms RC, 2004, NEUROIMAGE, V21, P436, DOI 10.1016/j.neuroimage.2003.08.041; Deelchand DK, 2010, J MAGN RESON, V206, P74, DOI 10.1016/j.jmr.2010.06.006; Duong TQ, 2003, MAGN RESON MED, V49, P1019, DOI 10.1002/mrm.10472; Emir UE, 2012, NMR BIOMED, V25, P152, DOI 10.1002/nbm.1727; HAASE A, 1985, PHYS MED BIOL, V30, P341, DOI 10.1088/0031-9155/30/4/008; Haller S, 2010, EUR RADIOL, V20, P696, DOI 10.1007/s00330-009-1595-z; Hamilton JP, 2011, HUM BRAIN MAPP, V32, P22, DOI 10.1002/hbm.20997; HENNIG T, 1994, MAGNET RESON MED, V31, P85, DOI 10.1002/mrm.1910310115; Hulvershorn J, 2005, NEUROIMAGE, V24, P216, DOI 10.1016/j.neuroimage.2004.09.033; Johnston SJ, 2010, NEUROIMAGE, V49, P1066, DOI 10.1016/j.neuroimage.2009.07.056; KLOSE U, 1990, MAGNET RESON MED, V14, P26, DOI 10.1002/mrm.1910140104; Koush Y, 2013, J NEUROSCI METH, V218, P148, DOI 10.1016/j.jneumeth.2013.05.002; Koush Y, 2013, NEUROIMAGE, V81, P422, DOI 10.1016/j.neuroimage.2013.05.010; Koush Y, 2011, MATERIALS, V4, P1548, DOI 10.3390/ma4091548; Koush Y, 2012, NEUROIMAGE, V59, P478, DOI 10.1016/j.neuroimage.2011.07.076; LaConte SM, 2007, HUM BRAIN MAPP, V28, P1033, DOI 10.1002/hbm.20326; LaConte SM, 2011, NEUROIMAGE, V56, P440, DOI 10.1016/j.neuroimage.2010.06.052; Linden DEJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038115; Mangia S, 2006, MAGN RESON IMAGING, V24, P343, DOI 10.1016/j.mri.2005.12.023; Mathiak KA, 2010, EUR ARCH PSY CLIN N, V260, pS132, DOI 10.1007/s00406-010-0135-9; MAUDSLEY AA, 1983, J MAGN RESON, V51, P147, DOI 10.1016/0022-2364(83)90113-0; Mulkern RV, 2004, MAGN RESON IMAGING, V22, P1395, DOI 10.1016/j.mri.2004.10.011; Nair G, 2004, MAGN RESON MED, V52, P430, DOI 10.1002/mrm.20158; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peters AM, 2007, MAGN RESON IMAGING, V25, P748, DOI 10.1016/j.mri.2007.02.014; Posse S, 2003, NEUROIMAGE, V18, P760, DOI 10.1016/S1053-8119(03)00004-1; Posse S, 2007, MAGN RESON MED, V58, P236, DOI 10.1002/mrm.21287; Posse S, 2009, MAGN RESON MED, V61, P541, DOI 10.1002/mrm.21855; Richards TL, 1998, NEUROIMAG CLIN N AM, V8, P823; Rota G, 2009, HUM BRAIN MAPP, V30, P1605, DOI 10.1002/hbm.20621; Ruiz S, 2013, HUM BRAIN MAPP, V34, P200, DOI 10.1002/hbm.21427; Ruiz SM, 2010, SCHIZOPHR RES, V117, P178, DOI 10.1016/j.schres.2010.02.215; Schaller B, 2013, J NEUROSCI RES, V91, P1076, DOI 10.1002/jnr.23194; Scharnowski F, 2012, J NEUROSCI, V32, P17830, DOI 10.1523/JNEUROSCI.6334-11.2012; Schmidt CF, 2005, NEUROIMAGE, V26, P852, DOI 10.1016/j.neuroimage.2005.02.043; Shibata K, 2011, SCIENCE, V334, P1413, DOI 10.1126/science.1212003; Sijens PE, 2010, MAGN RESON IMAGING, V28, P314, DOI 10.1016/j.mri.2009.11.004; Silvennoinen MJ, 2003, MAGNET RESON MED, V49, P47, DOI 10.1002/mrm.10355; Sitaram R, 2008, IEEE SIGNAL PROC MAG, V25, P95, DOI 10.1109/MSP2007.910456; Sitaram R, 2012, NEUROREHAB NEURAL RE, V26, P256, DOI 10.1177/1545968311418345; Sitaram R, 2011, NEUROIMAGE, V56, P753, DOI 10.1016/j.neuroimage.2010.08.007; Subramanian L, 2011, J NEUROSCI, V31, P16309, DOI 10.1523/JNEUROSCI.3498-11.2011; Sulzer J, 2013, NEUROIMAGE, V76, P386, DOI 10.1016/j.neuroimage.2013.03.033; Tkac I, 2005, APPL MAGN RESON, V29, P139, DOI 10.1007/BF03166960; Tkac I, 2009, MAGN RESON MED, V62, P868, DOI 10.1002/mrm.22086; Tsai SY, 2007, MAGN RESON MED, V57, P859, DOI 10.1002/mrm.21225; Ugurbil K, 2003, MAGN RESON IMAGING, V21, P1263, DOI 10.1016/j.mri.2003.08.027; van der Veen JWC, 2000, RADIOLOGY, V217, P296, DOI 10.1148/radiology.217.1.r00oc36296; van der Zwaag W, 2009, NEUROIMAGE, V47, P1425, DOI 10.1016/j.neuroimage.2009.05.015; Veit R, 2012, SOC COGN AFFECT NEUR, V7, P623, DOI 10.1093/scan/nsr061; Weiskopf N, 2005, NEUROIMAGE, V24, P1068, DOI 10.1016/j.neuroimage.2004.10.012; Weiskopf N, 2003, NEUROIMAGE, V19, P577, DOI 10.1016/S1053-8119(03)00145-9; Weiskopf N, 2012, NEUROIMAGE, V62, P682, DOI 10.1016/j.neuroimage.2011.10.009; Yacoub E, 2003, MAGNET RESON MED, V49, P655, DOI 10.1002/mrm.10433; Yacoub E, 2007, NEUROIMAGE, V37, P1161, DOI 10.1016/j.neuroimage.2007.05.020; Yoo SS, 2007, NEUROREPORT, V18, P1915, DOI 10.1097/WNR.0b013e3282f202ac; Zhu XH, 2001, MAGN RESON MED, V46, P841, DOI 10.1002/mrm.1267; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	66	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91620	10.1371/journal.pone.0091620	http://dx.doi.org/10.1371/journal.pone.0091620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614912	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000332839300144
J	Arai-Nunota, N; Mizobuchi, M; Ogata, H; Yamazaki-Nakazawa, A; Kumata, C; Kondo, F; Hosaka, N; Koiwa, F; Kinugasa, E; Shibata, T; Akizawa, T				Arai-Nunota, Noriko; Mizobuchi, Masahide; Ogata, Hiroaki; Yamazaki-Nakazawa, Ai; Kumata, Chiaki; Kondo, Fumiko; Hosaka, Nozomu; Koiwa, Fumihiko; Kinugasa, Eriko; Shibata, Takanori; Akizawa, Tadao			Intravenous Phosphate Loading Increases Fibroblast Growth Factor 23 in Uremic Rats	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; VITAMIN-D METABOLISM; HEMODIALYSIS-PATIENTS; MINERAL METABOLISM; SERUM PHOSPHORUS; RENAL-FUNCTION; HEALTHY-MEN; FGF23; FIBROBLAST-GROWTH-FACTOR-23	Oral phosphate loading and calcitriol stimulate Fibroblast growth factor 23 (FGF23) secretion, but the mechanisms underlying the stimulation of FGF23 remain to be studied. We compared the effect of intravenous phosphate loading with that of oral loading on FGF23 levels in normal and 5/6 nephrectomized uremic rats. Uremic rats (Nx) and sham-operated rats were fed a normal phosphate diet for 2 weeks and then divided into 3 groups: 1) with the same phosphate diet (NP), 2) with a high phosphate diet (HP), and 3) NP rats with intravenous phosphate infusion using a microinfusion pump (IV). Blood and urine were obtained 1 day (early phase) and 7 days (late phase) after the interventions. In the early and late phases, serum phosphate levels and fractional excretion of phosphate (FEP) were comparable in the HP and IV groups in both Sham and Nx rats. Serum phosphate levels in the HP and IV groups were equally and significantly higher than those in the NP group only in the late phase in Nx rats. In the early phase, FGF23 levels were comparable in the NP, HP, and IV groups, but were significantly higher in the HP and IV groups compared to the NP group in the late phase in Nx rats. 1 alpha-hydroxylase and sodium dependent phosphate co-transporter 2a expression levels in the kidney in Nx rats were equally and significantly decreased in the HP and IV groups compared with the NP group, while 24-hydroxylase expression was equally and significantly increased. These results show that chronic intravenous phosphate loading increases bioactive FGF23, indicating that an alternative pathway for FGF23 regulation, in addition to the dietary route, may be present. This pathway is clearer under conditions produced by a kidney injury in which phosphate is easily overloaded.	[Arai-Nunota, Noriko; Mizobuchi, Masahide; Yamazaki-Nakazawa, Ai; Kondo, Fumiko; Hosaka, Nozomu; Shibata, Takanori; Akizawa, Tadao] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan; [Ogata, Hiroaki; Kumata, Chiaki; Kinugasa, Eriko] Showa Univ, Northern Yokohama Hosp, Dept Internal Med, Yokohama, Kanagawa, Japan; [Koiwa, Fumihiko] Showa Univ, Fujigaoka Hosp, Dept Med, Div Nephrol, Yokohama, Kanagawa 227, Japan	Showa University; Showa University; Showa University	Mizobuchi, M (corresponding author), Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan.	mizobu@med.showa-u.ac.jp	Ogata, Hiroaki/A-7946-2011	Ogata, Hiroaki/0000-0002-0046-5575				Antoniucci DM, 2006, J CLIN ENDOCR METAB, V91, P3144, DOI 10.1210/jc.2006-0021; Berndt T, 2007, P NATL ACAD SCI USA, V104, P11085, DOI 10.1073/pnas.0704446104; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Cancela ALE, 2011, NEPHRON CLIN PRACT, V117, pC74, DOI 10.1159/000319650; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hasegawa H, 2010, KIDNEY INT, V78, P975, DOI 10.1038/ki.2010.313; Hsu HJ, 2009, AM J MED SCI, V337, P116, DOI 10.1097/MAJ.0b013e3181815498; HUGHES MR, 1975, SCIENCE, V190, P578, DOI 10.1126/science.1188357; Imanishi Y, 2004, KIDNEY INT, V65, P1943, DOI 10.1111/j.1523-1755.2004.00604.x; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P948, DOI 10.1093/ndt/gfn571; Kawata T, 2007, J AM SOC NEPHROL, V18, P2683, DOI 10.1681/ASN.2006070783; Krieger NS, 2012, AM J PHYSIOL-RENAL, V303, pF431, DOI 10.1152/ajprenal.00199.2012; Larsson T, 2003, KIDNEY INT, V64, P2272, DOI 10.1046/j.1523-1755.2003.00328.x; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Nagano N, 2006, KIDNEY INT, V69, P531, DOI 10.1038/sj.ki.5000020; Nishida Y, 2006, KIDNEY INT, V70, P2141, DOI 10.1038/sj.ki.5002000; Perwad F, 2005, ENDOCRINOLOGY, V146, P5358, DOI 10.1210/en.2005-0777; Quarles LD, 2013, SEMIN NEPHROL, V33, P130, DOI 10.1016/j.semnephrol.2012.12.014; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Saito H, 2005, J BIOL CHEM, V280, P2543, DOI 10.1074/jbc.M408903200; Saji F, 2010, AM J PHYSIOL-RENAL, V299, pF1212, DOI 10.1152/ajprenal.00169.2010; Sato T, 2004, AM J KIDNEY DIS, V44, P481, DOI 10.1053/j.ajkd.2004.05.026; Shimada T, 2005, AM J PHYSIOL-RENAL, V289, pF1088, DOI 10.1152/ajprenal.00474.2004; Vervloet MG, 2011, CLIN J AM SOC NEPHRO, V6, P383, DOI 10.2215/CJN.04730510; Voormolen N, 2007, NEPHROL DIAL TRANSPL, V22, P2909, DOI 10.1093/ndt/gfm286; Wolf M, 2010, J AM SOC NEPHROL, V21, P1427, DOI 10.1681/ASN.2009121293; Yilmaz MI, 2010, KIDNEY INT, V78, P679, DOI 10.1038/ki.2010.194	33	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91096	10.1371/journal.pone.0091096	http://dx.doi.org/10.1371/journal.pone.0091096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625659	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300055
J	Bu, CF; Wu, SF; Yang, YS; Zheng, MG				Bu, Chongfeng; Wu, Shufang; Yang, Yongsheng; Zheng, Mingguo			Identification of Factors Influencing the Restoration of Cyanobacteria-Dominated Biological Soil Crusts	PLOS ONE			English	Article							GURBANTUNGGUT DESERT; NITROGENASE ACTIVITY; ALGAL CRUSTS; BIOMASS; STABILIZATION; INOCULATION; EROSION; SURFACE	Biological soil crusts (BSCs) cover >35% of the Earth's land area and contribute to important ecological functions in arid and semiarid ecosystems, including erosion reduction, hydrological cycling, and nutrient cycling. Artificial rapid cultivation of BSCs can provide a novel alternative to traditional biological methods for controlling soil and water loss such as the planting of trees, shrubs, and grasses. At present, little is known regarding the cultivation of BSCs in the field due to lack of knowledge regarding the influencing factors that control BSCs growth. Thus, we determined the effects of various environmental factors (shade; watering; N, P, K, and Ca concentrations) on the growth of cyanobacteria-dominated BSCs from the Sonoran Desert in the southwestern United States. The soil surface changes and chlorophyll a concentrations were used as proxies of BSC growth and development. After 4 months, five factors were found to impact BSC growth with the following order of importance: NH4NO3 approximate to watering frequency>shading>CaCO3 approximate to KH2PO4. The soil water content was the primary positive factor affecting BSC growth, and BSCs that were watered every 5 days harbored greater biomass than those watered every 10 days. Groups that received NH4NO3 consistently exhibited poor growth, suggesting that fixed N amendment may suppress BSC growth. The effect of shading on the BSC biomass was inconsistent and depended on many factors including the soil water content and availability of nutrients. KH2PO4 and CaCO3 had nonsignificant effects on BSC growth. Collectively, our results indicate that the rapid restoration of BSCs can be controlled and realized by artificial "broadcasting" cultivation through the optimization of environmental factors.	[Bu, Chongfeng; Wu, Shufang] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [Bu, Chongfeng; Yang, Yongsheng] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [Bu, Chongfeng; Yang, Yongsheng] Minist Water Resources, Yangling, Shaanxi, Peoples R China; [Wu, Shufang] Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling, Shaanxi, Peoples R China; [Zheng, Mingguo] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Bu, CF (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China.	buchongfeng@163.com	Lang, Ming/HIK-0758-2022		National Natural Science Foundation of China [41071192, 40701096]; West Light Foundation of the Chinese Academy of Sciences [B2008132]; 111 project [B12007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); 111 project(Ministry of Education, China - 111 Project)	The National Natural Science Foundation of China (Grant Nos 41071192 & 40701096), the West Light Foundation of the Chinese Academy of Sciences (No. B2008132), and the 111 project (No. B12007) provided funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020453; Belnap J, 2003, FRONT ECOL ENVIRON, V1, P181, DOI 10.2307/3868062; BELNAP J, 1994, ARID SOIL RES REHAB, V8, P1; Bowker MA, 2002, MICROB ECOL, V43, P13, DOI 10.1007/s00248-001-1013-9; Bowker MA, 2009, SOIL BIOL BIOCHEM, V42, P1; Bowker MA, 2008, SOIL BIOL BIOCHEM, V40, P2309, DOI 10.1016/j.soilbio.2008.05.008; Bu C, 2015, PLANT BIOSYST, V149, P364, DOI 10.1080/11263504.2013.819820; Bu CF, 2013, SOIL USE MA IN PRESS; Bu CF, 2013, CLEAN-SOIL AIR WATER, V41, P899, DOI 10.1002/clen.201100675; [卜崇峰 BU Chongfeng], 2008, [地理科学进展, Progress in Geography], V27, P26; Chen Lan-zhou, 2002, Acta Hydrobiologica Sinica, V26, P155; Chen YanQin, 2011, Journal of Northwest A & F University - Natural Science Edition, V39, P44; De Philippis R, 2003, REC RES DEV MICROBIO, V7, P13; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Evans RD, 1999, CRIT REV PLANT SCI, V18, P183, DOI 10.1016/S0735-2689(99)00384-6; Guo YR, 2008, ENVIRON GEOL, V54, P653, DOI 10.1007/s00254-007-1130-y; Housman DC, 2006, J ARID ENVIRON, V66, P620, DOI 10.1016/j.jaridenv.2005.11.014; Hu CX, 2002, J APPL PHYCOL, V14, P281, DOI 10.1023/A:1021128530086; Institute of Soil Science Chinese Academic Sciences, 1978, AN PHYS CHEM PROP SO; [赵允格 Zhao Yunge], 2010, [生态学报, Acta Ecologica Sinica], V30, P4668; Kidron GJ, 2009, EARTH SURF PROC LAND, V34, P1594, DOI 10.1002/esp.1843; Lan SB, 2011, SOIL BIOL BIOCHEM, V43, P857, DOI 10.1016/j.soilbio.2010.12.007; Li XR, 2010, EARTH SURF PROC LAND, V35, P932, DOI 10.1002/esp.1963; Maestre FT, 2006, MICROB ECOL, V52, P365, DOI 10.1007/s00248-006-9017-0; Metting B., 1991, BIOL SURFACE FEATURE; Rao Ben-Qiang, 2009, Acta Hydrobiologica Sinica, V33, P937, DOI 10.3724/SP.J.0000.2009.50937; Rao Ben-Qiang, 2009, Acta Hydrobiologica Sinica, V33, P756, DOI 10.3724/SP.J.1035.2009.40756; Tang Dong-Shan, 2007, Acta Hydrobiologica Sinica, V31, P339; Tighe M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048565; Tsujimura S, 2000, J APPL PHYCOL, V12, P1, DOI 10.1023/A:1008126232188; Wang WB, 2009, SOIL BIOL BIOCHEM, V41, P926, DOI 10.1016/j.soilbio.2008.07.001; [王雪芹 Wang Xueqin], 2004, [冰川冻土, Journal of Glaciology and Geocryology], V26, P632; Wei J. C., 2005, ARID ZONE RES, V2, P287; Wu N, 2009, J ARID ENVIRON, V73, P828, DOI 10.1016/j.jaridenv.2009.04.002; Wu N, 2006, CHINESE SCI BULL, V51, P124, DOI 10.1007/s11434-006-8216-x; Xie Zuo-Ming, 2008, Acta Hydrobiologica Sinica, V32, P272; Xie ZM, 2007, SOIL BIOL BIOCHEM, V39, P567, DOI 10.1016/j.soilbio.2006.09.004; Zhang YM, 2006, GEODERMA, V132, P441, DOI 10.1016/j.geoderma.2005.06.008	38	36	38	8	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90049	10.1371/journal.pone.0090049	http://dx.doi.org/10.1371/journal.pone.0090049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625498	gold, Green Published, Green Submitted			2022-12-27	WOS:000332851300013
J	Englund, E; Pattanaik, B; Ubhayasekera, SJK; Stensjo, K; Bergquist, J; Lindberg, P				Englund, Elias; Pattanaik, Bagmi; Ubhayasekera, Sarojini Jayantha K.; Stensjo, Karin; Bergquist, Jonas; Lindberg, Pia			Production of Squalene in Synechocystis sp PCC 6803	PLOS ONE			English	Article							THERMOSYNECHOCOCCUS-ELONGATUS BP-1; BACTERIUM PRODUCING HOPANOIDS; PENTOSE-PHOSPHATE CYCLE; NON-MEVALONATE PATHWAY; HOPENE CYCLASE; ISOPRENOID BIOSYNTHESIS; CHOLESTEROL-BIOSYNTHESIS; SEQUENCE-ANALYSIS; STRAIN PCC-6803; KEY ENZYME	In recent years, there has been an increased interest in the research and development of sustainable alternatives to fossil fuels. Using photosynthetic microorganisms to produce such alternatives is advantageous, since they can achieve direct conversion of carbon dioxide from the atmosphere into the desired product, using sunlight as the energy source. Squalene is a naturally occurring 30-carbon isoprenoid, which has commercial use in cosmetics and in vaccines. If it could be produced sustainably on a large scale, it could also be used instead of petroleum as a raw material for fuels and as feedstock for the chemical industry. The unicellular cyanobacterium Synechocystis PCC 6803 possesses a gene, slr2089, predicted to encode squalene hopene cyclase (Shc), an enzyme converting squalene into hopene, the substrate for forming hopanoids. Through inactivation of slr2089 (shc), we explored the possibility to produce squalene using cyanobacteria. The inactivation led to accumulation of squalene, to a level over 70 times higher than in wild type cells, reaching 0.67 mg OD750-1 L-1. We did not observe any significant growth deficiency in the Delta shc strain compared to the wild type Synechocystis, even at high light conditions, suggesting that the observed squalene accumulation was not detrimental to growth, and that formation of hopene by Shc is not crucial for growth under normal conditions, nor for high-light stress tolerance. Effects of different light intensities and growth stages on squalene accumulation in the Delta shc strain were investigated. We also identified a gene, sll0513, as a putative squalene synthase in Synechocystis, and verified its function by inactivation. In this work, we show that it is possible to use the cyanobacterium Synechocystis to generate squalene, a hydrocarbon of commercial interest and a potential biofuel. We also report the first identification of a squalene hopene cyclase, and the second identification of squalene synthase, in cyanobacteria.	[Englund, Elias; Pattanaik, Bagmi; Stensjo, Karin; Lindberg, Pia] Uppsala Univ, Dept Chem, Angstrom & Sci Life Lab, Uppsala, Sweden; [Ubhayasekera, Sarojini Jayantha K.; Bergquist, Jonas] BMC, Dept Chem, Uppsala, Sweden; [Ubhayasekera, Sarojini Jayantha K.; Bergquist, Jonas] Sci Life Lab, Uppsala, Sweden	Uppsala University	Lindberg, P (corresponding author), Uppsala Univ, Dept Chem, Angstrom & Sci Life Lab, Uppsala, Sweden.	pia.lindberg@kemi.uu.se	Stensjo, Karin/E-3801-2017; Bergquist, Jonas/C-5894-2015; Stensjö, Karin/D-3240-2009	Stensjo, Karin/0000-0001-6993-8476; Bergquist, Jonas/0000-0002-4597-041X	Swedish Energy Agency; Knut and Alice Wallenberg Foundation; Swedish Research Council [VR-621-2011-4423]; CF Lundstrom Foundation; Carl Trygger Foundation	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); CF Lundstrom Foundation; Carl Trygger Foundation	The research leading to these results has received funding from the Swedish Energy Agency, the Knut and Alice Wallenberg Foundation (project MoSE), the Swedish Research Council (grant no VR-621-2011-4423), the CF Lundstrom Foundation, and the Carl Trygger Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkley SJ, 2004, J BACTERIOL, V186, P8156, DOI 10.1128/JB.186.23.8156-8158.2004; Bentley FK, 2013, BIOENERG RES, V6, P917, DOI 10.1007/s12155-013-9325-4; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cunningham FX, 2000, J BACTERIOL, V182, P5841, DOI 10.1128/JB.182.20.5841-5848.2000; Do R, 2009, CLIN GENET, V75, P19, DOI 10.1111/j.1399-0004.2008.01099.x; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; Ershov YV, 2002, J BACTERIOL, V184, P5045, DOI 10.1128/JB.184.18.5045-5051.2002; Feil C, 1996, EUR J BIOCHEM, V242, P51, DOI 10.1111/j.1432-1033.1996.0051r.x; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gu PD, 1998, J BIOL CHEM, V273, P12515, DOI 10.1074/jbc.273.20.12515; Huang HH, 2010, NUCLEIC ACIDS RES, V38, P2577, DOI 10.1093/nar/gkq164; JURGENS UJ, 1992, FEMS MICROBIOL LETT, V92, P285; Kaneko T, 1997, PLANT CELL PHYSIOL, V38, P1171, DOI 10.1093/oxfordjournals.pcp.a029103; Kannenberg EL, 1999, NATURWISSENSCHAFTEN, V86, P168, DOI 10.1007/s001140050592; KLEEMANN G, 1994, BBA-LIPID LIPID MET, V1210, P317, DOI 10.1016/0005-2760(94)90235-6; Kufryk GI, 2002, FEMS MICROBIOL LETT, V206, P215; Lee S, 2008, J BACTERIOL, V190, P3808, DOI 10.1128/JB.01939-07; Lichtenthaler HK, 2000, BIOCHEM SOC T, V28, P785, DOI 10.1042/BST0280785; Lindberg P, 2010, METAB ENG, V12, P70, DOI 10.1016/j.ymben.2009.10.001; OCHS D, 1992, J BACTERIOL, V174, P298, DOI 10.1128/jb.174.1.298-302.1992; Okada K, 2005, J BIOL CHEM, V280, P20672, DOI 10.1074/jbc.M500865200; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; Pearson A, 2009, ISME J, V3, P352, DOI 10.1038/ismej.2008.116; Perzl M, 1997, MICROBIOL-UK, V143, P1235, DOI 10.1099/00221287-143-4-1235; Poliquin K, 2004, J BACTERIOL, V186, P4685, DOI 10.1128/JB.186.14.4685-4693.2004; REIPEN IG, 1995, MICROBIOL-SGM, V141, P155, DOI 10.1099/00221287-141-1-155; ROHMER M, 1984, J GEN MICROBIOL, V130, P1137; Rohmer M, 1996, J AM CHEM SOC, V118, P2564, DOI 10.1021/ja9538344; Schmerk CL, 2011, J BACTERIOL, V193, P6712, DOI 10.1128/JB.05979-11; Seipke RF, 2009, J BACTERIOL, V191, P5216, DOI 10.1128/JB.00390-09; Siedenburg G, 2011, APPL ENVIRON MICROB, V77, P3905, DOI 10.1128/AEM.00300-11; Sozer O, 2010, PLANT CELL PHYSIOL, V51, P823, DOI 10.1093/pcp/pcq031; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; SUMMERS C, 1993, GENE, V136, P185, DOI 10.1016/0378-1119(93)90462-C; Tamagnini P, 1997, APPL ENVIRON MICROB, V63, P1801, DOI 10.1128/AEM.63.5.1801-1807.1997; Tansey TR, 2000, BBA-MOL CELL BIOL L, V1529, P49, DOI 10.1016/S1388-1981(00)00137-2; Tippelt A, 1998, BBA-LIPID LIPID MET, V1391, P223, DOI 10.1016/S0005-2760(97)00212-9; Welander PV, 2009, J BACTERIOL, V191, P6145, DOI 10.1128/JB.00460-09; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; Wendt KU, 1999, J MOL BIOL, V286, P175, DOI 10.1006/jmbi.1998.2470	40	66	70	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90270	10.1371/journal.pone.0090270	http://dx.doi.org/10.1371/journal.pone.0090270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625633	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300017
J	Goyet, S; Vlieghe, E; Kumar, V; Newell, S; Moore, CE; Bousfield, R; Leang, HC; Chuop, S; Thong, P; Rammaert, B; Hem, S; van Griensven, J; Rachmat, A; Fassier, T; Lim, K; Tarantola, A				Goyet, Sophie; Vlieghe, Erika; Kumar, Varun; Newell, Steven; Moore, Catrin E.; Bousfield, Rachel; Leang, Heng C.; Chuop, Sokheng; Thong, Phe; Rammaert, Blandine; Hem, Sopheak; van Griensven, Johan; Rachmat, Agus; Fassier, Thomas; Lim, Kruy; Tarantola, Arnaud			Etiologies and Resistance Profiles of Bacterial Community-Acquired Pneumonia in Cambodian and Neighboring Countries' Health Care Settings: A Systematic Review (1995 to 2012)	PLOS ONE			English	Review							LOWER RESPIRATORY-INFECTIONS; STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; CLINICAL CHARACTERISTICS; MYCOPLASMA-PNEUMONIAE; CHLAMYDIA-PNEUMONIAE; CHILDREN YOUNGER; PHNOM-PENH; EPIDEMIOLOGY; MELIOIDOSIS	Objectives: Community-acquired pneumonia (CAP) is one of the most important causes of morbidity and mortality worldwide. Etiological data for Cambodia is scarce. We aimed to describe the main etiological agents causing CAP, and their resistance patterns in Cambodia and the greater Mekong region. Methods: A review of bacterial etiologies of CAP and antimicrobial resistance in Cambodia and neighboring countries was conducted via: (1) a systematic review of published literature in all NCBI databases using Pubmed, Google scholar, EMBASE, the World Health Organization and the Cambodian Ministry of Health libraries; (2) a review of unpublished data from Cambodia provided by national and international stakeholders working at different tiers of the healthcare system. Results: Twenty three articles and five data sources reported etiologies for 5919 CAP patients diagnosed between May 1995 and December 2012, including 1421 (24.0%), 3571 (60.3%) and 927 (15.7%) from Cambodia, Thailand and Vietnam, respectively. Streptococcus pneumoniae and Haemophilus influenzae were the most common pathogens ranking among the five most prevalent in 12 and 10 studies, respectively. Gram-negative bacteria such as Burkholderia pseudomallei and Klebsiella pneumoniae were also frequently diagnosed, particularly in bacteremic CAP in Thai adults and Cambodian children. In Thailand and Vietnam, Mycoplasma pneumoniae and Chlamydia pneumoniae were frequently identified in settings using indirect laboratory testing. Conclusions: Based on this analysis, CAP data in Cambodia seems to present etiological and resistance profiles comparable to those of neighboring countries. Findings have been shared with the national authorities upon the revision of the national therapeutic guidelines and were disseminated using a specially created website.	[Goyet, Sophie; Hem, Sopheak; Tarantola, Arnaud] Inst Pasteur Cambodge, Epidemiol Unit, Phnom Penh, Cambodia; [Vlieghe, Erika; van Griensven, Johan] Inst Trop Med, B-2000 Antwerp, Belgium; [Kumar, Varun; Moore, Catrin E.; Bousfield, Rachel] Angkor Hosp Children, Siem Reap, Cambodia; [Newell, Steven; Rachmat, Agus] Naval Med Res Unit2, Phnom Penh, Cambodia; [Moore, Catrin E.] Wellcome Trust Major Overseas Programme,Res, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Moore, Catrin E.; Bousfield, Rachel] Univ Oxford, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Leang, Heng C.; Chuop, Sokheng] Natl Inst Publ Hlth, Phnom Penh, Cambodia; [Thong, Phe; van Griensven, Johan; Lim, Kruy] Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia; [Rammaert, Blandine] Hop Necker Enfants Malad, APHP, Serv Malad Infect & Trop, Paris, France; [Fassier, Thomas] Univ Hlth Sci, Fac Med, Phnom Penh, Cambodia	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Institute of Tropical Medicine (ITM); Mahidol Oxford Tropical Medicine Research Unit (MORU); University of Oxford; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Tarantola, A (corresponding author), Inst Pasteur Cambodge, Epidemiol Unit, Phnom Penh, Cambodia.	atarantola@pasteur-kh.org	Moore, Catrin/K-1980-2017; Tarantola, Arnaud/D-2149-2015	Moore, Catrin/0000-0002-8639-9846; Tarantola, Arnaud/0000-0002-6946-7958; Fassier, Thomas/0000-0001-5853-8450; Goyet, Sophie/0000-0002-1835-4478; , Varun/0000-0003-4976-6229; Rammaert, Blandine/0000-0002-9346-5848	Agence Francaise de Developpement; U.S. Department of Defense Global Emerging Infectious Systems (DoD-GEIS); Wellcome Trust of Great Britain; Li KaShing-University of Oxford Global Health Program; Belgian Directorate General of Development Cooperation [2.08]; Institute of Tropical Medicine, Antwerp (Belgium) [2.08]; SOFI-A grant of the Institute of Tropical Medicine, Antwerp (Belgium)	Agence Francaise de Developpement; U.S. Department of Defense Global Emerging Infectious Systems (DoD-GEIS)(United States Department of Defense); Wellcome Trust of Great Britain(Wellcome Trust); Li KaShing-University of Oxford Global Health Program; Belgian Directorate General of Development Cooperation; Institute of Tropical Medicine, Antwerp (Belgium); SOFI-A grant of the Institute of Tropical Medicine, Antwerp (Belgium)	The studies which gathered data used in this work were supported by The Agence Francaise de Developpement, by the U.S. Department of Defense Global Emerging Infectious Systems (DoD-GEIS), by the Wellcome Trust of Great Britain, the Li KaShing-University of Oxford Global Health Program, by Project 2.08 of the third Framework Agreement between the Belgian Directorate General of Development Cooperation and the Institute of Tropical Medicine, Antwerp (Belgium) and the SOFI-A grant of the Institute of Tropical Medicine, Antwerp (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2001, PEDIATR INFECT DIS J, V20, P718, DOI 10.1097/00006454-200107000-00018; Anh DD, 2007, TOHOKU J EXP MED, V213, P167, DOI 10.1620/tjem.213.167; [Anonymous], 1999, CLIN THERAPEUTIC GUI; Balm MND, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-58; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brar Navdeep K, 2011, Ther Adv Respir Dis, V5, P61, DOI 10.1177/1753465810381518; CALIBAN, 2012, CALIBAN REP; Chen TC, 2011, INT J INFECT DIS, V15, pE211, DOI 10.1016/j.ijid.2010.11.008; Cherian T, 2005, J HEALTH POPUL NUTR, V23, P1; Chung KP, 2011, J ANTIMICROB CHEMOTH, V66, P1182, DOI 10.1093/jac/dkr025; Communicable Disease Control Department Ministry of Health, CDC MOH MONTHL B SUR; Eang MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-469; Gentile A, 2012, INT J INFECT DIS, V16, pE5, DOI 10.1016/j.ijid.2011.09.013; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Guerrier G, 2013, PEDIATR INFECT DIS J, V32, pE8, DOI 10.1097/INF.0b013e31826fd40d; Hara K, 2011, INTERNAL MED, V50, P991, DOI 10.2169/internalmedicine.50.4738; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Jean SS, 2011, INT J ANTIMICROB AG, V37, P291, DOI 10.1016/j.ijantimicag.2011.01.009; Jones RN, 2013, DIAGN MICR INFEC DIS, V77, P258, DOI 10.1016/j.diagmicrobio.2013.07.003; Kang CI, 2013, INFECT CHEMOTHER, V45, P22, DOI 10.3947/ic.2013.45.1.22; Kasper MR, 2012, AM J TROP MED HYG, V86, P246, DOI 10.4269/ajtmh.2012.11-0409; Kim SY, 2013, DIAGN MICR INFEC DIS, V76, P486, DOI 10.1016/j.diagmicrobio.2013.04.006; Likitnukul S, 2003, PEDIATR INFECT DIS J, V22, P749, DOI 10.1097/01.inf.0000078356.68105.d7; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Lochindarat S, 2007, INT J TUBERC LUNG D, V11, P814; Long R, 2009, CLIN INFECT DIS, V48, P1354, DOI 10.1086/598196; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Macfarlane J, 2000, THORAX, V55, P153, DOI 10.1136/thorax.55.2.153; Mandell GL, 2010, PRINCIPLES PRACTICE; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Measure DHS, 2006, CAMB DEM HLTH SURV 2; Measure DHS, 2011, CAMB DEM HLTH SURV 2; Meumann EM, 2012, CLIN INFECT DIS, V54, P362, DOI 10.1093/cid/cir808; Musher D, 2013, J INFECT; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Okada K, 2012, INT J TUBERC LUNG D, V16, P1619, DOI 10.5588/ijtld.12.0201; Olsen SJ, 2010, EPIDEMIOL INFECT, V138, P1811, DOI 10.1017/S0950268810000646; Olsen SJ, 2006, INT J INFECT DIS, V10, P439, DOI 10.1016/j.ijid.2006.06.004; Overtoom Rob, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS21, DOI 10.1016/S0035-9203(08)70007-5; Pagnarith Y, 2010, AM J TROP MED HYG, V82, P1106, DOI 10.4269/ajtmh.2010.10-0030; Phares CR, 2007, CLIN INFECT DIS, V45, pE147, DOI 10.1086/523003; Prapasiri Prabda, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P706; Rammaert B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-3; Rammaert B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-126; Reechaipichitkul Wipa, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1261; Reechaipichitkul Wipa, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P430; Reechaipichitkul Wipa, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P156; Reechaipichitkul Wipa, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P151; Reechaipichitkul Wipa, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P664; Reechaipichitkul Wipa, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P355; Reechaipichitkul Wipa, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P320; Rimrang B, 2012, J ANTIMICROB CHEMOTH, V67, P2626, DOI 10.1093/jac/dks267; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; Rudan I, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001099; Samransamruajkit R, 2008, JPN J INFECT DIS, V61, P36; Sar B, 2009, SE ASIAN J TROP MED, V40, P104; Scott JAG, 2002, J INFECT DIS, V186, P220, DOI 10.1086/341205; Song JH, 2008, INT J ANTIMICROB AG, V31, P107, DOI 10.1016/j.ijantimicag.2007.09.014; Song JH, 2011, INT J ANTIMICROB AG, V38, P108, DOI 10.1016/j.ijantimicag.2011.02.017; Song JH, 2004, ANTIMICROB AGENTS CH, V48, P2101, DOI 10.1128/AAC.48.6.2101-2107.2004; Srifuengfung Somporn, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P461; Stoesser N, 2013, PEDIAT INFECT DIS J; Tram TT, 1998, PEDIATR INFECT DIS J, V17, pS192, DOI 10.1097/00006454-199809001-00023; van der Heijden YF, 2013, INT J ANTIMICROB AGE; Vlieghe E, 2011, EMERG INFECT DIS, V17, P1289, DOI 10.3201/eid1707.101069; Vlieghe ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059775; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Vong S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-97; Vugt SF, 2013, EUR RESP J; Watanabe Hiroshi, 2008, Journal of Infection and Chemotherapy, V14, P105, DOI 10.1007/s10156-007-0577-9; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; World Bank, 2013, DAT CAMB	75	17	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e89637	10.1371/journal.pone.0089637	http://dx.doi.org/10.1371/journal.pone.0089637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626053	Green Published, gold			2022-12-27	WOS:000332851300007
J	Kasonde, M; Niska, RW; Rose, C; Henderson, FL; Segolodi, TM; Turner, K; Smith, DK; Thigpen, MC; Paxton, LA				Kasonde, Michael; Niska, Richard W.; Rose, Charles; Henderson, Faith L.; Segolodi, Tebogo M.; Turner, Kyle; Smith, Dawn K.; Thigpen, Michael C.; Paxton, Lynn A.			Bone Mineral Density Changes among HIV-Uninfected Young Adults in a Randomised Trial of Pre-Exposure Prophylaxis with Tenofovir-Emtricitabine or Placebo in Botswana	PLOS ONE			English	Article							CALCIUM SUPPLEMENTATION; LAMIVUDINE; EFAVIRENZ; BLACK; AGE; DF	Background: Tenofovir-emtricitabine (TDF-FTC) pre-exposure prophylaxis (PrEP) has been found to be effective for prevention of HIV infection in several clinical trials. Two studies of TDF PrEP among men who have sex with men showed slight bone mineral density (BMD) loss. We investigated the effect of TDF and the interaction of TDF and hormonal contraception on BMD among HIV-uninfected African men and women. Method: We evaluated the effects on BMD of using daily oral TDF-FTC compared to placebo among heterosexual men and women aged 18-29 years enrolled in the Botswana TDF2 PrEP study. Participants had BMD measurements at baseline and thereafter at 6-month intervals with dual-energy X-ray absorptiometry (DXA) scans at the hip, spine, and forearm. Results: A total of 220 participants (108 TDF-FTC, 112 placebo) had baseline DXA BMD measurements at three anatomic sites. Fifteen (6.8%) participants had low baseline BMD (z-score of <-22.0 at any anatomic site), including 3/114 women (2.6%) and 12/106 men (11.3%) (p = 0.02). Low baseline BMD was associated with being underweight (p = 0.02), having high blood urea nitrogen (p = 0.02) or high alkaline phosphatase (p = 0.03), and low creatinine clearance (p = 0.04). BMD losses of >3.0% at any anatomic site at any time after baseline were significantly greater for the TDF-FTC treatment group [34/68 (50.0%) TDF-FTC vs. 26/79 (32.9%) placebo; p = 0.04]. There was a small but significant difference in the mean percent change in BMD from baseline for TDF-FTC versus placebo at all three sites at month 30 [forearm 20.84% (p = 0.01), spine -1.62% (p = 0.0002), hip -1.51% (p = 0.003)]. Conclusion: Use of TDF-FTC was associated with a small but statistically significant decrease in BMD at the forearm, hip and lumbar spine. A high percentage (6.8%) of healthy Batswana young adults had abnormal baseline BMD Further evaluation is needed of the longer-term use of TDF in HIV-uninfected persons.	[Kasonde, Michael; Henderson, Faith L.; Segolodi, Tebogo M.] Ctr Dis Control & Prevent Botswana, HIV Prevent Res Unit, Gaborone, Botswana; [Niska, Richard W.; Rose, Charles; Turner, Kyle; Smith, Dawn K.; Thigpen, Michael C.; Paxton, Lynn A.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Kasonde, M (corresponding author), Ctr Dis Control & Prevent Botswana, HIV Prevent Res Unit, Gaborone, Botswana.	kasondem@bw.cdc.gov			Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention; Division of AIDS, National Institutes of Health	Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Division of AIDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was supported by the Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, and the Division of AIDS, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; BELL NH, 1995, CALCIFIED TISSUE INT, V56, P11, DOI 10.1007/BF00298737; Berenson AB, 2004, OBSTET GYNECOL, V103, P899, DOI 10.1097/01.AOG.0000117082.49490.d5; BILECKOT R, 1991, REV RHUM, V58, P787; Choopanya K, 2013, ANTIRETROVIRAL PROPH; Cromer BA, 1999, DRUG SAFETY, V20, P213, DOI 10.2165/00002018-199920030-00002; Dumond JB, 2007, AIDS, V21, P1899, DOI 10.1097/QAD.0b013e328270385a; Ferrari S, 2012, OSTEOPOROS INT; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gong G, 2006, J NATL MED ASSOC, V98, P746; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hawkins T, 2005, JAIDS-J ACQ IMM DEF, V39, P406, DOI 10.1097/01.qai.0000167155.44980.e8; International Society for Clinical Densitometry (ISCD), 2007, POS STAT BMID REP ME; JOHNSTON CC, 1992, NEW ENGL J MED, V327, P82, DOI 10.1056/NEJM199207093270204; Lee EY, 2012, J CLIN ENDOCR METAB, V97, P3310, DOI 10.1210/jc.2012-1488; Liu AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023688; LLOYD T, 1993, JAMA-J AM MED ASSOC, V270, P841, DOI 10.1001/jama.270.7.841; Martin A, 2009, CLIN INFECT DIS, V49, P1591, DOI 10.1086/644769; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; Nordstrom P, 2007, J CLIN ENDOCR METAB, V92, P1902, DOI 10.1210/jc.2006-2613; Perrot S, 2009, J CLIN INFECT DIS, V51, P963; Riggs BL, 2008, J BONE MINER RES, V23, P205, DOI 10.1359/JBMR.071020; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Winzenberg T, 2006, BMJ-BRIT MED J, V333, P775, DOI 10.1136/bmj.38950.561400.55; Womack JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017217; World Health Organisation, 1994, ASS FRACT RISK ITS A	27	61	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90111	10.1371/journal.pone.0090111	http://dx.doi.org/10.1371/journal.pone.0090111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625530	gold, Green Submitted, Green Published			2022-12-27	WOS:000332851300014
J	Li, Y; Liu, YY; Chen, XJ; Xiong, XH; Li, FS				Li, Yi; Liu, Yuan-Yuan; Chen, Xue-Jun; Xiong, Xiao-Hui; Li, Fang-Shi			Synthesis, Spectroscopic Characterization, X-Ray Structure, and DFT Calculations of Some New 1,4-Dihydro-2,6-Dimethyl-3,5-Pyridinedicarboxamides	PLOS ONE			English	Article							ANTITUBERCULAR ACTIVITY	A series of novel 1,4-dihydro-2,6- dimethyl-3,5-pyridinedicarboxamides were synthesized and characterized by infrared absorption spectrum (IR), proton nuclear magnetic resonance (H-1 NMR), elemental analysis, ultraviolet spectrum (UV), and fluorescence techniques, together with X-ray single crystal diffraction. The results of density functional theory (DFT) and time-dependent density functional theory (TDDFT) calculations provided a reasonable explanation on the molecular structures, the molecular frontier orbital, and the spectra of electronic absorption and emission. The present work will be helpful to systematically understanding of the structures and the optical properties of 1,4-dihydropyridines for studying the structure-activity relationship and to develop new drugs and their analytical methods.	[Li, Yi; Xiong, Xiao-Hui] Nanjing Tech Univ, Coll Food Sci & Light Ind, Nanjing, Jiangsu, Peoples R China; [Liu, Yuan-Yuan] Southeast Univ, ChengXian Coll, Dept Chem & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China; [Chen, Xue-Jun; Li, Fang-Shi] Nanjing Tech Univ, Coll Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Tech University; Southeast University - China; Nanjing Tech University	Liu, YY (corresponding author), Southeast Univ, ChengXian Coll, Dept Chem & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China.	Liuyuanyuan1985419@163.com; Fangshi.li@njtech.edu.cn	liu, yuanyuan/GWZ-5838-2022		Natural Science Youth Foundation of Jiangsu Province, China [BK20130749]; Project of the Twelfth Five Year Plan of China [2012BAK17B09]; Project of Food Fast Detection Technology of Jiangsu Province, China [BM2012026]	Natural Science Youth Foundation of Jiangsu Province, China; Project of the Twelfth Five Year Plan of China; Project of Food Fast Detection Technology of Jiangsu Province, China	The Natural Science Youth Foundation of Jiangsu Province, China (BK20130749); The Project of the Twelfth Five Year Plan of China (2012BAK17B09); The Project of Food Fast Detection Technology of Jiangsu Province, China (BM2012026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Desai B, 2001, BIOORGAN MED CHEM, V9, P1993, DOI 10.1016/S0968-0896(01)00141-9; Fassihi A, 2009, EUR J MED CHEM, V44, P3253, DOI 10.1016/j.ejmech.2009.03.027; Frisch G. W., 2013, GAUSSIAN 09; FUKUI K, 1982, SCIENCE, V218, P747, DOI 10.1126/science.218.4574.747; GANIS P, 1971, J AM CHEM SOC, V93, P3328, DOI 10.1021/ja00743a004; Ghorai MK, 2010, J ORG CHEM, V75, P7061, DOI 10.1021/jo101680f; JANIS RA, 1983, J MED CHEM, V26, P775, DOI 10.1021/jm00360a001; Kemp William, 1996, ORGANIC SPECTROSCOPY, V3rd; Li Y, 2013, MOLECULES, V18, P877, DOI 10.3390/molecules18010877; Li Y, 2011, J MOL STRUCT, V997, P110, DOI 10.1016/j.molstruc.2011.05.006; Li Y, 2011, J MOL STRUCT, V987, P206, DOI 10.1016/j.molstruc.2010.12.023; Merrick JP, 2007, J PHYS CHEM A, V111, P11683, DOI 10.1021/jp073974n; Mojarrad JS, 2004, BIOORGAN MED CHEM, V12, P3215, DOI 10.1016/j.bmc.2004.03.063; Shafii B., 2008, Journal of Sciences-Islamic Republic of Iran, V19, P323; Shan RD, 2004, J MED CHEM, V47, P254, DOI 10.1021/jm030333h; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Silverstein R., 1977, SPECTROMETRIC IDENTI; STOUT DM, 1982, CHEM REV, V82, P223, DOI 10.1021/cr00048a004; Suarez M, 2003, TETRAHEDRON, V59, P9179, DOI 10.1016/j.tet.2003.09.047; Zhang QM, 2010, TETRAHEDRON, V66, P8095, DOI 10.1016/j.tet.2010.07.043	20	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91361	10.1371/journal.pone.0091361	http://dx.doi.org/10.1371/journal.pone.0091361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625887	gold, Green Published, Green Submitted			2022-12-27	WOS:000332851300078
J	Liu, FF; Yu, H				Liu, Feifan; Yu, Hong			Learning to Rank Figures within a Biomedical Article	PLOS ONE			English	Article							RERANKING; SEARCH; ADAPTATION; ENGINE	Hundreds of millions of figures are available in biomedical literature, representing important biomedical experimental evidence. This ever-increasing sheer volume has made it difficult for scientists to effectively and accurately access figures of their interest, the process of which is crucial for validating research facts and for formulating or testing novel research hypotheses. Current figure search applications can't fully meet this challenge as the "bag of figures" assumption doesn't take into account the relationship among figures. In our previous study, hundreds of biomedical researchers have annotated articles in which they serve as corresponding authors. They ranked each figure in their paper based on a figure's importance at their discretion, referred to as "figure ranking". Using this collection of annotated data, we investigated computational approaches to automatically rank figures. We exploited and extended the state-of-the-art listwise learning-to-rank algorithms and developed a new supervised-learning model BioFigRank. The cross-validation results show that BioFigRank yielded the best performance compared with other state-of-the-art computational models, and the greedy feature selection can further boost the ranking performance significantly. Furthermore, we carry out the evaluation by comparing BioFigRank with three-level competitive domain-specific human experts: (1) First Author, (2) Non-Author-In-Domain-Expert who is not the author nor co-author of an article but who works in the same field of the corresponding author of the article, and (3) Non-Author-Out-Domain-Expert who is not the author nor co-author of an article and who may or may not work in the same field of the corresponding author of an article. Our results show that BioFigRank outperforms Non-Author-Out-Domain-Expert and performs as well as Non-Author-In-Domain-Expert. Although BioFigRank underperforms First Author, since most biomedical researchers are either in-or out-domain-experts for an article, we conclude that BioFigRank represents an artificial intelligence system that offers expert-level intelligence to help biomedical researchers to navigate increasingly proliferated big data efficiently.	[Liu, Feifan] Univ Wisconsin, Dept Comp Sci, Milwaukee, WI 53201 USA; [Yu, Hong] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01655 USA; [Yu, Hong] VA Cent Western Massachusetts, Northampton, MA USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Massachusetts System; University of Massachusetts Worcester	Yu, H (corresponding author), Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01655 USA.	hongyubennett@gmail.com	Liu, Feifan/D-2478-2012	Liu, Feifan/0000-0003-0881-6365	National Institutes of Health [1R01GM095476]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health (http://www.nih.gov/) with the grant number 1R01GM095476. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL S, 2009, AMIA ANN S P; Agarwal Shashank, 2009, AMIA Annu Symp Proc, V2009, P6; Bockhorst JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039618; Braschler M, 2004, INFORM RETRIEVAL, V7, P7, DOI 10.1023/B:INRT.0000009438.69013.fa; Burges C., 2005, P 22 INT C MACH LEAR, V119, P89, DOI [10.1145/1102351.1102363, DOI 10.1145/1102351.1102363]; Burges C. J., 2007, P ADV NEUR INF PROC, V19, P193; Cao Z., 2007, P 24 INT C MACH LEAR, P129, DOI DOI 10.1145/1273496.1273513; Cass T, 1998, SCIENCE, V282, P636, DOI 10.1126/science.282.5389.636; Charniak E, 2005, P 43 ANN M ASS COMP, P180; Collins M, 2005, COMPUT LINGUIST, V31, P25, DOI 10.1162/0891201053630273; COLLINS M, 2002, P 40 ANN M ASS COMP; DEMNERFUSHMAN D, 2009, INT J MED INFORM; Esparza J, 2007, J EXP MED, V204, P701, DOI 10.1084/jem.20070073; Freund Y., 2003, J MACHINE LEARNING R, V4, P933, DOI DOI 10.1162/JMLR.2003.4.6.933; Hearst MA, 2007, BIOINFORMATICS, V23, P2196, DOI 10.1093/bioinformatics/btm301; HUANG L, 2008, P ACL; Huang ML, 2011, BIOINFORMATICS, V27, P1032, DOI 10.1093/bioinformatics/btr042; Joachims T, 2006, PROC 22 ACM SIGKDD I, P217, DOI DOI 10.1145/1150402.1150429; Jun Xu, 2007, 30th Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P391; Kahn CE, 2007, AM J ROENTGENOL, V188, P1475, DOI 10.2214/AJR.06.1740; LI Z, 2009, FOREST RERANKING MAC; Liu F, 2011, IEEE T AUDIO SPEECH, V19, P538, DOI 10.1109/TASL.2010.2052119; Liu Y, 2008, INT CONF ACOUST SPEE, P4921; Marcotte E, 2001, Brief Bioinform, V2, P363, DOI 10.1093/bib/2.4.363; Mervis J, 2012, SCIENCE, V336, P22, DOI 10.1126/science.336.6077.22; Murphy RF, 2001, 2ND ANNUAL IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, PROCEEDINGS, P119, DOI 10.1109/BIBE.2001.974420; Nallapati R., 2004, Proceedings of Sheffield SIGIR 2004. The Twenty-Seventh Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P64, DOI 10.1145/1008992.1009006; Pennisi E, 2005, SCIENCE, V309, P94, DOI 10.1126/science.309.5731.94; Qin T, 2008, INFORM PROCESS MANAG, V44, P838, DOI 10.1016/j.ipm.2007.07.016; Radev Dragomir, 2002, P 11 INT C WORLD WID, P408, DOI [10.1145/511446.511500, DOI 10.1145/511446.511500]; Rafkind B, 2006, EXPLORING TEXT IMAGE; Ranganathan S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S1; Shatkay H, 2006, BIOINFORMATICS, V22, pE446, DOI 10.1093/bioinformatics/btl235; Shen LB, 2005, MACH LEARN, V60, P73, DOI 10.1007/s10994-005-0918-9; Simon N, 2012, NAT BIOTECHNOL, V30, P334, DOI 10.1038/nbt.2182; Trelles O, 2011, NAT REV GENET, V12, DOI 10.1038/nrg2857-c1; Xia Fen, 2008, P 25 INT C MACH LEAR, P1192, DOI DOI 10.1145/1390156.1390306; Xu JX, 2000, ACM T INFORM SYST, V18, P79, DOI 10.1145/333135.333138; Xu SH, 2008, BIOINFORMATICS, V24, P1968, DOI 10.1093/bioinformatics/btn340; Yates R. B., 1999, MODERN INFORM RETRIE; Yisong Yue, 2007, 30th Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P271; Yu Hong, 2006, AMIA Annu Symp Proc, P834; Yu H, 2006, BIOINFORMATICS, V22, pE547, DOI 10.1093/bioinformatics/btl261; Yu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012983; Yu Hong, 2009, J Biomed Discov Collab, V4, P1, DOI 10.1186/1747-5333-4-1; Zheng Z., 2010, P 2010 C N AM CHAPT, P483; Zhou ZY, 2006, INT CONF ACOUST SPEE, P141	47	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e61567	10.1371/journal.pone.0061567	http://dx.doi.org/10.1371/journal.pone.0061567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625719	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300001
J	Croci, R; Pezzullo, M; Tarantino, D; Milani, M; Tsay, SC; Sureshbabu, R; Tsai, YJ; Mastrangelo, E; Rohayem, J; Bolognesi, M; Hwu, JR				Croci, Romina; Pezzullo, Margherita; Tarantino, Delia; Milani, Mario; Tsay, Shwu-Chen; Sureshbabu, Radhakrishnan; Tsai, Yi-Jin; Mastrangelo, Eloise; Rohayem, Jacques; Bolognesi, Martino; Hwu, Jih Ru			Structural Bases of Norovirus RNA Dependent RNA Polymerase Inhibition by Novel Suramin-Related Compounds	PLOS ONE			English	Article							GROWTH-FACTOR; VACCINE; PATHOGENESIS; ANTAGONIST; INFECTION; RECEPTOR; PPNDS; DRUG	Noroviruses (NV) are +ssRNA viruses responsible for severe gastroenteritis; no effective vaccines/antivirals are currently available. We previously identified Suramin (9) as a potent inhibitor of NV-RNA dependent RNA polymerase (NV-RdRp). Despite significant in vitro activities versus several pharmacological targets, Suramin clinical use is hampered by pharmacokinetics/toxicity problems. To improve Suramin access to NV-RdRp in vivo, a Suramin-derivative, 8, devoid of two sulphonate groups, was synthesized, achieving significant anti-human-NV-RdRp activity (IC50 = 28 nM); the compound inhibits also murine NV (mNV) RdRp. The synthesis process led to the isolation/characterization of lower molecular weight intermediates (3-7) hosting only one sulphonate head. The crystal structures of both hNV/mNV-RdRps in complex with 6, were analyzed, providing new knowledge on the interactions that a small fragment can establish with NV-RdRps, and establishing a platform for structure-guided optimization of potency, selectivity and drugability.	[Croci, Romina; Pezzullo, Margherita; Tarantino, Delia; Milani, Mario; Mastrangelo, Eloise; Bolognesi, Martino] Univ Milan, Dept Biosci, Milan, Italy; [Milani, Mario; Tsai, Yi-Jin] CNR IBF, Ist Biofis, Milan, Italy; [Tsay, Shwu-Chen; Hwu, Jih Ru] Natl Cent Univ, Dept Chem, Jhongli, Taiwan; [Sureshbabu, Radhakrishnan; Tsai, Yi-Jin; Hwu, Jih Ru] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan; [Sureshbabu, Radhakrishnan; Tsai, Yi-Jin; Hwu, Jih Ru] Natl Tsing Hua Univ, Frontier Res Ctr Fundamental & Appl Sci Matters, Hsinchu, Taiwan; [Rohayem, Jacques] Riboxx GmbH, Radebeul, Germany; [Rohayem, Jacques] Tech Univ Dresden, Inst Virol, Dresden, Germany	University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); National Central University; National Tsing Hua University; National Tsing Hua University; Technische Universitat Dresden	Bolognesi, M (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	martino.bolognesi@unimi.it; jrhwu@mx.nthu.edu.tw	Mastrangelo, Eloise/AAX-1385-2020; Bolognesi, Martino/B-7924-2017; Milani, Mario/B-6446-2015	Bolognesi, Martino/0000-0002-9253-5170; Milani, Mario/0000-0001-6098-3991; Mastrangelo, Eloise/0000-0002-5968-8386; Hwu, Jih Ru/0000-0002-9225-8484	National Science Council [NSC 102-2923-I-008-001]; Ministry of Education of the R.O.C., Taiwan [102N2011E1, 102N2018E1]; National Central University [102G918]; European Commission [2606444]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education of the R.O.C., Taiwan(Ministry of Education, Taiwan); National Central University; European Commission(European CommissionEuropean Commission Joint Research Centre)	National Science Council (NSC 102-2923-I-008-001), Ministry of Education of the R.O.C., Taiwan (grants nos. 102N2011E1 and 102N2018E1), and National Central University (102G918). The work at University of Milano and CNR (Milano, Italy) and at Riboxx GmbH (Dresden Germany) was supported by the European Commission SILVER project, within the 7th Framework Program Cooperation Project Grant Agreement No. 2606444. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmar RL, 2012, EXPERT REV VACCINES, V11, P1023, DOI [10.1586/erv.12.78, 10.1586/ERV.12.78]; Bartsch SM, 2012, VACCINE, V30, P7097, DOI 10.1016/j.vaccine.2012.09.040; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; Bookser BC, 2005, J MED CHEM, V48, P7808, DOI 10.1021/jm050394a; Camp D, 2012, J NAT PROD, V75, P72, DOI 10.1021/np200687v; Cheetham S, 2006, J VIROL, V80, P10372, DOI 10.1128/JVI.00809-06; Clarke IN, 1997, J GEN VIROL, V78, P291, DOI 10.1099/0022-1317-78-2-291; Clarke IN, 2000, J INFECT DIS, V181, pS309, DOI 10.1086/315575; DUNN PM, 1988, BRIT J PHARMACOL, V93, P243, DOI 10.1111/j.1476-5381.1988.tb11427.x; Eltahla AA, 2013, J BIOMOL SCREEN, V18, P1027, DOI 10.1177/1087057113489883; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fullerton SWB, 2007, J VIROL, V81, P1858, DOI 10.1128/JVI.01462-06; Hansman GS, 2005, ARCH VIROL, V150, P2529, DOI 10.1007/s00705-005-0599-5; Hansman GS, 2010, CALICIVIRUSES: MOLECULAR AND CELLULAR VIROLOGY, P1; Hawking F, 1978, Adv Pharmacol Chemother, V15, P289, DOI 10.1016/S1054-3589(08)60486-X; Jagielski AK, 2006, EUR J PHARMACOL, V537, P205, DOI 10.1016/j.ejphar.2006.03.029; KAPLAN LD, 1987, AM J MED, V82, P615, DOI 10.1016/0002-9343(87)90108-2; Karst SM, 2010, VIRUSES-BASEL, V2, P748, DOI 10.3390/v2030748; Kassack MU, 2004, EUR J MED CHEM, V39, P345, DOI 10.1016/j.ejmech.2004.01.007; Kaur M, 2002, INVEST NEW DRUG, V20, P209, DOI 10.1023/A:1015666024386; Kraszni M, 2003, J MED CHEM, V46, P2241, DOI 10.1021/jm030767c; Lee JH, 2011, J GEN VIROL, V92, P1607, DOI 10.1099/vir.0.031104-0; Lee S, 2012, J CHEM INF MODEL, V52, P440, DOI 10.1021/ci2004913; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Lustberg MB, 2012, CANCER CHEMOTH PHARM, V70, P49, DOI 10.1007/s00280-012-1887-x; Mastrangelo E, 2012, J MOL BIOL, V419, P198, DOI 10.1016/j.jmb.2012.03.008; Mitsuya H, 1984, Princess Takamatsu Symp, V15, P277; Padiya KJ, 2012, ORG LETT, V14, P2814, DOI 10.1021/ol301009d; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Pinnen F, 2007, J MED CHEM, V50, P2506, DOI 10.1021/jm070037v; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; SOLA F, 1995, CANCER CHEMOTH PHARM, V36, P217, DOI 10.1007/BF00685849; Souza M, 2007, J VIROL, V81, P9183, DOI 10.1128/JVI.00558-07; Steiner RA, 2003, ACTA CRYSTALLOGR D, V59, P2114, DOI 10.1107/S0907444903018675; Suzuki E, 2004, MOL PHARMACOL, V66, P1738, DOI 10.1124/mol.104.003038; Tarantino D, 2013, ANTIVIR RES; Thomas G, MED CHEM; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wood CR, 2003, J EXP BIOL, V206, P627, DOI 10.1242/jeb.00105; Zamai M, 2002, BIOPHYS J, V82, P2652, DOI 10.1016/S0006-3495(02)75607-5; Zamyatkin DF, 2008, J BIOL CHEM, V283, P7705, DOI 10.1074/jbc.M709563200; Zamyatkin DF, 2009, J MOL BIOL, V390, P10, DOI 10.1016/j.jmb.2009.04.069	43	34	36	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91765	10.1371/journal.pone.0091765	http://dx.doi.org/10.1371/journal.pone.0091765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622391	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300125
J	Huang, BR; Chang, PC; Yeh, WL; Lee, CH; Tsai, CF; Lin, CJ; Lin, HY; Liu, YS; Wu, CYJ; Ko, PY; Huang, SS; Hsu, HC; Lu, DY				Huang, Bor-Ren; Chang, Pei-Chun; Yeh, Wei-Lan; Lee, Chih-Hao; Tsai, Cheng-Fang; Lin, Chingju; Lin, Hsiao-Yun; Liu, Yu-Shu; Wu, Caren Yu-Ju; Ko, Pei-Ying; Huang, Shiang-Suo; Hsu, Horng-Chaung; Lu, Dah-Yuu			Anti-Neuroinflammatory Effects of the Calcium Channel Blocker Nicardipine on Microglial Cells: Implications for Neuroprotection	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE SYNTHASE; CEREBRAL-BLOOD-FLOW; FACTOR-KAPPA-B; SIGNALING PATHWAY; GLIOMA-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE	Background/Objective: Nicardipine is a calcium channel blocker that has been widely used to control blood pressure in severe hypertension following events such as ischemic stroke, traumatic brain injury, and intracerebral hemorrhage. However, accumulating evidence suggests that inflammatory processes in the central nervous system that are mediated by microglial activation play important roles in neurodegeneration, and the effect of nicardipine on microglial activation remains unresolved. Methodology/Principal Findings: In the present study, using murine BV-2 microglia, we demonstrated that nicardipine significantly inhibits microglia-related neuroinflammatory responses. Treatment with nicardipine inhibited microglial cell migration. Nicardipine also significantly inhibited LPS plus IFN-gamma-induced release of nitric oxide (NO), and the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Furthermore, nicardipine also inhibited microglial activation by peptidoglycan, the major component of the Gram-positive bacterium cell wall. Notably, nicardipine also showed significant anti-neuroinflammatory effects on microglial activation in mice in vivo. Conclusion/Significance: The present study is the first to report a novel inhibitory role of nicardipine on neuroinflammation and provides a new candidate agent for the development of therapies for inflammation-related neurodegenerative diseases.	[Huang, Bor-Ren; Hsu, Horng-Chaung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Huang, Bor-Ren] Taichung Tzu Chi Hosp, Neurosurg Dept, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan; [Huang, Bor-Ren] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chang, Pei-Chun] Asia Univ, Dept Bioinformat, Taichung, Taiwan; [Yeh, Wei-Lan] Changhua Christian Hosp, Dept Cell & Tissue Engn, Changhua, Taiwan; [Lee, Chih-Hao] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Tsai, Cheng-Fang] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Lin, Chingju] China Med Univ, Sch Med, Dept Physiol, Taichung, Taiwan; [Lin, Hsiao-Yun] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Liu, Yu-Shu; Wu, Caren Yu-Ju] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Ko, Pei-Ying] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Huang, Shiang-Suo] Chung Shan Med Univ, Dept Pharmacol, Coll Med, Taichung, Taiwan; [Huang, Shiang-Suo] Chung Shan Med Univ, Inst Med, Coll Med, Taichung, Taiwan; [Hsu, Horng-Chaung] China Med Univ Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Lu, Dah-Yuu] China Med Univ, Grad Inst Neural & Cognit Sci, Taichung, Taiwan	China Medical University Taiwan; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; Asia University Taiwan; Changhua Christian Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Asia University Taiwan; China Medical University Taiwan; National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Lu, DY (corresponding author), China Med Univ, Grad Inst Neural & Cognit Sci, Taichung, Taiwan.	dahyuu@mail.cmu.edu.tw	Liu, Yu-Shu/GQZ-6251-2022; Lu, Dah-Yuu/P-2563-2015		National Science Council [NSC 101-2320-B-039-048-MY2, NSC 102-2320-B-039-051-MY3, NSC 102-2320-B-039-026-MY3]; Taichung Tzu Chi Hospital; Buddhist Tzu Chi Medical Foundation [TTCRD 101-03]; China Medical University [CMU101-ASIA-10]; Asia University [99-A-01]	National Science Council(Ministry of Science and Technology, Taiwan); Taichung Tzu Chi Hospital; Buddhist Tzu Chi Medical Foundation; China Medical University(China Medical University); Asia University	This work was supported by grants from the National Science Council (NSC 101-2320-B-039-048-MY2, NSC 102-2320-B-039-051-MY3 and NSC 102-2320-B-039-026-MY3), Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (TTCRD 101-03), China Medical University (CMU101-ASIA-10), and Asia University (99-A-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenta F, 2004, CLIN EXP HYPERTENS, V26, P351, DOI 10.1081/CEH-120034139; Amenta F, 1996, J HYPERTENS, V14, pS29, DOI 10.1097/00004872-199610003-00006; Amenta F, 2008, CLIN EXP HYPERTENS, V30, P808, DOI 10.1080/10641960802580190; Babu CS, 2011, INT J DEV NEUROSCI, V29, P93, DOI 10.1016/j.ijdevneu.2010.08.001; Bal-Price A, 2001, J NEUROSCI, V21, P6480; BECKMAN JS, 1994, PROG BRAIN RES, V103, P371; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Casamassima F, 2010, AM J MED GENET B, V153B, P1373, DOI 10.1002/ajmg.b.31122; CHAO CC, 1995, J LEUKOCYTE BIOL, V58, P65, DOI 10.1002/jlb.58.1.65; Chen JH, 2012, INT IMMUNOPHARMACOL, V12, P94, DOI 10.1016/j.intimp.2011.10.019; Chen JH, 2011, J CELL BIOCHEM, V112, P2931, DOI 10.1002/jcb.23209; Cho S, 2005, J CEREBR BLOOD F MET, V25, P493, DOI 10.1038/sj.jcbfm.9600058; Czeh M, 2011, DEV NEUROSCI-BASEL, V33, P199, DOI 10.1159/000328989; Degoute CS, 2007, DRUGS, V67, P1053, DOI 10.2165/00003495-200767070-00007; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Gasior M, 1996, J NEURAL TRANSM, V103, P819, DOI 10.1007/BF01273360; Gianino John W, 2012, Mo Med, V109, P384; Guillot-Sestier MV, 2013, CNS NEUROL DISORD-DR, V12, P593; HALEY EC, 1994, J NEUROSURG, V80, P788, DOI 10.3171/jns.1994.80.5.0788; Hashioka S, 2012, NEUROPHARMACOLOGY, V63, P685, DOI 10.1016/j.neuropharm.2012.05.033; Hayashi M, 2000, HYPERTENS RES, V23, P521, DOI 10.1291/hypres.23.521; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Huang BR, 2013, TOXICOL APPL PHARM, V269, P43, DOI 10.1016/j.taap.2013.03.004; Huang SM, 2011, J CELL BIOCHEM, V112, P643, DOI 10.1002/jcb.22966; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Kim Sang Yong, 2012, J Cerebrovasc Endovasc Neurosurg, V14, P84, DOI 10.7461/jcen.2012.14.2.84; Knott C, 2000, MOL CELL NEUROSCI, V16, P724, DOI 10.1006/mcne.2000.0914; Koizumi S, 2002, LIFE SCI, V72, P431, DOI 10.1016/S0024-3205(02)02273-7; Koizumi S, 2013, GLIA, V61, P47, DOI 10.1002/glia.22358; Komagiri Y, 2011, CELL CALCIUM, V49, P35, DOI 10.1016/j.ceca.2010.11.006; Leung YM, 2013, BIOMEDICINE-TAIWAN, V3, P130, DOI 10.1016/j.biomed.2012.11.003; Leung YM, 2011, BIOMEDICINE-TAIWAN, V1, P16, DOI 10.1016/j.biomed.2011.10.003; Liang X, 2007, J MOL NEUROSCI, V33, P94, DOI 10.1007/s12031-007-0058-8; Lin C, 2013, NEUROSCIENCE, V231, P216, DOI 10.1016/j.neuroscience.2012.11.051; Lin HY, 2014, NEUROBIOL AGING, V35, P191, DOI 10.1016/j.neurobiolaging.2013.06.020; Lin HY, 2011, J CELL PHYSIOL, V226, P1573, DOI 10.1002/jcp.22489; Lin HY, 2010, INT IMMUNOPHARMACOL, V10, P883, DOI 10.1016/j.intimp.2010.04.026; Liu YX, 2011, NEUROPHARMACOLOGY, V60, P373, DOI 10.1016/j.neuropharm.2010.10.002; Loihl AK, 1998, PROG BRAIN RES, V118, P253; Lu DY, 2007, BRIT J PHARMACOL, V151, P396, DOI 10.1038/sj.bjp.0707187; Lu DY, 2006, BIOCHEM PHARMACOL, V72, P992, DOI 10.1016/j.bcp.2006.06.038; Lu DY, 2013, INT J NEUROPSYCHOPH, V16, P433, DOI 10.1017/S1461145712000338; Lu DY, 2012, NEURO-ONCOLOGY, V14, P1367, DOI 10.1093/neuonc/nos262; Lu DY, 2010, BIOCHEM PHARMACOL, V80, P1201, DOI 10.1016/j.bcp.2010.06.046; Lu DY, 2010, J CELL BIOCHEM, V110, P697, DOI 10.1002/jcb.22580; Lu DY, 2009, EUR J PHARMACOL, V613, P146, DOI 10.1016/j.ejphar.2009.03.001; Maa MC, 2013, BIOMEDICINE-TAIWAN, V3, P1, DOI 10.1016/j.biomed.2012.12.006; Matsui T, 2010, BIOCHEM BIOPH RES CO, V396, P566, DOI 10.1016/j.bbrc.2010.04.149; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003; Mikami C, 2001, CEREBROVASC DIS, V11, P44, DOI 10.1159/000047610; Narotam PK, 2008, J NEUROSURG, V109, P1065, DOI 10.3171/JNS.2008.109.12.1065; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Patel Anita R, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P73; Politis M, 2011, HUM BRAIN MAPP, V32, P258, DOI 10.1002/hbm.21008; Powers WJ, 2001, NEUROLOGY, V57, P18, DOI 10.1212/WNL.57.1.18; Qian L, 2010, J NEURAL TRANSM, V117, P971, DOI 10.1007/s00702-010-0428-1; Qureshi AI, 2011, NEUROCRIT CARE, V15, P559, DOI 10.1007/s12028-011-9538-3; Qureshi AI, 2006, CRIT CARE MED, V34, P1975, DOI 10.1097/01.CCM.0000220763.85974.E8; Qureshi Ai, 2012, J Vasc Interv Neurol, V5, P6; Rasmuson S., 2011, INT PSYCHOGERIATR, V18, P1; Saijonmaa Outi, 1997, Blood Pressure, V6, P24, DOI 10.3109/08037059709086442; Sanz JM, 2012, BRIT J PHARMACOL, V167, P1702, DOI 10.1111/j.1476-5381.2012.02112.x; Sato Shoichiro, 2012, Rinsho Shinkeigaku, V52, P642; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schut Ewout S, 2008, Pract Neurol, V8, P8, DOI 10.1136/jnnp.2007.139725; Su PY, 2013, BIOMEDICINE-TAIWAN, V3, P181, DOI 10.1016/j.biomed.2013.08.001; Tejada JG, 2007, AM J NEURORADIOL, V28, P844; Triggle DJ, 2007, BIOCHEM PHARMACOL, V74, P1, DOI 10.1016/j.bcp.2007.01.016; Tsai CF, 2012, INT J MOL SCI, V13, P9877, DOI 10.3390/ijms13089877; Uslu S, 2012, NEUROCHEM RES, V37, P1554, DOI 10.1007/s11064-012-0750-0; Wang JY, 2003, J NEUROSCI RES, V72, P508, DOI 10.1002/jnr.10597; Yermakova A, 2000, CURR PHARM DESIGN, V6, P1755, DOI 10.2174/1381612003398672; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; Zhang XL, 2012, J INT MED RES, V40, P1036, DOI 10.1177/147323001204000322; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	76	47	52	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91167	10.1371/journal.pone.0091167	http://dx.doi.org/10.1371/journal.pone.0091167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621589	Green Submitted, gold, Green Published			2022-12-27	WOS:000332845300055
J	Li, J; Liu, C; Guo, QP; Yang, HL; Li, B				Li, Jun; Liu, Chen; Guo, Qianping; Yang, Huilin; Li, Bin			Regional Variations in the Cellular, Biochemical, and Biomechanical Characteristics of Rabbit Annulus Fibrosus	PLOS ONE			English	Article							INTERVERTEBRAL DISC; ANULUS FIBROSUS; MECHANICAL-PROPERTIES; DEGENERATION; MATRIX; EXPRESSION; THERAPIES; CELLS; DIFFERENTIATION; FIBERS	Tissue engineering of annulus fibrosus (AF), the essential load-bearing disc component, remains challenging due to the intrinsic heterogeneity of AF tissue. In order to provide a set of characterization data of AF tissue, which serve as the benchmark for constructing tissue engineered AF, we analyzed tissues and cells from various radial zones of AF, i.e., inner AF (iAF), middle AF (mAF), and outer AF (oAF), using a rabbit model. We found that a radial gradient in the cellular, biochemical, and biomechanical characteristics of rabbit AF existed. Specifically, the iAF cells (iAFCs) had the highest expression of collagen-II and aggrecan genes, while oAF cells (oAFCs) had the highest collagen-I gene expression. The contents of DNA, total collagen and collagen-I sequentially increased from iAF, mAF to oAF, while glycosaminoglycan (GAG) and collagen-II levels decreased. The cell traction forces of primary AFCs gradually decreased from iAFCs, mAFCs to oAFCs, being 336.6 +/- 155.3, 199.0 +/- 158.8, and 123.8 +/- 76.1 Pa, respectively. The storage moduli of iAF, mAF, and oAF were 0.032 +/- 0.002, 2.121 +/- 0.656, and 4.130 +/- 0.159 MPa, respectively. These measurements have established a set of reference data for functional evaluation of the efficacy of AF tissue engineering strategies using a convenient and cost-effective rabbit model, the findings of which may be further translated to human research.	[Li, Jun; Liu, Chen; Yang, Huilin; Li, Bin] Soochow Univ, Affiliated Hosp 1, Dept Orthopaed, Suzhou, Jiangsu, Peoples R China; [Guo, Qianping; Yang, Huilin; Li, Bin] Soochow Univ, Inst Orthoped, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Li, B (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Orthopaed, Suzhou, Jiangsu, Peoples R China.	binli@suda.edu.cn	Li, Bin/B-7802-2012	Li, Jun/0000-0002-3257-9315	National Natural Science Foundation of China [81171479]; Natural Science Foundation of Jiangsu Province [BK2011291]; Graduate Research and Innovation Program of Jiangsu Province [CXZZ12_0843]; Jiangsu Provincial Special Program of Medical Science [BL2012004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Graduate Research and Innovation Program of Jiangsu Province; Jiangsu Provincial Special Program of Medical Science	This study was supported by grants from the National Natural Science Foundation of China (81171479), Natural Science Foundation of Jiangsu Province (BK2011291), the Graduate Research and Innovation Program of Jiangsu Province (CXZZ12_0843), and the Jiangsu Provincial Special Program of Medical Science(BL2012004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2005, J BIOMECH, V38, P1972, DOI 10.1016/j.jbiomech.2005.03.028; Adams MA, 2012, J ANAT, V221, P497, DOI 10.1111/j.1469-7580.2012.01551.x; Bowles RD, 2010, TISSUE ENG PT A, V16, P1339, DOI [10.1089/ten.tea.2009.0442, 10.1089/ten.TEA.2009.0442]; Bron J, 2009, EUR SPINE J, V18, P301, DOI 10.1007/s00586-008-0856-x; Bruehlmann SB, 2002, J ANAT, V201, P159, DOI 10.1046/j.1469-7580.2002.00080.x; BUCKWALTER JA, 1993, J BONE JOINT SURG AM, V75A, P1533, DOI 10.2106/00004623-199310000-00015; Chou AI, 2006, SPINE, V31, P1875, DOI 10.1097/01.brs.0000229222.98051.9a; Cortes DH, 2013, J ORTHOP RES, V31, P1725, DOI 10.1002/jor.22430; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Driscoll TP, 2013, J ORTHOP RES, V31, P864, DOI 10.1002/jor.22312; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Feng G, 2010, J BONE JOINT SURG AM, V92A, P675, DOI 10.2106/JBJS.H.01672; Guerin HL, 2007, J ORTHOP RES, V25, P508, DOI 10.1002/jor.20324; Hakkinen A, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-2; Hegewald AA, 2008, FRONT BIOSCI-LANDMRK, V13, P1507, DOI 10.2741/2777; Herbert EG, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/7/074021; Horner HA, 2002, SPINE, V27, P1018, DOI 10.1097/00007632-200205150-00004; Hudson KD, 2013, CURR OPIN BIOTECH, V24, P872, DOI 10.1016/j.copbio.2013.04.012; Hughes SPF, 2012, J BONE JOINT SURG BR, V94B, P1298, DOI 10.1302/0301-620X.94B10.28986; Hutton WC, 1999, SPINE, V24, P1507, DOI 10.1097/00007632-199908010-00002; Iatridis JC, 2009, NAT MATER, V8, P923, DOI 10.1038/nmat2577; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Koepsell L, 2011, J BIOMED MATER RES A, V99A, P564, DOI 10.1002/jbm.a.33216; Kroeber MW, 2002, SPINE, V27, P2684, DOI 10.1097/00007632-200212010-00007; Lewis NT, 2008, MICRON, V39, P1008, DOI 10.1016/j.micron.2007.08.009; Li B, 2010, SENSORS-BASEL, V10, P9948, DOI 10.3390/s101109948; Li B, 2008, J BIOMECH, V41, P3349, DOI 10.1016/j.jbiomech.2008.09.025; Li F, 2008, CELL MOTIL CYTOSKEL, V65, P332, DOI 10.1002/cm.20263; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; MCNALLY DS, 1992, SPINE, V17, P66, DOI 10.1097/00007632-199201000-00011; Nerurkar NL, 2010, J BIOMECH, V43, P1017, DOI 10.1016/j.jbiomech.2009.12.001; Nerurkar NL, 2010, SPINE, V35, P867, DOI 10.1097/BRS.0b013e3181d74414; Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]; O'Halloran DM, 2007, TISSUE ENG, V13, P1927, DOI 10.1089/ten.2005.0608; SKAGGS DL, 1994, SPINE, V19, P1310, DOI 10.1097/00007632-199406000-00002; Smith LJ, 2006, J ANAT, V209, P359, DOI 10.1111/j.1469-7580.2006.00610.x; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; STOKES IAF, 1987, J ORTHOPAED RES, V5, P348, DOI 10.1002/jor.1100050306; Wan YQ, 2008, BIOMATERIALS, V29, P643, DOI 10.1016/j.biomaterials.2007.10.031; Yu J, 2007, J ANAT, V210, P460, DOI 10.1111/j.1469-7580.2007.00707.x	41	19	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91799	10.1371/journal.pone.0091799	http://dx.doi.org/10.1371/journal.pone.0091799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622282	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300130
J	Liao, B; Li, Y; Jiang, Y; Cai, LJ				Liao, Bo; Li, Yun; Jiang, Yan; Cai, Lijun			Using Multi-Instance Hierarchical Clustering Learning System to Predict Yeast Gene Function	PLOS ONE			English	Article							PROTEIN FUNCTION; SCALE DATA; ANNOTATION; ALGORITHM; ONTOLOGY; TOOL	Time-course gene expression datasets, which record continuous biological processes of genes, have recently been used to predict gene function. However, only few positive genes can be obtained from annotation databases, such as gene ontology (GO). To obtain more useful information and effectively predict gene function, gene annotations are clustered together to form a learnable and effective learning system. In this paper, we propose a novel multi-instance hierarchical clustering (MIHC) method to establish a learning system by clustering GO and compare this method with other learning system establishment methods. Multi-label support vector machine classifier and multi-label K-nearest neighbor classifier are used to verify these methods in four yeast time-course gene expression datasets. The MIHC method shows good performance, which serves as a guide to annotators or refines the annotation in detail.	[Liao, Bo; Li, Yun; Jiang, Yan; Cai, Lijun] Hunan Univ, Coll Informat Sci & Engn, Changsha 410082, Hunan, Peoples R China	Hunan University	Liao, B (corresponding author), Hunan Univ, Coll Informat Sci & Engn, Changsha 410082, Hunan, Peoples R China.	dragonbw@163.com; in_ljcai@yeah.net			Program for New Century Excellent Talents in University [NCET-10-0365]; National Nature Science Foundation of China [60973082, 11171369, 61272395, 61370171]; National Nature Science Foundation of Hunan Province [12JJ2041]; Planned Science and Technology Project of Hunan Province [2009FJ3195, 2012FJ2012]; Fundamental Research Funds for the Central Universities, Hunan university	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science Foundation of Hunan Province; Planned Science and Technology Project of Hunan Province; Fundamental Research Funds for the Central Universities, Hunan university(Fundamental Research Funds for the Central Universities)	This work is supported by the Program for New Century Excellent Talents in University (Grant NCET-10-0365), National Nature Science Foundation of China (Grant 60973082, 11171369, 61272395,61370171), National Nature Science Foundation of Hunan Province (Grant 12JJ2041), the Planned Science and Technology Project of Hunan Province (Grant 2009FJ3195, 2012FJ2012) and supported by the Fundamental Research Funds for the Central Universities, Hunan university. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chen Y, 2004, NUCLEIC ACIDS RES, V32, P6414, DOI 10.1093/nar/gkh978; Clare A, 2003, BIOINFORMATICS, V19, pII42, DOI 10.1093/bioinformatics/btg1058; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Eblen JD, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S5; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Hvidsten T R, 2001, Pac Symp Biocomput, P299; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kim WK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s5; Laegreid A, 2003, GENOME RES, V13, P965, DOI 10.1101/gr.1144503; Langfelder P, 2012, J STAT SOFTWARE, V46; Li YX, 2012, IEEE ACM T COMPUT BI, V9, P98, DOI 10.1109/TCBB.2011.73; Liang S, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-61; Ma P, 2006, NUCLEIC ACIDS RES, V34, P1261, DOI 10.1093/nar/gkl013; Magi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038767; Mitsakakis N, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-8; MURTAGH F, 1983, COMPUT J, V26, P354, DOI 10.1093/comjnl/26.4.354; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Ostergard PRJ, 2002, DISCRETE APPL MATH, V120, P197, DOI 10.1016/S0166-218X(01)00290-6; Punnen AP, 2012, DISCRETE OPTIM, V9, P205, DOI 10.1016/j.disopt.2012.05.002; Schietgat L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-2; Schlkopf B., 2006, ADV NEURAL INFORM PR, V19, P1609; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tibshirani R, 1999, CLUSTERING METHODS A; Vapnik V.N., 2006, ESTIMATION DEPENDENC, VVolume 40; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Zhang ML, 2007, PATTERN RECOGN, V40, P2038, DOI 10.1016/j.patcog.2006.12.019; Zhou Zhi-Hua, 2004, TECH REP	33	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90962	10.1371/journal.pone.0090962	http://dx.doi.org/10.1371/journal.pone.0090962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621610	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300038
J	Reddy, CA; Somepalli, V; Golakoti, T; Kanugula, AK; Karnewar, S; Rajendiran, K; Vasagiri, N; Prabhakar, S; Kuppusamy, P; Kotamraju, S; Kutala, VK				Reddy, Cheruku Apoorva; Somepalli, Venkateswarlu; Golakoti, Trimurtulu; Kanugula, Anantha KoteswaraRao; Karnewar, Santosh; Rajendiran, Karthikraj; Vasagiri, Nagarjuna; Prabhakar, Sripadi; Kuppusamy, Periannan; Kotamraju, Srigiridhar; Kutala, Vijay Kumar			Mitochondrial-Targeted Curcuminoids: A Strategy to Enhance Bioavailability and Anticancer Efficacy of Curcumin	PLOS ONE			English	Article							OVARIAN-CANCER CELLS; OXIDATIVE STRESS; BREAST-CANCER; SUPPRESSES PROLIFERATION; STAT3 PHOSPHORYLATION; SIGNALING PATHWAYS; GENE-EXPRESSION; BNIP3 GENE; APOPTOSIS; PROTEIN	Although the anti-cancer effects of curcumin has been shown in various cancer cell types, in vitro, pre-clinical and clinical studies showed only a limited efficacy, even at high doses. This is presumably due to low bioavailability in both plasma and tissues, particularly due to poor intracellular accumulation. A variety of methods have been developed to achieve the selective targeting of drugs to cells and mitochondrion. We used a novel approach by conjugation of curcumin to lipophilic triphenylphosphonium (TPP) cation to facilitate delivery of curcumin to mitochondria. TPP is selectively taken up by mitochondria driven by the membrane potential by several hundred folds. In this study, three mitocurcuminoids (mitocurcuminoids-1, 2, and 3) were successfully synthesized by tagging TPP to curcumin at different positions. ESI-MS analysis showed significantly higher uptake of the mitocurcuminoids in mitochondria as compared to curcumin in MCF-7 breast cancer cells. All three mitocurcuminoids exhibited significant cytotoxicity to MCF-7, MDA-MB-231, SKNSH, DU-145, and HeLa cancer cells with minimal effect on normal mammary epithelial cells (MCF-10A). The IC50 was much lower for mitocurcuminoids when compared to curcumin. The mitocurcuminoids induced significant ROS generation, a drop in Delta circle divide m, cell-cycle arrest and apoptosis. They inhibited Akt and STAT3 phosphorylation and increased ERK phosphorylation. Mitocurcuminoids also showed upregulation of pro-apoptotic BNIP3 expression. In conclusion, the results of this study indicated that mitocurcuminoids show substantial promise for further development as a potential agent for the treatment of various cancers.	[Reddy, Cheruku Apoorva; Vasagiri, Nagarjuna; Kutala, Vijay Kumar] Nizams Inst Med Sci, Dept Clin Pharmacol & Therapeut, Hyderabad, AP, India; [Somepalli, Venkateswarlu; Golakoti, Trimurtulu] Laila Impex R&D Ctr, Vijayawada, AP, India; [Kanugula, Anantha KoteswaraRao; Karnewar, Santosh; Kotamraju, Srigiridhar] Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad 500007, AP, India; [Rajendiran, Karthikraj; Prabhakar, Sripadi] Indian Inst Chem Technol, Natl Ctr Mass Spectrometry, Hyderabad 500007, AP, India; [Kuppusamy, Periannan] Dartmouth Coll, Geisel Sch Med, Dept Radiol, Hanover, NH 03755 USA	Nizam's Institute of Medical Sciences; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Dartmouth College	Kotamraju, S (corresponding author), Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad 500007, AP, India.	giridhar@iict.res.in; vijaykutala@gmail.com	Karnewar, Santosh/AAI-8536-2021; Kanugula, Anantha Koteswararao/H-8187-2019; RAJENDIRAN, KARTHIKRAJ/K-3571-2019	RAJENDIRAN, KARTHIKRAJ/0000-0001-9680-8079; Kutala, Vijay Kumar/0000-0002-7253-8999	DST [SR/SO/HS-110/2008, SR/SO/HS-0021/2010]; CSIR, India [CSC-0111]; CSIR; ICMR	DST(Department of Science & Technology (India)); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); ICMR(Indian Council of Medical Research (ICMR))	This study was supported by the grants from DST (Grant No.: SR/SO/HS-110/2008, Grant No.: SR/SO/HS-0021/2010) and CSIR (Grant. No.: CSC-0111), India (as part ofthe SMiLE project). Senior research fellowship to AKK from CSIR and Junior reserach fellowship to NV from ICMR is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Aggarwal S, 2006, MOL PHARMACOL, V69, P195, DOI 10.1124/mol.105.017400; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Biasutto L, 2008, BIOORG MED CHEM LETT, V18, P5594, DOI 10.1016/j.bmcl.2008.08.100; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Cheng G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-285; DAIRKEE SH, 1991, BREAST CANCER RES TR, V18, P57, DOI 10.1007/BF01975444; DAVIS S, 1985, J BIOL CHEM, V260, P3844; Dayton A, 2010, CANCER BIOL THER, V10, P1027, DOI 10.4161/cbt.10.10.13250; Fu SQ, 2010, CANCER-AM CANCER SOC, V116, P4670, DOI 10.1002/cncr.25414; Ghosh A, 2010, FREE RADICAL BIO MED, V49, P1674, DOI 10.1016/j.freeradbiomed.2010.08.028; Glienke W, 2010, CANCER INVEST, V28, P166, DOI 10.3109/07357900903287006; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; Javvadi P, 2008, MOL PHARMACOL, V73, P1491, DOI 10.1124/mol.107.043554; Kijima T, 2002, CELL GROWTH DIFFER, V13, P355; Kubli DA, 2005, BIOCHEM J, V405, P407; Kubli DA, 2008, AM J PHYSIOL-HEART C, V295, pH2025, DOI 10.1152/ajpheart.00552.2008; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lakshmi SVV, 2013, MOL CELL BIOCHEM, V374, P203, DOI 10.1007/s11010-012-1520-7; Modica-Napolitano JS, 2001, ADV DRUG DELIVER REV, V49, P63, DOI 10.1016/S0169-409X(01)00125-9; Mukhopadhyay A, 2001, ONCOGENE, V20, P7597, DOI 10.1038/sj.onc.1204997; Murai M, 2005, BRIT J CANCER, V92, P1165, DOI 10.1038/sj.bjc.6602422; Murai M, 2005, CLIN CANCER RES, V11, P1021; Murphy MP, 1997, TRENDS BIOTECHNOL, V15, P326, DOI 10.1016/S0167-7799(97)01068-8; Naushad SM, 2011, CELL BIOCHEM BIOPHYS, V61, P715, DOI 10.1007/s12013-011-9245-x; Pandian RP, 2003, ARCH BIOCHEM BIOPHYS, V420, P169, DOI 10.1016/j.abb.2003.09.008; Porteous CM, 2010, BBA-GEN SUBJECTS, V1800, P1009, DOI 10.1016/j.bbagen.2010.06.001; Prakobwong S, 2011, CARCINOGENESIS, V32, P1372, DOI 10.1093/carcin/bgr032; Rao VA, 2010, J BIOL CHEM, V285, P34447, DOI 10.1074/jbc.M110.133579; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; RUBY AJ, 1995, CANCER LETT, V94, P79, DOI 10.1016/0304-3835(95)03827-J; Selvendiran K, 2007, J BIOL CHEM, V282, P28609, DOI 10.1074/jbc.M703796200; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; Thangapazham RL, 2006, AAPS J, V8, pE443, DOI 10.1208/aapsj080352; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Weir NM, 2007, CANCER BIOL THER, V6, P178, DOI 10.4161/cbt.6.2.3577	40	65	69	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e89351	10.1371/journal.pone.0089351	http://dx.doi.org/10.1371/journal.pone.0089351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622734	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300008
J	Zhao, X; Liu, L; Zhang, XX; Shi, JX; Huang, ZW				Zhao, Xian; Liu, Li; Zhang, Xiao-xiao; Shi, Jia-xin; Huang, Zhen-wei			The Effect of Belief in Free Will on Prejudice	PLOS ONE			English	Article							IMPLICIT THEORIES; WEAKENING BELIEF; SELF-CONTROL; EXPRESSION; MOTIVATION; ATTITUDES; PREDICTS	The current research examined the role of the belief in free will on prejudice across Han Chinese and white samples. Belief in free will refers to the extent to which people believe human beings truly have free will. In Study 1, the beliefs of Han Chinese people in free will were measured, and their social distances from the Tibetan Chinese were used as an index of ethnic prejudice. The results showed that the more that Han Chinese endorsed the belief in free will, the less that they showed prejudice against the Tibetan Chinese. In Study 2, the belief of the Han Chinese in free will was manipulated, and their explicit feelings towards the Uyghur Chinese were used as an indicator of ethnic prejudice. The results showed that the participants in the condition of belief in free will reported less prejudice towards Uyghur Chinese compared to their counterparts in the condition of disbelief in free will. In Study 3, white peoples' belief in free will was manipulated, and their pro-black attitudes were measured as an indirect indicator of racial prejudice. The results showed that, compared to the condition of disbelief in free will, the participants who were primed by a belief in free will reported stronger pro-black attitudes. These three studies suggest that endorsement of the belief in free will can lead to decreased ethnic/racial prejudice compared to denial of the belief in free will. The theoretical and practical implications are discussed.	[Zhao, Xian; Liu, Li; Zhang, Xiao-xiao; Shi, Jia-xin; Huang, Zhen-wei] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [Zhao, Xian] Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA	Beijing Normal University; University of Kansas	Liu, L (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China.	l.liu@bnu.edu.cn	Liu, Li/T-6645-2017	Liu, Li/0000-0002-4898-3013	National Natural Science Foundation of China [71071021]; MOE Project of the Key Research Institute of Humanities and Social Sciences in University [2009JJDXLX001]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOE Project of the Key Research Institute of Humanities and Social Sciences in University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Natural Science Foundation of China (71071021), the MOE Project of the Key Research Institute of Humanities and Social Sciences in University (2009JJDXLX001), and the Fundamental Research Funds for the Central Universities awarded to Li Liu. The funders had no role in study design, data collection, decision to publish or preparation of the manuscript.	Allport G. W., 1954, NATURE PREJUDICE; Baumeister RF, 2008, PERSPECT PSYCHOL SCI, V3, P14, DOI 10.1111/j.1745-6916.2008.00057.x; Baumeister RF, 2012, SOC PERSONAL PSYCHOL, V6, P736, DOI 10.1111/j.1751-9004.2012.00458.x; Baumeister RF, 2009, PERS SOC PSYCHOL B, V35, P260, DOI 10.1177/0146167208327217; Bogardus ES, 1925, J APPL SOCIOL, V9, P299; Carey JM, 2013, J PERS, V81, P130, DOI 10.1111/j.1467-6494.2012.00799.x; Crandall CS, 2001, PERS SOC PSYCHOL B, V27, P30, DOI 10.1177/0146167201271003; Dasgupta N, 2001, J PERS SOC PSYCHOL, V81, P800, DOI 10.1037/0022-3514.81.5.800; DWECK CS, 1995, PSYCHOL INQ, V6, P267, DOI 10.1207/s15327965pli0604_1; Gaertner S. L., 2000, REDUCING INTERGROUP; Gailliot MT, 2009, J EXP SOC PSYCHOL, V45, P288, DOI 10.1016/j.jesp.2008.09.003; Galinsky AD, 2000, J PERS SOC PSYCHOL, V78, P708, DOI 10.1037//0022-3514.78.4.708; Hillman B, 2006, MOD CHINA, V32, P251, DOI 10.1177/0097700405286186; Job V, 2010, PSYCHOL SCI, V21, P1686, DOI 10.1177/0956797610384745; KATZ I, 1988, J PERS SOC PSYCHOL, V55, P893, DOI 10.1037/0022-3514.55.6.893; Madrid PA, 2008, PROF PSYCHOL-RES PR, V39, P86, DOI 10.1037/0735-7028.39.1.86; Marger M.N., 2009, RACE ETHNIC RELATION, V8th; Muraven M, 2008, J APPL SOC PSYCHOL, V38, P314, DOI 10.1111/j.1559-1816.2007.00307.x; Nichols S, 2009, ARE WE FREE PSYCHOL, P128; No S, 2008, J PERS SOC PSYCHOL, V95, P991, DOI 10.1037/a0012978; Paulhus DL, 2011, J PERS ASSESS, V93, P96, DOI 10.1080/00223891.2010.528483; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P488, DOI 10.1037/0022-3514.89.4.488; Pettigrew TF, 1998, ANNU REV PSYCHOL, V49, P65, DOI 10.1146/annurev.psych.49.1.65; Plant EA, 1998, J PERS SOC PSYCHOL, V75, P811, DOI 10.1037/0022-3514.75.3.811; Rigoni D, 2013, COGNITION, V127, P264, DOI 10.1016/j.cognition.2013.01.009; Rigoni D, 2012, CONSCIOUS COGN, V21, P1482, DOI 10.1016/j.concog.2012.04.004; Stephens NM, 2013, J CROSS CULT PSYCHOL, V44, P606, DOI 10.1177/0022022112454330; Stillman TF, 2011, PHILOS PSYCHOL, V24, P381, DOI 10.1080/09515089.2011.556607; Stillman TF, 2010, J EXP SOC PSYCHOL, V46, P951, DOI 10.1016/j.jesp.2010.05.012; Stillman TF, 2010, SOC PSYCHOL PERS SCI, V1, P43, DOI 10.1177/1948550609351600; USA Today/CNN Gallup, 2005, US TODAY; Vohs KD, 2008, PSYCHOL SCI, V19, P49, DOI 10.1111/j.1467-9280.2008.02045.x; Vohs KD, 2012, J EXP SOC PSYCHOL, V48, P943, DOI 10.1016/j.jesp.2012.03.002; von Hippel W, 2000, PERS SOC PSYCHOL B, V26, P523, DOI 10.1177/0146167200267001; WEINER B, 1985, PSYCHOL BULL, V97, P74, DOI 10.1037/0033-2909.97.1.74; WEINER B, 1993, AM PSYCHOL, V48, P957, DOI 10.1037/0003-066X.48.9.957; WEINER B, 1988, J PERS SOC PSYCHOL, V55, P738, DOI 10.1037/0022-3514.55.5.738	37	15	15	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91572	10.1371/journal.pone.0091572	http://dx.doi.org/10.1371/journal.pone.0091572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24622280	Green Submitted, gold, Green Published			2022-12-27	WOS:000332845300106
J	Carl, N; Billari, FC				Carl, Noah; Billari, Francesco C.			Generalized Trust and Intelligence in the United States	PLOS ONE			English	Article							VOCABULARY; EDUCATION	Generalized trust refers to trust in other members of society; it may be distinguished from particularized trust, which corresponds to trust in the family and close friends. An extensive empirical literature has established that generalized trust is an important aspect of civic culture. It has been linked to a variety of positive outcomes at the individual level, such as entrepreneurship, volunteering, self-rated health, and happiness. However, two recent studies have found that it is highly correlated with intelligence, which raises the possibility that the other relationships in which it has been implicated may be spurious. Here we replicate the association between intelligence and generalized trust in a large, nationally representative sample of U.S. adults. We also show that, after adjusting for intelligence, generalized trust continues to be strongly associated with both self-rated health and happiness. In the context of substantial variation across countries, these results bolster the view that generalized trust is a valuable social resource, not only for the individual but for the wider society as well.	[Carl, Noah] Univ Oxford, Dept Sociol, Oxford, England; Univ Oxford, Nuffield Coll, Oxford, England	University of Oxford; University of Oxford	Carl, N (corresponding author), Univ Oxford, Dept Sociol, Oxford, England.	noah.carl@nuffield.ox.ac.uk		Billari, Francesco C./0000-0003-4717-6129	Nuffield College, Oxford; Economic and Social Research Council, UK; Economic and Social Research Council [1369462] Funding Source: researchfish	Nuffield College, Oxford; Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	N.C. is funded by Nuffield College, Oxford, and the Economic and Social Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algan Y, 2010, AM ECON REV, V100, P2060, DOI 10.1257/aer.100.5.2060; Ali A, 2013, PSYCHOL MED, V43, P1303, DOI 10.1017/S0033291712002139; Beaujean AA, 2010, PERS INDIV DIFFER, V48, P294, DOI 10.1016/j.paid.2009.10.019; Bekkers R, 2012, POLIT BEHAV, V34, P225, DOI 10.1007/s11109-011-9165-x; Bjornskov C, 2012, SOUTH ECON J, V78, P1346, DOI 10.4284/0038-4038-78.4.1346; Calvo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042793; Caplan B, 2010, INTELLIGENCE, V38, P636, DOI 10.1016/j.intell.2010.09.005; Cosmides L, 2010, P NATL ACAD SCI USA, V107, P9007, DOI 10.1073/pnas.0914623107; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Fairbrother M, 2013, SOC SCI RES, V42, P347, DOI 10.1016/j.ssresearch.2012.09.008; Giordano GN, 2012, SOC SCI MED, V75, P340, DOI 10.1016/j.socscimed.2012.03.011; Guiso L, 2006, J ECON PERSPECT, V20, P23, DOI 10.1257/jep.20.2.23; Helliwell J., 2011, INT J WELL BEING, V1, P42, DOI DOI 10.5502/IJW.V1I1.9; Hooghe M, 2012, INTELLIGENCE, V40, P604, DOI 10.1016/j.intell.2012.08.006; Huang MH, 2009, SOC SCI RES, V38, P31, DOI 10.1016/j.ssresearch.2008.07.004; Jen MH, 2010, HEALTH PLACE, V16, P1022, DOI 10.1016/j.healthplace.2010.06.008; Jensen AR, 2001, BEHAV BRAIN SCI, V24, P1109, DOI 10.1017/S0140525X01280133; Ligon E, 1994, 64 GSS NAT OP RES CT; Lynn R, 2004, PERS INDIV DIFFER, V36, P201, DOI 10.1016/S0191-8869(03)00079-5; Oswald AJ, 2010, SCIENCE, V327, P576, DOI 10.1126/science.1180606; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Ronconi L, 2012, HEALTH ECON, V21, P201, DOI 10.1002/hec.1696; Simpson B, 2006, SOC FORCES, V84, P1625, DOI 10.1353/sof.2006.0066; Smith A, 1991, INQUIRY NATURE CAUSE, V4; Smith T.W., 2012, GEN SOCIAL SURVEYS 1; Stephenson B., 1978, 3 GSS NAT OP RES CTR; Sturgis P, 2010, INTELLIGENCE, V38, P45, DOI 10.1016/j.intell.2009.11.006; Tabellini G, 2008, J EUR ECON ASSOC, V6, P255, DOI 10.1162/JEEA.2008.6.2-3.255; Tokuda Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003985; WOLFLE LM, 1980, SOCIOL EDUC, V53, P104, DOI 10.2307/2112492; Yamagishi T., 2001, TRUST SOC	31	42	42	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91786	10.1371/journal.pone.0091786	http://dx.doi.org/10.1371/journal.pone.0091786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24619035	gold, Green Published, Green Submitted			2022-12-27	WOS:000332842400129
J	Le Coz, GM; Anton, F; Hanesch, U				Le Coz, Glenn-Marie; Anton, Fernand; Hanesch, Ulrike			Glucocorticoid-Mediated Enhancement of Glutamatergic Transmission May Outweigh Anti-Inflammatory Effects under Conditions of Neuropathic Pain	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ACTIVATED PROTEIN-KINASE; PERIPHERAL-NERVE INJURY; TNF-ALPHA; SCIATIC-NERVE; SPINAL-CORD; EXPRESSION; RATS; HYPERALGESIA; RECEPTORS	At the clinical level comorbidity between chronic pain and dysfunctional hypothalamus-pituitary-adrenal (HPA) axis is well established. We aimed to identify causal relationships in a model of neuropathic pain (chronic constriction injury, CCI) by studying the effects of glucocorticoid receptor agonist (dexamethasone) and antagonist (RU-486) administration on pain behavior and spinal biochemical mediators. Daily injections were performed in Sprague Dawley rats. Weight, plasma corticosterone levels and mechanical pain thresholds were assessed before and during 21 days post-CCI. At days four and 21 we investigated the mRNA expression of spinal mediators. In the dexamethasone-injected group, we observed a diminution of body weight and plasma corticosterone levels during the 21 days post surgery period and a more pronounced pain sensitivity until day 7 post-CCI. This enhanced pain sensitivity in the early period following nerve injury was accompanied by a transient increase of the glutamate receptors mGluR5 and NMDA at day 4. However, at this time point we did not observe any effect of the agonist/antagonist injections on the mRNA expression of pro-inflammatory cytokines. The RU-486-injected rats showed a slight mechanical hypoalgesia until 7 days post-CCI, but without any significant correlation with the expression of the measured markers. Our results indicate that glucocorticoid-related modulations of neuropathic pain processing may rather depend on a modification of glutamatergic transmission than on a change in pro-inflammatory cytokine expression.	[Le Coz, Glenn-Marie; Anton, Fernand; Hanesch, Ulrike] Univ Luxembourg, Lab Neurophysiol & Psychobiol, Luxembourg, Luxembourg	University of Luxembourg	Hanesch, U (corresponding author), Univ Luxembourg, Lab Neurophysiol & Psychobiol, Luxembourg, Luxembourg.	ulrike.hanesch@uni.lu			University of Luxembourg [F3R-INS-PUL-08MPMG, F3R-INS-PUL-11STPA]	University of Luxembourg	This work was supported by grant from the University of Luxembourg (F3R-INS-PUL-08MPMG and F3R-INS-PUL-11STPA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Alexander JK, 2009, BRAIN BEHAV IMMUN, V23, P851, DOI 10.1016/j.bbi.2009.04.001; Aloisi AM, 2011, PSYCHONEUROENDOCRINO, V36, P1032, DOI 10.1016/j.psyneuen.2010.12.017; Aschner M, 1998, NEUROTOXICOLOGY, V19, P269; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chrousos George P., 2000, Journal of Allergy and Clinical Immunology, V106, pS275; Clark A, 2000, ARTHRITIS RES, V2, P172, DOI 10.1186/ar83; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Davis MC, 2001, ANN BEHAV MED, V23, P215, DOI 10.1207/S15324796ABM2303_9; DAWSON J, 1993, AGENTS ACTIONS, V38, P255, DOI 10.1007/BF01976218; Gomez-Nicola D, 2008, J NEUROCHEM, V107, P1741, DOI 10.1111/j.1471-4159.2008.05746.x; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Junger H, 2000, PAIN, V85, P145, DOI 10.1016/S0304-3959(99)00262-6; Kalariti N., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P113; Kanczkowski W, 2013, P NATL ACAD SCI USA, V110, P14801, DOI 10.1073/pnas.1313945110; Kingery WS, 2001, ANESTH ANALG, V92, P476, DOI 10.1213/00000539-200102000-00037; Kuehl LK, 2010, PAIN, V149, P539, DOI 10.1016/j.pain.2010.03.026; LEE SW, 1988, P NATL ACAD SCI USA, V85, P1204, DOI 10.1073/pnas.85.4.1204; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Li HQ, 2007, ANESTHESIOLOGY, V107, P469, DOI 10.1097/01.anes.0000278907.37774.8d; Liberman AC, 2007, CYTOKINE GROWTH F R, V18, P45, DOI 10.1016/j.cytogfr.2007.01.005; Lu J, 2003, NEUROSCIENCE, V121, P123, DOI 10.1016/S0306-4522(03)00421-4; McEwen BS, 2010, METABOLISM, V59, pS9, DOI 10.1016/j.metabol.2010.07.012; McMahon SB, 2005, EXP NEUROL, V192, P444, DOI 10.1016/j.expneurol.2004.11.001; Michaux GPN, 2012, PAIN, V153, P420, DOI 10.1016/j.pain.2011.10.043; Milligan ED, 2003, J NEUROSCI, V23, P1026; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Opree A, 2000, J NEUROSCI, V20, P6289, DOI 10.1523/JNEUROSCI.20-16-06289.2000; Osikowicz M, 2013, EXP PHYSIOL, V98, P372, DOI 10.1113/expphysiol.2012.069922; Ou Guo-Kun, 2013, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V29, P97; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SNYDER DS, 1982, J IMMUNOL, V129, P1803; Soro A, 1995, J ENDOCRINOL INVEST, V18, P833, DOI 10.1007/BF03349829; Straub RH, 2013, SEMIN ARTHR IN PRESS, DOI [10.1016/j.semarthrit.2013.04.008, DOI 10.1016/J.SEMAR-THRIT.2013.04.008]; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Takasaki I, 2005, EUR J PHARMACOL, V524, P80, DOI 10.1016/j.ejphar.2005.09.045; Urban MO, 2003, NEUROPHARMACOLOGY, V44, P983, DOI 10.1016/S0028-3908(03)00118-7; Wang SX, 2005, J NEUROSCI, V25, P488, DOI 10.1523/JNEUROSCI.4127-04.2005; Wang SX, 2004, J NEUROSCI, V24, P8595, DOI 10.1523/JNEUROSCI.3058-04.2004; Wen YR, 2007, ANESTHESIOLOGY, V107, P312, DOI 10.1097/01.anes.0000270759.11086.e7; Wen ZH, 2005, NEUROSCIENCE, V133, P807, DOI 10.1016/j.neuroscience.2005.03.015; Yan P, 2003, EXP NEUROL, V183, P286, DOI 10.1016/S0014-4886(03)00135-3	44	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91393	10.1371/journal.pone.0091393	http://dx.doi.org/10.1371/journal.pone.0091393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618816	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400085
J	Li, CL; Li, FN; Zhao, K; Yao, J; Cheng, Y; Zhao, L; Li, ZY; Lu, N; Guo, QL				Li, Chenglin; Li, Fanni; Zhao, Kai; Yao, Jing; Cheng, Yao; Zhao, Li; Li, Zhiyu; Lu, Na; Guo, Qinglong			LFG-500 Inhibits the Invasion of Cancer Cells via Down-Regulation of PI3K/AKT/NF-kappa B Signaling Pathway	PLOS ONE			English	Article							NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; MATRIX METALLOPROTEINASES; MATRIX-METALLOPROTEINASE-9 EXPRESSION; STAT3 ACTIVATION; GENE-EXPRESSION; TUMOR INVASION; METASTASIS; CARCINOMA; ERK1/2	Cancer cell invasion, one of the crucial events in local growth and metastatic spread of tumors, possess a broad spectrum of mechanisms, especially altered expression of matrix metalloproteinases. LFG-500 is a novel synthesized flavonoid with strong anti-cancer activity, whose exact molecular mechanism remains incompletely understood. This current study was designed to examine the effects of LFG-500 on tumor metastasis using in vitro and in vivo assays. LFG-500 could inhibit adhesion, migration and invasion of MDA-MB-231 human breast carcinoma cells. Meanwhile, it reduced the activities and expression of MMP-2 and MMP-9 via suppressing the transcriptional activation of NF-kappa B rather than AP-1 or STAT3. Moreover, LFG-500 repressed TNF-alpha induced cell invasion through inhibiting NF-kappa B and subsequent MMP-9 activity. Further elucidation of the mechanism revealed that PI3K/AKT but not MAPK signaling pathway was involved in the inhibitory effect of LFG-500 on NF-kappa B activation. LFG-500 could also suppress lung metastasis of B16F10 murine melanoma cells in vivo. Taken together, these results demonstrated that LFG-500 could block cancer cell invasion via down-regulation of PI3K/AKT/NF-kappa B signaling pathway, which provides new evidence for the anti-cancer activity of LFG-500.	[Li, Chenglin; Li, Fanni; Zhao, Kai; Yao, Jing; Cheng, Yao; Zhao, Li; Li, Zhiyu; Lu, Na; Guo, Qinglong] China Pharmaceut Univ, Minist Educ, Key Lab Drug Qual Control & Pharmacovigilance, State Key Lab Nat Med,Jiangsu Key Lab Carcinogene, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Lu, N (corresponding author), China Pharmaceut Univ, Minist Educ, Key Lab Drug Qual Control & Pharmacovigilance, State Key Lab Nat Med,Jiangsu Key Lab Carcinogene, Nanjing, Jiangsu, Peoples R China.	Luna555@163.com; anticancer_drug@163.com			Natural Science Foundation of China [21072232]; State Key Laboratory of Natural Medicines, China Pharmaceutical University [JKGZ201101, SKLNMZZ201210, SKLNMZZCX201303, SKLNMZZJQ201302]; Natural Science Foundation of Jiangsu province [BK2011620, BK20130220]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1193]; National Science & Technology Major Project [2013ZX0 9103-001-007, 2012ZX09304-001]; China Postdoctoral Science Foundation [2013M 541733]; Jiangsu Planned Projects for Postdoctoral Research Funds [1301015B]; Natural Science Foundation of the Higher Education Institutions of Jiangsu Province [13KJB350007]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Natural Medicines, China Pharmaceutical University; Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Science & Technology Major Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Planned Projects for Postdoctoral Research Funds; Natural Science Foundation of the Higher Education Institutions of Jiangsu Province	This work was supported by the Natural Science Foundation of China (No. 21072232), the Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (No. JKGZ201101, SKLNMZZ201210, SKLNMZZCX201303, SKLNMZZJQ201302), the Natural Science Foundation of Jiangsu province (No. BK2011620, BK20130220), the Program for Changjiang Scholars and Innovative Research Team in University (IRT1193), the National Science & Technology Major Project (No. 2013ZX0 9103-001-007, 2012ZX09304-001), the China Postdoctoral Science Foundation funded project (2013M 541733), the Jiangsu Planned Projects for Postdoctoral Research Funds (1301015B), and the Natural Science Foundation of the Higher Education Institutions of Jiangsu Province (13KJB350007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Albini A, 1998, Pathol Oncol Res, V4, P230; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BODE W, 1994, EMBO J, V13, P1263, DOI 10.1002/j.1460-2075.1994.tb06378.x; Campbell KJ, 2001, BIOCHEM SOC T, V29, P688; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chen P, 2011, TOXICOLOGY, V282, P122, DOI 10.1016/j.tox.2011.01.018; Chen Y, 2009, TOXICOLOGY, V259, P10, DOI 10.1016/j.tox.2009.01.010; Cheng JCH, 2006, ONCOGENE, V25, P7009, DOI 10.1038/sj.onc.1209706; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dolle L, 2006, CURR CANCER DRUG TAR, V6, P729, DOI 10.2174/156800906779010263; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Ellenrieder V, 1999, ANN ONCOL, V10, P46, DOI 10.1023/A:1008380501633; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hong S, 2005, J BIOL CHEM, V280, P25202, DOI 10.1074/jbc.M413985200; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Jemal A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1672; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Johnson LL, 1998, CURR OPIN CHEM BIOL, V2, P466, DOI 10.1016/S1367-5931(98)80122-1; Jones JL, 2003, J PATHOL, V201, P562, DOI 10.1002/path.1483; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Khasigov PZ, 2003, BIOCHEMISTRY-MOSCOW+, V68, P711, DOI 10.1023/A:1025051214001; Lee YC, EUR J PHARM, V632, P23; Li C, 2011, CATAL TODAY, V175, P1, DOI 10.1016/j.cattod.2011.08.002; Li CH, 2013, J NUTR BIOCHEM, V24, P1766, DOI 10.1016/j.jnutbio.2013.03.006; Li YM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.347; Lin YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071903; Mburu YK, 2012, J BIOL CHEM, V287, P3581, DOI 10.1074/jbc.M111.294876; Moon SK, 2004, J CELL PHYSIOL, V198, P417, DOI 10.1002/jcp.10435; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Ozes ON, 1999, NATURE, V401, P82; Philip S, 2003, J BIOL CHEM, V278, P14487, DOI 10.1074/jbc.M207309200; Qi Q, 2008, BIOCHEM CELL BIOL, V86, P386, DOI [10.1139/O08-104, 10.1139/o08-104]; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Schroer N, 2011, CANCER RES, V71, P87, DOI 10.1158/0008-5472.CAN-10-2193; Shishodia S, 2003, CANCER RES, V63, P4375; Sigala JLD, 2004, SCIENCE, V304, P1963, DOI 10.1126/science.1098387; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Tian YP, 2010, BIOCHEM BIOPH RES CO, V397, P420, DOI 10.1016/j.bbrc.2010.05.108; Troussard AA, 2000, ONCOGENE, V19, P5444, DOI 10.1038/sj.onc.1203928; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang L, 2010, CANCER LETT, V297, P42, DOI 10.1016/j.canlet.2010.04.022; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wu KJ, 2013, CELL SIGNAL, V25, P2625, DOI 10.1016/j.cellsig.2013.08.028; Wu T., 2011, BIOMED PREV NUTR, V1, P132; Yilmaz M, 2007, TRENDS MOL MED, V13, P535, DOI 10.1016/j.molmed.2007.10.004; Zhao J, 2008, EUR J PHARMACOL, V589, P127, DOI 10.1016/j.ejphar.2008.04.063	57	29	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91332	10.1371/journal.pone.0091332	http://dx.doi.org/10.1371/journal.pone.0091332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618693	gold, Green Submitted, Green Published			2022-12-27	WOS:000332842400079
J	Li, GR; Sun, CL; Wang, YJ; Liu, YJ; Gang, XK; Gao, Y; Li, F; Xiao, XC; Wang, GX				Li, Guangren; Sun, Chenglin; Wang, Yanjun; Liu, Yujia; Gang, Xiaokun; Gao, Ying; Li, Fei; Xiao, Xianchao; Wang, Guixia			A Clinical and Neuropathological Study of Chinese Patients with Diabetic Peripheral Neuropathy	PLOS ONE			English	Article							OXIDATIVE STRESS; ALDOSE REDUCTASE; POLYOL PATHWAY; SCHWANN-CELLS; PATHOGENESIS; SORBITOL; RETINOPATHY	Objective: To examine whether the neuropathological and metabolic changes of peripheral nerves are correlated to clinical features in diabetes mellitus type 2 patients with peripheral neuropathy. Methods: 147 type 2 diabetic patients with signs/symptoms of diabetic peripheralneuropathy (DPN) aged 53.4 +/- 12.3 years and 134 healthy volunteers aged 55.5 +/- 11.7 years were investigated for fasting plasma glucose (FPG), hemoglobin A1C (HbA1c), and red blood cell sorbitol (RBC sorbitol) in addition to nerve conduction velocity (NCV). Among the 147 diabetic patients, 10 patients underwent superficial peroneal nerve biopsy for light and electron microscopy. Results: In the experimental group, the levels of HbA1c and RBC sorbitol showed significant increase compared with the controlled group, whereas motor nerve conduction velocity (MNCV) and sensory nerve conduction velocity (SNCV) both showed decline and SNCV decreased at a greater extent. Morphologically, there were various degrees of nerve fiber loss, associated with axon degeneration and capillary luminal narrowing in 10 patients undergone nerve biopsy. Conclusion: The metabolic change of sorbitol, the consequently observed changes in NCV and histopathology of peripheral nerves are positively correlated with the duration of diabetes and overall level of blood glucose.	[Sun, Chenglin; Liu, Yujia; Gang, Xiaokun; Gao, Ying; Li, Fei; Xiao, Xianchao; Wang, Guixia] Jilin Univ, Hosp Univ 1, Dept Endocrinol & Metab, Changchun 130023, Jilin, Peoples R China; [Li, Guangren] Jilin Univ, China Japan Union Hosp, Dept Neurol, Changchun 130023, Jilin, Peoples R China; [Wang, Yanjun] Jilin Univ, Hosp Univ 2, Dept Endocrinol & Metab, Changchun 130023, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Wang, GX (corresponding author), Jilin Univ, Hosp Univ 1, Dept Endocrinol & Metab, Changchun 130023, Jilin, Peoples R China.	gxwang6688@yahoo.com	Wang, Yanbo/HFZ-8018-2022; wang, yan/GSE-6489-2022					Ando H, 2006, J DIABETES COMPLICAT, V20, P367, DOI 10.1016/j.jdiacomp.2005.09.002; Askwith T, 2009, AM J PHYSIOL-ENDOC M, V297, pE620, DOI 10.1152/ajpendo.00287.2009; Beiswenger KK, 2008, ACTA HISTOCHEM, V110, P351, DOI 10.1016/j.acthis.2007.12.004; Chattopadhyay M, 2008, J NEUROSCI, V28, P6652, DOI 10.1523/JNEUROSCI.5530-07.2008; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; Duby JJ, 2004, AM J HEALTH-SYST PH, V61, P160, DOI 10.1093/ajhp/61.2.160; Kempler Peter, 2002, Orv Hetil, V143, P1113; Miranda-Massari JR, 2011, CURR CLIN PHARMACOL, V6, P260, DOI 10.2174/157488411798375967; Morrison JFB, 2008, EXP PHYSIOL, V93, P213, DOI 10.1113/expphysiol.2007.039222; Obrosova IG, 2011, CURR PHARM BIOTECHNO, V12, P373; Reddy GB, 2008, MOL VIS, V14, P593; Reinisch CM, 2008, DIABETES CARE, V31, P1219, DOI 10.2337/dc07-1832; Said G, 2003, BRAIN, V126, P376, DOI 10.1093/brain/awg029; Sim HJ, 2009, J CHROMATOGR B, V877, P1607, DOI 10.1016/j.jchromb.2009.03.041; Spallone V, 2011, EUR J PAIN, V15, P153, DOI 10.1016/j.ejpain.2010.06.011; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; Stavniichuk R, 2012, BIOCHEM PHARMACOL, V83, P932, DOI 10.1016/j.bcp.2012.01.015; Takizawa M, 2008, DIABETES RES CLIN PR, V82, P119, DOI 10.1016/j.diabres.2008.07.008; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Winkler Gabor, 2010, Orvosi Hetilap, V151, P971, DOI 10.1556/OH.2010.28898; Yagihashi S, 2007, DIABETES RES CLIN PR, V77, pS184, DOI 10.1016/j.diabres.2007.01.054; Younger DS, 2010, NEUROL RES INT, V2010, DOI 10.1155/2010/140379	22	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91772	10.1371/journal.pone.0091772	http://dx.doi.org/10.1371/journal.pone.0091772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618902	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400126
J	Muthuraman, M; Hellriegel, H; Hoogenboom, N; Anwar, AR; Mideksa, KG; Krause, H; Schnitzler, A; Deuschl, G; Raethjen, J				Muthuraman, Muthuraman; Hellriegel, Helge; Hoogenboom, Nienke; Anwar, Abdul Rauf; Mideksa, Kidist Gebremariam; Krause, Holger; Schnitzler, Alfons; Deuschl, Guenther; Raethjen, Jan			Beamformer Source Analysis and Connectivity on Concurrent EEG and MEG Data during Voluntary Movements	PLOS ONE			English	Article							VOLUME CONDUCTION; GRANGER CAUSALITY; COHERENT SOURCES; COMBINING MEG; MOTOR AREAS; BRAIN-AREAS; MODEL; MAGNETOENCEPHALOGRAPHY; LOCALIZATION; SYSTEMS	Electroencephalography (EEG) and magnetoencephalography (MEG) are the two modalities for measuring neuronal dynamics at a millisecond temporal resolution. Different source analysis methods, to locate the dipoles in the brain from which these dynamics originate, have been readily applied to both modalities alone. However, direct comparisons and possible advantages of combining both modalities have rarely been assessed during voluntary movements using coherent source analysis. In the present study, the cortical and sub-cortical network of coherent sources at the finger tapping task frequency (2-4 Hz) and the modes of interaction within this network were analysed in 15 healthy subjects using a beamformer approach called the dynamic imaging of coherent sources (DICS) with subsequent source signal reconstruction and renormalized partial directed coherence analysis (RPDC). MEG and EEG data were recorded simultaneously allowing the comparison of each of the modalities separately to that of the combined approach. We found the identified network of coherent sources for the finger tapping task as described in earlier studies when using only the MEG or combined MEG+EEG whereas the EEG data alone failed to detect single sub-cortical sources. The signal-to-noise ratio (SNR) level of the coherent rhythmic activity at the tapping frequency in MEG and combined MEG+EEG data was significantly higher than EEG alone. The functional connectivity analysis revealed that the combined approach had more active connections compared to either of the modalities during the finger tapping (FT) task. These results indicate that MEG is superior in the detection of deep coherent sources and that the SNR seems to be more vital than the sensitivity to theoretical dipole orientation and the volume conduction effect in the case of EEG.	[Muthuraman, Muthuraman; Hellriegel, Helge; Anwar, Abdul Rauf; Mideksa, Kidist Gebremariam; Deuschl, Guenther; Raethjen, Jan] Univ Kiel, Dept Neurol, Kiel, Germany; [Anwar, Abdul Rauf; Mideksa, Kidist Gebremariam] Univ Kiel, Inst Circuit & Syst Theory, Kiel, Germany; [Hoogenboom, Nienke; Krause, Holger; Schnitzler, Alfons] Univ Dusseldorf, Dept Neurol, Dusseldorf, Germany	University of Kiel; University of Kiel; Heinrich Heine University Dusseldorf	Muthuraman, M (corresponding author), Univ Kiel, Dept Neurol, Kiel, Germany.	m.muthuraman@neurologie.uni-kiel.de	Muthuraman, Muthuraman/ABD-2021-2020; Schnitzler, Alfons/AAT-1054-2021; Schnitzler, Alfons/K-4625-2014; Schnitzler, Alfons/Q-5520-2019; Deuschl, Gunther/A-7986-2010	Muthuraman, Muthuraman/0000-0001-6158-2663; Schnitzler, Alfons/0000-0002-6414-7939; Schnitzler, Alfons/0000-0002-6414-7939; Deuschl, Gunther/0000-0002-4176-9196	Project D2 [Sonderforschungsbereich (SFB) 855]	Project D2	This work was supported by Sonderforschungsbereich (SFB) 855, Project D2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2006, MAGN RESON IMAGING, V24, P181, DOI 10.1016/j.mri.2005.10.022; Ahlfors SP, 2010, BRAIN TOPOGR, V23, P227, DOI 10.1007/s10548-010-0154-x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amjad AM, 1997, J NEUROSCI METH, V73, P69, DOI 10.1016/S0165-0270(96)02214-5; Babiloni F, 2004, HUM BRAIN MAPP, V22, P52, DOI 10.1002/hbm.20011; Babiloni F, 2001, HUM BRAIN MAPP, V14, P197, DOI 10.1002/hbm.1052; Baillet S, 1999, IEEE T BIO-MED ENG, V46, P522, DOI 10.1109/10.759053; Ball T, 1999, NEUROIMAGE, V10, P682, DOI 10.1006/nimg.1999.0507; Bouet R, 2012, NEUROIMAGE, V59, P3955, DOI 10.1016/j.neuroimage.2011.10.052; Cheyne D, 1990, ADV BIOMAGNETISM, P177; COHEN D, 1983, ELECTROEN CLIN NEURO, V56, P38, DOI 10.1016/0013-4694(83)90005-6; COHEN D, 1972, SCIENCE, V175, P664, DOI 10.1126/science.175.4022.664; COHEN D, 1987, PHYS MED BIOL, V32, P85, DOI 10.1088/0031-9155/32/1/013; CUFFIN BN, 1979, ELECTROEN CLIN NEURO, V47, P132, DOI 10.1016/0013-4694(79)90215-3; de Jongh A, 2005, J CLIN NEUROPHYSIOL, V22, P153, DOI 10.1097/01.WNP.0000158947.68733.51; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Feige B, 2000, J NEUROPHYSIOL, V84, P2622, DOI 10.1152/jn.2000.84.5.2622; FERGUSON AS, 1994, IEEE T BIO-MED ENG, V41, P455, DOI 10.1109/10.293220; Fuchs M, 1998, ELECTROEN CLIN NEURO, V107, P93, DOI 10.1016/S0013-4694(98)00046-7; Goldenholz DM, 2009, HUM BRAIN MAPP, V30, P1077, DOI 10.1002/hbm.20571; Gramfort A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-45; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; Haufe S, 2013, NEUROIMAGE, V64, P120, DOI 10.1016/j.neuroimage.2012.09.036; Henson RN, 2009, NEUROIMAGE, V47, P581, DOI 10.1016/j.neuroimage.2009.04.063; Hepp-Reymond MC, 1988, FUNCTIONAL ORG MOTOR; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Huang MX, 2007, NEUROIMAGE, V37, P731, DOI 10.1016/j.neuroimage.2007.06.002; Jones EG, 2002, PHILOS T R SOC B, V357, P1659, DOI 10.1098/rstb.2002.1168; JOURNEE HL, 1983, IEEE T BIO-MED ENG, V30, P304, DOI 10.1109/TBME.1983.325120; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Lin FH, 2013, MAGN RESON MED, V70, P595, DOI 10.1002/mrm.24479; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; Llinas R, 2005, TRENDS NEUROSCI, V28, P325, DOI 10.1016/j.tins.2005.04.006; McClelland VM, 2012, J NEUROSCI METH, V205, P190, DOI 10.1016/j.jneumeth.2011.11.001; MEIJS JWH, 1987, ELECTROEN CLIN NEURO, V66, P286, DOI 10.1016/0013-4694(87)90078-2; MELCHER JR, 1988, ELECTROEN CLIN NEURO, V70, P460, DOI 10.1016/0013-4694(88)90024-7; Michalareas G, 2013, HUM BRAIN MAPP, V34, P890, DOI 10.1002/hbm.21482; Mima T, 1999, CLIN NEUROPHYSIOL, V110, P1892, DOI 10.1016/S1388-2457(99)00238-2; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Molins A, 2008, NEUROIMAGE, V42, P1069, DOI 10.1016/j.neuroimage.2008.05.064; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; Muthuraman M, 2012, NEUROIMAGE, V60, P1331, DOI 10.1016/j.neuroimage.2012.01.088; Muthuraman M, 2010, BIOMED SIGNAL PROCES, V5, P205, DOI 10.1016/j.bspc.2010.02.006; Muthuraman M, 2008, IEEE ENG MED BIO, P4716, DOI 10.1109/IEMBS.2008.4650266; Nedelko V, 2010, RESTOR NEUROL NEUROS, V28, P737, DOI 10.3233/RNN-2010-0542; Neumaier A, 2001, ACM T MATH SOFTWARE, V27, P27, DOI 10.1145/382043.382304; PARKER F, 1992, BRAIN RES, V584, P11, DOI 10.1016/0006-8993(92)90872-7; Pollok B, 2004, J PHYSIOL-LONDON, V554, P871, DOI 10.1113/jphysiol.2003.051235; Pollok B, 2006, J PHYSIOL-PARIS, V99, P8, DOI 10.1016/j.jphysparis.2005.06.002; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; ROTHWELL JC, 1991, EXP PHYSIOL, V76, P159, DOI 10.1113/expphysiol.1991.sp003485; Salmelin R, 1995, ELECTROEN CLIN NEURO, V95, P444, DOI 10.1016/0013-4694(95)00193-X; Schelter B, 2009, J NEUROSCI METH, V179, P121, DOI 10.1016/j.jneumeth.2009.01.006; Schlee W, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-16; SCHLITT HA, 1995, IEEE T BIO-MED ENG, V42, P52, DOI 10.1109/10.362919; Schnitzler A, 2000, ACTA NEUROBIOL EXP, V60, P271; Schoffelen JM, 2008, NEUROIMAGE, V41, P437, DOI 10.1016/j.neuroimage.2008.01.045; Sharon D, 2007, NEUROIMAGE, V36, P1225, DOI 10.1016/j.neuroimage.2007.03.066; STARR A, 1991, BRAIN RES, V558, P181, DOI 10.1016/0006-8993(91)90767-P; Stegeman DF, 2010, CLIN NEUROPHYSIOL, V121, P1633, DOI 10.1016/j.clinph.2010.03.052; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Tapio S, 2001, ALGORITHM 808 ARFIT, P58; Tarkiainen A, 2003, CLIN NEUROPHYSIOL, V114, P1977, DOI 10.1016/S1388-2457(03)00195-0; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; van den Broek SP, 1998, ELECTROEN CLIN NEURO, V106, P522, DOI 10.1016/S0013-4694(97)00147-8; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Winter WR, 2007, STAT MED, V26, P3946, DOI 10.1002/sim.2978; Wu T, 2005, J PHYSIOL-LONDON, V562, P605, DOI 10.1113/jphysiol.2004.076042; Yanagisawa T, 2009, NEUROIMAGE, V45, P1099, DOI 10.1016/j.neuroimage.2008.12.069	75	31	31	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91441	10.1371/journal.pone.0091441	http://dx.doi.org/10.1371/journal.pone.0091441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618596	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400094
J	Peng, J; Cai, S; Wang, L; Zhao, N; Zhang, TJ; Chen, ZX; Meng, FH				Peng, Jing; Cai, Shuang; Wang, Lin; Zhao, Nan; Zhang, Ting-jian; Chen, Zai-xing; Meng, Fan-hao			A Metabonomic Analysis of Serum from Rats Treated with Ricinine Using Ultra Performance Liquid Chromatography Coupled with Mass Spectrometry	PLOS ONE			English	Article							HEPATIC SECRETION; TOF-MS; PLASMA; LIVER; LYSOPHOSPHATIDYLCHOLINE; COMMUNIS; URINE; ACIDS; CIRRHOSIS; SEVERITY	A metabonomic approach based on ultra performance liquid chromatography coupled with mass spectrometry (UPLC/MS) was used to study the hepatotoxicity of ricinine in rats. Potential biomarkers of ricinine toxicity and toxicological mechanism were analyzed by serum metabonomic method. The significant differences in the metabolic profiling of the control and treated rats were clear by using the principal components analysis (PCA) of the chromatographic data. Significant changes of metabolite biomarkers like phenylalanine, tryptophan, cholic acid, LPC and PC were detected in the serum. These biochemical changes were related to the metabolic disorders in amino acids and phospholipids. This research indicates that UPLC/MS-based metabonomic analysis of serum samples can be used to predict the hepatotoxicity and further understand the toxicological mechanism induced by ricinine. This work shows that metabonomics method is a valuable tool in drug mechanism study.	[Peng, Jing; Cai, Shuang; Wang, Lin; Zhao, Nan; Zhang, Ting-jian; Chen, Zai-xing; Meng, Fan-hao] China Med Univ, Sch Pharm, Shenyang, Liaoning, Peoples R China; [Cai, Shuang] China Med Univ, Affiliated Hosp 1, Dept Pharm, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Meng, FH (corresponding author), China Med Univ, Sch Pharm, Shenyang, Liaoning, Peoples R China.	fhmeng@cmu.edu.cn			National Natural Science Foundation of China [81274182]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the foundation from National Natural Science Foundation of China (No. 81274182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradberry Sally M., 2003, Toxicological Reviews, V22, P65, DOI 10.2165/00139709-200322010-00007; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Brindle JT, 2003, ANALYST, V128, P32, DOI 10.1039/b209155k; BRINDLEY DN, 1993, J NUTR BIOCHEM, V4, P442, DOI 10.1016/0955-2863(93)90061-Z; Dunn WB, 2008, INT J EPIDEMIOL, V37, P23, DOI 10.1093/ije/dym281; Ferraz AC, 1999, PHARMACOL BIOCHEM BE, V63, P367, DOI 10.1016/S0091-3057(99)00007-6; Fuchs B, 2005, CLIN BIOCHEM, V38, P925, DOI 10.1016/j.clinbiochem.2005.06.006; GANDHI VM, 1994, J AM OIL CHEM SOC, V71, P827, DOI 10.1007/BF02540457; Gika HG, 2007, J PROTEOME RES, V6, P3291, DOI 10.1021/pr070183p; GRAHAM A, 1991, BIOCHIM BIOPHYS ACTA, V1081, P151, DOI 10.1016/0005-2760(91)90020-I; Griffin JL, 2004, PHYSIOL GENOMICS, V17, P140, DOI 10.1152/physiolgenomics.00158.2003; Guallar-Hoyas C, 2012, BIOANALYSIS, V4, P2227, DOI [10.4155/BIO.12.193, 10.4155/bio.12.193]; Hasim A, 2012, MOL BIOL REP, V39, P8955, DOI 10.1007/s11033-012-1764-z; Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781; KANG SS, 1985, J NAT PROD, V48, P155, DOI 10.1021/np50037a041; Lafaye A, 2003, RAPID COMMUN MASS SP, V17, P2541, DOI 10.1002/rcm.1243; Li HK, 2007, J PROTEOME RES, V6, P1364, DOI 10.1021/pr060513q; LIMBERG B, 1984, GUT, V25, P1291, DOI 10.1136/gut.25.11.1291; Lindon JC, 2005, PHARMACOGENOMICS, V6, P691, DOI 10.2217/14622416.6.7.691; MONTANARI A, 1988, HEPATOLOGY, V8, P1034, DOI 10.1002/hep.1840080509; MORGAN MY, 1982, GUT, V23, P362, DOI 10.1136/gut.23.5.362; National Pharmacopoeia Committee, 2010, RIC COMM 1, P330; Ostrow J. Donald, 1993, P673; Palmeira CM, 2004, TOXICOLOGY, V203, P1, DOI 10.1016/j.tox.2004.06.001; Robinson T, 1987, BIOCHEM, V17, P1903; SEKAS G, 1985, J LAB CLIN MED, V105, P190; Takatera A, 2006, J CHROMATOGR B, V838, P31, DOI 10.1016/j.jchromb.2006.03.006; Wang JS, 2009, METABOLOMICS, V5, P407, DOI 10.1007/s11306-009-0165-3; Worbs S, 2011, TOXINS, V3, P1332, DOI 10.3390/toxins3101332	29	8	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90416	10.1371/journal.pone.0090416	http://dx.doi.org/10.1371/journal.pone.0090416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618672	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400016
J	Zeng, J; Liu, D; Qiu, ZX; Huang, Y; Chen, BJ; Wang, L; Xu, H; Huang, N; Liu, LX; Li, WM				Zeng, Jing; Liu, Dan; Qiu, Zhixin; Huang, Yi; Chen, Bojiang; Wang, Lei; Xu, Huan; Huang, Na; Liu, Lunxu; Li, Weimin			GSK3 beta Overexpression Indicates Poor Prognosis and Its Inhibition Reduces Cell Proliferation and Survival of Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; FACTOR-KAPPA-B; THERAPEUTIC TARGET; GENE-EXPRESSION; PROSTATE-CANCER; GROWTH; CARCINOMA; BETA; GSK3	Background: Glycogen synthase kinase 3 beta (GSK3 beta) is centrally involved in diverse cellular processes, including proliferation and apoptosis. This study aimed to investigate the influence of GSK3 beta expression on the prognosis of human non-small cell lung cancer (NSCLC) and the effects of GSK3 beta inhibition in NSCLC cell lines. Methods: Immunohistochemical and western blot assays were used to evaluate the GSK3 beta expression level in human NSCLC tissues. Lentiviral RNA interference was performed to inhibit the expression of GSK3 beta in the A549, H292, H1299 and SK-MES-1 cell lines. Cell survival, apoptosis and motility were evaluated in vivo and in vitro. Results: The levels of GSK3 beta were greater in NSCLC tissues (n = 211) than in control tissues (n = 194) (P<0.001). The 5-year follow-up analysis showed that positive GSK3 beta expression was indicative of poor prognosis (P = 0.006). Furthermore, knockdown of GSK3 beta in NSCLC cell lines suppressed cell proliferation, arrested tumor cells in G0/G1 phase, induced apoptosis and reduced cell motility. A xenograft model showed that the deregulation of GSK3 beta attenuated tumorigenesis, as confirmed by reduced cell proliferation based on Ki-67 and significantly increased apoptotic cell death. The inhibition of GSK3 beta had inconsistent effects on the expression of beta-catenin, depending on the cell type examined. Conclusion: Aberrant expression of GSK3 beta serves as an independent marker of poor prognosis for NSCLC. The inhibition of GSK3 beta suppressed tumorigenesis by attenuating cell proliferation, increasing apoptosis and restraining cell motility. These results identify GSK3 beta as a tumor promoter and a potential therapeutic target in NSCLC.	[Zeng, Jing; Liu, Dan; Qiu, Zhixin; Chen, Bojiang; Wang, Lei; Huang, Na; Li, Weimin] Sichuan Univ, West China Hosp, Dept Resp Med, Chengdu 610064, Sichuan Provinc, Peoples R China; [Huang, Yi] Sichuan Acad Med Sci, Clin Lab Dept, Chengdu, Sichuan Provinc, Peoples R China; [Huang, Yi] Sichuan Prov Peoples Hosp, Chengdu, Sichuan Provinc, Peoples R China; [Xu, Huan] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu 610064, Sichuan Provinc, Peoples R China; [Liu, Lunxu] Sichuan Univ, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan University; Sichuan University	Li, WM (corresponding author), Sichuan Univ, West China Hosp, Dept Resp Med, Chengdu 610064, Sichuan Provinc, Peoples R China.	weimi003@gmail.com	liu, liu/GXF-0906-2022; qiu, zhixin/HHC-0554-2022; liu, li/HGC-0900-2022	qiu, zhixin/0000-0003-0256-4419; 	Nature Science Foundation of China [81201851, 81641028]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Nature Science Foundation of China (81201851 to Dan liu and 81641028 to Weimin Li). The website of the National Nature Science Foundation of China is http://www.nsfc.gov.cn/Portal0/default166.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler JT, 2009, MOL CANCER THER, V8, P914, DOI 10.1158/1535-7163.MCT-08-0712; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bilim V, 2009, BRIT J CANCER, V101, P2005, DOI 10.1038/sj.bjc.6605437; Cao Q, 2006, CELL RES, V16, P671, DOI 10.1038/sj.cr.7310078; Cho YJ, 2010, APMIS, V118, P782, DOI 10.1111/j.1600-0463.2010.02659.x; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Erdal E, 2005, INT J CANCER, V115, P903, DOI 10.1002/ijc.20972; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kobayashi T, 2006, MOL CELL BIOL, V26, P898, DOI 10.1128/MCB.26.3.898-911.2006; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Le Floch N, 2004, FASEB J, V18, P144, DOI 10.1096/fj.04-2373fje; Liao XB, 2003, MOL CANCER THER, V2, P1215; Liu D, 2011, J CANCER RES CLIN, V137, P1629, DOI 10.1007/s00432-011-1037-6; Liu D, 2011, CANCER-AM CANCER SOC, V117, P3763, DOI 10.1002/cncr.25959; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma C, 2007, CANCER RES, V67, P7756, DOI 10.1158/0008-5472.CAN-06-4665; Mishra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-144; Naito S, 2010, CLIN CANCER RES, V16, P5124, DOI 10.1158/1078-0432.CCR-10-0275; Nowicki MO, 2008, NEURO-ONCOLOGY, V10, P690, DOI 10.1215/15228517-2008-041; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Peeraer G, 2011, MED TEACH, V33, pE382, DOI 10.3109/0142159X.2011.579199; Qiu ZX, 2012, CANCER SCI, V103, P1774, DOI 10.1111/j.1349-7006.2012.02375.x; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Shakoori A, 2007, CANCER SCI, V98, P1388, DOI 10.1111/j.1349-7006.2007.00545.x; Soto-Cerrato V, 2007, MOL CANCER THER, V6, P362, DOI 10.1158/1535-7163.MCT-06-0266; Sun AJ, 2007, PROSTATE, V67, P976, DOI 10.1002/pros.20586; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Xiaonong Z, 2007, CHINESE J CANC PREVE, V14, P881; Zheng HC, 2007, ANTICANCER RES, V27, P3561; Zhou Y, 2008, LEUKEMIA LYMPHOMA, V49, P1945, DOI 10.1080/10428190802304966	36	60	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91231	10.1371/journal.pone.0091231	http://dx.doi.org/10.1371/journal.pone.0091231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618715	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400060
J	Park, CY; Kang, JG; Chon, S; Noh, J; Oh, SJ; Lee, CB; Park, SW				Park, Cheol-Young; Kang, Jun Goo; Chon, Suk; Noh, Junghyun; Oh, Seung Joon; Lee, Chang Beom; Park, Sung Woo			Comparison between the Therapeutic Effect of Metformin, Glimepiride and Their Combination as an Add-On Treatment to Insulin Glargine in Uncontrolled Patients with Type 2 Diabetes	PLOS ONE			English	Article							INDIVIDUALIZING GLYCEMIC TARGETS; ORAL-THERAPY; PLUS METFORMIN; ROSIGLITAZONE; MANAGEMENT; SULFONYLUREA; REGIMENS; MELLITUS; FAILURE	Aims:To compare the commonly prescribed oral anti-diabetic drug (OAD) combinations to use as an add-on therapy with insulin glargine in patients with uncontrolled type 2 diabetes despite submaximal doses of OADs. Methods:People with inadequately controlled type 2 diabetes (n = 99) were randomly assigned on a 1:1:1 basis to receive insulin glargin, with fixed doses of glimepiride, metformin, and glimepiride plus metformin. Outcomes assessed included HbA1c, the changes in fasting glucose levels, body weight, serum lipids values, insulin dose and symptomatic hypoglycemia. Results:After 24 weeks, HbA1C levels improved from (mean +/- SD) 8.5 +/- 0.9% to 7.7 +/- 0.8% (69.0 +/- 10.0 mmol/mol to 60.8 +/- 8.6 mmol/mol) with insulin glargine plus metformin, from 8.4 +/- 1.0% to 7.7 +/- 1.3% (68.8 +/- 10.6 mmol/mol to 61.1 +/- 14.4 mmol/mol) with insulin glargine plus glimepiride and from 8.7 +/- 0.9% to 7.3 +/- 0.6% (71.7 +/- 9.8 mmol/mol to 56.2 +/- 6.7 mmol/mol) with insulin glargine plus glimepirde plus metformin. The decrease in HbA1c was more pronounced with insulin glargine plus glimepiride plus metformin than with insulin glargine plus metformin (0.49% [CI, 0.16% to 0.82%]; P = 0.005) (5.10 mmol/mol [CI, 1.64 to 8.61]; P = 0.005) and insulin glargine plus glimepiride (0.59% [CI, 0.13% to 1.05%]; P = 0.012) (5.87 mmol/mol [CI, 1.10 to 10.64]; P = 0.012) (overall P = 0.02). Weight gain and the risk of hypoglycemia of any type did not significantly differ among the treatment groups. Conclusion:The combination therapy of metformin and glimepiride plus glargine insulin resulted in a significant improvement in overall glycemic control as compared with the other combinations.	[Park, Cheol-Young; Park, Sung Woo] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Endocrinol & Metab, Jongro, South Korea; [Kang, Jun Goo] Hallym Univ, Sacred Heart Hosp, Sch Med, Dept Endocrinol & Metab, Gyeonggi, South Korea; [Chon, Suk; Oh, Seung Joon] Kyung Hee Univ, Sch Med, Dept Endocrinol & Metab, Seoul, South Korea; [Noh, Junghyun] Inje Univ, Ilsan Paik Hosp, Dept Endocrinol & Metab, Goyang, South Korea; [Lee, Chang Beom] Hanyang Univ, Sch Med, Dept Endocrinol & Metab, Seoul 133791, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Hallym University; Kyung Hee University; Inje University; Hanyang University	Park, SW (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Endocrinol & Metab, Jongro, South Korea.	sungwoo0913.park@samsung.com	Noh, Junghyun/AAU-8113-2020; Noh, Junghyun/ABD-9067-2021; Park, Cheol-Young/C-6690-2018	Noh, Junghyun/0000-0002-7964-0515; Park, Cheol-Young/0000-0002-9415-9965	Sanofi-Korea	Sanofi-Korea	This study was funded by Sanofi-Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Aron D, 2011, ANN INTERN MED, V155, P340, DOI 10.7326/0003-4819-155-5-201109060-00025; Blickle JF, 2009, DIABETES OBES METAB, V11, P379, DOI 10.1111/j.1463-1326.2008.00980.x; CHOW CC, 1995, DIABETES CARE, V18, P307, DOI 10.2337/diacare.18.3.307; Fritsche A, 2003, ANN INTERN MED, V138, P952, DOI 10.7326/0003-4819-138-12-200306170-00006; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Houlden R, 2007, DIABETES RES CLIN PR, V78, P254, DOI 10.1016/j.diabres.2007.03.021; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Ismail-Beigi F, 2011, ANN INTERN MED, V154, P554, DOI 10.7326/0003-4819-154-8-201104190-00007; Ko SH, 2011, DIABETES METAB J, V35, P431, DOI 10.4093/dmj.2011.35.5.431; Meneghini LF, 2010, ENDOCR PRACT, V16, P588, DOI 10.4158/EP09281.OR; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; Rosenstock J, 2006, DIABETES CARE, V29, P554, DOI 10.2337/diacare.29.03.06.dc05-0695; Schwartz S, 2003, DIABETES CARE, V26, P2238, DOI 10.2337/diacare.26.8.2238; Skyler JS, 2009, DIABETES CARE, V32, P187, DOI 10.2337/dc08-9026; *STAT KOR, 2009 STAT RES CAUS D; Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus, 2007, REP TASK FORC TEAM B; Triplitt C, 2006, DIABETES CARE, V29, P2371, DOI 10.2337/dc06-0564; Vinik AI, 2007, DIABETES CARE, V30, P795, DOI 10.2337/dc06-1712; Yki-Jarvinen H, 1999, ANN INTERN MED, V130, P389, DOI 10.7326/0003-4819-130-5-199903020-00002; YKIJARVINEN H, 1992, NEW ENGL J MED, V327, P1426, DOI 10.1056/NEJM199211123272005; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	22	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e87799	10.1371/journal.pone.0087799	http://dx.doi.org/10.1371/journal.pone.0087799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614911	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300004
J	Piron, R; De Koker, S; De Paepe, A; Goossens, J; Grooten, J; Nauwynck, H; Depicker, A				Piron, Robin; De Koker, Stefaan; De Paepe, Annelies; Goossens, Julie; Grooten, Johan; Nauwynck, Hans; Depicker, Ann			Boosting In Planta Production of Antigens Derived from the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) and Subsequent Evaluation of Their Immunogenicity	PLOS ONE			English	Article							N-GLYCOSYLATION PATTERN; MYSTERY SWINE DISEASE; LELYSTAD-VIRUS; PROTEIN-PRODUCTION; FUSION PROTEINS; NEUTRALIZING ANTIBODIES; EPIDEMIC ABORTION; ARABIDOPSIS SEEDS; SUBUNIT VACCINE; DENDRITIC CELLS	Porcine reproductive and respiratory syndrome (PRRS) is a disease of swine, caused by an arterivirus, the PRRS virus (PRRSV). This virus infects pigs worldwide and causes huge economic losses. Due to genetic drift, current vaccines are losing their power. Adaptable vaccines could provide a solution to this problem. This study aims at producing in planta a set of antigens derived from the PRRSV glycoproteins (GPs) to be included in a subunit vaccine. We selected the GP3, GP4 and GP5 and optimized these for production in an Arabidopsis seed platform by removing transmembrane domains (Tm) and/or adding stabilizing protein domains, such as the green fluorescent protein (GFP) and immunoglobulin (IgG) 'Fragment crystallizable' (Fc) chains. Accumulation of the GPs with and without Tm was low, reaching no more than 0.10% of total soluble protein (TSP) in homozygous seed. However, addition of stabilizing domains boosted accumulation up to a maximum of 2.74% of TSP when GFP was used, and albeit less effectively, also the Fc chains of the porcine IgG3 and murine IgG2a increased antigen accumulation, to 0.96% and 1.81% of TSP respectively, while the murine IgG3 Fc chain did not. Antigens with Tm were less susceptible to these manipulations to increase yield. All antigens were produced in the endoplasmic reticulum and accordingly, they carried high-mannose N-glycans. The immunogenicity of several of those antigens was assessed and we show that vaccination with purified antigens did elicit the production of antibodies with virus neutralizing activity in mice but not in pigs.	[Piron, Robin; De Paepe, Annelies; Depicker, Ann] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Piron, Robin; De Paepe, Annelies; Depicker, Ann] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [De Koker, Stefaan; Grooten, Johan] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Goossens, Julie] VUB, Dept Biosci Engn, Brussels, Belgium; [Nauwynck, Hans] Univ Ghent, Dept Virol Parasitol & Immunol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Vrije Universiteit Brussel; Ghent University	Depicker, A (corresponding author), VIB, Dept Plant Syst Biol, Ghent, Belgium.	anpic@psb.vib-ugent.be		Piron, Robin/0000-0003-2647-4995; Depicker, Ann/0000-0003-0105-7407; De Paepe, Annelies/0000-0002-0975-0452; Nauwynck, Hans/0000-0001-5470-0713	Agency for Innovation by Science and Technology (IWT); Fonds voor Wetenschappelijk Onderzoek (FWO)	Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fonds voor Wetenschappelijk Onderzoek (FWO)(FWO)	Robin Piron received a predoctoral scholarship for Strategic Basic Research from the Agency for Innovation by Science and Technology (IWT). Stefaan De Koker received a postdoctoral grant from the Fonds voor Wetenschappelijk Onderzoek (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan HT, 2013, PLANT BIOTECHNOL J, V11, P315, DOI 10.1111/pbi.12015; Chen X, 2011, J VIROL METHODS, V173, P153, DOI 10.1016/j.jviromet.2011.02.001; Chia MY, 2011, VET IMMUNOL IMMUNOP, V140, P215, DOI 10.1016/j.vetimm.2011.01.002; Chia MY, 2010, VET IMMUNOL IMMUNOP, V135, P234, DOI 10.1016/j.vetimm.2009.12.003; COLLINS JE, 1992, J VET DIAGN INVEST, V4, P117, DOI 10.1177/104063879200400201; Costers S, 2010, ARCH VIROL, V155, P371, DOI 10.1007/s00705-009-0582-7; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Czajkowsky DM, 2012, EMBO MOL MED, V4, P1015, DOI 10.1002/emmm.201201379; De Buck S, 2013, PLANT BIOTECHNOL J, V11, P1006, DOI 10.1111/pbi.12094; De Buck Sylvie, 2012, Methods Mol Biol, V911, P305, DOI 10.1007/978-1-61779-968-6_19; De Jaeger G, 2002, NAT BIOTECHNOL, V20, P1265, DOI 10.1038/nbt755; Diaz I, 2006, VIROLOGY, V351, P249, DOI 10.1016/j.virol.2006.03.046; Duran JP, 1997, VIRUS GENES, V14, P19, DOI 10.1023/A:1007931322271; Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941; Geldhof MF, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-182; GODING JW, 1978, J IMMUNOL METHODS, V20, P241, DOI 10.1016/0022-1759(78)90259-4; Gomord V, 1997, PLANT J, V11, P313, DOI 10.1046/j.1365-313X.1997.11020313.x; Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x; Goossens A, 1999, PLANT PHYSIOL, V120, P1095, DOI 10.1104/pp.120.4.1095; He X, 2012, PLANT MOL BIOL, V79, P157, DOI 10.1007/s11103-012-9902-5; Hu JZ, 2012, VACCINE, V30, P2068, DOI 10.1016/j.vaccine.2012.01.059; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Karniychuk UU, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-30; Key KF, 2003, J CLIN MICROBIOL, V41, P2433, DOI 10.1128/JCM.41.6.2433-2439.2003; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; KREBBERS E, 1988, PLANT PHYSIOL, V87, P859, DOI 10.1104/pp.87.4.859; Labarque GG, 2000, J GEN VIROL, V81, P1327, DOI 10.1099/0022-1317-81-5-1327; Loos A, 2011, PLANT PHYSIOL, V155, P2036, DOI 10.1104/pp.110.171330; Loos A, 2011, PLANT BIOTECHNOL J, V9, P179, DOI 10.1111/j.1467-7652.2010.00540.x; Lopez OJ, 2004, VET IMMUNOL IMMUNOP, V102, P155, DOI 10.1016/j.vetimm.2004.09.005; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mardassi H, 1996, VIROLOGY, V221, P98, DOI 10.1006/viro.1996.0356; MEULENBERG JJM, 1995, VIROLOGY, V206, P155, DOI 10.1016/S0042-6822(95)80030-1; MEULENBERG JJM, 1993, VIROLOGY, V192, P62, DOI 10.1006/viro.1993.1008; Meulenberg JJM, 1997, VET MICROBIOL, V55, P197, DOI 10.1016/S0378-1135(96)01335-1; Meulenberg JJM, 1997, J VIROL, V71, P6061, DOI 10.1128/JVI.71.8.6061-6067.1997; Morandini F, 2011, PLANT BIOTECHNOL J, V9, P911, DOI 10.1111/j.1467-7652.2011.00605.x; Nagels B, 2012, CRIT REV PLANT SCI, V31, P148, DOI 10.1080/07352689.2011.616075; Nam HM, 2013, ARCH VIROL, V158, P1275, DOI 10.1007/s00705-013-1612-z; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Nielsen HS, 2001, J GEN VIROL, V82, P1263, DOI 10.1099/0022-1317-82-6-1263; Obregon P, 2006, PLANT BIOTECHNOL J, V4, P195, DOI 10.1111/j.1467-7652.2005.00171.x; Opriessnig T, 2002, J VIROL, V76, P11837, DOI 10.1128/JVI.76.23.11837-11844.2002; Paul M, 2010, EXPERT REV VACCINES, V9, P821, DOI [10.1586/erv.10.88, 10.1586/ERV.10.88]; Pearse BR, 2010, BBA-MOL CELL RES, V1803, P684, DOI 10.1016/j.bbamcr.2009.10.008; Peckham GD, 2006, PROTEIN EXPRES PURIF, V49, P183, DOI 10.1016/j.pep.2006.03.011; PlanaDuran J, 1997, VET MICROBIOL, V55, P361, DOI 10.1016/S0378-1135(96)01317-X; Prieto C, 2011, VET J, V189, P323, DOI 10.1016/j.tvjl.2010.07.010; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rybicki EP, 2010, PLANT BIOTECHNOL J, V8, P620, DOI 10.1111/j.1467-7652.2010.00507.x; Rybicki ER, 2009, DRUG DISCOV TODAY, V14, P16, DOI 10.1016/j.drudis.2008.10.002; Stadejek T, 2008, ARCH VIROL, V153, P1479, DOI 10.1007/s00705-008-0146-2; Tan MCAA, 1997, EUR J IMMUNOL, V27, P2426, DOI 10.1002/eji.1830270942; TERPSTRA C, 1991, VET QUART, V13, P131, DOI 10.1080/01652176.1991.9694297; Van Breedam W, 2011, VET IMMUNOL IMMUNOP, V141, P246, DOI 10.1016/j.vetimm.2011.03.008; Van Droogenbroeck B, 2007, P NATL ACAD SCI USA, V104, P1430, DOI 10.1073/pnas.0609997104; Vanhee M, 2009, VET RES, V40, DOI 10.1051/vetres/2009046; Vimolmangkang S, 2012, PLANTA, V235, P513, DOI 10.1007/s00425-011-1523-8; Virdi V, 2013, P NATL ACAD SCI USA, V110, P11809, DOI 10.1073/pnas.1301975110; Wang W, 2012, VACCINE, V30, P7072, DOI 10.1016/j.vaccine.2012.09.048; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wissink EHJ, 2005, J VIROL, V79, P12495, DOI 10.1128/JVI.79.19.12495-12506.2005; Wu WH, 2005, VIRUS RES, V114, P177, DOI 10.1016/j.virusres.2005.06.014; Wu WH, 2001, VIROLOGY, V287, P183, DOI 10.1006/viro.2001.1034; Ye LL, 2011, NAT BIOTECHNOL, V29, P158, DOI 10.1038/nbt.1742; Yusibov V, 2011, HUM VACCINES, V7, P313, DOI 10.4161/hv.7.3.14207; Zhou L, 2010, VIRUS RES, V154, P31, DOI 10.1016/j.virusres.2010.07.016; Zuckermann FA, 2007, VET MICROBIOL, V123, P69, DOI 10.1016/j.vetmic.2007.02.009	69	10	10	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91386	10.1371/journal.pone.0091386	http://dx.doi.org/10.1371/journal.pone.0091386			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614617	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300118
J	Rawlence, NJ; Till, CE; Scofield, RP; Tennyson, AJD; Collins, CJ; Lalas, C; Loh, G; Matisoo-Smith, E; Waters, JM; Spencer, HG; Kennedy, M				Rawlence, Nicolas J.; Till, Charlotte E.; Scofield, R. Paul; Tennyson, Alan J. D.; Collins, Catherine J.; Lalas, Chris; Loh, Graeme; Matisoo-Smith, Elizabeth; Waters, Jonathan M.; Spencer, Hamish G.; Kennedy, Martyn			Strong Phylogeographic Structure in a Sedentary Seabird, the Stewart Island Shag (Leucocarbo chalconotus)	PLOS ONE			English	Article							CORMORANT PHALACROCORAX-CARBO; POPULATION GENETIC-STRUCTURE; DOUBLE-CRESTED CORMORANTS; NEW-ZEALAND; ANCIENT DNA; AVES PHALACROCORACIDAE; CONCERTED EVOLUTION; CYANORAMPHUS; EXTRACTION; PHYLOGENY	New Zealand's endemic Stewart Island Shag (Leucocarbo chalconotus) comprises two regional groups (Otago and Foveaux Strait) that show consistent differentiation in relative frequencies of pied versus dark-bronze morphotypes, the extent of facial carunculation, body size and breeding time. We used modern and ancient DNA (mitochondrial DNA control region one), and morphometric approaches to investigate the phylogeography and taxonomy of L. chalconotus and its closely related sister species, the endemic Chatham Island Shag (L. onslowi). Our analysis shows Leucocarbo shags in southern New Zealand comprise two well-supported clades, each containing both pied and dark-bronze morphs. However, the combined monophyly of these populations is not supported, with the L. chalconotus Otago lineage sister to L. onslowi. Morphometric analysis indicates that Leucocarbo shags from Otago are larger on average than those from Foveaux Strait. Principal coordinate analysis of morphometric data showed substantial morphological differentiation between the Otago and Foveaux Strait clades, and L. onslowi. The phylogeographic partitioning detected within L. chalconotus is marked, and such strong structure is rare for phalacrocoracid species. Our phylogenetic results, together with consistent differences in relative proportions of plumage morphs and facial carunculation, and concordant differentiation in body size and breeding time, suggest several alternative evolutionary hypotheses that require further investigation to determine the level of taxonomic distinctiveness that best represents the L. chalconotus Otago and Foveaux Strait clades.	[Rawlence, Nicolas J.; Till, Charlotte E.; Collins, Catherine J.; Waters, Jonathan M.; Spencer, Hamish G.; Kennedy, Martyn] Univ Otago, Dept Zool, Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand; [Till, Charlotte E.] Arizona State Univ, Lab Mol Anthropol, Sch Human Evolut & Social Change, Tempe, AZ USA; [Scofield, R. Paul] Canterbury Museum, Christchurch, New Zealand; [Tennyson, Alan J. D.] Museum New Zealand Papa Tongarewa, Wellington, New Zealand; [Lalas, Chris] Univ Otago, Dept Marine Sci, Dunedin, New Zealand; [Loh, Graeme] Dept Conservat, Dunedin, New Zealand; [Matisoo-Smith, Elizabeth] Univ Otago, Dept Anat, Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand	University of Otago; Arizona State University; Arizona State University-Tempe; University of Otago; University of Otago	Rawlence, NJ (corresponding author), Univ Otago, Dept Zool, Allan Wilson Ctr Mol Ecol & Evolut, POB 56, Dunedin, New Zealand.	nic.rawlence@otago.ac.nz; martyn.kennedy@otago.ac.nz	Spencer, Hamish G/B-9637-2008; Waters, Jon/B-4983-2009; Kennedy, Martyn/A-9551-2008; Scofield, R. Paul/A-4271-2011	Spencer, Hamish G/0000-0001-7531-597X; Waters, Jon/0000-0002-1514-7916; Kennedy, Martyn/0000-0001-9376-6520; Scofield, R. Paul/0000-0002-7510-6980; Matisoo-Smith, Elizabeth/0000-0002-3500-8307	Royal Society of New Zealand Marsden Fund; Department of Zoology (University of Otago); Allan Wilson Centre for Molecular Ecology and Evolution	Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Department of Zoology (University of Otago); Allan Wilson Centre for Molecular Ecology and Evolution	Funding was provided by the Royal Society of New Zealand Marsden Fund, the Department of Zoology (University of Otago) and the Allan Wilson Centre for Molecular Ecology and Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE JC, 1989, SCIENCE, V243, P646, DOI 10.1126/science.243.4891.646; Barlow EJ, 2011, IBIS, V153, P768, DOI 10.1111/j.1474-919X.2011.01159.x; BLACKBURN A, 1968, Notornis, V15, P51; Boon WM, 2008, EMU, V108, P251, DOI 10.1071/MU07030; Boon WM, 2000, BIRD CONSERV INT, V10, P211, DOI 10.1017/S0959270900000198; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Buller WL., 1888, HIST BIRDS NZ, V2; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; Calderon L, 2014, MOL PHYLOGENET EVOL, V72, P42, DOI 10.1016/j.ympev.2013.12.011; Cooper A, 2000, SCIENCE, V289, P1139; Crossland Andrew C., 2012, Notornis, V59, P71; Driesch A, 1976, PEABODY MUSEUM BULLE, V1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Falla R. A., 1932, Records of the Auckland Institute and Museum, V1, P139; Falla RA, 1978, THE NEW GUIDE TO THE; Gibb GC, 2013, MOL PHYLOGENET EVOL, V68, P229, DOI 10.1016/j.ympev.2013.03.021; Gill BJ, 2010, CHECKLIST OF THE BIR; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Heather BD, 2005, THE FIELDGUIDE TO TH; Holland BR, 2010, SYST BIOL, V59, P433, DOI 10.1093/sysbio/syq023; Joseph L, 2009, EMU, V109, P1, DOI 10.1071/MU08024; Kinsky F.C., 1970, ANNOTATED CHECKLIST; Knapp M, 2012, ANN ANAT, V194, P3, DOI 10.1016/j.aanat.2011.03.008; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lalas C., 1983, THESIS; Lalas Chris, 2009, DOC Research & Development Series, V314, P1; Lambert DM, 2005, J HERED, V96, P279, DOI 10.1093/jhered/esi035; Marchant S., 1990, HANDBOOK OF AUSTRALI, V1; Marion L, 2006, EVOL ECOL, V20, P193, DOI 10.1007/s10682-005-5828-6; Mercer DM, 2013, CONSERV GENET, V14, P823, DOI 10.1007/s10592-013-0477-8; Morris-Pocock JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-14; Peters JL, 1931, CHECK LIST OF BIRDS, V1; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; R Core Team, 2018, R LANG ENV STAT COMP; Rohland N, 2010, MOL ECOL RESOUR, V10, P677, DOI 10.1111/j.1755-0998.2009.02824.x; Schuckard Rob, 2006, Notornis, V53, P297; Scofield RP, 2013, PHOTOGRAPHIC GUIDE B; SIEGELCAUSEY D, 1988, CONDOR, V90, P885, DOI 10.2307/1368846; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Turbott EG, 1990, CHECKLIST OF THE BIR; Waits JL, 2003, WATERBIRDS, V26, P196, DOI 10.1675/1524-4695(2003)026[0196:LMDVID]2.0.CO;2; Walsh PS, 2013, BIOTECHNIQUES, V54, P134; Watt JPC, 1973, NOTORNIS, V22, P265; Wilmshurst JM, 2008, P NATL ACAD SCI USA, V105, P7676, DOI 10.1073/pnas.0801507105; Winney BJ, 2001, HEREDITY, V86, P45, DOI 10.1046/j.1365-2540.2001.00807.x; Worthy T. H., 1998, Records of the Canterbury Museum, V12, P79; Worthy TH, 1996, NEW ZEAL J ZOOL, V23, P89, DOI 10.1080/03014223.1996.9518069; Worthy TH, 2011, ZOOL J LINN SOC-LOND, V163, P277, DOI 10.1111/j.1096-3642.2011.00693.x	48	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90769	10.1371/journal.pone.0090769	http://dx.doi.org/10.1371/journal.pone.0090769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614677	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300040
J	Sahay, S; Nagarajan, K; Mehendale, S; Deb, S; Gupta, A; Bharat, S; Bhatt, S; Kumar, AB; Kanthe, V; Sinha, A; Chandhiok, N				Sahay, Seema; Nagarajan, Karikalan; Mehendale, Sanjay; Deb, Sibnath; Gupta, Abhilasha; Bharat, Shalini; Bhatt, Shripad; Kumar, Athokpam Bijesh; Kanthe, Vidisha; Sinha, Anju; Chandhiok, Nomita			Community and Healthcare Providers' Perspectives on Male Circumcision: A Multi-Centric Qualitative Study in India	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HIV-INFECTION; PREVENTION; ACCEPTABILITY; INTERVENTION; RISK; TRANSMISSION; ACQUISITION	Background: Although male circumcision (MC) is recommended as an HIV prevention option, the religious, cultural and biomedical dimensions of its feasibility, acceptability and practice in India have not been explored till date. This study explores beliefs, experiences and understanding of the community and healthcare providers (HCPs) about adult MC as an HIV prevention option in India. Methods: This qualitative study covered 134 in-depth interviews from Belgaum, Kolkata, Meerut and Mumbai cities of India. Of these, 62 respondents were the members of circumcising (CC)/non-circumcising communities (NCC); including medically and traditionally circumcised men, parents of circumcised children, spouses of circumcised men, and religious clerics. Additionally, 58 registered healthcare providers (RHCPs) such as general and pediatric surgeons, pediatricians, skin and venereal disease specialists, general practitioners, and operation theatre nurses were interviewed. Fourteen traditional circumcisers were also interviewed. The data were coded and analyzed in QSR NUD*IST ver. 6.0. The study has not explored the participants' views about neonatal versus adult circumcision. Results: Members of CC/NCC, traditional circumcisers and RCHPs expressed sharp religious sensitivities around the issue of MC. Six themes emerged: Male circumcision as the religious rite; Multiple meanings of MC: MC for 'religious identity/privilege/sacrifice' or 'hygiene'; MC inflicts pain and cost; Medical indications outweigh faith; Hesitation exists in accepting 'foreign' evidence supporting MC; and communication is the key for acceptance of MCs. Medical indications could make members of NCC accept MC following appropriate counseling. Majority of the RHCPs demanded local in-country evidence. Conclusion: HCPs must educate high-risk groups regarding the preventive and therapeutic role of MC. Communities need to discuss and create new social norms about male circumcision for better societal acceptance especially among the NCC. Feasibility studies on MC as an individual specific option for the high risk groups in health care setting needs to be explored.	[Sahay, Seema; Nagarajan, Karikalan; Kumar, Athokpam Bijesh; Kanthe, Vidisha] Natl AIDS Res Inst, Pune, Maharashtra, India; [Mehendale, Sanjay] Natl Inst Epidemiol, Madras, Tamil Nadu, India; [Deb, Sibnath] Pondicherry Univ, Pondicherry, India; [Gupta, Abhilasha] LLRM Coll, HRRC, Meerut, Uttar Pradesh, India; [Bharat, Shalini] Tata Inst Social Sci, Pune, Maharashtra, India; [Bhatt, Shripad] RMRC, Belgaum, India; [Sinha, Anju; Chandhiok, Nomita] Indian Council Med Res, Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE); Pondicherry University; Tata Institute of Social Sciences; Indian Council of Medical Research (ICMR); ICMR - National Institute of Traditional Medicine (NITM); Indian Council of Medical Research (ICMR)	Sahay, S (corresponding author), Natl AIDS Res Inst, Pune, Maharashtra, India.	ssahay@nariindia.org		Sahay, Seema/0000-0001-6064-827X; Bharat, Shalini/0000-0002-2413-6987	Indian Council of Medical Research [5/8/1/08/RHN]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The study was sponsored by Indian Council of Medical Research (letter no. 5/8/1/08/RHN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAP Task Force on Circumcision 2012, 2013, J Med Ethics, V39, P442, DOI 10.1136/medethics-2013-101456; Alahmad G., 2012, J IMA, V44; Andrews W, 1996, CAN MED ASSOC J, V154, P769; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey R C, 2001, Lancet Infect Dis, V1, P223, DOI 10.1016/S1473-3099(01)00117-7; Becker MHR, 1984, COMPLIANCE MED ADVIC; Beidelman T, 1987, ENCY RELIG; Bitega JP, 2011, JAIDS-J ACQ IMM DEF, V58, pE127, DOI 10.1097/QAI.0b013e3182354e65; Blank S, 2012, PEDIATRICS, V130, P585, DOI 10.1542/peds.2012-1989; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burt RS, 2005, BROKERAGE CLOSURE IN; Calhoun CJ, 2002, ELEMENTARY FORMS REL, P105; CAMERON DW, 1989, LANCET, V2, P403; Chandhiok N, 2007, REPROD HEALTH MATTER, V15, P53, DOI 10.1016/S0968-8080(07)29309-7; DeMeo J, 1997, GEOGRAPHY GENITAL MU; Frisch M, 2013, PEDIATRICS, V131, P796, DOI 10.1542/peds.2012-2896; Gibbs, 1997, SOCIAL RES UPDATE; Gilliam FD, 2010, AIDS BEHAV, V14, P1207, DOI 10.1007/s10461-009-9656-5; Glaser B., 1977, DISCOVERY GROUNDED T; Glick L.B, 2005, MARKED YOUR FLESH CI; Goldman Ronald, 1997, CIRCUMCISION HIDDEN; Gollaher D, 1999, J SOC HIST, V28, P5; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Hankins C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001127; Hastings J, 1971, ENCY RELIG ETHICS EN; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019814; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018299; Hosken F., 1993, HOSKEN REPORT GENITA; Joint United Nations Programme on HIV/AIDS World Health Organization, 2007, MAL CIRC GLOB TRENDS; Kagimu M, 2012, AFR HEALTH SCI, V12, P119, DOI 10.4314/ahs.v12i2.7; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Kebaabetswe P, 2003, SEX TRANSM INFECT, V79, P214, DOI 10.1136/sti.79.3.214; Lissouba P, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-253; Madhivanan P, 2008, AIDS, V22, P983, DOI 10.1097/QAD.0b013e3282ffde52; Mattson CL, 2005, AIDS CARE, V17, P182, DOI 10.1080/09540120512331325671; NACO, 2012, NACO TECHN REP IND H; NACO National AIDS Control Organisation. Department of AIDS Control. Ministry of Health and Family Welfare Goverment of India, 2013, ANN REP 2012 13, P1; Ngalande RC, 2006, AIDS BEHAV, V10, P377, DOI 10.1007/s10461-006-9076-8; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Rain-Taljaard RC, 2003, AIDS CARE, V15, P315, DOI 10.1080/0954012031000105379; Reynolds SJ, 2004, LANCET, V363, P1039, DOI 10.1016/S0140-6736(04)15840-6; Scott BE, 2005, AIDS CARE, V17, P304, DOI 10.1080/09540120412331299744; SIEGFRIED N, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003362; SIKAND Y, 1994, ECON POLIT WEEKLY, V29, P2214; Sunil TS, 1999, POPUL RES POLICY REV, V18, P563, DOI 10.1023/A:1006386010561; Tetali S, 2007, NATL MED J INDIA, V20, P158; Turner L, 2004, DESIGN IMPLEMENTATIO; UNAIDS, 2007, MAL CIRC GLOB TRENDS; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; Van Howe RS, 1999, INT J STD AIDS, V10, P8, DOI 10.1258/0956462991913015; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x; Waldeck SE, 2003, U CINCI LAW REV, V72, P455; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Willms DG, 2011, SEX TRANSM INFECT, V87, P611, DOI 10.1136/sextrans-2011-050045; Wouabe ED, 2013, SCOPING REPORT INTER	56	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91213	10.1371/journal.pone.0091213	http://dx.doi.org/10.1371/journal.pone.0091213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614575	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300096
J	Blake, J; Riddell, A; Theiss, S; Gonzalez, AP; Haase, B; Jauch, A; Janssen, JWG; Ibberson, D; Pavlinic, D; Moog, U; Benes, V; Runz, H				Blake, Jonathon; Riddell, Andrew; Theiss, Susanne; Gonzalez, Alexis Perez; Haase, Bettina; Jauch, Anna; Janssen, Johannes W. G.; Ibberson, David; Pavlinic, Dinko; Moog, Ute; Benes, Vladimir; Runz, Heiko			Sequencing of a Patient with Balanced Chromosome Abnormalities and Neurodevelopmental Disease Identifies Disruption of Multiple High Risk Loci by Structural Variation	PLOS ONE			English	Article							CRITICAL REGION; GENOME; GENES; PREVALENCE; REARRANGEMENTS; RETARDATION; ASSOCIATION; CHILDREN	Balanced chromosome abnormalities (BCAs) occur at a high frequency in healthy and diseased individuals, but cost-efficient strategies to identify BCAs and evaluate whether they contribute to a phenotype have not yet become widespread. Here we apply genome-wide mate-pair library sequencing to characterize structural variation in a patient with unclear neurodevelopmental disease (NDD) and complex de novo BCAs at the karyotype level. Nucleotide-level characterization of the clinically described BCA breakpoints revealed disruption of at least three NDD candidate genes (LINC00299, NUP205, PSMD14) that gave rise to abnormal mRNAs and could be assumed as disease-causing. However, unbiased genome-wide analysis of the sequencing data for cryptic structural variation was key to reveal an additional submicroscopic inversion that truncates the schizophrenia-and bipolar disorder-associated brain transcription factor ZNF804A as an equally likely NDD-driving gene. Deep sequencing of fluorescent-sorted wild-type and derivative chromosomes confirmed the clinically undetected BCA. Moreover, deep sequencing further validated a high accuracy of mate-pair library sequencing to detect structural variants larger than 10 kB, proposing that this approach is powerful for clinical-grade genome-wide structural variant detection. Our study supports previous evidence for a role of ZNF804A in NDD and highlights the need for a more comprehensive assessment of structural variation in karyotypically abnormal individuals and patients with neurocognitive disease to avoid diagnostic deception.	[Blake, Jonathon; Haase, Bettina; Ibberson, David; Pavlinic, Dinko; Benes, Vladimir] EMBL Heidelberg, Genom Core Facil, Heidelberg, Germany; [Riddell, Andrew; Gonzalez, Alexis Perez] EMBL Heidelberg, Flow Cytometry Core Facil, Heidelberg, Germany; [Theiss, Susanne; Jauch, Anna; Janssen, Johannes W. G.; Moog, Ute; Runz, Heiko] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany; [Ibberson, David] Heidelberg Univ, CellNetworks Sequencing Core Facil, Heidelberg, Germany; [Runz, Heiko] Heidelberg Univ, Mol Med Partnership Unit MMPU, EMBL, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Runz, H (corresponding author), Heidelberg Univ, Inst Human Genet, Heidelberg, Germany.	runz@uni-heidelberg.de	Gonzalez, Alexis/O-9802-2016	Gonzalez, Alexis/0000-0002-8674-2034; Haase, Bettina/0000-0002-9811-473X; Benes, Vladimir/0000-0002-0352-2547	European Union [A28]	European Union(European Commission)	The study was supported through project no. A28 of the European Union-supported programme INTERREG IV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Holou WN, 2010, J NEUROSURG-PEDIATR, V5, P578, DOI 10.3171/2010.2.PEDS09464; Burrage LC, 2013, AM J MED GENET A, V161A, P841, DOI 10.1002/ajmg.a.35751; Byrne A, 2010, EXP CELL RES, V316, P258, DOI 10.1016/j.yexcr.2009.08.018; Chen W, 2008, GENOME RES, V18, P1143, DOI 10.1101/gr.076166.108; Cocchella A, 2010, AM J MED GENET B, V153B, P1342, DOI 10.1002/ajmg.b.31107; Currall Benjamin B, 2013, Curr Genet Med Rep, V1, P81; Edmondson AC, 2011, CIRC-CARDIOVASC GENE, V4, P145, DOI 10.1161/CIRCGENETICS.110.957563; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; Gardner R, 2012, CHROMOSOME ABNORMALI, V4th; Girgenti MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032404; Gribble SM, 2009, NAT PROTOC, V4, P1722, DOI 10.1038/nprot.2009.183; Hachet V, 2012, MOL BIOL CELL, V23, P3111, DOI 10.1091/mbc.E12-03-0204; Hill MJ, 2012, HUM MOL GENET, V21, P1018, DOI 10.1093/hmg/ddr532; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Ng BL, 2006, CYTOM PART A, V69A, P1028, DOI 10.1002/cyto.a.20330; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Ravel C, 2006, HUM REPROD, V21, P1484, DOI 10.1093/humrep/del024; Riley B, 2010, MOL PSYCHIATR, V15, P29, DOI 10.1038/mp.2009.109; Steinberg S, 2011, MOL PSYCHIATR, V16, P59, DOI 10.1038/mp.2009.149; STEVENSON J, 1976, DEV MED CHILD NEUROL, V18, P431; Talkowski ME, 2012, AM J HUM GENET, V91, P1128, DOI 10.1016/j.ajhg.2012.10.016; Talkowski ME, 2012, NEW ENGL J MED, V367, P2226, DOI 10.1056/NEJMoa1208594; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Tsai NP, 2012, CELL, V151, P1581, DOI 10.1016/j.cell.2012.11.040; Walter H, 2011, MOL PSYCHIATR, V16, P462, DOI 10.1038/mp.2010.18; WILLIAMS H, 2011, TLS TIMES LIT S 0114, P16	33	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90894	10.1371/journal.pone.0090894	http://dx.doi.org/10.1371/journal.pone.0090894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625750	Green Published, gold			2022-12-27	WOS:000332851300039
J	Courcoul, A; Moyen, JL; Brugere, L; Faye, S; Henault, S; Gares, H; Boschiroli, ML				Courcoul, Aurelie; Moyen, Jean-Louis; Brugere, Laure; Faye, Sandy; Henault, Sylvie; Gares, Helene; Boschiroli, Maria-Laura			Estimation of Sensitivity and Specificity of Bacteriology, Histopathology and PCR for the Confirmatory Diagnosis of Bovine Tuberculosis Using Latent Class Analysis	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; GOLD STANDARD; TESTS; SURVEILLANCE; ABSENCE; CATTLE; IS6110; ASSAY	Bacteriology and histopathology are the most commonly used tests used for official confirmatory diagnosis of bovine tuberculosis (bTB) in cattle in most countries. PCR is also being used increasingly because it allows a fast diagnosis. This test could be applied as a supplement to or replacement for current bTB confirmatory diagnostic tests but its characteristics have first to be evaluated. The aim of this study was to estimate and compare sensitivities and specificities of bacteriology, histopathology and PCR under French field conditions, in the absence of a gold standard using latent class analysis. The studied population consisted of 5,211 animals from which samples were subjected to bacteriology and PCR (LSI VetMAX (TM) Mycobacterium tuberculosis Complex PCR Kit, Life Technologies) as their herd of origin was either suspected or confirmed infected with bTB or because bTB-like lesions were detected during slaughterhouse inspection. Samples from 697 of these animals (all with bTB-like lesions) were subjected to histopathology. Bayesian models were developed, allowing for dependence between bacteriology and PCR, while assuming independence from histopathology. The sensitivity of PCR was higher than that of bacteriology (on average 87.7% [82.5-92.3%] versus 78.1% [72.9-82.8%]) while specificity of both tests was very good (on average 97.0% for PCR [94.3-99.0%] and 99.1% for bacteriology [97.1-100.0%]). Histopathology was at least as sensitive as PCR (on average 93.6% [89.9-96.9%]) but less specific than the two other tests (on average 83.3% [78.7-87.6%]). These results suggest that PCR has the potential to replace bacteriology to confirm bTB in samples submitted from suspect cattle.	[Courcoul, Aurelie] Paris Est Univ, Epidemiol Unit, Hlth Anim Lab, Anses, Maisons Alfort, France; [Moyen, Jean-Louis; Brugere, Laure; Faye, Sandy; Gares, Helene] Reg Anal & Res Lab Dordogne LDAR24, Coulounieix Chamiers, France; [Henault, Sylvie; Boschiroli, Maria-Laura] Paris Est Univ, Bacterial Zoonoses Unit, Bovine TB Reference Lab, Hlth Anim Lab,Anses, Maisons Alfort, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Boschiroli, ML (corresponding author), Paris Est Univ, Bacterial Zoonoses Unit, Bovine TB Reference Lab, Hlth Anim Lab,Anses, Maisons Alfort, France.	Maria-laura.BOSCHIROLI@anses.fr	Boschiroli, Maria Laura/AAR-3319-2021		French Ministry of Agriculture	French Ministry of Agriculture	This work was supported by the French Ministry of Agriculture. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branscum AJ, 2005, PREV VET MED, V68, P145, DOI 10.1016/j.prevetmed.2004.12.005; Cardoso MA, 2009, ZOONOSES PUBLIC HLTH, V56, P465, DOI 10.1111/j.1863-2378.2008.01199.x; Clegg TA, 2011, VET MICROBIOL, V151, P68, DOI 10.1016/j.vetmic.2011.02.027; Corner LAL, 2012, VET MICROBIOL, V156, P162, DOI 10.1016/j.vetmic.2011.10.016; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Enoe C, 2000, PREV VET MED, V45, P61, DOI 10.1016/S0167-5877(00)00117-3; Gardner IA, 2000, PREV VET MED, V45, P107, DOI 10.1016/S0167-5877(00)00119-7; Gardner IA, 2011, PREV VET MED, V101, P18, DOI 10.1016/j.prevetmed.2011.04.002; Henault S, 2006, DEV BIOLOGICALS, V126, P123; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; Johnson WO, 2009, PREV VET MED, V91, P116, DOI 10.1016/j.prevetmed.2009.06.006; Jones G, 2010, BIOMETRICS, V66, P855, DOI 10.1111/j.1541-0420.2009.01330.x; Karolemeas K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043217; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; [OIE OIE], 2012, MAN DIAGN TESTS VACC, P674; Parra A, 2008, VET MICROBIOL, V127, P315, DOI 10.1016/j.vetmic.2007.09.001; Paul S, 2013, PREV VET MED, V109, P258, DOI 10.1016/j.prevetmed.2012.10.007; Proano-Perez F, 2011, PREV VET MED, V101, P65, DOI 10.1016/j.prevetmed.2011.04.018; Schiller I, 2011, VET MICROBIOL, V151, P153, DOI 10.1016/j.vetmic.2011.02.039; Taylor G Michael, 2007, BMC Vet Res, V3, P12, DOI 10.1186/1746-6148-3-12; Thacker TC, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-50; THIERRY D, 1990, J CLIN MICROBIOL, V28, P2668, DOI 10.1128/JCM.28.12.2668-2673.1990; Toft N, 2005, PREV VET MED, V68, P19, DOI 10.1016/j.prevetmed.2005.01.006; Toft N, 2007, VET MICROBIOL, V120, P77, DOI 10.1016/j.vetmic.2006.10.025; Varello K, 2008, J VET DIAGN INVEST, V20, P164, DOI 10.1177/104063870802000204; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0	26	43	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90334	10.1371/journal.pone.0090334	http://dx.doi.org/10.1371/journal.pone.0090334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625670	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300018
J	Gupta, R; Deswal, R				Gupta, Ravi; Deswal, Renu			Refolding of beta-Stranded Class I Chitinases of Hippophae rhamnoides Enhances the Antifreeze Activity during Cold Acclimation	PLOS ONE			English	Article							PROTEINS; PURIFICATION; DEGLYCOSYLATION; IDENTIFICATION; GLYCOPROTEINS; DYNAMICS; CLEAVAGE; SEQUENCE; ACID	Class I chitinases hydrolyse the beta-1,4-linkage of chitin and also acquire antifreeze activity in some of the overwintering plants during cold stress. Two chitinases, HrCHT1a of 31 kDa and HrCHT1b of 34 kDa, were purified from cold acclimated and non-acclimated seabuckthorn seedlings using chitin affinity chromatography. 2-D gels of HrCHT1a and HrCHT1b showed single spots with pIs 7.0 and 4.6 respectively. N-terminal sequence of HrCHT1b matched with the class I chitinase of rice and antifreeze proteins while HrCHT1a could not be sequenced as it was N-terminally blocked. Unlike previous reports, where antifreeze activity of chitinase was cold inducible, our results showed that antifreeze activity is constitutive property of class I chitinase as both HrCHT1a and HrCHT1b isolated even from non-acclimated seedlings, exhibited antifreeze activity. Interestingly, HrCHT1a and HrCHT1b purified from cold acclimated seedlings, exhibited 4 and 2 times higher antifreeze activities than those purified from non-acclimated seedlings, suggesting that antifreeze activity increased during cold acclimation. HrCHT1b exhibited 23-33% higher hydrolytic activity and 2-4 times lower antifreeze activity than HrCHT1a did. HrCHT1b was found to be a glycoprotein; however, its antifreeze activity was independent of glycosylation as even deglycosylated HrCHT1b exhibited antifreeze activity. Circular dichroism (CD) analysis showed that both these chitinases were rich in unusual beta-stranded conformation (36-43%) and the content of beta-strand increased (similar to 11%) during cold acclimation. Surprisingly, calcium decreased both the activities of HrCHT1b while in case of HrCHT1a, a decrease in the hydrolytic activity and enhancement in its antifreeze activity was observed. CD results showed that addition of calcium also increased the beta-stranded conformation of HrCHT1a and HrCHT1b. This is the first report, which shows that antifreeze activity is constitutive property of class I chitinase and cold acclimation and calcium regulate these activities of chitinases by changing the secondary structure.	[Gupta, Ravi; Deswal, Renu] Univ Delhi, Dept Bot, Mol Plant Physiol & Prote Lab, Delhi 110007, India	University of Delhi	Deswal, R (corresponding author), Univ Delhi, Dept Bot, Mol Plant Physiol & Prote Lab, Delhi 110007, India.	rdeswal@botany.du.ac.in	Gupta, Ravi/K-5977-2019; Deswal, Renu/P-7051-2019	Gupta, Ravi/0000-0001-5242-9528; Deswal, Renu/0000-0002-7298-1050	Department of Biotechnology, Government of India [BT/PR10799/NDB/51/171/2008]; University of Delhi	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University of Delhi(University of Delhi)	This work was supported by a grant (BT/PR10799/NDB/51/171/2008) from Department of Biotechnology, Government of India, and a small research grant provided by University of Delhi to RD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Edge ASB, 2003, BIOCHEM J, V376, P339, DOI 10.1042/BJ20030673; Fernandez-Caballero C, 2009, J AGR FOOD CHEM, V57, P8893, DOI 10.1021/jf9016543; Ghangal R, 2012, PLANT PHYSIOL BIOCH, V51, P123, DOI 10.1016/j.plaphy.2011.10.005; Graether SP, 2003, J MOL BIOL, V327, P1155, DOI 10.1016/S0022-2836(03)00235-3; Graether SP, 2001, BIOPHYS J, V81, P1677, DOI 10.1016/S0006-3495(01)75821-3; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Gupta R, 2012, J PROTEOME RES, V11, P2684, DOI 10.1021/pr200944z; Hakim A, 2013, J BIOL CHEM, V288, P12295, DOI 10.1074/jbc.M113.450973; Hiilovaara-Teijo M, 1999, PLANT PHYSIOL, V121, P665, DOI 10.1104/pp.121.2.665; HON WC, 1995, PLANT PHYSIOL, V109, P879, DOI 10.1104/pp.109.3.879; IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154, DOI 10.1080/00021369.1971.10860050; Jarzabek M, 2009, CRYOBIOLOGY, V58, P268, DOI 10.1016/j.cryobiol.2009.01.007; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Kang SC, 1999, J INVERTEBR PATHOL, V73, P276, DOI 10.1006/jipa.1999.4843; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JH, 2012, J BIOL CHEM, V287, P11460, DOI 10.1074/jbc.M111.331835; Li N, 1998, ARCH BIOCHEM BIOPHYS, V360, P25, DOI 10.1006/abbi.1998.0930; MERRIL CR, 1983, METHOD ENZYMOL, V96, P230; Middleton AJ, 2012, J MOL BIOL, V416, P713, DOI 10.1016/j.jmb.2012.01.032; Nakamura T, 2008, PLANT PHYSIOL, V147, P391, DOI 10.1104/pp.106.081497; Perez-Iratxeta C, 2007, BMC STRUCT BIOL, P8; Ruelland E, 2009, ADV BOT RES, V49, P35, DOI 10.1016/S0065-2296(08)00602-2; Seebach D, 2004, CHEM BIODIVERS, V1, P1111, DOI 10.1002/cbdv.200490087; STICHER L, 1993, PLANT PHYSIOL, V101, P1239, DOI 10.1104/pp.101.4.1239; Stressmann M, 2004, PLANT PHYSIOL, V135, P364, DOI 10.1104/pp.103.038158; Sun YL, 2012, BIOCHEM GENET, V50, P600, DOI 10.1007/s10528-012-9504-6; Taira T, 2005, BIOSCI BIOTECH BIOCH, V69, P189, DOI 10.1271/bbb.69.189; TAMS JW, 1995, ANAL BIOCHEM, V228, P48, DOI 10.1006/abio.1995.1313; Thompson SE, 2001, APPL ENVIRON MICROB, V67, P4001, DOI 10.1128/AEM.67.9.4001-4008.2001; Tsvetkova NM, 2002, BIOPHYS J, V82, P464, DOI 10.1016/S0006-3495(02)75411-8; Wen CM, 2002, BIOTECHNOL APPL BIOC, V35, P213, DOI 10.1042/BA20020001; YAMAGAMI T, 1994, BIOSCI BIOTECH BIOCH, V58, P322, DOI 10.1271/bbb.58.322; Yeh S, 2000, PLANT PHYSIOL, V124, P1251, DOI 10.1104/pp.124.3.1251; Yu XM, 2001, PLANT PHYSIOL, V126, P1232, DOI 10.1104/pp.126.3.1232; Yu XM, 2001, PHYSIOL PLANTARUM, V112, P78, DOI 10.1034/j.1399-3054.2001.1120111.x; Zhang DQ, 2004, BIOCHEM J, V377, P589, DOI 10.1042/BJ20031249; Zhang SH, 2011, BIOL PLANTARUM, V55, P141, DOI 10.1007/s10535-011-0019-5	38	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91723	10.1371/journal.pone.0091723	http://dx.doi.org/10.1371/journal.pone.0091723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626216	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300128
J	Robino, A; Mezzavilla, M; Pirastu, N; Dognini, M; Tepper, BJ; Gasparini, P				Robino, Antonietta; Mezzavilla, Massimo; Pirastu, Nicola; Dognini, Maddalena; Tepper, Beverly J.; Gasparini, Paolo			A Population-Based Approach to Study the Impact of PROP Perception on Food Liking in Populations along the Silk Road	PLOS ONE			English	Article							GENETIC TASTE SENSITIVITY; BITTER-TASTE; INDIVIDUAL-DIFFERENCES; 6-N-PROPYLTHIOURACIL PROP; TAS2R38; PHENYLTHIOCARBAMIDE; PTC; POLYMORPHISMS; SENSATIONS; PREFERENCE	Taste is one of the main factors determining food choices. Differences in PROP bitter taste perception have been implicated in individual differences in food preferences and selection. The present study examined associations between, PROP phenotypes, self-reported food liking and TAS2R38 polymorphisms, the major gene implicated in PROP bitterness, in six different populations of the Caucasus and Central Asia, located along the ancient Silk Road. Differences in the distribution of PROP phenotypes across populations were detected, with a higher frequency of super tasters in Tajikistan (31.3%) and Armenia (39.0%) and a higher frequency of non tasters in Georgia (50.9%). While no relationships were observed between PROP phenotypes and food liking using standard statistical tests, we used an approach based on comparison of distance matrices derived from these data. The first matrix compared the food liking ratings of each population to all others pairwise using the Kruskal-Wallis test (at p<0.00063), and the second one compared the distribution of PROP phenotypes across all populations in a similar manner calculating the chi-square statistic as a distance measure. A strong correlation between the two matrices was found (Mantel test: r = 0.67, p-value = 0.03), suggesting that the pattern of food liking across populations was closely related to the distribution of PROP phenotypes. This same relationship was not observed when TAS2R38 genotypes were substituted for PROP phenotypes in this analysis. Our data suggest that a population-based approach utilizing distance matrices is a useful technique for detecting PROP-related differences in food liking and can be applied to other taste phenotypes.	[Robino, Antonietta; Mezzavilla, Massimo; Pirastu, Nicola; Gasparini, Paolo] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy; [Robino, Antonietta; Mezzavilla, Massimo; Pirastu, Nicola; Gasparini, Paolo] Univ Trieste, Trieste, Italy; [Dognini, Maddalena] Condotta Slow Food, Trieste, Italy; [Tepper, Beverly J.] Rutgers State Univ, Dept Food Sci, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA	IRCCS Burlo Garofolo; University of Trieste; Rutgers State University New Brunswick	Robino, A (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.	antonietta.robino@burlo.trieste.it	Pirastu, Nicola/AHB-6226-2022; Mezzavilla, Massimo/AAL-8225-2020; Mezzavilla, Massimo/J-2948-2018; Gasparini, Paolo/B-6173-2014; Robino, Antonietta/K-9398-2016	Mezzavilla, Massimo/0000-0002-9000-4595; Mezzavilla, Massimo/0000-0002-9000-4595; Pirastu, Nicola/0000-0002-5363-3886; Robino, Antonietta/0000-0003-2152-2353; Gasparini, Paolo/0000-0002-0859-0856	Ministry of Health (IRCCS-Burlo Garofolo - Ricerca Corrente)	Ministry of Health (IRCCS-Burlo Garofolo - Ricerca Corrente)	The study was funded by the sponsors of the scientific expedition Marcopolo 2010, and by Ministry of Health (IRCCS-Burlo Garofolo - Ricerca Corrente). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranowski JC, 2010, PUBLIC HEALTH NUTR, V13, P1587, DOI 10.1017/S1368980009993004; Baranowski T, 2011, NUTR RES, V31, P594, DOI 10.1016/j.nutres.2011.07.004; BARTOSHUK LM, 1994, PHYSIOL BEHAV, V56, P1165, DOI 10.1016/0031-9384(94)90361-1; Behrens M, 2006, CELL MOL LIFE SCI, V63, P1501, DOI 10.1007/s00018-006-6113-8; Behrens M, 2013, CHEM SENSES, V38, P475, DOI 10.1093/chemse/bjt016; Bembich S, 2010, CHEM SENSES, V35, P801, DOI 10.1093/chemse/bjq080; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Cabras T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030962; Calo C, 2011, PHYSIOL BEHAV, V104, P1065, DOI 10.1016/j.physbeh.2011.06.013; Campbell MC, 2012, MOL BIOL EVOL, V29, P1141, DOI 10.1093/molbev/msr293; Carrai M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020464; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Coletta A, 2013, EAT BEHAV, V14, P180, DOI 10.1016/j.eatbeh.2013.02.006; Dinehart ME, 2006, PHYSIOL BEHAV, V87, P304, DOI 10.1016/j.physbeh.2005.10.018; Drayna D, 2003, HUM GENET, V112, P567, DOI 10.1007/s00439-003-0911-y; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; Drewnowski A, 2007, J AM DIET ASSOC, V107, P1340, DOI 10.1016/j.jada.2007.05.013; EFRON B, 1992, J ROY STAT SOC B MET, V54, P83; Feeney E, 2011, P NUTR SOC, V70, P135, DOI 10.1017/S0029665110003976; Feeney E, 2011, NUTR B, V36, P20330; Ferrucci LM, 2010, ASIAN PAC J CANCER P, V11, P1621; Goldstein GL, 2007, PHYSIOL BEHAV, V90, P809, DOI 10.1016/j.physbeh.2007.01.004; Gorovic N, 2011, SCAND J CLIN LAB INV, V71, P274, DOI 10.3109/00365513.2011.559553; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Green BG, 2004, CHEM SENSES, V29, P617, DOI 10.1093/chemse/bjh065; Guo SW, 1998, ANN NY ACAD SCI, V855, P810, DOI 10.1111/j.1749-6632.1998.tb10664.x; Guo SW, 2001, ANN HUM BIOL, V28, P111; Hayes JE, 2008, PHYSIOL BEHAV, V95, P77, DOI 10.1016/j.physbeh.2008.04.023; Hayes JE, 2008, CHEM SENSES, V33, P255, DOI 10.1093/chemse/bjm084; Hayes JE, 2013, FOOD QUAL PREFER, V30, P202, DOI 10.1016/j.foodqual.2013.05.013; Hayes JE, 2011, PHYSIOL BEHAV, V104, P1072, DOI 10.1016/j.physbeh.2011.08.003; Hayes JE, 2011, CHEM SENSES, V36, P311, DOI 10.1093/chemse/bjq132; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Keller KL, 2002, APPETITE, V38, P3, DOI 10.1006/appe.2001.0441; Khataan NH, 2009, J NUTRIGENET NUTRIGE, V2, P251, DOI 10.1159/000297217; Kim UK, 2005, CLIN GENET, V67, P275, DOI 10.1111/j.1399-0004.2004.00361.x; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Lucock M, 2011, FOOD FUNCT, V2, P457, DOI 10.1039/c1fo10054h; Mangold JE, 2008, J MED GENET, V45, P578, DOI 10.1136/jmg.2008.057844; MANTEL N, 1967, CANCER RES, V27, P209; Melis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059810; Mennella JA, 2005, PEDIATRICS, V115, pE216, DOI 10.1542/peds.2004-1582; Mennella JA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-60; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Nenadic O, 2007, J STAT SOFTW, V20; Ooi SX, 2010, ASIA PAC J CLIN NUTR, V19, P491; Pemberton TJ, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-13; Pirastu N, 2012, J FOOD SCI, V77, pS413, DOI 10.1111/j.1750-3841.2012.02852.x; Prescott J, 2004, PHYSIOL BEHAV, V82, P459, DOI 10.1016/j.physbeh.2004.04.009; REYNOLDS J, 1983, GENETICS, V105, P767; Sacerdote C, 2007, AM J EPIDEMIOL, V166, P576, DOI 10.1093/aje/kwm113; Shafaie Y, 2013, AM J CLIN NUTR; TENENHAUS M, 1985, PSYCHOMETRIKA, V50, P91, DOI 10.1007/BF02294151; Tepper BJ, 2008, OBESITY, V16, P2289, DOI 10.1038/oby.2008.357; Tepper BJ, 2008, ANNU REV NUTR, V28, P367, DOI 10.1146/annurev.nutr.28.061807.155458; Tepper BJ, 2011, APPETITE, V56, P104, DOI 10.1016/j.appet.2010.11.144; Tepper BJ, 2009, ANN NY ACAD SCI, V1170, P126, DOI 10.1111/j.1749-6632.2009.03916.x; Tepper BJ, 1998, AM J HUM GENET, V63, P1271, DOI 10.1086/302124; Tepper BJ, 2002, PHYSIOL BEHAV, V75, P305, DOI 10.1016/S0031-9384(01)00664-3; Tepper BJ, 2001, PHYSIOL BEHAV, V73, P571, DOI 10.1016/S0031-9384(01)00500-5; Tsuji M, 2012, EUR J CLIN NUTR, V66, P47, DOI 10.1038/ejcn.2011.127; Ullrich NV, 2004, J AM DIET ASSOC, V104, P543, DOI 10.1016/j.jada.2004.01.011; Walker Christopher J., 1990, ARMENIA SURVIVAL NAT; Zhao LQ, 2003, PHYSIOL BEHAV, V78, P625, DOI 10.1016/S0031-9384(03)00057-X	66	27	27	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91716	10.1371/journal.pone.0091716	http://dx.doi.org/10.1371/journal.pone.0091716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626196	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300127
J	Graham, SL; Hunt, JE; Millard, P; McSeveny, T; Tylianakis, JM; Whitehead, D				Graham, Scott L.; Hunt, John E.; Millard, Peter; McSeveny, Tony; Tylianakis, Jason M.; Whitehead, David			Effects of Soil Warming and Nitrogen Addition on Soil Respiration in a New Zealand Tussock Grassland	PLOS ONE			English	Article							CARBON-CYCLE FEEDBACKS; ATMOSPHERIC CO2; ORGANIC-MATTER; TEMPERATURE SENSITIVITY; MICROBIAL BIOMASS; ROOT RESPIRATION; CLIMATE; AVAILABILITY; RESPONSES; FLUX	Soil respiration (R-S) represents a large terrestrial source of CO2 to the atmosphere. Global change drivers such as climate warming and nitrogen deposition are expected to alter the terrestrial carbon cycle with likely consequences for R-S and its components, autotrophic (R-A) and heterotrophic respiration (R-H). Here we investigate the impacts of a 3 degrees C soil warming treatment and a 50 kg ha(-1) y(-1) nitrogen addition treatment on R-S, R-H and their respective seasonal temperature responses in an experimental tussock grassland. Average respiration in untreated soils was 0.96 +/- 0.09 mu mol m(-2) s(-1) over the course of the experiment. Soil warming and nitrogen addition increased R-S by 41% and 12% respectively. These treatment effects were additive under combined warming and nitrogen addition. Warming increased R-H by 37% while nitrogen addition had no effect. Warming and nitrogen addition affected the seasonal temperature response of R-S by increasing the basal rate of respiration (R-10) by 14% and 20% respectively. There was no significant interaction between treatments for R10. The treatments had no impact on activation energy (E-0). The seasonal temperature response of R-H was not affected by either warming or nitrogen addition. These results suggest that the additional CO2 emissions from New Zealand tussock grassland soils as a result of warming-enhanced R-S constitute a potential positive feedback to rising atmospheric CO2 concentration.	[Graham, Scott L.; Tylianakis, Jason M.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Graham, Scott L.; Hunt, John E.; Millard, Peter; McSeveny, Tony; Whitehead, David] Landcare Res, Lincoln, New Zealand; [Tylianakis, Jason M.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England	University of Canterbury; Landcare Research - New Zealand; Imperial College London	Graham, SL (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	scott.graham@ucf.edu	Hunt, John/AAX-6121-2020; Whitehead, David/AAB-1608-2019; Millard, Peter/F-1048-2011; Tylianakis, Jason/B-6634-2011	Tylianakis, Jason/0000-0001-7402-5620; Millard, Peter/0000-0001-5114-6219; Hunt, John/0000-0002-8966-8773; Graham, Scott/0000-0002-4751-9868	Miss E.L. Hellaby Indigenous Grassland Research Trust; Ministry for Business, Innovation and Employment; Rutherford Discovery Fellowship; Marsden Fund [UOC-0705]	Miss E.L. Hellaby Indigenous Grassland Research Trust; Ministry for Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Rutherford Discovery Fellowship; Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	SLG was supported by a fellowship from the Miss E.L. Hellaby Indigenous Grassland Research Trust. JEH, PM, TM, and DW received funding from the Ministry for Business, Innovation and Employment. JMT was funded by a Rutherford Discovery Fellowship administered by the Royal Society of New Zealand. This work was funded by the Marsden Fund (UOC-0705) and the Miss E.L. Hellaby Indigenous Grassland Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn M, 2008, ECOSYSTEMS, V11, P1352, DOI 10.1007/s10021-008-9198-0; Bahn M, 2006, GLOBAL CHANGE BIOL, V12, P995, DOI 10.1111/j.1365-2486.2006.01144.x; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Burton AJ, 2008, J INTEGR PLANT BIOL, V50, P1467, DOI 10.1111/j.1744-7909.2008.00750.x; Chen XW, 2011, CLIMATIC CHANGE, V107, P459, DOI 10.1007/s10584-010-9942-2; Contosta AR, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00133.1; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Craine JM, 2001, GLOBAL CHANGE BIOL, V7, P947, DOI 10.1046/j.1354-1013.2001.00455.x; Crawley M.J., 2007, R BOOK; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Graham SL, 2012, ANN BOT-LONDON, V110, P253, DOI 10.1093/aob/mcs073; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hartley IP, 2007, GLOBAL CHANGE BIOL, V13, P1761, DOI 10.1111/j.1365-2486.2007.01373.x; Hewitt A.E., 2010, NZ SOIL CLASSIFICATI, Vthird; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/ngeo844, 10.1038/NGEO844]; JONG ED, 1974, CAN J SOIL SCI, V54, P299, DOI 10.4141/cjss74-039; Kirschbaum MUF, 2004, GLOBAL CHANGE BIOL, V10, P1870, DOI 10.1111/j.1365-2486.2004.00852.x; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Leuzinger S, 2011, TRENDS ECOL EVOL, V26, P236, DOI 10.1016/j.tree.2011.02.011; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Melillo JM, 2011, P NATL ACAD SCI USA, V108, P9508, DOI 10.1073/pnas.1018189108; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Norby RJ, 2004, NEW PHYTOL, V162, P281, DOI 10.1111/j.1469-8137.2004.01047.x; PETERJOHN WT, 1993, OECOLOGIA, V93, P18, DOI 10.1007/BF00321185; Pinheiro J., 2021, NLME LINEAR NONLINEA; Pinheiro J, 2000, MIXED EFFECTS MODELS; R Core Team, 2021, R LANGUAGE ENV STAT; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schindlbacher A, 2012, GLOBAL CHANGE BIOL, V18, P2270, DOI 10.1111/j.1365-2486.2012.02696.x; Schindlbacher A, 2009, GLOBAL CHANGE BIOL, V15, P901, DOI 10.1111/j.1365-2486.2008.01757.x; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sparks JP, 2009, OECOLOGIA, V159, P1, DOI 10.1007/s00442-008-1188-6; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Trotter CM, 2004, GLOBAL ENV CHANGE OC, P311; Trumbore S, 2000, ECOL APPL, V10, P399, DOI 10.1890/1051-0761(2000)010[0399:AOSOMA]2.0.CO;2; Uchida Y, 2010, PLANT SOIL, V337, P375, DOI 10.1007/s11104-010-0533-9; USDA, 2006, KEYS SOIL TAX; Uselman SM, 2000, PLANT SOIL, V222, P191, DOI 10.1023/A:1004705416108; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wan S, 2007, GLOBAL CHANGE BIOL, V13, P2411, DOI 10.1111/j.1365-2486.2007.01433.x; Yan LM, 2010, GLOBAL CHANGE BIOL, V16, P2345, DOI 10.1111/j.1365-2486.2009.02091.x; Zhou X, 2007, GLOBAL CHANGE BIOL, V13, P761, DOI 10.1111/j.1365-2486.2007.01333.x; Zhou YM, 2011, TREE PHYSIOL, V31, P707, DOI 10.1093/treephys/tpr066; Zhu BA, 2011, GLOBAL CHANGE BIOL, V17, P2172, DOI 10.1111/j.1365-2486.2010.02354.x	53	37	39	19	230	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91204	10.1371/journal.pone.0091204	http://dx.doi.org/10.1371/journal.pone.0091204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621790	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300063
J	Gubernator, J; Lipka, D; Korycinska, M; Kempinska, K; Milczarek, M; Wietrzyk, J; Hrynyk, R; Barnert, S; Suss, R; Kozubek, A				Gubernator, Jerzy; Lipka, Dominik; Korycinska, Mariola; Kempinska, Katarzyna; Milczarek, Magdalena; Wietrzyk, Joanna; Hrynyk, Rafal; Barnert, Sabine; Suess, Regine; Kozubek, Arkadiusz			Efficient Human Breast Cancer Xenograft Regression after a Single Treatment with a Novel Liposomal Formulation of Epirubicin Prepared Using the EDTA Ion Gradient Method	PLOS ONE			English	Article							LONG-CIRCULATING LIPOSOMES; TO-LIPID RATIO; THERMOSENSITIVE LIPOSOMES; DRUG-RELEASE; IN-VITRO; DOXORUBICIN; TUMOR; ANTHRACYCLINES; RETENTION; CISPLATIN	Liposomes act as efficient drug carriers. Recently, epirubicin (EPI) formulation was developed using a novel EDTA ion gradient method for drug encapsulation. This formulation displayed very good stability and drug retention in vitro in a two-year long-term stability experiment. The cryo-TEM images show drug precipitate structures different than ones formed with ammonium sulfate method, which is usually used to encapsulate anthracyclines. Its pharmacokinetic properties and its efficacy in the human breast MDA-MB-231 cancer xenograft model were also determined. The liposomal EPI formulation is eliminated slowly with an AUC of 7.6487, while the free drug has an AUC of only 0.0097. The formulation also had a much higher overall antitumor efficacy than the free drug.	[Gubernator, Jerzy; Lipka, Dominik; Korycinska, Mariola; Kozubek, Arkadiusz] Univ Wroclaw, Fac Biotechnol, Dept Lipids & Liposomes, PL-50138 Wroclaw, Poland; [Kempinska, Katarzyna; Milczarek, Magdalena; Wietrzyk, Joanna] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Expt Oncol, Wroclaw, Poland; [Hrynyk, Rafal] Natl Res Inst, Cent Inst Labour Protect, Dept Personal Protect Equipment, Warsaw, Poland; [Barnert, Sabine; Suess, Regine] Univ Freiburg, Dept Pharmaceut Technol, D-79106 Freiburg, Germany	University of Wroclaw; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Central Institute for Labour Protection - National Research Institute; University of Freiburg	Gubernator, J (corresponding author), Univ Wroclaw, Fac Biotechnol, Dept Lipids & Liposomes, PL-50138 Wroclaw, Poland.	gubern@ibmb.uni.wroc.pl	Milczarek, Magdalena/AAC-5660-2020; Wietrzyk, Joanna/O-4392-2018	Wietrzyk, Joanna/0000-0003-4980-6606; Milczarek, Magdalena/0000-0001-6696-5305	Pharmaceutical Research Institute, Warsaw, Poland	Pharmaceutical Research Institute, Warsaw, Poland	This study was supported by the Pharmaceutical Research Institute, Warsaw, Poland. The funders had only role in drug and cancer type selection, but not on data collection and analysis, decision to publish, or preparation of the manuscript.	Banno B, 2010, J PHARM SCI-US, V99, P2295, DOI 10.1002/jps.21988; Birtle AJ, 2000, CLIN ONCOL-UK, V12, P146, DOI 10.1053/clon.2000.9141; Cern A, 2012, J CONTROL RELEASE, V160, P147, DOI 10.1016/j.jconrel.2011.11.029; Dos Santos N, 2002, BBA-BIOMEMBRANES, V1561, P188, DOI 10.1016/S0005-2736(02)00345-0; GABIZON A, 1994, CANCER RES, V54, P987; Gabizon A, 1997, ADV DRUG DELIVER REV, V24, P337, DOI 10.1016/S0169-409X(96)00476-0; GABIZON AA, 1994, HEMATOL ONCOL CLIN N, V8, P431; GABIZON AA, 1992, CANCER RES, V52, P891; Gubernator J, 2010, J CONTROL RELEASE, V146, P68, DOI 10.1016/j.jconrel.2010.05.021; Ickenstein LM, 2003, BBA-BIOMEMBRANES, V1614, P135, DOI 10.1016/S0005-2736(03)00196-2; Johnston MJW, 2008, J LIPOSOME RES, V18, P145, DOI [10.1080/08982100802129372, 10.1080/08982100802129372 ]; Johnston MJW, 2006, BBA-BIOMEMBRANES, V1758, P55, DOI 10.1016/j.bbamem.2006.01.009; Koning GA, 2010, PHARM RES-DORDR, V27, P1750, DOI 10.1007/s11095-010-0154-2; Laginha KM, 2005, CLIN CANCER RES, V11, P6944, DOI 10.1158/1078-0432.CCR-05-0343; Lipka Dominik, 2013, Int J Nanomedicine, V8, P3573, DOI 10.2147/IJN.S47745; Lohr M, 2009, ANN ONCOL, V20, P9; MAYHEW EG, 1992, INT J CANCER, V51, P302, DOI 10.1002/ijc.2910510221; Mylonakis N, 2010, LUNG CANCER, V68, P240, DOI 10.1016/j.lungcan.2009.06.017; Nielsen D, 2000, CANCER CHEMOTH PHARM, V46, P459, DOI 10.1007/s002800000178; Popovic Z, 2010, ANGEW CHEM INT EDIT, V49, P8649, DOI 10.1002/anie.201003142; Riviere J.E., 2018, VET PHARM THERAPEUTI; Stathopoulos GP, 2010, ANTICANCER RES, V30, P1317; Stathopoulos GP, 2006, ANTICANCER RES, V26, P1489; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Tian W, 2010, EUR J PHARM SCI, V41, P232, DOI 10.1016/j.ejps.2010.06.008; TIDEFELT U, 1991, CANCER CHEMOTH PHARM, V29, P7, DOI 10.1007/BF00686328; TODOROV DK, 1995, J CANCER RES CLIN, V121, P164, DOI 10.1007/BF01198098; Zucker D, 2009, J CONTROL RELEASE, V139, P73, DOI 10.1016/j.jconrel.2009.05.036	28	13	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91487	10.1371/journal.pone.0091487	http://dx.doi.org/10.1371/journal.pone.0091487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621591	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300094
J	Wei, XL; Zou, GY; Walley, J; Yin, J; Lonnroth, K; Uplekar, M; Wang, WB; Sun, Q				Wei, Xiaolin; Zou, Guanyang; Walley, John; Yin, Jia; Lonnroth, Knut; Uplekar, Mukund; Wang, Weibing; Sun, Qiang			China Tuberculosis Policy at Crucial Crossroads: Comparing the Practice of Different Hospital and Tuberculosis Control Collaboration Models Using Survey Data	PLOS ONE			English	Article							PUBLIC-HEALTH SYSTEM; FINANCIAL INCENTIVES; RURAL CHINA; TB SERVICES; CARE; SHANGHAI; PATIENT; MARKET; DELAY	Background: Currently three hospital and tuberculosis (TB) collaboration models exist in China: the dispensary model where TB has to be diagnosed and treated in TB dispensaries, the specialist model where TB specialist hospital also treat TB patients, and the integrated model where TB diagnosis and treatment is integrated into a general hospital. The study compared effects of the three models through exploring patient experience in TB diagnosis and treatment. Methods: We selected two sites in each model of TB service in four provinces of China. In each site, 50 patients were selected from TB patient registries for a structured questionnaire survey, with a total of 293 patients recruited. All participants were newly registered uncomplicated TB cases without any major complications or resistance to first-line anti-TB drugs, and having successfully completed treatment. Diagnostic and treatment procedures were reviewed from medical charts of the surveyed patients to compare with national guidelines. Results: Specialist sites had the highest patient expenditure, hospitalization rates and mostly used second-line anti-TB drugs, while the integrated model reported the opposite. The median health expenditure was USD 1,499 for the specialist sites and USD 306 for the integrated sites, with 83% and 15% patients respectively having unnecessary hospitalization. 74% of the specialist sites and 19% of the integrated sites used second-line anti-TB drugs. Mixed results were identified in the two dispensary sites. One site had median health expenditure of USD 138 with 12% of patients hospitalized, while the other had USD 912 and 65% respectively. Conclusion: The study observed prohibitive financial expenditure and a high level of deviation from national guidelines in all sites, which may be related to the profit-seeking behavior of public hospitals. The study supports the integrated model as the better policy option for future TB health reform in China.	[Wei, Xiaolin; Yin, Jia] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Zou, Guanyang] Univ Leeds, Nuffield Ctr Int Hlth & Dev, China HSD Program, Leeds, W Yorkshire, England; [Walley, John] Univ Leeds, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England; [Lonnroth, Knut; Uplekar, Mukund] World Hlth Org, Global TB Programme, Geneva, Switzerland; [Wang, Weibing] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Sun, Qiang] Shandong Univ, Ctr Hlth Management & Policy, Jinan 250100, Peoples R China	Chinese University of Hong Kong; University of Leeds; University of Leeds; World Health Organization; Fudan University; Shandong University	Sun, Q (corresponding author), Shandong Univ, Ctr Hlth Management & Policy, Jinan 250100, Peoples R China.	qiangs@sdu.edu.cn	Walley, John D/AAY-1375-2021; Lonnroth, Knut/H-5470-2017; Lönnroth, Knut/L-2339-2014	Walley, John D/0000-0001-7290-0989; Lonnroth, Knut/0000-0001-6944-0256; Lönnroth, Knut/0000-0001-5054-8240	Department of International Development, UK Government [HRPC09]	Department of International Development, UK Government	The work is part of the COMDIS Health Service Delivery Research Consortium (COMDIS/HSD), funded by Department of International Development, UK Government [grant number: HRPC09]. However, DFID has no role in design, data collection and interpretation of the study, decision to publish, or preparation of the manuscript.	Ayuo P O, 2008, East Afr Med J, V85, P263; Barber SL, 2011, INT J HEALTH PLAN M, V26, P339, DOI 10.1002/hpm.1109; Chen XY, 2004, LANCET, V364, P417; Chiang CY, 2007, INT J TUBERC LUNG D, V11, P739; China National Centre for TB Control and Prevention, 2008, CHIN TUB PREV CONTR; Fan YL, 2008, CHINESE J ANTITUBERC, V30, P532; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Kiwuwa MS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-122; Lin SF, 2009, CHINESE J ANTITUBERC, V31, P26; Long Q, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-393; Ma J, 2008, HEALTH AFFAIR, V27, P937, DOI 10.1377/hlthaff.27.4.937; Ministry of Health, 2004, NOT FURTH STRENGHT T; National Technic Steering Group Of The Epidemiological Sampling Survey For Tuberculosis, 2002, Zhonghua Jie He He Hu Xi Za Zhi, V25, P3; Shan SX, 2007, J CHINESE ANTITUBERC, V29, P61; Singh AA, 2004, INT J TUBERC LUNG D, V8, P1255; Sun Q, 2008, INT J TUBERC LUNG D, V12, P625; TBCTA, 2006, INT STAND TUB CAR DI, P29; Wang L, 2009, INT J TUBERC LUNG D, V13, P1486; Wang LX, 2010, B WORLD HEALTH ORGAN, V88, P937, DOI 10.2471/BLT.09.071753; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Wang LX, 2007, CHIN J ANTITUBERC, V29, P479, DOI [10.3969/j.issn.1000-6621.2007.06.002, DOI 10.3969/J.ISSN.1000-6621.2007.06.002]; Wei XL, 2009, INT J TUBERC LUNG D, V13, P514; Wei XL, 2009, HEALTH POLICY, V90, P206, DOI 10.1016/j.healthpol.2008.10.005; Wei XL, 2009, TROP MED INT HEALTH, V14, P754, DOI 10.1111/j.1365-3156.2009.02286.x; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2007, ENG ALL HLTH CAR PRO; WHO, 2005, GLOB TUB CONTR SURV, P75; WHO, 2011, 42 UN WORLD C LUNG H; Xia S, 2006, CHINESE J ANTITUBERC, V28, P354; Xu B, 2005, INT J TUBERC LUNG D, V9, P784; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Yan F, 2007, HEALTH POLICY, V82, P186, DOI 10.1016/j.healthpol.2006.08.001; Yao H, 2008, INT J TUBERC LUNG D, V12, P1166; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789; Zou GY, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-21	40	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90596	10.1371/journal.pone.0090596	http://dx.doi.org/10.1371/journal.pone.0090596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24621996	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300024
J	Tamayo, T; Rathmann, W; Kramer, U; Sugiri, D; Grabert, M; Holl, RW				Tamayo, Teresa; Rathmann, Wolfgang; Kraemer, Ursula; Sugiri, Dorothea; Grabert, Matthias; Holl, Reinhard W.			Is Particle Pollution in Outdoor Air Associated with Metabolic Control in Type 2 Diabetes?	PLOS ONE			English	Article							LONG-TERM EXPOSURE; CARDIOVASCULAR-DISEASE; STATEMENT; MORTALITY; MELLITUS; OBESITY	Background: There is growing evidence that air pollutants are associated with the risk of type 2 diabetes. Subclinical inflammation may be a mechanism linking air pollution with diabetes. Information is lacking whether air pollution also contributes to worse metabolic control in newly diagnosed type 2 diabetes. We examined the hypothesis that residential particulate matter (PM10) is associated with HbA(1c) concentration in newly diagnosed type 2 diabetes. Methods: Nationwide regional levels of particulate matter with a diameter of <= 10 mu m (PM10) were obtained in 2009 from background monitoring stations in Germany (Federal Environmental Agency) and assigned to place of residency of 9,102 newly diagnosed diabetes patients registered in the DPV database throughout Germany (age 65.5 +/- 13.5 yrs; males: 52.1%). Mean HbA(1c) (%) levels stratified for air pollution quartiles (PM10 in mu g/m(3)) were estimated using linear regression models adjusting for age, sex, BMI, diabetes duration, geographic region, year of ascertainment, and social indicators. Findings: In both men and women, adjusted HbA(1c) was significantly lower in the lowest quartile of PM10 exposure in comparison to quartiles Q2-Q4. Largest differences in adjusted HbA(1c) (95% CI) were seen comparing lowest quartiles of exposure with highest quartiles (men %: -0.42 (-0.62; -0.23)/mmol/mol: -28.11 (-30.30; -26.04), women, %: -0.28 (-0.47; -0.09)/mmol/mol: -0.28 (-0.47; -0.09)). Interpretation: Air pollution may be associated with higher HbA(1c) levels in newly diagnosed type 2 diabetes patients. Further studies are warranted to examine this association.	[Tamayo, Teresa; Rathmann, Wolfgang] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Kraemer, Ursula; Sugiri, Dorothea] Univ Dusseldorf, Leibniz Ctr, Inst Environm Med IUF, Dusseldorf, Germany; [Grabert, Matthias; Holl, Reinhard W.] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Ulm University	Tamayo, T (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany.	teresa.tamayo@ddz.uni-duesseldorf.de		Holl, Reinhard/0000-0003-1395-4842	Competence Network for Diabetes mellitus of the Federal Ministry of Education and Research [01GI1110D/01GI1106]	Competence Network for Diabetes mellitus of the Federal Ministry of Education and Research	Data are part of the BMBF Diabetes Meta-Database project which was funded by the Competence Network for Diabetes mellitus of the Federal Ministry of Education and Research (support codes 01GI1110D/01GI1106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awa WL, 2012, EUR J ENDOCRINOL, V167, P245, DOI 10.1530/EJE-12-0143; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2008, J OCCUP ENVIRON MED, V50, P32, DOI 10.1097/JOM.0b013e31815dba70; Brook RD, 2013, SCI TOTAL ENVIRON, V448, P66, DOI 10.1016/j.scitotenv.2012.07.034; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Chuang KJ, 2011, OCCUP ENVIRON MED, V68, P64, DOI 10.1136/oem.2009.052704; Cohen BE, 2009, DIABETES RES CLIN PR, V86, P67, DOI 10.1016/j.diabres.2009.07.006; Coogan PF, 2012, CIRCULATION, V125, P767, DOI 10.1161/CIRCULATIONAHA.111.052753; Dijkema MBA, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-76; Flemming J, 2002, ITM AIR POLLUTION MO; Kahn SE, 2013, DIABETES CARE, V36, P4, DOI 10.2337/dc12-1526; Kowall B, 2011, EUR J EPIDEMIOL, V26, P637, DOI 10.1007/s10654-011-9609-y; Kramer U, 2010, ENVIRON HEALTH PERSP, V118, P1273, DOI 10.1289/ehp.0901689; Malmqvist E, 2013, ENVIRON HEALTH PERSP, V121, P488, DOI 10.1289/ehp.1205736; Pope CA, 2007, INHAL TOXICOL, V19, P33, DOI 10.1080/08958370701492961; Puett RC, 2011, ENVIRON HEALTH PERSP, V119, P384, DOI 10.1289/ehp.1002344; Raaschou-Nielsen O, 2013, DIABETOLOGIA, V56, P36, DOI 10.1007/s00125-012-2698-7; Rajagopalan S, 2012, DIABETES, V61, P3037, DOI 10.2337/db12-0190; Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; STERN R, 2004, FORMULATION CRITERIA; Sun QH, 2009, CIRCULATION, V119, P538, DOI 10.1161/CIRCULATIONAHA.108.799015; Teichert T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083042; Xu XH, 2010, ARTERIOSCL THROM VAS, V30, P2518, DOI 10.1161/ATVBAHA.110.215350; Zanobetti A, 2002, EPIDEMIOLOGY, V13, P588, DOI 10.1097/00001648-200209000-00016; Zheng Z, 2013, J HEPATOL, V58, P148, DOI 10.1016/j.jhep.2012.08.009; Zoungas S, 2012, DIABETOLOGIA, V55, P636, DOI 10.1007/s00125-011-2404-1	28	33	36	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91639	10.1371/journal.pone.0091639	http://dx.doi.org/10.1371/journal.pone.0091639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619127	gold, Green Published, Green Submitted			2022-12-27	WOS:000332842400110
J	Truck, J; Snape, MD; Tatangeli, F; Voysey, M; Yu, LM; Faust, SN; Heath, PT; Finn, A; Pollard, AJ				Trueck, Johannes; Snape, Matthew D.; Tatangeli, Florencia; Voysey, Merryn; Yu, Ly-Mee; Faust, Saul N.; Heath, Paul T.; Finn, Adam; Pollard, Andrew J.			Pneumococcal Serotype-Specific Antibodies Persist through Early Childhood after Infant Immunization: Follow-Up from a Randomized Controlled Trial	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINATION; OTITIS-MEDIA; CHILDREN; CARRIAGE; BOOSTER; IMMUNOGENICITY; REPLACEMENT; DISEASE; ACQUISITION	Background: In a previous UK multi-center randomized study 278 children received three doses of 7-valent (PCV-7) or 13-valent (PCV-13) pneumococcal conjugate vaccine at 2, 4 and 12 months of age. At 13 months of age, most of these children had pneumococcal serotype-specific IgG concentrations >= 0.35 mu g/ml and opsonophagocytic assay (OPA) titers >= 8. Methods: Children who had participated in the original study were enrolled again at 3.5 years of age. Persistence of immunity following infant immunization with either PCV-7 or PCV-13 and the immune response to a PCV-13 booster at preschool age were investigated. Results: In total, 108 children were followed-up to the age of 3.5 years and received a PCV-13 booster at this age. At least 76% of children who received PCV-7 or PCV-13 in infancy retained serotype-specific IgG concentrations >= 0.35 mu g/ml against each of 5/7 shared serotypes. For serotypes 4 and 18C, persistence was lower at 22-42%. At least 71% of PCV-13 group participants had IgG concentrations >= 0.35 mu g/ml against each of 4/6 of the additional PCV-13 serotypes; for serotypes 1 and 3 this proportion was 45% and 52%. In the PCV-7 group these percentages were significantly lower for serotypes 1, 5 and 7F. A pre-school PCV-13 booster was highly immunogenic and resulted in low rates of local and systemic adverse effects. Conclusion: Despite some decline in antibody from 13 months of age, these data suggest that a majority of pre-school children maintain protective serotype-specific antibody concentrations following conjugate vaccination at 2, 4 and 12 months of age.	[Trueck, Johannes; Snape, Matthew D.; Tatangeli, Florencia; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Trueck, Johannes; Snape, Matthew D.; Tatangeli, Florencia; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Voysey, Merryn; Yu, Ly-Mee] Univ Oxford, Ctr Stat Med, Oxford, England; [Faust, Saul N.] Univ Southampton, Univ Hosp Southampton NHS Foundat Trust, NIHR Wellcome Trust Clin Res Facil, Southampton, Hants, England; [Faust, Saul N.] Univ Southampton, Univ Hosp Southampton NHS Foundat Trust, NIHR Resp Biomed Res Unit, Southampton, Hants, England; [Faust, Saul N.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Faust, Saul N.] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Heath, Paul T.] Univ London, St Georges Vaccine Inst, London, England; [Finn, Adam] Univ Hosp Bristol NHS Fdn Trust, Bristol Childrens Vaccine Ctr, Bristol, Avon, England; [Finn, Adam] Univ Bristol, Bristol, Avon, England	University of Oxford; University of Oxford; University of Oxford; University of Southampton; University of Southampton; University of Southampton; University of Southampton; St Georges University London; University of London; University of Bristol; University of Bristol	Truck, J (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England.	johannes.truck@paediatrics.ox.ac.uk	Faust, Saul/J-9779-2014; Trück, Johannes/E-3459-2012	Faust, Saul/0000-0003-3410-7642; Trück, Johannes/0000-0002-0418-7381; Snape, Matthew/0000-0003-0531-5426; Heath, Paul/0000-0002-7540-7433; Finn, Adam/0000-0003-1756-5668; Voysey, Merryn/0000-0001-6324-6559; Yu, Ly-Mee/0000-0003-0331-7364	Pfizer Vaccine Research; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; NIHR Thames Valley and Hampshire and Isle of Wight Comprehensive Local Research Networks; NIHR South West Medicines for Children Network (MCRN), London; South East MCRN; Southampton NIHR Wellcome Trust Clinical Research Facility; ESPID Fellowship Award	Pfizer Vaccine Research; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Thames Valley and Hampshire and Isle of Wight Comprehensive Local Research Networks; NIHR South West Medicines for Children Network (MCRN), London; South East MCRN; Southampton NIHR Wellcome Trust Clinical Research Facility; ESPID Fellowship Award	This work was supported by Pfizer Vaccine Research and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre with support from the NIHR Thames Valley and Hampshire and Isle of Wight Comprehensive Local Research Networks, NIHR South West Medicines for Children Network (MCRN), London and South East MCRN and Southampton NIHR Wellcome Trust Clinical Research Facility. JT was supported by an ESPID Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NJ, 2012, VACCINE, V30, P6802, DOI 10.1016/j.vaccine.2012.09.019; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Duggan ST, 2012, PEDIATR DRUGS, V14, P67, DOI 10.2165/11207010-000000000-00000; Ekstrom N, 2005, INFECT IMMUN, V73, P369, DOI 10.1128/IAI.73.1.369-377.2005; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506; Givon-Lavi N, 2010, PEDIATR INFECT DIS J, V29, P756, DOI 10.1097/INF.0b013e3181d99345; Hanage WP, 2010, EPIDEMICS-NETH, V2, P80, DOI 10.1016/j.epidem.2010.03.005; Heath PT, 2000, JAMA-J AM MED ASSOC, V284, P2334, DOI 10.1001/jama.284.18.2334; Henckaerts I, 2007, VACCINE, V25, P2518, DOI 10.1016/j.vaccine.2006.09.029; Hsu KK, 2010, PEDIATR INFECT DIS J, V29, P289, DOI 10.1097/INF.0b013e3181c15471; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Khatami A, 2011, PEDIATR INFECT DIS J, V30, P197, DOI 10.1097/INF.0b013e3181f728fd; Madhi SA, 2007, VACCINE, V25, P2451, DOI 10.1016/j.vaccine.2006.09.019; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Perrett KP, 2010, CLIN INFECT DIS, V50, P1601, DOI 10.1086/652765; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Poolman J, 2009, VACCINE, V27, P3213, DOI 10.1016/j.vaccine.2009.03.017; R Core Team, 2021, R LANGUAGE ENV STAT; Rodrigues F, 2012, VACCINE, V30, P3951, DOI 10.1016/j.vaccine.2012.03.058; Rudolph K, 2012, DIAGN MICROBIOL INFE, V75, P271; Scott JAG, 2007, VACCINE, V25, P2398, DOI 10.1016/j.vaccine.2006.09.008; Silfverdal SA, 2011, PEDIATR INFECT DIS J, V30, pE155, DOI 10.1097/INF.0b013e31821feeb7; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Sleeman KL, 2005, PEDIATR INFECT DIS J, V24, P121, DOI 10.1097/01.inf.0000151030.10159.b1; Snape MD, 2010, PEDIATR INFECT DIS J, V29, pE80, DOI 10.1097/INF.0b013e3181faa6be; Tocheva AS, 2011, VACCINE, V29, P4400, DOI 10.1016/j.vaccine.2011.04.004; Truck J, 2013, IMMUNOBIOLOGY, V218, P368, DOI 10.1016/j.imbio.2012.05.008; Truck J, 2010, EARLY HUM DEV, V86, P695, DOI 10.1016/j.earlhumdev.2010.08.010; van Gils EJM, 2010, JAMA-J AM MED ASSOC, V304, P1099, DOI 10.1001/jama.2010.1290	31	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91413	10.1371/journal.pone.0091413	http://dx.doi.org/10.1371/journal.pone.0091413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618837	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400088
J	Woods, SE; Qi, PM; Rosalia, E; Chavarria, T; Discua, A; Mkandawire, J; Fox, JG; Garcia, A				Woods, Stephanie E.; Qi, Peimin; Rosalia, Elizabeth; Chavarria, Tony; Discua, Allan; Mkandawire, John; Fox, James G.; Garcia, Alexis			Laser-Assisted In Vitro Fertilization Facilitates Fertilization of Vitrified-Warmed C57BL/6 Mouse Oocytes with Fresh and Frozen-Thawed Spermatozoa, Producing Live Pups	PLOS ONE			English	Article							AUTOLOGOUS CUMULUS CELLS; CRYOPRESERVED MOUSE; ZONA-PELLUCIDA; EFFICIENT VITRIFICATION; MICRODISSECTED OOCYTES; EMBRYO-TRANSFER; EXCIMER-LASER; DEGREES-C; SPERM; IMPLANTATION	The utility of cryopreserved mouse gametes for reproduction of transgenic mice depends on development of assisted reproductive technologies, including vitrification of unfertilized mouse oocytes. Due to hardening of the zona pellucida, spermatozoa are often unable to penetrate vitrified-warmed (V-W) oocytes. Laser-assisted in vitro fertilization (LAIVF) facilitates fertilization by allowing easier penetration of spermatozoa through a perforation in the zona. We investigated the efficiency of V-W C57BL/6NTac oocytes drilled by the XYClone laser, compared to fresh oocytes. By using DAP213 for cryoprotection, 83% (1,470/1,762) of vitrified oocytes were recovered after warming and 78% were viable. Four groups were evaluated for two-cell embryo and live offspring efficiency: 1) LAIVF using V-W oocytes, 2) LAIVF using fresh oocytes, 3) conventional IVF using V-W oocytes and 4) conventional IVF using fresh oocytes. First, the groups were tested using fresh C57BL/6NTac spermatozoa (74% motile, 15 million/ml). LAIVF markedly improved the two-cell embryo efficiency using both V-W (76%, 229/298) and fresh oocytes (69%, 135/197), compared to conventional IVF (7%, 12/182; 6%, 14/235, respectively). Then, frozen-thawed C57BL/6NTac spermatozoa (35% motile, 15 million/ml) were used and LAIVF was again found to enhance fertilization efficiency, with two-cell embryo rates of 87% (298/343) using V-W oocytes (P<0.05, compared to fresh spermatozoa), and 73% (195/266) using fresh oocytes. Conventional IVF with frozen-thawed spermatozoa using V-W (6%, 10/168) and fresh (5%, 15/323) oocytes produced few two-cell embryos. Although live offspring efficiency following embryo transfer was greater with conventional IVF (35%, 18/51; LAIVF: 6%, 50/784), advantage was seen with LAIVF in live offspring obtained from total oocytes (5%, 50/1,010; conventional IVF: 2%, 18/908). Our results demonstrated that zona-drilled V-W mouse oocytes can be used for IVF procedures using both fresh and frozen-thawed spermatozoa, producing live pups. The ability to cryopreserve mouse gametes for LAIVF may facilitate management of large-scale transgenic mouse production facilities.	[Woods, Stephanie E.; Qi, Peimin; Rosalia, Elizabeth; Chavarria, Tony; Discua, Allan; Mkandawire, John; Fox, James G.; Garcia, Alexis] MIT, Div Comparat Med, Transgen Core Facil, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Garcia, A (corresponding author), MIT, Div Comparat Med, Transgen Core Facil, Cambridge, MA 02139 USA.	agarcia@mit.edu			National Institutes of Health (NIH) National Research Service Award [T32-RR070036]; NIH National Cancer Institute Program Project [P01CA10451]; NATIONAL CANCER INSTITUTE [P01CA026731, P01CA028842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Cancer Institute Program Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	SEW was supported by a National Institutes of Health (NIH) National Research Service Award (T32-RR070036; http://grants.nih.gov/training/nrsa.htm). PQ, ER, AD, JGF, AG and in part TC were supported by departmental funding. JM and in part TC were supported by a NIH National Cancer Institute Program Project (P01CA10451; http://grants.nih.gov/grants/guide/pa-files/PAR-09-025.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca Y, 2000, ILAR J, V41, P207; ANTINORI S, 1994, HUM REPROD, V9, P1891, DOI 10.1093/oxfordjournals.humrep.a138354; Anzai M, 2006, J REPROD DEVELOP, V52, P601, DOI 10.1262/jrd.18040; Bath ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009387; Borg CL, 2010, HUM REPROD UPDATE, V16, P205, DOI 10.1093/humupd/dmp032; ELDANASOURI I, 1993, HUM REPROD, V8, P464, DOI 10.1093/oxfordjournals.humrep.a138072; ENGINSU ME, 1995, HUM REPROD, V10, P1761, DOI 10.1093/oxfordjournals.humrep.a136170; Fan ZQ, 2009, LAB ANIM-UK, V43, P72, DOI 10.1258/la.2008.008029; Farouk FNO, 2008, J REPROD DEVELOP, V54, P385, DOI 10.1262/jrd.20018; Farouk FN, 2011, ANIM SCI J, V82, P420, DOI 10.1111/j.1740-0929.2010.00869.x; Germond M, 1996, HUM REPROD, V11, P1043; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Kaneko T, 2009, CRYOBIOLOGY, V59, P59, DOI 10.1016/j.cryobiol.2009.04.006; Kohaya N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058063; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; LAUFER N, 1993, FERTIL STERIL, V59, P889; Li MW, 2013, REPRODUCTION, V145, P245, DOI 10.1530/REP-12-0477; Liow SL, 1996, HUM REPROD, V11, P1273; Liu L, 2009, J AM ASSOC LAB ANIM, V48, P39; Meng QG, 2007, ACTA VET HUNG, V55, P369, DOI 10.1556/AVet.55.2007.3.11; Mochida K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049316; Nakagata N, 2000, MAMM GENOME, V11, P572, DOI 10.1007/s003350010109; Nakagata N, 2013, CRYOBIOLOGY, V67, P188, DOI 10.1016/j.cryobiol.2013.06.011; Nakao K, 1997, EXP ANIM TOKYO, V46, P231, DOI 10.1538/expanim.46.231; Peters DD, 2006, BIOL REPROD, V74, P246, DOI 10.1095/biolreprod.105.045112; Peters DD, 2009, MAMM GENOME, V20, P664, DOI 10.1007/s00335-009-9227-0; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Sakamoto W, 2005, COMPARATIVE MED, V55, P136; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Shimada M, 2008, DEVELOPMENT, V135, P2001, DOI 10.1242/dev.020461; Sztein JM, 1997, CRYOBIOLOGY, V35, P46, DOI 10.1006/cryo.1997.2024; Tanii I, 2011, REPRODUCTION, V141, P163, DOI 10.1530/REP-10-0201; The Jackson Laboratory, 2005, CRYOPR COURS; Wang YP, 2008, CRYOLETTERS, V29, P111; WHITTINGHAM DG, 1972, SCIENCE, V178, P411, DOI 10.1126/science.178.4059.411	35	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91892	10.1371/journal.pone.0091892	http://dx.doi.org/10.1371/journal.pone.0091892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618785	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400140
J	Nie, P; Li, HO; Duan, YH; Wang, XM; Ji, XP; Cheng, ZP; Wang, AB; Chen, JH				Nie, Pei; Li, Haiou; Duan, Yanhua; Wang, Ximing; Ji, Xiaopeng; Cheng, Zhaoping; Wang, Anbiao; Chen, Jiuhong			Impact of Sinogram Affirmed Iterative Reconstruction (SAFIRE) Algorithm on Image Quality with 70 kVp-Tube-Voltage Dual-Source CT Angiography in Children with Congenital Heart Disease	PLOS ONE			English	Article							FILTERED BACK-PROJECTION; RADIATION-DOSE REDUCTION; COMPUTED-TOMOGRAPHY; CARDIAC CT; EXPERIENCE; INFANTS	Purpose: To compare the image quality and diagnostic accuracy between sinogram affirmed iterative reconstruction (SAFIRE) algorithm and filtered back projection (FBP) reconstruction algorithm at 70 kVp-tube-voltage DSCT angiography in children with congenital heart disease (CHD). Materials and Methods: Twenty-eight patients (mean age: 13 months; range: 2-48 months; male: 16; female: 12; mean weight: 8 kg) with CHD underwent 70 kVp DSCT angiography. Imaging data were reconstructed with both FBP and SAFIRE algorithms. Subjective image quality was evaluated on a five-point scale. The parameters of image noise, signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) on the objective image quality were compared for the two reconstruction algorithms. Surgery was performed in 20 patients, whereas conventional cardiac angiography (CCA) was performed in 8 patients. The diagnostic accuracy was evaluated on the surgical and/or CCA findings. The effective radiation doses were calculated. Results: Compared to FBP algorithm, SAFIRE algorithm had significantly higher scores for subjective image quality (P<0.05), and lower image noise (P<0.05) as well as higher SNR & CNR values (P>0.05). There was no significant difference in the diagnostic accuracy between the FBP and SAFIRE algorithm (chi(2) = 1.793, P>0.05). The mean effective dose for 70 kVp DSCT angiography was 0.30+/-0.13 mSv. Conclusions: The SAFIRE algorithm can significantly reduce image noise and improve the image quality at 70 kVp DSCT angiography for the assessment of CHD in children.	[Nie, Pei; Li, Haiou; Duan, Yanhua; Wang, Ximing; Ji, Xiaopeng; Cheng, Zhaoping] Shandong Univ, Shandong Med Imaging Res Inst, Shandong Prov Key Lab Diag & Treatment Cardiocere, Jinan 250100, Shandong, Peoples R China; [Wang, Anbiao] Shandong Prov Hosp, Dept Cardiovasc Surg, Jinan, Shandong, Peoples R China; [Chen, Jiuhong] Siemens Ltd China, CT Res Collaborat, Beijing, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Siemens AG	Wang, XM (corresponding author), Shandong Univ, Shandong Med Imaging Res Inst, Shandong Prov Key Lab Diag & Treatment Cardiocere, Jinan 250100, Shandong, Peoples R China.	Wangximing369@hotmail.com		Cheng, Zhaoping/0000-0001-7217-7284				Alkadhi H, 2011, EUR J RADIOL, V80, P36, DOI 10.1016/j.ejrad.2010.12.099; Alkadhi H, 2011, EUR RADIOL, V21, P505, DOI 10.1007/s00330-010-1984-3; Bahner ML, 2005, INVEST RADIOL, V40, P229, DOI 10.1097/01.rli.0000155281.32319.52; Baumueller S, 2012, EUR RADIOL, V22, P2597, DOI 10.1007/s00330-012-2524-0; Bittencourt MS, 2011, INT J CARDIOVAS IMAG, V27, P1081, DOI 10.1007/s10554-010-9756-3; Cheng ZP, 2010, EUR RADIOL, V20, P2503, DOI 10.1007/s00330-010-1822-7; Ebersberger U, 2013, EUR RADIOL, V23, P125, DOI 10.1007/s00330-012-2580-5; Gnannt R, 2012, AM J NEURORADIOL, V33, P1014, DOI 10.3174/ajnr.A2910; Goo HW, 2011, RADIOL CLIN N AM, V49, P997, DOI 10.1016/j.rcl.2011.06.001; Goo HW, 2010, KOREAN J RADIOL, V11, P4, DOI 10.3348/kjr.2010.11.1.4; Han BK, 2012, J CARDIOVASC COMPUT, V6, P200, DOI 10.1016/j.jcct.2012.04.008; Kalra MK, 2012, J COMPUT ASSIST TOMO, V36, P339, DOI 10.1097/RCT.0b013e31825586c0; Katsura M, 2012, EUR RADIOL, V22, P1613, DOI 10.1007/s00330-012-2452-z; Korn A, 2012, AM J NEURORADIOL, V33, P218, DOI 10.3174/ajnr.A2749; Leschka S, 2008, EUR RADIOL, V18, P1809, DOI 10.1007/s00330-008-0966-1; Mahesh Mahadevappa, 2011, Pediatr Radiol, V41 Suppl 2, P493, DOI 10.1007/s00247-011-2169-1; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; Moscariello A, 2011, EUR RADIOL, V21, P2130, DOI 10.1007/s00330-011-2164-9; Nie P, 2012, EUR RADIOL, V22, P2057, DOI 10.1007/s00330-012-2479-1; Oda S, 2012, AM J ROENTGENOL, V198, P1126, DOI 10.2214/AJR.11.7117; Pache G, 2011, EUR J RADIOL, V80, pE440, DOI 10.1016/j.ejrad.2011.01.032; Park EA, 2012, INT J CARDIOVAS IMAG, V28, P1775, DOI 10.1007/s10554-011-0004-2; Paul JF, 2010, PEDIATR RADIOL, V40, P869, DOI 10.1007/s00247-010-1614-x; Ren QG, 2012, EUR J RADIOL, V81, P2597, DOI 10.1016/j.ejrad.2011.12.041; Singh S, 2012, RADIOLOGY, V263, P537, DOI 10.1148/radiol.12110268; Siripornpitak S, 2013, EUR J RADIOL, V82, P1067, DOI 10.1016/j.ejrad.2011.11.042; Utsunomiya D, 2012, EUR RADIOL, V22, P1287, DOI 10.1007/s00330-011-2361-6; Winklehner A, 2011, EUR RADIOL, V21, P2521, DOI 10.1007/s00330-011-2227-y; Young C, 2011, EUR RADIOL, V21, P518, DOI 10.1007/s00330-010-2036-8	29	26	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91123	10.1371/journal.pone.0091123	http://dx.doi.org/10.1371/journal.pone.0091123			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614683	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300079
J	Silva, AM; Oliveira, MI; Sette, L; Almeida, CR; Oliveira, MJ; Barbosa, MA; Santos, SG				Silva, Andreia M.; Oliveira, Marta I.; Sette, Laura; Almeida, Catarina R.; Oliveira, Maria J.; Barbosa, Mario A.; Santos, Susana G.			Resveratrol as a Natural Anti-Tumor Necrosis Factor-alpha Molecule: Implications to Dendritic Cells and Their Crosstalk with Mesenchymal Stromal Cells	PLOS ONE			English	Article							MIXED LYMPHOCYTE-REACTION; NF-KAPPA-B; STEM-CELLS; COSTIMULATORY MOLECULES; RHEUMATOID-ARTHRITIS; INDUCED ACTIVATION; IN-VITRO; T-CELLS; EXPRESSION; DIFFERENTIATION	Dendritic cells (DC) are promising targets for inducing tolerance in inflammatory conditions. Thus, this study aims to investigate the effects of the natural anti-inflammatory molecule resveratrol on human DC at phenotypic and functional levels, including their capacity to recruit mesenchymal stem/stromal cells (MSC). Primary human monocyte-derived DC and bone marrow MSC were used. DC immunophenotyping revealed that small doses of resveratrol (10 mu M) reduce cell activation in response to tumor necrosis factor (TNF)-alpha, significantly decreasing surface expression of CD83 and CD86. Functionally, IL-12/IL-23 secretion induced by TNF-alpha was significantly reduced by resveratrol, while IL-10 levels increased. Resveratrol also inhibited T cell proliferation, in response to TNF-alpha-stimulated DC. The underlying mechanism was investigated by Western blot and imaging flow cytometry (ImageStream(X)), and likely involves impairment of nuclear translocation of the p65 NF-kappa B subunit. Importantly, results obtained demonstrate that DC are able to recruit MSC through extracellular matrix components, and that TNF-alpha impairs DC-mediated recruitment. Matrix metalloproteinases (MMP) produced by both cell populations were visualized by gelatin zymography. Finally, time-lapse microscopy analysis revealed a significant decrease on DC and MSC motility in co-cultures, indicating cell interaction, and TNF-alpha further decreased MSC motility, while resveratrol recovered it. Thus, the current study points out the potential of resveratrol as a natural anti-TNF-alpha drug, capable of modulating DC phenotype and function, as well as DC-mediated MSC recruitment.	[Silva, Andreia M.; Oliveira, Marta I.; Sette, Laura; Almeida, Catarina R.; Oliveira, Maria J.; Barbosa, Mario A.; Santos, Susana G.] Univ Porto, INEB Inst Engn Biomed, P-4100 Oporto, Portugal; [Silva, Andreia M.] Univ Porto, Fac Engn, P-4100 Oporto, Portugal; [Silva, Andreia M.; Barbosa, Mario A.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal; [Oliveira, Maria J.] Univ Porto, Fac Ciencias, P-4100 Oporto, Portugal; [Oliveira, Maria J.] Univ Porto, Fac Med, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Santos, SG (corresponding author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	susana.santos@ineb.up.pt	Almeida, Catarina R/A-7018-2012; Santos, Susana G/L-9351-2013; Barbosa, Mário A/F-5964-2011; Silva, Andreia M./AAY-1152-2021; Oliveira, Marta I A/M-9386-2013; Oliveira, Maria Jose/K-3275-2013	Almeida, Catarina R/0000-0001-6670-6004; Santos, Susana G/0000-0002-8604-2978; Barbosa, Mário A/0000-0003-3568-7482; Silva, Andreia M./0000-0001-6365-1407; Oliveira, Marta I A/0000-0002-0578-9202; Oliveira, Maria Jose/0000-0002-0724-0272	FEDER funds through Programa Operacional Factores de Competitividade - COMPETE; Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia [PEst-C/SAU/LA0002/2013, PTDC/SAU-BEB/099954/2008]; FCT-POPH [SFRH/BPD/37090/2007, SFRH/BPD/48533/2008]; FCT-POPH-FSE; North Region Operational Program [ON.2]	FEDER funds through Programa Operacional Factores de Competitividade - COMPETE; Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia; FCT-POPH; FCT-POPH-FSE; North Region Operational Program	This work was financed by FEDER funds through Programa Operacional Factores de Competitividade - COMPETE and by Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia in the framework of projects PEst-C/SAU/LA0002/2013 and PTDC/SAU-BEB/099954/2008. MIO is recipient of a post-doctoral fellowship from FCT-POPH (SFRH/BPD/37090/2007). CRA was funded by a post-doctoral fellowship from FCT-POPH (SFRH/BPD/48533/2008), SGS and MJO were funded by FCT-POPH-FSE (Ciencia2007). CRA and SGS were also funded by North Region Operational Program (ON.2), in the framework of the "Project on Biomedical Engineering for Regenerative Therapies and Cancer - NORTE-07-0124-FEDER-000005", through QREN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MB, 2009, RESTOR NEUROL NEUROS, V27, P307, DOI 10.3233/RNN-2009-0480; Almeida CR, 2012, J R SOC INTERFACE, V9, P261, DOI 10.1098/rsif.2011.0357; Augustin MA, 2013, ANN NY ACAD SCI, V1290, P107, DOI 10.1111/nyas.12130; Bertelli AAE, 2001, THERAPIE, V56, P613; Bi XL, 2005, INT IMMUNOPHARMACOL, V5, P185, DOI 10.1016/j.intimp.2004.08.008; Bocker WG, 2008, J MOL MED, V86, P1183, DOI 10.1007/s00109-008-0378-3; Bouffi C, 2009, RHEUMATOLOGY, V48, P1185, DOI 10.1093/rheumatology/kep162; Chapuis F, 1997, EUR J IMMUNOL, V27, P431, DOI 10.1002/eji.1830270213; Chomarat P, 2003, J IMMUNOL, V171, P2262, DOI 10.4049/jimmunol.171.5.2262; Csiszar A, 2006, AM J PHYSIOL-HEART C, V291, pH1694, DOI 10.1152/ajpheart.00340.2006; Dai Z, 2007, PHYTOMEDICINE, V14, P806, DOI 10.1016/j.phymed.2007.04.003; Deng YH, 2011, PHYTOTHER RES, V25, P451, DOI 10.1002/ptr.3279; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Elmali N, 2007, INFLAMMATION, V30, P1, DOI 10.1007/s10753-006-9012-0; Elmali N, 2005, INFLAMM RES, V54, P158, DOI 10.1007/s00011-004-1341-6; Feldmann M, 2005, J AUTOIMMUN, V25, P26, DOI 10.1016/j.jaut.2005.09.006; Fu XB, 2009, WOUND REPAIR REGEN, V17, P185, DOI 10.1111/j.1524-475X.2009.00454.x; Garbi N, 2010, CURR OPIN IMMUNOL, V22, P601, DOI 10.1016/j.coi.2010.08.007; Ghannam S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt2; Gu XL, 1999, J AGR FOOD CHEM, V47, P3223, DOI 10.1021/jf981211e; Hacquard-Bouder C, 2004, ARTHRITIS RHEUM-US, V50, P1624, DOI 10.1002/art.20211; Hacquard-Bouder C, 2007, ARTHRITIS RHEUM-US, V56, P1478, DOI 10.1002/art.22572; Jongbloed SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1864; Kang OH, 2009, PHARMACOL RES, V59, P330, DOI 10.1016/j.phrs.2009.01.009; Kim GY, 2004, INT IMMUNOPHARMACOL, V4, P245, DOI 10.1016/j.intimp.2003.12.009; Kim YA, 2004, ONCOL REP, V11, P441; Kundu JK, 2004, BIOFACTORS, V21, P33, DOI 10.1002/biof.552210108; Lee B, 2005, J NUTR, V135, P2767, DOI 10.1093/jn/135.12.2767; Leiro JM, 2010, MOL IMMUNOL, V47, P1114, DOI 10.1016/j.molimm.2009.10.030; MANGI RJ, 1975, YALE J BIOL MED, V48, P217; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Miwa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052926; Neves AR, 2012, CURR MED CHEM, V19, P1663; Okada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044338; Oliveira MI, 2012, EUR CELLS MATER, V24, P136, DOI 10.22203/eCM.v024a10; Poulsen MM, 2013, ANN NY ACAD SCI, V1290, P74, DOI 10.1111/nyas.12141; Ryu J, 2011, ANTICANCER RES, V31, P4223; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Santos SG, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2492; Scheinecker C, 1998, J IMMUNOL, V161, P3966; Schildknecht A, 2010, P NATL ACAD SCI USA, V107, P199, DOI 10.1073/pnas.0910620107; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Spaggiari GM, 2013, IMMUNOL CELL BIOL, V91, P27, DOI 10.1038/icb.2012.62; Svajger U, 2010, IMMUNOLOGY, V129, P525, DOI 10.1111/j.1365-2567.2009.03205.x; Tondreau T, 2009, CYTOTHERAPY, V11, P559, DOI 10.1080/14653240903051541; Verhasselt V, 1997, J IMMUNOL, V158, P2919; Woo JH, 2004, ONCOGENE, V23, P1845, DOI 10.1038/sj.onc.1207307; Zhu J, 2008, BIOCHEM BIOPH RES CO, V369, P471, DOI 10.1016/j.bbrc.2008.02.034	48	23	24	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91406	10.1371/journal.pone.0091406	http://dx.doi.org/10.1371/journal.pone.0091406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614867	Green Submitted, gold, Green Published			2022-12-27	WOS:000332839300122
J	Wong, MCS; Wang, HHX; Kwan, MWM; Zhang, DDX; Liu, KQL; Chan, SWM; Fan, CKM; Fong, BCY; Li, STS; Griffiths, SM				Wong, Martin C. S.; Wang, Harry H. X.; Kwan, Mandy W. M.; Zhang, Daisy D. X.; Liu, Kirin Q. L.; Chan, Sky W. M.; Fan, Carmen K. M.; Fong, Brian C. Y.; Li, Shannon T. S.; Griffiths, Sian M.			Comparative Effectiveness of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and Human Glucagon-Like Peptide-1 (GLP-1) Analogue as Add-On Therapies to Sulphonylurea among Diabetes Patients in the Asia-Pacific Region: A Systematic Review	PLOS ONE			English	Review							PLACEBO-CONTROLLED TRIAL; GLYCEMIC CONTROL; JAPANESE PATIENTS; DOUBLE-BLIND; CHINESE PATIENTS; DRUG-THERAPY; OPEN-LABEL; TYPE-2; EFFICACY; METFORMIN	The prevalence of diabetes mellitus is rising globally, and it induces a substantial public health burden to the healthcare systems. Its optimal control is one of the most significant challenges faced by physicians and policy-makers. Whereas some of the established oral hypoglycaemic drug classes like biguanide, sulphonylureas, thiazolidinediones have been extensively used, the newer agents like dipeptidyl peptidase-4 (DPP-4) inhibitors and the human glucagon-like peptide-1 (GLP-1) analogues have recently emerged as suitable options due to their similar efficacy and favorable side effect profiles. These agents are widely recognized alternatives to the traditional oral hypoglycaemic agents or insulin, especially in conditions where they are contraindicated or unacceptable to patients. Many studies which evaluated their clinical effects, either alone or as add-on agents, were conducted in Western countries. There exist few reviews on their effectiveness in the Asia-Pacific region. The purpose of this systematic review is to address the comparative effectiveness of these new classes of medications as add-on therapies to sulphonylurea drugs among diabetic patients in the Asia-Pacific countries. We conducted a thorough literature search of the MEDLINE and EMBASE from the inception of these databases to August 2013, supplemented by an additional manual search using reference lists from research studies, meta-analyses and review articles as retrieved by the electronic databases. A total of nine randomized controlled trials were identified and described in this article. It was found that DPP-4 inhibitors and GLP-1 analogues were in general effective as add-on therapies to existing sulphonylurea therapies, achieving HbA1c reductions by a magnitude of 0.59-0.90% and 0.77-1.62%, respectively. Few adverse events including hypoglycaemic attacks were reported. Therefore, these two new drug classes represent novel therapies with great potential to be major therapeutic options. Future larger-scale research should be conducted among other Asia-Pacific region to evaluate their efficacy in other ethnic groups.	[Wong, Martin C. S.; Wang, Harry H. X.; Kwan, Mandy W. M.; Zhang, Daisy D. X.; Liu, Kirin Q. L.; Chan, Sky W. M.; Fan, Carmen K. M.; Fong, Brian C. Y.; Li, Shannon T. S.; Griffiths, Sian M.] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Wang, Harry H. X.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland	Chinese University of Hong Kong; University of Glasgow	Wong, MCS (corresponding author), Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Fac Med, Hong Kong, Hong Kong, Peoples R China.	wong_martin@cuhk.edu.hk	Wang, Harry H.X./E-9027-2015; Wong, Martin/L-4568-2014	Wang, Harry H.X./0000-0002-0361-6527; Wong, Martin/0000-0001-7706-9370; ZHANG, Dexing/0000-0003-0073-4752				Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Aronoff S, 2000, DIABETES CARE, V23, P1605, DOI 10.2337/diacare.23.11.1605; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Barnett AH, 2011, NEW MECH GLUCOSE CON; Barnett AH, 2011, NEW MECH GLUCOSE CON; Bi Y, 2008, CHINESE MED J-PEKING, V121, P677, DOI 10.1097/00029330-200804020-00003; Castell C, 1999, DIABETES RES CLIN PR, V43, P33, DOI 10.1016/S0168-8227(98)00125-9; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Eldor R, 2012, DIABETES-METAB RES, V28, P85, DOI 10.1002/dmrr.2358; FDA Drug Safety Podcast, 2013, FDA INV REP POSS INC; Feinglos MN, 2008, CONTEMP ENDOCRINOL S, P1, DOI 10.1007/978-1-60327-043-4; Garber AJ, 1997, AM J MED, V103, P491, DOI 10.1016/S0002-9343(97)00254-4; Green Brian D, 2006, Diab Vasc Dis Res, V3, P159, DOI 10.3132/dvdr.2006.024; GROOP L, 1987, DIABETES CARE, V10, P671, DOI 10.2337/diacare.10.6.671; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; Guisasola FA, 2008, DIABETES OBES METAB, V10, P8, DOI 10.1111/j.1463-1326.2008.00881.x; Holt R.I.G., 2010, TXB DIABETES; Inagaki N, 2013, DIABETES OBES METAB, V15, P833, DOI 10.1111/dom.12110; Inagaki N, 2012, CLIN THER, V34, P1892, DOI 10.1016/j.clinthera.2012.07.007; Juutilainen A, 2005, DIABETES CARE, V28, P2901, DOI 10.2337/diacare.28.12.2901; Kadowaki T, 2011, J DIABETES INVEST, V2, P210, DOI 10.1111/j.2040-1124.2010.00084.x; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kaku K, 2010, DIABETES OBES METAB, V12, P341, DOI 10.1111/j.1463-1326.2009.01194.x; Kawamori R, 2002, DIABETES-METAB RES, V18, pS9, DOI 10.1002/dmrr.296; Kim YG, 2013, DIABETOLOGIA, V56, P696, DOI 10.1007/s00125-012-2827-3; Kobayashi M, 2006, DIABETES RES CLIN PR, V73, P198, DOI 10.1016/j.diabres.2006.01.013; Levetan C, 2007, CURR MED RES OPIN, V23, P945, DOI 10.1185/030079907X178766; Lopatynski J, 2001, Pol Arch Med Wewn, V106, P781; Mest HJ, 2005, DIABETOLOGIA, V48, P616, DOI 10.1007/s00125-005-1707-5; Mohan V, 2009, DIABETES RES CLIN PR, V83, P106, DOI 10.1016/j.diabres.2008.10.009; Mosenzon O, 2013, DIABETES-METAB RES, V29, P417, DOI 10.1002/dmrr.2413; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Owens DR, 2001, LANCET, V358, P739, DOI 10.1016/S0140-6736(01)05842-1; Richter B, 2008, COCHRANE DATABASE SY; Riedel AA, 2007, PHARMACOTHERAPY, V27, P1102, DOI 10.1592/phco.27.8.1102; Rosenstock J, 1996, DIABETES CARE, V19, P1194, DOI 10.2337/diacare.19.11.1194; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schade DS, 1998, J CLIN PHARMACOL, V38, P636, DOI 10.1002/j.1552-4604.1998.tb04471.x; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Seino Y, 2012, DIABETES OBES METAB, V14, P910, DOI 10.1111/j.1463-1326.2012.01618.x; Seino Y, 2012, J DIABETES INVEST, V3, P517, DOI 10.1111/j.2040-1124.2012.00226.x; Seino Y, 2012, J DIABETES INVEST, V3, P388, DOI 10.1111/j.2040-1124.2012.00193.x; Shyangdan DS, 2013, COCHRANE DATABASE SY; Sicree R, 2009, GLOBAL BURDEN DIABET; Simonson DC, 1997, DIABETES CARE, V20, P597, DOI 10.2337/diacare.20.4.597; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Takihata M, 2013, DIABETES OBES METAB, V15, P455, DOI 10.1111/dom.12055; Task Force on Conceptual Model and Preventive Protocols Working Group on Primary Care Food and Health Bureau, 2010, MOD 6 DRUG TREATM HY; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van Dijk CE, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-7; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; WILLIAMS G, 1994, LANCET, V343, P95, DOI 10.1016/S0140-6736(94)90822-2; Wong MCS, 2013, INT J PUBLIC HEALTH, V58, P269, DOI 10.1007/s00038-012-0364-y; World Health Organization, 2012, DIAB ATL W PAC REG; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zeng ZP, 2013, CURR MED RES OPIN, V29, P921, DOI 10.1185/03007995.2013.805123; Zhang SL, 2011, CHINESE MED J-PEKING, V124, P2461, DOI 10.3760/cma.j.issn.0366-6999.2011.16.012	61	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90963	10.1371/journal.pone.0090963	http://dx.doi.org/10.1371/journal.pone.0090963			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614606	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000332839300060
J	Sadoh, WE; Eregie, CO; Nwaneri, DU; Sadoh, AE				Sadoh, Wilson E.; Eregie, Charles O.; Nwaneri, Damian U.; Sadoh, Ayebo E.			The Diagnostic Value of Both Troponin T and Creatinine Kinase Isoenzyme (CK-MB) in Detecting Combined Renal and Myocardial Injuries in Asphyxiated Infants	PLOS ONE			English	Article							MARKERS; SERUM	Background: Troponin T (cTnT) and Creatinine Kinase Isoenzyme (CK-MB) are both markers of myocardial injuries. However, CK-MB is also elevated in acute kidney injury. Objective: The diagnostic value of both cTnT and cardiac CK-MB in combined myocardial and acute kidney injuries (AKI) in asphyxiated neonates was evaluated. Method: 40 asphyxiated infants and 40 non-asphyxiated controls were consecutively recruited. Serum levels of cTnT, CK-MB and creatinine were measured. Myocardial injury and AKI were defined as cTnT>95th percentile of the control and serum creatinine >1.0 mg/dl respectively. Results: Of the 40 subjects, 9 (22.50%), 8 (20.00%) and 4 (10.00%) had myocardial injury, AKI and combined AKI and myocardial injuries respectively. The mean cTnT and CK-MB values were highest in infants with combined AKI and myocardial injuries. The Mean cTnT in infants with AKI, myocardial injury and combined AKI and myocardial injuries were 0.010 +/- 0.0007 ng/ml, 0.067 +/- 0.040 ng/ml and 0.084 +/- 0.067 ng/ml respectively, p = 0.006. The mean CK-MB in infants with AKI, myocardial injury and combined AKI and myocardial injuries were 2.78 +/- 0.22 ng/ml, 1.28 +/- 0.11 ng/ml and 4.58 +/- 0.52 ng/ml respectively, p = <0.0001. Conclusion: In severe perinatal asphyxia, renal and myocardial injuries could co-exist. Elevated cTnT signifies the presence of myocardial injury. Elevated CK-MB indicates either myocardial injury, AKI or both. Therefore renal injury should be excluded in asphyxiated infants with elevated CK-MB.	[Sadoh, Wilson E.] Univ Benin, Teaching Hosp, Dept Child Hlth, Benin, Nigeria; [Eregie, Charles O.; Nwaneri, Damian U.; Sadoh, Ayebo E.] Univ Benin, Teaching Hosp, Inst Child Hlth, Benin, Nigeria	University of Benin; University of Benin	Sadoh, WE (corresponding author), Univ Benin, Teaching Hosp, Dept Child Hlth, Benin, Nigeria.	sadohehi@yahoo.com	Nwaneri, Damian/AAZ-1200-2020	Nwaneri, Damian/0000-0001-7860-3942				Askenazi DJ, 2009, PEDIATR NEPHROL, V24, P265, DOI 10.1007/s00467-008-1060-2; Azra Haider Batool, 2006, Curr Probl Pediatr Adolesc Health Care, V36, P178; BEHRMAN RE, 1970, AM J OBSTET GYNECOL, V108, P956, DOI 10.1016/0002-9378(70)90341-8; BHAYANA V, 1995, CLIN BIOCHEM, V28, P1, DOI 10.1016/0009-9120(94)00065-4; Boo NY, 2005, J PAEDIATR CHILD H, V41, P331, DOI 10.1111/j.1440-1754.2005.00626.x; Clark SJ, 2001, ARCH DIS CHILD-FETAL, V84, pF34, DOI 10.1136/fn.84.1.F34; Correale Michele, 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P270; Costello AM de L, 1994, ARCH DIS CHILD FETAL, V71, pF ; EREGIE CO, 1991, DEV MED CHILD NEUROL, V33, P146; Fahey J, 2005, J MIDWIFERY WOM HEAL, V50, P677; Finster M, 2005, ANESTHESIOLOGY, V102, P855, DOI 10.1097/00000542-200504000-00022; McIntosh N, 2003, FORFAR ARNEILS TXB P, P197; Moller JC, 1998, BIOL NEONATE, V73, P367, DOI 10.1159/000013999; Nicholson JP, 2004, NELSON TXB PAEDIAT, P2393; Ogunlesi TA, 2008, NIGER MED PRACT, V53, P40; Omoigberale AI, 2010, NIGER J CLIN PRACT, V13, P321; PRIMHAK RA, 1985, ACTA PAEDIATR SCAND, V74, P595, DOI 10.1111/j.1651-2227.1985.tb11036.x; Sadoh WE, 2012, PAEDIATR INT CHILD H, V32, P43, DOI 10.1179/1465328111Y.0000000046; Sanjay A, 2004, MANUAL NEONATAL CARE, P536; Sarafidis K, 2012, PEDIATR NEPHROL, V27, P1575, DOI 10.1007/s00467-012-2162-4; Shah P, 2004, ARCH DIS CHILD-FETAL, V89, P152, DOI 10.1136/adc.2002.023093; Sobki SH, 2000, SAUDI MED J, V21, P843; Uzodimma CC, 2012, WORLD J PEDIATR CONG, V3, P330, DOI 10.1177/2150135112442693	23	12	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91338	10.1371/journal.pone.0091338	http://dx.doi.org/10.1371/journal.pone.0091338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625749	gold, Green Published, Green Submitted			2022-12-27	WOS:000332851300074
J	Sargent, B; Schweighofer, N; Kubo, M; Fetters, L				Sargent, Barbara; Schweighofer, Nicolas; Kubo, Masayoshi; Fetters, Linda			Infant Exploratory Learning: Influence on Leg Joint Coordination	PLOS ONE			English	Article							WHITE-MATTER DISORDER; MOTOR-PERCEPTUAL TASK; FULL-TERM INFANTS; 3-MONTH-OLD INFANTS; CEREBRAL-PALSY; SPONTANEOUS KICKING; PRETERM; MEMORY; DYNAMICS; CLASSIFICATION	A critical issue in the study of infant development is to identify the processes by which task-specific action emerges from spontaneous movement. Emergent leg action has been studied by providing contingent reinforcement to specific leg movements using an overhead infant-activated mobile, however, there is limited information on the strategies used by infants to support the emergence of task-specific leg action from spontaneous movement. The purpose of this study is to (1) determine the ability of 3 month old infants to learn, through discovery, the contingency between leg action and mobile activation using a virtual threshold, and (2) identify strategies, defined by variance of the end-effectors (feet) and hip-knee joint coordination, used by infants that learned the contingency. Fourteen 3 month old infants participated in 2 sessions of mobile reinforcement on consecutive days. As a group, infants increased the percentage of mobile activation to meet performance criteria on Day 2, but did not meet memory or learning criteria across days. However, five infants learned the contingency based on individual learning criteria. When interacting with the mobile on Day 2 as compared to spontaneous kicking on Day 1, infants who learned the contingency, but not infants who did not learn the contingency, increased variance of the end-effectors (feet) in the vertical, task-specific direction and demonstrated less in-phase hip-knee joint coordination. An important discovery is that infants can discover this very specific contingency, suggesting that this movement behavior (action) can be shaped in future work. This may have implications for the rehabilitation of infants with atypical leg action.	[Sargent, Barbara] Univ So Calif, Div Biokinesiol & Phys Therapy, Los Angeles, CA 90089 USA; [Schweighofer, Nicolas] Univ So Calif, Dept Neurosci, Div Biokinesiol & Phys Therapy, Los Angeles, CA USA; [Schweighofer, Nicolas] Univ So Calif, Dept Comp Sci, Los Angeles, CA 90089 USA; [Kubo, Masayoshi] Niigata Univ Hlth & Welf, Dept Phys Therapy, Niigata, Japan; [Fetters, Linda] Univ So Calif, Keck Sch Med, Div Biokinesiol & Phys Therapy, Dept Pediat, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; Niigata University; University of Southern California	Sargent, B (corresponding author), Univ So Calif, Div Biokinesiol & Phys Therapy, Los Angeles, CA 90089 USA.	bsargent@usc.edu	Sargent, Barbara/ABG-2160-2021; Schweighofer, Nicolas/A-3675-2008	Sargent, Barbara/0000-0002-2261-6610; Schweighofer, Nicolas/0000-0003-3362-6088	Foundation for Physical Therapy; Education Section of the American Physical Therapy Association	Foundation for Physical Therapy; Education Section of the American Physical Therapy Association	This research was supported by scholarships from the Foundation for Physical Therapy and the Education Section of the American Physical Therapy Association to Barbara Sargent (http://foundation4pt.org/;http://www.aptaeducation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph K. E., 1997, MONOGRAPHS SOC RES C, V62; Adolph KE, 2008, CURR DIR PSYCHOL SCI, V17, P213, DOI 10.1111/j.1467-8721.2008.00577.x; Angulo-Kinzler RM, 2001, INFANT BEHAV DEV, V24, P239, DOI 10.1016/S0163-6383(01)00083-2; Angulo-Kinzler RM, 2002, MOTOR CONTROL, V6, P52, DOI 10.1123/mcj.6.1.52; Angulo-Kinzler RM, 2001, J MOTOR BEHAV, V33, P363, DOI 10.1080/00222890109601920; Bayley N, 2006, MANUAL BAYLEY SCALES; Chen YP, 2002, INFANT BEHAV DEV, V25, P195, DOI 10.1016/S0163-6383(02)00121-2; Fetters L, 2004, HUM MOVEMENT SCI, V22, P729, DOI 10.1016/j.humov.2004.02.001; Fetters L, 2010, DEV PSYCHOBIOL, V52, P524, DOI 10.1002/dev.20455; Fowler EG, 2009, GAIT POSTURE, V29, P102, DOI 10.1016/j.gaitpost.2008.07.007; Garciaguirre JS, 2007, CHILD DEV, V78, P664, DOI 10.1111/j.1467-8624.2007.01020.x; GEKOSKI MJ, 1984, INFANT BEHAV DEV, V7, P267, DOI 10.1016/S0163-6383(84)80042-9; Gibson E. J., 2000, ECOLOGICAL APPROACH; Haley DW, 2006, PSYCHONEUROENDOCRINO, V31, P108, DOI 10.1016/j.psyneuen.2005.06.007; Heathcock JC, 2004, PHYS THER, V84, P808, DOI 10.1093/ptj/84.9.808; Himpens E, 2008, DEV MED CHILD NEUROL, V50, P334, DOI 10.1111/j.1469-8749.2008.02047.x; JENSEN JL, 1994, J MOTOR BEHAV, V26, P303, DOI 10.1080/00222895.1994.9941686; Kelso J. A., 1986, PHYS LETT A, V134, P8; Lobo MA, 2013, RES DEV DISABIL, V34, P1721, DOI 10.1016/j.ridd.2013.02.010; OHR PS, 1991, AM J MENT RETARD, V96, P151; Ostensjo S, 2004, DEV MED CHILD NEUROL, V46, P580; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; ROVEE CK, 1969, J EXP CHILD PSYCHOL, V8, P33, DOI 10.1016/0022-0965(69)90025-3; Rovee-Collier C K, 1979, Adv Child Dev Behav, V13, P195, DOI 10.1016/S0065-2407(08)60348-1; Sanger TD, 2006, PEDIATRICS, V118, P2159, DOI 10.1542/peds.2005-3016; SCHNEIDER K, 1990, J MOTOR BEHAV, V22, P493; SODERKVIST I, 1993, J BIOMECH, V26, P1473, DOI 10.1016/0021-9290(93)90098-Y; Thelen E, 1991, MONOGRAPHS SOC RES C, V56; Thelen E., 1994, DYNAMIC SYSTEMS APPR; Tiernan CW, 2008, J MOTOR BEHAV, V40, P133, DOI 10.3200/JMBR.40.2.133-142; Vaal J, 2000, EXP BRAIN RES, V135, P94, DOI 10.1007/s002210000508; vanEmmerik REA, 1996, J BIOMECH, V29, P1175, DOI 10.1016/0021-9290(95)00128-X; Watanabe H, 2011, HUM MOVEMENT SCI, V30, P125, DOI 10.1016/j.humov.2010.07.003	33	30	30	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91500	10.1371/journal.pone.0091500	http://dx.doi.org/10.1371/journal.pone.0091500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9JS	24626202	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300090
J	Taskinen, M; Louhimo, R; Koivula, S; Chen, P; Rantanen, V; Holte, H; Delabie, J; Karjalainen-Lindsberg, ML; Bjorkholm, M; Fluge, O; Pedersen, LM; Fjorden, K; Jerkeman, M; Eriksson, M; Hautaniemi, S; Leppa, S				Taskinen, Minna; Louhimo, Riku; Koivula, Satu; Chen, Ping; Rantanen, Ville; Holte, Harald; Delabie, Jan; Karjalainen-Lindsberg, Marja-Liisa; Bjorkholm, Magnus; Fluge, Oystein; Pedersen, Lars Moller; Fjorden, Karin; Jerkeman, Mats; Eriksson, Mikael; Hautaniemi, Sampsa; Leppa, Sirpa			Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CHEMOTHERAPY PLUS RITUXIMAB; RANDOMIZED CONTROLLED-TRIAL; AGGRESSIVE LYMPHOMAS; DISTINCT SUBGROUPS; CHOP CHEMOTHERAPY; HODGKIN-LYMPHOMA; ELDERLY-PATIENTS; YOUNG-PATIENTS; EXPRESSION	Background: Despite improved survival for the patients with diffuse large B-cell lymphoma (DLBCL), the prognosis after relapse is poor. The aim was to identify molecular events that contribute to relapse and treatment resistance in DLBCL. Methods: We analysed 51 prospectively collected pretreatment tumour samples from clinically high risk patients treated in a Nordic phase II study with dose-dense chemoimmunotherapy and central nervous system prophylaxis with high resolution array comparative genomic hybridization (aCGH) and gene expression microarrays. Major finding was validated at the protein level immunohistochemically in a trial specific tissue microarray series of 70, and in an independent validation series of 146 patients. Results: We identified 31 genes whose expression changes were strongly associated with copy number aberrations. In addition, gains of chromosomes 2p15 and 18q12.2 were associated with unfavourable survival. The 2p15 aberration harboured COMMD1 gene, whose expression had a significant adverse prognostic impact on survival. Immunohistochemical analysis of COMMD1 expression in two series confirmed the association of COMMD1 expression with poor prognosis. Conclusion: COMMD1 is a potential novel prognostic factor in DLBCLs. The results highlight the value of integrated comprehensive analysis to identify prognostic markers and genetic driver events not previously implicated in DLBCL.	[Taskinen, Minna; Koivula, Satu; Leppa, Sirpa] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland; [Taskinen, Minna; Louhimo, Riku; Koivula, Satu; Chen, Ping; Rantanen, Ville; Hautaniemi, Sampsa; Leppa, Sirpa] Univ Helsinki, Genome Scale Biol Program, Helsinki, Finland; [Holte, Harald] Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Delabie, Jan] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Karjalainen-Lindsberg, Marja-Liisa] Univ Helsinki, Dept Pathol, Haartman Inst, Helsinki, Finland; [Bjorkholm, Magnus] Karolinska Univ Hosp, Dept Med, Stockholm, Sweden; [Fluge, Oystein] Haukeland Hosp, Dept Oncol & Med Phys, N-5021 Bergen, Norway; [Pedersen, Lars Moller] Odense Univ Hosp, Dept Hematol, DK-5000 Odense, Denmark; [Fjorden, Karin; Jerkeman, Mats; Eriksson, Mikael] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Oslo; University of Oslo; University of Helsinki; Karolinska Institutet; Karolinska University Hospital; University of Bergen; Haukeland University Hospital; University of Southern Denmark; Odense University Hospital; Lund University; Skane University Hospital	Leppa, S (corresponding author), Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland.	sirpa.leppa@helsinki.fi	Hautaniemi, Sampsa/CAG-0362-2022; Hautaniemi, Sampsa/A-3122-2009; Holte, Harald/AAO-5647-2020; Chen, Ping/AAL-8264-2020	Hautaniemi, Sampsa/0000-0002-7749-2694; Hautaniemi, Sampsa/0000-0002-7749-2694; Chen, Ping/0000-0002-8068-1891; Leppa, Sirpa/0000-0002-8265-511X; Delabie, Jan/0000-0001-5023-0689; Rantanen, Ville/0000-0002-0105-7071	Finnish Academy of Sciences; Finnish Cancer Societies; Sigrid Juselius Foundation; University of Helsinki; Helsinki Biomedical Graduate Program; Helsinki University Central Hospital; Amgen; Roche Norway	Finnish Academy of Sciences(Academy of Finland); Finnish Cancer Societies; Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Helsinki; Helsinki Biomedical Graduate Program; Helsinki University Central Hospital; Amgen(Amgen); Roche Norway	This work was supported by the grants from the Finnish Academy of Sciences (SH, SL, MT), Finnish Cancer Societies (SH, SL, MT), Sigrid Juselius Foundation (SH, SL), University of Helsinki (SL), Helsinki Biomedical Graduate Program (RL), Helsinki University Central Hospital (SL), Amgen (SL, HH) and Roche Norway (HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; Chen P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr513; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Drevillon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018334; Fukuhara N, 2006, CANCER SCI, V97, P499, DOI 10.1111/j.1349-7006.2006.00209.x; Habermann TM, 2006, J CLIN ONCOL, V24, P3121, DOI 10.1200/JCO.2005.05.1003; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Holte H, 2013, ANN ONCOL, V24, P1385, DOI 10.1093/annonc/mds621; Houldsworth J, 2004, BLOOD, V103, P1862, DOI 10.1182/blood-2003-04-1359; Huang JZ, 2002, BLOOD, V99, P2285, DOI 10.1182/blood.V99.7.2285; Hyman E, 2002, CANCER RES, V62, P6240; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jardin F, 2010, BLOOD, V116, P1092, DOI 10.1182/blood-2009-10-247122; Kreisel F, 2011, CANCER GENET-NY, V204, P129, DOI 10.1016/j.cancergen.2010.12.010; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Maine GN, 2007, CELL MOL LIFE SCI, V64, P1997, DOI 10.1007/s00018-007-7078-y; Maine GN, 2007, CELL CYCLE, V6, P672, DOI 10.4161/cc.6.6.3989; Maine GN, 2009, BIOCHEM J, V417, P601, DOI 10.1042/BJ20080854; Monti S, 2012, CANCER CELL, V22, P359, DOI 10.1016/j.ccr.2012.07.014; Morin RD, 2013, BLOOD, V122, P1256, DOI 10.1182/blood-2013-02-483727; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ovaska K, 2010, GENOME MED, V2, DOI 10.1186/gm186; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pfreundschuh M, 2004, BLOOD, V104, P626, DOI 10.1182/blood-2003-06-2094; Pfreundschuh M, 2008, LANCET ONCOL, V9, P105, DOI 10.1016/S1470-2045(08)70002-0; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Robledo C, 2009, CANCER-AM CANCER SOC, V115, P3728, DOI 10.1002/cncr.24430; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tagawa H, 2005, BLOOD, V106, P1770, DOI 10.1182/blood-2005-02-0542; Takeuchi I, 2009, HAEMATOL-HEMATOL J, V94, P61, DOI 10.3324/haematol.12986; Thoms HC, 2010, CANCER RES, V70, P139, DOI 10.1158/0008-5472.CAN-09-1397; van de Sluis B, 2010, J CLIN INVEST, V120, P2119, DOI 10.1172/JCI40583; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100	47	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91031	10.1371/journal.pone.0091031	http://dx.doi.org/10.1371/journal.pone.0091031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625556	gold, Green Submitted, Green Published			2022-12-27	WOS:000332851300052
J	Villa, F; Bagstad, KJ; Voigt, B; Johnson, GW; Portela, R; Honzak, M; Batker, D				Villa, Ferdinando; Bagstad, Kenneth J.; Voigt, Brian; Johnson, Gary W.; Portela, Rosimeiry; Honzak, Miroslav; Batker, David			A Methodology for Adaptable and Robust Ecosystem Services Assessment	PLOS ONE			English	Article							ATTRIBUTION NETWORKS SPANS; ECONOMIC VALUATION; BENEFIT TRANSFER; KNOWLEDGE; DYNAMICS; DESIGN; CLASSIFICATION; CONSERVATION; TRANSPARENT; INTEGRATION	Ecosystem Services (ES) are an established conceptual framework for attributing value to the benefits that nature provides to humans. As the promise of robust ES-driven management is put to the test, shortcomings in our ability to accurately measure, map, and value ES have surfaced. On the research side, mainstream methods for ES assessment still fall short of addressing the complex, multi-scale biophysical and socioeconomic dynamics inherent in ES provision, flow, and use. On the practitioner side, application of methods remains onerous due to data and model parameterization requirements. Further, it is increasingly clear that the dominant "one model fits all" paradigm is often ill-suited to address the diversity of real-world management situations that exist across the broad spectrum of coupled human-natural systems. This article introduces an integrated ES modeling methodology, named ARIES (ARtificial Intelligence for Ecosystem Services), which aims to introduce improvements on these fronts. To improve conceptual detail and representation of ES dynamics, it adopts a uniform conceptualization of ES that gives equal emphasis to their production, flow and use by society, while keeping model complexity low enough to enable rapid and inexpensive assessment in many contexts and for multiple services. To improve fit to diverse application contexts, the methodology is assisted by model integration technologies that allow assembly of customized models from a growing model base. By using computer learning and reasoning, model structure may be specialized for each application context without requiring costly expertise. In this article we discuss the founding principles of ARIES - both its innovative aspects for ES science and as an example of a new strategy to support more accurate decision making in diverse application contexts.	[Villa, Ferdinando] Basque Fdn Sci, IKERBASQUE, Basque Ctr Climate Change BC3, Bilbao, Bizkaia, Spain; [Bagstad, Kenneth J.] US Geol Survey, Geosci & Environm Change Sci Ctr, Denver, CO 80225 USA; [Voigt, Brian] Univ Vermont, Gund Inst Ecol Econ, Rubenstein Sch Environm & Nat Resources, Burlington, VT USA; [Johnson, Gary W.] Univ Vermont, Dept Comp Sci, Burlington, VT USA; [Portela, Rosimeiry; Honzak, Miroslav] Conservat Int, Arlington, VA USA; [Batker, David] Earth Econ, Tacoma, WA USA	Basque Centre for Climate Change (BC3); Basque Foundation for Science; United States Department of the Interior; United States Geological Survey; University of Vermont; University of Vermont; Conservation International	Villa, F (corresponding author), Basque Fdn Sci, IKERBASQUE, Basque Ctr Climate Change BC3, Bilbao, Bizkaia, Spain.	ferdinando.villa@bc3research.org	Azkarate, Ainhoa/K-9087-2013; BITOUN, RACHEL Elisabeth/AAC-9538-2021	Azkarate, Ainhoa/0000-0003-0471-3094; BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Johnson, Gary/0000-0001-8609-9256; Bagstad, Kenneth/0000-0001-8857-5615; Villa, Ferdinando/0000-0002-5114-3007	US National Science Foundation [9982938]; ASSETS project; ESPA/NERC [NE-J002267-1]; Mendenhall Postdoctoral Research Program; World Bank WAVES partnership; US Agency for International Development [EEM-A-00-10-00001]; NERC [NE/J000957/1] Funding Source: UKRI; Natural Environment Research Council [NE/J000957/1] Funding Source: researchfish	US National Science Foundation(National Science Foundation (NSF)); ASSETS project; ESPA/NERC; Mendenhall Postdoctoral Research Program; World Bank WAVES partnership; US Agency for International Development(United States Agency for International Development (USAID)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The development of ARIES was originally funded by the US National Science Foundation (grant 9982938), and receives support from the ASSETS project funded by ESPA/NERC (grant NE-J002267-1). UNEP-WCMC and Conservation International also provided support for the development of specific components. Mendenhall Postdoctoral Research Program funded Bagstad's work at the U. S. Geological Survey. The World Bank WAVES partnership supported the case study in Madagascar. Funding for Brian Voigt was provided by the US Agency for International Development (EEM-A-00-10-00001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argent RM, 2004, ENVIRON MODELL SOFTW, V19, P219, DOI 10.1016/S1364-8152(03)00150-6; ARIES Consortium, 2012, ART INT EC SERV ARIE; Bagstad K, 2012, ECOSYSTEM SERVICE VA; Bagstad KJ, 2013, ECOSYST SERV, V5, pE27, DOI 10.1016/j.ecoser.2013.07.004; Bagstad KJ, 2013, ECOSYST SERV, V4, P117, DOI 10.1016/j.ecoser.2012.07.012; Bagstad KJ, 2011, ARIES REP SER, V1; Bagstad KJ, ECOLOGY SOC; Basque Centre for Climate Change (BC3), 2013, INT SRING U EC SERV; Bateman IJ, 2011, ENVIRON RESOUR ECON, V48, P177, DOI 10.1007/s10640-010-9418-x; Bolte J., 2010, ENVISIONING PUGET SO; Bolte JP, 2007, ENVIRON MODELL SOFTW, V22, P570, DOI 10.1016/j.envsoft.2005.12.033; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Boumans R, 2002, ECOL ECON, V41, P529, DOI 10.1016/S0921-8009(02)00098-8; Bourassa SC, 2006, J HOUS ECON, V15, P80, DOI 10.1016/j.jhe.2006.03.001; Boyd J, 2007, ECOL ECON, V63, P616, DOI 10.1016/j.ecolecon.2007.01.002; Brand J, 2002, ETUDE IMPACT DEFORES; Burkhard B, 2012, ECOL INDIC, V21, P17, DOI 10.1016/j.ecolind.2011.06.019; Carpenter SR, 2003, ECOSYSTEMS THEIR SER, P49; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Chan KMA, 2012, ECOL ECON, V74, P8, DOI 10.1016/j.ecolecon.2011.11.011; Conservation International, 2013, FUT CLIM CLIM PROJ A; Corbera E, 2012, SCIENCE, V335, P655, DOI 10.1126/science.335.6069.655-c; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Coulthard TJ, 2013, CAESAR LISFLOOD; Cowell R.G., 1999, PROBABILISTIC NETWOR; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Daily GC, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P3; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Daniel TC, 2012, P NATL ACAD SCI USA, V109, P8812, DOI 10.1073/pnas.1114773109; David O, 2013, ENVIRON MODELL SOFTW, V39, P201, DOI 10.1016/j.envsoft.2012.03.006; de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7; Earth Economics, 2013, ECOSYSTEM VALUATION; Eigenbrod F, 2010, J APPL ECOL, V47, P377, DOI 10.1111/j.1365-2664.2010.01777.x; Farley J, 2012, SOLUTIONS, V2, P64; Farley J, 2008, CONSERV BIOL, V22, P1399, DOI 10.1111/j.1523-1739.2008.01090.x; Farley J, 2012, ECOSYST SERV, V1, P40, DOI 10.1016/j.ecoser.2012.07.002; Figueira J, 2005, INT SER OPER RES MAN, V78, P1, DOI 10.1007/b100605; Fisher B, 2008, ECOL APPL, V18, P2050, DOI 10.1890/07-1537.1; Fisher B, 2011, PROG PHYS GEOG, V35, P595, DOI 10.1177/0309133311422968; Gangemi A, 2002, LECT NOTES ARTIF INT, V2473, P166; German DM, 2009, INT FED INFO PROC, V299, P185; Ghermandi A, 2013, ECOL ECON, V86, P1, DOI 10.1016/j.ecolecon.2012.11.006; Gruber TR, 1995, INT J HUM-COMPUT ST, V43, P907, DOI 10.1006/ijhc.1995.1081; Haines-Young R., 2011, EEABSS07007; Holling CS, 2001, ECOSYSTEMS, V4, P390, DOI 10.1007/s10021-001-0101-5; Jax K, 2013, ECOL ECON, V93, P260, DOI 10.1016/j.ecolecon.2013.06.008; Johnson G, 2012, MODELLING ECOSYSTEM; Johnson GW, 2012, INT J AGRIC ENVIRON, V3, P54, DOI 10.4018/jaeis.2012070104; Johnson GW, 2010, LECT NOTES COMPUT SC, V6016, P238, DOI 10.1007/978-3-642-12156-2_18; Jose Martinez-Harms Maria, 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P17, DOI 10.1080/21513732.2012.663792; Kull C. A., 2000, Environment and History, V6, P423, DOI 10.3197/096734000129342361; Kumar P., 2010, EC ECOSYSTEMS BIODIV; Leavesley G. H., 1995, Computer models of watershed hydrology., P281; Liu S, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 12: ECOLOGICAL ECONOMICS OF ESTUARIES AND COASTS, P55; LOOMIS JB, 1992, WATER RESOUR RES, V28, P701, DOI 10.1029/91WR02596; Madin JS, 2008, TRENDS ECOL EVOL, V23, P159, DOI 10.1016/j.tree.2007.11.007; Marcot BG, 2012, FOREST ECOL MANAG, V285, P123, DOI 10.1016/j.foreco.2012.08.024; Martin-Lopez B, 2008, CONSERV BIOL, V22, P624, DOI 10.1111/j.1523-1739.2008.00921.x; McCann RK, 2006, CAN J FOREST RES, V36, P3053, DOI 10.1139/X06-238; McConnell V., 2005, VALUE OPEN SPACE EVI; McDermott M, 2013, ENVIRON SCI POLICY, V33, P416, DOI 10.1016/j.envsci.2012.10.006; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Millennium Ecosystem Assessment(MA), 2005, MILL EC ASS LIV OUR; Moore RV, 2005, ENVIRON SCI POLICY, V8, P279, DOI 10.1016/j.envsci.2005.03.009; Nahlik AM, 2012, ECOL ECON, V77, P27, DOI 10.1016/j.ecolecon.2012.01.001; Page Lawrence, 1999, 199966 STANF INFOLAB; Palomo I, 2013, ECOSYST SERV, V4, P104, DOI 10.1016/j.ecoser.2012.09.001; Poppy GM, 2013, PHILOS T ROYAL SOC B; Portela R., 2012, ASSESSING VALUING EC; RANDRIANARIJAONA P, 1983, AMBIO, V12, P308; Raskin RG, 2005, COMPUT GEOSCI-UK, V31, P1119, DOI 10.1016/j.cageo.2004.12.004; RENARD KG, 1991, J SOIL WATER CONSERV, V46, P30; Rodriguez JP, 2006, ECOL SOC, V11; Roose E, 1996, LAND HUSBANDRY COMPO; Sagoff M, 2011, ECOL ECON, V70, P497, DOI 10.1016/j.ecolecon.2010.10.006; Salzman J, 2005, NEW YORK U LAW REV, V80, P870; Schagner JP, 2013, ECOSYST SERV, V4, P33, DOI 10.1016/j.ecoser.2013.02.003; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Simmhan YL, 2005, SIGMOD REC, V34, P31, DOI 10.1145/1084805.1084812; Smith B, 2011, TELLUS A, V63, P87, DOI 10.1111/j.1600-0870.2010.00477.x; Solonitompoarinony J, 2000, DOMMAGE HORS SITE ER; Syrbe RU, 2012, ECOL INDIC, V21, P80, DOI 10.1016/j.ecolind.2012.02.013; Tallis H, 2009, ANN NY ACAD SCI, V1162, P265, DOI 10.1111/j.1749-6632.2009.04152.x; Tallis HT, 2011, INVEST 2 2 0 USERS G; Troy A, 2006, ECOL ECON, V60, P435, DOI 10.1016/j.ecolecon.2006.04.007; van Nes EH, 2005, ECOLOGY, V86, P1797, DOI 10.1890/04-0550; Vigerstol KL, 2011, J ENVIRON MANAGE, V92, P2403, DOI 10.1016/j.jenvman.2011.06.040; Villa F, 2002, ECOL ECON, V41, P445, DOI 10.1016/S0921-8009(02)00093-9; Villa F, 2002, CONSERV BIOL, V16, P515, DOI 10.1046/j.1523-1739.2002.00425.x; Villa F, 2013, PHILOS T ROYAL SOC B; Villa F, 2013, THINKLAB SOFTWARE RE; Villa F, 2007, J INTELL INF SYST, V29, P79, DOI 10.1007/s10844-006-0032-x; Villa F, 2007, ENVIRON MANAGE, V39, P887, DOI 10.1007/s00267-006-0269-8; Villa F, 2011, ECON AGRAR RECUR NAT, V11, P83, DOI 10.7201/earn.2011.01.04; Villa F, 2009, ENVIRON SCI ENG, P23, DOI 10.1007/978-3-540-88351-7_2; Villa F, 2009, ENVIRON MODELL SOFTW, V24, P577, DOI 10.1016/j.envsoft.2008.09.009; Waage S, 2013, GLOBA PUBLIC TRENDS; Wallace KJ, 2007, BIOL CONSERV, V139, P235, DOI 10.1016/j.biocon.2007.07.015; Wegner G, 2011, GLOBAL ENVIRON CHANG, V21, P492, DOI 10.1016/j.gloenvcha.2010.12.008; Wendland KJ, 2010, ECOL ECON, V69, P2093, DOI 10.1016/j.ecolecon.2009.01.002; Wilson MA, 2006, ECOL ECON, V60, P335, DOI 10.1016/j.ecolecon.2006.08.015	102	258	280	15	252	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91001	10.1371/journal.pone.0091001	http://dx.doi.org/10.1371/journal.pone.0091001			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625496	gold, Green Published, Green Submitted			2022-12-27	WOS:000332851300050
J	Woodhouse, C; Camelo, JL; Wehby, GL				Woodhouse, Cristina; Lopez Camelo, Jorge; Wehby, George L.			A Comparative Analysis of Prenatal Care and Fetal Growth in Eight South American Countries	PLOS ONE			English	Article							BIRTH-WEIGHT; RACIAL DISPARITIES; INFANT HEALTH; OUTCOMES; IMPACT; BRAZIL	There has been little work that comprehensively compared the relationship between prenatal care and infant health across multiple countries using similar data sources and analytical models. Such comparative analyses are useful for understanding the background of differences in infant health between populations. We evaluated the association between prenatal care visits and fetal growth measured by birth weight (BW) in grams or low birth weight (<2500 grams; LBW) adjusted for gestational age in eight South American countries using similarly collected data across countries and the same analytical models. OLS and logistic regressions were estimated adjusting for a large set of relevant infant, maternal, and household characteristics and birth year and hospital fixed effects. Birth data were acquired from 140 hospitals that are part of the Latin American Collaborative Study of Congenital Malformations (ECLAMC) network. The analytical sample included 56,014 liveborn infants (similar to 69% of total sample) with complete data born without congenital anomalies in the years 1996-2011 in Brazil, Argentina, Chile, Venezuela, Ecuador, Colombia, Bolivia, and Uruguay. Prenatal care visits were significantly (at p<.05) and positively associated with BW and negatively associated with LBW for all countries. The OLS coefficients ranged from 9 grams per visit in Bolivia to 36 grams in Uruguay. The association with LBW was strongest for Chile (OR = 0.87 per visit) and lowest for Argentina and Venezuela (OR = 0.95). The association decreased in the recent decade compared to earlier years. Our findings suggest that estimates of association between prenatal care and fetal growth are population-specific and may not be generalizable to other populations. Furthermore, as one of the indicators for a country's healthcare system for maternal and child health, prenatal care is a highly variable indicator between countries in South America.	[Woodhouse, Cristina] Univ Iowa, Coll Med, Iowa City, IA USA; [Lopez Camelo, Jorge] Consejo Nacl Invest Cient & Tecn, CEMIC, RA-1033 Buenos Aires, DF, Argentina; [Wehby, George L.] Univ Iowa, Iowa City, IA 52242 USA; [Wehby, George L.] Univ Iowa, Coll Publ Hlth, Dept Hlth Management & Policy, Natl Bur Econ Res, Iowa City, IA USA	University of Iowa; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Iowa; National Bureau of Economic Research; University of Iowa	Wehby, GL (corresponding author), Univ Iowa, Iowa City, IA 52242 USA.	george-wehby@uiowa.edu		Lopez-Camelo, Jorge S./0000-0002-3146-5447	National Institutes of Health (NIH)/Fogarty International [R03 TW0081180]; FOGARTY INTERNATIONAL CENTER [R03TW008110] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/Fogarty International; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by grant R03 TW0081180 from the National Institutes of Health (NIH)/Fogarty International. The NIH/Fogarty International had no role in the study design, data collection and analysis, or manuscript writing and submission. No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received.	Abrevaya J., 2001, EMPIR ECON, V26, P247, DOI DOI 10.1007/S001810000052; Castilla EE, 2004, COMMUNITY GENET, V7, P76, DOI 10.1159/000080776; Cox RG, 2011, MATERN CHILD HLTH J, V15, P931, DOI 10.1007/s10995-009-0542-6; Padilho PD, 2009, NUTR HOSP, V24, P207; DONALDSON PJ, 1984, MED CARE, V22, P177, DOI 10.1097/00005650-198402000-00009; Ferri CP, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-209; Jewell RT, 2007, APPL ECON, V39, P415, DOI 10.1080/00036840500439028; Jewell RT, 2006, HEALTH ECON, V15, P1245, DOI 10.1002/hec.1121; Lau C, 2011, OBSTET GYNECOL, V117, P978, DOI 10.1097/AOG.0b013e318212140e; Liu XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037336; Martin Joyce A, 2011, Natl Vital Stat Rep, V60, P1; Nyarko KA, 2013, AM J PUBLIC HEALTH, V103, P1675, DOI 10.2105/AJPH.2012.301021; Nyarko KA, 2013, J PEDIATR-US, V162, P42, DOI 10.1016/j.jpeds.2012.06.040; Reichman NE, 2009, HEALTH ECON, V18, P761, DOI 10.1002/hec.1402; Serruya Suzanne Jacob, 2004, Cad. Saúde Pública, V20, P1281, DOI 10.1590/S0102-311X2004000500022; VanderWeele TJ, 2009, J CLIN EPIDEMIOL, V62, P438, DOI 10.1016/j.jclinepi.2008.08.001; Varvarigou AA, 2010, J PEDIATR ENDOCR MET, V23, P215, DOI 10.1515/JPEM.2010.23.3.215; Wardlaw TM, 2004, LOW BIRTHW COUNTR RE; WBG, 2012, WORLD DATABANK; Wehby GL, 2014, HEALTH ECON, V23, P69, DOI 10.1002/hec.2901; Wehby GL, 2010, ECON HUM BIOL, V8, P197, DOI 10.1016/j.ehb.2010.04.002; Wehby GL, 2009, HEALTH ECON, V18, P1307, DOI 10.1002/hec.1431; Wehby GL, 2009, ECON HUM BIOL, V7, P84, DOI 10.1016/j.ehb.2008.10.001; Wehby GL, 2009, HEALTH POLICY PLANN, V24, P175, DOI 10.1093/heapol/czp005; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; World Health Organization, 2012, WORLD HLTH STAT 2012; World Health Organization, 2012, MAT NEWB CHILD AD HL; You D., 2012, LEVELS TRENDS CHILD; Zhang L, 2011, MATERN CHILD HLTH J, V15, P910, DOI 10.1007/s10995-009-0516-8	29	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91292	10.1371/journal.pone.0091292	http://dx.doi.org/10.1371/journal.pone.0091292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9JS	24625630	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300071
J	Xu, H; Mohtashami, M; Stewart, B; Boulianne, G; Trimble, WS				Xu, Hao; Mohtashami, Mahmood; Stewart, Bryan; Boulianne, Gabrielle; Trimble, William S.			Drosophila SNAP-29 Is an Essential SNARE That Binds Multiple Proteins Involved in Membrane Traffic	PLOS ONE			English	Article							APICAL PLASMA-MEMBRANE; CANINE KIDNEY-CELLS; EPITHELIAL-CELLS; MOLECULAR-MECHANISMS; EARLY ENDOSOMES; EPS15 HOMOLOGY; EH-DOMAIN; FUSION; EXOCYTOSIS; SYNTAXIN	Each membrane fusion event along the secretory and endocytic pathways requires a specific set of SNAREs to assemble into a 4-helical coiled-coil, the so-called trans-SNARE complex. Although most SNAREs contribute one helix to the trans-SNARE complex, members of the SNAP-25 family contribute two helixes. We report the characterization of the Drosophila homologue of SNAP-29 (dSNAP-29), which is expressed throughout development. Unlike the other SNAP-25 like proteins in fruit fly (i.e., dSNAP-25 and dSNAP-24), which form SDS-resistant SNARE complexes with their cognate SNAREs, dSNAP-29 does not participate in any SDS-resistant complexes, despite its interaction with dsyntaxin1 and dsyntaxin 16 in vitro. Immunofluorescence studies indicated that dSNAP-29 is distributed in various tissues, locating in small intracellular puncta and on the plasma membrane, where it associates with EH domain-containing proteins implicated in the endocytic pathway. Overexpression and RNAi studies suggested that dSNAP-29 mediates an essential process in Drosophila development.	[Xu, Hao] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; [Mohtashami, Mahmood] Sunnybrook Res Inst, Dept Immunol, Toronto, ON, Canada; [Stewart, Bryan] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Boulianne, Gabrielle] Univ Toronto, Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Boulianne, Gabrielle] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Trimble, William S.] Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Trimble, William S.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Southern Mississippi; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Mississauga; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Xu, H (corresponding author), Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.	hao.xu@usm.edu	XU, HAO/B-3194-2011	XU, HAO/0000-0002-5776-0276; Stewart, Bryan/0000-0003-2520-3632	Canadian Institutes of Health Research (GLB); Natural Sciences and Engineering Research Council of Canada (WST)	Canadian Institutes of Health Research (GLB); Natural Sciences and Engineering Research Council of Canada (WST)	These studies were supported by grants from the Canadian Institutes of Health Research (GLB) and the Natural Sciences and Engineering Research Council of Canada (WST). GLB and WST are Canada Research Chair holders. HX is a USM intramural development grant recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean AJ, 1997, NATURE, V385, P826, DOI 10.1038/385826a0; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BRAND AH, 1993, DEVELOPMENT, V118, P401; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Chen D, 2000, BLOOD, V96, P1782, DOI 10.1182/blood.V96.5.1782.h8001782_1782_1788; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chin LS, 2000, J BIOL CHEM, V275, P1191, DOI 10.1074/jbc.275.2.1191; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Confalonieri S, 2002, FEBS LETT, V513, P24, DOI 10.1016/S0014-5793(01)03241-0; Foster LJ, 1999, AM J PHYSIOL-CELL PH, V276, pC1108, DOI 10.1152/ajpcell.1999.276.5.C1108; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; Gonzalo S, 1999, J BIOL CHEM, V274, P21313, DOI 10.1074/jbc.274.30.21313; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hohenstein AC, 2001, BIOCHEM BIOPH RES CO, V285, P167, DOI 10.1006/bbrc.2001.5141; Holt M, 2006, J BIOL CHEM, V281, P17076, DOI 10.1074/jbc.M513838200; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jurado S, 2013, NEURON, V77, P542, DOI 10.1016/j.neuron.2012.11.029; Kang J, 2011, DEV BIOL, V355, P77, DOI 10.1016/j.ydbio.2011.04.013; Kawasaki F, 2009, P NATL ACAD SCI USA, V106, P14658, DOI 10.1073/pnas.0907144106; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Kwong J, 2000, J CELL SCI, V113, P2273; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; Leung SM, 1998, J BIOL CHEM, V273, P17732, DOI 10.1074/jbc.273.28.17732; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Low SH, 1998, J BIOL CHEM, V273, P3422, DOI 10.1074/jbc.273.6.3422; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Mohtashami M, 2001, J NEUROCHEM, V77, P1407, DOI 10.1046/j.1471-4159.2001.00363.x; Niemeyer BA, 2000, J CELL SCI, V113, P4055; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Olswang-Kutz Y, 2009, J CELL SCI, V122, P471, DOI 10.1242/jcs.038521; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Pelham HRB, 2001, TRENDS CELL BIOL, V11, P99, DOI 10.1016/S0962-8924(01)01929-8; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Rapaport D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009759; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Rotem-Yehudar R, 2001, J BIOL CHEM, V276, P33054, DOI 10.1074/jbc.M009913200; ROTHMAN JE, 1994, ADV SEC MESS PHOSPH, V29, P81; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Santolini E, 1999, EXP CELL RES, V253, P186, DOI 10.1006/excr.1999.4694; Sato M, 2011, MOL BIOL CELL, V22, P2579, DOI 10.1091/mbc.E11-04-0279; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Stewart BA, 2002, J NEUROBIOL, V51, P261, DOI 10.1002/neu.10059; Su QN, 2001, P NATL ACAD SCI USA, V98, P14038, DOI 10.1073/pnas.251532398; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Vilinsky I, 2002, GENETICS, V162, P259; Wang GY, 1997, J CELL SCI, V110, P505; Wei SH, 2000, EMBO J, V19, P1279, DOI 10.1093/emboj/19.6.1279; Wesolowski J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049886; Wong SH, 1999, MOL BIOL CELL, V10, P119, DOI 10.1091/mbc.10.1.119; Xu H, 2002, J CELL SCI, V115, P4447, DOI 10.1242/jcs.00139; Xu H, 2002, DEV BIOL, V251, P294, DOI 10.1006/dbio.2002.0830	60	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91471	10.1371/journal.pone.0091471	http://dx.doi.org/10.1371/journal.pone.0091471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626111	Green Submitted, gold, Green Published			2022-12-27	WOS:000332851300087
J	Coviello, L; Sohn, Y; Kramer, ADI; Marlow, C; Franceschetti, M; Christakis, NA; Fowler, JH				Coviello, Lorenzo; Sohn, Yunkyu; Kramer, Adam D. I.; Marlow, Cameron; Franceschetti, Massimo; Christakis, Nicholas A.; Fowler, James H.			Detecting Emotional Contagion in Massive Social Networks	PLOS ONE			English	Article							BEHAVIOR; HAPPINESS; WEATHER; SPREAD; MOOD	Happiness and other emotions spread between people in direct contact, but it is unclear whether massive online social networks also contribute to this spread. Here, we elaborate a novel method for measuring the contagion of emotional expression. With data from millions of Facebook users, we show that rainfall directly influences the emotional content of their status messages, and it also affects the status messages of friends in other cities who are not experiencing rainfall. For every one person affected directly, rainfall alters the emotional expression of about one to two other people, suggesting that online social networks may magnify the intensity of global emotional synchrony.	[Coviello, Lorenzo; Franceschetti, Massimo] Univ Calif San Diego, Elect & Comp Engn Dept, San Diego, CA 92103 USA; [Sohn, Yunkyu; Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, San Diego, CA 92103 USA; [Kramer, Adam D. I.; Marlow, Cameron] Facebook Inc, Menlo Pk, CA USA; [Christakis, Nicholas A.] Yale Univ, Dept Sociol, New Haven, CT USA; [Christakis, Nicholas A.] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Fowler, James H.] Univ Calif San Diego, Sch Med, Div Med Genet, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Facebook Inc; Yale University; Yale University; University of California System; University of California San Diego	Fowler, JH (corresponding author), Univ Calif San Diego, Dept Polit Sci, San Diego, CA 92103 USA.	fowler@ucsd.edu	Fowler, James H/C-2750-2008	Fowler, James H/0000-0001-7795-1638	Army Research Office [W911NF-11-1-0363]; James S. McDonnell Foundation	Army Research Office; James S. McDonnell Foundation	This work was partially supported by Army Research Office Grant W911NF-11-1-0363, and a grant from the James S. McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Aral S, 2012, SCIENCE, P1; Bollen J, 2011, ARTIF LIFE, V17, P237, DOI 10.1162/artl_a_00034; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Cacioppo JT, 2009, J PERS SOC PSYCHOL, V97, P977, DOI 10.1037/a0016076; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Centola D, 2011, SCIENCE, V334, P1269, DOI 10.1126/science.1207055; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Christakis N.A., 2009, CONNECTED SURPRISING; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; Christakis Nicholas A, 2009, Nor Epidemiol, V19, P5; Easterlin RA, 2003, P NATL ACAD SCI USA, V100, P11176, DOI 10.1073/pnas.1633144100; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Goncalves P., 2013, P 1 ACM C ONL OSC NE, P27; Goodall J., 1968, ANIM BEHAV MONOGR, V1, P165; Gruzd A, 2011, SYST SCI HICSS 2011; Guillory J, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P745; Hannak A., 2012, P 6 INT AAAI C WEBL; Hatfield E., 1993, CURR DIR PSYCHOL SCI, V2, P96, DOI [DOI 10.1111/1467-8721.EP10770953, 10.1111/1467-8721.ep10770953]; HOWES MJ, 1985, J PERS SOC PSYCHOL, V49, P1110, DOI 10.1037/0022-3514.49.4.1110; Hu X., 2013, P 6 ACM INT C WEB SE; Kahneman D, 2006, SCIENCE, V312, P1908, DOI 10.1126/science.1129688; Keller MC, 2005, PSYCHOL SCI, V16, P724, DOI 10.1111/j.1467-9280.2005.01602.x; Keltner D, 1997, J PERS SOC PSYCHOL, V73, P687, DOI 10.1037/0022-3514.73.4.687; Klimstra TA, 2011, EMOTION, V11, P1495, DOI 10.1037/a0024649; Kramer A.D., 2012, P SIGCHI C HUMAN FAC, P767, DOI DOI 10.1145/2207676.2207787; Pennebaker J, 2007, DEV PSYCHOL PROPERTI; Pugh SD, 2001, ACAD MANAGE J, V44, P1018, DOI 10.2307/3069445; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Rosenquist JN, 2011, MOL PSYCHIATR, V16, P273, DOI 10.1038/mp.2010.13; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; ZAJONC RB, 1985, SCIENCE, V228, P15, DOI 10.1126/science.3883492	37	243	249	10	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90315	10.1371/journal.pone.0090315	http://dx.doi.org/10.1371/journal.pone.0090315			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24621792	Green Published, gold			2022-12-27	WOS:000332845300020
J	McPartland, JM; Guy, GW; Di Marzo, V				McPartland, John M.; Guy, Geoffrey W.; Di Marzo, Vincenzo			Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System	PLOS ONE			English	Review							CANNABINOID CB1 RECEPTOR; ACID AMIDE HYDROLASE; MESSENGER-RNA EXPRESSION; ANXIETY-LIKE BEHAVIOR; EXCITATORY SYNAPTIC-TRANSMISSION; POLYUNSATURATED FATTY-ACIDS; CHRONIC ETHANOL; RAT-BRAIN; CROSS-TOLERANCE; HIPPOCAMPAL-NEURONS	Background: The "classic" endocannabinoid (eCB) system includes the cannabinoid receptors CB1 and CB2, the eCB ligands anandamide (AEA) and 2-arachidonoylglycerol (2-AG), and their metabolic enzymes. An emerging literature documents the "eCB deficiency syndrome" as an etiology in migraine, fibromyalgia, irritable bowel syndrome, psychological disorders, and other conditions. We performed a systematic review of clinical interventions that enhance the eCB system-ways to upregulate cannabinoid receptors, increase ligand synthesis, or inhibit ligand degradation. Methodology/Principal Findings: We searched PubMed for clinical trials, observational studies, and preclinical research. Data synthesis was qualitative. Exclusion criteria limited the results to 184 in vitro studies, 102 in vivo animal studies, and 36 human studies. Evidence indicates that several classes of pharmaceuticals upregulate the eCB system, including analgesics (acetaminophen, non-steroidal anti-inflammatory drugs, opioids, glucocorticoids), antidepressants, antipsychotics, anxiolytics, and anticonvulsants. Clinical interventions characterized as "complementary and alternative medicine" also upregulate the eCB system: massage and manipulation, acupuncture, dietary supplements, and herbal medicines. Lifestyle modification (diet, weight control, exercise, and the use of psychoactive substances-alcohol, tobacco, coffee, cannabis) also modulate the eCB system. Conclusions/Significance: Few clinical trials have assessed interventions that upregulate the eCB system. Many preclinical studies point to other potential approaches; human trials are needed to explore these promising interventions.	[McPartland, John M.; Guy, Geoffrey W.] GW Pharmaceut, Porton Sci Pk, Salisbury, Wilts, England; [McPartland, John M.] Univ Vermont, Dept Family Med, Burlington, VT USA; [Di Marzo, Vincenzo] CNR, Ist Chim Biomol, Endocannabinoid Res Grp, I-80125 Naples, Italy	University of Vermont; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR)	McPartland, JM (corresponding author), GW Pharmaceut, Porton Sci Pk, Salisbury, Wilts, England.	mcpruitt@myfairpoint.net	Di Marzo, Vincenzo/AAD-7742-2019	Di Marzo, Vincenzo/0000-0002-1490-3070	Unitec New Zealand; GW Pharmaceuticals	Unitec New Zealand; GW Pharmaceuticals	This study was initially supported by an AssocPro (Associate Professor) grant, Unitec New Zealand to JM; subsequent funding by GW Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto MD, 1998, J PHARMACOL EXP THER, V287, P598; Adermark L, 2011, NEUROPHARMACOLOGY, V61, P1160, DOI 10.1016/j.neuropharm.2011.01.014; Ahn DK, 2007, PAIN, V132, P23, DOI 10.1016/j.pain.2007.01.015; Allen KL, 2009, J CHEM NEUROANAT, V37, P266, DOI 10.1016/j.jchemneu.2009.02.001; Allen KV, 2003, NEUROPHARMACOLOGY, V44, P264, DOI 10.1016/S0028-3908(02)00364-7; Alvheim AR, 2012, OBESITY, V20, P1984, DOI 10.1038/oby.2012.38; Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Andersson M, 2005, J NEUROSCI RES, V82, P264, DOI 10.1002/jnr.20630; Artmann A, 2008, BBA-MOL CELL BIOL L, V1781, P200, DOI 10.1016/j.bbalip.2008.01.006; Ates M, 2003, EUR J NEUROSCI, V17, P597, DOI 10.1046/j.1460-9568.2003.02470.x; Atsak P, 2012, P NATL ACAD SCI USA, V109, P3504, DOI 10.1073/pnas.1200742109; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Balerio GN, 2006, PSYCHOPHARMACOLOGY, V184, P504, DOI 10.1007/s00213-005-0251-9; Banni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044813; Banni S, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-7; Basavarajappa BS, 2008, J NEUROCHEM, V107, P1001, DOI 10.1111/j.1471-4159.2008.05685.x; Basavarajappa BS, 1998, BRAIN RES, V793, P212, DOI 10.1016/S0006-8993(98)00175-9; Basavarajappa BS, 1999, J NEUROCHEM, V72, P522, DOI 10.1046/j.1471-4159.1999.0720522.x; Basavarajappa BS, 2003, EUR J PHARMACOL, V466, P73, DOI 10.1016/S0014-2999(03)01557-7; Basavarajappa BS, 2000, BBA-MOL BASIS DIS, V1535, P78, DOI 10.1016/S0925-4439(00)00085-5; Basavarajappa BS, 1999, BRAIN RES, V815, P89, DOI 10.1016/S0006-8993(98)01072-5; Batetta B, 2009, J NUTR, V139, P1495, DOI 10.3945/jn.109.104844; Bell J, 1857, BOSTON MED SURGICAL, V56, P209; Bennetzen MF, 2011, INT J OBESITY, V35, P1377, DOI 10.1038/ijo.2011.8; Bento AF, 2011, AM J PATHOL, V178, P1153, DOI 10.1016/j.ajpath.2010.11.052; Berger A, 2001, P NATL ACAD SCI USA, V98, P6402, DOI 10.1073/pnas.101119098; Bermudez-Silva FJ, 2010, PHARMACOL BIOCHEM BE, V95, P375, DOI 10.1016/j.pbb.2010.03.012; Berrendero F, 2003, EUR J NEUROSCI, V18, P2197, DOI 10.1046/j.1460-9568.2003.02951.x; Berrendero F, 2002, PSYCHOPHARMACOLOGY, V163, P111, DOI 10.1007/s00213-002-1144-9; Bertolacci L, 2013, J AM CHEM SOC, V135, P22, DOI 10.1021/ja308733u; Bisogno T, 1997, BBA-LIPID LIPID MET, V1345, P338, DOI 10.1016/S0005-2760(97)00009-X; Bisogno T, 1999, ARCH BIOCHEM BIOPHYS, V370, P300, DOI 10.1006/abbi.1999.1410; Bisogno T, 2001, BRIT J PHARMACOL, V134, P845, DOI 10.1038/sj.bjp.0704327; Bisset KM, 2011, NEUROCHEM INT, V59, P706, DOI 10.1016/j.neuint.2011.06.019; BOHLMANN F, 1979, PHYTOCHEMISTRY, V18, P1371, DOI 10.1016/0031-9422(79)83025-3; Bonhaus DW, 1998, J PHARMACOL EXP THER, V287, P884; Bortolato M, 2007, BIOL PSYCHIAT, V62, P1103, DOI 10.1016/j.biopsych.2006.12.001; Botta B, 2003, PHYTOCHEMISTRY, V64, P599, DOI 10.1016/S0031-9422(03)00201-2; Bowles NP, 2012, NEUROSCIENCE, V204, P83, DOI 10.1016/j.neuroscience.2011.08.048; Bradshaw HB, 2006, AM J PHYSIOL-REG I, V291, pR349, DOI 10.1152/ajpregu.00933.2005; Braida D, 2004, EUR J PHARMACOL, V506, P63, DOI 10.1016/j.ejphar.2004.10.043; Breivogel CS, 1999, J NEUROCHEM, V73, P2447, DOI 10.1046/j.1471-4159.1999.0732447.x; Brown I, 2010, CARCINOGENESIS, V31, P1584, DOI 10.1093/carcin/bgq151; Buczynski MW, 2013, NEUROPSYCHOPHARMACOL, V38, P574, DOI 10.1038/npp.2012.210; Burdyga G, 2010, AM J PHYSIOL-GASTR L, V299, pG63, DOI 10.1152/ajpgi.00059.2010; Burkey TH, 1997, EUR J PHARMACOL, V323, pR3, DOI 10.1016/S0014-2999(97)00146-5; Burkey TH, 1997, EUR J PHARMACOL, V336, P295, DOI 10.1016/S0014-2999(97)01255-7; BURSTEIN SH, 1995, BIOCHEM PHARMACOL, V49, P855, DOI 10.1016/0006-2952(94)00538-W; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P4888, DOI 10.1073/pnas.0900835106; Capasso R, 2008, BRIT J PHARMACOL, V155, P681, DOI 10.1038/bjp.2008.294; Carr RL, 2011, TOXICOL SCI, V122, P112, DOI 10.1093/toxsci/kfr081; Chen L, 2009, J PAIN, V10, P732, DOI 10.1016/j.jpain.2008.12.012; Cheng MC, 2008, INT J NEUROPSYCHOPH, V11, P207, DOI 10.1017/S1461145707008048; Chicca A, 2009, INT IMMUNOPHARMACOL, V9, P850, DOI 10.1016/j.intimp.2009.03.006; Chouker A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010752; Chu J, 2010, CELL SIGNAL, V22, P684, DOI 10.1016/j.cellsig.2009.12.003; Cichewicz DL, 1999, J PHARMACOL EXP THER, V289, P859; Cichewicz DL, 2001, J PHARMACOL EXP THER, V297, P121; Cichewicz DL, 2001, FASEB J, V15, pA228; Cippitelli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028142; Clarke RBC, 2010, NEUROPHARMACOLOGY, V58, P799, DOI 10.1016/j.neuropharm.2009.12.006; Coddington E, 2007, ENDOCRINOLOGY, V148, P493, DOI 10.1210/en.2006-0740; Connell K, 2006, NEUROSCI LETT, V397, P180, DOI 10.1016/j.neulet.2005.12.008; CONSROE P, 1976, PSYCHOPHARMACOLOGY, V50, P47, DOI 10.1007/BF00634153; Cooper ZD, 2010, PSYCHOPHARMACOLOGY, V211, P141, DOI 10.1007/s00213-010-1875-y; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; Cottone E, 2009, NEUROREPORT, V20, P595, DOI 10.1097/WNR.0b013e32832a0a5f; Cox ML, 2007, EUR J PHARMACOL, V567, P125, DOI 10.1016/j.ejphar.2007.04.010; Crouzin N, 2011, FREE RADICAL BIO MED, V51, P1643, DOI 10.1016/j.freeradbiomed.2011.07.012; D'Souza DC, 2008, NEUROPSYCHOPHARMACOL; D'Souza DC, 2008, PSYCHOPHARMACOLOGY, V198, P587, DOI 10.1007/s00213-007-1042-2; da Silva SG, 2010, NEUROCHEM INT, V57, P492, DOI 10.1016/j.neuint.2010.07.001; Dania M, 2007, EUR J PHARMACOL, V573, P214, DOI 10.1016/j.ejphar.2007.07.012; Darmani NA, 2005, NEUROPHARMACOLOGY, V48, P1154, DOI 10.1016/j.neuropharm.2005.01.001; Darmani NA, 2002, J PHARMACOL EXP THER, V300, P34, DOI 10.1124/jpet.300.1.34; De Chiara V, 2010, NEUROPSYCHOPHARMACOL, V35, P374, DOI 10.1038/npp.2009.141; Rodrigues LCD, 2011, BRAIN RES, V1382, P230, DOI 10.1016/j.brainres.2011.01.069; De Petrocellis L, 2011, BRIT J PHARMACOL, V163, P1479, DOI 10.1111/j.1476-5381.2010.01166.x; De Petrocellis L, 2010, J NEUROIMMUNE PHARM, V5, P103, DOI 10.1007/s11481-009-9177-z; Dhopeshwarkar AS, 2011, EUR J PHARMACOL, V654, P26, DOI 10.1016/j.ejphar.2010.11.033; Di Filippo M, 2008, J NEUROL NEUROSUR PS, V79, P1224, DOI 10.1136/jnnp.2007.139071; Di Marzo V, 2009, DIABETOLOGIA, V52, P213, DOI 10.1007/s00125-008-1178-6; Di Marzo V, 2000, J NEUROCHEM, V74, P1627, DOI 10.1046/j.1471-4159.2000.0741627.x; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Di Marzo V, 1998, NATURE, V396, P636, DOI 10.1038/25267; Di Marzo V, 1998, BBA-LIPID LIPID MET, V1392, P153, DOI 10.1016/S0005-2760(98)00042-3; Di Marzo V, 2011, HANDB EXP PHARMACOL, V203, P75, DOI 10.1007/978-3-642-17214-4_4; Di Marzo V, 2011, P NATL ACAD SCI USA, V108, P12567, DOI 10.1073/pnas.1109567108; Di Marzo V, 2010, INT DAIRY J, V20, P231, DOI 10.1016/j.idairyj.2009.11.015; Di S, 2005, ENDOCRINOLOGY, V146, P4292, DOI 10.1210/en.2005-0610; Di S, 2003, J NEUROSCI, V23, P4850; diTomaso E, 1996, NATURE, V382, P677, DOI 10.1038/382677a0; Dubreucq S, 2012, NEUROPSYCHOPHARMACOL, V37, P1885, DOI 10.1038/npp.2012.36; Dunnett AJ, 2007, J BODYW MOV THER, V11, P99, DOI 10.1016/j.jbmt.2006.12.004; Easley RB, 2000, PEDIATR EMERG CARE, V16, P39, DOI 10.1097/00006565-200002000-00012; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Evanson NK, 2010, ENDOCRINOLOGY, V151, P4811, DOI 10.1210/en.2010-0285; Falenski KW, 2010, NEUROPSYCHOPHARMACOL, V35, P1775, DOI 10.1038/npp.2010.44; FAN F, 1994, J PHARMACOL EXP THER, V271, P1383; Fattore L, 2007, EUR J NEUROSCI, V25, P2191, DOI 10.1111/j.1460-9568.2007.05470.x; Ferrer B, 2007, BIOCHEM J, V404, P97, DOI 10.1042/BJ20061898; Feuerecker M, 2012, EUR J APPL PHYSIOL, V112, P2777, DOI 10.1007/s00421-011-2237-0; Feuerecker M, 2012, ALCOHOL ALCOHOLISM, V47, P226, DOI 10.1093/alcalc/agr162; Fichna J, 2012, INFLAMM BOWEL DIS, V18, P1137, DOI 10.1002/ibd.21873; Fowler CJ, 1999, ARCH BIOCHEM BIOPHYS, V362, P191, DOI 10.1006/abbi.1998.1025; Fride E, 2004, NEUROENDOCRINOL LETT, V25, P24; FRIDE E, 1995, BRAIN RES, V697, P83, DOI 10.1016/0006-8993(95)00790-W; Fride E, 2001, EUR J PHARMACOL, V419, P207, DOI 10.1016/S0014-2999(01)00953-0; FRIDE E, 1995, J PHARMACOL EXP THER, V272, P699; Fu LW, 2009, J APPL PHYSIOL, V106, P1800, DOI 10.1152/japplphysiol.91648.2008; Gao JT, 2011, J NAT PROD, V74, P1636, DOI 10.1021/np200147c; Garcia-Gutierrez MS, 2010, J PSYCHOPHARMACOL, V24, P757, DOI 10.1177/0269881109106910; Gatta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031111; Gerard N, 2011, BIOL PSYCHIAT, V70, P777, DOI 10.1016/j.biopsych.2011.05.010; Gertsch J, 2008, P NATL ACAD SCI USA, V105, P9099, DOI 10.1073/pnas.0803601105; Giuffrida A, 2004, NEUROPSYCHOPHARMACOL, V29, P2108, DOI 10.1038/sj.npp.1300558; Glass M, 1999, MOL PHARMACOL, V56, P1362, DOI 10.1124/mol.56.6.1362; Glass M, 1997, NEUROSCIENCE, V77, P299, DOI 10.1016/S0306-4522(96)00428-9; Gobshtis N, 2007, EUR J PHARMACOL, V554, P155, DOI 10.1016/j.ejphar.2006.10.028; Goddard M, 2010, PHARMACOLOGY, V86, P125, DOI 10.1159/000317059; Goffin K, 2008, NEUROPHARMACOLOGY, V54, P1103, DOI 10.1016/j.neuropharm.2008.02.018; Gonsiorek W, 2000, MOL PHARMACOL, V57, P1045; Gonzalez S, 2002, BRAIN RES, V954, P73, DOI 10.1016/S0006-8993(02)03344-9; Gonzalez S, 2002, DRUG ALCOHOL DEPEN, V66, P77, DOI 10.1016/S0376-8716(01)00186-7; Gould GG, 2012, PROG NEURO-PSYCHOPH, V38, P260, DOI 10.1016/j.pnpbp.2012.04.011; GRAY GA, 1987, NEUROPHARMACOLOGY, V26, P229, DOI 10.1016/0028-3908(87)90213-9; Green K, 2001, OPHTHALMIC RES, V33, P217, DOI 10.1159/000055673; Guhring H, 2002, EUR J PHARMACOL, V454, P153, DOI 10.1016/S0014-2999(02)02485-8; Guijarro A, 2008, ANN SURG, V247, P779, DOI 10.1097/SLA.0b013e318166fd5f; Guindon J, 2009, CNS NEUROL DISORD-DR, V8, P403, DOI 10.2174/187152709789824660; Gutierrez M, 2011, J NAT PROD, V74, P2313, DOI 10.1021/np200610t; Haney M, 2003, PSYCHOPHARMACOLOGY, V166, P77, DOI 10.1007/s00213-002-1279-8; Hanus L, 2003, BRAIN RES, V983, P144, DOI 10.1016/S0006-8993(03)03046-4; Harinantenaina L, 2006, CHEM PHARM BULL, V54, P1046, DOI 10.1248/cpb.54.1046; Hassanzadeh P, 2012, NEUROCHEM RES, V37, P1112, DOI 10.1007/s11064-012-0716-2; Hayakawa K, 2008, BRAIN RES, V1188, P157, DOI 10.1016/j.brainres.2007.09.090; Hesketh SA, 2008, PSYCHOPHARMACOLOGY, V198, P29, DOI 10.1007/s00213-007-1033-3; Heyman E, 2012, PSYCHONEUROENDOCRINO, V37, P844, DOI 10.1016/j.psyneuen.2011.09.017; Hill MN, 2008, J NEUROCHEM, V106, P2322, DOI 10.1111/j.1471-4159.2008.05567.x; Hill MN, 2008, HIPPOCAMPUS, V18, P221, DOI 10.1002/hipo.20386; Hill MN, 2007, J NEUROCHEM, V103, P47, DOI 10.1111/j.1471-4159.2007.04688.x; Hill MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2591, DOI 10.1038/sj.npp.1301092; Hill MN, 2011, J NEUROSCI, V31, P10506, DOI 10.1523/JNEUROSCI.0496-11.2011; Hill MN, 2010, PSYCHONEUROENDOCRINO, V35, P1333, DOI 10.1016/j.psyneuen.2010.03.005; Hill MN, 2010, P NATL ACAD SCI USA, V107, P9406, DOI 10.1073/pnas.0914661107; Hill MN, 2010, HIPPOCAMPUS, V20, P513, DOI 10.1002/hipo.20647; Hill MN, 2008, J NEURAL TRANSM, V115, P1673, DOI 10.1007/s00702-008-0131-7; Hill MN, 2005, BEHAV PHARMACOL, V16, P333, DOI 10.1097/00008877-200509000-00006; Hill MN, 2005, NEUROPSYCHOPHARMACOL, V30, P508, DOI 10.1038/sj.npp.1300601; Hirvonen J, 2011, J NUCL MED, V52; Hoffman AF, 2010, J NEUROSCI, V30, P545, DOI 10.1523/JNEUROSCI.4920-09.2010; Hogestatt ED, 2005, J BIOL CHEM, V280, P31405, DOI 10.1074/jbc.M501489200; Hohmann AG, 2005, NATURE, V435, P1108, DOI 10.1038/nature03658; Hohmann J, 2011, PHYTOCHEMISTRY, V72, P1848, DOI 10.1016/j.phytochem.2011.06.008; Homberg JR, 2013, BEHAV BRAIN RES, V236, P295, DOI 10.1016/j.bbr.2012.09.005; Hong S, 2009, GUT, V58, P202, DOI 10.1136/gut.2008.157594; Hong SS, 2011, GASTROENTEROLOGY, V140, P627, DOI 10.1053/j.gastro.2010.11.003; Horvath B, 2012, FREE RADICAL BIO MED, V52, P1325, DOI 10.1016/j.freeradbiomed.2012.01.014; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Hu L, 2001, Z NATURFORSCH C, V56, P983; Hu SSJ, 2008, BRIT J PHARMACOL, V153, P1538, DOI 10.1038/bjp.2008.33; Hu W, 2011, BRAIN RES BULL, V85, P374, DOI 10.1016/j.brainresbull.2011.04.005; Hutchins-Wiese HL, 2012, J NUTR BIOCHEM, V23, P986, DOI 10.1016/j.jnutbio.2011.05.005; Iwata N, 2011, CHEM PHARM BULL, V59, P1409, DOI 10.1248/cpb.59.1409; Jafari MR, 2007, BEHAV PHARMACOL, V18, P691, DOI 10.1097/FBP.0b013e3282f00c10; Jelsing J, 2009, NEUROSCI LETT, V463, P125, DOI 10.1016/j.neulet.2009.07.011; Justinova Z, 2008, NEUROPSYCHOPHARMACOL, V33, P2870, DOI 10.1038/npp.2008.21; Katsuyama S, 2013, EUR J PAIN, V17, P664, DOI 10.1002/j.1532-2149.2012.00242.x; Kelley BG, 2004, NEUROPHARMACOLOGY, V46, P709, DOI 10.1016/j.neuropharm.2003.11.005; Kim HY, 2013, PROSTAG LEUKOTR ESS, V88, P121, DOI 10.1016/j.plefa.2012.08.002; Kim J, 2004, NAT NEUROSCI, V7, P697, DOI 10.1038/nn1262; King AR, 2009, CHEM BIOL, V16, P1045, DOI 10.1016/j.chembiol.2009.09.012; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kleinloog D, 2012, J PSYCHOPHARMACOL, V26, P1307, DOI 10.1177/0269881112446534; Ko JY, 2012, ARTHRITIS RHEUM-US, V64, P1204, DOI 10.1002/art.33457; Korte G, 2010, PHYTOMEDICINE, V17, P19, DOI 10.1016/j.phymed.2009.10.001; Korte G, 2009, J MED FOOD, V12, P1407, DOI 10.1089/jmf.2008.0243; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Laaris N, 2010, NEUROPHARMACOLOGY, V59, P121, DOI 10.1016/j.neuropharm.2010.04.013; Lafourcade M, 2011, NAT NEUROSCI, V14, P345, DOI 10.1038/nn.2736; Larrieu T, 2012, J PHYSIOL BIOCHEM, V68, P671, DOI 10.1007/s13105-012-0179-6; Le Foll B, 2006, BEHAV PHARMACOL, V17, P195; Lee TTY, 2013, NEUROSCIENCE, V249, P106, DOI 10.1016/j.neuroscience.2012.11.017; Leonti M, 2010, BIOCHEM PHARMACOL, V79, P1815, DOI 10.1016/j.bcp.2010.02.015; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liem-Moolenaar M, 2010, J PSYCHOPHARMACOL, V24, P1697, DOI 10.1177/0269881109358200; Ligresti A, 2012, PHARMACOL RES, V66, P163, DOI 10.1016/j.phrs.2012.04.003; Lile JA, 2012, DRUG ALCOHOL DEPEN, V122, P61, DOI 10.1016/j.drugalcdep.2011.09.010; LOEWE S, 1945, SCIENCE, V102, P615, DOI 10.1126/science.102.2659.615; Loewe WS, 1941, J PHARM EXPT THERAPE, V72, P72; Loewe WS, 1944, MARIHUANA PROBLMES C, P149; Loewe WS, 1928, ERGEBNISSE PHYSL, V27, P47; Loewe WS, 1940, J AM PHARM ASSOC SCI, V29, P162; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Luk T, 2004, BRIT J PHARMACOL, V142, P495, DOI 10.1038/sj.bjp.0705792; Lundberg DJ, 2005, NEUROPHARMACOLOGY, V49, P1170, DOI 10.1016/j.neuropharm.2005.07.012; Luszczki JJ, 2012, PHARMACOL REP, V64, P723; Macleod MR, 2004, STROKE, V35, P1203, DOI 10.1161/01.STR.0000125719.25853.20; Malcher-Lopes R, 2006, J NEUROSCI, V26, P6643, DOI 10.1523/JNEUROSCI.5126-05.2006; Mallet C, 2008, PAIN, V139, P190, DOI 10.1016/j.pain.2008.03.030; Malone DT, 1998, BRIT J PHARMACOL, V124, P1419, DOI 10.1038/sj.bjp.0701980; Marco EM, 2006, BEHAV BRAIN RES, V172, P46, DOI 10.1016/j.bbr.2006.04.012; Marini P, 2009, BBA-MOL CELL RES, V1793, P1289, DOI 10.1016/j.bbamcr.2009.05.002; Massa F, 2010, J NEUROSCI, V30, P6273, DOI 10.1523/JNEUROSCI.2648-09.2010; Matias I, 2005, J NEUROCHEM, V93, P1141, DOI 10.1111/j.1471-4159.2005.03103.x; Matias I, 2008, BBA-MOL CELL BIOL L, V1781, P52, DOI 10.1016/j.bbalip.2007.11.001; Matias I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042399; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; Mato S, 2010, MOL PHARMACOL, V77, P424, DOI 10.1124/mol.109.060079; McPartland JM, 2007, BRIT J PHARMACOL, V152, P583, DOI 10.1038/sj.bjp.0707399; McPartland J M, 1997, Altern Ther Health Med, V3, P39; McPartland J. M., 2001, Journal of Cannabis Therapeutics, V1, P103, DOI 10.1300/J175v01n03_08; McPartland J. M., 2004, EVOLUTION CANNABIS C, P71; McPartland JM, 1997, ARCH PHYS MED REHAB, V78, P61, DOI 10.1016/S0003-9993(97)90011-3; McPartland JM, 1999, ALTERN THER HEALTH M, V5, P57; McPartland JM, 2000, J OSTEOPATH MED, V100, P89; McPartland JM, 2008, ADDICT BIOL, V13, P411, DOI 10.1111/j.1369-1600.2008.00126.x; McPartland JM, 2005, J AM OSTEOPATH ASSOC, V105, P283; Mechoulam R, 1998, EUR J PHARMACOL, V359, P1, DOI 10.1016/S0014-2999(98)00649-9; Meschler JP, 1999, PHARMACOL BIOCHEM BE, V62, P473, DOI 10.1016/S0091-3057(98)00195-6; Micale V, 2009, NEUROBIOL DIS, V36, P70, DOI 10.1016/j.nbd.2009.06.015; Micale V, 2009, NEUROPSYCHOPHARMACOL, V34, P593, DOI 10.1038/npp.2008.98; Mitrirattanakul S, 2007, ALCOHOL CLIN EXP RES, V31, P855, DOI 10.1111/j.1530-0277.2007.00366.x; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Muhammad I, 2001, J NAT PROD, V64, P1322, DOI 10.1021/np0102861; Naderi N, 2008, J NEURAL TRANSM, V115, P1501, DOI 10.1007/s00702-008-0076-x; Naderi N, 2008, PHARMACOL BIOCHEM BE, V89, P64, DOI 10.1016/j.pbb.2007.11.001; Nakane S, 2000, BIOL PHARM BULL, V23, P758, DOI 10.1248/bpb.23.758; Navarro M, 1997, NEUROREPORT, V8, P491, DOI 10.1097/00001756-199701200-00023; NOVELLI GP, 1983, BRIT J ANAESTH, V55, P997, DOI 10.1093/bja/55.10.997; Onaivi ES, 2011, CURR NEUROPHARMACOL, V9, P205, DOI 10.2174/157015911795017416; Ortiz S, 2004, ALCOHOL ALCOHOLISM, V39, P88, DOI 10.1093/alcalc/agh036; Ottani A, 2006, EUR J PHARMACOL, V531, P280, DOI 10.1016/j.ejphar.2005.12.015; Palermo FA, 2011, GEN COMP ENDOCR, V171, P293, DOI 10.1016/j.ygcen.2011.02.009; Palu AK, 2008, J ETHNOPHARMACOL, V115, P502, DOI 10.1016/j.jep.2007.10.023; Park HJ, 2011, CELL MOL NEUROBIOL, V31, P1123, DOI 10.1007/s10571-011-9718-x; Patel S, 2005, EUR J NEUROSCI, V21, P1057, DOI 10.1111/j.1460-9568.2005.03916.x; Patel S, 2009, NEUROPSYCHOPHARMACOL, V34, P2699, DOI 10.1038/npp.2009.101; Penetar DM, 2005, DRUG ALCOHOL DEPEN, V79, P211, DOI 10.1016/j.drugalcdep.2005.01.008; PEREZREYES M, 1991, LIFE SCI, V48, P507, DOI 10.1016/0024-3205(91)90465-N; Perra S, 2005, PSYCHOPHARMACOLOGY, V183, P368, DOI 10.1007/s00213-005-0195-0; Perra S, 2008, ALCOHOL CLIN EXP RES, V32, P443, DOI 10.1111/j.1530-0277.2007.00588.x; PERTWEE RG, 1988, NEUROPHARMACOLOGY, V27, P1265, DOI 10.1016/0028-3908(88)90029-9; PERTWEE RG, 1991, PHARMACOL BIOCHEM BE, V40, P581, DOI 10.1016/0091-3057(91)90366-A; PERTWEE RG, 1993, BRIT J PHARMACOL, V110, P1483, DOI 10.1111/j.1476-5381.1993.tb13989.x; Petitet F, 1998, LIFE SCI, V63, pPL1, DOI 10.1016/S0024-3205(98)00238-0; Pisani V, 2010, MOVEMENT DISORD, V25, P920, DOI 10.1002/mds.23014; Piscitelli F, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-51; Prather PL, 2009, J PHARMACOL EXP THER, V331, P1147; PRYOR GT, 1977, PHARMACOL BIOCHEM BE, V6, P123, DOI 10.1016/0091-3057(77)90168-X; PRYOR GT, 1978, PHARMACOL BIOCHEM BE, V8, P295, DOI 10.1016/0091-3057(78)90320-9; Pugh G, 1996, J PHARMACOL EXP THER, V279, P608; QUAGHEBEUR K, 1994, PHYTOCHEMISTRY, V37, P159, DOI 10.1016/0031-9422(94)85016-X; Quartu M, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-8; Quistad CB, 2001, TOXICOL APPL PHARM, V173, P48, DOI 10.1006/taap.2001.9175; Raduner S, 2006, J BIOL CHEM, V281, P14192, DOI 10.1074/jbc.M601074200; Raichlen DA, 2013, EUR J APPL PHYSIOL, V113, P869, DOI 10.1007/s00421-012-2495-5; Raichlen DA, 2012, J EXP BIOL, V215, P1331, DOI 10.1242/jeb.063677; Reche I, 1998, NEUROPHARMACOLOGY, V37, P215, DOI 10.1016/S0028-3908(98)00005-7; Reche I, 1996, EUR J PHARMACOL, V318, P11, DOI 10.1016/S0014-2999(96)00752-2; Reich CG, 2009, BEHAV BRAIN RES, V203, P264, DOI 10.1016/j.bbr.2009.05.013; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Rimondini R, 2002, FASEB J, V16, P27, DOI 10.1096/fj.01-0593com; Roberts JD, 2006, EUR J PHARMACOL, V530, P54, DOI 10.1016/j.ejphar.2005.11.036; Robinson L, 2010, BEHAV BRAIN RES, V208, P584, DOI 10.1016/j.bbr.2010.01.004; Rodriguez-Gaztelumendi A, 2009, J NEUROCHEM, V108, P1423, DOI 10.1111/j.1471-4159.2009.05898.x; Rollinger JM, 2009, PLANTA MED, V75, P195, DOI 10.1055/s-0028-1088397; Roloff AM, 2009, MOL PHARMACOL, V75, P892, DOI 10.1124/mol.108.051482; ROMERO J, 1995, PHARMACOL BIOCHEM BE, V51, P731, DOI 10.1016/0091-3057(95)00023-P; Rossi S, 2008, J NEUROSCI, V28, P7284, DOI 10.1523/JNEUROSCI.5346-07.2008; Rossi S, 2009, NEUROBIOL DIS, V36, P51, DOI 10.1016/j.nbd.2009.06.013; Rossi S, 2009, NEUROPHARMACOLOGY, V56, P590, DOI 10.1016/j.neuropharm.2008.10.013; Rotter A, 2013, EUR ADDICT RES, V19, P13, DOI 10.1159/000338642; Rousseaux C, 2007, NAT MED, V13, P35, DOI 10.1038/nm1521; Russo EB, 2004, NEUROENDOCRINOL LETT, V25, P31; Sandercock P, 2002, LANCET, V360, P586, DOI 10.1016/S0140-6736(02)09812-4; Sang N, 2006, J PHYSIOL-LONDON, V572, P735, DOI 10.1113/jphysiol.2006.105569; Sarchielli P, 2007, NEUROPSYCHOPHARMACOL, V32, P1384, DOI 10.1038/sj.npp.1301246; Sasso O, 2012, PHARMACOL RES, V65, P553, DOI 10.1016/j.phrs.2012.02.012; Savinainen JR, 2001, BRIT J PHARMACOL, V134, P664, DOI 10.1038/sj.bjp.0704297; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Schoffelmeer ANM, 2006, NEUROPHARMACOLOGY, V51, P773, DOI 10.1016/j.neuropharm.2006.05.019; Schuchardt JP, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-145; Schulze DR, 2012, PSYCHOPHARMACOLOGY, V222, P425, DOI 10.1007/s00213-012-2661-9; Sciolino NR, 2010, NEUROSCIENCE, V168, P371, DOI 10.1016/j.neuroscience.2010.04.007; Secher A, 2010, NEUROENDOCRINOLOGY, V91, P155, DOI 10.1159/000245220; Selley DE, 2004, MOL PHARMACOL, V66, P1275, DOI 10.1124/mol.104.000604; Sepe N, 1998, BBA-LIPID LIPID MET, V1389, P101, DOI 10.1016/S0005-2760(97)00132-X; Shen MX, 1999, MOL PHARMACOL, V55, P8, DOI 10.1124/mol.55.1.8; Sim LJ, 1996, J NEUROSCI, V16, P8057; Sim-Selley LJ, 2002, J PHARMACOL EXP THER, V303, P36, DOI 10.1124/jpet.102.035618; da Silva KABS, 2011, PAIN, V152, P1872, DOI 10.1016/j.pain.2011.04.005; Sitachitta N, 1998, J NAT PROD, V61, P681, DOI 10.1021/np970576a; Smith AD, 2006, BRAIN RES, V1115, P16, DOI 10.1016/j.brainres.2006.07.075; Soderstrom K, 1997, ADV EXP MED BIOL, V433, P73; Solinas M, 2004, EUR J NEUROSCI, V19, P3183, DOI 10.1111/j.0953-816X.2004.03420.x; Solinas M, 2007, J PHARMACOL EXP THER, V321, P1127, DOI 10.1124/jpet.106.116830; Sousa VC, 2011, NEUROPSYCHOPHARMACOL, V36, P472, DOI 10.1038/npp.2010.179; Spano MS, 2004, BRIT J PHARMACOL, V143, P343, DOI 10.1038/sj.bjp.0705932; Sparling PB, 2003, NEUROREPORT, V14, P2209, DOI 10.1097/00001756-200312020-00015; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Straiker A, 2005, J PHYSIOL-LONDON, V569, P501, DOI 10.1113/jphysiol.2005.091918; Su TF, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-98; SULKOWSKI A, 1977, PSYCHOPHARMACOLOGY, V52, P47, DOI 10.1007/BF00426599; Sundram S, 2005, N-S ARCH PHARMACOL, V371, P428, DOI 10.1007/s00210-005-1074-2; Suplita RL, 2008, NEUROPHARMACOLOGY, V54, P161, DOI 10.1016/j.neuropharm.2007.07.006; Thors L, 2010, BRIT J PHARMACOL, V160, P549, DOI 10.1111/j.1476-5381.2010.00716.x; Toyota M, 2002, CHEM PHARM BULL, V50, P1390, DOI 10.1248/cpb.50.1390; Trezza V, 2012, J NEUROSCI, V32, P14899, DOI 10.1523/JNEUROSCI.0114-12.2012; Umathe SN, 2009, PROG NEURO-PSYCHOPH, V33, P1191, DOI 10.1016/j.pnpbp.2009.06.020; Uriguen L, 2004, NEUROPHARMACOLOGY, V46, P966, DOI 10.1016/j.neuropharm.2004.01.003; Valenti M, 2005, J NEUROCHEM, V95, P662, DOI 10.1111/j.1471-4159.2005.03406.x; Valjent E, 2002, BRIT J PHARMACOL, V135, P564, DOI 10.1038/sj.bjp.0704479; van der Worp HB, 2011, J MOL CELL CARDIOL, V51, P449, DOI 10.1016/j.yjmcc.2011.04.008; Van Laere K, 2010, J NUCL MED, V51, P1413, DOI 10.2967/jnumed.110.077156; Vann RE, 2012, NEUROPHARMACOLOGY, V62, P1019, DOI 10.1016/j.neuropharm.2011.10.011; Vigano D, 2004, EUR J NEUROSCI, V20, P1849, DOI 10.1111/j.1460-9568.2004.03645.x; Villares J, 2007, NEUROSCIENCE, V145, P323, DOI 10.1016/j.neuroscience.2006.11.012; Vinod KY, 2006, NEUROCHEM INT, V49, P619, DOI 10.1016/j.neuint.2006.05.002; Vinod KY, 2012, ADDICT BIOL, V17, P62, DOI 10.1111/j.1369-1600.2010.00299.x; Vinod KY, 2010, J PSYCHIATR RES, V44, P591, DOI 10.1016/j.jpsychires.2009.11.013; Wamsteeker JI, 2010, J NEUROSCI, V30, P11188, DOI 10.1523/JNEUROSCI.1046-10.2010; Wang J, 2012, J PHYSIOL-LONDON, V590, P5795, DOI 10.1113/jphysiol.2012.238659; Wang MN, 2012, J PSYCHOPHARMACOL, V26, P56, DOI 10.1177/0269881111409606; Wang QA, 2011, STROKE, V42, P389, DOI 10.1161/STROKEAHA.110.597336; Wang S, 2007, PAIN, V131, P96, DOI 10.1016/j.pain.2006.12.019; Wang W, 2010, NEUROPSYCHOPHARMACOL, V35, P2249, DOI 10.1038/npp.2010.99; Watanabe S, 2003, PROSTAG LEUKOTR ESS, V69, P51, DOI 10.1016/S0952-3278(03)00056-5; Weis F, 2010, BRIT J ANAESTH, V105, P139, DOI 10.1093/bja/aeq117; WELCH SP, 1992, J PHARMACOL EXP THER, V262, P10; Werling LL, 2009, INT J DEV NEUROSCI, V27, P263, DOI 10.1016/j.ijdevneu.2008.12.008; Willi GC, 2001, NES NUTR WS, V5, P169; Wolf SA, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-12; Wong BS, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2011.01874.x; Wood JT, 2010, J LIPID RES, V51, P1416, DOI 10.1194/jlr.M002436; Wu RW, 2011, BONE, V49, P1255, DOI 10.1016/j.bone.2011.08.022; Yan ZC, 2007, BIOCHEM BIOPH RES CO, V354, P427, DOI 10.1016/j.bbrc.2006.12.213; Yasari S, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/181687; Yin HH, 2007, EUR J NEUROSCI, V25, P3226, DOI 10.1111/j.1460-9568.2007.05606.x; You TJ, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-194; Zank TK, 2000, BIOCHEM SOC T, V28, P654; Zhang J, 2010, J PAIN, V11, P1250, DOI 10.1016/j.jpain.2010.02.013; Zhuang SY, 1998, MOL BRAIN RES, V62, P141, DOI 10.1016/S0169-328X(98)00232-0; Zoppi S, 2011, NEUROPSYCHOPHARMACOL, V36, P805, DOI 10.1038/npp.2010.214	344	86	89	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e89566	10.1371/journal.pone.0089566	http://dx.doi.org/10.1371/journal.pone.0089566			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622769	gold, Green Submitted, Green Published			2022-12-27	WOS:000332845300009
J	Nakamura, Y; Bryan, J				Nakamura, Yumiko; Bryan, Joseph			Targeting SUR1/Abcc8-Type Neuroendocrine K-ATP Channels in Pancreatic Islet Cells	PLOS ONE			English	Article							INDUCED INSULIN-SECRETION; GLUCAGON-SECRETION; INTRAISLET INSULIN; ALPHA-CELL; BETA-CELLS; GLUCOSE; HYPOGLYCEMIA; MOUSE; MICE; LACKING	ATP-sensitive K+ (K-ATP) channels play a regulatory role in hormone-secreting pancreatic islet alpha-, beta- and delta-cells. Targeted channel deletion would assist analysis and dissection of the intraislet regulatory network. Toward this end Abcc8/Sur1 flox mice were generated and tested by crossing with glucagon-(GCG)-cre mice to target alpha-cell K-ATP channels selectively. Agonist resistance was used to quantify the percent of alpha-cells lacking channels. 41% of Sur1(loxP/loxP);GCG-cre(+) and similar to 64% of Sur1(loxP/-);GCG-cre(+) alpha-cells lacked K-ATP channels, while similar to 65% of alpha-cells expressed enhanced yellow fluorescent protein (EYFP) in ROSA-EYFP/GCG-cre matings. The results are consistent with a stochastic two-recombination event mechanism and a requirement that both floxed alleles are deleted.	[Nakamura, Yumiko; Bryan, Joseph] Pacific Northwest Diabet Res Inst, Seattle, WA 98122 USA	Pacific Northwest Diabetes Research Institute (PNDRI)	Nakamura, Y (corresponding author), Pacific Northwest Diabet Res Inst, Seattle, WA 98122 USA.	ynakamura@pnri.org		Brusgaard, Klaus/0000-0002-2096-4988	Pacific Northwest Diabetes Research Institute (PNDRI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098647] Funding Source: NIH RePORTER	Pacific Northwest Diabetes Research Institute (PNDRI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by internal funds from the Pacific Northwest Diabetes Research Institute (PNDRI); but Drs. Nakamura and Bryan are employees of PNDRI. The funders, PNDRI, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoplan A, 2005, ADV GENET, V55, P1, DOI 10.1016/S0065-2660(05)55001-6; Allister EM, 2013, DIABETES, V62, P1623, DOI 10.2337/db12-0981; Araki K, 1997, J BIOCHEM, V122, P977, DOI 10.1093/oxfordjournals.jbchem.a021860; Berts A, 1996, BBA-MOL CELL RES, V1310, P212, DOI 10.1016/0167-4889(95)00173-5; Berts A, 1996, ENDOCRINOLOGY, V137, P693, DOI 10.1210/en.137.2.693; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; de Heer J, 2008, DIABETOLOGIA, V51, P2263, DOI 10.1007/s00125-008-1149-y; De Leon DD, 2008, J BIOL CHEM, V283, P25786, DOI 10.1074/jbc.M804372200; Farhy LS, 2008, AM J PHYSIOL-ENDOC M, V295, pE575, DOI 10.1152/ajpendo.90372.2008; Farhy Leon S, 2010, J Diabetes Sci Technol, V4, P1345; Gosmanov NR, 2005, DIABETES CARE, V28, P1124, DOI 10.2337/diacare.28.5.1124; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hauge-Evans AC, 2009, DIABETES, V58, P403, DOI 10.2337/db08-0792; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Karimian N, 2013, DIABETES; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Larsson H, 1998, DIABETOLOGIA, V41, P772, DOI 10.1007/s001250050986; Le Marchand SJ, 2010, J BIOL CHEM, V285, P14389, DOI 10.1074/jbc.M109.069195; MacDonald PE, 2007, PLOS BIOL, V5, P1236, DOI 10.1371/journal.pbio.0050143; Mohamed Z, 2012, J CLIN RES PEDIATR E, V4, P169, DOI [10.4274/jcrpe.821, 10.4274/Jcrpe.821]; Nenquin M, 2004, J BIOL CHEM, V279, P32316, DOI 10.1074/jbc.M402076200; Nyman LR, 2010, AM J PHYSIOL-ENDOC M, V298, pE807, DOI 10.1152/ajpendo.00715.2009; Quoix N, 2007, FEBS LETT, V581, P4235, DOI 10.1016/j.febslet.2007.07.068; Quoix N, 2009, DIABETES, V58, P412, DOI 10.2337/db07-1298; Raju B, 2005, DIABETES, V54, P757, DOI 10.2337/diabetes.54.3.757; Robertson RP, 2011, DIABETES OBES METAB, V13, P106, DOI 10.1111/j.1463-1326.2011.01448.x; Rorsman P, 2008, TRENDS ENDOCRIN MET, V19, P277, DOI 10.1016/j.tem.2008.07.003; Rui CX, 2013, DIABETES, V62, P1612, DOI 10.2337/db12-0347; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Shiota C, 2005, AM J PHYSIOL-ENDOC M, V289, pE570, DOI 10.1152/ajpendo.00102.2005; Shiota C, 2002, J BIOL CHEM, V277, P37176, DOI 10.1074/jbc.M206757200; Slucca M, 2010, DIABETES, V59, P128, DOI 10.2337/db09-1098; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STAGNER JI, 1992, DIABETES, V41, P93, DOI 10.2337/diabetes.41.1.93; Szollosi A, 2007, J BIOL CHEM, V282, P14768, DOI 10.1074/jbc.M701382200; Szollosi A, 2007, J BIOL CHEM, V282, P1747, DOI 10.1074/jbc.M609875200; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Unger RH, 2010, P NATL ACAD SCI USA, V107, P16009, DOI 10.1073/pnas.1006639107; WARD WK, 1984, J CLIN INVEST, V74, P1318, DOI 10.1172/JCI111542	42	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91525	10.1371/journal.pone.0091525	http://dx.doi.org/10.1371/journal.pone.0091525			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621811	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300100
J	Steen, DA; Hopkins, BC; Van Dyke, JU; Hopkins, WA				Steen, David A.; Hopkins, Brittney C.; Van Dyke, James U.; Hopkins, William A.			Prevalence of Ingested Fish Hooks in Freshwater Turtles from Five Rivers in the Southeastern United States	PLOS ONE			English	Article							LOGGERHEAD SEA-TURTLES; CHELYDRA-SERPENTINA; PELAGIC LONGLINES; SNAPPING TURTLE; MORTALITY; BYCATCH; CONSERVATION; MANAGEMENT; FISHERIES; PATTERNS	Freshwater turtles may ingest baited fish hooks because many are opportunistic scavengers. Although the ingestion of fish hooks is known to be a source of mortality in multiple vertebrate groups, the prevalence of hook ingestion by freshwater turtles has not been well studied. We trapped turtles from five rivers in the southeastern United States and used radiographs to examine over 600 individuals of four species. Depending on the species, sex, and age class, 0-33% of turtles contained ingested fish hooks. For some species, larger turtles were more likely to contain a fish hook than smaller individuals. Freshwater turtle demography suggests that even small increases in adult mortality may lead to population declines. If our study areas are representative of other aquatic systems that receive fishing pressure, this work likely identifies a potential conflict between a widespread, common recreational activity (i.e., fishing) and an imperiled taxonomic group.	[Steen, David A.; Hopkins, Brittney C.; Hopkins, William A.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA; [Van Dyke, James U.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Virginia Polytechnic Institute & State University; University of Sydney	Steen, DA (corresponding author), Auburn Univ, Inst Environm, Alabama Nat Heritage Program, Auburn, AL 36849 USA.	davidasteen@gmail.com		Van Dyke, James/0000-0002-3933-111X	Tennessee Valley Authority [00050623]; E.I. DuPont de Nemours [LBIO-65967]; Fralin Life Sciences Institute (Virginia Tech); Virginia Tech's Open Access Subvention Fund	Tennessee Valley Authority; E.I. DuPont de Nemours; Fralin Life Sciences Institute (Virginia Tech); Virginia Tech's Open Access Subvention Fund	Research was funded by the Tennessee Valley Authority (grant # 00050623), E.I. DuPont de Nemours (grant # LBIO-65967), and the Fralin Life Sciences Institute (Virginia Tech). Publishing costs were provided by Virginia Tech's Open Access Subvention Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barko VA, 2004, J WILDLIFE MANAGE, V68, P1145, DOI 10.2193/0022-541X(2004)068[1145:PFTACO]2.0.CO;2; Borkowski R, 1997, J ZOO WILDLIFE MED, V28, P109; Broadhurst MK, 2007, DIS AQUAT ORGAN, V74, P27, DOI 10.3354/dao074027; Brown JD, 2002, J WILDLIFE DIS, V38, P699, DOI 10.7589/0090-3558-38.4.699; Bulte G, 2010, AQUAT CONSERV, V20, P31, DOI [10.1002/aqc.1063, 10.1002/aqc.1089]; Casale P, 2008, AQUAT CONSERV, V18, P945, DOI 10.1002/aqc.894; Chaloupka M, 2004, MAR ECOL PROG SER, V280, P285, DOI 10.3354/meps280285; CONGDON JD, 1993, CONSERV BIOL, V7, P826, DOI 10.1046/j.1523-1739.1993.740826.x; CONGDON JD, 1994, AM ZOOL, V34, P397; Cooke SJ, 2004, BIOSCIENCE, V54, P857, DOI 10.1641/0006-3568(2004)054[0857:TRORFI]2.0.CO;2; Cooke SJ, 2006, BIOL CONSERV, V128, P93, DOI 10.1016/j.biocon.2005.09.019; Dau BK, 2009, J WILDLIFE DIS, V45, P355, DOI 10.7589/0090-3558-45.2.355; Deflorio M, 2005, FISHERIES SCI, V71, P1010, DOI 10.1111/j.1444-2906.2005.01058.x; Elsey RM, 2006, SOUTHEAST NAT, V5, P443, DOI 10.1656/1528-7092(2006)5[443:FHOMTA]2.0.CO;2; Ernst CH, 2009, TURTLES US CANADA; Fratto ZW, 2008, J WILDLIFE MANAGE, V72, P1628, DOI 10.2193/2007-216; Galois P, 2007, CHELONIAN CONSERV BI, V6, P288, DOI 10.2744/1071-8443(2007)6[288:TIIESS]2.0.CO;2; GARBER SD, 1995, ECOL APPL, V5, P1151, DOI 10.2307/2269362; GIBBONS JW, 1979, HERPETOLOGICA, V35, P86; Grosse AM, 2011, J WILDLIFE MANAGE, V75, P762, DOI 10.1002/jwmg.104; Heinrich GL, 2012, HERPETOL CONSERV BIO, V7, P349; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Hopkins BC, 2013, ENVIRON SCI TECHNOL, V47, P2416, DOI 10.1021/es304261s; Howey CAF, 2013, COPEIA, P58, DOI 10.1643/CE-12-040; Klemens MW., 2000, TURTLE CONSERVATION; Larocque SM, 2012, ANIM CONSERV, V15, P53, DOI 10.1111/j.1469-1795.2011.00487.x; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Lewison RL, 2007, CONSERV BIOL, V21, P79, DOI 10.1111/j.1523-1739.2006.00592.x; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Lewison RL, 2003, ECOL APPL, V13, P743, DOI 10.1890/1051-0761(2003)013[0743:EFBAEO]2.0.CO;2; Lowry MB, 2005, AQUAT CONSERV, V15, P7, DOI 10.1002/aqc.639; McGrath SP, 2009, J FISH BIOL, V74, P220, DOI 10.1111/j.1095-8649.2008.02135.x; Meka JM, 2004, N AM J FISH MANAGE, V24, P1309, DOI 10.1577/M03-108.1; Moore JE, 2010, BIOL CONSERV, V143, P795, DOI 10.1016/j.biocon.2009.12.023; Moore MJC, 2006, BIOL CONSERV, V130, P386, DOI 10.1016/j.biocon.2006.01.001; Muoneke Maurice I., 1994, Reviews in Fisheries Science, V2, P123; Nemoz M, 2004, BIOLOGIA, V59, P185; NUFER AJ, 1992, N AM J FISH MANAGE, V12, P634; Oros J, 2004, VET REC, V155, P169, DOI 10.1136/vr.155.6.169; Parga ML, 2012, B MAR SCI, V88, P731, DOI 10.5343/bms.2011.1063; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Read AJ, 2007, BIOL CONSERV, V135, P155, DOI 10.1016/j.biocon.2006.10.030; Rhodin AGJ, 2010, CHELONIANS RES MONOG, V5, DOI DOI 10.3854/CRM.5.000.CHECKLIST.V3.2010; Steen DA, 2006, ANIM CONSERV, V9, P269, DOI 10.1111/j.1469-1795.2006.00032.x; Stokes Lesley W., 2011, Endangered Species Research, V14, P1, DOI 10.3354/esr00339; *TN WILDL RES AG, 2012, 2012 TENN FISH GUID; *VA DEP GAM INL FI, 2014, 2014 FRESHW FISH VIR; Wallace BP, 2010, CONSERV LETT, V3, P131, DOI 10.1111/j.1755-263X.2010.00105.x; Watson JW, 2005, CAN J FISH AQUAT SCI, V62, P965, DOI 10.1139/F05-004	49	17	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91368	10.1371/journal.pone.0091368	http://dx.doi.org/10.1371/journal.pone.0091368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621919	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300082
J	Wallace, LA; Li, J; McDaid, LM				Wallace, Lesley A.; Li, Jessica; McDaid, Lisa M.			HIV Prevalence and Undiagnosed Infection among a Community Sample of Gay and Bisexual Men in Scotland, 2005-2011: Implications for HIV Testing Policy and Prevention	PLOS ONE			English	Article							HOMOSEXUAL-MEN; SEX; SETTINGS; RISK; TRANSMISSION; BARRIERS; OUTREACH; UNAWARE; AWARE	Objective: To examine HIV prevalence, HIV testing behaviour, undiagnosed infection and risk factors for HIV positivity among a community sample of gay men in Scotland. Methods: Cross-sectional survey of gay and bisexual men attending commercial gay venues in Glasgow and Edinburgh, Scotland with voluntary anonymous HIV testing of oral fluid samples in 2011. A response rate of 65.2% was achieved (1515 participants). Results: HIV prevalence (4.8%, 95% confidence interval, CI 3.8% to 6.2%) remained stable compared to previous survey years (2005 and 2008) and the proportion of undiagnosed infection among HIV-positive men (25.4%) remained similar to that recorded in 2008. Half of the participants who provided an oral fluid sample stated that they had had an HIV test in the previous 12 months; this proportion is significantly higher when compared to previous study years (50.7% versus 33.8% in 2005, p<0.001). Older age (>25 years) was associated with HIV positivity (1.8% in those,25 versus 6.4% in older ages group) as was a sexually transmitted infection (STI) diagnosis within the previous 12 months (adjusted odds ratio 2.13, 95% CI 1.09-4.14). There was no significant association between age and having an STI or age and any of the sexual behaviours recorded. Conclusion: HIV transmission continues to occur among gay and bisexual men in Scotland. Despite evidence of recent testing within the previous six months, suggesting a willingness to test, the current opt-out policy may have reached its limit with regards to maximising HIV test uptake. Novel strategies are required to improve regular testing opportunities and more frequent testing as there are implications for the use of other biomedical HIV interventions.	[Wallace, Lesley A.] Natl Serv Scotland, Hlth Protect Scotland, Glasgow, Lanark, Scotland; [Li, Jessica] Univ Sheffield, Sect Publ Hlth, Sheffield, S Yorkshire, England; [McDaid, Lisa M.] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	NHS National Services Scotland; University of Sheffield; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Wallace, LA (corresponding author), Natl Serv Scotland, Hlth Protect Scotland, Glasgow, Lanark, Scotland.	lesley.wallace@nhs.net		McDaid, Lisa/0000-0002-7711-8723	UK Medical Research Council (MRC) as part of the Sexual Health programme at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow [MC_U130031238/MC_UU_12017/2]; Health Protection Scotland; MRC as part of the Sexual Health programme at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow [MC_U130031238/MC_UU_12017/2]; MRC [MC_UU_12017/2, MC_U130031238] Funding Source: UKRI; Medical Research Council [MC_U130031238, MC_UU_12017/2] Funding Source: researchfish	UK Medical Research Council (MRC) as part of the Sexual Health programme at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow; Health Protection Scotland; MRC as part of the Sexual Health programme at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The 2011 survey was funded by the UK Medical Research Council (MRC) as part of the Sexual Health programme (MC_U130031238/MC_UU_12017/2) at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow and Health Protection Scotland. Jessica Li (at the time of conducting the analysis) and Dr. Lisa McDaid are funded by the MRC as part of the Sexual Health programme (MC_U130031238/MC_UU_12017/2) at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, HIV TESTING NEW HIV; [Anonymous], 2013, HIV UK 2013 REPORT D; Bernstein KT, 2010, JAIDS-J ACQ IMM DEF, V53, P537, DOI 10.1097/QAI.0b013e3181c3ef29; Bilardi JE, 2013, AIDS BEHAV, V17, P2093, DOI 10.1007/s10461-012-0395-7; Birrell PJ, 2013, LANCET INFECT DIS, V13, P313, DOI 10.1016/S1473-3099(12)70341-9; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention (CDC), 2007, MMWR Morb Mortal Wkly Rep, V56, P1233; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cullen B, 2010, HPS WEEKLY REPORT, V44, P72; Flowers P, 2013, HIV MED, V14, P92, DOI 10.1111/j.1468-1293.2012.01041.x; Hall HI, 2012, AIDS, V26, P893, DOI 10.1097/QAD.0b013e328351f73f; Hart GJ, 2005, SEX TRANSM INFECT, V81, P367, DOI 10.1136/sti.2004.013995; Health Protection Agency, 2011, HLTH PROTECTION WEEK, V5, P24; Health Protection Agency, 2011, SEX TRANSM INF MEN W; Jin FY, 2010, JAIDS-J ACQ IMM DEF, V53, P144, DOI 10.1097/QAI.0b013e3181b48f33; Knussen C, 2011, SEX TRANSM INFECT, V87, P257, DOI 10.1136/sti.2010.045047; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; McDaid LM, 2013, SEX TRANSM INFECT, V89, P223, DOI 10.1136/sextrans-2012-050605; McDaid LM, 2011, SEX TRANSM INFECT, V87, P221, DOI 10.1136/sti.2010.044560; McDonald SA, 2012, SEX TRANSM INFECT, V88, P194, DOI 10.1136/sextrans-2011-050132; National Institute for Health and Clinical Excellence, 2011, INCR UPT HIV TEST ME; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; Platteau T, 2012, ACTA CLIN BELG, V67, P172, DOI 10.2143/ACB.67.3.2062651; Presanis AM, 2010, AIDS, V24, P2849, DOI 10.1097/QAD.0b013e32834021ed; Prestage G, 2012, SEX HEALTH, V9, P453, DOI 10.1071/SH12033; Scottish Government, 2005, RESP RESP STRAT ACT; Sexual Health Epidemiology Group, 2009, SCOTL SEX HLTH INF 2; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; Thornton AC, 2012, HIV MED, V13, P416, DOI 10.1111/j.1468-1293.2012.00992.x; Wallace L. A., 2012, HPS Weekly Report, V46, P265; Williamson LM, 2007, JAIDS-J ACQ IMM DEF, V45, P224, DOI 10.1097/QAI.0b013e318058a01e	31	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90805	10.1371/journal.pone.0090805	http://dx.doi.org/10.1371/journal.pone.0090805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621479	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000332845300030
J	Zaravinos, A; Lambrou, GI; Mourmouras, N; Katafygiotis, P; Papagregoriou, G; Giannikou, K; Delakas, D; Deltas, C				Zaravinos, Apostolos; Lambrou, George I.; Mourmouras, Nikos; Katafygiotis, Patroklos; Papagregoriou, Gregory; Giannikou, Krinio; Delakas, Dimitris; Deltas, Constantinos			New miRNA Profiles Accurately Distinguish Renal Cell Carcinomas and Upper Tract Urothelial Carcinomas from the Normal Kidney	PLOS ONE			English	Article							MICRORNA EXPRESSION; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; CANCER; CLASSIFICATION; INHIBITION; SUBTYPES; TUMORS; IDENTIFICATION; PROLIFERATION	Background: Upper tract urothelial carcinomas (UT-UC) can invade the pelvicalyceal system making differential diagnosis of the various histologically distinct renal cell carcinoma (RCC) subtypes and UT-UC, difficult. Correct diagnosis is critical for determining appropriate surgery and post-surgical treatments. We aimed to identify microRNA (miRNA) signatures that can accurately distinguish the most prevalent RCC subtypes and UT-UC form the normal kidney. Methods and Findings: miRNA profiling was performed on FFPE tissue sections from RCC and UT-UC and normal kidney and 434 miRNAs were significantly deregulated in cancerous vs. the normal tissue. Hierarchical clustering distinguished UT-UCs from RCCs and classified the various RCC subtypes among them. qRT-PCR validated the deregulated expression profile for the majority of the miRNAs and ROC analysis revealed their capability to discriminate between tumour and normal kidney. An independent cohort of freshly frozen RCC and UT-UC samples was used to validate the deregulated miRNAs with the best discriminatory ability (AUC>0.8, p<0.001). Many of them were located within cytogenetic regions that were previously reported to be significantly aberrated. miRNA targets were predicted using the miRWalk algorithm and ingenuity pathway analysis identified the canonical pathways and curated networks of the deregulated miRNAs. Using the miRWalk algorithm, we further identified the top anti-correlated mRNA/miRNA pairs, between the deregulated miRNAs from our study and the top co-deregulated mRNAs among 5 independent ccRCC GEO datasets. The AB8/13 undifferentiated podocyte cells were used for functional assays using luciferase reporter constructs and the developmental transcription factor TFCP2L1 was proved to be a true target of miR-489, which was the second most upregulated miRNA in ccRCC. Conclusions: We identified novel miRNAs specific for each RCC subtype and UT-UC, we investigated their putative targets, the networks and pathways in which they participate and we functionally verified the true targets of the top deregulated miRNAs.	[Zaravinos, Apostolos; Papagregoriou, Gregory; Deltas, Constantinos] Univ Cyprus, Dept Biol Sci, Mol Med Res Ctr, Nicosia, Cyprus; [Zaravinos, Apostolos; Papagregoriou, Gregory; Deltas, Constantinos] Univ Cyprus, Dept Biol Sci, Lab Mol & Med Genet, Nicosia, Cyprus; [Lambrou, George I.] Univ Athens, Dept Pediat 1, Choremeio Res Lab, Athens, Greece; [Mourmouras, Nikos; Katafygiotis, Patroklos; Delakas, Dimitris] Asklipieio Gen Hosp, Dept Urol, Athens, Greece; [Giannikou, Krinio] Univ Athens, Sch Med, Dept Med Genet, GR-11527 Athens, Greece	University of Cyprus; University of Cyprus; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens	Zaravinos, A (corresponding author), Karolinska Inst Huddinge, Dept Lab Med, Stockholm, Sweden.	zaravinos.apostolos@ucy.ac.cy; Deltas@ucy.ac.cy	Deltas, Constantinos/A-4936-2013; Giannikou, Krinio/AAC-9214-2022; Zaravinos, Apostolos/B-2528-2019; Lambrou, George/F-9674-2011	Deltas, Constantinos/0000-0001-5549-9169; Zaravinos, Apostolos/0000-0003-4625-5562; Papagregoriou, Gregory/0000-0002-2440-9789; Lambrou, George/0000-0001-8389-1360	Cyprus Research Promotion Foundation [New Infrastructure/SigmaTPATH/0308/24]; EU	Cyprus Research Promotion Foundation; EU(European Commission)	This project was funded by the Cyprus Research Promotion Foundation, New Infrastructure/Sigma TPATH/0308/24 (co-funding by the EU Structural Funds) to CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, CURR OPIN PHARMACOL, V9, P351, DOI 10.1016/j.coph.2009.06.020; Bratslavsky G, 2007, CLIN CANCER RES, V13, P4667, DOI 10.1158/1078-0432.CCR-06-2510; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Feng ZH, 2011, J MOL CELL BIOL, V3, P44, DOI 10.1093/jmcb/mjq040; Ficarra V, 2006, EUR UROL, V50, P786, DOI 10.1016/j.eururo.2006.04.009; Fridman E, 2010, J MOL DIAGN, V12, P687, DOI 10.2353/jmoldx.2010.090187; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Girgis AH, 2012, CANCER RES, V72, P5273, DOI 10.1158/0008-5472.CAN-12-0656; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Higgins JPT, 2007, AM J SURG PATHOL, V31, P673, DOI 10.1097/01.pas.0000213438.01278.5f; Huang Y, 2009, EJSO-EUR J SURG ONC, V35, P1119, DOI 10.1016/j.ejso.2009.04.010; Izquierdo L, 2013, BJU INT; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Kirkali Z, 2003, CRIT REV ONCOL HEMAT, V47, P155, DOI 10.1016/S1040-8428(03)00079-9; Klatte T, 2009, J CLIN ONCOL, V27, P746, DOI 10.1200/JCO.2007.15.8345; KOVACS G, 1991, GENE CHROMOSOME CANC, V3, P249, DOI 10.1002/gcc.2870030403; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Lopez-Beltran A, 2008, SEMIN DIAGN PATHOL, V25, P232, DOI 10.1053/j.semdp.2008.07.006; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meloni-Ehrig AM, 2002, AM J MED GENET, V115, P164, DOI 10.1002/ajmg.10697; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Osanto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038298; Petillo D, 2009, INT J ONCOL, V35, P109, DOI 10.3892/ijo_00000318; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Roupret M, 2012, ACTAS UROL ESP, V36, P2, DOI 10.1016/j.acuro.2011.09.001; Roupret M, 2011, EUR UROL, V59, P584, DOI 10.1016/j.eururo.2010.12.042; Sato A, 2013, INT J ONCOL, V43, P1441, DOI 10.3892/ijo.2013.2073; Spector Y, 2013, MOL ONCOL, V7, P732, DOI 10.1016/j.molonc.2013.03.002; SPEICHER MR, 1994, AM J PATHOL, V145, P356; Storkel S, 1997, CANCER, V80, P987, DOI 10.1002/(SICI)1097-0142(19970901)80:5<987::AID-CNCR24>3.0.CO;2-R; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Tazi E, 2011, UROL J, V8, P1; Teicher BA, 2012, CLIN CANCER RES, V18, P5537, DOI 10.1158/1078-0432.CCR-12-2587; Thapa RJ, 2013, MOL CANCER THER, V12, P1568, DOI 10.1158/1535-7163.MCT-12-1010; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; vandenBerg E, 1997, CANCER GENET CYTOGEN, V95, P103, DOI 10.1016/S0165-4608(96)00289-0; Velickovic M, 2001, CANCER RES, V61, P4815; Wach S, 2013, BRIT J CANCER, V109, P714, DOI 10.1038/bjc.2013.313; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; White NMA, 2011, J UROLOGY, V186, P1077, DOI 10.1016/j.juro.2011.04.110; Wu Y, 2011, J CANCER RES CLIN, V137, P887, DOI 10.1007/s00432-010-0951-3; Yamada Y, 2013, CANCER SCI, V104, P304, DOI 10.1111/cas.12072; Yi ZJ, 2010, J CANCER RES CLIN, V136, P855, DOI 10.1007/s00432-009-0726-x; Yoshimoto T, 2007, J PATHOL, V213, P392, DOI 10.1002/path.2239; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004; Zaravinos A, 2014, ONCOSCIENCE ADV PUBL; Zaravinos A, 2007, INT J ONCOL, V31, P1051; Zaravinos A, 2012, J UROLOGY, V188, P615, DOI 10.1016/j.juro.2012.03.122	51	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91646	10.1371/journal.pone.0091646	http://dx.doi.org/10.1371/journal.pone.0091646			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621579	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300111
J	Zhou, CH; Liu, L; Liu, L; Zhang, MX; Guo, H; Pan, J; Yin, XX; Ma, TF; Wu, YQ				Zhou, Cheng-Hua; Liu, Lian; Liu, Lu; Zhang, Ming-Xing; Guo, Hao; Pan, Jin; Yin, Xiao-Xing; Ma, Teng-Fei; Wu, Yu-Qing			Salusin-beta Not Salusin-alpha Promotes Vascular Inflammation in ApoE-Deficient Mice via the I-kappa B alpha/NF-kappa B Pathway	PLOS ONE			English	Article							ATHEROSCLEROSIS; MECHANISMS; DISEASE; SERUM; RESPONSES	Objective: Vascular inflammation plays an important role in the development and progression of atherosclerosis. Recently, salusins (salusin-alpha and salusin-beta) have been reported to be associated wtih atherosclerosis. However, its underlying mechanism remains incompletely known. In this study, we observed the effects of salusins on vascular inflammation in apoE-deficient (apoE-/-) mice. Methods and Results: Six-week old male apoE-/- mice were infused with salusin-alpha, salusin-beta or vehicle for 8 weeks via osmotic mini-pumps. Our results showed that apoE-/- mice receiving vehicle alone developed severe atherosclerotic lesions and dyslipidemia, with significantly up-regulated levels of IL-6, TNF-alpha, VCAM-1 and MCP-1. For apoE-/- mice receiving 8 weeks of salusin-beta infusion, the atherosclerotic lesions were markedly aggravated, and the levels of IL-6, TNF-alpha, VCAM-1 and MCP-1 were substantially increased, despite a similar plasma lipid concentration with that of apoE-/- mice. However, after 8 week-infusion of salusin-alpha, apoE-/- mice presented significant amelioration in atherosclerotic lesions, along with remarkably up-regulated level of high-density lipoprotein-cholesterol (HDL-C) and down-regulated levels of IL-6 and TNF-alpha, but without any effect on the expressions of VCAM-1 and MCP-1. Furthermore, the activation of nuclear factor-kappa B (NF-kappa B), an important transcription factor essential for inflammatory molecules, and the degradation of I-kappa B alpha, an inhibitor of NF-kappa B, were markedly increased in apoE-/- mice receiving vehicle alone. Treatment with salusin-beta not salusin-alpha could remarkably accelerate the process of NF-kappa B nuclear translocation and I-kappa B alpha degradation. Conclusion: Salusin-beta, but not salusin-alpha, promotes vascular inflammation in apoE-deficient mice via the I-kappa B alpha/NF-kappa B pathway. These findings provide further insight into the mechanism of salusins in atherosclerosis and potential targets for the prevention and treatment of atherosclerosis.	[Zhou, Cheng-Hua; Liu, Lian; Zhang, Ming-Xing; Guo, Hao; Pan, Jin; Yin, Xiao-Xing; Ma, Teng-Fei] Xuzhou Med Coll, Sch Pharm, Xuzhou, Jiangsu, Peoples R China; [Liu, Lu; Wu, Yu-Qing] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China; [Wu, Yu-Qing] Xuzhou Med Coll, Dept Anesthet Pharmacol, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University	Zhou, CH (corresponding author), Xuzhou Med Coll, Sch Pharm, Xuzhou, Jiangsu, Peoples R China.	chzhou1212@163.com; xzmcyqwu@126.com	zhang, xu/GYE-3558-2022; Ma, Tengfei/B-6383-2017; Yin, Xiaoxing/AFS-9632-2022	Ma, Tengfei/0000-0002-8916-7370; 	National Natural Science Foundation of China [81001431]; Natural Science Foundation of Jiangsu Higher Education Institutions of China [11KJB310014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Higher Education Institutions of China	This work is supported by National Natural Science Foundation of China (81001431,http://www.nsfc.gov.cn), Natural Science Foundation of Jiangsu Higher Education Institutions of China (11KJB310014,http://www.ec.js.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen F, 1999, CLIN CHEM, V45, P7; Constans J, 2006, CLIN CHIM ACTA, V368, P33, DOI 10.1016/j.cca.2005.12.030; Du SL, 2013, SCAND J CLIN LAB INV; Egashira K, 2003, HYPERTENSION, V41, P834, DOI 10.1161/01.HYP.0000051642.65283.36; Fujimoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076714; Gehrig SM, 2008, EXP PHYSIOL, V93, P1190, DOI 10.1113/expphysiol.2008.042838; Hofmann MA, 2001, J CLIN INVEST, V107, P675, DOI 10.1172/JCI10588; Koya T, 2012, AM J PHYSIOL-HEART C, V303, pH96, DOI 10.1152/ajpheart.00009.2012; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Linton MF, 2003, INT J OBESITY, V27, pS35, DOI 10.1038/sj.ijo.0802498; Little PJ, 2007, VASC HEALTH RISK MAN, V3, P117; Nagashima M, 2010, ATHEROSCLEROSIS, V212, P70, DOI 10.1016/j.atherosclerosis.2010.04.027; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sato K, 2006, PEPTIDES, V27, P2561, DOI 10.1016/j.peptides.2006.06.005; Sato K, 2010, REGUL PEPTIDES, V162, P68, DOI 10.1016/j.regpep.2010.02.010; Shichiri M, 2003, NAT MED, V9, P1166, DOI 10.1038/nm913; Ti Y, 2012, J HUM HYPERTENS, V26, P603, DOI 10.1038/jhh.2011.71; Watanabe T, 2008, HYPERTENS RES, V31, P463, DOI 10.1291/hypres.31.463; Watanabe T, 2008, CIRCULATION, V117, P638, DOI 10.1161/CIRCULATIONAHA.107.712539; Zhou CH, 2012, CAN J PHYSIOL PHARM, V90, P463, DOI 10.1139/Y2012-022	24	23	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91468	10.1371/journal.pone.0091468	http://dx.doi.org/10.1371/journal.pone.0091468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621517	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300090
J	Brassey, CA; Sellers, WI				Brassey, Charlotte A.; Sellers, William I.			Scaling of Convex Hull Volume to Body Mass in Modern Primates, Non-Primate Mammals and Birds	PLOS ONE			English	Article							EMU DROMAIUS-NOVAEHOLLANDIAE; MITOCHONDRIAL GENOME; MOLECULAR PHYLOGENY; EVOLUTION; LIMB; PROPORTIONS; KINEMATICS; MECHANICS; SKELETON; ANIMALS	The volumetric method of 'convex hulling' has recently been put forward as a mass prediction technique for fossil vertebrates. Convex hulling involves the calculation of minimum convex hull volumes (vol(CH)) from the complete mounted skeletons of modern museum specimens, which are subsequently regressed against body mass (M-b) to derive predictive equations for extinct species. The convex hulling technique has recently been applied to estimate body mass in giant sauropods and fossil ratites, however the biomechanical signal contained within volCH has remained unclear. Specifically, when volCH scaling departs from isometry in a group of vertebrates, how might this be interpreted? Here we derive predictive equations for primates, non-primate mammals and birds and compare the scaling behaviour of Mb to volCH between groups. We find predictive equations to be characterised by extremely high correlation coefficients (r(2) = 0.97-0.99) and low mean percentage prediction error (11-20%). Results suggest non-primate mammals scale body mass to volCH isometrically (b = 0.92, 95%CI = 0.85-1.00, p = 0.08). Birds scale body mass to volCH with negative allometry (b = 0.81, 95%CI = 0.70-0.91, p = 0.011) and apparent density (vol(CH)/M-b) therefore decreases with mass (r(2) = 0.36, p<0.05). In contrast, primates scale body mass to volCH with positive allometry (b = 1.07, 95%CI = 1.01-1.12, p = 0.05) and apparent density therefore increases with size (r(2) = 0.46, p = 0.025). We interpret such departures from isometry in the context of the 'missing mass' of soft tissues that are excluded from the convex hulling process. We conclude that the convex hulling technique can be justifiably applied to the fossil record when a large proportion of the skeleton is preserved. However we emphasise the need for future studies to quantify interspecific variation in the distribution of soft tissues such as muscle, integument and body fat.	[Brassey, Charlotte A.; Sellers, William I.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Brassey, CA (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	charlotte.brassey-2@postgrad.manchester.ac.uk	Brassey, Charlotte A/R-2029-2017; Sellers, William Irvin/Q-3843-2019	Brassey, Charlotte A/0000-0002-6552-541X; Sellers, William Irvin/0000-0002-2913-5406	Natural Environment Research Council [NE/1528134/1]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council's Doctoral Training Grant (NE/1528134/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; ALEXANDER RM, 1983, J ZOOL, V200, P215; ALEXANDER RM, 1979, J ZOOL, V187, P169; Allen V, 2009, ANAT REC, V292, P1442, DOI 10.1002/ar.20973; Arnason U, 2000, J MOL EVOL, V50, P569, DOI 10.1007/s002390010060; Auerbach BM, 2004, AM J PHYS ANTHROPOL, V125, P331, DOI 10.1002/ajpa.20032; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Bates KT, 2009, PALAEONTOL ELECTRON, V12; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Brassey CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082668; Brassey CA, 2013, ANAT REC, V296, P395, DOI 10.1002/ar.22658; BROWN F, 1985, NATURE, V316, P788, DOI 10.1038/316788a0; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Budgey R., 2000, IBSC25WPIE3; Burbidge ML, 2003, CONSERV GENET, V4, P167, DOI 10.1023/A:1023386506067; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Colbert E, 1962, WEIGHTS DINOSAURS; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Crainic TG, 2000, EUR J OPER RES, V122, P272, DOI 10.1016/S0377-2217(99)00233-7; Currey JD, 2003, J BONE MINER RES, V18, P591, DOI 10.1359/jbmr.2003.18.4.591; CURREY JD, 1985, J ZOOL, V206, P453; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; de Berg M., 2008, COMPUTATIONAL GEOMET, V3; De Esteban-Trivigno S, 2011, MAMM BIOL, V76, P755, DOI 10.1016/j.mambio.2011.07.004; Dumont ER, 2010, P ROY SOC B-BIOL SCI, V277, P2193, DOI 10.1098/rspb.2010.0117; Falkingham PL, 2012, PALAEONTOL ELECTRON, V15; Field DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082000; Finstermeier K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069504; FOWLER ME, 1991, J ZOO WILDLIFE MED, V22, P204; Franzen JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005723; Gartner GEA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P43, DOI 10.1086/648509; GILL FB, 2007, ORNITHOLOGY; Grand T.I., 1990, P39; Greenewalt C.H., 1962, SMITHSON MISC COLLNS, V144, P1, DOI DOI 10.1007/S00360-016-1016-Y; Gregory WK, 1905, SCIENCE, V22, P572, DOI 10.1126/science.22.566.572; Guha S, 2007, MOL PHYLOGENET EVOL, V42, P585, DOI 10.1016/j.ympev.2006.06.020; HARTMAN FRANK A., 1961, SMITHSONIAN MISC COLL, V143, P1; Hasegawa M, 2003, GENES GENET SYST, V78, P267, DOI 10.1266/ggs.78.267; Hassanin A, 2003, SYST BIOL, V52, P206, DOI 10.1080/10635150390192726; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Hill W. C. O., 1953, PRIMATES COMP ANATOM, V1; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; Hughes S, 2006, MOL PHYLOGENET EVOL, V40, P285, DOI 10.1016/j.ympev.2006.02.004; Hutchinson JR, 2007, J THEOR BIOL, V246, P660, DOI 10.1016/j.jtbi.2007.01.023; Jasinoski SC, 2006, ZOOL J LINN SOC-LOND, V146, P301, DOI 10.1111/j.1096-3642.2006.00200.x; JOHANSON DC, 1979, SCIENCE, V203, P321, DOI 10.1126/science.104384; KAISER A, 1993, J FIELD ORNITHOL, V64, P246; KENDEIGH S C, 1970, Condor, V72, P60, DOI 10.2307/1366475; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Liu R, 2008, P GRAPH INT 2008 WIN; Maxwell EE, 2007, J MORPHOL, V268, P423, DOI 10.1002/jmor.10527; MCNAB BK, 1994, AM NAT, V144, P628, DOI 10.1086/285697; MORRIS CA, 1995, POULTRY SCI, V74, P1683, DOI 10.3382/ps.0741683; Motani R, 2001, PALEOBIOLOGY, V27, P735, DOI 10.1666/0094-8373(2001)027<0735:EBMFST>2.0.CO;2; Moya-Sola S, 2004, SCIENCE, V306, P1339, DOI 10.1126/science.1103094; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Napier J. R., 1959, Fossil Mammals of Africa, V16, P1; O'Connor PM, 2009, J EXP ZOOL PART A, V311A, P629, DOI 10.1002/jez.548; Packard GC, 2009, J ZOOL, V279, P102, DOI 10.1111/j.1469-7998.2009.00594.x; PATAK A, 1993, J EXP BIOL, V175, P233; Phillips MJ, 2010, SYST BIOL, V59, P90, DOI 10.1093/sysbio/syp079; Polk JD, 2000, J HUM EVOL, V39, P297, DOI 10.1006/jhev.2000.0420; PRANGE HD, 1979, AM NAT, V113, P103, DOI 10.1086/283367; Reid B, 1975, BIOGEOGRAPHY ECOLOGY, P301; Remes Kristian, 2011, P305; Robinson TJ, 2011, SYST BIOL, V60, P439, DOI 10.1093/sysbio/syr045; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Ruff CB, 2003, AM J PHYS ANTHROPOL, V120, P16, DOI 10.1002/ajpa.10118; Sales J, 1999, BRIT POULTRY SCI, V40, P145, DOI 10.1080/00071669987999; Sales J, 1997, BRIT POULTRY SCI, V38, P378, DOI 10.1080/00071669708418006; Schmidt M, 2005, J EXP BIOL, V208, P3367, DOI 10.1242/jeb.01781; Schmidt M, 2008, J EXP BIOL, V211, P3775, DOI 10.1242/jeb.019802; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Scott K.M., 1990, P301; Sellers WI, 2012, BIOL LETTERS, V8, P842, DOI 10.1098/rsbl.2012.0263; Sellers WI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078733; Smith NC, 2006, J ANAT, V209, P765, DOI 10.1111/j.1469-7580.2006.00658.x; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Smith RJ, 2002, J HUM EVOL, V43, P271, DOI 10.1006/jhev.2002.0573; SMITH RJ, 1993, AM J PHYS ANTHROPOL, V90, P215, DOI 10.1002/ajpa.1330900208; Taylor MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078214; Thomas MG, 2000, P ROY SOC B-BIOL SCI, V267, P2493, DOI 10.1098/rspb.2000.1310; TURCEK FRANTISEK J., 1966, EKOL POLSKA SER A, V14, P617; Videan EN, 2007, ZOO BIOL, V26, P93, DOI 10.1002/zoo.20122; Wedel MJ, 2006, INTEGR ZOOL, V1, P80, DOI 10.1111/j.1749-4877.2006.00019.x; Wirestam R, 2008, AUK, V125, P965, DOI 10.1525/auk.2008.07145	86	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91691	10.1371/journal.pone.0091691	http://dx.doi.org/10.1371/journal.pone.0091691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618736	gold, Green Published, Green Accepted			2022-12-27	WOS:000332842400119
J	Huntsman, BM; Petty, JT				Huntsman, Brock M.; Petty, J. Todd			Density-Dependent Regulation of Brook Trout Population Dynamics along a Core-Periphery Distribution Gradient in a Central Appalachian Watershed	PLOS ONE			English	Article							RESIDENT BROWN TROUT; BULL TROUT; SALVELINUS-FONTINALIS; SALMO-TRUTTA; VARIABLE ENVIRONMENT; HABITAT SELECTION; MOTTLED SCULPIN; CHINOOK SALMON; STREAM; TEMPERATURE	Spatial population models predict strong density-dependence and relatively stable population dynamics near the core of a species' distribution with increasing variance and importance of density-independent processes operating towards the population periphery. Using a 10-year data set and an information-theoretic approach, we tested a series of candidate models considering density-dependent and density-independent controls on brook trout population dynamics across a core-periphery distribution gradient within a central Appalachian watershed. We sampled seven sub-populations with study sites ranging in drainage area from 1.3-60 km(2) and long-term average densities ranging from 0.335-0.006 trout/m. Modeled response variables included per capita population growth rate of young-of-the-year, adult, and total brook trout. We also quantified a stock-recruitment relationship for the headwater population and coefficients of variability in mean trout density for all sub-populations over time. Density-dependent regulation was prevalent throughout the study area regardless of stream size. However, density-independent temperature models carried substantial weight and likely reflect the effect of year-to-year variability in water temperature on trout dispersal between cold tributaries and warm main stems. Estimated adult carrying capacities decreased exponentially with increasing stream size from 0.24 trout/m in headwaters to 0.005 trout/m in the main stem. Finally, temporal variance in brook trout population size was lowest in the high-density headwater population, tended to peak in mid-sized streams and declined slightly in the largest streams with the lowest densities. Our results provide support for the hypothesis that local density-dependent processes have a strong control on brook trout dynamics across the entire distribution gradient. However, the mechanisms of regulation likely shift from competition for limited food and space in headwater streams to competition for thermal refugia in larger main stems. It also is likely that source-sink dynamics and dispersal from small headwater habitats may partially influence brook trout population dynamics in the main stem.	[Huntsman, Brock M.; Petty, J. Todd] W Virginia Univ, Div Forestry & Nat Resources, Morgantown, WV 26506 USA	West Virginia University	Huntsman, BM (corresponding author), W Virginia Univ, Div Forestry & Nat Resources, Morgantown, WV 26506 USA.	brockhunts@gmail.com		Huntsman, Brock/0000-0003-4090-1949	WV Department of Natural Resources [NRAC 387]; US Fish and Wildlife Service; US Geological Survey	WV Department of Natural Resources; US Fish and Wildlife Service(US Fish & Wildlife Service); US Geological Survey(United States Geological Survey)	This work was funded by WV Department of Natural Resources (NRAC 387), the US Fish and Wildlife Service, and the US Geological Survey. The funders were not involved in any details of this study.	Benda L, 2004, BIOSCIENCE, V54, P413, DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; Breininger DR, 2004, ECOL APPL, V14, P1079, DOI 10.1890/03-5002; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Cornell KL, 2010, LANDSCAPE ECOL, V25, P109, DOI 10.1007/s10980-009-9405-1; Dunham J, 2003, N AM J FISH MANAGE, V23, P894, DOI 10.1577/M02-028; Dunham JB, 1997, CAN J FISH AQUAT SCI, V54, P1025, DOI 10.1139/cjfas-54-5-1025; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; FAUSCH KD, 1981, CAN J FISH AQUAT SCI, V38, P1220, DOI 10.1139/f81-164; Flebbe PA, 2006, T AM FISH SOC, V135, P1371, DOI 10.1577/T05-217.1; Goniea TM, 2006, T AM FISH SOC, V135, P408, DOI 10.1577/T04-113.1; Goswami VR, 2011, ECOLOGY, V92, P1680, DOI 10.1890/10-2317.1; Grossman GD, 2012, FRESHWATER BIOL, V57, P1434, DOI 10.1111/j.1365-2427.2012.02806.x; Grossman GD, 2010, FRESHWATER BIOL, V55, P1494, DOI 10.1111/j.1365-2427.2009.02361.x; Grossman GD, 2006, ECOL MONOGR, V76, P217, DOI 10.1890/04-1623; Guo QF, 2005, OIKOS, V108, P47, DOI 10.1111/j.0030-1299.2005.13149.x; Haak AL, 2010, FISHERIES, V35, P530, DOI 10.1577/1548-8446-35.11.530; Hansburger Jeff L., 2008, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V62, P142; Hartman KJ, 2001, PROCEEDINGS OF THE FIFTY-FIFTH ANNUAL CONFERENCE OF THE SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P38; Hense Z, 2010, N AM J FISH MANAGE, V30, P1041, DOI 10.1577/M09-029.1; Hixon MA, 2002, ECOLOGY, V83, P1490, DOI 10.2307/3071969; Hixon MA, 1997, SCIENCE, V277, P946, DOI 10.1126/science.277.5328.946; Hughes NF, 1998, ECOLOGY, V79, P281, DOI 10.1890/0012-9658(1998)079[0281:AMOHSB]2.0.CO;2; Isaak DJ, 2004, T AM FISH SOC, V133, P1254, DOI 10.1577/T03-010.1; Johnston FD, 2007, CAN J FISH AQUAT SCI, V64, P113, DOI 10.1139/F06-172; Johnston FD, 2009, ECOL APPL, V19, P449, DOI 10.1890/07-1507.1; Kanda LL, 2009, ECOLOGY, V90, P1574, DOI 10.1890/08-1263.1; Kendall BE, 2000, AM NAT, V155, P628, DOI 10.1086/303350; Kiffney PM, 2006, CAN J FISH AQUAT SCI, V63, P2518, DOI 10.1139/F06-138; Kim M, 2011, ECOL FRESHW FISH, V20, P144, DOI 10.1111/j.1600-0633.2010.00471.x; Kratzer JF, 2013, N AM J FISH MANAGE, V33, P130, DOI 10.1080/02755947.2012.743934; Krebs CJ, 2002, WILDLIFE RES, V29, P1, DOI 10.1071/WR01074; Kunin WE, 2009, P R SOC B, V276, P1495, DOI 10.1098/rspb.2008.1767; Limm MP, 2009, ENVIRON BIOL FISH, V85, P141, DOI 10.1007/s10641-009-9473-8; Lobon-Cervia J, 2007, CAN J FISH AQUAT SCI, V64, P1429, DOI 10.1139/F07-111; Lobon-Cervia J, 2012, FRESHWATER BIOL, V57, P2181, DOI 10.1111/j.1365-2427.2012.02863.x; Lobon-Cervia J, 2009, FRESHWATER BIOL, V54, P1149, DOI 10.1111/j.1365-2427.2008.02159.x; Martin RW, 2009, J FRESHWATER ECOL, V24, P497, DOI 10.1080/02705060.2009.9664323; McClurg SE, 2007, ECOL APPL, V17, P1087, DOI 10.1890/06-0392; McMahon TE, 2007, T AM FISH SOC, V136, P1313, DOI 10.1577/T06-217.1; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; Nicola GG, 2009, OECOLOGIA, V160, P515, DOI 10.1007/s00442-009-1317-x; Nicola GG, 2008, FRESHWATER BIOL, V53, P2364, DOI 10.1111/j.1365-2427.2008.02056.x; Nislow KH, 2006, FRESHWATER BIOL, V51, P388, DOI 10.1111/j.1365-2427.2005.01492.x; PETRANKA JW, 1986, ECOLOGY, V67, P729, DOI 10.2307/1937696; Petty JT, 2007, T AM FISH SOC, V136, P1750, DOI 10.1577/T06-034.1; Petty JT, 2014, HYDROBIOLOGIA, V727, P151, DOI 10.1007/s10750-013-1794-0; Petty JT, 2012, T AM FISH SOC, V141, P1060, DOI 10.1080/00028487.2012.681102; Petty JT, 2010, FRESHWATER BIOL, V55, P780, DOI 10.1111/j.1365-2427.2009.02321.x; Petty JT, 2005, T AM FISH SOC, V134, P572, DOI 10.1577/T03-229.1; Petty JT, 2005, RESTOR ECOL, V13, P348, DOI 10.1111/j.1526-100X.2005.00044.x; Petty JT, 2012, NAT ED, V3, P17; Pope SE, 2000, ECOLOGY, V81, P2498; Poplar-Jeffers IO, 2009, RESTOR ECOL, V17, P404, DOI 10.1111/j.1526-100X.2008.00396.x; Previtali MA, 2009, ECOLOGY, V90, P1996, DOI 10.1890/08-0405.1; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Rieman BE, 2007, T AM FISH SOC, V136, P1552, DOI 10.1577/T07-028.1; Rypel AL, 2012, ECOSYSTEMS, V15, P555, DOI 10.1007/s10021-012-9528-0; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; SEMLITSCH RD, 1987, ECOLOGY, V68, P1003, DOI 10.2307/1938371; Steiner CF, 2013, OIKOS, V122, P1195, DOI 10.1111/j.1600-0706.2012.20936.x; Stevens MHH, 2009, USE R, P3, DOI 10.1007/978-0-387-89882-7_1; Taniguchi Y, 1998, CAN J FISH AQUAT SCI, V55, P1894, DOI 10.1139/cjfas-55-8-1894; Tincher M, 2013, THESIS W VIRGINIA U; Turchin P, 1999, OIKOS, V84, P153, DOI 10.2307/3546876; Utz RM, 2006, CAN J FISH AQUAT SCI, V63, P2675, DOI 10.1139/F06-152; Utz RM, 2009, CAN J FISH AQUAT SCI, V66, P1072, DOI 10.1139/F09-063; Van Buskirk J, 2005, ECOLOGY, V86, P1936, DOI 10.1890/04-1237; Wagner T, 2013, T AM FISH SOC, V142, P353, DOI 10.1080/00028487.2012.734892; Warren DR, 2012, GLOBAL CHANGE BIOL, V18, P1804, DOI 10.1111/j.1365-2486.2012.02670.x; WATERS TF, 1983, T AM FISH SOC, V112, P137, DOI 10.1577/1548-8659(1983)112<137:ROBTBB>2.0.CO;2; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Wenger SJ, 2011, CAN J FISH AQUAT SCI, V68, P988, DOI [10.1139/F2011-034, 10.1139/f2011-034]; Werner EE, 2007, OIKOS, V116, P1713, DOI 10.1111/j.2007.0030-1299.16039.x; Williams CK, 2003, ECOLOGY, V84, P2654, DOI 10.1890/03-0038; Young RG, 2010, T AM FISH SOC, V139, P137, DOI 10.1577/T08-148.1; Zorn TG, 2007, T AM FISH SOC, V136, P691, DOI 10.1577/T06-032.1; Zorn TG, 2007, T AM FISH SOC, V136, P706, DOI 10.1577/T06-275.1	77	35	36	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91673	10.1371/journal.pone.0091673	http://dx.doi.org/10.1371/journal.pone.0091673			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618602	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400114
J	Thibault, K; Calvino, B; Rivals, I; Marchand, F; Dubacq, S; McMahon, SB; Pezet, S				Thibault, Karine; Calvino, Bernard; Rivals, Isabelle; Marchand, Fabien; Dubacq, Sophie; McMahon, Stephen B.; Pezet, Sophie			Molecular Mechanisms Underlying the Enhanced Analgesic Effect of Oxycodone Compared to Morphine in Chemotherapy-Induced Neuropathic Pain	PLOS ONE			English	Article							VINCRISTINE-INDUCED NEUROPATHY; CONTROLLED-RELEASE OXYCODONE; GENE-EXPRESSION; CANCER PAIN; SPINAL-CORD; RECEPTOR SUBUNITS; BRAIN-REGIONS; RAT MODEL; HYPERALGESIA; INHIBITION	Oxycodone is a m-opioid receptor agonist, used for the treatment of a large variety of painful disorders. Several studies have reported that oxycodone is a more potent pain reliever than morphine, and that it improves the quality of life of patients. However, the neurobiological mechanisms underlying the therapeutic action of these two opioids are only partially understood. The aim of this study was to define the molecular changes underlying the long-lasting analgesic effects of oxycodone and morphine in an animal model of peripheral neuropathy induced by a chemotherapic agent, vincristine. Using a behavioural approach, we show that oxycodone maintains an optimal analgesic effect after chronic treatment, whereas the effect of morphine dies down. In addition, using DNA microarray technology on dorsal root ganglia, we provide evidence that the long-term analgesic effect of oxycodone is due to an up-regulation in GABA(B) receptor expression in sensory neurons. These receptors are transported to their central terminals within the dorsal horn, and subsequently reinforce a presynaptic inhibition, since only the long-lasting (and not acute) anti-hyperalgesic effect of oxycodone was abolished by intrathecal administration of a GABA(B) receptor antagonist; in contrast, the morphine effect was unaffected. Our study demonstrates that the GABA(B) receptor is functionally required for the alleviating effect of oxycodone in neuropathic pain condition, thus providing new insight into the molecular mechanisms underlying the sustained analgesic action of oxycodone.	[Thibault, Karine; Calvino, Bernard; Dubacq, Sophie; Pezet, Sophie] ESPCI ParisTech, Brain Plast Unit, Paris, France; [Thibault, Karine; Calvino, Bernard; Dubacq, Sophie; Pezet, Sophie] CNRS, UMR 8249, Paris, France; [Thibault, Karine; McMahon, Stephen B.] Kings Coll London, Wolfson Ctr Age Related Dis, Neurorestorat Grp, London WC2R 2LS, England; [Rivals, Isabelle] ESPCI ParisTech, Equipe Stat Appl, Paris, France; [Marchand, Fabien] INSERM, U1107, NEURO DOL, Clermont Ferrand, France; [Marchand, Fabien] Univ Auvergne, Clermont Univ, Clermont Ferrand, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of London; King's College London; UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	Thibault, K (corresponding author), Paris Descartes Univ, CNRS, FR3636, Glia Glia & Glia Neuron Interact Neurophysiopatho, Paris, France.	karine.thibault@parisdescartes.fr	PEZET, sophie/AAR-1239-2021; MARCHAND, Fabien/K-1285-2015; Rivals, Isabelle/AAE-7971-2022	PEZET, sophie/0000-0002-3305-3315; Rivals, Isabelle/0000-0002-8736-7010; McMahon, Stephen/0000-0003-4656-5536	Institut UPSA de la douleur; "Centre National de la Recherche Scientifique", CNRS; Mundipharma laboratory (ML); Fondation pour la Recherche Medicale	Institut UPSA de la douleur; "Centre National de la Recherche Scientifique", CNRS(Centre National de la Recherche Scientifique (CNRS)); Mundipharma laboratory (ML); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the "Institut UPSA de la douleur" and the "Centre National de la Recherche Scientifique", CNRS. KT received a two year doctoral fellowship from Mundipharma laboratory (ML). KT received one year of post-doctoral fellowship from "Fondation pour la Recherche Medicale". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aley KO, 1996, NEUROSCIENCE, V73, P259, DOI 10.1016/0306-4522(96)00020-6; Ammon-Treiber S, 2005, ADDICT BIOL, V10, P81, DOI 10.1080/13556210412331308994; Authier N, 1999, NEUROREPORT, V10, P965, DOI 10.1097/00001756-199904060-00013; Authier N, 2003, NEUROTOXICOLOGY, V24, P797, DOI 10.1016/S0161-813X(03)00043-3; Barrera-Chacon JM, 2011, SPINAL CORD, V49, P36, DOI 10.1038/sc.2010.101; Bartoi T, 2010, J BIOL CHEM, V285, P20625, DOI 10.1074/jbc.M109.049700; Benke D, 1999, J BIOL CHEM, V274, P27323, DOI 10.1074/jbc.274.38.27323; Benke D, 2002, J RECEPT SIGNAL TR R, V22, P253, DOI 10.1081/RRS-120014600; Bouhassira D, 2008, PAIN, V136, P380, DOI 10.1016/j.pain.2007.08.013; Bruera E, 1998, J CLIN ONCOL, V16, P3222, DOI 10.1200/JCO.1998.16.10.3222; Calver AR, 2000, NEUROSCIENCE, V100, P155, DOI 10.1016/S0306-4522(00)00262-1; CASEY EB, 1973, BRAIN, V96, P69, DOI 10.1093/brain/96.1.69; Charles KJ, 2001, NEUROSCIENCE, V106, P447, DOI 10.1016/S0306-4522(01)00296-2; Chen YP, 2005, J PHARMACOL EXP THER, V315, P696, DOI 10.1124/jpet.105.091314; Courteix C, 1998, J PHARMACOL EXP THER, V285, P63; Curtis GB, 1999, EUR J CLIN PHARMACOL, V55, P425, DOI 10.1007/s002280050651; Dunbar SA, 2006, EUR J PHARMACOL, V535, P152, DOI 10.1016/j.ejphar.2006.02.007; Falk E., 1917, MUNCHEN MED WOCHEN, V20, P381; FOX S, 1978, NEUROSCIENCE, V3, P495, DOI 10.1016/0306-4522(78)90016-7; Fritschy JM, 2004, J COMP NEUROL, V477, P235, DOI 10.1002/cne.20188; Gatti A, 2009, CLIN DRUG INVEST, V29, P31, DOI 10.2165/0044011-200929001-00005; Goudet C, 2009, BRAIN RES REV, V60, P43, DOI 10.1016/j.brainresrev.2008.12.007; HOLZ GG, 1989, J NEUROSCI, V9, P657; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; Kaplan R, 1998, J CLIN ONCOL, V16, P3230, DOI 10.1200/JCO.1998.16.10.3230; Kato A, 2008, ONCOLOGY-BASEL, V74, P55, DOI 10.1159/000143220; Khoromi S, 2007, PAIN, V130, P66, DOI 10.1016/j.pain.2006.10.029; Kiraly KP, 2006, BRAIN RES BULL, V70, P233, DOI 10.1016/j.brainresbull.2006.05.005; Lenz H, 2009, ANESTH ANALG, V109, P1279, DOI 10.1213/ane.0b013e3181b0f0bb; Malan TP, 2002, ANESTHESIOLOGY, V96, P1161, DOI 10.1097/00000542-200205000-00020; MALCANGIO M, 1993, J PHARMACOL EXP THER, V266, P1490; Malcangio M, 1998, PAIN, V76, P151, DOI 10.1016/S0304-3959(98)00037-2; Marchand F, 2003, J PHARMACOL EXP THER, V307, P268, DOI 10.1124/jpet.103.052613; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Minami K, 2009, J PHARMACOL SCI, V111, P60, DOI 10.1254/jphs.09139FP; Mucci-LoRusso P, 1998, EUR J PAIN-LONDON, V2, P239, DOI 10.1016/S1090-3801(98)90020-9; Nakamura A, 2013, BRIT J PHARMACOL, V168, P375, DOI 10.1111/j.1476-5381.2012.02139.x; Nozaki-Taguchi N, 2001, PAIN, V93, P69, DOI 10.1016/S0304-3959(01)00294-9; Park JH, 2010, BRAIN RES, V1322, P24, DOI 10.1016/j.brainres.2010.02.001; Parkitna JMR, 2004, J NEUROCHEM, V91, P38, DOI 10.1111/j.1471-4159.2004.02697.x; Prosser HM, 2001, MOL CELL NEUROSCI, V17, P1059, DOI 10.1006/mcne.2001.0995; Queva S, 2003, BRIT J PHARMACOL, V140, P315, DOI 10.1038/sj.bjp.0705447; SANDLER SG, 1969, NEUROLOGY, V19, P367, DOI 10.1212/WNL.19.4.367; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Tapocik JD, 2009, J NEUROSCI, V29, P5295, DOI 10.1523/JNEUROSCI.4020-08.2009; Thibault K, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2010.07.010; Thibault K, 2008, EUR J PHARMACOL, V600, P71, DOI 10.1016/j.ejphar.2008.10.004; Thibault K, 2008, PAIN, V140, P305, DOI 10.1016/j.pain.2008.09.006; Watson CPN, 2003, PAIN, V105, P71, DOI 10.1016/S0304-3959(03)00160-X; Watson CPN, 1998, NEUROLOGY, V50, P1837; Weng HR, 2003, PAIN, V103, P131, DOI 10.1016/S0304-3959(02)00445-1	51	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91297	10.1371/journal.pone.0091297	http://dx.doi.org/10.1371/journal.pone.0091297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618941	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400069
J	Vasantha, M; Venkatesan, P				Vasantha, Mahalingam; Venkatesan, Perumal			Structural Equation Modeling of Latent Growth Curves of Weight Gain among Treated Tuberculosis Patients	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; MALNUTRITION	Tuberculosis still remains a major public health problem even though it is treatable and curable. Weight gain measurement during anti tuberculosis (TB) treatment period is an important component to assess the progress of TB patients. In this study, Latent Growth Models (LGMs) were implemented in a longitudinal design to predict the change in weight of TB patients who were given three different regimens under randomized controlled clinical trial for anti-TB treatment. Linear and Quadratic LGMs were fitted using Mplus software. The age, sex and treatment response of the TB patients were used as time invariant independent variables of the growth trajectories. The quadratic trend was found to be better in explaining the changes in weight without grouping than the quadratic model for three group comparisons. A significant increase in the change of weight over time was identified while a significant quadratic effect indicated that weights were sustained over time. The growth rate was similar in both the groups. The treament response had significant association with the growth rate of weight scores of the patients.	[Vasantha, Mahalingam; Venkatesan, Perumal] Indian Council Med Res, Natl Inst Res TB, Dept Stat, Madras, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Venkatesan, P (corresponding author), Indian Council Med Res, Natl Inst Res TB, Dept Stat, Madras, Tamil Nadu, India.	venkaticmr@gmail.com		Venkatesan, Perumal/0000-0002-4491-7553				Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Balasubramanian R, 1991, INDIAN J TUBERC, V38, P51; Baldwin MR, 2004, INT J TUBERC LUNG D, V8, P1484; Bernabe-Ortiz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018474; Biesanz JC, 2004, PSYCHOL METHODS, V9, P30, DOI 10.1037/1082-989X.9.1.30; Bollen KA, 2006, WILEY SER PROBAB ST, P1; Byrne B.M., 2003, UNDERSTANDING STAT, V2, P177, DOI [10.1207/S15328031US0203_02, DOI 10.1207/S15328031US0203_02, 10.1207/s15328031us0203_02]; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Chaudhuri K., 1993, Indian Journal of Tuberculosis, V40, P83; COCHRAN WG, 1952, ANN MATH STAT, V23, P315, DOI 10.1214/aoms/1177729380; Hoa NB, 2013, INT J TUBERC LUNG D, V17, P61, DOI 10.5588/ijtld.12.0369; Khan A, 2006, AM J RESP CRIT CARE, V174, P344, DOI 10.1164/rccm.200511-1834OC; Krapp F, 2008, INT J TUBERC LUNG D, V12, P1153; Marsh HW, 2009, STRUCT EQU MODELING, V16, P439, DOI 10.1080/10705510903008220; Mathew R, 1997, INT J TUBERC LUNG D, V1, P509; MCARDLE JJ, 1987, CHILD DEV, V58, P110, DOI 10.1111/j.1467-8624.1987.tb03494.x; Muthen B., 2010, MPLUS USERS GUIDE; PARAMASIVAN CN, 1993, TUBERCLE LUNG DIS, V74, P23, DOI 10.1016/0962-8479(93)90064-5; Schumacker R. E, 2004, BEGINNERS GUIDE STRU, V2nd, DOI DOI 10.4135/9781412973380.N17; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Schwenk A, 2004, AM J CLIN NUTR, V79, P1006; Stoolmiller M., 1995, ANAL CHANGE, P103; van de Schoot R, 2012, EUR J DEV PSYCHOL, V9, P486, DOI 10.1080/17405629.2012.686740; van Lettow M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-61; Vasantha M, 2008, Indian J Tuberc, V55, P64; Vasantha M, 2009, Indian J Tuberc, V56, P5; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2012, GLOB TUB CONTR; Zudien MV, 2011, PLOS ONE, V6	29	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91152	10.1371/journal.pone.0091152	http://dx.doi.org/10.1371/journal.pone.0091152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618577	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400052
J	Guan, XW; Vengoechea, J; Zheng, SY; Sloan, AE; Chen, YW; Brat, DJ; O'Neill, BP; de Groot, J; Yust-Katz, S; Yung, WKA; Cohen, ML; Aldape, KD; Rosenfeld, S; Verhaak, RGW; Barnholtz-Sloan, JS				Guan, Xiaowei; Vengoechea, Jaime; Zheng, Siyuan; Sloan, Andrew E.; Chen, Yanwen; Brat, Daniel J.; O'Neill, Brian Patrick; de Groot, John; Yust-Katz, Shlomit; Yung, Wai-Kwan Alfred; Cohen, Mark L.; Aldape, Kenneth D.; Rosenfeld, Steven; Verhaak, Roeland G. W.; Barnholtz-Sloan, Jill S.			Molecular Subtypes of Glioblastoma Are Relevant to Lower Grade Glioma	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; IDH1 MUTATIONS; CLASSIFICATION; TEMOZOLOMIDE; MULTIFORME; SURVIVAL; OLIGODENDROGLIOMAS; DIAGNOSIS; PROFILES; PATHWAYS	Background: Gliomas are the most common primary malignant brain tumors in adults with great heterogeneity in histopathology and clinical course. The intent was to evaluate the relevance of known glioblastoma (GBM) expression and methylation based subtypes to grade II and III gliomas (ie. lower grade gliomas). Methods: Gene expression array, single nucleotide polymorphism (SNP) array and clinical data were obtained for 228 GBMs and 176 grade II/II gliomas (GII/III) from the publically available Rembrandt dataset. Two additional datasets with IDH1 mutation status were utilized as validation datasets (one publicly available dataset and one newly generated dataset from MD Anderson). Unsupervised clustering was performed and compared to gene expression subtypes assigned using the Verhaak et al 840-gene classifier. The glioma-CpG Island Methylator Phenotype (G-CIMP) was assigned using prediction models by Fine et al. Results: Unsupervised clustering by gene expression aligned with the Verhaak 840-gene subtype group assignments. GII/IIIs were preferentially assigned to the proneural subtype with IDH1 mutation and G-CIMP. GBMs were evenly distributed among the four subtypes. Proneural, IDH1 mutant, G-CIMP GII/III s had significantly better survival than other molecular subtypes. Only 6% of GBMs were proneural and had either IDH1 mutation or G-CIMP but these tumors had significantly better survival than other GBMs. Copy number changes in chromosomes 1p and 19q were associated with GII/IIIs, while these changes in CDKN2A, PTEN and EGFR were more commonly associated with GBMs. Conclusions: GBM gene-expression and methylation based subtypes are relevant for GII/III s and associate with overall survival differences. A better understanding of the association between these subtypes and GII/IIIs could further knowledge regarding prognosis and mechanisms of glioma progression.	[Guan, Xiaowei; Vengoechea, Jaime; Sloan, Andrew E.; Chen, Yanwen; Cohen, Mark L.; Barnholtz-Sloan, Jill S.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH USA; [Vengoechea, Jaime] Univ Hosp Case Med Ctr, Dept Internal Med, Cleveland, OH USA; [Zheng, Siyuan; de Groot, John; Yust-Katz, Shlomit; Yung, Wai-Kwan Alfred; Aldape, Kenneth D.; Verhaak, Roeland G. W.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Sloan, Andrew E.] Univ Hosp Case Med Ctr, Dept Neurol Surg, Cleveland, OH USA; [Brat, Daniel J.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [O'Neill, Brian Patrick] Mayo Clin, Dept Neurol, Rochester, MN USA; [Cohen, Mark L.] Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH USA; [Rosenfeld, Steven] Cleveland Clin, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University of Texas System; UTMD Anderson Cancer Center; Case Western Reserve University; Case Western Reserve University Hospital; Emory University; Mayo Clinic; Case Western Reserve University; Case Western Reserve University Hospital; Cleveland Clinic Foundation	Verhaak, RGW (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	rverhaak@mdanderson.org; jsb42@case.edu	Barnholtz-Sloan, Jill/A-4817-2011; Zheng, sy/GRS-3136-2022; Sloan, Andrew/AAE-9842-2020; Verhaak, Roel/ABE-7058-2020; Yung, W.K. Alfred/W-5016-2019	Barnholtz-Sloan, Jill/0000-0001-6190-9304; 	NCI [P30 CA043703, HHSN261201000057C, P50 CA108961, FP00073233]; National Cancer Institute [U24CA143883]; NATIONAL CANCER INSTITUTE [P30CA015083, U24CA143883, P30CA043703, P30CA016672, P50CA108961] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	JSB-S, XG, JV, YC, and AES were supported in part by NCI grant P30 CA043703 and NCI contract HHSN261201000057C. SZ and RGWV acknowledge support by National Cancer Institute grant U24CA143883. BPO was supported in part by NCI grant P50 CA108961 and NCI contract FP00073233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Baysan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047839; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Brennan CW, 2013, SOMATIC GENOMI UNPUB; Cavaliere R, 2005, LANCET NEUROL, V4, P760, DOI 10.1016/S1474-4422(05)70222-2; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Cooper LAD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012548; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dubbink HJ, 2009, NEUROLOGY, V73, P1792, DOI 10.1212/WNL.0b013e3181c34ace; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Giannini C, 2001, J NEUROPATH EXP NEUR, V60, P248, DOI 10.1093/jnen/60.3.248; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Iwamoto FM, 2008, J NEURO-ONCOL, V88, P293, DOI 10.1007/s11060-008-9563-z; Jiao YC, 2012, ONCOTARGET, V3, P709, DOI 10.18632/oncotarget.588; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; LANG FF, 1994, J NEUROSURG, V81, P427, DOI 10.3171/jns.1994.81.3.0427; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Lin CL, 2003, SURG NEUROL, V60, P402, DOI 10.1016/S0090-3019(03)00322-7; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Noushmehr H, CANC CELL, V17, P510; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Schomas DA, 2009, NEURO-ONCOLOGY, V11, P437, DOI 10.1215/15228517-2008-102; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; van den Bent MJ, 2010, ACTA NEUROPATHOL, V120, P297, DOI 10.1007/s00401-010-0725-7; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yip S, 2012, J PATHOL, V226, P7, DOI 10.1002/path.2995	34	59	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91216	10.1371/journal.pone.0091216	http://dx.doi.org/10.1371/journal.pone.0091216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614622	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300098
J	Hunter, EJ; Siegmund, T; Chan, RW				Hunter, Eric J.; Siegmund, Thomas; Chan, Roger W.			Strain Modulations as a Mechanism to Reduce Stress Relaxation in Laryngeal Tissues	PLOS ONE			English	Article							TIME-DEPENDENT BEHAVIOR; FUNDAMENTAL-FREQUENCY; MODEL; ELASTOMERS; TEACHERS; VIBRATO	Vocal fold tissues in animal and human species undergo deformation processes at several types of loading rates: a slow strain involved in vocal fold posturing (on the order of 1 Hz or so), cyclic and faster posturing often found in speech tasks or vocal embellishment (1-10 Hz), and shear strain associated with vocal fold vibration during phonation (100 Hz and higher). Relevant to these deformation patterns are the viscous properties of laryngeal tissues, which exhibit non-linear stress relaxation and recovery. In the current study, a large strain time-dependent constitutive model of human vocal fold tissue is used to investigate effects of phonatory posturing cyclic strain in the range of 1 Hz to 10 Hz. Tissue data for two subjects are considered and used to contrast the potential effects of age. Results suggest that modulation frequency and extent (amplitude), as well as the amount of vocal fold overall strain, all affect the change in stress relaxation with modulation added. Generally, the vocal fold cover reduces the rate of relaxation while the opposite is true for the vocal ligament. Further, higher modulation frequencies appear to reduce the rate of relaxation, primarily affecting the ligament. The potential benefits of cyclic strain, often found in vibrato (around 5 Hz modulation) and intonational inflection, are discussed in terms of vocal effort and vocal pitch maintenance. Additionally, elderly tissue appears to not exhibit these benefits to modulation. The exacerbating effect such modulations may have on certain voice disorders, such as muscle tension dysphonia, are explored.	[Hunter, Eric J.] Michigan State Univ, E Lansing, MI 48824 USA; [Hunter, Eric J.] Univ Utah, Natl Ctr Voice & Speech, Salt Lake City, UT USA; [Siegmund, Thomas] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Chan, Roger W.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	Michigan State University; Utah System of Higher Education; University of Utah; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hunter, EJ (corresponding author), Michigan State Univ, E Lansing, MI 48824 USA.	eric.hunter@ncvs2.org	Chan, Roger W/HII-4167-2022; Siegmund, Thomas/B-6371-2008	Chan, Roger W/0000-0002-7135-9702; Siegmund, Thomas/0000-0001-8162-9609; Hunter, Eric/0000-0001-5571-464X	National Institutes of Health [R01 DC006101, R01 DC008612]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006101, R01DC008612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding for this work was provided in part by National Institutes of Health grants R01 DC006101 (P.I.: Roger W. Chan) and R01 DC008612 (P.I.: Ingo R. Titze). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIPOURHAGHIGHI F, 1985, J ACOUST SOC AM, V78, P1939, DOI 10.1121/1.392701; Bergstrom JS, 2000, MECH MATER, V32, P627, DOI 10.1016/S0167-6636(00)00028-4; Bergstrom JS, 1998, J MECH PHYS SOLIDS, V46, P931, DOI 10.1016/S0022-5096(97)00075-6; Bretos J, 2003, J VOICE, V17, P343, DOI 10.1067/S0892-1997(03)00006-7; Chan RW, 2009, LOGOP PHONIATR VOCO, P1; Hunter EJ, 2004, J ACOUST SOC AM, V115, P1747, DOI 10.1121/1.1652033; Hunter EJ, 2010, 12 NCVS; Hunter EJ, 2007, J APPL PHYSIOL, V103, P206, DOI 10.1152/japplphysiol.00892.2006; Hunter EJ, 2010, J SPEECH LANG HEAR R, V53, P862, DOI 10.1044/1092-4388(2009/09-0040); MIN YB, 1995, ANN OTO RHINOL LARYN, V104, P563, DOI 10.1177/000348949510400711; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Perlman A. L., 1985, VOCAL FOLD PHYSL BIO, P273; Tembrock G., 1996, AKUSTISCHE KOMMUNIKA; Titze IR, 2007, J ACOUST SOC AM, V121, P469, DOI 10.1121/1.2390676; Titze IR, 2007, J ACOUST SOC AM, V121, P2254, DOI 10.1121/1.2697573; TITZE IR, 1994, J VOICE, V8, P215, DOI 10.1016/S0892-1997(05)80292-9; Yamaguchi C, 2009, AM J PRIMATOL, V71, P617, DOI 10.1002/ajp.20697; Zhang K, 2006, J ACOUST SOC AM, V119, P1050, DOI 10.1121/1.2159433; Zhang K, 2009, J VOICE, V23, P277, DOI 10.1016/j.jvoice.2007.09.010; Zhang K, 2009, J MECH BEHAV BIOMED, V2, P93, DOI 10.1016/j.jmbbm.2008.05.005	20	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90762	10.1371/journal.pone.0090762	http://dx.doi.org/10.1371/journal.pone.0090762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614616	Green Submitted, gold, Green Published			2022-12-27	WOS:000332839300039
J	Rowell, EA; Wang, LQ; Chunder, N; Hancock, WW; Wells, AD				Rowell, Emily A.; Wang, Liqing; Chunder, Neelanjana; Hancock, Wayne W.; Wells, Andrew D.			Regulation of T Cell Differentiation and Alloimmunity by the Cyclin-Dependent Kinase Inhibitor p18ink4c	PLOS ONE			English	Article							TRANSPLANTATION TOLERANCE; IN-VIVO; EFFECTOR FUNCTION; CLONAL EXPANSION; P27(KIP1); P18(INK4C); EXPRESSION; CDK6; PROLIFERATION; APOPTOSIS	Cellular proliferation in response to mitogenic stimuli is negatively regulated by the Cip/Kip and the Ink4 families of cyclin-dependent kinase (CDK) inhibitors. Several of these proteins are elevated in anergic T cells, suggesting a potential role in the induction or maintenance of tolerance. Our previous studies showed that p27(kip1) is required for the induction of T cell anergy and transplantation tolerance by costimulatory blockade, but a role for Ink4 proteins in these processes has not been established. Here we show that CD4+ T cells from mice genetically deficient for p18(ink4c) divide more rapidly than wild-type cells in response to antigenic, costimulatory and growth factor signals. However, this gain of proliferative function was accompanied by a moderate increase in the rate of cell death, and was accompanied by an overall defect in the generation of alloreactive IFN gamma-producing effector cells. Consistent with this, p18(ink4c)-deficient T cells were unable to induce graft-vs-host disease in vivo, and p18(ink4c) deficiency cooperated with costimulatory blockade to significantly increase the survival of fully mismatched allografts in a cardiac transplantation model. While both p18(ink4c) and p27(kip1) act to restrict T cell proliferation, p18(ink4c) exerts an opposite effect from p27(kip1) on alloimmunity and organ transplant rejection, most likely by sustaining T cell survival and the development of effector function. Our studies point to additional important links between the cell cycle machinery and the processes of T cell differentiation, survival and tolerance.	[Rowell, Emily A.; Hancock, Wayne W.; Wells, Andrew D.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wang, Liqing; Chunder, Neelanjana; Hancock, Wayne W.; Wells, Andrew D.] Childrens Hosp Philadelphia, Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Wells, AD (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	adwells@mail.med.upenn.edu			NIH [AI054643]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI054643, R01AI054643] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI054643 to ADW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; Chunder N, 2012, J IMMUNOL, V189, P5659, DOI 10.4049/jimmunol.1202313; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Dick FA, 2003, MOL CELL, V12, P639, DOI 10.1016/S1097-2765(03)00344-7; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Franklin DS, 1998, GENE DEV, V12, P2899, DOI 10.1101/gad.12.18.2899; Guan KL, 1996, MOL BIOL CELL, V7, P57, DOI 10.1091/mbc.7.1.57; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Guo Y, 2002, ONCOGENE, V21, P7545, DOI 10.1038/sj.onc.1205907; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Kovalev GI, 2001, J IMMUNOL, V167, P3285, DOI 10.4049/jimmunol.167.6.3285; Kozar K, 2005, CELL CYCLE, V4, P388, DOI 10.4161/cc.4.3.1551; Li LQ, 2006, NAT IMMUNOL, V7, P1157, DOI 10.1038/ni1398; Li XC, 2001, IMMUNITY, V14, P407, DOI 10.1016/S1074-7613(01)00121-2; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Mahony D, 1998, ONCOGENE, V16, P603, DOI 10.1038/sj.onc.1201570; Myers TK, 2004, EXP CELL RES, V300, P365, DOI 10.1016/j.yexcr.2004.07.024; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Noh SJ, 1999, CANCER RES, V59, P558; Rowell EA, 2005, J IMMUNOL, V174, P3359, DOI 10.4049/jimmunol.174.6.3359; Rowell EA, 2006, J IMMUNOL, V177, P5169, DOI 10.4049/jimmunol.177.8.5169; Rowell EA, 2006, CRIT REV IMMUNOL, V26, P189, DOI 10.1615/CritRevImmunol.v26.i3.10; Shen R, 2002, J IMMUNOL, V169, P714, DOI 10.4049/jimmunol.169.2.714; Singh A, 2010, MOL CELL BIOL, V30, P5145, DOI 10.1128/MCB.01045-09; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; Thullberg M, 2000, FEBS LETT, V470, P161, DOI 10.1016/S0014-5793(00)01307-7; Thullberg M, 2000, ONCOGENE, V19, P2870, DOI 10.1038/sj.onc.1203579; Tourigny MR, 2002, IMMUNITY, V17, P179, DOI 10.1016/S1074-7613(02)00364-3; Tsukiyama T, 2001, J IMMUNOL, V166, P304, DOI 10.4049/jimmunol.166.1.304; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; Venkataramani R, 1998, NAT STRUCT BIOL, V5, P74, DOI 10.1038/nsb0198-74; Wan YSY, 2003, IMMUNITY, V18, P331, DOI 10.1016/S1074-7613(03)00053-0; Wells AD, 2003, IMMUNOL REV, V196, P25, DOI 10.1046/j.1600-065X.2003.00080.x; Wolfraim LA, 2005, J IMMUNOL, V174, P2481, DOI 10.4049/jimmunol.174.5.2481; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang SM, 2000, J IMMUNOL, V165, P6270, DOI 10.4049/jimmunol.165.11.6270; Zindy F, 1997, CELL GROWTH DIFFER, V8, P1139	41	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91587	10.1371/journal.pone.0091587	http://dx.doi.org/10.1371/journal.pone.0091587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614758	Green Submitted, gold, Green Published			2022-12-27	WOS:000332839300140
J	Sahin, G; Thompson, LH; Lavisse, S; Ozgur, M; Rbah-Vidal, L; Dolle, F; Hantraye, P; Kirik, D				Sahin, Gurdal; Thompson, Lachlan H.; Lavisse, Sonia; Ozgur, Merve; Rbah-Vidal, Latifa; Dolle, Frederic; Hantraye, Philippe; Kirik, Deniz			Differential Dopamine Receptor Occupancy Underlies L-DOPA-Induced Dyskinesia in a Rat Model of Parkinson's Disease	PLOS ONE			English	Article							LEVODOPA-INDUCED DYSKINESIA; IN-VIVO; STRIATAL NEURONS; ULTRASTRUCTURAL-LOCALIZATION; INVOLUNTARY MOVEMENTS; STRIATONIGRAL NEURONS; NONHUMAN-PRIMATES; F-18 FALLYPRIDE; DEFICIENT MICE; BASAL GANGLIA	Dyskinesia is a major side effect of an otherwise effective L-DOPA treatment in Parkinson's patients. The prevailing view for the underlying presynaptic mechanism of L-DOPA-induced dyskinesia (LID) suggests that surges in dopamine (DA) via uncontrolled release from serotonergic terminals results in abnormally high level of extracellular striatal dopamine. Here we used high-sensitivity online microdialysis and PET imaging techniques to directly investigate DA release properties from serotonergic terminals both in the parkinsonian striatum and after neuronal transplantation in 6-OHDA lesioned rats. Although L-DOPA administration resulted in a drift in extracellular DA levels, we found no evidence for abnormally high striatal DA release from serotonin neurons. The extracellular concentration of DA remained at or below levels detected in the intact striatum. Instead, our results showed that an inefficient release pool of DA associated with low D2 receptor binding remained unchanged. Taken together, these findings suggest that differential DA receptor activation rather than excessive release could be the underlying mechanism explaining LID seen in this model. Our data have important implications for development of drugs targeting the serotonergic system to reduce DA release to manage dyskinesia in patients with Parkinson's disease.	[Sahin, Gurdal; Thompson, Lachlan H.; Ozgur, Merve; Kirik, Deniz] Lund Univ, BRAINS Unit, Dept Expt Med Sci, Lund, Sweden; [Thompson, Lachlan H.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Lavisse, Sonia; Rbah-Vidal, Latifa; Hantraye, Philippe] CEA, Mol Imaging Res Ctr MIRCen, Inst Imagerie Biomed I2BM, Fontenay Aux Roses, France; [Dolle, Frederic] CEA, Serv Hosp Frederic Joliot, Inst Imagerie Biomed I2BM, F-91406 Orsay, France	Lund University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Sahin, G (corresponding author), Lund Univ, BRAINS Unit, Dept Expt Med Sci, Lund, Sweden.	Gurdal.Sahin@med.lu.se	RBAH-VIDAL, Latifa/M-4118-2015; Sahin, Gurdal/GLT-3712-2022; RBAH-VIDAL, Latifa/D-9150-2014; Dollé, Frédéric/R-5756-2017; Thompson, Lachlan/B-4545-2013	RBAH-VIDAL, Latifa/0000-0002-2273-2443; Sahin, Gurdal/0000-0002-9998-5983; Thompson, Lachlan/0000-0003-2632-0304; Ozgur Erat, Merve/0000-0002-0909-8433	Swedish Research Council [K2009-61P-20945-03-1]; Swedish Parkinson Foundation [334/10]; European Research Council (ERC) [242932]; European Union [LSHB-CT-2005-512146]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Parkinson Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); European Union(European Commission)	The authors would like to acknowledge the Swedish Research Council (K2009-61P-20945-03-1), Swedish Parkinson Foundation (grant no. 334/10), the European Research Council (ERC) Starting Grant (TreatPD, 242932) and European Union 6th Framework Program project Diagnostic Molecular Imaging (DiMI, LSHB-CT-2005-512146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 1999, NEUROBIOL DIS, V6, P461, DOI 10.1006/nbdi.1999.0259; ARAI R, 1994, BRAIN RES, V667, P295, DOI 10.1016/0006-8993(94)91511-3; Aubert I, 2005, ANN NEUROL, V57, P17, DOI 10.1002/ana.20296; Caille I, 1996, BRAIN RES, V730, P17, DOI 10.1016/0006-8993(96)00424-6; Cao XB, 2010, J NEUROSCI, V30, P7335, DOI 10.1523/JNEUROSCI.0252-10.2010; Carlsson T, 2006, NEUROBIOL DIS, V21, P657, DOI 10.1016/j.nbd.2005.09.008; Carlsson T, 2007, J NEUROSCI, V27, P8011, DOI 10.1523/JNEUROSCI.2079-07.2007; Carlsson T, 2009, BRAIN, V132, P319, DOI 10.1093/brain/awn305; Carta M, 2011, NEUROSCIENCE, V198, P245, DOI 10.1016/j.neuroscience.2011.07.070; Cederfjall E, 2011, NEUROBIOLOGY DIS; CHERGUI K, 1994, NEUROSCIENCE, V62, P641, DOI 10.1016/0306-4522(94)90465-0; Christian BT, 2000, SYNAPSE, V38, P71, DOI 10.1002/1098-2396(200010)38:1<71::AID-SYN8>3.0.CO;2-2; Constantinescu CC, 2011, SYNAPSE, V65, P778, DOI 10.1002/syn.20904; Darmopil S, 2009, BIOL PSYCHIAT, V66, P603, DOI 10.1016/j.biopsych.2009.04.025; DESCARRIES L, 1992, BRAIN RES, V569, P1, DOI 10.1016/0006-8993(92)90363-E; Dumartin B, 2000, P NATL ACAD SCI USA, V97, P1879, DOI 10.1073/pnas.97.4.1879; Dumartin B, 1998, J NEUROSCI, V18, P1650; Eskow KL, 2009, SYNAPSE, V63, P610, DOI 10.1002/syn.20630; Everett GM, 1970, SCIENCE, V168, P847, DOI DOI 10.1126/SCIENCE.168.3933.849; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; FREUND TF, 1984, NEUROSCIENCE, V13, P1189, DOI 10.1016/0306-4522(84)90294-X; Garcia J, 2011, NEUROBIOL DIS, V43, P576, DOI 10.1016/j.nbd.2011.05.004; Gerfen CR, 2002, J NEUROSCI, V22, P5042, DOI 10.1523/JNEUROSCI.22-12-05042.2002; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gonon F, 1997, J NEUROSCI, V17, P5972; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; HERSCH SM, 1995, J NEUROSCI, V15, P5222; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jones SR, 1998, J NEUROSCI, V18, P1979; Kim DS, 2006, NEUROSCIENCE, V137, P1381, DOI 10.1016/j.neuroscience.2005.10.054; Kuhnast B, 2009, J LABELLED COMPD RAD, V52, pS286; Lane EL, 2006, NEUROBIOL DIS, V22, P334, DOI 10.1016/j.nbd.2005.11.011; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; Lee CS, 2000, BRAIN, V123, P1365, DOI 10.1093/brain/123.7.1365; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Lindgren HS, 2010, J NEUROCHEM, V112, P1465, DOI 10.1111/j.1471-4159.2009.06556.x; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Mela F, 2012, NEUROBIOL DIS, V45, P573, DOI 10.1016/j.nbd.2011.09.015; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; Moss J, 2008, J NEUROSCI, V28, P11221, DOI 10.1523/JNEUROSCI.2780-08.2008; Mukherjee J, 2005, BRAIN RES, V1032, P77, DOI 10.1016/j.brainres.2004.11.005; MUKHERJEE J, 1995, NUCL MED BIOL, V22, P283, DOI 10.1016/0969-8051(94)00117-3; Munoz A, 2008, BRAIN, V131, P3380, DOI 10.1093/brain/awn235; Muriel MP, 1999, ANN NEUROL, V46, P103, DOI 10.1002/1531-8249(199907)46:1<103::AID-ANA15>3.0.CO;2-Z; Nahimi A, 2012, J NEUROCHEM, V120, P806, DOI 10.1111/j.1471-4159.2011.07598.x; Navailles S, 2011, PSYCHOPHARMACOLOGY, V213, P213, DOI 10.1007/s00213-010-2029-y; Navailles S, 2010, NEUROBIOL DIS, V38, P136, DOI 10.1016/j.nbd.2010.01.012; NG KY, 1970, SCIENCE, V170, P76, DOI 10.1126/science.170.3953.76; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Core Team, 2012, R LANG ENV STAT COMP; Rice ME, 2011, NEUROSCIENCE, V198, P112, DOI 10.1016/j.neuroscience.2011.08.066; SESACK SR, 1994, J NEUROSCI, V14, P88; Slifstein M, 2010, SYNAPSE, V64, P350, DOI 10.1002/syn.20734; St-Hilaire M, 2005, NEUROBIOL DIS, V20, P450, DOI 10.1016/j.nbd.2005.04.001; Stocchi F, 2005, ARCH NEUROL-CHICAGO, V62, P905, DOI 10.1001/archneur.62.6.905; SUAUDCHAGNY MF, 1995, J NEUROCHEM, V65, P2603; Tanaka H, 1999, NEUROREPORT, V10, P631, DOI 10.1097/00001756-199902250-00034; Thorre K, 1997, J CHROMATOGR B, V694, P297, DOI 10.1016/S0378-4347(97)00126-6; Ulusoy A, 2010, P NATL ACAD SCI USA, V107, P13159, DOI 10.1073/pnas.1003432107; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Westin JE, 2007, BIOL PSYCHIAT, V62, P800, DOI 10.1016/j.biopsych.2006.11.032; Winkler C, 2002, NEUROBIOL DIS, V10, P165, DOI 10.1006/nbdi.2002.0499; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E	64	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90759	10.1371/journal.pone.0090759	http://dx.doi.org/10.1371/journal.pone.0090759			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614598	Green Published, gold			2022-12-27	WOS:000332839300038
J	Hiraoka, N; Kikuchi, J; Yamauchi, T; Koyama, D; Wada, T; Uesawa, M; Akutsu, M; Mori, S; Nakamura, Y; Ueda, T; Kano, Y; Furukawa, Y				Hiraoka, Nobuya; Kikuchi, Jiro; Yamauchi, Takahiro; Koyama, Daisuke; Wada, Taeko; Uesawa, Mitsuyo; Akutsu, Miyuki; Mori, Shigehisa; Nakamura, Yuichi; Ueda, Takanori; Kano, Yasuhiko; Furukawa, Yusuke			Purine Analog-Like Properties of Bendamustine Underlie Rapid Activation of DNA Damage Response and Synergistic Effects with Pyrimidine Analogues in Lymphoid Malignancies	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MANTLE CELL LYMPHOMA; NON-HODGKINS-LYMPHOMA; PREVIOUSLY UNTREATED PATIENTS; REFRACTORY MULTIPLE-MYELOMA; PHASE-II MULTICENTER; INDOLENT B-CELL; IN-VITRO; PLUS RITUXIMAB; OPEN-LABEL	Bendamustine has shown considerable clinical activity against indolent lymphoid malignancies as a single agent or in combination with rituximab, but combination with additional anti-cancer drugs may be required for refractory and/or relapsed cases as well as other intractable tumors. In this study, we attempted to determine suitable anti-cancer drugs to be combined with bendamustine for the treatment of mantle cell lymphoma, diffuse large B-cell lymphoma, aggressive lymphomas and multiple myeloma, all of which are relatively resistant to this drug, and investigated the mechanisms underlying synergism. Isobologram analysis revealed that bendamustine had synergistic effects with alkylating agents (4-hydroperoxy-cyclophosphamide, chlorambucil and melphalan) and pyrimidine analogues (cytosine arabinoside, gemcitabine and decitabine) in HBL-2, B104, Namalwa and U266 cell lines, which represent the above entities respectively. In cell cycle analysis, bendamustine induced late S-phase arrest, which was enhanced by 4-hydroperoxy-cyclophosphamide, and potentiated early S-phase arrest by cytosine arabinoside (Ara-C), followed by a robust increase in the size of sub-G1 fractions. Bendamustine was able to elicit DNA damage response and subsequent apoptosis faster and with shorter exposure than other alkylating agents due to rapid intracellular incorporation via equilibrative nucleoside transporters (ENTs). Furthermore, bendamustine increased the expression of ENT1 at both mRNA and protein levels and enhanced the uptake of Ara-C and subsequent increase in Ara-C triphosphate (Ara-CTP) in HBL-2 cells to an extent comparable with the purine analog fludarabine. These purine analog-like properties of bendamustine may underlie favorable combinations with other alkylators and pyrimidine analogues. Our findings may provide a theoretical basis for the development of more effective bendamustine-based combination therapies.	[Hiraoka, Nobuya; Kikuchi, Jiro; Koyama, Daisuke; Wada, Taeko; Furukawa, Yusuke] Jichi Med Univ, Ctr Mol Med, Div Stem Cell Regulat, Shimotsuke, Tochigi, Japan; [Yamauchi, Takahiro; Ueda, Takanori] Univ Fukui, Div Hematol & Oncol, Fac Med Sci, Eiheiji, Fukui, Japan; [Uesawa, Mitsuyo; Akutsu, Miyuki; Kano, Yasuhiko] Tochigi Canc Ctr, Dept Hematol, Utsunomiya, Tochigi, Japan; [Mori, Shigehisa] Saitama Med Univ, Med Educ Ctr, Moroyama, Saitama, Japan; [Nakamura, Yuichi] Saitama Med Univ, Dept Hematol, Moroyama, Saitama, Japan	Jichi Medical University; University of Fukui; Tochigi Prefectural Cancer Center; Saitama Medical University; Saitama Medical University	Furukawa, Y (corresponding author), Jichi Med Univ, Ctr Mol Med, Div Stem Cell Regulat, Shimotsuke, Tochigi, Japan.	furuyu@jichi.ac.jp	Furukawa, Yusuke/Y-1342-2018	Furukawa, Yusuke/0000-0002-7249-6418	High-Tech Research Center Project for Private Universities: Matching Fund Subsidy from MEXT; JSPS; Japan Leukemia Research Fund; Takeda Science Foundation; Naito Foundation; Yasuda Medical Foundation; Uehara Memorial Foundation; Eisai Co.; Janssen Pharmaceutical K.K.; Novartis Pharmaceuticals Co.; Jichi Medical University; Grants-in-Aid for Scientific Research [25118721] Funding Source: KAKEN	High-Tech Research Center Project for Private Universities: Matching Fund Subsidy from MEXT; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Leukemia Research Fund(Japan Leukemia Research Fund (JLRF)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Yasuda Medical Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Eisai Co.(Eisai Co Ltd); Janssen Pharmaceutical K.K.; Novartis Pharmaceuticals Co.; Jichi Medical University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the High-Tech Research Center Project for Private Universities: Matching Fund Subsidy from MEXT, a Grant-in-Aid for Scientific Research from JSPS (to J.K. and Y.F.), and research grants from Japan Leukemia Research Fund, Takeda Science Foundation (to J.K.), The Naito Foundation, The Yasuda Medical Foundation, and The Uehara Memorial Foundation (to Y.F.). YF received research funding from Eisai Co., Janssen Pharmaceutical K.K., and Novartis Pharmaceuticals Co. N.H. is a winner of the Young Scientist Award of Jichi Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1988, CANCER, V61, P483, DOI 10.1002/1097-0142(19880201)61:3<483::AID-CNCR2820610313>3.0.CO;2-L; Beeharry N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040342; BOYD VL, 1986, J MED CHEM, V29, P1206, DOI 10.1021/jm00157a015; Cai B, 2013, CANCER LETT, V335, P343, DOI 10.1016/j.canlet.2013.02.046; Castegnaro S, 2012, LEUKEMIA LYMPHOMA, V53, P2262, DOI 10.3109/10428194.2012.688200; CHAN KK, 1994, CANCER RES, V54, P6421; Chow KU, 2003, BIOCHEM PHARMACOL, V66, P711, DOI 10.1016/S0006-2952(03)00410-6; Chow KU, 2003, LEUKEMIA LYMPHOMA, V44, P165, DOI 10.1080/1042819021000054670; Chow KU, 2001, HAEMATOLOGICA, V86, P485; Damaj G, 2013, J CLIN ONCOL, V31, P104, DOI 10.1200/JCO.2012.43.7285; Fernandez-Calotti PX, 2011, NUCLEOS NUCLEOT NUCL, V30, P1324, DOI 10.1080/15257770.2011.597372; Friedberg JW, 2008, J CLIN ONCOL, V26, P204, DOI 10.1200/JCO.2007.12.5070; Furukawa Y, 2007, LEUKEMIA, V21, P1005, DOI 10.1038/sj.leu.2404593; Gandhi V, 1996, BLOOD, V87, P256, DOI 10.1182/blood.V87.1.256.bloodjournal871256; HARTMANN M, 1972, BIOCHIM BIOPHYS ACTA, V287, P386, DOI 10.1016/0005-2787(72)90282-1; Herold M, 2006, J CANCER RES CLIN, V132, P105, DOI 10.1007/s00432-005-0023-2; HILL BT, 1972, BIOCHEM PHARMACOL, V21, P495, DOI 10.1016/0006-2952(72)90322-X; Hiraoka N, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.66; Hitz F, 2013, ANN HEMATOL, V92, P1033, DOI 10.1007/s00277-013-1751-z; Kikuchi J, 2013, J BIOL CHEM, V288, P25593, DOI 10.1074/jbc.M113.480574; Knauf WU, 2009, J CLIN ONCOL, V27, P4378, DOI 10.1200/JCO.2008.20.8389; Koenigsmann M, 2004, LEUKEMIA LYMPHOMA, V45, P1821, DOI 10.1080/1042819042000223822; Koster W, 2004, CLIN DRUG INVEST, V24, P611; Koyama D, 2014, PROTEASOME INHIBITOR, DOI [10.1038/leu.2013.366, DOI 10.1038/LEU.2013.366]; Layman RM, 2013, CANCER CHEMOTH PHARM, V71, P1183, DOI 10.1007/s00280-013-2112-2; Lentzsch S, 2012, BLOOD, V119, P4608, DOI 10.1182/blood-2011-12-395715; Leoni LM, 2008, CLIN CANCER RES, V14, P309, DOI 10.1158/1078-0432.CCR-07-1061; McCloskey James K, 2013, Clin Adv Hematol Oncol, V11, P184; Offidani M, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.58; Ogura M, 2010, CANCER SCI, V101, P2054, DOI 10.1111/j.1349-7006.2010.01633.x; Ohmachi K, 2013, J CLIN ONCOL, V31, P2103, DOI 10.1200/JCO.2012.46.5203; Pastor-Anglada M, 2004, LEUKEMIA, V18, P385, DOI 10.1038/sj.leu.2403271; Petersen AJ, 1996, EUR J HAEMATOL, V56, P213; Rasschaert M, 2007, BRIT J CANCER, V96, P1692, DOI 10.1038/sj.bjc.6603776; Robinson KS, 2008, J CLIN ONCOL, V26, P4473, DOI 10.1200/JCO.2008.17.0001; Roue G, 2008, CLIN CANCER RES, V14, P6907, DOI 10.1158/1078-0432.CCR-08-0388; Rummel MJ, 2013, LANCET, V381, P1203, DOI 10.1016/S0140-6736(12)61763-2; Schwanen C, 2002, LEUKEMIA, V16, P2096, DOI 10.1038/sj.leu.2402651; Staib P, 1999, BLOOD, V94, p63A; Strumberg D, 1996, ANTI-CANCER DRUG, V7, P415, DOI 10.1097/00001813-199606000-00007; Tageja N, 2010, CANCER CHEMOTH PHARM, V66, P413, DOI 10.1007/s00280-010-1317-x; Visani G, 2011, BLOOD, V118, P3419, DOI 10.1182/blood-2011-04-351924; Visco C, 2013, J CLIN ONCOL, V31, P1442, DOI 10.1200/JCO.2012.45.9842; Visco C, 2013, AM J HEMATOL, V88, P289, DOI 10.1002/ajh.23391; Visco C, 2012, BLOOD CELL MOL DIS, V48, P68, DOI 10.1016/j.bcmd.2011.09.007; Weide R, 2007, LEUKEMIA LYMPHOMA, V48, P1299, DOI 10.1080/10428190701361828; Wright AMP, 2000, LEUKEMIA, V14, P52, DOI 10.1038/sj.leu.2401633; Yamauchi T, 2005, BIOCHEM PHARMACOL, V69, P1795, DOI 10.1016/j.bcp.2005.03.013; Yamauchi T, 1996, CANCER RES, V56, P1800; Yamauchi T, 2009, BIOCHEM PHARMACOL, V77, P1780, DOI 10.1016/j.bcp.2009.03.011	50	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90675	10.1371/journal.pone.0090675	http://dx.doi.org/10.1371/journal.pone.0090675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626203	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300029
J	Johnbeck, CB; Jensen, MM; Nielsen, CH; Hag, AMF; Knigge, U; Kjaer, A				Johnbeck, Camilla Bardram; Jensen, Mette Munk; Nielsen, Carsten Haagen; Hag, Anne Mette Fisker; Knigge, Ulrich; Kjaer, Andreas			F-18-FDG and F-18-FLT-PET Imaging for Monitoring Everolimus Effect on Tumor-Growth in Neuroendocrine Tumors: Studies in Human Tumor Xenografts in Mice	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SURROGATE MARKER; MAMMALIAN TARGET; IN-VIVO; PET; INHIBITION; PROLIFERATION; THERAPY; RECIST; VALIDATION	Introduction: The mTOR inhibitor everolimus has shown promising results in some but not all neuroendocrine tumors. Therefore, early assessment of treatment response would be beneficial. In this study, we investigated the in vivo and in vitro treatment effect of everolimus in neuroendocrine tumors and evaluated the performance of F-18-FDG and the proliferation tracer F-18-FLT for treatment response assessment by PET imaging. Methods: The effect of everolimus on the human carcinoid cell line H727 was examined in vitro with the MTT assay and in vivo on H727 xenograft tumors. The mice were scanned at baseline with F-18-FDG or F-18-FLT and then treated with either placebo or everolimus (5 mg/kg daily) for 10 days. PET/CT scans were repeated at day 1,3 and 10. Results: Everolimus showed significant inhibition of H727 cell proliferation in vitro at concentrations above 1 nM. In vivo tumor volumes measured relative to baseline were significantly lower in the everolimus group compared to the control group at day 3 (126 +/- 6% vs. 152 +/- 6%; p = 0.016), day 7 (164 +/- 7% vs. 226 +/- 13%; p<0.001) and at day 10 (194 +/- 10% vs. 281 +/- 18%; p<0.001). Uptake of F-18-FDG and F-18-FLT showed little differences between control and treatment groups, but individual mean uptake of F-18-FDG at day 3 correlated with tumor growth day 10(r(2) = 0.45; P = 0.034), F-18-FLT mean uptake at day 1 correlated with tumor growth day 7 (r(2) = 0.63; P = 0.019) and at day 3 F-18-FLT correlated with tumor growth day 7 (r(2) = 0.87; P<0.001) and day 10 (r(2) = 0.58; P = 0.027). Conclusion: Everolimus was effective in vitro and in vivo in human xenografts lung carcinoid NETs and especially early F-18-FLT uptake predicted subsequent tumor growth. We suggest that F-18-FLT PET can be used for tailoring therapy for neuroendocrine tumor patients through early identification of responders and non-responders.	[Johnbeck, Camilla Bardram; Jensen, Mette Munk; Nielsen, Carsten Haagen; Hag, Anne Mette Fisker; Kjaer, Andreas] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Johnbeck, Camilla Bardram; Jensen, Mette Munk; Nielsen, Carsten Haagen; Hag, Anne Mette Fisker; Kjaer, Andreas] Rigshosp, Fac Hlth Sci, Cluster Mol Imaging, DK-2100 Copenhagen, Denmark; [Johnbeck, Camilla Bardram; Jensen, Mette Munk; Nielsen, Carsten Haagen; Hag, Anne Mette Fisker; Kjaer, Andreas] Univ Copenhagen, Copenhagen, Denmark; [Knigge, Ulrich] Rigshosp, Dept Surg Gastroenterol C, DK-2100 Copenhagen, Denmark; [Knigge, Ulrich] Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Johnbeck, CB (corresponding author), Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark.	Camillabj@sund.ku.dk	Kjaer, Andreas/E-8932-2015	Kjaer, Andreas/0000-0002-2706-5547	National Advances Technology Foundation; Danish Cancer Society; Lundbeck Foundation; Novo Nordic Foundation; Danish Medical Research Council; Svend Andersen Foundation; Research Council for Strategic Research; Rigshospitalets Research Council; Research Foundation of the Capital Region; Arvid Nilsson Foundation; John and Birthe Meyer Foundation; A. P. Moeller Foundation; Novo Nordisk Fonden [NNF13OC0007149] Funding Source: researchfish; The Danish Cancer Society [R72-A4569] Funding Source: researchfish	National Advances Technology Foundation; Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Novo Nordic Foundation(Novo Nordisk Foundation); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Svend Andersen Foundation; Research Council for Strategic Research; Rigshospitalets Research Council; Research Foundation of the Capital Region; Arvid Nilsson Foundation; John and Birthe Meyer Foundation; A. P. Moeller Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	The National Advances Technology Foundation, Danish Cancer Society, The Lundbeck Foundation, Novo Nordic Foundation, The Danish Medical Research Council, Svend Andersen Foundation, Research Council for Strategic Research, Rigshospitalets Research Council, the Research Foundation of the Capital Region, the Arvid Nilsson Foundation, the John and Birthe Meyer Foundation and A. P. Moeller Foundation supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide N, 2010, J NUCL MED, V51, P1559, DOI 10.2967/jnumed.109.073288; Benjamin RS, 2007, J CLIN ONCOL, V25, P1760, DOI 10.1200/JCO.2006.07.3411; Binderup T, 2011, CURR MED IMAGING REV, V7, P234, DOI 10.2174/157340511796411221; Binderup T, 2010, CLIN CANCER RES, V16, P978, DOI 10.1158/1078-0432.CCR-09-1759; Castellano D, 2012, ONCOLOGIST, DOI [10.1634/theoncologist.2012-0263, DOI 10.1634/THE0NC0L0GIST.2012-0263]; Cejka D, 2009, BRIT J CANCER, V100, P1739, DOI 10.1038/sj.bjc.6605076; Chalkidou A, 2012, EUR J CANCER, V48, P3499, DOI 10.1016/j.ejca.2012.05.001; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; El Ali HH, 2012, DIAGNOSTICS, V2, P42, DOI 10.3390/diagnostics2040042; Fazio N, 2013, CHEST, V143, P955, DOI 10.1378/chest.12-1108; Frilling A, 2012, ENDOCR-RELAT CANCER, V19, pR163, DOI 10.1530/ERC-12-0024; Fuereder T, 2011, CLIN CANCER RES, V17, P5322, DOI 10.1158/1078-0432.CCR-10-1659; Jensen MM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-168; Jensen MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050618; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Jensen MA, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011024, 10.1371/journal.pone.0012965]; KONG XB, 1992, ANTIMICROB AGENTS CH, V36, P808, DOI 10.1128/AAC.36.4.808; Li ZL, 2012, CANCER RES, V72, P5014, DOI 10.1158/0008-5472.CAN-12-0635; Missiaglia E, 2010, J CLIN ONCOL, V28, P245, DOI 10.1200/JCO.2008.21.5988; Modlin IM, 2010, MED J AUSTRALIA, V193, P46, DOI 10.5694/j.1326-5377.2010.tb03742.x; Munk Jensen M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053410, DOI 10.1371/J0URNAL.P0NE.0053410.PUBMED:23308217]; Nogova L, 2009, J NUCL MED, V50, P1815, DOI 10.2967/jnumed.109.065367; Pavel M, 2013, NEUROENDOCRINOLOGY, V97, P99, DOI 10.1159/000336089; Pavel ME, 2011, LANCET, V378, P2005, DOI 10.1016/S0140-6736(11)61742-X; Rasey JS, 2002, J NUCL MED, V43, P1210; Schwarzenberg J, 2012, J NUCL MED, V53, P29, DOI 10.2967/jnumed.111.092387; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Soloviev D, 2012, EUR J CANCER, V48, P416, DOI 10.1016/j.ejca.2011.11.035; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Tehrani OS, 2013, J NUCL MED, V54, P903, DOI 10.2967/jnumed.112.112201; Therasse P, 2006, EUR J CANCER, V42, P1031, DOI 10.1016/j.ejca.2006.01.026; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Van den Abbeele AD, 2002, EUR J CANCER, V38, pS60, DOI 10.1016/S0959-8049(02)80604-9; Van den Abbeele AD, 2008, ONCOLOGIST, V13, P8, DOI 10.1634/theoncologist.13-S2-8; Vanderhoek M, 2011, LEUKEMIA RES, V35, P310, DOI 10.1016/j.leukres.2010.06.010; von Wichert G, 2000, CANCER RES, V60, P4573; Weber WA, 2006, EUR J NUCL MED MOL I, V33, pS27, DOI 10.1007/s00259-006-0133-3; Wei LH, 2008, CLIN CANCER RES, V14, P3416, DOI 10.1158/1078-0432.CCR-07-1824; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2007, BEST PRACT RES CL EN, V21, P163, DOI 10.1016/j.beem.2007.01.006; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Yao JC, 2010, J CLIN ONCOL, V28, P69, DOI 10.1200/JCO.2009.24.2669; Zannetti A, 2012, J NUCL MED, V53, P443, DOI 10.2967/jnumed.111.096503; Zatelli MC, 2010, ENDOCR-RELAT CANCER, V17, P719, DOI 10.1677/ERC-10-0097	45	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91387	10.1371/journal.pone.0091387	http://dx.doi.org/10.1371/journal.pone.0091387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626055	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300080
J	Gil-Humanes, J; Piston, F; Altamirano-Fortoul, R; Real, A; Comino, I; Sousa, C; Rosell, CM; Barro, F				Gil-Humanes, Javier; Piston, Fernando; Altamirano-Fortoul, Rossana; Real, Ana; Comino, Isabel; Sousa, Carolina; Rosell, Cristina M.; Barro, Francisco			Reduced-Gliadin Wheat Bread: An Alternative to the Gluten-Free Diet for Consumers Suffering Gluten-Related Pathologies	PLOS ONE			English	Article							CELIAC-DISEASE; OPAQUE-2 CORN; NUTRITIONAL-VALUE; ALPHA-GLIADIN; EPITOPES; MALIGNANCY; MODEL; INTEGRATION; PREVALENCE; EXPRESSION	Wheat flour cannot be tolerated by those who suffer allergies to gluten. Human pathologies associated with grain proteins have increased worldwide in recent years, and the only effective treatment available is a lifelong gluten-free diet, which is complicated to follow and detrimental to gut health. This manuscript describes the development of wheat bread potentially suitable for celiac patients and other gluten-intolerant individuals. We have made bread using wheat flour with very low content of the specific gluten proteins (near gliadin-free) that are the causal agents for pathologies such as celiac disease. Loaves were compared with normal wheat breads and rice bread. Organoleptic, nutritional, and immunotoxic properties were studied. The reduced-gliadin breads showed baking and sensory properties, and overall acceptance, similar to those of normal flour, but with up to 97% lower gliadin content. Moreover, the low-gliadin flour has improved nutritional properties since its lysine content is significantly higher than that of normal flour. Conservative estimates indicate that celiac patients could safely consume 67 grams of bread per day that is made with low-gliadin flour. However, additional studies, such as feeding trials with gluten-intolerant patients, are still needed in order to determine whether or not the product can be consumed by the general celiac population, as well as the actual tolerated amount that can be safely ingested. The results presented here offer a major opportunity to improve the quality of life for millions of sufferers of gluten intolerance throughout the world.	[Gil-Humanes, Javier; Piston, Fernando; Barro, Francisco] CSIC, Inst Agr Sostenible, Cordoba, Spain; [Altamirano-Fortoul, Rossana; Rosell, Cristina M.] CSIC, Inst Agroquim & Tecnol Alimentos, E-46010 Valencia, Spain; [Real, Ana; Comino, Isabel; Sousa, Carolina] Univ Seville, Fac Farm, Dept Microbiol & Parasitol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Sevilla	Gil-Humanes, J (corresponding author), CSIC, Inst Agr Sostenible, Cordoba, Spain.	javigil@ias.csic.es; fbarro@ias.csic.es	Barro, Francisco/J-3254-2014; Barro, Francisco/E-8572-2017; Gil-Humanes, Javier/AAU-4381-2020; Piston, Fernando/AAD-6975-2020; Rosell, Cristina M/F-4888-2010	Barro, Francisco/0000-0002-7652-229X; Rosell, Cristina M/0000-0001-7197-5874; Altamirano-Fortoul, Rossana/0000-0002-5323-8931; Sousa Martin, Carolina/0000-0002-9235-9496; Gil Humanes, Javier/0000-0002-7283-6945	Spanish Ministry of Economy and Competitiveness [AGL2010-19643-C02-02]; European Regional Development Fund (FEDER); Junta de Andalucia [P09AGR-4783]; Generalitat Valenciana [Prometeo 2012/064]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund (FEDER)(European Commission); Junta de Andalucia(Junta de Andalucia); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	The Spanish Ministry of Economy and Competitiveness (Project AGL2010-19643-C02-02), the European Regional Development Fund (FEDER), and Junta de Andalucia (Project P09AGR-4783) supported this work. Authors also acknowledge the financial support of Generalitat Valenciana (Project Prometeo 2012/064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AACCI, 2000, APPR METH AN; Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Altenbach Susan B, 2011, GM Crops, V2, P66, DOI 10.4161/gmcr.2.1.15884; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Arentz-Hansen H, 2002, GASTROENTEROLOGY, V123, P803, DOI 10.1053/gast.2002.35381; Bethune MT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040034; Catassi C, 2007, AM J CLIN NUTR, V85, P160, DOI 10.1093/ajcn/85.1.160; CICLITIRA PJ, 1980, CLIN SCI, V59, pP25; Comino I, 2011, GUT, V60, P915, DOI 10.1136/gut.2010.225268; Corrao G, 2001, LANCET, V358, P356, DOI 10.1016/S0140-6736(01)05554-4; Perez LC, 2012, EUR J INTERN MED, V23, P9, DOI 10.1016/j.ejim.2011.08.030; CROMWELL GL, 1967, J ANIM SCI, V26, P1325, DOI 10.2527/jas1967.2661325x; De Palma G, 2009, BRIT J NUTR, V102, P1154, DOI 10.1017/S0007114509371767; Demirkesen I, 2010, J FOOD ENG, V96, P295, DOI 10.1016/j.jfoodeng.2009.08.004; DREWS JE, 1969, J NUTR, V97, P537, DOI 10.1093/jn/97.4.537; Fido RJ, 1997, J CEREAL SCI, V26, P271, DOI 10.1006/jcrs.1997.0138; FRISONI M, 1995, GUT, V36, P375, DOI 10.1136/gut.36.3.375; Frizzi A, 2008, PLANT BIOTECHNOL J, V6, P13, DOI 10.1111/j.1467-7652.2007.00290.x; Gevers H. O., 1992, Quality protein maize., P49; Ghosh S, 2004, ECOL FOOD NUTR, V43, P107, DOI 10.1080/03670240490280267; Gil-Humanes J, 2008, J CEREAL SCI, V48, P565, DOI 10.1016/j.jcs.2008.03.005; Gil-Humanes J, 2011, J EXP BOT, V62, P4203, DOI 10.1093/jxb/err119; Gil-Humanes J, 2010, P NATL ACAD SCI USA, V107, P17023, DOI 10.1073/pnas.1007773107; Glover DV, 1992, QUALITY PROTEIN MAIZ, P49; GUPTA HO, 1979, J AGR FOOD CHEM, V27, P390, DOI 10.1021/jf60222a046; Hager AS, 2012, EUR FOOD RES TECHNOL, V235, P333, DOI 10.1007/s00217-012-1763-2; HOLMES GKT, 1989, GUT, V30, P333, DOI 10.1136/gut.30.3.333; Hournard NM, 2007, PLANT BIOTECHNOL J, V5, P605, DOI 10.1111/j.1467-7652.2007.00265.x; ICC, 1994, 1161 ICC INT ASS CER; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Ivarsson A, 2000, ACTA PAEDIATR, V89, P165, DOI 10.1080/080352500750028771; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Kasarda D.D., 1989, WHEAT UNIQUE, V277, P302; Kasarda DD, 2013, J AGR FOOD CHEM, V61, P1155, DOI 10.1021/jf305122s; KIES C, 1972, J NUTR, V102, P757, DOI 10.1093/jn/102.6.757; KLEIN RG, 1971, J ANIM SCI, V32, P256; Kupper C, 2005, GASTROENTEROLOGY, V128, pS121, DOI 10.1053/j.gastro.2005.02.024; LEONARD JN, 1983, BRIT MED J, V286, P16, DOI 10.1136/bmj.286.6358.16; LOGAN RFA, 1989, GASTROENTEROLOGY, V97, P265, DOI 10.1016/0016-5085(89)90060-7; Ludvigsson JF, 2013, AM J GASTROENTEROL, V108, P818, DOI 10.1038/ajg.2013.60; Marco C, 2008, EUR FOOD RES TECHNOL, V227, P1205, DOI 10.1007/s00217-008-0838-6; Mariani P, 1998, J PEDIATR GASTR NUTR, V27, P519, DOI 10.1097/00005176-199811000-00004; Segura MEM, 2011, PLANT FOOD HUM NUTR, V66, P224, DOI 10.1007/s11130-011-0244-2; MCCARTHY CF, 1991, EUR J GASTROEN HEPAT, V3, P125; MERTZ ET, 1964, SCIENCE, V145, P279, DOI 10.1126/science.145.3629.279; Moron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002294; Moron B, 2008, AM J CLIN NUTR, V87, P405, DOI 10.1093/ajcn/87.2.405; Murray JA, 2004, AM J CLIN NUTR, V79, P669; Pellegrineschi A, 2002, GENOME, V45, P421, DOI 10.1139/G01-154; Piston F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-136; Rojas JA, 2000, EUR FOOD RES TECHNOL, V212, P57, DOI 10.1007/s002170000209; Rosell CM, 2012, WOODHEAD PUBL FOOD S, P687; Sapone A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-23; Sciarini LS, 2012, J FOOD ENG, V111, P590, DOI 10.1016/j.jfoodeng.2012.03.011; Shewry PR, 2007, J CEREAL SCI, V46, P239, DOI 10.1016/j.jcs.2007.06.006; Shewry PR, 2003, ADV GENET, V49, P111, DOI 10.1016/S0065-2660(03)01003-4; Silvester JA, 2007, CAN J GASTROENTEROL, V21, P557, DOI 10.1155/2007/342685; Sollid LM, 2011, J INTERN MED, V269, P604, DOI 10.1111/j.1365-2796.2011.02376.x; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Spaenij-Dekking L, 2005, GASTROENTEROLOGY, V129, P797, DOI 10.1053/j.gastro.2005.06.017; Trier JS, 1998, GASTROENTEROLOGY, V115, P211, DOI 10.1016/S0016-5085(98)70383-X; Tye-Din JA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001012; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; van den Broeck HC, 2010, THEOR APPL GENET, V121, P1527, DOI 10.1007/s00122-010-1408-4; van den Broeck HC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-41; van Herpen TWJM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-1; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; Wen SS, 2012, P NATL ACAD SCI USA, V109, P20543, DOI 10.1073/pnas.1217927109; Wenefrida Ida, 2009, Recent Pat DNA Gene Seq, V3, P219; WHO, 2003, E79832 WHO; Wu XR, 2007, PLANT J, V50, P627, DOI 10.1111/j.1365-313X.2007.03076.x; YOUNG VR, 1971, J NUTR, V101, P1475, DOI 10.1093/jn/101.11.1475; Zuidmeer L, 2008, J ALLERGY CLIN IMMUN, V121, P1210, DOI 10.1016/j.jaci.2008.02.019	74	56	58	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90898	10.1371/journal.pone.0090898	http://dx.doi.org/10.1371/journal.pone.0090898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621595	gold, Green Published			2022-12-27	WOS:000332845300035
J	Guedes, PT; de Oliveira, BCEPD; Manso, PPD; Caputo, LFG; Cotta-Pereira, G; Pelajo-Machado, M				Guedes, Priscila Tavares; Pereira Dias de Oliveira, Barbara Cristina Euzebio; de Abreu Manso, Pedro Paulo; Goncalves Caputo, Luzia Fatima; Cotta-Pereira, Gerson; Pelajo-Machado, Marcelo			Histological Analyses Demonstrate the Temporary Contribution of Yolk Sac, Liver, and Bone Marrow to Hematopoiesis during Chicken Development	PLOS ONE			English	Article							COLONY-FORMING CELLS; STEM-CELLS; DEFINITIVE ERYTHROPOIESIS; AVIAN DEVELOPMENT; EMBRYO AORTA; SIRIUS RED; MOUSE; ONTOGENY; ORIGIN; TISSUE	The use of avian animal models has contributed to the understanding of many aspects of the ontogeny of the hematopoietic system in vertebrates. However, specific events that occur in the model itself are still unclear. There is a lack of consensus, among previous studies, about which is the intermediate site responsible for expansion and differentiation of hematopoietic cells, and the liver's contribution to the development of this system. Here we aimed to evaluate the presence of hematopoiesis in the yolk sac and liver in chickens, from the stages of intra-aortic clusters in the aorta-genital ridges-mesonephros (AGM) region until hatching, and how it relates to the establishment of the bone marrow. Gallus gallus domesticus L. embryos and their respective yolk sacs at embryonic day 3 (E3) and up to E21 were collected and processed according to standard histological techniques for paraffin embedding. The slides were stained with hematoxylin-eosin, Lennert's Giemsa, and Sirius Red at pH 10.2, and investigated by light microscopy. This study demonstrated that the yolk sac was a unique hematopoietic site between E4 and E12. Hematopoiesis occurred in the yolk sac and bone marrow between E13 and E20. The liver showed granulocytic differentiation in the connective tissue of portal spaces at E15 and onwards. The yolk sac showed expansion of erythrocytic and granulocytic lineages from E6 to E19, and E7 to E20, respectively. The results suggest that the yolk sac is the major intermediate erythropoietic and granulopoietic site where expansion and differentiation occur during chicken development. The hepatic hematopoiesis is restricted to the portal spaces and represented by the granulocytic lineage.	[Guedes, Priscila Tavares; Pereira Dias de Oliveira, Barbara Cristina Euzebio; de Abreu Manso, Pedro Paulo; Goncalves Caputo, Luzia Fatima; Pelajo-Machado, Marcelo] Oswaldo Cruz Inst Fiocruz, Pathol Lab, Rio De Janeiro, Brazil; [Cotta-Pereira, Gerson] Santa Casa Misericordia Rio de Janeiro, Lab Immunochem & Histochem, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Pelajo-Machado, M (corresponding author), Oswaldo Cruz Inst Fiocruz, Pathol Lab, Rio De Janeiro, Brazil.	mpelajo@ioc.fiocruz.br	de Abreu Manso, Pedro Paulo/M-7326-2018; Machado, Marcelo Pelajo/I-5359-2012	de Abreu Manso, Pedro Paulo/0000-0002-7255-0429; Pelajo Machado, Marcelo/0000-0002-7295-7018	CNPq; Faperj; Fiocruz	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fiocruz	Priscila Tavares Guedes was a PhD fellow at the Oswaldo Cruz Institute/Fiocruz, Rio de Janeiro, Brazil. This study was supported by CNPq, Faperj, and Fiocruz grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Silva M, 2003, DEVELOPMENT, V130, P5437, DOI 10.1242/dev.00755; Ayres-Silva JD, 2011, CELL TISSUE RES, V344, P455, DOI 10.1007/s00441-011-1170-1; BOGOMOLETZ W, 1980, ARCH ANAT CYTOL PATH, V28, P252; Caprioli A, 1998, P NATL ACAD SCI USA, V95, P1641, DOI 10.1073/pnas.95.4.1641; Caprioli A, 2001, DEV BIOL, V238, P64, DOI 10.1006/dbio.2001.0362; CARSON FL, 1973, AM J CLIN PATHOL, V59, P365; CORMIER F, 1986, DEV BIOL, V118, P167, DOI 10.1016/0012-1606(86)90084-9; CORMIER F, 1988, DEVELOPMENT, V102, P279; CUDENNEC CA, 1981, P NATL ACAD SCI-BIOL, V78, P2412, DOI 10.1073/pnas.78.4.2412; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Dantschakoff W, 1909, ARCH MIKRO ANAT ENTW, V74, P855, DOI 10.1007/BF02979951; Dantschakoff Wera., 1908, Anatomische Hefte Wiesbaden Abt 1, V37; DIETERLENLIEVRE F, 1976, ANN INST PASTEUR IMM, VC127, P857; DIETERLENLIEVRE F, 1975, J EMBRYOL EXP MORPH, V33, P607; DIETERLENLIEVRE F, 1981, DEV BIOL, V88, P180, DOI 10.1016/0012-1606(81)90228-1; DIETERLENLIEVRE F, 1984, DEV COMP IMMUNOL S, V3, P75; Godin I, 2005, INT J DEV BIOL, V49, P251, DOI 10.1387/ijdb.041945ig; GORDON MY, 1993, BLOOD REV, V7, P190, DOI 10.1016/0268-960X(93)90005-O; Haff R, 1914, ARCH MIKROSK ANAT, V84, P321, DOI 10.1007/BF02991372; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Huang X, 2007, CELL DEATH DIFFER, V14, P1851, DOI 10.1038/sj.cdd.4402225; JOHNSON GR, 1975, NATURE, V258, P726, DOI 10.1038/258726a0; Jordan HE, 1936, AM J ANAT, V59, P249, DOI 10.1002/aja.1000590204; JUURLINK BH, 1973, CAN J ZOOL, V51, P509, DOI 10.1139/z73-076; KARRER HE, 1961, J ULTRA MOL STRUCT R, V5, P116, DOI 10.1016/S0022-5320(61)90009-0; KAUFMAN MH, 1998, ATLAS MOUSE DEV; KINGSBURY JW, 1956, ANAT RECORD, V124, P165, DOI 10.1002/ar.1091240204; LASSILA O, 1978, NATURE, V272, P353, DOI 10.1038/272353a0; LENNERT K, 1978, MALIGNANT LYMPHOMAS; Marks P A, 1966, Curr Top Dev Biol, V1, P213, DOI 10.1016/S0070-2153(08)60014-9; MAYER P, 1903, Z WISSENSCHAFTLICHE, V20, P409; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Nagai H, 2008, DEV DYNAM, V237, P3332, DOI 10.1002/dvdy.21746; NICOLA NA, 1982, BLOOD, V60, P1019; Niimi Gen, 2008, Italian Journal of Anatomy and Embryology, V113, P9; OGAWA M, 1983, BLOOD, V61, P823; Romanoff A.L., 1960, AVIAN EMBRYO STRUCTU; Russel ES, 1966, BIOL LAB MOUSE; Schoenwolf G., 2020, LARSENS HUMAN EMBRYO, V6th edn; Sheng GJ, 2010, INT J DEV BIOL, V54, P1033, DOI 10.1387/ijdb.103105gs; Stewart JR, 2000, J MORPHOL, V244, P81, DOI 10.1002/(SICI)1097-4687(200005)244:2<81::AID-JMOR1>3.0.CO;2-D; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; TURPEN JB, 1982, DEV BIOL, V89, P138, DOI 10.1016/0012-1606(82)90302-5; VASSE J, 1981, J EMBRYOL EXP MORPH, V62, P129; Wehrend A, 2004, ANAT HISTOL EMBRYOL, V33, P180, DOI 10.1111/j.1439-0264.2004.00532.x; WONG GK, 1993, ANAT REC, V235, P131, DOI 10.1002/ar.1092350114; ZON LI, 1995, BLOOD, V86, P2876	48	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90975	10.1371/journal.pone.0090975	http://dx.doi.org/10.1371/journal.pone.0090975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621665	gold, Green Published			2022-12-27	WOS:000332845300040
J	Prentice, JR; Blackwell, CS; Raoof, N; Bacon, P; Ray, J; Hickman, SJ; Wilkinson, JM				Prentice, Jennifer R.; Blackwell, Christopher S.; Raoof, Naz; Bacon, Paul; Ray, Jaydip; Hickman, Simon J.; Wilkinson, J. Mark			Auditory and Visual Health after Ten Years of Exposure to Metal-on-Metal Hip Prostheses: A Cross-Sectional Study Follow Up	PLOS ONE			English	Article							RESURFACING ARTHROPLASTY; SIGHT	Case reports of patients with mal-functioning metal-on-metal hip replacement (MoMHR) prostheses suggest an association of elevated circulating metal levels with visual and auditory dysfunction. However, it is unknown if this is a cumulative exposure effect and the impact of prolonged low level exposure, relevant to the majority of patients with a well-functioning prosthesis, has not been studied. Twenty four male patients with a well-functioning MoMHR and an age and time since surgery matched group of 24 male patients with conventional total hip arthroplasty (THA) underwent clinical and electrophysiological assessment of their visual and auditory health at a mean of ten years after surgery. Median circulating cobalt and chromium concentrations were higher in patients after MoMHR versus those with THA (P<0.0001), but were within the Medicines and Healthcare Products Regulatory Agency (UK) investigation threshold. Subjective auditory tests including pure tone audiometric and speech discrimination findings were similar between groups (P>0.05). Objective assessments, including amplitude and signal-to-noise ratio of transient evoked and distortion product oto-acoustic emissions (TEOAE and DPOAE, respectively), were similar for all the frequencies tested (P>0.05). Auditory brainstem responses (ABR) and cortical evoked response audiometry (ACR) were also similar between groups (P>0.05). Ophthalmological evaluations, including self-reported visual function by visual functioning questionnaire, as well as binocular low contrast visual acuity and colour vision were similar between groups (P>0.05). Retinal nerve fibre layer thickness and macular volume measured by optical coherence tomography were also similar between groups (P>0.05). In the presence of moderately elevated metal levels associated with well-functioning implants, MoMHR exposure does not associate with clinically demonstrable visual or auditory dysfunction.	[Prentice, Jennifer R.; Blackwell, Christopher S.; Wilkinson, J. Mark] Univ Sheffield, Dept Human Metab, Sheffield, S Yorkshire, England; [Raoof, Naz] Sheffield Teaching Hosp NHS Fdn Trust, Dept Ophthalmol, Sheffield, S Yorkshire, England; [Bacon, Paul; Ray, Jaydip] Sheffield Teaching Hosp NHS Fdn Trust, Dept Otolaryngol, Sheffield, S Yorkshire, England; [Hickman, Simon J.] Sheffield Teaching Hosp NHS Fdn Trust, Dept Neurol, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield	Wilkinson, JM (corresponding author), Univ Sheffield, Dept Human Metab, Sheffield, S Yorkshire, England.	j.m.wilkinson@sheffield.ac.uk	Raoof, Naz/AAL-4240-2020		Sheffield Musculoskeletal Biomedical Research Unit through National Institute of Health Research in the United Kingdom (NIHR)	Sheffield Musculoskeletal Biomedical Research Unit through National Institute of Health Research in the United Kingdom (NIHR)	This study was funded by Sheffield Musculoskeletal Biomedical Research Unit through its core grant from the National Institute of Health Research in the United Kingdom (NIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostoli P, 2013, EXP TOXICOL PATHOL, V65, P719, DOI 10.1016/j.etp.2012.09.006; BOOTHROYD A, 1968, J ACOUST SOC AM, V43, P362, DOI 10.1121/1.1910787; Clark MJ, 2014, AM J NEUROR IN PRESS; Daniel J, 2007, J BONE JOINT SURG BR, V89B, P169, DOI 10.1302/0301-620X.89B2.18519; HARTMANN A, 2012, CLIN ORTHOP RELAT RE; Heisel C, 2008, J BONE JOINT SURG AM, V90A, P125, DOI 10.2106/JBJS.H.00437; Henderson APD, 2008, BRAIN, V131, P277, DOI 10.1093/brain/awm285; Holland JP, 2012, J BONE JOINT SURG BR, V94B, P471, DOI 10.1302/0301-620X.94B4.27895; Ikeda T, 2010, MUSCLE NERVE, V42, P140, DOI 10.1002/mus.21638; JEWETT DL, 1971, BRAIN, V94, P681, DOI 10.1093/brain/94.4.681; Katz B, 1995, Trans Am Ophthalmol Soc, V93, P685; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; MEECHAM HM, 1991, J NEUROL NEUROSUR PS, V54, P374, DOI 10.1136/jnnp.54.4.374; Oldenburg M., 2009, J ARTHROPLASTY, V24, P825, DOI [10.1016/j.arth.2008.07.017 e15-825.e20, DOI 10.1016/J.ARTH.2008.07.017]; Prentice JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066186; Raphael BA, 2006, AM J OPHTHALMOL, V142, P1026, DOI 10.1016/j.ajo.2006.06.060; Rising JP, 2012, NEW ENGL J MED, V367, DOI 10.1056/NEJMp1206794; Rizzetti MC, 2009, LANCET, V373, P1052, DOI 10.1016/S0140-6736(09)60490-6; Steens W, 2006, ACTA ORTHOP, V77, P830, DOI 10.1080/17453670610013079; Tower SS, 2010, J BONE JOINT SURG AM, V92A, P2847, DOI 10.2106/JBJS.J.00125	20	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90838	10.1371/journal.pone.0090838	http://dx.doi.org/10.1371/journal.pone.0090838			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621561	Green Published, Green Accepted, gold			2022-12-27	WOS:000332845300032
J	Sasson, M; Lee, M; Jan, C; Fontes, F; Motta, J				Sasson, Morris; Lee, Marcos; Jan, Carmen; Fontes, Flavia; Motta, Jorge			Prevalence and Associated Factors of Obesity among Panamanian Adults. 1982-2010	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; MORTALITY; OVERWEIGHT; INCOME; COUNTRIES; EPIDEMIC; COHORT; RISK	Background: In Central America, there has been a marked increase in obesity in the last 30 years. Over this time frame, in Panama, there have been lifestyle changes associated with economic development and urbanization that may have facilitated increases in body weight. The aim of the study is to describe the change in the prevalence of obesity in the country since 1982 and to analyze the association of obesity with gender, place of residence and socioeconomic factors. Methods: We analyzed three nationally representative cross-sectional studies and one sub-national study of Panamanian adults that evaluated anthropometric and socioeconomic variables; ENPA-1982 (n = 11 611), ENV-II 2003 (n = 14 737), ENV-III 2008 (n = 15 484), PREFREC-2010 (n = 3 590). We also evaluated one nationally representative study that evaluated people's perception of their body weight, ENSCAVI-2007 (n = 25 748). Results: In 1982, the prevalence in males of a body mass index (BMI) >= 30 kg/m(2) was 3.8% (3.3 - 4.2) and in females 7.6% (6.9 - 8.2). In 2003, the prevalence in males increased to 14.4% (13.6 - 15.2) and in females to 21.8% (20.8 - 22.7). In 2008, the prevalence in males was 16.9% (16.0 - 17.7) and in females it was 23.8% (22.8 - 24.7). Nevertheless, in 2007, the national perception of being obese was only 4% among males and 6.7% among females. The highest prevalence of obesity was noted in urban areas. Female gender and higher income were found to be positively associated with obesity. Income level was positively associated with abdominal obesity in men but not in women. Conclusions: There has been a marked increase of obesity in Panama in the last 3 decades. Initiatives to control this problem will have to take into consideration the observed gender difference and the lifestyle changes that have contributed to the rise of this problem.	[Sasson, Morris; Lee, Marcos; Jan, Carmen; Motta, Jorge] Gorgas Mem Inst Hlth Studies, Panama City, Panama; [Fontes, Flavia] Minist Hlth, Dept Nutr, Panama City, Panama	Instituto Conmemorativo Gorgas de Estudios de la Salud; Ministerio de Salud de la Republica de Panama	Motta, J (corresponding author), Gorgas Mem Inst Hlth Studies, Panama City, Panama.	drjmotta@gmail.com	Motta, Jorge Alejandro/ABI-6006-2020					Aballay LR, 2013, NUTR REV, V71, P168, DOI 10.1111/j.1753-4887.2012.00533.x; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Akil L, 2011, ETHNIC DIS, V21, P58; Alvarez V, 2009, EXPERT REV CARDIOVAS, V7, P281; Barcelo A, 2012, DIABETES CARE, V35, P738, DOI 10.2337/dc11-1614; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Chopra M, 2002, B WORLD HEALTH ORGAN, V80, P952; Clark Ashley E., 2013, Yale Journal of Biology and Medicine, V86, P29; Contraloria Panama website, 2008, ENC NIV VID ENV; Cossrow N, 2004, J CLIN ENDOCR METAB, V89, P2590, DOI 10.1210/jc.2004-0339; Cuevas A, 2011, CURR OPIN ENDOCRINOL, V18, P134, DOI 10.1097/MED.0b013e3283449167; Dahly DL, 2010, J NUTR, V140, P366, DOI 10.3945/jn.109.114207; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Filozof C, 2001, Obes Rev, V2, P99, DOI 10.1046/j.1467-789x.2001.00029.x; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2008, J CLIN ENDOCR METAB, V93, pS1, DOI 10.1210/jc.2008-1356; Garcia-Garcia E, 2008, SALUD PUBLICA MEXICO, V50, P530, DOI 10.1590/S0036-36342008000600015; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; Herman KM, 2013, QUALITY LIFE RES INT; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; ICGES website, 2010, PREV FACT RIESG AS E; ICGES website, TAS AJ MORT TOD ENF; ICGES website, 2007, ENC NAC SAL CAL VID; Kuchler F, 2003, INT J OBESITY, V27, P856, DOI 10.1038/sj.ijo.0802293; Lemon SC, 2009, BODY IMAGE, V6, P90, DOI 10.1016/j.bodyim.2008.11.004; Liu JK, 2013, OBESITY, V21, P644, DOI 10.1002/oby.20265; de Mola CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050252; Lovejoy JC, 1996, METABOLISM, V45, P1119, DOI 10.1016/S0026-0495(96)90011-6; MacDonald J, 2009, REV PANAM SALUD PUBL, V26, P290, DOI 10.1590/S1020-49892009001000002; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mokdad AH, 2000, JAMA-J AM MED ASSOC, V284, P1650, DOI 10.1001/jama.284.13.1650; Monteiro CA, 2001, J NUTR, V131, p881S, DOI 10.1093/jn/131.3.881S; Motta J, 2012, ANALISIS MORTALIDAD; Motta JA, 2013, REV PANAM SALUD PUBL, V34, P114; Neuman M, 2013, AM J CLIN NUTR, V97, P428, DOI 10.3945/ajcn.112.045997; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Pisabarro R, 2009, REV MED URUG, V25, P14; Popkin BM, 1998, NUTR REV, V56, P106; Rodriquez J RF, 2009, ENCUESTA NACL SALUD; Schulz LO, 2006, DIABETES CARE, V29, P1866, DOI 10.2337/dc06-0138; Seubsman SA, 2010, J EPIDEMIOL, V20, P13, DOI 10.2188/jea.JE20090014; Solomon CG, 1997, AM J CLIN NUTR, V66, P1044, DOI 10.1093/ajcn/66.4.1044S; Stoddard P, 2011, SOC SCI MED, V73, P1635, DOI 10.1016/j.socscimed.2011.09.006; The World Bank website, PAN ENC NIV VID 2008; The World Bank website, URB POP; The World Bank website, PAN OV; The World Bank website, LIV STAND MEAS STUD; The World Bank website, 2003, ENC NIV VID ENV; The World Bank website, GDP PER CAP; Thompson D, 1999, ARCH INTERN MED, V159, P2177, DOI 10.1001/archinte.159.18.2177; Uauy R, 2001, J NUTR, V131, p893S, DOI 10.1093/jn/131.3.893S; Webber L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039589; WHO website, OV OB MEAN BOD MASS; Xiao YY, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-355	58	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91689	10.1371/journal.pone.0091689	http://dx.doi.org/10.1371/journal.pone.0091689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24621825	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300119
J	Zhang, BC; Zhang, J; Sun, L				Zhang, Bao-cun; Zhang, Jian; Sun, Li			Streptococcus iniae SF1: Complete Genome Sequence, Proteomic Profile, and Immunoprotective Antigens	PLOS ONE			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; TURBOT SCOPHTHALMUS-MAXIMUS; BIOFILM FORMATION; BINDING-PROTEIN; ALPHA-ENOLASE; STAPHYLOCOCCUS-AUREUS; NEURAMINIDASE VACCINE; GENETIC COMPETENCE; BACILLUS-SUBTILIS; AQUATIC PATHOGEN	Streptococcus iniae is a Gram-positive bacterium that is reckoned one of the most severe aquaculture pathogens. It has a broad host range among farmed marine and freshwater fish and can also cause zoonotic infection in humans. Here we report for the first time the complete genome sequence as well as the host factor-induced proteomic profile of a pathogenic S. iniae strain, SF1, a serotype I isolate from diseased fish. SF1 possesses a single chromosome of 2,149,844 base pairs, which contains 2,125 predicted protein coding sequences (CDS), 12 rRNA genes, and 45 tRNA genes. Among the protein-encoding CDS are genes involved in resource acquisition and utilization, signal sensing and transduction, carbohydrate metabolism, and defense against host immune response. Potential virulence genes include those encoding adhesins, autolysins, toxins, exoenzymes, and proteases. In addition, two putative prophages and a CRISPR-Cas system were found in the genome, the latter containing a CRISPR locus and four cas genes. Proteomic analysis detected 21 secreted proteins whose expressions were induced by host serum. Five of the serum-responsive proteins were subjected to immunoprotective analysis, which revealed that two of the proteins were highly protective against lethal S. iniae challenge when used as purified recombinant subunit vaccines. Taken together, these results provide an important molecular basis for future study of S. iniae in various aspects, in particular those related to pathogenesis and disease control.	[Zhang, Bao-cun; Zhang, Jian; Sun, Li] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Zhang, Bao-cun; Zhang, Jian] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Sun, Li] Zhejiang Univ, Collaborat Innovat Ctr Deep Sea Biol, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang University	Sun, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	lsun@qdio.ac.cn		Zhang, Bao-cun/0000-0001-6104-0848	National Natural Science Foundation of China [31025030]; Shandong Scientific and Technological Project [2010GHY10511]; Taishan Scholar Program of Shandong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Scientific and Technological Project; Taishan Scholar Program of Shandong Province	This work was supported by grants from the National Natural Science Foundation of China (31025030), the Shandong Scientific and Technological Project (2010GHY10511), and the Taishan Scholar Program of Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian PV, 2004, VACCINE, V22, P2737, DOI 10.1016/j.vaccine.2004.01.042; Agnew W, 2007, VET MICROBIOL, V122, P1, DOI 10.1016/j.vetmic.2007.03.002; Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Albanesi D, 2004, J BACTERIOL, V186, P2655, DOI 10.1128/JB.186.9.2655-2663.2004; Allen JP, 2012, INFECT IMMUN, V80, P1707, DOI 10.1128/IAI.00027-12; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amagai M, 2002, J INVEST DERMATOL, V118, P845, DOI 10.1046/j.1523-1747.2002.01751.x; Andrade MA, 2002, GENOME BIOL, V3; Aviles F, 2013, VET MICROBIOL, V162, P151, DOI 10.1016/j.vetmic.2012.08.018; Bachrach G, 2001, APPL ENVIRON MICROB, V67, P3756, DOI 10.1128/AEM.67.8.3756-3758.2001; Baiano JCF, 2009, EMERG INFECT DIS, V15, P1891, DOI 10.3201/eid1512.090232; Baiano JCF, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-67; Barnes AC, 2003, DIS AQUAT ORGAN, V53, P241, DOI 10.3354/dao053241; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Biswas I, 2008, J BACTERIOL, V190, P68, DOI 10.1128/JB.00990-07; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bose B, 2008, MOL MICROBIOL, V70, P570, DOI 10.1111/j.1365-2958.2008.06414.x; Buchanan JT, 2005, INFECT IMMUN, V73, P6935, DOI 10.1128/IAI.73.10.6935-6944.2005; Cartron ML, 2006, BIOMETALS, V19, P143, DOI 10.1007/s10534-006-0003-2; Chen C, 2013, FISH SHELLFISH IMMUN, V35, P1677, DOI 10.1016/j.fsi.2013.08.020; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Cheng S, 2010, VACCINE, V28, P2636, DOI 10.1016/j.vaccine.2010.01.016; Coats MT, 2011, MICROB PATHOGENESIS, V50, P343, DOI 10.1016/j.micpath.2011.02.010; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Deroo T, 1996, VACCINE, V14, P561, DOI 10.1016/0264-410X(95)00157-V; Desrosiers DC, 2007, MOL MICROBIOL, V65, P137, DOI 10.1111/j.1365-2958.2007.05771.x; Dinis M, 2009, J INFECT DIS, V199, P116, DOI 10.1086/594372; Du J, 2001, MODERN FISHERIES, V5, P28; El Aamri F, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00025-13; Emanuelsson C, 2007, MOL IMMUNOL, V44, P3256, DOI 10.1016/j.molimm.2007.01.019; Eppinger M, 2004, NAT REV MICROBIOL, V2, P872, DOI 10.1038/nrmicro1024; Esgleas M, 2008, MICROBIOL-SGM, V154, P2668, DOI 10.1099/mic.0.2008/017145-0; Eyngor M, 2008, APPL ENVIRON MICROB, V74, P6892, DOI 10.1128/AEM.00853-08; Eyngor M, 2010, FEMS MICROBIOL LETT, V305, P109, DOI 10.1111/j.1574-6968.2010.01919.x; Fabret C, 1999, J BACTERIOL, V181, P1975, DOI 10.1128/JB.181.7.1975-1983.1999; Ferrando ML, 2010, MICROBIOL-SGM, V156, P2818, DOI 10.1099/mic.0.037960-0; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fuller JD, 2002, INFECT IMMUN, V70, P5730, DOI 10.1128/IAI.70.10.5730-5739.2002; GILSON E, 1988, EMBO J, V7, P3971, DOI 10.1002/j.1460-2075.1988.tb03284.x; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Grebe TW, 1999, ADV MICROB PHYSIOL, V41, P139, DOI 10.1016/S0065-2911(08)60167-8; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hoe N, 1999, EMERG INFECT DIS, V5, P254, DOI 10.3201/eid0502.990210; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Jedrzejas MJ, 2004, FRONT BIOSCI-LANDMRK, V9, P891, DOI 10.2741/1299; Jiao XD, 2010, VACCINE, V28, P1832, DOI 10.1016/j.vaccine.2009.11.083; JURGENS D, 1987, J EXP MED, V165, P720, DOI 10.1084/jem.165.3.720; Kascakova S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038624; Kilbourne ED, 1995, VACCINE, V13, P1799, DOI 10.1016/0264-410X(95)00127-M; Kohler C, 2003, J BACTERIOL, V185, P6928, DOI 10.1128/JB.185.23.6928-6937.2003; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lang SH, 2003, J BIOL CHEM, V278, P38167, DOI 10.1074/jbc.M303544200; Locke JB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002824; Locke JB, 2007, J BACTERIOL, V189, P1279, DOI 10.1128/JB.01175-06; Long JP, 2004, INFECT IMMUN, V72, P4309, DOI 10.1128/IAI.72.7.4309-4313.2004; Lopez R, 2000, RES MICROBIOL, V151, P437, DOI 10.1016/S0923-2508(00)00172-8; Low D. E., 1999, Emerging infections 3., P53; Lowe BA, 2007, INFECT IMMUN, V75, P1255, DOI 10.1128/IAI.01484-06; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lyon WR, 1998, EMBO J, V17, P6263, DOI 10.1093/emboj/17.21.6263; Lyon WR, 2003, J BACTERIOL, V185, P3661, DOI 10.1128/JB.185.12.3661-3667.2003; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; McLean MJ, 1998, J MOL EVOL, V47, P691, DOI 10.1007/PL00006428; Milani CJE, 2010, MICROBIOL-SGM, V156, P543, DOI 10.1099/mic.0.028365-0; Millard CM, 2012, APPL ENVIRON MICROB, V78, P8219, DOI 10.1128/AEM.02216-12; Miller JD, 2005, INFECT IMMUN, V73, P921, DOI 10.1128/IAI.73.2.921-934.2005; Mills S, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S7; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Nawawi RA, 2008, J FISH DIS, V31, P305, DOI 10.1111/j.1365-2761.2007.00880.x; Necsulea A, 2007, MOL BIOL EVOL, V24, P2169, DOI 10.1093/molbev/msm148; Nemoto K, 2003, CHEMOTHERAPY, V49, P121, DOI 10.1159/000070617; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Ogata H., 1999, NUCLEIC ACIDS RES, V27, P29, DOI DOI 10.1093/nar/27.1.29; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Pritchard DG, 2007, APPL ENVIRON MICROB, V73, P7150, DOI 10.1128/AEM.01783-07; Qi FX, 2004, INFECT IMMUN, V72, P4895, DOI 10.1128/IAI.72.8.4895-4899.2004; Quach D, 2009, J BACTERIOL, V191, P2023, DOI 10.1128/JB.01216-08; Reynolds J, 2011, J MOL BIOL, V412, P862, DOI 10.1016/j.jmb.2011.06.018; Saier MH, 2000, MICROBIOL-SGM, V146, P1775, DOI 10.1099/00221287-146-8-1775; Senadheera D, 2009, J BACTERIOL, V191, P6415, DOI 10.1128/JB.00793-09; Senadheera MD, 2007, J BACTERIOL, V189, P1451, DOI 10.1128/JB.01161-06; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Shibata Y, 2005, INFECT IMMUN, V73, P3512, DOI 10.1128/IAI.73.6.3512-3520.2005; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sun Y, 2010, VACCINE, V28, P3905, DOI 10.1016/j.vaccine.2010.03.071; Szurmant H, 2007, J BACTERIOL, V189, P3280, DOI 10.1128/JB.01936-06; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; van der Ploeg JR, 2010, VIRUS GENES, V41, P450, DOI 10.1007/s11262-010-0525-0; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Wang J Y, 2002, BIOCHEMISTRY; Ware D, 2005, J MICROBIOL, V43, P398; Wen YT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007013; WILLIAMSON R, 1980, J BACTERIOL, V144, P105, DOI 10.1128/JB.144.1.105-113.1980; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Zhang AD, 2009, VACCINE, V27, P1348, DOI 10.1016/j.vaccine.2008.12.047; Zhang J, 2013, J PROTEOMICS, V91, P430, DOI 10.1016/j.jprot.2013.07.033; Zhang WW, 2007, APPL ENVIRON MICROB, V73, P2825, DOI 10.1128/AEM.02872-06; Zheng WJ, 2010, FISH SHELLFISH IMMUN, V28, P829, DOI 10.1016/j.fsi.2010.01.013; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; Zinkernagel AS, 2008, CELL HOST MICROBE, V4, P170, DOI 10.1016/j.chom.2008.07.002	111	29	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91324	10.1371/journal.pone.0091324	http://dx.doi.org/10.1371/journal.pone.0091324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621602	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300076
J	Alford, JE; Gumbs, J; Anderson, EC				Alford, Justine E.; Gumbs, Jade; Anderson, Emma C.			A New Role for Clathrin Adaptor Proteins 1 and 3 in Lipoplex Trafficking	PLOS ONE			English	Article							INTRACELLULAR TRAFFICKING; HIV-1 GAG; GENE DELIVERY; PLASMID DNA; TRANSFECTION; COMPLEX; CELLS	Intracellular protein trafficking through secretory and endocytic pathways depends on the function of adaptor proteins that bind motifs on cargo proteins. The adaptor proteins then recruit coat proteins such as clathrin, enabling the formation of a transport vesicle. While studying the role of the clathrin adaptor proteins, AP-1, AP-2 and AP-3 in viral protein trafficking, we discovered that AP-1 and AP-3 potentially have a role in successful transfection of mammalian cells with DNA-liposome complexes (lipoplexes). We showed that AP-1, -2 and -3 are not required for lipoplexes to enter cells, but that lipoplexes and/or released DNA are unable to reach the nucleus in the absence of AP-1 or AP-3, leading to minimal exogenous gene expression. In contrast, gene expression from liposome-delivered mRNA, which does not require nuclear entry, was not impaired by the absence of AP-1 or AP-3. Despite the use of lipoplexes to mediate gene delivery being so widely used in cell biology and, more recently, gene therapy, the mechanism by which lipoplexes or DNA reach the nucleus is poorly characterised. This work sheds light on the components involved in this process, and demonstrates a novel role for AP-1 and AP-3 in trafficking lipoplexes.	[Alford, Justine E.; Gumbs, Jade; Anderson, Emma C.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Anderson, EC (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	e.c.anderson@warwick.ac.uk			UK Medical Research Council [G0701220]; Medical Research Council [G0701220] Funding Source: researchfish; MRC [G0701220] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council (grant number G0701220 to ECA and a PhD studentship to JEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo C, 2009, P NATL ACAD SCI USA, V106, P21161, DOI 10.1073/pnas.0909176106; Batonick M, 2005, VIROLOGY, V342, P190, DOI 10.1016/j.virol.2005.08.001; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Cardarelli F, 2012, MOL PHARMACEUT, V9, P334, DOI 10.1021/mp200374e; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; DOWTY ME, 1995, P NATL ACAD SCI USA, V92, P4572, DOI 10.1073/pnas.92.10.4572; Duzgunes N, 2012, METHOD ENZYMOL, V509, P355, DOI 10.1016/B978-0-12-391858-1.00018-6; El Ouahabi A, 1999, J HISTOCHEM CYTOCHEM, V47, P1159; Elouahabi A, 2005, MOL THER, V11, P336, DOI 10.1016/j.ymthe.2004.12.006; Farina F, 2013, NUCLEIC ACIDS RES, V41, P4926, DOI 10.1093/nar/gkt204; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; Hoekstra D, 2007, BIOCHEM SOC T, V35, P68, DOI 10.1042/BST0350068; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Kyere SK, 2012, VIRUS RES, V169, P411, DOI 10.1016/j.virusres.2012.06.007; Lechardeur D, 1999, GENE THER, V6, P482, DOI 10.1038/sj.gt.3300867; Mesika A, 2005, HUM GENE THER, V16, P200, DOI 10.1089/hum.2005.16.200; Miller AM, 2009, ADV DRUG DELIVER REV, V61, P603, DOI 10.1016/j.addr.2009.02.008; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Rehman ZU, 2013, ACS NANO, V7, P3767, DOI 10.1021/nn3049494; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Schmidt MR, 2009, P NATL ACAD SCI USA, V106, P15344, DOI 10.1073/pnas.0904268106; Vaughan EE, 2006, MOL THER, V13, P422, DOI 10.1016/j.ymthe.2005.10.004	23	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91429	10.1371/journal.pone.0091429	http://dx.doi.org/10.1371/journal.pone.0091429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618578	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400092
J	Screen, M; Raheem, O; Holmlund-Hampf, J; Jonson, PH; Huovinen, S; Hackman, P; Udd, B				Screen, Mark; Raheem, Olayinka; Holmlund-Hampf, Jeanette; Jonson, Per Harald; Huovinen, Sanna; Hackman, Peter; Udd, Bjarne			Gene Expression Profiling in Tibial Muscular Dystrophy Reveals Unfolded Protein Response and Altered Autophagy	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INCLUSION-BODY MYOSITIS; VALOSIN-CONTAINING PROTEIN; C-TERMINAL TITIN; DISTAL MYOPATHY; ER STRESS; RIMMED VACUOLES; MUSCLE; MUTATIONS; DISEASE	Tibial muscular dystrophy (TMD) is a late onset, autosomal dominant distal myopathy that results from mutations in the two last domains of titin. The cascade of molecular events leading from the causative Titin mutations to the preterm death of muscle cells in TMD is largely unknown. In this study we examined the mRNA and protein changes associated with the myopathology of TMD. To identify these components we performed gene expression profiling using muscle biopsies from TMD patients and healthy controls. The profiling results were confirmed through quantitative real-time PCR and protein level analysis. One of the pathways identified was activation of endoplasmic reticulum (ER) stress response. ER stress activates the unfolded protein response (UPR) pathway. UPR activation was supported by elevation of the marker genes HSPA5, ERN1 and the UPR specific XBP1 splice form. However, UPR activation appears to be insufficient to correct the protein abnormalities causing its activation because degenerative TMD muscle fibres show an increase in ubiquitinated protein inclusions. Abnormalities of VCP-associated degradation pathways are also suggested by the presence of proteolytic VCP fragments in western blotting, and VCP's accumulation within rimmed vacuoles in TMD muscle fibres together with p62 and LC3B positive autophagosomes. Thus, pathways controlling turnover and degradation, including autophagy, are distorted and lead to degeneration and loss of muscle fibres.	[Screen, Mark; Holmlund-Hampf, Jeanette; Jonson, Per Harald; Hackman, Peter; Udd, Bjarne] Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; [Screen, Mark; Holmlund-Hampf, Jeanette; Jonson, Per Harald; Hackman, Peter; Udd, Bjarne] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland; [Raheem, Olayinka; Huovinen, Sanna; Udd, Bjarne] Tampere Univ Hosp, Dept Neurol, Neuromuscular Res Unit, Tampere, Finland; [Raheem, Olayinka; Huovinen, Sanna; Udd, Bjarne] Univ Tampere, FIN-33101 Tampere, Finland; [Huovinen, Sanna] Tampere Univ Hosp, Fimlab Labs, Dept Pathol, Tampere, Finland; [Udd, Bjarne] Vaasa Cent Hosp, Dept Neurol, Vaasa, Finland	University of Helsinki; University of Helsinki; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Vaasa Central Hospital	Screen, M (corresponding author), Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland.	mark.screen@helsinki.fi	Jonson, pH/GPX-1306-2022	Huovinen, Sanna/0000-0001-7659-7921; Jonson, Per Harald/0000-0003-2423-359X	Folkhalsan Research Foundation; University of Helsinki; National Doctoral Program of Musculoskeletal Disorders and Biomaterials; Liv och Halsa Foundation; Vaasa Central Hospital District Medical Research funds	Folkhalsan Research Foundation; University of Helsinki; National Doctoral Program of Musculoskeletal Disorders and Biomaterials; Liv och Halsa Foundation; Vaasa Central Hospital District Medical Research funds	The study received funding from the Folkhalsan Research Foundation, the University of Helsinki, the National Doctoral Program of Musculoskeletal Disorders and Biomaterials. Research grants from the Liv och Halsa Foundation and Vaasa Central Hospital District Medical Research funds are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askanas V, 2008, ACTA NEUROPATHOL, V116, P583, DOI 10.1007/s00401-008-0449-0; Boito CA, 2007, VIRCHOWS ARCH, V451, P1047, DOI 10.1007/s00428-007-0515-3; Carmignac V, 2007, ANN NEUROL, V61, P340, DOI 10.1002/ana.21089; Ceyhan-Birsoy O, 2013, NEUROLOGY, V81, P1205, DOI 10.1212/WNL.0b013e3182a6ca62; Charton K, 2010, HUM MOL GENET, V19, P4608, DOI 10.1093/hmg/ddq388; Chauveau C, 2013, HUM MOL GEN IN PRESS; Chen YN, 2013, TRENDS CELL BIOL, V23, P547, DOI 10.1016/j.tcb.2013.06.005; Ching JK, 2013, HUM MOL GENET, V22, P1167, DOI 10.1093/hmg/dds524; Eisenberg I, 2008, HUM MOL GENET, V17, P3663, DOI 10.1093/hmg/ddn261; Fukuzawa A, 2008, J CELL SCI, V121, P1841, DOI 10.1242/jcs.028019; Gautel M, 1999, REV PHYSIOL BIOCH P, V138, P97, DOI 10.1007/BF02346661; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; Hackman P, 2008, NEUROMUSCULAR DISORD, V18, P922, DOI 10.1016/j.nmd.2008.07.010; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Halawani D, 2010, J NEUROSCI, V30, P6132, DOI 10.1523/JNEUROSCI.5874-09.2010; Haravuori H, 2001, NEUROLOGY, V56, P869, DOI 10.1212/WNL.56.7.869; Ito H, 2005, J CELL BIOCHEM, V95, P932, DOI 10.1002/jcb.20445; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kolmerer B, 1996, J MOL BIOL, V256, P556, DOI 10.1006/jmbi.1996.0108; Kuga A, 2011, HUM MOL GENET, V20, P2975, DOI 10.1093/hmg/ddr201; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Lee HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036221; Liewluck T, 2007, MUSCLE NERVE, V35, P322, DOI 10.1002/mus.20691; LIN HY, 1993, MOL BIOL CELL, V4, P1109, DOI 10.1091/mbc.4.11.1109; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Nogalska A, 2010, AM J PATHOL, V177, P1377, DOI 10.2353/ajpath.2010.100050; Nogalska A, 2009, ACTA NEUROPATHOL, V118, P407, DOI 10.1007/s00401-009-0564-6; Olive M, 2008, NEUROPATH APPL NEURO, V34, P76, DOI 10.1111/j.1365-2990.2007.00864.x; Palmio J, 2013, J NEUROL NU IN PRESS; Palmio J, 2011, NEUROMUSCULAR DISORD, V21, P551, DOI 10.1016/j.nmd.2011.05.008; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pollazzon M, 2010, J NEUROL, V257, P575, DOI 10.1007/s00415-009-5372-3; Raheem O, 2010, AM J PATHOL, V177, P3025, DOI 10.2353/ajpath.2010.100179; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Tsuruta Y, 2001, ACTA NEUROPATHOL, V101, P579; Udd B, 2005, NEUROLOGY, V64, P636, DOI 10.1212/01.WNL.0000151853.50144.82; UDD B, 1992, J MED GENET, V29, P383, DOI 10.1136/jmg.29.6.383; UDD B, 1993, ARCH NEUROL-CHICAGO, V50, P604, DOI 10.1001/archneur.1993.00540060044015; Udd B, 1998, NEUROMUSCULAR DISORD, V8, P327, DOI 10.1016/S0960-8966(98)00024-8; Van den Bergh PYK, 2003, ANN NEUROL, V54, P248, DOI 10.1002/ana.10647; Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2010, CURR OPIN NEUROL, V23, P482, DOI 10.1097/WCO.0b013e32833d3897; Yan CZ, 2001, ACTA NEUROPATHOL, V101, P9; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	50	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90819	10.1371/journal.pone.0090819	http://dx.doi.org/10.1371/journal.pone.0090819			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618559	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400031
J	Splith, K; Fellmer, P; Matia, I; Varga, M; Oliverius, M; Kuhn, S; Feldbrugge, L; Krenzien, F; Hau, HM; Wiltberger, G; Schmelzle, M; Jonas, S				Splith, Katrin; Fellmer, Peter; Matia, Ivan; Varga, Martin; Oliverius, Martin; Kuhn, Stephanie; Feldbruegge, Linda; Krenzien, Felix; Hau, Hans-Michael; Wiltberger, Georg; Schmelzle, Moritz; Jonas, Sven			Antibody-Mediated Rejection of Arterialised Venous Allografts Is Inhibited by Immunosuppression in Rats	PLOS ONE			English	Article							VEIN ALLOGRAFTS; FRESH; RECONSTRUCTION; CYCLOSPORINE; DOGS; TRANSPLANTATION; SENSITIZATION; CHILDREN; MOFETIL; DISEASE	Objectives and Design: We determined in a rat model (1) the presence and dynamics of alloantibodies recognizing MHC complexes on quiescent Brown-Norway (BN) splenic cells in the sera of Lewis (LEW) recipients of Brown-Norway iliolumbar vein grafts under tacrolimus immunosuppression; and (2) the presence of immunoglobulins in the wall of acute rejected vein allografts. Materials and Methods: Flow cytometry was used for the analysis of day 0, 14 and 30 sera obtained from Lewis recipients of isogeneic iliolumbar vein grafts (group A) or Brown-Norway grafts (group B, C) for the presence of donor specific anti-MHC class I and II antibodies. Tacrolimus 0.2 mg/kg daily was administered from day 1 to day 30 (group C). Histology was performed on day 30. Results: Sera obtained preoperatively and on day 30 were compared in all groups. The statistically significant decrease of anti MHC class I and II antibody binding was observed only in allogenic non-immunosuppressed group B (splenocytes: MHC class I-day 0 (93%+/-67%) vs day 30 (66%+/-67%), p = 0.02, MHC class II-day 0 (105%+/-63%) vs day 30 (83%+/-65%), p = 0.003; B-cells: MHC class I-day 0 (83%+/-65%) vs day 30 (55%+/-66%), p = 0.003, MHC class II-day 0 (101%+/-61%) vs day 30 (79%+/-66%), p = 0.006; T-cells: MHC class I-day 0 (71%+/-67%) vs day 30 (49%+/-65%), p = 0.04). No free clusters of immunoglobulin G deposition were detected in any experimental group. Conclusion: Arterialized venous allografts induce strong donor-specific anti-MHC class I and anti-MHC class II antibody production with subsequent immune-mediated destruction of these allografts with no evidence of immunoglobulin G deposition. Low-dose tacrolimus suppress the donor-specific antibody production.	[Splith, Katrin; Kuhn, Stephanie; Feldbruegge, Linda; Schmelzle, Moritz; Jonas, Sven] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Fellmer, Peter; Matia, Ivan; Feldbruegge, Linda; Krenzien, Felix; Hau, Hans-Michael; Wiltberger, Georg; Schmelzle, Moritz; Jonas, Sven] Univ Leipzig, Dept Visceral Transplantat Thorac & Vasc Surg, D-04109 Leipzig, Germany; [Varga, Martin; Oliverius, Martin] Inst Clin & Expt Med, Transplant Surg Dept, Prague, Czech Republic	Leipzig University; Leipzig University; Institute for Clinical & Experimental Medicine (IKEM)	Matia, I (corresponding author), Univ Leipzig, Dept Visceral Transplantat Thorac & Vasc Surg, D-04109 Leipzig, Germany.	ivan.matia@medizin.uni-leipzig.de	Oliverius, Martin/K-1693-2017; Oliverius, Martin/N-5599-2019; Hau, Hans-Michael/AAJ-1005-2021	Oliverius, Martin/0000-0002-8649-3824; Oliverius, Martin/0000-0002-8649-3824; Splith, Katrin/0000-0002-1841-1495; Krenzien, Felix/0000-0003-0593-9917; , Linda/0000-0002-3372-609X	German Federal Ministry of Education and Research [BMBF 1315883]; German Research Foundation (DFG); Leipzig University	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	This work was supported by funding from the German Federal Ministry of Education and Research (BMBF 1315883). This work was supported by the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma N, 1999, J VASC SURG, V29, P694, DOI 10.1016/S0741-5214(99)70316-2; Balzer KM, 2004, TISSUE ANTIGENS, V64, P13, DOI 10.1111/j.0001-2815.2004.00236.x; BANDLIEN KO, 1983, ARCH SURG-CHICAGO, V118, P829; Farber A, 2003, J VASC SURG, V38, P15, DOI 10.1016/S0741-5214(03)00330-6; Fellmer PT, 2013, ZENTRALBL CHIR; Freguin-Bouilland C, 2011, TRANSPLANTATION, V91, P35, DOI 10.1097/TP.0b013e3181fe12d6; Hamada N, 2010, ATHEROSCLEROSIS, V208, P97, DOI 10.1016/j.atherosclerosis.2009.07.040; Lopez-Cepero M, 2002, TRANSPLANTATION, V73, P817, DOI 10.1097/00007890-200203150-00029; Madden R, 2002, AM J KIDNEY DIS, V40, P1240, DOI 10.1053/ajkd.2002.36892; Matia I, 2010, EUR J VASC ENDOVASC, V39, P478, DOI 10.1016/j.ejvs.2009.11.016; Matia I, 2007, TRANSPL INT, V20, P371, DOI 10.1111/j.1432-2277.2006.00446.x; MILLER VM, 1993, J VASC SURG, V18, P216, DOI 10.1016/0741-5214(93)90601-H; Mingoli A, 1996, J SURG RES, V62, P95, DOI 10.1006/jsre.1996.0180; Mirelli M, 2005, TRANSPLANT P, V37, P2688, DOI 10.1016/j.transproceed.2005.06.034; O'Connor MJ, 2013, J HEART LUNG TRANSPL, V32, P390, DOI 10.1016/j.healun.2012.12.009; Plissonnier D, 2000, TRANSPLANTATION, V69, P2601, DOI 10.1097/00007890-200006270-00021; Posner MP, 1996, J AM COLL SURGEONS, V183, P208; Randon C, 2010, J VASC SURG, V51, P869, DOI 10.1016/j.jvs.2009.11.062; Shaddy RE, 2004, ANN THORAC SURG, V77, P1734, DOI 10.1016/j.athoracsur.2003.10.047; Shaddy RE, 2001, ANN THORAC SURG, V71, P43, DOI 10.1016/S0003-4975(00)02183-4; Tepperman E, 2010, CAN J SURG, V53, P57; Thaunat O, 2005, P NATL ACAD SCI USA, V102, P14723, DOI 10.1073/pnas.0507223102; Thaunat O, 2006, ARTERIOSCL THROM VAS, V26, P2359, DOI 10.1161/01.ATV.0000241980.09816.ac; Thaunat O, 2012, TRANSPL IMMUNOL, V26, P101, DOI 10.1016/j.trim.2011.11.003; van Herck H, 2000, LAB ANIM, V34, P10, DOI 10.1258/002367700780577993; Varga M, 2012, BRATISL MED J, V113, P5, DOI 10.4149/BLL_2012_001; Vicenti F, 2002, TRANSPLANTATION, V73, P775, DOI 10.1097/00007890-200203150-00021; WAGNER E, 1994, TRANSPLANTATION, V58, P537, DOI 10.1097/00007890-199409150-00002; WAGNER E, 1995, J THORAC CARDIOV SUR, V110, P1732, DOI 10.1016/S0022-5223(95)70037-4	29	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91212	10.1371/journal.pone.0091212	http://dx.doi.org/10.1371/journal.pone.0091212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618652	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400056
J	Zhou, ZY; Zheng, J; Dai, YK; Zhou, Z; Chen, S				Zhou, Zhiyong; Zheng, Jian; Dai, Yakang; Zhou, Zhe; Chen, Shi			Robust Non-Rigid Point Set Registration Using Student's-t Mixture Model	PLOS ONE			English	Article								The Student's-t mixture model, which is heavily tailed and more robust than the Gaussian mixture model, has recently received great attention on image processing. In this paper, we propose a robust non-rigid point set registration algorithm using the Student's-t mixture model. Specifically, first, we consider the alignment of two point sets as a probability density estimation problem and treat one point set as Student's-t mixture model centroids. Then, we fit the Student's-t mixture model centroids to the other point set which is treated as data. Finally, we get the closed-form solutions of registration parameters, leading to a computationally efficient registration algorithm. The proposed algorithm is especially effective for addressing the non-rigid point set registration problem when significant amounts of noise and outliers are present. Moreover, less registration parameters have to be set manually for our algorithm compared to the popular coherent points drift (CPD) algorithm. We have compared our algorithm with other state-of-the-art registration algorithms on both 2D and 3D data with noise and outliers, where our non-rigid registration algorithm showed accurate results and outperformed the other algorithms.	[Zhou, Zhiyong; Zheng, Jian; Dai, Yakang; Zhou, Zhe; Chen, Shi] Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, Suzhou, Peoples R China	Chinese Academy of Sciences; Suzhou Institute of Biomedical Engineering & Technology, CAS	Dai, YK (corresponding author), Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, Suzhou, Peoples R China.	daiyk@sibet.ac.cn	JIAN, ZHENG/ABC-1339-2021		Hundred Talents Program of CAS; NSFC grants [61301042, 61201117]; NSFJ grant [BK2012189]	Hundred Talents Program of CAS(Chinese Academy of Sciences); NSFC grants(National Natural Science Foundation of China (NSFC)); NSFJ grant	This work was supported in part by the Hundred Talents Program of CAS, NSFC grants (61301042, 61201117) and NSFJ grant (BK2012189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hundred Talents Program of CAS: http://www.1000plan.org/qrjh/channel/7, NSFC: http://www.nsfc.gov.cn/Portal0/default152.htm, SFJ: http://www.jstd.gov.cn.	Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bing J., 2011, PATTERN ANAL MACHINE, V33, P1633; Chatzis SP, 2009, IEEE T PATTERN ANAL, V31, P1657, DOI 10.1109/TPAMI.2008.215; Chen Z, 2002, NEURAL COMPUT, V14, P2791, DOI 10.1162/089976602760805296; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; Chui HL, 2000, IEEE WORKSHOP ON MATHEMATICAL METHODS IN BIOMEDICAL IMAGE ANALYSIS, PROCEEDINGS, P190, DOI 10.1109/MMBIA.2000.852377; Gerogiannis D., 2007, 2007 IEEE 11 INT C C, P1; Gerogiannis D, 2009, IMAGE VISION COMPUT, V27, P1285, DOI 10.1016/j.imavis.2008.11.013; GEWEKE J, 1993, J APPL ECONOM, V8, pS19, DOI 10.1002/jae.3950080504; Gold S, 1998, PATTERN RECOGN, V31, P1019, DOI 10.1016/S0031-3203(98)80010-1; Li QD, 2011, COMPUT AIDED DESIGN, V43, P394, DOI 10.1016/j.cad.2011.01.007; Li XL, 2012, IEEE T MED IMAGING, V31, P1849, DOI 10.1109/TMI.2012.2203922; Liu JJ, 2007, PR IEEE COMP DESIGN, P17; Madsen RE, 2005, 22 INT C MACH LEARN, P545; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Peel D, 2000, STAT COMPUT, V10, P339, DOI 10.1023/A:1008981510081; Revow M, 1996, IEEE T PATTERN ANAL, V18, P592, DOI 10.1109/34.506410; Sfikas G, 2008, P IEEE INT C COMP VI, V1, P1, DOI DOI 10.1109/CVPR.2008.4587416; Spiegel M.R., 2013, SCHAUMSOUTLINE PROBA, V4th; Svensen M, 2005, NEUROCOMPUTING, V64, P235, DOI 10.1016/j.neucom.2004.11.018; Tsin Y, 2004, LECT NOTES COMPUT SC, V3023, P558; Wang P, 2011, SCI CHINA INFORM SCI, V54, P2639, DOI 10.1007/s11432-011-4465-7; Yuille A. L., 1988, Second International Conference on Computer Vision (IEEE Cat. No.88CH2664-1), P344, DOI 10.1109/CCV.1988.590011; YUILLE AL, 1989, INT J COMPUT VISION, V3, P155, DOI 10.1007/BF00126430	26	10	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91381	10.1371/journal.pone.0091381	http://dx.doi.org/10.1371/journal.pone.0091381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618749	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400083
J	Wang, RP; Sun, PD				Wang, Ruipeng; Sun, Peter D.			Natural Killer Cell-Mediated Shedding of ULBP2	PLOS ONE			English	Article							SOLUBLE UL16-BINDING PROTEIN-2; NKG2D LIGAND EXPRESSION; CLINICAL-SIGNIFICANCE; POOR-PROGNOSIS; CUTTING EDGE; NK CELLS; T-CELLS; RECEPTOR; APOPTOSIS; ACTIVATION	UL16 binding proteins (ULBPs) are a family of cell surface proteins that are present in transformed and stressed cells and ligands for NKG2D. Soluble NKG2D ligands have been found in sera from cancer patients with their protein concentrations correlated with poor cancer prognosis. Here we show, for the first time, that human tumor cells lost their surface expression of ULBP2, but not ULBP1 and ULBP3, during NK cell-mediated cytolysis. In contrast to spontaneous shedding of NKG2D ligands, NK cytolysis-mediated shedding of ULBP2 was linked to target cell apoptosis, although both resulted from metalloproteinase cleavages. Inhibition of ULBP2 shedding by a metalloproteinase inhibitor BB-94 lead to reduced NK cell-mediated cytotoxicity and cytokine production. These results illustrate a regulation of NK cell effector functions through cytolysis-induced NKG2D ligand shedding. Consequently, compounds inhibiting NKG2D ligand shedding may offer therapeutic means to reduce excessive pathogenic NK cell activities.	[Wang, Ruipeng; Sun, Peter D.] NIAID, Struct Immunol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sun, PD (corresponding author), NIAID, Struct Immunol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	psun@nih.gov	Wang, Ruipeng/I-1407-2013	Wang, Ruipeng/0000-0002-1003-1420	National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000853, ZIAAI000697] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funding is provided by the National Institute of Allergy and Infectious Diseases Intramural research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Boutet P, 2009, J IMMUNOL, V182, P49, DOI 10.4049/jimmunol.182.1.49; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; DRANSFIELD I, 1995, BLOOD, V85, P3264, DOI 10.1182/blood.V85.11.3264.bloodjournal85113264; Ferraro C, 2000, CELL DEATH DIFFER, V7, P197, DOI 10.1038/sj.cdd.4400595; Fogel LA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4232; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hilpert J, 2012, J IMMUNOL, V189, P1360, DOI 10.4049/jimmunol.1200796; Koolwijk P, 2001, BLOOD, V97, P3123, DOI 10.1182/blood.V97.10.3123; Li K, 2009, CANCER IMMUNOL IMMUN, V58, P641, DOI 10.1007/s00262-008-0585-3; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Madge LA, 1999, J BIOL CHEM, V274, P13643, DOI 10.1074/jbc.274.19.13643; Nuckel H, 2010, LEUKEMIA, V24, P1152, DOI 10.1038/leu.2010.74; Paschen A, 2009, CLIN CANCER RES, V15, P5208, DOI 10.1158/1078-0432.CCR-09-0886; Phenix BN, 2001, BLOOD, V98, P1078, DOI 10.1182/blood.V98.4.1078; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Schleinitz N, 2010, IMMUNOLOGY, V131, P451, DOI 10.1111/j.1365-2567.2010.03360.x; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Tian ZG, 2012, J AUTOIMMUN, V39, P206, DOI 10.1016/j.jaut.2012.05.006; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Wang RP, 2012, J LEUKOCYTE BIOL, V91, P299, DOI 10.1189/jlb.0611308; Yamaguchi K, 2012, CANCER SCI, V103, P1405, DOI 10.1111/j.1349-7006.2012.02330.x	29	8	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91133	10.1371/journal.pone.0091133	http://dx.doi.org/10.1371/journal.pone.0091133			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614922	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300083
J	Arnal, A; Gomez-Diaz, E; Cerda-Cuellar, M; Lecollinet, S; Pearce-Duvet, J; Busquets, N; Garcia-Bocanegra, I; Pages, N; Vittecoq, M; Hammouda, A; Samraoui, B; Garnier, R; Ramos, R; Selmi, S; Gonzalez-Solis, J; Jourdain, E; Boulinier, T				Arnal, Audrey; Gomez-Diaz, Elena; Cerda-Cuellar, Marta; Lecollinet, Sylvie; Pearce-Duvet, Jessica; Busquets, Nuria; Garcia-Bocanegra, Ignacio; Pages, Nonito; Vittecoq, Marion; Hammouda, Abdessalem; Samraoui, Boudjema; Garnier, Romain; Ramos, Rauel; Selmi, Slaheddine; Gonzalez-Solis, Jacob; Jourdain, Elsa; Boulinier, Thierry			Circulation of a Meaban-Like Virus in Yellow-Legged Gulls and Seabird Ticks in the Western Mediterranean Basin	PLOS ONE			English	Article							ORNITHODOROS ALECTOROBIUS MARITIMUS; BURGDORFERI-SENSU-LATO; NILE-VIRUS; LARUS-MICHAHELLIS; BORNE FLAVIVIRUSES; PHYLOGENETIC-RELATIONSHIPS; SOUTHERN FRANCE; BIRDS; EVOLUTION; DISEASE	In recent years, a number of zoonotic flaviviruses have emerged worldwide, and wild birds serve as their major reservoirs. Epidemiological surveys of bird populations at various geographical scales can clarify key aspects of the eco-epidemiology of these viruses. In this study, we aimed at exploring the presence of flaviviruses in the western Mediterranean by sampling breeding populations of the yellow-legged gull (Larus michahellis), a widely distributed, anthropophilic, and abundant seabird species. For 3 years, we sampled eggs from 19 breeding colonies in Spain, France, Algeria, and Tunisia. First, ELISAs were used to determine if the eggs contained antibodies against flaviviruses. Second, neutralization assays were used to identify the specific flaviviruses present. Finally, for colonies in which ELISA-positive eggs had been found, chick serum samples and potential vectors, culicid mosquitoes and soft ticks (Ornithodoros maritimus), were collected and analyzed using serology and PCR, respectively. The prevalence of flavivirus-specific antibodies in eggs was highly spatially heterogeneous. In northeastern Spain, on the Medes Islands and in the nearby village of L'Escala, 56% of eggs had antibodies against the flavivirus envelope protein, but were negative for neutralizing antibodies against three common flaviviruses: West Nile, Usutu, and tick-borne encephalitis viruses. Furthermore, little evidence of past flavivirus exposure was obtained for the other colonies. A subset of the Ornithodoros ticks from Medes screened for flaviviral RNA tested positive for a virus whose NS5 gene was 95% similar to that of Meaban virus, a flavivirus previously isolated from ticks of Larus argentatus in western France. All ELISA-positive samples subsequently tested positive for Meaban virus neutralizing antibodies. This study shows that gulls in the western Mediterranean Basin are exposed to a tick-borne Meaban-like virus, which underscores the need of exploring the spatial and temporal distribution of this flavivirus as well as its potential pathogenicity for animals and humans.	[Arnal, Audrey; Pearce-Duvet, Jessica; Garnier, Romain; Ramos, Rauel; Boulinier, Thierry] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France; [Arnal, Audrey; Vittecoq, Marion] Ctr Rech Tour Valat, Arles, France; [Gomez-Diaz, Elena] Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona, Spain; [Cerda-Cuellar, Marta] IRTA, Barcelona, Spain; [Cerda-Cuellar, Marta; Busquets, Nuria; Pages, Nonito] Univ Autonoma Barcelona, IRTA, Ctr Recerca Sanitat Anim CReSA, Bellaterra, Cerdanyola Del, Spain; [Lecollinet, Sylvie] Virol INRA, Anim Hlth Lab ANSES, ENVA, ANSES,UMR1161, Maisons Alfort, France; [Gonzalez-Solis, Jacob] Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain; [Gonzalez-Solis, Jacob] Univ Barcelona, Dept Biol Anim, Barcelona, Spain; [Garcia-Bocanegra, Ignacio] Univ Cordoba, Dept Sanidad Anim, Cordoba, Spain; [Hammouda, Abdessalem; Selmi, Slaheddine] Fac Sci Gabes, Dept Sci Vie, Gabes, Tunisia; [Samraoui, Boudjema] Univ Guelma, Lab Rech & Conservat Zones Humides, Guelma, Algeria; [Samraoui, Boudjema] King Saud Univ, Ctr Excellence Res Biodivers, Riyadh, Saudi Arabia; [Jourdain, Elsa] INRA, Unite Epidemiol Anim, UR346, F-63122 St Genes Champanelle, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; IRTA; Autonomous University of Barcelona; IRTA; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; University of Barcelona; University of Barcelona; Universidad de Cordoba; Universite de Gabes; Universite 8 Mai 1945 de Guelma; King Saud University; INRAE	Jourdain, E (corresponding author), INRA, Unite Epidemiol Anim, UR346, F-63122 St Genes Champanelle, France.	elsa.jourdain@clermont.inra.fr	Bocanegra, Ignacio Garcia/G-1443-2016; Busquets, Núria/T-8431-2017; arnal, audrey/ABR-6358-2022; Pages, Nonito/Q-1274-2016; Gómez-Díaz, Elena/AAA-9141-2019; Lecollinet, Sylvie/AAV-5276-2021; González-Solís, Jacob/AAB-1161-2019; Slaheddine, Selmi/AAD-1495-2021; Cerda, Marta/U-4534-2018; Gonzalez-Solis, Jacob/C-3942-2008; Gonzalez-Solis, Jacob/AAZ-5338-2021; Lecollinet, Sylvie/M-1728-2019; Gómez-Díaz, Elena/G-2503-2011; Samraoui, Boudjéma/E-6761-2011; Ramos, Raül/S-3112-2016	Bocanegra, Ignacio Garcia/0000-0003-3388-2604; Pages, Nonito/0000-0001-6020-7175; Gómez-Díaz, Elena/0000-0002-4146-9003; Slaheddine, Selmi/0000-0002-7204-9159; Cerda, Marta/0000-0001-6842-1299; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Gómez-Díaz, Elena/0000-0002-4146-9003; Samraoui, Boudjéma/0000-0002-0608-9021; Ramos, Raül/0000-0002-0551-8605; BOULINIER, Thierry/0000-0002-5898-7667; HAMMOUDA, Abdessalem/0000-0003-4078-7592; Lecollinet, Sylvie/0000-0001-8535-2133	Chateaubriand Postdoctoral Fellowship; National Science Foundation; Ministerio de Educacion y Ciencia, Spain; European Commission [PERG08-GA-ERG-2010- 276838]; Algerian Ministere de l'Enseignement Superieur et de la Recherche Scientifique (DGRSDT/MESRS); DSFP program, King Saud University, Saudi Arabia; OSU OREME; ANR [11 BSV7 003 EVEMATA, 13 BSV7 018 ESPEVEC]; INIA [FAU2008-00012-C02-01]; AIRD; CNRS	Chateaubriand Postdoctoral Fellowship; National Science Foundation(National Science Foundation (NSF)); Ministerio de Educacion y Ciencia, Spain(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Algerian Ministere de l'Enseignement Superieur et de la Recherche Scientifique (DGRSDT/MESRS); DSFP program, King Saud University, Saudi Arabia; OSU OREME; ANR(French National Research Agency (ANR)); INIA(Instituto de Investigacion Agropecuaria (INIA)); AIRD; CNRS(Centre National de la Recherche Scientifique (CNRS))	J. Pearce-Duvet was supported by a Chateaubriand Postdoctoral Fellowship and a National Science Foundation Postdoctoral Fellowship. E. Gomez-Diaz. was supported by a Juan de la Cierva contract from the Ministerio de Educacion y Ciencia, Spain, and a Marie Curie Reintegration Grant from the European Commission (PERG08-GA-ERG-2010- 276838). B. Samraoui was supported by the Algerian Ministere de l'Enseignement Superieur et de la Recherche Scientifique (DGRSDT/MESRS) and by the DSFP program, King Saud University, Saudi Arabia. Support from the OSU OREME, ANR (11 BSV7 003 EVEMATA and 13 BSV7 018 ESPEVEC grants), INIA (FAU2008-00012-C02-01), AIRD, and CNRS is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero M, 2011, EMERG INFECT DIS, V17, P1498, DOI 10.3201/eid1708.110077; Alba A, 2014, ZOONOSES PUBLIC HLTH, V61, P181, DOI 10.1111/zph.12048; Arens M, 1999, CLIN MICROBIOL REV, V12, P612, DOI 10.1128/CMR.12.4.612; Arizaga J, 2010, WATERBIRDS, V33, P444, DOI 10.1675/063.033.0403; Baaloudj A, 2012, ARDEOLA, V59, P137, DOI 10.13157/arla.59.1.2012.137; Beck C, 2013, INT J ENV RES PUB HE, V10, P6049, DOI 10.3390/ijerph10116049; Berthold P, 2001, AUK, V2nd; Bofill D, 2006, EMERG INFECT DIS, V12, P1163, DOI 10.3201/eid1207.060164; Bosch M, 1999, ARDEA, V87, P83; Boulinier T, 2008, TRENDS ECOL EVOL, V23, P282, DOI 10.1016/j.tree.2007.12.006; Calistri Paolo, 2010, Open Virol J, V4, P29, DOI 10.2174/1874357901004020029; Calzolari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014324; CHASTEL C, 1988, CR ACAD SCI III-VIE, V307, P479; CHASTEL C, 1983, REV EPIDEMIOL SANTE, V31, P445; CHASTEL C, 1985, ARCH VIROL, V83, P129, DOI 10.1007/BF01309911; Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6; Cramp S., 1988, HDB BIRDS EUROPE; Dauphin G, 2007, VACCINE, V25, P5563, DOI 10.1016/j.vaccine.2006.12.005; Dietrich M, 2011, VECTOR-BORNE ZOONOT, V11, P453, DOI 10.1089/vbz.2010.0009; Dobler G, 2010, VET MICROBIOL, V140, P221, DOI 10.1016/j.vetmic.2009.08.024; EpiSouth, 2010, W NIL VIR CIRC EPISO; EstradaPena A, 1996, ACAROLOGIA, V37, P19; Figuerola J, 2007, EMERG INFECT DIS, V13, P1915, DOI 10.3201/eid1312.070343; Figuerola J, 2007, AVIAN PATHOL, V36, P209, DOI 10.1080/03079450701332329; Garcia-Bocanegra I, 2011, VECTOR-BORNE ZOONOT, V11, P1107, DOI 10.1089/vbz.2009.0237; Garnier R, 2012, P ROY SOC B-BIOL SCI, V279, P2033, DOI 10.1098/rspb.2011.2277; Gasparini J, 2002, ECOL LETT, V5, P519, DOI 10.1046/j.1461-0248.2002.00345.x; Gasparini J, 2001, P ROY SOC B-BIOL SCI, V268, P647, DOI 10.1098/rspb.2000.1411; Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; Gibbs SEJ, 2005, CLIN DIAGN LAB IMMUN, V12, P665, DOI 10.1128/CDLI.12.5.665-667.2005; Gomez-Diaz E, 2012, BIOL LETTERS, V8, P616, DOI 10.1098/rsbl.2012.0179; Gomez-Diaz E, 2011, ENVIRON MICROBIOL, V13, P2453, DOI 10.1111/j.1462-2920.2011.02515.x; Gomez-Diaz E, 2010, EVOL APPL, V3, P391, DOI 10.1111/j.1752-4571.2010.00127.x; Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Hammouda A, 2011, VECTOR-BORNE ZOONOT, V11, P1583, DOI 10.1089/vbz.2011.0639; Hars J, 2004, FAUNE SAUVAGE, V261, P54; Heinze DM, 2012, J VIROL, V86, P8663, DOI 10.1128/JVI.01013-12; Hobson-Peters J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/379738; Hofle U, 2000, EMERG INFECT DIS, V267, P1741; Hubalek Z, 2008, VIRAL IMMUNOL, V21, P247, DOI 10.1089/vim.2007.0111; Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001; Jimenez-Clavero MA, 2010, VET REC, V167, P379, DOI 10.1136/vr.c3155; Jourdain E, 2007, VECTOR-BORNE ZOONOT, V7, P15, DOI 10.1089/vbz.2006.0543; Jourdain E, 2007, VECTOR-BORNE ZOONOT, V7, P448, DOI 10.1089/vbz.2006.0592; Jourdain E, 2007, EMERG INFECT DIS, V13, P365, DOI 10.3201/eid1303.060301; JUPP PG, 1972, J MED ENTOMOL, V9, P393, DOI 10.1093/jmedent/9.5.393; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Labuda M, 2004, PARASITOLOGY, V129, pS221, DOI 10.1017/S0031182004005220; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Llorente F, 2013, EMERG INFECT DIS, V19, P1023, DOI 10.3201/eid1906.130122; Lundstrom JO, 1999, J VECTOR ECOL, V24, P1; Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x; Malkinson M, 2002, EMERG INFECT DIS, V8, P392, DOI 10.3201/eid0804.010217; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; McCoy KD, 2005, MOL ECOL, V14, P2825, DOI 10.1111/j.1365-294X.2005.02631.x; Meslin FX, 1997, EMERG INFECT DIS, V3, P223, DOI 10.3201/eid0302.970220; Monaco F, 2011, RES VET SCI, V91, P321, DOI 10.1016/j.rvsc.2011.01.008; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Murgue B, 2001, EMERG INFECT DIS, V7, P692; Murgue B, 2001, ANN NY ACAD SCI, V951, P117; Murphy FA, 1998, EMERG INFECT DIS, V4, P429, DOI 10.3201/eid0403.980324; Nemeth NM, 2009, AM J TROP MED HYG, V80, P864, DOI 10.4269/ajtmh.2009.80.864; NUTTALL PA, 1984, ARCH VIROL, V79, P35, DOI 10.1007/BF01314301; Oliphant T, 2007, EXPERT OPIN BIOL TH, V7, P885, DOI 10.1517/14712598.7.6.885; Oro D, 2007, ANIM CONSERV, V10, P117, DOI 10.1111/j.1469-1795.2006.00082.x; Oro D, 2008, ECOLOGY, V89, P838, DOI 10.1890/06-1936.1; Pearce-Duvet JMC, 2009, EMERG INFECT DIS, V15, P1147, DOI 10.3201/eid1507.090036; Pedersen AB, 2011, MOL ECOL, V20, P872, DOI 10.1111/j.1365-294X.2010.04938.x; Peruski LF, 2003, BIOTECHNIQUES, V35, P840, DOI 10.2144/03354ss01; PORTERFIELD JS, 1975, MED BIOL, V53, P400; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramos R, 2009, MAR ECOL PROG SER, V377, P289, DOI 10.3354/meps07792; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rappole JH, 2000, EMERG INFECT DIS, V6, P319, DOI 10.3201/eid0604.000401; Reed Kurt D, 2003, Clin Med Res, V1, P5; Sanchez-Seco MP, 2005, J VIROL METHODS, V126, P101, DOI 10.1016/j.jviromet.2005.01.025; SOL D, 1995, BIRD STUDY, V42, P216, DOI 10.1080/00063659509477170; Sotelo E, 2009, VIROLOGY, V395, P289, DOI 10.1016/j.virol.2009.09.013; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vazquez A, 2011, EUROSURVEILLANCE, V16, P22; Vazquez A, 2012, VECTOR-BORNE ZOONOT, V12, P223, DOI 10.1089/vbz.2011.0687; Vazquez A, 2011, AM J TROP MED HYG, V85, P178, DOI 10.4269/ajtmh.2011.11-0042; Vidal E, 1998, BIODIVERS CONSERV, V7, P1013, DOI 10.1023/A:1008805030578; Webster RG, 2007, J WILDLIFE DIS, V43, pS1; Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025; Woolhouse M, 2007, CRIT REV MICROBIOL, V33, P231, DOI 10.1080/10408410701647560	90	30	32	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e89601	10.1371/journal.pone.0089601	http://dx.doi.org/10.1371/journal.pone.0089601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625959	Green Published, gold			2022-12-27	WOS:000332851300006
J	Guo, DG; Li, QX; Lv, Q; Wei, QJ; Cao, SY; Gu, JR				Guo, Donggeng; Li, Qiuxia; Lv, Qing; Wei, Qiujing; Cao, Shuangyan; Gu, Jieruo			MiR-27a Targets sFRP1 in hFOB Cells to Regulate Proliferation, Apoptosis and Differentiation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; ANIMAL DEVELOPMENT; WNT; EXPRESSION; ADIPOGENESIS; OSTEOGENESIS; MICRORNA-27A; CONTRIBUTES; INHIBITION	MicroRNAs (miRNAs) play a key role in the regulation of almost all the physiological and pathological processes, including bone metabolism. Recent studies have suggested that miR-27 might play a key role in osteoblast differentiation and bone formation. Increasing evidence indicates that the canonical Wnt signaling pathway contributes to different stages of bone formation. In this study, we identify miR-27a can promote osteoblast differentiation by repressing a new target, secreted frizzled-related proteins 1 (sFRP1) expression at the transcriptional level. Here, 21 candidate targets of miR-27a involved in canonical Wnt/beta-catenin signaling were predicted, and a significant decrease in sFRP1 luciferase activity was observed both in 293T and MG63 cells co-transfected with the matched luciferase reporter constructs and miR-27a mimic. Furthermore, the presence of exogenous miR-27a significantly decreased sFRP1 mRNA and protein expression in hFOB1.19 cells during both proliferation and osteogenic differentiation. The over-expression of miR-27a or knockdown sFRP1 significantly increased the percentage of apoptotic hFOBs, the percentage of cells in the G2-M phase of the cell cycle and the expression of key osteoblastic markers, including ALP, SPP1, RUNX2 and ALP activity. Over-expression of miR-27a or knockdown of endogenous sFRP1 led to an accumulation of beta-catenin in hFOBs. In the present study, we demonstrate that miR-27a induced gene silencing effect is a vital mechanism contributing to bone metabolism in hFOB cells in vitro, which is partly affected by the post-transcriptional regulation of sFRP1, during osteoblast proliferation, apoptosis and differentiation.	[Guo, Donggeng; Li, Qiuxia; Lv, Qing; Wei, Qiujing; Cao, Shuangyan; Gu, Jieruo] Sun Yat Sen Univ, Dept Rheumatol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Gu, JR (corresponding author), Sun Yat Sen Univ, Dept Rheumatol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China.	gujieruo@163.com			5010 Subject of Sun Yat-sen University	5010 Subject of Sun Yat-sen University	This work was financially supported by the 5010 Subject of Sun Yat-sen University (2007-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bodine PVN, 2005, J CELL BIOCHEM, V96, P1212, DOI 10.1002/jcb.20599; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen XL, 2013, INT J MOL SCI, V14, P14076, DOI 10.3390/ijms140714076; Gong Y, 2013, MOL CELL BIOCH; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hicok KC, 1998, J BONE MINER RES, V13, P205, DOI 10.1359/jbmr.1998.13.2.205; Huang ZQ, 2012, BIOCHEM BIOPH RES CO, V423, P265, DOI 10.1016/j.bbrc.2012.05.106; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kang T, 2013, J BIOL CHEM; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Liu G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075251; Liu GZ, 2009, J CELL BIOL, V185, P67, DOI 10.1083/jcb.200810137; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Qiang YW, 2008, BONE, V42, P669, DOI 10.1016/j.bone.2007.12.006; Rawadi G, 2005, EXPERT OPIN THER TAR, V9, P1063, DOI 10.1517/14728222.9.5.1063; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734; Subramaniam M, 2002, J CELL BIOCHEM, V87, P9, DOI 10.1002/jcb.10259; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Tang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051702; Wang T, 2010, BIOCHEM BIOPH RES CO, V402, P186, DOI 10.1016/j.bbrc.2010.08.031; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Xavier CP, 2014, CELL SIGNAL, V26, P94, DOI 10.1016/j.cellsig.2013.09.016; Yen ML, 2007, STEM CELLS, V25, P125, DOI 10.1634/stemcells.2006-0295; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503	38	71	79	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91354	10.1371/journal.pone.0091354	http://dx.doi.org/10.1371/journal.pone.0091354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625818	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300076
J	Liu, JG; Yang, GY; Hu, ZL				Liu, Jian-Guo; Yang, Guang-Yong; Hu, Zhao-Long			A Knowledge Generation Model via the Hypernetwork	PLOS ONE			English	Article							NETWORK STRUCTURE; DIFFUSION; DYNAMICS	The influence of the statistical properties of the network on the knowledge diffusion has been extensively studied. However, the structure evolution and the knowledge generation processes are always integrated simultaneously. By introducing the Cobb-Douglas production function and treating the knowledge growth as a cooperative production of knowledge, in this paper, we present two knowledge-generation dynamic evolving models based on different evolving mechanisms. The first model, named "HDPH model," adopts the hyperedge growth and the hyperdegree preferential attachment mechanisms. The second model, named "KSPH model," adopts the hyperedge growth and the knowledge stock preferential attachment mechanisms. We investigate the effect of the parameters (alpha, beta) on the total knowledge stock of the two models. The hyperdegree distribution of the HDPH model can be theoretically analyzed by the mean-field theory. The analytic result indicates that the hyperdegree distribution of the HDPH model obeys the power-law distribution and the exponent is gamma = 2+1/m. Furthermore, we present the distributions of the knowledge stock for different parameters (alpha, beta). The findings indicate that our proposed models could be helpful for deeply understanding the scientific research cooperation.	[Liu, Jian-Guo; Yang, Guang-Yong; Hu, Zhao-Long] Shanghai Univ Sci & Technol, Res Ctr Complex Syst Sci, Shanghai 201800, Peoples R China	University of Shanghai for Science & Technology	Liu, JG (corresponding author), Shanghai Univ Sci & Technol, Res Ctr Complex Syst Sci, Shanghai 201800, Peoples R China.	liujg004@ustc.edu.cn	Liu, Jianguo/B-4492-2012	Liu, Jianguo/0000-0002-5641-0266	National Natural Science Foundation of China [91024026, 71071098, 71171136]; Shanghai Leading Scientific Project [XTKX2012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Scientific Project	This work supported by the National Natural Science Foundation of China (Grant Nos. 91024026, 71071098, 71171136), Shanghai Leading Scientific Project (Grant NO. XTKX2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Berge C., 1989, HYPERGRAPHS COMBINAT; Berge C., 1973, GRAPHS HYPERGRAPHS; Cowan R, 2004, J ECON DYN CONTROL, V28, P1557, DOI 10.1016/j.jedc.2003.04.002; Cowan R, 2004, CREATION NETWORKS KN; DOUGLAS PH, 1976, J POLIT ECON, V84, P903, DOI 10.1086/260489; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Hu F, 2013, ACTA PHYS SIN-CH ED, V62, DOI 10.7498/aps.62.198901; [胡枫 Hu Feng], 2013, [中国科学. 物理学, 力学, 天文学, Scientia Sinica Physica, Mechanica & Astronomica], V43, P16; Kim H, 2009, EXPERT SYST APPL, V36, P8986, DOI 10.1016/j.eswa.2008.11.039; Lin M, 2010, PHYSICA A, V389, P473, DOI 10.1016/j.physa.2009.10.004; Morone P, 2004, J EVOL ECON, V14, P327, DOI 10.1007/s00191-004-0211-2; Morone P, 2004, JASSS-J ARTIF SOC S, V7, P1; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Stauffer D, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046128; Tang FC, 2010, EXPERT SYST APPL, V37, P1586, DOI 10.1016/j.eswa.2009.06.039; Tang FC, 2006, EXPERT SYST APPL, V30, P796, DOI 10.1016/j.eswa.2005.07.039; Wang JW, 2010, EUR PHYS J B, V77, P493, DOI 10.1140/epjb/e2010-00297-8; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xuan ZG, 2011, EXPERT SYST APPL, V38, P14935, DOI 10.1016/j.eswa.2011.05.054; Yang GY, 2013, CHINESE PHYS B, V23; Zlatic V, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036118	24	27	33	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e89746	10.1371/journal.pone.0089746	http://dx.doi.org/10.1371/journal.pone.0089746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626143	Green Submitted, gold, Green Published			2022-12-27	WOS:000332851300008
J	Senn, N; Rarau, P; Salib, M; Manong, D; Siba, P; Rogerson, S; Mueller, I; Genton, B				Senn, Nicolas; Rarau, Patricia; Salib, Mary; Manong, Doris; Siba, Peter; Rogerson, Stephen; Mueller, Ivo; Genton, Blaise			Use of Antibiotics within the IMCI Guidelines in Outpatient Settings in Papua New Guinean Children: An Observational and Effectiveness Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CHILDHOOD ILLNESS IMCI; INTEGRATED MANAGEMENT; HOSPITALIZED CHILDREN; FEBRILE ILLNESSES; SEVERE PNEUMONIA; MALARIA; BACTERIAL; INFECTION; DIAGNOSIS	Introduction: There is a need to investigate the effectiveness and appropriateness of antibiotics prescription within the Integrated Management of Childhood Illness (IMCI) strategy in the context of routine outpatient clinics. Methods: Making use of a passive case detection system established for a malaria prevention trial in outpatient clinics in Papua New Guinea, the appropriateness and effectiveness of the use of antibiotics within the IMCI was assessed in 1605 young children. Main outcomes were prescription of antibiotics and re-attendances within 14 days for mild pneumonia, mild diarrhoea and uncomplicated malaria whether they were managed with or without antibiotics (proxy of effectiveness). Appropriateness was assessed for both mild and severe cases, while effectiveness was assessed only for mild diseases. Results: A total of 6975 illness episodes out of 8944 fulfilled inclusion criteria (no previous attendance <14 days+full medical records). Clinical incidence rates (episodes/child/year; 95% CI) were 0.85 (0.81-0.90) for pneumonia, 0.62 (0.58-0.66) for malaria and 0.72 (0.65-0.93) for diarrhoea. Fifty three percent of 6975 sick children were treated with antibiotics, 11% were not treated with antibiotics when they should have been and in 29% antibiotics were prescribed when they should not have been. Re-attendance rates within 14 days following clinical diagnosis of mild pneumonia were 9% (126/1401) when managed with antibiotics compared to 8% (56/701) when managed without (adjusted Hazard Ratio (aHR) = 1.00 (0.57-1.76), p = 0.98). Rates for mild diarrhoea were 8% (73/874) and 9% (79/866) respectively (aHR = 0.8 (0.42-1.57), p = 0.53). Conclusion: Non-adherence to IMCI recommendations for prescription of antibiotics is common in routine settings in Papua New Guinea. Although recommended, the use of antibiotics in young children with mild pneumonia as defined by IMCI criteria did not impact on their outcome. Better tools and new strategies for the identification of bacterial infections that require antibiotics are urgently needed.	[Senn, Nicolas; Rarau, Patricia; Salib, Mary; Manong, Doris; Siba, Peter; Mueller, Ivo] PNG Inst Med Res, Vector Born Unit, Madang, MAD, Papua N Guinea; [Senn, Nicolas; Genton, Blaise] Swiss Trop & Publ Hlth Inst, Hlth Intervent Unit, Basel, BS, Switzerland; [Senn, Nicolas; Genton, Blaise] Univ Basel, Basel, BS, Switzerland; [Senn, Nicolas; Rogerson, Stephen] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Dept Infect & Immun, Melbourne, Vic 3050, Australia; [Mueller, Ivo] Ctr Recerca Salut Int Barcelona CRESIB, Barcelona, Spain	PNG Institute Of Medical Research; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Melbourne; Walter & Eliza Hall Institute; ISGlobal; CRESIB	Senn, N (corresponding author), PNG Inst Med Res, Vector Born Unit, Madang, MAD, Papua N Guinea.	nicolas.senn@gmail.com		Rogerson, Stephen/0000-0003-4287-1982; Rarau, Patricia/0000-0003-0795-4686	Leenaards Foundation (Lausanne, Switzerland)	Leenaards Foundation (Lausanne, Switzerland)	Nicolas Senn is supported by an academic "bridge-releve" scholarship provided by the Leenaards Foundation (Lausanne, Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Animut A, 2009, JPN J INFECT DIS, V62, P107; Bassat Q, 2011, AM J TROP MED HYG, V85, P626, DOI 10.4269/ajtmh.2011.11-0223; Bisoffi Z, 2011, MALARIA J, V10, P1475; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Carrol ED, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006621; Deressa W, 2007, T ROY SOC TROP MED H, V101, P939, DOI 10.1016/j.trstmh.2007.04.018; Diez-Padrisa N, 2012, TROP MED INT HEALTH, V17, P1100, DOI 10.1111/j.1365-3156.2012.03035.x; Duke T, 2002, B WORLD HEALTH ORGAN, V80, P16; El Arifeen S, 2004, LANCET, V364, P1595, DOI 10.1016/S0140-6736(04)17312-1; Factor SH, 2001, B WORLD HEALTH ORGAN, V79, P1096; Falk G, 2009, FAM PRACT, V26, P10, DOI 10.1093/fampra/cmn095; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Flood RG, 2008, PEDIATR INFECT DIS J, V27, P95, DOI 10.1097/INF.0b013e318157aced; Gwer S, 2007, AM J TROP MED HYG, V77, P6, DOI 10.4269/ajtmh.2007.77.6; Hament JM, 1999, FEMS IMMUNOL MED MIC, V26, P189, DOI 10.1111/j.1574-695X.1999.tb01389.x; Hazir T, 2011, CLIN INFECT DIS, V52, P293, DOI 10.1093/cid/ciq142; Horwood C, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-62; Horwood C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005937; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manning L, 2011, ANTIMICROB AGENTS CH, V55, P4454, DOI 10.1128/AAC.00526-11; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Paediatric Society of Papua New Guinea, 2005, STAND TREATM COMM IL; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Roca A, 2006, TROP MED INT HEALTH, V11, P373, DOI 10.1111/j.1365-3156.2006.01566.x; Schellenberg JA, 2004, HEALTH POLICY PLANN, V19, P1, DOI 10.1093/heapol/czh001; Schmidt HJ, 2010, RESPIROLOGY, V15, P733, DOI 10.1111/j.1440-1843.2010.01745.x; Schuetz P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007498.pub2; Schuetz P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-107; Senn N, 2011, CLIN INFECT DIS, V23, P23; Senn N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001195; Shah D, 1999, Indian Pediatr, V36, P767; SHANN F, 1984, LANCET, V2, P537; VELEMA JP, 1991, INT J EPIDEMIOL, V20, P474, DOI 10.1093/ije/20.2.474; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2005, COUNTR HLTH INF PROF; WHO, 2007, INT MAN CHILDH ILLN	37	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90990	10.1371/journal.pone.0090990	http://dx.doi.org/10.1371/journal.pone.0090990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626194	Green Published, Green Accepted, gold			2022-12-27	WOS:000332851300048
J	Ursekar, CP; Teo, SK; Hirata, H; Harada, I; Chiam, KH; Sawada, Y				Ursekar, Chaitanya Prashant; Teo, Soo-Kng; Hirata, Hiroaki; Harada, Ichiro; Chiam, Keng-Hwee; Sawada, Yasuhiro			Design and Construction of an Equibiaxial Cell Stretching System That Is Improved for Biochemical Analysis	PLOS ONE			English	Article							MECHANICAL STRAIN; IN-VITRO; BIAXIAL STRAIN; RESPONSES; UNIFORM; FIBROBLASTS; ACTIVATION; DEVICE	We describe the design and validation of an equibiaxial stretching device in which cells are confined to regions of homogeneous strain. Using this device, we seek to overcome a significant limitation of existing equibiaxial stretching devices, in which strains are not homogeneous over the entire region of cell culture. We cast PDMS in a mold to produce a membrane with a cylindrical wall incorporated in the center, which was used to confine cell monolayers to the central membrane region subjected to homogeneous equibiaxial strain. We demonstrated that the presence of the wall to hold the culture medium did not affect strain homogeneity over the majority of the culture surface and also showed that cells adhered well onto the PDMS membranes. We used our device in cyclic strain experiments and demonstrated strain-dependent changes in extracellular signal-regulated kinase (ERK) and tyrosine phosphorylation upon cell stretching. Furthermore, we examined cell responses to very small magnitudes of strain ranging from 1% to 6% and were able to observe a graduated increase in ERK phosphorylation in response to these strains. Collectively, we were able to study cellular biochemical response with a high degree of accuracy and sensitivity to fine changes in substrate strain. Because we have designed our device along the lines of existing equibiaxial stretching technologies, we believe that our innovations can be incorporated into existing systems. This device would provide a useful addition to the set of tools applied for in vitro studies of cell mechanobiology.	[Ursekar, Chaitanya Prashant; Hirata, Hiroaki; Chiam, Keng-Hwee; Sawada, Yasuhiro] Natl Univ Singapore, Mechanobiol Inst Singapore, Singapore 117548, Singapore; [Teo, Soo-Kng] Agcy Sci Technol & Res, Inst High Performance Comp, Singapore, Singapore; [Harada, Ichiro; Sawada, Yasuhiro] Nadogaya Hosp, Locomot Syndrome Res Inst, Lab Mech Med, Kashiwa, Chiba, Japan; [Harada, Ichiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan; [Chiam, Keng-Hwee] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Sawada, Yasuhiro] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); Tokyo Institute of Technology; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore	Sawada, Y (corresponding author), Natl Univ Singapore, Mechanobiol Inst Singapore, Singapore 117548, Singapore.	dbssy@nus.edu.sg	Teo, Soo Kng/H-8212-2019; Sokabe, Masahiro/I-1565-2012; Sawada, Yasuhiro/H-8044-2012	Teo, Soo Kng/0000-0001-5659-3763; Sawada, Yasuhiro/0000-0003-0625-3335; Hirata, Hiroaki/0000-0002-2604-9158; Ursekar, Chaitanya/0000-0001-9253-0559	Seed Fund of the Mechanobiology Institute, Research Centre of Excellence; National Research Foundation of Singapore; Singapore Ministry of Education	Seed Fund of the Mechanobiology Institute, Research Centre of Excellence; National Research Foundation of Singapore(National Research Foundation, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore)	This work was supported by the Seed Fund of the Mechanobiology Institute, Research Centre of Excellence financed by the National Research Foundation of Singapore (http://www.nrf.gov.sg/) and the Singapore Ministry of Education (http://www.science.nus.edu.sg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2004, ARTHRITIS RHEUM-US, V50, P3541, DOI 10.1002/art.20601; Arold SP, 2007, ANN BIOMED ENG, V35, P1156, DOI 10.1007/s10439-007-9262-5; Arold SP, 2009, AM J PHYSIOL-LUNG C, V296, pL574, DOI 10.1152/ajplung.90454.2008; Brosig M, 2010, INT J BIOCHEM CELL B, V42, P1717, DOI 10.1016/j.biocel.2010.07.001; Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3; Cheng GC, 1997, CIRC RES, V80, P28, DOI 10.1161/01.RES.80.1.28; Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095; Hsu HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012470; Huang L, 2010, ANN BIOMED ENG, V38, P1728, DOI 10.1007/s10439-010-9968-7; Hull JL, 2005, HDB PLASTIC PROCESSE, P455, DOI DOI 10.1002/0471786586.CH7/SUMMARY.ACCESSED; HUNG CT, 1994, J BIOMECH, V27, P227, DOI 10.1016/0021-9290(94)90212-7; Iqbal J, 2005, BIOCHEM BIOPH RES CO, V328, P751, DOI 10.1016/j.bbrc.2004.12.087; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kaunas R, 2006, CELL SIGNAL, V18, P1924, DOI 10.1016/j.cellsig.2006.02.008; Lammerding Jan, 2008, V464, P13; Lee AA, 1999, J MOL CELL CARDIOL, V31, P1833, DOI 10.1006/jmcc.1999.1017; Lee AA, 1996, AM J PHYSIOL-CELL PH, V271, pC1400, DOI 10.1152/ajpcell.1996.271.4.C1400; Leong WS, 2012, J TISSUE ENG REGEN M, V6, ps68, DOI 10.1002/term.1548; Masuda T, 2008, J BIOTECHNOL, V133, P231, DOI 10.1016/j.jbiotec.2007.08.007; Quaglino A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-55; Rana OR, 2008, AM J PHYSIOL-HEART C, V294, pH532, DOI 10.1152/ajpheart.00649.2007; SCHAFFER JL, 1994, J ORTHOP RES, V12, P709, DOI 10.1002/jor.1100120514; Sheskin D., 2011, HDB PARAMETRIC NONPA, Vfifth, DOI [DOI 10.1201/9781420036268, 10.2307/2685909]; Sotoudeh M, 1998, ANN BIOMED ENG, V26, P181, DOI 10.1114/1.88; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; Tschumperlin DJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1173, DOI 10.1152/ajplung.1998.275.6.L1173; Wang JHC, 2004, J BIOMECH, V37, P573, DOI 10.1016/j.jbiomech.2003.09.011; Waters CM, 2001, J APPL PHYSIOL, V91, P1600, DOI 10.1152/jappl.2001.91.4.1600; Xie KY, 2012, MED ENG PHYS, V34, P826, DOI 10.1016/j.medengphy.2011.09.024	32	28	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90665	10.1371/journal.pone.0090665	http://dx.doi.org/10.1371/journal.pone.0090665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626190	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300028
J	Zimbone, M; Baeri, P; Calcagno, L; Musumeci, P; Contino, A; Barcellona, ML; Bonaventura, G				Zimbone, Massimo; Baeri, Pietro; Calcagno, Lucia; Musumeci, Paolo; Contino, Annalinda; Barcellona, Maria Luisa; Bonaventura, Gabriele			Dynamic Light Scattering on Bioconjugated Laser Generated Gold Nanoparticles	PLOS ONE			English	Article							ABLATION; DNA; COLLOIDS; DISSOCIATION; DEGRADATION; ADSORBATES; SIZE	Gold nanoparticles (AuNPs) conjugated to DNA are widely used for biomedical targeting and sensing applications. DNA functionalization is easily reached on laser generated gold nanoparticles because of their unique surface chemistry, not reproducible by other methods. In this context, we present an extensive investigation concerning the attachment of DNA to the surface of laser generated nanoparticles using Dynamic Light Scattering and UV-Vis spectroscopy. The DNA conjugation is highlighted by the increase of the hydrodynamic radius and by the UV-Vis spectra behavior. Our investigation indicates that Dynamic Light Scattering is a suitable analytical tool to evidence, directly and qualitatively, the binding between a DNA molecule and a gold nanoparticle, therefore it is ideal to monitor changes in the conjugation process when experimental conditions are varied.	[Zimbone, Massimo; Baeri, Pietro; Calcagno, Lucia; Musumeci, Paolo] Univ Catania, Dipartimento Fis & Astron, Catania, Italy; [Contino, Annalinda] Univ Catania, Dipartimento Sci Chim, I-95125 Catania, Italy; [Barcellona, Maria Luisa; Bonaventura, Gabriele] Univ Catania, Dipartimento Sci Farmaco, Catania, Italy	University of Catania; University of Catania; University of Catania	Barcellona, ML (corresponding author), Univ Catania, Dipartimento Sci Farmaco, Catania, Italy.	marsirin@gmail.com	Musumeci, Paolo/ABE-8253-2020; Contino, Annalinda/A-2765-2012	Musumeci, Paolo/0000-0002-5160-1522; Contino, Annalinda/0000-0003-2443-9352; CALCAGNO, Lucia/0000-0003-0403-6708; ZIMBONE, MASSIMO/0000-0003-4539-3998				Berne B.J., 1976, DYNAMIC LIGHT SCATTE, P376, DOI 10.1002/bbpc.19770810123; Besner S, 2008, APPL PHYS A-MATER, V93, P955, DOI 10.1007/s00339-008-4773-y; Bhatt N, 2011, LANGMUIR, V27, P6132, DOI 10.1021/la200241d; BLATCHFORD CG, 1982, SURF SCI, V120, P435, DOI 10.1016/0039-6028(82)90161-3; Bohren C.F., 2008, ABSORPTION SCATTERIN; Cai WB, 2008, NANOTECHNOL SCI APPL, V1, P17, DOI 10.2147/NSA.S3788; Cuenca AG, 2006, CANCER-AM CANCER SOC, V107, P459, DOI 10.1002/cncr.22035; Le DV, 2013, TALANTA, V107, P233, DOI 10.1016/j.talanta.2013.01.016; Galletto P, 1999, J PHYS CHEM B, V103, P8706, DOI 10.1021/jp991937t; Garcia MA, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/28/283001; Haiss W, 2007, ANAL CHEM, V79, P4215, DOI 10.1021/ac0702084; Herdt AR, 2006, COLLOID SURFACE B, V51, P130, DOI 10.1016/j.colsurfb.2006.06.006; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Hill HD, 2009, ACS NANO, V3, P418, DOI 10.1021/nn800726e; Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Hurst SJ, 2006, ANAL CHEM, V78, P8313, DOI 10.1021/ac0613582; Jans H, 2009, ANAL CHEM, V81, P9425, DOI 10.1021/ac901822w; Jin RC, 2003, J AM CHEM SOC, V125, P1643, DOI 10.1021/ja021096v; Kreibig U, 1908, SPRINGER SERIES MAT; Lin J, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-170; Liu J, 2006, NAT PROTOC, V1, P246, DOI 10.1038/nprot.2006.38; Mafune F, 2004, CHEM PHYS LETT, V397, P133, DOI 10.1016/j.cplett.2004.08.108; Mafune F, 2002, J PHYS CHEM B, V106, P7575, DOI 10.1021/jp020577y; Majzik A, 2009, GOLD BULL, V42, P2; Martin MN, 2010, LANGMUIR, V26, P7410, DOI 10.1021/la100591h; Mie G, 1908, ANN PHYS-BERLIN, V25, P377, DOI 10.1002/andp.19083300302; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004; Petersen S, 2009, J PHYS CHEM C, V113, P19830, DOI 10.1021/jp905962f; Philip D, 2008, SPECTROCHIM ACTA A, V71, P80, DOI 10.1016/j.saa.2007.11.012; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; Sajti CL, 2010, APPL PHYS A-MATER, V101, P259, DOI 10.1007/s00339-010-5813-y; Sethi M, 2009, ACS APPL MATER INTER, V1, P1270, DOI 10.1021/am900157m; Shim JY, 2007, J COLLOID INTERF SCI, V316, P977, DOI 10.1016/j.jcis.2007.08.021; Storhoff JJ, 1998, J AM CHEM SOC, V120, P1959, DOI 10.1021/ja972332i; Sylvestre JP, 2004, J PHYS CHEM B, V108, P16864, DOI 10.1021/jp047134+; TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055; Ullien D, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/42/424015; Walter Johanna G., 2010, Journal of Nanobiotechnology, V8, P21, DOI 10.1186/1477-3155-8-21; Wei F, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3373325; Yang GW, 2007, PROG MATER SCI, V52, P648, DOI 10.1016/j.pmatsci.2006.10.016; Zhang X, 2012, J AM CHEM SOC, V134, P7266, DOI 10.1021/ja3014055; Zhang YJ, 2012, CHINESE SCI BULL, V57, P238, DOI 10.1007/s11434-011-4747-x; Zimbone M, 2012, APPL SURF SCI, V258, P9246, DOI 10.1016/j.apsusc.2011.08.112; Zimbone M, 2011, MATER LETT, V65, P2906, DOI 10.1016/j.matlet.2011.06.054; Zu YB, 2009, ANAL CHEM, V81, P8523, DOI 10.1021/ac901459v	47	14	15	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e89048	10.1371/journal.pone.0089048	http://dx.doi.org/10.1371/journal.pone.0089048			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625863	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300005
J	Grieb, B; Engler, G; Sharott, A; von Nicolai, C; Streichert, T; Papageorgiou, I; Schulte, A; Westphal, M; Lamszus, K; Engel, AK; Moll, CKE; Hamel, W				Grieb, Benjamin; Engler, Gerhard; Sharott, Andrew; von Nicolai, Constantin; Streichert, Thomas; Papageorgiou, Ismini; Schulte, Alexander; Westphal, Manfred; Lamszus, Katrin; Engel, Andreas K.; Moll, Christian K. E.; Hamel, Wolfgang			High-Frequency Stimulation of the Subthalamic Nucleus Counteracts Cortical Expression of Major Histocompatibility Complex Genes in a Rat Model of Parkinson's Disease	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; CLASS-II INDUCIBILITY; SUBSTANTIA-NIGRA; 6-HYDROXYDOPAMINE LESION; DOPAMINERGIC-NEURONS; BETA-OSCILLATIONS; CEREBRAL-CORTEX; MESSENGER-RNA; BASAL GANGLIA; MOTOR CORTEX	High-frequency stimulation of the subthalamic nucleus (STN-HFS) is widely used as therapeutic intervention in patients suffering from advanced Parkinson's disease. STN-HFS exerts a powerful modulatory effect on cortical motor control by orthodromic modulation of basal ganglia outflow and via antidromic activation of corticofugal fibers. However, STN-HFS-induced changes of the sensorimotor cortex are hitherto unexplored. To address this question at a genomic level, we performed mRNA expression analyses using Affymetrix microarray gene chips and real-time RT-PCR in sensorimotor cortex of parkinsonian and control rats following STN-HFS. Experimental parkinsonism was induced in Brown Norway rats by bilateral nigral injections of 6-hydroxydopamine and was assessed histologically, behaviorally, and electrophysiologically. We applied prolonged (23h) unilateral STN-HFS in awake and freely moving animals, with the non-stimulated hemisphere serving as an internal control for gene expression analyses. Gene enrichment analysis revealed strongest regulation in major histocompatibility complex (MHC) related genes. STN-HFS led to a cortical downregulation of several MHC class II (RT1-Da, Db1, Ba, and Cd74) and MHC class I (RT1CE) encoding genes. The same set of genes showed increased expression levels in a comparison addressing the effect of 6-hydroxydopamine lesioning. Hence, our data suggest the possible association of altered microglial activity and synaptic transmission by STN-HFS within the sensorimotor cortex of 6-hydroxydopamine treated rats.	[Grieb, Benjamin; Engler, Gerhard; Sharott, Andrew; von Nicolai, Constantin; Engel, Andreas K.; Moll, Christian K. E.] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany; [Streichert, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Hamburg, Germany; [Papageorgiou, Ismini] Heidelberg Univ, Inst Physiol & Pathophysiol, Div Gen Neurophysiol, Heidelberg, Germany; [Schulte, Alexander; Westphal, Manfred; Lamszus, Katrin; Hamel, Wolfgang] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany; [Grieb, Benjamin] Heidelberg Univ, Ctr Psychosocial Med, Dept Gen Psychiat, Heidelberg, Germany; [von Nicolai, Constantin] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen	Grieb, B (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany.	benjamin.grieb@med.uni-heidelberg.de	Engel, Andreas K./AAH-6384-2019; Engel, Andreas K/C-7781-2012; Papageorgiou, Ismini/AAI-7329-2020; /H-8186-2012	Engel, Andreas K./0000-0003-4899-8466; Engel, Andreas K/0000-0003-4899-8466; Papageorgiou, Ismini/0000-0001-5810-0483; Sharott, Andrew/0000-0002-1594-3349	University Medical Center Hamburg-Eppendorf	University Medical Center Hamburg-Eppendorf	The study received intramural funding from the University Medical Center Hamburg-Eppendorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNEW WF, 1986, EXP NEUROL, V92, P162, DOI 10.1016/0014-4886(86)90132-9; AKIYAMA H, 1989, BRAIN RES, V489, P247, DOI 10.1016/0006-8993(89)90857-3; Alberts JL, 2008, EXP NEUROL, V214, P1, DOI 10.1016/j.expneurol.2008.07.019; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Alla JA, 2009, BIOCHEM BIOPH RES CO, V387, P186, DOI 10.1016/j.bbrc.2009.07.011; Ashby P, 2001, CLIN NEUROPHYSIOL, V112, P431, DOI 10.1016/S1388-2457(00)00532-0; Baker KB, 2002, MOVEMENT DISORD, V17, P969, DOI 10.1002/mds.10206; Bar-Gad I, 2003, PROG NEUROBIOL, V71, P439, DOI 10.1016/j.pneurobio.2003.12.001; BENABID AL, 1994, STEREOT FUNCT NEUROS, V62, P76, DOI 10.1159/000098600; Brazhnik E, 2012, J NEUROSCI, V32, P7869, DOI 10.1523/JNEUROSCI.0943-12.2012; Cassidy M, 2002, BRAIN, V125, P1235, DOI 10.1093/brain/awf135; Chung SJ, 2006, EUR NEUROL, V56, P127, DOI 10.1159/000095704; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Darbaky Y, 2003, EUR J NEUROSCI, V18, P951, DOI 10.1046/j.1460-9568.2003.02803.x; Dejean C, 2009, CEREB CORTEX, V19, P1055, DOI 10.1093/cercor/bhn149; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Drai D, 2000, J NEUROSCI METH, V96, P119, DOI 10.1016/S0165-0270(99)00194-6; Dymecki J, 1996, FOLIA NEUROPATHOL, V34, P102; Ferro MM, 2005, J NEUROSCI METH, V148, P78, DOI 10.1016/j.jneumeth.2005.04.005; Fox CM, 2001, BRAIN RES, V896, P56, DOI 10.1016/S0006-8993(00)03270-4; Gimsa U, 2006, J NEUROSCI METH, V150, P212, DOI 10.1016/j.jneumeth.2005.06.013; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grieb B, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00095; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Harnack D, 2004, J NEUROSCI METH, V138, P207, DOI 10.1016/j.jneumeth.2004.04.019; Harnack D, 2008, EXP NEUROL, V210, P257, DOI 10.1016/j.expneurol.2007.10.002; Havik B, 2007, NEUROSCIENCE, V148, P925, DOI 10.1016/j.neuroscience.2007.07.024; Healy-Stoffel M, 2012, J NEUROSCI METH, V210, P187, DOI 10.1016/j.jneumeth.2012.07.013; Henning J, 2007, EUR J NEUROSCI, V25, P239, DOI 10.1111/j.1460-9568.2006.05264.x; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hummon AB, 2007, BIOTECHNIQUES, V42, P467, DOI 10.2144/000112401; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Kadar E, 2011, BRAIN RES, V1391, P1, DOI 10.1016/j.brainres.2011.03.059; Kemmel V, 2010, PHYSIOL GENOMICS, V41, P146, DOI 10.1152/physiolgenomics.00208.2009; KITAI ST, 1981, BRAIN RES, V214, P411, DOI 10.1016/0006-8993(81)91204-X; Krack P, 2002, MOVEMENT DISORD, V17, pS188, DOI 10.1002/mds.10163; Kuriakose R, 2010, CEREB CORTEX, V20, P1926, DOI 10.1093/cercor/bhp269; Levy R, 2002, J NEUROSCI, V22, P2855, DOI 10.1523/JNEUROSCI.22-07-02855.2002; Li S, 2007, J NEUROPHYSIOL, V98, P3525, DOI 10.1152/jn.00808.2007; Liu F, 2011, CURR NEUROPHARMACOL, V9, P260, DOI 10.2174/157015911795017155; MacKinnon CD, 2005, EUR J NEUROSCI, V21, P1394, DOI 10.1111/j.1460-9568.2005.03952.x; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; McRitchie DA, 1997, EXP NEUROL, V144, P202, DOI 10.1006/exnr.1997.6418; Monakow K H, 1978, Exp Brain Res, V33, P395; Nambu A, 2005, J NEUROL, V252, P1, DOI 10.1007/s00415-005-4002-y; Neumann H, 1998, P NATL ACAD SCI USA, V95, P5779, DOI 10.1073/pnas.95.10.5779; Neumann H, 1996, EUR J NEUROSCI, V8, P2582, DOI 10.1111/j.1460-9568.1996.tb01552.x; Neumann H, 2001, GLIA, V36, P191, DOI 10.1002/glia.1108; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; PENNYPACKER KR, 1995, TRENDS PHARMACOL SCI, V16, P317, DOI 10.1016/S0165-6147(00)89061-6; Raz A, 2010, ANESTH ANALG, V111, P1285, DOI 10.1213/ANE.0b013e3181f565f2; SAKAI K, 1994, BRAIN RES, V633, P144, DOI 10.1016/0006-8993(94)91533-4; Sarro SM, 2010, LEUKEMIA RES, V34, P1670, DOI 10.1016/j.leukres.2010.06.031; Schulte A, 2011, GLIA, V59, P590, DOI 10.1002/glia.21127; Schulte T, 2006, NEUROSCIENCE, V138, P1377, DOI 10.1016/j.neuroscience.2005.12.034; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Sharott A, 2005, EUR J NEUROSCI, V21, P1413, DOI 10.1111/j.1460-9568.2005.03973.x; Shebl FM, 2010, CANCER EPIDEM BIOMAR, V19, P978, DOI 10.1158/1055-9965.EPI-10-0064; Shen KZ, 2003, SYNAPSE, V50, P314, DOI 10.1002/syn.10274; Spieles-Engemann AL, 2011, J PARKINSON DIS, V1, P123, DOI 10.3233/JPD-2011-11008; Strackx E, 2008, EXP NEUROL, V211, P413, DOI 10.1016/j.expneurol.2008.02.006; Tan SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021328; Temel Y, 2004, NEUROSCI LETT, V367, P92, DOI 10.1016/j.neulet.2004.05.087; Temel Y, 2005, EXP NEUROL, V193, P43, DOI 10.1016/j.expneurol.2004.12.025; Temperli P, 2003, NEUROLOGY, V60, P78, DOI 10.1212/WNL.60.1.78; Thobois S, 2010, BRAIN, V133, P1111, DOI 10.1093/brain/awq032; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; UHL GR, 1985, NEUROLOGY, V35, P1215, DOI 10.1212/WNL.35.8.1215; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Walker HC, 2012, MOVEMENT DISORD, V27, P1404, DOI 10.1002/mds.25137; Walker HC, 2009, NEUROSURGERY, V65, P302, DOI 10.1227/01.NEU.0000349764.34211.74; Walker QD, 2012, NEUROPHARMACOLOGY, V62, P2267, DOI 10.1016/j.neuropharm.2012.01.029; West MJ, 2002, PROG BRAIN RES, V135, P43; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WONG GHW, 1984, NATURE, V310, P688, DOI 10.1038/310688a0; Zaidel A, 2010, BRAIN, V133, P2007, DOI 10.1093/brain/awq144	85	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91663	10.1371/journal.pone.0091663	http://dx.doi.org/10.1371/journal.pone.0091663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621597	gold, Green Published, Green Submitted			2022-12-27	WOS:000332845300114
J	Hoonhorst, SJM; ten Hacken, NHT; Loi, ATL; Koenderman, L; Lammers, JWJ; Telenga, ED; Boezen, HM; van den Berge, M; Postma, DS				Hoonhorst, Susan J. M.; ten Hacken, Nick H. T.; Loi, Adele T. Lo Tam; Koenderman, Leo; Lammers, Jan Willem J.; Telenga, Eef D.; Boezen, H. Marike; van den Berge, Maarten; Postma, Dirkje S.			Lower Corticosteroid Skin Blanching Response Is Associated with Severe COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INHALED CORTICOSTEROIDS; GLUCOCORTICOIDS; STANDARDIZATION; FLUTICASONE; SENSITIVITY; PROPIONATE; PHENOTYPES; EFFICACY; PLACEBO	Background: Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation caused by ongoing inflammatory and remodeling processes of the airways and lung tissue. Inflammation can be targeted by corticosteroids. However, airway inflammation is generally less responsive to steroids in COPD than in asthma. The underlying mechanisms are yet unclear. This study aimed to assess whether skin corticosteroid insensitivity is associated with COPD and COPD severity using the corticosteroid skin blanching test. Methods: COPD patients GOLD stage I-IV (n = 27, 24, 22, and 16 respectively) and healthy never-smokers and smokers (n = 28 and 56 respectively) were included. Corticosteroid sensitivity was assessed by the corticosteroid skin blanching test. Budesonide was applied in 8 logarithmically increasing concentrations (0-100 mu g/ml) on subject's forearm. Assessment of blanching was performed after 7 hours using a 7-point scale (normal skin to intense blanching). All subjects performed spirometry and body plethysmography. Results: Both GOLD III and GOLD IV COPD patients showed significantly lower skin blanching responses than healthy never-smokers and smokers, GOLD I, and GOLD II patients. Their area under the dose-response curve values of the skin blanching response were 586 and 243 vs. 1560, 1154, 1380, and 1309 respectively, p<0.05. Lower FEV1 levels and higher RV/TLC ratios were significantly associated with lower skin blanching responses (p = 0.001 and p = 0.004 respectively). GOLD stage I, II, III and IV patients had similar age and packyears. Conclusions: In this study, severe and very severe COPD patients had lower skin corticosteroid sensitivity than mild and moderate COPD patients and non-COPD controls with comparable age and packyears. Our findings together suggest that the reduced skin blanching response fits with a subgroup of COPD patients that has an early-onset COPD phenotype.	[Hoonhorst, Susan J. M.; ten Hacken, Nick H. T.; Telenga, Eef D.; van den Berge, Maarten; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands; [Hoonhorst, Susan J. M.; ten Hacken, Nick H. T.; Telenga, Eef D.; Boezen, H. Marike; van den Berge, Maarten; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; [Loi, Adele T. Lo Tam; Koenderman, Leo; Lammers, Jan Willem J.] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands; [Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; University of Groningen	Postma, DS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands.	d.s.postma@umcg.nl	Koenderman, Leo/AAE-7870-2020	Koenderman, Leo/0000-0002-5636-6453; Telenga, Eef/0000-0003-1741-9206; van den Berge, Maarten/0000-0002-9336-7340	Top Institute Pharma [T1-108]; Nycomed; GlaxoSmithKline; University Medical Center Groningen (UMCG); University of Groningen (RUG) [NCT00807469, NCT00850863]; Royal Netherlands Academy of Arts and Sciences [NCT00848406]	Top Institute Pharma; Nycomed; GlaxoSmithKline(GlaxoSmithKline); University Medical Center Groningen (UMCG); University of Groningen (RUG); Royal Netherlands Academy of Arts and Sciences	This study was funded by grant T1-108 from Top Institute Pharma, with partners Nycomed, GlaxoSmithKline, University Medical Center Groningen (UMCG), and University of Groningen (RUG) (NCT00807469 and NCT00850863); and the Royal Netherlands Academy of Arts and Sciences (NCT00848406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2010, CHEST, V137, P318, DOI 10.1378/chest.09-1305; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BROWN PH, 1991, LANCET, V337, P576, DOI 10.1016/0140-6736(91)91639-C; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; GAILLARD RC, 1985, J CLIN ENDOCR METAB, V61, P1009, DOI 10.1210/jcem-61-6-1009; Global Initiative for Chronic Obstructive Lung Disease, 2010, GLOB STRAT DIAGN MAN; Haigh JM, 1997, INT J PHARM, V152, P179, DOI 10.1016/S0378-5173(97)00078-1; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Jenkins CR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-59; Johnson M, 1998, J ALLERGY CLIN IMMUN, V101, pS434, DOI 10.1016/S0091-6749(98)70155-1; Jones PW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-71; Kiml V, 2013, AM J RESP CRIT CARE, V187, P228, DOI 10.1164/rccm.201210-1843CI; Kumsta R, 2008, BIOL PSYCHOL, V79, P179, DOI 10.1016/j.biopsycho.2008.04.007; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; Livingston E, 2007, EUR RESPIR J, V29, P64, DOI 10.1183/09031936.06.00120505; Lo Tam Loi AT, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2012-002178, DOI 10.1136/BMJ0PEN-2012-002178.PRINT]; MCKENZIE AW, 1962, ARCH DERMATOL, V86, P608, DOI 10.1001/archderm.1962.01590110044005; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Panarelli M, 1998, J CLIN ENDOCR METAB, V83, P1846, DOI 10.1210/jc.83.6.1846; Provost PR, 2013, J STEROID BIOCH MOL; Rennard Stephen I, 2008, Proc Am Thorac Soc, V5, P878, DOI 10.1513/pats.200804-035QC; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; Snyder EM, 2011, PHARMACOTHERAPY, V31, P748, DOI 10.1592/phco.31.8.748; Soriano JB, 2007, CHEST, V131, P682, DOI 10.1378/chest.06-1696; Svanes C, 2010, THORAX, V65, P14, DOI 10.1136/thx.2008.112136; Telenga ED, 2012, RESP MED; van den Berge M., 2013, THORAX; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Wilson AM, 2003, EUR J CLIN PHARMACOL, V58, P643, DOI 10.1007/s00228-002-0547-1	30	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91788	10.1371/journal.pone.0091788	http://dx.doi.org/10.1371/journal.pone.0091788			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622644	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300128
J	Moore, JA; Draheim, HM; Etter, D; Winterstein, S; Scribner, KT				Moore, Jennifer A.; Draheim, Hope M.; Etter, Dwayne; Winterstein, Scott; Scribner, Kim T.			Application of Large-Scale Parentage Analysis for Investigating Natal Dispersal in Highly Vagile Vertebrates: A Case Study of American Black Bears (Ursus americanus)	PLOS ONE			English	Article							DENSITY-DEPENDENT DISPERSAL; SPATIALLY-STRUCTURED POPULATIONS; SEX-BIASED DISPERSAL; INBREEDING AVOIDANCE; HABITAT SELECTION; GENOTYPING ERRORS; BROWN BEAR; MAMMALS; EVOLUTION; BIRDS	Understanding the factors that affect dispersal is a fundamental question in ecology and conservation biology, particularly as populations are faced with increasing anthropogenic impacts. Here we collected georeferenced genetic samples (n = 2,540) from three generations of black bears (Ursus americanus) harvested in a large (47,739 km(2)), geographically isolated population and used parentage analysis to identify mother-offspring dyads (n = 337). We quantified the effects of sex, age, habitat type and suitability, and local harvest density at the natal and settlement sites on the probability of natal dispersal, and on dispersal distances. Dispersal was male-biased (76% of males dispersed) but a small proportion (21%) of females also dispersed, and female dispersal distances (mean +/- SE = 48.9 +/- 7.7 km) were comparable to male dispersal distances (59.0 +/- 3.2 km). Dispersal probabilities and dispersal distances were greatest for bears in areas with high habitat suitability and low harvest density. The inverse relationship between dispersal and harvest density in black bears suggests that 1) intensive harvest promotes restricted dispersal, or 2) high black bear population density decreases the propensity to disperse. Multigenerational genetic data collected over large landscape scales can be a powerful means of characterizing dispersal patterns and causal associations with demographic and landscape features in wild populations of elusive and wide-ranging species.	[Moore, Jennifer A.] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Draheim, Hope M.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Etter, Dwayne] Michigan Dept Nat Resources, Wildlife Div, E Lansing, MI USA; [Moore, Jennifer A.; Winterstein, Scott; Scribner, Kim T.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	Grand Valley State University; Michigan State University; Michigan State University	Moore, JA (corresponding author), Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA.	moorejen@gvsu.edu			Michigan Department of Natural Resources through the Wildlife and Sportfish Restoration Program, Michigan State University Department of Fisheries and Wildlife [F11AF00640]	Michigan Department of Natural Resources through the Wildlife and Sportfish Restoration Program, Michigan State University Department of Fisheries and Wildlife	Michigan Department of Natural Resources through the Wildlife and Sportfish Restoration Program F11AF00640, Michigan State University Department of Fisheries and Wildlife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bitume EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026927; Broseth H, 2005, J APPL ECOL, V42, P453, DOI 10.1111/j.1365-2664.2005.01031.x; Carter NH, 2010, URSUS, V21, P57, DOI 10.2192/09GR011.1; Cattadori IM, 2003, OIKOS, V100, P439, DOI 10.1034/j.1600-0706.2003.12072.x; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Clutton-Brock TH, 2012, MOL ECOL, V21, P472, DOI 10.1111/j.1365-294X.2011.05232.x; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Costello CM, 2008, MOL ECOL, V17, P4713, DOI 10.1111/j.1365-294X.2008.03930.x; Costello CM, 2010, J MAMMAL, V91, P116, DOI 10.1644/09-MAMM-A-015R1.1; Czetwertynski SM, 2007, URSUS, V18, P1, DOI 10.2192/1537-6176(2007)18[1:EOHODP]2.0.CO;2; Davis JM, 2004, TRENDS ECOL EVOL, V19, P411, DOI 10.1016/j.tree.2004.04.006; Draheim H, WILDLIFE BI IN PRESS; Dreher BP, 2007, J WILDLIFE MANAGE, V71, P2684, DOI 10.2193/2006-398; ELOWE KD, 1989, J WILDLIFE MANAGE, V53, P962, DOI 10.2307/3809596; ENNIS S, 1994, ANIM GENET, V25, P425, DOI 10.1111/j.1365-2052.1994.tb00533.x; Epperson BK, 2005, HEREDITY, V95, P7, DOI 10.1038/sj.hdy.6800680; ETTER DR, 2002, BLACK BEAR POPULATIO; Frawley BJ, 2009, 2008 MICHIGAN BLACK; GARSHELIS DL, 1981, J WILDLIFE MANAGE, V45, P912, DOI 10.2307/3808099; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; HESTBECK JB, 1982, OIKOS, V39, P157, DOI 10.2307/3544480; HORNER MA, 1990, J MAMMAL, V71, P402, DOI 10.2307/1381953; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; LAMBIN X, 1994, ECOLOGY, V75, P224, DOI 10.2307/1939396; Lambin Xavier, 2001, P110; Lehmann L, 2003, AM NAT, V162, P638, DOI 10.1086/378823; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; MEAGHER TR, 1986, THEOR POPUL BIOL, V29, P87, DOI 10.1016/0040-5809(86)90006-7; Miller MA, 2003, URSUS, V14, P130; Murrell DJ, 2002, OIKOS, V97, P229, DOI 10.1034/j.1600-0706.2002.970209.x; NOVAK JM, 1991, J WILDLIFE MANAGE, V55, P31, DOI 10.2307/3809238; Obbard ME, 2008, J WILDLIFE MANAGE, V72, P869, DOI 10.2193/2006-158; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Peacock E, 2004, ESTIMATION BLACK BEA; PIANKA ER, 1975, AM NAT, V109, P453, DOI 10.1086/283013; Proctor MF, 2004, CAN J ZOOL, V82, P1108, DOI 10.1139/z04-077; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; R Development Team, 2006, R LANG ENV STAT COMP; Riester M, 2009, BIOINFORMATICS, V25, P2134, DOI 10.1093/bioinformatics/btp064; Rogers L. L., 1987, MAMMALIAN DISPERSAL, P75; ROGERS LL, 1987, WILDLIFE MONOGR, P1; Ronce Ophelie, 2001, P341; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Roy J, 2012, ECOL EVOL, V2, P525, DOI 10.1002/ece3.207; SCHWARTZ CC, 1992, J WILDLIFE MANAGE, V56, P426, DOI 10.2307/3808854; Shih CC, 2009, CONSERV GENET, V10, P1845, DOI 10.1007/s10592-009-9830-3; Silverman B.W., 1986, DENSITY ESTIMATION S; STAMPS JA, 1987, BEHAV ECOL SOCIOBIOL, V21, P273, DOI 10.1007/BF00299964; Stamps JA, 2009, AM NAT, V174, P623, DOI 10.1086/644526; Stamps JA, 2006, ANIM BEHAV, V72, P1279, DOI 10.1016/j.anbehav.2006.03.010; Stoen OG, 2006, OECOLOGIA, V148, P356, DOI 10.1007/s00442-006-0384-5; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P1837, DOI 10.1098/rspb.1999.0854; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WILLEY CH, 1974, J WILDLIFE MANAGE, V38, P97, DOI 10.2307/3800203; WOLFF JO, 1992, NATURE, V359, P409, DOI 10.1038/359409a0; Wolff JO, 1997, J ANIM ECOL, V66, P1, DOI 10.2307/5959; Wu H, 2010, CONSERV GENET, V11, P1215, DOI 10.1007/s10592-009-9922-0; Zedrosser A, 2007, ANIM BEHAV, V74, P369, DOI 10.1016/j.anbehav.2006.09.015; [No title captured]	65	28	28	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91168	10.1371/journal.pone.0091168	http://dx.doi.org/10.1371/journal.pone.0091168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621593	Green Published, gold			2022-12-27	WOS:000332845300056
J	Westmark, CJ				Westmark, Cara J.			Soy Infant Formula and Seizures in Children with Autism: A Retrospective Study	PLOS ONE			English	Article							FED BREAST-MILK; EPILEPSY; EXPOSURE; BEHAVIOR; GENDER; MODELS	Seizures are a common phenotype in many neurodevelopmental disorders including fragile X syndrome, Down syndrome and autism. We hypothesized that phytoestrogens in soy-based infant formula were contributing to lower seizure threshold in these disorders. Herein, we evaluated the dependence of seizure incidence on infant formula in a population of autistic children. Medical record data were obtained on 1,949 autistic children from the SFARI Simplex Collection. An autism diagnosis was determined by scores on the ADI-R and ADOS exams. The database included data on infant formula use, seizure incidence, the specific type of seizure exhibited and IQ. Soy-based formula was utilized in 17.5% of the study population. Females comprised 13.4% of the subjects. There was a 2.6-fold higher rate of febrile seizures [4.2% versus 1.6%, OR = 2.6, 95% CI = 1.3-5.3], a 2.1-fold higher rate of epilepsy comorbidity [3.6% versus 1.7%, OR = 2.2, 95% CI = 1.1-4.7] and a 4-fold higher rate of simple partial seizures [1.2% versus 0.3%, OR = 4.8, 95% CI = 1.0-23] in the autistic children fed soy-based formula. No statistically significant associations were found with other outcomes including: IQ, age of seizure onset, infantile spasms and atonic, generalized tonic clonic, absence and complex partial seizures. Limitations of the study included: infant formula and seizure data were based on parental recall, there were significantly less female subjects, and there was lack of data regarding critical confounders such as the reasons the subjects used soy formula, age at which soy formula was initiated and the length of time on soy formula. Despite these limitations, our results suggest that the use of soy-based infant formula may be associated with febrile seizures in both genders and with a diagnosis of epilepsy in males in autistic children. Given the lack of data on critical confounders and the retrospective nature of the study, a prospective study is required to confirm the association.	Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Westmark, CJ (corresponding author), Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA.	westmark@wisc.edu	Westmark, Cara/AAX-4408-2020; Westmark, Cara J/L-4647-2019		FRAXA Research Foundation; National Institutes of Health (NIH) [1UL1RR025011, 9U54TR000021]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER	FRAXA Research Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by FRAXA Research Foundation (www.fraxa.org) and National Institutes of Health (NIH) (www.nih.gov) [1UL1RR025011 and 9U54TR000021]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adgent MA, 2011, ENVIRON HEALTH PERSP, V119, P1811, DOI 10.1289/ehp.1103579; Amiet C, 2008, BIOL PSYCHIAT, V64, P577, DOI 10.1016/j.biopsych.2008.04.030; Andres A, 2012, PEDIATRICS, V129, P1134, DOI 10.1542/peds.2011-3121; [Anonymous], 2008, ANN ICRP, V38, P1; Bernbaum JC, 2008, ENVIRON HEALTH PERSP, V116, P416, DOI 10.1289/ehp.10409; Berry-Kravis E, 2010, AJIDD-AM J INTELLECT, V115, P461, DOI 10.1352/1944-7558-115.6.461; Bhatia J, 2008, PEDIATRICS, V121, P1062, DOI 10.1542/peds.2008-0564; Brooks-Kayal A, 2010, BRAIN DEV-JPN, V32, P731, DOI 10.1016/j.braindev.2010.04.010; Brown NM, 2001, LAB INVEST, V81, P735, DOI 10.1038/labinvest.3780282; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Gilchrist JM, 2010, J PEDIATR-US, V156, P215, DOI 10.1016/j.jpeds.2009.08.043; Hessl D, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.5.e88; Irizarry MC, 2012, ARCH NEUROL-CHICAGO, V69, P368, DOI 10.1001/archneurol.2011.830; Jing HK, 2010, EARLY HUM DEV, V86, P119, DOI 10.1016/j.earlhumdev.2010.02.001; Li JA, 2010, DEV NEUROPSYCHOL, V35, P762, DOI 10.1080/87565641.2010.508547; Lott IT, 2012, PROG BRAIN RES, V197, P101, DOI 10.1016/B978-0-444-54299-1.00006-6; McCary LM, 2013, J INTELL DISABIL RES, V57, P803, DOI 10.1111/j.1365-2788.2012.01609.x; Nakayama J, 2006, EPILEPSY RES, V70, pS190, DOI 10.1016/j.eplepyres.2005.11.023; NELSON KB, 1976, NEW ENGL J MED, V295, P1029, DOI 10.1056/NEJM197611042951901; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Polack FP, 1999, CLIN PEDIATR, V38, P703, DOI 10.1177/000992289903801202; Ricci M., 2005, ANIM LAB NEWS, V4, P1; Russ SA, 2012, PEDIATRICS, V129, P256, DOI 10.1542/peds.2010-1371; Setchell KDR, 1998, AM J CLIN NUTR, V68, p1453S, DOI 10.1093/ajcn/68.6.1453S; Setchell KDR, 1997, LANCET, V350, P23, DOI 10.1016/S0140-6736(96)09480-9; Shukla SK, 2010, NAT PROD RES, V24, P873, DOI 10.1080/14786410903417378; Soucy NV, 2006, TOXICOL SCI, V90, P230, DOI 10.1093/toxsci/kfj077; Spencer CM, 2011, AUTISM RES, V4, P40, DOI 10.1002/aur.168; Weber KS, 2001, DEV BRAIN RES, V126, P217, DOI 10.1016/S0165-3806(00)00138-3; Wei P, 2012, ASIAN PAC J TROP MED, V5, P243, DOI 10.1016/S1995-7645(12)60033-9; Yates JRW, 2011, ARCH DIS CHILD, V96, P1020, DOI 10.1136/adc.2011.211995	32	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e80488	10.1371/journal.pone.0080488	http://dx.doi.org/10.1371/journal.pone.0080488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622158	Green Submitted, gold, Green Published			2022-12-27	WOS:000332845300001
J	Bharti, RK; Srivastava, S; Thakur, IS				Bharti, Randhir K.; Srivastava, Shaili; Thakur, Indu Shekhar			Proteomic Analysis of Carbon Concentrating Chemolithotrophic Bacteria Serratia sp for Sequestration of Carbon Dioxide	PLOS ONE			English	Article							ESCHERICHIA-COLI; INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE; CO2; BIOSYNTHESIS; PROTEINS; ANHYDRASE; SEQUENCE; ENZYME; MICROCOMPARTMENTS; PURIFICATION	A chemolithotrophic bacterium enriched in the chemostat in presence of sodium bicarbonate as sole carbon source was identified as Serratia sp. by 16S rRNA sequencing. Carbon dioxide sequestering capacity of bacterium was detected by carbonic anhydrase enzyme and ribulose-1, 5-bisphosphate carboxylase/oxygenase (RuBisCO). The purified carbonic anhydrase showed molecular weight of 29 kDa. Molecular weight of RuBisCO was 550 kDa as determined by fast protein liquid chromatography (FPLC), however, sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) showed presence of two subunits whose molecular weights were 56 and 14 kDa. The Western blot analysis of the crude protein and purified sample cross reacted with RuBisCO large-subunit polypeptides antibodies showed strong band pattern at molecular weight around 56 kDa regions. Whole cell soluble proteins of Serratia sp. grown under autotrophic and heterotrophic conditions were resolved by two-dimensional gel electrophoresis and MALDI-TOF/MS for differential expression of proteins. In proteomic analysis of 63 protein spots, 48 spots were significantly up-regulated in the autotrophically grown cells; seven enzymes showed its utilization in autotrophic carbon fixation pathways and other metabolic activities of bacterium including lipid metabolisms indicated sequestration potency of carbon dioxide and production of biomaterials.	[Bharti, Randhir K.; Srivastava, Shaili; Thakur, Indu Shekhar] Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Thakur, IS (corresponding author), Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India.	isthakur@hotmail.com			Department of Biotechnology, Government of India, New Delhi, India; University Grants Commission	Department of Biotechnology, Government of India, New Delhi, India; University Grants Commission(University Grants Commission, India)	This research work was supported by the research grants of Department of Biotechnology, Government of India, New Delhi, India. One of the authors (Srivastava S.) is thankful to University Grants Commission for Dr. D. S Kothari post Doctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger MR, 2006, J EXP BOT, V57, P249, DOI 10.1093/jxb/eri286; BAHR J T, 1981, Photosynthesis Research, V2, P235, DOI 10.1007/BF00056260; Banfield JF, 2005, OMICS, V9, P301, DOI 10.1089/omi.2005.9.301; Battchikova N, 2010, J PROTEOME RES, V9, P5896, DOI 10.1021/pr100651w; Burns BP, 1995, MICROBIOL-UK, V141, P3113, DOI 10.1099/13500872-141-12-3113; CHAUDHURI S, 1985, BIOCHEM J, V226, P217, DOI 10.1042/bj2260217; DUNCAN K, 1984, FEBS LETT, V170, P59, DOI 10.1016/0014-5793(84)81368-X; EVANS MCW, 1966, P NATL ACAD SCI USA, V55, P928, DOI 10.1073/pnas.55.4.928; Gardebrecht A, 2012, ISME J, V6, P766, DOI 10.1038/ismej.2011.137; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; HARRIS RA, 1986, ADV ENZYME REGUL, V25, P219, DOI 10.1016/0065-2571(86)90016-6; HILDITCH CM, 1991, PHYTOCHEMISTRY, V30, P745, DOI 10.1016/0031-9422(91)85245-U; Ho SH, 2011, BIOTECHNOL ADV, V29, P189, DOI 10.1016/j.biotechadv.2010.11.001; Innocenti A, 2008, BIOORG MED CHEM LETT, V18, P2267, DOI 10.1016/j.bmcl.2008.03.012; Jaiswal PK, 2011, J IND MICROBIOL BIOT, V38, P503, DOI 10.1007/s10295-010-0793-7; Jehmlich N, 2010, APPL MICROBIOL BIOT, V88, P575, DOI 10.1007/s00253-010-2753-6; Joseph P, 2011, BIOORGAN MED CHEM, V19, P1172, DOI 10.1016/j.bmc.2010.12.048; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Kichise T, 1999, INT J BIOL MACROMOL, V25, P69, DOI 10.1016/S0141-8130(99)00017-3; Kim IG, 2012, CHEMOSPHERE, V87, P1091, DOI 10.1016/j.chemosphere.2012.02.003; Kinney JN, 2012, J BIOL CHEM, V287, P17729, DOI 10.1074/jbc.M112.355305; Kumar A, 2010, TRENDS BIOTECHNOL, V28, P371, DOI 10.1016/j.tibtech.2010.04.004; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kurian D, 2006, PROTEOMICS, V6, P1483, DOI 10.1002/pmic.200500413; LENNARZ WJ, 1961, BIOCHEM BIOPH RES CO, V6, P112, DOI 10.1016/0006-291X(61)90395-3; Liang XQ, 2000, ARCH BIOCHEM BIOPHYS, V380, P373, DOI 10.1006/abbi.2000.1941; LONG JJ, 1994, J BIOL CHEM, V269, P2827; Mehlan H, 2013, PROTEOMICS, V13, P2805, DOI 10.1002/pmic.201300167; Mishra M, 2011, INT BIODETER BIODEGR, V65, P301, DOI 10.1016/j.ibiod.2010.12.002; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; Ozensoy O, 2004, BIOCHEMISTRY-MOSCOW+, V69, P216, DOI 10.1023/B:BIRY.0000018954.38006.9a; Palumbo AV, 2004, ADV ENVIRON RES, V8, P425, DOI 10.1016/S1093-0191(02)00124-7; PELROY RA, 1972, ARCH MIKROBIOL, V87, P303, DOI 10.1007/BF00409131; Price GD, 1998, CAN J BOT, V76, P973, DOI 10.1139/b98-081; Qiao JJ, 2013, GENE, V512, P6, DOI 10.1016/j.gene.2012.10.004; Scheibe R, 2004, PHYSIOL PLANTARUM, V120, P21, DOI 10.1111/j.0031-9317.2004.0222.x; Schilling CH, 2000, J THEOR BIOL, V203, P249, DOI 10.1006/jtbi.2000.1088; Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002; SHARKEY TD, 1991, PHOTOSYNTH RES, V28, P41, DOI 10.1007/BF00027175; Shrestha RK, 2006, ENVIRON INT, V32, P781, DOI 10.1016/j.envint.2006.05.001; STRAUSS G, 1993, EUR J BIOCHEM, V215, P633, DOI 10.1111/j.1432-1033.1993.tb18074.x; Taneja S, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-5; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; THAKUR IS, 1995, WORLD J MICROB BIOT, V11, P643, DOI 10.1007/BF00361007; Thakur SS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003699; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Wohlbrand L, 2013, PROTEOMIC TOOLS ENV, DOI [10.1002/pmic.201300175, DOI 10.1002/PMIC.201300175]; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; Wu WW, 2007, J PROTEOME RES, V6, P2447, DOI 10.1021/pr060621c; YEAMAN SJ, 1989, BIOCHEM J, V257, P625, DOI 10.1042/bj2570625; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v; Zhang Y, 1998, J BACTERIOL, V180, P3295, DOI 10.1128/JB.180.13.3295-3303.1998; Zimmermann AG, 1998, PROG NUCLEIC ACID RE, V61, P181, DOI 10.1016/S0079-6603(08)60827-2	57	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91300	10.1371/journal.pone.0091300	http://dx.doi.org/10.1371/journal.pone.0091300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619032	Green Submitted, gold, Green Published			2022-12-27	WOS:000332842400070
J	Liu, L; Zhang, X; Yan, B; Gu, QH; Zhang, XD; Jiao, JP; Sun, DZ; Wang, N; Yue, XQ				Liu, Long; Zhang, Xi; Yan, Bing; Gu, Qunhao; Zhang, Xiaodong; Jiao, Jianpeng; Sun, Dazhi; Wang, Ning; Yue, Xiaoqiang			Elevated Plasma D-Dimer Levels Correlate with Long Term Survival of Gastric Cancer Patients	PLOS ONE			English	Article							HEMOSTATIC PARAMETERS; POOR-PROGNOSIS; UP-REGULATION; COAGULATION; PROGRESSION; METASTASIS; CARCINOMA; STAGE; SERUM	Background: Increasing evidence indicated plasma D-dimer could be regarded as a marker in cancers, however, its role in gastric cancer is still largely unknown. Methods: Plasma D-dimer levels were measured by enzyme linked fluorescent immunoassays and evaluated by receiver operating characteristic (ROC) curves for peritoneal dissemination in gastric cancer and healthy subjects. The overall survival (OS) characteristics were determined using Kaplan-Meier and Cox regression analyses. Results: The average of the plasma D-dimer levels for gastric cancer patients was significantly higher than the healthy subjects. A Spearman correlation analysis showed that plasma D-dimer levels correlated with the depth of invasion, lymph node metastasis, peritoneal dissemination, distant metastasis, tumor size and TNM stage. The mean plasma D-dimer level was 2.20 +/- 1.51 mu g/mL in peritoneal dissemination patients and 1.01 +/- 0.79 mu g/mL in non-peritoneal dissemination patients (P<0.001). Additionally, the mean plasma D-dimer concentration in patients alive at the final follow-up evaluation was 0.79 +/- 0.72 mu g/mL, which was significantly lower than the amounts determined for the deceased patients (1.36 +/- 1.13 mu g/mL) (P<0.001). The AUC of D-dimer was 0.833 (95% CI: 0.780-0.885). At a cut-off value of 1.465 mu g/mL, the D-dimer measurement had a sensitivity of 78.00%, a specificity of 83.76% and an accuracy of 82.59%. The median OS was 48.10 months (95% CI: 43.88-52.31) in patients with plasma D-dimer levels less than 1.465 mu g/mL and 22.39 months (95% CI: 16.95-27.82) in patients with plasma D-dimer levels exceeding 1.465 mu g/mL (log-rank test, P<0.001). Importantly, plasma D-dimer levels exceeding 1.465 mu g/mL were significantly associated with poor OS, as determined using a multivariate Cox regression analysis (hazard ratio [HR], 2.28; 95% CI: 1.36-3.81; P = 0.002). Conclusions: Plasma D-dimer levels are increased in gastric cancer patients and may be a valuable biomarker for peritoneal dissemination, with high D-dimer levels predicting poor outcomes for gastric cancer patients.	[Liu, Long; Yue, Xiaoqiang] Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China; [Zhang, Xi] Second Mil Med Univ, Dept Anat, Shanghai, Peoples R China; [Yan, Bing; Jiao, Jianpeng; Sun, Dazhi] Second Mil Med Univ, Changzheng Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China; [Gu, Qunhao; Zhang, Xiaodong] Shanghai Univ Tradit Chinese Med, Yueyang Hosp, Dept Gen Surg, Shanghai, Peoples R China; [Wang, Ning] Second Mil Med Univ, Changhai Hosp, Dept Oncol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Shanghai University of Traditional Chinese Medicine; Naval Medical University	Yue, XQ (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China.	xiaoqiangyue888@163.com		Yue, Xiaoqiang/0000-0001-6872-9664	National Natural Science Foundation of China [81102693, 81102565]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grants 81102693 and 81102565). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2012, BRIT J CANCER, V106, P733, DOI 10.1038/bjc.2011.592; Altiay G, 2007, CLIN ONCOL-UK, V19, P494, DOI 10.1016/j.clon.2007.04.002; Ay C, 2012, HAEMATOL-HEMATOL J, V97, P1158, DOI 10.3324/haematol.2011.054718; BICK RL, 1992, SEMIN THROMB HEMOST, V18, P353, DOI 10.1055/s-2007-1002575; Blackwell K, 2004, CANCER-AM CANCER SOC, V101, P77, DOI 10.1002/cncr.20336; Buccheri GR, 2003, CANCER, V97, P3044, DOI 10.1002/cncr.11432; Buller HR, 2007, J THROMB HAEMOST, V5, P246, DOI 10.1111/j.1538-7836.2007.02497.x; CORREA P, 1992, CANCER RES, V52, P6735; Dupuy E, 2003, J HEPATOL, V38, P793, DOI 10.1016/S0168-8278(03)00086-2; Fidan E, 2012, TUMOR BIOL, V33, P1519, DOI 10.1007/s13277-012-0403-6; Gadducci A, 2009, CRIT REV ONCOL HEMAT, V69, P12, DOI 10.1016/j.critrevonc.2008.05.001; Hajjari M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0670-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Ke B, 2013, TUMOR BIOL, V34, P3137, DOI 10.1007/s13277-013-0882-0; Kwon HC, 2009, JPN J CLIN ONCOL, V27, P4124; Kwon HC, 2008, JPN J CLIN ONCOL, V38, P2, DOI 10.1093/jjco/hym157; Liu Y, 2012, J BIOMED RES, V26, P315, DOI 10.7555/JBR.26.20110087; LUZZATTO G, 1990, SEMIN ONCOL, V17, P147; Mei DY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0709-2; SEITZ R, 1993, BLOOD COAGUL FIBRIN, V4, P249, DOI 10.1097/00001721-199304000-00006; Sun Da-zhi, 2010, Zhong Xi Yi Jie He Xue Bao, V8, P332, DOI 10.3736/jcim20100406; Tas Faruk, 2013, J Gastrointest Cancer, V44, P285, DOI 10.1007/s12029-013-9490-x; TATSUTA M, 1993, INT J CANCER, V53, P70, DOI 10.1002/ijc.2910530114; Trotti A, 2009, AJCC CANC STAGING MA, P117; Unsal E, 2004, RESP MED, V98, P93, DOI 10.1016/j.rmed.2003.07.001; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Wang Yu, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P514, DOI 10.3736/jcim20090604; Xu G, 2005, PRAC J MED PHARM, V22, P977; Yamashita H, 2005, JPN J CLIN ONCOL, V35, P595, DOI 10.1093/jjco/hyi150; Yigit E, 2008, EUR J INTERN MED, V19, P602, DOI 10.1016/j.ejim.2007.06.036; Yonemura Y, 2006, EJSO-EUR J SURG ONC, V32, P602, DOI 10.1016/j.ejso.2006.03.003	32	51	60	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90547	10.1371/journal.pone.0090547	http://dx.doi.org/10.1371/journal.pone.0090547			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618826	gold, Green Submitted, Green Published			2022-12-27	WOS:000332842400022
J	Mazars, C; Briere, C; Grat, S; Pichereaux, C; Rossignol, M; Pereda-Loth, V; Eche, B; Boucheron-Dubuisson, E; Le Disquet, I; Medina, FJ; Graziana, A; Carnero-Diaz, E				Mazars, Christian; Briere, Christian; Grat, Sabine; Pichereaux, Carole; Rossignol, Michel; Pereda-Loth, Veronica; Eche, Brigitte; Boucheron-Dubuisson, Elodie; Le Disquet, Isabel; Javier Medina, Francisco; Graziana, Annick; Carnero-Diaz, Eugenie			Microgravity Induces Changes in Microsome-Associated Proteins of Arabidopsis Seedlings Grown on Board the International Space Station	PLOS ONE			English	Article							POLAR AUXIN TRANSPORT; SHOOT GRAVITROPISM; ROOT GRAVITROPISM; PLANT-CELLS; GLUCOSINOLATE BIOSYNTHESIS; PLASMA-MEMBRANE; JASMONIC ACID; LENTIL ROOT; GENE FAMILY; THALIANA	The "GENARA A'' experiment was designed to monitor global changes in the proteome of membranes of Arabidopsis thaliana seedlings subjected to microgravity on board the International Space Station (ISS). For this purpose, 12-day-old seedlings were grown either in space, in the European Modular Cultivation System (EMCS) under microgravity or on a 1 g centrifuge, or on the ground. Proteins associated to membranes were selectively extracted from microsomes and identified and quantified through LC-MS-MS using a label-free method. Among the 1484 proteins identified and quantified in the 3 conditions mentioned above, 80 membrane-associated proteins were significantly more abundant in seedlings grown under microgravity in space than under 1 g (space and ground) and 69 were less abundant. Clustering of these proteins according to their predicted function indicates that proteins associated to auxin metabolism and trafficking were depleted in the microsomal fraction in mu g space conditions, whereas proteins associated to stress responses, defence and metabolism were more abundant in mu g than in 1 g indicating that microgravity is perceived by plants as a stressful environment. These results clearly indicate that a global membrane proteomics approach gives a snapshot of the cell status and its signaling activity in response to microgravity and highlight the major processes affected.	[Mazars, Christian; Briere, Christian; Grat, Sabine; Graziana, Annick] Univ Toulouse UPS, Lab Rech Sci Vegetales, CNRS, UMR5546, Castanet Tolosan, France; [Pichereaux, Carole; Rossignol, Michel] CNRS, IPBS, Federat Rech Agrobiosci Interact & Biodivers Plat, Toulouse, France; [Pereda-Loth, Veronica; Eche, Brigitte] Univ Toulouse, GSBMS, Toulouse, France; [Boucheron-Dubuisson, Elodie; Le Disquet, Isabel; Carnero-Diaz, Eugenie] Sorbonne Univ, Univ Paris 06, CNRS, UR5,PCMP,EAC 7180, Paris, France; [Javier Medina, Francisco] CSIC, Ctr Invest Biol, Madrid, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Mazars, C (corresponding author), Univ Toulouse UPS, Lab Rech Sci Vegetales, CNRS, UMR5546, Castanet Tolosan, France.	mazars@lrsv.ups-tlse.fr	Medina, F. Javier/M-2278-2014	Medina, F. Javier/0000-0002-0866-7710; Pichereaux, Carole/0000-0002-7559-5358; Mazars, Christian/0000-0002-0670-6042	CNRS -CNES - Universite Paul Sabatier	CNRS -CNES - Universite Paul Sabatier	Funding was supported by CNRS -CNES - Universite Paul Sabatier. The funders had no role in study design, data collection and anlysis, decision to publish, or preparation of the manuscript.	Aarrouf J, 1999, PHYSIOL PLANTARUM, V105, P708, DOI 10.1034/j.1399-3054.1999.105416.x; Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Azri W, 2009, PHYSIOL PLANTARUM, V136, P193, DOI 10.1111/j.1399-3054.2009.01230.x; Bak S, 2001, PLANT CELL, V13, P101, DOI 10.1105/tpc.13.1.101; Bak S, 2001, PLANT PHYSIOL, V127, P108, DOI 10.1104/pp.127.1.108; Barjaktarovic Z, 2007, J EXP BOT, V58, P4357, DOI 10.1093/jxb/erm302; Barlier I, 2000, P NATL ACAD SCI USA, V97, P14819, DOI 10.1073/pnas.260502697; BELL E, 1995, P NATL ACAD SCI USA, V92, P8675, DOI 10.1073/pnas.92.19.8675; Benjamins R, 2001, DEVELOPMENT, V128, P4057; Benjamins R, 2003, PLANT PHYSIOL, V132, P1623, DOI 10.1104/pp.103.019943; Blancaflor EB, 2013, AM J BOT, V100, P143, DOI 10.3732/ajb.1200283; Boot KJM, 2012, J EXP BOT, V63, P4213, DOI 10.1093/jxb/ers106; Bouyssie D, 2007, MOL CELL PROTEOMICS, V6, P1621, DOI 10.1074/mcp.T600069-MCP200; Brinckmann Enno, 2004, J Gravit Physiol, V11, P67; CASPAR T, 1989, PLANTA, V177, P185, DOI 10.1007/BF00392807; Chen RJ, 1999, PLANT PHYSIOL, V120, P343, DOI 10.1104/pp.120.2.343; Cho D, 2012, PLANT PHYSIOL, V160, P1293, DOI 10.1104/pp.112.201442; CLAASSEN DE, 1994, INT REV CYTOL, V156, P301, DOI 10.1016/S0074-7696(08)62257-3; Correll MJ, 2013, PLANTA, V238, P519, DOI 10.1007/s00425-013-1909-x; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Davies E, 1999, J Gravit Physiol, V6, pP21; Dayanandan P, 2011, J BIOSCIENCES, V36, P911, DOI 10.1007/s12038-011-9150-x; Driss-Ecole D, 2000, PLANTA, V211, P396, DOI 10.1007/s004250000298; Driss-Ecole D, 2003, PHYSIOL PLANTARUM, V118, P305, DOI 10.1034/j.1399-3054.2003.00121.x; Fang ZY, 2009, PLANT SCI, V176, P170, DOI 10.1016/j.plantsci.2008.09.007; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Fukaki H, 1998, PLANT J, V14, P425, DOI 10.1046/j.1365-313X.1998.00137.x; Fukaki H, 1996, PLANT PHYSIOL, V110, P945, DOI 10.1104/pp.110.3.945; Galvan-Ampudia CS, 2007, TRENDS PLANT SCI, V12, P541, DOI 10.1016/j.tplants.2007.10.004; Hansen CH, 2001, J BIOL CHEM, V276, P24790, DOI 10.1074/jbc.M102637200; Harada A, 2003, P NATL ACAD SCI USA, V100, P8583, DOI 10.1073/pnas.1336802100; HARDHAM AR, 1978, J CELL BIOL, V77, P14, DOI 10.1083/jcb.77.1.14; Hasenstein KH, 1999, ADV SPACE RES-SERIES, V24, P677, DOI 10.1016/S0273-1177(99)00399-3; Herranz R, 2013, ASTROBIOLOGY, V13, P1, DOI 10.1089/ast.2012.0876; Hoson T, 2000, Biol Sci Space, V14, P75, DOI 10.2187/bss.14.75; Hoson T, 2003, INT REV CYTOL, V229, P209, DOI 10.1016/S0074-7696(03)29005-7; Hoson T, 2003, PLANT SOIL, V255, P19, DOI 10.1023/A:1026105431505; Hoson T, 1999, Biol Sci Space, V13, P264; Jambunathan N, 2001, PLANT CELL, V13, P2225, DOI 10.1105/tpc.13.10.2225; Kamada Motoshi, 2004, Biol Sci Space, V18, P156; KISS JZ, 1989, PLANTA, V177, P198, DOI 10.1007/BF00392808; Kittang AI, 2014, PLANT BIOLOGY, V16, P528, DOI 10.1111/plb.12132; Li JJ, 2011, PLANT CELL, V23, P4411, DOI 10.1105/tpc.111.092684; Loth-Pereda V, 2011, PLANT PHYSIOL, V156, P2141, DOI 10.1104/pp.111.180646; Marquardt J, 1997, Biol Sci Space, V11, P244; Martzivanou M, 2003, PHYSIOL PLANTARUM, V118, P221, DOI 10.1034/j.1399-3054.2003.00092.x; MASSON PH, 1995, BIOESSAYS, V17, P119, DOI 10.1002/bies.950170207; Mei Y, 2012, CELL RES, V22, P581, DOI 10.1038/cr.2011.150; MELAN MA, 1993, PLANT PHYSIOL, V101, P441, DOI 10.1104/pp.101.2.441; Mongrand S, 2010, TRENDS PLANT SCI, V15, P656, DOI 10.1016/j.tplants.2010.09.003; Mukherjee AK, 2010, J PROTEOMICS, V73, P709, DOI 10.1016/j.jprot.2009.10.005; Nagasaki N, 2008, FEBS J, V275, P2267, DOI 10.1111/j.1742-4658.2008.06379.x; Nechitailo GS, 2005, ADV SPACE RES-SERIES, V36, P1329, DOI 10.1016/j.asr.2005.06.043; Normanly J, 1999, CURR OPIN PLANT BIOL, V2, P207, DOI 10.1016/S1369-5266(99)80037-5; Oka M, 1995, Biol Sci Space, V9, P331, DOI 10.2187/bss.9.331; Paul AL, 2013, AM J BOT, V100, P226, DOI 10.3732/ajb.1200338; Paul AL, 2012, ASTROBIOLOGY, V12, P40, DOI 10.1089/ast.2011.0696; PERBAL G, 1993, ACTA BOT GALLICA, V140, P615, DOI 10.1080/12538078.1993.10515642; PERBAL G, 1986, NATURWISSENSCHAFTEN, V73, P444, DOI 10.1007/BF00367293; Perbal G, 2003, TRENDS PLANT SCI, V8, P498, DOI 10.1016/j.tplants.2003.09.005; Perbal G, 2002, PHYSIOL PLANTARUM, V114, P336, DOI 10.1034/j.1399-3054.2002.1140302.x; Plaxton WC, 2011, PLANT PHYSIOL, V156, P1006, DOI 10.1104/pp.111.175281; Pollard SK, 2008, MULTTEST RESAMPLING; R Core Team, 2018, R LANG ENV STAT COMP; Rautengarten C, 2011, PLANT CELL, V23, P1373, DOI 10.1105/tpc.111.083931; SALISBURY FB, 1988, PLANT PHYSIOL, V88, P1186, DOI 10.1104/pp.88.4.1186; Salmi ML, 2011, PLANTA, V233, P911, DOI 10.1007/s00425-010-1343-2; Schenck CA, 2013, AM J BOT, V100, P194, DOI 10.3732/ajb.1200339; Schneider K, 2005, J BIOL CHEM, V280, P13962, DOI 10.1074/jbc.M413578200; Silady RA, 2004, PLANT PHYSIOL, V136, P3095, DOI 10.1104/pp.104.050583; Sobol M A, 2007, J Gravit Physiol, V14, pP109; Staswick PE, 2009, PLANT PHYSIOL, V150, P1310, DOI 10.1104/pp.109.138529; Stenzel I, 2003, PLANT MOL BIOL, V51, P895, DOI 10.1023/A:1023049319723; Strohm AK, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00274; Stutte GW, 2006, PLANTA, V224, P1038, DOI 10.1007/s00425-006-0290-4; Sun JQ, 2011, NEW PHYTOL, V191, P360, DOI 10.1111/j.1469-8137.2011.03713.x; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Titapiwatanakun B, 2009, PLANT J, V57, P27, DOI 10.1111/j.1365-313X.2008.03668.x; Tran HT, 2010, PLANT CELL ENVIRON, V33, P1789, DOI 10.1111/j.1365-3040.2010.02184.x; Tripathy BC, 1996, PLANT PHYSIOL, V110, P801, DOI 10.1104/pp.110.3.801; Ueda J, 1999, J PLANT RES, V112, P487, DOI 10.1007/PL00013904; Vellosillo T, 2007, PLANT CELL, V19, P831, DOI 10.1105/tpc.106.046052; Wakabayashi Kazuyuki, 2003, Biol Sci Space, V17, P228; Wakabayashi K, 2009, J PLANT PHYSIOL, V166, P947, DOI 10.1016/j.jplph.2008.12.006; Wang H, 2006, J EXP BOT, V57, P827, DOI 10.1093/jxb/erj066; Wang LS, 2011, PLANT PHYSIOL, V157, P1283, DOI 10.1104/pp.111.183723; Wee CW, 2010, BIOTECHNOL LETT, V32, P1361, DOI 10.1007/s10529-010-0307-8; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Yamauchi Y, 1997, PLANT CELL PHYSIOL, V38, P530, DOI 10.1093/oxfordjournals.pcp.a029201; Yang SH, 2006, PLANT J, V45, P166, DOI 10.1111/j.1365-313X.2005.02585.x; Yano D, 2003, P NATL ACAD SCI USA, V100, P8589, DOI 10.1073/pnas.1430749100; Yee TW, 2012, VGAM VECTOR GEN LINE; Young LS, 2006, PLANT PHYSIOL, V142, P564, DOI 10.1104/pp.106.084798	93	33	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91814	10.1371/journal.pone.0091814	http://dx.doi.org/10.1371/journal.pone.0091814			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618597	Green Published, gold			2022-12-27	WOS:000332842400134
J	Zhuang, L; Zhang, ZY; An, XP; Fan, H; Ma, MJ; Anderson, BD; Jiang, JF; Liu, W; Cao, WC; Tong, YG				Zhuang, Lu; Zhang, Zhiyi; An, Xiaoping; Fan, Hang; Ma, Maijuan; Anderson, Benjamin D.; Jiang, Jiafu; Liu, Wei; Cao, Wuchun; Tong, Yigang			An Efficient Strategy of Screening for Pathogens in Wild-Caught Ticks and Mosquitoes by Reusing Small RNA Deep Sequencing Data	PLOS ONE			English	Article							SMALL SILENCING RNAS; SPOTTED-FEVER; DERMACENTOR-SILVARUM; METAGENOMIC ANALYSIS; VIRAL GENOME; RICKETTSIA; VIRUS; DISCOVERY; CHINA	This paper explored our hypothesis that sRNA (18 similar to 30 bp) deep sequencing technique can be used as an efficient strategy to identify microorganisms other than viruses, such as prokaryotic and eukaryotic pathogens. In the study, the clean reads derived from the sRNA deep sequencing data of wild-caught ticks and mosquitoes were compared against the NCBI nucleotide collection (non-redundant nt database) using Blastn. The blast results were then analyzed with in-house Python scripts. An empirical formula was proposed to identify the putative pathogens. Results showed that not only viruses but also prokaryotic and eukaryotic species of interest can be screened out and were subsequently confirmed with experiments. Specially, a novel Rickettsia spp. was indicated to exist in Haemaphysalis longicornis ticks collected in Beijing. Our study demonstrated the reuse of sRNA deep sequencing data would have the potential to trace the origin of pathogens or discover novel agents of emerging/re-emerging infectious diseases.	[Zhuang, Lu; Zhang, Zhiyi; An, Xiaoping; Fan, Hang; Ma, Maijuan; Jiang, Jiafu; Liu, Wei; Cao, Wuchun; Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Anderson, Benjamin D.] Univ Florida, Coll Publ Hlth & Hlth Profess, Emerging Pathogens Inst, Gainesville, FL USA	Beijing Institute of Microbiology & Epidemiology; State University System of Florida; University of Florida	Cao, WC (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	caowc@nic.bmi.ac.cn; tong.yigang@gmail.com	Fan, Hang/AAA-8489-2022	Fan, Hang/0000-0002-7927-1684; Ma, Mai-Juan/0000-0002-8105-462X; Tong, Yigang/0000-0002-8503-8045	Natural Science Foundation of China [81222037, 81290344, 81130086, 81072250]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (81222037, 81290344, 81130086, 81072250). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyari R, 2009, IMMUNOL REV, V227, P176, DOI 10.1111/j.1600-065X.2008.00722.x; Cao WC, 2008, J MED ENTOMOL, V45, P741, DOI 10.1603/0022-2585(2008)45[741:MDOSFG]2.0.CO;2; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen Z., 1999, CHINESE J VECTOR BIO, V5, P18; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Culley AI, 2006, SCIENCE, V312, P1795, DOI 10.1126/science.1127404; Dantas-Torres F, 2007, LANCET INFECT DIS, V7, P724, DOI 10.1016/S1473-3099(07)70261-X; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Galkiewicz JP, 2008, APPL ENVIRON MICROB, V74, P7828, DOI 10.1128/AEM.01303-08; Garcia ME, 2002, J CLIN MICROBIOL, V40, P1567, DOI 10.1128/JCM.40.4.1567-1568.2002; Giampetruzzi A, 2012, VIRUS RES, V163, P262, DOI 10.1016/j.virusres.2011.10.010; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Huang Y, 2012, J GEN VIROL; Huang Y, 2013, J GEN VIROL, V94, P663, DOI 10.1099/vir.0.048231-0; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lin Y., 1999, CHINESE J ZOONOSES, V2, P5; Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024758; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Nga PT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002215; Raoult D, 1996, LANCET, V348, P412, DOI 10.1016/S0140-6736(05)65037-4; Reeves WK, 2005, ANN NY ACAD SCI, V1063, P343, DOI 10.1196/annals.1355.055; Tian ZC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-19; van Mierlo JT, 2010, CELL HOST MICROBE, V7, P87, DOI 10.1016/j.chom.2010.02.001; Walker DH, 2008, MED CLIN N AM, V92, P1345, DOI 10.1016/j.mcna.2008.06.002; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Zhang JZ, 2000, J CLIN MICROBIOL, V38, P3498, DOI 10.1128/JCM.38.9.3498-3501.2000; Zhang JZ, 2000, EMERG INFECT DIS, V6, P432, DOI 10.3201/eid0604.000426; Zhang LJ, 2006, J CLIN MICROBIOL, V44, P2465, DOI 10.1128/JCM.02272-05	30	9	11	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90831	10.1371/journal.pone.0090831	http://dx.doi.org/10.1371/journal.pone.0090831			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618575	gold, Green Submitted, Green Published			2022-12-27	WOS:000332842400032
J	Jin, HY; Zhang, B; Yao, H; Du, YH; Wang, XF; Leng, Q				Jin, Heiying; Zhang, Bei; Yao, Hang; Du, Yonghong; Wang, Xiaofeng; Leng, Qiang			Smooth Muscle Enfoldment Internal Sphincter Construction after Intersphincteric Resection for Rectal Cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; ANTERIOR	Objective: To assess smooth muscle enfoldment and internal sphincter construction (SMESC) for improvement of continence after intersphincteric resection (ISR) for rectal cancer. Methods: Twenty-four Bama miniature pigs were randomly divided into a conventional ISR group and experimental SMESC group, with 12 pigs in each group. The proximal sigmoid colon was anastomosed directly to the anus in the ISR group. In the SMESC group, internal sphincter construction was performed. At 12 weeks before and after surgery, rectal resting pressure and anal canal length were assessed. Three-dimensional ultrasound was used to determine the thickness of the internal sphincter. After the animals were sacrificed, the rectum and anus were resected and pathological examinations were performed to evaluate the differences in sphincter thickness and muscle fibers. Results: All 24 animals in the SMESC group and the ISR group survived the surgery. Twelve weeks post-surgery, the rectal resting pressure, length of the anal high-pressure zone and the postoperative internal sphincter thickness for the ISR group were significantly lower than for the SMESC group. There was a thickened area (about 2 cm) above the anastomotic stoma among animals from the SMESC group; in addition, the smooth muscles were significantly enlarged and enfolded when compared to the ISR group. Conclusion: This animal model study shows that the SMESC procedure achieved acceptable reconstruction of the internal anal neo-sphincter (IAN/S), without increasing surgical risk. However, the findings in this experimental animal model must be confirmed by clinical trials to determine the safety and efficacy of this procedure in clinical practice.	[Jin, Heiying; Zhang, Bei; Yao, Hang; Du, Yonghong; Wang, Xiaofeng; Leng, Qiang] Nanjing Univ Tradit Chinese Med, Affiliated Hosp 1, Natl Ctr Colorectal Surg, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine	Jin, HY (corresponding author), Nanjing Univ Tradit Chinese Med, Affiliated Hosp 1, Natl Ctr Colorectal Surg, Nanjing, Jiangsu, Peoples R China.	jinheiying@hotmail.com			National Nature Science Foundation of China [30973837, 81273944]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study is funded by the National Nature Science Foundation of China (No. 30973837, 81273944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi Y, 2013, SURG TODAY, V43, P838, DOI 10.1007/s00595-012-0394-3; Barisic G, 2011, COLORECTAL DIS, V13, P638, DOI 10.1111/j.1463-1318.2010.02244.x; Chamlou R, 2007, ANN SURG, V246, P916, DOI 10.1097/SLA.0b013e31815c29ff; Gong X, 2012, COLORECTAL DIS, V14, pe802, DOI 10.1111/j.1463-1318.2012.03177.x; Hirano A, 2011, AM J SURG, V201, P508, DOI 10.1016/j.amjsurg.2009.12.016; Kim JC, 2012, SURG TODAY, V42, P547, DOI 10.1007/s00595-011-0048-x; Konanz J, 2013, INT J COLORECTAL DIS, V28, P679, DOI 10.1007/s00384-013-1683-z; Laforest A, 2012, COLORECTAL DIS, V14, P1231, DOI 10.1111/j.1463-1318.2012.02956.x; Lim SW, 2011, WORLD J SURG, V35, P2811, DOI 10.1007/s00268-011-1277-2; Liu J, 2012, CHIN J GASTROINTEST, V15, P1312; Martin ST, 2012, BRIT J SURG, V99, P603, DOI 10.1002/bjs.8677; Rullier E, 2013, DIS COLON RECTUM, V56, P560, DOI 10.1097/DCR.0b013e31827c4a8c; Sato Yuichiro, 2008, Kurume Medical Journal, V55, P7, DOI 10.2739/kurumemedj.55.7; Zhuang CP, 2009, CHIN J GASTROINTEST, V12, P364	14	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91491	10.1371/journal.pone.0091491	http://dx.doi.org/10.1371/journal.pone.0091491			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626174	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300089
J	Kooiman, J; Seth, M; Share, D; Dixon, S; Gurm, HS				Kooiman, Judith; Seth, Milan; Share, David; Dixon, Simon; Gurm, Hitinder S.			The Association between Contrast Dose and Renal Complications Post PCI across the Continuum of Procedural Estimated Risk	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; CROSS-BLUE-SHIELD; INDUCED NEPHROPATHY; SAFE LIMITS; MEDIA; PREDICTION; INSIGHTS	Background: Prior studies have proposed to restrict the contrast volume (CV) to,3x calculated creatinine clearance (CCC), to prevent contrast induced nephropathy (CIN) post percutaneous coronary interventions (PCI). The predictive value of this algorithm for CIN and therefore the benefit of this approach in high risk patients has been questioned. The aim of our study was to assess the association between contrast dose and the occurrence of CIN in patients at varying predicted risks of CIN and baseline CCC following contemporary PCI. Methods: Consecutive patients undergoing PCI between 2010-2012 were included. Baseline risk of CIN was calculated using a previously validated risk tool. High contrast dose was defined as CV/CCC>3. Likelihood ratio tests were used to evaluate whether the effect of a high contrast dose on the risk of CIN and nephropathy requiring dialysis (NRD) varied across the spectrum of baseline predicted risk. Results: Of the 82,120 PCI included in our analysis, 25% were performed using a high contrast dose. Patients treated with a high compared with a low contrast dose were at increased risks of CIN and NRD, throughout the entire range of baseline predicted risk and CCC in our population. The effect size of a high contrast dose on risks of both outcomes varied significantly with baseline predicted CIN risk and CCC (CIN p = 0.004, NRD p<0.001 for adding interactions), and was largest for patients with predicted CIN risk <10% and pre-existing chronic kidney disease. Conclusions: The use of a high contrast dose is associated with increased risks of CIN and NRD across the continuum of baseline predicted risk and CCC. Efforts to reduce contrast dose may therefore be effective in preventing renal complications in all patients undergoing PCI.	[Kooiman, Judith] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Zuid Holland, Netherlands; [Kooiman, Judith] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Zuid Holland, Netherlands; [Seth, Milan; Gurm, Hitinder S.] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Share, David] Blue Cross Blue Shield Michigan, Detroit, MI USA; [Dixon, Simon] Beaumont Hosp, Royal Oak, MI USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Michigan System; University of Michigan; Beaumont Health	Gurm, HS (corresponding author), Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA.	hgurm@med.umich.edu		Gurm, Hitinder/0000-0002-1646-0218	Blue Cross Blue Shield of Michigan; National Institutes of Health; Agency for Healthcare Research and Quality	Blue Cross Blue Shield of Michigan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The BMC2 registry is funded by Blue Cross Blue Shield of Michigan. Hitinder S. Gurm receives research funding from the National Institutes of Health and Agency for Healthcare Research and Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown JR, 2010, CIRC-CARDIOVASC INTE, V3, P346, DOI 10.1161/CIRCINTERVENTIONS.109.910638; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Freeman RV, 2002, AM J CARDIOL, V90, P1068, DOI 10.1016/S0002-9149(02)02771-6; Gupta R, 2005, CATHETER CARDIO INTE, V64, P442, DOI 10.1002/ccd.20316; Gurm HS, 2013, J AM COLL CARDIOL, V61, P2242, DOI 10.1016/j.jacc.2013.03.026; Gurm HS, 2011, J AM COLL CARDIOL, V58, P907, DOI 10.1016/j.jacc.2011.05.023; Kalra N, 2012, J AM COLL CARDIOL, V59, P432, DOI 10.1016/j.jacc.2011.09.060; Kline-Rogers Eva, 2002, J Interv Cardiol, V15, P387, DOI 10.1111/j.1540-8183.2002.tb01072.x; Marenzi G, 2009, ANN INTERN MED, V150, P170, DOI 10.7326/0003-4819-150-3-200902030-00006; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Meier P, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-23; Moscucci M, 2006, CIRCULATION, V113, P814, DOI 10.1161/CIRCULATIONAHA.105.541995; Nayak KR, 2010, CATHETER CARDIO INTE, V75, P1076, DOI 10.1002/ccd.22414; Nyman U, 2008, ACTA RADIOL, V49, P658, DOI 10.1080/02841850802050762; Reed M, 2009, JACC-CARDIOVASC INTE, V2, P645, DOI 10.1016/j.jcin.2009.05.002; Reed MC, 2010, J INVASIVE CARDIOL, V22, P467; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Slocum NK, 2012, AM HEART J, V163, P829, DOI 10.1016/j.ahj.2012.02.011; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0	22	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90233	10.1371/journal.pone.0090233	http://dx.doi.org/10.1371/journal.pone.0090233			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625555	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300015
J	Lopez, CM; Wallich, R; Riesbeck, K; Skerka, C; Zipfel, PF				Lopez, Crisanto M.; Wallich, Reinhard; Riesbeck, Kristian; Skerka, Christine; Zipfel, Peter F.			Candida albicans Uses the Surface Protein Gpm1 to Attach to Human Endothelial Cells and to Keratinocytes via the Adhesive Protein Vitronectin	PLOS ONE			English	Article							FACTOR-H; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; STREPTOCOCCUS-PNEUMONIAE; COMPLEMENT INHIBITOR; EXTRACELLULAR-MATRIX; BINDING PROTEINS; YEAST; PLASMINOGEN; ADHERENCE; RECEPTOR	Candida albicans is a major cause of invasive fungal infections worldwide. Upon infection and when in contact with human plasma as well as body fluids the fungus is challenged by the activated complement system a central part of the human innate immune response. C. albicans controls and evades host complement attack by binding several human complement regulators like Factor H, Factor H-like protein 1 and C4BP to the surface. Gpm1 (Phosphoglycerate mutase 1) is one fungal Factor H/FHL1 -binding protein. As Gpm1 is surface exposed, we asked whether Gpm1 also contributes to host cell attachment. Here, we show by flow cytometry and by laser scanning microscopy that candida Gpm1 binds to human umbilical vein endothelial cells (HUVEC) to keratinocytes (HaCaT), and also to monocytic U937 cells. Wild type candida did bind, but the candida gpm1 Delta/Delta knock-out mutant did not bind to these human cells. In addition Gpm1when attached to latex beads also conferred attachment to human endothelial cells. When analyzing Gpm1-binding to a panel of extracellular matrix proteins, the human glycoprotein vitronectin was identified as a new Gpm1 ligand. Vitronectin is a component of the extracellular matrix and also a regulator of the terminal complement pathway. Vitronectin is present on the surface of HUVEC and keratinocytes and acts as a surface ligand for fungal Gpm1. Gpm1 and vitronectin colocalize on the surface of HUVEC and HaCaT as revealed by laser scanning microscopy. The Gpm1 vitronectin interaction is inhibited by heparin and the interaction is also ionic strength dependent. Taken together, Gpm1 the candida surface protein binds to vitronectin and mediates fungal adhesion to human endothelial cells. Thus fungal Gpm1 and human vitronectin represent a new set of proteins that are relevant for fungal attachment to human cells interaction. Blockade of the Gpm1 vitronectin interaction might provide a new target for therapy.	[Lopez, Crisanto M.; Skerka, Christine; Zipfel, Peter F.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Wallich, Reinhard] Heidelberg Univ, Inst Immunol, Heidelberg, Germany; [Riesbeck, Kristian] Lund Univ, Dept Lab Med Malmo, Malmo, Sweden; [Zipfel, Peter F.] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Ruprecht Karls University Heidelberg; Lund University; Friedrich Schiller University of Jena	Zipfel, PF (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany.	peter.zipfel@hki-jena.de	Lopez, Crisanto/AAO-3704-2020	Riesbeck, Kristian/0000-0001-6274-6965	Deutshce Forschungsgemeinschaft	Deutshce Forschungsgemeinschaft	Funding was provided by Deutshce Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia AS, 2006, INFECT IMMUN, V74, P1597, DOI 10.1128/IAI.74.3.1597-1611.2006; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; Berends ETM, 2013, CELL MICROBIOL, V15, P1955, DOI 10.1111/cmi.12170; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; BRAMONO K, 1994, J MED VET MYCOL, V32, P473; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; Cunha CSE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000911; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; Ebanks RO, 2006, PROTEOMICS, V6, P2147, DOI 10.1002/pmic.200500100; Francois PP, 1999, J BIOL CHEM, V274, P37611, DOI 10.1074/jbc.274.53.37611; GilNavarro I, 1997, J BACTERIOL, V179, P4992, DOI 10.1128/jb.179.16.4992-4999.1997; GomezDuarte OG, 1997, INFECT IMMUN, V65, P3857; Gow NAR, CURRENT OPINION MICR, V15, P406; Gozalbo D, 1998, INFECT IMMUN, V66, P2052, DOI 10.1128/IAI.66.5.2052-2059.1998; Gropp K, 2009, MOL IMMUNOL, V47, P465, DOI 10.1016/j.molimm.2009.08.019; Grubb SEW, 2008, INFECT IMMUN, V76, P4370, DOI 10.1128/IAI.00332-08; Hallstrom T, 2013, MOL BIOL, V13, P4, DOI DOI 10.1128/MBI0.00481-13; Hallstrom T, 2009, J IMMUNOL, V183, P2593, DOI 10.4049/jimmunol.0803226; HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9; Henderson B, 2013, CURR TOP MICROBIOL, V358, P155, DOI 10.1007/82_2011_188; Ifrim D. C., 2014, CLIN VACCINE IMMUNOL; JAKAB E, 1993, APMIS, V101, P187, DOI 10.1111/j.1699-0463.1993.tb00100.x; Jawhara S, 2012, J IMMUNOL, V189, P2468, DOI 10.4049/jimmunol.1200524; Karkowska-Kuleta J, 2011, PEPTIDES, V32, P2488, DOI 10.1016/j.peptides.2011.10.021; KLOTZ SA, 1993, MICROB PATHOGENESIS, V14, P133, DOI 10.1006/mpat.1993.1014; KLOTZ SA, 1990, FEMS MICROBIOL LETT, V68, P249, DOI 10.1016/S0378-1097(05)80049-7; Lesiak-Markowicz I, 2011, J INFECT DIS, V204, P802, DOI 10.1093/infdis/jir455; LIMPER AH, 1994, IMMUNOL LETT, V42, P139, DOI 10.1016/0165-2478(94)90077-9; Luo SS, 2013, MOL IMMUNOL, V56, P161, DOI 10.1016/j.molimm.2013.05.218; Luo SS, 2013, J INFECT DIS, V207, P594, DOI 10.1093/infdis/jis718; Luo SS, 2009, MOL IMMUNOL, V47, P541, DOI 10.1016/j.molimm.2009.07.017; Meri T, 2004, INFECT IMMUN, V72, P6633, DOI 10.1128/IAI.72.11.6633-6641.2004; Meri T, 2002, INFECT IMMUN, V70, P5185, DOI 10.1128/IAI.70.9.5185-5192.2002; OLLERT MW, 1993, INFECT IMMUN, V61, P4560, DOI 10.1128/IAI.61.11.4560-4568.1993; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Pitarch A, 2002, MOL CELL PROTEOMICS, V1, P967, DOI 10.1074/mcp.M200062-MCP200; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; Preissner KT, 2011, SEMIN THROMB HEMOST, V37, P408, DOI 10.1055/s-0031-1276590; Preissner KT, 1998, THROMB RES, V89, P1, DOI 10.1016/S0049-3848(97)00298-3; Roth-Ben Arie Z, 1998, FEMS MICROBIOL LETT, V163, P121, DOI 10.1111/j.1574-6968.1998.tb13035.x; Santoni G, 2002, INFECT IMMUN, V70, P3804, DOI 10.1128/IAI.70.7.3804-3815.2002; Santoni G, 2001, MICROB PATHOGENESIS, V31, P159, DOI 10.1006/mpat.2001.0459; SHEEHAN M, 1995, CLIN EXP IMMUNOL, V101, P136; Singh B, 2011, MOL MICROBIOL, V81, P80, DOI 10.1111/j.1365-2958.2011.07678.x; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Singh B, 2010, MOL MICROBIOL, V75, P1426, DOI 10.1111/j.1365-2958.2010.07066.x; Spreghini E, 1999, J INFECT DIS, V180, P156, DOI 10.1086/314822; Sturtevant Joy, 1997, Revista Iberoamericana de Micologia, V14, P90; Sun JN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001181; Szolnoky G, 2001, J INVEST DERMATOL, V117, P205, DOI 10.1046/j.1523-1747.2001.14071.x; Voss S, 2013, J BIOL CHEM, V288, P15614, DOI 10.1074/jbc.M112.443507; Zhu WD, 2012, P NATL ACAD SCI USA, V109, P14194, DOI 10.1073/pnas.1117676109; Zipfel PF, 2013, MOL IMMUNOL, V56, P152, DOI 10.1016/j.molimm.2013.05.222; Zipfel PF, 2011, INT J MED MICROBIOL, V301, P423, DOI 10.1016/j.ijmm.2011.04.010; Zipfel PF, 2009, IMMUNOL LETT, V126, P1, DOI 10.1016/j.imlet.2009.07.005; Zipfel PF, 2009, COMPLEMENT REGULATOR	57	43	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90796	10.1371/journal.pone.0090796	http://dx.doi.org/10.1371/journal.pone.0090796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625558	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300034
J	Meier, RPH; Seebach, JD; Morel, P; Mahou, R; Borot, S; Giovannoni, L; Parnaud, G; Montanari, E; Bosco, D; Wandrey, C; Berney, T; Buhler, LH; Muller, YD				Meier, Raphael P. H.; Seebach, Joerg D.; Morel, Philippe; Mahou, Redouan; Borot, Sophie; Giovannoni, Laurianne; Parnaud, Geraldine; Montanari, Elisa; Bosco, Domenico; Wandrey, Christine; Berney, Thierry; Buehler, Leo H.; Muller, Yannick D.			Survival of Free and Encapsulated Human and Rat Islet Xenografts Transplanted into the Mouse Bone Marrow	PLOS ONE			English	Article							MEDIATED INFLAMMATORY REACTION; T-REGULATORY CELLS; PORCINE; XENOTRANSPLANTATION; REJECTION; MICE; BIOCOMPATIBILITY; MICROCAPSULES; MACROPHAGES; LANGERHANS	Bone marrow was recently proposed as an alternative and potentially immune-privileged site for pancreatic islet transplantation. The aim of the present study was to assess the survival and rejection mechanisms of free and encapsulated xenogeneic islets transplanted into the medullary cavity of the femur, or under the kidney capsule of streptozotocin-induced diabetic C57BL/6 mice. The median survival of free rat islets transplanted into the bone marrow or under the kidney capsule was 9 and 14 days, respectively, whereas that of free human islets was shorter, 7 days (bone marrow) and 10 days (kidney capsule). Infiltrating CD8(+) T cells and redistributed CD4(+) T cells, and macrophages were detected around the transplanted islets in bone sections. Recipient mouse splenocytes proliferated in response to donor rat stimulator cells. One month after transplantation under both kidney capsule or into bone marrow, encapsulated rat islets had induced a similar degree of fibrotic reaction and still contained insulin positive cells. In conclusion, we successfully established a small animal model for xenogeneic islet transplantation into the bone marrow. The rejection of xenogeneic islets was associated with local and systemic T cell responses and macrophage recruitment. Although there was no evidence for immune-privilege, the bone marrow may represent a feasible site for encapsulated xenogeneic islet transplantation.	[Meier, Raphael P. H.; Morel, Philippe; Borot, Sophie; Giovannoni, Laurianne; Parnaud, Geraldine; Montanari, Elisa; Bosco, Domenico; Berney, Thierry; Buehler, Leo H.; Muller, Yannick D.] Univ Hosp Geneva, Dept Surg, Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [Meier, Raphael P. H.; Morel, Philippe; Borot, Sophie; Giovannoni, Laurianne; Parnaud, Geraldine; Montanari, Elisa; Bosco, Domenico; Berney, Thierry; Buehler, Leo H.; Muller, Yannick D.] Univ Geneva, Geneva, Switzerland; [Seebach, Joerg D.; Muller, Yannick D.] Univ Hosp, Dept Internal Med, Div Clin Immunol & Allergol, Geneva, Switzerland; [Seebach, Joerg D.; Muller, Yannick D.] Fac Med, Geneva, Switzerland; [Mahou, Redouan; Wandrey, Christine] Ecole Polytech Fed Lausanne, Inst Ingn Biol, Lausanne, Switzerland; [Mahou, Redouan; Wandrey, Christine] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, Lausanne, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Muller, YD (corresponding author), Univ Hosp Geneva, Dept Surg, Cell Isolat & Transplantat Ctr, Geneva, Switzerland.	yannick.muller@unige.ch	Seebach, Jörg/AAA-3746-2020; giovannoni, laurianne/AFM-0316-2022; giovannoni, laurianne/AAH-2648-2022; Meier, Raphaël P H/AAR-7882-2021; Berney, Thierry/ABE-9450-2021; Mahou, Redouan/AAH-5056-2021	Meier, Raphaël P H/0000-0001-9050-0436; Berney, Thierry/0000-0002-4230-9378; Buhler, Leo/0000-0002-9461-8498; Bosco, Domenico/0000-0003-3453-9613; Seebach, Jorg/0000-0001-5748-4577; Muller, Yannick/0000-0003-0513-7156	Swiss National Science Foundation [205321-116397/1, 205320_130572/1, 205321_141286/1]; Fondation Insuleman Geneva; Juvenile Diabetes Research Foundation [31-2008-416]; E. & L. Schmidheiny Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Insuleman Geneva; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); E. & L. Schmidheiny Foundation	This work was supported by grants from the Swiss National Science Foundation (grants 205321-116397/1, 205320_130572/1, 205321_141286/1), Fondation Insuleman Geneva, the Juvenile Diabetes Research Foundation (# 31-2008-416 to T. B.), the E. & L. Schmidheiny Foundation (to Y.D.M.), and by contributions of the Wilsdorf Foundation and the Swiss National Science Foundation (# 320030-138376) to J.D.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanstoot HJ, 2007, PEDIATR DIABETES, V8, P8, DOI 10.1111/j.1399-5448.2007.00326.x; Andres A, 2005, TRANSPLANTATION, V79, P543, DOI 10.1097/01.TP.0000151764.39095.CA; [Anonymous], 2006, DIABET MED, V23, P857; Auchincloss H, 1998, ANNU REV IMMUNOL, V16, P433, DOI 10.1146/annurev.immunol.16.1.433; Basta G, 2011, DIABETES CARE, V34, P2406, DOI 10.2337/dc11-0731; Bell GI, 2012, STEM CELLS DEV, V21, P97, DOI 10.1089/scd.2010.0583; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; Cantarelli E, 2009, BLOOD, V114, P4566, DOI 10.1182/blood-2009-03-209973; Carlsson PO, 2001, DIABETES, V50, P489, DOI 10.2337/diabetes.50.3.489; Ciceri F, 2010, CELL TRANSPLANT, V19, P1511, DOI 10.3727/096368910X514279; Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x; Friedman T, 1999, DIABETES, V48, P2340, DOI 10.2337/diabetes.48.12.2340; Giraldo Jaime A, 2010, J Diabetes Sci Technol, V4, P1238; Goto M, 2008, XENOTRANSPLANTATION, V15, P225, DOI 10.1111/j.1399-3089.2008.00482.x; Hobbs HA, 2001, J INVEST MED, V49, P572, DOI 10.2310/6650.2001.33722; Karaoz E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.14; Karsten V, 1999, HORM METAB RES, V31, P448, DOI 10.1055/s-2007-978773; Li SQ, 2009, TRANSPL IMMUNOL, V21, P70, DOI 10.1016/j.trim.2008.10.004; Loganathan G, 2013, TRANSPLANTATION, V95, P1439, DOI 10.1097/TP.0b013e318293b7b8; Luo JZQ, 2013, TRANSPLANTATION, V95, P801, DOI 10.1097/TP.0b013e31828235c7; Maffi P, 2013, DIABETES; Mahou R, 2012, J MATER SCI-MATER M, V23, P171, DOI 10.1007/s10856-011-4512-3; Merani S, 2006, TRANSPLANTATION, V82, P1472, DOI 10.1097/01.tp.0000243166.64244.3d; Mirenda V, 2005, DIABETES, V54, P1048, DOI 10.2337/diabetes.54.4.1048; Muller Yannick D, 2011, Self Nonself, V2, P26; Muller YD, 2012, CURR OPIN ORGAN TRAN, V17, P155, DOI 10.1097/MOT.0b013e3283508e17; Muller YD, 2011, DIABETES, V60, P2331, DOI 10.2337/db11-0159; Muller YD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010352; Niclauss N, 2008, TRANSPLANTATION, V86, P1603, DOI 10.1097/TP.0b013e31818f671a; Nilsson B, 2011, CURR OPIN ORGAN TRAN, V16, P620, DOI 10.1097/MOT.0b013e32834c2393; Oh BJ, 2013, AM J TRANSPLANT, V13, P1429, DOI 10.1111/ajt.12222; Pepper AR, 2009, XENOTRANSPLANTATION, V16, P502, DOI 10.1111/j.1399-3089.2009.00548.x; Salazar-Banuelos A, 2008, AM J SURG, V195, P674, DOI 10.1016/j.amjsurg.2007.12.040; SIEBERS U, 1993, INT J ARTIF ORGANS, V16, P96, DOI 10.1177/039139889301600207; Teramura Y, 2009, BIOMATERIALS, V30, P2270, DOI 10.1016/j.biomaterials.2009.01.036; Toso C, 2005, CELL TRANSPLANT, V14, P159, DOI 10.3727/000000005783983223; Toso C, 2003, TRANSPLANT INT, V16, P405, DOI 10.1007/s00147-003-0555-9; Vaithilingam V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059120; Vaithilingam Vijayaganapathy, 2011, Rev Diabet Stud, V8, P51, DOI 10.1900/RDS.2011.8.51; WOLF LA, 1995, TRANSPLANTATION, V60, P1164, DOI 10.1097/00007890-199511270-00018; WREN SM, 1993, TRANSPLANTATION, V56, P905, DOI 10.1097/00007890-199310000-00025; Yi SN, 2003, J IMMUNOL, V170, P2750, DOI 10.4049/jimmunol.170.5.2750; Yi SN, 2000, TRANSPLANTATION, V70, P896, DOI 10.1097/00007890-200009270-00007	43	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91268	10.1371/journal.pone.0091268	http://dx.doi.org/10.1371/journal.pone.0091268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625569	Green Submitted, gold, Green Published			2022-12-27	WOS:000332851300070
J	Ni, XQ; Zhang, JW				Ni, Xiaoqing; Zhang, Jiawei			Association between 9p21 Genomic Markers and Ischemic Stroke Risk: Evidence Based on 21 Studies	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CHROMOSOME 9P21; MYOCARDIAL-INFARCTION; GENETIC-VARIANTS; GENOMEWIDE ASSOCIATION; NONCODING RNA; LOCUS; POLYMORPHISMS; METAANALYSIS; ANRIL	Epidemiological studies indicate a genetic contribution to ischemic stroke risk, but specific genetic variants remain unknown. Recently independent studies reported an association between coronary heart disease and single-nucleotide polymorphisms (SNPs) located at chromosome 9p21 (rs10757278 and proxy SNPs). Given that stroke is a common complication after myocardial infarction, several validation studies have been conducted among various ethnic populations to investigate if the same loci was associated with ischemic stroke (IS), but the results have been inconsistent. To investigate this inconsistency and derive a more precise estimation of the relationship, a meta-analysis of 34,128 cases and 153,428 controls from 21 studies was performed. Potential sources of heterogeneity including ethnicity, sample size, control source and ischemic stroke subtypes were also assessed. Overall, the summary odds ratio of IS was 1.11 (95% CI: 1.07-1.15, P, 10 25) for rs10757278. In the subgroup analysis by ethnicity, significantly increased risks were found in East Asians (3188 cases and 4503 controls; OR = 1.14, 95% CI: 1.07-1.21, P<10(-5)) and Caucasians (30505 cases and 145153controls; OR = 1.08, 95% CI: 1.04-1.12, P<10(-5)) for the polymorphism; while no significant associations were found among African Americans (435 cases and 3772 controls; OR = 0.97, 95% CI: 0.63-1.51, P = 0.90) in all genetic models. In the subgroup analyses by IS subtypes, significant association was detected only in large vessel stroke group, while no significant associations among small vessel or cardioembolic stroke. When stratified by sample size, and control source, significantly increased risks were found for the polymorphism in all genetic models. This meta-analysis provides accurate and comprehensive estimates of the association of genetic variant at chromosome 9p21 and IS, but these associations vary in different ethnic populations.	[Ni, Xiaoqing] Binzhou Med Univ, Hosp Chinese Peoples Liberat Army 107, Dept Geriatr, Yantai, Shandong, Peoples R China; [Zhang, Jiawei] Binzhou Med Univ, Hosp Chinese Peoples Liberat Army 107, Dept Urol, Yantai, Shandong, Peoples R China	Binzhou Medical University; Binzhou Medical University	Zhang, JW (corresponding author), Binzhou Med Univ, Hosp Chinese Peoples Liberat Army 107, Dept Urol, Yantai, Shandong, Peoples R China.	Jiawei_Zhang001@163.com						Adams RJ, 2003, CIRCULATION, V108, P1278, DOI 10.1161/01.CIR.0000090444.87006.CF; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cheng YC, 2012, STROKE, V43, P980, DOI 10.1161/STROKEAHA.111.632075; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dichgans M, 2007, LANCET NEUROL, V6, P149, DOI 10.1016/S1474-4422(07)70028-5; Ding H, 2009, CIRC-CARDIOVASC GENE, V2, P338, DOI 10.1161/CIRCGENETICS.108.810226; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Gschwendtner A, 2009, ANN NEUROL, V65, P531, DOI 10.1002/ana.21590; Heckman MG, 2013, EUR J NEUROL, V20, P300, DOI 10.1111/j.1468-1331.2012.03846.x; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu WL, 2009, BRAIN RES BULL, V79, P431, DOI 10.1016/j.brainresbull.2009.04.001; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Jerrard-Dunne P, 2003, STROKE, V34, P1364, DOI 10.1161/01.STR.0000069723.17984.FD; Karvanen J, 2009, GENET EPIDEMIOL, V33, P237, DOI 10.1002/gepi.20374; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Lemmens R, 2009, EUR J HUM GENET, V17, P1287, DOI 10.1038/ejhg.2009.42; Lin HF, 2011, J INVEST MED, V59, P926, DOI 10.2310/JIM.0b013e318214ea49; Luke MM, 2009, CEREBROVASC DIS, V28, P499, DOI 10.1159/000236914; Markus HS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000225; Matarin M, 2008, STROKE, V39, P1586, DOI 10.1161/STROKEAHA.107.502963; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Murabito JM, 2012, CIRC-CARDIOVASC GENE, V5, P100, DOI 10.1161/CIRCGENETICS.111.961292; Olsson S, 2011, EUR J NEUROL, V18, P365, DOI 10.1111/j.1468-1331.2010.03096.x; Palomaki GE, 2010, JAMA-J AM MED ASSOC, V303, P648, DOI 10.1001/jama.2010.118; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Pasternak RC, 2004, CIRCULATION, V109, P2605, DOI 10.1161/01.CIR.0000128518.26834.93; Plant SR, 2011, CEREBROVASC DIS, V31, P117, DOI 10.1159/000321510; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; SACCO RL, 1989, ANN NEUROL, V25, P382, DOI 10.1002/ana.410250410; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Smith JG, 2009, CIRC-CARDIOVASC GENE, V2, P159, DOI 10.1161/CIRCGENETICS.108.835173; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Wahlstrand B, 2009, J HYPERTENS, V27, P769, DOI 10.1097/HJH.0b013e328326f7eb; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Yamagishi K, 2009, EUR HEART J, V30, P1222, DOI 10.1093/eurheartj/ehp087; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Zee RYL, 2007, STROKE, V38, pE111, DOI 10.1161/STROKEAHA.107.497669; Zhang WL, 2012, STROKE, V43, P14, DOI 10.1161/STROKEAHA.111.625442	45	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90255	10.1371/journal.pone.0090255	http://dx.doi.org/10.1371/journal.pone.0090255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625579	Green Submitted, gold, Green Published			2022-12-27	WOS:000332851300016
J	Tapia, LI; Shaw, CA; Aideyan, LO; Jewell, AM; Dawson, BC; Haq, TR; Piedra, PA				Tapia, Lorena I.; Shaw, Chad A.; Aideyan, Letisha O.; Jewell, Alan M.; Dawson, Brian C.; Haq, Taha R.; Piedra, Pedro A.			Gene Sequence Variability of the Three Surface Proteins of Human Respiratory Syncytial Virus (HRSV) in Texas	PLOS ONE			English	Article							SMALL HYDROPHOBIC PROTEIN; CIRCULATION PATTERNS; FUSION PROTEIN; SUBGROUP-B; GROUP-A; MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC ANALYSIS; CONSECUTIVE SEASONS; ATTACHMENT PROTEIN; STRUCTURAL BASIS	Human respiratory syncytial virus (HRSV) has three surface glycoproteins: small hydrophobic (SH), attachment (G) and fusion (F), encoded by three consecutive genes (SH-G-F). A 270-nt fragment of the G gene is used to genotype HRSV isolates. This study genotyped and investigated the variability of the gene and amino acid sequences of the three surface proteins of HRSV strains collected from 1987 to 2005 from one center. Sixty original clinical isolates and 5 prototype strains were analyzed. Sequences containing SH, F and G genes were generated, and multiple alignments and phylogenetic trees were analyzed. Genetic variability by protein domains comparing virus genotypes was assessed. Complete sequences of the SH-G-F genes were obtained for all 65 samples: HRSV-A = 35; HRSV-B = 30. In group A strains, genotypes GA5 and GA2 were predominant. For HRSV-B strains, the genotype GB4 was predominant from 1992 to 1994 and only genotype BA viruses were detected in 2004-2005. Different genetic variability at nucleotide level was detected between the genes, with G gene being the most variable and the highest variability detected in the 270-nt G fragment that is frequently used to genotype the virus. High variability (>10%) was also detected in the signal peptide and transmembrane domains of the F gene of HRSV A strains. Variability among the HRSV strains resulting in non-synonymous changes was detected in hypervariable domains of G protein, the signal peptide of the F protein, a not previously defined domain in the F protein, and the antigenic site empty set in the pre-fusion F. Divergent trends were observed between HRSV -A and -B groups for some functional domains. A diverse population of HRSV -A and -B genotypes circulated in Houston during an 18 year period. We hypothesize that diverse sequence variation of the surface protein genes provide HRSV strains a survival advantage in a partially immune-protected community.	[Tapia, Lorena I.; Aideyan, Letisha O.; Jewell, Alan M.; Piedra, Pedro A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Tapia, Lorena I.] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Virol, Santiago 7, Chile; [Tapia, Lorena I.] Univ Chile, Fac Med, Dept Pediat & Cirugi Infantil Norte, Santiago 7, Chile; [Shaw, Chad A.; Dawson, Brian C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Haq, Taha R.] Baylor Coll Med, Sch Med, Houston, TX 77030 USA; [Piedra, Pedro A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Universidad de Chile; Universidad de Chile; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Tapia, LI (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	ltapia@med.uchile.cl	Tapia, Lorena/I-5678-2016					Agenbach E, 2005, VIRUS GENES, V30, P267, DOI 10.1007/s11262-004-5633-2; ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Bocchini JA, 2009, PEDIATRICS, V124, P1216, DOI [10.1542/peds.2009-1806, 10.1542/peds.2009-2345]; Bukreyev A, 1997, J VIROL, V71, P8973, DOI 10.1128/JVI.71.12.8973-8982.1997; Carter SD, 2010, FEBS LETT, V584, P2786, DOI 10.1016/j.febslet.2010.05.006; Chen MD, 2000, J INFECT DIS, V182, P1228, DOI 10.1086/315829; Choi Y, 2012, VIRAL IMMUNOL, V25, P193, DOI 10.1089/vim.2011.0094; Cianci C, 2005, J ANTIMICROB CHEMOTH, V55, P289, DOI 10.1093/jac/dkh558; Collins P. L., 2006, FIELDS VIROLOGY, P1601; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; CONNORS M, 1995, VIROLOGY, V208, P478, DOI 10.1006/viro.1995.1178; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Day ND, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-34; Eckardt-Michel J, 2008, J VIROL, V82, P3236, DOI 10.1128/JVI.01887-07; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fuentes S, 2007, J VIROL, V81, P8361, DOI 10.1128/JVI.02717-06; Galiano MC, 2005, J CLIN MICROBIOL, V43, P2266, DOI 10.1128/JCM.43.5.2266-2273.2005; Gan SW, 2008, PROTEIN SCI, V17, P813, DOI 10.1110/ps.073366208; GARCIA O, 1994, J VIROL, V68, P5448; Hall CB, 2010, LANCET, V375, P1500, DOI 10.1016/S0140-6736(10)60401-1; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; Karron RA, 2005, J INFECT DIS, V191, P1093, DOI 10.1086/427813; Kim YK, 2007, J MED VIROL, V79, P820, DOI 10.1002/jmv.20891; Kochva U, 2003, PROTEIN SCI, V12, P2668, DOI 10.1110/ps.03151103; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; LAMBERT DM, 1988, VIROLOGY, V164, P458, DOI 10.1016/0042-6822(88)90560-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEVINE S, 1987, J GEN VIROL, V68, P2521, DOI 10.1099/0022-1317-68-9-2521; Li Z, 2011, J VIROL, V85, P32, DOI 10.1128/JVI.01673-10; Lima HN, 2012, VIRUS RES, V163, P82, DOI 10.1016/j.virusres.2011.08.013; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; McLellan JS, 2013, CURR TOP MICROBIOL, V372, P83, DOI 10.1007/978-3-642-38919-1_4; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Melero JA, 1997, J GEN VIROL, V78, P2411, DOI 10.1099/0022-1317-78-10-2411; Moura FEA, 2004, J MED VIROL, V74, P156, DOI 10.1002/jmv.20159; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Piedra PA, 2003, VACCINE, V21, P2448, DOI 10.1016/S0264-410X(03)00098-7; Polack FP, 2005, P NATL ACAD SCI USA, V102, P8996, DOI 10.1073/pnas.0409478102; Rebuffo-Scheer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025468; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; ROBERTS SR, 1994, J VIROL, V68, P4538, DOI 10.1128/JVI.68.7.4538-4546.1994; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Shaikh FY, 2012, MBIO, V3, DOI 10.1128/mBio.00270-11; Shingai M, 2008, INT IMMUNOL, V20, P1169, DOI 10.1093/intimm/dxn074; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; Smith G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050852; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444; The Impact RSV Study Group, 1998, PEDIATRICS, V3, P531; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Whitehead SS, 1999, J VIROL, V73, P3438, DOI 10.1128/JVI.73.4.3438-3442.1999; Zhang ZY, 2010, J CLIN MICROBIOL, V48, P1201, DOI 10.1128/JCM.02258-09; Zlateva KT, 2007, J CLIN MICROBIOL, V45, P3022, DOI 10.1128/JCM.00339-07; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005; Zlateva KT, 2004, J VIROL, V78, P4675, DOI 10.1128/JVI.78.9.4675-4683.2004	67	45	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90786	10.1371/journal.pone.0090786	http://dx.doi.org/10.1371/journal.pone.0090786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625544	Green Submitted, gold, Green Published			2022-12-27	WOS:000332851300033
J	Tsai, YL; Wang, HC; Lo, CF; Tang-Nelson, K; Lightner, D; Ou, BR; Hour, AL; Tsai, CF; Yen, CC; Chang, HFG; Teng, PH; Lee, PY				Tsai, Yun-Long; Wang, Han-Ching; Lo, Chu-Fang; Tang-Nelson, Kathy; Lightner, Donald; Ou, Bor-Rung; Hour, Ai-Ling; Tsai, Chuan-Fu; Yen, Cheng-Chi; Chang, Hsiao-Fen Grace; Teng, Ping-Hua; Lee, Pei-Yu			Validation of a Commercial Insulated Isothermal PCR-based POCKIT Test for Rapid and Easy Detection of White Spot Syndrome Virus Infection in Litopenaeus vannamei	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SYNDROME BACULOVIRUS WSBV; PENAEUS-MONODON; TISSUE TROPISM; NESTED PCR; AMPLIFICATION; SHRIMP; WSSV; CRABS; DNA	Timely pond-side detection of white spot syndrome virus (WSSV) plays a critical role in the implementation of bio-security measures to help minimize economic losses caused by white spot syndrome disease, an important threat to shrimp aquaculture industry worldwide. A portable device, namely POCKIT (TM), became available recently to complete fluorescent probe-based insulated isothermal PCR (iiPCR), and automatic data detection and interpretation within one hour. Taking advantage of this platform, the IQ Plus (TM) WSSV Kit with POCKIT system was established to allow simple and easy WSSV detection for on-site users. The assay was first evaluated for its analytical sensitivity and specificity performance. The 95% limit of detection (LOD) of the assay was 17 copies of WSSV genomic DNA per reaction (95% confidence interval [ CI], 13 to 24 copies per reaction). The established assay has detection sensitivity similar to that of OIE-registered IQ2000 (TM) WSSV Detection and Protection System with serial dilutions of WSSV-positive Litopenaeus vannamei DNA. No cross-reaction signals were generated from infectious hypodermal and haematopoietic necrosis virus (IHHNV), monodon baculovirus (MBV), and hepatopancreatic parvovirus (HPV) positive samples. Accuracy analysis using700 L. vannamei of known WSSV infection status shows that the established assayhassensitivity93.5% (95% CI: 90.61-95.56%) and specificity 97% (95% CI: 94.31-98.50%). Furthermore, no discrepancy was found between the two assays when 100 random L. vannamei samples were tested in parallel. Finally, excellent correlation was observed among test results of three batches of reagents with 64 samples analyzed in three different laboratories. Working in a portable device, IQ Plus (TM) WSSV Kit with POCKIT system allows reliable, sensitive and specific on-site detection of WSSV in L. vannamei.	[Tsai, Yun-Long; Tsai, Chuan-Fu; Yen, Cheng-Chi; Chang, Hsiao-Fen Grace; Teng, Ping-Hua; Lee, Pei-Yu] GeneReach Biotechnol Corp, Dept Res & Dev, Taichung, Taiwan; [Wang, Han-Ching] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 70101, Taiwan; [Lo, Chu-Fang] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan; [Tang-Nelson, Kathy; Lightner, Donald] Univ Arizona, Dept Vet Sci & Microbiol, Tucson, AZ USA; [Ou, Bor-Rung] Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung 40704, Taiwan; [Hour, Ai-Ling] Fu Jen Catholic Univ, Dept Life Sci, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University; University of Arizona; Tunghai University; Fu Jen Catholic University	Lee, PY (corresponding author), GeneReach Biotechnol Corp, Dept Res & Dev, Taichung, Taiwan.	pylee@genereachbiotech.com	Lo, Chu-Fang/G-3088-2014; Wang, Han-Ching/AAT-6086-2021	Lo, Chu-Fang/0000-0001-5136-8129; Wang, Han-Ching/0000-0001-7283-4942	Central Taiwan Science Park, National Science Council, Taiwan [302403501]	Central Taiwan Science Park, National Science Council, Taiwan	This work was supported in part by a grant from Central Taiwan Science Park, National Science Council, Taiwan, Grant no. 302403501 (http://www.ctspb.most.gov.tw/english/00home/home.aspx?v=20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Belcher CR, 1998, J VIROL METHODS, V74, P21, DOI 10.1016/S0166-0934(98)00067-6; Chaivisuthangkura P, 2009, J VIROL METHODS, V162, P188, DOI 10.1016/j.jviromet.2009.08.005; Chang HFG, 2012, BIOTECHNOL J, V7, P662, DOI 10.1002/biot.201100453; Chou PH, 2011, J VIROL METHODS, V173, P67, DOI 10.1016/j.jviromet.2011.01.009; Durand SV, 2002, J FISH DIS, V25, P381, DOI 10.1046/j.1365-2761.2002.00367.x; Hameed ASS, 2003, DIS AQUAT ORGAN, V57, P157, DOI 10.3354/dao057157; Huang SW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-242; Jian XF, 2005, DIS AQUAT ORGAN, V67, P171, DOI 10.3354/dao067171; Kasornchandra J, 1998, AQUACULTURE, V164, P243, DOI 10.1016/S0044-8486(98)00190-2; Kiatpathomchai W, 2001, DIS AQUAT ORGAN, V47, P235, DOI 10.3354/dao047235; Kono T, 2004, J VIROL METHODS, V115, P59, DOI 10.1016/j.jviromet.2003.09.015; Lo CF, 1996, DIS AQUAT ORGAN, V25, P133, DOI 10.3354/dao025133; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Lo CF, 1997, DIS AQUAT ORGAN, V30, P53, DOI 10.3354/dao030053; Lotz JM, 2002, DIS AQUAT ORGAN, V50, P199, DOI 10.3354/dao050199; Mekata T, 2009, LETT APPL MICROBIOL, V48, P25, DOI 10.1111/j.1472-765X.2008.02479.x; Mori Y, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-3; Musthaq SS, 2006, J INVERTEBR PATHOL, V93, P75, DOI 10.1016/j.jip.2006.06.006; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Natividad KDT, 2008, J VIROL METHODS, V149, P28, DOI 10.1016/j.jviromet.2008.01.013; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Nunan LM, 2011, J VIROL METHODS, V171, P318, DOI 10.1016/j.jviromet.2010.11.015; O.I.E, 2009, MAN DIAGN TESTS AQ A; Sanchez-Paz A, 2010, VET RES, V41, DOI 10.1051/vetres/2010015; Seetang-Nun Y, 2013, MOL CELL PROBE, V27, P71, DOI 10.1016/j.mcp.2012.11.005; Teng PH, 2007, J VIROL METHODS, V146, P317, DOI 10.1016/j.jviromet.2007.07.027; Tsai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045278; Tsai YL, 2012, J VIROL METHODS, V181, P134, DOI 10.1016/j.jviromet.2012.01.017; Vaseeharan B, 2003, LETT APPL MICROBIOL, V37, P443, DOI 10.1046/j.1472-765X.2003.01428.x; Xie XX, 2005, VIRUS RES, V108, P63, DOI 10.1016/j.virusres.2004.08.002; Yuan L, 2007, J VIROL METHODS, V146, P96, DOI 10.1016/j.jviromet.2007.06.009	32	40	48	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90545	10.1371/journal.pone.0090545	http://dx.doi.org/10.1371/journal.pone.0090545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625894	Green Published, gold			2022-12-27	WOS:000332851300024
J	Bricard, Y; Ralliere, C; Lebret, V; Lefevre, F; Rescan, PY				Bricard, Yoann; Ralliere, Cecile; Lebret, Veronique; Lefevre, Florence; Rescan, Pierre-Yves			Early Fish Myoseptal Cells: Insights from the Trout and Relationships with Amniote Axial Tenocytes	PLOS ONE			English	Article							MYOTENDINOUS JUNCTION; MUSCLE DEVELOPMENT; DIFFERENTIAL EXPRESSION; TELEOST DERMOMYOTOME; MUSCULAR-DYSTROPHY; ZEBRAFISH EMBRYOS; COLLAGEN-XII; ADHESION; TENDON; GROWTH	The trunk muscle in fish is organized as longitudinal series of myomeres which are separated by sheets of connective tissue called myoseptum to which myofibers attach. In this study we show in the trout that the myoseptum separating two somites is initially acellular and composed of matricial components such as fibronectin, laminin and collagen I. However, myoseptal cells forming a continuum with skeletogenic cells surrounding axial structures are observed between adjacent myotomes after the completion of somitogenesis. The myoseptal cells do not express myogenic markers such as Pax3, Pax7 and myogenin but express several tendon-associated collagens including col1a1, col5a2 and col12a1 and angiopoietin-like 7, which is a secreted molecule involved in matrix remodelling. Using col1a1 as a marker gene, we observed in developing trout embryo an initial labelling in disseminating cells ventral to the myotome. Later, labelled cells were found more dorsally encircling the notochord or invading the intermyotomal space. This opens the possibility that the sclerotome gives rise not only to skeletogenic mesenchymal cells, as previously reported, but also to myoseptal cells. We furthermore show that myoseptal cells differ from skeletogenic cells found around the notochord by the specific expression of Scleraxis, a distinctive marker of tendon cells in amniotes. In conclusion, the location, the molecular signature and the possible sclerotomal origin of the myoseptal cells suggest that the fish myoseptal cells are homologous to the axial tenocytes in amniotes.	[Bricard, Yoann; Ralliere, Cecile; Lebret, Veronique; Lefevre, Florence; Rescan, Pierre-Yves] French Natl Inst Agr Res, Fish Physiol & Genom, Rennes, France	INRAE	Rescan, PY (corresponding author), French Natl Inst Agr Res, Fish Physiol & Genom, Rennes, France.	pierre-yves.rescan@rennes.inra.fr		, Florence/0000-0002-5573-8411	European Community [222719]; INRA PHASE department; Britany province (Region Bretagne)	European Community(European Commission); INRA PHASE department; Britany province (Region Bretagne)(Region Bretagne)	The research leading to these results received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 222719. YB received a PhD fellowship from the INRA PHASE department and the Britany province (Region Bretagne). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDE.RM, 1969, J MAR BIOL ASSOC UK, V49, P263, DOI 10.1017/S0025315400035906; Ayala MD, 2013, FISH PHYSIOL BIOCHEM, V39, P807, DOI 10.1007/s10695-012-9742-x; Bader HL, 2009, MATRIX BIOL, V28, P32, DOI 10.1016/j.matbio.2008.09.580; BREMNER HA, 1985, J FOOD SCI, V50, P975, DOI 10.1111/j.1365-2621.1985.tb12993.x; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Charvet B, 2013, DEVELOPMENT, V140, P4602, DOI 10.1242/dev.096024; Charvet B, 2011, CELL TISSUE RES, V346, P439, DOI 10.1007/s00441-011-1266-7; Comes N, 2011, GENES CELLS, V16, P243, DOI 10.1111/j.1365-2443.2010.01483.x; della Gaspera B, 2009, DEV BIOL, V328, P392, DOI 10.1016/j.ydbio.2009.01.039; Devoto SH, 2006, EVOL DEV, V8, P101, DOI 10.1111/j.1525-142X.2006.05079.x; Dumont E, 2008, J EXP BIOL, V211, P1163, DOI 10.1242/jeb.015461; Duran I, 2011, MICROSC RES TECHNIQ, V74, P440, DOI 10.1002/jemt.20929; Gabillard JC, 2003, MOL REPROD DEV, V64, P32, DOI 10.1002/mrd.10222; Gemballa S, 2003, P ROY SOC B-BIOL SCI, V270, P1229, DOI 10.1098/rspb.2003.2345; Goody MF, 2010, DEV BIOL, V344, P809, DOI 10.1016/j.ydbio.2010.05.513; Govoroun M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-196; Grotmol S, 2003, ANAT EMBRYOL, V207, P263, DOI 10.1007/s00429-003-0349-y; Hall TE, 2007, P NATL ACAD SCI USA, V104, P7092, DOI 10.1073/pnas.0700942104; Henry CA, 2005, DEV BIOL, V287, P346, DOI 10.1016/j.ydbio.2005.08.049; Hollway GE, 2007, DEV CELL, V12, P207, DOI 10.1016/j.devcel.2007.01.001; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; JOLY JS, 1993, DEVELOPMENT, V119, P1261; KOCH M, 1995, J CELL BIOL, V130, P1005, DOI 10.1083/jcb.130.4.1005; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Kudo H, 2004, DEV BIOL, V267, P473, DOI 10.1016/j.ydbio.2003.12.007; Litvin J, 2004, J CELL BIOCHEM, V92, P1044, DOI 10.1002/jcb.20115; MorinKensicki EM, 1997, DEVELOPMENT, V124, P159; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Rescan PY, 2008, J EXP ZOOL PART B, V310B, P541, DOI 10.1002/jez.b.21230; Rescan PY, 2005, DEV DYNAM, V233, P605, DOI 10.1002/dvdy.20337; Saito M, 2001, EUR J BIOCHEM, V268, P2817, DOI 10.1046/j.1432-1327.2001.02160.x; Snow CJ, 2008, DEV DYNAM, V237, P2542, DOI 10.1002/dvdy.21670; Snow CJ, 2009, GENE EXPR PATTERNS, V9, P37, DOI 10.1016/j.gep.2008.08.003; Steinbacher P, 2008, DEV DYNAM, V237, P3233, DOI 10.1002/dvdy.21745; Stellabotte F, 2007, DEV DYNAM, V236, P2432, DOI 10.1002/dvdy.21253; Stellabotte F, 2007, DEVELOPMENT, V134, P1253, DOI 10.1242/dev.000067; Summers AP, 2002, COMP BIOCHEM PHYS A, V133, P1159, DOI 10.1016/S1095-6433(02)00241-6; Sztal T, 2011, DEV DYNAM, V240, P422, DOI 10.1002/dvdy.22537; Sztal TE, 2012, HUM MOL GENET, V21, P4718, DOI 10.1093/hmg/dds312; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Tozer Samuel, 2005, Birth Defects Research, V75, P226, DOI 10.1002/bdrc.20049; Weber P, 1998, J NEUROBIOL, V35, P1	44	19	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91876	10.1371/journal.pone.0091876	http://dx.doi.org/10.1371/journal.pone.0091876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622730	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300136
J	Mayo-Wilson, E; Grant, S; Burton, J; Parsons, A; Underhill, K; Montgomery, P				Mayo-Wilson, Evan; Grant, Sean; Burton, Jennifer; Parsons, Amanda; Underhill, Kristen; Montgomery, Paul			Preventive Home Visits for Mortality, Morbidity, and Institutionalization in Older Adults: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; MULTIFACTORIAL FALL PREVENTION; HEALTH-PROMOTION PROGRAM; QUALITY-OF-LIFE; COMPREHENSIVE GERIATRIC ASSESSMENT; FRAIL ELDERLY-PEOPLE; PRIMARY-CARE; FUNCTIONAL DECLINE; ECONOMIC-EVALUATION; EXERCISE PROGRAM	Background: Home visits for older adults aim to prevent cognitive and functional impairment, thus reducing institutionalization and mortality. Visitors may provide information, investigate untreated problems, encourage medication compliance, and provide referrals to services. Methods and Findings: Data Sources: Ten databases including CENTRAL and Medline searched through December 2012. Study Selection: Randomized controlled trials enrolling community-dwelling persons without dementia aged over 65 years. Interventions included visits at home by a health or social care professional that were not related to hospital discharge. Data Extraction and Synthesis: Two authors independently extracted data. Outcomes were pooled using random effects. Main Outcomes and Measures: Mortality, institutionalization, hospitalization, falls, injuries, physical functioning, cognitive functioning, quality of life, and psychiatric illness. Results: Sixty-four studies with 28642 participants were included. Home visits were not associated with absolute reductions in mortality at longest follow-up, but some programs may have small relative effects (relative risk = 0.93 [0.87 to 0.99]; absolute risk = 0.00 [-0.01 to 0.00]). There was moderate quality evidence of no overall effect on the number of people institutionalized (RR = 1.02 [0.88 to 1.18]) or hospitalized (RR = 0.96 [0.91 to 1.01]). There was high quality evidence for number of people who fell, which is consistent with no effect or a small effect (odds ratio = 0.86 [0.73 to 1.01]), but there was no evidence that these interventions increased independent living. There was low and very low quality evidence of effects for quality of life (standardised mean difference = -0.06 [-0.11 to -0.01]) and physical functioning (SMD = -0.10 [-0.17 to -0.03]) respectively, but these may not be clinically important. Conclusions: Home visiting is not consistently associated with differences in mortality or independent living, and investigations of heterogeneity did not identify any programs that are associated with consistent benefits. Due to poor reporting of intervention components and delivery, we cannot exclude the possibility that some programs may be effective.	[Mayo-Wilson, Evan] UCL, Ctr Outcomes Res & Effectiveness, Res Dept Clin Educ & Hlth Psychol, London, England; [Grant, Sean; Burton, Jennifer; Montgomery, Paul] Univ Oxford, Ctr Evidence Based Intervent, Dept Social Policy & Intervent, Oxford, England; [Parsons, Amanda] Yale Univ, Sch Law, New Haven, CT 06520 USA; [Underhill, Kristen] Yale Univ, Sch Law, Yale Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA	University of London; University College London; University of Oxford; Yale University; Yale University	Mayo-Wilson, E (corresponding author), UCL, Ctr Outcomes Res & Effectiveness, Res Dept Clin Educ & Hlth Psychol, London, England.	e.mayo-wilson@ucl.ac.uk	Grant, Sean/L-9912-2016; Mayo-Wilson, Evan/J-6289-2019	Grant, Sean/0000-0002-7775-3022; Mayo-Wilson, Evan/0000-0001-6126-2459; Montgomery, Paul/0000-0001-8008-1370	Nordic Campbell Centre (Denmark); linked Clarendon Fund; Green Templeton College Annual Fund Scholarship	Nordic Campbell Centre (Denmark); linked Clarendon Fund; Green Templeton College Annual Fund Scholarship	This work was sponsored by a grant from the Nordic Campbell Centre (Denmark). The authors received internal support from the Centre for Evidence Based Intervention, Department of Social Policy and Intervention, University of Oxford (UK). EMW received internal support from the Centre for Outcomes Research and Effectiveness (CORE), Research Department of Clinical, Educational & Health Psychology, University College London (UK). SG is supported by a linked Clarendon Fund & Green Templeton College Annual Fund Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi CA, 1997, J AM GERIATR SOC, V45, P1044, DOI 10.1111/j.1532-5415.1997.tb05964.x; Altman DG, 2013, AM J GASTROENTEROL, V108, P1231, DOI 10.1038/ajg.2012.457; ARCHBOLD PG, 1995, RES NURS HEALTH, V18, P3, DOI 10.1002/nur.4770180103; BALABAN DJ, 1988, J FAM PRACTICE, V26, P307; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Bernabei R, 1998, BMJ-BRIT MED J, V316, P1348, DOI 10.1136/bmj.316.7141.1348; Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Bouman A, 2008, J GERONTOL A-BIOL, V63, P291, DOI 10.1093/gerona/63.3.291; Bouman A, 2008, J AM GERIATR SOC, V56, P397, DOI 10.1111/j.1532-5415.2007.01565.x; Bouman A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-74; BULA CJ, 1995, J AM GERIATR SOC, V43, P1016; Burton J, 2009, CAMPBELL SYSTEMATIC, V5; Byles JE, 2004, MED J AUSTRALIA, V181, P186, DOI 10.5694/j.1326-5377.2004.tb06233.x; Campbell AJ, 2005, BMJ-BRIT MED J, V331, P817, DOI 10.1136/bmj.38601.447731.55; Campbell AJ, 1999, AGE AGEING, V28, P513, DOI 10.1093/ageing/28.6.513; Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065; Caplan GA, 2004, J AM GERIATR SOC, V52, P1417, DOI 10.1111/j.1532-5415.2004.52401.x; CARPENTER GI, 1990, BMJ-BRIT MED J, V300, P1253, DOI 10.1136/bmj.300.6734.1253; Chandler JM, 1998, ARCH PHYS MED REHAB, V79, P24, DOI 10.1016/S0003-9993(98)90202-7; Ciaschini PM, 2009, AGE AGEING, V38, P724, DOI 10.1093/ageing/afp176; Ciaschini PM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-62; Ciechanowski P, 2004, JAMA-J AM MED ASSOC, V291, P1569, DOI 10.1001/jama.291.13.1569; Clark J, 2001, BRIT MED J, V323, P708, DOI 10.1136/bmj.323.7315.708; CLARKE M, 1992, AM J EPIDEMIOL, V136, P1517, DOI 10.1093/oxfordjournals.aje.a116473; Clemson L, 2004, J AM GERIATR SOC, V52, P1487, DOI 10.1111/j.1532-5415.2004.52411.x; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; Comans TA, 2010, J GERONTOL A-BIOL, V65, P672, DOI 10.1093/gerona/glq054; Counsell SR, 2007, JAMA-J AM MED ASSOC, V298, P2623, DOI 10.1001/jama.298.22.2623; Counsell SR, 2006, J AM GERIATR SOC, V54, P1136, DOI 10.1111/j.1532-5415.2006.00791.x; Counsell SR, 2009, J AM GERIATR SOC, V57, P1420, DOI 10.1111/j.1532-5415.2009.02383.x; Cutchin Malcolm P, 2009, BMC Geriatr, V9, P54, DOI 10.1186/1471-2318-9-54; Dahlin-Ivanoff S, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-27; Dalby DM, 2000, CAN MED ASSOC J, V162, P497; Dapp U, 2005, J PUBLIC HEALTH-HEID, V13, P122, DOI 10.1007/s10389-004-0097-3; Dapp U, 2011, J GERONTOL A-BIOL, V66, P591, DOI 10.1093/gerona/glr021; Davison J, 2005, AGE AGEING, V34, P162, DOI 10.1093/ageing/afi053; Day L, 2002, BMJ-BRIT MED J, V325, P1; de Vries OJ, 2010, ARCH INTERN MED, V170, P1110, DOI 10.1001/archinternmed.2010.169; Department of Health, 2001, NAT SERV FRAM OLD PE; DUNN RB, 1994, ARCH GERONTOL GERIAT, V18, P15, DOI 10.1016/0167-4943(94)90044-2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Eldridge Sandra, 2005, J Health Serv Res Policy, V10, P133, DOI 10.1258/1355819054338942; Elkan R, 2001, BMJ-BRIT MED J, V323, P719, DOI 10.1136/bmj.323.7315.719; Elkan R, 2004, WHAT IS EFFECTIVENES; Elley CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-185; Elley CR, 2008, J AM GERIATR SOC, V56, P1383, DOI 10.1111/j.1532-5415.2008.01802.x; Engelhardt JB, 1996, J AM GERIATR SOC, V44, P847, DOI 10.1111/j.1532-5415.1996.tb03747.x; EPSTEIN AM, 1990, JAMA-J AM MED ASSOC, V263, P538, DOI 10.1001/jama.263.4.538; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; FABACHER D, 1994, J AM GERIATR SOC, V42, P630, DOI 10.1111/j.1532-5415.1994.tb06862.x; Fairhall Nicola, 2008, BMC Geriatr, V8, P27, DOI 10.1186/1471-2318-8-27; Ferrer Assumpta, 2010, Rev Esp Geriatr Gerontol, V45, P79, DOI 10.1016/j.regg.2009.10.013; Fleischer S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-185; Fletcher AE, 2004, LANCET, V364, P1667, DOI 10.1016/S0140-6736(04)17353-4; Flood C, 2005, AGE AGEING, V34, P47, DOI 10.1093/ageing/afh232; Fordyce M, 1997, J Am Board Fam Pract, V10, P398; Fox PJ, 2010, HEALTH EDUC BEHAV, V37, P831, DOI 10.1177/1090198110366003; Gallagher EM, 1996, CAN J AGING, V15, P84, DOI 10.1017/S0714980800013301; GERMAN PS, 1995, AM J PUBLIC HEALTH, V85, P379, DOI 10.2105/AJPH.85.3.379; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Gill TM, 2004, ARCH PHYS MED REHAB, V85, P1043, DOI 10.1016/j.apmr.2003.10.021; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Gitlin LN, 2006, J AM GERIATR SOC, V54, P950, DOI 10.1111/j.1532-5415.2006.00733.x; Gitlin LN, 2006, J AM GERIATR SOC, V54, P809, DOI 10.1111/j.1532-5415.2006.00703.x; Gitlin LN, 2009, J AM GERIATR SOC, V57, P476, DOI 10.1111/j.1532-5415.2008.02147.x; Graham SA, 2006, EFFECTS HOME BASED P; Grant SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065442; Green J, 2002, LANCET, V359, P199, DOI 10.1016/S0140-6736(02)07443-3; Gunner-Svensson F, 1984, Scand J Prim Health Care, V2, P49, DOI 10.3109/02813438409017704; Guralnik JM, 2002, J AM GERIATR SOC, V50, P1599, DOI 10.1046/j.1532-5415.2002.50421.x; Gustafsson S, 2012, J AM GERIATR SOC, V60, P447, DOI 10.1111/j.1532-5415.2011.03861.x; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; HALL N, 1992, CAN J AGING, V11, P72, DOI 10.1017/S0714980800014537; HANSEN FR, 1992, AGE AGEING, V21, P445, DOI 10.1093/ageing/21.6.445; Hart B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7202; Hay WI, 1998, CAN FAM PHYSICIAN, V44, P2677; Hebert R, 2001, AGE AGEING, V30, P265, DOI 10.1093/ageing/30.3.265; Hendriks MRC, 2008, J AM GERIATR SOC, V56, P1390, DOI 10.1111/j.1532-5415.2008.01803.x; HENDRIKSEN C, 1984, BMJ-BRIT MED J, V289, P1522, DOI 10.1136/bmj.289.6457.1522; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hinrichs Timo, 2009, BMC Geriatr, V9, P37, DOI 10.1186/1471-2318-9-37; Hogan DB, 2001, CAN MED ASSOC J, V165, P537; HOLLAND R, 2006, INT J PHARM PRACT, V14, P71, DOI DOI 10.1211/ijpp.14.1.0009; Holland R, 2005, BMJ-BRIT MED J, V330, P393; HORNBROOK MC, 1994, GERONTOLOGIST, V34, P16, DOI 10.1093/geront/34.1.16; Huang TT, 2004, PUBLIC HEALTH NURS, V21, P247, DOI 10.1111/j.0737-1209.2004.21307.x; Huss A, 2008, J GERONTOL A-BIOL, V63, P298, DOI 10.1093/gerona/63.3.298; Jitapunkul Sutthichai, 1998, Journal of the Medical Association of Thailand, V81, P352; June KJ, 2009, J KOREAN ACAD NURS, V39, P366, DOI 10.4040/jkan.2009.39.3.366; Karatay G, 2012, WESTERN J NURS RES, V34, P883, DOI 10.1177/0193945911410329; Kerse NM, 1999, BRIT MED J, V319, P683, DOI 10.1136/bmj.319.7211.683; Kingston P, 2001, REV CLIN GERONTOLOGY, V11, P209; Kono A, 2004, AGING CLIN EXP RES, V16, P293; Kono A, 2012, J GERONTOL A-BIOL, V67, P302, DOI 10.1093/gerona/glr176; Kono A, 2009, AGING CLIN EXP RES, V21, P167; Krebs DE, 1998, ARCH PHYS MED REHAB, V79, P1489, DOI 10.1016/S0003-9993(98)90408-7; Kronborg Christian, 2006, Eur J Health Econ, V7, P238, DOI 10.1007/s10198-006-0361-2; La Grow SJ, 2006, INJURY PREV, V12, P296, DOI 10.1136/ip.2006.012252; Legault C, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-27; Lenaghan E, 2007, AGE AGEING, V36, P292, DOI 10.1093/ageing/afm036; Leveille SG, 1998, J AM GERIATR SOC, V46, P1191, DOI 10.1111/j.1532-5415.1998.tb04533.x; Lightbody E, 2002, AGE AGEING, V31, P203, DOI 10.1093/ageing/31.3.203; Lin MR, 2007, J AM GERIATR SOC, V55, P499, DOI 10.1111/j.1532-5415.2007.01146.x; Liu-Ambrose T, 2008, J AM GERIATR SOC, V56, P1821, DOI [10.1111/j.1532-5415.2008.01931.x, 10.1111/j.1532-5415.2008.01984.x]; Luker KA, 1981, NURS TIMES, V77, P137; Luukinen H, 2007, PREV MED, V44, P265, DOI 10.1016/j.ypmed.2006.09.011; Luukinen H, 2006, SCAND J PRIM HEALTH, V24, P199, DOI 10.1080/02813430600958476; Mahoney JE, 2007, J AM GERIATR SOC, V55, P489, DOI 10.1111/j.1532-5415.2007.01144.x; Mann WC, 1999, ARCH FAM MED, V8, P210, DOI 10.1001/archfami.8.3.210; Markle-Reid M, 2006, J ADV NURS, V54, P381, DOI 10.1111/j.1365-2648.2006.03817.x; Markle-Reid M, 2006, MED CARE RES REV, V63, P531, DOI 10.1177/1077558706290941; Markle-Reid M, 2010, CAN J AGING, V29, P139, DOI 10.1017/S0714980809990377; Matzen Lars Erik, 2007, Ugeskr Laeger, V169, P2109; Matzen Lars Erik, 2007, Ugeskr Laeger, V169, P2113; Mayo-Wilson E, 2007, AM J PUBLIC HEALTH, V97, P630, DOI 10.2105/AJPH.2006.094169; Mayo-Wilson E, 2013, TRIALS, V14, DOI [10.1192/bjp.bp.112.123745, 10.1186/1745-6215-14-242, 10.1007/s11292-013-9180-5]; MCEWAN RT, 1990, BRIT J GEN PRACT, V40, P94; MCMURDO MET, 1995, AGE AGEING, V24, P425, DOI 10.1093/ageing/24.5.425; MELIN AL, 1992, MED CARE, V30, P1004, DOI 10.1097/00005650-199211000-00004; Melis RJF, 2008, J GERONTOL A-BIOL, V63, P283, DOI 10.1093/gerona/63.3.283; Melis RJF, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-65; Messier SP, 2000, J AM GERIATR SOC, V48, P131, DOI 10.1111/j.1532-5415.2000.tb03903.x; Michael YL, 2010, ANN INTERN MED, V153, P815, DOI 10.7326/0003-4819-153-12-201012210-00008; Miller DK, 1996, J AM GERIATR SOC, V44, P513, DOI 10.1111/j.1532-5415.1996.tb01435.x; Montgomery P, 2013, J CLIN EPIDEMIOL, V66, P874, DOI 10.1016/j.jclinepi.2013.03.006; Moore AA, 1997, AM J MED, V102, P371, DOI 10.1016/S0002-9343(97)00089-2; Moyer VA, 2012, ANN INTERN MED, V157, P197, DOI 10.7326/0003-4819-157-3-201208070-00462; Nelson ME, 2004, J GERONTOL A-BIOL, V59, P154; Newbury J, 2001, 75 HLTH ASSESSMENTS; Newbury JW, 2001, MED J AUSTRALIA, V175, P104, DOI 10.5694/j.1326-5377.2001.tb143541.x; Newcomer R, 2004, EVAL HEALTH PROF, V27, P323, DOI 10.1177/0163278704270011; Nicolaides-Bouman A, 2004, BMC HEALTH SERV RES, V4, P1, DOI 10.1186/1472-6963-4-35; Nicolaides-Bouman A, 2007, J ADV NURS, V58, P425, DOI 10.1111/j.1365-2648.2007.04235.x; OKTAY JS, 1990, AM J PUBLIC HEALTH, V80, P39, DOI 10.2105/AJPH.80.1.39; Pacini M, 2007, PHARMACOECONOMICS, V25, P171, DOI 10.2165/00019053-200725020-00008; Parsons J, 2012, AGE AGEING, V41, P24, DOI 10.1093/ageing/afr118; PATHY MSJ, 1992, LANCET, V340, P890, DOI 10.1016/0140-6736(92)93294-W; Peeters Geeske M E E, 2007, BMC Geriatr, V7, P15, DOI 10.1186/1471-2318-7-15; Penninx BWJH, 2002, J GERONTOL B-PSYCHOL, V57, pP124, DOI 10.1093/geronb/57.2.P124; Pierce CA, 2008, ORGAN RES METHODS, V11, P188, DOI 10.1177/1094428106296641; Pighills AC, 2011, J AM GERIATR SOC, V59, P26, DOI 10.1111/j.1532-5415.2010.03221.x; Ploeg J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1480; Poulsen T, 2007, EUR J AGEING, V4, P115, DOI 10.1007/s10433-007-0057-1; Poulstrup A, 2000, EUR J PUBLIC HEALTH, V10, P45, DOI 10.1093/eurpub/10.1.45; Rejeski WJ, 1997, MED SCI SPORT EXER, V29, P977, DOI 10.1097/00005768-199708000-00001; Robertson MC, 2001, J EPIDEMIOL COMMUN H, V55, P600, DOI 10.1136/jech.55.8.600; Robertson MC, 2001, BRIT MED J, V322, P697, DOI 10.1136/bmj.322.7288.697; Robertson MC, 2001, BRIT MED J, V322, P701, DOI 10.1136/bmj.322.7288.701; Robichaud L, 2000, ARCH GERONTOL GERIAT, V30, P73, DOI 10.1016/S0167-4943(99)00053-9; Rosie J, 2007, AGE AGEING, V36, P555, DOI 10.1093/ageing/afm093; Rostgaard T., 1998, CARING CHILDREN OLDE; RUBENSTEIN LZ, 1994, AGING-CLIN EXP RES, V6, P105, DOI 10.1007/BF03324224; Sahlen KG, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-220; Salminen M, 2008, AGING CLIN EXP RES, V20, P487; Salminen M, 2009, ARCH GERONTOL GERIAT, V48, P22, DOI 10.1016/j.archger.2007.09.006; Salminen MJ, 2009, J AM GERIATR SOC, V57, P612, DOI 10.1111/j.1532-5415.2009.02176.x; Schraeder C, 2001, J GERONTOL A-BIOL, V56, pM106, DOI 10.1093/gerona/56.2.M106; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Scogin F, 2007, PSYCHOL AGING, V22, P657, DOI 10.1037/0882-7974.22.4.657; Sevick MA, 2000, MED SCI SPORT EXER, V32, P1534; Shapiro A, 2002, GERONTOLOGIST, V42, P334, DOI 10.1093/geront/42.3.334; Shearer NBC, 2010, NURS RES, V59, P203, DOI 10.1097/NNR.0b013e3181dbbd4a; SILVERMAN M, 1995, J AM GERIATR SOC, V43, P733, DOI 10.1111/j.1532-5415.1995.tb07041.x; Sjosten NM, 2007, EUR J PUBLIC HEALTH, V17, P464, DOI 10.1093/eurpub/ckl272; Sjosten NM, 2007, PUBLIC HEALTH, V121, P308, DOI 10.1016/j.puhe.2006.09.018; Sjosten NA, 2008, INT J GERIATR PSYCH, V23, P504, DOI 10.1002/gps.1927; Sommers LS, 2000, ARCH INTERN MED, V160, P1825, DOI 10.1001/archinte.160.12.1825; Sorensen K H, 1988, Compr Gerontol B, V2, P85; Spice CL, 2009, AGE AGEING, V38, P33, DOI 10.1093/ageing/afn192; StataCorp, 2021, STATA STAT SOFTWARE; Steinberg M, 2000, J EPIDEMIOL COMMUN H, V54, P227, DOI 10.1136/jech.54.3.227; Stevens M, 2001, J AM GERIATR SOC, V49, P1442, DOI 10.1046/j.1532-5415.2001.4911235.x; Stevens M, 2001, J AM GERIATR SOC, V49, P1455; Stewart S, 2005, AGE AGEING, V34, P41, DOI 10.1093/ageing/afh230; Strandberg TE, 2007, LANCET, V369, P1328, DOI 10.1016/S0140-6736(12)62167-9; Stuck AE, 2000, ARCH INTERN MED, V160, P977, DOI 10.1001/archinte.160.7.977; Stuck AE, 2002, JAMA-J AM MED ASSOC, V287, P1022, DOI 10.1001/jama.287.8.1022; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; STUCK AE, 1995, NEW ENGL J MED, V333, P1184, DOI 10.1056/NEJM199511023331805; Stuck AE, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-2; The Cochrane Collaboration, 2011, REV MAN REVMAN VERS; Theander E, 2005, SCAND J PUBLIC HEALT, V33, P392, DOI 10.1080/14034940510005842; Thomas R, 2007, CAN J AGING, V26, P379, DOI 10.3138/cja.26.4.379; TINETTI ME, 1993, J AM GERIATR SOC, V41, P315, DOI 10.1111/j.1532-5415.1993.tb06710.x; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Toseland RW, 1996, MED CARE, V34, P624, DOI 10.1097/00005650-199606000-00011; TOWNSEND J, 1988, BMJ-BRIT MED J, V297, P544, DOI 10.1136/bmj.297.6647.544; Tulloch A J, 1979, J R Coll Gen Pract, V29, P733; Turner S AG, 2011, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003600.PUB3; Underhill K, 2007, AIDS, V21, P266, DOI 10.1097/QAD.0b013e32801199fe; United Nations, 2011, WORLD POP PROSP 2010; Vaapio S, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-20; van Haastregt JCM, 2000, BMJ-BRIT MED J, V321, P994, DOI 10.1136/bmj.321.7267.994; van Haastregt JCM, 2000, BMJ-BRIT MED J, V320, P754, DOI 10.1136/bmj.320.7237.754; van Hout HPJ, 2010, J GERONTOL A-BIOL, V65, P734, DOI 10.1093/gerona/glq037; VANROSSUM E, 1993, BMJ-BRIT MED J, V307, P27, DOI 10.1136/bmj.307.6895.27; Vass M, 2005, J AM GERIATR SOC, V53, P563, DOI 10.1111/j.1532-5415.2005.53201.x; VETTER NJ, 1984, BRIT MED J, V288, P369, DOI 10.1136/bmj.288.6414.369; VETTER NJ, 1992, BMJ-BRIT MED J, V304, P888, DOI 10.1136/bmj.304.6831.888; von Renteln-Kruse W, 2003, Z GERONTOL GERIATR, V36, P378, DOI 10.1007/s00391-003-0179-9; WAGNER EH, 1994, AM J PUBLIC HEALTH, V84, P1800, DOI 10.2105/AJPH.84.11.1800; Wallace JI, 1998, J GERONTOL A-BIOL, V53, pM301, DOI 10.1093/gerona/53A.4.M301; Wasson J H, 1999, Eff Clin Pract, V2, P1; Whitehead Craig, 2003, Aust Health Rev, V26, P88; WILLIAMS EI, 1992, J PUBLIC HEALTH MED, V14, P138; Williams K, 2002, ACTIVITIES ADAPTATIO, V27, P1, DOI DOI 10.1300/J016V27N02_01; Wolf B, 2001, CLIN REHABIL, V15, P624, DOI 10.1191/0269215501cr456oa; Wyman JF, 2007, J AM GERIATR SOC, V55, P1548, DOI 10.1111/j.1532-5415.2007.01315.x; Yamada Y, 2003, GERIATR GERONTOL INT, V3, P236, DOI DOI 10.1111/j.1444-1586.2003.00103.x; Yates SM, 2001, J GERONTOL A-BIOL, V56, pM226, DOI 10.1093/gerona/56.4.M226; ZIMMER JG, 1985, AM J PUBLIC HEALTH, V75, P134, DOI 10.2105/AJPH.75.2.134	211	72	73	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e89257	10.1371/journal.pone.0089257	http://dx.doi.org/10.1371/journal.pone.0089257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24622676	Green Published, gold			2022-12-27	WOS:000332845300007
J	Mia, MM; Boersema, M; Bank, RA				Mia, Masum M.; Boersema, Miriam; Bank, Ruud A.			Interleukin-1 beta Attenuates Myofibroblast Formation and Extracellular Matrix Production in Dermal and Lung Fibroblasts Exposed to Transforming Growth Factor-beta 1	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TELOPEPTIDE LYSYL HYDROXYLASE; HEDGEHOG PATHWAY ACTIVATION; PYRIDINOLINE CROSS-LINKS; MUSCLE ACTIN EXPRESSION; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; COLLAGEN-SYNTHESIS; SONIC HEDGEHOG; CYTOSKELETAL FEATURES	One of the most potent pro-fibrotic cytokines is transforming growth factor (TGF beta). TGF beta is involved in the activation of fibroblasts into myofibroblasts, resulting in the hallmark of fibrosis: the pathological accumulation of collagen. Interleukin-1 beta (IL1 beta) can influence the severity of fibrosis, however much less is known about the direct effects on fibroblasts. Using lung and dermal fibroblasts, we have investigated the effects of IL1 beta, TGF beta 1, and IL1 beta in combination with TGF beta 1 on myofibroblast formation, collagen synthesis and collagen modification (including prolyl hydroxylase, lysyl hydroxylase and lysyl oxidase), and matrix metalloproteinases (MMPs). We found that IL1 beta alone has no obvious pro-fibrotic effect on fibroblasts. However, IL1 beta is able to inhibit the TGF beta 1-induced myofibroblast formation as well as collagen synthesis. Glioma-associated oncogene homolog 1 (GLI1), the Hedgehog transcription factor that is involved in the transformation of fibroblasts into myofibroblasts is upregulated by TGF beta 1. The addition of IL1 beta reduced the expression of GLI1 and thereby also indirectly inhibits myofibroblast formation. Other potentially anti-fibrotic effects of IL1 beta that were observed are the increased levels of MMP1, -2, -9 and -14 produced by fibroblasts exposed to TGF beta 1/IL1 beta in comparison with fibroblasts exposed to TGF beta 1 alone. In addition, IL1 beta decreased the TGF beta 1-induced upregulation of lysyl oxidase, an enzyme involved in collagen cross-linking. Furthermore, we found that lung and dermal fibroblasts do not always behave identically towards IL1 beta. Suppression of COL1A1 by IL1 beta in the presence of TGF beta 1 is more pronounced in lung fibroblasts compared to dermal fibroblasts, whereas a higher upregulation of MMP1 is seen in dermal fibroblasts. The role of IL1 beta in fibrosis should be reconsidered, and the differences in phenotypical properties of fibroblasts derived from different organs should be taken into account in future anti-fibrotic treatment regimes.	[Mia, Masum M.; Boersema, Miriam; Bank, Ruud A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Med Biol, Groningen, Netherlands	University of Groningen	Bank, RA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Med Biol, Groningen, Netherlands.	R.A.Bank@umcg.nl		Mia, Md Masum/0000-0001-8281-6377	Netherlands Institute for Regenerative Medicine (NIRM) [FES0908]; Netherlands Organisation for Health Research and Development (ZonMW) [40-00506-98-9021]	Netherlands Institute for Regenerative Medicine (NIRM); Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	The authors thankfully acknowledge the financial support of the Netherlands Institute for Regenerative Medicine (NIRM, grant No. FES0908). Microscopical imaging was performed at the UMCG Imaging Center (UMIC), which is supported by the Netherlands Organisation for Health Research and Development (ZonMW grant 40-00506-98-9021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkhordar RA, 2002, J ENDODONT, V28, P157, DOI 10.1097/00004770-200203000-00003; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Branski RC, 2007, J VOICE, V21, P651, DOI 10.1016/j.jvoice.2006.06.005; Brinckmann J, 2005, MATRIX BIOL, V24, P459, DOI 10.1016/j.matbio.2005.07.002; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; Bujak M, 2008, AM J PATHOL, V173, P57, DOI 10.2353/ajpath.2008.070974; Bujak M, 2009, ARCH IMMUNOL THER EX, V57, P165, DOI 10.1007/s00005-009-0024-y; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chaudhuri V, 2007, J CUTAN PATHOL, V34, P146, DOI 10.1111/j.1600-0560.2006.00584.x; Chen YP, 2012, GASTROENTEROLOGY, V143, P1319, DOI 10.1053/j.gastro.2012.07.115; Choi SS, 2011, INT J BIOCHEM CELL B, V43, P238, DOI 10.1016/j.biocel.2010.10.015; Choi SS, 2010, J BIOL CHEM, V285, P36551, DOI 10.1074/jbc.M110.168542; Choi SS, 2009, AM J PHYSIOL-GASTR L, V297, pG1093, DOI 10.1152/ajpgi.00292.2009; Cigna N, 2012, AM J PATHOL, V181, P2126, DOI 10.1016/j.ajpath.2012.08.019; COUNTS DF, 1981, J PHARMACOL EXP THER, V219, P675; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; DESMOULIERE A, 1994, CELL MOTIL CYTOSKEL, V29, P195, DOI 10.1002/cm.970290302; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Fabian SL, 2012, AM J PATHOL, V180, P1441, DOI 10.1016/j.ajpath.2011.12.039; Furuyama A, 2008, MATRIX BIOL, V27, P429, DOI 10.1016/j.matbio.2008.02.005; GABBIANI G, 1994, PATHOL RES PRACT, V190, P851; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Gieling RG, 2009, AM J PHYSIOL-GASTR L, V296, pG1324, DOI 10.1152/ajpgi.90564.2008; Guo J, 2013, ARCH TOXICO; Guy CD, 2012, HEPATOLOGY, V55, P1711, DOI 10.1002/hep.25559; HEINO J, 1990, BIOCHEM J, V271, P827, DOI 10.1042/bj2710827; Hinz B, 2003, THROMB HAEMOSTASIS, V90, P993, DOI 10.1160/TH03-05-0328; Hisatomi K, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-24; Honda A, 2008, J DERMATOL SCI, V49, P63, DOI 10.1016/j.jdermsci.2007.09.007; Hong HH, 2002, J PERIODONTOL, V73, P145, DOI 10.1902/jop.2002.73.2.145; Horn A, 2012, ARTHRITIS RHEUM-US, V64, P2724, DOI 10.1002/art.34444; Horn A, 2012, ANN RHEUM DIS, V71, P785, DOI 10.1136/annrheumdis-2011-200883; Hwang MW, 2001, J AM COLL CARDIOL, V38, P1546, DOI 10.1016/S0735-1097(01)01591-1; Ishida W, 2006, J INVEST DERMATOL, V126, P1733, DOI 10.1038/sj.jid.5700303; Kagan HM, 2000, ACTA TROP, V77, P147, DOI 10.1016/S0001-706X(00)00128-5; Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Lawrance IC, 2001, INFLAMM BOWEL DIS, V7, P226, DOI 10.1097/00054725-200108000-00008; LAZARD D, 1993, P NATL ACAD SCI USA, V90, P999, DOI 10.1073/pnas.90.3.999; Li SF, 2012, RESPIRATION, V84, P509, DOI 10.1159/000340041; Liu L, 2013, AM J RESP CELL MOL, V48, P703, DOI 10.1165/rcmb.2012-0347OC; Bolanos AL, 2012, AM J PHYSIOL-LUNG C, V303, pL978, DOI 10.1152/ajplung.00184.2012; Lu HK, 2010, J PERIODONTAL RES, V45, P451, DOI 10.1111/j.1600-0765.2009.01255.x; Maleszewska M, 2013, IMMUNOBIOLOGY, V218, P443, DOI 10.1016/j.imbio.2012.05.026; Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904; Mirastschijski U, 2010, WOUND REPAIR REGEN, V18, P223, DOI 10.1111/j.1524-475X.2010.00574.x; Moon DO, 2010, INT IMMUNOPHARMACOL, V10, P605, DOI 10.1016/j.intimp.2010.02.011; Mori Y, 2004, ARTHRITIS RHEUM-US, V50, P4008, DOI 10.1002/art.20658; Nakayama S, 2008, LIFE SCI, V82, P210, DOI 10.1016/j.lfs.2007.11.003; Namazi MR, 2011, INT J DERMATOL, V50, P85, DOI 10.1111/j.1365-4632.2010.04678.x; Philips GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023943; POOLE A, 1985, BRIT J EXP PATHOL, V66, P567; Pratap A, 2012, J DRUG TARGET, V20, P770, DOI 10.3109/1061186X.2012.719900; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Seth P, 2010, ARTHRITIS RHEUM-US, V62, P1167, DOI 10.1002/art.27315; Shimokawa T, 2008, J BIOL CHEM, V283, P14345, DOI 10.1074/jbc.M800299200; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Siwik DA, 2000, CIRC RES, V86, P1259, DOI 10.1161/01.RES.86.12.1259; Swiderska-Syn M, 2013, HEPATOLOGY, V57, P1814, DOI 10.1002/hep.26230; Szauter KM, 2005, PATHOL BIOL, V53, P448, DOI 10.1016/j.patbio.2004.12.033; Thampatty BP, 2007, GENE, V386, P154, DOI 10.1016/j.gene.2006.08.027; Trackman PC, 2005, J CELL BIOCHEM, V96, P927, DOI 10.1002/jcb.20605; Usuki J, 2012, J NIPPON MED SCH, V79, P46, DOI 10.1272/jnms.79.46; van der Slot AJ, 2005, BBA-MOL BASIS DIS, V1741, P95, DOI 10.1016/j.bbadis.2004.09.009; van der Slot AJ, 2004, MATRIX BIOL, V23, P251, DOI 10.1016/j.matbio.2004.06.001; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; van der Slot-Verhoeven AJ, 2005, BBA-MOL BASIS DIS, V1740, P60, DOI 10.1016/j.bbadis.2005.02.007; Vesey DA, 2002, J LAB CLIN MED, V140, P342, DOI 10.1067/mlc.2002.128468; Vesey DA, 2002, KIDNEY INT, V62, P31, DOI 10.1046/j.1523-1755.2002.00401.x; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xiao Hua, 2008, Shengli Xuebao, V60, P355	75	63	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91559	10.1371/journal.pone.0091559	http://dx.doi.org/10.1371/journal.pone.0091559			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622053	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300104
J	Nakamaru, M; Takada, T; Ohtsuki, A; Suzuki, SU; Miura, K; Tsuji, K				Nakamaru, Mayuko; Takada, Takenori; Ohtsuki, Akiko; Suzuki, Sayaki U.; Miura, Kanan; Tsuji, Kazuki			Ecological Conditions Favoring Budding in Colonial Organisms under Environmental Disturbance	PLOS ONE			English	Article							CONDITION-DEPENDENT DISPERSAL; GROUP SELECTION; INCLUSIVE FITNESS; EVOLUTION; DEMOGRAPHY; ALTRUISM; COALITIONS; PLANTS; CORAL; SIZE	Dispersal is a topic of great interest in ecology. Many organisms adopt one of two distinct dispersal tactics at reproduction: the production of small offspring that can disperse over long distances (such as seeds and spawned eggs), or budding. The latter is observed in some colonial organisms, such as clonal plants, corals and ants, in which (super) organisms split their body into components of relatively large size that disperse to a short distance. Contrary to the common dispersal viewpoint, short-dispersal colonial organisms often flourish even in environments with frequent disturbances. In this paper, we investigate the conditions that favor budding over long-distance dispersal of small offspring, focusing on the life history of the colony growth and the colony division ratio. These conditions are the relatively high mortality of very small colonies, logistic growth, the ability of dispersers to peacefully seek and settle unoccupied spaces, and small spatial scale of environmental disturbance. If these conditions hold, budding is advantageous even when environmental disturbance is frequent. These results suggest that the demography or life history of the colony underlies the behaviors of the colonial organisms.	[Nakamaru, Mayuko; Ohtsuki, Akiko; Suzuki, Sayaki U.; Miura, Kanan] Tokyo Inst Technol, Dept Value & Decis Sci, Tokyo 152, Japan; [Takada, Takenori] Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 060, Japan; [Ohtsuki, Akiko; Suzuki, Sayaki U.] Grad Univ Adv Studies, Kanagawa, Japan; [Tsuji, Kazuki] Univ Ryukyus, Fac Agr, Nishihara, Okinawa 90301, Japan	Tokyo Institute of Technology; Hokkaido University; Graduate University for Advanced Studies - Japan; University of the Ryukyus	Nakamaru, M (corresponding author), Tokyo Inst Technol, Dept Value & Decis Sci, Tokyo 152, Japan.	nakamaru@valdes.titech.ac.jp	Nakamaru, Mayuko/N-9127-2013; Tsuji, Kazuki/D-6607-2014	Nakamaru, Mayuko/0000-0003-2116-1711; Tsuji, Kazuki/0000-0002-2027-8582; Suzuki, Sayaki/0000-0002-6744-8139	JSPS KAKENHI [21770076, 23370006, 25340115, 20033015, 21247006]; Inamori Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Inamori Foundation	This work is supported by JSPS KAKENHI Grant Number 21770076 (M.N.), 23370006 (T. T.), 25340115 (T. T.), 20033015 (K. T.), 21247006 (K. T.), and Inamori Foundation (M.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; Bradley BJ, 2007, P ROY SOC B-BIOL SCI, V274, P2179, DOI 10.1098/rspb.2007.0407; Carpintero S, 2004, BIOL CONSERV, V115, P279, DOI 10.1016/S0006-3207(03)00147-2; Caswell H, 2000, MATRIX POPULATION MO, V2nd; Clobert J, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199608898.001.0001; Coffroth MA, 1998, EVOLUTION, V52, P379, DOI 10.1111/j.1558-5646.1998.tb01639.x; Cronin AL, 2012, ANIM BEHAV, V84, P1243, DOI 10.1016/j.anbehav.2012.08.036; Gardner A, 2006, J EVOLUTION BIOL, V19, P1707, DOI 10.1111/j.1420-9101.2006.01104.x; Gardner A, 2009, J EVOLUTION BIOL, V22, P1036, DOI 10.1111/j.1420-9101.2009.01719.x; Gardner A, 2009, J EVOLUTION BIOL, V22, P659, DOI 10.1111/j.1420-9101.2008.01681.x; Goodnight CJ, 1997, AM NAT, V150, pS59, DOI 10.1086/286050; GOODNIGHT KF, 1992, AM NAT, V140, P1028, DOI 10.1086/285454; Gyllenberg M, 2008, J MATH BIOL, V57, P285, DOI 10.1007/s00285-008-0158-2; Gyllenberg M, 2011, THEOR POPUL BIOL, V79, P139, DOI 10.1016/j.tpb.2011.02.004; Gyllenberg Mats, 2011, Journal of Biological Dynamics, V5, P191, DOI 10.1080/17513758.2010.519403; Harper J. L, 1977, POPULATION BIOL PLAN; Heinsohn R, 2000, P ROY SOC B-BIOL SCI, V267, P243, DOI 10.1098/rspb.2000.0993; Holldobler B., 1990, pi; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Honnay O, 2010, EVOL ECOL, V24, P1393, DOI 10.1007/s10682-010-9408-z; Kummerli R, 2009, EVOLUTION, V63, P939, DOI 10.1111/j.1558-5646.2008.00548.x; Lehmann L, 2006, EVOLUTION, V60, P1137; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; Liu J, 2006, BIOL INVASIONS, V8, P1461, DOI 10.1007/s10530-005-5838-x; Nakamaru M, 2007, J THEOR BIOL, V248, P288, DOI 10.1016/j.jtbi.2007.05.012; Nichols J., 2001, DISPERSAL; Ono S, 2003, J THEOR BIOL, V220, P55, DOI 10.1006/jtbi.2003.3144; PASSERA L, 1994, WESTV STUD, P23; Ronce Ophelie, 2001, P341; Sharp SP, 2008, P ROY SOC B-BIOL SCI, V275, P2125, DOI 10.1098/rspb.2008.0398; SLATKIN M, 1978, P NATL ACAD SCI USA, V75, P3531, DOI 10.1073/pnas.75.7.3531; SLATKIN M, 1977, THEOR POPUL BIOL, V12, P253, DOI 10.1016/0040-5809(77)90045-4; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stearns S.C., 1992, pi; Stroeymeyt N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013059; Suzuki JI, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P311; TAYLOR PD, 1992, P ROY SOC B-BIOL SCI, V249, P299, DOI 10.1098/rspb.1992.0118; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Tsuji K, 2010, ENCY ANIMAL BEHAV, P469; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Williams DA, 2005, J ANIM ECOL, V74, P150, DOI 10.1111/j.1365-2656.2004.00907.x; Williams G. C., 1966, P307; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969; Wynee-Edwards V, 1962, ANIMAL DISPERSION RE; Yamaguchi M., 1983, Galaxea, V2, P21	45	4	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91210	10.1371/journal.pone.0091210	http://dx.doi.org/10.1371/journal.pone.0091210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621824	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300064
J	Ren, DB; Kordis, AA; Sonenshine, DE; Daines, DA				Ren, Dabin; Kordis, Alexis A.; Sonenshine, Daniel E.; Daines, Dayle A.			The ToxAvapA Toxin-Antitoxin Locus Contributes to the Survival of Nontypeable Haemophilus influenzae during Infection	PLOS ONE			English	Article							OTITIS-MEDIA; SYSTEMS; STRAIN	Nontypeable Haemophilus influenzae (NTHi) is an opportunistic pathogen that is a common cause of acute and recurrent mucosal infections. One uncharacterized NTHi toxin-antitoxin (TA) module, NTHI1912-1913, is a host inhibition of growth (higBA) homologue. We hypothesized that this locus, which we designated toxAvapA, contributed to NTHi survival during infection. We deleted toxAvapA and determined that growth of the mutant in defined media was not different from the parent strain. We tested the mutant for persistence during long-term in vitro co-culture with primary human respiratory tissues, which revealed that the Delta toxAvapA mutant was attenuated for survival. We then performed challenge studies using the chinchilla model of otitis media and determined that mutant survival was also reduced in vivo. Following purification, the toxin exhibited ribonuclease activity on RNA in vitro, while the antitoxin did not. A microarray comparison of the transcriptome revealed that the tryptophan biosynthetic regulon was significantly repressed in the mutant compared to the parent strain. HPLC studies of conditioned medium confirmed that there was no significant difference in the concentration of tryptophan remaining in the supernatant, indicating that the uptake of tryptophan by the mutant was not affected. We conclude that the role of the NTHi toxAvapA TA module in persistence following stress is multifactorial and includes effects on essential metabolic pathways.	[Ren, Dabin] Rochester Gen Hosp, Res Inst, Dept Res, Rochester, NY 14621 USA; [Kordis, Alexis A.; Sonenshine, Daniel E.; Daines, Dayle A.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA	Rochester General Hospital; Old Dominion University	Daines, DA (corresponding author), Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA.	ddaines@odu.edu	Sonenshine, Daniel/AAF-3625-2020; Daines, Dayle A./J-4393-2019		National Institute on Deafness and other Communication Disorders [DC010187]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010187] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded by the National Institute on Deafness and other Communication Disorders grant DC010187 to D. A. D. Website: http://www.nidcd.nih.gov/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARENKAMP SJ, 1984, J PEDIATR-US, V105, P533, DOI 10.1016/S0022-3476(84)80415-1; Budde PP, 2007, J BACTERIOL, V189, P491, DOI 10.1128/JB.00909-06; Coleman HN, 2003, J CLIN MICROBIOL, V41, P4408, DOI 10.1128/JCM.41.9.4408-4410.2003; Cook GM, 2013, BBA-GENE REGUL MECH, V1829, P523, DOI 10.1016/j.bbagrm.2013.02.007; Coutard B, 2012, PROTEIN EXPRES PURIF, V82, P352, DOI 10.1016/j.pep.2012.01.014; Daines DA, 2007, J BACTERIOL, V189, P5041, DOI 10.1128/JB.00290-07; Fivian-Hughes AS, 2010, J BACTERIOL, V192, P4348, DOI 10.1128/JB.00454-10; FRIGGE M, 1989, AM STAT, V43, P50, DOI 10.2307/2685173; Goulard C, 2010, J BACTERIOL, V192, P3669, DOI 10.1128/JB.00336-10; Grevers G, 2010, INT J PEDIATR OTORHI, V74, P572, DOI 10.1016/j.ijporl.2010.03.049; Harrison A, 2005, J BACTERIOL, V187, P4627, DOI 10.1128/JB.187.13.4627-4636.2005; HERRIOTT RM, 1970, J BACTERIOL, V101, P517, DOI 10.1128/JB.101.2.517-524.1970; Hurley JM, 2009, J BIOL CHEM, V284, P18605, DOI 10.1074/jbc.M109.008763; Jurenaite M, 2013, J BACTERIOL, V195, P3165, DOI 10.1128/JB.00237-13; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Ren D, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-263; Schuessler DL, 2013, MOL MICROBIOL; Tian QB, 1996, BIOCHEM BIOPH RES CO, V220, P280, DOI 10.1006/bbrc.1996.0396; Tuomanen E., 1986, REV INFECT DIS S, V8, P279; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Williams JJ, 2011, FEMS MICROBIOL LETT, V322, P41, DOI 10.1111/j.1574-6968.2011.02330.x; Xie G, 2003, MICROBIOL MOL BIOL R, V67, P303, DOI 10.1128/MMBR.67.3.303-342.2003; ZIEGLER F, 1992, J AUTOM CHEM, V14, P145, DOI 10.1155/S1463924692000270	24	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91523	10.1371/journal.pone.0091523	http://dx.doi.org/10.1371/journal.pone.0091523			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621787	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300099
J	Yamazaki, M; Naganawa, S; Kawai, H; Ikeda, M; Bokura, K; Isoda, H; Nakashima, T				Yamazaki, Masahiro; Naganawa, Shinji; Kawai, Hisashi; Ikeda, Mitsuru; Bokura, Kiminori; Isoda, Haruo; Nakashima, Tsutomu			Visualization of White Matter Tracts Using a Non-Diffusion Weighted Magnetic Resonance Imaging Method: Does Intravenous Gadolinium Injection Four Hours Prior to the Examination Affect the Visualization of White Matter Tracts?	PLOS ONE			English	Article							HEAVILY T-2-WEIGHTED 3D-FLAIR; NEPHROGENIC SYSTEMIC FIBROSIS; ENDOLYMPHATIC HYDROPS; COCHLEAR PERILYMPH; MENIERES-DISEASE; BRAIN-STEM; CONTRAST AGENTS; 3 TESLA; SEQUENCES; FLUID	Objectives: Visualization of white matter (WM)-tracts such as the corticospinal tract (CST), medial lemniscus (ML), and superior cerebellar peduncle (SCP) using delayed enhanced (DE)-heavily T2-weighted three-dimensional fluid-attenuated inversion-recovery (hT2w-3D-FLAIR) imaging has recently been reported. In that report, all patients were clinically suspected of having Meniere's disease, because DE-hT2w-3D-FLAIR imaging of the inner ear has been reported to separately visualize perilymph and endolymph fluid and can identify the presence of endolymphatic hydrops. Therefore, the previous report could not rule out the possible effect of delayed enhancement. From this perspective, the purpose of this study was to elucidate if the use of gadolinium affects the visualization of WM-tracts on hT2w-3D-FLAIR. Materials and Methods: The records of nine patients with suspected Meniere's disease who underwent plain (P) and DE-hT2w-3D-FLAIR by 3-Tesla were retrospectively analyzed. The regions of interest were set on the CST, ML, and SCP, and on contiguous brain parenchyma: The thalamus (Th), pontine parenchyma (PP), and cerebellar parenchyma (CP), respectively. The signal intensity ratio between each WM-tract and the relevant contiguous brain parenchyma was calculated for both Pand DE-hT2w-3D-FLAIR images, and statistically compared using paired t-tests. Results: The CST/Th signal intensity ratio was 3.75 +/- 0.67 on P-hT2w-3D-FLAIR and 3.62 +/- 0.50 on DE-hT2w-3D-FLAIR (p = 0.24). The ML/PP signal intensity ratio was 2.19 +/- 0.59 on P-hT2w-3D-FLAIR and 2.08 +/- 0.53 on DE-hT2w-3D-FLAIR (p = 0.25). The SCP/CP signal intensity ratio was 4.08 +/- 0.91 on P-hT2w-3D-FLAIR and 4.04 +/- 0.96 on DE-hT2w-3D-FLAIR (p = 0.43). There were no significant differences in the signal intensity ratios between P-and DE-hT2w-3D-FLAIR images. Conclusions: The use of gadolinium is not necessary for visualization of WM-tracts using hT2w-3D-FLAIR, and P-hT2w-3D-FLAIR without gadolinium may have future clinical applications as an imaging procedure.	[Yamazaki, Masahiro; Naganawa, Shinji; Kawai, Hisashi; Bokura, Kiminori] Nagoya Univ, Grad Sch Med, Dept Radiol, Nagoya, Aichi 4648601, Japan; [Ikeda, Mitsuru; Isoda, Haruo] Nagoya Univ, Grad Sch Med, Dept Radiol Technol, Nagoya, Aichi 4648601, Japan; [Nakashima, Tsutomu] Nagoya Univ, Grad Sch Med, Dept Otorhinolaryngol, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University; Nagoya University	Yamazaki, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Radiol, Nagoya, Aichi 4648601, Japan.	yamazaki@med.nagoya-u.ac.jp	Ikeda, Mitsuru/B-5163-2010; Naganawa, Shinji/I-1572-2012; Isoda, Haruo/I-7028-2014; Nakashima, Tsutomu/B-8259-2012; YAMAZAKI, Masahiro/I-7436-2014	Ikeda, Mitsuru/0000-0002-5695-3527; Naganawa, Shinji/0000-0002-0214-613X; Isoda, Haruo/0000-0002-3249-7520; Nakashima, Tsutomu/0000-0003-3930-9120; 	Japan Society for the Promotion of Science (JSPS) [24791288, 22390233, 21390460]; Japanese Ministry of Health, Labour and Welfare [H23-Nanchi-Ippan-021]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the grants from the Japan Society for the Promotion of Science (JSPS: http://www.jsps.go.jp/english/index.html) for Masahiro Yamazaki (JSPS KAKENHI Grant Number 24791288), Shinji Naganawa (JSPS KAKENHI Grant Number 22390233) and Tsutomu Nakashima (JSPS KAKENHI Grant Number 21390460), and the grants from Japanese Ministry of Health, Labour and Welfare (http://www.mhlw.go.jp/english/) for Tsutomu Nakashima (Grant Number H23-Nanchi-Ippan-021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DECOENE B, 1993, NEURORADIOLOGY, V35, P327, DOI 10.1007/BF00588360; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Habgood MD, 2000, CELL MOL NEUROBIOL, V20, P231, DOI 10.1023/A:1007001923498; Hirabayashi H, 2002, MOVEMENT DISORD, V17, pS130, DOI 10.1002/mds.10154; Kaewlai R, 2012, AM J ROENTGENOL, V199, pW17, DOI 10.2214/AJR.11.8144; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kitajima M, 2012, AM J NEURORADIOL, V33, P922, DOI 10.3174/ajnr.A2874; KJOS BO, 1985, AM J ROENTGENOL, V144, P1165, DOI 10.2214/ajr.144.6.1165; Kuo PH, 2007, RADIOLOGY, V242, P647, DOI 10.1148/radiol.2423061640; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Naganawa S, 2008, AM J NEURORADIOL, V29, P724, DOI 10.3174/ajnr.A0894; Naganawa S, 2006, EUR RADIOL, V16, P733, DOI 10.1007/s00330-005-0046-8; Naganawa S, 2004, EUR RADIOL, V14, P1901, DOI 10.1007/s00330-004-2372-7; Naganawa S, 2011, MAGN RESON MED SCI, V10, P269, DOI 10.2463/mrms.10.269; Naganawa S, 2010, MAGN RESON MED SCI, V9, P237, DOI 10.2463/mrms.9.237; Naganawa S, 2010, MAGN RESON MED SCI, V9, P73, DOI 10.2463/mrms.9.73; Nakashima T, 2007, LARYNGOSCOPE, V117, P415, DOI 10.1097/MLG.0b013e31802c300c; Nakashima T, 2010, ACTA OTO-LARYNGOL, V130, P338, DOI [10.1080/00016480903143986, 10.3109/00016480903143986]; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Patel MD, 2010, MAGN RESON MATER PHY, V23, P399, DOI 10.1007/s10334-010-0201-3; Petty MA, 2002, PROG NEUROBIOL, V68, P311, DOI 10.1016/S0301-0082(02)00128-4; Sieber MA, 2009, J MAGN RESON IMAGING, V30, P1268, DOI 10.1002/jmri.21971; Sone M, 2007, OTOL NEUROTOL, V28, P1029, DOI 10.1097/MAO.0b013e3181587d95; Sugiura M, 2006, LARYNGOSCOPE, V116, P826, DOI 10.1097/01.MLG.0000215206.75542.BF; Tagaya M, 2011, ACTA OTO-LARYNGOL, V131, P474, DOI 10.3109/00016489.2010.534114; Takahara T, 2010, EUR RADIOL, V20, P1221, DOI 10.1007/s00330-009-1665-2; Taoka T, 2009, AM J NEURORADIOL, V30, P1700, DOI 10.3174/ajnr.A1698; Teranishi M, 2009, EUR ARCH OTO-RHINO-L, V266, P1871, DOI 10.1007/s00405-009-0989-5; Weigel M, 2012, MAGN RESON MED, V67, P1528, DOI 10.1002/mrm.24286; YAGISHITA A, 1994, RADIOLOGY, V191, P455, DOI 10.1148/radiology.191.2.8153321; Yamada K, 2003, RADIOLOGY, V227, P295, DOI 10.1148/radiol.2271020313; Yamazaki M, 2012, AM J NEURORADIOL, V33, P773, DOI 10.3174/ajnr.A2821; Yamazaki M, 2013, EUR C RAD 2013 EPOS, DOI [10.1594/ecr2013/C-0108, DOI 10.1594/ECR2013/C-0108.ACCESSED]; Yamazaki M, 2012, NEURORADIOLOGY, V54, P1161, DOI 10.1007/s00234-012-1078-9; Yamazaki M, 2010, MAGN RESON MED SCI, V9, P65, DOI 10.2463/mrms.9.65; Yamazaki M, 2009, NEURORADIOLOGY, V51, P855, DOI 10.1007/s00234-009-0588-6; Zrinzo L, 2008, BRAIN, V131, P1588, DOI 10.1093/brain/awn075	37	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91860	10.1371/journal.pone.0091860	http://dx.doi.org/10.1371/journal.pone.0091860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622649	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300135
J	Zhang, ZF; Wang, T; Liu, LH; Guo, HQ				Zhang, Ze-Feng; Wang, Tao; Liu, Li-Hua; Guo, Hui-Qin			Risks of Proteinuria Associated with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RENAL-CELL CARCINOMA; RANDOMIZED PHASE-III; VENOUS THROMBOEMBOLIC EVENTS; METASTATIC COLORECTAL-CANCER; ADVANCED PANCREATIC-CANCER; SOFT-TISSUE SARCOMA; DOUBLE-BLIND; 2ND-LINE TREATMENT; GASTROINTESTINAL PERFORATION; ANGIOGENESIS INHIBITOR	Background: Vascular endothelial growth factor tyrosine-kinase inhibitors (VEGFR-TKIs) have emerged as an effective targeted therapy in the treatment of cancer patients, the overall incidence and risk of proteinuria associated these drugs is unclear. We performed a systematic review and meta-analysis of published clinical trials to quantify the incidence and risk of proteinuria associated with VEGFR-TKIs. Methodology: Databases from PubMed, Web of Science and abstracts presented at ASCO meeting up to May 31, 2013 were searched to identify relevant studies. Eligible studies included prospective phase II and III trials evaluating VEGFR-TKIs in cancer patients with adequate data on proteinuria. Statistical analyses were conducted to calculate the summary incidence, Odds ratio (OR) and 95% confidence intervals (CIs) by using either random effects or fixed effect models according to the heterogeneity of included studies. Principal Findings: A total of 6,882 patients with a variety of solid tumors from 33 clinical trials were included in our analysis. The incidence of all-grade and high-grade (grade 3 or higher) proteinuria was 18.7% (95% CI, 13.3%-25.6%) and 2.4% (95% CI, 1.6%-3.7%), respectively. Patients treated with VEGFR-TKIs had a significantly increased risk of all-grade (OR 2.92, 95%CI: 1.09-7.82, p = 0.033) and high-grade proteinuria (OR 1.97, 95%CI: 1.01-3.84, p = 0.046) when compared to patients treated with control medication. No evidence of publication bias was observed. Conclusions: The use of VEGFR-TKIs is associated with a significant increased risk of developing proteinuria. Physicians should be aware of this adverse effect and should monitor cancer patients receiving VEGFR-TKIs.	[Zhang, Ze-Feng; Wang, Tao] Hebei Med Univ, Affiliated Hosp 4, Dept Thorac Surg, Shijiazhuang, Peoples R China; [Liu, Li-Hua] Hebei Med Univ, Affiliated Hosp 4, Dept Biol Therapy, Shijiazhuang, Peoples R China; [Guo, Hui-Qin] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100730, Peoples R China; [Guo, Hui-Qin] Peking Union Med Coll, Beijing 100021, Peoples R China	Hebei Medical University; Hebei Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, T (corresponding author), Hebei Med Univ, Affiliated Hosp 4, Dept Thorac Surg, Shijiazhuang, Peoples R China.	wangtao130928@163.com						Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Batchelor TT, 2010, J CLIN ONCOL, V28, P2817, DOI 10.1200/JCO.2009.26.3988; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bible KC, 2010, LANCET ONCOL, V11, P962, DOI 10.1016/S1470-2045(10)70203-5; Campbell NP, 2012, LUNG CANCER, V78, P76, DOI 10.1016/j.lungcan.2012.06.011; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Choueiri TK, 2010, J CLIN ONCOL, V28, P2280, DOI 10.1200/JCO.2009.27.2757; Cohen EEW, 2008, J CLIN ONCOL, V26, P4708, DOI 10.1200/JCO.2007.15.9566; Cortes J, 2012, ANN ONCOL, V23, P1130, DOI 10.1093/annonc/mdr432; Cunningham D, 2013, BRIT J CANCER, V108, P493, DOI 10.1038/bjc.2012.545; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Funakoshi T, 2013, J HUM HYPERTENS, V27, P601, DOI 10.1038/jhh.2013.30; Gianni L, 2013, J CLIN ONCOL, V31, P1719, DOI 10.1200/JCO.2012.44.7912; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Hainsworth JD, 2013, CLIN GENITOURIN CANC, V11, P270, DOI 10.1016/j.clgc.2013.04.006; Hapani S, 2009, LANCET ONCOL, V10, P559, DOI 10.1016/S1470-2045(09)70112-3; Hsu CH, 2010, J HEPATOL, V53, P126, DOI 10.1016/j.jhep.2010.01.035; Hurwitz HI, 2011, J CLIN ONCOL, V29, P1757, DOI 10.1200/JCO.2010.32.3220; Ibrahim EM, 2013, INT J CLIN ONCOL, V18, P1060, DOI 10.1007/s10147-012-0497-2; Infante JR, 2013, CANCER-AM CANCER SOC, V119, P2555, DOI 10.1002/cncr.28112; Iwamoto FM, 2010, NEURO-ONCOLOGY, V12, P855, DOI 10.1093/neuonc/noq025; Je YJ, 2009, LANCET ONCOL, V10, P967, DOI 10.1016/S1470-2045(09)70222-0; Jonasch E, 2010, CANCER-AM CANCER SOC, V116, P57, DOI 10.1002/cncr.24685; KidneyDisease Outcomes Quality Initiative (K/DOQI), 2004, AM J KIDNEY DIS, V43, pS1; KINCAIDSMITH P, 1991, AM J KIDNEY DIS, V17, P144, DOI 10.1016/S0272-6386(12)81119-X; Kindler HL, 2012, INVEST NEW DRUG, V30, P382, DOI 10.1007/s10637-010-9526-z; Kuei A, 2013, J CLIN ONCOL, V31; Kummar S, 2013, J CLIN ONCOL, V31, P2296, DOI 10.1200/JCO.2012.47.4288; Launay-Vacher V, 2009, ANTI-CANCER DRUG, V20, P81, DOI 10.1097/CAD.0b013e3283161012; Lim WT, 2011, CLIN CANCER RES, V17, P5481, DOI 10.1158/1078-0432.CCR-10-3409; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mayer EL, 2010, ANN ONCOL, V21, P2370, DOI 10.1093/annonc/mdq260; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2013, J CLIN ONCOL, V31, P3791, DOI 10.1200/JCO.2012.47.4940; Motzer RJ, 2013, LANCET ONCOL, V14, P552, DOI 10.1016/S1470-2045(13)70093-7; Mulders P, 2012, EUR J CANCER, V48, P527, DOI 10.1016/j.ejca.2011.12.022; Nalluri SR, 2008, JAMA-J AM MED ASSOC, V300, P2277, DOI 10.1001/jama.2008.656; NCI Cancer Therapy Evaluation Program, 2006, CTC V 2 0 COMM TERM; Nosov DA, 2012, J CLIN ONCOL, V30, P1678, DOI 10.1200/JCO.2011.35.3524; Qi WX, 2013, ANN ONCOL, V24, P2943, DOI 10.1093/annonc/mdt292; Qi WX, 2014, CRIT REV ONCOL HEMAT, V89, P394, DOI 10.1016/j.critrevonc.2013.10.002; Qi WX, 2013, BRIT J CLIN PHARMACO, V76, P348, DOI 10.1111/bcp.12149; Qi WX, 2013, INT J CANCER, V132, P2967, DOI 10.1002/ijc.27979; Qi WX, 2013, BRIT J CLIN PHARMACO, V75, P919, DOI 10.1111/j.1365-2125.2012.04417.x; Qi WX, 2013, CANCER CHEMOTH PHARM, V71, P431, DOI 10.1007/s00280-012-2025-5; Qi WX, 2011, LUNG, V189, P437, DOI 10.1007/s00408-011-9332-1; Ramalingam SS, 2010, J THORAC ONCOL, V5, P1279, DOI 10.1097/JTO.0b013e3181e2fcb0; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Rini B, 2012, CANCER-AM CANCER SOC, V118, P6152, DOI 10.1002/cncr.27632; Rixe O, 2007, LANCET ONCOL, V8, P975, DOI 10.1016/S1470-2045(07)70285-1; Robinson ES, 2010, CLIN J AM SOC NEPHRO, V5, P477, DOI 10.2215/CJN.08111109; Scappaticci FA, 2007, JNCI-J NATL CANCER I, V99, P1232, DOI 10.1093/jnci/djm086; Schmoll HJ, 2012, J CLIN ONCOL, V30, P3588, DOI 10.1200/JCO.2012.42.5355; Schrijvers BF, 2004, KIDNEY INT, V65, P2003, DOI 10.1111/j.1523-1755.2004.00621.x; Sleijfer S, 2009, J CLIN ONCOL, V27, P3126, DOI 10.1200/JCO.2008.21.3223; Sonpavde G, 2013, CRIT REV ONCOL HEMAT, V87, P80, DOI 10.1016/j.critrevonc.2012.12.006; Spano JP, 2008, LANCET, V371, P2101, DOI 10.1016/S0140-6736(08)60661-3; Sternberg CN, 2013, EUR J CANCER, V49, P1287, DOI 10.1016/j.ejca.2012.12.010; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Tan EH, 2011, J THORAC ONCOL, V6, P1418, DOI 10.1097/JTO.0b013e318220c93e; Tannir NM, 2011, EUR J CANCER, V47, P2706, DOI 10.1016/j.ejca.2011.09.002; Toh HC, 2013, CANCER-AM CANCER SOC, V119, P380, DOI 10.1002/cncr.27758; Tomita Y, 2011, EUR J CANCER, V47, P2592, DOI 10.1016/j.ejca.2011.07.014; U.S. Food and Drug Administration. FDA Briefing Document, FDA BRIEF DOC ONC DR; US Food and Drug Administration, HIGHL PRESCR INF VOT; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Vuorela P, 2000, OBSTET GYNECOL, V95, P353, DOI 10.1016/S0029-7844(99)00565-7; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wells SA, 2012, J CLIN ONCOL, V30, P134, DOI 10.1200/JCO.2011.35.5040; Wells SA, 2010, J CLIN ONCOL, V28, P767, DOI 10.1200/JCO.2009.23.6604; Wu SH, 2008, LANCET ONCOL, V9, P117, DOI 10.1016/S1470-2045(08)70003-2; Wu SH, 2010, J AM SOC NEPHROL, V21, P1381, DOI 10.1681/ASN.2010020167; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407; Zhu XL, 2007, AM J KIDNEY DIS, V49, P186, DOI 10.1053/j.ajkd.2006.11.039; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	85	54	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90135	10.1371/journal.pone.0090135	http://dx.doi.org/10.1371/journal.pone.0090135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621598	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300015
J	Ghrenassia, E; Roulin, L; Aline-Fardin, A; Marzac, C; Feger, F; Gay, J; Pacanowski, J; Hertig, A; Coppo, P				Ghrenassia, Etienne; Roulin, Louise; Aline-Fardin, Aude; Marzac, Christophe; Feger, Frederic; Gay, Julie; Pacanowski, Jerome; Hertig, Alexandre; Coppo, Paul			The Spectrum of Chronic CD8(+) T-Cell Expansions: Clinical Features in 14 Patients	PLOS ONE			English	Article							REPLICATIVE SENESCENCE; LYMPHOCYTOSIS SYNDROME; SICCA SYNDROME; HIV-INFECTION; NEUTROPENIA; DISEASE; MUTATIONS; HEALTH	Chronic CD8(+) T-cell expansions can result in parotid gland swelling and other organ infiltration in HIV-infected patients, or in persistent cytopenias. We report 14 patients with a CD8(+) T-cell expansion to better characterize the clinical spectrum of this ill-defined entity. Patients (9 women/5 men) were 65 year-old (range, 25-74). Six patients had >= 1 symptomatic organ infiltration, and 9 had >= 1 cytopenia with a CD8(+) (. 50% of total lymphocyte count) and/or a CD8(+)/CD57(+) (. 30% of total lymphocyte count) T-cell expansion for at least 3 months. One patient had both manifestations. A STAT3 mutation, consistent with the diagnosis of large granular lymphocyte leukemia, was found in 2 patients with cytopenia. Organ infiltration involved lymph nodes, the liver, the colon, the kidneys, the skin and the central nervous system. Three patients had a HIV infection for 8 years (range, 0.5-20 years). Two non-HIV patients with hypogammaglobulinemia had been treated with a B-cell depleting monoclonal antibody (rituximab) for a lymphoma. One patient had a myelodysplastic syndrome with colon infiltration and agranulocytosis. The outcome was favorable with efficient antiretroviral therapy and steroids in HIV-infected patients and intravenous immunoglobulins in 2/3 non-HIV patients. Six patients had an agranulocytosis of favorable outcome with granulocyte-colony stimulating factor only (3 cases), cyclophosphamide, methotrexate and cyclosporine A, or no treatment (1 case each). Three patients had a pure red cell aplasia, of favorable outcome in 2 cases with methotrexate and cyclosporine A; one patient was unresponsive. Chronic CD8(+) T-cell expansions with organ infiltration in immunocompromised patients may involve other organs than parotid glands; they are non clonal and of favorable outcome after correction of the immune deficiency and/or steroids. In patients with bone marrow infiltration and unexplained cytopenia, CD8(+) T-cell expansions can be clonal or not; their identification suggests that cytopenias are immune-mediated. Our results extend the clinical spectrum of chronic CD8(+) T-cell expansions.	[Ghrenassia, Etienne; Roulin, Louise; Gay, Julie; Coppo, Paul] Hop Univ Est Parisien, AP HP, Serv Hematol, Paris, France; [Aline-Fardin, Aude] Hop Univ Est Parisien, AP HP, Serv Anat Pathol, Paris, France; [Marzac, Christophe; Feger, Frederic] Hop Univ Est Parisien, AP HP, Lab Immunohematol, Paris, France; [Pacanowski, Jerome] Hop Univ Est Parisien, AP HP, Serv Malad Infect & Trop, Paris, France; [Hertig, Alexandre] Hop Univ Est Parisien, AP HP, Paris, France; [Aline-Fardin, Aude; Gay, Julie; Hertig, Alexandre; Coppo, Paul] Univ Paris 06, Paris, France; [Coppo, Paul] Inst Gustave Roussy, INSERM, U1009, F-94805 Villejuif, France; [Coppo, Paul] Ctr Reference Microangiopathies Thrombot, Paris, France	Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Coppo, P (corresponding author), Hop Univ Est Parisien, AP HP, Serv Hematol, Paris, France.	paul.coppo@sat.aphp.fr						Akhtari M, 2009, AUTOIMMUN REV, V9, P62, DOI 10.1016/j.autrev.2009.03.006; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Basu D, 2006, ARTHRIT RHEUM-ARTHR, V55, P466, DOI 10.1002/art.21980; Batliwalla F, 1996, HUM IMMUNOL, V48, P68, DOI 10.1016/0198-8859(96)00077-8; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Capsoni F, 2005, ARTHRITIS RES THER, V7, P208, DOI 10.1186/ar1803; Chou JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064702; Coppo P, 2003, ANN RHEUM DIS, V62, P476, DOI 10.1136/ard.62.5.476; Coppo Paul, 2004, Eur J Intern Med, V15, P451, DOI 10.1016/j.ejim.2004.08.009; DANGEAC AD, 1994, EUR J IMMUNOL, V24, P1503, DOI 10.1002/eji.1830240707; Dock JN, 2011, AGING DIS, V2, P382; DWYER E, 1993, J CLIN INVEST, V92, P495, DOI 10.1172/JCI116593; FERRERO D, 1993, HAEMATOLOGICA, V78, P49; Focosi D, 2010, J LEUKOCYTE BIOL, V87, P107, DOI 10.1189/jlb.0809566; GRILLOTCOURVALIN C, 1987, BLOOD, V69, P1204; ITESCU S, 1993, J CLIN INVEST, V91, P2216, DOI 10.1172/JCI116448; ITESCU S, 1989, LANCET, V2, P466; ITESCU S, 1990, ANN INTERN MED, V112, P3, DOI 10.7326/0003-4819-112-1-3; Jerez A, 2012, BLOOD, V120, P3048, DOI 10.1182/blood-2012-06-435297; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; LABALETTE M, 1994, CLIN EXP IMMUNOL, V95, P465; Lamy T, 2011, BLOOD, V117, P2764, DOI 10.1182/blood-2010-07-296962; Lassoued K, 1998, AM J HEMATOL, V57, P241, DOI 10.1002/(SICI)1096-8652(199803)57:3<241::AID-AJH12>3.0.CO;2-D; Liote H, 2010, EUR RESPIR J, V35, P681, DOI 10.1183/09031936.00080209; Loschi M, 2011, ACTA HAEMATOL-BASEL, V126, P211, DOI 10.1159/000330515; Mohty M, 2002, LEUKEMIA, V16, P2129, DOI 10.1038/sj.leu.2402645; Nitta H, 2012, BRIT J HAEMATOL, V157, P641, DOI 10.1111/j.1365-2141.2012.09057.x; OKSENHENDLER E, 1992, LANCET, V340, P207, DOI 10.1016/0140-6736(92)90471-E; Rajala HLM, 2013, BLOOD, V121, P4541, DOI 10.1182/blood-2012-12-474577; Ramadan KMA, 2005, J CLIN PATHOL, V58, P1118, DOI 10.1136/jcp.2004.020875; Roden AC, 2008, ARCH PATHOL LAB MED, V132, P1774, DOI 10.1043/1543-2165-132.11.1774; Sato K, 2012, ACTA HAEMATOL-BASEL, V128, P107, DOI 10.1159/000338259; Smith PR, 2000, J CLIN PATHOL, V53, P177, DOI 10.1136/jcp.53.3.177; Stemberger C, 2009, SEMIN IMMUNOL, V21, P62, DOI 10.1016/j.smim.2009.02.004; Strioga M, 2011, IMMUNOLOGY, V134, P17, DOI 10.1111/j.1365-2567.2011.03470.x; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; VINCI G, 1987, EXP HEMATOL, V15, P54; WANG ECY, 1995, J IMMUNOL, V155, P5046; YAMASHITA N, 1993, NAT IMMUN, V12, P79; Zafrani L, 2007, KIDNEY INT, V72, P219, DOI 10.1038/sj.ki.5002207	42	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91505	10.1371/journal.pone.0091505	http://dx.doi.org/10.1371/journal.pone.0091505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618699	gold, Green Published, Green Submitted			2022-12-27	WOS:000332842400098
J	Good, SP; Mallia, DV; Lin, JC; Bowen, GJ				Good, Stephen P.; Mallia, Derek V.; Lin, John C.; Bowen, Gabriel J.			Stable Isotope Analysis of Precipitation Samples Obtained via Crowdsourcing Reveals the Spatiotemporal Evolution of Superstorm Sandy	PLOS ONE			English	Article							WATER; FRACTIONATION; RATIOS; VAPOR; RAIN	Extra-tropical cyclones, such as 2012 Superstorm Sandy, pose a significant climatic threat to the northeastern United Sates, yet prediction of hydrologic and thermodynamic processes within such systems is complicated by their interaction with mid-latitude water patterns as they move poleward. Fortunately, the evolution of these systems is also recorded in the stable isotope ratios of storm-associated precipitation and water vapor, and isotopic analysis provides constraints on difficult-to-observe cyclone dynamics. During Superstorm Sandy, a unique crowdsourced approach enabled 685 precipitation samples to be obtained for oxygen and hydrogen isotopic analysis, constituting the largest isotopic sampling of a synoptic-scale system to date. isotopically, these waters span an enormous range of values (>21 parts per thousand for delta O-18, >160 parts per thousand for delta H-2) and exhibit strong spatiotemporal structure. Low isotope ratios occurred predominantly in the west and south quadrants of the storm, indicating robust isotopic distillation that tracked the intensity of the storm's warm core. Elevated values of deuterium-excess (>25 parts per thousand) were found primarily in the New England region after Sandy made landfall. Isotope mass balance calculations and Lagrangian back-trajectory analysis suggest that these samples reflect the moistening of dry continental air entrained from a mid-latitude trough. These results demonstrate the power of rapid-response isotope monitoring to elucidate the structure and dynamics of water cycling within synoptic-scale systems and improve our understanding of storm evolution, hydroclimatological impacts, and paleo-storm proxies.	[Good, Stephen P.; Bowen, Gabriel J.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Mallia, Derek V.; Lin, John C.] Univ Utah, Dept Atmospher Sci, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Good, SP (corresponding author), Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA.	s.good@utah.edu	Good, Stephen/H-4432-2013	Good, Stephen/0000-0003-4363-1577	National Science Foundation, NSF [EF-01241286]	National Science Foundation, NSF(National Science Foundation (NSF))	This project was funded by the National Science Foundation, NSF Grant EF-01241286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes EA, 2013, P NATL ACAD SCI USA, V110, P15211, DOI 10.1073/pnas.1308732110; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Brown D, 2013, J GEOPHYS RES-ATMOS, V118, P54, DOI 10.1029/2012JD018507; Coplen TB, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035481; DANSGAARD W, 1964, TELLUS, V16, P436; Emanuel K, 2003, ANNU REV EARTH PL SC, V31, P75, DOI 10.1146/annurev.earth.31.100901.141259; Frappier AB, 2007, GEOLOGY, V35, P111, DOI 10.1130/G23145A.1; Fudeyasu H, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009313; Gedzelman S, 2003, MON WEATHER REV, V131, P1112, DOI 10.1175/1520-0493(2003)131<1112:PHWSIO>2.0.CO;2; GEDZELMAN SD, 1990, MON WEATHER REV, V118, P495, DOI 10.1175/1520-0493(1990)118<0495:TICOPF>2.0.CO;2; GEDZELMAN SD, 1982, J APPL METEOROL, V21, P1385, DOI 10.1175/1520-0450(1982)021<1385:TICOCP>2.0.CO;2; Gupta P, 2009, RAPID COMMUN MASS SP, V23, P2534, DOI 10.1002/rcm.4100; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Janjic ZI, 2003, METEOROL ATMOS PHYS, V82, P271, DOI 10.1007/s00703-001-0587-6; Kim SY, 2013, ENVIRON SCI TECHNOL, V47, P8316, DOI 10.1021/es4009486; Lambert WJ, 2008, J PALEOLIMNOL, V39, P117, DOI 10.1007/s10933-007-9101-6; Lawrence JR, 1996, GEOPHYS RES LETT, V23, P527, DOI 10.1029/96GL00425; Lawrence JR, 1998, J GEOPHYS RES-ATMOS, V103, P11381, DOI 10.1029/97JD03627; Lawrence JR, 2002, J ATMOS CHEM, V41, P67, DOI 10.1023/A:1013808530364; Lin J, 2013, AGU GEOPHYS MONOGRAP; Lin JC, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003161; Lin Y., 2005, 19 INT C HYDR SAN DI, V1, P2, DOI DOI 10.1002/2014WR015442; MAJOUBE M, 1971, J CHIM PHYS PCB, V68, P1423, DOI 10.1051/jcp/1971681423; MERLIVAT L, 1979, J GEOPHYS RES-OCEANS, V84, P5029, DOI 10.1029/JC084iC08p05029; Miller DL, 2006, P NATL ACAD SCI USA, V103, P14294, DOI 10.1073/pnas.0606549103; Rabenhorst T., 2013, WEATHERWISE, V66, P14, DOI [10.1080/00431672.2013.762838, DOI 10.1080/00431672.2013.762838]; Risi C, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035920; Soderberg K, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00160.1; STEWART MK, 1975, J GEOPHYS RES, V80, P1133, DOI 10.1029/JC080i009p01133; Trenberth KE, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008303; Uemura R, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010209; van Geldern R, 2012, LIMNOL OCEANOGR-METH, V10, P1024, DOI 10.4319/lom.2012.10.1024; Wen DY, 2012, ATMOS ENVIRON, V54, P373, DOI 10.1016/j.atmosenv.2012.02.042; Zhang R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026267; Zhu T, 2013, GEOPHYS RES LETT, V40, P3325, DOI 10.1002/grl.50626	35	83	87	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91117	10.1371/journal.pone.0091117	http://dx.doi.org/10.1371/journal.pone.0091117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618882	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400048
J	Peco, B; Laffan, SW; Moles, AT				Peco, Begona; Laffan, Shawn W.; Moles, Angela T.			Global Patterns in Post-Dispersal Seed Removal by Invertebrates and Vertebrates	PLOS ONE			English	Article							SPECIES-ENERGY THEORY; PATCH USE; PREDATION; CLIMATE; SEASONALITY; ABUNDANCE; RICHNESS; NUTRIENT	It is commonly accepted that species interactions such as granivory are more intense in the tropics. However, this has rarely been tested. A global dataset of post-dispersal seed removal by invertebrates and vertebrates for 79 native plant species from semi-natural and natural terrestrial habitats ranging from 55 degrees N to 45 degrees S, was compiled from the global literature to test the hypothesis that post-dispersal seed removal by invertebrates and vertebrates is more intense at lower latitudes. We also quantified the relationship between post-dispersal seed removal by vertebrates and by invertebrates to global climatic features including temperature, actual evapotranspiration (AET) and rainfall seasonality. Linear mixed effect models were applied to describe the relationships between seed removal and latitude, hemisphere and climatic variables controlling for the effect of seed mass. Post-dispersal seed removal by invertebrates was negatively related to latitude. In contrast, post-dispersal seed removal by vertebrates was positively but weakly related to latitude. Mean annual temperature and actual evapotranspiration were positively related to post-dispersal seed removal by invertebrates, but not to post-dispersal seed removal by vertebrates, which was only marginally negatively related to rainfall seasonality. The inclusion of seed mass improved the fit of all models, but the term for seed mass was not significant in any model. Although a good climatic model for predicting post-dispersal seed predation by vertebrates at the global level was not found, our results suggest different and opposite latitudinal patterns of post-dispersal seed removal by invertebrates vs vertebrates. This is the first time that a negative relationship between post-dispersal seed removal by invertebrates and latitude, and a positive relationship with temperature and AET have been documented at a global-scale. These results have important implications for understanding global patterns in plant-animal interactions, and the factors that shape plant reproductive ecology, and also for predicting how this plant-animal interaction might respond to climate change.	[Peco, Begona] Univ Autonoma Madrid, Fac Ciencias, Dept Interuniv Ecol, Terr Ecol Grp, E-28049 Madrid, Spain; [Laffan, Shawn W.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Moles, Angela T.] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia	Autonomous University of Madrid; University of New South Wales Sydney; University of New South Wales Sydney	Peco, B (corresponding author), Univ Autonoma Madrid, Fac Ciencias, Dept Interuniv Ecol, Terr Ecol Grp, Darwin S-N, E-28049 Madrid, Spain.	begonna.peco@uam.es	Peco, Begoña/C-1197-2012; Moles, Angela T/C-3083-2008; Laffan, Shawn W/A-3761-2008	Peco, Begoña/0000-0003-2149-1438; Moles, Angela T/0000-0003-2041-7762; Laffan, Shawn W/0000-0002-5996-0570	Spanish Ministry of Economy and Competition [CGL2011 24871]; Spanish Ministry of Education (Salvador de Madariaga) [PR2011-0491]; Australian Research Council	Spanish Ministry of Economy and Competition(Spanish Government); Spanish Ministry of Education (Salvador de Madariaga); Australian Research Council(Australian Research Council)	This work was supported by the Spanish Ministry of Economy and Competition (Project CGL2011 24871), the Madrid Government (REMEDINAL2-S2009/AMB-1783), and the Spanish Ministry of Education (Salvador de Madariaga grant PR2011-0491 for the sabbatical of BP in the University of New South Wales). ATM was supported by a QEII fellowship from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn C-H, 1994, J JAPANESE SOC PHOTO, V33, P12, DOI DOI 10.4287/JSPRS.33.2_12; Algar AC, 2007, GLOBAL ECOL BIOGEOGR, V16, P170, DOI 10.1111/j.1466-8238.2006.00275.x; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; [Anonymous], 2004, AM NAT; Archibald DW, 2012, AM NAT, V179, P536, DOI 10.1086/664623; Bates D, 2008, LME4 LINEAR MIXED EF; BROWN JH, 1979, ANNU REV ECOL SYST, V10, P201, DOI 10.1146/annurev.es.10.110179.001221; BROWN JS, 1992, ANN ZOOL FENN, V29, P301; BROWN JS, 1994, ECOLOGY, V75, P2286, DOI 10.2307/1940884; Buckley LB, 2008, ECOLOGY, V89, P48, DOI 10.1890/07-0845.1; Carrara R, 2010, ECOGRAPHY, V33, P942, DOI 10.1111/j.1600-0587.2009.05756.x; Coley P.D., 1991, PLANT ANIMAL INTERAC, P25; Crawley MJ, 2000, SEEDS ECOLOGY REGENE, P157; Crawley MJ, 1992, SEEDS ECOLOGY REGENE, P157; Dobzhansky T., 1950, American Scientist, V38, P209; Domisch T, 2009, ECOL ENTOMOL, V34, P369, DOI 10.1111/j.1365-2311.2009.01086.x; Garcia D, 2000, J ECOL, V88, P436, DOI 10.1046/j.1365-2745.2000.00459.x; Garcia D, 2011, ECOL MONOGR, V81, P103, DOI 10.1890/10-0470.1; Garibaldi LA, 2011, GLOBAL ECOL BIOGEOGR, V20, P609, DOI 10.1111/j.1466-8238.2010.00623.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hulme PE, 1998, SEED SCI RES, V8, P513, DOI 10.1017/S0960258500004487; Hulme Philip E., 2002, P132; Hurlbert AH, 2003, AM NAT, V161, P83, DOI 10.1086/345459; Isaac Joanne L., 2009, Endangered Species Research, V7, P115, DOI 10.3354/esr00093; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; MacArthur R.H., 1972, pvii; Manson RH, 1998, OIKOS, V82, P37, DOI 10.2307/3546915; McGaughran A, 2009, J INSECT PHYSIOL, V55, P129, DOI 10.1016/j.jinsphys.2008.10.009; Mittelbach GG, 2007, ECOL LETT, V15, P912; Moles AT, 2007, GLOBAL ECOL BIOGEOGR, V16, P109, DOI 10.1111/j.1466-8238.2006.00259.x; Moles AT, 2011, NEW PHYTOL, V191, P777, DOI 10.1111/j.1469-8137.2011.03732.x; Moles AT, 2011, FUNCT ECOL, V25, P380, DOI 10.1111/j.1365-2435.2010.01814.x; Moles AT, 2003, J BIOGEOGR, V30, P105, DOI 10.1046/j.1365-2699.2003.00781.x; Moles AT, 2003, ECOLOGY, V84, P3148, DOI 10.1890/02-0662; Monkkonen M, 2006, GLOBAL ECOL BIOGEOGR, V15, P290, DOI 10.1111/j.1466-822x.2006.00224.x; Morales-Romero D, 2012, J ARID ENVIRON, V77, P123, DOI 10.1016/j.jaridenv.2011.09.005; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; PULLIAM HR, 1975, ECOLOGY, V56, P1158, DOI 10.2307/1936155; R Development Core Team, 2011, R LANG ENV STAT COMP; Royal Botanical Gardens KEW, 2008, SEED INF DAT SID VER; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Shine R, 2005, ANNU REV ECOL EVOL S, V36, P23, DOI 10.1146/annurev.ecolsys.36.102003.152631; Tummers B., 2006, DATA THIEF 3; Vander Wall SB, 2005, ECOLOGY, V86, P801, DOI 10.1890/04-0847; Venables WN., 2002, MODERN APPL STAT S 4; Wang B, 2009, ECOLOGY, V90, P3023, DOI 10.1890/08-2188.1; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Westerman PR, 2011, WEED RES, V51, P157, DOI 10.1111/j.1365-3180.2010.00834.x; Williams SE, 2008, DIVERS DISTRIB, V14, P69, DOI 10.1111/j.1472-4642.2007.00418.x; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109	53	18	18	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91256	10.1371/journal.pone.0091256	http://dx.doi.org/10.1371/journal.pone.0091256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618879	gold, Green Published, Green Submitted			2022-12-27	WOS:000332842400067
J	Song, JJ; Zhou, Y; Li, S; Wang, BJ; Zheng, X; Wu, J; Gibbert, K; Dittmer, U; Lu, MJ; Yang, DL				Song, Jingjiao; Zhou, Yun; Li, Sheng; Wang, Baoju; Zheng, Xin; Wu, Jun; Gibbert, Kathrin; Dittmer, Ulf; Lu, Mengji; Yang, Dongliang			Susceptibility of Different Hepatitis B Virus Isolates to Interferon-Alpha in a Mouse Model Based on Hydrodynamic Injection	PLOS ONE			English	Article							CORE PROMOTER; IN-VITRO; GENE-EXPRESSION; HBV REPLICATION; GENOTYPES; PROTEIN; EPIDEMIOLOGY; INHIBITION; ENTECAVIR; INFECTION	Interferon alpha (IFN-alpha) is commonly used for the treatment of chronic hepatitis B (CHB) patients. Many factors including viral genetics may determine the outcome of IFN-alpha therapy. In this study, we tested whether the expression of IFN-alpha directly in the liver inhibits HBV gene expression and replication using a HBV hydrodynamic injection (HI) mouse model. Two replication-competent clones from different HBV isolates that belonging to HBV genotype A and B based on a pAAV vector (pAAV-HBV-A and pAAV-HBV-B) were compared for their susceptibility to IFN-alpha. HBV clones were injected into mice either alone or in combination with a murine (m) IFN-alpha expression plasmid (pmIFN-alpha). HBsAg and HBeAg concentrations and HBV DNA levels in mice differed after injection of these two HBV clones. Co-application of pmIFN-alpha together with the two distinct isolates resulted in markedly different kinetics of decline of HBsAg, HBeAg, and HBV DNA levels in the mice. Immunohistochemical staining of liver sections with anti-HBc showed that mIFN-alpha application completely inhibited the expression of HBcAg in mice inoculated with pAAV-HBV-B, whereas the expression of HBcAg was only reduced in mice with pAAV-HBV-A. Consistently, mice injected with pAAV-HBV-B and pmIFN-alpha showed higher expression levels of the IFN-stimulated genes (ISGs) ISG15, OAS, PKR as well as proinflammatory cytokine IL-6 in the liver. In addition, expression levels of anti-inflammatory cytokine IL-10 was down-regulated significantly in liver of the mice injected with pAAV-HBV-B and pmIFN-alpha. Our data demonstrate that IFN-alpha exerts antiviral activity in HBV mouse model, but different HBV isolates may have diverse susceptibility to IFN-alpha.	[Song, Jingjiao] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Clin Immunol, Wuhan 430074, Peoples R China; [Song, Jingjiao] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Ctr Med Expt, Wuhan 430074, Peoples R China; [Zhou, Yun; Li, Sheng; Wang, Baoju; Zheng, Xin; Wu, Jun; Yang, Dongliang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China; [Gibbert, Kathrin; Dittmer, Ulf; Lu, Mengji] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Duisburg Essen	Lu, MJ (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany.	mengji.lu@uni-due.de; dlyang@hust.edu.cn	Sutter, Kathrin/AAE-9019-2020; Lu, Mengji/ABF-9410-2020; Sutter, Kathrin/AAY-9167-2020	Sutter, Kathrin/0000-0001-6397-6551; 	National Major Science and Technology Project for Infectious Diseases of China [2012ZX10004503]; State Major Basic Research Program of China [2005CB522901, 2007CB512804, 2009CB522500]; National Natural Science Foundation of China [30271170, 81201289]; International Science & Technology Cooperation Program of China [2011DFA31030]; Deutsche Forschungsgemeinschaft [Transregio TRR60, GK1045/2]	National Major Science and Technology Project for Infectious Diseases of China; State Major Basic Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from National Major Science and Technology Project for Infectious Diseases of China (2012ZX10004503), State Major Basic Research Program of China (2005CB522901, 2007CB512804 and 2009CB522500), National Natural Science Foundation of China (30271170, 81201289) and International Science & Technology Cooperation Program of China (2011DFA31030) to D. Yang and grants of Deutsche Forschungsgemeinschaft (Transregio TRR60 and GK1045/2) to M. Lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J HEPATOL, V42, pS84; Boglione L, 2013, J VIRAL HEPATITIS, V20, pe11, DOI 10.1111/jvh.12018; Buckwold VE, 1996, J VIROL, V70, P5845, DOI 10.1128/JVI.70.9.5845-5851.1996; CHEN HS, 1993, J VIROL, V67, P1218, DOI 10.1128/JVI.67.3.1218-1226.1993; Chen JL, 2013, HEPATOLOGY, V57, P470, DOI 10.1002/hep.26064; Chevaliez Stephane, 2009, V189, P203, DOI 10.1007/978-3-540-79086-0_8; Cull VS, 2002, IMMUNOLOGY, V106, P428, DOI 10.1046/j.1365-2567.2002.01423.x; Erhardt A, 2000, HEPATOLOGY, V31, P716, DOI 10.1002/hep.510310323; Ferir G, 2008, REV MED VIROL, V18, P19, DOI 10.1002/rmv.554; Flink HJ, 2006, AM J GASTROENTEROL, V101, P297, DOI 10.1111/j.1572-0241.2006.00418.x; Foster GR, 1998, J VIRAL HEPATITIS, V5, P143, DOI 10.1046/j.1365-2893.1998.00103.x; Guidotti LG, 1996, J VIROL, V70, P7056, DOI 10.1128/JVI.70.10.7056-7061.1996; Hoofnagle JH, 1997, NEW ENGL J MED, V336, P347, DOI 10.1056/NEJM199701303360507; Hou J, 2007, J MED VIROL, V79, P1055, DOI 10.1002/jmv.20935; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; Isogawa M, 2005, J VIROL, V79, P7269, DOI 10.1128/JVI.79.11.7269-7272.2005; Kao JH, 2000, J HEPATOL, V33, P998, DOI 10.1016/S0168-8278(00)80135-X; Kao JH, 2007, HEPATOL RES, V37, pS47, DOI 10.1111/j.1872-034X.2007.00105.x; Kao Jia-Horng, 2011, Korean Journal of Internal Medicine, V26, P255, DOI 10.3904/kjim.2011.26.3.255; KELLEY KA, 1985, NUCLEIC ACIDS RES, V13, P825, DOI 10.1093/nar/13.3.825; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Li J, 1999, J VIROL, V73, P1239, DOI 10.1128/JVI.73.2.1239-1244.1999; Liaw YF, 2011, HEPATOLOGY, V53, P62, DOI 10.1002/hep.23952; Lu M, 2005, J VIROL, V79, P6368, DOI 10.1128/JVI.79.10.6368-6376.2005; Lurie Y, 2005, J HEPATOL, V42, P184; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; McMahon BJ, 2005, SEMIN LIVER DIS, V25, P3, DOI 10.1055/s-2005-915644; Mendy ME, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-23; Meng ZJ, 2008, J VIROL METHODS, V150, P27, DOI 10.1016/j.jviromet.2008.02.008; Moucari R, 2009, ANTIVIR THER, V14, P1183, DOI 10.3851/IMP1458; Niederau C, 1996, NEW ENGL J MED, V334, P1422, DOI 10.1056/NEJM199605303342202; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sanchez-Tapias JM, 2002, GASTROENTEROLOGY, V123, P1848, DOI 10.1053/gast.2002.37041; Scaglioni PP, 1997, J VIROL, V71, P345, DOI 10.1128/JVI.71.1.345-353.1997; Shim JH, 2010, J HEPATOL, V52, P176, DOI 10.1016/j.jhep.2009.11.007; Thomas H, 2003, J HEPATOL, V39, pS93, DOI 10.1016/S0168-8278(03)00207-1; Tian YJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002159; Tseng TC, 2008, GASTROENTEROLOGY, V134, P1272, DOI 10.1053/j.gastro.2007.12.046; von Freyend MJ, 2011, J VIRAL HEPATITIS, V18, P216, DOI 10.1111/j.1365-2893.2010.01302.x; Wang Y, 2007, ANTIVIR RES, V75, P139, DOI 10.1016/j.antiviral.2007.02.001; Westland C, 2003, GASTROENTEROLOGY, V125, P107, DOI 10.1016/S0016-5085(03)00700-5; Wiegand J, 2008, ANTIVIR THER, V13, P211; Wieland SF, 2005, P NATL ACAD SCI USA, V102, P9913, DOI 10.1073/pnas.0504273102; Wieland SF, 2000, J VIROL, V74, P4165, DOI 10.1128/JVI.74.9.4165-4173.2000; Wieland SF, 2003, J VIROL, V77, P1227, DOI 10.1128/JVI.77.2.1227-1236.2003; Wieland SF, 2004, P NATL ACAD SCI USA, V101, P2129, DOI 10.1073/pnas.0308478100; WONG DKH, 1993, ANN INTERN MED, V119, P312, DOI 10.7326/0003-4819-119-4-199308150-00011; Wu J, 2007, HEPATOLOGY, V46, P1769, DOI 10.1002/hep.21897; Lei YC, 2006, WORLD J GASTROENTERO, V12, P4492, DOI 10.3748/wjg.v12.i28.4492; Yu XM, 1996, J VIROL, V70, P8719, DOI 10.1128/JVI.70.12.8719-8726.1996; Zhang XY, 2011, HEPATOLOGY, V53, P1476, DOI 10.1002/hep.24195; Zhang YH, 2013, VIRUS RES, V171, P65, DOI 10.1016/j.virusres.2012.10.027; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994; ZWARTHOFF EC, 1985, NUCLEIC ACIDS RES, V13, P791, DOI 10.1093/nar/13.3.791	57	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90977	10.1371/journal.pone.0090977	http://dx.doi.org/10.1371/journal.pone.0090977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618716	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400041
J	Swarnkar, G; Zhang, KH; Mbalaviele, G; Long, FX; Abu-Amer, Y				Swarnkar, Gaurav; Zhang, Kaihua; Mbalaviele, Gabriel; Long, Fanxin; Abu-Amer, Yousef			Constitutive Activation of IKK2/NF-kappa B Impairs Osteogenesis and Skeletal Development	PLOS ONE			English	Article							NF-KAPPA-B; IKK-BETA; BONE-FORMATION; INFLAMMATION; DICKKOPF-1; INHIBITION; SCLEROSTIN; EXPRESSION; CYTOKINES; DIFFERENTIATION	Pathologic conditions impair bone homeostasis. The transcription factor NF-kappa B regulates bone homeostasis and is central to bone pathologies. Whereas contribution of NF-kappa B to heightened osteoclast activity is well-documented, the mechanisms underlying NF-kappa B impact on chondrocytes and osteoblasts are scarce. In this study, we examined the effect of constitutively active IKK2 (IKK2ca) on chondrogenic and osteogenic differentiation. We show that retroviral IKK2ca but not GFP, IKK2WT, or the inactive IKK2 forms IKK2KM and IKK2SSAA, strongly suppressed osteogenesis and chondrogenesis, in vitro. In order to explore the effect of constitutive NF-kappa B activation on bone formation in vivo, we activated this pathway in a conditional fashion. Specifically, we crossed the R26StopIKK2ca mice with mice carrying the Col2-cre in order to express IKK2ca in osteoblasts and chondrocytes. Both chondrocytes and osteoblasts derived from Col2Cre/IKK2ca expressed IKK2ca. Mice were born alive yet died shortly thereafter. Histologically, newborn Col2Cre+/RosaIKK2ca heterozygotes (Cre+IKK2ca_w/f (het)) and homozygotes (Cre+IKK2ca_f/f (KI)) showed smaller skeleton, deformed vertebrate and reduced or missing digit ossification. The width of neural arches, as well as ossification in vertebral bodies of Cre+IKK2ca_w/f and Cre+IKK2ca_f/f, was reduced or diminished. H&E staining of proximal tibia from new born pups revealed that Cre+IKK2ca_f/f displayed disorganized hypertrophic zones within the smaller epiphysis. Micro-CT analysis indicated that 4-wk old Cre+IKK2ca_w/f has abnormal trabecular bone in proximal tibia compared to WT littermates. Mechanistically, ex-vivo experiments showed that expression of differentiation markers in calvarial osteoblasts derived from newborn IKK2ca knock-in mice was diminished compared to WT-derived cells. In situ hybridization studies demonstrated that the hypertrophic chondrocyte marker type-X collagen, the pre-hypertrophic chondrocyte markers Indian hedgehog and alkaline phosphatase, and the early markers Aggrecan and type-II collagen were reduced in Cre+IKK2ca_w/f and Cre+IKK2ca_f/f mice. Altogether, the in-vitro, in vivo and ex-vivo evidence suggest that IKK2ca perturbs osteoblast and chondrocyte maturation and impairs skeletal development.	[Swarnkar, Gaurav; Zhang, Kaihua; Long, Fanxin; Abu-Amer, Yousef] Washington Univ, Sch Med, Dept Orthoped, St Louis, MO 63130 USA; [Mbalaviele, Gabriel] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Abu-Amer, Y (corresponding author), Washington Univ, Sch Med, Dept Orthoped, St Louis, MO 63130 USA.	abuamery@wustl.edu	SWARNKAR, GAURAV/AAE-3223-2021		NIH Grants [AR049192, AR054326, P30 AR057235]; Shriners Hospital for Children [85100]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235, R01AR054326, R01AR049192] Funding Source: NIH RePORTER	NIH Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospital for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by NIH Grants: AR049192, AR054326 (to Y. A.-A.), #P30 AR057235 and by grant #85100 from the Shriners Hospital for Children (to Y. A.-A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amer Y., 2006, FUTURE MED, V1, P133, DOI DOI 10.2217/17460816.1.1.133; Abu-Amer Y, 2008, AUTOIMMUNITY, V41, P204, DOI 10.1080/08916930701694543; Abu-Amer Y, 2009, CURR OPIN PHARMACOL, V9, P427, DOI 10.1016/j.coph.2009.06.007; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Boyce Brendan F., 2005, Keio Journal of Medicine, V54, P127, DOI 10.2302/kjm.54.127; Boyce BF, 2010, ANN NY ACAD SCI, V1192, P367, DOI 10.1111/j.1749-6632.2009.05315.x; Cao Q, 2011, NEUROSCIENCE, V192, P140, DOI 10.1016/j.neuroscience.2011.06.060; Chang J, 2013, P NATL ACAD SCI USA, V110, P9469, DOI 10.1073/pnas.1300532110; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Cheung WW, 2010, PEDIAT NEPHROLOGY, P1; Cohen-Kfir E, 2011, ENDOCRINOLOGY, V152, P4514, DOI 10.1210/en.2011-1128; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Ghishan FK, 2011, AM J PHYSIOL-GASTR L, V300, pG191, DOI 10.1152/ajpgi.00496.2010; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Haynes DR, 2004, INFLAMM RES, V53, P596, DOI 10.1007/s00011-004-1303-z; Heiland GR, 2010, ANN RHEUM DIS, V69, P2152, DOI 10.1136/ard.2010.132852; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Horwood N, 2008, AUTOIMMUNITY, V41, P230, DOI 10.1080/08916930701694766; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Ke HZ, 2012, ENDOCR REV, V33, P747, DOI 10.1210/er.2011-1060; Lamberti C, 2001, J BIOL CHEM, V276, P42276, DOI 10.1074/jbc.M104227200; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Li XM, 2007, J CELL BIOCHEM, V100, P527, DOI 10.1002/jcb.21017; Maniati E, 2011, J CLIN INVEST, V121, P4685, DOI 10.1172/JCI45797; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Otero JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038694; Otero JE, 2010, J BONE MINER RES, V25, P1282, DOI 10.1002/jbmr.4; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Pinzone JJ, 2009, BLOOD, V113, P517, DOI 10.1182/blood-2008-03-145169; Qiang YW, 2008, BLOOD, V112, P196, DOI 10.1182/blood-2008-01-132134; Reikeras O, 2005, ACTA ORTHOP, V76, P749, DOI 10.1080/17453670510045327; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Romas E, 2006, RHEUM DIS CLIN N AM, V32, P759, DOI 10.1016/j.rdc.2006.07.004; Ruocco MG, 2005, ANN RHEUM DIS, V64, P81, DOI 10.1136/ard.2005.042721; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002; Sarahrudi K, 2012, J ORTHOP RES, V30, P1549, DOI 10.1002/jor.22129; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schett G, 2005, CURR PHARM DESIGN, V11, P3039, DOI 10.2174/1381612054865046; Schopf L, 2006, ARTHRITIS RHEUM-US, V54, P3163, DOI 10.1002/art.22081; SIEBENLIST U, 2001, P NATL ACAD SCI USA, V89, P4333; Swarnkar G, 2012, BRIT J PHARMACOL, V165, P1526, DOI 10.1111/j.1476-5381.2011.01637.x; Sweeney SE, 2004, INT J BIOCHEM CELL B, V36, P372, DOI 10.1016/S1357-2725(03)00259-0; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tanaka Yoshiya, 2005, Current Drug Targets - Inflammation and Allergy, V4, P325, DOI 10.2174/1568010054022015; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tilg H, 2008, GUT, V57, P684, DOI 10.1136/gut.2006.117382; Ting AY, 2002, SCIENCE, V298, P1189, DOI 10.1126/science.1079331; Voorzanger-Rousselot N, 2007, BRIT J CANCER, V97, P964, DOI 10.1038/sj.bjc.6603959; Walsh NC, 2005, IMMUNOL REV, V208, P228, DOI 10.1111/j.0105-2896.2005.00338.x; Wang SY, 2011, J RHEUMATOL, V38, P821, DOI 10.3899/jrheum.100089; Yao YC, 2013, J CELL BIOCHEM, V114, P1223, DOI 10.1002/jcb.24467; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	57	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91421	10.1371/journal.pone.0091421	http://dx.doi.org/10.1371/journal.pone.0091421			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618907	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400090
J	Zhao, YL; Yan, H; Yang, RH; Li, Q; Dang, SN; Wang, YY				Zhao, Yaling; Yan, Hong; Yang, Ruihai; Li, Qiang; Dang, Shaonong; Wang, Yuying			Prevalence and Determinants of Metabolic Syndrome among Adults in a Rural Area of Northwest China	PLOS ONE			English	Article							INTERNATIONAL-DIABETES-FEDERATION; 3RD NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE; RISK-FACTORS; US ADULTS; PHYSICAL-ACTIVITY; NUTRITION; TRENDS; DEFINITIONS; POPULATION	Objectives: To evaluate the prevalence and determinants of metabolic syndrome (MetS) among adults in a rural area of Northwest China. Methods: A population-based cross-sectional study was conducted in 2010 among adults aged 18 to 80 years in rural areas of Hanzhong, in Northwest China. Interview, physical and clinical examinations, and fasting blood glucose and lipid measurements were completed for 2990 adults. The definitions of MetS proposed by the Third Report of the National Cholesterol Education Program Expert Panel (Adults Treatment Panel III, ATP III) and the International Diabetes Federation (IDF), and the modified ATP III definition for Asian population were used and compared. Proportions were adjusted for age and sex. Results: The prevalence of MetS was 7.9%, 10.8% and 15.1% according to ATP III, IDF and modified ATP III criteria, respectively. Agreement between ATP III and IDF criteria and that between ATP III and modified ATP III criteria were moderate (Kappa = 0.52 and 0.64, respectively), whereas agreement between IDF and modified ATP III criteria was good (Kappa = 0.83). The prevalence of MetS increased with age, and was higher in women than in men (10.4% versus 5.4%, 13.6% versus 8.1% and 17.4% versus 12.8%, according to ATP III, IDF and modified ATP III criteria, respectively). The most common MetS component was high blood pressure. Having family history of hypertension, lack of physical activity, high economical level, overweight and obesity were positively associated with MetS. Conclusions: MetS is prevalent among rural adults in Northwest China and high blood pressure is the most common MetS component. Prevention and treatment of hypertension and MetS should be a public health priority to reduce cardiovascular diseases in rural areas of Northwest China. More attention should be given to the elderly, women, people with family history of hypertension and obese people who are at high risk of MetS.	[Zhao, Yaling; Yan, Hong; Li, Qiang; Dang, Shaonong] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian 710049, Shaanxi, Peoples R China; [Yang, Ruihai] Hanzhong Peoples Hosp, Dept Cardiovasc Dis, Hanzhong, Shaanxi, Peoples R China; [Wang, Yuying] Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Yan, H (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian 710049, Shaanxi, Peoples R China.	yanhonge@mail.xjtu.edu.cn	Shaonong, Dang/J-7421-2019	Shaonong, Dang/0000-0002-6980-8169	China Medical Board [08-925]; Science and Technology Research and Development Program of Shaanxi Province, China [2013K14-02-15]	China Medical Board; Science and Technology Research and Development Program of Shaanxi Province, China	This work was supported by the China Medical Board (Grant No. 08-925, http://www.chinamedicalboard.org/) and the Science and Technology Research and Development Program of Shaanxi Province, China (Grant No. 2013K14-02-15, http://www.sninfo.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Anjana RM, 2009, METABOLISM, V58, P344, DOI 10.1016/j.metabol.2008.10.006; Bee Ying Tan Jr, 2008, Malays J Nutr, V14, P65; Bener A, 2009, METAB SYNDR RELAT D, V7, P221, DOI 10.1089/met.2008.0077; Cai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036936; Chen XR, 2009, NUTR METAB CARDIOVAS, V19, P27, DOI 10.1016/j.numecd.2008.01.010; *CHIN NUTR SOC, 2010, DIET GUID CHIN 2011; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cortez-Dias N, 2011, REV PORT CARDIOL, V30, P139; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Feng Y, 2006, OBESITY, V14, P2089, DOI 10.1038/oby.2006.244; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Ford ES, 2004, ATHEROSCLEROSIS, V173, P309, DOI 10.1016/j.atherosclerosis.2003.12.022; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; Freiberg MS, 2004, DIABETES CARE, V27, P2954, DOI 10.2337/diacare.27.12.2954; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026; He Y, 2006, J AM COLL CARDIOL, V47, P1588, DOI 10.1016/j.jacc.2005.11.074; He Y, 2013, NUTR METAB CARDIOVAS, V23, P920, DOI 10.1016/j.numecd.2012.09.001; Hu SS, 2012, BIOMED ENVIRON SCI, V25, P251, DOI 10.3967/0895-3988.2012.03.001; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232; International Diabetes Federation, 2013, IDF CONS WORLDW DEF; Kaykhaei MA, 2012, IRAN J PUBLIC HEALTH, V41, P70; Koutsovasilis A, 2009, INTERNAL MED, V48, P179, DOI 10.2169/internalmedicine.48.1654; Krauss RM, 2000, CIRCULATION, V102, P2284; Lao XQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-64; Lee WY, 2005, DIABETES RES CLIN PR, V67, P70, DOI 10.1016/j.diabres.2004.05.006; Li G, 2010, ASIA PAC J CLIN NUTR, V19, P98; Li JB, 2010, J INT MED RES, V38, P1142, DOI 10.1177/147323001003800343; Mason C, 2009, OBESITY, V17, P1789, DOI 10.1038/oby.2009.87; Mattsson N, 2008, ANN MED, V40, P542, DOI 10.1080/07853890802307709; McAlister FA, 2011, CAN MED ASSOC J, V183, P1007, DOI 10.1503/cmaj.101767; Nestel P, 2007, ASIA PAC J CLIN NUTR, V16, P362; Ng SW, 2009, SOC SCI MED, V68, P1305, DOI 10.1016/j.socscimed.2009.01.035; Nilsson PM, 2007, DIABETIC MED, V24, P464, DOI 10.1111/j.1464-5491.2007.02142.x; Paek KW, 2006, J KOREAN MED SCI, V21, P701, DOI 10.3346/jkms.2006.21.4.701; Park HS, 2007, DIABETES OBES METAB, V9, P50, DOI 10.1111/j.1463-1326.2005.00569.x; Park J, 2008, ASIA PAC J CLIN NUTR, V17, P471; Patry-Parisien J, 2012, HEALTH REP, V23, P53; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Riediger ND, 2011, CAN MED ASSOC J, V183, pE1127, DOI 10.1503/cmaj.110070; Sanisoglu SY, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-92; Sung KC, 2009, AM J CARDIOL, V103, P1732, DOI 10.1016/j.amjcard.2009.02.027; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Trivedi T, 2013, J RURAL HEALTH, V29, P188, DOI 10.1111/j.1748-0361.2012.00422.x; Villegas R, 2009, METAB SYNDR RELAT D, V7, P37, DOI 10.1089/met.2008.0042; Wang Hui-Jun, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P318; Wang J, 2003, AM J CLIN NUTR, V77, P379, DOI 10.1093/ajcn/77.2.379; WANG L, 2005, REPORT CHINA HLTH NU; Wang W, 2010, J INT MED RES, V38, P150, DOI 10.1177/147323001003800117; Wang ZH, 2008, ASIA PAC J CLIN NUTR, V17, P123; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Xu H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-683; Xu WH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-246; Zhang Bing, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P330; Zhao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061779; Zhao Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-140; Zuo H, 2009, METABOLISM, V58, P1102, DOI 10.1016/j.metabol.2009.04.008	68	54	57	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91578	10.1371/journal.pone.0091578	http://dx.doi.org/10.1371/journal.pone.0091578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614618	gold, Green Submitted, Green Published			2022-12-27	WOS:000332839300138
J	Hafkamp-de Groen, E; van der Valk, RJP; Mohangoo, AD; van der Wouden, JC; Duijts, L; Jaddoe, VW; Hofman, A; de Koning, HJ; de Jongste, JC; Raat, H				Hafkamp-de Groen, Esther; van der Valk, Ralf J. P.; Mohangoo, Ashna D.; van der Wouden, Johannes C.; Duijts, Liesbeth; Jaddoe, Vincent W.; Hofman, Albert; de Koning, Harry J.; de Jongste, Johan C.; Raat, Hein			Evaluation of Systematic Assessment of Asthma-Like Symptoms and Tobacco Smoke Exposure in Early Childhood by Well-Child Professionals: A Randomised Trial	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; BASE-LINE; PRIMARY PREVENTION; CONSORT STATEMENT; SUBGROUP ANALYSIS; HEALTH; QUESTIONNAIRE; INTERVENTION; COTININE; VALIDITY	Objectives: This study aimed to evaluate the effectiveness of systematic assessment of asthma-like symptoms and environmental tobacco smoke (ETS) exposure during regular preventive well-child visits between age 1 and 4 years by well-child professionals. Methods: Sixteen well-child centres in Rotterdam, the Netherlands, were randomised into 8 centres where the brief assessment form regarding asthma-like symptoms and ETS exposure was used and 8 centres that applied usual care. 3596 and 4179 children (born between April 2002 and January 2006) and their parents visited the intervention and control centres, respectively. At child's age 6 years, physician-diagnosed asthma ever, wheezing, fractional exhaled nitric oxide (FeNO), airway resistance (Rint), health-related quality of life (HRQOL) and ETS exposure at home ever were measured. Linear mixed models were applied. Results: No differences in asthma, wheezing, FeNO, Rint or HRQOL measurements between intervention and control group were found using multilevel regression in an intention-to-treat analysis (p > 0.05). Children of whom the parents were interviewed by using the brief assessment form at the intervention well-child centres had a decreased risk on ETS exposure at home ever, compared to children who visited the control well-child centres, in an explorative per-protocol analysis (aOR = 0.71, 95% CI: 0.59-0.87). Conclusions: Systematic assessment and counselling of asthma-like symptoms and ETS exposure in early childhood by well-child care professionals using a brief assessment form was not effective in reducing the prevalence of physician-diagnosed asthma ever and wheezing, and did not improve FeNO, Rint or HRQOL at age 6 years. Our results hold some promise for interviewing parents and using information leaflets at well-child centres to reduce ETS exposure at home in preschool children.	[Hafkamp-de Groen, Esther; van der Valk, Ralf J. P.; Jaddoe, Vincent W.] Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands; [Hafkamp-de Groen, Esther; de Koning, Harry J.; Raat, Hein] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [van der Valk, Ralf J. P.; Duijts, Liesbeth; de Jongste, Johan C.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Div Resp Med, Dept Paediat, Rotterdam, Netherlands; [van der Valk, Ralf J. P.; Duijts, Liesbeth; Jaddoe, Vincent W.; Hofman, Albert] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Mohangoo, Ashna D.] TNO, Netherlands Org Appl Sci Res, Dept Child Hlth, Leiden, Netherlands; [van der Wouden, Johannes C.] Vrije Univ Amsterdam, Med Ctr, EMGO, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands; [Duijts, Liesbeth] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Div Neonatol, Dept Paediat, Rotterdam, Netherlands; [Jaddoe, Vincent W.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Paediat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Netherlands Organization Applied Science Research; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Hafkamp-de Groen, E (corresponding author), Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands.	e.hafkamp@erasmusmc.nl	de+Koning, Harry/AAF-9062-2019; van der Wouden, Johannes C/O-5109-2019	de+Koning, Harry/0000-0003-4682-3646; van der Wouden, Johannes C/0000-0001-6639-6050; Hindori-Mohangoo, Ashna/0000-0003-2364-2893	Netherlands Organisation for Health Research and Development (ZonMw) [22000128]; European Respiratory Society/Marie Curie Joint Research Fellowship [MC 1226-2009, PCOFUND-GA-2008-229571]; Netherlands Organization for Health Research and Development (ZonMw - VIDI)	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); European Respiratory Society/Marie Curie Joint Research Fellowship; Netherlands Organization for Health Research and Development (ZonMw - VIDI)(Netherlands Organization for Health Research and Development)	This study was funded by the Netherlands Organisation for Health Research and Development (ZonMw: project no. 22000128). L. Duijts received funding by means of a European Respiratory Society/Marie Curie Joint Research Fellowship (MC 1226-2009) under grant agreement RESPIRE, PCOFUND-GA-2008-229571. V. W. Jaddoe received additional grants from the Netherlands Organization for Health Research and Development (ZonMw - VIDI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Arshad SH, 2003, THORAX, V58, P489, DOI 10.1136/thorax.58.6.489; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Becker A, 2004, J ALLERGY CLIN IMMUN, V113, P650, DOI 10.1016/j.jaci.2004.01.754; Beydon N, 2003, AM J RESP CRIT CARE, V168, P640, DOI 10.1164/rccm.200303-449OC; Brunekreef B, 2000, EPIDEMIOLOGY, V11, P350, DOI 10.1097/00001648-200005000-00023; BURGMEIJER RJF, 1997, OP WEG NAAR VOLWASSE; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Cane RS, 2000, ARCH DIS CHILD, V82, P327, DOI 10.1136/adc.82.4.327; Chan-Yeung M, 2005, J ALLERGY CLIN IMMUN, V116, P49, DOI 10.1016/j.jaci.2005.03.029; CPB Netherlands Bureau for Economic Policy Analysis, 2005, 133 CPB, V133; Dijkstra NS, 2001, PROGRAMMERINGSTUDIE; Duijts L, 2012, CHEST, V141, P876, DOI 10.1378/chest.11-0112; Emmons KM, 2001, AM J PREV MED, V20, P68, DOI 10.1016/S0749-3797(00)00254-3; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hafkamp-de Groen E, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-65; Hafkamp-de Groen E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-555; HealthActCHQ, 2008, CHILD HLTH QUEST SCO; Howden-Chapman P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1411; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; Jenkins MA, 1996, INT J EPIDEMIOL, V25, P609, DOI 10.1093/ije/25.3.609; Lai CKW, 2009, THORAX, V64, P476, DOI 10.1136/thx.2008.106609; Landgraf JM, 1999, CHILD HLTH QUESTIONN; Lanphear BP, 2001, PEDIATRICS, V107, P505, DOI 10.1542/peds.107.3.505; Margolis PA, 1997, PEDIATR PULM, V23, P417, DOI 10.1002/(SICI)1099-0496(199706)23:6<417::AID-PPUL4>3.0.CO;2-F; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Merkus PJFM, 2010, EUR RESPIR J, V36, P157, DOI 10.1183/09031936.00125009; Ministry of Health Welfare and Sport, 2003, BAS JEUGDG HEIDSZ 0; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; Pilotto LS, 2004, INT J EPIDEMIOL, V33, P208, DOI 10.1093/ije/dyh018; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Postma J, 2009, J ASTHMA, V46, P564, DOI 10.1080/02770900902912638; Priest N, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001746.pub2; Raat H, 2005, J EPIDEMIOL COMMUN H, V59, P75, DOI 10.1136/jech.2003.012914; Schonberger HJAM, 2005, EUR RESPIR J, V25, P660, DOI 10.1183/09031936.05.00067704; Spratt M, 2010, AM J EPIDEMIOL, V172, P478, DOI 10.1093/aje/kwq137; Statistics Netherlands, 2004, DUTCH STAND CLASS ED; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Swertz O, 2004, MIGRANTS NETHERLANDS; Taylor DR, 2006, THORAX, V61, P817, DOI 10.1136/thx.2005.056093; Twisk J, 2004, J CLIN EPIDEMIOL, V57, P223, DOI 10.1016/j.jclinepi.2003.07.009; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; van der Valk RJP, 2013, ALLERGY, V68, P788, DOI 10.1111/all.12146; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Wang XB, 1997, INT J EPIDEMIOL, V26, P978, DOI 10.1093/ije/26.5.978; Wilson SR, 2011, CHEST, V139, P581, DOI 10.1378/chest.10-0772; Wilson SR, 2001, CHEST, V120, P1709, DOI 10.1378/chest.120.5.1709; Wit E, 2004, STAT MICROARRAYS DES	50	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90982	10.1371/journal.pone.0090982	http://dx.doi.org/10.1371/journal.pone.0090982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626147	Green Published, gold			2022-12-27	WOS:000332851300046
J	Seifert, G; Calaminus, G; Wiener, A; Cysarz, D				Seifert, Georg; Calaminus, Gabriele; Wiener, Andreas; Cysarz, Dirk			Heart Rate Variability Reflects the Natural History of Physiological Development in Healthy Children and Is Not Associated with Quality of Life	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BLOOD-PRESSURE; AUTONOMIC FUNCTION; CHILDHOOD-CANCER; ADOLESCENTS; SLEEP; SURVIVAL; PERFORMANCE; MODULATION	Background: Quality of life (QoL), being the sum expression of diverse influencing factors, is not easy to determine. A clinically relevant option would be to identify and measure quality of life on the basis of physiological parameters which correlate plausibly and statistically with psychometrically measured QoL. Analysis of heart rate variability (HRV) offers readily measurable physiological parameters which could be of use here. A correlation of HRV with both course of disease and QoL has been reported in patients with chronic illness. Various psychometric instruments have been developed for use in paediatric oncology. The aim of this study was to obtain data on HRV and QoL and their correlations, initially in healthy children. Methods: Holter ECG and quality of life were examined in 160 children and adolescents (72 male) aged between 8 and 18 years. QoL was determined with the established questionnaire PEDQoL. Standard parameters of HRV from the frequency domain were calculated and correlated with QoL domains using Spearman (nonparametric) correlation analysis. Results: Minor but significant associations were revealed only with regard to the PEDQoL domain "autonomy'' on the one hand and heart rate and HRV (e. g. MRR, MRRn, MRRd, HRV_ULF, SDNN) parameters which evidently reflect distinct physiological functions on the other. Conclusions: In healthy children and adolescents we have a first indication that there is a correlation between parameters of HRV and QoL. However, to a greater extent, HRV reflects associated physiological processes of the autonomic nervous system. A higher correlation is more likely to be found in chronically ill children.	[Seifert, Georg] Charite, Dept Paediat Oncol & Haematol, D-13353 Berlin, Germany; [Calaminus, Gabriele; Wiener, Andreas] Univ Hosp Muenster, Childrens Hosp, Dept Paediat Haematol & Oncol, Munster, Germany; [Cysarz, Dirk] Univ Witten Herdecke, Inst Integrat Med, Integrated Curriculum Anthroposoph Med, Witten, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster; Witten Herdecke University	Seifert, G (corresponding author), Charite, Dept Paediat Oncol & Haematol, D-13353 Berlin, Germany.	georg.seifert@charite.de	Cysarz, Dirk/F-8845-2010	Cysarz, Dirk/0000-0001-8303-0261	SOFTWARE AG Foundation Germany	SOFTWARE AG Foundation Germany	The study was funded by the SOFTWARE AG Foundation Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audette JF, 2006, AGE AGEING, V35, P388, DOI 10.1093/ageing/afl006; Aziz W, 2012, CLIN AUTON RES, V22, P91, DOI 10.1007/s10286-011-0149-z; Bai XP, 2009, AM J PHYSIOL-HEART C, V297, pH765, DOI 10.1152/ajpheart.01283.2008; Berntson GG, 2004, DYNAMIC ELECTROCARDIOGRAPHY, P57, DOI 10.1002/9780470987483.ch7; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Boneva RS, 2007, AUTON NEUROSCI-BASIC, V137, P94, DOI 10.1016/j.autneu.2007.08.002; Bonnemeier H, 2003, J CARDIOVASC ELECTR, V14, P791, DOI 10.1046/j.1540-8167.2003.03078.x; Brosschot JF, 2007, INT J PSYCHOPHYSIOL, V63, P39, DOI 10.1016/j.ijpsycho.2006.07.016; Buccelletti F, 2009, EUR REV MED PHARMACO, V13, P299; Buchheit M, 2006, INT J SPORTS MED, V27, P697, DOI 10.1055/s-2005-872929; Buchheit M, 2005, MED SCI SPORT EXER, V37, P1530, DOI 10.1249/01.mss.0000177556.05081.77; Burton AR, 2010, EXP BRAIN RES, V204, P71, DOI 10.1007/s00221-010-2296-1; Calaminus G, 2007, KLIN PADIATR, V219, P152, DOI 10.1055/s-2007-973846; Calaminus G, 2000, KLIN PADIATR, V212, P211, DOI 10.1055/s-2000-9679; Charkoudian N, 2009, MAYO CLIN PROC, V84, P822, DOI 10.1016/S0025-6196(11)60492-8; Chessa M, 2002, HERZ, V27, P785, DOI 10.1007/s00059-002-2340-4; Christ M, 1999, LANCET, V354, P1303, DOI 10.1016/S0140-6736(05)76079-7; Coelho L, 2001, Rev Port Cardiol, V20, P25; Cysarz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019400; De Civita M, 2005, PHARMACOECONOMICS, V23, P659, DOI 10.2165/00019053-200523070-00003; DiVall SA, 2008, ANN NY ACAD SCI, V1135, P19, DOI 10.1196/annals.1429.026; Eiser C, 2007, ARCH DIS CHILD, V92, P348, DOI 10.1136/adc.2005.086405; Faulkner MS, 2003, HEART LUNG, V32, P10, DOI 10.1067/mhl.2003.6; Faulkner MS, 2001, NURS RES, V50, P95, DOI 10.1097/00006199-200103000-00005; Fayed Nora, 2011, Qual Life Res, V20, P1247, DOI 10.1007/s11136-011-9851-5; Frisen A, 2007, ACTA PAEDIATR, V96, P963, DOI 10.1111/j.1651-2227.2007.00333.x; Gilliam FR, 2007, PACE, V30, P56; Griffiths LJ, 2010, INT J PEDIATR OBES, V5, P282, DOI 10.3109/17477160903473697; Guizar JM, 2005, INDIAN PEDIATR, V42, P464; Hathaway DK, 2000, WESTERN J NURS RES, V22, P749, DOI 10.1177/01939450022044728; Kardelen F, 2006, PEDIATR DIABETES, V7, P45, DOI 10.1111/j.1399-543X.2006.00141.x; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; Kim DH, 2010, J KOREAN MED SCI, V25, P1140, DOI 10.3346/jkms.2010.25.8.1140; Koschke M, 2009, PSYCHOSOM MED, V71, P852, DOI 10.1097/PSY.0b013e3181b8bb7a; KUMMELL HC, 1993, CLIN CARDIOL, V16, P776; Marques AH, 2010, NEUROIMMUNOMODULAT, V17, P205, DOI 10.1159/000258725; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Mormont MC, 2000, CLIN CANCER RES, V6, P3038; Nagai N, 2004, INT J OBESITY, V28, P27, DOI 10.1038/sj.ijo.0802470; Nakamura Y, 2009, REV ENDOCR METAB DIS, V10, P19, DOI 10.1007/s11154-008-9092-2; Newton JL, 2011, QJM-INT J MED, V104, P681, DOI 10.1093/qjmed/hcr029; Nordlund B, 2011, ACTA PAEDIATR, V100, P1454, DOI 10.1111/j.1651-2227.2011.02359.x; Okano Y, 2007, J HUM HYPERTENS, V21, P135, DOI 10.1038/sj.jhh.1002117; Okano Y, 2005, CLIN EXP HYPERTENS, V27, P169, DOI 10.1081/CEH-200048749; Okano Y, 2004, CLIN EXP HYPERTENS, V26, P145, DOI 10.1081/CEH-120028553; Patton GC, 2007, LANCET, V369, P1130, DOI 10.1016/S0140-6736(07)60366-3; Payot A, 2011, CURR PROB PEDIATR AD, V41, P91, DOI 10.1016/j.cppeds.2010.10.008; Pemberger S, 2005, SUPPORT CARE CANCER, V13, P49, DOI 10.1007/s00520-004-0724-0; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; Rachow T, 2011, PSYCHOPHYSIOLOGY, V48, P1323, DOI 10.1111/j.1469-8986.2011.01210.x; Riihimaa PH, 2002, DIABETIC MED, V19, P932, DOI 10.1046/j.1464-5491.2002.00816.x; Roach D, 2004, J AM COLL CARDIOL, V43, P2271, DOI 10.1016/j.jacc.2004.01.050; Rodriguez-Colon SM, 2011, INT J PEDIATR OBES, V6, P128, DOI 10.3109/17477166.2010.490265; Schulz S, 2010, PHYSIOL MEAS, V31, P303, DOI 10.1088/0967-3334/31/3/003; Schwartz CE, 1999, SOC SCI MED, V48, P1531, DOI 10.1016/S0277-9536(99)00047-7; Shirtcliff EA, 2009, CHILD DEV, V80, P327, DOI 10.1111/j.1467-8624.2009.01263.x; Solans M, 2011, VALUE HEALTH, V11, P742; Spiegelhalder K, 2011, J SLEEP RES, V20, P137, DOI 10.1111/j.1365-2869.2010.00863.x; Tapanainen JM, 2002, AM J CARDIOL, V90, P347, DOI 10.1016/S0002-9149(02)02488-8; Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, 2009, CIRCULATION, V93, P1043; Taylor J, 2011, EPILEPSIA, V2011, P1528; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Valentini M, 2009, PROG CARDIOVASC DIS, V52, P11, DOI 10.1016/j.pcad.2009.05.004; van Gestel AJR, 2011, RESPIROLOGY, V16, P939, DOI 10.1111/j.1440-1843.2011.01992.x; van Litsenburg RRL, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-25; Varni JW, 2007, J PEDIATR PSYCHOL, V32, P1151, DOI 10.1093/jpepsy/jsm008; von Kanel R, 2009, EUR J CARDIOV PREV R, V16, P645, DOI 10.1097/HJR.0b013e3283299542; Wilson IB, 1999, SOC SCI MED, V48, P1577; Yang AC, 2011, J AFFECT DISORDERS, V131, P179, DOI 10.1016/j.jad.2010.11.030; Yang TF, 2001, CHILD NERV SYST, V17, P602, DOI 10.1007/s003810100505	70	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91036	10.1371/journal.pone.0091036	http://dx.doi.org/10.1371/journal.pone.0091036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9JS	24625571	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300053
J	Sonsteng, KM; Prigge, JR; Talago, EA; June, RK; Schmidt, EE				Sonsteng, Katherine M.; Prigge, Justin R.; Talago, Emily A.; June, Ronald K.; Schmidt, Edward E.			Hydrodynamic Delivery of Cre Protein to Lineage-Mark or Time-Stamp Mouse Hepatocytes In situ	PLOS ONE			English	Article							GENE-THERAPY; LIVER; MICE; EXPRESSION; REPORTER; VECTORS; VIVO; REGENERATION; MUTAGENESIS; RECOMBINASE	Cre-responsive fluorescent marker alleles are powerful tools for cell lineage tracing in mice; however their utility is limited by regulation of Cre activity. When targeting hepatocytes, hydrodynamic delivery of a Cre-expression plasmid can convert Cre-responsive alleles without inducing the intracellular or systemic antiviral responses often associated with viral-derived Cre-expression vectors. In this method, rapid high-volume intravenous inoculation induces hepatocyte-targeted uptake of extracellular molecules. Here we tested whether hydrodynamic delivery of Cre protein or Cre fused to the HIV-TAT cell-penetrating peptide could convert Cre-responsive reporters in hepatocytes of mice. Hydrodynamic delivery of 2 nmol of either Cre or TAT-Cre protein converted the reporter allele in 5 to 20% of hepatocytes. Neither protein gave detectable Cre activity in endothelia, non-liver organs, or non-hepatocyte cells in liver. Using mice homozygous for a Cre-responsive marker that directs red-(Cre-naive) or green-(Cre-converted) fluorescent proteins to the nucleus, we assessed sub-saturation Cre-activity. One month after hydrodynamic inoculation with Cre protein, 58% of hepatocyte nuclei that were green were also red, indicating that less than half of the hepatocytes that had obtained enough Cre to convert one marker allele to green were able to convert all alleles. For comparison, one month after hydrodynamic delivery of a Cre-expression plasmid with a weak promoter, only 26% of the green nuclei were also red. Our results show that hydrodynamic delivery of Cre protein allows rapid allelic conversion in hepatocytes, but Cre-activity is sub-saturating so many cells will not convert multiple Cre-responsive alleles.	[Sonsteng, Katherine M.; Prigge, Justin R.; Talago, Emily A.; Schmidt, Edward E.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA; [June, Ronald K.] Montana State Univ, Dept Mech & Ind Engn, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Schmidt, EE (corresponding author), Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA.	eschmidt@montana.edu			NIH/NIA [AG040020]; Montana Agricultural Experiment Station; NIH-CoBRE [GM103394, GM103500]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103394, P20GM103500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040020] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Montana Agricultural Experiment Station; NIH-CoBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH/NIA grant (AG040020) and funds from the Montana Agricultural Experiment Station to EES. Infrastructure support was provided by NIH-CoBRE grants (GM103394 and GM103500) to Montana State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea TC, 2003, J NEUROSCI, V23, P2314; Benihoud K, 2000, J GENE MED, V2, P194, DOI 10.1002/(SICI)1521-2254(200005/06)2:3<194::AID-JGM102>3.0.CO;2-5; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Buffone A, 2013, J BIOL CHEM, V288, P1620, DOI 10.1074/jbc.M112.400929; Christ M, 2000, HUM GENE THER, V11, P415, DOI 10.1089/10430340050015888; Grompe M, 1999, SEMIN LIVER DIS, V19, P7, DOI 10.1055/s-2007-1007093; Gump JM, 2010, J BIOL CHEM, V285, P1500, DOI 10.1074/jbc.M109.021964; Hans S, 2011, DEV DYNAM, V240, P108, DOI 10.1002/dvdy.22497; Huang M, 2013, HEPATOLOGY, V57, P277, DOI 10.1002/hep.25959; Iverson SV, 2011, HEPATOLOGY, V54, P655, DOI 10.1002/hep.24398; Jayandharan GR, 2011, P NATL ACAD SCI USA, V108, P3743, DOI 10.1073/pnas.1012753108; June RK, 2010, J AM CHEM SOC, V132, P10680, DOI 10.1021/ja1040418; JUTILA MA, 1993, J LEUKOCYTE BIOL, V54, P30, DOI 10.1002/jlb.54.1.30; Keng VW, 2011, HEPATOLOGY, V53, P781, DOI 10.1002/hep.24091; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kimura T, 2007, MOL THER, V15, P1390, DOI 10.1038/sj.mt.6300180; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; MACK A, 1992, NUCLEIC ACIDS RES, V20, P4451, DOI 10.1093/nar/20.17.4451; Mahonen AJ, 2004, BIOCHEM BIOPH RES CO, V320, P366, DOI 10.1016/j.bbrc.2004.05.175; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Overturf K, 1997, AM J PATHOL, V151, P1273; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Prigge JR, 2013, MAMM GENOME, V24, P389, DOI 10.1007/s00335-013-9469-8; Rollins MF, 2010, J CELL SCI, V123, P2402, DOI 10.1242/jcs.068106; Schlabach MR, 2010, P NATL ACAD SCI USA, V107, P2538, DOI 10.1073/pnas.0914803107; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; Schuler M, 2004, GENESIS, V39, P167, DOI 10.1002/gene.20039; Sebestyen MG, 2006, J GENE MED, V8, P852, DOI 10.1002/jgm.921; Shi JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046590; Shigekawa M, 2012, AM J PATHOL, V181, P2105, DOI 10.1016/j.ajpath.2012.08.038; Song YC, 2008, EUR J IMMUNOL, V38, P3178, DOI 10.1002/eji.200838678; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suvorova ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006158; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Weisend CM, 2009, GENESIS, V47, P789, DOI 10.1002/dvg.20568; Zhou XJ, 2012, WORLD J GASTROENTERO, V18, P1892, DOI 10.3748/wjg.v18.i16.1892; Zhu HZ, 2006, FEBS LETT, V580, P4346, DOI 10.1016/j.febslet.2006.06.094	42	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91219	10.1371/journal.pone.0091219	http://dx.doi.org/10.1371/journal.pone.0091219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626158	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300066
J	Ubbink, DT; Tump, E; Koenders, JA; Kleiterp, S; Goslings, JC; Brolmann, FE				Ubbink, Dirk T.; Tump, Evelien; Koenders, Josje A.; Kleiterp, Sieta; Goslings, J. Carel; Brolmann, Fleur E.			Which Reasons Do Doctors, Nurses, and Patients Have for Hospital Discharge? A Mixed-Methods Study	PLOS ONE			English	Article							QUALITATIVE RESEARCH; HEALTH-CARE; CRITERIA; DELAYS	Background: The decision to discharge a patient from a hospital is a complex process governed by many medical and non-medical factors, while the actual reasons for discharge frequently remain ill-defined. Aim: To define relevant discharge criteria as perceived by doctors, nurses and patients for the development of a standard hospital discharge policy, we collected actual reasons and most pivotal medical and organisational criteria for discharge among all stakeholders. Setting: A tertiary referral university teaching hospital. Methods: We conducted a mixed methods analysis, using patient questionnaires, interviews and a focus group with caregivers, and observations during the daily rounds of doctors, nurses and patients during their hospital stay. Fourteen wards of the Surgery, Paediatrics and Neurology departments contributed. Results: We observed 426 patients during their hospital stay. Forty doctors and nurses were interviewed, and 7 senior nurses attended a focus group. The most commonly used discharge criteria were clinical factors, organisational discharge issues and patient-related factors. A total of 269 patients returned their questionnaires. About one third of the adult patients and nearly half of the children (or their parents) felt their personal situation and assistance needed at home was insufficiently taken into account before discharge. Patients were least satisfied with the information given about what they were allowed to do or should avoid after discharge and their involvement in the planning of their discharge. Thus, besides obvious medical reasons for discharge, several non-medical reasons were signalled by all stakeholders as important issues to be improved. Conclusions: A set of discharge criteria could be defined that is useful for a more uniform hospital discharge policy that may help reduce unnecessary length of stay and improve patient satisfaction.	[Ubbink, Dirk T.; Koenders, Josje A.] Univ Amsterdam, Acad Med Ctr, Dept Qual Assurance & Proc Innovat, NL-1105 AZ Amsterdam, Netherlands; [Ubbink, Dirk T.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [Tump, Evelien] Univ Amsterdam, Acad Med Ctr, Dept Paediat, NL-1105 AZ Amsterdam, Netherlands; [Kleiterp, Sieta] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands; [Goslings, J. Carel] Univ Amsterdam, Acad Med Ctr, Dept Trauma Surg, NL-1105 AZ Amsterdam, Netherlands; [Brolmann, Fleur E.] St Lucas Andreas Hosp, Dept Plast Reconstruct & Hand Surg, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Sint Lucas Andreas Hospital	Ubbink, DT (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Qual Assurance & Proc Innovat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	d.ubbink@amc.nl	Ubbink, Dirk/AAF-1266-2021	Ubbink, Dirk/0000-0001-9398-8879	hospital's internal committee	hospital's internal committee	This study was funded by an unrestricted grant from the hospital's internal committee for quality improvement projects to perform this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], JCI ACC STAND HOSP; de Vries EN, 2009, QUAL SAF HEALTH CARE, V18, P121, DOI 10.1136/qshc.2008.027524; Delnoij DMJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-88; Fiore JF, 2012, COLORECTAL DIS, V14, P270, DOI 10.1111/j.1463-1318.2010.02477.x; Fiore JF, 2012, DIS COLON RECTUM, V55, P416, DOI 10.1097/DCR.0b013e318244a8f2; Fox MT, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-70; Holland DE, 2011, PROF CASE MANAG, V16, P240, DOI 10.1097/NCM.0b013e31822361d8; Hwabejire JO, 2013, JAMA SURG, V148, P956, DOI 10.1001/jamasurg.2013.2148; Kehlet H, 2008, ANN SURG, V248, P189, DOI 10.1097/SLA.0b013e31817f2c1a; Kleefstra SM, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2008.030825; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Middleton Sandy, 2004, Aust Health Rev, V28, P255; Moons P, 2005, ONTSLAGMANAGEMENT BE; NSW Health, 2001, SHAR RESP PAT CAR HO; Ou LX, 2011, AUST HEALTH REV, V35, P357, DOI 10.1071/AH09843; Ou LX, 2009, AUST HEALTH REV, V33, P513, DOI 10.1071/AH090513; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; Pieper B, 2007, J WOUND OSTOMY CONT, V34, P245, DOI 10.1097/01.WON.0000270817.06942.00; Pieper B, 2006, J WOUND OSTOMY CONT, V33, P281, DOI 10.1097/00152192-200605000-00009; Saklad M., 1941, ANESTHESIOLOGY, V2, P281, DOI DOI 10.1097/00000542-194105000-00004; SELKER HP, 1989, MED CARE, V27, P112, DOI 10.1097/00005650-198902000-00003; Shepperd S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub4; Srivastava R, 2009, J HOSP MED, V4, P481, DOI 10.1002/jhm.490; Stikvoort-Lodewijks MJ, 2008, ZORGEN POSTOPERATIEV; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Ubbink DT, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000891; Weiss ME, 2014, HEALTH SERV RES, V49, P304, DOI 10.1111/1475-6773.12092; Wong ELY, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-242; Zander K, 2010, PROF CASE MANAG, V15, P188, DOI 10.1097/NCM.0b013e3181e26a80	29	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91333	10.1371/journal.pone.0091333	http://dx.doi.org/10.1371/journal.pone.0091333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625666	gold, Green Published, Green Submitted			2022-12-27	WOS:000332851300072
J	Wallace, LMK; Theou, O; Kirkland, SA; Rockwood, MRH; Davidson, KW; Shimbo, D; Rockwood, K				Wallace, Lindsay M. K.; Theou, Olga; Kirkland, Susan A.; Rockwood, Michael R. H.; Davidson, Karina W.; Shimbo, Daichi; Rockwood, Kenneth			Accumulation of Non-Traditional Risk Factors for Coronary Heart Disease Is Associated with Incident Coronary Heart Disease Hospitalization and Death	PLOS ONE			English	Article							FRAILTY INDEX; DEFICIT ACCUMULATION; ELDERLY-PEOPLE; OLDER-ADULTS; AGE	Background: Assessing multiple traditional risk factors improves prediction for late-life diseases, including coronary heart disease (CHD). It appears that non-traditional risk factors can also predict risk. The objective was to investigate contributions of non-traditional risk factors to coronary heart disease risk using a deficit accumulation approach. Methods: Community-dwelling adults with no known history of CHD (n = 2195, mean age 46.9 +/- 18.7 years, 51.8% women) participated in the 1995 Nova Scotia Health Survey. Three risk factor indices were constructed to quantify the proportion of deficits present in individuals: 1) a 17-item Non-Traditional Risk Factor Index (e. g. sinusitis, arthritis); 2) a 9-item Traditional Risk Factor Index (e. g. hypertension, diabetes); and 3) a frailty index (25 items combined from the other two index measures). Ten-year risks of CHD events (defined as CHD-related hospitalization and CHD-related mortality) were evaluated. Results: The Non-Traditional Risk Factor Index, made up of health deficits unrelated to CHD, was independently associated with incident CHD events over 10 years after controlling for age, sex, and the Traditional Risk Factor Index [adjusted {adj.} Hazard Ratio {HR} = 1.31; Confidence Interval {CI} 1.14-1.51]. When all health deficits, both those related and unrelated to CHD, were included in a frailty index the corresponding adjusted hazard ratio was 1.61; CI 1.40-1.85. Conclusion: Both traditional and non-traditional risk factor indices are independently associated with incident CHD events. CHD risk assessment may benefit from consideration of general health information as well as from traditional risk factors.	[Wallace, Lindsay M. K.; Theou, Olga; Kirkland, Susan A.; Rockwood, Michael R. H.; Rockwood, Kenneth] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Kirkland, Susan A.] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Rockwood, Kenneth] QEII Hlth Sci Ctr, Ctr Hlth Care Elderly, Halifax, NS, Canada; [Davidson, Karina W.; Shimbo, Daichi] Columbia Univ, Presbyterian Hosp, Dept Med, New York, NY USA	Dalhousie University; Dalhousie University; Queen Elizabeth II Health Sciences Centre; Columbia University; NewYork-Presbyterian Hospital	Rockwood, K (corresponding author), Dalhousie Univ, Dept Med, Halifax, NS, Canada.	Kenneth.Rockwood@dal.ca	Davidson, Karina/GWC-0996-2022; Theou, Olga/AAS-9923-2020; Rockwood, Kenneth/AAD-8951-2019; Davidson, Karina/AAG-2388-2019	Davidson, Karina/0000-0002-9162-477X; Theou, Olga/0000-0001-6460-782X; Davidson, Karina/0000-0002-9162-477X; Kirkland, Susan/0000-0002-8182-2369	Canadian Institutes of Health Research [MOP-209888]; Dalhousie Medical Research Foundation; Banting Postdoctoral Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Dalhousie Medical Research Foundation; Banting Postdoctoral Fellowship	This work was supported the Canadian Institutes of Health Research [grant MOP-209888] [KR]; Dalhousie Medical Research Foundation [KR]; Banting Postdoctoral Fellowship [OT]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afilalo J, 2009, AM J CARDIOL, V103, P1616, DOI 10.1016/j.amjcard.2009.01.375; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Davidson KW, 2009, AM J CARDIOL, V103, P755, DOI 10.1016/j.amjcard.2008.11.035; de Vries NM, 2011, AGEING RES REV, V10, P104, DOI 10.1016/j.arr.2010.09.001; Drubbel I, 2013, J GERONTOL A-BIOL, V68, P301, DOI 10.1093/gerona/gls161; Ekerstad N, 2011, CIRCULATION, V124, P2397, DOI 10.1161/CIRCULATIONAHA.111.025452; Ensrud KE, 2008, ARCH INTERN MED, V168, P382, DOI 10.1001/archinternmed.2007.113; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gharacholou SM, 2012, AM J CARDIOL, V109, P1569, DOI 10.1016/j.amjcard.2012.01.384; Green P, 2012, JACC-CARDIOVASC INTE, V5, P974, DOI 10.1016/j.jcin.2012.06.011; Hanon O, 2009, ARCH CARDIOVASC DIS, V102, P829, DOI 10.1016/j.acvd.2009.09.004; Howlett SE, 2013, AGE AGEING, V42, P416, DOI 10.1093/ageing/aft059; JARRETT PG, 1995, ARCH INTERN MED, V155, P1060, DOI 10.1001/archinte.155.10.1060; Krishnan M, 2014, AGE AGEING, V43, P122, DOI 10.1093/ageing/aft084; Kulminski AM, 2008, J AM GERIATR SOC, V56, P898, DOI 10.1111/j.1532-5415.2008.01656.x; Kulminski AM, 2007, J AM GERIATR SOC, V55, P935, DOI 10.1111/j.1532-5415.2007.01155.x; Lee DH, 2010, CIRCULATION, V121, P973, DOI 10.1161/CIRCULATIONAHA.108.841437; Mitnitski A B, 2001, ScientificWorldJournal, V1, P323; Mitnitski A, 2013, BIOGERONTOLOGY, V14, P709, DOI 10.1007/s10522-013-9446-3; Newman AB, 2001, J GERONTOL A-BIOL, V56, pM158, DOI 10.1093/gerona/56.3.M158; Parks RJ, 2012, J GERONTOL A-BIOL, V67, P217, DOI 10.1093/gerona/glr193; Rockwood K, 2006, J AM GERIATR SOC, V54, P975, DOI 10.1111/j.1532-5415.2006.00738.x; Rockwood K, 2011, CAN MED ASSOC J, V183, pE487, DOI 10.1503/cmaj.101271; Romero-Ortuno R, 2012, AGE AGEING, V41, P684, DOI 10.1093/ageing/afs051; Samaras N, 2010, ANN EMERG MED, V56, P261, DOI 10.1016/j.annemergmed.2010.04.015; Schoenenberger AW, 2013, EUR HEART J, V34, P684, DOI 10.1093/eurheartj/ehs304; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Song XW, 2011, NEUROLOGY, V77, P227, DOI 10.1212/WNL.0b013e318225c6bc; Tang Z, 2013, AGE AGEING, V42, P346, DOI 10.1093/ageing/aft004; Weiss CO, 2011, CLIN GERIATR MED, V27, P39, DOI 10.1016/j.cger.2010.08.003; Wou F, 2013, AGE AGEING, V42, P776, DOI 10.1093/ageing/aft055	31	34	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90475	10.1371/journal.pone.0090475	http://dx.doi.org/10.1371/journal.pone.0090475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625791	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300021
J	Zhu, F; Liu, Q; Fu, YC; Shen, BR				Zhu, Fei; Liu, Quan; Fu, Yuchen; Shen, Bairong			Segmentation of Neuronal Structures Using SARSA (lambda)-Based Boundary Amendment with Reinforced Gradient-Descent Curve Shape Fitting	PLOS ONE			English	Article							SPEECH	The segmentation of structures in electron microscopy (EM) images is very important for neurobiological research. The low resolution neuronal EM images contain noise and generally few features are available for segmentation, therefore application of the conventional approaches to identify the neuron structure from EM images is not successful. We therefore present a multi-scale fused structure boundary detection algorithm in this study. In the algorithm, we generate an EM image Gaussian pyramid first, then at each level of the pyramid, we utilize Laplacian of Gaussian function (LoG) to attain structure boundary, we finally assemble the detected boundaries by using fusion algorithm to attain a combined neuron structure image. Since the obtained neuron structures usually have gaps, we put forward a reinforcement learning-based boundary amendment method to connect the gaps in the detected boundaries. We use a SARSA (lambda)-based curve traveling and amendment approach derived from reinforcement learning to repair the incomplete curves. Using this algorithm, a moving point starts from one end of the incomplete curve and walks through the image where the decisions are supervised by the approximated curve model, with the aim of minimizing the connection cost until the gap is closed. Our approach provided stable and efficient structure segmentation. The test results using 30 EM images from ISBI 2012 indicated that both of our approaches, i.e., with or without boundary amendment, performed better than six conventional boundary detection approaches. In particular, after amendment, the Rand error and warping error, which are the most important performance measurements during structure segmentation, were reduced to very low values. The comparison with the benchmark method of ISBI 2012 and the recent developed methods also indicates that our method performs better for the accurate identification of substructures in EM images and therefore useful for the identification of imaging features related to brain diseases.	[Zhu, Fei; Shen, Bairong] Soochow Univ, Ctr Syst Biol, Suzhou, Jiangsu, Peoples R China; [Zhu, Fei; Liu, Quan; Fu, Yuchen] Soochow Univ, Sch Comp Sci & Technol, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Shen, BR (corresponding author), Soochow Univ, Ctr Syst Biol, Suzhou, Jiangsu, Peoples R China.	bairong.shen@suda.edu.cn	Shen, Bairong/E-6431-2012; Shen, Bairong/W-1254-2019	Shen, Bairong/0000-0003-2899-1531; Shen, Bairong/0000-0003-2899-1531	National Natural Science Foundation of China [61303108, 61272005, 91230117, 61272258]; High Education Natural Foundation of Jiangsu [13KJB520020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Education Natural Foundation of Jiangsu	This paper is supported by National Natural Science Foundation of China (61303108, 61272005, 91230117,61272258), High Education Natural Foundation of Jiangsu (13KJB520020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attique M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033616; Baddeley B, 2008, IEEE T SYST MAN CY B, V38, P950, DOI 10.1109/TSMCB.2008.921000; Baird L, 1999, ADV NEUR IN, V11, P968; BUCKLAND M, 1994, J AM SOC INFORM SCI, V45, P12, DOI 10.1002/(SICI)1097-4571(199401)45:1<12::AID-ASI2>3.0.CO;2-L; Burget R, 2012, IEEE INT S BIOM IM N, P1; Busoniu L, 2010, AUTOM CONTROL ENG SE, P1, DOI 10.1201/9781439821091-f; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; Caruyer E, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P50, DOI 10.1109/ISBI.2012.6235481; Caskey CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027372; Chalana V, 1997, IEEE T MED IMAGING, V16, P642, DOI 10.1109/42.640755; Cheng J, 2010, NEUROINFORMATICS, V8, P157, DOI 10.1007/s12021-010-9073-y; Cornelius Weber ME, 2008, REINFORCEMENT LEARNI; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dollar P., 2006, P IEEE COMP SOC C CO, V2, P1964, DOI DOI 10.1109/CVPR.2006.298; Eggert LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045081; Giuly RJ, 2013, BIOINFORMATICS, V29, P1359, DOI 10.1093/bioinformatics/btt154; Gousias IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059990; Goutte Cyril GE, 2005, PROBABILISTIC INTERP, P345; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jain V, 2010, PROC CVPR IEEE, P2488, DOI 10.1109/CVPR.2010.5539950; Jurrus E, 2013, NEUROINFORMATICS, V11, P5, DOI 10.1007/s12021-012-9149-y; Jurrus E, 2009, MED IMAGE ANAL, V13, P180, DOI 10.1016/j.media.2008.05.002; Keihaninejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033096; Li XY, 2013, IEEE T IMAGE PROCESS, V22, P1915, DOI 10.1109/TIP.2013.2237922; Ma WY, 2000, IEEE T IMAGE PROCESS, V9, P1375, DOI 10.1109/83.855433; Ma XL, 2007, IEEE T NEURAL NETWOR, V18, P573, DOI 10.1109/TNN.2006.888376; Martin DR, 2004, IEEE T PATTERN ANAL, V26, P530, DOI 10.1109/TPAMI.2004.1273918; Mori Y, 2009, SIGNAL PROCESS-IMAGE, V24, P65, DOI 10.1016/j.image.2008.10.013; Pelvig DP, 2008, NEUROBIOL AGING, V29, P1754, DOI 10.1016/j.neurobiolaging.2007.04.013; Plaza SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044448; Powers D.M.W, 2007, SIE07001 FLIND U; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Ren JC, 2012, KNOWL-BASED SYST, V26, P144, DOI 10.1016/j.knosys.2011.07.016; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seghier ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017547; Somkantha K, 2011, IEEE T BIO-MED ENG, V58, P567, DOI 10.1109/TBME.2010.2091129; Szepesv?ri, 2010, SYNTHESIS LECT ARTIF, V4, DOI [10.2200/S00268ED1V01Y201005AIM009, DOI 10.2200/S00268ED1V01Y201005AIM009]; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Wang S, 2013, BIOMEDICAL ENG ONLIN, V12, P1; Yu XT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013874; Yu ZY, 2004, J STRUCT BIOL, V145, P168, DOI 10.1016/j.jsb.2003.10.027; Zhang Q, 2012, BIOPOLYMERS, V97, P709, DOI 10.1002/bip.22052; Zhang Y, 2007, BILING-LANG COGN, V10, P147, DOI 10.1017/S1366728907002908; Zhang Y, 2011, DEVELOPMENTAL SCI, V14, P566, DOI 10.1111/j.1467-7687.2010.01004.x; Zhang Y, 2009, NEUROIMAGE, V46, P226, DOI 10.1016/j.neuroimage.2009.01.028	48	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90873	10.1371/journal.pone.0090873	http://dx.doi.org/10.1371/journal.pone.0090873			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625699	gold, Green Published, Green Submitted			2022-12-27	WOS:000332851300038
J	Davel, AP; Brum, PC; Rossoni, LV				Davel, Ana P.; Brum, Patricia C.; Rossoni, Luciana V.			Isoproterenol Induces Vascular Oxidative Stress and Endothelial Dysfunction via a Gi alpha-Coupled beta(2)-Adrenoceptor Signaling Pathway	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SPONTANEOUSLY HYPERTENSIVE-RATS; BETA-ADRENOCEPTOR AGONISTS; ENHANCED EXPRESSION; G(I) PROTEINS; BETA-2-ADRENERGIC RECEPTOR; SUPEROXIDE-PRODUCTION; TARGETED DISRUPTION; DOWN-REGULATION; KNOCKOUT MICE	Objective: Sustained beta-adrenergic stimulation is a hallmark of sympathetic hyperactivity in cardiovascular diseases. It is associated with oxidative stress and altered vasoconstrictor tone. This study investigated the beta-adrenoceptor subtype and the signaling pathways implicated in the vascular effects of b-adrenoceptor overactivation. Methods and Results: Mice lacking the beta(1)- or beta(2)-adrenoceptor subtype (beta 1KO, beta 2KO) and wild-type (WT) were treated with isoproterenol (ISO, 15 mu g.g(-1). day(-1), 7 days). ISO significantly enhanced the maximal vasoconstrictor response (Emax) of the aorta to phenylephrine in WT (+34%) and beta 1KO mice (+35%) but not in beta 2KO mice. The nitric oxide synthase (NOS) inhibitor L-NAME abolished the differences in phenylephrine response between the groups, suggesting that ISO impaired basal NO availability in the aorta of WT and beta 1KO mice. Superoxide dismutase (SOD), pertussis toxin (PTx) or PD 98,059 (p-ERK 1/2 inhibitor) incubation reversed the hypercontractility of aortic rings from ISO-treated WT mice; aortic contraction of ISO-treated beta 2KO mice was not altered. Immunoblotting revealed increased aortic expression of Gi alpha-3 protein (+50%) and phosphorylated ERK1/2 (+90%) and decreased eNOS dimer/monomer ratio in ISO-treated WT mice. ISO enhanced the fluorescence response to dihydroethidium (+100%) in aortas from WT mice, indicating oxidative stress that was normalized by SOD, PTx and L-NAME. The ISO effects were abolished in beta 2KO mice. Conclusions: The beta(2)-adrenoceptor/Gi alpha signaling pathway is implicated in the enhanced vasoconstrictor response and eNOS uncoupling-mediated oxidative stress due to ISO treatment. Thus, long-term beta(2)-AR activation might results in endothelial dysfunction.	[Davel, Ana P.] State Univ Campinas UNICAMP, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil; [Davel, Ana P.; Rossoni, Luciana V.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Brum, Patricia C.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo	Rossoni, LV (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil.	lrossoni@icb.usp.br	Davel, Ana P/L-8801-2013; Rossoni, Luciana Venturini/AFR-0021-2022; Rossoni, Luciana Venturini/C-7226-2012; Brum, Patricia C/E-6605-2011	Davel, Ana P/0000-0002-9862-4262; Rossoni, Luciana Venturini/0000-0002-0944-9483; Brum, Patricia C/0000-0002-4750-6506	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANDSRIVASTAVA MB, 1992, BIOCHEM J, V288, P79, DOI 10.1042/bj2880079; Antoniades C, 2006, CIRCULATION, V114, P1193, DOI 10.1161/CIRCULATIONAHA.106.612325; Antoniades C, 2009, EUR HEART J, V30, P1142, DOI 10.1093/eurheartj/ehp061; Au DH, 2003, CHEST, V123, P1964, DOI 10.1378/chest.123.6.1964; Baloglu E, 2007, EUR J PHARMACOL, V564, P167, DOI 10.1016/j.ejphar.2007.02.054; Banerjee SK, 2003, COMP BIOCHEM PHYS C, V136, P377, DOI 10.1016/j.cca.2003.10.011; Banquet S, 2011, CELL SIGNAL, V23, P1136, DOI 10.1016/j.cellsig.2011.02.008; Bauersachs J, 1999, CIRCULATION, V100, P292, DOI 10.1161/01.CIR.100.3.292; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; Cai S, 2005, DIABETOLOGIA, V48, P1933, DOI 10.1007/s00125-005-1857-5; Carll AP, 2011, CARDIOVASC TOXICOL, V11, P91, DOI 10.1007/s12012-011-9103-5; Cheng J, 2010, J PHARMACOL EXP THER, V332, P57, DOI 10.1124/jpet.109.159863; Chruscinski A, 2001, MOL PHARMACOL, V60, P955, DOI 10.1124/mol.60.5.955; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Davel AP, 2012, J VASC RES, V49, P342, DOI 10.1159/000337486; Davel AP, 2011, BRAZ J MED BIOL RES, V44, P920, DOI [10.1590/S0100-879X2011007500104, 10.1590/S0100-879X2011000900014]; Davel APC, 2008, AM J PHYSIOL-HEART C, V295, pH211, DOI 10.1152/ajpheart.00581.2007; Davel APC, 2006, BRIT J PHARMACOL, V148, P629, DOI 10.1038/sj.bjp.0706749; Ferro A, 2004, BRIT J PHARMACOL, V143, P397, DOI 10.1038/sj.bjp.0705933; Flacco N, 2013, BRIT J PHARMACOL, V169, P413, DOI 10.1111/bph.12121; Fukuda LE, 2008, J CARDIOVASC PHARM, V52, P413, DOI 10.1097/FJC.0b013e31818a8927; Gava AL, 2004, AUTON NEUROSCI-BASIC, V114, P47, DOI 10.1016/j.autneu.2004.07.003; Ge C, 2006, CAN J PHYSIOL PHARM, V84, P739, DOI 10.1139/Y05-123; Hjalmarson A, 1999, LANCET, V353, P2001; Hothersall JD, 2011, BRIT J PHARMACOL, V164, P317, DOI 10.1111/j.1476-5381.2011.01269.x; ITOH H, 1988, J BIOL CHEM, V263, P6656; Kietadisorn R, 2012, AM J PHYSIOL-ENDOC M, V302, pE481, DOI 10.1152/ajpendo.00540.2011; Kim HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043884; Kim N, 2006, BBA-MOL CELL RES, V1763, P1067, DOI 10.1016/j.bbamcr.2006.08.002; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; Lembo G, 1997, HYPERTENSION, V30, P1128, DOI 10.1161/01.HYP.30.5.1128; Li Y, 2002, CIRC RES, V91, P247, DOI 10.1161/01.RES.0000029969.39875.4B; Lobato NS, 2012, LIFE SCI, V91, P600, DOI 10.1016/j.lfs.2012.04.013; MA XL, 1993, CIRC RES, V72, P403, DOI 10.1161/01.RES.72.2.403; MIAN KB, 1995, BRIT J PHARMACOL, V115, P993, DOI 10.1111/j.1476-5381.1995.tb15909.x; Moens AL, 2011, J MOL CELL CARDIOL, V51, P559, DOI 10.1016/j.yjmcc.2011.03.009; MOLENAAR P, 1990, J PHARMACOL EXP THER, V255, P393; Morisco C, 2001, J MOL CELL CARDIOL, V33, P561, DOI 10.1006/jmcc.2000.1332; Murray DR, 2012, J MOL CELL CARDIOL, V52, P206, DOI 10.1016/j.yjmcc.2011.09.022; Murray DR, 2000, CIRCULATION, V101, P2338, DOI 10.1161/01.CIR.101.20.2338; Negrao CE, 2000, AM J PHYSIOL-HEART C, V278, pH168, DOI 10.1152/ajpheart.2000.278.1.H168; Ogut O, 2008, J CELL MOL MED, V12, P2158, DOI 10.1111/j.1582-4934.2008.00536.x; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Parati G, 2012, EUR HEART J, V33, P1058, DOI 10.1093/eurheartj/ehs041; Patterson AJ, 2004, CRIT CARE MED, V32, P1041, DOI 10.1097/01.CCM.0000120049.43113.90; Pourageaud F, 2005, N-S ARCH PHARMACOL, V372, P14, DOI 10.1007/s00210-005-1082-2; Queen LR, 2006, J PHYSIOL-LONDON, V576, P585, DOI 10.1113/jphysiol.2006.115998; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Ryall JG, 2008, AM J PHYSIOL-HEART C, V294, pH2587, DOI 10.1152/ajpheart.00985.2007; Saha S, 2008, J MOL CELL CARDIOL, V44, P336, DOI 10.1016/j.yjmcc.2007.11.003; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Soltysinska E, 2011, PFLUG ARCH EUR J PHY, V462, P529, DOI 10.1007/s00424-011-1005-7; Srivastava S, 2007, CARDIOVASC RES, V74, P445, DOI 10.1016/j.cardiores.2007.02.016; WONG YH, 1992, SCIENCE, V255, P339, DOI 10.1126/science.1347957; Xiao RP, 1999, CIRC RES, V84, P43; Xu J, 2008, J CARDIOVASC PHARM, V52, P42, DOI 10.1097/FJC.0b013e31817dfc8f; Xu Q, 2011, BRIT J PHARMACOL, V162, P1012, DOI 10.1111/j.1476-5381.2010.01043.x; Zemancikova A, 2008, PHYSIOL RES, V57, P299, DOI 10.33549/physiolres.931447; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442	61	38	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91877	10.1371/journal.pone.0091877	http://dx.doi.org/10.1371/journal.pone.0091877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622771	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300137
J	Ely, B; Scott, LE				Ely, Bert; Scott, LaTia Etheredge			Correction of the Caulobacter crescentus NA1000 Genome Annotation	PLOS ONE			English	Article							GENES; TECHNOLOGIES; BACTERIA; SEQUENCE; TOOL; DNA	Bacterial genome annotations are accumulating rapidly in the GenBank database and the use of automated annotation technologies to create these annotations has become the norm. However, these automated methods commonly result in a small, but significant percentage of genome annotation errors. To improve accuracy and reliability, we analyzed the Caulobacter crescentus NA1000 genome utilizing computer programs Artemis and MICheck to manually examine the third codon position GC content, alignment to a third codon position GC frame plot peak, and matches in the GenBank database. We identified 11 new genes, modified the start site of 113 genes, and changed the reading frame of 38 genes that had been incorrectly annotated. Furthermore, our manual method of identifying protein-coding genes allowed us to remove 112 noncoding regions that had been designated as coding regions. The improved NA1000 genome annotation resulted in a reduction in the use of rare codons since noncoding regions with atypical codon usage were removed from the annotation and 49 new coding regions were added to the annotation. Thus, a more accurate codon usage table was generated as well. These results demonstrate that a comparison of the location of peaks third codon position GC content to the location of protein coding regions could be used to verify the annotation of any genome that has a GC content that is greater than 60%.	[Ely, Bert; Scott, LaTia Etheredge] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Ely, B (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	ely@sc.edu			National Science Foundation [EF-0826792]	National Science Foundation(National Science Foundation (NSF))	This work was funded in part by National Science Foundation (nsf.gov) grant EF-0826792 to BE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Christen B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.58; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cruveiller S, 2005, NUCLEIC ACIDS RES, V33, pW471, DOI 10.1093/nar/gki498; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DeFrancesco L, 2012, NAT BIOTECHNOL, V30, P126, DOI 10.1038/nbt0212-126a; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Fang G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-450; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Huang XQ, 2006, NUCLEIC ACIDS RES, V34, P201, DOI 10.1093/nar/gkj419; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101; Larsen TS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-21; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Marks ME, 2010, J BACTERIOL, V192, P3678, DOI 10.1128/JB.00255-10; Nielsen P, 2005, BIOINFORMATICS, V21, P4322, DOI 10.1093/bioinformatics/bti701; Otto TD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1268; Pareja-Tobes P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049239; Rogers YH, 2005, NATURE, V437, P326, DOI 10.1038/437326a; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Skovgaard M, 2001, TRENDS GENET, V17, P425, DOI 10.1016/S0168-9525(01)02372-1; Stothard P, 2006, CURR OPIN MICROBIOL, V9, P505, DOI 10.1016/j.mib.2006.08.002; Ussery DW, 2004, MICROBIOL-SGM, V150, P2015, DOI 10.1099/mic.0.27338-0; Wang FY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004027; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warren AS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-131; Yu JF, 2011, DNA RES, V18, P435, DOI 10.1093/dnares/dsr030	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91668	10.1371/journal.pone.0091668	http://dx.doi.org/10.1371/journal.pone.0091668			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621776	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300117
J	Evans-Lacko, S; Knapp, M				Evans-Lacko, Sara; Knapp, Martin			Importance of Social and Cultural Factors for Attitudes, Disclosure and Time off Work for Depression: Findings from a Seven Country European Study on Depression in the Workplace	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; MENTAL-DISORDERS; GLOBAL BURDEN; SELF-STIGMA; COST; ENGLAND; BRAIN; FLEXIBILITY; EMPLOYEES; KNOWLEDGE	Objectives: Depression is experienced by a large proportion of the workforce and associated with high costs to employers and employees. There is little research on how the social costs of depression vary by social and cultural context. This study investigates individual, workplace and societal factors associated with greater perceived discomfort regarding depression in the workplace, greater likelihood of employees taking time off of work as a result of depression and greater likelihood of disclosure of depression to one's employer. Methods: Employees and managers (n = 7,065) were recruited from seven European countries to participate in the IDEA survey. Multivariable logistic regression models were used to examine associations between individual characteristics and country contextual characteristics in relation to workplace perceptions, likelihood of taking time off work and disclosing depression to an employer. Results: Our findings suggest that structural factors such as benefit systems and flexible working hours are important for understanding workplace perceptions and consequences for employees with depression. However, manager responses that focus on offering help to the employee with depression appear to have stronger associations with positive perceptions in the workplace, and also with openness and disclosure by employees with depression. Conclusion: This study highlights the importance of individual, workplace and societal factors that may be associated with how people with depression are perceived and treated in the workplace, and, hence, factors that may be associated with openness and disclosure among employees with depression. Some responses, such as flexible working hours, may be helpful but are not necessarily sufficient, and our findings also emphasise the importance of support and openness of managers in addition to flexible working hours.	[Evans-Lacko, Sara] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London WC2R 2LS, England; [Knapp, Martin] Univ London London Sch Econ & Polit Sci, London WC2A 2AE, England	University of London; King's College London; University of London; London School Economics & Political Science	Evans-Lacko, S (corresponding author), Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London WC2R 2LS, England.	Sara.Evans-Lacko@kcl.ac.uk	Evans-Lacko, Sara/F-8489-2014	Evans-Lacko, Sara/0000-0003-4691-2630; Knapp, Martin/0000-0003-1427-0215	Lundbeck	Lundbeck(Lundbeck Corporation)	Funding for this study was provided by Lundbeck. The funders had no role in study design, data collection and analysis or decision to publish. Lundbeck put together the questionnaire with the European Depression Association and reviewed the manuscript before submission.	Alonso J, 2009, J AFFECT DISORDERS, V118, P180, DOI 10.1016/j.jad.2009.02.006; Angermeyer MC, 2013, SOC PSYCH PSYCH EPID, V48, P1513, DOI 10.1007/s00127-012-0618-2; Blair-Loy M, 2009, WORK OCCUPATION, V36, P279, DOI 10.1177/0730888409343912; Brohan E, 2013, EPIDEMIOLOGY PSYCHIA; Brohan E, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-11; Corrigan PW, 2013, AM J PUBLIC HEALTH, V103, P794, DOI 10.2105/AJPH.2012.301037; Corrigan PW, 2012, PSYCHIATR REHABIL J, V35, P381, DOI 10.1037/h0094497; de Girolamo G, 2006, SOC PSYCH PSYCH EPID, V41, P853, DOI 10.1007/s00127-006-0097-4; de Graaf R, 2012, SOC PSYCH PSYCH EPID, V47, P1873, DOI 10.1007/s00127-012-0496-7; Ekman M, 2013, J AFFECT DISORDERS, V150, P790, DOI 10.1016/j.jad.2013.03.003; Ellison ML, 2003, J VOCATIONAL REHABIL, V18; Evans-Lacko S, 2012, PSYCHOL MED, V42, P1741, DOI 10.1017/S0033291711002558; Evans-Lacko S, 2012, BRIT J PSYCHIAT; Evans-Lacko S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069792; Evans-Lacko S, 2013, BRIT J PSYCHIAT, V202, pS77, DOI 10.1192/bjp.bp.113.126672; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Henderson C, 2013, BRIT J PSYCHIAT, V202, pS70, DOI 10.1192/bjp.bp.112.112938; Irvine A, 2011, SOC POLICY ADMIN, V45, P752, DOI 10.1111/j.1467-9515.2011.00795.x; Jain G, 2013, J OCCUP ENVIRON MED, V55, P252, DOI 10.1097/JOM.0b013e31828349c9; Kessler RC, 2006, AM J PSYCHIAT, V163, P1561, DOI 10.1176/appi.ajp.163.9.1561; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Lasalvia A., 2012, LANCET; Lerner D, 2004, PSYCHIAT SERV, V55, P1371, DOI 10.1176/appi.ps.55.12.1371; McDaid D, 2005, INT REV PSYCHIATR, V17, P365, DOI 10.1080/09540260500238397; McDaid D., 2014, EC WELLBEING WELLBEI, V5, P215; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; OECD, 2013, DIR EMPL LAB SOC AFF; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Plaisier I, 2010, J AFFECT DISORDERS, V125, P198, DOI 10.1016/j.jad.2010.01.072; Rusch N, 2011, PSYCHIAT SERV, V62, P675, DOI [10.1176/appi.ps.62.6.675, 10.1176/ps.62.6.pss6206_0675]; Sanderson K, 2006, CAN J PSYCHIAT, V51, P63, DOI 10.1177/070674370605100202; Schomerus G, 2012, ACTA PSYCHIAT SCAND, V125, P440, DOI 10.1111/j.1600-0447.2012.01826.x; Thomas CM, 2003, BRIT J PSYCHIAT, V183, P514, DOI 10.1192/bjp.183.6.514; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang JL, 2012, AM J EPIDEMIOL, V176, P52, DOI 10.1093/aje/kwr473; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; World Health Organisation, 2013, DEPR FACTSH; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	39	29	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91053	10.1371/journal.pone.0091053	http://dx.doi.org/10.1371/journal.pone.0091053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24622046	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300046
J	Makkar, N; Chandra, T; Agrawal, P; Bansal, H; Singh, S; Anand, T; Gupta, MK; Kumar, R				Makkar, Nayani; Chandra, Tany; Agrawal, Prachi; Bansal, Harshit; Singh, Simranjeet; Anand, Tanu; Gupta, Mannan Kumar; Kumar, Rajesh			Evaluating Awareness and Practices Pertaining to Radioactive Waste Management among Scrap Dealers in Delhi, India	PLOS ONE			English	Article							RADIATION ACCIDENT	Objectives: With nuclear technology rapidly taking the spotlight in the last 50 years, radiation accidents seem to be a harsh reality of the modern world. The Mayapuri Radiation accident of 2010 was the worst radiation accident India has yet dealt with. Two years thereafter, we designed a study to assess the awareness and practices regarding radioactive waste among scrap dealers aiming to assess deficiencies in radiation disaster preparedness. Methodology: A community based cross-sectional study. The study population consisted of 209 volunteers (from 108 scrap dealerships) including 108 shop-owners and 101 workers segregated as Group A consisting of 54 dealerships in Mayapuri and Group B of 54 dealerships from the rest of the city. Subjects were then interviewed using a semi-structured questionnaire. Results: Awareness about radioactive waste varied significantly with level of education (p = 0.024), Kuppuswamy's socio-economic scale (p = 0.005), age of the scrap dealer (p = 0.049) and his work experience (p = 0.045). The larger dealerships in Mayapuri were more aware about radioactive waste (p = 0.0004), the accident in 2010 (p = 0.0002), the symbol for radiation hazard (p = 0.016), as well as the emergency guidelines and the agencies to contact in the event of a radiation accident. Conclusions: Our findings seem to signify that while governmental and non-governmental agencies were successful in implementing prompt disaster response and awareness programs, the community continues to be inadequately prepared. These go on to suggest that though concerted awareness and training programs do benefit the affected community, economic and social development is the key to disaster prevention and mitigation.	[Makkar, Nayani; Chandra, Tany; Agrawal, Prachi; Bansal, Harshit; Singh, Simranjeet; Anand, Tanu; Gupta, Mannan Kumar; Kumar, Rajesh] Maulana Azad Med Coll, New Delhi, India	Maulana Azad Medical College	Makkar, N (corresponding author), Maulana Azad Med Coll, New Delhi, India.	nayanisingh@gmail.com	AGRAWAL, PRACHI/AAG-5109-2021	AGRAWAL, PRACHI/0000-0001-5486-6510; Anand, Tanu/0000-0003-2911-2332				AERB G.S.R, 1987, 125 AT EN SAF DISP R; [Anonymous], 2010, HINDU; Atomic Energy Regulatory Board (AERB) Government of India, 2010, AERBSECPRESS201006 G; Atomic Energy Regulatory Board (AERB) Government of India, 2010, AERBSECPRESS201002 G; Atomic Energy Regulatory Board (AERB) Government of India, 2010, AERBSECPRESS201007 G; Atomic Energy Regulatory Board (AERB) Government of India, 2011, AERBITSDPRESS201101; Atomic Energy Regulatory Board (AERB) Government of India, 2010, AERB NEWSL, V23, P9; Atomic Energy Regulatory Board (AERB) Government of India, 2010, AERBSECPRESS201004 G; Atomic Energy Regulatory Board (AERB) Government of India, 2010, AERBSECPRESS201003 G; Bagla P, 2010, SCIENCE, V328, P679, DOI 10.1126/science.328.5979.679-a; Department of Atomic Energy (DAE) Government of India, 2004, 303 GSR DAE GOV IND; Dey AB, 2012, RADIAT PROT DOSIM, V151, P645, DOI 10.1093/rpd/ncs162; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Greenpeace India, 2010, MELT POT REG RAD EM; Nenot JC, 2009, J RADIOL PROT, V29, P301, DOI 10.1088/0952-4746/29/3/R01; Ortiz P, 2002, SAFETY, V21, P11; Park K, 2011, TXB PREVENTIVE SOCIA, P638; Perappadan BS, 2010, HINDU; Remesh B. P., 2010, Economic and Political Weekly, V45, P16; StataCorp, 2011, STAT STAT SOFTW REL; Turai I., 2001, CENTRAL EURO J OCCUP, V7, P3; Yardley J, 2010, NEW YORK TIMES	23	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91579	10.1371/journal.pone.0091579	http://dx.doi.org/10.1371/journal.pone.0091579			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622341	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300107
J	Steingrimsdottir, L; Halldorsson, TI; Siggeirsdottir, K; Cotch, MF; Einarsdottir, BO; Eiriksdottir, G; Sigurdsson, S; Launer, LJ; Harris, TB; Gudnason, V; Sigurdsson, G				Steingrimsdottir, Laufey; Halldorsson, Thorhallur I.; Siggeirsdottir, Kristin; Cotch, Mary Frances; Einarsdottir, Berglind O.; Eiriksdottir, Gudny; Sigurdsson, Sigurdur; Launer, Lenore J.; Harris, Tamara B.; Gudnason, Vilmundur; Sigurdsson, Gunnar			Hip Fractures and Bone Mineral Density in the Elderly-Importance of Serum 25-Hydroxyvitamin D	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; GENE/ENVIRONMENT SUSCEPTIBILITY-REYKJAVIK; OLDER-ADULTS; NONSPINE FRACTURES; MUSCLE STRENGTH; DIETARY-INTAKE; RISK; METAANALYSIS; ASSOCIATION; CALCIUM	Background: The significance of serum 25-hydroxyvitamin D [25(OH) D] concentrations for hip fracture risk of the elderly is still uncertain. Difficulties reaching both frail and healthy elderly people in randomized controlled trials or large cohort studies may in part explain discordant findings. We determined hazard ratios for hip fractures of elderly men and women related to serum 25(OH) D, including both the frail and the healthy segment of the elderly population. Methods: The AGES-Reykjavik Study is a prospective study of 5764 men and women, age 66-96 years, based on a representative sample of the population of Reykjavik, Iceland. Participation was 71.8%. Hazard ratios of incident hip fractures and baseline bone mineral density were determined according to serum concentrations of 25(OH) D at baseline. Results: Mean follow-up was 5.4 years. Compared with referent values (50-75 nmol/L), hazard ratios for hip fractures were 2.24 (95% CI 1.63, 3.09) for serum 25(OH) D <30 nmol/L, adjusting for age, sex, body mass index, height, smoking, alcohol intake and season, and 2.08 (95% CI 1.51, 2.87), adjusting additionally for physical activity. No difference in risk was associated with 30-50 nmol/L or >= 75 nmol/L in either model compared with referent. Analyzing the sexes separately, hazard ratios were 2.61 (95% CI 1.47, 4.64) in men and 1.93 (95% CI 1.31, 2.84) in women. Values <30 nmol/L were associated with significantly lower bone mineral density of femoral neck compared with referent, z-scores -0.14 (95% CI - 0.27, -0.00) in men and -0.11 (95% CI -0.22, -0.01) in women. Conclusions: Our results lend support to the overarching importance of maintaining serum 25(OH) D above 30 nmol/L for bone health of elderly people while potential benefits of having much higher levels could not be detected.	[Steingrimsdottir, Laufey; Halldorsson, Thorhallur I.] Univ Iceland, Unit Nutr Res, Reykjavik, Iceland; [Steingrimsdottir, Laufey; Halldorsson, Thorhallur I.] Landspitali Univ Hosp, Reykjavik, Iceland; [Siggeirsdottir, Kristin; Einarsdottir, Berglind O.; Eiriksdottir, Gudny; Sigurdsson, Sigurdur; Gudnason, Vilmundur; Sigurdsson, Gunnar] Iceland Heart Assoc Res Inst, Kopavogur, Iceland; [Launer, Lenore J.; Harris, Tamara B.] NIA, Intramural Res Program, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Cotch, Mary Frances] NEI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA; [Gudnason, Vilmundur; Sigurdsson, Gunnar] Univ Iceland, Reykjavik, Iceland	University of Iceland; Landspitali National University Hospital; Icelandic Heart Association; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Iceland	Steingrimsdottir, L (corresponding author), Univ Iceland, Unit Nutr Res, Reykjavik, Iceland.	laufey@hi.is	Halldorsson, Tohrhallur/M-1823-2015; Gudnason, Vilmundur/K-6885-2015; Steingrimsdottir, Laufey/L-3150-2015; Gudnason, Vilmundur/AAE-7126-2019	Halldorsson, Tohrhallur/0000-0001-5115-0162; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Halldorsson, Thorhallur/0000-0002-3488-0777; Cotch, Mary Frances/0000-0002-2046-4350; Einarsdottir, Berglind Osk/0000-0002-5227-8149	National Institutes of Health, USA [N01-AG-12100]; National Institute on Aging Intramural Research Program, the National Eye Institute USA [Z01-EY000401]; National Institutes of Health, Hjartavernd (The Icelandic Heart Association); Althingi (Icelandic Parliament); NATIONAL EYE INSTITUTE [Z01EY000401, ZIAEY000401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG012100, ZIAAG007380] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging Intramural Research Program, the National Eye Institute USA; National Institutes of Health, Hjartavernd (The Icelandic Heart Association); Althingi (Icelandic Parliament); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institutes of Health, USA contract N01-AG-12100, and the National Institute on Aging Intramural Research Program, the National Eye Institute USA (Z01-EY000401), National Institutes of Health, Hjartavernd (The Icelandic Heart Association), and Althingi (Icelandic Parliament). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5463; Avenell A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub3; Barbour KE, 2012, J BONE MINER RES, V27, P1177, DOI 10.1002/jbmr.1545; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Bjornsson G, 1982, 24 ABC IC HEART ASS; Black DM, 2008, J BONE MINER RES, V23, P1326, DOI 10.1359/JBMR.080316; Boonen S, 2007, J CLIN ENDOCR METAB, V92, P1415, DOI 10.1210/jc.2006-1404; Bouillon R, 2013, J CLIN ENDOCR METAB, V98, pE1283, DOI 10.1210/jc.2013-1195; Cameron ID, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub3; Cauley JA, 2010, J BONE MINER RES, V25, P545, DOI 10.1359/jbmr.090826; Chung Mei, 2009, Evid Rep Technol Assess (Full Rep), P1; Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Dawson-Hughes B, 2013, CALCIFIED TISSUE INT, V92, P184, DOI 10.1007/s00223-012-9606-5; Eysteinsdottir T, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-12; Gerdhem P, 2005, OSTEOPOROSIS INT, V16, P1425, DOI 10.1007/s00198-005-1860-1; Grimnes G, 2012, OSTEOPOROSIS INT, V23, P201, DOI 10.1007/s00198-011-1752-5; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holvik K, 2013, J CLIN ENDOCR METAB, V98, P3341, DOI 10.1210/jc.2013-1468; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Johnell Olof, 2006, Evid Based Med, V11, P13, DOI 10.1136/ebm.11.1.13; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Kalyani RR, 2010, J AM GERIATR SOC, V58, P1299, DOI 10.1111/j.1532-5415.2010.02949.x; Lai JKC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-331; Looker AC, 2008, J BONE MINER RES, V23, P143, DOI 10.1359/JBMR.071003; Looker AC, 2013, J BONE MINER RES, V28, P997, DOI 10.1002/jbmr.1828; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Melhus H, 2010, J CLIN ENDOCR METAB, V95, P2637, DOI 10.1210/jc.2009-2699; Muir SW, 2011, J AM GERIATR SOC, V59, P2291, DOI 10.1111/j.1532-5415.2011.03733.x; Rabenda V, 2011, OSTEOPOROSIS INT, V22, P893, DOI 10.1007/s00198-010-1469-x; Rianon NJ, 2014, J CLIN DENSITOM, V17, P25, DOI 10.1016/j.jocd.2013.03.005; Robinson-Cohen C, 2011, J CLIN ENDOCR METAB, V96, P2186, DOI 10.1210/jc.2010-2878; Roddam AW, 2007, AM J EPIDEMIOL, V166, P1327, DOI 10.1093/aje/kwm210; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Schwartz AV, 1999, J AM GERIATR SOC, V47, P1371; Siggeirsdottir K, 2007, EUR J EPIDEMIOL, V22, P631, DOI 10.1007/s10654-007-9163-9; Sigurdsson G, 2006, BONE, V39, P644, DOI 10.1016/j.bone.2006.03.020; Snellman G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011555; Steingrimsdottir L, 2005, JAMA-J AM MED ASSOC, V294, P2336, DOI 10.1001/jama.294.18.2336	42	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91122	10.1371/journal.pone.0091122	http://dx.doi.org/10.1371/journal.pone.0091122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621578	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300054
J	Vincent, SJ; Coutts, BA; Jones, RAC				Vincent, Stuart J.; Coutts, Brenda A.; Jones, Roger A. C.			Effects of Introduced and Indigenous Viruses on Native Plants: Exploring Their Disease Causing Potential at the Agro-Ecological Interface	PLOS ONE			English	Article							YELLOW-MOSAIC-VIRUS; NON-NECROTIC STRAINS; ANNUAL PASTURE LEGUMES; POTATO LEAFROLL VIRUS; HYPERSENSITIVE RESISTANCE; BIOLOGICAL-PROPERTIES; AUSTRALIA INCIDENCES; TERRESTRIAL ORCHIDS; DWARF-VIRUS; SEED STOCKS	The ever increasing movement of viruses around the world poses a major threat to plants growing in cultivated and natural ecosystems. Both generalist and specialist viruses move via trade in plants and plant products. Their potential to damage cultivated plants is well understood, but little attention has been given to the threat such viruses pose to plant biodiversity. To address this, we studied their impact, and that of indigenous viruses, on native plants from a global biodiversity hot spot in an isolated region where agriculture is very recent (<185 years), making it possible to distinguish between introduced and indigenous viruses readily. To establish their potential to cause severe or mild systemic symptoms in different native plant species, we used introduced generalist and specialist viruses, and indigenous viruses, to inoculate plants of 15 native species belonging to eight families. We also measured resulting losses in biomass and reproductive ability for some host-virus combinations. In addition, we sampled native plants growing over a wide area to increase knowledge of natural infection with introduced viruses. The results suggest that generalist introduced viruses and indigenous viruses from other hosts pose a greater potential threat than introduced specialist viruses to populations of native plants encountered for the first time. Some introduced generalist viruses infected plants in more families than others and so pose a greater potential threat to biodiversity. The indigenous viruses tested were often surprisingly virulent when they infected native plant species they were not adapted to. These results are relevant to managing virus disease in new encounter scenarios at the agro-ecological interface between managed and natural vegetation, and within other disturbed natural vegetation situations. They are also relevant for establishing conservation policies for endangered plant species and avoiding spread of damaging viruses to undisturbed natural vegetation beyond the agro-ecological interface.	[Vincent, Stuart J.; Coutts, Brenda A.; Jones, Roger A. C.] Dept Agr & Food, S Perth, WA, Australia; [Vincent, Stuart J.] Murdoch Univ, State Agr Biotechnol Ctr, Sch Biol Sci & Biotechnol, Murdoch, WA 6150, Australia; [Coutts, Brenda A.; Jones, Roger A. C.] Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia	Government of Western Australia; Department of Agriculture & Food - Western Australia; Murdoch University; University of Western Australia	Jones, RAC (corresponding author), Dept Agr & Food, S Perth, WA, Australia.	roger.jones@uwa.edu.au	Jones, Roger A.C./B-1200-2011	Jones, Roger A.C./0000-0003-3593-3102	Floriculture and Plant Pathology Research Groups of the Department of Agriculture and Food for Western Australia (DAFWA)	Floriculture and Plant Pathology Research Groups of the Department of Agriculture and Food for Western Australia (DAFWA)	This work was funded by the Floriculture and Plant Pathology Research Groups of the Department of Agriculture and Food for Western Australia (DAFWA). The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Alexander HM, 2014, EUR J PLANT PATHOL, V138, P529, DOI 10.1007/s10658-013-0317-1; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Bedhomme S, 2012, MOL BIOL EVOL, V29, P1481, DOI 10.1093/molbev/msr314; Bos L., 1981, Plant diseases and vectors: ecology and epidemiology; ed. by K. Maramoresh and K. F. Harris., P1; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Cheng Y, 2000, ANN APPL BIOL, V136, P215, DOI 10.1111/j.1744-7348.2000.tb00028.x; Cheng Y, 1999, AUST J AGR RES, V50, P589, DOI 10.1071/A98116; Cheng Y, 2002, ANN APPL BIOL, V140, P69, DOI 10.1111/j.1744-7348.2002.tb00158.x; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; Cooper I, 2006, ADV VIRUS RES, V67, P1, DOI 10.1016/S0065-3527(06)67001-2; Coutts BA, 2008, AUST J AGR RES, V59, P844, DOI 10.1071/AR07475; Coutts BA, 2008, AUST J AGR RES, V59, P836, DOI 10.1071/AR08034; Coutts BA, 2006, AUST J AGR RES, V57, P975, DOI 10.1071/AR05407; Coutts BA, 2000, AUST J AGR RES, V51, P925, DOI 10.1071/AR00014; Coutts BA, 2002, ANN APPL BIOL, V140, P37, DOI 10.1111/j.1744-7348.2002.tb00155.x; Coutts BA, 2011, ARCH VIROL, V156, P1757, DOI 10.1007/s00705-011-1046-4; Dwyer GI, 2007, PLANT DIS, V91, P164, DOI 10.1094/PDIS-91-2-0164; Fargette D, 2006, ANNU REV PHYTOPATHOL, V44, P235, DOI 10.1146/annurev.phyto.44.120705.104644; Friess N, 1996, NEW PHYTOL, V132, P103, DOI 10.1111/j.1469-8137.1996.tb04514.x; Gibbs AJ, 2008, ARCH VIROL, V153, P1411, DOI 10.1007/s00705-008-0134-6; Gibbs AJ, 1960, ANN APPL BIOL, V48, P75, DOI 10.1111/j.1744-7348.1960.tb03506.x; Gibbs A, 2008, ARCH VIROL, V153, P2177, DOI 10.1007/s00705-008-0256-x; Gibbs A. J., 1983, Physiological plant ecology III. Responses to the chemical and biological environment., P537; Gibbs AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002523; Harper J. L., 1990, Pests, pathogens and plant communities., P3; HARRISON BD, 1981, ANN APPL BIOL, V99, P195, DOI 10.1111/j.1744-7348.1981.tb04787.x; HARVEY H. L., 1956, Journal of the Department of Agriculture for Western Australia, V5, P329; Hawkes JR, 2005, AUST J AGR RES, V56, P257, DOI 10.1071/AR04259; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; Humphries AW, 2014, RANGELAND J, V36, P41, DOI 10.1071/RJ13055; Jones R. A. C., 2012, CAB Reviews, V7, P1, DOI 10.1079/PAVSNNR20127022; Jones RAC, 2014, VIRUS RES, V186, P3, DOI 10.1016/j.virusres.2013.11.003; Jones R. A. C., 1990, PLANT PATHOL, V19, P90, DOI DOI 10.1071/APP9900090; Jones RAC, 2005, ANN APPL BIOL, V146, P337, DOI 10.1111/j.1744-7348.2005.040096.x; Jones RAC, 2004, AUST J AGR RES, V55, P757, DOI 10.1071/AR04011; Jones RAC, 2003, AUST J AGR RES, V54, P849, DOI 10.1071/AR03087; JONES RAC, 1994, AUST J AGR RES, V45, P1427, DOI 10.1071/AR9941427; Jones RAC, 1996, ANN APPL BIOL, V129, P491, DOI 10.1111/j.1744-7348.1996.tb05771.x; JONES RAC, 1988, ANN APPL BIOL, V113, P507, DOI 10.1111/j.1744-7348.1988.tb03328.x; JONES RAC, 1992, AUST J AGR RES, V43, P1229, DOI 10.1071/AR9921229; JONES RAC, 1989, ANN APPL BIOL, V115, P263, DOI 10.1111/j.1744-7348.1989.tb03385.x; Jones RAC, 1998, J AGR SCI-CAMBRIDGE, V131, P155, DOI 10.1017/S002185969800570X; JONES RAC, 1979, PHYTOPATHOLOGY, V69, P446, DOI 10.1094/Phyto-69-446; Jones RAC, 2006, ADV VIRUS RES, V67, P205, DOI 10.1016/S0065-3527(06)67006-1; Jones RAC, 2013, CROP PASTURE SCI, V64, P216, DOI 10.1071/CP13134; Jones RAC, 2013, CROP PASTURE SCI, V64, P199, DOI 10.1071/CP13108; Jones RAC, 2012, CROP PASTURE SCI, V63, P399, DOI 10.1071/CP12117; Jones RAC, 2009, VIRUS RES, V141, P113, DOI 10.1016/j.virusres.2008.07.028; Koenig R, 1989, POTATO VIRUS; Latham LJ, 2003, AUSTRALAS PLANT PATH, V32, P387, DOI 10.1071/AP03031; Latham LJ, 1997, AUST J AGR RES, V48, P359, DOI 10.1071/A96084; Latham LJ, 2001, AUST J AGR RES, V52, P397, DOI 10.1071/AR00079; Lovisolo O, 2003, ADV VIRUS RES, V62, P325, DOI 10.1016/S0065-3527(03)62006-3; MacClement W. D., 1956, AM J BOT, V34, P793; Malmstrom CM, 2011, VIRUS RES, V159, P84, DOI 10.1016/j.virusres.2011.05.010; Malmstrom CM, 2005, OECOLOGIA, V145, P153, DOI 10.1007/s00442-005-0099-z; Malmstrom CM, 2005, NEW PHYTOL, V168, P217, DOI 10.1111/j.1469-8137.2005.01479.x; Maskell LC, 1999, ANN APPL BIOL, V135, P401, DOI 10.1111/j.1744-7348.1999.tb00867.x; McKirdy SJ, 1997, AUST J AGR RES, V48, P31, DOI 10.1071/A96040; MCKIRDY SJ, 1993, AUST J AGR RES, V44, P1195, DOI 10.1071/AR9931195; MCKIRDY SJ, 1994, AUST J AGR RES, V45, P183, DOI 10.1071/AR9940183; MCKIRDY SJ, 1995, AUST J AGR RES, V46, P763, DOI 10.1071/AR9950763; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Power Alison G., 2008, P15, DOI 10.1007/978-3-540-75763-4_2; Prendeville HR, 2012, AM J BOT, V99, P1033, DOI 10.3732/ajb.1100509; Rodelo-Urrego M, 2013, MOL ECOL, V22, P2325, DOI 10.1111/mec.12232; Roossinck MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003304; Sacristan S, 2008, MOL PLANT PATHOL, V9, P369, DOI 10.1111/J.1364-3703.2007.00460.X; SHIVAS R G, 1989, Australasian Plant Pathology, V18, P29, DOI 10.1071/APP9890029; Spetz C, 2003, J GEN VIROL, V84, P2565, DOI 10.1099/vir.0.19208-0; Stevens M, 2005, MOL PLANT PATHOL, V6, P1, DOI 10.1111/j.1364-3703.2004.00258.x; Tatineni S, 2011, P NATL ACAD SCI USA, V108, P17366, DOI 10.1073/pnas.1113227108; Thackray DJ, 2002, ANN APPL BIOL, V141, P45, DOI 10.1111/j.1744-7348.2002.tb00194.x; Thresh J. M., 1980, Comparative epidemiology. A tool for better disease management. (Proceedings of the session of comparative epidemiology, 3rd International Congress of Plant Pathology, Munich 16-23 August, 1978.), P57; Thresh J.M., 1980, APPLIED BIOL, V5, P1; Thresh JM, 1981, PESTS PATHOGENS VEGE; TORRANCE L, 1981, PLANT PATHOL, V30, P1, DOI 10.1111/j.1365-3059.1981.tb01218.x; Torrance L, 1986, DEV APPL BIOL, V1, P103; Van Regenmortel MHV, 2000, VIRUS TAXONOMY, P477; Varsani A, 2008, J GEN VIROL, V89, P2063, DOI 10.1099/vir.0.2008/003590-0; Vincent SJ, 2012, EV IMP INF REC INTR; Webster CG, 2007, PLANT PATHOL, V56, P729, DOI 10.1111/j.1365-3059.2007.01653.x; Whattam M, 2014, HDB PLANT BIOSECURIT, P149, DOI [10.1007/978-94-007-7365-3_6, DOI 10.1007/978-94-007-7365-3_6]; WILSON CR, 1990, ANN APPL BIOL, V116, P103, DOI 10.1111/j.1744-7348.1990.tb06589.x; WILSON CR, 1993, AUST J AGR RES, V44, P1891, DOI 10.1071/AR9931891; WILSON CR, 1992, J GEN VIROL, V73, P3219, DOI 10.1099/0022-1317-73-12-3219; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Wylie SJ, 2009, PHYTOPATHOLOGY, V99, P512, DOI 10.1094/PHYTO-99-5-0512; Wylie SJ, 2008, PLANT DIS, V92, P1596, DOI 10.1094/PDIS-92-12-1596; Wylie SJ, 2013, VIRUS RES, V171, P22, DOI 10.1016/j.virusres.2012.10.003; Wylie SJ, 2012, ARCH VIROL, V157, P2447, DOI 10.1007/s00705-012-1452-2; Wylie SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/s00705-011-1166-x	92	29	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91224	10.1371/journal.pone.0091224	http://dx.doi.org/10.1371/journal.pone.0091224			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621926	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300066
J	Weissbrod, L; Malkinson, D; Cucchi, T; Gadot, Y; Finkelstein, I; Bar-Oz, G				Weissbrod, Lior; Malkinson, Dan; Cucchi, Thomas; Gadot, Yuval; Finkelstein, Israel; Bar-Oz, Guy			Ancient Urban Ecology Reconstructed from Archaeozoological Remains of Small Mammals in the Near East	PLOS ONE			English	Article							POPULATION-DENSITY; MESOPOTAMIA; SPRAWL; CITIES; SITE; MICE; AREA	Modern rapidly expanding cities generate intricate patterns of species diversity owing to immense complexity in urban spatial structure and current growth trajectories. We propose to identify and uncouple the drivers that give rise to these patterns by looking at the effect of urbanism on species diversity over a previously unexplored long temporal frame that covers early developments in urbanism. To provide this historical perspective we analyzed archaeozoological remains of small mammals from ancient urban and rural sites in the Near East from the 2nd to the 1st millennium BCE, and compared them to observations from modern urban areas. Our data show that ancient urban assemblages consistently comprised two main taxa (Mus musculus domesticus and Crocidura sp.), whereas assemblages of contemporaneous rural sites were significantly richer. Low species diversity also characterizes high-density core areas of modern cities, suggesting that similar ecological drivers have continued to operate in urban areas despite the vast growth in their size and population densities, as well as in the complexity of their technologies and social organization. Research in urban ecology has tended to emphasize the relatively high species diversity observed in low-density areas located on the outskirts of cities, where open and vegetated patches are abundant. The fact that over several millennia urban evolution did not significantly alter species diversity suggests that low diversity is an attribute of densely-populated settlements. The possibility that high diversity in peripheral urban areas arose only recently as a short-term phenomenon in urban ecology merits further research based on long-term data.	[Weissbrod, Lior; Bar-Oz, Guy] Univ Haifa, Zinman Inst Archaeol, IL-31999 Haifa, Israel; [Malkinson, Dan] Univ Haifa, Dept Geog, IL-31999 Haifa, Israel; [Malkinson, Dan] Univ Haifa, Golan Res Inst, Katzrin, Israel; [Cucchi, Thomas] Museum Natl Hist Nat, CNRS, UMR Archeozool Archeobot Soc Prat & Environm 7209, Paris, France; [Cucchi, Thomas] Univ Aberdeen, Dept Archaeol, Aberdeen, Scotland; [Gadot, Yuval; Finkelstein, Israel] Tel Aviv Univ, Jacob M Alkow Dept Archaeol & Ancient Near Easter, IL-69978 Tel Aviv, Israel	University of Haifa; University of Haifa; University of Haifa; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); University of Aberdeen; Tel Aviv University	Weissbrod, L (corresponding author), Univ Haifa, Zinman Inst Archaeol, IL-31999 Haifa, Israel.	lweissbr@research.haifa.ac.il	BarOz, Guy/ABF-6518-2020; Cucchi, Thomas/Q-4014-2018; Weissbrod, Lior/I-8735-2019	BarOz, Guy/0000-0002-1009-5619; Cucchi, Thomas/0000-0001-6021-5001; Weissbrod, Lior/0000-0003-3401-8180	European Research Council under the European Community's Seventh Framework Program (FP7)/ERC [229418]; Israel Science Foundation [52/10]	European Research Council under the European Community's Seventh Framework Program (FP7)/ERC(European Research Council (ERC)); Israel Science Foundation(Israel Science Foundation)	The research was funded by a post-doctoral grant awarded to L.W. from the European Research Council under the European Community's Seventh Framework Program (FP7/2007e2013)/ERC grant agreement number 229418. The laboratory work was also supported by funding by the Israel Science Foundation (Grant 52/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage P.L., 1985, T LONDON MIDDLESEX A, V36, P107; ARMITAGE PL, 1985, BIOLOGIST, V32, P65; AUFFRAY JC, 1990, Z SAUGETIERKD, V55, P1; Baylac M, 2005, DEV PRIMATOL-PROG PR, P145, DOI 10.1007/0-387-27614-9_6; BOCEK B, 1986, AM ANTIQUITY, V51, P589, DOI 10.2307/281754; Bookstein F L, 1997, Med Image Anal, V1, P225; BROSHI M, 1992, B AM SCH ORIENTAL RE, P47, DOI 10.2307/1357138; CANOVA L, 1994, REV ECOL-TERRE VIE, V49, P87; Castillo E, 2003, INT BIODETER BIODEGR, V52, P135, DOI 10.1016/S0964-8305(03)00033-7; Cavia R, 2009, LANDSCAPE URBAN PLAN, V90, P11, DOI 10.1016/j.landurbplan.2008.10.017; Childe V.G., 1950, TOWN PLAN REV, V21, P3; Christensen JT, 1996, AFR J ECOL, V34, P298, DOI 10.1111/j.1365-2028.1996.tb00624.x; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Cowgill GL, 2004, ANNU REV ANTHROPOL, V33, P525, DOI 10.1146/annurev.anthro.32.061002.093248; Cucchi T, 2011, HOLOCENE, V21, P1195, DOI 10.1177/0959683611405233; Cucchi T, 2012, EVOLUTION HOUSE MOUS, P67; Cucchi T, 2013, BIOL J LINN SOC, V108, P917, DOI 10.1111/bij.12004; Czamanski D, 2008, INT REV ENVIRON RESO, V2, P321, DOI 10.1561/101.00000019; De Cupere B, 2009, INT J OSTEOARCHAEOL, V19, P1, DOI 10.1002/oa.965; Dearborn DC, 2010, CONSERV BIOL, V24, P432, DOI 10.1111/j.1523-1739.2009.01328.x; DICKMAN CR, 1987, J APPL ECOL, V24, P337, DOI 10.2307/2403879; Dor M., 1947, Mammalia Paris, V11, P50, DOI 10.1515/mamm.1947.11.1.50; Evin A, 2013, J ARCHAEOL SCI, V40, P735, DOI 10.1016/j.jas.2012.08.005; FALCONER SE, 1995, AM ANTIQUITY, V60, P37, DOI 10.2307/282075; Finkelstein I, 1995, TEL AVIV, V22, P37; Flannery K.V., 1972, ANNU REV ECOL SYST, V3, P399, DOI 10.1146/annurev.es.03.110172.002151; Fletcher R., 2007, LIMITS SETTLEMENT GR; Gaston K., 2010, URBAN ECOL, P1; Gillham O., 2002, LIMITLESS CITY PRIME; Gippoliti Spartaco, 2006, Aldrovandia, V2, P69; Gonen R., 1984, B AM SCH ORIENT RES, V253, P61; Grayson DK, 2001, J WORLD PREHIST, V15, P1, DOI 10.1023/A:1011165119141; Greenberg R., 2002, EARLY URBANIZATIONS; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hofmann R., 2012, TELLS SOCIAL ENV SPA, P19; Hofmann R., 2012, TELLS SOCIAL ENV SPA, V3, P15; Hsieh T. C., 2013, INEXT ONLINE INTERPO; Jenkins E, 2012, J SOC ARCHAEOL, V12, P380, DOI 10.1177/1469605312455765; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; Luck Gary W., 2010, P88; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; Lyman R. Lee, 2004, ZOOARCHAEOLOGY CONSE; Mahan CG, 2005, NORTHEAST NAT, V12, P307, DOI 10.1656/1092-6194(2005)012[0307:SMUOSA]2.0.CO;2; McKinney M. L., 2010, URBAN ECOL, P287, DOI DOI 10.1017/CBO9780511778483.013; Mendelssohn H., 1999, MAMMALIA ISRAEL; Mendelssohn H, 1987, MAMMALS PLANTS ANIMA; Misonne X, 1963, RONGEURS RUWENZORI R; Mitteroecker P, 2007, SYST BIOL, V56, P818, DOI 10.1080/10635150701648029; Pickett STA, 2008, BIOSCIENCE, V58, P139, DOI 10.1641/B580208; Redman CL, 1978, RISE CIVILIZATION EA; Ripley B. D., 1996, PATTERN RECOGNITION; Rosen AM., 1986, CITIES CLAY GEOARCHE; Rosenstock E., 2012, UNIVERSITATSFORSCHUN, V207, P33; Setzer H. W., 1959, Journal of the Egyptian Public Health Association, V34, P93; Shiloh Y., 1980, B AM SCH ORIENT RES, V239, P25, DOI DOI 10.2307/1356754; Shochat E, 2010, BIOSCIENCE, V60, P199, DOI 10.1525/bio.2010.60.3.6; Smith ME, 2010, CAMB ARCHAEOL J, V20, P229, DOI 10.1017/S0959774310000259; Strona G, 2012, NED ONLINE SOFTWARE; Tchernov E., 1984, BAR INT SERIES, P91; Tikhonova GN, 2012, RUSS J ECOL+, V43, P236, DOI 10.1134/S1067413612030162; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Ur JA, 2010, J ARCHAEOL RES, V18, P387, DOI 10.1007/s10814-010-9041-y; Valenzuela-Lamas S, 2011, BIOL J LINN SOC, V102, P483, DOI 10.1111/j.1095-8312.2010.01603.x; Weissbrod L, 2013, J ARCHAEOL SCI, V40, P257, DOI 10.1016/j.jas.2012.07.001; Weissbrod L., 2010, ARCHAEOLOGY ANTHROPO, P295	67	11	11	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91795	10.1371/journal.pone.0091795	http://dx.doi.org/10.1371/journal.pone.0091795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AC9HN	24622726	gold, Green Published, Green Submitted			2022-12-27	WOS:000332845300129
J	Berzkalns, A; Bates, J; Ye, W; Mukasa, L; France, AM; Patil, N; Yang, ZH				Berzkalns, Anna; Bates, Joseph; Ye, Wen; Mukasa, Leonard; France, Anne Marie; Patil, Naveen; Yang, Zhenhua			The Road to Tuberculosis (Mycobacterium tuberculosis) Elimination in Arkansas; a Re-Examination of Risk Groups	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGIC ANALYSIS; UNITED-STATES; RURAL-COMMUNITY; SURVEILLANCE; POPULATION; TRENDS	Objectives: This study was conducted to generate knowledge useful for developing public health interventions for more effective tuberculosis control in Arkansas. Methods: The study population included 429 culture-confirmed reported cases (January 1, 2004-December 31, 2010). Mycobacterium tuberculosis genotyping data were used to identify cases likely due to recent transmission (clustered) versus reactivation (non-clustered). Poisson regression models estimated average decline rate in incidence over time and assessed the significance of differences between subpopulations. A multinomial logistic model examined differences between clustered and non-clustered incidence. Results: A significant average annual percent decline was found for the overall incidence of culture-confirmed (9%; 95% CI: 5.5%, 16.9%), clustered (6%; 95% CI: 0.5%, 11.6%), and non-clustered tuberculosis cases (12%; 95% CI: 7.6%, 15.9%). However, declines varied among demographic groups. Significant declines in clustered incidence were only observed in males, non-Hispanic blacks, 65 years and older, and the rural population. Conclusions: These findings suggest that the Arkansas tuberculosis control program must target both traditional and non-traditional risk groups for successful tuberculosis elimination. The present study also demonstrates that a thorough analysis of TB trends in different population subgroups of a given geographic region or state can lead to the identification of non-traditional risk factors for TB transmission. Similar studies in other low incidence populations would provide beneficial data for how to control and eventually eliminate TB in the U.S.	[Berzkalns, Anna; Yang, Zhenhua] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Bates, Joseph; Mukasa, Leonard; Patil, Naveen] Arkansas Dept Hlth, Little Rock, AR 72205 USA; [Bates, Joseph; Mukasa, Leonard] Univ Arkansas Med Sci, Fay W Boozman Coll Publ Hlth, Dept Epidemiol, Little Rock, AR 72205 USA; [Ye, Wen] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [France, Anne Marie] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Patil, Naveen] Univ Arkansas Med Sci, Coll Med, Little Rock, AR 72205 USA	University of Michigan System; University of Michigan; University of Arkansas System; University of Arkansas Medical Sciences; University of Michigan System; University of Michigan; Centers for Disease Control & Prevention - USA; University of Arkansas System; University of Arkansas Medical Sciences	Yang, ZH (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	zhenhua@umich.edu						Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Borgdorff MW, 2005, EMERG INFECT DIS, V11, P597, DOI 10.3201/eid1104.041103; Braden CR, 1997, J INFECT DIS, V175, P1446, DOI 10.1086/516478; Buchanan I., 2004, CALCULATING POISSON; Burzynski J, 2008, SEMIN RESP CRIT CARE, V29, P492, DOI 10.1055/s-0028-1085701; Cain KP, 2007, AM J RESP CRIT CARE, V175, P75, DOI 10.1164/rccm.200608-1178OC; Centers for Disease Control and Prevention, 2004, REP TUB US 2003; Centers for Disease Control and Prevention, 2010, REP TUB US 2010; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P181; Centers for Disease Control and Prevention (CDC), 2008, REP TUB US 2008; Centers for Disease Control and Prevention (CDC), 2009, REP TUB US 2009; Christianson S, 2010, TUBERCULOSIS, V90, P31, DOI 10.1016/j.tube.2009.12.003; Dillaha JA, 2002, EMERG INFECT DIS, V8, P1246; Eberhardt MS, 2004, AM J PUBLIC HEALTH, V94, P1682, DOI 10.2105/AJPH.94.10.1682; Ellis BA, 2002, EMERG INFECT DIS, V8, P1197; France AM, 2007, AM J EPIDEMIOL, V166, P662, DOI 10.1093/aje/kwm135; Ghosh S, 2012, INFECT GENET EVOL, V12, P782, DOI 10.1016/j.meegid.2011.10.013; Jasmer RM, 1999, ANN INTERN MED, V130, P971, DOI 10.7326/0003-4819-130-12-199906150-00004; Kempf MC, 2005, J CLIN MICROBIOL, V43, P870, DOI 10.1128/JCM.43.2.870-878.2005; National Center for Health Statistics, 2020, DIFF CHAR AD DAY SER; National TB Controllers Association/Center for Disease Control and Prevention Advisory Group on Tubercolosis Genotyping, 2004, GUID APPL GEN TUB PR; Nguyen LN, 2004, RESPIROLOGY, V9, P313, DOI 10.1111/j.1440-1843.2004.00603.x; O'Donnell MR, 2010, INT J TUBERC LUNG D, V14, P733; Oren E, 2011, AM J PUBLIC HEALTH, V101, P1256, DOI 10.2105/AJPH.2010.300030; Orszag P., 2009, OMB B, V10, P1; Pratt RH, 2011, J AM GERIATR SOC, V59, P851, DOI 10.1111/j.1532-5415.2011.03369.x; SAS Institute Inc, 2008, SAS VERS 9 2; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Talarico S, 2011, TUBERCULOSIS, V91, P244, DOI 10.1016/j.tube.2011.01.007; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; U.S. Census Bureau, 2010, 2010 CENS INT POP SE; *US CENS BUR, 2004, AM COMM SURV	32	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90664	10.1371/journal.pone.0090664	http://dx.doi.org/10.1371/journal.pone.0090664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618839	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400024
J	Gil-Ibanez, P; Bernal, J; Morte, B				Gil-Ibanez, Pilar; Bernal, Juan; Morte, Beatriz			Thyroid Hormone Regulation of Gene Expression in Primary Cerebrocortical Cells: Role of Thyroid Hormone Receptor Subtypes and Interactions with Retinoic Acid and Glucocorticoids	PLOS ONE			English	Article							MOUSE CEREBRAL-CORTEX; TRANSCRIPTIONAL REGULATION; GANGLIONIC EMINENCE; RESPONSE ELEMENT; BRAIN; RAT; DEXAMETHASONE; DEFICIENCY; MIGRATION; STRIATUM	The effects of thyroid hormone on brain development and function are largely mediated by the binding of 3,5,3'-triiodo-L-thyronine (T3) to its nuclear receptors (TR) to regulate positively or negatively gene expression. We have analyzed by quantitative polymerase chain reaction the effect of T3 on primary cultured cells from the embryonic mouse cerebral cortex, on the expression of Hr, Klf9, Shh, Dio3, Aldh1a1, and Aldh1a3. In particular we focused on T3 receptor specificity, and on the crosstalk between T3, retinoic acid and dexamethasone. To check for receptor subtype specificity we used cerebrocortical cells derived from wild type mice and from mice deficient in thyroid hormone receptor subtypes. Receptor subtype specificity was found for Dio3 and Aldh1a1, which were induced by T3 only in cells expressing the T3 receptor alpha 1 subtype. Interactions of T3 with retinoic acid signaling through the control of retinoic acid metabolism are likely to be important during development. T3 had opposing influences on retinoic acid synthesizing enzymes, increasing the expression of Aldh1a1, and decreasing Aldh1a3, while increasing the retinoic acid degrading enzyme Cyp26b1. Dexamethasone increased Klf9 and Aldh1a1 expression. The effects of T3 and dexamethasone on Aldh1a1 were highly synergistic, with mRNA increments of up to 20 fold. The results provide new data on thyroid hormone regulation of gene expression and underscore the importance of thyroid hormone interactions with retinoic acid and glucocorticoids during neural development.	[Gil-Ibanez, Pilar; Bernal, Juan; Morte, Beatriz] CSIC, Inst Invest Biomed, Madrid, Spain; [Gil-Ibanez, Pilar; Bernal, Juan; Morte, Beatriz] Univ Autonoma Madrid UAM, Madrid, Spain; [Gil-Ibanez, Pilar; Bernal, Juan; Morte, Beatriz] Inst Salud Carlos III, Ctr Biomed Res Rare Dis Ciberer, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Bernal, J (corresponding author), CSIC, Inst Invest Biomed, Madrid, Spain.	jbernal@iib.uam.es; bmorte@iib.uam.es	Gil-Ibanez, Pilar/AAW-2415-2021; Bernal, Juan/J-6086-2014	Bernal, Juan/0000-0002-5867-4951; Morte, Beatriz/0000-0003-0702-7815	Plan Nacional de I+D [SAF2011-25608]; Ramon Areces Foundation; Center for Biomedical Research on Rare Diseases (CIBERER), Instituto Carlos III, Spain; unta de Ampliacion de Estudios (JAE) from the Consejo Superior de Investigaciones Cientificas (CSIC)	Plan Nacional de I+D; Ramon Areces Foundation; Center for Biomedical Research on Rare Diseases (CIBERER), Instituto Carlos III, Spain; unta de Ampliacion de Estudios (JAE) from the Consejo Superior de Investigaciones Cientificas (CSIC)	Supported with grants from Plan Nacional de I+D SAF2011-25608, the Ramon Areces Foundation, and the Center for Biomedical Research on Rare Diseases (CIBERER), Instituto Carlos III, Spain. PG-I is recipient of a Junta de Ampliacion de Estudios (JAE) predoctoral contract from the Consejo Superior de Investigaciones Cientificas (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DW, 2011, BRAIN RES, V1408, P81, DOI 10.1016/j.brainres.2011.06.051; Attia RR, 2010, J BIOL CHEM, V285, P2375, DOI 10.1074/jbc.M109.039081; Barca-Mayo O, 2011, MOL ENDOCRINOL, V25, P575, DOI 10.1210/me.2010-0213; BARINAGA M, 1983, NATURE, V306, P84, DOI 10.1038/306084a0; BEDO G, 1989, NATURE, V339, P231, DOI 10.1038/339231a0; Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; Bonett RM, 2009, ENDOCRINOLOGY, V150, P1757, DOI 10.1210/en.2008-1441; Castillo AI, 2004, MOL CELL BIOL, V24, P502, DOI 10.1128/MCB.24.2.502-513.2004; Chatonnet F, 2013, P NATL ACAD SCI USA, V110, pE766, DOI 10.1073/pnas.1210626110; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Crandall JE, 2011, J NEUROCHEM, V119, P723, DOI 10.1111/j.1471-4159.2011.07471.x; Cuevas E, 2005, EUR J NEUROSCI, V22, P541, DOI 10.1111/j.1460-9568.2005.04243.x; Dentice M, 2007, P NATL ACAD SCI USA, V104, P14466, DOI 10.1073/pnas.0706754104; Denver RJ, 2009, ENDOCRINOLOGY, V150, P3935, DOI 10.1210/en.2009-0050; Desouza LA, 2011, ENDOCRINOLOGY, V152, P1989, DOI 10.1210/en.2010-1396; DIAMOND DJ, 1985, J MOL BIOL, V181, P41, DOI 10.1016/0022-2836(85)90323-7; Diez D, 2008, ENDOCRINOLOGY, V149, P3989, DOI 10.1210/en.2008-0350; EVANS RM, 1982, P NATL ACAD SCI-BIOL, V79, P7659, DOI 10.1073/pnas.79.24.7659; Flamant F, 2013, BBA-GEN SUBJECTS, V1830, P3900, DOI 10.1016/j.bbagen.2012.06.003; Furlow JD, 2002, ENDOCRINOLOGY, V143, P3295, DOI 10.1210/en.2002-220126; Galton VA, 2007, ENDOCRINOLOGY, V148, P3080, DOI 10.1210/en.2006-1727; Gil-Ibanez P, 2012, 94 ANN M END SOC HOU; Gil-Ibanez P, 2013, ENDOCRINOLOGY, V154, P1940, DOI 10.1210/en.2012-2189; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hernandez A, 2012, ENDOCRINOLOGY, V153, P2919, DOI 10.1210/en.2011-1905; Jacobs FMJ, 2007, DEVELOPMENT, V134, P2673, DOI 10.1242/dev.02865; Kumar S, 2012, BBA-MOL CELL BIOL L, V1821, P198, DOI 10.1016/j.bbalip.2011.04.004; Liao XH, 2011, ENDOCRINOLOGY, V152, P1180, DOI 10.1210/en.2010-0900; Lin JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052407; Liu YY, 2002, MOL ENDOCRINOL, V16, P2439, DOI 10.1210/me.2001-0324; Lu Z, 2001, BBA-MOL CELL BIOL L, V1532, P213, DOI 10.1016/S1388-1981(01)00135-4; Mayerl S, 2012, ENDOCRINOLOGY, V153, P1528, DOI 10.1210/en.2011-1633; Morte B, 2010, ENDOCRINOLOGY, V151, P2381, DOI 10.1210/en.2009-0944; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Pandak WM, 1997, J LIPID RES, V38, P2483; Ruiz F, 2000, EUR J PHARMACOL, V404, P29, DOI 10.1016/S0014-2999(00)00584-7; Samarut E, 2012, MOL CELL ENDOCRINOL, V348, P348, DOI 10.1016/j.mce.2011.03.025; Smith D, 2001, CEREB CORTEX, V11, P894, DOI 10.1093/cercor/11.10.894; Steineger HH, 1997, BIOCHIMIE, V79, P107, DOI 10.1016/S0300-9084(97)81499-X; Thompson CC, 1996, J NEUROSCI, V16, P7832; YAFFE BM, 1984, J BIOL CHEM, V259, P6284	41	49	49	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91692	10.1371/journal.pone.0091692	http://dx.doi.org/10.1371/journal.pone.0091692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618783	gold, Green Submitted, Green Published			2022-12-27	WOS:000332842400120
J	Mogk, S; Meiwes, A; Shtopel, S; Schraermeyer, U; Lazarus, M; Kubata, B; Wolburg, H; Duszenko, M				Mogk, Stefan; Meiwes, Andreas; Shtopel, Swetlana; Schraermeyer, Ulrich; Lazarus, Michael; Kubata, Bruno; Wolburg, Hartwig; Duszenko, Michael			Cyclical Appearance of African Trypanosomes in the Cerebrospinal Fluid: New Insights in How Trypanosomes Enter the CNS	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; BRUCEI-BRUCEI; NERVOUS-SYSTEM; LONG SLENDER; BRAIN; MODEL; MICE; DIFFERENTIATION; INFECTION; PATHOGENESIS	It is textbook knowledge that human infective forms of Trypanosoma brucei, the causative agent of sleeping sickness, enter the brain across the blood-brain barrier after an initial phase of weeks (rhodesiense) or months (gambiense) in blood. Based on our results using an animal model, both statements seem questionable. As we and others have shown, the first infection relevant crossing of the blood brain border occurs via the choroid plexus, i.e. via the blood-CSF barrier. In addition, counting trypanosomes in blood-free CSF obtained by an atlanto-occipital access revealed a cyclical infection in CSF that was directly correlated to the trypanosome density in blood infection. We also obtained conclusive evidence of organ infiltration, since parasites were detected in tissues outside the blood vessels in heart, spleen, liver, eye, testis, epididymis, and especially between the cell layers of the pia mater including the Virchow-Robin space. Interestingly, in all organs except pia mater, heart and testis, trypanosomes showed either a more or less degraded appearance of cell integrity by loss of the surface coat (VSG), loss of the microtubular cytoskeleton and loss of the intracellular content, or where taken up by phagocytes and degraded intracellularly within lysosomes. This is also true for trypanosomes placed intrathecally into the brain parenchyma using a stereotactic device. We propose a different model of brain infection that is in accordance with our observations and with well-established facts about the development of sleeping sickness.	[Mogk, Stefan; Meiwes, Andreas; Shtopel, Swetlana; Duszenko, Michael] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Schraermeyer, Ulrich] Univ Tubingen, Inst Ophthalmol, Tubingen, Germany; [Lazarus, Michael] Univ Tsukuba, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki, Japan; [Kubata, Bruno] AU NEPAD Agcy Reg Off, Nairobi, Kenya; [Wolburg, Hartwig] Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany; [Duszenko, Michael] Tongji Univ, Fac Med & Life Sci, Shanghai 200092, Peoples R China	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Tsukuba; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Tongji University	Duszenko, M (corresponding author), Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany.	michael.duszenko@uni-tuebingen.de	Lazarus, Michael/G-3130-2010	Lazarus, Michael/0000-0003-3863-4474	German research foundation [DU 136/15-1]; IZKF, University of Tubingen	German research foundation(German Research Foundation (DFG)); IZKF, University of Tubingen	This work was supported by the German research foundation, grant DU 136/15-1; A.M. received a personal fellowship from IZKF, University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottan S, 2012, IEEE T BIO-MED ENG, V59, P1532, DOI 10.1109/TBME.2012.2187448; Bruce SirD., 1914, Transactions of the Royal Society of Tropical Medicine and Hygiene London, V8, DOI 10.1016/S0035-9203(14)90016-5; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Claes F, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000486; Darsaud A, 2004, SLEEP, V27, P42, DOI 10.1093/sleep/27.1.42; Delgado M, 2009, CELL DEATH DIFFER, V16, P406, DOI 10.1038/cdd.2008.161; Denninger V, 2008, METHOD ENZYMOL, V451, P373, DOI 10.1016/S0076-6879(08)03225-4; Duszenko M, 2006, TRENDS PARASITOL, V22, P536, DOI 10.1016/j.pt.2006.08.010; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Figarella K, 2006, CELL DEATH DIFFER, V13, P1802, DOI 10.1038/sj.cdd.4401862; Figarella K, 2005, CELL DEATH DIFFER, V12, P335, DOI 10.1038/sj.cdd.4401564; Frankmann S, 1987, NEW APPROACH REPEATE; Frevert U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043913; Gonzalez-Rey E, 2006, ANN NY ACAD SCI, V1070, P303, DOI 10.1196/annals.1317.032; Grab DJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000479; Grab DJ, 2008, J NEUROVIROL, V14, P344, DOI 10.1080/13550280802282934; Grandgenett PM, 2007, PLOS PATHOG, V3, P1432, DOI 10.1371/journal.ppat.0030150; GRASSIZUCCONI G, 1995, BRAIN RES BULL, V37, P123, DOI 10.1016/0361-9230(94)00265-3; GREENWOOD BM, 1980, T ROY SOC TROP MED H, V74, P716, DOI 10.1016/0035-9203(80)90184-4; Gruszynski AE, 2003, J BIOL CHEM, V278, P24665, DOI 10.1074/jbc.M301497200; HAMM B, 1990, MOL BIOCHEM PARASIT, V40, P13, DOI 10.1016/0166-6851(90)90075-W; HESSE F, 1995, MOL BIOCHEM PARASIT, V70, P157, DOI 10.1016/0166-6851(95)00027-X; Huang YL, 1995, J NEUROSCI METH, V63, P13, DOI 10.1016/0165-0270(95)00080-1; Jennings F W, 1983, Contrib Microbiol Immunol, V7, P147; JENNINGS FW, 1979, INT J PARASITOL, V9, P381, DOI 10.1016/0020-7519(79)90089-4; Koopmann R, 2012, NAT METHODS, V9, P259, DOI [10.1038/NMETH.1859, 10.1038/nmeth.1859]; Kreier J, 1977, PARASITIC PROTOZOA, V1, P205; Kubata BK, 2000, J EXP MED, V192, P1327, DOI 10.1084/jem.192.9.1327; Kubata BK, 2007, TRENDS PARASITOL, V23, P325, DOI 10.1016/j.pt.2007.05.005; LAI YL, 1983, J APPL PHYSIOL, V54, P1754, DOI 10.1152/jappl.1983.54.6.1754; LAMBERT PH, 1981, J CLIN INVEST, V67, P77, DOI 10.1172/JCI110035; Leggat PA, 2001, TRAVEL MED INFECT DI, V1, P137; Lentner C, 1981, GEIGY SCI TABLES, P1; Masocha W, 2012, VIRULENCE, V3, P202, DOI 10.4161/viru.19178; Mogk S, 2012, NEUROLOGY PSYCHAIT B, V18, P49; Mulenga C, 2001, NEUROPATH APPL NEURO, V27, P77, DOI 10.1046/j.0305-1846.2001.00306.x; Myburgh E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002384; ORMEROD WE, 1986, T ROY SOC TROP MED H, V80, P626, DOI 10.1016/0035-9203(86)90161-6; Osterauer R, 2010, EVOL DEV, V12, P474, DOI 10.1111/j.1525-142X.2010.00433.x; Paxinos Ge WC, 1998, RAT BRAIN STEREOTAXI; PENTREATH VW, 1995, T ROY SOC TROP MED H, V89, P9, DOI 10.1016/0035-9203(95)90637-1; PENTREATH VW, 1992, ANN TROP MED PARASIT, V86, P29, DOI 10.1080/00034983.1992.11812627; POLTERA AA, 1980, CLIN EXP IMMUNOL, V40, P496; Radwanska M, 2002, AM J TROP MED HYG, V67, P684, DOI 10.4269/ajtmh.2002.67.684; RASEROKA B H, 1986, Parasitology Today, V2, P147, DOI 10.1016/0169-4758(86)90182-1; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Reuner B, 1997, MOL BIOCHEM PARASIT, V90, P269, DOI 10.1016/S0166-6851(97)00160-6; Schlitzer Martin, 2009, Pharm Unserer Zeit, V38, P552, DOI 10.1002/pauz.200900344; SCHMIDT H, 1983, VIRCHOWS ARCH A, V399, P333, DOI 10.1007/BF00612951; SCHULTZBERG M, 1988, J NEUROSCI RES, V21, P56, DOI 10.1002/jnr.490210109; Seed JR, 1997, J PARASITOL, V83, P656, DOI 10.2307/3284243; STEVENS DR, 1977, ACTA NEUROPATHOL, V38, P173, DOI 10.1007/BF00688062; VANMARCK EAE, 1981, ANN SOC BELG MED TR, V61, P57; VICKERMAN K, 1965, NATURE, V208, P762, DOI 10.1038/208762a0; Wewer C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-51; Wheeler RJ, 2010, TRENDS PARASITOL, V26, P457, DOI 10.1016/j.pt.2010.05.005; WHO, 2013, AFR TRYP SLEEP SICKN; Wilkinson SR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001252; Wolburg H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034304	60	37	37	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91372	10.1371/journal.pone.0091372	http://dx.doi.org/10.1371/journal.pone.0091372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618708	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400081
J	Shi, XZ; Wang, L; Xu, S; Zhang, XW; Zhao, XF; Vasta, GR; Wang, JX				Shi, Xiu-Zhen; Wang, Lei; Xu, Sen; Zhang, Xiao-Wen; Zhao, Xiao-Fan; Vasta, Gerardo Raul; Wang, Jin-Xing			A Galectin from the Kuruma Shrimp (Marsupenaeus japonicus) Functions as an Opsonin and Promotes Bacterial Clearance from Hemolymph	PLOS ONE			English	Article							OYSTER CRASSOSTREA-VIRGINICA; C-TYPE LECTINS; RECOGNITION RECEPTORS; FENNEROPENAEUS-CHINENSIS; ADAPTIVE IMMUNITY; CHINESE SHRIMP; INNATE; PHOSPHATIDYLSERINE; HEMOCYTES; DIVERSITY	Galectins are a lectin family characterized by a conserved sequence motif in the carbohydrate recognition domain, which preferential binds to galactosyl moieties. However, few studies about the biological roles of galectins in invertebrates have been reported except for the galectin (CvGal1) from the eastern oyster Crassostrea virginica. Furthermore, galectins have been described in only a few crustacean species, and no functional studies have been reported so far. In this study, we identified and functionally characterized a galectin from the kuruma shrimp Marsupenaeus japonicus, which we designated MjGal. Upon Vibrio anguillarum challenge, expression of MjGal was up-regulated mostly in hemocytes and hepatopancreas, and the protein bound to both Gram-positive and Gram-negative bacteria through the recognition of lipoteichoic acid (LTA) or lipopolysaccharide (LPS), respectively. By also binding to the shrimp hemocyte surface, MjGal functions as an opsonin for microbial pathogens, promoting their phagocytosis. Further, as shown by RNA interference, MjGal participates in clearance of bacteria from circulation, and thereby contributes to the shrimp's immune defense against infectious challenge. Elucidation of functional and mechanistic aspects of shrimp immunity will enable the development of novel strategies for intervention in infectious diseases currently affecting the shrimp farming industry worldwide.	[Shi, Xiu-Zhen; Wang, Lei; Xu, Sen; Zhang, Xiao-Wen; Zhao, Xiao-Fan; Wang, Jin-Xing] Shandong Univ, MOE Key Lab Plant Cell Engn & Germplasm Innovat, Shandong Prov Key Lab Anim Cells & Dev Biol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Vasta, Gerardo Raul] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Vasta, Gerardo Raul] Inst Marine & Environm Technol, Baltimore, MD USA	Shandong University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology	Wang, JX (corresponding author), Shandong Univ, MOE Key Lab Plant Cell Engn & Germplasm Innovat, Shandong Prov Key Lab Anim Cells & Dev Biol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	jxwang@sdu.edu.cn	Wang, Jin-Xing/AAU-1514-2021; Zhao, Xiao-Fan/AGW-9886-2022	Zhao, Xiao-Fan/0000-0003-1809-4730; Wang, Jin-Xing/0000-0003-0283-3930	National Natural Science Foundation of China [31130056]; Special Fund for the Major State Basic Research Project [2012CB114405]; Ph.D. Programs Foundation of the Ministry of Education of China [20110131130003]; Provincial Natural Science Foundation of Shandong, China [ZR2011CM014]; National Science Foundation [IOS 1050518, IOB-0618409, IOS-0822257]; National Institutes of Health [5R01GM070589-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070589] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for the Major State Basic Research Project; Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); Provincial Natural Science Foundation of Shandong, China; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financially supported by grants from the National Natural Science Foundation of China (No. 31130056), the Special Fund for the Major State Basic Research Project (No. 2012CB114405), the Ph.D. Programs Foundation of the Ministry of Education of China (No. 20110131130003), Provincial Natural Science Foundation of Shandong, China (No. ZR2011CM014) to JXW, and grants IOS 1050518, IOB-0618409, IOS-0822257 from the National Science Foundation, and 5R01GM070589-06 from the National Institutes of Health to GRV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrionuevo P, 2007, J IMMUNOL, V178, P436, DOI 10.4049/jimmunol.178.1.436; Chen HY, 2006, J IMMUNOL, V177, P4991, DOI 10.4049/jimmunol.177.8.4991; Feng CG, 2013, J BIOL CHEM, V288, P24394, DOI 10.1074/jbc.M113.476531; Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999; Han F, 2010, FISH SHELLFISH IMMUN, V29, P875, DOI 10.1016/j.fsi.2010.07.030; Hernandez JD, 2002, GLYCOBIOLOGY, V12, p127R, DOI 10.1093/glycob/cwf081; Hsu DK, 2006, METHOD ENZYMOL, V417, P256, DOI 10.1016/S0076-6879(06)17018-4; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; JOHANSSON MW, 1988, J CELL BIOL, V106, P1795, DOI 10.1083/jcb.106.5.1795; Kim JY, 2008, DEV COMP IMMUNOL, V32, P1131, DOI 10.1016/j.dci.2008.03.002; Kurz S, 2013, J BIOL CHEM, V288, P24410, DOI 10.1074/jbc.M113.478933; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; McTaggart SJ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-63; Rabinovich GA, 2002, BBA-GEN SUBJECTS, V1572, P274, DOI 10.1016/S0304-4165(02)00314-8; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Shi XZ, 2009, COMP BIOCHEM PHYS B, V153, P54, DOI 10.1016/j.cbpb.2009.01.011; Stowell SR, 2008, J BIOL CHEM, V283, P20547, DOI 10.1074/jbc.M802495200; Stowell SR, 2007, BLOOD, V109, P219, DOI 10.1182/blood-2006-03-007153; Stowell SR, 2009, MOL BIOL CELL, V20, P1408, DOI 10.1091/mbc.E08-07-0786; Sun C, 2011, FISH SHELLFISH IMMUN, V30, P295, DOI 10.1016/j.fsi.2010.10.022; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tasumi S, 2007, J IMMUNOL, V179, P3086, DOI 10.4049/jimmunol.179.5.3086; Vasta GR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00199; Vasta GR, 2012, ADV EXP MED BIOL, V946, P21, DOI 10.1007/978-1-4614-0106-3_2; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Vasta GR, 2004, CURR OPIN STRUC BIOL, V14, P617, DOI 10.1016/j.sbi.2004.09.008; Vasta GR, 1999, DEV COMP IMMUNOL, V23, P401, DOI 10.1016/S0145-305X(99)00020-8; Wang XW, 2013, FISH SHELLFISH IMMUN, V34, P981, DOI 10.1016/j.fsi.2012.08.008; Wang XW, 2013, DEV COMP IMMUNOL, V39, P27, DOI 10.1016/j.dci.2012.04.009; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Zhang XW, 2009, MOL IMMUNOL, V46, P1626, DOI 10.1016/j.molimm.2009.02.029	35	45	48	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91794	10.1371/journal.pone.0091794	http://dx.doi.org/10.1371/journal.pone.0091794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618590	Green Submitted, gold, Green Published			2022-12-27	WOS:000332842400133
J	Takahashi, S; Saito, K; Jia, HJ; Kato, H				Takahashi, Shoko; Saito, Kenji; Jia, Huijuan; Kato, Hisanori			An Integrated Multi-Omics Study Revealed Metabolic Alterations Underlying the Effects of Coffee Consumption	PLOS ONE			English	Article							RISK; CYCLE	Many epidemiological studies have indicated that coffee consumption may reduce the risks of developing obesity and diabetes, but the underlying mechanisms of these effects are poorly understood. Our previous study revealed the changes on gene expression profiles in the livers of C57BL/6J mice fed a high-fat diet containing three types of coffee (caffeinated, decaffeinated and green unroasted coffee), using DNA microarrays. The results revealed remarkable alterations in lipid metabolism-related molecules which may be involved in the anti-obesity effects of coffee. We conducted the present study to further elucidate the metabolic alterations underlying the effects of coffee consumption through comprehensive proteomic and metabolomic analyses. Proteomics revealed an up-regulation of isocitrate dehydrogenase (a key enzyme in the TCA cycle) and its related proteins, suggesting increased energy generation. The metabolomics showed an upregulation of metabolites involved in the urea cycle, with which the transcriptome data were highly consistent, indicating accelerated energy expenditure. The TCA cycle and the urea cycle are likely be accelerated in a concerted manner, since they are directly connected by mutually providing each other's intermediates. The up-regulation of these pathways might result in a metabolic shift causing increased ATP turnover, which is related to the alterations of lipid metabolism. This mechanism may play an important part in the suppressive effects of coffee consumption on obesity, inflammation, and hepatosteatosis. This study newly revealed global metabolic alterations induced by coffee intake, providing significant insights into the association between coffee intake and the prevention of type 2 diabetes, utilizing the benefits of multi-omics analyses.	[Takahashi, Shoko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Takahashi, Shoko; Saito, Kenji; Jia, Huijuan; Kato, Hisanori] Univ Tokyo, Org Interdisciplinary Res Projects, Tokyo, Japan	University of Tokyo; University of Tokyo	Kato, H (corresponding author), Univ Tokyo, Org Interdisciplinary Res Projects, Tokyo, Japan.	akatoq@mail.ecc.u-tokyo.ac.jp			All Japan Coffee Association	All Japan Coffee Association(All Japan Coffee Association)	This study was partly supported by a grant from the All Japan Coffee Association. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBER T, 1985, BIOCHEM J, V230, P675, DOI 10.1042/bj2300675; Carlsson S, 2004, INT J EPIDEMIOL, V33, P616, DOI 10.1093/ije/dyh185; Evans GA, 2000, NAT BIOTECHNOL, V18, P127, DOI 10.1038/72480; Fukushima Y, 2009, J AGR FOOD CHEM, V57, P11100, DOI 10.1021/jf901278u; Goodman N, 2002, CURR OPIN BIOTECH, V13, P68, DOI 10.1016/S0958-1669(02)00287-2; Jia HJ, 2013, MOL NUTR FOOD RES, V57, P291, DOI 10.1002/mnfr.201200538; Kato H, 2008, ASIA PAC J CLIN NUTR, V17, P12; Kato Hisanori, 2011, J Tradit Complement Med, V1, P25; Monton MRN, 2007, J CHROMATOGR A, V1168, P237, DOI 10.1016/j.chroma.2007.02.065; Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; SHAMBAUGH GE, 1977, AM J CLIN NUTR, V30, P2083, DOI 10.1093/ajcn/30.12.2083; Takahashi S, 2013, J FUNCT FOO IN PRESS; Takahashi S, 2011, BIOCHEM BIOPH RES CO, V405, P462, DOI 10.1016/j.bbrc.2011.01.054; van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97; van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X; Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c	18	11	12	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91134	10.1371/journal.pone.0091134	http://dx.doi.org/10.1371/journal.pone.0091134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618914	Green Submitted, gold, Green Published			2022-12-27	WOS:000332842400049
J	Zhong, Z; Ramshesh, VK; Rehman, H; Liu, QL; Theruvath, TP; Krishnasamy, Y; Lemasters, JJ				Zhong, Zhi; Ramshesh, Venkat K.; Rehman, Hasibur; Liu, Qinlong; Theruvath, Tom P.; Krishnasamy, Yasodha; Lemasters, John J.			Acute Ethanol Causes Hepatic Mitochondrial Depolarization in Mice: Role of Ethanol Metabolism	PLOS ONE			English	Article							ALCOHOLIC FATTY LIVER; PERMEABILITY TRANSITION INHIBITOR; RAT-LIVER; OXIDATIVE STRESS; REACTIVE OXYGEN; SWIFT INCREASE; N-METHYL-4-ISOLEUCINE CYCLOSPORINE; STIMULATES GLYCOGENOLYSIS; MOLECULAR-MECHANISMS; ADAPTIVE INCREASE	Background/Aims: An increase of ethanol metabolism and hepatic mitochondrial respiration occurs in vivo after a single binge of alcohol. Here, our aim was to determine how ethanol intake affects hepatic mitochondrial polarization status in vivo in relation to ethanol metabolism and steatosis. Methods: Hepatic mitochondrial polarization, permeability transition (MPT), and reduce pyridine nucleotides, and steatosis in mice were monitored by intravital confocal/multiphoton microscopy of the fluorescence of rhodamine 123 (Rh123), calcein, NAD(P) H, and BODIPY493/503, respectively, after gavage with ethanol (1-6 g/kg). Results: Mitochondria depolarized in an all-or-nothing fashion in individual hepatocytes as early as 1 h after alcohol. Depolarization was dose-and time-dependent, peaked after 6 to 12 h and maximally affected 94% of hepatocytes. This mitochondrial depolarization was not due to onset of the MPT. After 24 h, mitochondria of most hepatocytes recovered normal polarization and were indistinguishable from untreated after 7 days. Cell death monitored by propidium iodide staining, histology and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) was low throughout. After alcohol, mitochondrial NAD(P) H autofluorescence increased and decreased, respectively, in hepatocytes with polarized and depolarized mitochondria. Ethanol also caused steatosis mainly in hepatocytes with depolarized mitochondria. Depolarization was linked to ethanol metabolism, since deficiency of alcohol dehydrogenase and cytochrome-P450 2E1 (CYP2E1), the major ethanol-metabolizing enzymes, decreased mitochondrial depolarization by similar to 70% and similar to 20%, respectively. Activation of aldehyde dehydrogenase decreased depolarization, whereas inhibition of aldehyde dehydrogenase enhanced depolarization. Activation of aldehyde dehydrogenase also markedly decreased steatosis. Conclusions: Acute ethanol causes reversible hepatic mitochondrial depolarization in vivo that may contribute to steatosis and increased mitochondrial respiration. Onset of this mitochondrial depolarization is linked, at least in part, to metabolism of ethanol to acetaldehyde.	[Zhong, Zhi; Ramshesh, Venkat K.; Rehman, Hasibur; Liu, Qinlong; Theruvath, Tom P.; Krishnasamy, Yasodha; Lemasters, John J.] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Lemasters, John J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Zhong, Zhi; Ramshesh, Venkat K.; Lemasters, John J.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Zhong, Z (corresponding author), Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA.	zhong@musc.edu	Rehman, Hasibur/K-5224-2019	Rehman, Hasibur/0000-0003-1551-6520	National Institutes of Health (NIH) [R01 AA0177561, R01 DK37034]; Charleston Alcohol Research Center [P50 AA010761]; NIH [1P30 CA138313, C06 RR015455]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037034, R01DK073336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA010761] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charleston Alcohol Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in part, by Grants R01 AA0177561 and R01 DK37034 from the National Institutes of Health (NIH) and a grant from Charleston Alcohol Research Center [P50 AA010761]. The Cell & Molecular Imaging Core of the Hollings Cancer Center at the Medical University of South Carolina supported by NIH Grant 1P30 CA138313 provided instrumentation and assistance for confocal/multiphoton microscopy. The animals were housed in the Animal Resources at Medical University of South Carolina supported by NIH Grant C06 RR015455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2002, FREE RADICAL BIO MED, V32, P487, DOI 10.1016/S0891-5849(02)00740-2; ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6; Andringa KK, 2010, AM J PHYSIOL-GASTR L, V298, pG732, DOI 10.1152/ajpgi.00332.2009; Arteel GE, 1996, AM J PHYSIOL-GASTR L, V271, pG494, DOI 10.1152/ajpgi.1996.271.3.G494; Bailey SM, 1999, FREE RADICAL BIO MED, V27, P891, DOI 10.1016/S0891-5849(99)00138-0; Bergheim I, 2006, J PHARMACOL EXP THER, V316, P592, DOI 10.1124/jpet.105.095042; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Bradford BU, 2005, ALCOHOL, V35, P13, DOI 10.1016/j.alcohol.2004.12.001; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Choi S, 2005, CURR OPIN GASTROEN, V21, P702, DOI 10.1097/01.mog.0000182863.96421.47; Crabb DW, 2004, ALCOHOL, V34, P35, DOI 10.1016/j.alcohol.2004.07.005; De Rosa MF, 2008, J BIOL CHEM, V283, P4501, DOI 10.1074/jbc.M705473200; El-Assal O, 2004, CELL MOL IMMUNOL, V1, P205; Enomoto N, 2000, AM J PHYSIOL-GASTR L, V279, pG100, DOI 10.1152/ajpgi.2000.279.1.G100; Femandez-Checa JC, 2005, TOXICOL APPL PHARM, V204, P263, DOI 10.1016/j.taap.2004.10.001; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; FRENCH SW, 1984, HEPATOLOGY, V4, P912, DOI 10.1002/hep.1840040521; French SW, 2004, HEPATOL RES, V29, P69, DOI 10.1016/j.hepres.2004.02.006; FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6; GORES GJ, 1988, AM J PHYSIOL, V255, pC315, DOI 10.1152/ajpcell.1988.255.3.C315; Holmuhamedov E, 2009, ARCH BIOCHEM BIOPHYS, V481, P226, DOI 10.1016/j.abb.2008.10.036; Holmuhamedov EL, 2012, J BIOL CHEM, V287, P7692, DOI 10.1074/jbc.M111.293399; Ikejima K, 2007, J GASTROEN HEPATOL, V22, pS87, DOI 10.1111/j.1440-1746.2007.04961.x; ISHAK KG, 1991, ALCOHOL CLIN EXP RES, V15, P45, DOI 10.1111/j.1530-0277.1991.tb00518.x; JI SC, 1982, P NATL ACAD SCI-BIOL, V79, P5415, DOI 10.1073/pnas.79.17.5415; Kao E, 2012, HEPATOLOGY, V56, P594, DOI 10.1002/hep.25702; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; King AL, 2014, AM J PHYSIOL-GASTR L, V306, pG265, DOI 10.1152/ajpgi.00278.2013; KUBOTA M, 1992, P SOC EXP BIOL MED, V201, P114, DOI 10.3181/00379727-201-43488; LEMASTERS JJ, 1981, SCIENCE, V213, P661, DOI 10.1126/science.7256265; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Lemasters JJ, 2013, DRUG-INDUCED LIVER DISEASE, 3RD EDITION, P85, DOI 10.1016/B978-0-12-387817-5.00005-4; Leung TM, 2012, HEPATOLOGY, V55, P1596, DOI 10.1002/hep.25543; Levine JA, 2000, EUR J CLIN INVEST, V30, P779; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; Liu QL, 2012, FREE RADICAL BIO MED, V53, P250, DOI 10.1016/j.freeradbiomed.2012.05.012; Mandayam S, 2004, SEMIN LIVER DIS, V24, P217, DOI 10.1055/s-2004-832936; Matsuhashi T, 1998, FREE RADICAL BIO MED, V24, P139, DOI 10.1016/S0891-5849(97)00210-4; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; Micuda S, 2005, BASIC CLIN PHARMACOL, V96, P257, DOI 10.1111/j.1742-7843.2005.pto960322.x; Mokuda O, 2004, ANN NUTR METAB, V48, P276, DOI 10.1159/000080463; Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256; NIEMINEN AL, 1995, BIOCHEM J, V307, P99, DOI 10.1042/bj3070099; Nieminen AL, 1997, AM J PHYSIOL-CELL PH, V272, pC1286; Pessayre D, 2012, DRUG METAB REV, V44, P34, DOI 10.3109/03602532.2011.604086; Pritchard MT, 2007, GASTROENTEROLOGY, V132, P1117, DOI 10.1053/j.gastro.2007.01.053; Rehman H, 2008, J PHARMACOL EXP THER, V327, P699, DOI 10.1124/jpet.108.143578; Rehman H, 2008, TRANSPLANTATION, V85, P1322, DOI 10.1097/TP.0b013e31816de302; Rehman H, 2011, TRANSPLANTATION, V91, P406, DOI 10.1097/TP.0b013e318204bdb2; Rivera CA, 1998, AM J PHYSIOL-GASTR L, V275, pG1252, DOI 10.1152/ajpgi.1998.275.6.G1252; Rogers CQ, 2008, IUBMB LIFE, V60, P790, DOI 10.1002/iub.124; Ross DD, 2004, BEST PRACT RES CL HA, V17, P641, DOI 10.1016/j.beha.2004.08.014; Saito C, 2010, TOXICOL APPL PHARM, V242, P182, DOI 10.1016/j.taap.2009.10.006; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Setshedi M, 2010, OXID MED CELL LONGEV, V3, P178, DOI 10.4161/oxim.3.3.12288; SHELMET JJ, 1988, J CLIN INVEST, V81, P1137, DOI 10.1172/JCI113428; Shi YJ, 2012, J HEPATOL, V56, P137, DOI 10.1016/j.jhep.2011.05.025; Shuttleworth CW, 2010, NEUROCHEM INT, V56, P379, DOI 10.1016/j.neuint.2009.12.015; SIES H, 1974, H-S Z PHYSIOL CHEM, V355, P305, DOI 10.1515/bchm2.1974.355.1.305; SUTER PM, 1994, AM J PHYSIOL, V266, pR1204, DOI 10.1152/ajpregu.1994.266.4.R1204; Theruvath TP, 2008, HEPATOLOGY, V47, P236, DOI 10.1002/hep.21912; Thiele GM, 2001, ALCOHOL CLIN EXP RES, V25, p218S, DOI 10.1111/j.1530-0277.2001.tb02399.x; THURMAN RG, 1979, DRUG ALCOHOL DEPEN, V4, P119, DOI 10.1016/0376-8716(79)90052-8; THURMAN RG, 1982, J PHARMACOL EXP THER, V223, P45; THURMAN RG, 1976, MOL PHARMACOL, V12, P156; Thurman RG, 1996, ANN CLIN LAB SCI, V26, P351; Tsukamoto H, 2009, SEMIN LIVER DIS, V29, P178, DOI 10.1055/s-0029-1214373; VIDELA L, 1970, BIOCHEM J, V118, P275, DOI 10.1042/bj1180275; Williams CD, 2014, TOXICOL APPL PHARM, V274, P417, DOI 10.1016/j.taap.2013.12.003; Yin HQ, 2012, J BIOL CHEM, V287, P9817, DOI 10.1074/jbc.M111.333534; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; YUKI T, 1980, BIOCHEM J, V186, P119, DOI 10.1042/bj1860119; Zhong Z, 2007, AM J TRANSPLANT, V7, P1103, DOI 10.1111/j.1600-6143.2007.01770.x; Zhong Z, 2008, AM J PHYSIOL-GASTR L, V295, pG823, DOI 10.1152/ajpgi.90287.2008; Zhong Z, 2006, TRANSPLANTATION, V82, P241, DOI 10.1097/01.tp.0000228867.98158.d2; Zhou ZX, 2003, AM J PATHOL, V163, P1137, DOI 10.1016/S0002-9440(10)63473-6	77	56	56	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91308	10.1371/journal.pone.0091308	http://dx.doi.org/10.1371/journal.pone.0091308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618581	Green Submitted, gold, Green Published			2022-12-27	WOS:000332842400072
J	Middleton, CP; Senerchia, N; Stein, N; Akhunov, ED; Keller, B; Wicker, T; Kilian, B				Middleton, Christopher P.; Senerchia, Natacha; Stein, Nils; Akhunov, Eduard D.; Keller, Beat; Wicker, Thomas; Kilian, Benjamin			Sequencing of Chloroplast Genomes from Wheat, Barley, Rye and Their Relatives Provides a Detailed Insight into the Evolution of the Triticeae Tribe	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; NUCLEAR-DNA AMOUNTS; DIVERGENCE TIMES; 3-PHOSPHOGLYCERATE KINASE; PHYLOGENETIC ANALYSIS; MOLECULAR EVOLUTION; ANCIENT HAPLOTYPES; SORGHUM-BICOLOR; POLYPLOID WHEAT; ABSOLUTE RATES	Using Roche/454 technology, we sequenced the chloroplast genomes of 12 Triticeae species, including bread wheat, barley and rye, as well as the diploid progenitors and relatives of bread wheat Triticum urartu, Aegilops speltoides and Ae. tauschii. Two wild tetraploid taxa, Ae. cylindrica and Ae. geniculata, were also included. Additionally, we incorporated wild Einkorn wheat Triticum boeoticum and its domesticated form T. monococcum and two Hordeum spontaneum (wild barley) genotypes. Chloroplast genomes were used for overall sequence comparison, phylogenetic analysis and dating of divergence times. We estimate that barley diverged from rye and wheat approximately 8-9 million years ago (MYA). The genome donors of hexaploid wheat diverged between 2.1-2.9 MYA, while rye diverged from Triticum aestivum approximately 3-4 MYA, more recently than previously estimated. Interestingly, the A genome taxa T. boeoticum and T. urartu were estimated to have diverged approximately 570,000 years ago. As these two have a reproductive barrier, the divergence time estimate also provides an upper limit for the time required for the formation of a species boundary between the two. Furthermore, we conclusively show that the chloroplast genome of hexaploid wheat was contributed by the B genome donor and that this unknown species diverged from Ae. speltoides about 980,000 years ago. Additionally, sequence alignments identified a translocation of a chloroplast segment to the nuclear genome which is specific to the rye/wheat lineage. We propose the presented phylogeny and divergence time estimates as a reference framework for future studies on Triticeae.	[Middleton, Christopher P.; Keller, Beat; Wicker, Thomas] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Senerchia, Natacha] Univ Neuchatel, Inst Biol, Lab Evolutionary Bot, CH-2000 Neuchatel, Switzerland; [Stein, Nils; Kilian, Benjamin] Leibniz Inst Plant Genet & Crop Plant Res, Gatersleben, Germany; [Akhunov, Eduard D.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA	University of Zurich; University of Neuchatel; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Kansas State University	Wicker, T (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	wicker@botinst.uzh.ch	Stein, Nils/F-7507-2017; Wicker, Thomas/Z-1978-2019; Keller, Beat/K-3093-2019	Stein, Nils/0000-0003-3011-8731; Keller, Beat/0000-0003-2379-9225; , Thomas/0000-0002-6777-7135; Kilian, Benjamin/0000-0002-9145-6980	COST action [FA0604]; Swiss office for Education and research [37150503]	COST action(European Cooperation in Science and Technology (COST)); Swiss office for Education and research	This research was supported by COST action FA0604 and the Swiss office for Education and research grant number 37150503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov ED, 2003, GENOME RES, V13, P753, DOI 10.1101/gr.808603; Arbogast BS, 2002, ANNU REV ECOL SYST, V33, P707, DOI 10.1146/annurev.ecolsys.33.010802.150500; Bennett MD, 2011, ANN BOT-LONDON, V107, P467, DOI 10.1093/aob/mcq258; BENNETT MD, 1976, PHILOS T R SOC B, V274, P227, DOI 10.1098/rstb.1976.0044; Bordbar F, 2011, PLANT SYST EVOL, V291, P117, DOI 10.1007/s00606-010-0375-1; Bortiri Esteban, 2008, BMC Res Notes, V1, P61, DOI 10.1186/1756-0500-1-61; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Caldwell KS, 2004, GENETICS, V167, P941, DOI 10.1534/genetics.103.016303; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dvorak J, 2005, GENETICS, V171, P323, DOI 10.1534/genetics.105.041632; Edwards SV, 2000, EVOLUTION, V54, P1839; Eilam T, 2007, GENOME, V50, P1029, DOI 10.1139/G07-083; Escobar JS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-181; Feldman M., 1995, EVOLUTION CROP PLANT; Gandhi HT, 2005, THEOR APPL GENET, V111, P561, DOI 10.1007/s00122-005-2047-z; Golovnina KA, 2007, PLANT SYST EVOL, V264, P195, DOI 10.1007/s00606-006-0478-x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hirosawa S, 2004, GENES GENET SYST, V79, P271, DOI 10.1266/ggs.79.271; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Huang SX, 2002, PLANT MOL BIOL, V48, P805, DOI 10.1023/A:1014868320552; Isidore E, 2005, GENOME RES, V15, P526, DOI 10.1101/gr.3131005; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; JOHNSON BL, 1976, AM J BOT, V63, P1088, DOI 10.2307/2441653; Kihara H, 1944, AGR HORTIC, V19, P889; Kilian B, 2007, MOL BIOL EVOL, V24, P2657, DOI 10.1093/molbev/msm192; Kilian B, 2007, MOL BIOL EVOL, V24, P217, DOI 10.1093/molbev/msl151; Kilian B, 2009, PL GENET GENOM CROP, V7; Lloyd AH, 2011, MOL BIOL EVOL, V28, P2019, DOI 10.1093/molbev/msr021; Matsuo M, 2005, PLANT CELL, V17, P665, DOI 10.1105/tpc.104.027706; Nikiforova SV, 2013, MOL BIOL EVOL, V30, P1751, DOI 10.1093/molbev/mst092; Nock CJ, 2010, PLANT BIOTECHNOL J; Ogihara Y, 2002, MOL GENET GENOMICS, V266, P740, DOI 10.1007/s00438-001-0606-9; Ozkan H, 2010, AOB PLANTS, DOI 10.1093/aobpla/plq015; Paterson AH, 2009, PLANT PHYSIOL, V149, P125, DOI 10.1104/pp.108.129262; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Provan J, 2004, THEOR APPL GENET, V108, P1182, DOI 10.1007/s00122-003-1538-z; REES H, 1965, HEREDITY, V20, P73, DOI 10.1038/hdy.1965.9; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI 10.1007/s00122-007-0595-0; Schatz MC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-177; Scherrer B, 2005, PLANT CELL, V17, P361, DOI 10.1105/tpc.104.028225; Senerchia N, 2013, GENOME BIOL EVOL, V5, P1010, DOI 10.1093/gbe/evt064; Sheppard AE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000323; Soltis DE, 2004, TRENDS PLANT SCI, V9, P477, DOI 10.1016/j.tplants.2004.08.008; Steiper ME, 2008, EVOL ANTHROPOL, V17, P179, DOI 10.1002/evan.20177; Tamura K, 2011, MOL BIOL EVOL; Tsunewaki K, 1996, GENES GENET SYST, V71, P293, DOI 10.1266/ggs.71.293; TSUNEWAKI K, 1983, GENETICS, V104, P155; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wicker T, 2009, PLANT PHYSIOL, V149, P258, DOI 10.1104/pp.108.129734	56	111	117	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e85761	10.1371/journal.pone.0085761	http://dx.doi.org/10.1371/journal.pone.0085761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614886	Green Accepted, Green Published, gold			2022-12-27	WOS:000332839300003
J	Vandervoort, A; Houttekier, D; Stichele, RV; van der Steen, JT; Van den Block, L				Vandervoort, An; Houttekier, Dirk; Stichele, Robert Vander; van der Steen, Jenny T.; Van den Block, Lieve			Quality of Dying in Nursing Home Residents Dying with Dementia: Does Advanced Care Planning Matter? A Nationwide Postmortem Study	PLOS ONE			English	Article							OF-LIFE CARE; DIRECTIVES; PEOPLE; FAILURE; BELGIUM	Background: Advance care planning is considered a central component of good quality palliative care and especially relevant for people who lose the capacity to make decisions at the end of life, which is the case for many nursing home residents with dementia. We set out to investigate to what extent (1) advance care planning in the form of written advance patient directives and verbal communication with patient and/or relatives about future care and (2) the existence of written advance general practitioner orders are related to the quality of dying of nursing home residents with dementia. Methods: Cross-sectional study of deaths (2010) using random cluster-sampling. Representative sample of nursing homes in Flanders, Belgium. Deaths of residents with dementia in a three-month period were reported; for each the nurse most involved in care, GP and closest relative completed structured questionnaires. Findings: We identified 101 deaths of residents with dementia in 69 nursing homes (58% response rate). A written advance patient directive was present for 17.5%, GP-orders for 56.7%. Controlling for socio-demographic/clinical characteristics in multivariate regression analyses, chances of having a higher mean rating of emotional well-being (less fear and anxiety) on the Comfort Assessment in Dying with Dementia scale were three times higher with a written advance patient directive and more specifically when having a do-not-resuscitate order (AOR 3.45; CI, 1.1-11) than for those without either (AOR 2.99; CI, 1.1-8.3). We found no association between verbal communication or having a GP order and quality of dying. Conclusion: For nursing home residents with dementia there is a strong association between having a written advance directive and quality of dying. Where wishes are written, relatives report lower levels of emotional distress at the end of life. These results underpin the importance of advance care planning for people with dementia and beginning this process as early as possible.	[Vandervoort, An; Houttekier, Dirk; Stichele, Robert Vander; Van den Block, Lieve] Vrije Univ Brussel, End Of Life Care Res Grp, Brussels, Belgium; [Vandervoort, An; Houttekier, Dirk; Stichele, Robert Vander; Van den Block, Lieve] Univ Ghent, Brussels, Belgium; [Stichele, Robert Vander] Univ Ghent, Heymans Inst Pharmacol, B-9000 Ghent, Belgium; [van der Steen, Jenny T.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [van der Steen, Jenny T.] Vrije Univ Amsterdam, Med Ctr, Expertise Ctr Palliat Care, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands; [Van den Block, Lieve] Vrije Univ Brussel, Dept Family Med, Brussels, Belgium	Vrije Universiteit Brussel; Ghent University; Ghent University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Brussel	Van den Block, L (corresponding author), Vrije Univ Brussel, End Of Life Care Res Grp, Brussels, Belgium.	lvdblock@vub.ac.be	Stichele, Robert Vander/K-7203-2015; van der Steen, Jenny T./E-5118-2016; Houttekier, Dirk/F-4073-2011; Van den Block, Lieve/D-1247-2011	Stichele, Robert Vander/0000-0001-9118-9651; van der Steen, Jenny T./0000-0002-9063-7501; Houttekier, Dirk/0000-0003-0837-9898; Van den Block, Lieve/0000-0002-7770-348X	Vrije Universiteit Brussel (GOA HW, VUB); Dying Well; Research Foundation-Flanders (FWO)	Vrije Universiteit Brussel (GOA HW, VUB); Dying Well; Research Foundation-Flanders (FWO)(FWO)	This study is supported by a grant from Vrije Universiteit Brussel (GOA HW, VUB 2007) and is part of the Dying Well with Dementia study. L. Van den Block is a postdoctoral research fellow of the Research Foundation-Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarshi E, 2011, J PALLIAT MED, V14, P323, DOI 10.1089/jpm.2010.0312; Alhzeimer Europe, 2006, ALHZ EUR REP US ADV; Arnaert A, 1999, ACTA HOSP, V4, P19; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Bellelli G, 1997, ALZ DIS ASSOC DIS, V11, P71, DOI 10.1097/00002093-199706000-00003; Deliens L., 1991, HUISARTS NU, V20, P113; Dening KH, 2011, INT PSYCHOGERIATR, V23, P1535, DOI 10.1017/S1041610211001608; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Evans N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057965; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Hertogh CMPM, 2006, AGE AGEING, V35, P553, DOI 10.1093/ageing/afl103; Heyland DK, 2013, JAMA INTERN MED, V173, P778, DOI 10.1001/jamainternmed.2013.180; Meeussen K, 2012, INT PSYCHOGERIATR, V24, P1581, DOI 10.1017/S1041610212000865; Meeussen K, 2011, J PAIN SYMPTOM MANAG, V42, P565, DOI 10.1016/j.jpainsymman.2011.01.011; Mori M, 2013, SUPPORT CARE CANCER, V21, P629, DOI 10.1007/s00520-012-1581-x; Robinson L, 2012, AGE AGEING, V41, P263, DOI 10.1093/ageing/afr148; SCHNEIDERMAN LJ, 1992, ANN INTERN MED, V117, P599, DOI 10.7326/0003-4819-117-7-599; Seymour Jane, 2010, BMC Palliat Care, V9, P4, DOI 10.1186/1472-684X-9-4; TENO JM, 1994, J CLIN ETHIC, V5, P23; Teno JM, 1997, J AM GERIATR SOC, V45, P508, DOI 10.1111/j.1532-5415.1997.tb05179.x; TENO JM, 2003, GERIATRIC PALLIATIVE, P307; Teno JM, 2007, J AM GERIATR SOC, V55, P189, DOI 10.1111/j.1532-5415.2007.01045.x; van Soest-Poortvliet MC, 2013, J AM MED DIR ASSOC, V14, P179, DOI 10.1016/j.jamda.2012.09.019; Vandervoort A, 2013, J PAIN SYMPTOM MANAG; Vandervoort A, 2012, INT PSYCHOGERIATR, P1, DOI DOI 10.1080/13527258.2012.738334; Vandervoort A, 2013, J AM MED DIR ASSOC, V14, P485, DOI 10.1016/j.jamda.2013.01.016; Volicer L, 2001, ALZ DIS ASSOC DIS, V15, P194, DOI 10.1097/00002093-200110000-00005; World Health Organization, 2004, BETTER PALLIATIVE CA; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	29	70	71	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91130	10.1371/journal.pone.0091130	http://dx.doi.org/10.1371/journal.pone.0091130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614884	Green Submitted, gold, Green Published			2022-12-27	WOS:000332839300081
J	Yeh, TT; Cluff, T; Balasubramaniam, R				Yeh, Ting Ting; Cluff, Tyler; Balasubramaniam, Ramesh			Visual Reliance for Balance Control in Older Adults Persists When Visual Information Is Disrupted by Artificial Feedback Delays	PLOS ONE			English	Article							POSTURAL CONTROL; ELDERLY ADULTS; SPATIAL ORIENTATION; COGNITIVE TASKS; DUAL-TASK; ATTENTION; HEALTHY; STANCE; YOUNG; DYNAMICS	Sensory information from our eyes, skin and muscles helps guide and correct balance. Less appreciated, however, is that delays in the transmission of sensory information between our eyes, limbs and central nervous system can exceed several 10s of milliseconds. Investigating how these time-delayed sensory signals influence balance control is central to understanding the postural system. Here, we investigate how delayed visual feedback and cognitive performance influence postural control in healthy young and older adults. The task required that participants position their center of pressure (COP) in a fixed target as accurately as possible without visual feedback about their COP location (eyes-open balance), or with artificial time delays imposed on visual COP feedback. On selected trials, the participants also performed a silent arithmetic task (cognitive dual task). We separated COP time series into distinct frequency components using low and high-pass filtering routines. Visual feedback delays affected low frequency postural corrections in young and older adults, with larger increases in postural sway noted for the group of older adults. In comparison, cognitive performance reduced the variability of rapid center of pressure displacements in young adults, but did not alter postural sway in the group of older adults. Our results demonstrate that older adults prioritize vision to control posture. This visual reliance persists even when feedback about the task is delayed by several hundreds of milliseconds.	[Yeh, Ting Ting; Cluff, Tyler; Balasubramaniam, Ramesh] McMaster Univ, Dept Kinesiol, Sensorimotor Neurosci Lab, Hamilton, ON, Canada; [Cluff, Tyler] Queens Univ, Ctr Neurosci Studies, LIMB, Kingston, ON, Canada; [Balasubramaniam, Ramesh] Univ Calif Merced, Merced, CA USA	McMaster University; Queens University - Canada; University of California System; University of California Merced	Yeh, TT (corresponding author), McMaster Univ, Dept Kinesiol, Sensorimotor Neurosci Lab, Hamilton, ON, Canada.	yeht2@mcmaster.ca	Balasubramaniam, Ramesh/GWC-4248-2022; Yeh, Ting Ting/AAX-8155-2020	Balasubramaniam, Ramesh/0000-0001-7575-3080; YEH, TING-TING/0000-0003-0018-9467				Allison LK, 2006, EXP BRAIN RES, V175, P342, DOI 10.1007/s00221-006-0559-7; Amiridis IG, 2003, NEUROSCI LETT, V350, P137, DOI 10.1016/S0304-3940(03)00878-4; Balasubramaniam R, 2002, TRENDS COGN SCI, V6, P531, DOI 10.1016/S1364-6613(02)02021-1; Berger L, 2011, GAIT POSTURE, V33, P300, DOI 10.1016/j.gaitpost.2010.10.082; BLASZCZYK JW, 1993, PERCEPTION, V22, P1333, DOI 10.1068/p221333; Boulet J, 2010, PHILOS T R SOC A, V368, P423, DOI 10.1098/rsta.2009.0214; Brauer SG, 2002, GAIT POSTURE, V15, P83, DOI 10.1016/S0966-6362(01)00163-1; Cluff T, 2011, EXP BRAIN RES, V213, P15, DOI 10.1007/s00221-011-2768-y; Cluff T, 2010, EXP BRAIN RES, V203, P647, DOI 10.1007/s00221-010-2274-7; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Dault MC, 2003, COGNITIVE BRAIN RES, V16, P434, DOI 10.1016/S0926-6410(03)00058-2; Dault MC, 2001, GAIT POSTURE, V14, P110, DOI 10.1016/S0966-6362(01)00113-8; Dimitriou M, 2013, J NEUROSCI, V33, P10898, DOI 10.1523/JNEUROSCI.5669-12.2013; Doumas M, 2010, J NEUROPHYSIOL, V104, P1969, DOI 10.1152/jn.00345.2010; Ehrenfried T, 2003, COGNITIVE BRAIN RES, V17, P140, DOI 10.1016/S0926-6410(03)00088-0; Eikema DJA, 2013, NEUROSCIENCE, V234, P22, DOI 10.1016/j.neuroscience.2012.12.053; Franklin DW, 2008, J NEUROSCI, V28, P14165, DOI 10.1523/JNEUROSCI.4406-08.2008; Goble DJ, 2009, NEUROSCI BIOBEHAV R, V33, P271, DOI 10.1016/j.neubiorev.2008.08.012; Gu MJ, 1996, J BIOMECH, V29, P319, DOI 10.1016/0021-9290(95)00052-6; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; JEKA JJ, 1994, EXP BRAIN RES, V100, P495, DOI 10.1007/BF02738408; Jeka JJ, 1997, PHYS THER, V77, P476, DOI 10.1093/ptj/77.5.476; Jeka J, 2006, EXP BRAIN RES, V174, P517, DOI 10.1007/s00221-006-0502-y; Jeka JJ, 2010, J MOTOR BEHAV, V42, P197, DOI 10.1080/00222895.2010.481693; Kang HG, 2010, J NEUROPHYSIOL, V104, P3510, DOI 10.1152/jn.00820.2009; Kiemel T, 2006, J NEUROPHYSIOL, V95, P1410, DOI 10.1152/jn.01144.2004; Kiemel T, 2002, BIOL CYBERN, V87, P262, DOI 10.1007/s00422-002-0333-2; Knill DC, 2011, J NEUROSCI, V31, P1219, DOI 10.1523/JNEUROSCI.3522-09.2011; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Lockhart DB, 2007, NAT NEUROSCI, V10, P1329, DOI 10.1038/nn1986; Loeb GE, 1999, EXP BRAIN RES, V126, P1, DOI 10.1007/s002210050712; Mak L, 2011, SCI MOTRICITE, V74, P81; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Maki BE, 2001, NEUROREPORT, V12, P3583, DOI 10.1097/00001756-200111160-00042; McDowd JM, 1997, J GERONTOL B-PSYCHOL, V52, pP265, DOI 10.1093/geronb/52B.6.P265; McNevin NH, 2002, HUM MOVEMENT SCI, V21, P187, DOI 10.1016/S0167-9457(02)00095-7; Milton JG, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/065005; Morasso PG, 1999, NEURAL NETWORKS, V12, P1173, DOI 10.1016/S0893-6080(99)00058-1; Norris JA, 2005, J BIOMECH, V38, P1263, DOI 10.1016/j.jbiomech.2004.06.014; O'Connor KW, 2008, GAIT POSTURE, V28, P385, DOI 10.1016/j.gaitpost.2008.01.010; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Purves D., 2001, NEUROSCIENCE; Rougier P, 2004, GAIT POSTURE, V19, P154, DOI 10.1016/S0966-6362(03)00056-0; Freitas SMSF, 2012, GAIT POSTURE, V35, P83, DOI 10.1016/j.gaitpost.2011.08.011; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; Simoneau M, 1999, J AM GERIATR SOC, V47, P235, DOI 10.1111/j.1532-5415.1999.tb04584.x; Stevenson IH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000629; Stoffregen TA, 1999, J EXP PSYCHOL HUMAN, V25, P1641; Sundermier L, 1996, J GERONTOL A-BIOL, V51, pM45, DOI 10.1093/gerona/51A.2.M45; Szczepanska-Gieracha J, 2012, GAIT POSTURE, V35, P312, DOI 10.1016/j.gaitpost.2011.10.001; Teasdale N, 2001, GAIT POSTURE, V14, P203, DOI 10.1016/S0966-6362(01)00134-5; Ting LH, 2007, PROG BRAIN RES, V165, P299, DOI 10.1016/S0079-6123(06)65019-X; van den Heuvel MRC, 2009, NEUROSCI LETT, V452, P37, DOI 10.1016/j.neulet.2009.01.024; van der Kooij H, 2007, J NEUROPHYSIOL, V98, P730, DOI 10.1152/jn.00457.2006; WADE MG, 1995, J GERONTOL B-PSYCHOL, V50, pP51, DOI 10.1093/geronb/50B.1.P51; Wade MG, 1997, PHYS THER, V77, P619, DOI 10.1093/ptj/77.6.619; Weeks DL, 2003, GERONTOLOGY, V49, P225, DOI 10.1159/000070402; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; WOOLLACOTT MH, 1986, INT J AGING HUM DEV, V23, P97, DOI 10.2190/VXN3-N3RT-54JB-X16X; Yeh TT, 2010, NEUROSCI LETT, V481, P173, DOI 10.1016/j.neulet.2010.06.081	62	55	57	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91554	10.1371/journal.pone.0091554	http://dx.doi.org/10.1371/journal.pone.0091554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614576	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300136
J	Gasser, L; Daniel, M; Reinhard, T; Bohringer, D				Gasser, Laura; Daniel, Moritz; Reinhard, Thomas; Boehringer, Daniel			Long-Term Tracking of the Central Corneal Endothelial Mosaic	PLOS ONE			English	Article							TRENDS	Purpose: When comparing follow-up endothelial cell (EC) density measurements it is only possible to demonstrate cell loss in large cohorts or in pronounced cases due to the standard deviation of measurements. However, especially in clinical studies or refractive surgery patients, EC stability is an important factor. Thus we developed a computer program to achieve cell-by-cell alignment of conventional specular non-contact EC photographs. This is a pilot study to evaluate whether this new diagnostic technique is applicable in postoperative patients. Methods: Digitized endothelial cell photos of 30 eyes following implantation of a phakic posterior chamber intraocular lens for correction of high myopia were analyzed. All EC centroids were dotted on each image, and early and late follow-up pictures were automatically aligned on the basis of these centroids. The tracking results were confirmed via alternating image presentation of the corresponding image areas, and were reviewed for loss of individual cells. In addition, conventional EC density measurements were performed. Results: Mean time interval between first and second postoperative EC image was 1.4 years (range 3 months -2.2 years), with early images taken at a median of 5.5 months after IOL implantation (lower/upper quartile 1.2-12.3 months). Extrapolated central EC density was 2812 +/- 500/mm(2) at the first time point, and 2797 +/- 524/mm(2) at the second time point. In 26 out of 30 image pairs, the EC mosaic was successfully retraced; cell loss in this area was excluded via photo flickering. Only in 4 image pairs, the EC mosaic could not be matched. Conclusions: We demonstrate that the corneal EC mosaic of clinical routine non-contact microscope pictures can be superimposed and compared on single cell level over time with our new computer based program. This new method is valuable to judge on EC stability even in small cohorts since it does not require mean values and standard deviations.	[Gasser, Laura; Daniel, Moritz; Reinhard, Thomas; Boehringer, Daniel] Univ Hosp Freiburg, Ctr Eye, Freiburg, Germany	University of Freiburg	Gasser, L (corresponding author), Univ Hosp Freiburg, Ctr Eye, Freiburg, Germany.	laura.gasser@uniklinik-freiburg.de		Daniel, Moritz Claudius/0000-0003-2024-542X				Bohringer D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059261; Bredow L, 2011, J REFRACT SURG, V27, P858, DOI 10.3928/1081597X-20111017-01; Ghosheh Faris R., 2008, International Ophthalmology, V28, P147, DOI 10.1007/s10792-007-9177-z; Keenan TDL, 2012, ARCH OPHTHALMOL-CHIC, V130, P621, DOI 10.1001/archophthalmol.2011.2585; Kohnen T, 2010, J CATARACT REFR SURG, V36, P2168, DOI 10.1016/j.jcrs.2010.10.007; McCarey BE, 2008, CORNEA, V27, P1, DOI 10.1097/ICO.0b013e31815892da; R Core Team, 2018, R LANG ENV STAT COMP; Saxena R, 2008, OPHTHALMOLOGY, V115, P608, DOI 10.1016/j.ophtha.2007.05.036	8	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e88603	10.1371/journal.pone.0088603	http://dx.doi.org/10.1371/journal.pone.0088603			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625809	gold, Green Published, Green Submitted			2022-12-27	WOS:000332851300003
J	Fiorillo, AR; Tykoski, RS				Fiorillo, Anthony R.; Tykoski, Ronald S.			A Diminutive New Tyrannosaur from the Top of the World	PLOS ONE			English	Article							HORSESHOE CANYON FORMATION; TARBOSAURUS-BATAAR; DINOSAURIA; THEROPODA; DIVERSITY; EVOLUTION; ALBERTA; TEETH	Tyrannosaurid theropods were dominant terrestrial predators in Asia and western North America during the last of the Cretaceous. The known diversity of the group has dramatically increased in recent years with new finds, but overall understanding of tyrannosaurid ecology and evolution is based almost entirely on fossils from latitudes at or below southern Canada and central Asia. Remains of a new, relatively small tyrannosaurine were recovered from the earliest Late Maastrichtian (70-69Ma) of the Prince Creek Formation on Alaska's North Slope. Cladistic analyses show the material represents a new tyrannosaurine species closely related to the highly derived Tarbosaurus+Tyrannosaurus clade. The new taxon inhabited a seasonally extreme high-latitude continental environment on the northernmost edge of Cretaceous North America. The discovery of the new form provides new insights into tyrannosaurid adaptability, and evolution in an ancient greenhouse Arctic.	[Fiorillo, Anthony R.; Tykoski, Ronald S.] Perot Museum Nat & Sci, Dept Paleontol, Dallas, TX 75201 USA		Fiorillo, AR (corresponding author), Perot Museum Nat & Sci, Dept Paleontol, Dallas, TX 75201 USA.	anthony.fiorillo@perotmuseum.org		Fiorillo, Anthony/0000-0002-8998-0820	National Science Foundation Office of Polar Programs [OPP 0424594]	National Science Foundation Office of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The National Science Foundation Office of Polar Programs provided funding for this work (OPP 0424594). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald J.D., 1996, DINOSAUR EXTINCTION; Badgley C, 2013, PALEOBIOLOGY, V39, P373, DOI 10.1666/12024; Badgley C, 2010, ECOGRAPHY, V33, P220, DOI 10.1111/j.1600-0587.2010.06282.x; Bakker R.T., 1988, HUNTERIA, V1, P1, DOI DOI 10.5281/ZEN0D0.1037529; Brusatte SL, 2013, ACTA PALAEONTOL POL, V58, P47, DOI 10.4202/app.2011.0141; Brusatte SL, 2011, AM MUS NOVIT, P1, DOI 10.1206/3717.2; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; Carbone C, 2011, P ROY SOC B-BIOL SCI, V278, P2682, DOI 10.1098/rspb.2010.2497; Carr TD, 2005, J VERTEBR PALEONTOL, V25, P119, DOI 10.1671/0272-4634(2005)025[0119:ANGASO]2.0.CO;2; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Carr TD, 2011, NATURWISSENSCHAFTEN, V98, P241, DOI 10.1007/s00114-011-0762-7; Carr TD, 2010, CAN J EARTH SCI, V47, P1213, DOI 10.1139/E10-035; Conrad J.E., 1990, US GEOL SURV B C, P1; CRACRAFT J, 1985, ANN MO BOT GARD, V72, P794, DOI 10.2307/2399222; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; Eberth DA, 2010, CAN J EARTH SCI, V47, P1119, DOI 10.1139/E10-045; Fiorillo AR, 2008, PALAIOS, V23, P322, DOI 10.2110/palo.2007.p07-036r; Fiorillo AR, 2012, ACTA PALAEONTOL POL, V57, P561, DOI 10.4202/app.2011.0033; Fiorillo AR, 2000, J VERTEBR PALEONTOL, V20, P675, DOI 10.1671/0272-4634(2000)020[0675:TTFTPC]2.0.CO;2; Fiorillo AR, 2011, NEW PERSPECTIVES HOR, P456; FLAIG P. P., 2011, SPECIAL PUBLICATION, P233, DOI DOI 10.2110/SEPMSP.097.233; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021376; Gates TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042135; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Hurum JH, 2003, ACTA PALAEONTOL POL, V48, P161; Lambe LM., 1917, GEOL SURV, V83, P1, DOI [10.4095/101672, DOI 10.4095/101672]; Larson P., 2013, TYRANNOSAURID PALEOB, P15; Lawver LA, 2002, GEOL S AM S, P333; Lehman Thomas M., 2001, P310; LEHMAN TM, 1987, PALAEOGEOGR PALAEOCL, V60, P189, DOI 10.1016/0031-0182(87)90032-0; Loewen MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079420; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; MADDISON D, 2005, MACCLADE 4; Maddison WP, 2011, MESQUITE MODULAR SYS; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Osborn HF, 1905, B AM MUS NAT HIST, V21, P259; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Padian Kevin, 1993, Bulletin of the New Mexico Museum of Natural History and Science, V3, P379; Russell D. A., 1970, Publs Palaeont. nat. Mus. Canada, VNo. 1, P1; Sampson SD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1186; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; SPICER RA, 2003, CRETACEOUS WORLD, P86; Spicer RA, 2010, PALAEOGEOGR PALAEOCL, V295, P423, DOI 10.1016/j.palaeo.2010.02.025; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tsuihiji T, 2011, J VERTEBR PALEONTOL, V31, P497, DOI 10.1080/02724634.2011.557116; Witmer Lawrence M., 2010, Kirtlandia, V57, P61; Zelenitsky DK, 2009, P ROY SOC B-BIOL SCI, V276, P667, DOI 10.1098/rspb.2008.1075	51	45	47	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91287	10.1371/journal.pone.0091287	http://dx.doi.org/10.1371/journal.pone.0091287			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621577	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300073
J	Gole, VC; Chousalkar, KK; Roberts, JR; Sexton, M; May, D; Tan, J; Kiermeier, A				Gole, Vaibhav C.; Chousalkar, Kapil K.; Roberts, Juliet R.; Sexton, Margaret; May, Damian; Tan, Jessica; Kiermeier, Andreas			Effect of Egg Washing and Correlation between Eggshell Characteristics and Egg Penetration by Various Salmonella Typhimurium Strains	PLOS ONE			English	Article							BACTERIAL PENETRATION; SHELL; ENTERITIDIS; SURVIVAL; DISEASE; CUTICLE	Salmonella is an important foodborne pathogen, causing an estimated 11,992 cases of infection in Australia per year. Egg or egg product related salmonellosis is a major concern for the egg industry. Worldwide, S. Typhimurium is one of the most common serovars identified in Salmonella food poisoning cases. The current study investigated the ability of five S. Typhimurium strains to penetrate washed and unwashed eggs using whole egg and agar egg penetration methods. All S. Typhimurium strains were able to penetrate eggshells and survive in egg albumen (at 20 degrees C) according to whole egg penetration results. Polymerase Chain Reaction results demonstrated that S. Typhimurium strain 2 (10(3) and 10(5) CFU/mL), and strain 5 (10(3) and 10(5) CFU/mL) egg penetration was significantly higher (p<0.05) in washed eggs when compared to unwashed eggs. Statistical analysis of the agar penetration experiment indicated that S. Typhimurium was able to penetrate washed eggs at a significantly higher rate when compared to unwashed eggs (p<0.05). When compared to unwashed eggs, washed eggs also had significantly damaged cuticles. Statistical analysis also indicated that eggshell penetration by S. Typhimurium was related to various eggshell ultrastructural features such as cap quality, alignment, erosion, confluence, Type B bodies and cuticle cover.	[Gole, Vaibhav C.; Chousalkar, Kapil K.] Univ Adelaide, Sch Anim & Vet Sci, Roseworthy, SA, Australia; [Roberts, Juliet R.] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Sexton, Margaret] Primary Ind & Reg SA, Adelaide, SA, Australia; [May, Damian; Tan, Jessica; Kiermeier, Andreas] South Australian Res & Dev Inst, Adelaide, SA, Australia	University of Adelaide; University of New England; South Australian Research & Development Institute (SARDI)	Chousalkar, KK (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Roseworthy, SA, Australia.	kapil.chousalkar@adelaide.edu.au		chousalkar, Kapil/0000-0002-4134-3996; Kiermeier, Andreas/0000-0001-6240-2919	Australian Government's Cooperative Research Centres Program; International Postgraduate Research Scholarship	Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); International Postgraduate Research Scholarship(Australian Government)	This research was conducted within the Poultry CRC, established and supported under the Australian Government's Cooperative Research Centres Program. Salmonella isolates were obtained from Ms. Diane Davos, Australian Salmonella Reference Centre, Adelaide, South Australia, Australia. Mr. Vaibhav Gole is an International Postgraduate Research Scholarship recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLS AA, 1964, AVIAN DIS, V8, P245, DOI 10.2307/1588067; Baker R. C., 1990, Dairy, Food and Environmental Sanitation, V10, P273; Bell R, 2010, COMMUN DIS INTELL, V34, P396; Berrang ME, 1999, J APPL POULTRY RES, V8, P499, DOI 10.1093/japr/8.4.499; Board R.G., 1995, EGG SCI TECHNOLOGY, V4th, P81; Botey-Salo P, 2012, FOOD CONTROL, V28, P463, DOI 10.1016/j.foodcont.2012.05.033; Braun P., 1999, WORLD POULTRY SPECIA, P23; Chousalkar KK, 2010, INT J FOOD MICROBIOL, V142, P207, DOI 10.1016/j.ijfoodmicro.2010.06.029; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; De Reu K, 2006, INT J FOOD MICROBIOL, V112, P253, DOI 10.1016/j.ijfoodmicro.2006.04.011; European Food Safety Authority, 2005, EFSA J, V269, P39; Fitzsimmons G, 2012, COMMUN DIS INTELL, V36, pE213; Hall G, 2005, EMERG INFECT DIS, V11, P1257, DOI 10.3201/eid1108.041367; Hardy A, 2004, POSTGRAD MED J, V80, P541, DOI 10.1136/pgmj.2003.016584; Hutchison ML, 2004, J FOOD PROTECT, V67, P4, DOI 10.4315/0362-028X-67.1.4; Leleu S, 2011, J FOOD PROTECT, V74, P1649, DOI 10.4315/0362-028X.JFP-11-013; Luo YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040645; Martelli F, 2012, FOOD RES INT, V45, P745, DOI 10.1016/j.foodres.2011.03.054; May D., 2013, 24th Annual Australian Poultry Science Symposium, Sydney, New South Wales, Australia, 17-20 February 2013, P256; Messens W, 2005, BRIT POULTRY SCI, V46, P694, DOI 10.1080/00071660500395582; Messens W, 2005, WORLD POULTRY SCI J, V61, P71, DOI 10.1079/WPS200443; Messens W, 2011, WOODHEAD PUBL FOOD S, P163; Miyamoto T, 1998, J FOOD PROTECT, V61, P350, DOI 10.4315/0362-028X-61.3.350; R Core Team, 2013, R LANG ENV STAT COMP; Radkowski M, 2002, ARCH GEFLUGELKD, V66, P119; RAHN K, 1992, MOL CELL PROBE, V6, P271, DOI 10.1016/0890-8508(92)90002-F; Ricke S.C., 2001, COMPENDIUM METHODS M, V4th, P473, DOI [10.2105/9780875531755ch46, DOI 10.2105/9780875531755CH46]; Roberts J. R., 1994, Poultry Science Reviews, V5, P245; Samiullah, 2013, INT J FOOD MICROBIOL, V165, P77, DOI 10.1016/j.ijfoodmicro.2013.05.002; SCHOENI JL, 1995, INT J FOOD MICROBIOL, V24, P385, DOI 10.1016/0168-1605(94)00042-5; Sergeant ESG, 2003, SALMONELLA ENTERITID; Solomon S. E., 1992, POULTRY INT, V31, P24; Solomon SE, 1992, POULTRY INT, V31, P20; SPARKS NHC, 1984, BRIT POULTRY SCI, V25, P267, DOI 10.1080/00071668408454866; Wales AD, 2011, AVIAN PATHOL, V40, P429, DOI 10.1080/03079457.2011.606799; Wang H, 1998, J FOOD PROTECT, V61, P276, DOI 10.4315/0362-028X-61.3.276	36	58	61	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90987	10.1371/journal.pone.0090987	http://dx.doi.org/10.1371/journal.pone.0090987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621821	gold, Green Submitted, Green Published			2022-12-27	WOS:000332845300042
J	Khan, A; Khan, I; Ali, F; Ulhaq, S; Shafie, S				Khan, Arshad; Khan, Ilyas; Ali, Farhad; Ulhaq, Sami; Shafie, Sharidan			Effects of Wall Shear Stress on Unsteady MHD Conjugate Flow in a Porous Medium with Ramped Wall Temperature	PLOS ONE			English	Article							FREE-CONVECTION FLOW; VERTICAL PLATE; THERMAL-RADIATION; HEAT-TRANSFER; NATURAL-CONVECTION; GENERAL-SOLUTIONS; MASS DIFFUSION; FLUID	This study investigates the effects of an arbitrary wall shear stress on unsteady magnetohydrodynamic (MHD) flow of a Newtonian fluid with conjugate effects of heat and mass transfer. The fluid is considered in a porous medium over a vertical plate with ramped temperature. The influence of thermal radiation in the energy equations is also considered. The coupled partial differential equations governing the flow are solved by using the Laplace transform technique. Exact solutions for velocity and temperature in case of both ramped and constant wall temperature as well as for concentration are obtained. It is found that velocity solutions are more general and can produce a huge number of exact solutions correlative to various fluid motions. Graphical results are provided for various embedded flow parameters and discussed in details.	[Khan, Arshad; Ali, Farhad; Shafie, Sharidan] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Skudai, Malaysia; [Khan, Ilyas] Majmaah Univ, Coll Engn, Majmaah, Saudi Arabia; [Ulhaq, Sami] City Univ Sci & Informat Technol, Peshawar, Pakistan	Universiti Teknologi Malaysia; Majmaah University	Shafie, S (corresponding author), Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Skudai, Malaysia.	ridafie@yahoo.com	SHAFIE, SHARIDAN/A-2210-2013; Khan, Ilyas/C-8770-2019; Ali, Farhad/Y-5301-2018	SHAFIE, SHARIDAN/0000-0001-7795-2278; Khan, Ilyas/0000-0002-2056-9371; 				[Anonymous], 2012, AM J COMPUT APPL MAT, DOI DOI 10.5923/j.ajcam.20120203.10; [Anonymous], [No title captured]; Chandrakala P., 2011, INT J DYNAM FLUID, V7, P1; Chandran P, 2005, HEAT MASS TRANSFER, V41, P459, DOI 10.1007/s00231-004-0568-7; Das K., 2010, B SOC MATH BANJA LUK, V17, P15; Das S. S., 2012, International Journal of Energy and Environment, V3, P209; Das S. S., 2012, International Journal of Energy and Environment, V3, P109; Das SS, 2011, J APPL FLUID MECH, V4, P91; Das SS, 2009, INT J HEAT MASS TRAN, V52, P5962, DOI 10.1016/j.ijheatmasstransfer.2009.04.038; Fetecau C, 2013, Z NATURFORSCH A, V68, P659, DOI 10.5560/ZNA.2013-0041; Fetecau C, 2011, Z NATURFORSCH A, V66, P753, DOI 10.5560/ZNA.2011-0044; Fetecau C, 2013, Z NATURFORSCH A, V68, P130, DOI 10.5560/ZNA.2012-0083; Ghara N., 2012, AM J SCI IND RES, V3, P376; Ghosh SK, 2008, NONLINEAR ANAL-MODEL, V13, P419, DOI 10.15388/NA.2008.13.4.14548; Hayat T, 2008, J POROUS MEDIA, V11, P389, DOI 10.1615/JPorMedia.v11.i4.50; Hussanan A, 2013, J APPL MATH, DOI 10.1155/2013/434571; Jha BK, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.104401; Khan I, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.104401; Khan I, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.064401; Magyari E, 2011, INT COMMUN HEAT MASS, V38, P554, DOI 10.1016/j.icheatmasstransfer.2011.03.006; Narahari M, 2012, CHEM ENG COMMUN, V199, P628, DOI 10.1080/00986445.2011.611058; Narahari Marneni, 2011, Turkish Journal of Engineering and Environmental Sciences, V35, P187, DOI 10.3906/muh-1101-15; Narahari M., 2011, Journal of Applied Sciences, V11, P1096, DOI 10.3923/jas.2011.1096.1104; Narahari M., 2011, WORLD J MECH, V1, P176; Navier C, 1823, MEMOIRES LACADEMIE S, V6, P389; Patra1 RR, 2012, J APPL FLUID MECH, P59; Rajesh V, 2011, CHEM IND CHEM ENG Q, V17, P189, DOI 10.2298/CICEQ100829003R; Samiulhaq, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.044401; Seethamahalakshmi, 2011, ADV APPL SC RES, V2, P261; Seth G.S., 2013, INT J ENERGY TECH, V5, P1; Shercliff JA., 1965, TXB MAGNETOHYDRODYNA; Toki CJ, 2007, ZAMM-Z ANGEW MATH ME, V87, P4, DOI 10.1002/zamm.200510291	32	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90280	10.1371/journal.pone.0090280	http://dx.doi.org/10.1371/journal.pone.0090280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621775	Green Submitted, gold, Green Published			2022-12-27	WOS:000332845300019
J	Li, W; Wang, W; Li, Y; Wang, WW; Wang, T; Li, L; Han, ZQ; Wang, SX; Ma, D; Wang, H				Li, Wei; Wang, Wei; Li, Yan; Wang, Wenwen; Wang, Tian; Li, Li; Han, Zhiqiang; Wang, Shixuan; Ma, Ding; Wang, Hui			Proteomics Analysis of Normal and Senescent NG108-15 Cells: GRP78 Plays a Negative Role in Cisplatin-Induced Senescence in the NG108-15 Cell Line	PLOS ONE			English	Article							LUNG-CANCER CELLS; INDUCED APOPTOSIS; DNA-DAMAGE; GROWTH; CHEMOTHERAPY; EXPRESSION; RESISTANCE; INDUCTION; PROTEINS	Accelerated senescence (ACS) leading to proliferative arrest is a physiological mechanism of the DNA damage response that occurs during tumor therapy. Our experiment was designed to detect unknown genes that may play important roles in cisplatin-induced senescence and to illustrate the related senescence mechanism. Using 2-dimension electrophoresis (2-DE), we identified 5 protein spots with different expression levels in the normal and senescent NG108-15 cells. According to MALDI-TOF MS analysis, the 5 proteins were determined to be peptidylprolyl isomerase A (PPIA), peroxiredoxin 1 (PRX1), glutathione S-transferase mu 1 (GSTM1), vimentin (VIM) and glucose-regulated protein 78 (GRP78). Then, we investigated how cisplatin-induced senescence was mediated by GRP78 in the NG108-15 cells. Knockdown of GRP78 significantly increased P53 expression in NG108-15 cells. Additionally, 2-deoxy-D-glucose (2DG)-induced GRP78 overexpression protected the NG108-15 cells from cisplatin-induced senescence, which was accompanied by the obvious suppression of P53 and p-CDC2 expression. Inhibition of Ca2+ release from endoplasmic reticulum (ER) stores was also found to be associated with the anti-senescence effect of 2DG-induced GRP78 overexpression. In conclusion, we found 5 proteins that were differentially expressed in normal NG108-15 cells and senescent NG108-15 cells. GRP78 plays an important role in cisplatin-induced senescence in NG108-15 cells, mainly through its regulation of P53 expression and ER calcium efflux.	[Li, Wei; Li, Yan; Wang, Wenwen; Wang, Tian; Li, Li; Han, Zhiqiang; Wang, Shixuan; Ma, Ding; Wang, Hui] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Hubei, Peoples R China; [Wang, Wei] Southern Med Univ, Nanfang Hosp, Dept Gynecol & Obstet, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; Southern Medical University - China	Ma, D (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Hubei, Peoples R China.	dma@tjh.tjmu.edu.cn; huit71@sohu.com		Li, Li/0000-0003-2294-9842	National Basic Research Program of China 973 program; National Natural Science Foundation of China [2013CB911304, 81072132, 81001152, 81101963, 81172466, 30872751]	National Basic Research Program of China 973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China 973 program and the National Natural Science Foundation of China (No. 2013CB911304; 81072132; 81001152; 81101963; 81172466; 30872751). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bahlani S, 2011, ONCOGENE, V30, P4219, DOI 10.1038/onc.2011.134; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Asish G, 2008, PLOS ONE, V3, P3384; Baumeister P, 2009, MOL CANCER THER, V8, P1086, DOI 10.1158/1535-7163.MCT-08-1166; Bolesta E, 2012, MOL CELL BIOL, V32, P1879, DOI 10.1128/MCB.06214-11; Bosche B, 2013, BIOCHEM BIOPH RES CO, V434, P268, DOI 10.1016/j.bbrc.2013.03.047; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Cardus A, 2013, CARDIOVASC RES, V97, P571, DOI 10.1093/cvr/cvs352; DOUGLAS DT, 2009, GYNECOL ONCOL, V115, P112; Elmore LW, 2005, CLIN CANCER RES, V11, P2637, DOI 10.1158/1078-0432.CCR-04-1462; Fang K, 2007, ONCOL RES, V16, P479, DOI 10.3727/096504007783338331; Fernandez PM, 2000, BREAST CANCER RES TR, V59, P15, DOI 10.1023/A:1006332011207; Gannon HS, 2011, DEV BIOL, V353, P1, DOI 10.1016/j.ydbio.2011.02.007; Gerner C, 2000, J BIOL CHEM, V275, P39018, DOI 10.1074/jbc.M006495200; Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157; Goehe RW, 2012, J PHARMACOL EXP THER, V343, P763, DOI 10.1124/jpet.112.197590; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Hawkins LK, 2001, GENE THER, V8, P1123, DOI 10.1038/sj.gt.3301507; IKENOUCHI H, 1991, J CLIN INVEST, V88, P55, DOI 10.1172/JCI115304; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Koomagi R, 1999, ANTICANCER RES, V19, P4333; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIN HJ, 1995, CANCER RES, V55, P1224; Nishio K, 2001, HISTOCHEM CELL BIOL, V116, P321, DOI 10.1007/s004180100325; Petroulakis E, 2009, CANCER CELL, V16, P439, DOI 10.1016/j.ccr.2009.09.025; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Roninson IB, 2003, CANCER RES, V63, P2705; te Poele RH, 2002, CANCER RES, V62, P1876; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Wang QS, 2010, NEUROCHEM RES, V35, P13, DOI 10.1007/s11064-009-0023-8; Wang W, 2007, GYNECOL ONCOL, V105, P571, DOI 10.1016/j.ygyno.2007.01.051; Yaglom JA, 2007, CANCER RES, V67, P2373, DOI 10.1158/0008-5472.CAN-06-3796; Zu K, 2006, ONCOGENE, V25, P546, DOI 10.1038/sj.onc.1209071	35	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90114	10.1371/journal.pone.0090114	http://dx.doi.org/10.1371/journal.pone.0090114			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621580	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300014
J	Xia, Y; Chang, T; Wang, YM; Liu, YX; Li, WH; Li, M; Fan, HY				Xia, Yan; Chang, Ting; Wang, Yingmei; Liu, Yixiong; Li, Wenhui; Li, Ming; Fan, Heng-Yu			YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; HIPPO PATHWAY; CONTACT INHIBITION; PROLIFERATION; APOPTOSIS; DOMAIN; GROWTH; EXPRESSION; INDUCTION; SALVADOR	YAP is a key component of the Hippo signaling pathway and plays a critical role in the development and progression of multiple cancer types, including ovarian cancer. However, the effects of YAP on ovarian cancer development in vivo and its downstream effectors remain uncertain. In this study we found that strong YAP expression was associated with poor ovarian cancer patient survival. Specifically, we showed for the first time that high YAP expression levels were positively correlated with TEAD4 gene expression, and their co-expression was a prognostic marker for poor ovarian cancer survival. Hyperactivation of YAP by mutating its five inhibitory phosphorylation sites (YAP-5SA) increased ovarian cancer cell proliferation, resistance to chemotherapeutic drugs, cell migration, and anchorage-independent growth. In contrast, expression of a dominant negative YAP mutant reversed these phenotypes in ovarian cancer cells both in vitro and in vivo. Our results suggested that YAP caused these effects by promoting an epithelial-to-mesenchymal transition. Thus, YAP promotes ovarian cancer cell growth and tumorigenesis both in vitro and in vivo. Further, high YAP and TEAD4 expression is a prognostic marker for ovarian cancer progression and a potential target for ovarian cancer treatment.	[Xia, Yan; Fan, Heng-Yu] Zhejiang Univ, Inst Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Xia, Yan; Fan, Heng-Yu] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Chang, Ting] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurol, Xian 710032, Peoples R China; [Wang, Yingmei; Liu, Yixiong] Fourth Mil Med Univ, Xijing Hosp, Dept Pathol, Xian 710032, Peoples R China; [Li, Wenhui] Fourth Mil Med Univ, Xijing Hosp, Dept Obstet & Gynecol, Xian 710032, Peoples R China; [Li, Ming] Xi An Jiao Tong Univ, Affiliated Guangren Hosp, Xian 710049, Peoples R China	Zhejiang University; Zhejiang University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Xi'an Jiaotong University	Fan, HY (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	hyfan@zju.edu.cn			National Natural Science Foundation of China [81172473]; National Basic Research Program of China [2011CB944504, 2012CB944403]; Basic Scientific Research Funding of Zhejiang University [2011QN81001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Basic Scientific Research Funding of Zhejiang University	This study was supported by the National Natural Science Foundation of China (81172473), the National Basic Research Program of China (2011CB944504, 2012CB944403), and Basic Scientific Research Funding of Zhejiang University (2011QN81001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Buttitta F, 1997, BRIT J CANCER, V75, P230, DOI 10.1038/bjc.1997.38; Cai H, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-31; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hau JC, 2013, CHEMBIOCHEM, V14, P1218, DOI 10.1002/cbic.201300163; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Qin LF, 2002, CANCER LETT, V175, P27, DOI 10.1016/S0304-3835(01)00720-0; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang JY, 2013, HEPATOLOGY, V58, P1011, DOI 10.1002/hep.26420; Wang JY, 2013, MOL CELL, V51, P211, DOI 10.1016/j.molcel.2013.05.013; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xie Q, 2013, CANCER RES, V73, P3615, DOI 10.1158/0008-5472.CAN-12-3793; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yi CL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004060; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	37	115	127	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91770	10.1371/journal.pone.0091770	http://dx.doi.org/10.1371/journal.pone.0091770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622501	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300126
J	Brannstrom, K; Lindhagen-Persson, M; Gharibyan, AL; Iakovleva, I; Vestling, M; Sellin, ME; Brannstrom, T; Morozova-Roche, L; Forsgren, L; Olofsson, A				Brannstrom, Kristoffer; Lindhagen-Persson, Malin; Gharibyan, Anna L.; Iakovleva, Irina; Vestling, Monika; Sellin, Mikael E.; Brannstrom, Thomas; Morozova-Roche, Ludmilla; Forsgren, Lars; Olofsson, Anders			A Generic Method for Design of Oligomer-Specific Antibodies	PLOS ONE			English	Article							A-BETA OLIGOMERS; ALZHEIMERS-DISEASE; AMYLOID-BETA; MONOCLONAL-ANTIBODIES; PREFIBRILLAR OLIGOMERS; PASSIVE-IMMUNIZATION; PARKINSONS-DISEASE; TAU OLIGOMERS; SOLUTION NMR; IN-VIVO	Antibodies that preferentially and specifically target pathological oligomeric protein and peptide assemblies, as opposed to their monomeric and amyloid counterparts, provide therapeutic and diagnostic opportunities for protein misfolding diseases. Unfortunately, the molecular properties associated with oligomer-specific antibodies are not well understood, and this limits targeted design and development. We present here a generic method that enables the design and optimisation of oligomer-specific antibodies. The method takes a two-step approach where discrimination between oligomers and fibrils is first accomplished through identification of cryptic epitopes exclusively buried within the structure of the fibrillar form. The second step discriminates between monomers and oligomers based on differences in avidity. We show here that a simple divalent mode of interaction, as within e. g. the IgG isotype, can increase the binding strength of the antibody up to 1500 times compared to its monovalent counterpart. We expose how the ability to bind oligomers is affected by the monovalent affinity and the turnover rate of the binding and, importantly, also how oligomer specificity is only valid within a specific concentration range. We provide an example of the method by creating and characterising a spectrum of different monoclonal antibodies against both the A beta peptide and alpha-synuclein that are associated with Alzheimer's and Parkinson's diseases, respectively. The approach is however generic, does not require identification of oligomer-specific architectures, and is, in essence, applicable to all polypeptides that form oligomeric and fibrillar assemblies.	[Brannstrom, Kristoffer; Lindhagen-Persson, Malin; Gharibyan, Anna L.; Iakovleva, Irina; Vestling, Monika; Morozova-Roche, Ludmilla; Olofsson, Anders] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Sellin, Mikael E.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Brannstrom, Thomas] Umea Univ, Dept Med Biosci, Umea, Sweden; [Forsgren, Lars] Umea Univ, Dept Clin Pharmacol & Clin Neurosci, Umea, Sweden	Umea University; Umea University; Umea University; Umea University	Olofsson, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	anders.olofsson@medchem.umu.se	Gharibyan, Anna L./B-3401-2010; Morozova-Roche, Ludmilla/AAV-9983-2021; Brännström, Kristoffer/AAC-1204-2020; Morozova-Roche, Ludmilla A./AAU-9044-2021	Gharibyan, Anna L./0000-0001-9070-6215; Morozova-Roche, Ludmilla/0000-0001-5886-2023; Sellin, Mikael/0000-0002-8355-0803	Parkinsonfonden; Insamlingsstiftelsen Umea University; Alzheimerfonden; Swedish Research Council; Magn. Bergvalls stiftelse; O.E. och Edlas stiftelse; FAMY; Torsten Soderbergs stiftelse; Vasterbottens lans lansting (ALF medel); Medical Faculty of Umea University	Parkinsonfonden; Insamlingsstiftelsen Umea University; Alzheimerfonden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Magn. Bergvalls stiftelse; O.E. och Edlas stiftelse; FAMY; Torsten Soderbergs stiftelse; Vasterbottens lans lansting (ALF medel); Medical Faculty of Umea University	This work was supported by Parkinsonfonden, Insamlingsstiftelsen Umea University, Alzheimerfonden, J.C. Kempe, the Swedish Research Council, Magn. Bergvalls stiftelse, O.E. och Edlas stiftelse, FAMY, Torsten Soderbergs stiftelse, Vasterbottens lans lansting (ALF medel) and the Medical Faculty of Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson O, 2012, J NEUROSCI, V32, P9677, DOI 10.1523/JNEUROSCI.4742-11.2012; [Anonymous], 2012, INT J ALZHEIMERS DIS; Arai H, 2012, BBA-GEN SUBJECTS, V1820, P1908, DOI 10.1016/j.bbagen.2012.08.016; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bidinosti M, 2012, J BIOL CHEM, V287, P33691, DOI 10.1074/jbc.M112.379792; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; Castillo-Carranza Diana L, 2013, Front Biosci (Schol Ed), V5, P426; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Danzer KM, 2009, J NEUROCHEM, V111, P192, DOI 10.1111/j.1471-4159.2009.06324.x; Delrieu J, 2012, J NEUROCHEM, V120, P186, DOI 10.1111/j.1471-4159.2011.07458.x; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; DOTY P, 1953, DISCUSS FARADAY SOC, P51; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Frost JL, 2012, NEURODEGENER DIS, V10, P265, DOI 10.1159/000335913; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Haupt C, 2011, J MOL BIOL, V405, P341, DOI 10.1016/j.jmb.2010.10.059; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Kawasaki Y, 2011, DRUG DISCOV TODAY, V16, P985, DOI 10.1016/j.drudis.2011.07.010; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 2009, CNS NEUROL DISORD-DR, V8, P65, DOI 10.2174/187152709787601876; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lasagna-Reeves CA, 2011, CURR ALZHEIMER RES, V8, P659; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lee EB, 2006, J BIOL CHEM, V281, P4292, DOI 10.1074/jbc.M511018200; Leliveld SR, 2007, J NEUROSCI RES, V85, P2285, DOI 10.1002/jnr.21353; Lindhagen-Persson M, 2008, AMYLOID, V15, P240, DOI 10.1080/13506120802524916; Lindhagen-Persson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013928; Ma QL, 2006, J NEUROSCI RES, V83, P374, DOI 10.1002/jnr.20734; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Meinhardt K, 2012, P NATL ACAD SCI US; Morgado I, 2012, P NATL ACAD SCI USA, V109, P12503, DOI 10.1073/pnas.1206433109; Mougenot A. L., 2011, NEUROBIOL AGING; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Park MJ, 2011, J CLIN NEUROL, V7, P215, DOI 10.3988/jcn.2011.7.4.215; Perchiacca JM, 2012, P NATL ACAD SCI USA, V109, P84, DOI 10.1073/pnas.1111232108; Robert R, 2010, MOL IMMUNOL, V48, P59, DOI 10.1016/j.molimm.2010.09.012; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Sehlin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032014; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Shughrue PJ, 2010, NEUROBIOL AGING, V31, P189, DOI 10.1016/j.neurobiolaging.2008.04.003; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Sousa MM, 2001, AM J PATHOL, V159, P1993; Tayebi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019998; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Valera E, 2013, PHARM THER; Vilches-Moure JG, 2005, J VET DIAGN INVEST, V17, P346, DOI 10.1177/104063870501700407; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wegiel J, 2007, ACTA NEUROPATHOL, V113, P389, DOI 10.1007/s00401-006-0191-4	59	34	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90857	10.1371/journal.pone.0090857	http://dx.doi.org/10.1371/journal.pone.0090857			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618582	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400033
J	Groesbeck, AS; Rowell, K; Lepofsky, D; Salomon, AK				Groesbeck, Amy S.; Rowell, Kirsten; Lepofsky, Dana; Salomon, Anne K.			Ancient Clam Gardens Increased Shellfish Production: Adaptive Strategies from the Past Can Inform Food Security Today	PLOS ONE			English	Article							HUMAN IMPACTS; RESOURCE-MANAGEMENT; BRITISH-COLUMBIA; NORTHWEST COAST; COMMUNITY; PREDATORS; GROWTH; ISLAND; SUSTAINABILITY; RESILIENCE	Maintaining food production while sustaining productive ecosystems is among the central challenges of our time, yet, it has been for millennia. Ancient clam gardens, intertidal rock-walled terraces constructed by humans during the late Holocene, are thought to have improved the growing conditions for clams. We tested this hypothesis by comparing the beach slope, intertidal height, and biomass and density of bivalves at replicate clam garden and non-walled clam beaches in British Columbia, Canada. We also quantified the variation in growth and survival rates of littleneck clams (Leukoma staminea) we experimentally transplanted across these two beach types. We found that clam gardens had significantly shallower slopes than non-walled beaches and greater densities of L. staminea and Saxidomus giganteus, particularly at smaller size classes. Overall, clam gardens contained 4 times as many butter clams and over twice as many littleneck clams relative to non-walled beaches. As predicted, this relationship varied as a function of intertidal height, whereby clam density and biomass tended to be greater in clam gardens compared to non-walled beaches at relatively higher intertidal heights. Transplanted juvenile L. staminea grew 1.7 times faster and smaller size classes were more likely to survive in clam gardens than non-walled beaches, specifically at the top and bottom of beaches. Consequently, we provide strong evidence that ancient clam gardens likely increased clam productivity by altering the slope of soft-sediment beaches, expanding optimal intertidal clam habitat, thereby enhancing growing conditions for clams. These results reveal how ancient shellfish aquaculture practices may have supported food security strategies in the past and provide insight into tools for the conservation, management, and governance of intertidal seascapes today.	[Groesbeck, Amy S.; Salomon, Anne K.] Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada; [Rowell, Kirsten] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Lepofsky, Dana] Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; University of Washington; University of Washington Seattle; Simon Fraser University	Groesbeck, AS (corresponding author), Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada.	amysue72@gmail.com; anne.salomon@sfu.ca		Rowell, Kirsten/0000-0001-5827-8863	National Geographic Research and Exploration Grant [8636-09]; Natural Sciences and Engineering Research Council of Canada [385921-2009]; Social Sciences and Humanities Research Council [2011-0833]; David and Lucile Packard Foundation [2008-32497]	National Geographic Research and Exploration Grant(National Geographic Society); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This work was funded by a National Geographic Research and Exploration Grant (8636-09) to Dana Lepofsky, a Natural Sciences and Engineering Research Council of Canada Discovery Grant (385921-2009) to Anne K. Salomon, a Social Sciences and Humanities Research Council Insight Grant (2011-0833) to Dana Lepofsky, and a David and Lucile Packard Foundation Grant (2008-32497) to Kirsten Rowell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Miller KA, 2011, HIDROBIOLOGICA, V21, P365; Bates D, 2012, LME4 LINEAR MIXED EF; Berkes F., 2000, LINKING SOCIAL ECOLO; Braje TJ, 2007, AM ANTIQUITY, V72, P735, DOI 10.2307/25470443; Brown F., 2009, STAYING COURSE STAYI; BUTMAN CA, 1988, NATURE, V333, P771, DOI 10.1038/333771a0; Caldwell ME, 2012, J ISL COAST ARCHAEOL, V7, P219, DOI 10.1080/15564894.2011.586089; Campbell SK, 2010, ECOL SOC, V15; Cannon Aubrey, 2008, BAR International Series, V1865, P7; Cannon A, 2009, J ARCHAEOL SCI, V36, P1050, DOI 10.1016/j.jas.2008.12.007; COSTAPIERCE BA, 1987, BIOSCIENCE, V37, P320, DOI 10.2307/1310688; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Erlandson JM, 2008, J ARCHAEOL SCI, V35, P2144, DOI 10.1016/j.jas.2008.01.014; Erlandson JM, 2010, ANNU REV MAR SCI, V2, P231, DOI 10.1146/annurev.marine.010908.163749; Fitch JE, 1953, FISH B CAL DEP FISH, V90; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Food and Agriculture Organization of the United Nations, 2009, STAT FOOD INS WORLD; FRASER C. McLEAN, 1928, TRANS ROY SOC CANADA, V22, P249; Gelcich S, 2010, P NATL ACAD SCI USA, V107, P16794, DOI 10.1073/pnas.1012021107; Gunderson L., 2002, RESILIENCE BEHAV LAR; Haggan N, 2006, YEARS CHANGE LINKING; Harper JR, 2007, CLAM GARDEN FIELD IN; Harper JR, 1995, FINAL REPORT BROUGHT; Horan RD, 2011, P NATL ACAD SCI USA, V108, P7333, DOI 10.1073/pnas.1005431108; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JOHANNES RE, 1978, ANNU REV ECOL SYST, V9, P349, DOI 10.1146/annurev.es.09.110178.002025; Langouet L, 2009, J MARIT ARCHAEOL, V4, P131, DOI 10.1007/s11457-009-9053-2; Lepofsky D, 2005, AM ANTIQUITY, V70, P267, DOI 10.2307/40035704; Lepofsky D, 2008, BOTANY, V86, P129, DOI 10.1139/B07-094; Lepofsky Dana, 2013, Ecological Processes, V2; Menezes F., 2001, Development (London), V44, P29, DOI 10.1057/palgrave.development.1110288; Menge BA, 2008, ECOL LETT, V11, P151, DOI 10.1111/j.1461-0248.2007.01135.x; Moss ML, 2011, ARCHAEOLOGY OF NORTH PACIFIC FISHERIES, P1; Nakaoka M, 2000, ECOLOGY, V81, P1031, DOI 10.2307/177176; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Parks Canada, 2011, GULF ISL NAT PARK RE; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; PETERSON CH, 1989, ECOLOGY, V70, P1390, DOI 10.2307/1938198; PHIBBS F D, 1971, Proceedings National Shellfisheries Association, V61, P12; Pinkerton E, 2011, MAR POLICY, V35, P63, DOI 10.1016/j.marpol.2010.08.002; Quayle DB, 1972, B FISH RES BOARD CAN, V179; Quayle DB, 1943, CAN J FISH AQUAT SCI, V6, P140; R Core Team, 2012, R LANG ENV STAT COMP; Rick TC, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P1; Roegner GC, 2000, J PLANKTON RES, V22, P1779, DOI 10.1093/plankt/22.9.1779; Sarkar D., 2019, NLME LINEAR NONLINEA; Shaw WN, 1986, 821146 US AR CORPS E; SIMENSTAD CA, 1978, SCIENCE, V200, P403, DOI 10.1126/science.200.4340.403; Smee DL, 2006, J CHEM ECOL, V32, P605, DOI 10.1007/s10886-005-9021-8; Starr A., 2003, NEW POLIT SCI, V25, P19, DOI [10.1080/0739314032000071217, DOI 10.1080/0739314032000071217]; Steneck RS, 2012, P NATL ACAD SCI USA, V109, P7953, DOI 10.1073/pnas.1205591109; Stimpson CM, 2012, CONVERSATION BIOL AP; Szimanski A, 2005, ANCIENT SEA GARDENS; TAMBURRI MN, 1992, BIOL BULL, V183, P327, DOI 10.2307/1542218; THOMPSON DS, 1995, ESTUARIES, V18, P91, DOI 10.2307/1352285; Thompson L, 1949, AM ANTHROPOL, V51, P253, DOI 10.1525/aa.1949.51.2.02a00060; Trosper R., 2009, RESILIENCE RECIPROCI; Trosper RL, 2002, ECOL ECON, V41, P329, DOI 10.1016/S0921-8009(02)00041-1; Turner N., 2005, EARTHS BLANKET; Turner NJ, 2007, INDIAN J TRADIT KNOW, V6, P57; Turner Nancy J., 2005, KEEPING IT LIVING TR; Wagner E, 2012, MAR ECOL PROG SER, V468, P149, DOI 10.3354/meps09952; White E. A. F., 2006, THESIS S FRASER U BU; Whiteley J, 2007, J APPL ECOL, V44, P495, DOI 10.1111/j.1365-2664.2007.01283.x; Williams J., 2006, CLAM GARDENS ABORIGI; Williams SL, 2007, ANNU REV ECOL EVOL S, V38, P327, DOI 10.1146/annurev.ecolsys.38.091206.095543	67	87	89	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91235	10.1371/journal.pone.0091235	http://dx.doi.org/10.1371/journal.pone.0091235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24618748	gold, Green Published, Green Submitted			2022-12-27	WOS:000332842400061
J	Mielke, GI; da Silva, ICM; Owen, N; Hallal, PC				Mielke, Gregore I.; da Silva, Inacio C. M.; Owen, Neville; Hallal, Pedro C.			Brazilian Adults' Sedentary Behaviors by Life Domain: Population-Based Study	PLOS ONE			English	Article							PHYSICAL INACTIVITY; TIME; DISEASE	Background: There is rapidly-emerging evidence on the harmful health effects of sedentary behaviors. The aim of this paper was to quantify time in sedentary behaviors and document socio-demographic variations in different life domains among adults. Methods: A population-based survey was carried out in 2012 through face-to-face interviews with Brazilian adults aged 20+ years (N = 2,927). Information about time spent sedentary in a typical weekday was collected for five different domains (workplace, commuting, school/university, watching TV, and computer use at home). Descriptive and bivariate analyses examined variations in overall and domain-specific sedentary time by gender, age, educational attainment and socioeconomic position. Results: On average, participants reported spending 5.8 (SD 4.5) hours per day sitting. The median value was 4.5 (interquartile range: 2.5-8) hours. Men, younger adults, those with higher schooling and from the wealthiest socioeconomic groups had higher overall sedentary scores. TV time was higher in women, older adults and among those with low schooling and socioeconomic position. Sedentary time in transport was higher in men, younger adults, and participants with high schooling and high socioeconomic position. Computer use at home was more frequent among young adults and those from high socioeconomic groups. Sitting at work was higher in those with higher schooling and from the wealthiest socioeconomic groups. Sedentary behavior at school was related inversely to age and directly to schooling. Conclusion: Patterns of sedentary behavior are different by life domains. Initiatives to reduce prolonged sitting among Brazilian adults will be required on multiple levels for different life domains.	[Mielke, Gregore I.; da Silva, Inacio C. M.; Hallal, Pedro C.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, RS, Brazil; [Owen, Neville] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Universidade Federal de Pelotas; Baker Heart and Diabetes Institute	Mielke, GI (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, RS, Brazil.	gregore.mielke@gmail.com	Hallal, Pedro C/A-3249-2011; da Silva, Inacio Crochemore M/S-4743-2019; Silva, Inacio C M/L-9896-2017; Mielke, Gregore I/E-2141-2014; Owen, Neville/K-5986-2012	Hallal, Pedro C/0000-0003-1470-6461; da Silva, Inacio Crochemore M/0000-0001-5390-8360; Silva, Inacio C M/0000-0001-5390-8360; Mielke, Gregore I/0000-0002-3043-2715; Owen, Neville/0000-0003-2784-4820	Brazilian National Research Council (CNPq); Coordination for the Improvement of Higher Level - or Education-Personnel (CAPES); National Health and Medical Research Council of Australia Program [569940, 1003960]; Victorian Government's Operational Infrastructure Support Program; Wellcome Trust through a New Investigator Award	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Level - or Education-Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Health and Medical Research Council of Australia Program(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Wellcome Trust through a New Investigator Award(Wellcome Trust)	GM - was supported by Brazilian National Research Council (CNPq). ICMS - is supported by Coordination for the Improvement of Higher Level - or Education-Personnel (CAPES). NO - is supported by a National Health and Medical Research Council of Australia Program Grant [# 569940] and a Senior Principal Research Fellowship [# 1003960]; and, by the Victorian Government's Operational Infrastructure Support Program. PH - is funded by the Wellcome Trust through a New Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEP (Associacao Brasileira de Empresas de Pesquisa), 2010, AD CCEB 2010 CRIT CL; Bauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003; Bull FC, 2011, J HEALTH COMMUN, V16, P13, DOI 10.1080/10810730.2011.601226; Clark BK, 2010, J PHYS ACT HEALTH, V7, P595, DOI 10.1123/jpah.7.5.595; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Kohl Harold W 3rd, 2012, Lancet, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561; Levine James A., 1999, Science (Washington D C), V283, P212, DOI 10.1126/science.283.5399.212; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Rydin Y, 2012, LANCET, V379, P2079, DOI 10.1016/S0140-6736(12)60435-8; Sallis JF, 2008, HLTH BEHAV HLTH ED T, V260, P465; Stamatakis E., 2003, J EPIDEMIOLOGY COMMU, V63, P734; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; VICTORA CG, 1993, LANCET, V342, P97, DOI 10.1016/0140-6736(93)91291-S	21	45	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91614	10.1371/journal.pone.0091614	http://dx.doi.org/10.1371/journal.pone.0091614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619086	Green Published, gold			2022-12-27	WOS:000332842400109
J	Park, JS; Hoke, A				Park, Jae-Sung; Hoeke, Ahmet			Treadmill Exercise Induced Functional Recovery after Peripheral Nerve Repair Is Associated with Increased Levels of Neurotrophic Factors	PLOS ONE			English	Article							SPINAL-CORD-INJURY; AXONAL REGENERATION; VOLUNTARY EXERCISE; SKELETAL-MUSCLE; EXPRESSION; GROWTH; RATS; PLASTICITY; NEURONS; CELLS	Benefits of exercise on nerve regeneration and functional recovery have been reported in both central and peripheral nervous system disease models. However, underlying molecular mechanisms of enhanced regeneration and improved functional outcomes are less understood. We used a peripheral nerve regeneration model that has a good correlation between functional outcomes and number of motor axons that regenerate to evaluate the impact of treadmill exercise. In this model, the median nerve was transected and repaired while the ulnar nerve was transected and prevented from regeneration. Daily treadmill exercise resulted in faster recovery of the forelimb grip function as evaluated by grip power and inverted holding test. Daily exercise also resulted in better regeneration as evaluated by recovery of compound motor action potentials, higher number of axons in the median nerve and larger myofiber size in target muscles. Furthermore, these observations correlated with higher levels of neurotrophic factors, glial derived neurotrophic factor (GDNF), brain derived neurotrophic factor (BDNF) and insulin-like growth factor-1 (IGF-1), in serum, nerve and muscle suggesting that increase in muscle derived neurotrophic factors may be responsible for improved regeneration.	[Hoeke, Ahmet] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Hoke, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	ahoke@jhmi.edu			Dr. Miriam and Sheldon Adelson Medical Research Foundation; Ansari Center for Cell Therapy and Regeneration Research	Dr. Miriam and Sheldon Adelson Medical Research Foundation; Ansari Center for Cell Therapy and Regeneration Research	This study was supported by Dr. Miriam and Sheldon Adelson Medical Research Foundation and Ansari Center for Cell Therapy and Regeneration Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armada-da-Silva PAS, 2013, INT REV NEUROBIOL, V109, P125, DOI 10.1016/B978-0-12-420045-6.00006-7; Asensio-Pinilla E, 2009, EXP NEUROL, V219, P258, DOI 10.1016/j.expneurol.2009.05.034; Cheng FC, 2013, J NEUROSURG, V118, P594, DOI 10.3171/2012.8.JNS111580; Doyle LMF, 2006, NEUROSCIENCE, V141, P321, DOI 10.1016/j.neuroscience.2006.03.044; Edgerton VR, 2004, ANNU REV NEUROSCI, V27, P145, DOI 10.1146/annurev.neuro.27.070203.144308; Ghiani CA, 2007, GLIA, V55, P966, DOI 10.1002/glia.20521; Goldshmit Y, 2008, J NEUROTRAUM, V25, P449, DOI 10.1089/neu.2007.0392; Gomez-Pinilla F, 2001, EUR J NEUROSCI, V13, P1078, DOI 10.1046/j.0953-816x.2001.01484.x; Groover AL, 2013, PAIN; Gustafsson T, 1999, AM J PHYSIOL-HEART C, V276, pH679, DOI 10.1152/ajpheart.1999.276.2.H679; Gyorkos AM, 2013, NEUROSCIENCE; Haastert K, 2008, NEUROSCI LETT, V443, P179, DOI 10.1016/j.neulet.2008.07.087; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hoke A, 2003, J NEUROSCI, V23, P561; Houle JD, 2013, ANN NY ACAD SCI, V1279, P154, DOI 10.1111/nyas.12052; Hutchinson KJ, 2004, BRAIN, V127, P1403, DOI 10.1093/brain/awh160; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Liu G, 2010, EXP NEUROL, V226, P200, DOI 10.1016/j.expneurol.2010.08.032; Matsakas A, 2004, INT J SPORTS MED, V25, P502, DOI 10.1055/s-2004-820945; Mattson MP, 2000, BRAIN RES, V886, P47, DOI 10.1016/S0006-8993(00)02790-6; Molteni R, 2004, P NATL ACAD SCI USA, V101, P8473, DOI 10.1073/pnas.0401443101; Pedersen BK, 2013, COMPR PHYSIOL, V3, P1337, DOI 10.1002/cphy.c120033; Sabatier MJ, 2008, EXP NEUROL, V211, P489, DOI 10.1016/j.expneurol.2008.02.013; Scheib J., 2013, NAT REV NEUROL; Skinner RD, 1996, BRAIN RES, V729, P127, DOI 10.1016/S0006-8993(96)00556-2; Tillerson JL, 2003, NEUROSCIENCE, V119, P899, DOI 10.1016/S0306-4522(03)00096-4; Wilhelm JC, 2012, J NEUROSCI, V32, P5002, DOI 10.1523/JNEUROSCI.1411-11.2012; Wood K, 2012, DEV NEUROBIOL, V72, P688, DOI 10.1002/dneu.20960	28	48	51	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90245	10.1371/journal.pone.0090245	http://dx.doi.org/10.1371/journal.pone.0090245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618564	gold, Green Published, Green Submitted			2022-12-27	WOS:000332842400011
J	Weinheimer-Haus, EM; Judex, S; Ennis, WJ; Koh, TJ				Weinheimer-Haus, Eileen M.; Judex, Stefan; Ennis, William J.; Koh, Timothy J.			Low-Intensity Vibration Improves Angiogenesis and Wound Healing in Diabetic Mice	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; SKIN BLOOD-FLOW; GROWTH-FACTOR; MATRIX-METALLOPROTEINASES; LOW-MAGNITUDE; OLDER-ADULTS; EXERCISE; MACROPHAGE; EXPRESSION; MOUSE	Chronic wounds represent a significant health problem, especially in diabetic patients. In the current study, we investigated a novel therapeutic approach to wound healing - whole body low-intensity vibration (LIV). LIV is anabolic for bone, by stimulating the release of growth factors, and modulating stem cell proliferation and differentiation. We hypothesized that LIV improves the delayed wound healing in diabetic mice by promoting a pro-healing wound environment. Diabetic db/db mice received excisional cutaneous wounds and were subjected to LIV (0.4 g at 45 Hz) for 30 min/d or a non-vibrated sham treatment (controls). Wound tissue was collected at 7 and 15 d post-wounding and wound healing, angiogenesis, growth factor levels and wound cell phenotypes were assessed. LIV increased angiogenesis and granulation tissue formation at day 7, and accelerated wound closure and re-epithelialization over days 7 and 15. LIV also reduced neutrophil accumulation and increased macrophage accumulation. In addition, LIV increased expression of pro-healing growth factors and chemokines (insulin-like growth factor-1, vascular endothelial growth factor and monocyte chemotactic protein-1) in wounds. Despite no evidence of a change in the phenotype of CD11b+ macrophages in wounds, LIV resulted in trends towards a less inflammatory phenotype in the CD11b- cells. Our findings indicate that LIV may exert beneficial effects on wound healing by enhancing angiogenesis and granulation tissue formation, and these changes are associated with increases in pro-angiogenic growth factors.	[Weinheimer-Haus, Eileen M.; Koh, Timothy J.] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60680 USA; [Weinheimer-Haus, Eileen M.; Ennis, William J.; Koh, Timothy J.] Univ Illinois, Ctr Tissue Repair & Regenerat, Chicago, IL USA; [Ennis, William J.] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Judex, Stefan] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Koh, TJ (corresponding author), Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60680 USA.	tjkoh@uic.edu		Weinheimer-Haus, Eileen/0000-0001-5408-0024; Koh, Timothy/0000-0001-6549-7060	National Institutes of Health [R01GM092850, T32DE018381]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE018381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (R01GM092850 to TJK and T32DE018381 to EMWH; www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JA, 2001, CRIT CARE MED, V29, P1983, DOI 10.1097/00003246-200110000-00022; Adams V, 2004, ARTERIOSCL THROM VAS, V24, P684, DOI 10.1161/01.ATV.0000124104.23702.a0; Armstrong DG, 2002, J AM PODIAT MED ASSN, V92, P12, DOI 10.7547/87507315-92-1-12; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Brkovic A, 2007, J CELL BIOCHEM, V100, P727, DOI 10.1002/jcb.21124; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Emery CF, 2005, J GERONTOL A-BIOL, V60, P1432, DOI 10.1093/gerona/60.11.1432; Ennis WJ, 2008, GYNECOL ONCOL, V111, pS81, DOI 10.1016/j.ygyno.2008.07.054; Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612; Gomez-Cabello A, 2012, SPORTS MED, V42, P301, DOI 10.2165/11597670-000000000-00000; Goren I, 2003, DIABETES, V52, P2821, DOI 10.2337/diabetes.52.11.2821; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; GRANT M, 1987, J CLIN ENDOCR METAB, V65, P370, DOI 10.1210/jcem-65-2-370; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Gregor S, 2008, ARCH SURG-CHICAGO, V143, P189, DOI 10.1001/archsurg.2007.54; Hong KH, 2005, BLOOD, V105, P1405, DOI 10.1182/blood-2004-08-3178; Hui W, 2001, ANN RHEUM DIS, V60, P254, DOI 10.1136/ard.60.3.254; Ito WD, 1997, CIRC RES, V80, P829; Jordan MJ, 2005, J STRENGTH COND RES, V19, P459, DOI 10.1519/13293.1; Keylock KT, 2008, AM J PHYSIOL-REG I, V294, pR179, DOI 10.1152/ajpregu.00177.2007; Kiel DP, 2010, CLIN TRIALS, V7, P354, DOI 10.1177/1740774510371014; Lau E, 2011, J ORTHOP RES, V29, P1075, DOI 10.1002/jor.21334; Laufs U, 2004, CIRCULATION, V109, P220, DOI 10.1161/01.CIR.0000109141.48980.37; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lobmann R, 2002, DIABETOLOGIA, V45, P1011, DOI 10.1007/s00125-002-0868-8; Lohman EB, 2007, MED SCI MONITOR, V13, pCR71; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Maloney-Hinds C, 2008, MED SCI MONITOR, V14, pCR112; Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450; Mobius-Winkler S, 2009, J APPL PHYSIOL, V107, P1943, DOI 10.1152/japplphysiol.00532.2009; Pence BD, 2012, MED SCI SPORT EXER, V44, P1846, DOI 10.1249/MSS.0b013e31825a5971; Rehman J, 2004, J AM COLL CARDIOL, V43, P2314, DOI 10.1016/j.jacc.2004.02.049; Rittweger J, 2010, EUR J APPL PHYSIOL, V108, P877, DOI 10.1007/s00421-009-1303-3; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Stewart JM, 2005, AM J PHYSIOL-REG I, V288, pR623, DOI 10.1152/ajpregu.00513.2004; Trengove Naomi J., 1996, Wound Repair and Regeneration, V4, P234, DOI 10.1046/j.1524-475X.1996.40211.x; Trengove NJ, 2000, WOUND REPAIR REGEN, V8, P13, DOI 10.1046/j.1524-475x.2000.00013.x; Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x; Tuan TL, 1998, MOL MED TODAY, V4, P19, DOI 10.1016/S1357-4310(97)80541-2; Voigt J, 2011, INT J LOW EXTR WOUND, V10, P190, DOI 10.1177/1534734611424648; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; White R, 2008, J Wound Care, V17, P428; White R, 2008, J WOUND CARE, V17, P428; Williams DT, 2007, DIABETIC MED, V24, P1105, DOI 10.1111/j.1464-5491.2007.02218.x; Yamamoto T, 2000, J IMMUNOL, V164, P6174, DOI 10.4049/jimmunol.164.12.6174; Yoshida A, 1996, GROWTH FACTORS, V13, P57, DOI 10.3109/08977199609034566	52	53	53	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91355	10.1371/journal.pone.0091355	http://dx.doi.org/10.1371/journal.pone.0091355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618702	Green Submitted, gold, Green Published			2022-12-27	WOS:000332842400080
J	Witney, TH; Fortt, RR; Aboagye, EO				Witney, Timothy H.; Fortt, Robin R.; Aboagye, Eric O.			Preclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by F-18-ICMT-11-Positron Emission Tomography	PLOS ONE			English	Article							INDUCED TUMOR APOPTOSIS; TREATMENT RESPONSE; PET TRACER; CELL-DEATH; CHEMOTHERAPY; THERAPY; BIOMARKERS; MARKER; ERCC1; MODEL	Tumour response to therapy is assessed primarily in the clinic by monitoring reductions in tumour size. However, this approach lacks sensitivity since in many cases several weeks may elapse before there is evidence of tumour shrinkage. There is therefore a need to develop non-invasive imaging techniques for monitoring tumour treatment response in the clinic. Here, we assessed the pre-clinical utility of F-18-ICMT-11 positron emission tomography - a method for detecting caspase 3/7 activation - in non-small cell lung cancer (NSCLC). F-18-ICMT-11 uptake was compared to molecular biochemical measures of cell death in PC9 and A549 NSCLC cells following treatment with carboplatin in vitro and in vivo. Carboplatin-induced apoptosis in the ERCC1 low/mutant EGFR PC9 cells was characterised by time and dose-related increased caspase-3/7 activation, poly-ADP-ribose polymerase cleavage and Annexin V staining. F-18-ICMT-11 uptake was consequently increased up to 14-fold at 200 mu M carboplatin compared to vehicle treated cells (P<0.01). In contrast, necrosis was the predominant death mechanism in ERCC1 high/wt EGFR A549 cells and no change in F-18-ICMT-11 uptake was detected. In vivo, histological analysis of PC9 tumour xenografts indicated high pre-therapy necrosis. A 4.6-fold increase in cleaved caspase-3/7 was measured in non-necrotic regions of PC9 tumours at 48h post carboplatin therapy. Average PET-derived tumour F-18-ICMT-11 uptake was insensitive to changes in apoptosis in the presence of substantial pre-existing necrosis. PET-based voxel intensity sorting however, identified intra-tumoural regions of high F-18-ICMT-11 uptake, enabling accurate assessment of apoptosis and therefore therapy response. In A549 tumours that lacked high pre-therapy necrosis, carboplatin induced growth inhibition that was only minimally associated with apoptosis and thus not detectable by F-18-ICMT-11 PET.	[Witney, Timothy H.; Fortt, Robin R.; Aboagye, Eric O.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England	Imperial College London	Aboagye, EO (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England.	eric.aboagye@imperial.ac.uk	Witney, Timothy/R-9440-2017	Witney, Timothy/0000-0002-9475-2873; ABOAGYE, Eric/0000-0003-2276-6771	Innovative Medicines Initiative Joint Undertaking [115151]; European Union; Cancer Research UK [16584, 10337] Funding Source: researchfish	Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); Cancer Research UK(Cancer Research UK)	The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking (www.imi.europa.eu) under grant agreement number 115151, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007/2013) and EFPIA companies' in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam IS, 2010, BIOCONJUGATE CHEM, V21, P884, DOI 10.1021/bc9004415; Ardizzoni A, 2007, J NATL CANCER I, V99, P847, DOI 10.1093/jnci/djk196; Belhocine T, 2002, CLIN CANCER RES, V8, P2766; Brindle K, 2008, NAT REV CANCER, V8, P94, DOI 10.1038/nrc2289; Challapalli A, 2013, J NUCL MED, V54, P1551, DOI 10.2967/jnumed.112.118760; Cohen A, 2009, CELL RES, V19, P625, DOI 10.1038/cr.2009.17; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fortt R, 2012, NUCL MED BIOL, V39, P1000, DOI 10.1016/j.nucmedbio.2012.03.004; Galban S, 2010, CURR PHARM BIOTECHNO, V11, P701, DOI 10.2174/138920110792246627; Gallagher FA, 2009, P NATL ACAD SCI USA, V106, P19801, DOI 10.1073/pnas.0911447106; Girard N, 2009, AM J SURG PATHOL, V33, P1752, DOI 10.1097/PAS.0b013e3181b8cf03; Glaser M, 2011, BIOORG MED CHEM LETT, V21, P6945, DOI 10.1016/j.bmcl.2011.10.001; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Hoglund J, 2011, J NUCL MED, V52, P720, DOI 10.2967/jnumed.110.081786; Hu S, 2012, MOL IMAGING BIOL, V14, P762, DOI 10.1007/s11307-012-0551-5; Jablonski D, 2001, P NATL ACAD SCI USA, V98, P5393, DOI 10.1073/pnas.101092598; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Micha D, 2008, CLIN CANCER RES, V14, P7304, DOI 10.1158/1078-0432.CCR-08-0111; Nguyen QD, 2009, P NATL ACAD SCI USA, V106, P16375, DOI 10.1073/pnas.0901310106; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Pfaffle HN, 2013, CANC RES; Nguyen QD, 2013, CLIN CANCER RES, V19, P3914, DOI 10.1158/1078-0432.CCR-12-3814; Reed E, 2005, CLIN CANCER RES, V11, P6100, DOI 10.1158/1078-0432.CCR-05-1083; Rosell R, 2013, LANCET, V382, P720, DOI 10.1016/S0140-6736(13)61715-8; Sinkus R, 2012, EUR J CANCER, V48, P425, DOI 10.1016/j.ejca.2011.11.034; SMITH G, 2008, BALLET REV, V36, P7; Strauss LG, 1996, EUR J NUCL MED, V23, P1409, DOI 10.1007/BF01367602; Usmanij EA, 2013, J NUCL MED, V54, P1528, DOI 10.2967/jnumed.112.116921; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wallace-Brodeur RR, 1999, CELL MOL LIFE SCI, V55, P64, DOI 10.1007/s000180050270; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Witney TH, 2010, BRIT J CANCER, V103, P1400, DOI 10.1038/sj.bjc.6605945; Witney TH, 2012, CLIN CANCER RES, V18, P1063, DOI 10.1158/1078-0432.CCR-11-2462; Witney TH, 2009, NEOPLASIA, V11, P574, DOI 10.1593/neo.09254; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zhao BS, 2009, J NUCL MED, V50, P239, DOI 10.2967/jnumed.108.056655	41	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91694	10.1371/journal.pone.0091694	http://dx.doi.org/10.1371/journal.pone.0091694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618809	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400121
J	Krondorfer, I; Lipp, K; Brugger, D; Staudigl, P; Sygmund, C; Haltrich, D; Peterbauer, CK				Krondorfer, Iris; Lipp, Katharina; Brugger, Dagmar; Staudigl, Petra; Sygmund, Christoph; Haltrich, Dietmar; Peterbauer, Clemens K.			Engineering of Pyranose Dehydrogenase for Increased Oxygen Reactivity	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; AGARICUS-MELEAGRIS; ALCOHOL OXIDASE; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-BINDING; O-2 REACTIVITY; ACTIVE-SITE; ACTIVATION; IDENTIFICATION; ENZYME	Pyranose dehydrogenase (PDH), a member of the GMC family of flavoproteins, shows a very broad sugar substrate specificity but is limited to a narrow range of electron acceptors and reacts extremely slowly with dioxygen as acceptor. The use of substituted quinones or (organo) metals as electron acceptors is undesirable for many production processes, especially of food ingredients. To improve the oxygen reactivity, site-saturation mutagenesis libraries of twelve amino acids around the active site of Agaricus meleagris PDH were expressed in Saccharomyces cerevisiae. We established high-throughput screening assays for oxygen reactivity and standard dehydrogenase activity using an indirect Amplex Red/horseradish peroxidase and a DCIP/D-glucose based approach. The low number of active clones confirmed the catalytic role of H512 and H556. Only one position was found to display increased oxygen reactivity. Histidine 103, carrying the covalently linked FAD cofactor in the wild-type, was substituted by tyrosine, phenylalanine, tryptophan and methionine. Variant H103Y was produced in Pichia pastoris and characterized and revealed a five-fold increase of the oxygen reactivity.	[Krondorfer, Iris; Lipp, Katharina; Brugger, Dagmar; Staudigl, Petra; Sygmund, Christoph; Haltrich, Dietmar; Peterbauer, Clemens K.] Univ Nat Resources & Life Sci, Dept Food Sci & Technol, Food Biotechnol Lab, Vienna, Austria; [Lipp, Katharina] Univ Appl Sci Wiener Neustadt, Tulln, Austria	University of Natural Resources & Life Sciences, Vienna	Peterbauer, CK (corresponding author), Univ Nat Resources & Life Sci, Dept Food Sci & Technol, Food Biotechnol Lab, Vienna, Austria.	clemens.peterbauer@boku.ac.at	Haltrich, Dietmar/N-2624-2019	Haltrich, Dietmar/0000-0002-8722-8176; Peterbauer, Clemens/0000-0002-8033-198X	Austrian Science Fund (FWF) [P22094, W1224]; Austrian Science Fund (FWF) [P 22094] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was financed by the Austrian Science Fund (FWF; www.fwf.ac.at): Individual Grant P22094 to CKP Doctoral programme BioToP (Biomolecular Technology of Proteins; grant nr. W1224; IK and DB are members). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalde M, 2010, METHODS MOL BIOL, V634, P3, DOI 10.1007/978-1-60761-652-8_1; Ander P, 1997, J BIOTECHNOL, V53, P115, DOI 10.1016/S0168-1656(97)01680-5; Baron R, 2009, P NATL ACAD SCI USA, V106, P10603, DOI 10.1073/pnas.0903809106; Bowley DR, 2007, PROTEIN ENG DES SEL, V20, P81, DOI 10.1093/protein/gzl057; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Finnegan S, 2010, BIOCHEMISTRY-US, V49, P2952, DOI 10.1021/bi902048c; Fraaije MW, 1999, J BIOL CHEM, V274, P35514, DOI 10.1074/jbc.274.50.35514; Gadda G, 2006, ARCH BIOCHEM BIOPHYS, V451, P182, DOI 10.1016/j.abb.2006.04.005; Gadda G, 2012, BIOCHEMISTRY-US, V51, P2662, DOI 10.1021/bi300227d; Garcia-Ruiz E, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-17; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Georgescu Radu, 2003, V230, P171; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Giffhorn F, 2000, APPL MICROBIOL BIOT, V54, P727, DOI 10.1007/s002530000446; Gonzalez-Perez D, 2012, BIOENGINEERED, V3, P172, DOI 10.4161/bbug.19544; Graf MMH, 2013, J COMPUT AID MOL DES, V27, P295, DOI 10.1007/s10822-013-9645-7; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; Hernandez-Ortega A, 2012, BIOCHEMISTRY-US, V51, P6595, DOI 10.1021/bi300505z; Hernandez-Ortega A, 2011, J BIOL CHEM, V286, P41105, DOI 10.1074/jbc.M111.282467; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KENNEY WC, 1976, J BIOL CHEM, V251, P5386; Kittl R, 2008, CURR GENET, V53, P117, DOI 10.1007/s00294-007-0171-9; Klinman JP, 2007, ACCOUNTS CHEM RES, V40, P325, DOI 10.1021/ar6000507; Kujawa M, 2007, FEBS J, V274, P879, DOI 10.1111/j.1742-4658.2007.05634.x; Kujawa M, 2006, J BIOL CHEM, V281, P35104, DOI 10.1074/jbc.M604718200; Leferink NGH, 2009, J BIOL CHEM, V284, P4392, DOI 10.1074/jbc.M808202200; Li SL, 1997, BIOTECHNIQUES, V23, P588, DOI 10.2144/97234bm05; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; McDonald CA, 2011, J AM CHEM SOC, V133, P16809, DOI 10.1021/ja2081873; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; Peterbauer CK, 2010, APPL MICROBIOL BIOT, V85, P837, DOI 10.1007/s00253-009-2226-y; Pisanelli I, 2010, APPL MICROBIOL BIOT, V86, P599, DOI 10.1007/s00253-009-2308-x; Pommie C, 2004, J MOL RECOGNIT, V17, P17, DOI 10.1002/jmr.647; Saam J, 2010, J BIOL CHEM, V285, P24439, DOI 10.1074/jbc.M110.131193; Sedmera P, 2006, J MOL CATAL B-ENZYM, V41, P32, DOI 10.1016/j.molcatb.2006.04.004; Staudigl P, 2013, BIOMOLECULES, V3, P535, DOI 10.3390/biom3030535; Su QJ, 1999, BIOCHEMISTRY-US, V38, P8572, DOI 10.1021/bi990044o; Sucharitakul J, 2008, BIOCHEMISTRY-US, V47, P8485, DOI 10.1021/bi801039d; Sygmund C, 2008, J BIOTECHNOL, V133, P334, DOI 10.1016/j.jbiotec.2007.10.013; Sygmund C, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-38; Sygmund C, 2012, APPL MICROBIOL BIOT, V94, P695, DOI 10.1007/s00253-011-3667-7; Tan TC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053567, 10.1371/journal.pone.0073165]; Tasca F, 2010, BIOSENS BIOELECTRON, V25, P1710, DOI 10.1016/j.bios.2009.12.017; Volc J, 2004, J MOL CATAL B-ENZYM, V30, P177, DOI 10.1016/j.molcatb.2004.05.006; VOLC J, 1985, FOLIA MICROBIOL, V30, P141, DOI 10.1007/BF02922207; Volc J, 1997, ARCH MICROBIOL, V167, P119, DOI 10.1007/s002030050424; Volc J, 2001, ARCH MICROBIOL, V176, P178, DOI 10.1007/s002030100308; Weis R, 2004, FEMS YEAST RES, V5, P179, DOI 10.1016/j.femsyr.2004.06.016; Winkler A, 2007, J BIOL CHEM, V282, P24437, DOI 10.1074/jbc.M703642200; Zhao GH, 2008, BIOCHEMISTRY-US, V47, P9124, DOI 10.1021/bi8008642; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	52	14	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91145	10.1371/journal.pone.0091145	http://dx.doi.org/10.1371/journal.pone.0091145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614932	gold, Green Published, Green Submitted			2022-12-27	WOS:000332839300084
J	Lehmann, KDS; Goldman, BW; Dworkin, I; Bryson, DM; Wagner, AP				Lehmann, Kenna D. S.; Goldman, Brian W.; Dworkin, Ian; Bryson, David M.; Wagner, Aaron P.			From Cues to Signals: Evolution of Interspecific Communication via Aposematism and Mimicry in a Predator-Prey System	PLOS ONE			English	Article							BATESIAN MIMICRY; MULLERIAN MIMICRY; THEORETICAL INVESTIGATIONS; WARNING SIGNALS; MODEL; FREQUENCY; RECOGNITION; AUTOMIMICRY; DYNAMICS; STRATEGY	Current theory suggests that many signaling systems evolved from preexisting cues. In aposematic systems, prey warning signals benefit both predator and prey. When the signal is highly beneficial, a third species often evolves to mimic the toxic species, exploiting the signaling system for its own protection. We investigated the evolutionary dynamics of predator cue utilization and prey signaling in a digital predator-prey system in which prey could evolve to alter their appearance to mimic poison-free or poisonous prey. In predators, we observed rapid evolution of cue recognition (i.e. active behavioral responses) when presented with sufficiently poisonous prey. In addition, active signaling (i.e. mimicry) evolved in prey under all conditions that led to cue utilization. Thus we show that despite imperfect and dishonest signaling, given a high cost of consuming poisonous prey, complex systems of interspecific communication can evolve via predator cue recognition and prey signal manipulation. This provides evidence supporting hypotheses that cues may serve as steppings-tones in the evolution of more advanced communication and signaling systems that incorporate information about the environment.	[Lehmann, Kenna D. S.; Dworkin, Ian] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Goldman, Brian W.] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Lehmann, Kenna D. S.; Goldman, Brian W.; Dworkin, Ian; Bryson, David M.; Wagner, Aaron P.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Lehmann, Kenna D. S.; Dworkin, Ian] Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Lehmann, KDS (corresponding author), Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.	kdslehmann@gmail.com	Lehmann, Kenna/AAM-3416-2020	Dworkin, Ian/0000-0002-2874-287X	BEACON Center for the Study of Evolution in Action (NSF Cooperative Agreement) [DBI-0939454]; Michigan State University Institute for Cyber Enabled Research	BEACON Center for the Study of Evolution in Action (NSF Cooperative Agreement); Michigan State University Institute for Cyber Enabled Research	This work was supported by the BEACON Center for the Study of Evolution in Action (NSF Cooperative Agreement DBI-0939454) and the Michigan State University Institute for Cyber Enabled Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronsson M, 2008, ANIM BEHAV, V75, P417, DOI 10.1016/j.anbehav.2007.05.006; Auguie B, 2012, GRIDEXTRA FUNCTIONS; AVERY ML, 1985, J WILDLIFE MANAGE, V49, P1116, DOI 10.2307/3801404; Balogh ACV, 2005, P ROY SOC B-BIOL SCI, V272, P2269, DOI 10.1098/rspb.2005.3227; Balogh ACV, 2010, EVOLUTION, V64, P810, DOI 10.1111/j.1558-5646.2009.00852.x; Barnett CA, 2007, BEHAV ECOL, V18, P645, DOI 10.1093/beheco/arm027; Bates H.W., 1862, T LINN SOC LOND, V23, P495; Bradbury J.W., 2001, PRINCIPLES ANIMAL CO, Vsecond; BROWER JV, 1960, AM NAT, V94, P271, DOI 10.1086/282128; BROWER LP, 1970, P NATL ACAD SCI USA, V66, P1059, DOI 10.1073/pnas.66.4.1059; Bryson DM, 2013, PLOS ONE, DOI [10.1371/journal.pone.0083242, DOI 10.1371/J0URNAL.P0NE.0083242]; Caley MJ, 2003, P ROY SOC B-BIOL SCI, V270, P667, DOI 10.1098/rspb.2002.2263; Canty A, 2013, BOOT BOOTSTRAP R S S; Davison AC, 1997, BOOTSTRAP METHODS TH; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Edmunds M, 2000, BIOL J LINN SOC, V70, P459; EMLEN JM, 1968, AM NAT, V102, P235, DOI 10.1086/282540; ESTABROOK GF, 1974, AM NAT, V108, P443, DOI 10.1086/282925; Fish J, ROLES STANDING GENET, DOI [10.1101/002493, DOI 10.1101/002493]; Fisher RA, 1930, GENETICAL THEORY NAT; Fortuna MA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002928; Franks DW, 2007, J THEOR BIOL, V244, P631, DOI 10.1016/j.jtbi.2006.09.019; Franks DW, 2009, EVOLUTION, V63, P256, DOI 10.1111/j.1558-5646.2008.00509.x; Gamberale-Stille G, 2012, EVOLUTION, V66, P807, DOI 10.1111/j.1558-5646.2011.01482.x; Gavrilets S, 1998, J THEOR BIOL, V191, P415, DOI 10.1006/jtbi.1997.0615; Harper GR, 2008, NATURE, V451, P1103, DOI 10.1038/nature06532; Harper GR, 2007, P R SOC B, V274, P1955, DOI 10.1098/rspb.2007.0558; HASSON O, 1991, TRENDS ECOL EVOL, V6, P325, DOI 10.1016/0169-5347(91)90040-5; Holen OH, 2004, AM NAT, V164, P598, DOI 10.1086/424972; Holmgren NMA, 1999, BIOL J LINN SOC, V66, P145; Honma A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003411; HUHEEY J E, 1988, American Naturalist, V131, pS22, DOI 10.1086/284765; HUHEEY JE, 1976, EVOLUTION, V30, P86, DOI 10.1111/j.1558-5646.1976.tb00884.x; HUHEEY JE, 1964, ECOLOGY, V45, P185, DOI 10.2307/1937125; Ihalainen E, 2007, J EVOLUTION BIOL, V20, P780, DOI 10.1111/j.1420-9101.2006.01234.x; Iserbyt A, 2011, P ROY SOC B-BIOL SCI, V278, P3116, DOI 10.1098/rspb.2011.0126; Joron M, 1998, TRENDS ECOL EVOL, V13, P461, DOI 10.1016/S0169-5347(98)01483-9; KANNAN D, 1983, B MATH BIOL, V45, P347, DOI 10.1007/BF02459397; Kikuchi DW, 2010, AM NAT, V176, P830, DOI 10.1086/657041; Kikuchi DW, 2010, P ROY SOC B-BIOL SCI, V277, P1041, DOI 10.1098/rspb.2009.2000; Lev-Yadun S, 2009, ISR J PLANT SCI, V57, P107, DOI 10.1560/IJPS.57.1-2.107; Lewontin R. C., 1970, ANNU REV ECOL SYST, V1, P1, DOI [DOI 10.1146/ANNUREV.ES.01.110170.000245, 10.1146/annurev.es.01.110170.000245]; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Lindstrom L, 1997, P ROY SOC B-BIOL SCI, V264, P149, DOI 10.1098/rspb.1997.0022; Lindstrom L, 2004, EVOLUTION, V58, P1294, DOI 10.1554/03-271; Mappes J, 1997, EVOLUTION, V51, P2050, DOI 10.1111/j.1558-5646.1997.tb05129.x; MATESSI C, 1972, THEOR POPUL BIOL, V3, P41, DOI 10.1016/0040-5809(72)90033-0; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; MULLER F., 1879, T ENTOMOL SOC LOND, V1879, pxx; Ofria C, 2005, ARTIFICIAL LIFE MODELS IN SOFTWARE, P3, DOI 10.1007/1-84628-214-4_1; Penney HD, 2012, NATURE, V483, P461, DOI 10.1038/nature10961; Pfennig DW, 2007, BEHAV ECOL SOCIOBIOL, V61, P505, DOI 10.1007/s00265-006-0278-x; Pfennig DW, 2012, CURR ZOOL, V58, P608, DOI 10.1093/czoolo/58.4.608; POUGH FH, 1973, P NATL ACAD SCI USA, V70, P2261, DOI 10.1073/pnas.70.8.2261; Przeczek K, 2008, INTEGR ZOOL, V3, P149, DOI 10.1111/j.1749-4877.2008.00091.x; Randall JE, 2005, ZOOL STUD, V44, P299; RCore Team, 2020, R LANG ENV STAT COMP; Ries L, 2008, EVOLUTION, V62, P1798, DOI 10.1111/j.1558-5646.2008.00401.x; Rowland HM, 2010, ECOL LETT, V13, P1494, DOI 10.1111/j.1461-0248.2010.01539.x; Servedio MR, 2000, EVOLUTION, V54, P751; Sherratt TN, 2003, AM NAT, V162, P377, DOI 10.1086/378047; Sherratt TN, 2002, BEHAV ECOL, V13, P821, DOI 10.1093/beheco/13.6.821; SMITH SM, 1975, SCIENCE, V187, P759, DOI 10.1126/science.187.4178.759; Speed MP, 2010, AM NAT, V176, pE1, DOI 10.1086/652990; Tsoularis A, 2005, J BIOL SYST, V13, P273, DOI 10.1142/S0218339005001483; TURNER JRG, 1984, BIOL J LINN SOC, V23, P247, DOI 10.1111/j.1095-8312.1984.tb00143.x; Wagner A. P., 2013, ARXIV13101369; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickler W, 1968, MIMICY PLANTS ANIMAL; Wilson JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061610	70	12	12	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91783	10.1371/journal.pone.0091783	http://dx.doi.org/10.1371/journal.pone.0091783			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614755	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300159
J	Borges, AH; O'Connor, JL; Phillips, AN; Baker, JV; Vjecha, MJ; Losso, MH; Klinker, H; Lopardo, G; Williams, I; Lundgren, JD				Borges, Alvaro H.; O'Connor, Jemma L.; Phillips, Andrew N.; Baker, Jason V.; Vjecha, Michael J.; Losso, Marcelo H.; Klinker, Hartwig; Lopardo, Gustavo; Williams, Ian; Lundgren, Jens D.		INSIGHT SMART Study Grp; ESPRIT Study Grp; SILCAAT Sci Comm	Factors Associated with D-Dimer Levels in HIV-Infected Individuals	PLOS ONE			English	Article							FIBRIN D-DIMER; PLASMA D-DIMER; ANTIRETROVIRAL THERAPY; COAGULATION; BIOMARKERS; DISEASE; INTERLEUKIN-6; INTERRUPTION; INFLAMMATION; DEGRADATION	Background: Higher plasma D-dimer levels are strong predictors of mortality in HIV+ individuals. The factors associated with D-dimer levels during HIV infection, however, remain poorly understood. Methods: In this cross-sectional study, participants in three randomized controlled trials with measured D-dimer levels were included (N = 9,848). Factors associated with D-dimer were identified by linear regression. Covariates investigated were: age, gender, race, body mass index, nadir and baseline CD4(+) count, plasma HIV RNA levels, markers of inflammation (C-reactive protein [CRP], interleukin-6 [IL-6]), antiretroviral therapy (ART) use, ART regimens, co-morbidities (hepatitis B/C, diabetes mellitus, prior cardiovascular disease), smoking, renal function (estimated glomerular filtration rate [eGFR] and cystatin C) and cholesterol. Results: Women from all age groups had higher D-dimer levels than men, though a steeper increase of D-dimer with age occurred in men. Hepatitis B/C co-infection was the only co-morbidity associated with higher D-dimer levels. In this subgroup, the degree of hepatic fibrosis, as demonstrated by higher hyaluronic acid levels, but not viral load of hepatitis viruses, was positively correlated with D-dimer. Other factors independently associated with higher D-dimer levels were black race, higher plasma HIV RNA levels, being off ART at baseline, and increased levels of CRP, IL-6 and cystatin C. In contrast, higher baseline CD4+ counts and higher high-density lipoprotein cholesterol were negatively correlated with D-dimer levels. Conclusions: D-dimer levels increase with age in HIV+ men, but are already elevated in women at an early age due to reasons other than a higher burden of concomitant diseases. In hepatitis B/C co-infected individuals, hepatic fibrosis, but not hepatitis viral load, was associated with higher D-dimer levels.	[Borges, Alvaro H.; Lundgren, Jens D.] Univ Copenhagen, Rigshosp, Ctr Hlth & Infect Dis Res CHIP, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [O'Connor, Jemma L.; Phillips, Andrew N.] UCL, Res Dept Infect & Populat Hlth, London, England; [Baker, Jason V.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Baker, Jason V.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Vjecha, Michael J.] Vet Affairs Med Ctr, Washington, DC 20422 USA; [Losso, Marcelo H.] Hosp JM Ramos Mejia, Buenos Aires, DF, Argentina; [Klinker, Hartwig] Univ Wurzburg, Med Ctr, D-97070 Wurzburg, Germany; [Lopardo, Gustavo] Fdn Ctr Estudios Infectol, Buenos Aires, DF, Argentina; [Williams, Ian] UCL, Ctr Sexual Hlth & HIV Res, London, England	Rigshospitalet; University of Copenhagen; University of London; University College London; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Hospital Ramos Mejia; University of Buenos Aires; University of Wurzburg; University of London; University College London	Borges, AH (corresponding author), Univ Copenhagen, Rigshosp, Ctr Hlth & Infect Dis Res CHIP, Dept Infect Dis, DK-2100 Copenhagen, Denmark.	adb@cphiv.dk	Borges, Alvaro/G-3231-2016; Ostergaard, Lars/AAA-3020-2020; Emery, Sean/O-9122-2019; Emery, Sean/J-3825-2017; Phillips, Andrew N/B-4427-2008; Klinker, Hartwig/AAC-1134-2021; Brites, Carlos/D-1353-2013; Lundgren, Jens/AAE-6876-2019; Pulido, Federico/B-8417-2009	Borges, Alvaro/0000-0003-2020-3828; Ostergaard, Lars/0000-0003-2459-0511; Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Phillips, Andrew N/0000-0003-2384-4807; Brites, Carlos/0000-0002-4673-6991; Pulido, Federico/0000-0002-7414-8812; Leen, Clifford/0000-0001-8439-7719; Ristola, Matti/0000-0001-5115-2811; Medland, Nicholas Andrew/0000-0003-0403-8930; Lundgren, Jens/0000-0001-8901-7850; ABEL, Sylvie/0000-0002-3351-0547; Magenta, Lorenzo/0000-0002-7644-3647; Okhuysen, Pablo/0000-0002-1596-3411; Cabie, Andre/0000-0003-0117-3061; Ostergaard, Lars/0000-0002-7619-605X; Kozal, Michael/0000-0002-3100-8254; Easterbrook, Philippa/0000-0002-2603-5418; Gayet-Ageron, Angele/0000-0002-6164-9693; Koirala, Janak/0000-0002-3608-474X	NIH [U01AI46957, U01AI068641, U01AI042170, U01AI46362]; Chiron; Novartis; Gilead Pharmaceuticals; ViiV Health Care; CTS Inc., Durham, NC; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046957, U01AI046362, U01AI042170, P30AI094189, U01AI068641, UM1AI068641] Funding Source: NIH RePORTER; Medical Research Council [MR/J01477X/1, MC_U122886352, MC_UU_12023/16] Funding Source: researchfish; MRC [MC_UU_12023/16, MR/J01477X/1, MC_U122886352] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chiron; Novartis(Novartis); Gilead Pharmaceuticals(Gilead Sciences); ViiV Health Care; CTS Inc., Durham, NC; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by NIH [grant numbers: U01AI46957 and U01AI068641 (ESPRIT and SMART); U01AI042170 and U01AI46362 (SMART)]. The SILCAAT trial was supported by grants from Chiron and Novartis. In the ESPRIT and SILCAAT trials, laboratory measurements were performed by SAIC-Frederick. In the SMART trial, cholesterol was measured by Quest Diagnostics, Inc. JVB receives research support from Gilead Pharmaceuticals and ViiV Health Care. VC and JE are affiliated with International Drug Distribution (CTS Inc., Durham, NC) and received support from this company in wage form. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Armah KA, 2012, CLIN INFECT DIS, V55, P126, DOI 10.1093/cid/cis406; Baker J, 2010, HIV MED, V11, P608, DOI 10.1111/j.1468-1293.2010.00835.x; Baker J, 2010, J INFECT DIS, V201, P285, DOI 10.1086/649560; Baker JV, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000264; Baker JV, 2011, JAIDS-J ACQ IMM DEF, V56, P36, DOI 10.1097/QAI.0b013e3181f7f61a; Calmy A, 2009, AIDS, V23, P929, DOI 10.1097/QAD.0b013e32832995fa; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Di Castelnuovo A, 2013, HAEMATOLOGICA, V98, P1476, DOI 10.3324/haematol.2012.083410; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fichtenbaum Carl J, 2011, Curr Infect Dis Rep, V13, P94, DOI 10.1007/s11908-010-0153-9; Folsom AR, 2009, AM J HEMATOL, V84, P349, DOI 10.1002/ajh.21429; Funderburg NT, 2010, BLOOD, V115, P161, DOI 10.1182/blood-2009-03-210179; GORDGE MP, 1989, THROMB HAEMOSTASIS, V61, P522; HAGER K, 1995, GERONTOLOGY, V41, P159; Harper PL, 2007, INTERN MED J, V37, P607, DOI 10.1111/j.1445-5994.2007.01388.x; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Kabrhel C, 2010, ACAD EMERG MED, V17, P589, DOI 10.1111/j.1553-2712.2010.00765.x; Khaleghi M, 2009, J THROMB HAEMOST, V7, P34, DOI 10.1111/j.1538-7836.2008.03215.x; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lange LA, 2008, J THROMB HAEMOST, V6, P654, DOI 10.1111/j.1538-7836.2008.02906.x; LASSILA R, 1993, ARTERIOSCLER THROMB, V13, P1738, DOI 10.1161/01.ATV.13.12.1738; Ledwaba L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024243; LEE AJ, 1995, ARTERIOSCL THROM VAS, V15, P1094, DOI 10.1161/01.ATV.15.8.1094; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Peters L, 2011, ANTIVIR THER, V16, P667, DOI 10.3851/IMP1815; Pieper CF, 2000, J GERONTOL A-BIOL, V55, pM649, DOI 10.1093/gerona/55.11.M649; ROBSON SC, 1994, BRIT J HAEMATOL, V86, P322, DOI 10.1111/j.1365-2141.1994.tb04733.x; Rosendaal FR, 2002, ARTERIOSCL THROM VAS, V22, P201, DOI 10.1161/hq0202.102318; Shlipak MG, 2003, CIRCULATION, V107, P87, DOI 10.1161/01.CIR.0000042700.48769.59; Shorr AF, 2002, CHEST, V121, P1262, DOI 10.1378/chest.121.4.1262; Spadaro A, 2008, WORLD J GASTROENTERO, V14, P1549, DOI 10.3748/wjg.14.1549; Stouthard JML, 1996, THROMB HAEMOSTASIS, V76, P738; Tedaldi E, 2008, CLIN INFECT DIS, V47, P1468, DOI 10.1086/593102	36	49	49	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90978	10.1371/journal.pone.0090978	http://dx.doi.org/10.1371/journal.pone.0090978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626096	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300045
J	Etokebe, GE; Bulat-Kardum, L; Munthe, LA; Balen, S; Dembic, Z				Etokebe, Godfrey Essien; Bulat-Kardum, Ljiljana; Munthe, Ludvig Andre; Balen, Sanja; Dembic, Zlatko			Association of Variable Number of Tandem Repeats in the Coding Region of the FAM46A Gene, FAM46A rs11040 SNP and BAG6 rs3117582 SNP with Susceptibility to Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IDENTIFICATION; DETERMINANTS; POPULATION; FAMILIES; AFRICANS; RECEPTOR; C6ORF37; PROTEIN; ALLELE	We analyzed for association between the Family with sequence similarity 46, member A (FAM46A) gene (located on chromosome 6q14.1), BCL2-Associated Athanogene 6 (BAG6) gene (located on chromosome 6p21.3) and tuberculosis in Croatian Caucasian. We genotyped the FAM46A rs11040 SNP, FAM46A VNTR and BAG6 rs3117582 polymorphisms in a case-control study with 257 tuberculosis patients and 493 healthy individuals in a Croatian Caucasian population. We found that genotype FAM46A 3/3 (three VNTR repeats homozygote) was associated with susceptibility to tuberculosis (p<0.0015, P-corr<0.029, Odds ratio = 2.42, 95% Confidence Interval = 1.34-4.3). This association suggests that the protein domain encoded by the VNTR might be important for the function of the FAM46A protein, which, in turn, could be relevant in developing tuberculosis. In addition, we found that FAM46A rs11040 SNP:FAM46A VNTR:BAG6 haplotype 132 (G-3-C) is associated with susceptibility to tuberculosis (p<0.012, p(corr), <0.024, Odds ratio 3.45, 95% Confidence Interval = 1.26-9.74). This may suggests that the interaction between the FAM46A and BAG6 proteins may be involved in tuberculosis etiology. We found also that infection of human macrophages with heat-killed M. tuberculosis (H37Rv) led to over-expression of FAM46A (VNTR 3/4) transcript. This is the first study to show associations between the FAM46A gene VNTR polymorphisms, FAM46A rs11040 SNP: FAM46A VNTR: BAG6 haplotypes and any disease.	[Etokebe, Godfrey Essien; Dembic, Zlatko] Univ Oslo, Dept Oral Biol, Fac Dent, Mol Genet Lab, Oslo, Norway; [Bulat-Kardum, Ljiljana] Univ Rijeka, Sect Pulmol, Dept Internal Med, Clin Hosp Ctr, Rijeka, Croatia; [Munthe, Ludvig Andre] OUS Rikshosp, Dept Immunol, Oslo, Norway; [Balen, Sanja] Univ Rijeka, Clin Inst Transfus Med, Univ Hosp Ctr Rijeka, Sch Med, Rijeka, Croatia	University of Oslo; University of Rijeka; University of Oslo; National Hospital Norway; University of Rijeka	Etokebe, GE (corresponding author), Univ Oslo, Dept Oral Biol, Fac Dent, Mol Genet Lab, Oslo, Norway.	godfrey.etokebe@odont.uio.no	Balen, Sanja/S-5253-2018; Munthe, Ludvig/GRJ-3355-2022; Dembic, Zlatko/A-1833-2008	Balen, Sanja/0000-0003-2408-6868; Dembic, Zlatko/0000-0002-9970-6497; Munthe, Ludvig A/0000-0002-0344-3654				Awofeso N, 2010, PUBLIC HEALTH REP, V125, P25, DOI 10.1177/00333549101250S406; Barragan I, 2008, ANN HUM GENET, V72, P26, DOI 10.1111/j.1469-1809.2007.00393.x; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; Bellamy R., 1998, Tubercle and Lung Disease, V79, P83, DOI 10.1054/tuld.1998.0009; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Bellamy R, 2000, P NATL ACAD SCI USA, V97, P8005, DOI 10.1073/pnas.140201897; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Cui J, 2006, CLIN CHIM ACTA, V368, P155, DOI 10.1016/j.cca.2005.12.043; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Etokebe GE, 2010, SCAND J IMMUNOL, V71, P369, DOI 10.1111/j.1365-3083.2010.02379.x; Etokebe GE, 2009, ARCH ORAL BIOL, V54, P1002, DOI 10.1016/j.archoralbio.2009.08.005; Goldfeld AE, 1998, JAMA-J AM MED ASSOC, V279, P226, DOI 10.1001/jama.279.3.226; Grant AV, 2013, AM J HUM GENET, V92, P407, DOI 10.1016/j.ajhg.2013.01.013; Grover A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040836; Hannan AJ, 2010, DISCOV MED, V10, P314; Hannan AJ, 2010, TRENDS GENET, V26, P59, DOI 10.1016/j.tig.2009.11.008; Herb F, 2008, HUM MOL GENET, V17, P1052, DOI 10.1093/hmg/ddm378; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; Lagali PS, 2002, BIOCHEM BIOPH RES CO, V293, P356, DOI 10.1016/S0006-291X(02)00228-0; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Moller M, 2010, FEMS IMMUNOL MED MIC, V58, P3, DOI 10.1111/j.1574-695X.2009.00600.x; Moustafa JSE, 2012, HUM MOL GENET, V21, P3727, DOI 10.1093/hmg/dds187; Rodrigue S, 2006, FEMS MICROBIOL REV, V30, P926, DOI 10.1111/j.1574-6976.2006.00040.x; Simhadri VR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003377; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Songane M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041618; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; World Health Organization, 2012, 9 WHO; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200	33	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91385	10.1371/journal.pone.0091385	http://dx.doi.org/10.1371/journal.pone.0091385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625963	Green Published, gold			2022-12-27	WOS:000332851300079
J	Kong, XD; Li, L; Sun, L; Fu, KP; Long, J; Weng, XJ; Ye, XH; Liu, XX; Wang, B; Yan, SH; Ye, HM; Fan, ZQ				Kong, Xiangdong; Li, Lin; Sun, Lei; Fu, Kepeng; Long, Ju; Weng, Xunjin; Ye, Xuehe; Liu, Xinxiong; Wang, Bo; Yan, Shanhuo; Ye, Haiming; Fan, Zuqian			Rapid Diagnosis of Aneuploidy Using Segmental Duplication Quantitative Fluorescent PCR	PLOS ONE			English	Article							DEPENDENT PROBE AMPLIFICATION; PRENATAL-DIAGNOSIS; DOWN-SYNDROME; HUMAN-GENOME; TRISOMY-21; QUANTIFICATION; CHROMOSOME-21; MLPA	The aim of this study was use a simple and rapid procedure, called segmental duplication quantitative fluorescent polymerase chain reaction (SD-QF-PCR), for the prenatal diagnosis of fetal chromosomal aneuploidies. This method is based on the co-amplification of segmental duplications located on two different chromosomes using a single pair of fluorescent primers. The PCR products of different sizes were subsequently analyzed through capillary electrophoresis, and the aneuploidies were determined based on the relative dosage between the two chromosomes. Each primer set, containing five pairs of primers, was designed to simultaneously detect aneuploidies located on chromosomes 21, 18, 13, X and Y in a single reaction. We applied these two primer sets to DNA samples isolated from individuals with trisomy 21 (n = 36); trisomy 18 (n = 6); trisomy 13 (n = 4); 45, X (n = 5); 47, XXX (n = 3); 48, XXYY (n = 2); and unaffected controls (n = 40). We evaluated the performance of this method using the karyotyping results. A correct and unambiguous diagnosis with 100% sensitivity and 100% specificity, was achieved for clinical samples examined. Thus, the present study demonstrates that SD-QF-PCR is a robust, rapid and sensitive method for the diagnosis of common aneuploidies, and these analyses can be performed in less than 4 hours for a single sample, providing a competitive alternative for routine use.	[Kong, Xiangdong] Zhengzhou Univ, Affiliated Hosp 1, Prenatal Diag Ctr, Zhengzhou, Henan, Peoples R China; [Li, Lin] Lin Yi Peoples Hosp, Dept Genet Lab, Linyi, Shandong, Peoples R China; [Sun, Lei; Fu, Kepeng; Long, Ju; Weng, Xunjin; Ye, Xuehe; Liu, Xinxiong; Yan, Shanhuo; Ye, Haiming; Fan, Zuqian] Qinzhou Maternal & Child Hlth Care Hosp, Med Genet Lab, Guangxi, Peoples R China; [Wang, Bo] Hubei Maternal & Child Hlth Hosp, Genet Lab, Suizhou, Hubei, Peoples R China	Zhengzhou University	Sun, L (corresponding author), Qinzhou Maternal & Child Hlth Care Hosp, Med Genet Lab, Guangxi, Peoples R China.	sunshijie12345@163.com			Scientific Research and Technological Development of Guangxi Province [1140003A-48]; Then Health Project of Guangxi Province [Z2010032]; Scientific Research and Technological Development of Qinzhou City [20100901, 20136104]	Scientific Research and Technological Development of Guangxi Province; Then Health Project of Guangxi Province; Scientific Research and Technological Development of Qinzhou City	The study was supported by Scientific Research and Technological Development of Guangxi Province (1140003A-48), Then Health Project of Guangxi Province (project no. Z2010032) and Scientific Research and Technological Development of Qinzhou City (20100901 and 20136104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atef SH, 2011, PEDIATR RES, V70, P412, DOI 10.1038/pr.2011.637; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Baldus CD, 2004, P NATL ACAD SCI USA, V101, P3915, DOI 10.1073/pnas.0400272101; Boormans EM, 2010, OBSTET GYNECOL, V115, P297, DOI 10.1097/AOG.0b013e3181cbc652; Caine A, 2005, LANCET, V366, P123, DOI 10.1016/S0140-6736(05)66790-6; CASPERSSON T, 1970, CHROMOSOMA, V30, P215; Deutsch S, 2004, J MED GENET, V41, P908, DOI 10.1136/jmg.2004.023184; Driscoll DA, 2009, NEW ENGL J MED, V360, P2556, DOI 10.1056/NEJMcp0900134; Dudarewicz Lech, 2005, Journal of Applied Genetics, V46, P207; Guo QW, 2012, CLIN CHEM, V58, P1019, DOI 10.1373/clinchem.2011.178475; Helmy SMH, 2009, FETAL DIAGN THER, V25, P220, DOI 10.1159/000218031; Ho SSY, 2012, PRENATAL DIAG, V32, P321, DOI 10.1002/pd.2946; Lee HH, 1997, HUM GENET, V99, P364, DOI 10.1007/s004390050373; Mann K, 2004, EUR J HUM GENET, V12, P907, DOI 10.1038/sj.ejhg.5201224; MANSFIELD ES, 1993, HUM MOL GENET, V2, P43, DOI 10.1093/hmg/2.1.43; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Slater HR, 2003, J MED GENET, V40, P907, DOI 10.1136/jmg.40.12.907; VONEGGELING F, 1993, HUM GENET, V91, P567, DOI 10.1007/BF00205081; Willis AS, 2012, PRENATAL DIAG, V32, P315, DOI 10.1002/pd.3860; Zimmermann B, 2002, CLIN CHEM, V48, P362	21	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e88932	10.1371/journal.pone.0088932	http://dx.doi.org/10.1371/journal.pone.0088932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625828	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300004
J	Molina-Pinelo, S; Gutierrez, G; Pastor, MD; Hergueta, M; Moreno-Bueno, G; Garcia-Carbonero, R; Nogal, A; Suarez, R; Salinas, A; Pozo-Rodriguez, F; Lopez-Rios, F; Agullo-Ortuno, MT; Ferrer, I; Perpina, A; Palacios, J; Carnero, A; Paz-Ares, L				Molina-Pinelo, Sonia; Gutierrez, Gabriel; Dolores Pastor, Maria; Hergueta, Marta; Moreno-Bueno, Gema; Garcia-Carbonero, Rocio; Nogal, Ana; Suarez, Rocio; Salinas, Ana; Pozo-Rodriguez, Francisco; Lopez-Rios, Fernando; Teresa Agullo-Ortuno, Maria; Ferrer, Irene; Perpina, Asuncion; Palacios, Jose; Carnero, Amancio; Paz-Ares, Luis			MicroRNA-Dependent Regulation of Transcription in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN; PANCREATIC ADENOCARCINOMA; PROGNOSTIC-SIGNIFICANCE; EXPRESSION PROFILES; PREDICTS SURVIVAL; BREAST-CANCER; CARCINOMA; RESISTANCE; CEACAM6; MUC1	Squamous cell lung cancer (SCC) and adenocarcinoma are the most common histological subtypes of non-small cell lung cancer (NSCLC), and have been traditionally managed in the clinic as a single entity. Increasing evidence, however, illustrates the biological diversity of these two histological subgroups of lung cancer, and supports the need to improve our understanding of the molecular basis beyond the different phenotypes if we aim to develop more specific and individualized targeted therapy. The purpose of this study was to identify microRNA (miRNA)-dependent transcriptional regulation differences between SCC and adenocarcinoma histological lung cancer subtypes. In this work, paired miRNA (667 miRNAs by TaqMan Low Density Arrays (TLDA)) and mRNA profiling (Whole Genome 44 K array G112A, Agilent) was performed in tumor samples of 44 NSCLC patients. Nine miRNAs and 56 mRNAs were found to be differentially expressed in SCC versus adenocarcinoma samples. Eleven of these 56 mRNA were predicted as targets of the miRNAs identified to be differently expressed in these two histological conditions. Of them, 6 miRNAs (miR-149, miR-205, miR-375, miR-378, miR-422a and miR-708) and 9 target genes (CEACAM6, CGN, CLDN3, ABCC3, MLPH, ACSL5, TMEM45B, MUC1) were validated by quantitative PCR in an independent cohort of 41 lung cancer patients. Furthermore, the inverse correlation between mRNAs and microRNAs expression was also validated. These results suggest miRNA-dependent transcriptional regulation differences play an important role in determining key hallmarks of NSCLC, and may provide new biomarkers for personalized treatment strategies.	[Molina-Pinelo, Sonia; Dolores Pastor, Maria; Garcia-Carbonero, Rocio; Nogal, Ana; Suarez, Rocio; Salinas, Ana; Ferrer, Irene; Paz-Ares, Luis] Univ Seville, CSIC, Inst Biomed Sevilla IBIS, Mol Oncol & New Therapies Grp,HUVR, Seville, Spain; [Gutierrez, Gabriel] Univ Seville, Dept Genet, Seville, Spain; [Hergueta, Marta; Moreno-Bueno, Gema] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Dept Biochem, Madrid, Spain; [Garcia-Carbonero, Rocio; Paz-Ares, Luis] Hosp Univ Virgen del Rocio, Dept Med Oncol, Seville, Spain; [Nogal, Ana] Inst Ciencias Biomed Abel Salazar ICBAS, Oporto, Portugal; [Pozo-Rodriguez, Francisco] Hosp 12 Octubre, Serv Neumol, E-28041 Madrid, Spain; [Pozo-Rodriguez, Francisco] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Lopez-Rios, Fernando] Ctr Integral Oncol Clara Campal, Dept Pathol, Lab Dianas Terapeut, Madrid, Spain; [Teresa Agullo-Ortuno, Maria] Hosp Doce Octubre, Inst Invest Sanitaria I 12, Madrid, Spain; [Perpina, Asuncion] Hosp Severo Ochoa, Serv Neumol, Madrid, Spain; [Palacios, Jose] Hosp Univ Ramon & Cajal, Inst Invest Sanitaria Ramon & Cajal IRYCIS, Dept Pathol, Madrid, Spain; [Carnero, Amancio] Univ Seville, CSIC, Inst Biomed Sevilla IBIS, Mol Biol Canc Grp,HUVR, Seville, Spain; [Hergueta, Marta; Moreno-Bueno, Gema] IdiPAZ Inst Invest Sanitaria La Paz, Madrid, Spain; [Hergueta, Marta; Moreno-Bueno, Gema] Fdn MD Anderson Int, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); University of Sevilla; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Virgen del Rocio University Hospital; Universidade do Porto; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Universitario 12 de Octubre; Severo Ochoa University Hospital; Hospital Universitario Ramon y Cajal; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); University of Texas System; UTMD Anderson Cancer Center	Paz-Ares, L (corresponding author), Univ Seville, CSIC, Inst Biomed Sevilla IBIS, Mol Oncol & New Therapies Grp,HUVR, Seville, Spain.	lpazares@hotmail.com	Ferrer, Irene/C-9418-2015; Paz-Ares, Luis/AAH-2750-2019; Palacios, Jose/AAV-3765-2020; Agulló Ortuño, M. Teresa/T-1494-2017; Molina-Pinelo, Sonia/M-4643-2015; gutierrez, gabriel/S-7646-2017; Moreno-Bueno, Gema/K-9354-2016; IBIS, CANCER/P-3323-2015; Agulló-Ortuño, M. Teresa/ABA-3155-2021; Pozo, Gabriel Gutiérrez/N-7824-2019	Ferrer, Irene/0000-0002-2748-2607; Agulló Ortuño, M. Teresa/0000-0002-7617-6681; Molina-Pinelo, Sonia/0000-0002-5726-2453; gutierrez, gabriel/0000-0002-1354-2883; Moreno-Bueno, Gema/0000-0002-5030-6687; Agulló-Ortuño, M. Teresa/0000-0002-7617-6681; Pozo, Gabriel Gutiérrez/0000-0002-1354-2883; Carnero, Amancio/0000-0003-4357-3979; Garcia-Carbonero, Rocio/0000-0002-3342-397X; Pastor, Maria Dolores/0000-0003-2736-0447; Nogal, Ana/0000-0002-7576-0210	Fondo de Investigacion Sanitaria [PI081156, PI1102688, R12/0036/0028, CD1100153, CD0900148, PI10/02164]; Proyecto de Excelencia de la Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia [P08-CVI-04090]; Roche Fellowship in 75th Anniversary, Spain; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer, Consejeria de Salud, Servicio Andaluz de Salud [PI-0224/2009, PI-0046/2012]; Fundacion Mutua Madrilena; Madrid Regional Government [S2010/BMD-2303]; Spanish Ministry of Economy and Competitivity, ISCIII [PI12/00137, RTICC: RD12/0036/0028]; Consejeria de Ciencia e Innovacion [CTS-6844]; Consejeria de Salud of the Junta de Andalucia [PI-0135-2010, PI-0306-2012];  [SAF2010-20175]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Proyecto de Excelencia de la Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia; Roche Fellowship in 75th Anniversary, Spain; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer, Consejeria de Salud, Servicio Andaluz de Salud; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Madrid Regional Government; Spanish Ministry of Economy and Competitivity, ISCIII; Consejeria de Ciencia e Innovacion; Consejeria de Salud of the Junta de Andalucia(Junta de Andalucia); 	LPA is funded by Fondo de Investigacion Sanitaria (PI081156, PI1102688 and R12/0036/0028), Proyecto de Excelencia de la Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (P08-CVI-04090), and the Roche Fellowship in 75th Anniversary, Spain. SMP is funded by Fondo de Investigacion Sanitaria (CD1100153), Fundacion Cientifica de la Asociacion Espanola Contra el Cancer, Consejeria de Salud, Servicio Andaluz de Salud (PI-0224/2009 and PI-0046/2012), and Fundacion Mutua Madrilena (2009). MDP is funded by Fondo de Investigacion Sanitaria (CD0900148). RGC is funded by Fondo de Investigacion Sanitaria (PI10/02164). GMB is funded by SAF2010-20175 and Madrid Regional Government (S2010/BMD-2303). AC lab was supported by grants to from the Spanish Ministry of Economy and Competitivity, ISCIII (PI12/00137, RTICC: RD12/0036/0028), Consejeria de Ciencia e Innovacion (CTS-6844) and Consejeria de Salud of the Junta de Andalucia (PI-0135-2010 and PI-0306-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop JA, 2010, CLIN CANCER RES, V16, P610, DOI 10.1158/1078-0432.CCR-09-2638; Blumenthal RD, 2005, CANCER RES, V65, P8809, DOI 10.1158/0008-5472.CAN-05-0420; Blumenthal RD, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-2; Chang HH, 2011, CANCER-AM CANCER SOC, V117, P353, DOI 10.1002/cncr.25592; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Fassina A, 2011, CHEST, V140, P1305, DOI 10.1378/chest.11-0708; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gao JC, 2009, INT J ONCOL, V35, P337, DOI 10.3892/ijo_00000345; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Giatromanolaki A, 2000, CLIN CANCER RES, V6, P1917; Gibbs S, 2000, WOUND REPAIR REGEN, V8, P192, DOI 10.1046/j.1524-475x.2000.00192.x; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guddo F, 1998, J CLIN PATHOL, V51, P667, DOI 10.1136/jcp.51.9.667; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Huang W, 2012, AM J RESP CRIT CARE, V186, P1160, DOI 10.1164/rccm.201203-0534OC; Jantscheff P, 2003, J CLIN ONCOL, V21, P3638, DOI 10.1200/JCO.2003.55.135; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kayser G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056333; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Landi MT, 2010, CLIN CANCER RES, V16, P430, DOI 10.1158/1078-0432.CCR-09-1736; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Logsdon CD, 2003, CANCER RES, V63, P2649; Mashima T, 2005, JNCI-J NATL CANCER I, V97, P765, DOI 10.1093/jnci/dji133; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; MCGUCKIN MA, 1995, HUM PATHOL, V26, P432, DOI 10.1016/0046-8177(95)90146-9; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Molina-Pinelo S, 2012, DIS MARKERS, V32, P221, DOI [10.1155/2012/873749, 10.3233/DMA-2011-0882]; Mukhopadhyay S, 2011, AM J SURG PATHOL, V35, P15, DOI 10.1097/PAS.0b013e3182036d05; O'Brien C, 2008, CANCER RES, V68, P5380, DOI 10.1158/0008-5472.CAN-08-0234; Patnaik SK, 2010, CANCER RES, V70, P36, DOI 10.1158/0008-5472.CAN-09-3153; Perez-Moreno P, 2012, CLIN CANCER RES, V18, P2443, DOI 10.1158/1078-0432.CCR-11-2370; Perez-Soler R, 2009, ONCOGENE, V28, pS38, DOI 10.1038/onc.2009.200; Petersen I, 1997, CANCER RES, V57, P2331; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ring BZ, 2009, MODERN PATHOL, V22, P1032, DOI 10.1038/modpathol.2009.60; Romualdi C, 2005, NUCLEIC ACIDS RES, V33, pW644, DOI 10.1093/nar/gki497; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Scholzel S, 2000, AM J PATHOL, V156, P595, DOI 10.1016/S0002-9440(10)64764-5; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Tran QN, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S11; Valk K, 2010, ONCOLOGY-BASEL, V79, P283, DOI 10.1159/000322116; van der Deen M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-59; Wistuba II, 2007, CURR MOL MED, V7, P3, DOI 10.2174/156652407779940468; Xing LX, 2010, MODERN PATHOL, V23, P1157, DOI 10.1038/modpathol.2010.111; Yamashita Y, 2000, ONCOGENE, V19, P5919, DOI 10.1038/sj.onc.1203981; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008	51	58	61	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90524	10.1371/journal.pone.0090524	http://dx.doi.org/10.1371/journal.pone.0090524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625834	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300023
J	Saravu, K; Rishikesh, K; Parikh, CR				Saravu, Kavitha; Rishikesh, Kumar; Parikh, Chirag R.			Risk Factors and Outcomes Stratified by Severity of Acute Kidney Injury in Malaria	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; SEVERE FALCIPARUM-MALARIA; PLASMODIUM-VIVAX MALARIA; JAUNDICE; BIKANER; ADULTS; INDIA	Severe acute kidney injury (AKI) is known to have prognostic value for in-hospital outcomes in malaria. However, little is known about the association of AKI of lesser severity with malarial risk factors and outcomes - and such a gap is becoming increasingly relevant with the upsurge in the incidence of AKI due to Plasmodium falciparum malaria and Plasmodium vivax malaria over the last decade. We aimed to identify risk factors of AKI in malaria and assessed in-hospital outcomes stratified by severity of AKI. We performed an observational study of 1,191 hospitalized malaria patients enrolled between 2007 and 2011 in a tertiary care academic center in India. Patients were categorized based on peak serum creatinine into one of three groups: no AKI (<1.6 mg/dL), mild AKI (1.6-3.0 mg/dL), and severe AKI (>3 mg/dL). Plasmodium vivax was the predominant species (61.41%), followed by Plasmodium falciparum (36.41%) and mixed infections with both the species (2.18%). Mild and severe AKI were detected in 12% and 5.6% of patients, respectively. Mild AKI due to Plasmodium vivax (49%) and Plasmodium falciparum (48.5%) was distributed relatively equally within the sample population; however, cases of severe AKI due to Plasmodium falciparum (80%) and Plasmodium vivax (13%) was significantly different (P<0.001). On history and physical examination, risk factors for AKI were age, absence of fever, higher heart rate, lower diastolic blood pressure, icterus, and hepatomegaly. The only laboratory parameter associated with risk of AKI on multivariate analysis was direct bilirubin. Patients with mild and severe AKI had greater organ complications, supportive requirements, longer duration of hospital stay and in-hospital mortality in a dose-dependent relationship, than patients with no AKI. Mild AKI is associated with significant (P<0.05) morbidity compared to no AKI, and future studies should assess strategies for early diagnosis of AKI and prevent AKI progression.	[Saravu, Kavitha; Rishikesh, Kumar] Manipal Univ, Kasturba Med Coll, Dept Med, Manipal, Karnataka, India; [Parikh, Chirag R.] Yale Univ, Sch Med, Nephrol Sect, VA CT Healthcare Syst, New Haven, CT USA; [Parikh, Chirag R.] Program Appl Translat Res, New Haven, CT USA	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Saravu, K (corresponding author), Manipal Univ, Kasturba Med Coll, Dept Med, Manipal, Karnataka, India.	kavithasaravu@gmail.com; chirag.parikh@yale.edu	Saravu, Kavitha/H-4634-2019	Saravu, Kavitha/0000-0001-6399-1129; Parikh, Chirag/0000-0001-9051-7385; Kumar, Rishikesh/0000-0001-8993-4683	ICMR; Indian Council of Medical Research [AMR/46/2011-ECD-II]; National Institutes of Health [K24DK090203]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK090203] Funding Source: NIH RePORTER	ICMR(Indian Council of Medical Research (ICMR)); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	KS was a recipient of the "ICMR International Fellowship for Young Biomedical Scientists-2012-13" and is the principal investigator of an extramural research project (grant AMR/46/2011-ECD-II) from the Indian Council of Medical Research. CRP was supported by the mentoring grant from the National Institutes of Health-K24DK090203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MAN SEV MAL PRACT HD; BAUM M, 1969, BRIT MED J, V2, P229, DOI 10.1136/bmj.2.5651.229; BETTER OS, 1986, KIDNEY INT, V29, P598, DOI 10.1038/ki.1986.40; BLOOM D, 1975, KIDNEY INT, V8, P149, DOI 10.1038/ki.1975.94; Bruneel F, 1997, INTENS CARE MED, V23, P698, DOI 10.1007/s001340050396; CIOFFI WG, 1986, SURGERY, V100, P356; Kochar D. K., 2006, Journal of Vector Borne Diseases, V43, P104; Kochar DK, 2009, AM J TROP MED HYG, V80, P194, DOI 10.4269/ajtmh.2009.80.194; Nacher M, 2001, AM J TROP MED HYG, V65, P828, DOI 10.4269/ajtmh.2001.65.828; Naqvi R, 2003, NEPHROL DIAL TRANSPL, V18, P1820, DOI 10.1093/ndt/gfg260; Panda SK, 2003, INDIAN J NEPHROL, V13, P55; Parikh CR, 2008, CRIT CARE MED, V36, pS159, DOI 10.1097/CCM.0b013e318168c652; Prakash J, 2003, J Assoc Physicians India, V51, P265; Prakash J, 2002, INDIAN J NEPHROL, V12, P113; SHEEHY TW, 1967, ANN INTERN MED, V66, P807, DOI 10.7326/0003-4819-66-4-807; Sitprija V, 1996, AM J NEPHROL, V16, P513, DOI 10.1159/000169042; SITPRIJA V, 1988, KIDNEY INT, V34, P867, DOI 10.1038/ki.1988.262; Tangpukdee N, 2011, SE ASIAN J TROP MED, V42, P1305; Thanachartwet V, 2013, INT J NEPHROL, V2013, DOI 10.1155/2013/841518; TRANG TTM, 1992, CLIN INFECT DIS, V15, P874, DOI 10.1093/clind/15.5.874; Vannaphan S, 2010, SE ASIAN J TROP MED, V41, P1042; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Win KKYK, 2012, SE ASIAN J TROP MED, V43, P1071	23	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90419	10.1371/journal.pone.0090419	http://dx.doi.org/10.1371/journal.pone.0090419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625747	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300019
J	Shiraishi, N; Suzuki, Y; Matsumoto, D; Jeong, S; Sugiyama, M; Kondo, K; Kuzuya, M				Shiraishi, Nariaki; Suzuki, Yusuke; Matsumoto, Daisuke; Jeong, Seungwon; Sugiyama, Motoya; Kondo, Katsunori; Kuzuya, Masafumi			The Effect of Additional Training on Motor Outcomes at Discharge from Recovery Phase Rehabilitation Wards: A Survey from Multi-Center Stroke Data Bank in Japan	PLOS ONE			English	Article							UNIT	Objectives: The purpose of the present study was to examine the potential benefits of additional training in patients admitted to recovery phase rehabilitation ward using the data bank of post-stroke patient registry. Subjects and Methods: Subjects were 2507 inpatients admitted to recovery phase rehabilitation wards between November 2004 and November 2010. Participants were retrospectively divided into four groups based upon chart review; patients who received no additional rehabilitation, patients who were added with self-initiated off hours training, patients who were added with off hours training by ward staff, patients who received both self-initiated training and training by ward staff. Parameters for assessing outcomes included length of stay, motor/cognitive subscales of functional independent measures (FIM) and motor benefit of FIM calculated by subtracting the score at admission from that at discharge. Results: Participants were stratified into three groups depending on the motor FIM at admission (<= 28, 29 similar to 56, 57 <=) for comparison. Regarding outcome variables, significant inter-group differences were observed in all items examined within the subgroup who scored 28 or less and between 29 and 56. Meanwhile no such trends were observed in the group who scored 57 or more compared with those who scored less. In a decision tree created based upon Exhaustive Chi-squared Automatic Interaction Detection method, variables chosen were the motor FIM at admission (the first node) additional training (the second node), the cognitive FIM at admission(the third node). Conclusions: Overall the results suggest that additional training can compensate for the shortage of regular rehabilitation implemented in recovery phase rehabilitation ward, thus may contribute to improved outcomes assessed by motor FIM at discharge.	[Shiraishi, Nariaki; Kuzuya, Masafumi] Nagoya Univ, Grad Sch Med, Program Hlth & Community Med, Dept Geriatr, Nagoya, Aichi 4648601, Japan; [Shiraishi, Nariaki] Nihon Fukushi Univ, Dept Rehabil, Fac Hlth Sci, Nagoya, Aichi, Japan; [Suzuki, Yusuke] Nagoya Univ, Grad Sch Med, Dept Comprehens Community Care Syst, Nagoya, Aichi 4648601, Japan; [Matsumoto, Daisuke] Kio Univ, Fac Hlth Sci, Dept Phys Therapy, Koryo, Japan; [Jeong, Seungwon] Chubu Rosai Hosp, Dept Social Sci, Ctr Gerontol & Social Sci, Nagoya, Aichi, Japan; [Sugiyama, Motoya] Chubu Rosai Hosp, Dept Rehabil, Nagoya, Aichi, Japan; [Kondo, Katsunori] Nihon Fukushi Univ, Ctr Well Being & Soc, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Shiraishi, N (corresponding author), Nagoya Univ, Grad Sch Med, Program Hlth & Community Med, Dept Geriatr, Nagoya, Aichi 4648601, Japan.	n-shira@n-fukushi.ac.jp	Matsumoto, Daisuke/AFM-3401-2022; SHIRAO, N/H-3280-2019; Kuzuya, Masafumi/I-1583-2012; Matsumoto, Daisuke/ABG-8286-2021; Kondo, Katsunori/AAI-6373-2020	Matsumoto, Daisuke/0000-0002-6615-5318; Matsumoto, Daisuke/0000-0002-6615-5318; Jeong, Seungwon/0000-0003-2919-7508	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Grant-in-Aid for Scientific Research (C) by The Ministry of Education, Culture, Sports, Science and Technology of the Japanese government, issued for the research project entitled "The effect of additional training after stroke: a data base study.'' The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 1995, POSTSTROKE REHABILIT; Dobkin BH, 2010, NEUROREHAB NEURAL RE, V24, P235, DOI 10.1177/1545968309357558; Duncan P, 1998, STROKE, V29, P6; Galvin R, 2011, STROKE, V42, P681, DOI 10.1161/STROKEAHA.110.594689; Gan XM, 2011, J NEUROL SCI, V306, P108, DOI 10.1016/j.jns.2011.03.032; Indredavik B, 1999, STROKE, V30, P1524, DOI 10.1161/01.STR.30.8.1524; Indredavik B, 1999, STROKE, V30, P917, DOI 10.1161/01.STR.30.5.917; Kawano T, 2011, SOGO RIHABIRITESHON, V39, P1151; Kondo K, 2004, JPN J REHABIL MED, V41, P214; Kondo K, 2005, SOGO RIHABIRITESHON, V33, P1119; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Langhorne P, 2002, AGE AGEING, V31, P365, DOI 10.1093/ageing/31.5.365; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Maeshima S, 2003, AM J PHYS MED REHAB, V82, P456, DOI 10.1097/01.PHM.0000069195.87219.E0; Miyakoshi K, 2008, JPN J STROKE, V30, P69; Rabadi MH, 2011, MED SCI MONITOR, V17, pRA25, DOI 10.12659/MSM.881382; Skidmore ER, 2006, CLIN REHABIL, V20, P523, DOI 10.1191/0269215506cr980oa; Suzuki E, 2004, JPN J REHABIL MED, V41	19	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91738	10.1371/journal.pone.0091738	http://dx.doi.org/10.1371/journal.pone.0091738			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626224	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300130
J	Blok, CA; Kersbergen, KJ; van der Aa, NE; van Kooij, BJ; Anbeek, P; Isgum, I; de Vries, LS; Krediet, TG; Groenendaal, F; Vreman, HJ; van Bel, F; Benders, MJ				Blok, Cornelie A.; Kersbergen, Karina J.; van der Aa, Niek E.; van Kooij, Britt J.; Anbeek, Petronella; Isgum, Ivana; de Vries, Linda S.; Krediet, Tannette G.; Groenendaal, Floris; Vreman, Hendrik J.; van Bel, Frank; Benders, Manon J.			Unmyelinated White Matter Loss in the Preterm Brain Is Associated with Early Increased Levels of End-Tidal Carbon Monoxide	PLOS ONE			English	Article							HEME OXYGENASE-1; INFANTS; INJURY; HISTORY; LESIONS; STRESS; BIRTH; AGE	Objective: Increased levels of end-tidal carbon monoxide (ETCOc) in preterm infants during the first day of life are associated with oxidative stress, inflammatory processes and adverse neurodevelopmental outcome at 2 years of age. Therefore, we hypothesized that early ETCOc levels may also be associated with impaired growth of unmyelinated cerebral white matter. Methods: From a cohort of 156 extremely and very preterm infants in which ETCOc was determined within 24 h after birth, in 36 infants 3D-MRI was performed at term-equivalent age to assess cerebral tissue volumes of important brain regions. Results: Linear regression analysis between cerebral ventricular volume, unmyelinated white matter/total brain volume-, and cortical grey matter/total brain volume-ratio and ETCOc showed a positive, negative and positive correlation, respectively. Multivariable analyses showed that solely ETCOc was positively related to cerebral ventricular volume and cortical grey matter/total brain volume ratio, and that solely ETCOc was inversely related to the unmyelinated white matter/total brain volume ratio, suggesting that increased levels of ETCOc, associated with oxidative stress and inflammation, were related with impaired growth of unmyelinated white matter. Conclusion: Increased values of ETCOc, measured within the first 24 hours of life may be indicative of oxidative stress and inflammation in the immediate perinatal period, resulting in impaired growth of the vulnerable unmyelinated white matter of the preterm brain.	[Blok, Cornelie A.; Kersbergen, Karina J.; van der Aa, Niek E.; van Kooij, Britt J.; Anbeek, Petronella; de Vries, Linda S.; Krediet, Tannette G.; Groenendaal, Floris; van Bel, Frank; Benders, Manon J.] Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands; [Isgum, Ivana] Univ Med Ctr, Image Sci Inst, Utrecht, Netherlands; [Vreman, Hendrik J.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Stanford University	Krediet, TG (corresponding author), Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands.	f.vanbel@umcutrecht.nl	Groenendaal, Floris/P-6872-2019; de Vries, Linda S/AAB-6454-2021; Isgum, Ivana/H-8659-2014	Groenendaal, Floris/0000-0002-9284-1637; Isgum, Ivana/0000-0003-1869-5034				Anbeek P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081895; Avino TA, 2010, BRAIN RES, V1360, P138, DOI 10.1016/j.brainres.2010.08.091; Back SA, 2005, ANN NEUROL, V58, P108, DOI 10.1002/ana.20530; Billiards SS, 2008, BRAIN PATHOL, V18, P153, DOI 10.1111/j.1750-3639.2007.00107.x; Blackmon K, 2011, J NEUROSCI, V31, P15257, DOI 10.1523/JNEUROSCI.3039-11.2011; Blok CA, 2011, DEV MED CHILD NEUROL, V53, P1113, DOI 10.1111/j.1469-8749.2011.04110.x; Buntinx M, 2004, J NEUROSCI RES, V76, P834, DOI 10.1002/jnr.20118; Buser JR, 2010, J CEREBR BLOOD F MET, V30, P1053, DOI 10.1038/jcbfm.2009.286; Chau V, 2009, ANN NEUROL, V66, P155, DOI 10.1002/ana.21713; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; Elovitz MA, 2006, PEDIATR RES, V59, P50, DOI 10.1203/01.pdr.0000191141.21932.b6; Giedion A, 1973, PEDIATR RADIOL, V1, P45; Haynes RL, 2003, J NEUROPATH EXP NEUR, V62, P441, DOI 10.1093/jnen/62.5.441; Hemels MA, 2012, PEDIATR CRIT CARE ME, V13, P678, DOI 10.1097/PCC.0b013e3182455778; Horvath I, 1998, THORAX, V53, P668, DOI 10.1136/thx.53.8.668; Kersbergen KJ, 2013, J PEDIATR-US, V163, P666, DOI 10.1016/j.jpeds.2013.04.001; Kharitonov SA, 2002, BIOMARKERS, V7, P1, DOI 10.1080/13547500110104233; Krediet TG, 2006, ACTA PAEDIATR, V95, P1075, DOI 10.1080/08035250500537017; Leitch DN, 2005, RESP MED, V99, P32, DOI 10.1016/j.rmed.2004.03.027; Maunu J, 2011, DEV MED CHILD NEUROL, V53, P48, DOI 10.1111/j.1469-8749.2010.03785.x; May C, 2007, PEDIATR RES, V61, P474, DOI 10.1203/pdr.0b013e3180332bfe; PAPILE LA, 1983, J PEDIATR-US, V103, P273, DOI 10.1016/S0022-3476(83)80366-7; Rezaie P, 2002, NEUROPATHOLOGY, V22, P106, DOI 10.1046/j.1440-1789.2002.00438.x; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Shi Y, 2003, ARCH DIS CHILD, V88, P889, DOI 10.1136/adc.88.10.889; Stevenson DK, 1979, J PEDIAT, V94, P56; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Terheggen-Lagro SW, 2003, AM J RESP CRIT CARE, V168, P1227, DOI 10.1164/rccm.200302-248OC; Torrance HL, 2008, NEONATOLOGY, V94, P138, DOI 10.1159/000119724; van Bel F, 2005, J APPL PHYSIOL, V98, P1044, DOI 10.1152/japplphysiol.00760.2004; Van Kooij BJM, 2012, DEV MED CHILD NEUROL, V54, P260, DOI 10.1111/j.1469-8749.2011.04168.x; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Vreman HJ, 1998, CAN J PHYSIOL PHARM, V76, P1057; Yang ZG, 2007, ANN NEUROL, V61, P199, DOI 10.1002/ana.21068	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e89061	10.1371/journal.pone.0089061	http://dx.doi.org/10.1371/journal.pone.0089061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622422	gold, Green Published, Green Submitted			2022-12-27	WOS:000332845300005
J	MacIntosh, BJ; Swardfager, W; Crane, DE; Ranepura, N; Saleem, M; Oh, PI; Stefanovic, B; Herrmann, N; Lanctot, KL				MacIntosh, Bradley J.; Swardfager, Walter; Crane, David E.; Ranepura, Nipuni; Saleem, Mahwesh; Oh, Paul I.; Stefanovic, Bojana; Herrmann, Nathan; Lanctot, Krista L.			Cardiopulmonary Fitness Correlates with Regional Cerebral Grey Matter Perfusion and Density in Men with Coronary Artery Disease	PLOS ONE			English	Article							CARDIORESPIRATORY FITNESS; CARDIAC REHABILITATION; EXERCISE; VOLUME; PERFORMANCE; COMPLETION; CAPACITY; INFARCTS; RISK	Purpose: Physical activity is associated with positive effects on the brain but there is a paucity of clinical neuroimaging data in patients with coronary artery disease (CAD), a cardiovascular condition associated with grey matter loss. The purpose of this study was to determine which brain regions are impacted by cardiopulmonary fitness and with the change in fitness after 6 months of exercise-based cardiac rehabilitation. Methods: CAD patients underwent magnetic resonance imaging at baseline, and peak volume of oxygen uptake during exercise testing (VO2Peak) was measured at baseline and after 6 months of training. T1-weighted structural images were used to perform grey matter (GM) voxel-based morphometry (VBM). Pseudo-continuous arterial spin labeling (pcASL) was used to produce cerebral blood flow (CBF) images. VBM and CBF data were tested voxel-wise using VO2Peak and age as explanatory variables. Results: In 30 men with CAD (mean age 65 +/- 7 years), VBM and CBF identified 7 and 5 respective regions positively associated with baseline VO2Peak. These included the pre- and post-central, paracingulate, caudate, hippocampal regions and converging findings in the putamen. VO2Peak increased by 20% at follow-up in 29 patients (t = 9.6, df = 28, p<0.0001). Baseline CBF in the left post-central gyrus and baseline GM density in the right putamen predicted greater change in VO2Peak. Conclusion: Perfusion and GM density were associated with fitness at baseline and with greater fitness gains with exercise. This study identifies new neurobiological correlates of fitness and demonstrates the utility of multi-modal MRI to evaluate the effects of exercise in CAD patients.	[MacIntosh, Bradley J.; Swardfager, Walter; Crane, David E.; Stefanovic, Bojana; Lanctot, Krista L.] Sunnybrook Res Inst, Heart & Stroke Fdn Canadian Partnership Stroke Re, Toronto, ON, Canada; [MacIntosh, Bradley J.; Stefanovic, Bojana] Sunnybrook Res Inst, Toronto, ON, Canada; [Swardfager, Walter; Ranepura, Nipuni; Saleem, Mahwesh; Stefanovic, Bojana; Herrmann, Nathan; Lanctot, Krista L.] Sunnybrook Res Inst, Neuropsychopharmacol Res Grp, Toronto, ON, Canada; [MacIntosh, Bradley J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Oh, Paul I.] Univ Toronto, Dept Clin Pharmacol, Toronto, ON, Canada; [Herrmann, Nathan; Lanctot, Krista L.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Oh, Paul I.] Toronto Rehabil Inst, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute	MacIntosh, BJ (corresponding author), Sunnybrook Res Inst, Heart & Stroke Fdn Canadian Partnership Stroke Re, Toronto, ON, Canada.	bmac@sri.utoronto.ca	l, l/GZH-2874-2022; L, L/HGA-1686-2022; Swardfager, Walter/G-2574-2012; Lanctot, Krista L./AAY-4820-2020	Swardfager, Walter/0000-0002-0030-8908; Lanctot, Krista L./0000-0001-7024-6637; Oh, Paul/0000-0002-0603-6958; MacIntosh, Bradley/0000-0001-7300-2355	Canadian Institutes of Health Research [Lanctot MOP-114913]; Heart and Stroke Foundation Centre for Stroke Recovery	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation Centre for Stroke Recovery(Heart & Stroke Foundation of Canada)	Funding support was provided by: Canadian Institutes of Health Research (Lanctot MOP-114913) and the Heart and Stroke Foundation Centre for Stroke Recovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2002, INTERNAL MED, V41, P103, DOI 10.2169/internalmedicine.41.103; Ahlskog JE, 2011, MAYO CLIN PROC, V86, P876, DOI 10.4065/mcp.2011.0252; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Benar CG, 2002, NEUROIMAGE, V17, P1182, DOI 10.1006/nimg.2002.1164; Burns JM, 2008, NEUROLOGY, V71, P210, DOI 10.1212/01.wnl.0000317094.86209.cb; Chaddock L, 2012, J SPORT SCI, V30, P421, DOI 10.1080/02640414.2011.647706; Chen XH, 2006, PSYCHIAT RES-NEUROIM, V147, P105, DOI 10.1016/j.pscychresns.2006.01.009; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Evero N, 2012, J APPL PHYSIOL, V112, P1612, DOI 10.1152/japplphysiol.01365.2011; Gianaros PJ, 2006, NEUROIMAGE, V31, P754, DOI 10.1016/j.neuroimage.2006.01.003; Hamm L F, 2000, J Cardiopulm Rehabil, V20, P16, DOI 10.1097/00008483-200001000-00003; Holschneider DP, 2003, J CEREBR BLOOD F MET, V23, P925, DOI 10.1097/01.WCB.0000072797.66873.6A; Honea RA, 2009, ALZ DIS ASSOC DIS, V23, P188, DOI 10.1097/WAD.0b013e31819cb8a2; Hoschneider DP, 2007, BRAIN RES, V1184, P96, DOI 10.1016/j.brainres.2007.09.081; Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545; Jones N, 1982, CLIN EXERCISE TESTIN; Kakos Lynn S, 2010, Prev Cardiol, V13, P100, DOI 10.1111/j.1751-7141.2009.00065.x; Kamijo K, 2004, EUR J APPL PHYSIOL, V92, P305, DOI 10.1007/s00421-004-1097-2; Kavanagh T, 2002, CIRCULATION, V106, P666, DOI 10.1161/01.CIR.0000024413.15949.ED; Kleim JA, 2002, BRAIN RES, V934, P1, DOI 10.1016/S0006-8993(02)02239-4; Kuller LH, 2004, STROKE, V35, P1821, DOI 10.1161/01.STR.0000132193.35955.69; Last D, 2007, DIABETES CARE, V30, P1193, DOI 10.2337/dc06-2052; Lee CD, 2003, STROKE, V34, P2475, DOI 10.1161/01.STR.0000091843.02517.9D; Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P1217, DOI 10.1001/archneur.55.9.1217; MacIntosh BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085163; MacIntosh BJ, 2010, MAGN RESON MED, V63, P641, DOI 10.1002/mrm.22256; Marzolini S, 2008, MED SCI SPORT EXER, V40, P1557, DOI 10.1249/MSS.0b013e318177eb7f; Marzolini S, 2010, EUR J CARDIOV PREV R, V17, P35, DOI 10.1097/HJR.0b013e32832da020; Marzolini S, 2008, EUR J CARDIOV PREV R, V15, P698, DOI 10.1097/HJR.0b013e32830c1ce3; McCloskey DP, 2001, BRAIN RES, V891, P168, DOI 10.1016/S0006-8993(00)03200-5; Muranishi M, 2011, EXP BRAIN RES, V209, P235, DOI 10.1007/s00221-011-2545-y; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Rhyu IJ, 2010, NEUROSCIENCE, V167, P1239, DOI 10.1016/j.neuroscience.2010.03.003; Swardfager W, 2011, PSYCHOSOM MED, V73, P580, DOI 10.1097/PSY.0b013e318227fff9; Thomas AG, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00086; THOMAS BP, 2013, J MAGN RESON IMAGING; van Osch MJP, 2009, MAGN RESON MED, V62, P165, DOI 10.1002/mrm.22002; VANHEES L, 1995, AM J CARDIOL, V76, P1014, DOI 10.1016/S0002-9149(99)80287-2	42	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91251	10.1371/journal.pone.0091251	http://dx.doi.org/10.1371/journal.pone.0091251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622163	gold, Green Published, Green Submitted			2022-12-27	WOS:000332845300069
J	Ali, MP; Huang, DC; Nachman, G; Ahmed, N; Begum, MA; Rabbi, MF				Ali, M. P.; Huang, Dingcheng; Nachman, G.; Ahmed, Nur; Begum, Mahfuz Ara; Rabbi, M. F.			Will Climate Change Affect Outbreak Patterns of Planthoppers in Bangladesh?	PLOS ONE			English	Article							BROWN PLANTHOPPER; INSECTICIDE APPLICATIONS; POPULATION-DYNAMICS; FOREST; TEMPERATURE; RESISTANCE; HOMOPTERA; IMPACTS	Recently, planthoppers outbreaks have intensified across Asia resulting in heavy rice yield losses. The problem has been widely reported as being induced by insecticides while other factors such as global warming that could be potential drivers have been neglected. Here, we speculate that global warming may increase outbreak risk of brown planthopper (Nilaparvata lugens Stal.). We present data that demonstrate the relationship between climate variables (air temperature and precipitation) and the abundance of brown planthopper (BPH) during 1998-2007. Data show that BPH has become significantly more abundant in April over the 10-year period, but our data do not indicate that this is due to a change in climate, as no significant time trends in temperature and precipitation could be demonstrated. The abundance of BPH varied considerably between months within a year which is attributed to seasonal factors, including the availability of suitable host plants. On the other hand, the variation within months is attributed to fluctuations in monthly temperature and precipitation among years. The effects of these weather variables on BPH abundance were analyzed statistically by a general linear model. The statistical model shows that the expected effect of increasing temperatures is ambiguous and interacts with the amount of rainfall. According to the model, months or areas characterized by a climate that is either cold and dry or hot and wet are likely to experience higher levels of BPH due to climate change, whereas other combinations of temperature and rainfall may reduce the abundance of BPH. The analysis indicates that global warming may have contributed to the recent outbreaks of BPH in some rice growing areas of Asia, and that the severity of such outbreaks is likely to increase if climate change exaggerates. Our study highlights the need to consider climate change when designing strategies to manage planthoppers outbreaks.	[Ali, M. P.; Ahmed, Nur; Begum, Mahfuz Ara; Rabbi, M. F.] Bangladesh Rice Res Inst, Div Entomol, Gazipur, Bangladesh; [Huang, Dingcheng] Univ Chinese Acad Sci, Int Affairs Off, Beijing, Peoples R China; [Nachman, G.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Bangladesh Rice Research Institute (BRRI); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Copenhagen	Ali, MP (corresponding author), Bangladesh Rice Res Inst, Div Entomol, Gazipur, Bangladesh.	panna_ali@yahoo.com; huangdc@ucas.ac.cn	ALI, PANNA/P-1625-2017; Ahmed, Nur/D-5917-2019	ALI, PANNA/0000-0001-8197-7064; Ahmed, Nur/0000-0002-6915-3983	Bangladesh Rice Research Institute (BRRI)	Bangladesh Rice Research Institute (BRRI)	This research was supported by Bangladesh Rice Research Institute (BRRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MP, 2012, CEREAL RES COMMUN, V40, P502, DOI 10.1556/CRC.40.2012.0001; [Anonymous], 1988, METEOROL RES REPT; [Anonymous], INSECTICIDE ABUSE RI; Anyamba A, 2001, Cad Saude Publica, V17 Suppl, P133, DOI 10.1590/S0102-311X2001000700022; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Bottrell DG, 2012, J ASIA-PAC ENTOMOL, V15, P122, DOI 10.1016/j.aspen.2011.09.004; BRRI, 2012, BANGL RIC RES I ANN; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; Chien HV, 2009, FARMS APPL INSECTICI; Coley PD, 1998, CLIMATIC CHANGE, V39, P455, DOI 10.1023/A:1005307620024; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Esbjerg P., 2011, IOBC/WPRS Bulletin, V65, P43; Escalada MM, 2010, THAILAND INSECT INFL; Estay SA, 2009, J APPL ENTOMOL, V133, P491, DOI 10.1111/j.1439-0418.2008.01380.x; FLEMING RA, 1995, WATER AIR SOIL POLL, V82, P445, DOI 10.1007/BF01182854; Hart AJ, 1997, ANN APPL BIOL, V130, P427, DOI 10.1111/j.1744-7348.1997.tb07672.x; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; HEINRICHS EA, 1982, ENVIRON ENTOMOL, V11, P78, DOI 10.1093/ee/11.1.78; Heong K. L., 1998, ECOTOXICOLOGY PESTIC, P381, DOI DOI 10.1007/978-1-4615-5791-3; Heong KL, 2009, PLANTHOPPER OUTBREAK; Heong KL, 2010, ASSESSING BPH OUTBRE; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Hibino H., 1989, Advances in Disease Vector Research, V6, P209; Hu G, 2011, B ENTOMOL RES, V101, P187, DOI 10.1017/S0007485310000313; IPCC, 2007, CLIMATE CHANGE 2007; IRIN, 2012, HUM NEWS AN; Ishiguro K., 1991, Rice blast modeling and forecasting. Selected papers from the International Rice Research Conference, 27-31 August 1990, Seoul, Korea Republic., P39; Islam Z, 2009, RICE PLANTHOPPER OUT; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Karuppaiah V., 2012, World Journal of Agricultural Sciences, V8, P240; Kiritani K, 2006, POPUL ECOL, V48, P5, DOI 10.1007/s10144-005-0225-0; Kiritani K, 2001, INSECTS CLIMATE; Kontodimas DC, 2004, ENVIRON ENTOMOL, V33, P1, DOI 10.1603/0046-225X-33.1.1; Kulshreshtha J. P., 1974, Indian Farming, V24, P5; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; Logan JA, 2003, FRONT ECOL ENVIRON, V1, P130, DOI 10.2307/3867985; Luecha M, 2010, FARMERS INSECTICIDE; Matsumura M, 2010, JARQ-JPN AGR RES Q, V44, P225, DOI 10.6090/jarq.44.225; Matteson PC, 2000, ANNU REV ENTOMOL, V45, P549, DOI 10.1146/annurev.ento.45.1.549; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Moni, 2011, BPH CONTINUES THREAT; Moni, 2012, PLANTHOPPER PROBLEMS; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Petzoldt C, 2008, CLIMATE CHANGE AGR P; Pham Van Du, 2007, Omonrice, P94; Rahman MK, 2009, J ENV PROTECT, V1, P40; SAS, 2008, SAS ENT GUID 4 3; Schiller J.M., 2006, RICE LAOS; Shepard B.M., 1991, CRC HDB PEST MANAGEM, VIII, P255; Singh UP, 2002, BOR RIC E IND RIC WH; Soitong K, 2012, WILL PLANTHOPPERS CO; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Upmanu L, 1994, WATER RESOUR RES, V31, P2383; Williams DW, 1995, J BIOGEOGR, V22, P665, DOI 10.2307/2845968; Win S. S., 2011, Journal of Entomology, V8, P183, DOI 10.3923/je.2011.183.190; Woiwod IP, 1997, J INSECT CONSERV, V1, P149, DOI 10.1023/A:1018451613970; Yin JL, 2008, ENVIRON ENTOMOL, V37, P206, DOI 10.1603/0046-225X(2008)37[206:CAIAAT]2.0.CO;2	57	30	36	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91678	10.1371/journal.pone.0091678	http://dx.doi.org/10.1371/journal.pone.0091678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618677	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400116
J	Jia, FJ; Song, N; Zhao, CY; Xie, JX; Jiang, H				Jia, Fengju; Song, Ning; Zhao, Chenyang; Xie, Junxia; Jiang, Hong			Unexpected Improvements of Spatial Learning and Memory Abilities in Chronic Rotenone Intoxicated Mice	PLOS ONE			English	Article							PARKINSONS-DISEASE; MECHANISMS; EXPOSURE; NEUROGENESIS; MULTICENTER; PROGRESSION; DEMENTIA; FEATURES; CELLS	The liposoluble insecticide rotenone is commonly used as a mitochondrial complex I inhibitor to replicate Parkinson's disease (PD) pathological features. However, there was no assessment of the spatial learning and memory abilities in chronic rotenone-induced PD models. In the present study, by rotarod test and Thioflavine T staining, we first noted the impairment of motor coordination in rotenone-treated group for 3 months, as well as alpha-synuclein inclusions in the nigral dopaminergic neurons in C57BL/6 mice with intragastrical delivery of rotenone (5 mg/Kg) for 3 months rather than 1 month. We then evaluated spatial learning and memory abilities by Morris water maze task in this model. The results showed escape latency reduced in rotenone-intoxicated mice for 3 months, indicating an improvement of learning ability. However, it was delayed slightly but not significantly in rotenone-intoxicated mice for 1 month. Similarly, we demonstrated that spatial memory ability was enhanced in 3-month-treatment group, but impaired in 1-month-treatment group. There were no proliferating cell nuclear antigen and doublecortin positive cells in the hippocampus by double immunofluorescent staining, indicating the absence of hippocampal neurogenesis in rotenone-intoxicated mice. These results suggest that spatial learning and memory abilities are disturbed in chronic rotenone-intoxicated PD model.	[Jiang, Hong] Qingdao Univ, Dept Physiol, Shandong Prov Key Lab Pathogenesis & Prevent Neur, Qingdao 266071, Peoples R China; Qingdao Univ, Coll Med, State Key Disciplines Physiol, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University	Jiang, H (corresponding author), Qingdao Univ, Dept Physiol, Shandong Prov Key Lab Pathogenesis & Prevent Neur, Qingdao 266071, Peoples R China.	jhkyk@163.com			973 Program [2012CB526703, 2011CB504102]; National Natural Science Foundation of China [81171207]; Ministry of Education of China [20103706110002]; Municipal Science and Technology Bureau of Qingdao [12-1-4-2-(19)-jch]; Taishan Scholars Construction Project	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Municipal Science and Technology Bureau of Qingdao; Taishan Scholars Construction Project	This study was funded by grants from the 973 Program (2012CB526703, 2011CB504102 http://www.most.gov.cn/), National Natural Science Foundation of China (81171207 http://www.nsfc.gov.cn/Portal0/default152.htm), Ministry of Education of China (20103706110002http://www.moe.gov.cn/), the Municipal Science and Technology Bureau of Qingdao (12-1-4-2-(19)-jch http://www.qdstc.gov.cn/) and Taishan Scholars Construction Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2010, NEUROLOGY, V75, P1062, DOI 10.1212/WNL.0b013e3181f39d0e; Annerino DM, 2012, ACTA NEUROPATHOL, V124, P665, DOI 10.1007/s00401-012-1040-2; Aulic Suzana, 2013, Int J Cell Biol, V2013, P150952, DOI 10.1155/2013/150952; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Braak H, 2007, ACTA NEUROPATHOL, V113, P421, DOI 10.1007/s00401-007-0193-x; Cannon JR, 2009, NEUROBIOL DIS, V34, P279, DOI 10.1016/j.nbd.2009.01.016; Chinta SJ, 2013, J INTERN MED, V273, P429, DOI 10.1111/joim.12029; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Drolet RE, 2009, NEUROBIOL DIS, V36, P96, DOI 10.1016/j.nbd.2009.06.017; Ferrer I, 2012, NEUROBIOL DIS, V46, P508, DOI 10.1016/j.nbd.2011.10.019; Golts N, 2002, J BIOL CHEM, V277, P16116, DOI 10.1074/jbc.M107866200; Greene JG, 2009, EXP NEUROL, V218, P154, DOI 10.1016/j.expneurol.2009.04.023; Hanna-Pladdy B, 2013, DEMENT GER COGN D EX, V3, P168, DOI 10.1159/000351421; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Levy G, 2002, NEUROLOGY, V59, P1708, DOI 10.1212/01.WNL.0000036610.36834.E0; Lim SY, 2010, MOVEMENT DISORD, V25, pS123, DOI 10.1002/mds.22786; Marrinan S, 2013, MOV DISORD; Martin SJ, 2007, CELL MOL LIFE SCI, V64, P401, DOI 10.1007/s00018-007-6336-3; McDowell K, 2012, NEUROBIOL DIS, V46, P597, DOI 10.1016/j.nbd.2011.12.040; Moreira CG, 2012, NEUROTOX RES, V21, P291, DOI 10.1007/s12640-011-9278-3; Morgenstern NA, 2008, J PHYSIOL-LONDON, V586, P3751, DOI 10.1113/jphysiol.2008.154807; Nielsen SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067713; Olanow CW, 2009, NEUROLOGY, V72, pS1, DOI 10.1212/WNL.0b013e3181a1d44c; Pan-Montojo F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00898; Pan-Montojo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008762; Paz GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003098; Pfeiffer RF, 2011, PARKINSONISM RELAT D, V17, P10, DOI 10.1016/j.parkreldis.2010.08.003; Postuma R, 2010, BRAIN, V133, DOI 10.1093/brain/awq225; Ryan L, 2010, HIPPOCAMPUS, V20, P11, DOI 10.1002/hipo.20607; Savica R, 2009, NEUROLOGY, V73, P1752, DOI 10.1212/WNL.0b013e3181c34af5; Shimizu S, 2013, AGING DIS, V4, P1; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Spivey A, 2011, ENVIRON HEALTH PERSP, V119, pA259, DOI 10.1289/ehp.119-a259a; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tieu K, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a009316; Tolleson CM, 2013, DISCOV MED, V15, P61; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; Varcin M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/624925; Wang A, 2011, EUR J EPIDEMIOL, V26, P547, DOI 10.1007/s10654-011-9574-5; Xiong N, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-13; Xiong N, 2012, CRIT REV TOXICOL, V42, P613, DOI 10.3109/10408444.2012.680431; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao Z, 2014, NEUROSCIENCE, V257, P175, DOI 10.1016/j.neuroscience.2013.10.063	47	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91641	10.1371/journal.pone.0091641	http://dx.doi.org/10.1371/journal.pone.0091641			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618574	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400111
J	Karthik, L; Kumar, G; Keswani, T; Bhattacharyya, A; Chandar, SS; Rao, KVB				Karthik, L.; Kumar, Gaurav; Keswani, Tarun; Bhattacharyya, Arindam; Chandar, S. Sarath; Rao, K. V. Bhaskara			Protease Inhibitors from Marine Actinobacteria as a Potential Source for Antimalarial Compound	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MEROZOITES; ELASTASE INHIBITOR; CYSTEINE PROTEASES; MALARIA; SURFACE; PRECURSOR; RELEASE; COMPLEX; ELASNIN; EGRESS	The study was planned to screen the marine actinobacterial extract for the protease inhibitor activity and its anti-Pf activity under in vitro and in vivo conditions. Out of 100 isolates, only 3 isolates exhibited moderate to high protease inhibitor activities on trypsin, chymotrypsin and proteinase K. Based on protease inhibitor activity 3 isolates were chosen for further studies. The potential isolate was characterized by polyphasic approach and identified as Streptomyces sp LK3 (JF710608). The lead compound was identified as peptide from Streptomyces sp LK3. The double-reciprocal plot displayed inhibition mode is non-competitive and it confirms the irreversible nature of protease inhibitor. The peptide from Streptomyces sp LK3 extract showed significant anti plasmodial activity (IC50: 25.78 mu g/ml). In in vivo model, the highest level of parasitemia suppression (approximate to 45%) was observed in 600 mg/ kg of the peptide. These analyses revealed no significant changes were observed in the spleen and liver tissue during 8 dpi. The results confirmed up-regulation of TGF-beta and down regulation of TNF-alpha in tissue and serum level in PbA infected peptide treated mice compared to PbA infection. The results obtained infer that the peptide possesses anti-Pf activity activity. It suggests that the extracts have novel metabolites and could be considered as a potential source for drug development.	[Karthik, L.; Kumar, Gaurav; Rao, K. V. Bhaskara] VIT Univ, Sch Bio Sci & Technol, Environm Biotechnol Div, Vellore, Tamil Nadu, India; [Keswani, Tarun; Bhattacharyya, Arindam] Univ Calcutta, Dept Zool, Immunol Lab, Kolkata, W Bengal, India; [Chandar, S. Sarath] VIT Univ, Sch Bio Sci & Technol, Div Genet, Vellore, Tamil Nadu, India	Vellore Institute of Technology; University of Calcutta; Vellore Institute of Technology	Rao, KVB (corresponding author), VIT Univ, Sch Bio Sci & Technol, Environm Biotechnol Div, Vellore, Tamil Nadu, India.	kokatibhaskar@yahoo.co.in	LOGANATHAN, KARTHIK/AAE-9188-2021; Bhaskar, Kokati/AAB-3993-2019; Loganathan, KarthiK/P-1658-2016; Kumar, Gaurav/HHZ-2076-2022; Keswani, Tarun/AAQ-5012-2020; Rao, K.V.Bhaskara/C-1797-2019	LOGANATHAN, KARTHIK/0000-0002-2557-2086; Bhaskar, Kokati/0000-0002-6327-1452; Loganathan, KarthiK/0000-0002-2557-2086; Kumar, Gaurav/0000-0002-9464-7811; Keswani, Tarun/0000-0002-0307-692X; Rao, K.V.Bhaskara/0000-0002-6327-1452				Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; [Anonymous], 1991, MALARIA OBSTACLES OP; Blackman Michael J., 2000, Current Drug Targets, V1, P59, DOI 10.2174/1389450003349461; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Demuth H U, 1990, J Enzyme Inhib, V3, P249, DOI 10.3109/14756369009030375; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Ersmark K, 2006, MED RES REV, V26, P626, DOI 10.1002/med.20082; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Gelhaus C, 2005, BIOL CHEM, V386, P499, DOI 10.1515/BC.2005.059; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; HOLDER AA, 1985, NATURE, V317, P270, DOI 10.1038/317270a0; Karthik L, 2013, NANOMED-NANOTECHNOL, V9, P951, DOI 10.1016/j.nano.2013.02.002; Karthik L, 2010, INT J PHARM PHARM SC, V1, P199; Karthik L, 2013, ASIAN PAC J TROP MED, V6, P325, DOI 10.1016/S1995-7645(13)60065-6; Kauth CW, 2006, J BIOL CHEM, V281, P31517, DOI 10.1074/jbc.M604641200; Lee M, 2004, CHEM SOC REV, V33, P401, DOI 10.1039/b209224g; Li XR, 2004, J BIOL CHEM, V279, P5765, DOI 10.1074/jbc.M308716200; Macherla VR, 2005, J MED CHEM, V48, P3684, DOI 10.1021/jm048995+; Maskey RP, 2004, J ANTIBIOT, V57, P771, DOI 10.7164/antibiotics.57.771; McCoubrie JE, 2007, INFECT IMMUN, V75, P5565, DOI 10.1128/IAI.00405-07; MCKERROW JH, 1993, ANNU REV MICROBIOL, V47, P821, DOI 10.1146/annurev.mi.47.100193.004133; NAKAGAWA A, 1980, J ORG CHEM, V45, P3268, DOI 10.1021/jo01304a025; OHNO H, 1978, J ANTIBIOT, V31, P1116, DOI 10.7164/antibiotics.31.1116; Olliaro P, 1996, JAMA-J AM MED ASSOC, V275, P230, DOI 10.1001/jama.275.3.230; Olson JE, 1999, BIOORGAN MED CHEM, V7, P633, DOI 10.1016/S0968-0896(99)00004-8; Pachebat JA, 2001, MOL BIOCHEM PARASIT, V117, P83, DOI 10.1016/S0166-6851(01)00336-X; Pachebat JA, 2007, MOL BIOCHEM PARASIT, V151, P59, DOI 10.1016/j.molbiopara.2006.10.006; Peraud O., 2006, ISOLATION CHARACTERI; Peter I.T., 1998, CURRENT GLOBAL MALAR, P11; Prudhomme J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002335; Putrianti ED, 2010, CELL MICROBIOL, V12, P725, DOI 10.1111/j.1462-5822.2009.01419.x; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Senior K, 2005, DRUG DISCOV TODAY, V10, P1210, DOI 10.1016/S1359-6446(05)03601-9; Serkedjieva, 2005, BIOTECHNOL BIOTECHNO, V19, P126, DOI [10.1080/13102818.2005.10817203, DOI 10.1080/13102818.2005.10817203]; Stafford WHL, 1996, MOL BIOCHEM PARASIT, V80, P159, DOI 10.1016/0166-6851(96)02696-5; SUDA H, 1972, J ANTIBIOT, V25, P263, DOI 10.7164/antibiotics.25.263; TAGUCHI S, 1993, APPL ENVIRON MICROB, V59, P4338, DOI 10.1128/AEM.59.12.4338-4341.1993; UMEZAWA H, 1982, ANNU REV MICROBIOL, V36, P75, DOI 10.1146/annurev.mi.36.100182.000451; UMEZAWA H, 1970, J ANTIBIOT, V23, P259, DOI 10.7164/antibiotics.23.259; Umezawa H, 1972, ENZYME INHIBITOR MIC; UMEZAWA S, 1972, J ANTIBIOT, V25, P267, DOI 10.7164/antibiotics.25.267; Vekemans J, 2008, EXPERT REV VACCINES, V7, P223, DOI 10.1586/14760584.7.2.223; WHO, 1980, WHO TECHN REP SER, V2; WHO, 2010, WORLD MALARIA REPORT; Withers-Martinez C, 2012, INT J PARASITOL, V42, P597, DOI 10.1016/j.ijpara.2012.04.005; WMR, 2011, WORLD MALARIA REPORT; [WMR WHO], 2011, WORLD MAL REP 2011; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Yin HQ, 2008, SYST APPL MICROBIOL, V31, P302, DOI 10.1016/j.syapm.2008.05.003	52	112	114	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90972	10.1371/journal.pone.0090972	http://dx.doi.org/10.1371/journal.pone.0090972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618707	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400040
J	Matsumura, K; Rolfe, P; Lee, J; Yamakoshi, T				Matsumura, Kenta; Rolfe, Peter; Lee, Jihyoung; Yamakoshi, Takehiro			iPhone 4s Photoplethysmography: Which Light Color Yields the Most Accurate Heart Rate and Normalized Pulse Volume Using the iPhysioMeter Application in the Presence of Motion Artifact?	PLOS ONE			English	Article							SKIN; WAVELENGTH; SMARTPHONE; GREEN; TONE	Recent progress in information and communication technologies has made it possible to measure heart rate (HR) and normalized pulse volume (NPV), which are important physiological indices, using only a smartphone. This has been achieved with reflection mode photoplethysmography (PPG), by using a smartphone's embedded flash as a light source and the camera as a light sensor. Despite its widespread use, the method of PPG is susceptible to motion artifacts as physical displacements influence photon propagation phenomena and, thereby, the effective optical path length. Further, it is known that the wavelength of light used for PPG influences the photon penetration depth and we therefore hypothesized that influences of motion artifact could be wavelength-dependant. To test this hypothesis, we made measurements in 12 healthy volunteers of HR and NPV derived from reflection mode plethysmograms recorded simultaneously at three different spectral regions (red, green and blue) at the same physical location with a smartphone. We then assessed the accuracy of the HR and NPV measurements under the influence of motion artifacts. The analyses revealed that the accuracy of HR was acceptably high with all three wavelengths (all rs > 0.996, fixed biases: -0.12 to 0.10 beats per minute, proportional biases: r = -0.29 to 0.03), but that of NPV was the best with green light (r = 0.791, fixed biases: -0.01 arbitrary units, proportional bias: r = 0.11). Moreover, the signal-to-noise ratio obtained with green and blue light PPG was higher than that of red light PPG. These findings suggest that green is the most suitable color for measuring HR and NPV from the reflection mode photoplethysmogram under motion artifact conditions. We conclude that the use of green light PPG could be of particular benefit in ambulatory monitoring where motion artifacts are a significant issue.	[Matsumura, Kenta; Yamakoshi, Takehiro] Kanazawa Univ, Coll Sci & Engn, Kanazawa, Ishikawa, Japan; [Rolfe, Peter] Harbin Inst Technol, Dept Automat Measurement & Control, Harbin 150006, Heilongjiang, Peoples R China; [Rolfe, Peter] Oxford BioHorizons Ltd, Maidstone, Kent, England; [Lee, Jihyoung] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University; Harbin Institute of Technology; Kanazawa University	Matsumura, K (corresponding author), Kanazawa Univ, Coll Sci & Engn, Kanazawa, Ishikawa, Japan.	kenta16moon@se.kanazawa-u.ac.jp	Matsumura, Kenta/ABH-9288-2020	Matsumura, Kenta/0000-0002-4271-1543	Ministry of Education, Culture, Sports, Science and Technology, Japan [24680063]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The study was partially supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan via Grant-in-Aid for Young Scientists (A) No. 24680063. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; ANDERSON RR, 1981, J INVEST DERMATOL, V77, P13, DOI 10.1111/1523-1747.ep12479191; Apple, 2011, AV FDN PROGR GUID IO; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Challoner A., 1979, NONINVASIVE PHYSL ME, V1, P125; Clark JW., 2009, MED INSTRUMENTATION; Elgendi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076585; Futran ND, 2000, ARCH OTOLARYNGOL, V126, P659, DOI 10.1001/archotol.126.5.659; Gailite L, 2008, LASER MED SCI, V23, P189, DOI 10.1007/s10103-007-0471-9; GILTVEDT J, 1984, MED BIOL ENG COMPUT, V22, P212, DOI 10.1007/BF02442745; Gregoski MJ, 2012, INT J TELEMED APPL, V2012, DOI 10.1155/2012/696324; Hamer M, 2007, BIOL PSYCHOL, V74, P20, DOI 10.1016/j.biopsycho.2006.06.003; Hayes MJ, 2001, IEEE T BIO-MED ENG, V48, P452, DOI 10.1109/10.915711; Jonathan E, 2010, PHYSIOL MEAS, V31, pN79, DOI 10.1088/0967-3334/31/11/N01; Jonathan E, 2011, J BIOPHOTONICS, V4, P293, DOI 10.1002/jbio.201000050; KAMAL AAR, 1989, COMPUT METH PROG BIO, V28, P257, DOI 10.1016/0169-2607(89)90159-4; Krishnan R, 2010, IEEE T BIO-MED ENG, V57, P1867, DOI 10.1109/TBME.2009.2039568; Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2; Lee J, 2013, IEEE ENG MED BIO, P1724, DOI 10.1109/EMBC.2013.6609852; Lee J, 2013, PHYSIOL MEAS, V34, P359, DOI 10.1088/0967-3334/34/3/359; LINDBERG LG, 1991, MED BIOL ENG COMPUT, V29, P48, DOI 10.1007/BF02446295; Ludbrook J, 1997, CLIN EXP PHARMACOL P, V24, P193, DOI 10.1111/j.1440-1681.1997.tb01807.x; Maeda Y, 2011, J MED SYST, V35, P829, DOI 10.1007/s10916-010-9506-z; Maeda Y, 2011, J MED SYST, V35, P969, DOI 10.1007/s10916-010-9505-0; Magnenat-Thalmann N, 2002, IEEE T INF TECHNOL B, V6, P317, DOI 10.1109/TITB.2002.806097; Matsumura K, 2013, BEHAV RES METHODS, V45, P1272, DOI 10.3758/s13428-012-0312-z; Matsumura Kenta, 2012, BMC Res Notes, V5, P288, DOI 10.1186/1756-0500-5-288; Matsumura Kenta, 2011, BMC Res Notes, V4, P342, DOI 10.1186/1756-0500-4-342; McNally RJ, 2004, PSYCHOL SCI, V15, P493, DOI 10.1111/j.0956-7976.2004.00707.x; OBEID AN, 1988, MED BIOL ENG COMPUT, V26, P415, DOI 10.1007/BF02442302; Parker KH, 2009, MED BIOL ENG COMPUT, V47, P111, DOI 10.1007/s11517-009-0440-5; Sawada Y, 2001, INT J PSYCHOPHYSIOL, V41, P1, DOI 10.1016/S0167-8760(00)00162-8; Scully CG, 2012, IEEE T BIO-MED ENG, V59, P303, DOI 10.1109/TBME.2011.2163157; Spigulis J, 2007, APPL OPTICS, V46, P1754, DOI 10.1364/AO.46.001754; Tanaka G, 2003, INT J PSYCHOPHYSIOL, V48, P293, DOI 10.1016/S0167-8760(03)00056-4; Tanaka G, 2011, PHYSIOL MEAS, V32, P1869, DOI 10.1088/0967-3334/32/11/003; UGNELL H, 1995, MED ENG PHYS, V17, P571, DOI 10.1016/1350-4533(95)00008-B; Yamakoshi Ken-ichi, 2013, IEEE Rev Biomed Eng, V6, P9, DOI 10.1109/RBME.2012.2227703; Yamakoshi T, 2010, EUR J SPORT SCI, V10, P397, DOI 10.1080/17461391003699112	39	42	43	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91205	10.1371/journal.pone.0091205	http://dx.doi.org/10.1371/journal.pone.0091205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618594	gold, Green Published, Green Submitted			2022-12-27	WOS:000332842400055
J	Schoner, TA; Fuchs, SW; Reinhold-Hurek, B; Bode, HB				Schoener, Tim A.; Fuchs, Sebastian W.; Reinhold-Hurek, Barbara; Bode, Helge B.			Identification and Biosynthesis of a Novel Xanthomonadin-Dialkylresorcinol-Hybrid from Azoarcus sp BH72	PLOS ONE			English	Article							DIFFUSIBLE FACTOR; 3-HYDROXYBENZOIC ACID; PIGMENTS; MICROORGANISMS; FLEXIRUBIN; METABOLITES; UBIQUINONE; FRAGMENTATION; SUBSTANCES; DB-2073	A novel xanthomonadin-dialkylresorcinol hybrid named arcuflavin was identified in Azoarcus sp. BH72 by a combination of feeding experiments, HPLC-MS and MALDI-MS and gene clusters encoding the biosynthesis of this non-isoprenoid aryl-polyene containing pigment are reported. A chorismate-utilizing enzyme from the XanB2-type producing 3-and 4-hydroxybenzoic acid and an AMP-ligase encoded by these gene clusters were characterized, that might perform the first two steps of the polyene biosynthesis. Furthermore, a detailed analysis of the already known or novel biosynthesis gene clusters involved in the biosynthesis of polyene containing pigments like arcuflavin, flexirubin and xanthomonadin revealed the presence of similar gene clusters in a wide range of bacterial taxa, suggesting that polyene and polyene-dialkylresorcinol pigments are more widespread than previously realized.	[Schoener, Tim A.; Fuchs, Sebastian W.; Bode, Helge B.] Goethe Univ Frankfurt, Merck Stiftungsprof Mol Biotechnol, Fachbereich Biowissensch, D-60054 Frankfurt, Germany; [Reinhold-Hurek, Barbara] Univ Bremen, Lab Gen Microbiol, D-28359 Bremen, Germany	Goethe University Frankfurt; University of Bremen	Bode, HB (corresponding author), Goethe Univ Frankfurt, Merck Stiftungsprof Mol Biotechnol, Fachbereich Biowissensch, D-60054 Frankfurt, Germany.	h.bode@bio.uni-frankfurt.de	Bode, Helge B/F-7022-2014	Bode, Helge B/0000-0001-6048-5909	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Work in the Bode lab was funded by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH H, 1976, CHEM BER-RECL, V109, P2490, DOI 10.1002/cber.19761090717; ACHENBACH H, 1979, CHEM BER-RECL, V112, P209, DOI 10.1002/cber.19791120119; ACHENBACH H, 1979, CHEM BER-RECL, V112, P1999, DOI 10.1002/cber.19791120610; Andexer JN, 2011, P NATL ACAD SCI USA, V108, P4776, DOI 10.1073/pnas.1015773108; Andrewes AG, 1977, TETRAHEDRON LETT, V45, P4023; Bohm M, 2007, MOL PLANT MICROBE IN, V20, P526, DOI 10.1094/MPMI-20-5-0526; DIANESE JC, 1982, PHYTOPATHOLOGY, V72, P1284, DOI 10.1094/Phyto-72-1284; FAUTZ E, 1980, FEMS MICROBIOL LETT, V8, P87, DOI 10.1016/0378-1097(80)90075-0; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fuchs SW, 2013, ANGEW CHEM INT EDIT, V52, P4108, DOI 10.1002/anie.201210116; Fuchs SW, 2012, ANAL CHEM, V84, P6948, DOI 10.1021/ac300372p; Goel AK, 2002, J BACTERIOL, V184, P3539, DOI 10.1128/JB.184.13.3539-3548.2002; Han JI, 2011, J BACTERIOL, V193, P1183, DOI 10.1128/JB.00925-10; He YW, 2011, MOL PLANT MICROBE IN, V24, P948, DOI 10.1094/MPMI-02-11-0031; IMAI S, 1993, J ANTIBIOT, V46, P1319, DOI 10.7164/antibiotics.46.1319; JENKINS CL, 1985, ANN INST PASTEUR MIC, V136B, P257, DOI 10.1016/S0769-2609(85)80071-5; JENKINS CL, 1982, CURR MICROBIOL, V7, P195, DOI 10.1007/BF01568797; JENKINS CL, 1982, CURR MICROBIOL, V7, P323, DOI 10.1007/BF01566872; Joyce SA, 2008, ANGEW CHEM INT EDIT, V47, P1942, DOI 10.1002/anie.200705148; Juneja P, 2014, J MOL BIOL, V426, P105, DOI 10.1016/j.jmb.2013.09.006; KANDA N, 1975, J ANTIBIOT, V28, P935, DOI 10.7164/antibiotics.28.935; KATO S, 1993, J ANTIBIOT, V46, P1024, DOI 10.7164/antibiotics.46.1024; KITAHARA T, 1975, J ANTIBIOT, V28, P943, DOI 10.7164/antibiotics.28.943; Krause A, 2006, NAT BIOTECHNOL, V24, P1385, DOI 10.1038/nbt1243; Krause A, 2011, MOL PLANT MICROBE IN, V24, P1325, DOI 10.1094/MPMI-05-11-0139; Nanda AK, 2010, J INTEGR PLANT BIOL, V52, P195, DOI 10.1111/j.1744-7909.2010.00933.x; Phelan VV, 2009, CHEM BIOL, V16, P473, DOI 10.1016/j.chembiol.2009.04.007; Poplawsky AR, 2000, APPL ENVIRON MICROB, V66, P5123, DOI 10.1128/AEM.66.12.5123-5127.2000; POPLAWSKY AR, 1993, MOL PLANT MICROBE IN, V6, P545, DOI 10.1094/MPMI-6-545; Poplawsky AR, 1997, J BACTERIOL, V179, P439, DOI 10.1128/jb.179.2.439-444.1997; Rajagopal L, 1997, FEBS LETT, V415, P125, DOI 10.1016/S0014-5793(97)01109-5; Reimer D, 2011, NAT CHEM BIOL, V7, P888, DOI [10.1038/NCHEMBIO.688, 10.1038/nchembio.688]; REINHOLD B, 1986, APPL ENVIRON MICROB, V52, P520, DOI 10.1128/AEM.52.3.520-526.1986; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schoner TA, 2014, MICROB BIOTECHNOL, V7, P232, DOI 10.1111/1751-7915.12110; SIEBERT M, 1992, FEBS LETT, V307, P347, DOI 10.1016/0014-5793(92)80710-X; STARR MP, 1977, ARCH MICROBIOL, V113, P1, DOI 10.1007/BF00428572; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066633; Zhou L, 2013, MOL PLANT MICROBE IN, V26, P1239, DOI 10.1094/MPMI-04-13-0112-R; Zhou L, 2013, MOL MICROBIOL, V87, P80, DOI 10.1111/mmi.12084	41	18	18	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90922	10.1371/journal.pone.0090922	http://dx.doi.org/10.1371/journal.pone.0090922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618669	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400036
J	Karlskas, IL; Maudal, K; Axelsson, L; Rud, I; Eijsink, VGH; Mathiesen, G				Karlskas, Ingrid Lea; Maudal, Kristina; Axelsson, Lars; Rud, Ida; Eijsink, Vincent G. H.; Mathiesen, Geir			Heterologous Protein Secretion in Lactobacilli with Modified pSIP Vectors	PLOS ONE			English	Article							INDUCIBLE GENE-EXPRESSION; COMPLETE GENOME SEQUENCE; LACTIC-ACID BACTERIA; LACTOCOCCUS-LACTIS; PROTECTIVE ANTIGEN; BACILLUS-SUBTILIS; PLANTARUM; SAKEI; TRANSFORMATION; GASSERI	We describe new variants of the modular pSIP-vectors for inducible gene expression and protein secretion in lactobacilli. The basic functionality of the pSIP system was tested in Lactobacillus strains representing 14 species using pSIP411, which harbors the broad-host-range Lactococcus lactis SH71(rep) replicon and a beta-glucuronidase encoding reporter gene. In 10 species, the inducible gene expression system was functional. Based on these results, three pSIP vectors with different signal peptides were modified by replacing their narrow-host-range L. plantarum 256(rep) replicon with SH71(rep) and transformed into strains of five different species of Lactobacillus. All recombinant strains secreted the target protein NucA, albeit with varying production levels and secretion efficiencies. The Lp_3050 derived signal peptide generally resulted in the highest levels of secreted NucA. These modified pSIP vectors are useful tools for engineering a wide variety of Lactobacillus species.	[Karlskas, Ingrid Lea; Maudal, Kristina; Eijsink, Vincent G. H.; Mathiesen, Geir] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Axelsson, Lars; Rud, Ida] Nofima Norwegian Inst Food Fisheries & Aquacultur, As, Norway	Norwegian University of Life Sciences; Nofima	Mathiesen, G (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway.	geir.mathiesen@umb.no			FUGE programme of the Norwegian Research Council [183637]	FUGE programme of the Norwegian Research Council	This work was funded by the FUGE programme of the Norwegian Research Council, grant number 183637. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRNE S, 1992, CURR MICROBIOL, V24, P199, DOI 10.1007/BF01579282; Anbazhagan K, 2013, J APPL MICROBIOL, V115, P880, DOI 10.1111/jam.12269; Antelmann H, 2003, MOL MICROBIOL, V49, P143, DOI 10.1046/j.1365-2958.2003.03565.x; AUKRUST T, 1992, FOOD RES INT, V25, P253, DOI 10.1016/0963-9969(92)90121-K; Axelsson L, 2003, LETT APPL MICROBIOL, V37, P115, DOI 10.1046/j.1472-765X.2003.01360.x; Azcarate-Peril MA, 2008, APPL ENVIRON MICROB, V74, P4610, DOI 10.1128/AEM.00054-08; Bohmer N, 2012, APPL MICROBIOL BIOT, V96, P903, DOI 10.1007/s00253-012-4212-z; Bolhuis A, 1999, APPL ENVIRON MICROB, V65, P2934; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Brockmeier U, 2006, J MOL BIOL, V362, P393, DOI 10.1016/j.jmb.2006.07.034; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Chaillou S, 2005, NAT BIOTECHNOL, V23, P1527, DOI 10.1038/nbt1160; De Vuyst L, 2007, J MOL MICROB BIOTECH, V13, P194, DOI 10.1159/000104752; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; DEVOS WM, 1987, FEMS MICROBIOL LETT, V46, P281, DOI 10.1111/j.1574-6968.1987.tb02466.x; Diep DB, 2009, CURR PHARM BIOTECHNO, V10, P62, DOI 10.2174/138920109787048571; Dieye Y, 2001, J BACTERIOL, V183, P4157, DOI 10.1128/JB.183.14.4157-4166.2001; Eijsink VGH, 2002, ANTON LEEUW INT J G, V81, P639, DOI 10.1023/A:1020582211262; Felis Giovanna E, 2007, Curr Issues Intest Microbiol, V8, P44; Fredriksen L, 2012, APPL ENVIRON MICROB, V78, P5864, DOI 10.1128/AEM.01227-12; Fredriksen L, 2010, APPL ENVIRON MICROB, V76, P7359, DOI 10.1128/AEM.01031-10; Halbmayr E, 2008, J AGR FOOD CHEM, V56, P4710, DOI 10.1021/jf073260+; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; Klingberg TD, 2005, INT J FOOD MICROBIOL, V105, P419, DOI 10.1016/j.ijfoodmicro.2005.03.020; Kolandaswamy A, 2008, CURR MICROBIOL; Kruger C, 2002, NAT BIOTECHNOL, V20, P702, DOI 10.1038/nbt0702-702; Le Loir Y, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacConaill LE, 2003, APPL ENVIRON MICROB, V69, P6994, DOI 10.1128/AEM.69.12.6994-7001.2003; Mathiesen G, 2008, J APPL MICROBIOL, V105, P215, DOI 10.1111/j.1365-2672.2008.03734.x; Mathiesen G, 2004, J APPL MICROBIOL, V96, P819, DOI 10.1111/j.1365-2672.2004.02206.x; Mathiesen G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-425; Mohamadzadeh M, 2005, P NATL ACAD SCI USA, V102, P2880, DOI 10.1073/pnas.0500098102; Mohamadzadeh M, 2009, P NATL ACAD SCI USA, V106, P4331, DOI 10.1073/pnas.0900029106; Mohamadzadeh M, 2010, FUTURE MICROBIOL, V5, P1289, DOI 10.2217/FMB.10.78; Morais S, 2013, APPL ENVIRON MICROB, V79, P5242, DOI 10.1128/AEM.01211-13; Park DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059470; Pushnova EA, 2000, ANAL BIOCHEM, V284, P70, DOI 10.1006/abio.2000.4668; Risoen PA, 2000, MOL MICROBIOL, V37, P619, DOI 10.1046/j.1365-2958.2000.02029.x; Selle K, 2013, FEMS MICROBIOL REV, V37, P915, DOI 10.1111/1574-6976.12021; Skulj M, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-6; Sorvig E, 2005, MICROBIOL-SGM, V151, P2439, DOI 10.1099/mic.0.28084-0; Sorvig E, 2005, MICROBIOL-SGM, V151, P421, DOI 10.1099/mic.0.27389-0; Sorvig E, 2003, FEMS MICROBIOL LETT, V229, P119, DOI 10.1016/S0378-1097(03)00798-5; Stoeker L, 2011, CLIN VACCINE IMMUNOL, V18, P1834, DOI 10.1128/CVI.05277-11; Nguyen T, 2011, J AGR FOOD CHEM, V59, P5617, DOI 10.1021/jf104755r; Vaidyanathan H, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-37; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; Von Wright A, 2012, LACTIC ACID BACTERIA: MICROBIOLOGICAL AND FUNCTIONAL ASPECTS, 4TH EDITION, P1; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Wells JM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S17	54	39	40	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91125	10.1371/journal.pone.0091125	http://dx.doi.org/10.1371/journal.pone.0091125			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614815	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000332839300080
J	Sotelo, T; Soengas, P; Velasco, P; Rodriguez, VM; Cartea, ME				Sotelo, Tamara; Soengas, Pilar; Velasco, Pablo; Rodriguez, Victor M.; Elena Cartea, Maria			Identification of Metabolic QTLs and Candidate Genes for Glucosinolate Synthesis in Brassica oleracea Leaves, Seeds and Flower Buds	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ARABIDOPSIS; BIOSYNTHESIS; CYTOCHROME-P450; BIOAVAILABILITY; PHYTOCHEMICALS; ENVIRONMENT; TRYPTOPHAN; RESISTANCE; BROCCOLI	Glucosinolates are major secondary metabolites found in the Brassicaceae family. These compounds play an essential role in plant defense against biotic and abiotic stresses, but more interestingly they have beneficial effects on human health. We performed a genetic analysis in order to identify the genome regions regulating glucosinolates biosynthesis in a DH mapping population of Brassica oleracea. In order to obtain a general overview of regulation in the whole plant, analyses were performed in the three major organs where glucosinolates are synthesized (leaves, seeds and flower buds). Eighty two significant QTLs were detected, which explained a broad range of variability in terms of individual and total glucosinolate (GSL) content. A meta-analysis rendered eighteen consensus QTLs. Thirteen of them regulated more than one glucosinolate and its content. In spite of the considerable variability of glucosinolate content and profiles across the organ, some of these consensus QTLs were identified in more than one tissue. Consensus QTLs control the GSL content by interacting epistatically in complex networks. Based on in silico analysis within the B. oleracea genome along with synteny with Arabidopsis, we propose seven major candidate loci that regulate GSL biosynthesis in the Brassicaceae family. Three of these loci control the content of aliphatic GSL and four of them control the content of indolic glucosinolates. GSL-ALK plays a central role in determining aliphatic GSL variation directly and by interacting epistatically with other loci, thus suggesting its regulatory effect.	[Sotelo, Tamara; Soengas, Pilar; Velasco, Pablo; Rodriguez, Victor M.; Elena Cartea, Maria] Spanish Council Sci Res MBG CSIC, Dept Plant Genet, Grp Genet Breeding & Biochem Brass, Mision Biol Galicia, Pontevedra, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Mision Biologica de Galicia (MBG)	Sotelo, T (corresponding author), Spanish Council Sci Res MBG CSIC, Dept Plant Genet, Grp Genet Breeding & Biochem Brass, Mision Biol Galicia, Pontevedra, Spain.	tsotelo@mbg.csic.es	Rodriguez, Victor M/M-2742-2014; Velasco, Pablo/C-3902-2012	Rodriguez, Victor M/0000-0002-2861-4093; Velasco, Pablo/0000-0003-3046-8918	National Plan for Research and Development [AGL-2009-09922]; Ministry of Economy and Competitiveness	National Plan for Research and Development; Ministry of Economy and Competitiveness	This work was supported by the National Plan for Research and Development (AGL-2009-09922). Tamara Sotelo acknowledges a pre-doctoral research grant (F.P.I) from the Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak S, 2001, PLANT CELL, V13, P101, DOI 10.1105/tpc.13.1.101; Bjorkman M, 2011, PHYTOCHEMISTRY, V72, P538, DOI 10.1016/j.phytochem.2011.01.014; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Celenza JL, 2005, PLANT PHYSIOL, V137, P253, DOI 10.1104/pp.104.054395; Chen SX, 2003, PLANT J, V33, P923, DOI 10.1046/j.1365-313X.2003.01679.x; Elena Cartea Maria, 2008, Phytochemistry Reviews, V7, P213, DOI 10.1007/s11101-007-9072-2; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Feng J, 2012, NEW PHYTOL, V193, P96, DOI 10.1111/j.1469-8137.2011.03890.x; Forte A, 2008, ANN ITAL CHIR, V79, P261; Gao MQ, 2007, THEOR APPL GENET, V115, P277, DOI 10.1007/s00122-007-0568-3; Gao MQ, 2006, PLANT CELL REP, V25, P592, DOI 10.1007/s00299-005-0078-1; Goffinet B, 2000, GENETICS, V155, P463; Halkier BA, 1997, TRENDS PLANT SCI, V2, P425, DOI 10.1016/S1360-1385(97)01128-X; Hasan M, 2008, THEOR APPL GENET, V116, P1035, DOI 10.1007/s00122-008-0733-3; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Hull AK, 2000, P NATL ACAD SCI USA, V97, P2379, DOI 10.1073/pnas.040569997; Kliebenstein DJ, 2009, PHYTOCHEM REV, V8, P243, DOI 10.1007/s11101-008-9102-8; Kliebenstein DJ, 2001, GENETICS, V159, P359; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Li G, 2003, THEOR APPL GENET, V106, P1116, DOI 10.1007/s00122-002-1161-4; Li G, 2001, J AM SOC HORTIC SCI, V126, P427, DOI 10.21273/JASHS.126.4.427; Li GY, 2002, GENETICS, V162, P1937; Li GY, 2001, ECON BOT, V55, P255, DOI 10.1007/BF02864563; Liu Z, 2012, PLANT MOL BIOL, V79, P179, DOI 10.1007/s11103-012-9905-2; Lowe AJ, 2004, THEOR APPL GENET, V108, P1103, DOI 10.1007/s00122-003-1522-7; Iniguez-Luy FL, 2009, THEOR APPL GENET, V120, P31, DOI 10.1007/s00122-009-1157-4; Mahmood T, 2003, GENOME, V46, P753, DOI 10.1139/G03-051; Mikkelsen MD, 2000, J BIOL CHEM, V275, P33712, DOI 10.1074/jbc.M001667200; Mikkelsen MD, 2002, AMINO ACIDS, V22, P279, DOI 10.1007/s007260200014; Mithen RF, 2001, ADV BOT RES, V35, P213, DOI 10.1016/S0065-2296(01)35008-5; Naur P, 2003, PLANT PHYSIOL, V133, P63, DOI 10.1104/pp.102.019240; Papst C, 2004, THEOR APPL GENET, V108, P1545, DOI 10.1007/s00122-003-1579-3; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Pfalz M, 2009, PLANT CELL, V21, P985, DOI 10.1105/tpc.108.063115; Ramchiary N, 2007, THEOR APPL GENET, V116, P77, DOI 10.1007/s00122-007-0648-4; Sarikamis G, 2006, MOL BREEDING, V18, P219, DOI 10.1007/s11032-006-9029-y; SAS, 2011, I INC SAS 9 3 SAS EN; SORENSEN H, 1988, ABSTR PAP AM CHEM S, V195, P79; Utz HF, 2000, GENETICS, V154, P1839; UTZ HF, 2003, COMPUTER PROGRAM MAP; Van Horn L, 2008, J AM DIET ASSOC, V108, P287, DOI 10.1016/j.jada.2007.10.050; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; Velasco P, 2008, J AM SOC HORTIC SCI, V133, P551, DOI 10.21273/JASHS.133.4.551; Velasco P, 2007, J AGR FOOD CHEM, V55, P955, DOI 10.1021/jf0624897; Verkerk R, 2009, MOL NUTR FOOD RES, V53, pS219, DOI 10.1002/mnfr.200800065; Virgili F, 2008, FREE RADICAL BIO MED, V45, P1205, DOI 10.1016/j.freeradbiomed.2008.08.001; Wang H, 2011, GENE, V487, P135, DOI 10.1016/j.gene.2011.07.021; Wang JS, 2012, FOOD CHEM, V133, P735, DOI 10.1016/j.foodchem.2012.01.085; Wentzell AM, 2008, PLANT PHYSIOL, V147, P415, DOI 10.1104/pp.107.115279; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; Zang YX, 2009, FEBS J, V276, P3559, DOI 10.1111/j.1742-4658.2009.07076.x; ZENG ZB, 1994, GENETICS, V136, P1457; Zukalova H, 2002, ROST VYROBA, V48, P175	57	29	29	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91428	10.1371/journal.pone.0091428	http://dx.doi.org/10.1371/journal.pone.0091428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614913	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300124
J	Li, D; Zhang, HJ; Fu, LJ; An, XL; Zhang, BZ; Li, Y; Chen, ZR; Zheng, W; Yi, L; Zheng, TL				Li, Dong; Zhang, Huajun; Fu, Lijun; An, Xinli; Zhang, Bangzhou; Li, Yi; Chen, Zhangran; Zheng, Wei; Yi, Lin; Zheng, Tianling			A Novel Algicide: Evidence of the Effect of a Fatty Acid Compound from the Marine Bacterium, Vibrio sp BS02 on the Harmful Dinoflagellate, Alexandrium tamarense	PLOS ONE			English	Article							ALGAL BLOOMS; IDENTIFICATION; ACTINOMYCETE; DYNAMICS; DEATH; LYSIS; SEA	Alexandrium tamarense is a notorious bloom-forming dinoflagellate, which adversely impacts water quality and human health. In this study we present a new algicide against A. tamarense, which was isolated from the marine bacterium Vibrio sp. BS02. MALDI-TOF-MS, NMR and algicidal activity analysis reveal that this compound corresponds to palmitoleic acid, which shows algicidal activity against A. tamarense with an EC50 of 40 mu g/mL. The effects of palmitoleic acid on the growth of other algal species were also studied. The results indicate that palmitoleic acid has potential for selective control of the Harmful algal blooms (HABs). Over extended periods of contact, transmission electron microscopy shows severe ultrastructural damage to the algae at 40 mu g/mL concentrations of palmitoleic acid. All of these results indicate potential for controlling HABs by using the special algicidal bacterium and its active agent.	[Li, Dong; Zhang, Huajun; Fu, Lijun; An, Xinli; Zhang, Bangzhou; Li, Yi; Chen, Zhangran; Zheng, Wei; Zheng, Tianling] Xiamen Univ, State Key Lab Marine Environm Sci, Sch Life Sci, Xiamen, Peoples R China; [Li, Dong; Zhang, Huajun; Fu, Lijun; An, Xinli; Zhang, Bangzhou; Li, Yi; Chen, Zhangran; Zheng, Wei; Zheng, Tianling] Xiamen Univ, Key Lab MOE Coast & Wetland Ecosyst, Sch Life Sci, Xiamen, Peoples R China; [Li, Dong; Yi, Lin] Huaqiao Univ, Coll Chem Engn, Xiamen, Peoples R China	Xiamen University; Xiamen University; Huaqiao University	Yi, L (corresponding author), Huaqiao Univ, Coll Chem Engn, Xiamen, Peoples R China.	lyhxm@hqu.edu.cn; wshwzh@xmu.edu.cn	Zhang, Bangzhou/CAG-9625-2022		National Nature Science Foundation of China [40930847]; Special Fund for Ph.D. Program in University [20120121130001]; Public Science and Technology Research Funds Projects of Ocean [201305016, 201305041, 201305022]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Ph.D. Program in University; Public Science and Technology Research Funds Projects of Ocean	This work was supported by the National Nature Science Foundation of China (40930847) (http://isis.nsfc.gov.cn/portal/Proj_List.asp), Special Fund for Ph.D. Program in University (20120121130001) (http://211.68.23.117/SSO/loginshow?u = null), and Public Science and Technology Research Funds Projects of Ocean (201305016, 201305041, and 201305022) (http://www.soanbu.com/ and MELRI1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamsjah MA, 2005, BIOSCI BIOTECH BIOCH, V69, P2186, DOI 10.1271/bbb.69.2186; Alamsjah MA, 2009, DEV APPL PHYCOLOGY, V2, P263; Alamsjah MA, 2007, BIOSCI BIOTECH BIOCH, V71, P265, DOI 10.1271/bbb.60475; Anderson D, 2001, INTERGUVERNAMENTAL O, V268; Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Anderson DM, 1996, TOXICON, V34, P579, DOI 10.1016/0041-0101(95)00158-1; Anderson DM, 2009, OCEAN COAST MANAGE, V52, P342, DOI 10.1016/j.ocecoaman.2009.04.006; [Anonymous], MARINE POLLUTION B, V51, P1018; Baek SH, 2003, J MICROBIOL BIOTECHN, V13, P651; Bai SJJ, 2011, CURR MICROBIOL, V62, P1774, DOI 10.1007/s00284-011-9927-z; Bernbom N, 2011, APPL ENVIRON MICROB, V77, P8557, DOI 10.1128/AEM.06038-11; Cai WW, 2011, APPL ENVIRON MICROB, V77, P7837, DOI 10.1128/AEM.05783-11; Chen WM, 2011, ENZYME MICROB TECH, V49, P372, DOI 10.1016/j.enzmictec.2011.06.016; Chen WM, 2012, ARCH MICROBIOL, V194, P103, DOI 10.1007/s00203-011-0730-9; Chiang IZ, 2004, J PHYCOL, V40, P474, DOI 10.1111/j.1529-8817.2004.03096.x; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; D'Costa PM, 2012, CURR SCI INDIA, V102, P1552; Darehshouri A, 2008, PLANT BIOLOGY, V10, P732, DOI 10.1111/j.1438-8677.2008.00078.x; Fu LJ, 2011, WORLD J MICROB BIOT, V27, P2949, DOI 10.1007/s11274-011-0778-3; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Gumbo JR, 2011, PHYS CHEM EARTH, V36, P881, DOI 10.1016/j.pce.2011.07.050; Hirao S, 2012, BIOSCI BIOTECH BIOCH, V76, P372, DOI 10.1271/bbb.110645; IKAWA M, 1994, J CHEM ECOL, V20, P2429, DOI 10.1007/BF02033211; Jeong HJ, 2008, HARMFUL ALGAE, V7, P368, DOI 10.1016/j.hal.2007.12.004; Jeong HJ, 2002, PHYCOLOGIA, V41, P643, DOI 10.2216/i0031-8884-41-6-643.1; Kamaya Y, 2003, ENVIRON TOXICOL, V18, P289, DOI 10.1002/tox.10127; Kang YH, 2005, J APPL MICROBIOL, V98, P1030, DOI 10.1111/j.1365-2672.2005.02533.x; Kawano Y, 1997, J MAR BIOTECHNOL, V5, P225; Keawtawee T, 2012, FISHERIES SCI, V78, P641, DOI 10.1007/s12562-012-0497-1; Kim D, 2007, J APPL MICROBIOL, V102, P937, DOI 10.1111/j.1365-2672.2006.03172.x; Kim JD, 2009, MAR BIOTECHNOL, V11, P463, DOI 10.1007/s10126-008-9167-9; Kim YM, 2012, MOL CELLS, P1; Kodani S, 2002, J APPL PHYCOL, V14, P109, DOI 10.1023/A:1019533414018; Lee SO, 2000, APPL ENVIRON MICROB, V66, P4334, DOI 10.1128/AEM.66.10.4334-4339.2000; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; Nakai S, 2005, HYDROBIOLOGIA, V543, P71, DOI 10.1007/s10750-004-6822-7; Ni LX, 2012, CHEMOSPHERE, V88, P1051, DOI 10.1016/j.chemosphere.2012.05.009; Oh MY, 2010, J APPL PHYCOL, V22, P453, DOI 10.1007/s10811-009-9478-x; Ozaki K, 2009, J HEALTH SCI, V55, P578, DOI 10.1248/jhs.55.578; Pan G, 2011, HARMFUL ALGAE, V10, P381, DOI 10.1016/j.hal.2011.01.003; Paul C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021032; Pokrzywinski KL, 2012, HARMFUL ALGAE, V19, P23, DOI 10.1016/j.hal.2012.05.002; Sala MM, 2005, FEMS MICROBIOL ECOL, V54, P257, DOI 10.1016/j.femsec.2005.04.005; SECHER S, 2009, PLYMOUTH STUDENT SCI, V2, P212; Su JQ, 2011, BIOL CONTROL, V56, P132, DOI 10.1016/j.biocontrol.2010.10.004; Su RQ, 2007, HARMFUL ALGAE, V6, P799, DOI 10.1016/j.hal.2007.04.004; Sun XX, 2004, MAR POLLUT BULL, V48, P937, DOI 10.1016/j.marpolbul.2003.11.021; Takamura Y., 2004, MICROBES ENVIRON, V19, P31, DOI DOI 10.1264/JSME2.19.31; Tang Y, 2011, WATER RES, V45, P2855, DOI 10.1016/j.watres.2011.03.003; Wang BX, 2010, LETT APPL MICROBIOL, V51, P552, DOI 10.1111/j.1472-765X.2010.02936.x; Wang B.X., 2012, HARMFUL ALGAE, V13, P83; Wu JT, 2006, AQUAT TOXICOL, V80, P338, DOI 10.1016/j.aquatox.2006.09.011; Xu D, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033648, 10.1371/journal.pone.0042243]; Yang CY, 2012, HARMFUL ALGAE, V20, P132, DOI 10.1016/j.hal.2012.09.002; Yang XL, 2012, PLANT PHYSIOL BIOCH, V51, P153, DOI 10.1016/j.plaphy.2011.10.019; Yoshichika T., 1999, ENV SCI, V12, P329; Zhang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063018; Zheng XW, 2013, APPL MICROBIOL BIOT, V97, P9207, DOI 10.1007/s00253-012-4617-8	58	46	50	3	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91201	10.1371/journal.pone.0091201	http://dx.doi.org/10.1371/journal.pone.0091201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626054	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300064
J	Reid, JE; Wernisch, L				Reid, John E.; Wernisch, Lorenz			STEME: A Robust, Accurate Motif Finder for Large Data Sets	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; DNA-BINDING; DISCOVERY; SITES; IMPROVES; NETWORK; MODELS; TOOLS	Motif finding is a difficult problem that has been studied for over 20 years. Some older popular motif finders are not suitable for analysis of the large data sets generated by next-generation sequencing. We recently published an efficient approximation (STEME) to the EM algorithm that is at the core of many motif finders such as MEME. This approximation allows the EM algorithm to be applied to large data sets. In this work we describe several efficient extensions to STEME that are based on the MEME algorithm. Together with the original STEME EM approximation, these extensions make STEME a fully-fledged motif finder with similar properties to MEME. We discuss the difficulty of objectively comparing motif finders. We show that STEME performs comparably to existing prominent discriminative motif finders, DREME and Trawler, on 13 sets of transcription factor binding data in mouse ES cells. We demonstrate the ability of STEME to find long degenerate motifs which these discriminative motif finders do not find. As part of our method, we extend an earlier method due to Nagarajan et al. for the efficient calculation of motif E-values. STEME's source code is available under an open source license and STEME is available via a web interface.	[Reid, John E.; Wernisch, Lorenz] Inst Publ Hlth, MRC Biostat Unit, Cambridge, England	MRC Biostatistics Unit; University of Cambridge	Reid, JE (corresponding author), Inst Publ Hlth, MRC Biostat Unit, Cambridge, England.	john.reid@mrc-bsu.cam.ac.uk		Reid, John/0000-0002-7762-6760	Medical Research Council Unit Programme [U105260799]; Medical Research Council [MC_U105260799] Funding Source: researchfish; MRC [MC_U105260799] Funding Source: UKRI	Medical Research Council Unit Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council Unit Programme number U105260799. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bailey TL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-179; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Down TA, 2005, NUCLEIC ACIDS RES, V33, P1445, DOI 10.1093/nar/gki282; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Ettwiller L, 2007, NAT METHODS, V4, P563, DOI 10.1038/NMETH1061; Gordan R, 2008, LECT N BIOINFORMAT, V4955, P98; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hirji KF, 1997, COMMUN STAT-SIMUL C, V26, P1197, DOI 10.1080/03610919708813435; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Hu M, 2010, NUCLEIC ACIDS RES, V38, P2154, DOI 10.1093/nar/gkp1180; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jauch R, 2008, J MOL BIOL, V376, P758, DOI 10.1016/j.jmb.2007.11.091; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Morikawa M, 2011, NUCL ACIDS RES; Morris Q, 2011, NAT BIOTECHNOL, V29, P483, DOI 10.1038/nbt.1892; Nagarajan N, 2005, BIOINFORMATICS, V21, pI311, DOI 10.1093/bioinformatics/bti1044; Narlikar L, 2007, LECT NOTES COMPUT SC, V4453, P107; Norel R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.70; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Redhead E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-385; Reid JE, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr574; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Siddharthan R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000156; Thijs G, 2001, BIOINFORMATICS, V17, P1113, DOI 10.1093/bioinformatics/17.12.1113; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Valen E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000562; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148	42	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90735	10.1371/journal.pone.0090735	http://dx.doi.org/10.1371/journal.pone.0090735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625410	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300030
J	Takx, RAP; de Jong, PA; Leiner, T; Oudkerk, M; de Koning, HJ; Mol, CP; Viergever, MA; Isgum, I				Takx, Richard A. P.; de Jong, Pim A.; Leiner, Tim; Oudkerk, Matthijs; de Koning, Harry J.; Mol, Christian P.; Viergever, Max A.; Isgum, Ivana			Automated Coronary Artery Calcification Scoring in Non-Gated Chest CT: Agreement and Reliability	PLOS ONE			English	Article							ELECTRON-BEAM CT; ALL-CAUSE MORTALITY; LUNG-CANCER; CALCIUM SCORE; RISK-FACTORS; DISEASE; PREDICTION; GUIDELINES; MDCT	Objective: To determine the agreement and reliability of fully automated coronary artery calcium (CAC) scoring in a lung cancer screening population. Materials and Methods: 1793 low-dose chest CT scans were analyzed (non-contrast-enhanced, non-gated). To establish the reference standard for CAC, first automated calcium scoring was performed using a preliminary version of a method employing coronary calcium atlas and machine learning approach. Thereafter, each scan was inspected by one of four trained raters. When needed, the raters corrected initially automaticity-identified results. In addition, an independent observer subsequently inspected manually corrected results and discarded scans with gross segmentation errors. Subsequently, fully automatic coronary calcium scoring was performed. Agatston score, CAC volume and number of calcifications were computed. Agreement was determined by calculating proportion of agreement and examining Bland-Altman plots. Reliability was determined by calculating linearly weighted kappa (k) for Agatston strata and intraclass correlation coefficient (ICC) for continuous values. Results: 44 (2.5%) scans were excluded due to metal artifacts or gross segmentation errors. In the remaining 1749 scans, median Agatston score was 39.6 (P25-P75:0-345.9), median volume score was 60.4 mm(3) (P25-P75:0-361.4) and median number of calcifications was 2 (P25-P75:0-4) for the automated scores. The k demonstrated very good reliability (0.85) for Agatston risk categories between the automated and reference scores. The Bland-Altman plots showed underestimation of calcium score values by automated quantification. Median difference was 2.5 (p25-p75:0.0-53.2) for Agatston score, 7.6 (p25-p75:0.0-94.4) for CAC volume and 1 (p25-p75:0-5) for number of calcifications. The ICC was very good for Agatston score (0.90), very good for calcium volume (0.88) and good for number of calcifications (0.64). Discussion: Fully automated coronary calcium scoring in a lung cancer screening setting is feasible with acceptable reliability and agreement despite an underestimation of the amount of calcium when compared to reference scores.	[Takx, Richard A. P.; de Jong, Pim A.; Leiner, Tim] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Oudkerk, Matthijs] Ctr Med Imaging North East, Groningen, Netherlands; [Oudkerk, Matthijs] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [de Koning, Harry J.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Mol, Christian P.; Viergever, Max A.; Isgum, Ivana] Univ Med Ctr Utrecht, Images Sci Inst, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center	Isgum, I (corresponding author), Univ Med Ctr Utrecht, Images Sci Inst, Utrecht, Netherlands.	ivana@isi.uu.nl	Isgum, Ivana/H-8659-2014; Takx, Richard/T-2852-2019; de+Koning, Harry/AAF-9062-2019; Viergever, Max A/J-1215-2014; de Jong, Pim A/G-7220-2014	Isgum, Ivana/0000-0003-1869-5034; Takx, Richard/0000-0003-2252-3040; de+Koning, Harry/0000-0003-4682-3646; de Jong, Pim A/0000-0003-4840-6854; Oudkerk, Matthijs/0000-0003-2800-4110	Netherlands Organisation for Health Research and Development (ZonMw) [22000130]; Dutch Cancer Society Koningin Wilhelmina Fonds; Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RVVZ); Siemens Germany provided 4 digital workstations and LungCARE for the performance of 3D measurements; Rotterdam Oncologic Thoracic Steering Committee; G. Ph. Verhagen Trust, Flemish League Against Cancer, Foundation Against Cancer, and Erasmus Trust Fund; project Care4Me (Cooperative Advanced Research for Medical Efficiency [ITEA2 Call3-08004]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Dutch Cancer Society Koningin Wilhelmina Fonds(KWF Kankerbestrijding); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RVVZ); Siemens Germany provided 4 digital workstations and LungCARE for the performance of 3D measurements; Rotterdam Oncologic Thoracic Steering Committee; G. Ph. Verhagen Trust, Flemish League Against Cancer, Foundation Against Cancer, and Erasmus Trust Fund; project Care4Me (Cooperative Advanced Research for Medical Efficiency	The NELSON-trial was supported by the Netherlands Organisation for Health Research and Development (ZonMw, grant number 22000130, http:// www.zonmw.nl/); Dutch Cancer Society Koningin Wilhelmina Fonds; Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RVVZ); Siemens Germany provided 4 digital workstations and LungCARE for the performance of 3D measurements; Rotterdam Oncologic Thoracic Steering Committee; and the G. Ph. Verhagen Trust, Flemish League Against Cancer, Foundation Against Cancer, and Erasmus Trust Fund. The contribution of I. Isgum was financially partly supported by the project Care4Me (Cooperative Advanced Research for Medical Efficiency, grant number ITEA2 Call3-08004, http://www.compassis.com/care4me/) in the framework of the EU research programme ITEA (Information Technology for European Advancement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Achenbach S, 2000, RADIOLOGY, V216, P457, DOI 10.1148/radiology.216.2.r00au19457; BIELAK LF, 1994, RADIOLOGY, V192, P631, DOI 10.1148/radiology.192.3.8058926; Bland JM, 2005, HLF NORMAL DIS UNPUB; Buckens CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071204; Budoff MJ, 2011, J CARDIOVASC COMPUT, V5, P113, DOI 10.1016/j.jcct.2010.11.002; Callister TQ, 1998, RADIOLOGY, V208, P807, DOI 10.1148/radiology.208.3.9722864; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hokanson JE, 2004, AM J ROENTGENOL, V182, P1327, DOI 10.2214/ajr.182.5.1821327; Isgum I, 2010, SPIE MEDIMAG, V7624; Isgum I, 2012, IEEE T MED IMAGING, V31, P2322, DOI 10.1109/TMI.2012.2216889; Jacobs PC, 2012, AM J ROENTGENOL, V198, P505, DOI 10.2214/AJR.10.5577; Jacobs PCA, 2010, AM J ROENTGENOL, V194, P1244, DOI 10.2214/AJR.09.3047; Kim SM, 2008, AM J ROENTGENOL, V190, P917, DOI 10.2214/AJR.07.2979; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liu YC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/472347; Ma SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012036; McEvoy John W, 2012, Curr Treat Options Cardiovasc Med, V14, P69, DOI 10.1007/s11936-011-0154-5; Mets OM, 2013, JACC CARDIOVASC IMAG; Mets OM, 2013, JACC-CARDIOVASC IMAG, V6, P899, DOI 10.1016/j.jcmg.2013.02.008; Mets OM, 2012, JAMA-J AM MED ASSOC, V308, P1433, DOI 10.1001/jama.2012.12656; Nasir K, 2012, CIRC-CARDIOVASC IMAG, V5, P467, DOI 10.1161/CIRCIMAGING.111.964528; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Rumberger JA, 1999, MAYO CLIN PROC, V74, P243, DOI 10.4065/74.3.243; Rutten A, 2011, EUR J RADIOL, V80, P83, DOI 10.1016/j.ejrad.2010.06.009; Schmermund A, 2011, LANCET, V378, P641, DOI 10.1016/S0140-6736(11)61129-X; Sevrukov AB, 2005, AM J ROENTGENOL, V185, P1546, DOI 10.2214/AJR.04.1589; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; Shemesh J, 2006, CLIN IMAG, V30, P181, DOI 10.1016/j.clinimag.2005.11.002; van den Bergh KAM, 2010, BRIT J CANCER, V102, P27, DOI 10.1038/sj.bjc.6605459; Wender R, 2013, CA-CANCER J CLIN, V63, P107, DOI 10.3322/caac.21172; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; Winkelmann BR, 2009, BIOMARK MED, V3, P617, DOI [10.2217/BMM.09.51, 10.2217/bmm.09.51]; Wu MT, 2008, AM J ROENTGENOL, V190, P923, DOI 10.2214/AJR.07.2974; Xie X, 2013, VALIDAITON PROGNOSIS; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	37	63	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91239	10.1371/journal.pone.0091239	http://dx.doi.org/10.1371/journal.pone.0091239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625525	Green Published, gold			2022-12-27	WOS:000332851300068
J	Emad, A; Milenkovic, O				Emad, Amin; Milenkovic, Olgica			CaSPIAN: A Causal Compressive Sensing Algorithm for Discovering Directed Interactions in Gene Networks	PLOS ONE			English	Article							EXPRESSION REGULATORY NETWORKS; INFERENCE; INFORMATION; PURSUIT; MODELS	We introduce a novel algorithm for inference of causal gene interactions, termed CaSPIAN (Causal Subspace Pursuit for Inference and Analysis of Networks), which is based on coupling compressive sensing and Granger causality techniques. The core of the approach is to discover sparse linear dependencies between shifted time series of gene expressions using a sequential list-version of the subspace pursuit reconstruction algorithm and to estimate the direction of gene interactions via Granger-type elimination. The method is conceptually simple and computationally efficient, and it allows for dealing with noisy measurements. Its performance as a stand-alone platform without biological side-information was tested on simulated networks, on the synthetic IRMA network in Saccharomyces cerevisiae, and on data pertaining to the human HeLa cell network and the SOS network in E. coli. The results produced by CaSPIAN are compared to the results of several related algorithms, demonstrating significant improvements in inference accuracy of documented interactions. These findings highlight the importance of Granger causality techniques for reducing the number of false-positives, as well as the influence of noise and sampling period on the accuracy of the estimates. In addition, the performance of the method was tested in conjunction with biological side information of the form of sparse "scaffold networks'', to which new edges were added using available RNA-seq or microarray data. These biological priors aid in increasing the sensitivity and precision of the algorithm in the small sample regime.	[Emad, Amin; Milenkovic, Olgica] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Emad, A (corresponding author), Univ Illinois, Dept Elect & Comp Engn, 1406 W Green St, Urbana, IL 61801 USA.	emad2@illinois.edu			NSERC; NSF [CCF 0809895, CCF 1218764]; Emerging Frontiers for Science of Information Center [CCF 0939370]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); Emerging Frontiers for Science of Information Center	This work was supported in part by an NSERC graduate fellowship, and NSF grants CCF 0809895, CCF 1218764 and the Emerging Frontiers for Science of Information Center, CCF 0939370. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altay G, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-31; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Becker S, 2011, SIAM J IMAGING SCI, V4, P1, DOI 10.1137/090756855; Butte A J, 2000, Pac Symp Biocomput, P418; Cai XD, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003068; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Chen BS, 2011, MATH BIOSCI, V230, P23, DOI 10.1016/j.mbs.2010.12.007; Chen T, 1999, Pac Symp Biocomput, P29; Dai W, 2009, IEEE T INFORM THEORY, V55, P2230, DOI 10.1109/TIT.2009.2016006; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Della Gatta G, 2008, GENOME RES, V18, P939, DOI 10.1101/gr.073601.107; Deng M, 2012, 2012 IEEE STATISTICAL SIGNAL PROCESSING WORKSHOP (SSP), P696, DOI 10.1109/SSP.2012.6319797; Dingel J, 2009, BIOINFORMATICS, V25, P1686, DOI 10.1093/bioinformatics/btp281; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; DOUGHERTY J, 2008, EURASIP J BIOINFORMA, V2008, P1; El Samad H, 2005, INT J ROBUST NONLIN, V15, P691, DOI 10.1002/rnc.1018; Emmert-Streib Frank, 2012, Frontiers in Genetics, V3, P8, DOI [10.3389/fgene.2012.00313, 10.3389/fgene.2012.00008]; Ewens W., 2004, STAT METHODS BIOINFO; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Fujita A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-39; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Geweke JF, 2003, J AM STAT ASSOC, V79, P907; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hang XY, 2009, IEEE INT WORK GENOM, P25; Husmeier D, 2003, BIOINFORMATICS, V19, P2271, DOI 10.1093/bioinformatics/btg313; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Laubenbacher R, 2004, J THEOR BIOL, V229, P523, DOI 10.1016/j.jtbi.2004.04.037; Liang KC, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/253894; Liu WB, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/780541; Long PM, 2010, MACH LEARN, V78, P287, DOI 10.1007/s10994-009-5165-z; Lozano AC, 2009, BIOINFORMATICS, V25, pI110, DOI 10.1093/bioinformatics/btp199; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Margolin AA, 2007, ANN NY ACAD SCI, V1115, P51, DOI 10.1196/annals.1407.019; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Mukhopadhyay ND, 2007, BIOINFORMATICS, V23, P442, DOI 10.1093/bioinformatics/btl598; Olsen C, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/308959; Pearl J., 2000, CAUSALITY MODELS REA, V29; Penfold CA, 2011, INTERFACE FOCUS, V1, P857, DOI 10.1098/rsfs.2011.0053; PENROSE R, 1955, P CAMBRIDGE PHILOS S, V51, DOI [DOI 10.1017/S0305004100030401, 10.1017/S0305004100030401]; Perrin BE, 2003, BIOINFORMATICS, V19, pII138, DOI 10.1093/bioinformatics/btg1071; Prat Y, 2011, BIOINFORMATICS, V27, P655, DOI 10.1093/bioinformatics/btr002; Rao Arvind, 2008, Journal of Bioinformatics and Computational Biology, V6, P493, DOI 10.1142/S0219720008003515; Ruklisa Dace, 2005, Genome Inform, V16, P225; Sambo F, 2008, NETTAB2008 VAR IT; Shojaie A, 2010, BIOINFORMATICS, V26, pi517, DOI 10.1093/bioinformatics/btq377; Sima C, 2009, CURR GENOMICS, V10, P416, DOI 10.2174/138920209789177610; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vallabhajosyula RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005344; van den Berg E, 2008, SIAM J SCI COMPUT, V31, P890, DOI 10.1137/080714488; Watkinson J, 2009, ANN NY ACAD SCI, V1158, P302, DOI 10.1111/j.1749-6632.2008.03757.x; Werhli AV, 2006, BIOINFORMATICS, V22, P2523, DOI 10.1093/bioinformatics/btl391; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wright J, 2010, P IEEE, V98, P1031, DOI 10.1109/JPROC.2010.2044470; Xu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S18; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448; Zhao WT, 2008, IEEE ACM T COMPUT BI, V5, P262, DOI 10.1109/TCBB.2007.1067; Zou M, 2005, BIOINFORMATICS, V21, P71, DOI 10.1093/bioinformatics/bth463	62	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90781	10.1371/journal.pone.0090781	http://dx.doi.org/10.1371/journal.pone.0090781			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622336	gold, Green Published, Green Submitted			2022-12-27	WOS:000332845300028
J	Gimeno, J; Eattock, N; Van Deynze, A; Blumwald, E				Gimeno, Jacinta; Eattock, Nicholas; Van Deynze, Allen; Blumwald, Eduardo			Selection and Validation of Reference Genes for Gene Expression Analysis in Switchgrass (Panicum virgatum) Using Quantitative Real-Time RT-PCR	PLOS ONE			English	Article							CELLULOSE SYNTHASE GENES; BIOMASS PRODUCTION; NITROGEN; NORMALIZATION; RECALCITRANCE; ETHANOL; HARVEST; MARKERS; FORAGE; YIELDS	Switchgrass (Panicum virgatum) has received a lot of attention as a forage and bioenergy crop during the past few years. Gene expression studies are in progress to improve new traits and develop new cultivars. Quantitative real time PCR (qRT-PCR) has emerged as an important technique to study gene expression analysis. For accurate and reliable results, normalization of data with reference genes is essential. In this work, we evaluate the stability of expression of genes to use as reference for qRT-PCR in the grass P. virgatum. Eleven candidate reference genes, including eEF-1 alpha, UBQ6, ACT12, TUB6, eIF-4 alpha, GAPDH, SAMDC, TUA6, CYP5, U2AF, and FTSH4, were validated for qRT-PCR normalization in different plant tissues and under different stress conditions. The expression stability of these genes was verified by the use of two distinct algorithms, geNorm and NormFinder. Differences were observed after comparison of the ranking of the candidate reference genes identified by both programs but eEF-1 alpha, eIF-4a, CYP5 and U2AF are ranked as the most stable genes in the samples sets under study. Both programs discard the use of SAMDC and TUA6 for normalization. Validation of the reference genes proposed by geNorm and NormFinder were performed by normalization of transcript abundance of a group of target genes in different samples. Results show similar expression patterns when the best reference genes selected by both programs were used but differences were detected in the transcript abundance of the target genes. Based on the above research, we recommend the use of different statistical algorithms to identify the best reference genes for expression data normalization. The best genes selected in this study will help to improve the quality of gene expression data in a wide variety of samples in switchgrass.	[Gimeno, Jacinta; Eattock, Nicholas; Van Deynze, Allen; Blumwald, Eduardo] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Blumwald, E (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	eblumwald@ucdavis.edu	Blumwald, Eduardo/Y-2751-2019		University of California	University of California(University of California System)	Funding came from the University of California Discovery Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Appenzeller L, 2004, CELLULOSE, V11, P287, DOI 10.1023/B:CELL.0000046417.84715.27; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bouton J, 2007, EUPHYTICA, V154, P263, DOI 10.1007/s10681-006-9220-6; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Carroll A, 2012, PLANT PHYSIOL, V160, P726, DOI 10.1104/pp.112.199208; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; DeMartini JD, 2013, ENERG ENVIRON SCI, V6, P898, DOI 10.1039/c3ee23801f; Dombrowski JE, 2009, PLANT SCI, V176, P390, DOI 10.1016/j.plantsci.2008.12.005; Escamilla-Trevino LL, 2010, NEW PHYTOL, V185, P143, DOI 10.1111/j.1469-8137.2009.03018.x; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Guretzky JA, 2011, PLANT SOIL, V339, P69, DOI 10.1007/s11104-010-0376-4; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Heaton E, 2004, BIOMASS BIOENERG, V27, P21, DOI 10.1016/j.biombioe.2003.10.005; Holland N, 2000, PLANT PHYSIOL, V123, P1313, DOI 10.1104/pp.123.4.1313; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kalluri UC, 2004, PLANTA, V220, P47, DOI 10.1007/s00425-004-1329-z; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Li QF, 2010, PLANT MOL BIOL REP, V28, P49, DOI 10.1007/s11105-009-0124-1; Matts J, 2010, J PLANT PHYSIOL, V167, P896, DOI 10.1016/j.jplph.2010.02.001; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; Muir JP, 2001, AGRON J, V93, P896, DOI 10.2134/agronj2001.934896x; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Palmer NA, 2012, BIOENERG RES, V5, P649, DOI 10.1007/s12155-011-9171-1; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Parrish DJ, 2005, CRIT REV PLANT SCI, V24, P423, DOI 10.1080/07352680500316433; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ranik M, 2006, TREE PHYSIOL, V26, P545, DOI 10.1093/treephys/26.5.545; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Saathoff AJ, 2011, BIOENERG RES, V4, P120, DOI 10.1007/s12155-010-9106-2; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Somleva MN, 2008, PLANT BIOTECHNOL J, V6, P663, DOI 10.1111/j.1467-7652.2008.00350.x; Somleva MN, 2002, CROP SCI, V42, P2080, DOI 10.2135/cropsci2002.2080; Tanaka K, 2003, PLANT PHYSIOL, V133, P73, DOI 10.1104/pp.103.022442; Tobias CM, 2008, PLANT GENOME-US, V1, P111, DOI 10.3835/plantgenome2008.08.0003; Tobias CM, 2006, MOL ECOL NOTES, V6, P185, DOI 10.1111/j.1471-8286.2006.01187.x; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogel KP, 2002, AGRON J, V94, P413, DOI 10.2134/agronj2002.0413; Wang YW, 2011, THEOR APPL GENET, V122, P677, DOI 10.1007/s00122-010-1477-4; Wang YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034225, 10.1371/journal.pone.0039525, 10.1371/journal.pone.0037152]; Xu B, 2012, PLOS ONE, V7; Zhang JY, 2013, PLANT J, V74, P160, DOI 10.1111/tpj.12104	53	95	106	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91474	10.1371/journal.pone.0091474	http://dx.doi.org/10.1371/journal.pone.0091474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621568	gold, Green Published, Green Submitted			2022-12-27	WOS:000332845300091
J	He, YZ; Zhang, YC; Jin, CW; Deng, XB; Wei, MT; Wu, QB; Yang, TH; Zhou, YH; Wang, ZQ				He, Yazhou; Zhang, Yuanchuan; Jin, Chengwu; Deng, Xiangbing; Wei, Mingtian; Wu, Qingbin; Yang, Tinghan; Zhou, Yanhong; Wang, Ziqiang			Impact of XRCC2 Arg188His Polymorphism on Cancer Susceptibility: A Meta-Analysis	PLOS ONE			English	Article							DNA-REPAIR GENES; SINGLE-NUCLEOTIDE POLYMORPHISMS; EPITHELIAL OVARIAN-CANCER; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; RISK; RAD51; ASSOCIATION; VARIANTS; SMOKING	Background: Association between the single nucleotide polymorphism rs3218536 (known as Arg188His) located in the Xray repair cross complementing group 2 (XRCC2) gene and cancer susceptibility has been widely investigated. However, results thus far have remained controversial. A meta-analysis was performed to identify the impact of this polymorphism on cancer susceptibility. Methods: PubMed and Embase databases were searched systematically until September 7, 2013 to obtain all the records evaluating the association between the XRCC2 Arg188His polymorphism and the risk of all types of cancers. We used the odds ratio (OR) as measure of effect, and pooled the data in a Mantel-Haenszel weighed random-effects meta-analysis to provide a summary estimate of the impact of this polymorphism on breast cancer, ovarian cancer and other cancers. All the analyses were carried out in STATA 12.0. Results: With 30868 cases and 38656 controls, a total of 45 case-control studies from 26 publications were eventually included in our meta-analysis. No significant association was observed between the XRCC2 Arg188His polymorphism and breast cancer susceptibility (dominant model: OR = 0.94, 95% CI = 0.86-1.04, P = 0.232). However, a significant impact of this polymorphism was detected on decreased ovarian cancer risk (dominant model: OR = 0.83, 95% CI = 0.73-0.95, P = 0.007). In addition, we found this polymorphism was associated with increased upper aerodigestive tract (UADT) cancer susceptibility (dominant model: OR = 1.51, 95% CI = 1.04-2.20, P = 0.032). Conclusion: The Arg188His polymorphism might play different roles in carcinogenesis of various cancer types. Current evidence did not suggest that this polymorphism was directly associated with breast cancer susceptibility. However, this polymorphism might contribute to decreased gynecological cancer risk and increased UADT cancer risk. More preclinical and epidemiological studies were still imperative for further evaluation.	[He, Yazhou; Zhang, Yuanchuan; Jin, Chengwu; Deng, Xiangbing; Wei, Mingtian; Yang, Tinghan; Wang, Ziqiang] Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China; [Wu, Qingbin] Sichuan Univ, West China Hosp, West China Sch Med, Chengdu 610064, Sichuan Provinc, Peoples R China; [Zhou, Yanhong] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Wang, ZQ (corresponding author), Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China.	Wangzqzyh@126.com	zhang, yuanchuan/HHR-8901-2022; He, Yazhou/K-8890-2019	Wu, Qingbin/0000-0001-8149-5989				Auranen A, 2005, INT J CANCER, V117, P611, DOI 10.1002/ijc.21047; Bastos HN, 2009, THYROID, V19, P1067, DOI 10.1089/thy.2009.0099; Beesley J, 2007, CANCER EPIDEM BIOMAR, V16, P2557, DOI 10.1158/1055-9965.EPI-07-0542; Benhamou S, 2004, INT J CANCER, V112, P901, DOI 10.1002/ijc.20474; Braybrooke JP, 2000, J BIOL CHEM, V275, P29100, DOI 10.1074/jbc.M002075200; Brooks J, 2008, CANCER EPIDEM BIOMAR, V17, P1016, DOI 10.1158/1055-9965.EPI-08-0065; Cerbinskaite A, 2012, CANCER TREAT REV, V38, P89, DOI 10.1016/j.ctrv.2011.04.015; Clarkson SG, 2005, DNA REPAIR, V4, P1068, DOI 10.1016/j.dnarep.2005.07.001; Curtin K, 2009, CANCER EPIDEM BIOMAR, V18, P2476, DOI 10.1158/1055-9965.EPI-09-0187; Danoy P, 2007, BIOCHEM BIOPH RES CO, V352, P763, DOI 10.1016/j.bbrc.2006.11.083; Fayaz S, 2012, GENET MOL BIOL, V35, P32, DOI 10.1590/S1415-47572012005000011; Figueroa JD, 2007, CARCINOGENESIS, V28, P1788, DOI 10.1093/carcin/bgm132; Garcia-Closas M, 2006, HUM GENET, V119, P376, DOI 10.1007/s00439-006-0135-z; Garcia-Quispes WA, 2011, MUTAT RES-FUND MOL M, V709-10, P67, DOI 10.1016/j.mrfmmm.2011.03.003; Griffin CS, 2000, NAT CELL BIOL, V2, P757, DOI 10.1038/35036399; Han JL, 2004, CARCINOGENESIS, V25, P189, DOI 10.1093/carcin/bgh002; Han JL, 2004, CANCER RES, V64, P3009, DOI 10.1158/0008-5472.CAN-04-0246; Han JL, 2004, CANCER EPIDEM BIOMAR, V13, P330, DOI 10.1158/1055-9965.EPI-03-0332; Hung RJ, 2008, CANCER EPIDEM BIOMAR, V17, P3081, DOI 10.1158/1055-9965.EPI-08-0411; Jiao L, 2008, AM J GASTROENTEROL, V103, P360, DOI 10.1111/j.1572-0241.2007.01615.x; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Krupa R, 2011, MOL BIOL REP, V38, P2849, DOI 10.1007/s11033-010-0430-6; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Matullo G, 2005, CANCER EPIDEM BIOMAR, V14, P2569, DOI 10.1158/1055-9965.EPI-05-0189; Millikan RC, 2005, CANCER EPIDEM BIOMAR, V14, P2326, DOI 10.1158/1055-9965.EPI-05-0186; Perez LO, 2013, PATHOL ONCOL RES, V19, P553, DOI 10.1007/s12253-013-9616-2; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Rajaraman P, 2010, NEURO-ONCOLOGY, V12, P37, DOI 10.1093/neuonc/nop012; Romanowicz-Makowska H, 2012, EUR J GYNAECOL ONCOL, V33, P145; Romanowicz-Makowska H, 2012, ARCH MED SCI, V8, P1065, DOI 10.5114/aoms.2012.32417; Romanowicz-Makowska H, 2012, J OBSTET GYNAECOL RE, V38, P918, DOI 10.1111/j.1447-0756.2011.01811.x; Suwaki N, 2011, SEMIN CELL DEV BIOL, V22, P898, DOI 10.1016/j.semcdb.2011.07.019; Wang SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056797; Webb PM, 2005, CANCER EPIDEM BIOMAR, V14, P319, DOI 10.1158/1055-9965.EPI-04-0335; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Yu KD, 2010, BREAST CANCER RES TR, V123, P219, DOI 10.1007/s10549-010-0753-y; Zhang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069046; Zhang YG, 2011, CANCER-AM CANCER SOC, V117, P4312, DOI 10.1002/cncr.25979; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	40	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91202	10.1371/journal.pone.0091202	http://dx.doi.org/10.1371/journal.pone.0091202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621646	gold, Green Published, Green Submitted			2022-12-27	WOS:000332845300061
J	Semsey, S				Semsey, Szabolcs			A Mixed Incoherent Feed-Forward Loop Allows Conditional Regulation of Response Dynamics	PLOS ONE			English	Article							CU,ZN SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI; GENE-EXPRESSION; SMALL RNA; POSTTRANSCRIPTIONAL REGULATION; DEGRADATION; MANGANESE; FUR; AUTOREGULATION; REPRESSION	Expression of the SodA superoxide dismutase (MnSOD) in Escherichia coli is regulated by superoxide concentration through the SoxRS system and also by Fur (Ferric uptake regulator) through a mixed incoherent feed forward loop (FFL) containing the RyhB small regulatory RNA. In this work I theoretically analyze the function of this feed forward loop as part of the network controlling expression of the two cytoplasmic superoxide dismutases, SodA and SodB. I find that feed forward regulation allows faster response to superoxide stress at low intracellular iron levels compared to iron rich conditions. That is, it can conditionally modulate the response time of a superimposed transcriptional control mechanism.	Univ Copenhagen, Niels Bohr Inst, Ctr Models Life, DK-2100 Copenhagen, Denmark	University of Copenhagen; Niels Bohr Institute	Semsey, S (corresponding author), Univ Copenhagen, Niels Bohr Inst, Ctr Models Life, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	semsey@nbi.dk		Semsey, Szabolcs/0000-0002-4522-5495	Danish National Research Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond)	This research was supported by the Danish National Research Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbel-Goren R, 2013, NUCLEIC ACIDS RES, V41, P4825, DOI 10.1093/nar/gkt184; Argaman L, 2012, P NATL ACAD SCI USA, V109, P4621, DOI 10.1073/pnas.1113113109; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Battistoni A, 1998, BIOCHEM BIOPH RES CO, V243, P804, DOI 10.1006/bbrc.1998.8182; Beisel CL, 2011, MOL CELL, V41, P286, DOI 10.1016/j.molcel.2010.12.027; BENOV L, 1995, ARCH BIOCHEM BIOPHYS, V319, P508, DOI 10.1006/abbi.1995.1324; BENOV LT, 1994, J BIOL CHEM, V269, P25310; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; BROWN OR, 1995, ARCH BIOCHEM BIOPHYS, V319, P10, DOI 10.1006/abbi.1995.1262; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; COMPAN I, 1993, J BACTERIOL, V175, P1687, DOI 10.1128/JB.175.6.1687-1696.1993; Diaz JM, 2013, SCIENCE, V340, P1223, DOI 10.1126/science.1237331; Dubrac S, 2000, J BACTERIOL, V182, P3802, DOI 10.1128/JB.182.13.3802-3808.2000; El Bekay R, 2002, J LEUKOCYTE BIOL, V71, P255; FEE JA, 1991, MOL MICROBIOL, V5, P2599, DOI 10.1111/j.1365-2958.1991.tb01968.x; Gaudu P, 1996, P NATL ACAD SCI USA, V93, P10094, DOI 10.1073/pnas.93.19.10094; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; HOPKIN KA, 1992, J BIOL CHEM, V267, P24253; Hunziker A, 2010, P NATL ACAD SCI USA, V107, P12998, DOI 10.1073/pnas.0915003107; Kaplan S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.43; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mank NN, 2013, RNA BIOL, V10, P347, DOI 10.4161/rna.23769; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mills SA, 2005, BIOCHEMISTRY-US, V44, P13553, DOI 10.1021/bi0507579; Mitarai N, 2007, PHYS BIOL, V4, P164, DOI 10.1088/1478-3975/4/3/003; Mitarai N, 2009, P NATL ACAD SCI USA, V106, P10655, DOI 10.1073/pnas.0901466106; Mizuno K, 2004, J BIOL CHEM, V279, P27339, DOI 10.1074/jbc.M400813200; NIEDERHOFFER EC, 1990, J BACTERIOL, V172, P1930, DOI 10.1128/jb.172.4.1930-1938.1990; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Pesce A, 1997, J MOL BIOL, V274, P408, DOI 10.1006/jmbi.1997.1400; SCHRUM LW, 1994, ARCH BIOCHEM BIOPHYS, V309, P288, DOI 10.1006/abbi.1994.1115; Semsey S, 2006, NUCLEIC ACIDS RES, V34, P4960, DOI 10.1093/nar/gkl627; Semsey S, 2013, NUCLEIC ACIDS RES, V41, P6381, DOI 10.1093/nar/gkt351; Semsey S, 2009, J BACTERIOL, V191, P4487, DOI 10.1128/JB.00056-09; Shah IM, 2006, J MOL BIOL, V357, P718, DOI 10.1016/j.jmb.2005.12.088; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; Sneppen K, 2010, ANNU REV BIOPHYS, V39, P43, DOI 10.1146/annurev.biophys.093008.131241; Takeda K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002413; Vance CK, 1998, BIOCHEMISTRY-US, V37, P5518, DOI 10.1021/bi972580r	44	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91243	10.1371/journal.pone.0091243	http://dx.doi.org/10.1371/journal.pone.0091243			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621982	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300067
J	Szantho, E; Bhattoa, HP; Csoban, M; Antal-Szalmas, P; Ujfalusi, A; Kappelmayer, J; Hevessy, Z				Szantho, Eszter; Bhattoa, Harjit Pal; Csoban, Maria; Antal-Szalmas, Peter; Ujfalusi, Aniko; Kappelmayer, Janos; Hevessy, Zsuzsanna			Serum Thymidine Kinase Activity: Analytical Performance, Age-Related Reference Ranges and Validation in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; CD38 EXPRESSION; DEOXYTHYMIDINE KINASE; DEOXYRIBONUCLEIC-ACID; PROGNOSTIC INDICATORS; 1ST TREATMENT; TUMOR-MARKER; ZAP-70; CARCINOMA; ANTIGEN	Background: To date no age-related reference ranges are available for serum thymidine kinase (TK1) activity. Being a proliferation marker, it may be used as a prognostic marker in malignant diseases, including chronic lymphocytic leukemia (CLL). Our aim was to establish age-specific reference ranges for TK1 and examine its utility as a screening marker in CLL, a disease of the elderly. Methods: Serum TK1 activity was measured by a competitive chemiluminescent immunoassay in 369 healthy adults and 115 de novo CLL patients. Results: We observed a statistically significant decline in TK1 activity from young (18-35 years) to middle-aged (36-60 years) and further on to elderly (60-86 years) healthy individuals. Age-related reference range was: <30 U/L for young, <25 U/L for middle-aged and <19 U/L for elderly. There was no difference in TK1 activity between the studied healthy men and women. In CLL patients, TK1 activity was the highest in the advanced Rai stages. The area under the receiver operating characteristic curve (ROC-AUC) for TK1 was 0.840 (95% CI: 0.787-0.892), for differentiating CLL patients from age and sex matched healthy controls, with a cut-off value of 10.5 U/L (sensitivity: 80.9%, specificity: 73.4%). TK1 was significantly elevated in CD38+/Zap70+ CLL patients, and showed significant correlation with WBC and absolute B-cell count. Conclusion: In the healthy, serum TK1 activity does not differ in the two sexes but declines significantly with age. As such, use of age-related reference ranges is warranted, especially when evaluating CLL patients who generally belong to the elderly age group.	[Szantho, Eszter; Bhattoa, Harjit Pal; Csoban, Maria; Antal-Szalmas, Peter; Ujfalusi, Aniko; Kappelmayer, Janos; Hevessy, Zsuzsanna] Univ Debrecen, Med & Hlth Sci Ctr, Dept Lab Med, H-4012 Debrecen, Hungary	University of Debrecen	Hevessy, Z (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Dept Lab Med, H-4012 Debrecen, Hungary.	hevessy@med.unideb.hu	Hevessy, Zsuzsanna/AAA-1186-2019	Bhattoa, Harjit Pal/0000-0002-4909-0065	European Union; European Social Fund; OTKA [105073]; National Development Agency of Hungary (mAB-CHIC) [TECH-09-A1-2009-0113];  [TAMOP-4.2.2.A-11/1/KONV-2012-0025]	European Union(European Commission); European Social Fund(European Social Fund (ESF)); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency of Hungary (mAB-CHIC); 	The work is supported by the TAMOP-4.2.2.A-11/1/KONV-2012-0025 project. The project is co-financed by the European Union and the European Social Fund. This work is supported by the OTKA 105073 research grant (HPB) and by the National Office for Research and Technology (presently National Development Agency) of Hungary (TECH-09-A1-2009-0113; mAB-CHIC) (PAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahlo J, 2011, BLOOD S1, V118; BERK AJ, 1973, J BIOL CHEM, V248, P2722; Chen ZH, 2011, SENSORS-BASEL, V11, P11064, DOI 10.3390/s111211064; Chen ZH, 2008, ANTICANCER RES, V28, P3897; Clinical and Laboratory Standards Institute, 2008, C28A3 CLSI; D'Arena G, 2007, AM J HEMATOL, V82, P787, DOI 10.1002/ajh.20936; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Damle RN, 2002, BLOOD, V99, P4087, DOI 10.1182/blood.V99.11.4087; Durig J, 2002, LEUKEMIA, V16, P30, DOI 10.1038/sj.leu.2402339; Faria M, 2012, J CHROMATOGR B, V907, P13, DOI 10.1016/j.jchromb.2012.08.024; Foekens JA, 2001, CANCER RES, V61, P1421; Fujiwaki R, 2001, ONCOLOGY-BASEL, V61, P47, DOI 10.1159/000055352; Funaro A, 1997, TISSUE ANTIGENS, V49, P7, DOI 10.1111/j.1399-0039.1997.tb02703.x; Furman RR, 2010, HEMATOL-AM SOC HEMAT, P77, DOI 10.1182/asheducation-2010.1.77; GRONOWITZ JS, 1983, BRIT J CANCER, V47, P487, DOI 10.1038/bjc.1983.78; GRONOWITZ JS, 1980, INFECT IMMUN, V29, P425; HAGBERG H, 1984, SCAND J HAEMATOL, V32, P41; Hallek M, 1999, BLOOD, V93, P1732; HALLEK M, 1992, ANN HEMATOL, V65, P1, DOI 10.1007/BF01715117; Henny J, 2013, CLIN CHEM LAB MED, V51, P1335, DOI 10.1515/cclm-2013-0410; HOUSTEK J, 1968, J PEDIATR-US, V72, P186, DOI 10.1016/S0022-3476(68)80307-5; Hus I, 2006, ANN ONCOL, V17, P683, DOI 10.1093/annonc/mdj120; KALLANDER CFR, 1984, CANCER, V54, P2450, DOI 10.1002/1097-0142(19841201)54:11<2450::AID-CNCR2820541123>3.0.CO;2-R; Konoplev SN, 2010, AM J CLIN PATHOL, V134, P472, DOI 10.1309/AJCPHMYT93HUIZKW; Kornberg A, 1989, Biochim Biophys Acta, V1000, P57; Letestu R, 2010, BLOOD, V116, P4588, DOI 10.1182/blood-2010-06-288274; Magnac C, 2003, LEUKEMIA, V17, P133, DOI 10.1038/sj.leu.2402780; Malavasi F, 2011, BLOOD, V118, P3470, DOI 10.1182/blood-2011-06-275610; Molica S, 2014, LEUKEMIA LYMPHOMA, V55, P964, DOI 10.3109/10428194.2013.825908; Molica S, 2013, LEUKEMIA RES, V37, P943, DOI 10.1016/j.leukres.2013.02.016; Nisman B, 2013, CLIN CHEM LAB MED, V51, P439, DOI 10.1515/cclm-2012-0162; O'Neill K L, 2001, Expert Rev Mol Diagn, V1, P428, DOI 10.1586/14737159.1.4.428; Ohrvik A, 2004, CLIN CHEM, V50, P1597, DOI 10.1373/clinchem.2003.030379; Panteghini M, 2012, CLIN CHEM LAB MED, V50, P813, DOI [10.1515/cclm.2011.828, 10.1515/CCLM.2011.828]; REICHARD P, 1951, J BIOL CHEM, V188, P839; Rivkina A., 2011, Experimental Oncology, V33, P99; Sagatys EM, 2012, CANCER CONTROL, V19, P18, DOI 10.1177/107327481201900103; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; Siest G, 2013, CLIN CHEM LAB MED, V51, P47, DOI 10.1515/cclm-2012-0682; Stenman UH, 1999, SEMIN CANCER BIOL, V9, P83, DOI 10.1006/scbi.1998.0086; Thomas W M, 1995, Eur J Surg Oncol, V21, P632, DOI 10.1016/S0748-7983(95)95434-1; VAITUKAITIS JL, 1974, ANN CLIN LAB SCI, V4, P276; WEISSMAN SM, 1960, BIOCHIM BIOPHYS ACTA, V45, P101, DOI 10.1016/0006-3002(60)91430-X; Wierda WG, 2011, J CLIN ONCOL, V29, P4088, DOI 10.1200/JCO.2010.33.9002; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Wu CJ, 2003, J IMMUNOL METHODS, V277, P157, DOI 10.1016/S0022-1759(03)00062-0; Xu W, 2009, INT J HEMATOL, V90, P205, DOI 10.1007/s12185-009-0380-8; Zhou J, 2013, MOL CLIN ONCOL, V1, P18, DOI 10.3892/mco.2012.19	48	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91647	10.1371/journal.pone.0091647	http://dx.doi.org/10.1371/journal.pone.0091647			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621590	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300112
J	Ramos, JBE; Schulz, KG; Brownlee, C; Sett, S; Azevedo, EB				Barcelos e Ramos, Joana; Schulz, Kai Georg; Brownlee, Colin; Sett, Scarlett; Azevedo, Eduardo Brito			Effects of Increasing Seawater Carbon Dioxide Concentrations on Chain Formation of the Diatom Asterionellopsis glacialis	PLOS ONE			English	Article							MARINE DIATOMS; CO2 CONCENTRATION; SKELETONEMA-COSTATUM; INORGANIC CARBON; ORGANIC-MATTER; GROWTH; PHYTOPLANKTON; ACIDIFICATION; FLOTATION; PH	Diatoms can occur as single cells or as chain-forming aggregates. These two strategies affect buoyancy, predator evasion, light absorption and nutrient uptake. Adjacent cells in chains establish connections through various processes that determine strength and flexibility of the bonds, and at distinct cellular locations defining colony structure. Chain length has been found to vary with temperature and nutrient availability as well as being positively correlated with growth rate. However, the potential effect of enhanced carbon dioxide (CO2) concentrations and consequent changes in seawater carbonate chemistry on chain formation is virtually unknown. Here we report on experiments with semi-continuous cultures of the freshly isolated diatom Asterionellopsis glacialis grown under increasing CO2 levels ranging from 320 to 3400 mu atm. We show that the number of cells comprising a chain, and therefore chain length, increases with rising CO2 concentrations. We also demonstrate that while cell division rate changes with CO2 concentrations, carbon, nitrogen and phosphorus cellular quotas vary proportionally, evident by unchanged organic matter ratios. Finally, beyond the optimum CO2 concentration for growth, carbon allocation changes from cellular storage to increased exudation of dissolved organic carbon. The observed structural adjustment in colony size could enable growth at high CO2 levels, since longer, spiral-shaped chains are likely to create microclimates with higher pH during the light period. Moreover increased chain length of Asterionellopsis glacialis may influence buoyancy and, consequently, affect competitive fitness as well as sinking rates. This would potentially impact the delicate balance between the microbial loop and export of organic matter, with consequences for atmospheric carbon dioxide.	[Barcelos e Ramos, Joana; Azevedo, Eduardo Brito] Univ Azores, Ctr Climate Meteorol & Global Change, Angra Do Heroismo, Azores, Portugal; [Barcelos e Ramos, Joana; Azevedo, Eduardo Brito] Res Ctr Agr & Environm Sci & Technol Azores, Angra Do Heroismo, Azores, Portugal; [Schulz, Kai Georg] So Cross Univ, Sch Environm Sci & Management, Ctr Coastal Biogeochem, Lismore, NSW 2480, Australia; [Brownlee, Colin] Marine Biol Assoc UK, Plymouth, Devon, England; [Sett, Scarlett] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany	Universidade dos Acores; Southern Cross University; Marine Biological Association United Kingdom; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Ramos, JBE (corresponding author), Univ Azores, Ctr Climate Meteorol & Global Change, Angra Do Heroismo, Azores, Portugal.	joanabr@uac.pt	Barcelos e Ramos, Joana/ABD-3747-2020; Schulz, Kai/AEZ-9073-2022; Barcelos e Ramos, Joana/HDN-3479-2022; Schulz, Kai G./Q-5608-2017; Azevedo, Eduardo B/M-4266-2013	Schulz, Kai/0000-0002-8481-4639; Schulz, Kai G./0000-0002-8481-4639; Azevedo, Eduardo B/0000-0001-5172-7742; Ramos, Joana/0000-0003-4545-202X; Barcelos e Ramos, Joana/0000-0002-0879-2298	Azores Regional Science Fund; Fundation for Science and Tecnology of Portugal [PTDC/AAC-CLI/112735/2009]; Australian Research Council [FT120100384]; ARC [FT120100384]	Azores Regional Science Fund; Fundation for Science and Tecnology of Portugal; Australian Research Council(Australian Research Council); ARC(Australian Research Council)	The research was supported by Azores Regional Science Fund, the Fundation for Science and Tecnology of Portugal by the project ROPICO2 (PTDC/AAC-CLI/112735/2009), the Australian Research Council by project FT120100384, and by ARC grant FT120100384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach LT, 2011, LIMNOL OCEANOGR, V56, P2040, DOI 10.4319/lo.2011.56.6.2040; Barcelos e Ramos J, 2007, GLOBAL BIOGEOCHEMICA, V21; Beardall J, 2002, FUNCT PLANT BIOL, V29, P335, DOI 10.1071/PP01195; Beardall J, 2009, NEW PHYTOL, V181, P295, DOI 10.1111/j.1469-8137.2008.02660.x; Borchard C, 2012, BIOGEOSCIENCES, V9, P3405, DOI 10.5194/bg-9-3405-2012; Burkhardt S, 1999, LIMNOL OCEANOGR, V44, P683, DOI 10.4319/lo.1999.44.3.0683; Burkhardt S, 1999, GEOCHIM COSMOCHIM AC, V63, P3729, DOI 10.1016/S0016-7037(99)00217-3; Burkhardt S, 2001, LIMNOL OCEANOGR, V46, P1378, DOI 10.4319/lo.2001.46.6.1378; CHEN CY, 1994, MAR ECOL PROG SER, V109, P83, DOI 10.3354/meps109083; Chen XW, 2004, FUNCT PLANT BIOL, V31, P399, DOI 10.1071/FP03240; Crawfurd KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026695; Dickson AG, 2003, MAR CHEM, V80, P185, DOI 10.1016/S0304-4203(02)00133-0; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; FRYXELL GA, 1978, J PHYCOL, V14, P62, DOI 10.1111/j.0022-3646.1978.00062.x; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; Hoogstraten A, 2012, J PHYCOL, V48, P559, DOI 10.1111/j.1529-8817.2012.01148.x; Hopkinson BM, 2011, P NATL ACAD SCI USA, DOI DOI 10.1073/PNAS.1018062108.PR0CEED-INGS; IPCC, 2007, CONTRIBUTION WORKING; Kim JM, 2006, LIMNOL OCEANOGR, V51, P1629, DOI 10.4319/lo.2006.51.4.1629; Kooistra Wiebe H. C. F., 2007, P207; LAMPERT W, 1994, LIMNOL OCEANOGR, V39, P1543, DOI 10.4319/lo.1994.39.7.1543; Lewis E., 1998, PROGRAM DEV CO2 SYST; McCarthy A, 2012, J PHYCOL, V48, P635, DOI 10.1111/j.1529-8817.2012.01171.x; McGinn PJ, 2008, PLANT PHYSIOL, V146, P300, DOI 10.1104/pp.107.110569; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Milligan AJ, 2004, LIMNOL OCEANOGR, V49, P322, DOI 10.4319/lo.2004.49.2.0322; Morel FMM, 2002, FUNCT PLANT BIOL, V29, P301, DOI 10.1071/PP01199; Ploug H, 2008, LIMNOL OCEANOGR, V53, P914, DOI 10.4319/lo.2008.53.3.0914; Raven JA, 2003, PHOTOSYNTH RES, V77, P155, DOI 10.1023/A:1025877902752; RIEBESELL U, 1993, NATURE, V361, P249, DOI 10.1038/361249a0; Roberts K, 2007, PLANT PHYSIOL, V145, P230, DOI 10.1104/pp.107.102616; Schulz KG, 2008, BIOGEOSCIENCES, V5, P707, DOI 10.5194/bg-5-707-2008; Schulz KG, 2009, BIOGEOSCIENCES, V6, P2145, DOI 10.5194/bg-6-2145-2009; SHARP JH, 1974, LIMNOL OCEANOGR, V19, P984, DOI 10.4319/lo.1974.19.6.0984; SMAYDA THEODORE J., 1965, LIMNOL OCEANOGR, V10, P499; SMAYDA TJ, 1966, LIMNOL OCEANOGR, V11, P35, DOI 10.4319/lo.1966.11.1.0035; SMAYDA TJ, 1966, LIMNOL OCEANOGR, V11, P18, DOI 10.4319/lo.1966.11.1.0018; Takabayashi M, 2006, J PLANKTON RES, V28, P831, DOI 10.1093/plankt/fbl018; Tatters AO, 2012, SHORT VERSUS LONG TE; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; Vardi A, 2008, CURR BIOL, V18, P895, DOI 10.1016/j.cub.2008.05.037; Vardi Assaf, 2008, Commun Integr Biol, V1, P134; Wu Y, 2010, BIOGEOSCIENCES, V7, P2915, DOI 10.5194/bg-7-2915-2010	46	11	11	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90749	10.1371/journal.pone.0090749	http://dx.doi.org/10.1371/journal.pone.0090749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618939	Green Published, gold, Green Accepted			2022-12-27	WOS:000332842400028
J	Duechs, MJ; Tilp, C; Tomsic, C; Gantner, F; Erb, KJ				Duechs, Matthias J.; Tilp, Cornelia; Tomsic, Christopher; Gantner, Florian; Erb, Klaus J.			Development of a Novel Severe Triple Allergen Asthma Model in Mice Which Is Resistant to Dexamethasone and Partially Resistant to TLR7 and TLR9 Agonist Treatment	PLOS ONE			English	Article							AIRWAY INFLAMMATION; MURINE MODEL; INTERFERON-GAMMA; IMMUNE-RESPONSE; DUST-MITE; T-CELLS; LUNG; HYPERRESPONSIVENESS; HYPERREACTIVITY; PATHOPHYSIOLOGY	Severe asthma is characterised by persistent inflammation, hyperreactivity and remodeling of the airways. No efficient treatment is available, this is particularly the case for steroid resistant phenotypes. Our aim therefore was to develop a preclinical model showing characteristics of severe human asthma including steroid insensitivity. Mice were first sensitized with ovalbumin, extracts of cockroach or house dust mite followed by a challenge period of seven weeks. Further to this, an additional group of mice was sensitized with all three allergens and then challenged with allergen alternating weekly between allergens. All three allergens applied separately to the mice induced comparably strong Th2-type airway inflammation, airway hyperreactivity and airway remodeling, which was characterised by fibrosis and increased smooth muscle thickness. In contrast, application of all three allergens together resulted in a greater Th2 response and increased airway hyperreactivity and a stronger albeit not significant remodeling phenotype compared to using HDM or CRA. In this triple allergen model dexamethasone application, during the last 4 weeks of challenge, showed no suppressive effects on any of these parameters in this model. In contrast, both TLR7 agonist resiquimod and TLR9 agonist CpG-ODN reduced allergen-specific IgE, eosinophils, and collagen I in the lungs. The TLR9 agonist also reduced IL-4 and IL-5 whilst increasing IFN-gamma and strongly IL-10 levels in the lungs, effects not seen with the TLR7 agonist. However, neither TLR agonist had any effect on airway hyperreactivity and airway smooth muscle mass. In conclusion we have developed a severe asthma model, which is steroid resistant and only partially sensitive to TLR7 and TLR9 agonist treatment. This model may be particular useful to test new potential therapeutics aiming at treating steroid resistant asthma in humans and investigating the underlying mechanisms responsible for steroid insensitivity.	[Duechs, Matthias J.; Tilp, Cornelia; Tomsic, Christopher; Gantner, Florian; Erb, Klaus J.] Boehringer Ingelheim Pharma GmbH & Co KG, Resp Dis Res, Biberach, Germany	Boehringer Ingelheim	Erb, KJ (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Resp Dis Res, Biberach, Germany.	klaus.erb@bc.boehringer-ingelheim.com			Boehringer Ingelheim Pharma GmbH Co. KG	Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim)	The work was funded by Boehringer Ingelheim Pharma GmbH & Co. KG. The authors are all employed by BI Pharma. They pay the authors' salaries and pay for the experiments (Material used). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonicelli L, 2004, EUR RESPIR J, V23, P723, DOI 10.1183/09031936.04.00004904; Arizmendi NG, 2011, J IMMUNOL, V186, P3164, DOI 10.4049/jimmunol.0903812; Blacquiere MJ, 2010, INT ARCH ALLERGY IMM, V153, P173, DOI 10.1159/000312635; Boniface S, 2003, CLIN EXP ALLERGY, V33, P1238, DOI 10.1046/j.1365-2222.2003.01762.x; Boulares AH, 2003, AM J RESP CELL MOL, V28, P322, DOI 10.1165/rcmb.2001-0015OC; BRUSSELLE GG, 1994, CLIN EXP ALLERGY, V24, P73, DOI 10.1111/j.1365-2222.1994.tb00920.x; Camateros P, 2007, AM J RESP CRIT CARE, V175, P1241, DOI 10.1164/rccm.200701-054OC; Cho SH, 2005, AM J RESP CRIT CARE, V171, P224, DOI 10.1164/rccm.200310-1416OC; Christensen U, 2006, EUR J HUM GENET, V14, P227, DOI 10.1038/sj.ejhg.5201541; Chung KF, 1999, EUR RESPIR J, V13, P1198; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Doganci A, 2008, J IMMUNOL, V181, P1917, DOI 10.4049/jimmunol.181.3.1917; Du Q, 2009, CLIN EXP PHARMACOL P, V36, P43, DOI 10.1111/j.1440-1681.2008.05027.x; Duechs MJ, 2011, PULM PHARMACOL THER, V24, P203, DOI 10.1016/j.pupt.2010.12.009; Ekman AK, 2011, EUR J PHARMACOL, V652, P145, DOI 10.1016/j.ejphar.2010.11.009; Fanucchi MV, 2004, AM J RESP CRIT CARE, V170, P1153, DOI 10.1164/rccm.200404-533OC; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Goplen N, 2009, J ALLERGY CLIN IMMUN, V123, P925, DOI 10.1016/j.jaci.2009.02.009; Henderson WR, 2006, AM J RESP CRIT CARE, V173, P718, DOI 10.1164/rccm.200501-088OC; Holgate ST, 2011, J ALLERGY CLIN IMMUN, V128, P495, DOI 10.1016/j.jaci.2011.06.052; Jain VV, 2003, AM J PHYSIOL-LUNG C, V285, pL1137, DOI 10.1152/ajplung.00073.2003; Kaufman EH, 2011, J ALLERGY CLIN IMMUN, V127, P462, DOI 10.1016/j.jaci.2010.10.029; Kim J, 2004, AM J PHYSIOL-LUNG C, V287, pL503, DOI 10.1152/ajplung.00433.2003; Koch M, 2006, AM J RESP CELL MOL, V35, P211, DOI 10.1165/rcmb.2005-0293OC; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Li JJ, 2010, J IMMUNOL, V185, P4401, DOI 10.4049/jimmunol.1001039; Van LP, 2011, EUR J IMMUNOL, V41, P1992, DOI 10.1002/eji.201040914; Liu JY, 2001, AM J RESP CELL MOL, V25, P3, DOI 10.1165/ajrcmb.25.1.4481; Matsuse H, 2013, RESPIRATION, V85, P429, DOI 10.1159/000345861; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Mcmillan SJ, 2004, CLIN EXP ALLERGY, V34, P497, DOI 10.1111/j.1365-2222.2004.01895.x; Narala VR, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-90; Quarcoo D, 2004, CLIN EXP ALLERGY, V34, P1314, DOI 10.1111/j.1365-2222.2004.02023.x; Shannon J, 2008, CHEST, V133, P420, DOI 10.1378/chest.07-1881; Tanaka H, 2001, INFLAMM RES, V50, P616, DOI 10.1007/PL00000243; ten Hacken NHT, 1998, EUR RESPIR J, V11, P312, DOI 10.1183/09031936.98.11020312; Therien AG, 2008, AM J RESP CELL MOL, V39, P26, DOI 10.1165/rcmb.2007-0240OC; Trujillo-Vargas CM, 2007, AM J RESP CRIT CARE, V175, P336, DOI 10.1164/rccm.200601-054OC; Ulrich K, 2008, PULM PHARMACOL THER, V21, P637, DOI 10.1016/j.pupt.2008.02.006; Wegmann M, 2005, CLIN EXP ALLERGY, V35, P1263, DOI 10.1111/j.1365-2222.2005.02306.x; Wegmann M, 2007, AM J RESP CELL MOL, V36, P61, DOI 10.1165/rcmb.2006-0188OC; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Wohlleben G, 2004, INT IMMUNOL, V16, P585, DOI 10.1093/intimm/dxh062; Xirakia C, 2010, AM J RESP CRIT CARE, V181, P1207, DOI 10.1164/rccm.200908-1255OC	45	29	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91223	10.1371/journal.pone.0091223	http://dx.doi.org/10.1371/journal.pone.0091223			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618687	Green Submitted, gold, Green Published			2022-12-27	WOS:000332842400058
J	Huang, JL; Huang, YL; Zhang, ZY				Huang, Jinliang; Huang, Yaling; Zhang, Zhenyu			Coupled Effects of Natural and Anthropogenic Controls on Seasonal and Spatial Variations of River Water Quality during Baseflow in a Coastal Watershed of Southeast China	PLOS ONE			English	Article							LAND-USE CHANGE; SURFACE-WATER; TEMPORAL VARIABILITY; PHOSPHORUS TRANSFERS; NITROGEN-SOURCES; QIANTANG RIVER; NITRATE EXPORT; CATCHMENT; STREAMS; PATTERNS	Surface water samples of baseflow were collected from 20 headwater sub-watersheds which were classified into three types of watersheds (natural, urban and agricultural) in the flood, dry and transition seasons during three consecutive years (2010-2012) within a coastal watershed of Southeast China. Integrating spatial statistics with multivariate statistical techniques, river water quality variations and their interactions with natural and anthropogenic controls were examined to identify the causal factors and underlying mechanisms governing spatiotemporal patterns of water quality. Anthropogenic input related to industrial effluents and domestic wastewater, agricultural activities associated with the precipitation-induced surface runoff, and natural weathering process were identified as the potential important factors to drive the seasonal variations in stream water quality for the transition, flood and dry seasons, respectively. All water quality indicators except SRP had the highest mean concentrations in the dry and transition seasons. Anthropogenic activities and watershed characteristics led to the spatial variations in stream water quality in three types of watersheds. Concentrations of NH4+-N, SRP, K+, CODMn, and Cl- were generally highest in urban watersheds. NO3-N Concentration was generally highest in agricultural watersheds. Mg2+ concentration in natural watersheds was significantly higher than that in agricultural watersheds. Spatial autocorrelations analysis showed similar levels of water pollution between the neighboring sub-watersheds exhibited in the dry and transition seasons while non-point source pollution contributed to the significant variations in water quality between neighboring sub-watersheds. Spatial regression analysis showed anthropogenic controls played critical roles in variations of water quality in the JRW. Management implications were further discussed for water resource management. This research demonstrates that the coupled effects of natural and anthropogenic controls involved in watershed processes, contribute to the seasonal and spatial variation of headwater stream water quality in a coastal watershed with high spatial variability and intensive anthropogenic activities.	[Huang, Jinliang] Xiamen Univ, Coastal & Ocean Management Inst, Xiamen, Peoples R China; [Huang, Jinliang; Huang, Yaling; Zhang, Zhenyu] Xiamen Univ, Fujian Prov Key Lab Coastal Ecol & Environm Studi, Xiamen, Peoples R China	Xiamen University; Xiamen University	Huang, JL (corresponding author), Xiamen Univ, Coastal & Ocean Management Inst, Xiamen, Peoples R China.	jlhuang@xmu.edu.cn	Zhang, Zhenyu/W-3603-2019		Natural National Science Foundation of China [40810069004, 40901100]; Science Foundation of Fujian Province [2010Y0064]	Natural National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This study was supported by the Natural National Science Foundation of China (Grant No. 40810069004, Grant No. 40901100), and the Science Foundation of Fujian Province (2010Y0064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn DS, 2005, J HYDROL, V313, P234, DOI 10.1016/j.jhydrol.2005.02.038; Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; ALTMAN SJ, 1995, J ENVIRON QUAL, V24, P707, DOI 10.2134/jeq1995.00472425002400040023x; Baker A, 2003, HYDROL PROCESS, V17, P2499, DOI 10.1002/hyp.5140; Bowes MJ, 2005, SCI TOTAL ENVIRON, V344, P67, DOI 10.1016/j.scitotenv.2005.02.006; Brando PM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0152; Cao WZ, 2006, ENVIRON GEOCHEM HLTH, V28, P45, DOI 10.1007/s10653-005-9010-4; Carey RO, 2011, ECOL INDIC, V11, P1093, DOI 10.1016/j.ecolind.2010.12.009; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Chang H, 2008, WATER RES, V42, P3285, DOI 10.1016/j.watres.2008.04.006; Chang H, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045012; Chen NW, 2008, BIOGEOCHEMISTRY, V87, P169, DOI 10.1007/s10533-007-9175-2; de Souza ALT, 2013, FOREST ECOL MANAG, V298, P12, DOI 10.1016/j.foreco.2013.02.022; Duan SW, 2013, BIOGEOSCIENCES, V10, P1193, DOI 10.5194/bg-10-1193-2013; Duan SW, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001782; Dultz S, 2013, ENVIRON EARTH SCI, V69, P969, DOI 10.1007/s12665-012-1981-8; Edwards AC, 2008, J HYDROL, V350, P144, DOI 10.1016/j.jhydrol.2007.10.053; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Gardner KK, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007029; Haygarth P, 2004, HYDROL EARTH SYST SC, V8, P88, DOI 10.5194/hess-8-88-2004; Hill AR, 1996, J ENVIRON QUAL, V25, P743, DOI 10.2134/jeq1996.00472425002500040014x; House WA, 2003, APPL GEOCHEM, V18, P739, DOI 10.1016/S0883-2927(02)00158-0; Huang JL, 2013, OCEAN COAST MANAGE, V81, P29, DOI 10.1016/j.ocecoaman.2012.09.016; Huang JL, 2012, J COASTAL RES, V28, P930, DOI 10.2112/JCOASTRES-D-11-00176.1; Huang JL, 2013, ENVIRON MANAGE, V51, P32, DOI 10.1007/s00267-011-9793-2; Huang JL, 2012, APPL GEOGR, V34, P371, DOI 10.1016/j.apgeog.2012.01.001; [黄金良 Huang Jinliang], 2004, [水土保持学报, Journal of Soil and Water Conservation], V18, P75; Ishizawa H, 2007, SOC SCI RES, V36, P1042, DOI 10.1016/j.ssresearch.2006.06.005; Jarvie HP, 2006, SCI TOTAL ENVIRON, V360, P246, DOI 10.1016/j.scitotenv.2005.08.038; Jarvie HP, 2002, REG ENVIRON CHANGE, V3, P36, DOI 10.1007/s10113-001-0036-6; JONES DP, 1993, SOIL SCI SOC AM J, V57, P256, DOI 10.2136/sssaj1993.03615995005700010044x; Jordan P, 2007, HYDROL EARTH SYST SC, V11, P372, DOI 10.5194/hess-11-372-2007; Kannel PR, 2007, ENVIRON MONIT ASSESS, V129, P433, DOI 10.1007/s10661-006-9375-6; Kaushal SS, 2008, ENVIRON SCI TECHNOL, V42, P5872, DOI 10.1021/es800264f; Kney AD, 2007, J ENVIRON MANAGE, V82, P519, DOI 10.1016/j.jenvman.2006.01.014; Ko KS, 2009, GEOSCI J, V13, P191, DOI 10.1007/s12303-009-0019-z; Lee SW, 2009, LANDSCAPE URBAN PLAN, V92, P80, DOI 10.1016/j.landurbplan.2009.02.008; Li SY, 2013, PLOS ONE; Line DE, 2013, ENVIRON MONIT ASSESS, V185, P6277, DOI 10.1007/s10661-012-3024-z; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Martin C, 2004, HYDROL PROCESS, V18, P1237, DOI 10.1002/hyp.1395; May L, 2001, SCI TOTAL ENVIRON, V269, P117, DOI 10.1016/S0048-9697(00)00820-2; MEP, 2011, REP STAT ENV CHIN 20; Mitchell, 2001, HYDROLOGICAL PROCESS, V15, P3305; Mouri G, 2011, J ENVIRON MANAGE, V92, P1837, DOI 10.1016/j.jenvman.2011.03.005; Neal EG, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042385; Ouyang Y, 2006, WATER RES, V40, P3800, DOI 10.1016/j.watres.2006.08.030; Paerl HW, 2006, ECOL ENG, V26, P40, DOI 10.1016/j.ecoleng.2005.09.006; Pasieczna A, 2008, GEOCHEM-EXPLOR ENV A, V8, P323, DOI 10.1144/1467-7873/08-180; Pauwels H, 2001, APPL GEOCHEM, V16, P583, DOI 10.1016/S0883-2927(00)00062-7; Peterson BJ, 2001, SCIENCE, V292, P86, DOI 10.1126/science.1056874; Petry J, 2002, SCI TOTAL ENVIRON, V294, P95, DOI 10.1016/S0048-9697(02)00058-X; Porter-Goff ER, 2013, ECOL INDIC, V32, P97, DOI 10.1016/j.ecolind.2013.03.017; Pratt B, 2012, J HAZARD MATER, V209, P48, DOI 10.1016/j.jhazmat.2011.12.068; Randhir TO, 2009, J HYDROL, V364, P182, DOI 10.1016/j.jhydrol.2008.10.017; Redman CL, 1999, ECOSYSTEMS, V2, P296, DOI 10.1007/s100219900079; Rothwell JJ, 2010, SCI TOTAL ENVIRON, V408, P841, DOI 10.1016/j.scitotenv.2009.10.041; Sliva L, 2001, WATER RES, V35, P3462, DOI 10.1016/S0043-1354(01)00062-8; Smith AJ, 2013, ECOL INDIC, V29, P455, DOI 10.1016/j.ecolind.2013.01.021; Somura H, 2012, J HYDROL, V450, P25, DOI 10.1016/j.jhydrol.2012.05.032; St Laurent J, 2014, WATER RES, V48, P170, DOI 10.1016/j.watres.2013.09.031; State Environmental Protection Administrator of China (SEPAC), 2002, METH MON AN WAT WAST; Su SL, 2013, REG ENVIRON CHANGE, V13, P77, DOI 10.1007/s10113-012-0313-6; Su SL, 2013, ECOL INDIC, V24, P375, DOI 10.1016/j.ecolind.2012.07.015; Sun RH, 2013, J AM WATER RESOUR AS, V49, P741, DOI 10.1111/jawr.12033; Swaney DP, 2012, CURR OPIN ENV SUST, V4, P203, DOI 10.1016/j.cosust.2012.03.004; Tu J, 2008, SCI TOTAL ENVIRON, V407, P358, DOI 10.1016/j.scitotenv.2008.09.031; Tu J, 2013, ENVIRON MANAGE, V51, P1, DOI 10.1007/s00267-011-9738-9; UN-WWAP, 2009, 3 UN WWAP; VanLandeghem MM, 2012, WATER RES, V46, P6638, DOI 10.1016/j.watres.2012.05.002; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Weller DE, 2003, ESTUARIES, V26, P244, DOI 10.1007/BF02695965; Willett VB, 2004, J ENVIRON QUAL, V33, P201, DOI 10.2134/jeq2004.0201; Worrall F, 2001, J HYDROL, V243, P228, DOI 10.1016/S0022-1694(00)00411-X; Yang XY, 2010, J ENVIRON MANAGE, V91, P1943, DOI 10.1016/j.jenvman.2010.04.011; Yin XM, 2012, J FOOD AGRIC ENVIRON, V10, P1214; Zhou F, 2007, WATER RES, V41, P3429, DOI 10.1016/j.watres.2007.04.022	77	36	39	6	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91528	10.1371/journal.pone.0091528	http://dx.doi.org/10.1371/journal.pone.0091528			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618771	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400100
J	Makela, JA; Toppari, J; Rivero-Muller, A; Ventela, S				Makela, Juho-Antti; Toppari, Jorma; Rivero-Muller, Adolfo; Ventela, Sami			Reconstruction of Mouse Testicular Cellular Microenvironments in Long-Term Seminiferous Tubule Culture	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; PERITUBULAR MYOID CELLS; UNDIFFERENTIATED SPERMATOGONIA; GENE-EXPRESSION; SERTOLI-CELLS; GERMLINE TRANSMISSION; EPITHELIAL CYCLE; DEFINED STAGES; SELF-RENEWAL; IN-VIVO	Research on spermatogonia is hampered by complex architecture of the seminiferous tubule, poor viability of testicular tissue ex vivo and lack of physiologically relevant long-term culture systems. Therefore there is a need for an in vitro model that would enable long term survival and propagation of spermatogonia. We aimed at the most simplified approach to enable all different cell types within the seminiferous tubules to contribute to the creation of a niche for spermatogonia. In the present study we describe the establishment of a co-culture of mouse testicular cells that is based on proliferative and migratory activity of seminiferous tubule cells and does not involve separation, purification or differential plating of individual cell populations. The co-culture is composed of the constituents of testicular stem cell niche: Sertoli cells [identified by expression of Wilm's tumour antigen 1 (WT1) and secretion of glial cell line-derived neurotrophic factor, GDNF], peritubular myoid cells (expressing alpha smooth muscle actin, alpha SMA) and spermatogonia [expressing MAGE-B4, PLZF (promyelocytic leukaemia zinc finger), LIN28, Gpr125 (G protein-coupled receptor 125), CD9, c-Kit and Nanog], and can be maintained for at least five weeks. GDNF was found in the medium at a sufficient concentration to support proliferating spermatogonial stem cells (SSCs) that were able to start spermatogenic differentiation after transplantation to an experimentally sterile recipient testis. Gdnf mRNA levels were elevated by follicle-stimulating hormone (FSH) which shows that the Sertoli cells in the co-culture respond to physiological stimuli. After approximately 2-4 weeks of culture a spontaneous formation of cord-like structures was monitored. These structures can be more than 10 mm in length and branch. They are formed by peritubular myoid cells, Sertoli cells, fibroblasts and spermatogonia as assessed by gene expression profiling. In conclusion, we have managed to establish in vitro conditions that allow spontaneous reconstruction of testicular cellular microenvironments.	[Makela, Juho-Antti; Toppari, Jorma; Rivero-Muller, Adolfo; Ventela, Sami] Univ Turku, Dept Physiol, Turku, Finland; [Makela, Juho-Antti; Toppari, Jorma] Univ Turku, Dept Paediat, Turku, Finland; [Ventela, Sami] Turku Univ Hosp, Dept Otorhinolaryngol, FIN-20520 Turku, Finland; [Makela, Juho-Antti] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia	University of Turku; University of Turku; University of Turku; Australian Regenerative Medicine Institute; Monash University	Makela, JA (corresponding author), Univ Turku, Dept Physiol, Turku, Finland.	juho.makela@monash.edu	Rivero-Muller, Adolfo/A-5120-2008; Ventela, Sami/I-7253-2018	Rivero-Muller, Adolfo/0000-0002-9794-802X; Ventela, Sami/0000-0001-6672-6662	Sigrid Juselius Foundation; Emil Aaltonen's Foundation; Finnish Cultural Foundation; Finnish Medical Foundation; Academy of Finland; Turku University Hospital	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Emil Aaltonen's Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Medical Foundation; Academy of Finland(Academy of Finland); Turku University Hospital	This work was supported by grants from Sigrid Juselius Foundation (http://www.sigridjuselius.fi), Emil Aaltonen's Foundation (http://www.emilaaltonen.fi), Finnish Cultural Foundation (www.skr.fi), The Finnish Medical Foundation (http://www.laaketieteensaatio.fi), The Academy of Finland (www.aka.fi) and Turku University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JF, 1993, MECH DEVELOP, V40, P85, DOI 10.1016/0925-4773(93)90090-K; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; BUCCI LR, 1987, MUTAT RES, V176, P259, DOI 10.1016/0027-5107(87)90057-1; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; Chiarini-Garcia H, 2003, REPRODUCTION, V126, P669, DOI 10.1530/reprod/126.5.669; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1170, DOI 10.1095/biolreprod65.4.1170; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1179, DOI 10.1095/biolreprod65.4.1179; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; EDDY EM, 1976, ANAT REC, V185, P333, DOI 10.1002/ar.1091850307; Gassei K, 2006, J ANDROL, V27, P611, DOI 10.2164/jandrol.05207; Giuili G, 2002, EMBO REP, V3, P753, DOI 10.1093/embo-reports/kvf149; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; HADLEY MA, 1990, DEV BIOL, V140, P318, DOI 10.1016/0012-1606(90)90082-T; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; Kossack N, 2009, STEM CELLS, V27, P138, DOI 10.1634/stemcells.2008-0439; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; La Salle S, 2009, METHODS MOL BIOL, V558, P279, DOI 10.1007/978-1-60761-103-5_17; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makela JA, 2011, REPRODUCTION, V142, P711, DOI 10.1530/REP-11-0110; MARUYAMA I, 1985, J CELL BIOL, V101, P363, DOI 10.1083/jcb.101.2.363; Meachem SJ, 2005, J ENDOCRINOL, V186, P429, DOI 10.1677/joe.1.06121; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Osterlund C, 2000, CANCER RES, V60, P1054; Pan F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060054; Rahimi N, 1999, MOL BIOL CELL, V10, P3401, DOI 10.1091/mbc.10.10.3401; Rossi F, 2002, ENDOCRINOLOGY, V143, P3096, DOI 10.1210/en.143.8.3096; Sato T, 2013, NAT PROTOC, V8, P2098, DOI 10.1038/nprot.2013.138; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; SKINNER MK, 1989, MOL ENDOCRINOL, V3, P625, DOI 10.1210/mend-3-4-625; Sonne SB, 2006, VIRCHOWS ARCH, V449, P200, DOI 10.1007/s00428-006-0223-4; SORRENTINO V, 1991, ONCOGENE, V6, P149; Steger K, 1996, INT J ANDROL, V19, P122, DOI 10.1111/j.1365-2605.1996.tb00448.x; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; TOPPARI J, 1985, J ANDROL, V6, P334; TOPPARI J, 1986, J ENDOCRINOL, V108, P417, DOI 10.1677/joe.0.1080417; TOPPARI J, 1985, J ANDROL, V6, P325; TUNG PS, 1980, BIOL REPROD, V23, P207, DOI 10.1093/biolreprod/23.1.207; TUNG PS, 1990, BIOL REPROD, V42, P351, DOI 10.1095/biolreprod42.2.351; Ventea S, 2012, STEM CELLS, V30, P1008, DOI 10.1002/stem.1077; Ventela S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033209; Yamamoto K, 1998, BLOOD, V92, P2791, DOI 10.1182/blood.V92.8.2791.420k24_2791_2801; Yokonishi T, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108613; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; ZENZES MT, 1981, DIFFERENTIATION, V20, P157, DOI 10.1111/j.1432-0436.1981.tb01170.x; Zhang FP, 2003, P NATL ACAD SCI USA, V100, P13692, DOI 10.1073/pnas.2232815100; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38; Zhou Q, 2008, BIOL REPROD, V79, P35, DOI 10.1095/biolreprod.107.066795	61	20	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90088	10.1371/journal.pone.0090088	http://dx.doi.org/10.1371/journal.pone.0090088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619130	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400009
J	Mao, LG; Wang, QX; Yan, DD; Ma, TT; Liu, PF; Shen, J; Li, Y; Ouyang, CB; Guo, MX; Cao, AC				Mao, Liangang; Wang, Qiuxia; Yan, Dongdong; Ma, Taotao; Liu, Pengfei; Shen, Jin; Li, Yuan; Ouyang, Canbin; Guo, Meixia; Cao, Aocheng			Evaluation of Chloropicrin as a Soil Fumigant against Ralstonia solanacarum in Ginger (Zingiber officinale Rosc.) Production in China	PLOS ONE			English	Article							METHYL-BROMIDE ALTERNATIVES; SOILBORNE DISEASE; TOMATO; EFFICACY; PEPPER; COMBINATIONS; MANAGEMENT; NEMATODE; FILMS; WEED	Background: Chloropicrin (Pic) offers a potential alternative to methyl bromide (MB) against Ralstonia solanacarum in ginger (Zingiber officinale Rosc.) production. MB is scheduled to be withdrawn from routine use by 2015 in developing countries. Methods: Pic treatments were evaluated in a laboratory study and in three commercial ginger fields. Results: Laboratory studies showed that the EC50 value and EC80 value of Pic were 2.7 and 3.7 mg a.i. kg(-1) soil, respectively. Field trials in highly infested soil revealed that treatments of Pic at the dose of 50 g m(-2) covered with totally impermeable film (TIF) or polyethylene film (PE) sharply reduced Ralstonia solanacarum and maintained high ginger yields. Both of the Pic treatments provided results similar to, or in some cases slightly lower than, MB with respect to Ralstonia solanacarum control, plant survival, plant growth and yield. All of the fumigant treatments were significantly better than the non-treated control. Conclusions: The present study confirms that the Pic is a promising alternative with good efficacy against Ralstonia solanacarum for ginger production and could be used in integrated pest management programs in China.	[Mao, Liangang; Wang, Qiuxia; Yan, Dongdong; Ma, Taotao; Liu, Pengfei; Shen, Jin; Li, Yuan; Ouyang, Canbin; Guo, Meixia; Cao, Aocheng] Chinese Acad Agr Sci, Minist Agr, Inst Plant Protect, Dept Pesticides, Beijing 100193, Peoples R China; [Wang, Qiuxia; Yan, Dongdong; Li, Yuan; Ouyang, Canbin; Guo, Meixia; Cao, Aocheng] State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs	Cao, AC (corresponding author), Chinese Acad Agr Sci, Minist Agr, Inst Plant Protect, Dept Pesticides, Beijing 100193, Peoples R China.	caoac@vip.sina.com	yan, dongdong/M-4629-2017	Yan, Dongdong/0000-0002-8196-4615	Program on Substituted Technology for Methyl Bromide in China (Special Finance of Chinese Ministry of Agriculture) [2110402]; UNDIO Project on Phasing-out of Methyl Bromide in Agriculture Sector in China [TF/CPR-A/08/003]	Program on Substituted Technology for Methyl Bromide in China (Special Finance of Chinese Ministry of Agriculture); UNDIO Project on Phasing-out of Methyl Bromide in Agriculture Sector in China	This research was supported by the Program on Substituted Technology for Methyl Bromide in China (Special Finance of Chinese Ministry of Agriculture, 2110402) and UNDIO Project on Phasing-out of Methyl Bromide in Agriculture Sector in China (TF/CPR-A/08/003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell CH, 2000, CROP PROT, V19, P563, DOI 10.1016/S0261-2194(00)00073-9; Bringhurst RS, 1960, CALIFORNIA STRAWBEER, V7; Cao AC, 2014, PEST MANAG SCI, V70, P219, DOI 10.1002/ps.3535; Csinos AS, 1997, CROP PROT, V16, P585, DOI 10.1016/S0261-2194(97)00025-2; Desaeger JA, 2008, PEST MANAG SCI, V64, P230, DOI 10.1002/ps.1503; Dow AgroSciences, 2014, TEL SOIL FUM GUID AP; Fennimore SA, 2005, P ANN INT RES C METH, P1; Food and Agriculture Organization of the United Nations (FAO), 2013, FAOSTAT AGR; Gilreath JP, 2008, CROP PROT, V27, P648, DOI 10.1016/j.cropro.2007.09.008; Gilreath JP, 2005, CROP PROT, V24, P903, DOI 10.1016/j.cropro.2005.01.016; Gilreath JP, 2005, CROP PROT, V24, P285, DOI 10.1016/j.cropro.2004.08.008; Gilreath JP, 2004, CROP PROT, V23, P1193, DOI 10.1016/j.cropro.2004.03.020; Gullino ML, 2002, CROP PROT, V21, P741, DOI 10.1016/S0261-2194(02)00031-5; Hutchinson CM, 2000, PEST MANAG SCI, V56, P413, DOI 10.1002/(SICI)1526-4998(200005)56:5<413::AID-PS140>3.0.CO;2-J; KELMAN A, 1954, PHYTOPATHOLOGY, V44, P693; Klose S, 2006, SOIL BIOL BIOCHEM, V38, P1243, DOI 10.1016/j.soilbio.2005.09.025; Lombardo S, 2012, CROP PROT, V37, P59, DOI 10.1016/j.cropro.2012.02.010; Mao LG, 2012, PEST MANAG SCI, V68, P602, DOI 10.1002/ps.2303; Margesin R., 2005, MANUAL SOIL ANAL MON, P47; McKinney HH, 1923, J AGRIC RES, V26, P0195; Nelson D. W., 1985, METHODS SOIL ANAL, P539; Ou LT, 2008, J ENVIRON SCI HEAL B, V43, P376, DOI 10.1080/03601230802062018; Santos BM, 2006, CROP PROT, V25, P690, DOI 10.1016/j.cropro.2005.09.015; Schinner F., 1995, METHODS SOIL BIOL, P386; Steel R.G., 1980, PRINCIPLES PROCEDURE, P481; Stewart ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084168; Wang QX, 2010, J ENVIRON QUAL, V39, P917, DOI 10.2134/jeq2009.0342; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897, DOI 10.1111/j.1348-0421.1995.tb03275.x; Yan DD, 2012, J AGR FOOD CHEM, V60, P5023, DOI 10.1021/jf300532x	29	26	32	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91767	10.1371/journal.pone.0091767	http://dx.doi.org/10.1371/journal.pone.0091767			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618853	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400125
J	Lim, JS; Park, YH; Jang, JW; Park, SY; Kim, S				Lim, Jae-Sung; Park, Young Ho; Jang, Jae-Won; Park, So Yong; Kim, SangYun		Alzheimers Dis Neuroimaging	Differential White Matter Connectivity in Early Mild Cognitive Impairment According to CSF Biomarkers	PLOS ONE			English	Article							ALZHEIMERS ASSOCIATION WORKGROUPS; CEREBROSPINAL-FLUID; DIAGNOSTIC GUIDELINES; PHOSPHORYLATED TAU; NATIONAL INSTITUTE; DISEASE; RECOMMENDATIONS; A-BETA(1-42); INTEGRITY; DEMENTIA	Mild cognitive impairment (MCI) is a heterogeneous group and certain MCI subsets eventually convert to dementia. Cerebrospinal fluid (CSF) biomarkers are known to predict this conversion. We sought evidence for the differences in white matter connectivity between early amnestic MCI (EMCI) subgroups according to a CSF phosphorylated tau(181p)/amyloid beta(1-42) ratio of 0.10. From the Alzheimer's Disease Neuroimaging Initiative database, 16 high-ratio, 25 low-ratio EMCI patients, and 20 normal controls with diffusion tensor images and CSF profiles were included. Compared to the high-ratio group, radial diffusivity significantly increased in both sides of the corpus callosum and the superior and inferior longitudinal fasciculus in the low-ratio group. In widespread white matter skeleton regions, the low-ratio group showed significantly increased mean, axial, and radial diffusivity compared to normal controls. However, the high-ratio group showed no differences when compared to the normal group. In conclusion, our study revealed that there were significant differences in white matter connectivity between EMCI subgroups according to CSF phosphorylated tau(181p)/amyloid beta(1-42) ratios.	[Lim, Jae-Sung] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Neurol, Seoul, South Korea; [Park, Young Ho; Jang, Jae-Won; Park, So Yong; Kim, SangYun] Seoul Natl Univ, Bundang Hosp, Clin Neurosci Ctr, Songnam, South Korea; [Lim, Jae-Sung; Park, Young Ho; Jang, Jae-Won; Park, So Yong; Kim, SangYun] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Clin Neurosci Ctr, Songnam, South Korea.	neuroksy@snu.ac.kr	Lim, Jae-Sung/D-5555-2012	Lim, Jae-Sung/0000-0001-6157-2908	Alzheimer's Disease Neuroimaging Initiative (ADNI) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADNI, 2011, ADNI GO PROC MAN, P83; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Albin RL, 2013, J NUCL MED, V54, P887, DOI 10.2967/jnumed.112.112599; Amlien IK, 2013, RADIOLOGY, V266, P295, DOI 10.1148/radiol.12120319; Arenaza-Urquijo EM, 2011, AM J GERIAT PSYCHIAT, V19, P33, DOI 10.1097/JGP.0b013e3181e448e1; Benitez A, 2014, NEUROIMAGE-CLIN, V4, P64, DOI 10.1016/j.nicl.2013.11.001; Bozzali M, 2011, NEUROIMAGE, V54, P2045, DOI 10.1016/j.neuroimage.2010.08.069; Buchhave P, 2012, ARCH GEN PSYCHIAT, V69, P98, DOI 10.1001/archgenpsychiatry.2011.155; Chetelat G, 2013, NAT REV NEUROL, V9, P123, DOI [10.1038/nrneurol.2013.21, 10.1038/nrneurol.2013.21-c2]; Chiang GC, 2012, AM J NEURORADIOL, V33, P1392, DOI 10.3174/ajnr.A2984; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Clerx L, 2012, J ALZHEIMERS DIS, V29, P405, DOI 10.3233/JAD-2011-110797; Dimitra S, 2013, ACTA NEUROL BELG, V113, P441, DOI 10.1007/s13760-013-0197-3; Esposito R, 2013, PEERJ, V1, DOI 10.7717/peerj.135; Fieremans E, 2013, AM J NEURORADIOL, V34, P2105, DOI 10.3174/ajnr.A3553; Fischer P, 2007, NEUROLOGY, V68, P288, DOI 10.1212/01.wnl.0000252358.03285.9d; Hampel H, 2003, BRAIN RES BULL, V61, P243, DOI 10.1016/S0361-9230(03)00087-X; Jack CR, 2012, ANN NEUROL, V71, P765, DOI 10.1002/ana.22628; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Knopman DS, 2013, ANN NEUROL, V73, P472, DOI 10.1002/ana.23816; Landau SM, 2013, ANN NEUROL, V74, P826, DOI 10.1002/ana.23908; Lehmann M, 2013, BRAIN, V136, P844, DOI 10.1093/brain/aws327; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nir TM, 2013, NEUROIMAGE-CLIN, V3, P180, DOI 10.1016/j.nicl.2013.07.006; O'Dwyer L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021745; Parnetti L, 2012, J ALZHEIMERS DIS, V29, P229, DOI 10.3233/JAD-2011-111349; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Sexton CE, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.019; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sjogren M, 2001, CLIN CHEM, V47, P1776; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Thillainadesan S, 2012, INT PSYCHOGERIATR, V24, P1483, DOI 10.1017/S1041610212000270; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068	38	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91400	10.1371/journal.pone.0091400	http://dx.doi.org/10.1371/journal.pone.0091400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614676	Green Submitted, gold, Green Published			2022-12-27	WOS:000332839300119
J	Tseng, HY; Lin, CP; Hsu, JY; Pike, DA; Huang, WS				Tseng, Hui-Yun; Lin, Chung-Ping; Hsu, Jung-Ya; Pike, David A.; Huang, Wen-San			The Functional Significance of Aposematic Signals: Geographic Variation in the Responses of Widespread Lizard Predators to Colourful Invertebrate Prey	PLOS ONE			English	Article							BATESIAN MIMICRY; SEXUAL DICHROMATISM; NATURAL-SELECTION; WARNING SIGNALS; AVIAN PREDATORS; BIRD PREDATORS; AVOIDANCE; PATTERNS; COLORATION; BEETLES	Conspicuous colouration can evolve as a primary defence mechanism that advertises unprofitability and discourages predatory attacks. Geographic overlap is a primary determinant of whether individual predators encounter, and thus learn to avoid, such aposematic prey. We experimentally tested whether the conspicuous colouration displayed by Old World pachyrhynchid weevils (Pachyrhynchus tobafolius and Kashotonus multipunctatus) deters predation by visual predators (Swinhoe's tree lizard; Agamidae, Japalura swinhonis). During staged encounters, sympatric lizards attacked weevils without conspicuous patterns at higher rates than weevils with intact conspicuous patterns, whereas allopatric lizards attacked weevils with intact patterns at higher rates than sympatric lizards. Sympatric lizards also attacked masked weevils at lower rates, suggesting that other attributes of the weevils (size/shape/smell) also facilitate recognition. Allopatric lizards rapidly learned to avoid weevils after only a single encounter, and maintained aversive behaviours for more than three weeks. The imperfect ability of visual predators to recognize potential prey as unpalatable, both in the presence and absence of the aposematic signal, may help explain how diverse forms of mimicry exploit the predator's visual system to deter predation.	[Tseng, Hui-Yun; Lin, Chung-Ping] Tunghai Univ, Dept Life Sci, Taichung, Taiwan; [Tseng, Hui-Yun; Hsu, Jung-Ya; Huang, Wen-San] Natl Museum Nat Sci, Dept Biol, Taichung, Taiwan; [Lin, Chung-Ping] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Pike, David A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Pike, David A.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Townsville, Qld 4811, Australia; [Huang, Wen-San] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan	Tunghai University; National Taiwan Normal University; James Cook University; James Cook University; National Chung Hsing University	Lin, CP (corresponding author), Tunghai Univ, Dept Life Sci, Taichung, Taiwan.	treehops@thu.edu.tw; wshuang@mail.nmns.edu.tw	Pike, David A/B-2032-2012	Huang, Wen-San/0000-0003-0073-3557	National Science Council of Taiwan, Taiwan [NSC 99-2621-B-178-001-MY3, NSC 100-2311-B-029-004-MY3]	National Science Council of Taiwan, Taiwan(Ministry of Science and Technology, Taiwan)	This paper is supported by the National Science Council of Taiwan (NSC 99-2621-B-178-001-MY3 and NSC 100-2311-B-029-004-MY3), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrou MA, 2011, NATURE, V469, P84, DOI 10.1038/nature09660; Aronsson M, 2012, ANIM BEHAV, V84, P881, DOI 10.1016/j.anbehav.2012.07.011; Borer M, 2010, EVOLUTION, V64, P3629, DOI 10.1111/j.1558-5646.2010.01137.x; Chouteau M, 2011, AM NAT, V178, P810, DOI 10.1086/662667; Cogliati KM, 2010, ETHOLOGY, V116, P416, DOI 10.1111/j.1439-0310.2010.01755.x; COOPER WE, 1989, COPEIA, P472, DOI 10.2307/1445446; COOPER WE, 1994, ETHOLOGY, V97, P317; Dolenska M, 2009, BIOL J LINN SOC, V98, P234, DOI 10.1111/j.1095-8312.2009.01277.x; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; Endler JA, 2009, AM NAT, V173, pE62, DOI 10.1086/596528; Exnerova A, 2007, BEHAV ECOL, V18, P148, DOI 10.1093/beheco/arl061; Finkbeiner SD, 2012, P ROY SOC B-BIOL SCI, V279, P2769, DOI 10.1098/rspb.2012.0203; Gamberale-Stille G, 1999, EVOL ECOL, V13, P579, DOI 10.1023/A:1006741626575; GITTLEMAN JL, 1980, NATURE, V286, P149, DOI 10.1038/286149a0; Ham AD, 2006, BEHAV ECOL SOCIOBIOL, V60, P482, DOI 10.1007/s00265-006-0190-4; HASEGAWA M, 1994, J ETHOL, V12, P9, DOI 10.1007/BF02350074; Heiling AM, 2003, NATURE, V421, P334, DOI 10.1038/421334a; Holloway G.J., 1991, Chemoecology, V2, P7, DOI 10.1007/BF01240660; Huang WS, 2007, ZOOL SCI, V24, P181, DOI 10.2108/zsj.24.181; Hunter JS, 2009, BEHAV ECOL, V20, P1315, DOI 10.1093/beheco/arp144; JEFFORDS MR, 1979, EVOLUTION, V33, P275, DOI 10.1111/j.1558-5646.1979.tb04681.x; KANEHISA K, 1977, Applied Entomology and Zoology, V12, P225; Kapan DD, 2001, NATURE, V409, P338, DOI 10.1038/35053066; Kikuchi DW, 2010, AM NAT, V176, P830, DOI 10.1086/657041; Kodric-Brown A, 1998, AM ZOOL, V38, P70; Kuchta SR, 2008, EVOLUTION, V62, P984, DOI 10.1111/j.1558-5646.2008.00338.x; Langham GM, 2004, EVOLUTION, V58, P2783; Lindstedt C, 2008, ANIM BEHAV, V75, P1703, DOI 10.1016/j.anbehav.2007.10.024; LINSLEY EG, 1959, ANNU REV ENTOMOL, V4, P99, DOI 10.1146/annurev.en.04.010159.000531; Lynn SK, 2005, ANIM BEHAV, V70, P1221, DOI 10.1016/j.anbehav.2005.03.010; Maan ME, 2012, AM NAT, V179, pE1, DOI 10.1086/663197; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Marples NM, 1998, OIKOS, V83, P161, DOI 10.2307/3546557; Merrill RM, 2012, P ROY SOC B-BIOL SCI, V279, P4907, DOI 10.1098/rspb.2012.1968; Noonan BP, 2009, BIOL LETTERS, V5, P51, DOI 10.1098/rsbl.2008.0586; PASTEELS JM, 1983, ANNU REV ENTOMOL, V28, P263, DOI 10.1146/annurev.en.28.010183.001403; Pekar S, 2011, INVERTEBR BIOL, V130, P83, DOI 10.1111/j.1744-7410.2010.00217.x; Pfennig DW, 2001, NATURE, V410, P323, DOI 10.1038/35066628; Prudic KL, 2007, BEHAV ECOL, V18, P41, DOI 10.1093/beheco/arl046; REICHSTE.T, 1968, SCIENCE, V161, P861, DOI 10.1126/science.161.3844.861; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Saporito RA, 2007, COPEIA, P1006, DOI 10.1643/0045-8511(2007)7[1006:EEFAIT]2.0.CO;2; Schultze W., 1923, Philippine Journal of Science, V23, P609; Seago AE, 2009, J R SOC INTERFACE, V6, pS165, DOI 10.1098/rsif.2008.0354.focus; Shen T-J, 2009, ROLES CHEM VISUAL SE; Siddall EC, 2008, BEHAV ECOL, V19, P425, DOI 10.1093/beheco/arm155; SILLENTULLBERG B, 1985, OECOLOGIA, V67, P411, DOI 10.1007/BF00384948; SMITH SM, 1977, NATURE, V265, P535, DOI 10.1038/265535a0; Speed MP, 2000, ANIM BEHAV, V60, P269, DOI 10.1006/anbe.2000.1430; Starr Christopher K., 1992, Journal of Taiwan Museum, V45, P5; Svadova K, 2009, ANIM BEHAV, V77, P327, DOI 10.1016/j.anbehav.2008.09.034; TERRICK TD, 1995, ANIM BEHAV, V49, P857, DOI 10.1006/anbe.1995.0118; Tso IM, 2006, BEHAV ECOL, V17, P606, DOI 10.1093/beheco/ark010; Valkonen JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022272; Vesely P, 2013, ETHOLOGY, V119, P138, DOI 10.1111/eth.12045; Vitt L. J., 2013, HERPETOLOGY INTRO BI; Wallace A. R., 1895, NATURAL SELECTION TR; Wallace AR, 1889, DARWINISM; Welch V, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041919	59	30	32	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91777	10.1371/journal.pone.0091777	http://dx.doi.org/10.1371/journal.pone.0091777			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614681	gold, Green Published, Green Accepted			2022-12-27	WOS:000332839300158
J	Uzer, G; Pongkitwitoon, S; Ian, C; Thompson, WR; Rubin, J; Chan, ME; Judex, S				Uzer, Gunes; Pongkitwitoon, Suphannee; Ian, Cheng; Thompson, William R.; Rubin, Janet; Chan, Meilin E.; Judex, Stefan			Gap Junctional Communication in Osteocytes Is Amplified by Low Intensity Vibrations In Vitro	PLOS ONE			English	Article							FLUID SHEAR-STRESS; MESENCHYMAL STEM-CELLS; HIGH-FREQUENCY VIBRATION; BONE-CELLS; OSTEOBLASTIC CELLS; MECHANICAL-STRESS; TRABECULAR BONE; LOW-MAGNITUDE; INTERCELLULAR COMMUNICATION; CONNEXIN-43 HEMICHANNELS	The physical mechanism by which cells sense high-frequency mechanical signals of small magnitude is unknown. During exposure to vibrations, cell populations within a bone are subjected not only to acceleratory motions but also to fluid shear as a result of fluid-cell interactions. We explored displacements of the cell nucleus during exposure to vibrations with a finite element (FE) model and tested in vitro whether vibrations can affect osteocyte communication independent of fluid shear. Osteocyte like MLO-Y4 cells were subjected to vibrations at acceleration magnitudes of 0.15 g and 1 g and frequencies of 30 Hz and 100 Hz. Gap junctional intracellular communication (GJIC) in response to these four individual vibration regimes was investigated. The FE model demonstrated that vibration induced dynamic accelerations caused larger relative nuclear displacement than fluid shear. Across the four regimes, vibrations significantly increased GJIC between osteocytes by 25%. Enhanced GJIC was independent of vibration induced fluid shear; there were no differences in GJIC between the four different vibration regimes even though differences in fluid shear generated by the four regimes varied 23-fold. Vibration induced increases in GJIC were not associated with altered connexin 43 (Cx43) mRNA or protein levels, but were dependent on Akt activation. Combined, the in silico and in vitro experiments suggest that externally applied vibrations caused nuclear motions and that large differences in fluid shear did not influence nuclear motion (<1%) or GJIC, perhaps indicating that vibration induced nuclear motions may directly increase GJIC. Whether the increase in GJIC is instrumental in modulating anabolic and anti-catabolic processes associated with the application of vibrations remains to be determined.	[Uzer, Gunes; Pongkitwitoon, Suphannee; Ian, Cheng; Chan, Meilin E.; Judex, Stefan] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Uzer, Gunes; Thompson, William R.; Rubin, Janet] Univ N Carolina, Dept Med, Chapel Hill, NC USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of North Carolina; University of North Carolina Chapel Hill	Judex, S (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	stefan.judex@stonybrook.edu	Thompson, William R./B-2658-2009	Thompson, William R./0000-0002-7022-585X; Uzer, Gunes/0000-0002-1178-4942	NIBIB (NIH); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR064133] Funding Source: NIH RePORTER	NIBIB (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was kindly funded by NIBIB (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai ZW, 2000, J CLIN INVEST, V105, P161, DOI 10.1172/JCI7798; Ajubi NE, 1999, AM J PHYSIOL-ENDOC M, V276, pE171, DOI 10.1152/ajpendo.1999.276.1.E171; Alford AI, 2003, BONE, V33, P64, DOI 10.1016/S8756-3282(03)00167-4; Bacabac RG, 2004, BIOCHEM BIOPH RES CO, V315, P823, DOI 10.1016/j.bbrc.2004.01.138; Bacabac RG, 2006, FASEB J, V20, P858, DOI 10.1096/fj.05-4966.com; Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599; Batra N, 2012, BBA-BIOMEMBRANES, V1818, P1909, DOI 10.1016/j.bbamem.2011.09.018; Batra N, 2012, P NATL ACAD SCI USA, V109, P3359, DOI 10.1073/pnas.1115967109; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Chan ME, 2009, CELL MOL BIOENG, V2, P405, DOI 10.1007/s12195-009-0075-5; Cheng BX, 2001, J BONE MINER RES, V16, P249, DOI 10.1359/jbmr.2001.16.2.249; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Cherian PP, 2003, J BIOL CHEM, V278, P43146, DOI 10.1074/jbc.M302993200; CIVITELLI R, 1993, J CLIN INVEST, V91, P1888, DOI 10.1172/JCI116406; Coughlin TR, 2012, J BIOMECH, V45, P2222, DOI 10.1016/j.jbiomech.2012.06.020; Darling EM, 2008, J BIOMECH, V41, P454, DOI 10.1016/j.jbiomech.2007.06.019; DICK DAT, 1970, J PHYSIOL-LONDON, V210, P305, DOI 10.1113/jphysiol.1970.sp009212; Dickerson DA, 2008, BIOMECH MODEL MECHAN, V7, P191, DOI 10.1007/s10237-007-0085-y; Garman R, 2007, J ORTHOP RES, V25, P732, DOI 10.1002/jor.20354; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Gouw TH, 1966, FETT WISS TECHNOL, V68, P544, DOI [10.1002/lipi.19660680705, DOI 10.1002/LIPI.19660680705]; Grimston SK, 2006, ANN NY ACAD SCI, V1068, P214, DOI 10.1196/annals.1346.023; Guilak F, 2000, BIOCHEM BIOPH RES CO, V269, P781, DOI 10.1006/bbrc.2000.2360; Heinrich V, 1996, ANN BIOMED ENG, V24, P595, DOI 10.1007/BF02684228; Hu SH, 2005, BIOCHEM BIOPH RES CO, V329, P423, DOI 10.1016/j.bbrc.2005.02.026; Ilvesaro J, 2000, J BONE MINER RES, V15, P919, DOI 10.1359/jbmr.2000.15.5.919; Ishihara Y, 2008, J BONE MINER RES, V23, P350, DOI 10.1359/JBMR.071102; Jiang JX, 2007, FRONT BIOSCI-LANDMRK, V12, P1450, DOI 10.2741/2159; JONES SJ, 1993, ANAT EMBRYOL, V187, P343; Judex S, 2007, J BIOMECH, V40, P1333, DOI 10.1016/j.jbiomech.2006.05.014; Kamioka H, 2007, MICROSC MICROANAL, V13, P108, DOI 10.1017/S143192760707016X; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Klein-Nulend Jenneke, 2003, Curr Osteoporos Rep, V1, P5; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; Lau E, 2010, BONE, V46, P1508, DOI 10.1016/j.bone.2010.02.031; Li Z, 1999, BONE, V25, P661, DOI 10.1016/S8756-3282(99)00227-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd SA, 2013, J BONE MINERAL RES; Loiselle AE, 2013, J ORTHOP RES, V31, P147, DOI 10.1002/jor.22178; McGarry JG, 2004, FASEB J, V18, P482, DOI 10.1096/fj.04-2210fje; Nomura S, 2000, MATRIX BIOL, V19, P91, DOI 10.1016/S0945-053X(00)00050-0; Ozcivici E, 2007, J BIOMECH, V40, P3404, DOI 10.1016/j.jbiomech.2007.05.015; Ozcivici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011178; Patel MJ, 2009, J CELL BIOCHEM, V106, P306, DOI 10.1002/jcb.22007; Rangaswami H, 2012, J BIOL CHEM, V287, P21509, DOI 10.1074/jbc.M112.347245; Riddle RC, 2009, J ORTHOP RES, V27, P143, DOI 10.1002/jor.20723; Saunders MM, 2001, AM J PHYSIOL-CELL PH, V281, pC1917, DOI 10.1152/ajpcell.2001.281.6.C1917; Schiller PC, 2001, BONE, V28, P362, DOI 10.1016/S8756-3282(00)00458-0; SCHIRRMACHER K, 1992, CALCIFIED TISSUE INT, V51, P285, DOI 10.1007/BF00334489; Sen B, 2013, J BONE MINERAL RES; Sen B, 2011, STEM CELLS, V29, P1829, DOI 10.1002/stem.732; Sen B, 2011, J BIOMECH, V44, P593, DOI 10.1016/j.jbiomech.2010.11.022; Shafrir Y, 2002, AM J PHYSIOL-CELL PH, V282, pC479, DOI 10.1152/ajpcell.00394.2001; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Sugawara Y, 2008, BONE, V43, P19, DOI 10.1016/j.bone.2008.02.020; Sugawara Y, 2011, CALCIFIED TISSUE INT, V88, P416, DOI 10.1007/s00223-011-9471-7; Tanaka SM, 2003, J BIOMECH, V36, P73, DOI 10.1016/S0021-9290(02)00245-2; Taylor AF, 2007, AM J PHYSIOL-CELL PH, V292, pC545, DOI 10.1152/ajpcell.00611.2005; Thompson WR, 2013, STEM CELLS, V31, P2528, DOI 10.1002/stem.1476; Tirkkonen L, 2011, J R SOC INTERFACE, V8, P1736, DOI 10.1098/rsif.2011.0211; Turner CH, 2002, CALCIFIED TISSUE INT, V70, P435, DOI 10.1007/s00223-001-1024-z; Uzer G, 2013, J BIOMECH, V46, P2296, DOI 10.1016/j.jbiomech.2013.06.008; Uzer G, 2012, CELL MOL BIOENG, V5, P266, DOI 10.1007/s12195-012-0231-1; Verbruggen SW, 2012, J R SOC INTERFACE, V9, P2735, DOI 10.1098/rsif.2012.0286; Watabe H, 2011, EXP CELL RES, V317, P2642, DOI 10.1016/j.yexcr.2011.07.015; Xia XC, 2010, MOL CELL BIOL, V30, P206, DOI 10.1128/MCB.01844-08; Yellowley CE, 2000, J BONE MINER RES, V15, P209, DOI 10.1359/jbmr.2000.15.2.209; You J, 2000, J BIOMECH ENG-T ASME, V122, P387, DOI 10.1115/1.1287161; Ziambaras K, 1998, J BONE MINER RES, V13, P218, DOI 10.1359/jbmr.1998.13.2.218	71	37	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90840	10.1371/journal.pone.0090840	http://dx.doi.org/10.1371/journal.pone.0090840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614887	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300044
J	Chang, CY; Chen, WL; Liou, YF; Ke, CC; Lee, HC; Huang, HL; Ciou, LP; Chou, CC; Yang, MC; Ho, SY; Lin, YR				Chang, Chih-Yu; Chen, Wen-Liang; Liou, Yi-Fan; Ke, Chih-Chi; Lee, Hua-Chin; Huang, Hui-Ling; Ciou, Li-Ping; Chou, Chu-Chung; Yang, Mei-Chueh; Ho, Shinn-Ying; Lin, Yan-Ren			Increased Risk of Major Depression in the Three Years following a Femoral Neck Fracture-A National Population-Based Follow-Up Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; HIP FRACTURE; ELDERLY-PATIENTS; MORTALITY; SHAFT; OUTCOMES; SURGERY; FEMUR	Femoral neck fracture is common in the elderly, and its impact has increased in aging societies. Comorbidities, poor levels of activity and pain may contribute to the development of depression, but these factors have not been well addressed. This study aims to investigate the frequency and risk of major depression after a femoral neck fracture using a nationwide population-based study. The Taiwan Longitudinal Health Insurance Database was used in this study. A total of 4,547 patients who were hospitalized for femoral neck fracture within 2003 to 2007 were recruited as a study group; 13,641 matched non-fracture participants were enrolled as a comparison group. Each patient was prospectively followed for 3 years to monitor the occurrence of major depression. Cox proportional-hazards models were used to compute the risk of major depression between members of the study and comparison group after adjusting for residence and sociodemographic characteristics. The most common physical comorbidities that were present after the fracture were also analyzed. The incidences of major depression were 1.2% (n = 55) and 0.7% (n = 95) in the study and comparison groups, respectively. The stratified Cox proportional analysis showed a covariate-adjusted hazard ratio of major depression among patients with femoral neck fracture that was 1.82 times greater (95% CI, 1.30-2.53) than that of the comparison group. Most major depressive episodes (34.5%) presented within the first 200 days following the fracture. In conclusion, patients with a femoral neck fracture are at an increased risk of subsequent major depression. Most importantly, major depressive episodes mainly occurred within the first 200 days following the fracture.	[Chang, Chih-Yu; Chou, Chu-Chung; Yang, Mei-Chueh; Lin, Yan-Ren] Changhua Christian Hosp, Dept Emergency Med, Changhua, Taiwan; [Chang, Chih-Yu; Chen, Wen-Liang; Lee, Hua-Chin; Huang, Hui-Ling; Ho, Shinn-Ying; Lin, Yan-Ren] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Chang, Chih-Yu; Liou, Yi-Fan; Huang, Hui-Ling; Ciou, Li-Ping; Ho, Shinn-Ying] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Ke, Chih-Chi] Natl Chiao Tung Univ, Inst Multimedia Engn, Hsinchu, Taiwan; [Chou, Chu-Chung; Lin, Yan-Ren] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chou, Chu-Chung] Taipei Med Univ, Sch Med, Taipei, Taiwan	Changhua Christian Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chung Shan Medical University; Taipei Medical University	Ho, SY (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.	syho@mail.nctu.edu; h6213.lac@gmail.com	Ho, Shinn-Ying/AFD-8402-2022; Ho, Shinn-Ying/AAE-9394-2022; Lin, Yan-Ren/AAU-4136-2020	Ho, Shinn-Ying/0000-0002-1901-8353; Ho, Shinn-Ying/0000-0002-1901-8353; Lin, Yan-Ren/0000-0002-9015-2678	National Chiao Tung University; Changhua Christian Hospital; National Science Council [NSC 102-2314-B-371-010]	National Chiao Tung University; Changhua Christian Hospital; National Science Council(Ministry of Science and Technology, Taiwan)	The authors thank the National Chiao Tung University, Changhua Christian Hospital and National Science Council (NSC 102-2314-B-371-010) for financially supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alho A, 1997, ANN CHIR GYNAECOL FE, V86, P326; Ancelin ML, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.95; Browne JA, 2009, J TRAUMA, V66, P809, DOI 10.1097/TA.0b013e31816166bb; Cannada LK, 2009, J ORTHOP TRAUMA, V23, P254, DOI 10.1097/BOT.0b013e31819a6651; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Cole MG, 2003, AM J PSYCHIAT, V160, P1147, DOI 10.1176/appi.ajp.160.6.1147; Duggal NA, 2013, BRAIN BEHAV IMMUN, V33, P173, DOI 10.1016/j.bbi.2013.07.004; Enocson A, 2009, QUAL LIFE RES, V18, P1177, DOI 10.1007/s11136-009-9531-x; Fenn AM, 2013, BIOL PSYCHIAT; Gambatesa M, 2013, J MULTIDISCIP HEALTH, V6, P335, DOI 10.2147/JMDH.S48240; Gonzalez-Rozas M, 2012, AGING CLIN EXP RES, V24, P181; Gordon Jason, 2012, Arch Osteoporos, V7, P267; Hartholt KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022227; Holmes J, 2000, PSYCHOL MED, V30, P921, DOI 10.1017/S0033291799002548; Holvik K, 2010, J AGING HEALTH, V22, P1114, DOI 10.1177/0898264310378040; Hsu CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070458; Kim SM, 2012, BONE, V50, P1343, DOI 10.1016/j.bone.2012.02.633; Lai SC, 2013, J NEUROSCI NEUROENG, V2, P465; Miyanishi Keita, 2010, J Orthop Surg (Hong Kong), V18, P265; Phillips AC, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-60; Piscitelli P, 2012, CLIN CASES MINER BON, V9, P40; Roche JJW, 2005, BMJ-BRIT MED J, V331, P1374, DOI 10.1136/bmj.38643.663843.55; Sendtner E, 2010, DTSCH ARZTEBL INT, V107, P401, DOI 10.3238/arztebl.2010.0401; Shen HP, 2012, J NEUROSCI NEUROENG, V1, P90; Shyu YIL, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-225; Shyu YIL, 2004, OSTEOPOROSIS INT, V15, P95, DOI 10.1007/s00198-003-1533-x; Valaviciene R, 2012, INT ORTHOP, V36, P1681, DOI 10.1007/s00264-012-1531-8; WOLINSKY PR, 1995, CLIN ORTHOP RELAT R, P81	28	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e89867	10.1371/journal.pone.0089867	http://dx.doi.org/10.1371/journal.pone.0089867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9JS	24626193	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300010
J	Chen, WC; Chen, MF; Lin, PY				Chen, Wen-Cheng; Chen, Miao-Fen; Lin, Paul-Yang			Significance of DNMT3b in Oral Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DNA METHYLTRANSFERASE 1; PROMOTER HYPERMETHYLATION; NECK-CANCER; PRECANCEROUS LESIONS; GASTRIC-CARCINOMA; LUNG-CANCER; METHYLATION; GENE; EXPRESSION	The aim of this study was to explore specific molecular markers that could lead to new insights into the identification of innovative treatments. The role of DNMT3b and its predictive power in the prognosis of oral cancer were identified. Human oral cancer cell lines including SCC4 and SCC25 were selected for cellular experiments. Changes in tumor growth, aggressiveness and the responsible signaling pathway were investigated in vitro and in vivo. Furthermore, 125 oral cancer tissue specimens were analyzed using immunohistochemical staining on tissue microarray slides, and correlations calculated between the level of DNMT3b and the clinical outcome of patients. Our data revealed that inhibition of DNMT3b resulted in slower tumor growth, attenuated tumor invasion ability and epithelial mesenchymal transition, as determined by in vitro and in vivo experiments. Activated IL-6 signaling might be responsible to the induction of DNMT3b overexpression on oral cancer. Regarding clinical data, the incidence of DNMT3b immunoreactivity in oral cancer specimens was significantly higher than in non-malignant epithelium, and positively linked to expression of IL-6. Furthermore, expression of DNMT3b was significantly linked with the risk of lymph node involvement, disease recurrence and shorter survival in patients with pathological stage III-IV oral cancer. In conclusion, IL-6 -DNMT3b axis could be used to predict the prognosis of oral cancer in clinics, and targeting DNMT3b could represent a promising treatment strategy.	[Chen, Wen-Cheng; Chen, Miao-Fen] Chang Gung Mem Hosp, Dept Radiat Oncol, Chiayi, Taiwan; [Chen, Wen-Cheng; Chen, Miao-Fen; Lin, Paul-Yang] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Lin, Paul-Yang] Chang Gung Mem Hosp, Dept Pathol, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chen, WC (corresponding author), Chang Gung Mem Hosp, Dept Radiat Oncol, Chiayi, Taiwan.	rto_chen@yahoo.com.tw			Chang Gung Memorial Hospital, Taiwan [CMRPG6A0222-3]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	The work was support by Chang Gung Memorial Hospital, Taiwan, grant CMRPG6A0222-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Chen CC, 2011, HEAD NECK-J SCI SPEC, V33, P1132, DOI 10.1002/hed.21586; Chen MF, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-26; Chen MF, 2012, CLIN SCI, V122, P459, DOI 10.1042/CS20110434; Choi S, 2008, J DENT RES, V87, P14, DOI 10.1177/154405910808700104; Culig Z, 2013, EXPERT OPIN THER TAR, V17, P53, DOI 10.1517/14728222.2013.733368; Daniel FI, 2011, CANCER-AM CANCER SOC, V117, P677, DOI 10.1002/cncr.25482; Diez-Perez R, 2011, ONCOL REP, V25, P1203, DOI 10.3892/or.2011.1205; Foran E, 2010, MOL CANCER RES, V8, P471, DOI 10.1158/1541-7786.MCR-09-0496; Gasche JA, 2011, INT J CANCER, V129, P1053, DOI 10.1002/ijc.25764; Gotzmann J, 2004, MUTAT RES-REV MUTAT, V566, P9, DOI 10.1016/S1383-5742(03)00033-4; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hino R, 2009, CANCER RES, V69, P2766, DOI 10.1158/0008-5472.CAN-08-3070; Jones SA, 2005, J INTERF CYTOK RES, V25, P241, DOI 10.1089/jir.2005.25.241; Kato K, 2006, J CANCER RES CLIN, V132, P735, DOI 10.1007/s00432-006-0122-8; Kim HJ, 2006, CANCER, V107, P1042, DOI 10.1002/cncr.22087; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Quan JJ, 2012, CANCER METAST REV, V31, P209, DOI 10.1007/s10555-011-9335-7; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Robertson KD, 2002, ONCOGENE, V21, P5361, DOI 10.1038/sj.onc.1205609; Roth MJ, 2006, ONCOL REP, V15, P1591; Sharma S, 2005, HISTOPATHOLOGY, V46, P481, DOI 10.1111/j.1365-2559.2005.02142.x; Shaw R, 2006, INT J ORAL MAX SURG, V35, P101, DOI 10.1016/j.ijom.2005.06.014; Smith A, 2013, ORAL ONCOL, V49, P287, DOI 10.1016/j.oraloncology.2012.10.009; Su XW, 2010, ONCOL REP, V23, P819, DOI 10.3892/or_00000703; Takeshima M, 2008, J ORAL PATHOL MED, V37, P475, DOI 10.1111/j.1600-0714.2008.00644.x; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Viet C T, 2007, J Calif Dent Assoc, V35, P844	33	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e89956	10.1371/journal.pone.0089956	http://dx.doi.org/10.1371/journal.pone.0089956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625449	Green Submitted, gold, Green Published			2022-12-27	WOS:000332851300012
J	Guarnieri, MJ; Diaz, JV; Basu, C; Diaz, A; Pope, D; Smith, KR; Smith-Sivertsen, T; Bruce, N; Solomon, C; McCracken, J; Balmes, JR				Guarnieri, Michael J.; Diaz, Janet V.; Basu, Chandreyi; Diaz, Anaite; Pope, Daniel; Smith, Kirk R.; Smith-Sivertsen, Tone; Bruce, Nigel; Solomon, Colin; McCracken, John; Balmes, John R.			Effects of Woodsmoke Exposure on Airway Inflammation in Rural Guatemalan Women	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INDUCED SPUTUM; CHRONIC-BRONCHITIS; CARBON-MONOXIDE; BIOMASS SMOKE; GLOBAL BURDEN; MATRIX METALLOPROTEINASES; RESPIRATORY SYMPTOMS; LUNG-FUNCTION; RISK-FACTORS	Background: More than two-fifths of the world's population uses solid fuels, mostly biomass, for cooking. The resulting biomass smoke exposure is a major cause of chronic obstructive pulmonary disease (COPD) among women in developing countries. Objective: To assess whether lower woodsmoke exposure from use of a stove with a chimney, compared to open fires, is associated with lower markers of airway inflammation in young women. Design: We carried out a cross-sectional analysis on a sub-cohort of participants enrolled in a randomized controlled trial in rural Guatemala, RESPIRE. Participants: We recruited 45 indigenous women at the end of the 18-month trial; 19 women who had been using the chimney stove for 18-24 months and 26 women still using open fires. Measurements: We obtained spirometry and induced sputum for cell counts, gene expression of IL-8, TNF-alpha, MMP-9 and 12, and protein concentrations of IL-8, myeloperoxidase and fibronectin. Exhaled carbon monoxide (CO) and 48-hr personal CO tubes were measured to assess smoke exposure. Results: MMP-9 gene expression was significantly lower in women using chimney stoves. Higher exhaled CO concentrations were significantly associated with higher gene expression of IL-8, TNF-alpha, and MMP-9. Higher 48-hr personal CO concentrations were associated with higher gene expression of IL-8, TNF-alpha, MMP-9 and MMP-12; reaching statistical significance for MMP-9 and MMP-12. Conclusions: Compared to using an open wood fire for cooking, use of a chimney stove was associated with lower gene expression of MMP-9, a potential mediator of airway remodeling. Among all participants, indoor biomass smoke exposure was associated with higher gene expression of multiple mediators of airway inflammation and remodeling; these mechanisms may explain some of the observed association between prolonged biomass smoke exposure and COPD.	[Guarnieri, Michael J.; Diaz, Janet V.; Basu, Chandreyi; Solomon, Colin; Balmes, John R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Diaz, Anaite] Univ Valle Guatemala, Guatemala City, Guatemala; [Pope, Daniel; Bruce, Nigel] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Smith, Kirk R.; Balmes, John R.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Smith-Sivertsen, Tone] Uni Res, Res Unit Gen Practice, Bergen, Norway; [Solomon, Colin] Univ Sunshine Coast, Sch Hlth & Sport Sci, Sippy Downs, Qld, Australia; [McCracken, John] Univ Valle Guatemala, Emerging Infect Dis Unit, Guatemala City, Guatemala	University of California System; University of California San Francisco; Universidad del Valle de Guatemala; University of Liverpool; University of California System; University of California Berkeley; University of the Sunshine Coast; Universidad del Valle de Guatemala	Balmes, JR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	john.balmes@ucsf.edu	diaz-artiga, anaite/GOJ-7894-2022; Balmes, John/L-6281-2019	diaz-artiga, anaite/0000-0002-2508-8710; Pope, Daniel/0000-0003-2694-5478; Smith-Sivertsen, Tone/0000-0003-0714-7964	Norwegian Research Council; US National Institute of Environmental Health Sciences [R01ES010178]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010178] Funding Source: NIH RePORTER	Norwegian Research Council(Research Council of NorwayEuropean Commission); US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by grants from the Norwegian Research Council and the US National Institute of Environmental Health Sciences (R01ES010178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albalak R, 1999, THORAX, V54, P1004, DOI 10.1136/thx.54.11.1004; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Balakrishnan K, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-77; Banerjee A, 2012, INFLAMMATION, V35, P671, DOI 10.1007/s10753-011-9360-2; Beeh KM, 2003, RESP MED, V97, P634, DOI 10.1053/rmed.2003.1493; Beeh KM, 2003, CHEST, V123, P778, DOI 10.1378/chest.123.3.778; BEHERA D, 1991, CHEST, V100, P385, DOI 10.1378/chest.100.2.385; Bonjour S, 2013, ENVIRON HEALTH PERSP, V121, P784, DOI 10.1289/ehp.1205987; Culpitt SV, 2005, RESP MED, V99, P703, DOI 10.1016/j.rmed.2004.10.022; Demedts IK, 2006, THORAX, V61, P196, DOI 10.1136/thx.2005.042432; Dennis RJ, 1996, CHEST, V109, P115, DOI 10.1378/chest.109.1.115; Desai MA, 2004, WHO ENV BURDEN DIS S, V4; Di Stefano A, 2004, CLIN EXP ALLERGY, V34, P1156, DOI 10.1111/j.1365-2222.2004.02030.x; Diaz E, 2007, INT J TUBERC LUNG D, V11, P1372; DOSSING M, 1994, RESP MED, V88, P519, DOI 10.1016/S0954-6111(05)80334-8; Dutta A, 2012, INT J HYG ENV HLTH; Fahy JV, 1998, CLIN EXP ALLERGY, V28, P1047, DOI 10.1046/j.1365-2222.1998.00330.x; Finlay GA, 1997, THORAX, V52, P502, DOI 10.1136/thx.52.6.502; Finlay GA, 1997, AM J RESP CRIT CARE, V156, P240, DOI 10.1164/ajrccm.156.1.9612018; Golshan M, 2002, RESP MED, V96, P382, DOI 10.1053/rmed.2002.1288; Gueders MM, 2006, EUR J PHARM; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hu GP, 2010, CHEST, V138, P20, DOI 10.1378/chest.08-2114; Hung J, 2006, J FORMOS MED ASSOC, V105, P210, DOI 10.1016/S0929-6646(09)60307-7; Imai K, 2001, AM J RESP CRIT CARE, V163, P786, DOI 10.1164/ajrccm.163.3.2001073; Kurmi OP, 2010, THORAX, V65, P221, DOI 10.1136/thx.2009.124644; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mamessier E, 2003, J IMMUNOL METHODS, V280, P37, DOI 10.1016/S0022-1759(03)00230-8; McCracken JP, 2009, EPIDEMIOLOGY, V20, P127, DOI 10.1097/EDE.0b013e31818ef327; McCracken JP, 2013, PLOS ONE, V8; Montano M, 2004, CHEST, V125, P466, DOI 10.1378/chest.125.2.466; Mortimer KM, 2003, CHEST, V123, P1899, DOI 10.1378/chest.123.6.1899; Mukherjee B, 2011, J APPL TOXICOL; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Northcross A, 2010, J ENVIRON MONITOR, V12, P873, DOI 10.1039/b916068j; Orozco-Levi M, 2006, EUR RESPIR J, V27, P542, DOI 10.1183/09031936.06.00052705; Pandey M R, 1985, Tokai J Exp Clin Med, V10, P471; PANDEY MR, 1984, THORAX, V39, P331, DOI 10.1136/thx.39.5.331; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Peleman RA, 1999, EUR RESPIR J, V13, P839, DOI 10.1034/j.1399-3003.1999.13d24.x; PerezPadilla R, 1996, AM J RESP CRIT CARE, V154, P701, DOI 10.1164/ajrccm.154.3.8810608; Ramirez-Venegas A, 2006, AM J RESP CRIT CARE, V173, P393, DOI 10.1164/rccm.200504-568OC; Saetta M, 2001, AM J RESP CRIT CARE, V163, P1304, DOI 10.1164/ajrccm.163.6.2009116; Smith KR, 2013, ANNU REV PUBL HEALTH, V34, P159, DOI 10.1146/annurev-publhealth-031912-114404; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Smith KR, 2010, J EXPO SCI ENV EPID, V20, P406, DOI 10.1038/jes.2009.30; Smith-Sivertsen T, 2009, AM J EPIDEMIOL, V170, P211, DOI 10.1093/aje/kwp100; Thompson LM, 2011, INT J OCCUP ENV HEAL, V17, P103; Tsoumakidou M, 2003, RESP MED, V97, P863, DOI 10.1016/S0954-6111(03)00035-0; Vernooy JHJ, 2004, CHEST, V126, P1802, DOI 10.1378/chest.126.6.1802	51	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e88455	10.1371/journal.pone.0088455	http://dx.doi.org/10.1371/journal.pone.0088455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625755	gold, Green Submitted, Green Published			2022-12-27	WOS:000332851300002
J	Boerleider, AW; Francke, AL; van de Reep, M; Mannien, J; Wiegers, TA; Deville, WLJM				Boerleider, Agatha W.; Francke, Anneke L.; van de Reep, Merle; Mannien, Judith; Wiegers, Therese A.; Deville, Walter L. J. M.			"Being Flexible and Creative'': A Qualitative Study on Maternity Care Assistants' Experiences with Non-Western Immigrant Women	PLOS ONE			English	Article							HEALTH-CARE; PROFESSIONALS; MORTALITY	Background: Several studies conducted in developed countries have explored postnatal care professionals' experiences with non-western women. These studies reported different cultural practices, lack of knowledge of the maternity care system, communication difficulties, and the important role of the baby's grandmother as care-giver in the postnatal period. However, not much attention has been paid in existing literature to postnatal care professionals' approaches to these issues. Our main objective was to gain insight into how Dutch postnatal care providers - 'maternity care assistants' (MCA) - address issues encountered when providing care for non-western women. Methods: A generic qualitative research approach was used. Two researchers interviewed fifteen MCAs individually, analysing the interview material separately and then comparing and discussing their results. Analytical codes were organised into main themes and subthemes. Results: MCAs perceive caring for non-western women as interesting and challenging, but sometimes difficult too. To guarantee the health and safety of mother and baby, they have adopted flexible and creative approaches to address issues concerning traditional practices, socioeconomic status and communication. Furthermore, they employ several other strategies to establish relationships with non-western clients and their families, improve women's knowledge of the maternity care system and give health education. Conclusion: Provision of postnatal care to non-western clients may require special skills and measures. The quality of care for non-western clients might be improved by including these skills in education and retraining programmes for postnatal care providers on top of factual knowledge about traditional practices.	[Boerleider, Agatha W.; Francke, Anneke L.; van de Reep, Merle; Wiegers, Therese A.; Deville, Walter L. J. M.] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands; [Francke, Anneke L.] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Mannien, Judith] Vrije Univ Amsterdam, Med Ctr, Dept Midwifery Sci, AVAG, Amsterdam, Netherlands; [Mannien, Judith] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Deville, Walter L. J. M.] Univ Amsterdam, Fac Social & Behav Sci, Amsterdam, Netherlands; [Deville, Walter L. J. M.] Natl Knowledge & Advisory Ctr Migrants Refugees &, Utrecht, Netherlands	Netherlands Institute for Health Services Research; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam	Boerleider, AW (corresponding author), Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands.	agathawb75@yahoo.com		Mannien, Judith/0000-0003-1698-9979	Academy of Midwifery Amsterdam-Groningen (AVAG); Dutch Ministry of Education, Culture and Science	Academy of Midwifery Amsterdam-Groningen (AVAG); Dutch Ministry of Education, Culture and Science	This study was funded by the Academy of Midwifery Amsterdam-Groningen (AVAG) and the Dutch Ministry of Education, Culture and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cioffi J, 2004, J MIDWIFERY WOM HEAL, V49, P437, DOI 10.1016/j.jmwh.2004.01.019; El Fakiri F, 1999, KRAAMZORG ALLOCHTONE; Foets M, 2008, GEZONDHEIDS ZORG OND, P29; Fort A.L., 2006, POSTPARTUM CARE LEVE; Green J, 2009, QUALITATIVE METHODS, P198; Jirwe M, 2010, SCAND J CARING SCI, V24, P436, DOI 10.1111/j.1471-6712.2009.00733.x; Lyons SM, 2008, ETHNIC HEALTH, V13, P261, DOI 10.1080/13557850801903020; Mathai M, 2010, WHO TECHNICAL CONSUL; McAree T., 2010, EVIDENCE BASED MIDWI, V8, P91; Mill J., 2003, INT J QUAL METH, V2, P1, DOI [10.1177/160940690300200201, DOI 10.1177/160940690300200201]; Ockleford E. M., 2004, BRIT J MIDWIFERY, V12, P166, DOI DOI 10.12968/BJOM.2004.12.3.15363; Priebe S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-187; Puthussery S, 2008, J HEALTH SERV RES PO, V13, P195, DOI 10.1258/jhsrp.2008.007153; Ravelli ACJ, 2011, J EPIDEMIOL COMMUN H, V65, P696, DOI 10.1136/jech.2009.095406; Rice PL, 1999, MIDWIFERY, V15, P47, DOI 10.1016/S0266-6138(99)90037-2; Schutte JM, 2010, BJOG-INT J OBSTET GY, V117, P399, DOI 10.1111/j.1471-0528.2009.02382.x; Statistics Netherlands StatLine, 2012, GEB HERK LEEFT MOED; Tran M, 2001, J Qual Clin Pract, V21, P135, DOI 10.1046/j.1440-1762.2001.00431.x; Tucker CM, 2011, HEALTH PSYCHOL, V30, P342, DOI 10.1037/a0022967; Wiegers TA, 2006, J NEONATAL NURS, V12, P163, DOI [10.1016/j.jnn.2006.07.003, DOI 10.1016/J.JNN.2006.07.003]; Wiklund H, 2000, MIDWIFERY, V16, P105, DOI 10.1054/midw.1999.0197; Yelland J, 1998, MIDWIFERY, V14, P144, DOI 10.1016/S0266-6138(98)90029-8	22	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91843	10.1371/journal.pone.0091843	http://dx.doi.org/10.1371/journal.pone.0091843			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24622576	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300134
J	Edmondson, D; Green, P; Ye, SQ; Halazun, HJ; Davidson, KW				Edmondson, Donald; Green, Philip; Ye, Siqin; Halazun, Hadi J.; Davidson, Karina W.			Psychological Stress and 30-Day All-Cause Hospital Readmission in Acute Coronary Syndrome Patients: An Observational Cohort Study	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; SYMPTOMS; METAANALYSIS; ASSOCIATION; DEPRESSION; SURGERY; RISK	Background: Many acute coronary syndrome (ACS; myocardial infarction and unstable angina) patients are rehospitalized within 30 days of discharge, and recent US health policy initiatives have tied hospital Medicare reimbursement to 30-day readmission rates. Patient-perceived psychological stress is thought to impact prognosis after ACS. A recently offered "posthospital syndrome" model of 30-day readmissions posits that the stress level at the time of the index hospitalization itself may increase 30-day risk for readmission in ACS patients. We tested whether self-reported stress in the days surrounding the ACS hospitalization was associated with increased risk for readmission within 30 days. Methods: A mean of 8.5 days after discharge, 342 consecutively hospitalized ACS patients reported on how often they felt stress during the past two weeks. Readmission within 30 days of hospital discharge for any cause was determined by follow-up telephone calls to patients and confirmed by hospital records. Results: Overall, 40 (11.7%) participants were readmitted within 30 days, and 22 (6.4%) reported high stress. Readmission within 30 days was more common in patients with high stress (5 admissions, 23%) than in patients with low stress (35 admissions, 11%). After adjustment for demographic and clinical factors, as well as depression, high stress was associated with a 3-fold increased risk of 30-day readmission (HR = 3.21, 95% CI = 1.13, 9.10). Conclusions: Previous research has shown that stress in the days surrounding a hospitalization can mark long-term cardiovascular risk, but this is the first study to test a hypothesis of the posthospital syndrome model of early readmission. Further research is needed to confirm the association between stress and readmission risk, and to identify the processes of hospitalization that could be modified to both reduce the stress experienced and that would also be effective for reducing readmissions.	[Edmondson, Donald; Green, Philip; Ye, Siqin; Halazun, Hadi J.; Davidson, Karina W.] Columbia Univ, Med Ctr, Ctr Behav Cardiovasc Hlth, Dept Med, New York, NY 10027 USA	Columbia University	Edmondson, D (corresponding author), Columbia Univ, Med Ctr, Ctr Behav Cardiovasc Hlth, Dept Med, New York, NY 10027 USA.	dee2109@columbia.edu	Edmondson, Donald/G-7486-2016; Davidson, Karina/GWC-0996-2022; Davidson, Karina/AAG-2388-2019	Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Edmondson, Donald/0000-0002-4518-8196	New York State Department of Health ECRIP research program;  [HL088117];  [HL117832]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088117, R01HL117832] Funding Source: NIH RePORTER	New York State Department of Health ECRIP research program; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants HL088117 and HL117832, and in part by New York State Department of Health ECRIP research program. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official view of any of the sponsors. All authors had full access to the data and approved the manuscript. Dr. Edmondson is responsible for analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Edmondson D, 2013, JAMA INTERN MED, V173, P472, DOI 10.1001/jamainternmed.2013.2536; Edmondson D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038915; Fontanarosa PB, 2013, JAMA-J AM MED ASSOC, V309, P398, DOI 10.1001/jama.2013.42; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; FRASURESMITH N, 1991, AM J CARDIOL, V67, P121, DOI 10.1016/0002-9149(91)90432-K; Fredrikson M, 1990, ANN BEHAV MED; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Linden W, 2007, EUR HEART J, V28, P2972, DOI 10.1093/eurheartj/ehm504; Oxlad M, 2006, J PSYCHOSOM RES, V61, P775, DOI 10.1016/j.jpsychores.2006.09.008; Raikkonen K, 1996, METABOLISM, V45, P1533, DOI 10.1016/S0026-0495(96)90184-5; Richardson S, 2012, AM J CARDIOL, V110, P1711, DOI 10.1016/j.amjcard.2012.08.004; Shah SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047420; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Tully PJ, 2008, J BEHAV MED, V31, P281, DOI 10.1007/s10865-008-9153-8; Weiss D, 1997, CROSS CULTURAL ASSES, P219	18	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91477	10.1371/journal.pone.0091477	http://dx.doi.org/10.1371/journal.pone.0091477			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24621575	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300092
J	Montgomery, RA; Vucetich, JA; Roloff, GJ; Bump, JK; Peterson, RO				Montgomery, Robert A.; Vucetich, John A.; Roloff, Gary J.; Bump, Joseph K.; Peterson, Rolf O.			Where Wolves Kill Moose: The Influence of Prey Life History Dynamics on the Landscape Ecology of Predation	PLOS ONE			English	Article							CONTERMINOUS UNITED-STATES; RATIO-DEPENDENT PREDATION; ISLE ROYALE WOLVES; WOLF PREDATION; POPULATION-DYNAMICS; PATCHY ENVIRONMENTS; HABITAT SELECTION; WINTER SEVERITY; NATIONAL-PARK; LAND-COVER	The landscape ecology of predation is well studied and known to be influenced by habitat heterogeneity. Little attention has been given to how the influence of habitat heterogeneity on the landscape ecology of predation might be modulated by life history dynamics of prey in mammalian systems. We demonstrate how life history dynamics of moose (Alces alces) contribute to landscape patterns in predation by wolves (Canis lupus) in Isle Royale National Park, Lake Superior, USA. We use pattern analysis and kernel density estimates of moose kill sites to demonstrate that moose in senescent condition and moose in prime condition tend to be wolf-killed in different regions of Isle Royale in winter. Predation on senescent moose was clustered in one kill zone in the northeast portion of the island, whereas predation on prime moose was clustered in 13 separate kill zones distributed throughout the full extent of the island. Moreover, the probability of kill occurrence for senescent moose, in comparison to prime moose, increased in high elevation habitat with patches of dense coniferous trees. These differences can be attributed, at least in part, to senescent moose being more vulnerable to predation and making different risk-sensitive habitat decisions than prime moose. Landscape patterns emerging from prey life history dynamics and habitat heterogeneity have been observed in the predation ecology of fish and insects, but this is the first mammalian system for which such observations have been made.	[Montgomery, Robert A.; Roloff, Gary J.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Vucetich, John A.; Bump, Joseph K.; Peterson, Rolf O.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA	Michigan State University; Michigan Technological University	Montgomery, RA (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	montg164@msu.edu	Montgomery, Robert A./C-5541-2019	Montgomery, Robert A./0000-0001-5894-0589	National Science Foundation Graduate Research Fellowship program; National Science Foundation [DEB-0918247]; CESU from Isle Royale National Park, National Park Service [J6310110025]; Michigan Technological University	National Science Foundation Graduate Research Fellowship program(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); CESU from Isle Royale National Park, National Park Service; Michigan Technological University	This work was supported by the National Science Foundation Graduate Research Fellowship program and the National Science Foundation DEB-0918247 and CESU Task Agreement No. J6310110025 from Isle Royale National Park, National Park Service. R.O. Peterson was also supported by the Robbins Chair, Michigan Technological University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JR, 2011, P ROY SOC B-BIOL SCI, V278, P3336, DOI 10.1098/rspb.2011.0261; Andruskiw M, 2008, ECOLOGY, V89, P2273, DOI 10.1890/07-1428.1; ARDITI R, 1992, ECOLOGY, V73, P1544, DOI 10.2307/1940007; Arditi R., 2012, SPECIES INTERACT; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; BERGERUD AT, 1983, J WILDLIFE MANAGE, V47, P977, DOI 10.2307/3808156; Bergman EJ, 2006, ECOL APPL, V16, P273, DOI 10.1890/04-1532; Birkhofer K, 2011, OIKOS, V120, P1705, DOI 10.1111/j.1600-0706.2011.19546.x; Birkhofer K, 2010, BASIC APPL ECOL, V11, P486, DOI 10.1016/j.baae.2010.06.010; Briggs CJ, 2004, THEOR POPUL BIOL, V65, P299, DOI 10.1016/j.tpb.2003.11.001; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Bubenik AB., 1997, ECOLOGY MANAGEMENT N, P77; Bump JK, 2009, ECOLOGY, V90, P3159, DOI 10.1890/09-0292.1; Bunge J., J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; CARBYN LN, 1983, J WILDLIFE MANAGE, V47, P963, DOI 10.2307/3808155; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Cressie N., 2011, STAT SPATIO TEMPORAL; Davidson Z, 2012, J MAMMAL, V93, P677, DOI 10.1644/10-MAMM-A-424.1; De Roos AM, 2009, ECOLOGY, V90, P945, DOI 10.1890/07-1153.1; DELGIUDICE GD, 1991, J WILDLIFE DIS, V27, P407, DOI 10.7589/0090-3558-27.3.407; Floater GJ, 2001, ECOL MONOGR, V71, P447, DOI 10.1890/0012-9615(2001)071[0447:HCSIAM]2.0.CO;2; Fortin M.-J., 2002, ENCY ENV, V4, P2051, DOI [10.1002/9780470057339.vas039, DOI 10.1002/9780470057339]; Gervasi V, 2013, ECOLOGICAL APPL; GINZBURG LR, 1992, ECOLOGY, V73, P1536, DOI 10.2307/1940006; Gitzen RA, 2003, WILDLIFE SOC B, V31, P823; HASSELL MP, 1982, ECOL ENTOMOL, V7, P365, DOI 10.1111/j.1365-2311.1982.tb00678.x; Hebblewhite M, 2002, CAN J ZOOL, V80, P800, DOI 10.1139/Z02-059; Hebblewhite M, 2007, OECOLOGIA, V152, P377, DOI 10.1007/s00442-007-0661-y; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; Hoef JMV, 2001, SPATIAL UNCERTAINTY IN ECOLOGY, P214; Homer C, 2007, PHOTOGRAMM ENG REM S, V73, P337; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; HUBER NK, 1973, 754A US GEOL SURV; Huber NK, 1975, GEOLOGICAL SURVEY B, V1309; Hunter LTB, 1998, BEHAVIOUR, V135, P195, DOI 10.1163/156853998793066320; Husseman JS, 2003, OIKOS, V101, P591, DOI 10.1034/j.1600-0706.2003.12230.x; Jordan Peter A., 2000, Alces, V36, P233; Jost C, 2005, J ANIM ECOL, V74, P809, DOI 10.1111/j.1365-2656.2005.00977.x; Kauffman MJ, 2010, ECOLOGY, V91, P2742, DOI 10.1890/09-1949.1; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; Krefting LW, 1974, U MINNESOTA AGR EXPT, V15; Leblond M, 2010, ECOGRAPHY, V33, P1102, DOI 10.1111/j.1600-0587.2009.06104.x; MAY RM, 1978, J ANIM ECOL, V47, P833, DOI 10.2307/3674; McCann K. S., 2012, FOOD WEBS; McCoy MW, 2009, OIKOS, V118, P87, DOI 10.1111/j.1600-0706.2008.16878.x; McLaren BE, 1996, CAN J FOREST RES, V26, P782, DOI 10.1139/x26-088; MCLAREN BE, 1994, SCIENCE, V266, P1555, DOI 10.1126/science.266.5190.1555; MCNAUGHTON SJ, 1976, SCIENCE, V191, P92, DOI 10.1126/science.191.4222.92; Mech LD, 2001, J WILDLIFE MANAGE, V65, P998, DOI 10.2307/3803048; Miller TEX, 2011, TRENDS ECOL EVOL, V26, P457, DOI 10.1016/j.tree.2011.05.005; Mitchell R.J., 2001, DESIGN ANAL ECOLOGIC, P217; Montgomery RA, 2013, J ANIM ECOL, V82, P301, DOI 10.1111/1365-2656.12000; MURDOCH WW, 1989, AM NAT, V134, P288, DOI 10.1086/284981; Mysterud A, 1999, WILDLIFE SOC B, V27, P385; Ogada DL, 2008, OECOLOGIA, V156, P387, DOI 10.1007/s00442-008-0994-1; Perfecto I, 2008, ECOLOGY, V89, P915, DOI 10.1890/06-2121.1; Peterson R. O., 1977, US DEP INTERIOR NATL, V11; Peterson RO, 1998, J MAMMAL, V79, P828, DOI 10.2307/1383091; PETERSON RO, 1988, J MAMMAL, V69, P89, DOI 10.2307/1381751; Peterson RO, 2010, ECOL LETT, V13, P1124, DOI 10.1111/j.1461-0248.2010.01504.x; PHILLIPS RL, 1973, J WILDLIFE MANAGE, V37, P266, DOI 10.2307/3800117; Puttock GD, 1996, FOREST ECOL MANAG, V81, P169, DOI 10.1016/0378-1127(95)03644-X; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; Ritchie ME, 1999, NATURE, V400, P557, DOI 10.1038/23010; Rodewald AD, 2002, J WILDLIFE MANAGE, V66, P634, DOI 10.2307/3803130; ROWLINGSON BS, 1993, COMPUT GEOSCI, V19, P627, DOI 10.1016/0098-3004(93)90099-Q; Sand H, 2012, OIKOS, V121, P1454, DOI 10.1111/j.1600-0706.2012.20082.x; SIH A, 1984, AM NAT, V123, P143, DOI 10.1086/284193; Stenseth NC, 2004, P NATL ACAD SCI USA, V101, P10632, DOI 10.1073/pnas.0308674101; Stenseth NC, 1998, P NATL ACAD SCI USA, V95, P15430, DOI 10.1073/pnas.95.26.15430; Steury TD, 2010, J WILDLIFE MANAGE, V74, P539, DOI 10.2193/2008-327; Sundell J, 2004, J ANIM ECOL, V73, P167, DOI 10.1111/j.1365-2656.2004.00795.x; Venables WN., 2002, MODERN APPL STAT S 4; Vucetich J. A., 2011, ECOLOGICAL STUDIES W; Vucetich JA, 2004, OIKOS, V107, P309, DOI 10.1111/j.0030-1299.2004.13483.x; Vucetich JA, 2002, ECOLOGY, V83, P3003; Vucetich JA, 2011, J ANIM ECOL, V80, P1236, DOI 10.1111/j.1365-2656.2011.01855.x; Wickham JD, 2010, REMOTE SENS ENVIRON, V114, P1286, DOI 10.1016/j.rse.2010.01.018; Wikenros C, 2009, ACTA THERIOL, V54, P207, DOI 10.4098/j.at.0001-7051.082.2008; Wilmers CC, 2006, ECOL LETT, V9, P383, DOI 10.1111/j.1461-0248.2006.00890.x; Wilmers CC, 2004, ECOL MODEL, V177, P193, DOI 10.1016/j.ecolmodel.2004.02.007; Wilson RR, 2010, J WILDLIFE MANAGE, V74, P1343, DOI 10.2193/2009-438; Wright GJ, 2006, J WILDLIFE MANAGE, V70, P1070, DOI 10.2193/0022-541X(2006)70[1070:SONYEB]2.0.CO;2	84	20	20	1	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91414	10.1371/journal.pone.0091414	http://dx.doi.org/10.1371/journal.pone.0091414			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622241	Green Published, gold			2022-12-27	WOS:000332845300086
J	Senna, I; Maravita, A; Bolognini, N; Parise, CV				Senna, Irene; Maravita, Angelo; Bolognini, Nadia; Parise, Cesare V.			The Marble-Hand Illusion	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; ADAPTATION; EMBODIMENT; SOUNDS	Our body is made of flesh and bones. We know it, and in our daily lives all the senses constantly provide converging information about this simple, factual truth. But is this always the case? Here we report a surprising bodily illusion demonstrating that humans rapidly update their assumptions about the material qualities of their body, based on their recent multisensory perceptual experience. To induce a misperception of the material properties of the hand, we repeatedly gently hit participants' hand with a small hammer, while progressively replacing the natural sound of the hammer against the skin with the sound of a hammer hitting a piece of marble. After five minutes, the hand started feeling stiffer, heavier, harder, less sensitive, unnatural, and showed enhanced Galvanic skin response (GSR) to threatening stimuli. Notably, such a change in skin conductivity positively correlated with changes in perceived hand stiffness. Conversely, when hammer hits and impact sounds were temporally uncorrelated, participants did not spontaneously report any changes in the perceived properties of the hand, nor did they show any modulation in GSR. In two further experiments, we ruled out that mere audio-tactile synchrony is the causal factor triggering the illusion, further demonstrating the key role of material information conveyed by impact sounds in modulating the perceived material properties of the hand. This novel bodily illusion, the 'Marble-Hand Illusion', demonstrates that the perceived material of our body, surely the most stable attribute of our bodily self, can be quickly updated through multisensory integration.	[Senna, Irene; Maravita, Angelo; Bolognini, Nadia] Milano Bicocca Univ, Fac Psychol, Milan, Italy; [Bolognini, Nadia] IRCCS Ist Auxol Italiano, Milan, Italy; [Parise, Cesare V.] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Parise, Cesare V.] Bernstein Ctr Computat Neurosci, Tubingen, Germany; [Senna, Irene; Parise, Cesare V.] Univ Bielefeld, Cognit Neurosci Dept, D-33615 Bielefeld, Germany; [Senna, Irene; Parise, Cesare V.] Univ Bielefeld, Cognit Interact Technol Ctr Excellence, D-33615 Bielefeld, Germany	University of Milano-Bicocca; IRCCS Istituto Auxologico Italiano; Max Planck Society; University of Bielefeld; University of Bielefeld	Senna, I (corresponding author), Milano Bicocca Univ, Fac Psychol, Milan, Italy.	irene.senna@uni-bielefeld.de; cesare.parise@uni-bielefeld.de	Parise, Cesare/AAY-2913-2020; BOLOGNINI, NADIA/J-5746-2016	BOLOGNINI, NADIA/0000-0002-2921-8658; Senna, Irene/0000-0002-3237-8193	Bernstein Center for Computational Neuroscience, Tubingen; German Federal Ministry of Education and Research (BMBF) [FKZ: 01GQ1002]; EU [248587]; FAR grants (University of Milano-Bicocca)	Bernstein Center for Computational Neuroscience, Tubingen; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); FAR grants (University of Milano-Bicocca)	C.P. was supported by the Bernstein Center for Computational Neuroscience, Tubingen, funded by the German Federal Ministry of Education and Research (BMBF; FKZ: 01GQ1002), and by the EU grant 248587 "THE''; N.B. and A. M. were supported by FAR grants (University of Milano-Bicocca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; Ehrsson HH, 2008, BRAIN, V131, P3443, DOI 10.1093/brain/awn297; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Forgiarini M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00108; Giordano BL, 2006, J ACOUST SOC AM, V119, P1171, DOI 10.1121/1.2149839; Giummarra MJ, 2008, NEUROSCI BIOBEHAV R, V32, P143, DOI 10.1016/j.neubiorev.2007.07.001; Guest S, 2002, EXP BRAIN RES, V146, P161, DOI 10.1007/s00221-002-1164-z; Guterstam A, 2013, J COGNITIVE NEUROSCI, V25, P1078, DOI 10.1162/jocn_a_00393; Jousmaki V, 1998, CURR BIOL, V8, pR190, DOI 10.1016/S0960-9822(98)70120-4; Kagerer FA, 1997, EXP BRAIN RES, V115, P557, DOI 10.1007/PL00005727; Kleiner M, 2007, PERCEPTION, V36, P14; Knoblich G, 2005, PERCEPTION HUMAN BOD; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Michel C, 2007, J COGNITIVE NEUROSCI, V19, P341, DOI 10.1162/jocn.2007.19.2.341; Navarra J, 2007, NEUROSCI LETT, V413, P72, DOI 10.1016/j.neulet.2006.11.027; Newport R, 2011, CURR BIOL, V21, pR804, DOI 10.1016/j.cub.2011.08.044; Parise CV, 2012, CURR BIOL, V22, P46, DOI 10.1016/j.cub.2011.11.039; Ploghaus A, 2001, J NEUROSCIENCE; Rhudy JL, 2010, PAIN, V148, P320, DOI 10.1016/j.pain.2009.11.018; Tajadura-Jimenez A, 2012, CURR BIOL, V22, pR516, DOI 10.1016/j.cub.2012.04.028; Zampini M, 2005, ACTA PSYCHOL, V118, P277, DOI 10.1016/j.actpsy.2004.10.017	23	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91688	10.1371/journal.pone.0091688	http://dx.doi.org/10.1371/journal.pone.0091688			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24621793	gold, Green Published, Green Submitted			2022-12-27	WOS:000332845300118
J	Zhang, Y; Schiff, D; Park, D; Abounader, R				Zhang, Ying; Schiff, David; Park, Deric; Abounader, Roger			MicroRNA-608 and MicroRNA-34a Regulate Chordoma Malignancy by Targeting EGFR, Bcl-xL and MET	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; C-MET; DIFFERENTIAL EXPRESSION; P53; PROLIFERATION; HYBRIDIZATION; GLIOBLASTOMA; CHROMOSOME-7; ACTIVATION; BCL-X(L)	Chordomas are rare malignant tumors that originate from the notochord remnants and occur in the skull base, spine and sacrum. Due to a very limited understanding of the molecular pathogenesis of chordoma, there are no adjuvant and molecular therapies besides surgical resection and radiation therapy. microRNAs (miRNAs) are small noncoding regulatory RNA molecules with critical roles in cancer. The role of miRNAs in chordomas is mostly unknown. We uncover microRNA-608 (miR-608) and microRNA-34a (miR-34a) as novel tumor suppressive microRNAs that regulate malignancy in chordoma. We find that miR-608 and miR-34a expressions are downregulated in human chordoma cell lines and primary cells at least partially via alteration of their genes' copy numbers. We identify the commonly deregulated oncogenes EGFR and Bcl-xL as direct targets of miR-608 and the receptor tyrosine kinase MET as direct target of miR-34a. We show that EGFR and MET activations promote chordoma cell proliferation and invasion and that pharmacological inhibition of EGFR and MET inhibits chordoma cell proliferation and survival. We demonstrate that restoration of miR-608 and miR-34a inhibits cell proliferation and invasion and induces apoptosis in chordoma cells. We find that miR-34a inversely correlates with MET expression and miR-608 inversely correlates with EGFR expression in chordoma cells. These findings demonstrate for the first time that miR-608 and miR-34a regulate chordoma malignancy by regulating EGFR, MET and Bcl-xL.	[Zhang, Ying; Abounader, Roger] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Zhang, Ying; Abounader, Roger] Univ Virginia, Dept Immunol, Charlottesville, VA USA; [Zhang, Ying; Abounader, Roger] Univ Virginia, Dept Canc Biol, Charlottesville, VA USA; [Schiff, David; Abounader, Roger] Univ Virginia, Dept Neurol, Charlottesville, VA USA; [Park, Deric] Univ Virginia, Dept Neurosurg, Charlottesville, VA USA; [Abounader, Roger] Univ Virginia, Ctr Canc, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Zhang, Y (corresponding author), Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA.	yz5h@virginia.edu; ra6u@virginia.edu			National Institutes of Health [RO1 NS045209]; NIH [R01 CA134843]; NATIONAL CANCER INSTITUTE [P30CA044579, R01CA134843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by National Institutes of Health RO1 NS045209 and NIH R01 CA134843 to R. Abounader. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abounader R, 1999, J NATL CANCER I, V91, P1548, DOI 10.1093/jnci/91.18.1548; Abounader R, 2005, NEURO-ONCOLOGY, V7, P436, DOI 10.1215/S1152851705000050; Afanasyeva EA, 2011, CELL DEATH DIFFER, V18, P974, DOI 10.1038/cdd.2010.164; Bayrak OF, 2013, J NEURO-ONCOL, V115, P143, DOI 10.1007/s11060-013-1211-6; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bruederlein Silke, 2010, Sarcoma, V2010, P630129, DOI 10.1155/2010/630129; Bydon M, 2012, EXPERT OPIN THER TAR, V16, P1139, DOI 10.1517/14728222.2012.714772; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chugh R, 2007, ONCOLOGIST, V12, P1344, DOI 10.1634/theoncologist.12-11-1344; Coskun E, 2011, LEUKEMIA RES, V35, P208, DOI 10.1016/j.leukres.2010.05.007; De Martino I, 2009, ONCOGENE, V28, P1432, DOI 10.1038/onc.2008.495; Dewaele B, 2011, CLIN SARCOMA RES, V1, DOI 10.1186/2045-3329-1-4; Duan ZF, 2010, J ORTHOP RES, V28, P746, DOI 10.1002/jor.21055; Fasig JH, 2008, NEUROPATH APPL NEURO, V34, P95, DOI 10.1111/j.1365-2990.2007.00873.x; Grabellus F, 2010, TUMOR BIOL, V31, P157, DOI 10.1007/s13277-010-0021-0; Guan XX, 2013, FASEB J, V27, P1404, DOI 10.1096/fj.12-223420; Guan YL, 2010, CLIN CANCER RES, V16, P4289, DOI 10.1158/1078-0432.CCR-10-0207; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Le LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018846; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Li J, 2011, MOL CELL BIOCHEM, V357, P31, DOI 10.1007/s11010-011-0872-8; Li YQ, 2005, CANCER RES, V65, P9355, DOI 10.1158/0008-5472.CAN-05-1946; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Long C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066676; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Melo SA, 2011, FEBS LETT, V585, P2087, DOI 10.1016/j.febslet.2010.08.009; Minn AJ, 1996, GENE DEV, V10, P2621, DOI 10.1101/gad.10.20.2621; Naka T, 1997, MODERN PATHOL, V10, P832; Naka T, 2008, CANCER-AM CANCER SOC, V112, P104, DOI 10.1002/cncr.23141; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Nguyen-Huynh A, 2006, OTOLARYNG CLIN N AM, V39, P783, DOI 10.1016/j.otc.2006.04.006; Ostroumov E, 2008, SPINE, V33, P2774, DOI 10.1097/BRS.0b013e31817e2d1e; Pandey DP, 2009, MOL CELL BIOL, V29, P3783, DOI 10.1128/MCB.01875-08; Ptaszynski K, 2009, POL J PATHOL, V60, P81; Ruddel J, 2010, ANTICANCER RES, V30, P4579; Scheil S, 2001, GENE CHROMOSOME CANC, V32, P203, DOI 10.1002/gcc.1184; Schimanski CC, 2009, WORLD J GASTROENTERO, V15, P2089, DOI 10.3748/wjg.15.2089; Sciubba DM, 2008, NEUROSURG CLIN N AM, V19, P5, DOI 10.1016/j.nec.2007.09.006; Shalaby A, 2011, J PATHOL, V223, P336, DOI 10.1002/path.2818; Silber J, 2009, NEUROMOL MED, V11, P208, DOI 10.1007/s12017-009-8087-9; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Walter BA, 2011, J NEURO-ONCOL, V101, P199, DOI 10.1007/s11060-010-0250-5; Weinberger PM, 2005, ARCH OTOLARYNGOL, V131, P707, DOI 10.1001/archotol.131.8.707; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895; Zhang Y, 2012, FRONT BIOSCI-LANDMRK, V17, P700, DOI 10.2741/3952	49	66	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91546	10.1371/journal.pone.0091546	http://dx.doi.org/10.1371/journal.pone.0091546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621885	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300102
J	Araujo, CP; Osorio, ALAR; Jorge, KSG; Ramos, CAN; Filho, AFS; Vidal, CES; Roxo, E; Nishibe, C; Almeida, NF; Junior, AAF; Silva, MR; Neto, JDB; Cerqueira, VD; Zumarraga, MJ; Araujo, FR				Araujo, Cristina P.; Osorio, Ana Luiza A. R.; Jorge, Klaudia S. G.; Ramos, Carlos Alberto N.; Filho, Antonio Francisco S.; Vidal, Carlos Eugenio S.; Roxo, Eliana; Nishibe, Christiane; Almeida, Nalvo F.; Junior, Antonio A. F.; Silva, Marcio R.; Neto, Jose Diomedes B.; Cerqueira, Valiria D.; Zumarraga, Martin J.; Araujo, Flabio R.			Detection of Mycobacterium bovis in Bovine and Bubaline Tissues Using Nested-PCR for TbD1	PLOS ONE			English	Article							TUBERCULOSIS COMPLEX; STRAINS; CATTLE; IDENTIFICATION; AFRICANUM	In the present study, a nested-PCR system, targeting the TbD1 region, involving the performance of conventional PCR followed by real-time PCR, was developed to detect Mycobacterium bovis in bovine/bubaline tissue homogenates. The sensitivity and specificity of the reactions were assessed with DNA samples extracted from tuberculous and non-tuberculous mycobacteria, as well as other actinomycetales species and DNA samples extracted directly from bovine and bubaline tissue homogenates. In terms of analytical sensitivity, the DNA of M. bovis AN5 was detected up to 1.56 ng with conventional PCR, 97.6 pg with real-time PCR, and 1.53 pg with nested-PCR in the reaction mixture. The nested-PCR exhibited 100% analytical specificity for M. bovis when tested with the DNA of reference strains of environmental mycobacteria and closely-related Actinomycetales. A clinical sensitivity value of 76.0% was detected with tissue samples from animals that exhibited positive results in the comparative intradermal tuberculin test (CITT), as well as from those with lesions compatible with tuberculosis (LCT) that rendered positive cultures. A clinical specificity value of 100% was detected with tissue samples from animals with CITT-results, with no visible lesions (NVL) and negative cultures. No significant differences were found between the nested-PCR and culture in terms of detecting CITT+ animals with LCT or with NVL. No significant differences were recorded in the detection of CITT- animals with NVL. However, nested-PCR detected a significantly higher number of positive animals than the culture in the group of animals exhibiting LCT with no previous records of CITT. The use of the nested-PCR assay to detect M. bovis in tissue homogenates provided a rapid diagnosis of bovine and bubaline tuberculosis.	[Araujo, Cristina P.; Osorio, Ana Luiza A. R.; Jorge, Klaudia S. G.; Filho, Antonio Francisco S.] Univ Fed Mato Grosso do Sul, Programa Posgrad Ciencia Anim FAMEZ, Campo Grande, MS, Brazil; [Vidal, Carlos Eugenio S.] Univ Fed Santa Maria, PPGMV, Santa Maria, RS, Brazil; [Roxo, Eliana] Inst Biol Sao Paulo, Sao Paulo, Brazil; [Nishibe, Christiane; Almeida, Nalvo F.] Univ Fed Mato Grosso do Sul, Fac Comp, Campo Grande, MS, Brazil; [Junior, Antonio A. F.] Lab Nacl Agr, Pedro Leopoldo, MG, Brazil; [Silva, Marcio R.] Embrapa Gado Leite, Juiz De Fora, MG, Brazil; [Neto, Jose Diomedes B.; Cerqueira, Valiria D.] UFPA, Castanhal, PA, Brazil; [Zumarraga, Martin J.] Inst Nacl Tecnol Agr, Inst Biotecnol, Buenos Aires, DF, Argentina; [Araujo, Flabio R.] Embrapa Gado Corte, Campo Grande, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Federal de Santa Maria (UFSM); Universidade Federal de Mato Grosso do Sul; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal do Para; Instituto Nacional de Tecnologia Agropecuaria (INTA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Araujo, FR (corresponding author), Embrapa Gado Corte, Campo Grande, MS, Brazil.	flabio.araujo@embrapa.br	Cerqueira, Valíria/AAW-8867-2020; Silva, Marcio Roberto/V-9005-2019; cerqueira, valiria/AAG-7542-2019; de Souza Filho, Antonio Francisco/G-2382-2015; Fonseca, Antônio Augusto/AAW-4082-2020; Almeida, Nalvo/B-5856-2012; Roxo, Eliana/C-3313-2011	de Souza Filho, Antonio Francisco/0000-0003-4728-1228; Fonseca, Antônio Augusto/0000-0002-2962-5616; Roxo, Eliana/0000-0002-1415-6407; Nascimento Ramos, Carlos Albero/0000-0002-3084-172X; Almeida, Nalvo/0000-0001-5615-1746	CNPq [578278/2008, 479394/2011-3, 305857/2013-4, 310165/2010-5]; FUNDECT [23/200.152/2009, 23/200.582/2012, TO-0096/2012]; Embrapa [03.11.22.003.00.00]; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FUNDECT(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	CNPq (grants 578278/2008, 479394/2011-3, 305857/2013-4 and 310165/2010-5), FUNDECT (grants 23/200.152/2009, 23/200.582/2012 and TO-0096/2012), Embrapa (grants 03.11.22.003.00.00) and CAPES (PhD fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2010, EMERG INFECT DIS, V16, P1296, DOI 10.3201/eid1608.100314; ALFREDSEN S, 1992, VET REC, V131, P51, DOI 10.1136/vr.131.3.51; Ameni G, 2011, VET J, V188, P359, DOI 10.1016/j.tvjl.2010.05.005; [Anonymous], 2012, NORM INT DAS; Ansari-Lari M, 2005, VET PARASITOL, V133, P369, DOI 10.1016/j.vetpar.2005.06.005; Aranaz A, 2003, INT J SYST EVOL MICR, V53, P1785, DOI 10.1099/ijs.0.02532-0; Banu S, 2012, INT J TUBERC LUNG D, V16, P319, DOI 10.5588/ijtld.11.0426; Barandiaran S, 2013, REV ARGENT MICROBIOL, V45, P91; Beyene D, 2009, J INFECT DEV COUNTR, V3, P412, DOI 10.3855/jidc.411; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; CASTETS M, 1969, Bulletin de la Societe Medicale d'Afrique Noire de Langue Francaise, V14, P693; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Costa P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081337; Cousins DV, 2003, INT J SYST EVOL MICR, V53, P1305, DOI 10.1099/ijs.0.02401-0; DUFFIELD BJ, 1989, AUST VET J, V66, P307, DOI 10.1111/j.1751-0813.1989.tb13964.x; Flynn O, 2001, VET MICROBIOL, V78, P221, DOI 10.1016/S0378-1135(00)00297-2; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Johansen IS, 2004, J MOL DIAGN, V6, P231, DOI 10.1016/S1525-1578(10)60515-6; Lahlou O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047113; Mbugi Erasto V., 2012, Onderstepoort j. vet. res., V79, P01; Ministerio da Agricultura Pecuaria e Abastecimento, 2006, PROGR NAC CONTR ERR; Mostowy S, 2005, J BACTERIOL, V187, P6386, DOI 10.1128/JB.187.18.6386-6395.2005; Muller B, 2013, EMERG INFECT DIS, V19, P899, DOI 10.3201/eid1906.120543; Niemann S, 2000, J CLIN MICROBIOL, V38, P152; Niobe-Eyangoh SN, 2004, J CLIN MICROBIOL, V42, P5029, DOI 10.1128/JCM.42.11.5029-5035.2004; Parra A, 2008, VET MICROBIOL, V127, P315, DOI 10.1016/j.vetmic.2007.09.001; Petroff SA, 1915, J EXP MED, V21, P38, DOI 10.1084/jem.21.1.38; Rahim Zeaur, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P706; RODRIGUEZ JG, 1995, MICROBIOL-SGM, V141, P2131, DOI 10.1099/13500872-141-9-2131; Romero B, 2011, EMERG INFECT DIS, V17, P2393, DOI 10.3201/eid1712.101476; Sahraoui N, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-4; Schlesselman JJ, 1982, CASE CONTROL STUDIES, P205; Soini H, 2001, CLIN CHEM, V47, P809; Stavrum R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001973; Tanveer M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-171; Taylor G Michael, 2007, BMC Vet Res, V3, P12, DOI 10.1186/1746-6148-3-12; Thacker TC, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-50; Thakur A, 2012, INDIAN J MICROBIOL, V52, P289, DOI 10.1007/s12088-011-0200-8; Thomas SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027584; van der Merwe M, 2009, J S AFR VET ASSOC, V80, P142; van Ingen J, 2012, EMERG INFECT DIS, V18, P653, DOI 10.3201/eid1804.110888; Weber A, 1998, BERL MUNCH TIERARZTL, V111, P6; WELLS A. Q., 1937, LANCET, V232, P1221	43	20	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91023	10.1371/journal.pone.0091023	http://dx.doi.org/10.1371/journal.pone.0091023			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618787	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400043
J	Arreghini, M; Manzoni, GM; Castelnuovo, G; Santovito, C; Capodaglio, P				Arreghini, Marco; Manzoni, Gian Mauro; Castelnuovo, Gianluca; Santovito, Cristina; Capodaglio, Paolo			Impact of Fibromyalgia on Functioning in Obese Patients Undergoing Comprehensive Rehabilitation	PLOS ONE			English	Article							BODY-MASS INDEX; QUALITY-OF-LIFE; LOW-BACK-PAIN; KNEE OSTEOARTHRITIS; MUSCULOSKELETAL PAIN; GENERAL-POPULATION; RISK-FACTORS; WEIGHT-LOSS; PREVALENCE; GENDER	A possible link between fibromyalgia (FM) and obesity has been recently suggested but very scanty data on the prevalence of FM in obese populations are available. The aims of the present cross-sectional study were: 1) to estimate the prevalence of FM in a population of obese patients undergoing rehabilitation and 2) to investigate the effect of FM on obese patients' functional capacities. One hundred and thirty Italian obese (Body Mass Index, BMI >= 30) patients admitted to hospital for 1-month rehabilitation treatment took part in the study. All participants were interviewed by a rheumatologist according to the 2010 American College of Rheumatology (ACR) diagnostic criteria for FM. At admission and discharge from hospital (on average, after 28 days), the following measures were compared between the group of patients with FM and the other patients: body weight, body mass index, functional independence (FIM), obesity-related disability (TSD-OC), self-reported functioning and the Timed-Up-Go (TUG) test. Thirty seven patients out of 130 fulfilled the diagnostic criteria for FM. The prevalence rate was 27.7% (95% CI: 20 to 35.4). Between-group comparisons showed that FM patients had higher disability level at the first assessment, had lower scores on the FIM at the final assessment, scored lower on self-reported functioning both at the first and the final assessments and had a lower body weight. The prevalence of FM in our study is much higher than the rates reported in the general normal-weight population (on average, 3.5%) and the 5.15% rate previously reported in a bariatric population. Functional data showed that the FM obese group yielded lower performance capacity and higher disability level as compared to the non-FM obese group. However, due to the relatively small sample size and the selected population, such results need to be confirmed in larger obese subpopulations.	[Arreghini, Marco; Santovito, Cristina; Capodaglio, Paolo] Ist Auxol Italiano IRCCS, Rehabil Unit, Oggebbio, VB, Italy; [Manzoni, Gian Mauro; Castelnuovo, Gianluca] Ist Auxol Italiano IRCCS, Psychol Res Lab, Oggebbio, VB, Italy; [Manzoni, Gian Mauro; Castelnuovo, Gianluca] Catholic Univ Milan, Dept Psychol, Milan, Italy	IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano; Catholic University of the Sacred Heart	Capodaglio, P (corresponding author), Ist Auxol Italiano IRCCS, Rehabil Unit, Oggebbio, VB, Italy.	p.capodaglio@auxologico.it	Manzoni, Gian Mauro/L-3891-2019; Paolo, Capodaglio/AAB-7795-2019	Manzoni, Gian Mauro/0000-0003-3384-0359; Paolo, Capodaglio/0000-0003-3719-8789				[Anonymous], 1996, SPSS US MAN EX TESTS; Arnold LM, 2006, J CLIN PSYCHIAT, V67, P1219, DOI 10.4088/JCP.v67n0807; Arnold LM, 2004, ARTHRITIS RHEUM-US, V50, P944, DOI 10.1002/art.20042; Arranz L, 2012, RHEUMATOL INT, V32, P3605, DOI 10.1007/s00296-011-2250-y; Bazzichi L, 2007, CLIN EXP RHEUMATOL, V25, P225; Becker J, 2002, CLIN NEUROPHYSIOL, V113, P1429, DOI 10.1016/S1388-2457(02)00201-8; Bennett RM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-27; Bingefors K, 2004, EUR J PAIN, V8, P435, DOI 10.1016/j.ejpain.2004.01.005; Branco JC, 2010, SEMIN ARTHRITIS RHEU, V39, P448, DOI 10.1016/j.semarthrit.2008.12.003; Bureau UC, 2000, US CENS BUR US CENS; Capodaglio P, 2013, EUR J PHYS REHAB MED, V49, P395; Capodaglio P., 2013, DISABLING OBESITY DE, V1st ed.; Capodaglio P, 2013, DISABIL REHABIL, V35, P1199, DOI 10.3109/09638288.2012.726313; Capodaglio P, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-47; CARMAN WJ, 1994, AM J EPIDEMIOL, V139, P119, DOI 10.1093/oxfordjournals.aje.a116974; Carmona L, 2001, ANN RHEUM DIS, V60, P1040, DOI 10.1136/ard.60.11.1040; Christensen R, 2005, OSTEOARTHR CARTILAGE, V13, P20, DOI 10.1016/j.joca.2004.10.008; Cimolin V, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-55; Cohen J.E., 1988, STAT POWER ANAL BEHA; Donini LM, 2011, DISABIL REHABIL, V33, P2509, DOI 10.3109/09638288.2011.575529; FELSON DT, 1992, ANN INTERN MED, V116, P535, DOI 10.7326/0003-4819-116-7-535; Geoghegan JM, 2004, J HAND SURG-BRIT EUR, V29B, P315, DOI 10.1016/j.jhsb.2004.02.009; Hamilton B. B., 1987, REHABILITATION OUTCO, P137; Han TS, 1997, INT J OBESITY, V21, P600, DOI 10.1038/sj.ijo.0800448; Holmberg S, 2005, SCAND J RHEUMATOL, V34, P59, DOI 10.1080/03009740510017922; Hudson JI, 1996, RHEUM DIS CLIN N AM, V22, P285, DOI 10.1016/S0889-857X(05)70273-8; JACOBSEN S, 1993, SCAND J RHEUMATOL, V22, P69, DOI 10.3109/03009749309095118; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; MAKELA M, 1991, BRIT MED J, V303, P216, DOI 10.1136/bmj.303.6796.216; Malatesta D, 2009, MED SCI SPORT EXER, V41, P426, DOI 10.1249/MSS.0b013e31818606e7; Mannerkorpi K, 2006, ARCH PHYS MED REHAB, V87, P259, DOI 10.1016/j.apmr.2005.10.013; Mannerkorpi K, 1999, ARTHRIT CARE RES, V12, P193, DOI 10.1002/1529-0131(199906)12:3<193::AID-ART6>3.0.CO;2-N; MARTINEZ JE, 1995, J RHEUMATOL, V22, P270; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; McBeth J, 2012, NAT REV RHEUMATOL, V8, P108, DOI 10.1038/nrrheum.2011.216; Menegoni F, 2009, OBESITY, V17, P1951, DOI 10.1038/oby.2009.82; Mork PJ, 2010, ARTHRIT CARE RES, V62, P611, DOI 10.1002/acr.20118; Neumann L, 2008, CLIN RHEUMATOL, V27, P1543, DOI 10.1007/s10067-008-0966-1; Okifuji A, 2010, J PAIN, V11, P1329, DOI 10.1016/j.jpain.2010.03.006; Okifuji A, 2009, CLIN RHEUMATOL, V28, P475, DOI 10.1007/s10067-009-1094-2; Peltonen M, 2003, PAIN, V104, P549, DOI 10.1016/S0304-3959(03)00091-5; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; PRESCOTT E, 1993, SCAND J RHEUMATOL, V22, P233, DOI 10.3109/03009749309095129; Saber AA, 2008, OBES SURG, V18, P652, DOI 10.1007/s11695-008-9505-z; Salaffi F, 2005, CLIN EXP RHEUMATOL, V23, P819; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Stallings SP, 1997, J HAND SURG-AM, V22A, P211, DOI 10.1016/S0363-5023(97)80153-0; Ursini F, 2011, RHEUMATOL INT, V31, P1403, DOI 10.1007/s00296-011-1885-z; Vismara L, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-3; Wahner-Roedler DL, 2007, GENDER MED, V4, P329, DOI 10.1016/S1550-8579(07)80062-3; Wang HL, 2008, J RHEUMATOL, V35, P1366; White KP, 1999, J RHEUMATOL, V26, P1570; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2013, ARTHRIT CARE RES, V65, P777, DOI 10.1002/acr.21931; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Yunus MB, 2002, SCAND J RHEUMATOL, V31, P27, DOI 10.1080/030097402317255336	58	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91392	10.1371/journal.pone.0091392	http://dx.doi.org/10.1371/journal.pone.0091392			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618795	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400084
J	Bake, S; Selvamani, A; Cherry, J; Sohrabji, F				Bake, Shameena; Selvamani, Amutha; Cherry, Jessica; Sohrabji, Farida			Blood Brain Barrier and Neuroinflammation Are Critical Targets of IGF-1-Mediated Neuroprotection in Stroke for Middle-Aged Female Rats	PLOS ONE			English	Article							GROWTH-FACTOR-I; CEREBRAL-ARTERY OCCLUSION; TRANSIENT FOCAL ISCHEMIA; IGF-I; ENDOTHELIAL-CELLS; SEX-DIFFERENCES; INSULIN; EXPRESSION; ESTROGEN; INJURY	Ischemia-induced cerebral infarction is more severe in older animals as compared to younger animals, and is associated with reduced availability of insulin-like growth factor (IGF)-1. This study determined the effect of post-stroke IGF-1 treatment, and used microRNA profiling to identify mechanisms underlying IGF-1's neuroprotective actions. Post-stroke ICV administration of IGF-1 to middle-aged female rats reduced infarct volume by 39% when measured 24h later. MicroRNA analyses of ischemic tissue collected at the early post-stroke phase (4h) indicated that 8 out of 168 disease-related miRNA were significantly downregulated by IGF-1. KEGG pathway analysis implicated these miRNA in PI3K-Akt signaling, cell adhesion/ECM receptor pathways and T- and B-cell signaling. Specific components of these pathways were subsequently analyzed in vehicle and IGF-1 treated middle-aged females. Phospho-Akt was reduced by ischemia at 4h, but elevated by IGF-1 treatment at 24h. IGF-1 induced Akt activation was preceded by a reduction of blood brain barrier permeability at 4h post-stroke and global suppression of cytokines including IL-6, IL-10 and TNF-alpha. A subset of these cytokines including IL-6 was also suppressed by IGF-1 at 24h post-stroke. These data are the first to show that the temporal and mechanistic components of post-stroke IGF-1 treatment in older animals, and that cellular components of the blood brain barrier may serve as critical targets of IGF-1 in the aging brain.	[Bake, Shameena; Selvamani, Amutha; Cherry, Jessica; Sohrabji, Farida] Texas A&M Univ, Coll Med, Womens Hlth Neurosci Program, Dept Neurosci & Expt Therapeut, Bryan, TX USA	Texas A&M University System; Texas A&M University College Station	Sohrabji, F (corresponding author), Texas A&M Univ, Coll Med, Womens Hlth Neurosci Program, Dept Neurosci & Expt Therapeut, Bryan, TX USA.	sohrabji@medicine.tamhsc.edu		Sohrabji, Farida/0000-0002-6960-3411	NIH [NS074895]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074895] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH NS074895 to FS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg D, 2011, J CLIN ENDOCR METAB, V96, pE1055, DOI 10.1210/jc.2010-2802; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954; Bake S, 2004, ENDOCRINOLOGY, V145, P5471, DOI 10.1210/en.2004-0984; Bake S, 2008, ENDOCRINOLOGY, V149, P3881, DOI 10.1210/en.2008-0288; Brywe KG, 2005, ENDOCRINOLOGY, V146, P4665, DOI 10.1210/en.2005-0389; Chi OZ, 2007, EXP NEUROL, V204, P283, DOI 10.1016/j.expneurol.2006.11.001; Chisalita SI, 2004, AM J PHYSIOL-ENDOC M, V286, pE896, DOI 10.1152/ajpendo.00327.2003; Chisalita SI, 2006, GROWTH HORM IGF RES, V16, P258, DOI 10.1016/j.ghir.2006.06.003; Clark D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047792; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Denli AM, 2003, TRENDS BIOCHEM SCI, V28, P196, DOI 10.1016/S0968-0004(03)00058-6; DiNapoli VA, 2008, NEUROBIOL AGING, V29, P753, DOI 10.1016/j.neurobiolaging.2006.12.007; Faber JE, 2011, ARTERIOSCL THROM VAS, V31, P1748, DOI 10.1161/ATVBAHA.111.227314; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Garcia-Galloway E, 2003, MOL CELL NEUROSCI, V24, P1027, DOI 10.1016/j.mcn.2003.08.005; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; GLUCKMAN P, 1992, BIOCHEM BIOPH RES CO, V182, P593, DOI 10.1016/0006-291X(92)91774-K; Hatakeyama N, 2008, CELL TISSUE RES, V334, P243, DOI 10.1007/s00441-008-0690-9; Hochdorfer T, 2011, CELL SIGNAL, V23, P866, DOI 10.1016/j.cellsig.2011.01.012; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Israeli D, 2011, INT J BIOL SCI, V7, P1; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Jezierski MK, 2001, NEUROBIOL AGING, V22, P309; Jezierski MK, 2000, MOL BRAIN RES, V85, P77, DOI 10.1016/S0169-328X(00)00244-8; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Johnsen SP, 2005, J CLIN ENDOCR METAB, V90, P5937, DOI 10.1210/jc.2004-2088; JOHNSON SA, 1995, J IMMUNOL, V155, P4596; KIM JS, 1995, J NEUROIMMUNOL, V56, P127, DOI 10.1016/0165-5728(94)00138-E; Kleinschnitz C, 2013, BLOOD, V121, P679, DOI 10.1182/blood-2012-04-426734; Ko JA, 2009, CELL BIOCHEM FUNCT, V27, P388, DOI 10.1002/cbf.1587; Lee M, 2012, J NEUROL SCI, V313, P142, DOI 10.1016/j.jns.2011.08.048; Lee Won Jun, 2011, Immune Netw, V11, P223, DOI 10.4110/in.2011.11.4.223; Leon RL, 2012, ENDOCRINOLOGY, V153, P3386, DOI 10.1210/en.2011-1859; Lewis DK, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.007; Lin SY, 2009, EXP NEUROL, V217, P361, DOI 10.1016/j.expneurol.2009.03.021; Liu FD, 2009, J CEREBR BLOOD F MET, V29, P792, DOI 10.1038/jcbfm.2009.5; Manwani B, 2013, EXP NEUROL; Matsuzaki H, 1999, J NEUROCHEM, V73, P2037; McColl BW, 2009, NEUROSCIENCE, V158, P1049, DOI 10.1016/j.neuroscience.2008.08.019; Mitsui R, 2010, ARCH ORAL BIOL, V55, P963, DOI 10.1016/j.archoralbio.2010.07.023; Muller AP, 2012, MOL CELL NEUROSCI, V49, P9, DOI 10.1016/j.mcn.2011.07.008; Nordell VL, 2003, NEUROBIOL AGING, V24, P733, DOI 10.1016/S0197-4580(02)00193-8; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Petrea RE, 2009, STROKE, V40, P1032, DOI 10.1161/STROKEAHA.108.542894; Potter KA, 2013, BIOMATERIALS, V34, P7001, DOI 10.1016/j.biomaterials.2013.05.035; Quesada A, 2004, J NEUROSCI RES, V75, P107, DOI 10.1002/jnr.10833; Rizk NN, 2007, ENDOCRINE, V31, P66, DOI 10.1007/s12020-007-0012-0; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Selvamani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032662; Selvamani A, 2010, J NEUROSCI, V30, P6852, DOI 10.1523/JNEUROSCI.0761-10.2010; Selvamani A, 2010, NEUROBIOL AGING, V31, P1618, DOI 10.1016/j.neurobiolaging.2008.08.014; Siegel C, 2011, P NATL ACAD SCI USA, V108, P11662, DOI 10.1073/pnas.1102635108; Smith PF, 2003, IDRUGS, V6, P1173; Taglauer ES, 2008, BIOL REPROD, V79, P562, DOI 10.1095/biolreprod.107.066324; Towfighi A, 2007, NEUROLOGY, V69, P1898, DOI 10.1212/01.wnl.0000268491.89956.c2; Tureyen K, 2008, J NEUROCHEM, V105, P1313, DOI 10.1111/j.1471-4159.2008.05233.x; Turtzo LC, 2008, CEREBROVASC DIS, V26, P462, DOI 10.1159/000155983; Wang JM, 2000, BRAIN RES, V859, P381, DOI 10.1016/S0006-8993(00)02008-4; Wang Y, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/276540; Wine RN, 2009, NEUROTOX RES, V16, P280, DOI 10.1007/s12640-009-9060-y; Xie R, 2013, J CEREB BLOOD FLOW M; Yoshimoto T, 2001, BRAIN RES, V899, P148, DOI 10.1016/S0006-8993(01)02220-X; Zhuang Z, 2011, ANN CLIN LAB SCI, V41, P364	66	66	71	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91427	10.1371/journal.pone.0091427	http://dx.doi.org/10.1371/journal.pone.0091427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618563	gold, Green Submitted, Green Published			2022-12-27	WOS:000332842400091
J	Chernobrovkin, AL; Zubarev, RA				Chernobrovkin, Alexey L.; Zubarev, Roman A.			Detection of Viral Proteins in Human Cells Lines by Xeno-Proteomics: Elimination of the Last Valid Excuse for Not Testing Every Cellular Proteome Dataset for Viral Proteins	PLOS ONE			English	Article							PEPTIDE IDENTIFICATION; CULTURES; MISIDENTIFICATION; RETROVIRUS; DNA	Cell cultures used routinely in proteomic experiments may contain proteins from other species because of infection, transfection or just contamination. Since infection or contamination may affect the results of a biological experiment, it is important to test the samples for the presence of "alien'' proteins. Usually cells are tested only for the most common infections, and most of the existing tests are targeting specific contaminations. Here we describe a three-step procedure for reliable untargeted detection of viral proteins using proteomics data, and recommend this or similar procedure to be applied to every proteomics dataset submitted for publication.	[Chernobrovkin, Alexey L.; Zubarev, Roman A.] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Zubarev, Roman A.] SciLifeLab, Stockholm, Sweden	Karolinska Institutet; SciLifeLab	Zubarev, RA (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	roman.zubarev@ki.se	Zubarev, Roman A/W-7891-2018; Chernobrovkin, Alexey/ABF-5732-2020	Zubarev, Roman A/0000-0001-9839-2089; 	Knut and Alice Wallenberg Foundation; Swedish Research council	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research council(Swedish Research CouncilEuropean Commission)	This work was supported by the Knut and Alice Wallenberg Foundation as well as the Swedish Research council.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Alves G, 2013, J PROTEOME RES; [Anonymous], 2012, NAT METHODS, V9, P419, DOI 10.1038/nmeth.2011; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Castro F, 2013, INT J CANCER, V132, P308, DOI 10.1002/ijc.27675; Cmarik JL, 2011, VIRUSES-BASEL, V3, P2442, DOI 10.3390/v3122442; Colaert N, 2011, J PROTEOME RES, V10, P5555, DOI 10.1021/pr200913a; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; Foster LJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006387; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gholami AM, 2013, CELL REP; Gillet J-P, 2013, J NATL CANC I; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Knudsen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020873; Korch C, 2012, GYNECOL ONCOL, V127, P241, DOI 10.1016/j.ygyno.2012.06.017; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; Lee D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044954; Lokhov P, 2009, RAPID COMMUN MASS SP, V23, P680, DOI 10.1002/rcm.3928; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Lyutvinskiy Y, 2013, MOL CELL PROTEOMICS, V12, P2324, DOI 10.1074/mcp.O112.023804; Mansky LM, 1998, J GEN VIROL, V79, P1337, DOI 10.1099/0022-1317-79-6-1337; Masters JR, 2012, NATURE, V492, P186, DOI 10.1038/492186a; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; Merten OW, 2002, CYTOTECHNOLOGY, V39, P91, DOI 10.1023/A:1022969101804; Mobley A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063221; Nesvizhskii A.I., 2007, METHODS MOL BIOL, V367, P87, DOI DOI 10.1385/1-59745-275-0:87; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schweppe RE, 2013, J CLIN ENDOCR METAB, V98, P956, DOI 10.1210/jc.2012-4182; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025	36	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91433	10.1371/journal.pone.0091433	http://dx.doi.org/10.1371/journal.pone.0091433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618588	Green Submitted, gold, Green Published			2022-12-27	WOS:000332842400093
J	Huang, HY; Wang, H; Li, LM; Wu, ZJ; Chen, JP				Huang, Huayuan; Wang, Hui; Li, Linmiao; Wu, Zhengjun; Chen, Jinping			Genetic Diversity and Population Demography of the Chinese Crocodile Lizard (Shinisaurus crocodilurus) in China	PLOS ONE			English	Article							CONSERVATION; INFERENCE; EVOLUTION; PROGRAM	The Chinese crocodile lizard Shinisaurus crocodilurus is a critically endangered species, listed in Appendix II of CITES. Its populations and habitat in China have undergone significant changes in recent years. Understanding the genetic variability and phylogeography of this species is very important for successful conservation. In this study, samples were taken from 11 wild ponds and two captive populations in China. We sequenced mitochondrial CYTB, partial ND6, and partial tRNA-Glu and genotyped 10 microsatellite loci. Our analyses of these data showed low genetic variability, no strong isolation caused by distance, and a lack of a phylogeographic structure in this species. Based on our results, the basal divergence between two clades of S. crocodilurus in China may have been caused by the formation of the Pearl River system. We found a population expansion in one of these clades. Microsatellite analysis indicated the presence of three clusters, separated by significant genetic differences. We found that most individuals in the two captive populations were from the Luokeng (Guangdong) and Guangxi wild source populations, respectively.	[Huang, Huayuan; Wu, Zhengjun] Guangxi Normal Univ, Coll Life Sci, Key Lab Rare & Endangered Anim Ecol, Guilin, Guangxi Provinc, Peoples R China; [Huang, Huayuan; Wang, Hui; Li, Linmiao; Chen, Jinping] South China Inst Endangered Anim, Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China	Guangxi Normal University; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Wu, ZJ (corresponding author), Guangxi Normal Univ, Coll Life Sci, Key Lab Rare & Endangered Anim Ecol, Guilin, Guangxi Provinc, Peoples R China.	2581572507@qq.com; chenjp@gdei.gd.cn			Program for Innovative Research Team of Crossdiscipline; National Natural Science Foundation of China [31060288, 31360522]; Funding project for excellent talents in Guangxi higher schools; Chinese Academy of Sciences	Program for Innovative Research Team of Crossdiscipline; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding project for excellent talents in Guangxi higher schools; Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the Program for Innovative Research Team of Crossdiscipline and cooperation from Chinese Academy of Sciences, the National Natural Science Foundation of China (No. 31060288, 31360522), Funding project for excellent talents in Guangxi higher schools. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahl E, 1930, SITZUNGSBERICHTE GES, V1, P329; Allendorf F., 2007, CONSERVATION GENETIC; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bei RB, 2012, CONSERV GENET RESOUR, V4, P743, DOI 10.1007/s12686-012-9635-4; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Chen Z, 2006, J GUANGXI NORMAL U N, V24, P83; Cunningham M, 1998, BIOL CONSERV, V83, P19, DOI 10.1016/S0006-3207(97)00046-3; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gong MH, 2006, STUDY POPULATION HAB; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gullberg A, 1998, BIOL J LINN SOC, V65, P257, DOI 10.1006/bijl.1998.0221; Hoehn M, 2007, MOL ECOL, V16, P3299, DOI 10.1111/j.1365-294X.2007.03352.x; Huang C. M., 2008, Animal Biodiversity and Conservation, V31, P63; Huang W., 2009, CHINESE J WILDLIFE, V30, P287; Levy E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046351; Li Zheng-Chang, 2002, Chinese Journal of Zoology, V37, P76; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Peng SM, 1988, 30 INT GEOL C; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Quyet L. K., 2003, HAMADRYAD, V27, P193; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Row JR, 2010, MOL ECOL, V19, P5157, DOI 10.1111/j.1365-294X.2010.04872.x; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; TAJIMA F, 1989, GENETICS, V123, P585; Wan J. J, 2009, THESIS SICHUAN U; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yu Hai, 2005, Sichuan Journal of Zoology, V24, P395; Zeng ZF, 2003, THESIS GUANGXI NORMA; Zhang Y. X, 2002, BIOL SHINISAURUS CRO; Zhang YX, 1991, CROCODILE LIZARD CHI	32	11	11	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91570	10.1371/journal.pone.0091570	http://dx.doi.org/10.1371/journal.pone.0091570			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618917	gold, Green Submitted, Green Published			2022-12-27	WOS:000332842400106
J	Joo, S; Han, D; Lee, EJ; Park, S				Joo, Sungbae; Han, Donguk; Lee, Eun Ju; Park, Sangkyu			Use of Length Heterogeneity Polymerase Chain Reaction (LH-PCR) as Non-Invasive Approach for Dietary Analysis of Svalbard Reindeer, Rangifer tarandus platyrhynchus	PLOS ONE			English	Article							PREY DNA; WINTER; AMPLIFICATION; MACROALGAE; PENGUINS; PRIMERS; REGION; FECES; FOOD	To efficiently investigate the forage preference of Svalbard reindeer (Rangifer tarandus platyrhynchus), we applied length-heterogeneity polymerase chain reaction (LH-PCR) based on length differences of internal transcribed spacer (ITS) regions of ribosomal RNA (rRNA) to fecal samples from R. tarandus platyrhynchus. A length-heterogeneity (LH) database was constructed using both collected potential food sources of Svalbard reindeer and fecal samples, followed by PCR, cloning and sequencing. In total, eighteen fecal samples were collected between 2011 and 2012 from 2 geographic regions and 15 samples were successfully amplified by PCR. The LH-PCR analysis detected abundant peaks, 18.6 peaks on an average per sample, ranging from 100 to 500 bp in size and showing distinct patterns associated with both regions and years of sample collection. Principal component analysis (PCA) resulted in clustering of 15 fecal samples into 3 groups by the year of collection and region with a statistically significant difference at 99.9% level. The first 2 principal components (PCs) explained 71.1% of the total variation among the samples. Through comparison with LH database and identification by cloning and sequencing, lichens (Stereocaulon sp. and Ochrolechia sp.) and plant species (Salix polaris and Saxifraga oppositifolia) were detected as the food sources that contributed most to the Svalbard reindeer diet. Our results suggest that the use of LH-PCR analysis would be a non-invasive and efficient monitoring tool for characterizing the foraging strategy of Svalbard reindeer. Additionally, combining sequence information would increase its resolving power in identification of foraged diet components.	[Joo, Sungbae; Park, Sangkyu] Ajou Univ, Dept Biol Sci, Suwon 441749, South Korea; [Han, Donguk; Lee, Eun Ju] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea	Ajou University; Seoul National University (SNU)	Park, S (corresponding author), Ajou Univ, Dept Biol Sci, Suwon 441749, South Korea.	daphnia@ajou.ac.kr		Park, Sangkyu/0000-0003-3049-0728	National Research Foundation of Korea; Korean Government (MEST) [NRF-C1ABA001-2012-0021071]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0073291]; Ajou University [S2011-G0001-00078]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ajou University	This research was supported by the National Research Foundation of Korea Grant funded by the Korean Government (MEST) (NRF-C1ABA001-2012-0021071) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology(No. 2009-0073291), in addition to the intramural research fund (S2011-G0001-00078) from Ajou University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamot IA, 2011, THESIS NORWEGIAN U S; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Barrett RT, 2007, ICES J MAR SCI, V64, P1675, DOI 10.1093/icesjms/fsm152; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Bjorkvoll E, 2009, ARCT ANTARCT ALP RES, V41, P88, DOI [10.1657/1938-4246(07-100)[BJORKVOLL]2.0.CO;2, 10.1657/1523-0430-41.1.88]; Brusetti L, 2006, FEMS MICROBIOL ECOL, V56, P154, DOI 10.1111/j.1574-6941.2005.00059.x; Carlton JT, 2003, MAR ECOL PROG SER, V256, P271, DOI 10.3354/meps256271; Chandler DP, 1997, MOL ECOL, V6, P475, DOI 10.1046/j.1365-294X.1997.00205.x; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chun JY, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm051; Colman JE, 2001, WILDLIFE BIOL, V7, P275, DOI 10.2981/wlb.2001.032; DANELL K, 1994, ECOGRAPHY, V17, P153, DOI 10.1111/j.1600-0587.1994.tb00088.x; Deagle BE, 2005, J HERED, V96, P417, DOI 10.1093/jhered/esi036; Deagle BE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000831; Deagle BE, 2007, CONSERV GENET, V8, P743, DOI 10.1007/s10592-006-9197-7; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Dunshea G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005252; Hansen BB, 2007, POLAR BIOL, V30, P549, DOI 10.1007/s00300-006-0212-8; Hansen BB, 2012, POLAR RES, V31, DOI 10.3402/polar.v31i0.17258; Hansen BB, 2011, ECOLOGY, V92, P1917, DOI 10.1890/11-0095.1; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Joo S, 2010, J MICROBIOL METH, V81, P61, DOI 10.1016/j.mimet.2010.01.025; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; KLEIN D R, 1990, Rangifer, P123; LEWIS AP, 1994, NUCLEIC ACIDS RES, V22, P2859, DOI 10.1093/nar/22.14.2859; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindner Elke, 2003, Polar Record, V39, P245; Mathiesen Svein D., 2000, Rangifer, V20, P17; Mills DK, 2007, SOIL SCI SOC AM J, V71, P572, DOI 10.2136/sssaj2006.0147; Moreno LI, 2006, J FORENSIC SCI, V51, P1315, DOI 10.1111/j.1556-4029.2006.00264.x; Murray DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025776; Oehm J, 2011, MOL ECOL RESOUR, V11, P620, DOI 10.1111/j.1755-0998.2011.03001.x; REIMERS E, 1982, ARCTIC ALPINE RES, V14, P295, DOI 10.2307/1550792; Ritchie NJ, 2000, APPL ENVIRON MICROB, V66, P1668, DOI 10.1128/AEM.66.4.1668-1675.2000; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Staaland H., 1993, Rangifer, V13, P15; STAALAND H, 1988, Rangifer, V8, P2; Suzuki M, 1998, APPL ENVIRON MICROB, V64, P4522; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tyler N. J. C., 1986, RANGIFER, V6, P311, DOI DOI 10.7557/2.6.2.664; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Van der Wal R, 2000, OECOLOGIA, V123, P108, DOI 10.1007/s004420050995; van der Wal R, 1998, CAN J ZOOL, V76, P1117, DOI 10.1139/cjz-76-6-1117; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wiencke C., 2012, SEAWEED BIOL ECOLOGI, P265, DOI [10.1007/978-3-642-28451-9_13, DOI 10.1007/978-3-642-28451-9_13]; Wlodarska-Kowalczuk M, 2009, POLAR BIOL, V32, P897, DOI 10.1007/s00300-009-0590-9; Wulff A, 2009, BOT MAR, V52, P491, DOI 10.1515/BOT.2009.072	50	6	8	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91552	10.1371/journal.pone.0091552	http://dx.doi.org/10.1371/journal.pone.0091552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618847	gold, Green Published, Green Submitted			2022-12-27	WOS:000332842400104
J	Kim, H; Cho, J; Kim, YR; Song, Y; Chun, SI; Suh, JY; Kim, JK; Ryu, YH; Choi, SM; Cho, H; Cho, G				Kim, Hyungjun; Cho, Junghun; Kim, Young R.; Song, Youngkyu; Chun, Song-I; Suh, Ji-Yeon; Kim, Jeong Kon; Ryu, Yeon-Hee; Choi, Sun-Mi; Cho, Hyungjoon; Cho, Gyunggoo			Response of the Primary Auditory and Non-Auditory Cortices to Acoustic Stimulation: A Manganese-Enhanced MRI Study	PLOS ONE			English	Article							RESONANCE-IMAGING MEMRI; MEDIAL GENICULATE-BODY; VISUAL-CORTEX; INFERIOR COLLICULUS; FUNCTIONAL-ACTIVITY; SOCIAL STRESS; RAT; PROJECTIONS; PATHWAY; ORGANIZATION	Structural and functional features of various cerebral cortices have been extensively explored in neuroscience research. We used manganese-enhanced MRI, a non-invasive method for examining stimulus-dependent activity in the whole brain, to investigate the activity in the layers of primary cortices and sensory, such as auditory and olfactory, pathways under acoustic stimulation. Male Sprague-Dawley rats, either with or without exposure to auditory stimulation, were scanned before and 24-29 hour after systemic MnCl2 injection. Cortex linearization and layer-dependent signal extraction were subsequently performed for detecting layer-specific cortical activity. We found stimulus-dependent activity in the deep layers of the primary auditory cortex and the auditory pathways. The primary sensory and visual cortices also showed the enhanced activity, whereas the olfactory pathways did not. Further, we performed correlation analysis of the signal intensity ratios among different layers of each cortex, and compared the strength of correlations between with and without the auditory stimulation. In the primary auditory cortex, the correlation strength between left and right hemisphere showed a slight but not significant increase with the acoustic simulation, whereas, in the primary sensory and visual cortex, the correlation coefficients were significantly smaller. These results suggest the possibility that even though the primary auditory, sensory, and visual cortices showed enhanced activity to the auditory stimulation, these cortices had different associations for auditory processing in the brain network.	[Kim, Hyungjun; Song, Youngkyu; Chun, Song-I; Suh, Ji-Yeon; Kim, Jeong Kon; Cho, Gyunggoo] Korea Basic Sci Inst, Div MR, Ochang Eup, Chungbuk, South Korea; [Kim, Hyungjun; Ryu, Yeon-Hee; Choi, Sun-Mi] Korea Inst Oriental Med, Div Med Res, Taejon, South Korea; [Cho, Junghun; Cho, Hyungjoon] UNIST, Sch Nanobiosci & Chem Engn, Ulsan, South Korea; [Kim, Young R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging,Dept Radi, Charlestown, MA USA; [Kim, Jeong Kon] Univ Ulsan, Dept Radiol, Asan Med Ctr, Seoul, South Korea	Korea Basic Science Institute (KBSI); Korea Institute of Oriental Medicine (KIOM); Ulsan National Institute of Science & Technology (UNIST); Harvard University; Massachusetts General Hospital; University of Ulsan	Cho, H (corresponding author), UNIST, Sch Nanobiosci & Chem Engn, Ulsan, South Korea.	hjcho@unist.ac.kr; gyunggoo@kbsi.re.kr	Cho, HyungJoon/F-1423-2010	Kim, Hyungjun/0000-0001-7997-7663	Korea Basic Science Institute [E33601]; UNIST (Ulsan National Institute of Science and Technology) [1.130030.01]; Korea Institute of Oriental Medicine [K13290]	Korea Basic Science Institute; UNIST (Ulsan National Institute of Science and Technology); Korea Institute of Oriental Medicine	This research was supported by grants from the Korea Basic Science Institute (E33601), from the 2013 Future Challenge Research Fund (Project No. 1.130030.01) of UNIST (Ulsan National Institute of Science and Technology), and from the Korea Institute of Oriental Medicine (K13290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman BL, 2007, J NEUROPHYSIOL, V98, P545, DOI 10.1152/jn.00173.2007; BARTH DS, 1995, BRAIN RES, V678, P177, DOI 10.1016/0006-8993(95)00182-P; Bissig D, 2009, NEUROIMAGE, V44, P627, DOI 10.1016/j.neuroimage.2008.10.013; Blanchard RJ, 2001, PHYSIOL BEHAV, V73, P261, DOI 10.1016/S0031-9384(01)00449-8; Budinger E, 2008, BRAIN RES, V1220, P2, DOI 10.1016/j.brainres.2007.07.084; Budinger E, 2009, HEARING RES, V258, P16, DOI 10.1016/j.heares.2009.04.021; Campi KL, 2010, CEREB CORTEX, V20, P89, DOI 10.1093/cercor/bhp082; Cheung MM, 2012, NEUROIMAGE, V60, P1205, DOI 10.1016/j.neuroimage.2012.01.087; D'Amato FR, 2001, PHYSIOL BEHAV, V73, P421, DOI 10.1016/S0031-9384(01)00460-7; FISHMAN MC, 1973, VISION RES, V13, P1415, DOI 10.1016/0042-6989(73)90002-3; GAMES KD, 1988, HEARING RES, V34, P1, DOI 10.1016/0378-5955(88)90047-0; Holt AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014260; Huang SN, 2009, NEUROIMAGE, V46, P589, DOI 10.1016/j.neuroimage.2009.02.027; HUFFMAN RF, 1990, BRAIN RES REV, V15, P295, DOI 10.1016/0165-0173(90)90005-9; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jin SU, 2013, MAGN RESON IMAGING, V31, P1143, DOI 10.1016/j.mri.2013.03.003; Kanold PO, 2011, J NEUROPHYSIOL, V105, P1063, DOI 10.1152/jn.00807.2010; KORALEK KA, 1990, J COMP NEUROL, V299, P133, DOI 10.1002/cne.902990202; Koretsky AP, 2004, NMR BIOMED, V17, P527, DOI 10.1002/nbm.940; LEDOUX JE, 1985, J COMP NEUROL, V242, P182, DOI 10.1002/cne.902420204; Lee HJ, 2012, NEUROIMAGE, V60, P1046, DOI 10.1016/j.neuroimage.2012.01.065; Lee JW, 2007, MAGN RESON IMAGING, V25, P652, DOI 10.1016/j.mri.2006.10.003; Llano DA, 2008, J COMP NEUROL, V507, P1209, DOI 10.1002/cne.21602; PETERS A, 1985, J COMP NEUROL, V238, P263, DOI 10.1002/cne.902380303; ROMANSKI LM, 1993, CEREB CORTEX, V3, P515, DOI 10.1093/cercor/3.6.515; Rouiller EM, 2000, BRAIN RES BULL, V53, P727, DOI 10.1016/S0361-9230(00)00364-6; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Silva AC, 2008, J NEUROSCI METH, V167, P246, DOI 10.1016/j.jneumeth.2007.08.020; Slater BJ, 2013, NEUROSCIENCE, V229, P144, DOI 10.1016/j.neuroscience.2012.10.053; Smith PH, 2012, J COMP NEUROL, V520, P34, DOI 10.1002/cne.22682; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tanaka E, 2008, J ANAT, V213, P743, DOI 10.1111/j.1469-7580.2008.00990.x; Watanabe T, 2008, MAGN RESON MED, V60, P210, DOI 10.1002/mrm.21645; Watson C, 2006, RAT BRAIN STEREOTAXI; Winer JA, 1999, HEARING RES, V130, P42, DOI 10.1016/S0378-5955(98)00217-2; Yu X, 2005, NAT NEUROSCI, V8, P961, DOI 10.1038/nn1477; Yu X, 2008, NEUROIMAGE, V39, P223, DOI 10.1016/j.neuroimage.2007.08.029; Zhang JW, 2013, NEUROIMAGE, V65, P119, DOI 10.1016/j.neuroimage.2012.09.069	38	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90427	10.1371/journal.pone.0090427	http://dx.doi.org/10.1371/journal.pone.0090427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618696	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400018
J	Riva, S; Monti, M; Iannello, P; Pravettoni, G; Schulz, PJ; Antonietti, A				Riva, Silvia; Monti, Marco; Iannello, Paola; Pravettoni, Gabriella; Schulz, Peter J.; Antonietti, Alessandro			A Preliminary Mixed-Method Investigation of Trust and Hidden Signals in Medical Consultations	PLOS ONE			English	Article							PHYSICIAN TRUST; PATIENT TRUST; CARE; PERCEPTIONS; CONTINUITY; ATTITUDES; TALK	Background: Several factors influence patients' trust, and trust influences the doctor-patient relationship. Recent literature has investigated the quality of the personal relationship and its dynamics by considering the role of communication and the elements that influence trust giving in the frame of general practitioner (GP) consultations. Objective: We analysed certain aspects of the interaction between patients and GPs to understand trust formation and maintenance by focusing on communication channels. The impact of socio-demographic variables in trust relationships was also evaluated. Method: A cross-sectional design using concurrent mixed qualitative and quantitative research methods was employed. One hundred adults were involved in a semi-structured interview composed of both qualitative and quantitative items for descriptive and exploratory purposes. The study was conducted in six community-based departments adjacent to primary care clinics in Trento, Italy. Results: The findings revealed that patients trusted their GP to a high extent by relying on simple signals that were based on the quality of the one-to-one communication and on behavioural and relational patterns. Patients inferred the ability of their GP by adopting simple heuristics based mainly on the so-called social "honest signals'' rather than on content-dependent features. Furthermore, socio-demographic variables affected trust: less literate and elderly people tended to trust more. Conclusions: This study is unique in attempting to explore the role of simple signals in trust relationships within medical consultation: people shape trust and give meaning to their relationships through a powerful channel of communication that orbits not around words but around social relations. The findings have implications for both clinicians and researchers. For doctors, these results suggest a way of thinking about encounters with patients. For researchers, the findings underline the importance of analysing some new key factors around trust for future investigations in medical practice and education.	[Riva, Silvia; Pravettoni, Gabriella] Univ Milan, Dept Hlth Sci, Milan, Italy; [Riva, Silvia; Schulz, Peter J.] Univ Svizzera Italiana, Inst Commun & Hlth, Lugano, Switzerland; [Monti, Marco] IBM Italia, Milan, Italy; [Monti, Marco] Univ Vita Salute San Raffaele, Milan, Italy; [Monti, Marco] Max Planck Inst Human Dev, Dept Adapt Behav & Cognit, Berlin, Germany; [Iannello, Paola; Antonietti, Alessandro] Univ Cattolica Sacro Cuore, Dept Psychol, I-20123 Milan, Italy; [Pravettoni, Gabriella] Ist Europeo Oncol, Psychooncol Unit, Milan, Italy	University of Milan; Universita della Svizzera Italiana; Vita-Salute San Raffaele University; Max Planck Society; Catholic University of the Sacred Heart; IRCCS European Institute of Oncology (IEO)	Riva, S (corresponding author), Univ Milan, Dept Hlth Sci, Milan, Italy.	silvia.riva1@unimi.it	Pravettoni, Gabriella/C-6915-2011; Pravettoni, Gabriella/AAC-3500-2022; Antonietti, Alessandro/K-9096-2016; , Silvia/H-8838-2019; Riva, Silvia/M-3163-2013; Schulz, Peter/GQQ-1290-2022; Schulz, Peter/AAM-9816-2020	Pravettoni, Gabriella/0000-0002-4843-4663; Antonietti, Alessandro/0000-0002-7212-8076; Riva, Silvia/0000-0003-2153-0169; Schulz, Peter/0000-0003-4281-489X; Schulz, Peter/0000-0003-4281-489X; Iannello, Paola/0000-0002-2736-2541; Antonietti, Markus/0000-0002-8395-7558	Department for Adaptive Behaviour and Cognition, Max Planck Institute for Human Development, Berlin, Germany; lending institution La Cassa Rurale Giudicarie Valsabbia Paganella, Trento Province (Italy) [P.Iva 00158520221]	Department for Adaptive Behaviour and Cognition, Max Planck Institute for Human Development, Berlin, Germany; lending institution La Cassa Rurale Giudicarie Valsabbia Paganella, Trento Province (Italy)	This research was supported in part by the Department for Adaptive Behaviour and Cognition, Max Planck Institute for Human Development, Konigin-Luise-Strasse 5,14195, Berlin, Germany for the use of informatics software (Unipark) and by a grant from the lending institution La Cassa Rurale Giudicarie Valsabbia Paganella, (P.Iva 00158520221), Trento Province (Italy). Regulatory affairs and administration details on of the project can be asked directly via website at http://www.lacassarurale.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038014; Antonietti A, 2009, J NONVERBAL BEHAV, V33, P89, DOI 10.1007/s10919-008-0062-x; Baldi PL, 2013, STUD PSYCHOL, V55, P265; Beck Rainer S, 2002, J Am Board Fam Pract, V15, P25; BRODY DS, 1989, J GEN INTERN MED, V4, P506, DOI 10.1007/BF02599549; Calnan M., 2004, TRUST HLTH CARE AGEN; CATERINICCHIO RP, 1979, SOC SCI MED-MED SOC, VA13, P81, DOI 10.1016/0160-7979(79)90011-0; Colombo B., 2013, RES PSYCHOL BEHAV SC, V1, P38, DOI [10.12691/rpbs-1-3-2, DOI 10.12691/RPBS-1-3-2]; Creswell J., 2003, HDB MIXED METHODS SO, P209; Daley CE, 2004, J SOC PSYCHOL, V144, P549, DOI 10.3200/SOCP.144.6.549-570; Freeman GK, 2003, FAM PRACT, V20, P623, DOI 10.1093/fampra/cmg601; Gigerenzer G., 2007, GUT FEELINGS; GILHOOLY KJ, 1990, APPL COGNITIVE PSYCH, V4, P261, DOI 10.1002/acp.2350040404; Goold SD, 2002, SOC SCI MED, V54, P879, DOI 10.1016/S0277-9536(01)00070-3; Gopichandran V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069170; Hall MA, 2002, MED CARE RES REV, V59, P293, DOI 10.1177/1077558702059003004; Hall MA, 2001, MILBANK Q, V79, P613, DOI 10.1111/1468-0009.00223; Hatcher L., 1994, STEP BY STEP APPROAC; Hudon C, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-8; Makoul G, 2006, PATIENT EDUC COUNS, V60, P301, DOI 10.1016/j.pec.2005.06.010; Martinez A, 2003, COMPUT EDUC, V41, P353, DOI 10.1016/j.compedu.2003.06.001; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Onwuegbuzie AJ, 2007, QUAL REP, V12, P281; Papp KK, 2004, ACAD MED, V79, P394, DOI 10.1097/00001888-200405000-00007; Pentland A., 2010, HONEST SIGNALS THEY, P1; Pentland A, 2008, MIT SLOAN MANAGE REV, V50, P70; Rawaf MM, 2007, J NATL MED ASSOC, V99, P1248; Ridd M, 2009, BRIT J GEN PRACT, V59, P268, DOI 10.3399/bjgp09X420248; Riva S, 2011, ADV MED EDUC PRACT, V2, P59, DOI 10.2147/AMEP.S13004; Riva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048297; Robins L, 2011, PATIENT EDUC COUNS, V83, P73, DOI 10.1016/j.pec.2010.05.004; Street RL, 2007, SOC SCI MED, V65, P586, DOI 10.1016/j.socscimed.2007.03.036; Szalay L.B., 1978, SUBJECTIVE MEANING C; Tarrant C, 2003, BRIT J GEN PRACT, V53, P798; Tarrant C, 2010, ANN FAM MED, V8, P440, DOI 10.1370/afm.1160; Tarrant C, 2008, BRIT J GEN PRACT, V58, P780, DOI 10.3399/bjgp08X342615; Thom DH, 2002, FAM PRACT, V19, P476, DOI 10.1093/fampra/19.5.476; Thom DH, 1997, J FAM PRACTICE, V44, P169; THORNE SE, 1988, J ADV NURS, V13, P782, DOI 10.1111/j.1365-2648.1988.tb00570.x; Thornton RLJ, 2011, PATIENT EDUC COUNS, V85, pE201, DOI 10.1016/j.pec.2011.07.015; Wegwarth O., 2013, SIMPLE HEURISTICS SO, P67, DOI DOI 10.1093/ACPROF:OSO/9780195388435.003.0003; Young ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003875	42	35	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90941	10.1371/journal.pone.0090941	http://dx.doi.org/10.1371/journal.pone.0090941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24618683	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400037
J	Sarovich, DS; Price, EP; Webb, JR; Ward, LM; Voutsinos, MY; Tuanyok, A; Mayo, M; Kaestli, M; Currie, BJ				Sarovich, Derek S.; Price, Erin P.; Webb, Jessica R.; Ward, Linda M.; Voutsinos, Marcos Y.; Tuanyok, Apichai; Mayo, Mark; Kaestli, Mirjam; Currie, Bart J.			Variable Virulence Factors in Burkholderia pseudomallei (Melioidosis) Associated with Human Disease	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; IDENTIFICATION; AGENT	Burkholderia pseudomallei is a Gram-negative environmental bacterium that causes melioidosis, a potentially life-threatening infectious disease affecting mammals, including humans. Melioidosis symptoms are both protean and diverse, ranging from mild, localized skin infections to more severe and often fatal presentations including pneumonia, septic shock with multiple internal abscesses and occasionally neurological involvement. Several ubiquitous virulence determinants in B. pseudomallei have already been discovered. However, the molecular basis for differential pathogenesis has, until now, remained elusive. Using clinical data from 556 Australian melioidosis cases spanning more than 20 years, we identified a Burkholderia mallei-like actin polymerization bimA(Bm) gene that is strongly associated with neurological disease. We also report that a filamentous hemagglutinin gene, fhaB3, is associated with positive blood cultures but is negatively correlated with localized skin lesions without sepsis. We show, for the first time, that variably present virulence factors play an important role in the pathogenesis of melioidosis. Collectively, our study provides a framework for assessing other non-ubiquitous bacterial virulence factors and their association with disease, such as candidate loci identified from large-scale microbial genome-wide association studies.	[Sarovich, Derek S.; Price, Erin P.; Webb, Jessica R.; Ward, Linda M.; Voutsinos, Marcos Y.; Mayo, Mark; Kaestli, Mirjam; Currie, Bart J.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Tuanyok, Apichai] Univ Hawaii, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA; [Currie, Bart J.] Royal Darwin Hosp, Dept Infect Dis, Darwin, NT, Australia	Charles Darwin University; Menzies School of Health Research; University of Hawaii System	Sarovich, DS (corresponding author), Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.	derek.sarovich@menzies.edu.au	Sarovich, Derek/H-5587-2019; Price, Erin/N-2336-2013	Sarovich, Derek/0000-0002-6944-3980; Price, Erin/0000-0002-1079-4882; , Mirjam/0000-0002-6053-5141	Australian National Health and Medical Research Council [605820, 1046812]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the Australian National Health and Medical Research Council via project grant awards 605820 and 1046812. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Butler D, 2012, NATURE, V490, P456, DOI 10.1038/490456a; Cheng AC, 2008, PLOS MED, V5, P1173, DOI 10.1371/journal.pmed.0050175; Chieng S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-328; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Cruz-Migoni A, 2011, SCIENCE, V334, P821, DOI 10.1126/science.1211915; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; Currie BJ, 2000, ACTA TROP, V74, P145, DOI 10.1016/S0001-706X(99)00064-9; Dowling AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015693; El Tahir Y, 2001, INT J MED MICROBIOL, V291, P209, DOI 10.1078/1438-4221-00119; Fierer J, 2001, J CLIN INVEST, V107, P775, DOI 10.1172/JCI12561; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Gibney KB, 2008, CLIN INFECT DIS, V47, P603, DOI 10.1086/590931; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Kaestli M, 2012, J CLIN MICROBIOL, V50, P2059, DOI 10.1128/JCM.06737-11; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Limmathurotsakul D, 2007, AM J TROP MED HYG, V77, P118, DOI 10.4269/ajtmh.2007.77.118; Limmathurotsakul D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002105; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Lopez J, 2003, MICROBES INFECT, V5, P1125, DOI 10.1016/j.micinf.2003.07.004; Massey S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00174; Mukhopadhyay C, 2011, AM J TROP MED HYG, V85, P121, DOI 10.4269/ajtmh.2011.11-0166; Owen SJ, 2009, J INFECT DIS, V199, P1761, DOI 10.1086/599210; Poolman JT, 2007, EXPERT REV VACCINES, V6, P47, DOI 10.1586/14760584.6.1.47; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Sim SH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000178; Sitthidet C, 2008, J CLIN MICROBIOL, V46, P2418, DOI 10.1128/JCM.00368-08; Sitthidet C, 2011, J BACTERIOL, V193, P1901, DOI 10.1128/JB.01455-10; Sitthidet C, 2010, J BACTERIOL, V192, P5249, DOI 10.1128/JB.00608-10; Srinivasan A, 2001, NEW ENGL J MED, V345, P256, DOI 10.1056/NEJM200107263450404; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2004.04528.x; Tuanyok A, 2007, J BACTERIOL, V189, P9044, DOI 10.1128/JB.01264-07; Tuanyok A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-566; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385	35	74	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91682	10.1371/journal.pone.0091682	http://dx.doi.org/10.1371/journal.pone.0091682			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618705	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400118
J	Wood, S; Jayaraman, V; Huelsmann, EJ; Bonish, B; Burgad, D; Sivaramakrishnan, G; Qin, SS; DiPietro, LA; Zloza, A; Zhang, CX; Shafikhani, SH				Wood, Stephen; Jayaraman, Vijayakumar; Huelsmann, Erica J.; Bonish, Brian; Burgad, Derick; Sivaramakrishnan, Gayathri; Qin, Shanshan; DiPietro, Luisa A.; Zloza, Andrew; Zhang, Chunxiang; Shafikhani, Sasha H.			Pro-Inflammatory Chemokine CCL2 (MCP-1) Promotes Healing in Diabetic Wounds by Restoring the Macrophage Response	PLOS ONE			English	Article							CELL-LINEAGE; MOUSE; REPAIR; MICE; EXPRESSION; RECRUITMENT; NEUTROPHILS; DISEASE; DB/DB; PDGF	Prior studies suggest that the impaired healing seen in diabetic wounds derives from a state of persistent hyper-inflammation characterized by harmful increases in inflammatory leukocytes including macrophages. However, such studies have focused on wounds at later time points (day 10 or older), and very little attention has been given to the dynamics of macrophage responses in diabetic wounds early after injury. Given the importance of macrophages for the process of healing, we studied the dynamics of macrophage response during early and late phases of healing in diabetic wounds. Here, we report that early after injury, the diabetic wound exhibits a significant delay in macrophage infiltration. The delay in the macrophage response in diabetic wounds results from reduced Chemokine (C-C motif) ligand 2 (CCL2) expression. Importantly, one-time treatment with chemoattractant CCL2 significantly stimulated healing in diabetic wounds by restoring the macrophage response. Our data demonstrate that, rather than a hyper-inflammatory state; the early diabetic wound exhibits a paradoxical and damaging decrease in essential macrophage response. Our studies suggest that the restoration of the proper kinetics of macrophage response may be able to jumpstart subsequent healing stages. CCL2 chemokine-based therapy may be an attractive strategy to promote healing in diabetic wounds.	[Wood, Stephen; Jayaraman, Vijayakumar; Huelsmann, Erica J.; Bonish, Brian; Burgad, Derick; Sivaramakrishnan, Gayathri; Zloza, Andrew; Shafikhani, Sasha H.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Huelsmann, Erica J.; Zloza, Andrew; Shafikhani, Sasha H.] Rush Univ, Med Ctr, Ctr Canc, Chicago, IL 60612 USA; [Bonish, Brian] Rush Univ, Med Ctr, Dept Dermatol, Chicago, IL 60612 USA; [Huelsmann, Erica J.; Zloza, Andrew] Rush Univ, Med Ctr, Dev Ctr AIDS Res, Chicago, IL 60612 USA; [Qin, Shanshan; Zhang, Chunxiang] Rush Univ, Med Ctr, Dept Pharmacol, Chicago, IL 60612 USA; [DiPietro, Luisa A.] Univ Illinois, Coll Dent, Ctr Wound Healing & Tissue Regenerat, Chicago, IL USA	Rush University; Rush University; Rush University; Rush University; Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shafikhani, SH (corresponding author), Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA.	Sasha_Shafikhani@rush.edu	Shafikhani, Sasha/AAM-3460-2021; zhang, xiang chun/HCH-7063-2022	zhang, xiang chun/0000-0001-8303-6495; Shafikhani, Sasha/0000-0003-1755-9997; Zloza, Andrew/0000-0001-8844-6493	Rush University Committee on Research, Young Investigator Award Fund [31184]; National Institute of Health [R21NR013876-0]; NATIONAL INSTITUTE OF NURSING RESEARCH [R21NR013876] Funding Source: NIH RePORTER	Rush University Committee on Research, Young Investigator Award Fund; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by The Rush University Committee on Research, Young Investigator Award Fund #: 31184 to (SHS) and the National Institute of Health grant R21NR013876-0 to (CZ & SHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADZICK NS, 1985, J PEDIATR SURG, V20, P315; Avwioro G., 2011, JPCS, V1, P24; Beer HD, 1997, J INVEST DERMATOL, V109, P132, DOI 10.1111/1523-1747.ep12319188; Bellavance EC, 2011, J IMMUNOL, V186, P3309, DOI 10.4049/jimmunol.1002549; Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; BROWN GL, 1989, NEW ENGL J MED, V321, P76, DOI 10.1056/NEJM198907133210203; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Davies John Q, 2005, Methods Mol Biol, V290, P91; DiPietro LA, 2001, WOUND REPAIR REGEN, V9, P28, DOI 10.1046/j.1524-475x.2001.00028.x; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; DONG YL, 1993, J TRAUMA, V35, P340, DOI 10.1097/00005373-199309000-00002; Dvivedi Sanjay, 1997, Indian Journal of Experimental Biology, V35, P1243; Fang Y, 2010, BRIT J DERMATOL, V162, P478, DOI 10.1111/j.1365-2133.2009.09528.x; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Frevert CW, 1998, J IMMUNOL METHODS, V213, P41, DOI 10.1016/S0022-1759(98)00016-7; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Hackstein H, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-94; Ikejima S, 2005, DIABETES, V54, P182, DOI 10.2337/diabetes.54.1.182; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Kohlhapp FJ, 2012, J IMMUNOL, V188, P3639, DOI 10.4049/jimmunol.1101580; KREIPE H, 1987, J HISTOCHEM CYTOCHEM, V35, P1117, DOI 10.1177/35.10.3476670; Krischak G D, 2007, J Wound Care, V16, P76; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Low QEH, 2001, AM J PATHOL, V159, P457, DOI 10.1016/S0002-9440(10)61717-8; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Raman D, 2011, EXP CELL RES, V317, P575, DOI 10.1016/j.yexcr.2011.01.005; Roupe KM, 2010, J INVEST DERMATOL, V130, P1167, DOI 10.1038/jid.2009.284; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; STROBL H, 1995, BRIT J HAEMATOL, V90, P774, DOI 10.1111/j.1365-2141.1995.tb05195.x; Wang JF, 2007, J LEUKOCYTE BIOL, V82, P1554, DOI 10.1189/0507306; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Zloza A, 2012, NAT MED, V18, P422, DOI 10.1038/nm.2683	41	160	167	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91574	10.1371/journal.pone.0091574	http://dx.doi.org/10.1371/journal.pone.0091574			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618995	gold, Green Published, Green Submitted			2022-12-27	WOS:000332842400107
J	Walkowski, S; Singh, M; Puertas, J; Pate, M; Goodrum, K; Benencia, F				Walkowski, Stevan; Singh, Manindra; Puertas, Juan; Pate, Michelle; Goodrum, Kenneth; Benencia, Fabian			Osteopathic Manipulative Therapy Induces Early Plasma Cytokine Release and Mobilization of a Population of Blood Dendritic Cells	PLOS ONE			English	Article							ACUTE MENTAL STRESS; NITRIC-OXIDE; MONOCYTES	It has been claimed that osteopathic manipulative treatment (OMT) is able to enhance the immune response of individuals. In particular, it has been reported that OMT has the capability to increase antibody titers, enhance the efficacy of vaccination, and upregulate the numbers of circulating leukocytes. Recently, it has been shown in human patients suffering chronic low back pain, that OMT is able to modify the levels of cytokines such as IL-6 and TNF-alpha in blood upon repeated treatment. Further, experimental animal models show that lymphatic pump techniques can induce a transient increase of cytokines in the lymphatic circulation. Taking into account all these data, we decided to investigate in healthy individuals the capacity of OMT to induce a rapid modification of the levels of cytokines and leukocytes in circulation. Human volunteers were subjected to a mixture of lymphatic and thoracic OMT, and shortly after the levels of several cytokines were evaluated by protein array technology and ELISA multiplex analysis, while the profile and activation status of circulating leukocytes was extensively evaluated by multicolor flow cytometry. In addition, the levels of nitric oxide and C-reactive protein (CRP) in plasma were determined. In this study, our results show that OMT was not able to induce a rapid modification in the levels of plasma nitrites or CRP or in the proportion or activation status of central memory, effector memory or naive CD4 and CD8 T cells. A significant decrease in the proportion of a subpopulation of blood dendritic cells was detected in OMT patients. Significant differences were also detected in the levels of immune molecules such as IL-8, MCP-1, MIP-1 alpha and most notably, G-CSF. Thus, OMT is able to induce a rapid change in the immunological profile of particular circulating cytokines and leukocytes.	[Walkowski, Stevan] Ohio Univ, Heritage Coll Osteopath Med, Osteopath Manipulat Med Dept, Athens, OH 45701 USA; [Singh, Manindra; Benencia, Fabian] Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA; [Puertas, Juan; Pate, Michelle; Goodrum, Kenneth; Benencia, Fabian] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [Benencia, Fabian] Ohio Univ, Biomed Engn Program, Russ Coll Engn & Technol, Athens, OH 45701 USA; [Benencia, Fabian] Ohio Univ, Inst Diabet, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Benencia, F (corresponding author), Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA.	benencia@ohio.edu	Benencia, Fabian/AAH-1613-2020	Benencia, Fabian/0000-0003-3049-6150	Research & Scholarly Affairs Committee grant from Heritage College of Osteopathic Medicine, Ohio University; American Osteopathic Association [10-08-606]	Research & Scholarly Affairs Committee grant from Heritage College of Osteopathic Medicine, Ohio University; American Osteopathic Association	This work was funded by a Research & Scholarly Affairs Committee grant from the Heritage College of Osteopathic Medicine, Ohio University (http://www.oucom.ohiou.edu/) and a research grant (10-08-606) from the American Osteopathic Association (www.osteopathic.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bockenhauer Susan E., 2002, Journal of the American Osteopathic Association, V102, P371; Bonasio R, 2006, CURR OPIN IMMUNOL, V18, P503, DOI 10.1016/j.coi.2006.05.011; Breithaupt Thomas, 2001, Journal of the American Osteopathic Association, V101, P21; Calo L, 1998, ANGIOLOGY, V49, P419, DOI 10.1177/000331979804900601; Castlio Y, 1934, COLL J KANSAS CITY, V18, P196; Castlio Y, 1932, COLL J KANSAS CITY, V16, P111; Chikly BJ, 2005, J AM OSTEOPATH ASSOC, V105, P457; Creasy C, 2013, LYMPHAT RES BIOL, V11, P183, DOI 10.1089/lrb.2013.0007; Dugan EP, 2001, J AM OSTEOPATH ASSOC, V101, P472; Guiney PA, 2005, J AM OSTEOPATH ASSOC, V105, P7; Hodge LM, 2012, INT J OSTEOPATH MED, V15, P13, DOI 10.1016/j.ijosm.2011.11.004; Hodge LM, 2010, LYMPHAT RES BIOL, V8, P103, DOI 10.1089/lrb.2009.0011; Hodge Lisa M., 2007, Lymphatic Research and Biology, V5, P127, DOI 10.1089/lrb.2007.1001; Hruby Raymond J, 2007, Osteopath Med Prim Care, V1, P10, DOI 10.1186/1750-4732-1-10; Jackson Kelly M., 1998, Journal of the American Osteopathic Association, V98, P155; Knott EM, 2005, J AM OSTEOPATH ASSOC, V105, P447; Kop WJ, 2008, AM J CARDIOL, V101, P767, DOI 10.1016/j.amjcard.2007.11.006; Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1; Licciardone JC, 2013, J AM OSTEOPATH ASSOC, V113, P468; Licciardone JC, 2012, J AM OSTEOPATH ASSOC, V112, P596, DOI 10.7556/jaoa.2012.112.9.596; MEASEL JW, 1982, J AM OSTEOPATH ASSOC, V82, P59; Mesina Julian, 1998, Journal of the American Osteopathic Association, V98, P91; Noll D, 2005, INT J OSTEOPATH MED, V8, P124; Noll Donald R., 2000, Journal of the American Osteopathic Association, V100, P776; Noll DR, 2008, J AM OSTEOPATH ASSOC, V108, P69; Noll DR, 2013, J AM OSTEOPATH ASSOC, V113, P520, DOI 10.7556/jaoa.2013.003; Noll Donald R., 2004, Journal of the American Osteopathic Association, V104, P107; Noll Donald R., 1999, Journal of the American Osteopathic Association, V99, P143; Noll DR, 2004, ALTERN THER HEALTH M, V10, P74; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Palucka K, 2013, CURR OPIN IMMUNOL, V25, P396, DOI 10.1016/j.coi.2013.05.001; Patterson MM, 2005, J AM OSTEOPATH ASSOC, V105, P498; PAUL RT, 1986, J AM OSTEOPATH ASSOC, V86, P92; Ridgway D, 2003, CANCER INVEST, V21, P873, DOI 10.1081/CNV-120025091; Rivers WE, 2008, J AM OSTEOPATH ASSOC, V108, P646; Salamon E, 2004, INT J MOL MED, V14, P443; Schander A, 2012, EXP BIOL MED, V237, P58, DOI 10.1258/ebm.2011.011220; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Ward RC, 1997, FDN OSTEOPATHIC MED; Weinstein AA, 2010, BIOL PSYCHOL, V84, P228, DOI 10.1016/j.biopsycho.2010.01.016; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	42	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90132	10.1371/journal.pone.0090132	http://dx.doi.org/10.1371/journal.pone.0090132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614605	gold, Green Published, Green Submitted			2022-12-27	WOS:000332839300019
J	Wuyun, GW; Shu, M; Cao, ZJ; Huang, W; Zou, X; Li, S; Zhang, X; Luo, H; Wu, YH				Wuyun, Gaowa; Shu, Min; Cao, Zhijun; Huang, Wei; Zou, Xin; Li, Sheng; Zhang, Xin; Luo, Huan; Wu, Yanhong			Neural Representations of the Self and the Mother for Chinese Individuals	PLOS ONE			English	Article							ANTERIOR INSULA; LEFT PARIETAL; ACTIVATION; MEMORY; COGNITION; BRAIN; INTENTION; CULTURE; CORTEX; AREAS	An important question in social neuroscience is the similarities and differences in the neural representations between the self and close others. Most studies examining this topic have identified the medial prefrontal cortex (MPFC) region as the primary area involved in this process. However, several studies have reported conflicting data, making further investigation of this topic very important. In this functional magnetic resonance imaging (fMRI) study, we investigated the brain activity in the anterior cingulate cortex (ACC) when Chinese participants passively listened to their self-name (SN), their mother's name (MN), and unknown names (UN). The results showed that compared with UN recognition, SN perception was associated with a robust activation in a widely distributed bilateral network, including the cortical midline structure (the MPFC and ACC), the inferior frontal gyrus, and the middle temporal gyrus. The SN invoked the bilateral superior temporal gyrus in contrast to the MN; the MN recognition provoked a stronger activation in the central and posterior brain regions in contrast to the SN recognition. The SN and MN caused an activation of overlapping areas, namely, the ACC, MPFC, and superior frontal gyrus. These results suggest that Chinese individuals utilize certain common brain region in processing both the SN and the MN. The present findings provide evidence for the neural basis of the self and close others for Chinese individuals.	[Wuyun, Gaowa; Shu, Min; Cao, Zhijun; Huang, Wei; Zou, Xin; Li, Sheng; Zhang, Xin; Wu, Yanhong] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Luo, Huan] Chinese Acad Sci, Beijing, Peoples R China; [Wu, Yanhong] Capital Normal Univ, Learning & Cognit Lab, Beijing, Peoples R China	Peking University; Chinese Academy of Sciences; Capital Normal University	Wu, YH (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	wuyh@pku.edu.cn	Li, Sheng/A-2602-2010	Li, Sheng/0000-0002-6258-3147	Natural Science Foundation of China [31070982, 31371054]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Work was funded by Natural Science Foundation of China http://www.nsfc.gov.cn/ (31070982, 31371054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos T, 2012, EUR J SOC PSYCHOL, V42, P770, DOI 10.1002/ejsp.1882; Aron A, 2003, HANDBOOK OF SELF AND IDENTITY, P442; Berscheid E., 1998, HDB SOCIAL PSYCHOL, P193; Buckner RL, 1996, PSYCHON B REV, V3, P149, DOI 10.3758/BF03212413; Cabeza R, 1997, J COGNITIVE NEUROSCI, V9, P1, DOI 10.1162/jocn.1997.9.1.1; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Feinberg T. E., 2009, AXONS IDENTITY NEURO; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Han SH, 2010, SOC COGN AFFECT NEUR, V5, P332, DOI 10.1093/scan/nsp027; Heine SJ, 2001, J PERS, V69, P881, DOI 10.1111/1467-6494.696168; Hesse MD, 2006, NEUROSCIENCE, V140, P1209, DOI 10.1016/j.neuroscience.2006.03.030; Kampe KKW, 2003, J NEUROSCI, V23, P5258; KAPUR N, 1995, CORTEX, V31, P99, DOI 10.1016/S0010-9452(13)80108-6; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kiehl KA, 2001, PSYCHOPHYSIOLOGY, V38, P133, DOI 10.1111/1469-8986.3810133; Lundstrom BN, 2003, NEUROIMAGE, V20, P1934, DOI 10.1016/j.neuroimage.2003.07.017; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; Markus HR, 2003, PSYCHOL INQ, V14, P277, DOI 10.1207/S15327965PLI1403&4_17; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Modinos G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004618; Muller BW, 2002, NEUROIMAGE, V17, P231, DOI 10.1006/nimg.2002.1176; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Northoff G, 2011, CONSCIOUS COGN, V20, P52, DOI 10.1016/j.concog.2010.09.011; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Opitz B, 1999, CEREB CORTEX, V9, P379, DOI 10.1093/cercor/9.4.379; Perrin F, 2005, NEUROPSYCHOLOGIA, V43, P12, DOI 10.1016/j.neuropsychologia.2004.07.002; Qin PM, 2012, HUM BRAIN MAPP, V33, P154, DOI 10.1002/hbm.21201; Qin PM, 2010, HUM BRAIN MAPP, V31, P1993, DOI 10.1002/hbm.20989; Ray RD, 2010, SOC COGN AFFECT NEUR, V5, P318, DOI 10.1093/scan/nsp039; Rossion B, 2003, NEUROIMAGE, V19, P877, DOI 10.1016/S1053-8119(03)00105-8; Rushworth MFS, 2003, NEUROIMAGE, V20, pS89, DOI 10.1016/j.neuroimage.2003.09.011; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Seger CA, 2004, NEUROPSYCHOLOGIA, V42, P1168, DOI 10.1016/j.neuropsychologia.2004.02.003; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Sugiura M, 2008, NEUROIMAGE, V42, P414, DOI 10.1016/j.neuroimage.2008.03.054; Tacikowski P, 2012, HUM BRAIN MAPP, V19, P1; Talairach J., 1988, COPLANAR STEREOTAXIC; Vanderwal T, 2008, NEUROIMAGE, V41, P1437, DOI 10.1016/j.neuroimage.2008.03.058; Wang G, 2012, SOC COGN AFFECT NEUR, V7, P222, DOI 10.1093/scan/nsr002; Wu YH, 2010, SOC COGN AFFECT NEUR, V5, P324, DOI 10.1093/scan/nsq016; Zhu Y, 2007, NEUROIMAGE, V34, P1310, DOI 10.1016/j.neuroimage.2006.08.047	45	11	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91556	10.1371/journal.pone.0091556	http://dx.doi.org/10.1371/journal.pone.0091556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614597	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300137
J	Kityo, C; Gibb, DM; Gilks, CF; Goodall, RL; Mambule, I; Kaleebu, P; Pillay, D; Kasirye, R; Mugyenyi, P; Walker, AS; Dunn, DT				Kityo, Cissy; Gibb, Diana M.; Gilks, Charles F.; Goodall, Ruth L.; Mambule, Ivan; Kaleebu, Pontiano; Pillay, Deenan; Kasirye, Ronnie; Mugyenyi, Peter; Walker, A. Sarah; Dunn, David T.		DART Trial Team	High Level of Viral Suppression and Low Switch Rate to Second-Line Antiretroviral Therapy among HIV-Infected Adult Patients Followed over Five Years: Retrospective Analysis of the DART Trial	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; LOAD; OUTCOMES; RESISTANCE; ADHERENCE; PROGRAMS; UGANDA	In contrast to resource-rich countries, most HIV-infected patients in resource-limited countries receive treatment without virological monitoring. There are few long-term data, in this setting, on rates of viral suppression or switch to second-line antiretroviral therapy. The DART trial compared clinically driven monitoring (CDM) versus routine laboratory (CD4/haematology/biochemistry) and clinical monitoring (LCM) in HIV-infected adults initiating therapy. There was no virological monitoring in either study group during follow-up, but viral load was measured in Ugandan participants at trial closure. Two thousand three hundred and seventeen (2317) participants from this country initiated antiretroviral therapy with zidovudine/lamivudine plus tenofovir (n = 1717), abacavir (n = 300), or nevirapine (n = 300). Of 1896 (81.8%) participants who were alive and in follow-up at trial closure (median 5.1 years after therapy initiation), 1507 (79.5%) were on first-line and 389 (20.5%) on second-line antiretroviral therapy. The overall switch rate after the first year was 5.6 per 100 person-years; the rate was substantially higher in participants with low baseline CD4 counts (<50 cells/mm(3)). Among 1207 (80.1%) first-line participants with viral load measured, HIV RNA was <400 copies/ml in 963 (79.8%), 400-999 copies/ml in 37 (3.1%), 1,000-9,999 copies/ml in 110 (9.1%), and >= 10,000 copies/ml in 97 (8.0%). The proportion with HIV RNA <400 copies/ml was slightly lower (difference 7.1%, 95% CI 2.5 to 11.5%) in CDM (76.3%) than in LCM (83.4%). Among 252 (64.8%) second-line participants with viral load measured (median 2.3 years after switch), HIV RNA was <400 copies/ml in 226 (89.7%), with no difference between monitoring strategies. Low switch rates and high, sustained levels of viral suppression are achievable without viral load or CD4 count monitoring in the context of high-quality clinical care.	[Kityo, Cissy; Mugyenyi, Peter] Joint Clin Res Ctr, Kampala, Uganda; [Gibb, Diana M.; Goodall, Ruth L.; Walker, A. Sarah; Dunn, David T.] UCL, MRC Clin Trials Unit, London, England; [Gilks, Charles F.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4072, Australia; [Mambule, Ivan] Infect Dis Inst, Mulago, Uganda; [Kaleebu, Pontiano; Kasirye, Ronnie] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Pillay, Deenan] UCL, London, England	Joint Clinic Research Center - United Arab Emirates; Medical Research Council Clinical Trials Unit; University of London; University College London; University of Queensland; University of London; University College London	Dunn, DT (corresponding author), UCL, MRC Clin Trials Unit, London, England.	d.dunn@ucl.ac.uk	Gilks, Charles/B-4184-2012; kasirye, ronnie/AAW-7818-2021; Walker, Sarah/HDM-8717-2022	Gilks, Charles/0000-0002-8953-3123; Goodall, Ruth/0000-0003-0622-5035; Kasirye, Ronnie/0000-0002-5200-464X; Dunn, David/0000-0003-1836-4446; Grosskurth, Heiner/0000-0001-9960-7280; Kajungu PhD, Dan/0000-0002-3363-7062; Mambule, Ivan Kiggundu/0000-0002-0888-8695	United Kingdom (UK) Medical Research Council [G0600344]; UK Department for International Development (DFID); Rockefeller Foundation; MRC [G0600344, MC_U950080938, MC_U950080931] Funding Source: UKRI; Medical Research Council [MC_U950080938, G0600344, MC_U950080931] Funding Source: researchfish	United Kingdom (UK) Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID); Rockefeller Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the United Kingdom (UK) Medical Research Council [grant number G0600344], the UK Department for International Development (DFID) and the Rockefeller Foundation. GlaxoSmithKline, Gilead Sciences, Boehringer-Ingelheim and Abbott Laboratories donated drugs for DART. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajose O, 2012, AIDS, V26, P929, DOI 10.1097/QAD.0b013e328351f5b2; [Anonymous], 2013, PRIOR INCR ACC ART I; Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac; Calmy A, 2007, CLIN INFECT DIS, V44, P128, DOI 10.1086/510073; del Rio C, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6853; Estill J, 2013, AIDS, V27, P1483, DOI 10.1097/QAD.0b013e328360a4e5; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gilks CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057580; Gilks CF, 2012, ANTIVIR THER, V17, P1363, DOI 10.3851/IMP2253; Greig J, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-23; Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Hirnschall G, 2011, LANCET, V378, P209, DOI 10.1016/S0140-6736(11)60247-X; Hosseinipour Mina C, 2010, Curr HIV/AIDS Rep, V7, P168, DOI 10.1007/s11904-010-0046-4; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jourdain G, 2011, 18 C RETR OPP INF BO; Kaleebu P, 2006, AIDS, V20, P1391, DOI 10.1097/01.aids.0000233572.59522.45; Kantor R, 2009, CLIN INFECT DIS, V49, P454, DOI 10.1086/600396; Keiser O, 2009, AIDS, V23, P1867, DOI 10.1097/QAD.0b013e32832e05b2; Kiwuwa-Muyingo S, 2012, TROP MED INT HEALTH, V17, P584, DOI 10.1111/j.1365-3156.2012.02974.x; Kranzer K, 2011, TROP MED INT HEALTH, V16, P1297, DOI 10.1111/j.1365-3156.2011.02828.x; Lara AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033672; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Mambule I, 2011, 18 C RETR OPP INF BO; McMahon JH, 2013, B WORLD HEALTH ORGAN, V91, P377, DOI 10.2471/BLT.12.112946; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Mugavero MJ, 2011, CLIN INFECT DIS, V53, P927, DOI 10.1093/cid/cir526; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Munderi P, 2010, HIV MED, V11, P334, DOI 10.1111/j.1468-1293.2009.00786.x; Pasquet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013414; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; Reynolds SJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-381; Roberts T, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17324; Sawe FK, 2009, CLIN INFECT DIS, V49, P463, DOI 10.1086/600397; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; Smith DM, 2008, CLIN INFECT DIS, V46, P1598, DOI 10.1086/587110; Walensky RP, 2010, CLIN INFECT DIS, V51, P85, DOI 10.1086/653119; Walker AS, 2011, CURR OPIN INFECT DIS, V24, P27, DOI 10.1097/QCO.0b013e3283423e0e; WHO, 2010, ANT THER HIV INF AD	39	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90772	10.1371/journal.pone.0090772	http://dx.doi.org/10.1371/journal.pone.0090772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625508	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300032
J	Budge, PJ; Griffin, MR; Edwards, KM; Williams, JV; Verastegui, H; Hartinger, SM; Mausezahl, D; Johnson, M; Klemenc, JM; Zhu, YW; Gil, AI; Lanata, CF; Grigalva, CG				Budge, Philip J.; Griffin, Marie R.; Edwards, Kathryn M.; Williams, John V.; Verastegui, Hector; Hartinger, Stella M.; Maeusezahl, Daniel; Johnson, Monika; Klemenc, Jennifer M.; Zhu, Yuwei; Gil, Ana I.; Lanata, Claudio F.; Grigalva, Carlos G.		RESPIRA PERU Grp	Impact of Home Environment Interventions on the Risk of Influenza-Associated ARI in Andean Children: Observations from a Prospective Household-Based Cohort Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; RURAL PERU; PCR ASSAY; INFECTION; ILLNESS; PREVALENCE; BANGLADESH; MORTALITY; COMMUNITY; TECUMSEH	Background: The Respiratory Infections in Andean Peruvian Children (RESPIRA-PERU) study enrolled children who participated in a community-cluster randomized trial of improved stoves, solar water disinfection, and kitchen sinks (IHIP trial) and children from additional Andean households. We quantified the burden of influenza-associated acute respiratory illness (ARI) in this household-based cohort. Methods: From May 2009 to September 2011, we conducted active weekly ARI surveillance in 892 children age <3 years, of whom 272 (30.5%) had participated in the IHIP trial. We collected nasal swabs during ARI, tested for influenza and other respiratory viruses by RT-PCR, and determined influenza incidence and risk factors using mixed-effects regression models. Results: The overall incidence of influenza-associated ARI was 36.6/100 child-years; incidence of influenza A, B, and C was 20.5, 8.7, and 5.2/100 child-years, respectively. Influenza C was associated with fewer days of subjective fever (median 1 vs. 2) and malaise (median 0 vs. 2) compared to influenza A. Non-influenza ARI also resulted in fewer days of fever and malaise, and fewer healthcare visits than influenza A-associated ARI. Influenza incidence varied by calendar year (80% occurred in the 2010 season) and IHIP trial participation. Among households that participated in the IHIP trial, influenza-associated ARI incidence was significantly lower in intervention than in control households (RR 0.40, 95% CI: 0.20-0.82). Conclusions: Influenza burden is high among Andean children. ARI associated with influenza A and B had longer symptom duration and higher healthcare utilization than influenza C-associated ARI or non-influenza ARI. Environmental community interventions may reduce influenza morbidity.	[Budge, Philip J.] Vanderbilt Univ, Dept Internal Med, Div Infect Dis, Nashville, TN 37235 USA; [Griffin, Marie R.; Grigalva, Carlos G.] Vanderbilt Univ, Dept Hlth Policy, Nashville, TN 37235 USA; [Edwards, Kathryn M.] Vanderbilt Univ, Dept Pediat, Div Infect Dis, Vanderbilt Vaccine Res Program, Nashville, TN USA; [Edwards, Kathryn M.; Williams, John V.; Johnson, Monika; Klemenc, Jennifer M.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Williams, John V.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Verastegui, Hector; Hartinger, Stella M.; Gil, Ana I.; Lanata, Claudio F.] Inst Invest Nutr, Lima, Peru; [Hartinger, Stella M.; Maeusezahl, Daniel] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Hartinger, Stella M.; Maeusezahl, Daniel] Univ Basel, Basel, Switzerland; [Zhu, Yuwei] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Vanderbilt University	Grigalva, CG (corresponding author), Vanderbilt Univ, Dept Hlth Policy, 221 Kirkland Hall, Nashville, TN 37235 USA.	Carlos.grijalva@vanderbilt.edu	Lanata, Claudio F./N-7997-2018; Williams, John/ABE-3227-2020; Williams, John/F-6962-2010; Budge, Philip/ABE-6458-2020	Lanata, Claudio F./0000-0002-6994-7425; Williams, John/0000-0001-8377-5175; Williams, John/0000-0001-8377-5175; Budge, Philip/0000-0002-0069-2372; Hartinger, Stella/0000-0003-3523-1725	Vanderbilt University CTSA from National Institutes of Health [UL1 RR024975-01]; Pfizer [IIR WS1898786(0887X1-4492)]; Thrasher Research Fund [02832-9]; Agency of Healthcare Research and Quality [T32 HS 013833]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS013833] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007474] Funding Source: NIH RePORTER	Vanderbilt University CTSA from National Institutes of Health; Pfizer(Pfizer); Thrasher Research Fund; Agency of Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Vanderbilt University CTSA grant UL1 RR024975-01 from National Institutes of Health, an investigator initiated research grant from Pfizer (IIR WS1898786(0887X1-4492), http://www.pfizer.com) and grant 02832-9 from the Thrasher Research Fund (www.thrasherresearch.org/default.aspx). PJB was supported by the Agency of Healthcare Research and Quality (http://www.ahrq.gov) T32 HS 013833. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, Bull World Health Organ, V75 Suppl 1, P119; Azziz-Baumgartner E, 2012, B WORLD HEALTH ORGAN, V90, P12, DOI 10.2471/BLT.11.090209; Brooks WA, 2010, PEDIATR INFECT DIS J, V29, P216, DOI 10.1097/INF.0b013e3181bc23fd; Budge PJ, 2013, PEDIAT INFE IN PRESS; CDC, 2013, TYP INFL VIR; Commodore AA, 2013, INT J OCCUP ENV HEAL, V19, P43, DOI 10.1179/2049396712Y.0000000014; FOX JP, 1982, AM J EPIDEMIOL, V116, P228, DOI 10.1093/oxfordjournals.aje.a113408; Griffin Marie R, 2004, Pediatr Infect Dis J, V23, pS188, DOI 10.1097/01.inf.0000144660.53024.64; Grijalva CG, 2013, INT J EPIDE IN PRESS; Hartinger SM, 2013, INDOOR AIR, V23, P342, DOI 10.1111/ina.12027; Hartinger SM, 2011, CONTEMP CLIN TRIALS, V32, P864, DOI 10.1016/j.cct.2011.06.006; Homaira N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032056; Horby P, 2012, AM J EPIDEMIOL, V175, P1062, DOI 10.1093/aje/kws121; Huicho L, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-173; Klemenc J, 2012, J CLIN VIROL, V54, P371, DOI 10.1016/j.jcv.2012.05.005; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7; Mamelund SE, 2011, EPIDEMICS-NETH, V3, P46, DOI 10.1016/j.epidem.2011.02.001; MONTO AS, 1975, AM J EPIDEMIOL, V102, P553, DOI 10.1093/oxfordjournals.aje.a112193; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Olender S, 2003, AM J TROP MED HYG, V68, P721, DOI 10.4269/ajtmh.2003.68.721; Perez-Padilla R, 2013, SALUD PUBLICA MEXICO, V55, P92, DOI 10.1590/S0036-36342013000100013; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; REULAND DS, 1991, J PEDIATR-US, V119, P900, DOI 10.1016/S0022-3476(05)83040-9; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; WHO, 2009, FACT SHET N 211; Zaman RU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008452	28	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91247	10.1371/journal.pone.0091247	http://dx.doi.org/10.1371/journal.pone.0091247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622044	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000332845300068
J	Chu, DK; Zhao, ZW; Li, YM; Li, JP; Zheng, JY; Wang, WZ; Zhao, QC; Ji, G				Chu, Dake; Zhao, Zhengwei; Li, Yunming; Li, Jipeng; Zheng, Jianyong; Wang, Weizhong; Zhao, Qingchuan; Ji, Gang			Increased MicroRNA-630 Expression in Gastric Cancer Is Associated with Poor Overall Survival	PLOS ONE			English	Article							MORTALITY; EPIDEMIOLOGY; STATISTICS; TRENDS; ROLES; RNAS	MicroRNAs are noncoding RNAs that regulate multiple cellular processes during cancer progression. Among various microRNAs, MiR-630 has recently been identified to be implicated in many critical processes in human malignancies. We aimed to investigate the significance and prognostic value of miR-630 in human gastric cancer. Gastric cancer and adjacent normal specimens from 236 patients from who had not received neoadjuvant chemotherapy were collected. The expression of miR-630 was investigated by quantitative real-time PCR assay and its association with overall survival of patients was analyzed by statistical analysis. MiR-630 expression level was significantly elevated in gastric cancer in comparison to adjacent normal specimens. It is also proved that miR-630 expression was to be associated with gastric cancer invasion, lymph node metastasis, distant metastasis and TNM stage. In addition, survival analysis proved that elevated miR-630 expression was associated with poor overall survival of patients. Multivariate survival analysis also proved that miR-630 was an independent prognostic marker after adjusted for known prognostic factors. The present study proved the overexpression of miR-630 and its association with tumor progression in human gastric cancer. It also provided the first evidence that miR-630 expression was an independent prognostic factor for patients with gastric cancer, which might be a potential valuable biomarker for gastric cancer.	[Chu, Dake; Li, Jipeng; Zheng, Jianyong; Wang, Weizhong; Zhao, Qingchuan; Ji, Gang] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Chu, Dake; Li, Jipeng; Zheng, Jianyong; Wang, Weizhong; Zhao, Qingchuan; Ji, Gang] Fourth Mil Med Univ, Xijing Hosp, Xijing Hosp Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Chu, Dake] Fourth Mil Med Univ, Dept Biochem & Mol Biol, Xian 710032, Shaanxi, Peoples R China; [Zhao, Zhengwei] Fourth Mil Med Univ, Tangdu Hosp, Dept Gen Surg, Xian 710032, Shaanxi, Peoples R China; [Li, Yunming] Gen Hosp Chengdu Mil Reg, Dept Med Affair, Chengdu, Sichuan, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Ji, G (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China.	jigang@fmmu.edu.cn	JI, Gang/AAG-9877-2020	JI, Gang/0000-0002-2415-6275; Li, Yunming/0000-0001-6363-4869	National Natural Science Foundation of China [81201927, 81272204, 31270812]; China Postdoctoral Science Foundation [2012M521862]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from National Natural Science Foundation of China (No. 81201927, 81272204 and 31270812) and China Postdoctoral Science Foundation (No. 2012M521862). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray F, 2002, EUR J CANCER, V38, P99, DOI 10.1016/S0959-8049(01)00350-1; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Chan SH, 2008, ANTICANCER RES, V28, P907; Chen F, 2012, J BIOCHEM MOL TOXIC, V26, P79, DOI 10.1002/jbt.20412; Dassen AE, 2010, EUR J CANCER, V46, P1101, DOI 10.1016/j.ejca.2010.02.013; DeSantis C, 2013, CA-CANCER J CLIN, V63, P151, DOI 10.3322/caac.21173; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Farhana L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061015; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; Guo LH, 2013, INT J MOL SCI, V14, P14171, DOI 10.3390/ijms140714171; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang Y, 2011, CELL DEATH DIFFER, V18, P1220, DOI 10.1038/cdd.2010.188; Huang YP, 2012, CELL CYCLE, V11, P1247, DOI 10.4161/cc.11.6.19670; Inoue M, 2005, POSTGRAD MED J, V81, P419, DOI 10.1136/pgmj.2004.029330; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jing JJ, 2012, WORLD J GASTROENTERO, V18, P1262, DOI 10.3748/wjg.v18.i11.1262; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Krol Jacek, 2006, V342, P19, DOI 10.1385/1-59745-123-1:19; Lavy R, 2013, GASTRIC CANCER, V16, P121, DOI 10.1007/s10120-012-0155-4; Lin YS, 2011, WORLD J GASTROENTERO, V17, P4421, DOI 10.3748/wjg.v17.i39.4421; Liu XF, 2013, UNIVERSITAS-TAIWAN, V40, P1; Mazeh H, 2013, J CANCER, V4, P281, DOI 10.7150/jca.5836; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Patnaik SK, 2010, CANCER RES, V70, P36, DOI 10.1158/0008-5472.CAN-09-3153; Piva R, 2013, INT J ONCOL, V43, P985, DOI 10.3892/ijo.2013.2059; Shah AA, 2010, J APPL GENET, V51, P501, DOI 10.1007/BF03208880; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Srivastava K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050966; Wang SH, 2013, TUMOUR BIOL; Wang WB, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-102; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yanokura M, 2010, ONCOL LETT, V1, P935, DOI 10.3892/ol.2010.173; Zhao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069756	34	49	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90526	10.1371/journal.pone.0090526	http://dx.doi.org/10.1371/journal.pone.0090526			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621930	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300023
J	Sasaki, K; Yamashita, T; Yoshida, K; Inoue, K; Shichida, Y; Kandori, H				Sasaki, Kengo; Yamashita, Takahiro; Yoshida, Kazuho; Inoue, Keiichi; Shichida, Yoshinori; Kandori, Hideki			Chimeric Proton-Pumping Rhodopsins Containing the Cytoplasmic Loop of Bovine Rhodopsin	PLOS ONE			English	Article							STRUCTURAL-CHANGES; SENSORY RHODOPSIN; PHARAONIS PHOBORHODOPSIN; TRANSMEMBRANE HELICES; RETINAL CHROMOPHORE; M-INTERMEDIATE; BACTERIORHODOPSIN; LIGHT; PROTEIN; PHOTOCYCLE	G-protein-coupled receptors (GPCRs) transmit stimuli to intracellular signaling systems. Rhodopsin (Rh), which is a prototypical GPCR, possesses an 11-cis retinal. Photoisomerization of 11-cis to all-trans leads to structural changes in the protein of cytoplasmic loops, activating G-protein. Microbial rhodopsins are similar heptahelical membrane proteins that function as bacterial sensors, light-driven ion-pumps, or light-gated channels. They possess an all-trans retinal, and photoisomerization to 13-cis triggers structural changes in protein. Despite these similarities, there is no sequence homology between visual and microbial rhodopsins, and microbial rhodopsins do not activate G-proteins. In this study, new chimeric proton-pumping rhodopsins, proteorhodopsin (PR) and Gloeobacter rhodopsin (GR) were designed by replacing cytoplasmic loops with bovine Rh loops. Although G-protein was not activated by the PR chimeras, all 12 GR chimeras activated G-protein. The GR chimera containing the second cytoplasmic loop of bovine Rh did not activate G-protein. However, the chimera with a second and third double-loop further enhanced G-protein activation. Introduction of an E132Q mutation slowed the photocycle 30-fold and enhanced activation. The highest catalytic activity of the GR chimera was still 3,200 times lower than bovine Rh but only 64 times lower than amphioxus Go-rhodopsin. This GR chimera showed a strong absorption change of the amide-I band on a light-minus-dark difference FTIR spectrum which could represent a larger helical opening, important for G-protein activation. The light-dependent catalytic activity of this GR chimera makes it a potential optogenetic tool for enzymatic activation by light.	[Sasaki, Kengo; Yoshida, Kazuho; Inoue, Keiichi; Kandori, Hideki] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi, Japan; [Yamashita, Takahiro; Shichida, Yoshinori] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto, Japan; [Inoue, Keiichi] Japan Sci & Technol Agcy, PRESTO, Honcho Kawaguchi, Saitama, Japan	Nagoya Institute of Technology; Kyoto University; Japan Science & Technology Agency (JST)	Kandori, H (corresponding author), Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi, Japan.	kandori@nitech.ac.jp	Inoue, Keiichi/AEO-3337-2022	Inoue, Keiichi/0000-0002-6898-4347	Japanese Ministry of Education, Culture, Sports, Science and Technology [24115509, 24115508, 24655009, 25251036, 22247024, 25620011]; Grants-in-Aid for Scientific Research [25440167, 24655009] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology to TY (24115509), KI (24115508, 24655009), YS (25251036), and HK (22247024, 25620011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Devine EL, 2013, P NATL ACAD SCI USA, V110, P13351, DOI 10.1073/pnas.1306826110; Dioumaev AK, 2013, J PHYS CHEM B, V117, P7235, DOI 10.1021/jp402430w; Essen LO, 2002, CURR OPIN STRUC BIOL, V12, P516, DOI 10.1016/S0959-440X(02)00356-1; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Furutani Y, 2005, BIOCHEMISTRY-US, V44, P2909, DOI 10.1021/bi047893i; Geiser AH, 2006, PROTEIN SCI, V15, P1679, DOI 10.1110/ps.062192306; Han M, 1997, J BIOL CHEM, V272, P23081, DOI 10.1074/jbc.272.37.23081; Hashimoto K, 2010, BIOCHEMISTRY-US, V49, P3343, DOI 10.1021/bi100184k; Haupts U, 1999, ANNU REV BIOPH BIOM, V28, P367, DOI 10.1146/annurev.biophys.28.1.367; HAUSS T, 1994, P NATL ACAD SCI USA, V91, P11854, DOI 10.1073/pnas.91.25.11854; Hayashi S, 2001, J PHYS CHEM B, V105, P10124, DOI 10.1021/jp011362b; Hegemann P, 2011, NAT METHODS, V8, P39, DOI 10.1038/NMETH.F.327; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; HOLZ M, 1989, P NATL ACAD SCI USA, V86, P2167, DOI 10.1073/pnas.86.7.2167; Imasheva ES, 2009, BIOCHEMISTRY-US, V48, P10948, DOI 10.1021/bi901552x; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Kandori H, 2001, BIOCHEMISTRY-US, V40, P9238, DOI 10.1021/bi0103819; Kandori H, 2001, P NATL ACAD SCI USA, V98, P1571, DOI 10.1073/pnas.98.4.1571; Kandori H, 2006, CIS TRANS ISOMERIZAT, P53; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; Kawanabe A, 2011, J MICROBIOL, V49, P1, DOI 10.1007/s12275-011-0547-x; Kitajima-Ihara T, 2008, J BIOL CHEM, V283, P23533, DOI 10.1074/jbc.M802990200; Klare JP, 2004, PHOTOCH PHOTOBIO SCI, V3, P543, DOI 10.1039/b402656j; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Miranda MRM, 2009, BIOPHYS J, V96, P1471, DOI 10.1016/j.bpj.2008.11.026; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; Nagata T, 1997, BIOCHEMISTRY-US, V36, P6164, DOI 10.1021/bi962920t; Nakatsuma A, 2011, BIOPHYS J, V100, P1874, DOI 10.1016/j.bpj.2011.02.054; NAKAYAMA TA, 1991, J BIOL CHEM, V266, P4269; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Oka T, 2000, P NATL ACAD SCI USA, V97, P14278, DOI 10.1073/pnas.260504897; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Rink T, 2000, BIOPHYS J, V78, P1519, DOI 10.1016/S0006-3495(00)76704-X; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Sato H, 1999, ACTA CRYSTALLOGR D, V55, P1251, DOI 10.1107/S090744499900503X; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Shibata M, 2010, NAT NANOTECHNOL, V5, P208, DOI [10.1038/nnano.2010.7, 10.1038/NNANO.2010.7]; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Sineshchekov OA, 2010, BIOCHEMISTRY-US, V49, P6696, DOI 10.1021/bi100798w; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Spudich JL, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P1, DOI 10.1002/352760510X.ch1; SUBRAMANIAM S, 1993, EMBO J, V12, P1; Sun H, 1997, P NATL ACAD SCI USA, V94, P8860, DOI 10.1073/pnas.94.16.8860; Tachibanaki S, 1997, BIOCHEMISTRY-US, V36, P14173, DOI 10.1021/bi970932o; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Tsukamoto H, 2009, J BIOL CHEM, V284, P20676, DOI 10.1074/jbc.M109.016212; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; Watanabe Hiroshi C, 2010, Biophysics (Oxf), V6, P67, DOI 10.2142/biophysics.6.67; Yamada K, 2010, BIOCHEMISTRY-US, V49, P2416, DOI 10.1021/bi9020204; Yamashita T, 2000, J BIOL CHEM, V275, P34272, DOI 10.1074/jbc.M002954200; Yoshitsugu M, 2008, ANGEW CHEM INT EDIT, V47, P3923, DOI 10.1002/anie.200705989	62	9	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91323	10.1371/journal.pone.0091323	http://dx.doi.org/10.1371/journal.pone.0091323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621599	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300075
J	Yamato, M; Tamura, Y; Eguchi, A; Kume, S; Miyashige, Y; Nakano, M; Watanabe, Y; Kataoka, Y				Yamato, Masanori; Tamura, Yasuhisa; Eguchi, Asami; Kume, Satoshi; Miyashige, Yukiharu; Nakano, Masayuki; Watanabe, Yasuyoshi; Kataoka, Yosky			Brain Interleukin-1 beta and the Intrinsic Receptor Antagonist Control Peripheral Toll-Like Receptor 3-Mediated Suppression of Spontaneous Activity in Rats	PLOS ONE			English	Article							INTERFERON-ALPHA; SYSTEMIC INFLAMMATION; POLYCYTIDYLIC ACID; DEPRESSION; CYTOKINES; ACTIVATION; IL-1-BETA; ADENOSINE; CINGULATE; SYMPTOMS	During acute viral infections such as influenza, humans often experience not only transient fever, but also prolonged fatigue or depressive feelings with a decrease in social activity for days or weeks. These feelings are thought to be due to neuroinflammation in the brain. Recent studies have suggested that chronic neuroinflammation is a precipitating event of various neurological disorders, but the mechanism determining the duration of neuroinflammation has not been elucidated. In this study, neuroinflammation was induced by intraperitoneal injection of polyriboinosinic: polyribocytidylic acid (poly I: C), a Toll-like receptor-3 agonist that mimics viral infection in male Sprague-Dawley rats, and then investigated how the neuroinflammation shift from acute to the chronic state. The rats showed transient fever and prolonged suppression of spontaneous activity for several days following poly I: C injection. NS-398, a cyclooxygenase-2 inhibitor, completely prevented fever, but did not improve spontaneous activity, indicating that suppression of spontaneous activity was not induced by the arachidonate cascade that generated the fever. The animals overexpressed interleukin (IL)-1 beta and IL-1 receptor antagonist (IL-1ra) in the brain including the cerebral cortex. Blocking the IL-1 receptor in the brain by intracerebroventricular (i.c.v.) infusion of recombinant IL-1ra completely blocked the poly I: C-induced suppression of spontaneous activity and attenuated amplification of brain interferon (IFN)-alpha expression, which has been reported to produce fatigue-like behavior by suppressing the serotonergic system. Furthermore, i.c.v. infusion of neutralizing antibody for IL-1ra prolonged recovery from suppression of spontaneous activity. Our findings indicated that IL-1 beta is the key trigger of neuroinflammation and that IL-1ra prevents the neuroinflammation entering the chronic state.	[Yamato, Masanori; Tamura, Yasuhisa; Eguchi, Asami; Kume, Satoshi; Miyashige, Yukiharu; Nakano, Masayuki; Kataoka, Yosky] RIKEN Ctr Life Sci Technol, Cellular Funct Imaging Team, Kobe, Hyogo, Japan; [Watanabe, Yasuyoshi] RIKEN Ctr Life Sci Technol, Pathophysiol & Hlth Sci Team, Kobe, Hyogo, Japan; [Nakano, Masayuki; Watanabe, Yasuyoshi; Kataoka, Yosky] Osaka City Univ, Dept Physiol, Grad Sch Med, Osaka 558, Japan	RIKEN; RIKEN; Osaka Metropolitan University	Kataoka, Y (corresponding author), RIKEN Ctr Life Sci Technol, Cellular Funct Imaging Team, Kobe, Hyogo, Japan.	kataokay@riken.jp			Core Research for Evolution Science and Technology (CREST) of Japan Science and Technology (JST) [25460399, 25750169, 25108515]	Core Research for Evolution Science and Technology (CREST) of Japan Science and Technology (JST)	This study was supported in part by the Core Research for Evolution Science and Technology (CREST) of Japan Science and Technology (JST), Grant-in-Aid for Scientific Research C (MEXT KAKENHI Grant Number 25460399 to Y.K), and Grant-in-Aid for Young Scientists B (MEXT KAKENHI Grant Number 25750169 to M.Y.), Grant-in-Aid for Scientific Research on Innovative Areas (MEXT KAKENHI Grant Number 25108515 to Y. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abe Chikara, 2009, Journal of Pharmacological and Toxicological Methods, V59, P7, DOI 10.1016/j.vascn.2008.09.002; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Burak KW, 2002, GASTROENTEROLOGY, V122, P681, DOI 10.1053/gast.2002.31878; Cao CY, 2001, EUR J NEUROSCI, V13, P1781, DOI 10.1046/j.0953-816x.2001.01551.x; Chen GJ, 1999, ENDOCRINOLOGY, V140, P5549, DOI 10.1210/en.140.12.5549; CONN CA, 1995, AM J PHYSIOL-REG I, V268, pR78, DOI 10.1152/ajpregu.1995.268.1.R78; Craig AD, 2009, PHILOS T R SOC B, V364, P1933, DOI 10.1098/rstb.2009.0008; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Di Santo E, 1999, NEUROIMMUNOMODULAT, V6, P300, DOI 10.1159/000026388; DINARELLO CA, 1991, IMMUNOL TODAY, V12, P404, DOI 10.1016/0167-5699(91)90142-G; Flagmeyer I, 1997, BRAIN RES, V778, P178, DOI 10.1016/S0006-8993(97)01060-3; Fortier ME, 2004, AM J PHYSIOL-REG I, V287, pR759, DOI 10.1152/ajpregu.00293.2004; Hannestad J, 2012, J NUCL MED, V53, P601, DOI 10.2967/jnumed.111.097014; Harrison NA, 2009, BIOL PSYCHIAT, V66, P407, DOI 10.1016/j.biopsych.2009.03.015; Hu XM, 2005, J NEUROCHEM, V93, P26, DOI 10.1111/j.1471-4159.2004.02968.x; Kaneko N, 2006, NEUROPSYCHOPHARMACOL, V31, P2619, DOI 10.1038/sj.npp.1301137; Katafuchi T, 2005, EUR J NEUROSCI, V22, P2817, DOI 10.1111/j.1460-9568.2005.04478.x; Katafuchi T, 2003, NEUROSCIENCE, V120, P837, DOI 10.1016/S0306-4522(03)00365-8; Konsman JP, 2008, EUR J NEUROSCI, V28, P2499, DOI 10.1111/j.1460-9568.2008.06549.x; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Koo JW, 2009, CURR OPIN INVEST DR, V10, P664; Leon LR, 2004, FRONT BIOSCI, V9, P1877, DOI 10.2741/1381; Loddick SA, 1997, BIOCHEM BIOPH RES CO, V234, P211, DOI 10.1006/bbrc.1997.6436; Loftis JM, 2008, NEUROSCI LETT, V430, P264, DOI 10.1016/j.neulet.2007.11.001; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; MAGEE WE, 1972, LIFE SCI 2-BIOCH GEN, V11, P1081, DOI 10.1016/0024-3205(72)90216-0; Magrone T, 2012, CURR PHARM DESIGN, V18, P34, DOI 10.2174/138161212798919057; MANETTI R, 1995, EUR J IMMUNOL, V25, P2656, DOI 10.1002/eji.1830250938; Masino SA, 1999, J NEUROSCI, V19, P1932; Matsumoto M, 2004, MICROBIOL IMMUNOL, V48, P147, DOI 10.1111/j.1348-0421.2004.tb03500.x; McGeer PL, 2001, NEUROBIOL AGING, V22, P799, DOI 10.1016/S0197-4580(01)00289-5; Morikawa O, 1998, EUR J PHARMACOL, V349, P317, DOI 10.1016/S0014-2999(98)00187-3; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pinteaux E, 2006, GLIA, V53, P551, DOI 10.1002/glia.20308; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Rosenkranz MA, 2005, P NATL ACAD SCI USA, V102, P13319, DOI 10.1073/pnas.0504365102; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Song C, 2011, PROG NEURO-PSYCHOPH, V35, P760, DOI 10.1016/j.pnpbp.2010.06.020; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Traynor TR, 2007, BRAIN BEHAV IMMUN, V21, P311, DOI 10.1016/j.bbi.2006.09.007	40	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90950	10.1371/journal.pone.0090950	http://dx.doi.org/10.1371/journal.pone.0090950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621600	gold, Green Published, Green Submitted			2022-12-27	WOS:000332845300036
J	Caro, TM; Hermosilla, C; Silva, LMR; Cortes, H; Taubert, A				Caro, Tamara Munoz; Hermosilla, Carlos; Silva, Liliana M. R.; Cortes, Helder; Taubert, Anja			Neutrophil Extracellular Traps as Innate Immune Reaction against the Emerging Apicomplexan Parasite Besnoitia besnoiti	PLOS ONE			English	Article							IN-VITRO ISOLATION; BOVINE BESNOITIOSIS; TOXOPLASMA-GONDII; ANTIMICROBIAL ACTIVITY; EIMERIA-BOVIS; CATTLE; CELLS; BORN	Besnoitia besnoiti infection in cattle is an important emerging protozoan disease in Europe causing economic losses and severe clinical signs, such as generalized dermatitis, orchitis, and vulvitis in affected animals. Neutrophil extracellular trap (NET) formation was recently demonstrated as an important effector mechanism of PMN acting against several invading pathogens. In the present study, interactions of bovine PMN with tachyzoites of B. besnoiti were investigated in this respect in vitro. For the demonstration and quantification of NETs, extracellular DNA was stained by Sytox Orange or Pico Green. Fluorescent illustrations as well as scanning electron microscopy analyses (SEM) showed PMN-promoted NET formation rapidly being induced upon contact with B. besnoiti tachyzoites. Co-localization of extracellular DNA with histones, neutrophil elastase (NE) and myeloperoxidase (MPO) in parasite entrapping structures confirmed the classical characteristics of NET. Exposure of PMN to viable, UV attenuated and dead tachyzoites showed a significant induction of NET formation, but even tachyzoite homogenates significantly promoted NETs when compared to negative controls. NETs were abolished by DNase treatment and were reduced after PMN preincubation with NADPH oxidase-, NE- and MPO-inhibitors. Tachyzoite-triggered NET formation led to parasite entrapment as quantitative assays indicated that about one third of tachyzoites were immobilized in NETs. In consequence, tachyzoites were hampered from active invasion of host cells. Thus, transfer of tachyzoites, previously being confronted with PMN, to adequate host cells resulted in significantly reduced infection rates when compared to PMN-free infection controls. To our knowledge, we here report for the first time B. besnoiti-induced NET formation. Our results indicate that PMN-triggered extracellular traps may represent an important effector mechanism of the host early innate immune response against B. besnoiti which may lead to diminishment of initial parasite infection rates during the acute infection phase.	[Caro, Tamara Munoz; Hermosilla, Carlos; Taubert, Anja] Univ Giessen, Inst Parasitol, D-35390 Giessen, Germany; [Silva, Liliana M. R.; Cortes, Helder] Univ Evora, ICAAM, Evora, Portugal	Justus Liebig University Giessen; University of Evora	Caro, TM (corresponding author), Univ Giessen, Inst Parasitol, D-35390 Giessen, Germany.	Tamara.Munoz-Caro@vetmed.uni-giessen.de		Cortes, Helder/0000-0003-4644-2165; Silva, Liliana M. R./0000-0002-2217-9983	Institute of Parasitology of the Justus Liebig University Giessen	Institute of Parasitology of the Justus Liebig University Giessen	The present work was self-financed by the Institute of Parasitology of the Justus Liebig University Giessen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah DSA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00382; Abdallah DSA, 2012, INFECT IMMUN, V80, P768, DOI 10.1128/IAI.05730-11; Alvarez-Garcia G, 2013, TRENDS PARASITOL, V29, P407, DOI 10.1016/j.pt.2013.06.002; Aulik NA, 2010, INFECT IMMUN, V78, P4454, DOI 10.1128/IAI.00840-10; Baker VS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-41; Behrendt JH, 2008, VET PARASITOL, V151, P97, DOI 10.1016/j.vetpar.2007.11.013; Behrendt JH, 2010, VET IMMUNOL IMMUNOP, V133, P1, DOI 10.1016/j.vetimm.2009.06.012; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; BROWN GB, 1991, VET IMMUNOL IMMUNOP, V28, P201, DOI 10.1016/0165-2427(91)90115-S; Conejeros I, 2011, VET IMMUNOL IMMUNOP, V139, P308, DOI 10.1016/j.vetimm.2010.10.021; Conejeros I, 2012, RES VET SCI, V92, P103, DOI 10.1016/j.rvsc.2010.10.005; Cortes H, 2005, VET REC, V157, P262, DOI 10.1136/vr.157.9.262; EFSA European Food Safety Authority, 2010, EFSA J, V8, P1499, DOI [10.2903/j.efsa.2010.1499, DOI 10.2903/J.EFSA.2010.1499]; Fernandez-Garcia A, 2009, J PARASITOL, V95, P474, DOI 10.1645/GE-1772.1; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gabriel C, 2010, J IMMUNOL, V185, P4319, DOI 10.4049/jimmunol.1000893; Gentile A, 2012, VET PARASITOL, V184, P108, DOI 10.1016/j.vetpar.2011.09.014; Gollnick NS, 2010, VET REC, V166, P599, DOI 10.1136/vr.c2314; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Hermosilla C, 2008, PARASITOL RES, V102, P777, DOI 10.1007/s00436-007-0849-4; Jacquiet P, 2009, JOURN NAT GTV NANT, P1213; Lesser M, 2012, SCHWEIZ ARCH TIERH, V154, P469, DOI 10.1024/0036-7281/a000389; Linch SN, 2009, INFECT IMMUN, V77, P4976, DOI 10.1128/IAI.00306-09; Lippolis JD, 2006, VET IMMUNOL IMMUNOP, V113, P248, DOI 10.1016/j.vetimm.2006.05.004; MacLaren A, 2004, VET PARASITOL, V125, P301, DOI 10.1016/j.vetpar.2004.07.006; MacLaren A., 2002, Journal of Submicroscopic Cytology and Pathology, V34, P99; Martinelli S, 2004, J BIOL CHEM, V279, P44123, DOI 10.1074/jbc.M405883200; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Parker H, 2012, J LEUKOCYTE BIOL, V91, P369, DOI 10.1189/jlb.0711387; Rinaldi L, 2013, PARASITOL RES, V112, P1805, DOI 10.1007/s00436-012-3241-y; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Schares G, 2009, VET PARASITOL, V163, P315, DOI 10.1016/j.vetpar.2009.04.033; Taubert A, 2006, BERL MUNCH TIERARZTL, V119, P274; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018; von Kockritz-Blickwede M, 2010, METHOD MICROBIOL, V37, P139, DOI 10.1016/S0580-9517(10)37007-3; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; Wartha F, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe25; WILSON CB, 1979, J INFECT DIS, V140, P890, DOI 10.1093/infdis/140.6.890; Zhao Y, 2013, PARASITOL RES, V112, P3151, DOI 10.1007/s00436-013-3491-3	41	51	54	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91415	10.1371/journal.pone.0091415	http://dx.doi.org/10.1371/journal.pone.0091415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618849	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400089
J	Dangor, Z; Izu, A; Moore, DP; Nunes, MC; Solomon, F; Beylis, N; von Gottberg, A; McAnerney, JM; Madhi, SA				Dangor, Ziyaad; Izu, Alane; Moore, David P.; Nunes, Marta C.; Solomon, Fatima; Beylis, Natalie; von Gottberg, Anne; McAnerney, Johanna M.; Madhi, Shabir A.			Temporal Association in Hospitalizations for Tuberculosis, Invasive Pneumococcal Disease and Influenza Virus Illness in South African Children	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; MYCOBACTERIUM-TUBERCULOSIS; HUMAN METAPNEUMOVIRUS; BACTERIAL-INFECTIONS; PANDEMIC INFLUENZA; NATURAL-HISTORY; UNITED-STATES; COINFECTION; IMPACT	Introduction: The seasonal variability in hospitalization for tuberculosis may in part relate to super-imposed bacterial or predisposing respiratory viral infections. We aimed to study the temporal association between hospitalization for culture-confirmed pulmonary tuberculosis (PTB), invasive pneumococcal disease (IPD) and influenza virus epidemics in South African children. Methods: We undertook a retrospective analysis which examined seasonal trends, from 2005 to 2008, for hospitalization for culture-confirmed PTB and IPD among children in relation to the influenza epidemics in Soweto, South Africa. Original time-series of the influenza virus epidemics and hospitalization rates for PTB and IPD were decomposed into three components: a trend cycle component, a seasonal component and an irregular component using the X-11 seasonal adjustment method. To compare the seasonality amongst the three series, the trend and irregular components were removed and only seasonal components examined. Results: Across the study period, the influenza virus epidemics peaked during May to July (winter) months, which was closely followed by an increase in the incidence of hospitalization for IPD (August to October) and PTB (August to November). Discussion: Within-and between-year temporal changes associated with childhood TB hospitalization may in part be driven by factors which influence temporal changes in pneumococcal disease, including potential variability in the severity of influenza virus epidemics in temperate climates. The dynamics of the interplay between the host and these infectious agents appears to be complex and multifactorial.	[Dangor, Ziyaad; Izu, Alane; Moore, David P.; Nunes, Marta C.; Solomon, Fatima; Madhi, Shabir A.] Univ Witwatersrand, Fac Hlth Sci, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Dangor, Ziyaad] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat, Johannesburg, South Africa; [Izu, Alane; Moore, David P.; Nunes, Marta C.; Solomon, Fatima; Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa; [Beylis, Natalie] Natl Hlth Lab Serv, Mycobacteriol Referral Lab, Johannesburg, South Africa; [von Gottberg, Anne; McAnerney, Johanna M.; Madhi, Shabir A.] Natl Inst Communicable Dis, Ctr Resp & Meningitis Dis, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD)	Madhi, SA (corresponding author), Univ Witwatersrand, Fac Hlth Sci, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.	shabirm@nicd.ac.za	Moore, David/AAU-7186-2020	Moore, David/0000-0001-6091-1605; Dangor, Ziyaad/0000-0003-4089-147X; Nunes, Marta/0000-0003-3788-878X; von Gottberg, Anne/0000-0002-0243-7455	Medical Research Council: Respiratory and Meningeal Pathogens Unit; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases South African Research Chair Initiative; Carnegie Corporation of New York; National Research Foundation/Department of Science and Technology: South African Research Chair Initiative Program	Medical Research Council: Respiratory and Meningeal Pathogens Unit; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases South African Research Chair Initiative; Carnegie Corporation of New York; National Research Foundation/Department of Science and Technology: South African Research Chair Initiative Program	The authors acknowledge financial support from the Medical Research Council: Respiratory and Meningeal Pathogens Unit and the Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases South African Research Chair Initiative. ZD is funded in part by the Carnegie Corporation of New York. SAM is funded in part by National Research Foundation/Department of Science and Technology: South African Research Chair Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actuarial Society of South Africa (ASSA), 2011, ASSA2008 AIDS DEM MO; [Anonymous], STAT S AFR S GAUT SU; Archer B, 2009, EURO SURVEILL, V14; Bradshaw Benjamin S, 2008, Biodemography Soc Biol, V54, P74, DOI 10.1080/19485565.2008.9989133; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Dangor Z, 2013, PEDIATR INFECT DIS J, V32, P972, DOI 10.1097/INF.0b013e31828d9aa4; Davis BM, 2012, AM J EPIDEMIOL, V175, P363, DOI 10.1093/aje/kwr402; GRAY BM, 1989, PEDIATR INFECT DIS J, V8, pS23; Haynes L, 2012, J IMMUNOL, V189, P4921, DOI 10.4049/jimmunol.1201916; Jo EK, 2008, CURR OPIN INFECT DIS, V21, P279, DOI 10.1097/QCO.0b013e3282f88b5d; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Klugman KP, 2009, VACCINE, V27, pC9, DOI 10.1016/j.vaccine.2009.06.007; Ladiray D, 2001, SEASONAL ADJUSTMENT; Louw A, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-12; Ludewick HP, 2011, J GEN VIROL, V92, P1662, DOI 10.1099/vir.0.030825-0; Madhi SA, 2006, J INFECT DIS, V193, P1236, DOI 10.1086/503053; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Madhi SA, 2007, PEDIATR INFECT DIS J, V26, P693, DOI 10.1097/INF.0b013e3180621192; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; McAnerney JM, 2012, J INFECT DIS, V206, pS153, DOI 10.1093/infdis/jis575; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Moore DP, 2010, PEDIATR INFECT DIS J, V29, P1099, DOI 10.1097/INF.0b013e3181eaefff; Moore DP, 2012, EXPERT REV RESP MED, V6, P451, DOI [10.1586/ers.12.32, 10.1586/ERS.12.32]; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Noh JY, 2013, EMERG INFECT DIS, V19, P165, DOI 10.3201/eid1901.111613; Noymer A, 2011, VACCINE, V29, pB38, DOI 10.1016/j.vaccine.2011.02.053; Nunes MC, 2011, AIDS, V25, P453, DOI 10.1097/QAD.0b013e328341b7f1; Pedrosa J, 2000, INFECT IMMUN, V68, P577, DOI 10.1128/IAI.68.2.577-583.2000; Schleicher GK, 2003, INT J TUBERC LUNG D, V7, P1207; Short KR, 2012, FUTURE MICROBIOL, V7, P609, DOI [10.2217/FMB.12.29, 10.2217/fmb.12.29]; Singhania S, 2010, INT J TUBERC LUNG D, V14, P1497; Stensballe LG, 2008, CLIN INFECT DIS, V46, P1165, DOI 10.1086/529438; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Tasher D, 2011, CLIN INFECT DIS, V53, P1199, DOI 10.1093/cid/cir726; VOLKERT M, 1947, J EXP MED, V86, P203, DOI 10.1084/jem.86.3.203; Weinberger DM, 2014, CLIN INFECT DIS, V58, P188, DOI 10.1093/cid/cit721	37	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91464	10.1371/journal.pone.0091464	http://dx.doi.org/10.1371/journal.pone.0091464			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618667	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400095
J	Jo, M; Yun, HM; Park, KR; Park, MH; Lee, DH; Cho, SH; Yoo, HS; Lee, YM; Jeong, HS; Kim, Y; Jung, JK; Hwang, BY; Lee, MK; Kim, ND; Han, SB; Hong, JT				Jo, Miran; Yun, Hyung-Mun; Park, Kyung-Ran; Park, Mi Hee; Lee, Dong Hun; Cho, Seung Hee; Yoo, Hwan-Soo; Lee, Yong-Moon; Jeong, Heon Sang; Kim, Youngsoo; Jung, Jae Kyung; Hwang, Bang Yeon; Lee, Mi Kyeong; Kim, Nam Doo; Han, Sang Bae; Hong, Jin Tae			Anti-Cancer Effect of Thiacremonone through Down Regulation of Peroxiredoxin 6	PLOS ONE			English	Article							COLON-CANCER CELLS; DIALLYL DISULFIDE; SULFUR-COMPOUNDS; GENE-EXPRESSION; IN-VIVO; APOPTOSIS; LUNG; OVEREXPRESSION; INDUCTION; TUMOR	Thiacremonone (2, 4-dihydroxy-2, 5-dimethyl-thiophene-3-one) is an antioxidant substance as a novel sulfur compound generated from High-Temperature-High-Pressure-treated garlic. Peroxiredoxin 6 (PRDX6) is a member of peroxidases, and has glutathione peroxidase and calcium-independent phospholipase A2 (iPLA2) activities. Several studies have demonstrated that PRDX6 stimulates lung cancer cell growth via an increase of glutathione peroxidase activity. A docking model study and pull down assay showed that thiacremonone completely fits on the active site (cys-47) of glutathione peroxidase of PRDX6 and interacts with PRDX6. Thus, we investigated whether thiacremonone inhibits cell growth by blocking glutathione peroxidase of PRDX6 in the human lung cancer cells, A549 and NCI-H460. Thiacremonone (0-50 mu g/ml) inhibited lung cancer cell growth in a concentration dependent manner through induction of apoptotic cell death accompanied by induction of cleaved caspase-3, -8, -9, Bax, p21 and p53, but decrease of xIAP, cIAP and Bcl2 expression. Thiacremonone further inhibited glutathione peroxidase activity in lung cancer cells. However, the cell growth inhibitory effect of thiacremonone was not observed in the lung cancer cells transfected with mutant PRDX6 (C47S) and in the presence of dithiothreitol and glutathione. In an allograft in vivo model, thiacremonone (30 mg/kg) also inhibited tumor growth accompanied with the reduction of PRDX6 expression and glutathione peroxidase activity, but increased expression of cleaved caspase-3, -8, -9, Bax, p21 and p53. These data indicate that thiacremonone inhibits tumor growth via inhibition of glutathione peroxidase activity of PRDX6 through interaction. These data suggest that thiacremonone may have potentially beneficial effects in lung cancer.	[Jo, Miran; Yun, Hyung-Mun; Park, Kyung-Ran; Park, Mi Hee; Lee, Dong Hun; Cho, Seung Hee; Yoo, Hwan-Soo; Lee, Yong-Moon; Kim, Youngsoo; Jung, Jae Kyung; Hwang, Bang Yeon; Lee, Mi Kyeong; Han, Sang Bae; Hong, Jin Tae] Chungbuk Natl Univ, Coll Pharm, Chungbuk, South Korea; [Jo, Miran; Yun, Hyung-Mun; Park, Kyung-Ran; Park, Mi Hee; Lee, Dong Hun; Cho, Seung Hee; Yoo, Hwan-Soo; Lee, Yong-Moon; Kim, Youngsoo; Jung, Jae Kyung; Hwang, Bang Yeon; Lee, Mi Kyeong; Han, Sang Bae; Hong, Jin Tae] Chungbuk Natl Univ, Med Res Ctr, Chungbuk, South Korea; [Jeong, Heon Sang] Chungbuk Natl Univ, Coll Agr Life & Environm Sci, Chungbuk, South Korea; [Kim, Nam Doo] Daegu Gyeongbuk Med Innovat Fdn, New Drug Dev Ctr, Taegu, South Korea	Chungbuk National University; Chungbuk National University; Chungbuk National University	Hong, JT (corresponding author), Chungbuk Natl Univ, Coll Pharm, Chungbuk, South Korea.	jinthong@chungbuk.ac.kr		Jung, Jae-Kyung/0000-0002-0490-9663	National Research Foundation of Korea (NRF); Korean Government (MSIP) [MRC, 2008-0062275]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Government (MSIP)	This work was supported by a grant from the National Research Foundation of Korea (NRF) funded by the Korean Government (MSIP) (No. MRC, 2008-0062275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AF, 2007, CLIN CANCER RES, V13, P3388, DOI 10.1158/1078-0432.CCR-06-0873; Ban JO, 2007, J PHARMACOL SCI, V104, P374, DOI 10.1254/jphs.FP0070789; Bat-Chen W, 2010, NUTR CANCER, V62, P947, DOI 10.1080/01635581.2010.509837; Cao Min, 2009, Zhongguo Fei Ai Za Zhi, V12, P322, DOI 10.3779/j.issn.1009-3419.2009.04.12; Chang XZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1789; Chatterjee S, 2011, J BIOL CHEM, V286, P11696, DOI 10.1074/jbc.M110.206623; Chowdhury I, 2009, FREE RADICAL BIO MED, V46, P146, DOI 10.1016/j.freeradbiomed.2008.09.027; Conti A, 2011, AM J PATHOL, V178, P88, DOI 10.1016/j.ajpath.2010.11.035; Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201; Druesne-Pecollo N, 2011, ANTI-CANCER AGENT ME, V11, P254, DOI 10.2174/187152011795347540; Fatma N, 2008, BRAIN RES, V1233, P63, DOI 10.1016/j.brainres.2008.07.076; Fisher AB, 2011, ANTIOXID REDOX SIGN, V15, P831, DOI 10.1089/ars.2010.3412; Flohe L, 2003, BIOFACTORS, V19, P3, DOI 10.1002/biof.5520190102; Ho JN, 2010, MOL CANCER THER, V9, P825, DOI 10.1158/1535-7163.MCT-09-0904; Iciek M, 2012, CELL BIOCHEM FUNCT, V30, P198, DOI 10.1002/cbf.1835; Kang SW, 1998, J BIOL CHEM, V273, P6303, DOI 10.1074/jbc.273.11.6303; Kim SY, 2008, J BIOL CHEM, V283, P33563, DOI 10.1074/jbc.M806578200; Kim SH, 2011, CANCER PREV RES, V4, P897, DOI 10.1158/1940-6207.CAPR-10-0323; Kwon OC, 2006, KOREAN J FOOD SCI TE, V38, P331; Lai KC, 2012, PHYTOMEDICINE, V19, P625, DOI 10.1016/j.phymed.2012.02.004; Lee SB, 2009, MOL CELLS, V28, P583, DOI 10.1007/s10059-009-0152-6; Lee Y, 2011, BIOL PHARM BULL, V34, P677, DOI 10.1248/bpb.34.677; Manevich Y, 2002, P NATL ACAD SCI USA, V99, P11599, DOI 10.1073/pnas.182384499; Nagaraj NS, 2010, J NUTR BIOCHEM, V21, P405, DOI 10.1016/j.jnutbio.2009.01.015; Neumann CA, 2007, CURR OPIN PHARMACOL, V7, P375, DOI 10.1016/j.coph.2007.04.007; Ng KTP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031655; O'Donovan TR, 2011, AUTOPHAGY, V7, P509, DOI 10.4161/auto.7.5.15066; Pak JH, 2011, CANCER INVEST, V29, P21, DOI 10.3109/07357907.2010.535056; Pei YX, 2011, TOXICOL APPL PHARM, V257, P420, DOI 10.1016/j.taap.2011.09.026; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Schremmer Bruno, 2007, V44, P317; Sun M, 2012, PROSTATE, V72, P82, DOI 10.1002/pros.21409; Walsh B, 2009, REDOX REP, V14, P275, DOI 10.1179/135100009X12525712409652; Wang L, 2008, MOL PHARMACOL, V73, P119, DOI 10.1124/mol.107.040873; Xiao D, 2009, ENVIRON MOL MUTAGEN, V50, P201, DOI 10.1002/em.20431; Zhang XZ, 2009, CANCER SCI, V100, P2396, DOI 10.1111/j.1349-7006.2009.01314.x	36	15	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91508	10.1371/journal.pone.0091508	http://dx.doi.org/10.1371/journal.pone.0091508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618722	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400099
J	Lee, SK; Chun, JW; Lee, JS; Park, HJ; Jung, YC; Seok, JH; Kim, JJ				Lee, Seon-Koo; Chun, Ji Won; Lee, Jung Suk; Park, Hae-Jeong; Jung, Young-Chul; Seok, Jeong-Ho; Kim, Jae-Jin			Abnormal Neural Processing during Emotional Salience Attribution of Affective Asymmetry in Patients with Schizophrenia	PLOS ONE			English	Article							PREFRONTAL CORTEX; RECOGNITION; NEGATIVITY; PSYCHOSIS; NETWORKS; DEFICIT; STATE; FMRI	Aberrant emotional salience attribution has been reported to be an important clinical feature in patients with schizophrenia. Real life stimuli that incorporate both positive and negative emotional traits lead to affective asymmetry such as negativity bias and positivity offset. In this study, we investigated the neural correlates of emotional salience attribution in patients with schizophrenia when affective asymmetry was processed. Fifteen patients with schizophrenia and 14 healthy controls were scanned using functional magnetic resonance imaging (fMRI) while performing an emotion judgment task in which two pictures were juxtaposed. The task consisted of responding to affective asymmetry condition (ambivalent and neutral) and affective symmetry conditions (positive and negative), and group comparisons were performed for each condition. Significantly higher activity in the medial prefrontal cortex and inferior frontal gyrus was observed for the ambivalent condition than for the other conditions in controls, but not in patients. Compared with controls, patients showed decreased activities in the dorsolateral prefrontal cortex, dorsal anterior cingulate cortex, insula, and putamen for the ambivalent condition, but no changes were observed for the neutral condition. Multiple prefrontal hypoactivities during salience attribution of negativity bias in schizophrenia may underlie deficits in the integrative processing of emotional information. Regional abnormalities in the salience network may be the basis of defective emotional salience attribution in schizophrenia, which is likely involved in symptom formation and social dysfunction.	[Lee, Seon-Koo; Chun, Ji Won; Lee, Jung Suk; Jung, Young-Chul; Seok, Jeong-Ho; Kim, Jae-Jin] Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea; [Lee, Seon-Koo] Natl Hlth Insurance Ilsan Hosp, Dept Psychiat, Koyang Gyeonggi, South Korea; [Lee, Jung Suk] Bundang Jesaeng Hosp, Dept Psychiat, Songnam, South Korea; [Park, Hae-Jeong; Kim, Jae-Jin] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Jung, Young-Chul; Seok, Jeong-Ho; Kim, Jae-Jin] Yonsei Univ, Coll Med, Dept Psychiat, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, JJ (corresponding author), Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea.	jaejkim@yonsei.ac.kr		Chun, Ji-Won/0000-0002-0629-0358; JUNG, YOUNG-CHUL/0000-0002-0578-2510; Seok, Jeong-Ho/0000-0002-9402-7591; Kim, Jae-Jin/0000-0002-1395-4562	National Research Foundation of Korea (NRF); Korean government (MEST) [2011-0015859]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST; No. 2011-0015859). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Bechara A, 2003, ANN NY ACAD SCI, V985, P356, DOI 10.1111/j.1749-6632.2003.tb07094.x; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; CACIOPPO JT, 1994, PSYCHOL BULL, V115, P401, DOI 10.1037/0033-2909.115.3.401; Constant EL, 2011, PSYCHIAT RES, V185, P315, DOI 10.1016/j.psychres.2009.08.026; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Esslinger C, 2012, SCHIZOPHR RES, V140, P114, DOI 10.1016/j.schres.2012.06.025; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; FENIGSTEIN A, 1992, J PERS SOC PSYCHOL, V62, P129, DOI 10.1037/0022-3514.62.1.129; First M.B., 2016, STRUCTURED CLIN INTE; GRAY JA, 1995, NEUROPSYCHOLOGIA, V33, P1143, DOI 10.1016/0028-3932(95)00054-7; Guido G., 1998, EUROPEAN ADV CONSUME, V3, P114; Guido G, 2001, SALIENCE MARKETING S, P15; Habel U, 2010, SCHIZOPHR RES, V122, P113, DOI 10.1016/j.schres.2010.06.009; Heinz A, 2010, SCHIZOPHRENIA BULL, V36, P472, DOI 10.1093/schbul/sbq031; ILINSKY IA, 1985, J COMP NEUROL, V236, P315, DOI 10.1002/cne.902360304; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jung YC, 2006, BIOL PSYCHOL, V73, P253, DOI 10.1016/j.biopsycho.2006.04.006; Kanske P, 2011, CEREB CORTEX, V21, P1379, DOI 10.1093/cercor/bhq216; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keightley ML, 2003, NEUROPSYCHOLOGIA, V41, P585, DOI 10.1016/S0028-3932(02)00199-9; Kim JJ, 2003, AM J PSYCHIAT, V160, P919, DOI 10.1176/appi.ajp.160.5.919; Kring AM, 1999, BEHAV THER, V30, P373, DOI 10.1016/S0005-7894(99)80016-1; KRING AM, 1993, J ABNORM PSYCHOL, V102, P507, DOI 10.1037/0021-843X.102.4.507; Lang PJ, 1998, INT AFFECTIVE PICTUR; Mandal MK, 1999, PSYCHIAT RES, V87, P39, DOI 10.1016/S0165-1781(99)00047-5; Manoliu A, 2013, SCHIZOPHR B; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mier D, 2010, PSYCHOL MED, V40, P1607, DOI 10.1017/S0033291709992133; Naveau M, 2012, NEUROINFORMATICS, V10, P269, DOI 10.1007/s12021-012-9145-2; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Orliac F, 2013, SCHIZOPHR RES, V148, P74, DOI 10.1016/j.schres.2013.05.007; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P17, DOI 10.1503/jpn.100176; Park IH, 2009, PSYCHIAT RES-NEUROIM, V171, P155, DOI 10.1016/j.pscychresns.2008.03.010; Phan KL, 2004, NEUROIMAGE, V21, P768, DOI 10.1016/j.neuroimage.2003.09.072; Raulin ML, 1993, AMBIVALENCE; Sakagami M, 2007, CURR OPIN NEUROBIOL, V17, P228, DOI 10.1016/j.conb.2007.02.008; Sakagami M, 2006, NEURAL NETWORKS, V19, P1255, DOI 10.1016/j.neunet.2006.05.040; Santuzzi AM, 2002, SOC COGNITION, V20, P171, DOI 10.1521/soco.20.3.171.21105; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seiferth NY, 2009, NEUROPSYCHOPHARMACOL, V34, P477, DOI 10.1038/npp.2008.93; Seok JH, 2006, PSYCHIAT RES, V142, P53, DOI 10.1016/j.psychres.2005.08.021; Sommer IEC, 2008, BRAIN, V131, P3169, DOI 10.1093/brain/awn251; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Summerfield C, 2006, SCIENCE, V314, P1311, DOI 10.1126/science.1132028; Surguladze S, 2006, BIOL PSYCHIAT, V60, P423, DOI 10.1016/j.biopsych.2005.11.021; Taylor SF, 2005, NEUROPSYCHOPHARMACOL, V30, P984, DOI 10.1038/sj.npp.1300679; Taylor SF, 2003, NEUROIMAGE, V18, P650, DOI 10.1016/S1053-8119(02)00051-4; Urban NBL, 2012, PSYCHOPHARMACOLOGY, V221, P67, DOI 10.1007/s00213-011-2543-6; Walter H, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/neuro.08.062.2009; Xiao ZW, 2005, HUM BRAIN MAPP, V25, P212, DOI 10.1002/hbm.20105; Zink CF, 2003, J NEUROSCI, V23, P8092	54	15	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90792	10.1371/journal.pone.0090792	http://dx.doi.org/10.1371/journal.pone.0090792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24619004	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400029
J	Lim, TW; Frangakis, C; Latkin, C; Ha, TV; Minh, NL; Zelaya, C; Quan, VM; Go, VF				Lim, Travis W.; Frangakis, Constantine; Latkin, Carl; Tran Viet Ha; Nguyen Le Minh; Zelaya, Carla; Vu Minh Quan; Go, Vivian F.			Community-Level Income Inequality and HIV Prevalence among Persons Who Inject Drugs in Thai Nguyen, Vietnam	PLOS ONE			English	Article							SOCIOECONOMIC DETERMINANTS; HEALTH INEQUALITIES; POVERTY; MORTALITY; EPIDEMICS; MATTERS; WEALTH; USERS; RISK; AIDS	Socioeconomic status has a robust positive relationship with several health outcomes at the individual and population levels, but in the case of HIV prevalence, income inequality may be a better predictor than absolute level of income. Most studies showing a relationship between income inequality and HIV have used entire countries as the unit of analysis. In this study, we examine the association between income inequality at the community level and HIV prevalence in a sample of persons who inject drugs (PWID) in a concentrated epidemic setting. We recruited PWID and non-PWID community participants in Thai Nguyen, Vietnam, and administered a cross-sectional questionnaire; PWID were tested for HIV. We used ecologic regression to model HIV burden in our PWID study population on GINI indices of inequality calculated from total reported incomes of non-PWID community members in each commune. We also modeled HIV burden on interaction terms between GINI index and median commune income, and finally used a multi-level model to control for community level inequality and individual level income. HIV burden among PWID was significantly correlated with the commune GINI coefficient (r = 0.53, p = 0.002). HIV burden was also associated with GINI coefficient (beta = 0.082, p = 0.008) and with median commune income (beta = -0.018, p = 0.023) in ecological regression. In the multi-level model, higher GINI coefficient at the community level was associated with higher odds of individual HIV infection in PWID (OR = 1.46 per 0.01, p = 0.003) while higher personal income was associated with reduced odds of infection (OR = 0.98 per $10, p = 0.022). This study demonstrates a context where income inequality is associated with HIV prevalence at the community level in a concentrated epidemic. It further suggests that community level socioeconomic factors, both contextual and compositional, could be indirect determinants of HIV infection in PWID.	[Lim, Travis W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA; [Frangakis, Constantine] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Latkin, Carl] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Tran Viet Ha; Zelaya, Carla; Vu Minh Quan; Go, Vivian F.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Nguyen Le Minh] Thai Nguyen Ctr Prevent Med, Thai Nguyen, Vietnam	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lim, TW (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA.	tlim@jhsph.edu			National Institute on Drug Abuse, NIDA [5R01DA022962-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022962] Funding Source: NIH RePORTER	National Institute on Drug Abuse, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the National Institute on Drug Abuse, NIDA 5R01DA022962-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett T, 2006, AIDS 21 CENTURY FULL; Bartley M, 1997, BRIT MED J, V314, P1194, DOI 10.1136/bmj.314.7088.1194; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Commission on the Social Determinants of Health, 2006, CLOS GAP GEN HLTH EQ; Cuong NV, 2010, POVERTY INEQUALITY M; De P, 2007, ADDICTION, V102, P1730, DOI 10.1111/j.1360-0443.2007.01936.x; Deltas G, 2003, REV ECON STAT, V85, P226, DOI 10.1162/rest.2003.85.1.226; Deuchert E, 2007, ANN EPIDEMIOL, V17, P199, DOI 10.1016/j.annepidem.2006.09.005; Durevall D, 2012, WORLD DEV, V40, P1435, DOI 10.1016/j.worlddev.2011.12.003; Farquhar SA, 2005, AM J PUBLIC HEALTH, V95, P596, DOI 10.2105/AJPH.2004.048280; Fox AM, 2012, J BIOSOC SCI, V44, P459, DOI 10.1017/S0021932011000745; Fox AM, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S405; Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72; Haughton J., 2009, HDB POVERTY INEQUALI; Hien NT, 2004, AIDS EDUC PREV, V16, P137, DOI 10.1521/aeap.16.3.5.137.35527; Holmqvist G., 2009, HIV INCOME INEQUALIT; Holtgrave DR, 2003, SEX TRANSM INFECT, V79, P62, DOI 10.1136/sti.79.1.62; Israel BA, 2006, J URBAN HEALTH, V83, P1022, DOI 10.1007/s11524-006-9110-1; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kennedy BP, 1996, BRIT MED J, V312, P1004, DOI 10.1136/bmj.312.7037.1004; LATKIN C, 1995, DRUG ALCOHOL DEPEN, V38, P1, DOI 10.1016/0376-8716(94)01082-V; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Lobmayer P, 2000, SOCIOL HEALTH ILL, V22, P401, DOI 10.1111/1467-9566.00211; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Mishra D., 2012, TAKING STOCK UPDATE; Msisha WM, 2008, AIDS, V22, P741, DOI 10.1097/QAD.0b013e3282f3947f; National Institute of Hygiene and Epidemiology Family Health International, 2007, HIV STDS BEH BIOL SU; Nepal Binod, 2007, World Health Popul, V9, P73; Pan American Health Organization, 2001, MEAS HLTH IN GIN COE; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; Pilon R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022245; Piot P, 2007, PLOS MED, V4, P1571, DOI 10.1371/journal.pmed.0040314; Pronyk PM, 2008, SOC SCI MED, V66, P1999, DOI 10.1016/j.socscimed.2008.01.023; Reidpath DD, 2005, SOCIOL HEALTH ILL, V27, P468, DOI 10.1111/j.1467-9566.2005.00452.x; Ruger JP, 2011, GLOBAL HLTH DIS SYSE, P757; Sawers L, 2008, AIDS CARE, V20, P488, DOI 10.1080/09540120701868311; Singh GK, 2006, INT J EPIDEMIOL, V35, P969, DOI 10.1093/ije/dyl083; Talbott JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000543; *WHO, 2001, REP COMM MACR HLTH; Wilkinson RG, 1997, BRIT MED J, V314, P591, DOI 10.1136/bmj.314.7080.591; Wilkinson RG, 2007, SOC SCI MED, V65, P1965, DOI 10.1016/j.socscimed.2007.05.041	41	7	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90723	10.1371/journal.pone.0090723	http://dx.doi.org/10.1371/journal.pone.0090723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24618892	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400026
J	Ma, W; Ma, L; Zhe, H; Bao, CH; Wang, NN; Yang, SQ; Wang, K; Cao, FL; Cheng, YN; Cheng, YF				Ma, Wei; Ma, Lie; Zhe, Hong; Bao, Cihang; Wang, Nana; Yang, Shaoqi; Wang, Kai; Cao, Fangli; Cheng, Yanna; Cheng, Yufeng			Detection of Esophageal Squamous Cell Carcinoma by Cathepsin B Activity in Nude Mice	PLOS ONE			English	Article							STAGE PANCREATIC-CANCER; CYSTEINE CATHEPSINS; IN-VIVO; PROGNOSTIC-SIGNIFICANCE; PROTEASE ACTIVITY; STEFIN-A; ADENOCARCINOMA; METASTASIS; EXPRESSION; ENDOSCOPY	Background and Objective: Despite great progress in treatment, the prognosis for patients with esophageal squamous cell carcinoma (ESCC) remains poor, highlighting the importance of early detection. Although upper endoscopy can be used for the screening of esophagus, it has limited sensitivity for early stage disease. Thus, development of new diagnosis approach to improve diagnostic capabilities for early detection of ESCC is an important need. The aim of this study was to assess the feasibility of using cathepsin B (CB) as a novel imaging target for the detection of human ESCC by near-infrared optical imaging in nude mice. Methods: Initially, we examined specimens from normal human esophageal tissue, intraepithelial neoplasia lesions, tumor in situ, ESCC and two cell lines including one human ESCC cell line (Eca-109) and one normal human esophageal epithelial cell line (HET-1A) for CB expression by immunohistochemistry and western blot, respectively. Next, the ability of a novel CB activatable near-infrared fluorescence (NIRF) probe detecting CB activity presented in Eca-109 cells was confirmed by immunocytochemistry. We also performed in vivo imaging of tumor bearing mice injected with the CB probe and ex vivo imaging of resected tumor xenografts and visceral organs using a living imaging system. Finally, the sources of fluorescence signals in tumor tissue and CB expression in visceral organs were identified by histology. Results: CB was absent in normal human esophageal mucosa, but it was overexpressed in ESCC and its precursor lesions. The novel probe for CB activity specifically detected ESCC xenografts in vivo and in vitro. Conclusions: CB was highly upregulated in human ESCC and its precursor lesions. The elevated CB expression in ESCC allowed in vivo and in vitro detection of ESCC xenografts in nude mice. Our results support the usefulness of CB activity as a potential imaging target for the detection of human ESCC.	[Ma, Wei; Bao, Cihang; Wang, Nana; Cheng, Yufeng] Shandong Univ, Qilu Hosp, Dept Radiat Oncol, Jinan 250100, Peoples R China; [Ma, Wei; Zhe, Hong] Ningxia Med Univ, Gen Hosp, Canc Hosp, Dept Radiat Oncol, Yinchuan, Peoples R China; [Ma, Lie] Ningxia Med Univ, Gen Hosp, Cardiovasc & Cerebrovasc Dis Hosp, Dept Cardiol, Yinchuan, Peoples R China; [Yang, Shaoqi] Ningxia Med Univ, Gen Hosp, Digest Syst Dept, Yinchuan, Peoples R China; [Wang, Kai] Wendeng Ctr Hosp, Dept Oncol, Weihai, Peoples R China; [Cao, Fangli] Liaocheng Peoples Hosp, Dept Oncol, Liaocheng, Peoples R China; [Cheng, Yanna] Shandong Univ, Sch Pharmaceut Sci, Jinan 250100, Peoples R China	Shandong University; Ningxia Medical University; Ningxia Medical University; Ningxia Medical University; Shandong University	Cheng, YF (corresponding author), Shandong Univ, Qilu Hosp, Dept Radiat Oncol, Jinan 250100, Peoples R China.	qilucyf@126.com	Bao, Cihang/AAU-1371-2020		Science and Technology development planning of Shandong province [2012GGE27088]; China Postdoctoral Science Fund [2011M500531]; Laboratory Software Building Project of Shandong University [sy2012417]	Science and Technology development planning of Shandong province; China Postdoctoral Science Fund(China Postdoctoral Science Foundation); Laboratory Software Building Project of Shandong University	This work was supported by Science and Technology development planning of Shandong province (No. 2012GGE27088), China Postdoctoral Science Fund (No. 2011M500531), and Laboratory Software Building Project of Shandong University (sy2012417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andl CD, 2010, NEOPLASIA, V12, P485, DOI 10.1593/neo.10216; CAMPO E, 1994, AM J PATHOL, V145, P301; Chien CR, 2009, JNCI-J NATL CANCER I, V101, P1428, DOI 10.1093/jnci/djp304; Chwieralski CE, 2006, APOPTOSIS, V11, P143, DOI 10.1007/s10495-006-3486-y; Cruz-Monserrate Z, 2012, GUT, V61, P1315, DOI 10.1136/gutjnl-2011-300544; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Eser S, 2011, P NATL ACAD SCI USA, V108, P9945, DOI 10.1073/pnas.1100890108; Figueiredo JL, 2006, INT J CANCER, V118, P2672, DOI 10.1002/ijc.21713; Foekens JA, 1998, J CLIN ONCOL, V16, P1013, DOI 10.1200/JCO.1998.16.3.1013; Friedrichs B, 2003, J CLIN INVEST, V111, P1733, DOI 10.1172/JCI200315990; Habibollahi P, 2012, THERANOSTICS, V2, P227, DOI 10.7150/thno.4088; Hensley HH, 2012, NEOPLASIA, V14, P451, DOI 10.1596/neo.12480; Jedeszko C, 2004, BIOL CHEM, V385, P1017, DOI 10.1515/BC.2004.132; Kamangar F, 2007, ARCH IRAN MED, V10, P70; Kato H, 2007, DIGEST SURG, V24, P88, DOI 10.1159/000101894; Keereweer S, 2012, INT J CANCER, V131, P1633, DOI 10.1002/ijc.27430; Kobayashi H, 2010, CHEM REV, V110, P2620, DOI 10.1021/cr900263j; Li WD, 2005, CLIN CANCER RES, V11, P8753, DOI 10.1158/1078-0432.CCR-05-0597; Lin YS, 2013, J EPIDEMIOL, V23, P233, DOI 10.2188/jea.JE20120162; Liu JG, 2012, EUR J CARDIO-THORAC, V41, pE7, DOI 10.1093/ejcts/ezr240; Mahmood U, 2003, MOL CANCER THER, V2, P489; Matarrese P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-207; Parsons Simon, 2010, Ann R Coll Surg Engl; Qi YJ, 2012, J PROTEOMICS, V75, P3129, DOI 10.1016/j.jprot.2012.04.025; Shibata A, 2008, JPN J CLIN ONCOL, V38, P464, DOI 10.1093/jjco/hyn064; Sinha AA, 2002, CANCER-AM CANCER SOC, V94, P3141, DOI 10.1002/cncr.10604; Turk B, 2007, FEBS LETT, V581, P2761, DOI 10.1016/j.febslet.2007.05.038; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; von Burstin J, 2008, INT J CANCER, V123, P2138, DOI 10.1002/ijc.23780; Wang LS, 1999, AM J GASTROENTEROL, V94, P1933; Werle B, 2000, CANCER, V89, P2282, DOI 10.1002/1097-0142(20001201)89:11<2282::AID-CNCR17>3.0.CO;2-4; Wu YH, 2013, AM J NUCL MED MOLEC, V3, P1; Yhee JY, 2012, THERANOSTICS, V2, P179, DOI 10.7150/thno.3716; Zavasnik-Bergant T, 2006, TISSUE ANTIGENS, V67, P349, DOI 10.1111/j.1399-0039.2006.00585.x; Zhang H, 2008, GASTROINTEST ENDOSC, V68, P520, DOI 10.1016/j.gie.2008.02.023	35	8	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e92351	10.1371/journal.pone.0092351	http://dx.doi.org/10.1371/journal.pone.0092351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618814	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400141
J	Powell, TR; McGuffin, P; D'Souza, UM; Cohen-Woods, S; Hosang, GM; Martin, C; Matthews, K; Day, RK; Farmer, AE; Tansey, KE; Schalkwyk, LC				Powell, Timothy R.; McGuffin, Peter; D'Souza, Ursula M.; Cohen-Woods, Sarah; Hosang, Georgina M.; Martin, Charlotte; Matthews, Keith; Day, Richard K.; Farmer, Anne E.; Tansey, Katherine E.; Schalkwyk, Leonard C.			Putative Transcriptomic Biomarkers in the Inflammatory Cytokine Pathway Differentiate Major Depressive Disorder Patients from Control Subjects and Bipolar Disorder Patients	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FUNCTIONAL-CHARACTERIZATION; SEROTONIN TRANSPORTER; MOOD; CLASSIFICATION; METAANALYSIS; RECEPTOR; GENE; PATHOPHYSIOLOGY; ESCITALOPRAM	Mood disorders consist of two etiologically related, but distinctly treated illnesses, major depressive disorder (MDD) and bipolar disorder (BPD). These disorders share similarities in their clinical presentation, and thus show high rates of misdiagnosis. Recent research has revealed significant transcriptional differences within the inflammatory cytokine pathway between MDD patients and controls, and between BPD patients and controls, suggesting this pathway may possess important biomarker properties. This exploratory study attempts to identify disorder-specific transcriptional biomarkers within the inflammatory cytokine pathway, which can distinguish between control subjects, MDD patients and BPD patients. This is achieved using RNA extracted from subject blood and applying synthesized complementary DNA to quantitative PCR arrays containing primers for 87 inflammation-related genes. Initially, we use ANOVA to test for transcriptional differences in a 'discovery cohort' (total n = 90) and then we use t-tests to assess the reliability of any identified transcriptional differences in a 'validation cohort' (total n = 35). The two most robust and reliable biomarkers identified across both the discovery and validation cohort were Chemokine (C-C motif) ligand 24 (CCL24) which was consistently transcribed higher amongst MDD patients relative to controls and BPD patients, and C-C chemokine receptor type 6 (CCR6) which was consistently more lowly transcribed amongst MDD patients relative to controls. Results detailed here provide preliminary evidence that transcriptional measures within inflammation-related genes might be useful in aiding clinical diagnostic decision-making processes. Future research should aim to replicate findings detailed in this exploratory study in a larger medication-free sample and examine whether identified biomarkers could be used prospectively to aid clinical diagnosis.	[Powell, Timothy R.; McGuffin, Peter; D'Souza, Ursula M.; Cohen-Woods, Sarah; Hosang, Georgina M.; Martin, Charlotte; Farmer, Anne E.; Tansey, Katherine E.; Schalkwyk, Leonard C.] Kings Coll London, Inst Psychiat, MRC, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Cohen-Woods, Sarah] Univ Adelaide, Discipline Psychiat, Adelaide, SA, Australia; [Matthews, Keith; Day, Richard K.] Univ Dundee, Ninewells Hosp & Med Sch, Div Neurosci, Dundee DD1 9SY, Scotland	University of London; King's College London; University of Adelaide; University of Dundee	Powell, TR (corresponding author), Kings Coll London, Inst Psychiat, MRC, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England.	timothy.powell@kcl.ac.uk	Cohen-Woods, Sarah/ABF-3768-2021; Tansey, Katherine E/B-1033-2013; Schalkwyk, Leonard C/A-2150-2010; Hosang, Georgina/D-1164-2011; Cohen-Woods, Sarah/F-8674-2014	Tansey, Katherine E/0000-0002-9663-3376; Schalkwyk, Leonard C/0000-0001-7030-5756; Goss, Charlotte/0000-0002-3870-3313; Cohen-Woods, Sarah/0000-0003-2199-6129; Hosang, Georgina/0000-0002-4683-3636; Matthews, Keith/0000-0002-4478-5888; Powell, Timothy/0000-0001-9891-4895	European Commission [LSHB-CT-2003-503428]; GlaxoSmithKline; NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London [BRC 08/09PP]; Medical Research Council [G9817803B] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); GlaxoSmithKline(GlaxoSmithKline); NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The GENDEP project was funded by the European Commission Framework 6 Grant, EC Contract Ref. LSHB-CT-2003-503428. Lundbeck provided both nortriptyline and escitalopram free of charge for the GENDEP project. The BACC Study collection was funded by GlaxoSmithKline. The current study was financially supported by the NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Kings College London, under the Grant BRC 08/09PP. The funders had no role in the design and conduct of the study, in data collection, analysis, interpretation or writing the report. Timothy R. Powell is funded by a Medical Research Council PhD studentship.	Ai LS, 2004, J BIOMED SCI, V11, P818, DOI 10.1159/000081829; ALTSHULER LL, 1995, AM J PSYCHIAT, V152, P1130; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Banks WA, 1995, NEUROIMMUNOMODULAT, V2, P241, DOI 10.1159/000097202; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cattaneo A, 2013, NEUROPSYCHOPHARMACOL, V38, P377, DOI 10.1038/npp.2012.191; CLARK LA, 1995, ANNU REV PSYCHOL, V46, P121, DOI 10.1146/annurev.ps.46.020195.001005; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen-Woods S, 2010, AM J MED GENET B, V153B, P1298, DOI 10.1002/ajmg.b.31101; Craddock N, 2006, EUR J HUM GENET, V14, P660, DOI 10.1038/sj.ejhg.5201549; FARMER A, 1989, BRIT J PSYCHIAT, V155, P437, DOI 10.1192/bjp.155.4.437; Fisher HL, 2013, J AFFECT DISORDERS, V145, P136, DOI 10.1016/j.jad.2012.05.032; Games P. A., 1976, J EDUCATIONAL STATIS, V1, P113, DOI [10.3102/10769986001002113, DOI 10.2307/1164979]; Hiles SA, 2012, BRAIN BEHAV IMMUN, V26, P1180, DOI 10.1016/j.bbi.2012.06.001; Hirschfeld RMA, 2003, J CLIN PSYCHIAT, V64, P161, DOI 10.4088/JCP.v64n0209; Hosang GM, 2012, BRIT J PSYCHIAT, V201, P458, DOI 10.1192/bjp.bp.112.111047; Isung J, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.123; Jones I, 2002, PSYCHIAT GENETICS GE, P211; Judd Lewis L, 2003, Curr Psychiatry Rep, V5, P417, DOI 10.1007/s11920-003-0077-2; Keers R, 2012, CURR PSYCHIAT REP, V14, P129, DOI 10.1007/s11920-011-0251-x; KENDELL RE, 1976, BRIT J PSYCHIAT, V129, P15, DOI 10.1192/bjp.129.1.15; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kim JM, 2007, BIOL PSYCHIAT, V62, P423, DOI 10.1016/j.biopsych.2006.11.020; Leboyer M, 2012, J AFFECT DISORDERS, V141, P1, DOI 10.1016/j.jad.2011.12.049; Lehto SM, 2010, PSYCHONEUROENDOCRINO, V35, P226, DOI 10.1016/j.psyneuen.2009.06.007; Liu Y, 2012, J AFFECT DISORDERS, V139, P230, DOI 10.1016/j.jad.2011.08.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maes M, 1999, ADV EXP MED BIOL, V461, P25; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P287; Martin C, 2015, BIOMARK MED, V9, P169, DOI [10.2217/bmm.14.29, 10.2217/BMM.14.29]; MCGUFFIN P, 1986, PSYCHOL MED, V16, P461, DOI 10.1017/S0033291700009302; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Morselli PL, 2003, BIPOLAR DISORD, V5, P265, DOI 10.1034/j.1399-5618.2003.00037.x; Murray J.L., 1996, GLOBAL BURDEN DIS CO; Nemeroff CB, 2002, NAT NEUROSCI, V5, P1068, DOI 10.1038/nn943; Padmos RC, 2008, ARCH GEN PSYCHIAT, V65, P395, DOI 10.1001/archpsyc.65.4.395; Pariante CM, 2001, BIOL PSYCHIAT, V49, P391, DOI 10.1016/S0006-3223(00)01088-X; Patel VP, 1997, J EXP MED, V185, P1163, DOI 10.1084/jem.185.7.1163; Perlis RH, 2005, AM J MANAG CARE, V11, pS271; Powell TR, 2013, EUR NEUROPSYCHOPHARM, V23, P1105, DOI 10.1016/j.euroneuro.2012.09.009; Powell TR, 2013, J PSYCHOPHARMACOL, V27, P609, DOI 10.1177/0269881113490329; Powell TR, 2014, INT J METH PSYCH RES, DOI [10.1002mpr.1435, DOI 10.1002/7PR.1435]; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Simon NM, 2008, EUR NEUROPSYCHOPHARM, V18, P230, DOI 10.1016/j.euroneuro.2007.06.004; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Sullivan P, 2012, MOL PSYCHIATR, V17, P2, DOI 10.1038/mp.2011.94; Tsao CW, 2006, PROG NEURO-PSYCHOPH, V30, P899, DOI 10.1016/j.pnpbp.2006.01.029; Uher R, 2010, AM J PSYCHIAT, V167, P555, DOI 10.1176/appi.ajp.2009.09070932; Watson D, 2005, J ABNORM PSYCHOL, V114, P522, DOI 10.1037/0021-843X.114.4.522; WEHR TA, 1979, ARCH GEN PSYCHIAT, V36, P555; White JR, 1997, J LEUKOCYTE BIOL, V62, P667, DOI 10.1002/jlb.62.5.667; Wing JK, 1998, DIAGNOSIS CLIN MEASU; World Health Organization, 1992, INT CLASS DIS 10 REV	56	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91076	10.1371/journal.pone.0091076	http://dx.doi.org/10.1371/journal.pone.0091076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618828	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000332842400046
J	Puron-Sierra, L; Miranda, MI				Puron-Sierra, Liliana; Isabel Miranda, Maria			Histaminergic Modulation of Cholinergic Release from the Nucleus Basalis Magnocellularis into Insular Cortex during Taste Aversive Memory Formation	PLOS ONE			English	Article							CORTICAL ACETYLCHOLINE-RELEASE; DUAL-PROBE MICRODIALYSIS; H-3 RECEPTOR INHIBITION; K+-EVOKED RELEASE; ENHANCES ACETYLCHOLINE; AUDITORY-CORTEX; FRONTAL-CORTEX; SPATIAL MEMORY; DIAGONAL BAND; MEDIAL SEPTUM	The ability of acetylcholine (ACh) to alter specific functional properties of the cortex endows the cholinergic system with an important modulatory role in memory formation. For example, an increase in ACh release occurs during novel stimulus processing, indicating that ACh activity is critical during early stages of memory processing. During novel taste presentation, there is an increase in ACh release in the insular cortex (IC), a major structure for taste memory recognition. There is extensive evidence implicating the cholinergic efferents of the nucleus basalis magnocellularis (NBM) in cortical activity changes during learning processes, and new evidence suggests that the histaminergic system may interact with the cholinergic system in important ways. However, there is little information as to whether changes in cholinergic activity in the IC are modulated during taste memory formation. Therefore, in the present study, we evaluated the influence of two histamine receptor subtypes, H-1 in the NBM and H-3 in the IC, on ACh release in the IC during conditioned taste aversion (CTA). Injection of the H-3 receptor agonist R-alpha-methylhistamine (RAMH) into the IC or of the H-1 receptor antagonist pyrilamine into the NBM during CTA training impaired subsequent CTA memory, and simultaneously resulted in a reduction of ACh release in the IC. This study demonstrated that basal and cortical cholinergic pathways are finely tuned by histaminergic activity during CTA, since dual actions of histamine receptor subtypes on ACh modulation release each have a significant impact during taste memory formation.	[Puron-Sierra, Liliana; Isabel Miranda, Maria] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Conductual & Cognit, Queretaro, Qro, Mexico	Universidad Nacional Autonoma de Mexico	Miranda, MI (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Conductual & Cognit, Queretaro, Qro, Mexico.	mirandami@unam.mx	Miranda, María-Isabel I/G-8210-2014	Miranda, María-Isabel I/0000-0003-1823-2152	CONACYT [152208, 208245]; PAPPIT [IN220991]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPPIT	Funding provided by grants: CONACYT 152208, PAPPIT IN220991. This work was carried out in partial fulfillment of requirements to obtain the Doctoral Degree (Doctorado en Ciencias Biomedicas, UNAM) at the Instituto de Neurobiologia, UNAM), by Liliana Puron Sierra, who received a Graduate Scholarship 208245 from CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; ARRANG JM, 1995, ANN NY ACAD SCI, V757, P314, DOI 10.1111/j.1749-6632.1995.tb17489.x; ARRANG JM, 1995, BRIT J PHARMACOL, V114, P1518, DOI 10.1111/j.1476-5381.1995.tb13379.x; Bacciottini L, 2002, EUR J NEUROSCI, V15, P1669, DOI 10.1046/j.1460-9568.2002.02005.x; Bacciottini L, 2001, BEHAV BRAIN RES, V124, P183, DOI 10.1016/S0166-4328(01)00230-3; Baldi E, 2008, NEUROBIOL LEARN MEM; BARTUS RT, 1985, ANN NY ACAD SCI, V444, P332, DOI 10.1111/j.1749-6632.1985.tb37600.x; Benetti F., 2013, INT J NEUROPSYCHOPH, P1; Benetti F, 2012, INT J NEUROPSYCHOPH, P1; Benetti F, 2013, INT J NEUROPSYCHOPH, V16, P575, DOI 10.1017/S1461145712000181; Benetti F, 2012, NEUROBIOL LEARN MEM, V97, P54, DOI 10.1016/j.nlm.2011.09.004; Berman DE, 2000, J NEUROSCI, V20, P7017, DOI 10.1523/JNEUROSCI.20-18-07017.2000; Blandina P, 1996, INFLAMM RES, V45, pS54, DOI 10.1007/BF03354086; Blandina P, 1996, BRIT J PHARMACOL, V119, P1656, DOI 10.1111/j.1476-5381.1996.tb16086.x; Blandina P, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00033; Brabant C, 2013, BEHAV BRAIN RES, V243, P199, DOI 10.1016/j.bbr.2012.12.063; Bures J, 1998, CONDITIONED TASTE AV; Cangioli I, 2002, EUR J NEUROSCI, V16, P521, DOI 10.1046/j.1460-9568.2002.02092.x; Cecchi M, 1998, INFLAMM RES, V47, pS32; Cecchi M, 2001, EUR J NEUROSCI, V13, P68, DOI 10.1046/j.1460-9568.2001.01361.x; Clark EW, 2009, BEHAV NEUROSCI, V123, P764, DOI 10.1037/a0016398; DEALMEIDA MAMR, 1986, ARCH INT PHARMACOD T, V283, P193; DEALMEIDA MAMR, 1988, ARCH INT PHARMACOD T, V291, P202; Dere E, 2010, BEHAV BRAIN RES, V215, P209, DOI 10.1016/j.bbr.2009.12.045; Douchamps V, 2013, J NEUROSCI, V33, P8689, DOI 10.1523/JNEUROSCI.4483-12.2013; Esbenshade TA, 2012, J PHARMACOL EXP THER, V343, P233, DOI 10.1124/jpet.112.194126; FIBIGER HC, 1991, ADV EXP MED BIOL, V295, P399; FLICKER C, 1983, PHARMACOL BIOCHEM BE, V18, P973, DOI 10.1016/S0091-3057(83)80023-9; Gianlorenco ACL, 2011, BRAIN RES BULL, V86, P134, DOI 10.1016/j.brainresbull.2011.05.014; Giannoni P, 2012, J PHARMACOL EXP THER, V332, P164; Giannoni P, 2009, EUR J NEUROSCI, V29, P2363, DOI 10.1111/j.1460-9568.2009.06765.x; Giorgetti M, 1997, INFLAMM RES, V46, pS33, DOI 10.1007/s000110050044; Giovannini MG, 1998, J PHARMACOL EXP THER, V285, P1219; Giovannini MG, 2001, NEUROSCIENCE, V106, P43, DOI 10.1016/S0306-4522(01)00266-4; Gutierrez R, 2003, NEUROBIOL LEARN MEM, V80, P323, DOI 10.1016/S1074-7427(03)00066-2; HAGAN JJ, 1988, BEHAV BRAIN RES, V27, P9, DOI 10.1016/0166-4328(88)90105-2; Hasselmo M E, 1999, Prog Brain Res, V121, P3; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; HASSELMO ME, 1995, BEHAV BRAIN RES, V67, P1, DOI 10.1016/0166-4328(94)00113-T; HASSELMO ME, 1995, J NEUROSCI, V15, P6592; Hasselmo ME, 2002, NEURAL NETWORKS, V15, P689, DOI 10.1016/S0893-6080(02)00057-6; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hasselmo ME, 2011, NEUROPSYCHOPHARMACOL, V36, P52, DOI 10.1038/npp.2010.104; Heys JG, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00032; Miranda MI, 2008, LEARN MEMORY, V15, P468, DOI 10.1101/lm.964708; KHATEB A, 1995, NEUROSCIENCE, V69, P495, DOI 10.1016/0306-4522(95)00264-J; Kohler CA, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/328602; Kruk M, 2012, PHARMACOL REP, V64, P1316, DOI 10.1016/S1734-1140(12)70929-5; Lin JS, 2011, J PHARMACOL EXP THER, V336, P17, DOI 10.1124/jpet.110.170134; LOPEZGARCIA JC, 1993, PHARMACOL BIOCHEM BE, V45, P147; McGaugh JL, 1997, BEHAV BRAIN RES, V83, P31, DOI 10.1016/S0166-4328(97)86042-1; Miranda MI, 1999, P NATL ACAD SCI USA, V96, P6478, DOI 10.1073/pnas.96.11.6478; Miranda MI, 2003, NEUROBIOL LEARN MEM, V80, P211, DOI 10.1016/S1074-7427(03)00061-3; Miranda MI, 2002, P NATL ACAD SCI USA, V99, P11417, DOI 10.1073/pnas.182200499; Miranda MI, 1998, BRAIN RES PROTOC, V2, P215, DOI 10.1016/S1385-299X(97)00046-9; Miranda MI, 2000, BRAIN RES, V882, P230, DOI 10.1016/S0926-6410(00)00050-1; Montero-Pastor A, 2001, BRAIN RES, V900, P337, DOI 10.1016/S0006-8993(01)02325-3; Moron I, 2002, BEHAV BRAIN RES, V134, P425, DOI 10.1016/S0166-4328(02)00056-6; Munari L, 2013, NEUROPHARMACOLOGY, V70, P131, DOI 10.1016/j.neuropharm.2013.01.021; Naor C, 1996, BEHAV BRAIN RES, V79, P61, DOI 10.1016/0166-4328(95)00262-6; ONODERA K, 1994, PROG NEUROBIOL, V42, P685, DOI 10.1016/0301-0082(94)90017-5; Orsetti M, 1996, BRAIN RES, V724, P89, DOI 10.1016/0006-8993(96)00292-2; PANULA P, 1984, P NATL ACAD SCI-BIOL, V81, P2572, DOI 10.1073/pnas.81.8.2572; PANULA P, 1989, NEUROSCIENCE, V28, P585, DOI 10.1016/0306-4522(89)90007-9; Passani MB, 2007, BIOCHEM PHARMACOL, V73, P1113, DOI 10.1016/j.bcp.2006.12.002; Passani MB, 2011, J PHARMACOL EXP THER, V336, P24, DOI 10.1124/jpet.110.171306; Passani MB, 2000, NEUROSCI BIOBEHAV R, V24, P107, DOI 10.1016/S0149-7634(99)00053-6; Paxinos G., 2004, J CHEM INF MODEL, V5th; Power AE, 2004, CURR MED CHEM, V11, P987, DOI 10.2174/0929867043455558; Privou C, 1998, NEUROPHARMACOLOGY, V37, P1019, DOI 10.1016/S0028-3908(98)00087-2; Privou C, 1999, NEUROBIOL LEARN MEM, V71, P308, DOI 10.1006/nlme.1998.3885; Puron-Sierra L, 2010, NEUROBIOL LEARN MEM, V93, P216, DOI 10.1016/j.nlm.2009.10.001; Raddatz R, 2010, CURR TOP MED CHEM, V10, P153, DOI 10.2174/156802610790411027; Rasmusson AM, 2000, BIOL PSYCHIAT, V47, P526, DOI 10.1016/S0006-3223(99)00185-7; Robinson L, 2011, BEHAV BRAIN RES, V221, P443, DOI 10.1016/j.bbr.2011.01.055; Rokem A, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00066; Savage LM, 2012, BEHAV NEUROSCI, V126, P226, DOI 10.1037/a0027257; Silva MAD, 2013, P NATL ACAD SCI USA, V110, P15097, DOI 10.1073/pnas.1306884110; Weinberger NM, 1998, AUDIOL NEURO-OTOL, V3, P145, DOI 10.1159/000013787; Weinberger NM, 1998, SCIENCE, V280, P1174; Zlomuzica A, 2009, BRIT J PHARMACOL, V157, P86, DOI 10.1111/j.1476-5381.2009.00225.x	83	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91120	10.1371/journal.pone.0091120	http://dx.doi.org/10.1371/journal.pone.0091120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625748	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300057
J	Waters, PS; Dwyer, RM; Brougham, C; Glynn, CL; Wall, D; Hyland, P; Duignan, M; McLoughlin, M; Newell, J; Kerin, MJ				Waters, Peadar S.; Dwyer, Roisin M.; Brougham, Cathy; Glynn, Claire L.; Wall, Deirdre; Hyland, Peter; Duignan, Maria; McLoughlin, Mark; Newell, John; Kerin, Michael J.			Impact of Tumour Epithelial Subtype on Circulating microRNAs in Breast Cancer Patients	PLOS ONE			English	Article							DOWN-REGULATION; EXPRESSION; MARKERS; SERUM; RECOMMENDATIONS; BIOMARKERS; DIAGNOSIS; TISSUES	While a range of miRNAs have been shown to be dysregulated in the circulation of patients with breast cancer, little is known about the relationship between circulating levels and tumour characteristics. The aim of this study was to analyse alterations in circulating miRNA expression during tumour progression in a murine model of breast cancer, and to detemine the clinical relevance of identified miRNAs at both tissue and circulating level in patient samples. Athymic nude mice received a subcutaneous or mammary fat pad injection of MDA-MB-231 cells. Blood sampling was performed at weeks 1, 3 and 6 following tumour induction, and microRNA extracted. MicroRNA microArray analysis was performed comparing samples harvested at week 1 to those collected at week 6 from the same animals. Significantly altered miRNAs were validated across all murine samples by RQ-PCR (n = 45). Three miRNAs of interest were then quantified in the circulation(n = 166) and tissue (n = 100) of breast cancer patients and healthy control individuals. MicroArray-based analysis of murine blood samples revealed levels of 77 circulating microRNAs to be changed during disease progression, with 44 demonstrating changes >2-fold. Validation across all samples revealed miR-138 to be significantly elevated in the circulation of animals during disease development, with miR-191 and miR-106a levels significantly decreased. Analysis of patient tissue and blood samples revealed miR-138 to be significantly up-regulated in the circulation of patients with breast cancer, with no change observed in the tissue setting. While not significantly changed overall in breast cancer patients compared to controls, circulating miR-106a and miR-191 were significantly decreased in patients with basal breast cancer. In tissue, both miRNAs were significantly elevated in breast cancer compared to normal breast tissue. The data demonstrates an impact of tumour epithelial subtype on circulating levels of miRNAs, and highlights divergent miRNA profiles between tissue and blood samples from breast cancer patients.	[Waters, Peadar S.; Dwyer, Roisin M.; Brougham, Cathy; Glynn, Claire L.; Hyland, Peter; Duignan, Maria; McLoughlin, Mark; Kerin, Michael J.] Natl Univ Ireland Galway, Sch Med, Discipline Surg, Galway, Ireland; [Wall, Deirdre; Newell, John] Natl Univ Galway, HRB Clin Res Facil, Galway, Ireland; [Wall, Deirdre; Newell, John] Natl Univ Galway, Sch Math Stat & Appl Math, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Dwyer, RM (corresponding author), Natl Univ Ireland Galway, Sch Med, Discipline Surg, Galway, Ireland.	roisin.dwyer@nuigalway.ie	Dwyer, Roisin M/C-6654-2013	Dwyer, Roisin M/0000-0002-5854-0339; Wall, Deirdre/0000-0001-6510-6082; GLYNN, CLAIRE/0000-0002-1846-2858; Kerin, Michael/0000-0003-4164-5561; Newell, John/0000-0001-7685-6655	National Breast Cancer Research Institute	National Breast Cancer Research Institute	This study was funded by the National Breast Cancer Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra A, 2012, INT J ONCOL, V41, P1897, DOI 10.3892/ijo.2012.1647; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Colamaio M, 2011, J CLIN ENDOCR METAB, V96, pE1915, DOI 10.1210/jc.2011-0408; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Elyakim E, 2010, CANCER RES, V70, P8077, DOI 10.1158/0008-5472.CAN-10-1313; Feldman ED, 2012, CLIN OBSTET GYNECOL, V55, P662, DOI 10.1097/GRF.0b013e31825ca884; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Healy NA, 2012, INT J CANCER, V131, P2215, DOI 10.1002/ijc.27642; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hu ZB, 2012, CARCINOGENESIS, V33, P828, DOI 10.1093/carcin/bgs030; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Lee YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052979; Liu XQ, 2009, CANCER LETT, V286, P217, DOI 10.1016/j.canlet.2009.05.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Mar-Aguilar F, 2013, ASIA-PAC J CLIN ONCO, V9, P53, DOI 10.1111/j.1743-7563.2012.01548.x; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Mitomo S, 2008, CANCER SCI, V99, P280, DOI 10.1111/j.1349-7006.2007.00666.x; Nagpal N, 2013, CARCINOGENESIS; Ravert PK, 2010, J AM ACAD NURSE PRAC, V22, P668, DOI 10.1111/j.1745-7599.2010.00564.x; Riaz M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3415; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sturgeon CM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3527; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Waters PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050459; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhang Y, 2013, FEBS LETT, V587, P3069, DOI 10.1016/j.febslet.2013.06.058	30	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90605	10.1371/journal.pone.0090605	http://dx.doi.org/10.1371/journal.pone.0090605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626163	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300027
J	Breton, A; Jerbi, K; Henaff, MA; Cheylus, A; Baudouin, JY; Schmitz, C; Krolak-Salmon, P; Van der Henst, JB				Breton, Audrey; Jerbi, Karim; Henaff, Marie-Anne; Cheylus, Anne; Baudouin, Jean-Yves; Schmitz, Christina; Krolak-Salmon, Pierre; Van der Henst, Jean-Baptiste			Face the Hierarchy: ERP and Oscillatory Brain Responses in Social Rank Processing	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SELECTIVE ATTENTION; FACIAL EXPRESSIONS; TIME-COURSE; EARLY-STAGE; PERCEPTION; RACE; FAMILIARITY; GENDER; DOMINANCE	Recognition of social hierarchy is a key feature that helps us navigate through our complex social environment. Neuroimaging studies have identified brain structures involved in the processing of hierarchical stimuli but the precise temporal dynamics of brain activity associated with such processing remains largely unknown. Here, we used electroencephalography to examine the effect of social hierarchy on neural responses elicited by faces. In contrast to previous studies, the key manipulation was that a hierarchical context was constructed, not by varying facial expressions, but by presenting neutral-expression faces in a game setting. Once the performance-based hierarchy was established, participants were presented with high-rank, middle-rank and low-rank player faces and had to evaluate the rank of each face with respect to their own position. Both event-related potentials and task-related oscillatory activity were investigated. Three main findings emerge from the study. First, the experimental manipulation had no effect on the early N170 component, which may suggest that hierarchy did not modulate the structural encoding of neutral-expression faces. Second, hierarchy significantly modulated the amplitude of the late positive potential (LPP) within a 400-700 ms time-window, with more a prominent LPP occurring when the participants processed the face of the highest-rank player. Third, high-rank faces were associated with the highest reduction of alpha power. Taken together these findings provide novel electrophysiological evidence for enhanced allocation of attentional resource in the presence of high-rank faces. At a broader level, this study brings new insights into the neural processing underlying social categorization.	[Breton, Audrey; Cheylus, Anne; Baudouin, Jean-Yves; Van der Henst, Jean-Baptiste] Univ Lyon 1, CNRS, UMR 5304, L2C2, Bron, France; [Jerbi, Karim; Henaff, Marie-Anne; Schmitz, Christina; Krolak-Salmon, Pierre] CNRL, CNRS, UMR5292, INSERM,U1028, Bron, France; [Baudouin, Jean-Yves] Univ Bourgogne, Pole AAFE, Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Breton, A (corresponding author), Univ Lyon 1, CNRS, UMR 5304, L2C2, Bron, France.	abreton@isc.cnrs.fr; vanderhenst@isc.cnrs.fr	Cheylus, Anne/GSD-3809-2022; krolak-salmon, pierre/AAV-2152-2020; Schmitz, Christina/G-9195-2011	Cheylus, Anne/0000-0002-4243-3686; Schmitz, Christina/0000-0002-8377-9608; Baudouin, Jean-Yves/0000-0002-4405-7987	CNRS; INSERM; DGA	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); DGA	This study was supported by CNRS, INSERM and DGA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguera PE, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/158970; Baudouin JY, 2006, J EXP PSYCHOL HUMAN, V32, P789, DOI 10.1037/0096-1523.32.4.789; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Boyce WT, 2004, ANN NY ACAD SCI, V1036, P47, DOI 10.1196/annals.1330.003; Bradley MM, 2009, PSYCHOPHYSIOLOGY, V46, P1, DOI 10.1111/j.1469-8986.2008.00702.x; Brown D. E., 1991, HUMAN UNIVERSALS; CACIOPPO JT, 1994, PSYCHOL BULL, V115, P401, DOI 10.1037/0033-2909.115.3.401; Caharel S, 2002, INT J NEUROSCI, V112, P1499, DOI 10.1080/00207450290158368; Caharel S, 2005, BRAIN COGNITION, V59, P96, DOI 10.1016/j.bandc.2005.05.005; Caharel S, 2006, INT J PSYCHOPHYSIOL, V62, P141, DOI 10.1016/j.ijpsycho.2006.03.002; Caldara R, 2004, NEUROREPORT, V15, P905, DOI 10.1097/00001756-200404090-00034; Caldara R, 2003, CLIN NEUROPHYSIOL, V114, P515, DOI 10.1016/S1388-2457(02)00407-8; CHENEY DL, 1990, COGNITION, V37, P167, DOI 10.1016/0010-0277(90)90022-C; Chiao JY, 2008, GROUP PROCESS INTERG, V11, P201, DOI 10.1177/1368430207088038; Chiao JY, 2009, NEUROPSYCHOLOGIA, V47, P354, DOI 10.1016/j.neuropsychologia.2008.09.023; Conty L, 2007, NEUROPSYCHOLOGIA, V45, P3024, DOI 10.1016/j.neuropsychologia.2007.05.017; Crites SL, 1996, PSYCHOL SCI, V7, P318, DOI 10.1111/j.1467-9280.1996.tb00381.x; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Dalmaso M, 2012, BIOL LETTERS, V8, P450, DOI 10.1098/rsbl.2011.0881; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Eimer M, 2011, OXF HDB FACE PERCEPT; ELLIS L, 1995, ETHOL SOCIOBIOL, V16, P257, DOI 10.1016/0162-3095(95)00050-U; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Farrow TFD, 2011, NEUROIMAGE, V57, P1552, DOI 10.1016/j.neuroimage.2011.05.069; Fieder M, 2005, ETHOLOGY, V111, P940, DOI 10.1111/j.1439-0310.2005.01129.x; FISKE AP, 1992, PSYCHOL REV, V99, P689, DOI 10.1037/0033-295X.99.4.689; Freeman JB, 2010, NEUROREPORT, V21, P24, DOI 10.1097/WNR.0b013e3283320d54; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; George N, 1996, COGNITIVE BRAIN RES, V4, P65, DOI 10.1016/0926-6410(95)00045-3; Goffaux V, 2003, COGNITIVE SCI, V27, P313, DOI 10.1016/S0364-0213(03)00002-8; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Harris AM, 2008, J VISION, V8, DOI 10.1167/8.10.4; Henson RN, 2003, CEREB CORTEX, V13, P793, DOI 10.1093/cercor/13.7.793; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Hunt LT, 2012, NAT NEUROSCI, V15, P470, DOI 10.1038/nn.3017; Itier RJ, 2007, BRAIN RES, V1177, P79, DOI 10.1016/j.brainres.2007.07.094; Ito TA, 2005, COGN AFFECT BEHAV NE, V5, P21, DOI 10.3758/CABN.5.1.21; Ito TA, 2003, J PERS SOC PSYCHOL, V85, P616, DOI 10.1037/0022-3514.85.4.616; Ito TA, 2004, PERS SOC PSYCHOL B, V30, P1267, DOI 10.1177/0146167204264335; Jemel B, 2003, NEUROREPORT, V14, P525, DOI 10.1097/01.wnr.0000057864.05120.ba; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kloth N, 2006, EUR J NEUROSCI, V24, P3317, DOI 10.1111/j.1460-9568.2006.05211.x; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Kumaran D, 2012, NEURON, V76, P653, DOI 10.1016/j.neuron.2012.09.035; Lachaux J-P, 2007, INT C SERIES, V1300, P421; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Liu YL, 2012, J NEUROSCI, V32, P14563, DOI 10.1523/JNEUROSCI.3109-12.2012; Maclean EL, 2008, ANIM BEHAV, V76, P479, DOI 10.1016/j.anbehav.2008.01.025; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Maner JK, 2008, PERS SOC PSYCHOL B, V34, P488, DOI 10.1177/0146167207311910; Marsh AA, 2009, J COGNITIVE NEUROSCI, V21, P713, DOI 10.1162/jocn.2009.21052; Marzi T, 2007, INT J PSYCHOPHYSIOL, V65, P182, DOI 10.1016/j.ijpsycho.2007.04.003; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Mouchetant-Rostaing Y, 2003, J COGNITIVE NEUROSCI, V15, P900, DOI 10.1162/089892903322370816; Mouchetant-Rostaing Y, 2000, EUR J NEUROSCI, V12, P303, DOI 10.1046/j.1460-9568.2000.00888.x; Niederle M, 2007, Q J ECON, V122, P1067, DOI 10.1162/qjec.122.3.1067; Paller KA, 2000, NEUROIMAGE, V11, P98, DOI 10.1006/nimg.1999.0521; Pastor MC, 2008, BRAIN RES, V1189, P145, DOI 10.1016/j.brainres.2007.10.072; Paz-y-Mino G, 2004, NATURE, V430, P778, DOI 10.1038/nature02723; Ratcliff NJ, 2011, PERS SOC PSYCHOL B, V37, P1003, DOI 10.1177/0146167211407210; Rilling JK, 2004, BIOL PSYCHIAT, V56, P364, DOI 10.1016/j.biopsych.2004.06.027; RITTER W, 1992, ANN NY ACAD SCI, V658, P1, DOI 10.1111/j.1749-6632.1992.tb22837.x; Rossion B, 1999, CLIN NEUROPHYSIOL, V110, P449, DOI 10.1016/S1388-2457(98)00037-6; Sabatinelli D, 2007, J NEUROPHYSIOL, V98, P1374, DOI 10.1152/jn.00230.2007; Sabatinelli D, 2013, BIOL PSYCHOL, V92, P513, DOI 10.1016/j.biopsycho.2012.04.005; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Schweinberger SR, 2002, COGNITIVE BRAIN RES, V14, P398, DOI 10.1016/S0926-6410(02)00142-8; Schweinberger SR, 2002, NEUROPSYCHOLOGIA, V40, P2057, DOI 10.1016/S0028-3932(02)00050-7; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; Senholzi KB, 2013, SOC COGN AFFECT NEUR, V8, P937, DOI 10.1093/scan/nss091; Smith ML, 2007, NEUROIMAGE, V37, P974, DOI 10.1016/j.neuroimage.2007.05.030; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tanaka J, 1999, NEUROREPORT, V10, P829, DOI 10.1097/00001756-199903170-00030; Thomsen L, 2011, SCIENCE, V331, P477, DOI 10.1126/science.1199198; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Walker PM, 2008, SOC COGN AFFECT NEUR, V3, P16, DOI 10.1093/scan/nsm035; WHEELER L, 1966, J EXP SOC PSYCHOL, V2, P27, DOI 10.1016/0022-1031(66)90062-x; Wiese H, 2014, CEREB CORTEX, V24, P826, DOI 10.1093/cercor/bhs369; Wild-Wall N, 2008, BIOL PSYCHOL, V77, P138, DOI 10.1016/j.biopsycho.2007.10.001; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025; Zion-Golumbic E, 2010, J COGNITIVE NEUROSCI, V22, P263, DOI 10.1162/jocn.2009.21251; Zitek EM, 2012, J PERS SOC PSYCHOL, V102, P98, DOI 10.1037/a0025345	92	24	25	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91451	10.1371/journal.pone.0091451	http://dx.doi.org/10.1371/journal.pone.0091451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24622288	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300087
J	Ge, XL; Pan, SM; Zeng, FF; Tang, ZH; Wang, YW				Ge, Xiaoli; Pan, Shu-Ming; Zeng, Fangfang; Tang, Zi-Hui; Wang, Ying-Wei			A Simple Chinese Risk Score Model for Screening Cardiovascular Autonomic Neuropathy	PLOS ONE			English	Article							METABOLIC-SYNDROME; DYSFUNCTION; HYPERTENSION; SYSTEM	Background: The purpose of the present study was to develop and evaluate a risk score to predict people at high risk of cardiovascular autonomic dysfunction neuropathy (CAN) in Chinese population. Methods and Materials: A population-based sample of 2,092 individuals aged 30-80 years, without previously diagnosed CAN, was surveyed between 2011 and 2012. All participants underwent short-term HRV test. The risk score was derived from an exploratory set. The risk score was developed by stepwise backward multiple logistic regression. The coefficients from this model were transformed into components of a CAN score. This score was tested in a validation and entire sample. Results: The final risk score included age, body mass index, hypertension, resting hear rate, items independently and significantly (P<0.05) associated with the presence of previously undiagnosed CAN. The area under the receiver operating curve was 0.726 (95% CI 0.686-0.766) for exploratory set, 0.784 (95% CI 0.749-0.818) for validation set, and 0.756 (95% CI 0.729-0.782) for entire sample. In validation set, at optimal cutoff score of 5 of 10, the risk score system has the sensitivity, specificity, and percentage that needed subsequent testing were 69, 78, and 30%, respectively. Conclusion: We developed a CAN risk score system based on a set of variables not requiring laboratory tests. The score system is simple fast, inexpensive, noninvasive, and reliable tool that can be applied to early intervention to delay or prevent the disease in China.	[Ge, Xiaoli; Wang, Ying-Wei] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Anesthesiol, Shanghai 200030, Peoples R China; [Ge, Xiaoli; Pan, Shu-Ming] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Emergence Dept, Shanghai 200030, Peoples R China; [Zeng, Fangfang; Tang, Zi-Hui] Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University	Tang, ZH (corresponding author), Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China.	albert.tang@163.com; wangyingwei@yahoo.com	Tang, Zihui/P-2222-2016		China National Grant on Science and Technology	China National Grant on Science and Technology	The authors thank the grant from China National Grant on Science and Technology to support the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayad F, 2010, DIABETIC MED, V27, P804, DOI 10.1111/j.1464-5491.2010.03027.x; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Bian RW, 2011, ACTA GASTRO-ENT BELG, V74, P28; Camm AJ, 1996, EUR HEART J, V17, P354; Ding W, 2011, ACTA CARDIOL, V66, P465, DOI 10.1080/AC.66.4.2126595; Erdem A, 2012, J INTERV CARD ELECTR, V35, P253, DOI 10.1007/s10840-012-9741-y; Garruti G, 2012, EXP DIABETES RES, DOI 10.1155/2012/615835; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hazari MA, 2012, NEUROSCIENCES, V17, P173; Iodice V, 2011, J NEUROL SCI, V310, P133, DOI 10.1016/j.jns.2011.07.014; Jarczok MN, 2013, INT J CARDIOL, V167, P855, DOI 10.1016/j.ijcard.2012.02.002; Kamphuis MH, 2007, EUR J CARDIOV PREV R, V14, P796, DOI 10.1097/HJR.0b013e32829c7d0c; Laitinen T, 2011, DIABETIC MED, V28, P699, DOI 10.1111/j.1464-5491.2011.03278.x; Lambrecht R, 2007, AUTON NEUROSCI-BASIC, V131, P102, DOI 10.1016/j.autneu.2006.07.001; Li Y, 2008, STAT MED, V27, P937, DOI 10.1002/sim.3027; Liu JM, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-80; Meinhold JA, 2001, DIABETIC MED, V18, P607, DOI 10.1046/j.1464-5491.2001.00480.x; Min KB, 2008, INT HEART J, V49, P175, DOI 10.1536/ihj.49.175; Nanaiah Amrit, 2012, Indian J Endocrinol Metab, V16, P749, DOI 10.4103/2230-8210.100668; Spallone V, 2011, DIABETES-METAB RES, V27, P639, DOI 10.1002/dmrr.1239; Swartz MD, 2008, STAT MED, V27, P6158, DOI 10.1002/sim.3434; Tang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070571; Vespasiani G, 1996, COMPUT METH PROG BIO, V51, P211, DOI 10.1016/S0169-2607(96)01774-9; Vinik AI, 2007, CIRCULATION, V115, P387, DOI 10.1161/CIRCULATIONAHA.106.634949; Ziegler D, 2006, EXP CLIN ENDOCR DIAB, V114, P153, DOI 10.1055/s-2006-924083	25	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e89623	10.1371/journal.pone.0089623	http://dx.doi.org/10.1371/journal.pone.0089623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621478	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300010
J	Gutierrez-Ibanez, C; Iwaniuk, AN; Moore, BA; Fernandez-Juricic, E; Corfield, JR; Krilow, JM; Kolominsky, J; Wylie, DR				Gutierrez-Ibanez, Cristian; Iwaniuk, Andrew N.; Moore, Bret A.; Fernandez-Juricic, Esteban; Corfield, Jeremy R.; Krilow, Justin M.; Kolominsky, Jeffrey; Wylie, Douglas R.			Mosaic and Concerted Evolution in the Visual System of Birds	PLOS ONE			English	Article							ACCESSORY OPTIC-SYSTEM; LATERAL GENICULATE-NUCLEUS; PIGEONS COLUMBA-LIVIA; PHYLOGENETIC COMPARATIVE-ANALYSIS; ISTHMI PARS MAGNOCELLULARIS; AVIAN TELENCEPHALON; MOLECULAR PHYLOGENY; CHOLINE-ACETYLTRANSFERASE; LENTIFORMIS MESENCEPHALI; OPTOKINETIC NYSTAGMUS	Two main models have been proposed to explain how the relative size of neural structures varies through evolution. In the mosaic evolution model, individual brain structures vary in size independently of each other, whereas in the concerted evolution model developmental constraints result in different parts of the brain varying in size in a coordinated manner. Several studies have shown variation of the relative size of individual nuclei in the vertebrate brain, but it is currently not known if nuclei belonging to the same functional pathway vary independently of each other or in a concerted manner. The visual system of birds offers an ideal opportunity to specifically test which of the two models apply to an entire sensory pathway. Here, we examine the relative size of 9 different visual nuclei across 98 species of birds. This includes data on interspecific variation in the cytoarchitecture and relative size of the isthmal nuclei, which has not been previously reported. We also use a combination of statistical analyses, phylogenetically corrected principal component analysis and evolutionary rates of change on the absolute and relative size of the nine nuclei, to test if visual nuclei evolved in a concerted or mosaic manner. Our results strongly indicate a combination of mosaic and concerted evolution (in the relative size of nine nuclei) within the avian visual system. Specifically, the relative size of the isthmal nuclei and parts of the tectofugal pathway covary across species in a concerted fashion, whereas the relative volume of the other visual nuclei measured vary independently of one another, such as that predicted by the mosaic model. Our results suggest the covariation of different neural structures depends not only on the functional connectivity of each nucleus, but also on the diversity of afferents and efferents of each nucleus.	[Gutierrez-Ibanez, Cristian; Kolominsky, Jeffrey; Wylie, Douglas R.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Iwaniuk, Andrew N.; Corfield, Jeremy R.; Krilow, Justin M.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada; [Moore, Bret A.; Fernandez-Juricic, Esteban] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Corfield, Jeremy R.; Wylie, Douglas R.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada	University of Alberta; University of Lethbridge; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Alberta	Gutierrez-Ibanez, C (corresponding author), Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada.	cagutier@ualberta.ca	Iwaniuk, Andrew/H-7255-2019	Iwaniuk, Andrew/0000-0001-9273-3655; Gutierrez-Ibanez, Cristian/0000-0002-0468-8223	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this study was provided by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to ANI and DRW (http://www.nserc-crsng.gc.ca/Index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J COMP NEUROL, V500, P211; Asadollahi A, 2011, J NEUROSCI, V31, P6088, DOI 10.1523/JNEUROSCI.0023-11.2011; Asadollahi A, 2010, NAT NEUROSCI, V13, P889, DOI 10.1038/nn.2573; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Barton RA, 1998, P ROY SOC B-BIOL SCI, V265, P1933, DOI 10.1098/rspb.1998.0523; Bischof HJ, 1997, EUR J MORPHOL, V35, P246, DOI 10.1076/ejom.35.4.246.13080; BODNARENKO SR, 1988, J COMP NEUROL, V269, P431, DOI 10.1002/cne.902690310; BRECHA N, 1980, J COMP NEUROL, V189, P615, DOI 10.1002/cne.901890404; Brecha NC, 1978, SOME OBSERVATIONS OR; Brown DM, 1999, AUK, V116, P141, DOI 10.2307/4089461; BURNS S, 1981, EXP BRAIN RES, V42, P171; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; CROSSLAND WJ, 1979, J COMP NEUROL, V185, P87, DOI 10.1002/cne.901850106; Crowder NA, 2003, J NEUROPHYSIOL, V90, P1140, DOI 10.1152/jn.00653.2002; DEACON TW, 1990, INT J PRIMATOL, V11, P193, DOI 10.1007/BF02192869; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; Dobson SD, 2011, ANAT RES INT, V2011; Dobson SD, 2011, BIOL LETTERS, V7, P86, DOI 10.1098/rsbl.2010.0427; Donne-Gousse C, 2002, MOL PHYLOGENET EVOL, V23, P339, DOI 10.1016/S1055-7903(02)00019-2; Driskell AC, 2004, MOL PHYLOGENET EVOL, V31, P943, DOI 10.1016/j.ympev.2003.10.017; EHRLICH D, 1989, NEUROSCI LETT, V104, P1, DOI 10.1016/0304-3940(89)90319-4; Faunes M, 2013, J COMP NEUROL, V521, P1727, DOI 10.1002/cne.23253; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Finlay BL, 2001, BEHAV BRAIN SCI, V24, P263, DOI 10.1017/S0140525X01003958; FITE KV, 1981, J COMP NEUROL, V195, P279, DOI 10.1002/cne.901950208; Freckleton RP, 2002, J ANIM ECOL, V71, P542, DOI 10.1046/j.1365-2656.2002.00618.x; Frost B.J., 1994, P248; GAMLIN PDR, 1988, J COMP NEUROL, V269, P1, DOI 10.1002/cne.902690102; GAMLIN PDR, 1988, J COMP NEUROL, V269, P18, DOI 10.1002/cne.902690103; GAMLIN PDR, 1984, J COMP NEUROL, V226, P523, DOI 10.1002/cne.902260407; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GIOANNI H, 1991, EXP BRAIN RES, V86, P601; GIOANNI H, 1983, EXP BRAIN RES, V50, P237; GIOANNI H, 1983, EXP BRAIN RES, V50, P248; Gonzalez-Voyer A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-238; GRANDA RH, 1989, J COMP NEUROL, V287, P455, DOI 10.1002/cne.902870405; Gruberg E, 2006, J NEUROSCI, V26, P10368, DOI 10.1523/JNEUROSCI.3288-06.2006; GUNTURKUN O, 1990, NEUROSCI LETT, V111, P18, DOI 10.1016/0304-3940(90)90337-9; Gutierrez-Ibanez C, 2013, BRAIN BEHAV EVOLUT, V81, P27, DOI 10.1159/000343810; Gutierrez-Ibanez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037816; Gutierrez-Ibanez C, 2011, BRAIN BEHAV EVOLUT, V78, P286, DOI 10.1159/000330359; Gutierrez-Ibanez C, 2009, BRAIN BEHAV EVOLUT, V74, P280, DOI 10.1159/000270904; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hansen TF, 1997, EVOLUTION, V51, P1341, DOI 10.1111/j.1558-5646.1997.tb01457.x; Harmon AL, 2013, PACKAGE GEIGER; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hellmann B, 2004, J COMP NEUROL, V472, P395, DOI 10.1002/cne.20056; Hellmann B, 2001, J COMP NEUROL, V436, P153; Hunt S.P., 1984, P619; HUNT SP, 1975, J COMP NEUROL, V162, P433, DOI 10.1002/cne.901620403; HUNT SP, 1976, J COMP NEUROL, V170, P153, DOI 10.1002/cne.901700203; Husband S., 2001, AVIAN VISUAL COGNITI; Ives AR, 2007, SYST BIOL, V56, P252, DOI 10.1080/10635150701313830; Iwaniuk A., 2004, INT J COMP PSYCHOL, V17, P17; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P215, DOI 10.1159/000084313; Iwaniuk AN, 2006, BEHAV BRAIN RES, V167, P305, DOI 10.1016/j.bbr.2005.09.015; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; Iwaniuk AN, 2006, J COMP PHYSIOL A, V192, P1313, DOI 10.1007/s00359-006-0161-2; Iwaniuk AN, 2010, BRAIN BEHAV EVOLUT, V75, P122, DOI 10.1159/000311729; Johnson KP, 1999, AUK, V116, P792, DOI 10.2307/4089339; Karten H.J., 1967, STEREOTAXIC ATLAS BR; KARTEN HJ, 1973, J COMP NEUROL, V150, P253, DOI 10.1002/cne.901500303; KARTEN HJ, 1977, P NATL ACAD SCI USA, V74, P1753, DOI 10.1073/pnas.74.4.1753; Karten HJ, 1997, J COMP NEUROL, V387, P449; KARTEN HJ, 1970, J COMP NEUROL, V140, P35, DOI 10.1002/cne.901400103; Kimball RT, 2008, J AVIAN BIOL, V39, P438, DOI 10.1111/j.2008.0908-8857.04270.x; Klingenberg CP, 1996, NATO ADV SCI INST SE, V284, P23; KNUDSEN EI, 1983, J COMP NEUROL, V218, P187, DOI 10.1002/cne.902180206; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; Knudsen EI, 2011, EUR J NEUROSCI, V33, P1961, DOI 10.1111/j.1460-9568.2011.07696.x; Krutzfeldt NOE, 2005, J COMP NEUROL, V490, P40, DOI 10.1002/cne.20627; Kubke MF, 2004, BRAIN BEHAV EVOLUT, V63, P169, DOI 10.1159/000076242; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Lisney TJ, 2013, J COMP PHYSIOL A, V199, P385, DOI 10.1007/s00359-013-0802-1; Lisney TJ, 2012, J COMP PHYSIOL A, V198, P717, DOI 10.1007/s00359-012-0742-1; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Maddison W., 2018, MESQUITE MODULAR SYS; Marin G, 2005, J NEUROSCI, V25, P7081, DOI 10.1523/JNEUROSCI.1379-05.2005; Marin G, 2007, J NEUROSCI, V27, P8112, DOI 10.1523/JNEUROSCI.1420-07.2007; Marin GJ, 2012, J NEUROSCI, V32, P1110, DOI 10.1523/JNEUROSCI.4151-11.2012; MATURANA HR, 1982, BRAIN RES, V247, P227, DOI 10.1016/0006-8993(82)91248-3; MCKENNA OC, 1985, BRAIN BEHAV EVOLUT, V26, P91, DOI 10.1159/000118770; MEDINA L, 1994, J COMP NEUROL, V342, P497, DOI 10.1002/cne.903420403; MICELI D, 1987, J HIRNFORSCH, V28, P45; MICELI D, 1979, NEURAL MECHANISMS BE, P223; Midford PE, 2008, PDAP MESQUITE TRANSL; MORGAN B, 1981, EXP BRAIN RES, V42, P181; Mpodozis J, 1995, Int J Neurosci, V81, P123, DOI 10.3109/00207459509015304; Mpodozis J, 1996, J COMP NEUROL, V374, P204, DOI 10.1002/(SICI)1096-9861(19961014)374:2<204::AID-CNE4>3.0.CO;2-6; Mysore SP, 2011, J NEUROSCI, V31, P5186, DOI 10.1523/JNEUROSCI.4592-10.2011; Nguyen AP, 2004, J NEUROSCI, V24, P4962, DOI 10.1523/JNEUROSCI.0146-04.2004; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pakan JMP, 2006, J COMP NEUROL, V495, P84, DOI 10.1002/cne.20855; Pereira SL, 2007, SYST BIOL, V56, P656, DOI 10.1080/10635150701549672; PUBOLS BH, 1965, J NEUROPHYSIOL, V28, P312, DOI 10.1152/jn.1965.28.2.312; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; PURVIS A, 1993, SYST BIOL, V42, P569, DOI 10.2307/2992489; R Core Team, 2021, R LANGUAGE ENV STAT; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; REINER A, 1982, J COMP NEUROL, V204, P165, DOI 10.1002/cne.902040206; REMY M, 1991, J COMP NEUROL, V305, P57, DOI 10.1002/cne.903050107; Reperant J, 1973, J Hirnforsch, V14, P151; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; RIO JP, 1983, BRAIN RES, V271, P145, DOI 10.1016/0006-8993(83)91375-6; Schoenemann PT, 2004, BRAIN BEHAV EVOLUT, V63, P47, DOI 10.1159/000073759; SERENO MI, 1987, J COMP NEUROL, V261, P319, DOI 10.1002/cne.902610302; Smaers JB, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0269; SORENSON EM, 1989, J COMP NEUROL, V281, P641, DOI 10.1002/cne.902810412; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Striedter GF, 2008, J COMP NEUROL, V507, P1663, DOI 10.1002/cne.21640; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; Swanson DL, 2009, EVOLUTION, V63, P184, DOI 10.1111/j.1558-5646.2008.00522.x; Tombol T, 1998, CELL TISSUE RES, V291, P255, DOI 10.1007/s004410050995; Vega-Zuniga T, 2011, 2011 NEUR M PLANN; WAKITA M, 1992, BEHAV BRAIN RES, V51, P211, DOI 10.1016/S0166-4328(05)80215-3; WALLS G L, 1953, Univ Calif Publ Physiol, V9, P1; Wang Y, 2006, J COMP NEUROL, V494, P7, DOI 10.1002/cne.20821; Wang Y, 2004, J COMP NEUROL, V469, P275, DOI 10.1002/cne.11007; WANG YC, 1993, VISUAL NEUROSCI, V10, P21, DOI 10.1017/S0952523800003199; Whiting BA, 2003, J HUM EVOL, V44, P3, DOI 10.1016/S0047-2484(02)00162-8; WILD JM, 1989, J COMP NEUROL, V287, P1, DOI 10.1002/cne.902870102; Wink Michael, 2004, P517; Wink M, 2009, ARDEA, V97, P581, DOI 10.5253/078.097.0425; WINTERSON BJ, 1985, EXP BRAIN RES, V60, P215; WOODSON W, 1995, J COMP NEUROL, V362, P489, DOI 10.1002/cne.903620405; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160; Wylie DR, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00004; Wylie DRW, 2007, VISUAL NEUROSCI, V24, P691, DOI 10.1017/S0952523807070599; Wylie DRW, 2009, CAN J EXP PSYCHOL, V63, P328, DOI 10.1037/a0016826; Wylie DRW, 1998, J COMP NEUROL, V391, P456; Wylie DRW, 1997, J COMP NEUROL, V384, P517, DOI 10.1002/(SICI)1096-9861(19970811)384:4<517::AID-CNE3>3.0.CO;2-5; Yopak KE, 2010, P NATL ACAD SCI USA, V107, P12946, DOI 10.1073/pnas.1002195107	136	28	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90102	10.1371/journal.pone.0090102	http://dx.doi.org/10.1371/journal.pone.0090102			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621573	gold, Green Published, Green Submitted			2022-12-27	WOS:000332845300013
J	Li, L; Tan, JJ; Zhang, Y; Han, NJ; Di, XB; Xiao, T; Cheng, SJ; Gao, YN; Liu, Y				Li, Lin; Tan, Jinjing; Zhang, Ying; Han, Naijun; Di, Xuebing; Xiao, Ting; Cheng, Shujun; Gao, Yanning; Liu, Yu			DLK1 Promotes Lung Cancer Cell Invasion through Upregulation of MMP9 Expression Depending on Notch Signaling	PLOS ONE			English	Article							INHIBIT ADIPOCYTE DIFFERENTIATION; HEPATOCELLULAR-CARCINOMA; HUMAN PROSTATE; STEM-CELLS; PATHWAY; PROTEIN; GENE; ADIPOGENESIS; ACTIVATION; DROSOPHILA	The transmembrane and secreted protein delta-like 1 homolog (DLK1) belongs to the EGF-like family. It is widely accepted that DLK1 plays important roles in regulating cell differentiation, such as adipogenesis and osteogenesis. Aberrant expression of DLK1 has been found in various types of human cancers, including lung cancer. A previous study in this lab has revealed that DLK1 is associated with tumor invasion, although the mechanism is still unknown. To explore the potential effects that DLK1 might have on invasion, DLK1 was overexpressed or knocked down in the human lung cancer cell lines. The protein's influences on cell invasion were subsequently evaluated. A transwell assay showed that DLK1 overexpression significantly promoted cancer cell invasion. Western blotting and gelatin zymography analysis indicated that DLK1 could affect both matrix metalloproteinase-9 (MMP9) expression and its extracellular activity. An analysis of NOTCH1 and HES1 gene expression and Notch intracellular domain (NICD) nuclear translocation during DLK1 stimulation or depletion demonstrated that DLK1 could activate Notch signaling in lung cancer cells. Additionally, the elevated expression of MMP9 induced by DLK1 stimulation could be significantly decreased by inhibiting Notch signaling using c-secretase inhibitor (GSI). The data presented in this study suggest that DLK1 can promote the invasion of lung cancer cells by upregulating MMP9 expression, which depends on Notch signaling.	[Li, Lin; Tan, Jinjing; Zhang, Ying; Han, Naijun; Di, Xuebing; Xiao, Ting; Cheng, Shujun; Gao, Yanning; Liu, Yu] Peking Union Med Coll, Canc Inst Hosp, Dept Etiol & Carcinogenesis, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Li, Lin; Tan, Jinjing; Zhang, Ying; Han, Naijun; Di, Xuebing; Xiao, Ting; Cheng, Shujun; Gao, Yanning; Liu, Yu] Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Gao, YN (corresponding author), Peking Union Med Coll, Canc Inst Hosp, Dept Etiol & Carcinogenesis, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	yngao@cicams.ac.cn; liuyu@cicams.ac.cn	Tan, Jinjing/I-1042-2016		Natural Science Foundation of China [30930042, 81301852]; Specialized Research Fund for the Doctoral Program of Higher Education [20111106110017]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was funded by the Natural Science Foundation of China (30930042 and 81301852) and the Specialized Research Fund for the Doctoral Program of Higher Education (20111106110017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2007, J BIOL CHEM, V282, P7339, DOI 10.1074/jbc.M607530200; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Begum A, 2012, CANCER LETT, V318, P26, DOI 10.1016/j.canlet.2011.11.032; Bin Hafeez B, 2009, CLIN CANCER RES, V15, P452, DOI 10.1158/1078-0432.CCR-08-1631; Bray SJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-11; Ceder JA, 2008, EUR UROL, V54, P1344, DOI 10.1016/j.eururo.2008.03.006; Chu D, 2011, ANN ONCOL; Donnem T, 2010, CANCER-AM CANCER SOC, V116, P5676, DOI 10.1002/cncr.25551; Eliasz S, 2010, ONCOGENE, V29, P2488, DOI 10.1038/onc.2010.7; Falix FA, 2012, BBA-MOL BASIS DIS, V1822, P988, DOI 10.1016/j.bbadis.2012.02.003; Glittenberg M, 2006, EMBO J, V25, P4697, DOI 10.1038/sj.emboj.7601337; Herbst RS, 2007, NEW ENGL J MED, V356, P76, DOI 10.1056/NEJMe068218; Huang J, 2007, CARCINOGENESIS, V28, P1094, DOI 10.1093/carcin/bgl215; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kawakami T, 2006, HUM MOL GENET, V15, P821, DOI 10.1093/hmg/ddl001; Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06; Li L, 2005, ONCOGENE, V24, P4472, DOI 10.1038/sj.onc.1208637; Liu Yu, 2010, Zhongguo Fei Ai Za Zhi, V13, P923, DOI 10.3779/j.issn.1009-3419.2010.10.12; Ma Y, 2006, CLIN CANCER RES, V12, P1121, DOI 10.1158/1078-0432.CCR-05-1766; Nueda ML, 2008, J MOL BIOL, V379, P428, DOI 10.1016/j.jmb.2008.03.070; Nueda ML, 2007, J MOL BIOL, V367, P1281, DOI 10.1016/j.jmb.2006.10.043; Sanchez-Solana B, 2011, BBA-MOL CELL RES, V1813, P1153, DOI 10.1016/j.bbamcr.2011.03.004; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Wang YH, 2010, MOL CELL BIOL, V30, P3480, DOI 10.1128/MCB.00057-10; Wang YH, 2009, CELL METAB, V9, P287, DOI 10.1016/j.cmet.2009.01.013; Xu X, 2012, MOL CANCER THER, V11, P629, DOI 10.1158/1535-7163.MCT-11-0531; Yin D, 2006, ONCOGENE, V25, P1852, DOI 10.1038/sj.onc.1209219; Yu F, 2010, LIVER INT, V30, P703, DOI 10.1111/j.1478-3231.2010.02214.x	29	8	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91509	10.1371/journal.pone.0091509	http://dx.doi.org/10.1371/journal.pone.0091509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621612	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300097
J	Winhofer, Y; Krssak, M; Wolf, P; Tura, A; Anderwald, CH; Kosi, L; Reiter, G; Pacini, G; Trattnig, S; Luger, A; Krebs, M; Kautzky-Willer, A				Winhofer, Yvonne; Krssak, Martin; Wolf, Peter; Tura, Andrea; Anderwald, Christian-Heinz; Kosi, Lana; Reiter, Gert; Pacini, Giovanni; Trattnig, Siegfried; Luger, Anton; Krebs, Michael; Kautzky-Willer, Alexandra			Hepatic Rather Than Cardiac Steatosis Relates to Glucose Intolerance in Women with Prior Gestational Diabetes	PLOS ONE			English	Article							RESONANCE-SPECTROSCOPY; CARDIOVASCULAR-DISEASE; MYOCARDIAL STEATOSIS; INSULIN SENSITIVITY; MELLITUS; PREDICTOR; HEART; REPRODUCIBILITY; HYPERGLYCEMIA; TRIGLYCERIDE	Background: Increased myocardial lipid accumulation has been described in patients with pre- and overt type 2 diabetes and could underlie the development of left-ventricular dysfunction in metabolic diseases (diabetic cardiomyopathy). Since women with prior gestational diabetes (pGDM) display a generally young population at high risk of developing diabetes and associated cardiovascular complications, we aimed to assess whether myocardial lipid accumulation can be detected at early stages of glucose intolerance and relates to markers of hepatic steatosis (Fatty Liver Index), cardiac function, insulin sensitivity and secretion. Methods: Myocardial lipid content (MYCL), left-ventricular function (1 H-magnetic-resonance-spectroscopy and -imaging), insulin sensitivity/secretion (oral glucose tolerance test) and the fatty liver index (FLI) were assessed in 35 pGDM (45.6 +/- 7.0 years, 28.3 +/- 4.8 kg/m(2)) and 14 healthy control females (CON; 44.7 +/- 9.8 years, 26.1 +/- 2.5 kg/m(2)), matching for age and body-mass-index (each p>0.1). Results: Of 35 pGDM, 9 displayed normal glucose tolerance (NGT), 6 impaired glucose regulation (IGR) and 20 had been already diagnosed with type 2 diabetes (T2DM). MYCL and cardiac function were comparable between pGDM and CON; in addition, no evidence of left-ventricular dysfunction was observed. MYCL was inversely correlated with the ejection fraction in T2DM (R = -20.45, p<0.05), while the FLI was tightly correlated with metabolic parameters (such as HbA1C, fasting plasma glucose and HDL-cholesterol) and rose along GT-groups. Conclusions: There is no evidence of cardiac steatosis in middle-aged women with prior gestational diabetes, suggesting that cardiac complications might develop later in the time-course of diabetes and may be accelerated by the co-existence of further risk factors, whereas hepatic steatosis remains a valid biomarker for metabolic diseases even in this rather young female cohort.	[Winhofer, Yvonne; Krssak, Martin; Wolf, Peter; Anderwald, Christian-Heinz; Kosi, Lana; Luger, Anton; Krebs, Michael; Kautzky-Willer, Alexandra] Med Univ Vienna, Dept Internal Med 3, Div Endocrinol & Metab, Vienna, Austria; [Tura, Andrea; Anderwald, Christian-Heinz; Pacini, Giovanni] CNR, Inst Biomed Engn, Metab Unit, Padua, Italy; [Anderwald, Christian-Heinz] Mariahilf Community Pharm, Arnoldstein, Austria; [Anderwald, Christian-Heinz] Specialized Hosp Complex Agathenhof, Med Direct, Micheldorf, Austria; [Reiter, Gert] Siemens AG Healthcare, Vienna, Austria; [Trattnig, Siegfried] Med Univ Vienna, Dept Radiodiagnost, High Field MR, Ctr Excellence, Vienna, Austria	Medical University of Vienna; Consiglio Nazionale delle Ricerche (CNR); Siemens AG; Medical University of Vienna	Winhofer, Y (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Endocrinol & Metab, Vienna, Austria.	yvonne.winhofer@meduniwien.ac.at	Krssak, Martin/AAU-8183-2020; Anderwald, Christian Heinz/AAG-2271-2021	Krssak, Martin/0000-0001-9717-803X; Anderwald, Christian Heinz/0000-0001-7485-0815; Winhofer, Yvonne/0000-0002-0555-9044; Wolf, Peter/0000-0001-6779-734X; Kautzky-Willer, Alexandra/0000-0002-3520-4105; Trattnig, Siegfried/0000-0003-1623-3303; Krebs, Michael/0000-0002-9265-7274	"Jubilaumsfonds" of the Austrian National Bank [11198, 13249, 15363]; Austrian Heart Foundation; Medical Scientific Fund of the Mayor of the City of Vienna [12023]	"Jubilaumsfonds" of the Austrian National Bank; Austrian Heart Foundation; Medical Scientific Fund of the Mayor of the City of Vienna	The study was supported by the "Jubilaumsfonds" of the Austrian National Bank (Grant Nr. 11198 to AKW, Grant Nr. 13249 and 15363 to M. Krssak.), the Austrian Heart Foundation and the Medical Scientific Fund of the Mayor of the City of Vienna (Grant 12023, both to M. Krebs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bo S, 2004, J ENDOCRINOL INVEST, V27, P629, DOI 10.1007/BF03347494; Carr DB, 2006, DIABETES CARE, V29, P2078, DOI 10.2337/dc05-2482; Glenn DJ, 2011, HYPERTENSION, V57, P216, DOI 10.1161/HYPERTENSIONAHA.110.160655; Harmancey R, 2010, J LIPID RES, V51, P1380, DOI 10.1194/jlr.M001230; Iozzo P, 2009, J CLIN ENDOCR METAB, V94, P4472, DOI 10.1210/jc.2009-0436; Krssak M, 2011, DIABETOLOGIA, V54, P1871, DOI 10.1007/s00125-011-2146-0; Krssak M, 2010, EUR J RADIOL, V74, pE61, DOI 10.1016/j.ejrad.2009.03.062; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Ng ACT, 2010, CIRCULATION, V122, P2538, DOI 10.1161/CIRCULATIONAHA.110.955542; Prikoszovich T, 2011, DIABETES CARE, V34, P430, DOI 10.2337/dc10-1002; Reingold JS, 2005, AM J PHYSIOL-ENDOC M, V289, pE935, DOI 10.1152/ajpendo.00095.2005; Retnakaran R, 2009, CAN MED ASSOC J, V181, P371, DOI 10.1503/cmaj.090569; Rijzewijk LJ, 2008, J AM COLL CARDIOL, V52, P1793, DOI 10.1016/j.jacc.2008.07.062; Shah BR, 2008, DIABETES CARE, V31, P1668, DOI 10.2337/dc08-0706; Sullivan SD, 2012, CURR DIABETES REP, V12, P43, DOI 10.1007/s11892-011-0238-3; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; Szendroedi J, 2009, DIABETES CARE, V32, P209, DOI 10.2337/dc08-1123; Taegtmeyer H, 2002, CIRCULATION, V105, P1727, DOI 10.1161/01.CIR.0000012466.50373.E8; Tura A, 2001, AM J PHYSIOL-ENDOC M, V281, pE966, DOI 10.1152/ajpendo.2001.281.5.E966; Utz W, 2011, HEART, V97, P1585, DOI 10.1136/hrt.2011.224451; van de Weijer T, 2011, CARDIOVASC RES, V92, P10, DOI 10.1093/cvr/cvr212; van der Meer RW, 2007, RADIOLOGY, V245, P251, DOI 10.1148/radiol.2451061904; van der Meer RW, 2007, J CARDIOVASC MAGN R, V9, P645, DOI 10.1080/10976640601093703; Velagaleti RS, 2010, CIRC-CARDIOVASC IMAG, V3, P257, DOI 10.1161/CIRCIMAGING.109.911438; Waiter GD, 1999, MAGN RESON IMAGING, V17, P99, DOI 10.1016/S0730-725X(98)00158-1; Winhofer Y, 2013, EUR J CLIN INVEST, V43, P190, DOI 10.1111/eci.12031; Winhofer Y, 2012, DIABETES, V61, P1210, DOI 10.2337/db11-1275; Winzer C, 2004, DIABETES CARE, V27, P1721, DOI 10.2337/diacare.27.7.1721	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91607	10.1371/journal.pone.0091607	http://dx.doi.org/10.1371/journal.pone.0091607			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621572	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300110
J	Witz, S; Panwar, P; Schober, M; Deppe, J; Pasha, FA; Lemieux, MJ; Mohlmann, T				Witz, Sandra; Panwar, Pankaj; Schober, Markus; Deppe, Johannes; Pasha, Farhan Ahmad; Lemieux, M. Joanne; Moehlmann, Torsten			Structure-Function Relationship of a Plant NCS1 Member - Homology Modeling and Mutagenesis Identified Residues Critical for Substrate Specificity of PLUTO, a Nucleobase Transporter from Arabidopsis	PLOS ONE			English	Article							CATION SYMPORTER 1; MOLECULAR CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; ALLANTOIN TRANSPORT; SALVAGE PATHWAY; MECHANISM; PROTEINS; PERMEASE; TRANSLOCATOR; SEQUENCE	Plastidic uracil salvage is essential for plant growth and development. So far, PLUTO, the plastidic nucleobase transporter from Arabidopsis thaliana is the only known uracil importer at the inner plastidic membrane which represents the permeability barrier of this organelle. We present the first homology model of PLUTO, the sole plant NCS1 member from Arabidopsis based on the crystal structure of the benzyl hydantoin transporter MHP1 from Microbacterium liquefaciens and validated by molecular dynamics simulations. Polar side chains of residues Glu-227 and backbones of Val-145, Gly-147 and Thr-425 are proposed to form the binding site for the three PLUTO substrates uracil, adenine and guanine. Mutational analysis and competition studies identified Glu-227 as an important residue for uracil and to a lesser extent for guanine transport. A differential response in substrate transport was apparent with PLUTO double mutants E227Q G147Q and E227Q T425A, both of which most strongly affected adenine transport, and in V145A G147Q, which markedly affected guanine transport. These differences could be explained by docking studies, showing that uracil and guanine exhibit a similar binding mode whereas adenine binds deep into the catalytic pocket of PLUTO. Furthermore, competition studies confirmed these results. The present study defines the molecular determinants for PLUTO substrate binding and demonstrates key differences in structure-function relations between PLUTO and other NCS1 family members.	[Witz, Sandra; Schober, Markus; Deppe, Johannes; Moehlmann, Torsten] Univ Kaiserslautern, Dept Plant Physiol, D-67663 Kaiserslautern, Germany; [Panwar, Pankaj; Lemieux, M. Joanne] Univ Alberta, Dept Biochem, Membrane Prot Dis Res Grp, Edmonton, AB, Canada; [Pasha, Farhan Ahmad] King Abdullah Univ Sci & Technol, Catalysis Res Ctr, Thuwal, Saudi Arabia	University of Kaiserslautern; University of Alberta; King Abdullah University of Science & Technology	Mohlmann, T (corresponding author), Univ Kaiserslautern, Dept Plant Physiol, D-67663 Kaiserslautern, Germany.	moehlmann@biologie.uni-kl.de	Pasha, F. A./AAB-9581-2019; Pasha, Farhan Ahmad/A-7429-2008	Pasha, F. A./0000-0002-7132-6361; Lemieux, Joanne/0000-0003-4745-9153	DFG [MO 1032/3-2];  [IRTG1830]	DFG(German Research Foundation (DFG)); 	This work was supported by a DFG Grant (MO 1032/3-2) to SW and IRTG1830 "Complex membrane proteins in cellular development and disease". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman JL, 2011, BIOPHYS J, V101, P2399, DOI 10.1016/j.bpj.2011.09.061; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Chen MJ, 2011, PLANT CELL, V23, P2991, DOI 10.1105/tpc.111.085829; CHEVALLIER MR, 1982, EMBO J, V1, P375, DOI 10.1002/j.1460-2075.1982.tb01177.x; COOPER TG, 1987, J BACTERIOL, V169, P4660, DOI 10.1128/jb.169.10.4660-4667.1987; Geigenberger P, 2005, PLANT CELL, V17, P2077, DOI 10.1105/tpc.105.033548; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; KAMPFENKEL K, 1995, FEBS LETT, V374, P351, DOI 10.1016/0014-5793(95)01143-3; Kirchberger S, 2008, PLANT J, V56, P51, DOI 10.1111/j.1365-313X.2008.03583.x; Kosti V, 2010, J MOL BIOL, V397, P1132, DOI 10.1016/j.jmb.2010.02.037; Krypotou E, 2012, J BIOL CHEM, V287, P36792, DOI 10.1074/jbc.M112.400382; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linka N, 2010, MOL PLANT, V3, P21, DOI 10.1093/mp/ssp108; Liu XY, 2007, NEW PHYTOL, V175, P448, DOI 10.1111/j.1469-8137.2007.02117.x; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Ludwig A, 2000, PLANT J, V24, P503, DOI 10.1046/j.1365-313x.2000.00900.x; Mainguet SE, 2009, PLANT J, V60, P280, DOI 10.1111/j.1365-313X.2009.03963.x; Mourad GS, 2012, FEBS LETT, V586, P1370, DOI 10.1016/j.febslet.2012.03.058; Neuhaus HE, 1997, PLANT J, V11, P73, DOI 10.1046/j.1365-313X.1997.11010073.x; Papageorgiou L, 2008, J MOL BIOL, V382, P1121, DOI 10.1016/j.jmb.2008.08.005; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Schein JR, 2013, PLANT PHYSIOL BIOCH, V70, P52, DOI 10.1016/j.plaphy.2013.05.015; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Sukrong S, 2012, MOL PLANT, V5, P1310, DOI 10.1093/mp/sss065; SUMRADA R, 1977, J BACTERIOL, V131, P839, DOI 10.1128/JB.131.3.839-847.1977; Suzuki S, 2006, J BACTERIOL, V188, P3329, DOI 10.1128/JB.188.9.3329-3336.2006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaziri H, 2013, MOL MEMBR BIOL, V30, P114, DOI 10.3109/09687688.2012.748939; Vazquez-Ibar JL, 2004, J BIOL CHEM, V279, P49214, DOI 10.1074/jbc.M407408200; Vlanti A, 2008, MOL MICROBIOL, V68, P959, DOI 10.1111/j.1365-2958.2008.06198.x; Werner AK, 2011, TRENDS PLANT SCI, V16, P381, DOI 10.1016/j.tplants.2011.03.012; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Witz S, 2012, PLANT CELL, V24, P1549, DOI 10.1105/tpc.112.096743; Zhang J, 2006, J BIOL CHEM, V281, P28210, DOI 10.1074/jbc.M605129200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	37	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91343	10.1371/journal.pone.0091343	http://dx.doi.org/10.1371/journal.pone.0091343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621654	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300078
J	Zhang, SF; Liu, YX; Liu, ZX; Zhang, C; Cao, H; Ye, YQ; Wang, SL; Zhang, YA; Xiao, SF; Yang, P; Li, JD; Bai, ZM				Zhang, Shufang; Liu, Yanxuan; Liu, Zhenxiang; Zhang, Chong; Cao, Hui; Ye, Yongqing; Wang, Shunlan; Zhang, Ying'ai; Xiao, Sifang; Yang, Peng; Li, Jindong; Bai, Zhiming			Transcriptome Profiling of a Multiple Recurrent Muscle-Invasive Urothelial Carcinoma of the Bladder by Deep Sequencing	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; UPPER URINARY-TRACT; FACTOR A-CHAIN; MESSENGER-RNA; CANCER; EXPRESSION; GENE; PROSTATE; ISOFORM; MECHANISMS	Urothelial carcinoma of the bladder (UCB) is one of the commonly diagnosed cancers in the world. The UCB has the highest rate of recurrence of any malignancy. A genome-wide screening of transcriptome dysregulation between cancer and normal tissue would provide insight into the molecular basis of UCB recurrence and is a key step to discovering biomarkers for diagnosis and therapeutic targets. Compared with microarray technology, which is commonly used to identify expression level changes, the recently developed RNA-seq technique has the ability to detect other abnormal regulations in the cancer transcriptome, such as alternative splicing. In this study, we performed high-throughput transcriptome sequencing at similar to 50x coverage on a recurrent muscle-invasive cisplatin-resistance UCB tissue and the adjacent non-tumor tissue. The results revealed cancer-specific differentially expressed genes between the tumor and non-tumor tissue enriched in the cell adhesion molecules, focal adhesion and ECM-receptor interaction pathway. Five dysregulated genes, including CDH1, VEGFA, PTPRF, CLDN7, and MMP2 were confirmed by Real time qPCR in the sequencing samples and the additional eleven samples. Our data revealed that more than three hundred genes showed differential splicing patterns between tumor tissue and non-tumor tissue. Among these genes, we filtered 24 cancer-associated alternative splicing genes with differential exon usage. The findings from RNA-Seq were validated by Real time qPCR for CD44, PDGFA, NUMB, and LPHN2. This study provides a comprehensive survey of the UCB transcriptome, which provides better insight into the complexity of regulatory changes during recurrence and metastasis.	[Zhang, Shufang; Liu, Zhenxiang; Zhang, Chong; Cao, Hui; Wang, Shunlan; Zhang, Ying'ai; Xiao, Sifang; Yang, Peng; Li, Jindong; Bai, Zhiming] Cent South Univ, Xiangya Sch Med, Affiliated Haikou Hosp, Haikou Municipal Peoples Hosp, Haikou, Peoples R China; [Liu, Yanxuan] Xinxiang Med Univ, Dept Genet Dis, Affiliated Hosp 1, Xinxiang, Peoples R China; [Ye, Yongqing] Dept Shanghai Claison Biotechnol, Shanghai, Peoples R China	Xinxiang Medical University	Bai, ZM (corresponding author), Cent South Univ, Xiangya Sch Med, Affiliated Haikou Hosp, Haikou Municipal Peoples Hosp, Haikou, Peoples R China.	hkbaizhiming@163.com			Hainan Provincial Natural Science Foundation [813256]; Key Municipal Scientific Project of Haikou [2012-073]; Key Scientific Project of Hainan Province	Hainan Provincial Natural Science Foundation; Key Municipal Scientific Project of Haikou; Key Scientific Project of Hainan Province	This work was supported by 2013 Hainan Provincial Natural Science Foundation (Grant number: 813256), Key Municipal Scientific Project of Haikou (Grant number: 2012-073), and Key Scientific Project of Hainan Province (Title: Preliminary screening of molecular markers in bladder cancer by high-throughput transcriptome sequencing). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2010, CANCER SCI, V101, P488, DOI 10.1111/j.1349-7006.2009.01415.x; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chang SS, 2003, J UROLOGY, V170, P1085, DOI 10.1097/01.ju.0000086828.26001.ca; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; COLLINS T, 1987, NATURE, V328, P621, DOI 10.1038/328621a0; Cook JL, 2002, J MOL CELL CARDIOL, V34, P1525, DOI 10.1006/jmcc.2002.2106; Cook NL, 2009, J NEUROSCI RES, V87, P34, DOI 10.1002/jnr.21846; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Crews L, 2004, BRAIN PATHOL, V14, P312; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; DAVIES B, 1993, CANCER RES, V53, P5365; Dong L, 2009, ADV APPL BIOINFORMAT, V17; Drayton RM, 2012, EXPERT REV ANTICANC, V12, P271, DOI [10.1586/era.11.201, 10.1586/ERA.11.201]; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; El-Rifai W, 2000, AM J PATHOL, V156, P871, DOI 10.1016/S0002-9440(10)64956-5; Elsamman E, 2006, BJU INT, V97, P1202, DOI 10.1111/j.1464-410X.2006.06153.x; Emerich DF, 2004, EXPERT OPIN BIOL TH, V4, P1191, DOI 10.1517/14712598.4.8.1191; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gerhards S, 2001, UROLOGY, V57, P675, DOI 10.1016/S0090-4295(00)01087-6; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Hayne D, 2004, J UROLOGY, V172, P1051, DOI 10.1097/01.ju.0000136376.11896.62; Heldin CH, 2002, ARCH BIOCHEM BIOPHYS, V398, P284, DOI 10.1006/abbi.2001.2707; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim D, 2011, CSHL BIOL GEN C; Knowles MA, 2001, J CLIN PATHOL-MOL PA, V54, P215, DOI 10.1136/mp.54.4.215; Koberle B, 2012, MOL BASIS CISPLATIN; Kompier LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013821; Korkolopoulou P, 2001, EUR UROL, V39, P167, DOI 10.1159/000052432; Langer W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-676; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; LIPPONEN PK, 1995, J CANCER RES CLIN, V121, P303, DOI 10.1007/BF01209598; Marin-Aguilera M, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.09.006; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Misquitta-Ali CM, 2011, MOL CELL BIOL, V31, P138, DOI 10.1128/MCB.00709-10; Mitra AP, 2006, CLIN GENITOURIN CANC, V5, P67, DOI 10.3816/CGC.2006.n.020; Miyake H, 2002, J UROLOGY, V167, P1282, DOI 10.1016/S0022-5347(05)65282-2; Miyake H, 1999, MOL UROL, V3, P365; Miyake H, 2004, J UROLOGY, V172, P1127, DOI 10.1097/01.ju.0000129541.23460.48; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nazarenko I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018303; Norskov MS, 2011, PHARMACOGENOMICS J, V11, P292, DOI 10.1038/tpj.2010.38; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; RORSMAN F, 1988, MOL CELL BIOL, V8, P571, DOI 10.1128/MCB.8.2.571; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Smith SD, 2001, JAMA-J AM MED ASSOC, V285, P324, DOI 10.1001/jama.285.3.324; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Swana HS, 1999, NEW ENGL J MED, V341, P452, DOI 10.1056/NEJM199908053410614; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vasala K, 2003, UROLOGY, V62, P952, DOI 10.1016/S0090-4295(03)00660-5; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Herr HW, 2007, J UROLOGY, V177, P437, DOI 10.1016/j.juro.2006.09.027; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Williams SG, 2004, UROL RES, V32, P373, DOI 10.1007/s00240-003-0345-y; Wolff EM, 2005, NAT CLIN PRACT UROL, V2, P502, DOI 10.1038/ncpuro0318; Wong KM, 2011, ANNU REV GENOM HUM G, V12, P407, DOI 10.1146/annurev-genom-082509-141532; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; YEH HJ, 1991, CELL, V64, P209, DOI 10.1016/0092-8674(91)90222-K; Zaravinos A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018135; Zaravinos A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018255	75	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91466	10.1371/journal.pone.0091466	http://dx.doi.org/10.1371/journal.pone.0091466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622401	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300089
J	Asvadi, NH; Morgan, M; Herath, HM; Hewavitharana, AK; Shaw, PN; Cabot, PJ				Asvadi, Naghmeh Hajarol; Morgan, Michael; Herath, Herath M.; Hewavitharana, Amitha K.; Shaw, P. Nicholas; Cabot, Peter J.			Beta-Endorphin 1-31 Biotransformation and cAMP Modulation in Inflammation	PLOS ONE			English	Article							OPIOID RECEPTOR; GAMMA-ENDORPHIN; CYCLIC-AMP; METABOLISM; PEPTIDASE; TISSUE; PAIN; FRAGMENTS; RELEASE; IDENTIFICATION	A large body of evidence now exists for the immune cell expression, production, and the release of beta-endorphin (BE 1-31) within inflamed tissue. The inflammatory milieu is characterised by increased acidity, temperature and metabolic activity. Within these harsh conditions BE 1-31 is even more susceptible to increased enzymatic degradation over that of plasma or other non-injured tissue. To elucidate the biotransformation pathways of BE 1-31 and provide an insight to the impact of inflamed tissue environments, BE 1-31 and three of its major N-terminal fragments (BE 1-11, BE 1-13 and BE 1-17) were incubated in inflamed tissue homogenates at pH 5.5 for 2 hrs. In addition, the potency of BE 1-31 and five main N - terminal fragments (BE 1-9, BE 1-11, BE 1-13, BE 1-17, BE 1-20) was assessed at mu-opioid receptors (MOR), delta-opioid receptors (DOR), and kappa-opioid receptors (KOR). Opioid receptor potency was investigated by examining the modulation of forskolin induced cAMP accumulation. The majority of the N-terminal fragment of BE 1-31 had similar efficacy to BE 1-31 at MOR. The shortest of the major N-terminal fragments (BE 1-9), had partial agonist activity at MOR but possessed the highest potency of all tested peptides at DOR. There was limited effect for BE 1-31 and the biotransformed peptides at KOR. Major N-terminal fragments produced within inflamed tissue have increased presence within inflamed tissue over that of the parent molecule BE 1-31 and may therefore contribute to BE 1-31 efficacy within disease states that involve inflammation.	[Asvadi, Naghmeh Hajarol; Morgan, Michael; Herath, Herath M.; Hewavitharana, Amitha K.; Shaw, P. Nicholas; Cabot, Peter J.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia	University of Queensland	Cabot, PJ (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.	p.cabot@uq.edu.au	Morgan, Michael/AAC-2044-2021; Morgan, Michael/C-1323-2015; Hewavitharana, Amitha K/A-5533-2008; Shaw, Paul N/G-4418-2010; Cabot, Peter John/B-2424-2013; Shaw, Paul/Q-8454-2019	Morgan, Michael/0000-0002-3641-2774; Morgan, Michael/0000-0002-3641-2774; Hewavitharana, Amitha K/0000-0003-2935-9941; Shaw, Paul N/0000-0001-7154-592X; Cabot, Peter John/0000-0003-1778-3753; Shaw, Paul/0000-0001-7154-592X	IPRS Scholarship	IPRS Scholarship	Naghme Asavadi was supported by an IPRS Scholarship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SE, 1999, J RHEUMATOL, V26, P2018; [Anonymous], 1989, CLIN PHARMACOKINET, V17, P345; Baker DG, 1997, PSYCHONEUROENDOCRINO, V22, P517, DOI 10.1016/S0306-4530(97)00053-X; Berezniuk I, 2011, RECEPT SER, P93, DOI 10.1007/978-1-60761-993-2_5; Binder W, 2004, EUR J NEUROSCI, V20, P92, DOI 10.1111/j.1460-9568.2004.03459.x; BRUDEL M, 1995, J CHROMATOGR A, V712, P169, DOI 10.1016/0021-9673(95)00564-4; BURBACH JPH, 1981, J BIOL CHEM, V256, P2463; BURBACH JPH, 1980, BIOCHEM BIOPH RES CO, V92, P725, DOI 10.1016/0006-291X(80)90393-9; Cabot PJ, 1997, J CLIN INVEST, V100, P142, DOI 10.1172/JCI119506; Cabot PJ, 2001, PAIN, V93, P207, DOI 10.1016/S0304-3959(01)00322-0; Chaturvedi K, 2000, BIOPOLYMERS, V55, P334, DOI 10.1002/1097-0282(2000)55:4<334::AID-BIP1006>3.0.CO;2-S; DEWIED D, 1987, POL J PHARMACOL PHAR, V39, P623; Drolet G, 2001, PROG NEURO-PSYCHOPH, V25, P729, DOI 10.1016/S0278-5846(01)00161-0; Fichna J, 2004, CANCER METAST REV, V23, P351, DOI 10.1023/B:CANC.0000031773.46458.63; FOLEY KM, 1979, P NATL ACAD SCI USA, V76, P5377, DOI 10.1073/pnas.76.10.5377; GAFFORI O, 1985, LIFE SCI, V37, P357, DOI 10.1016/0024-3205(85)90506-5; Herath HMDR, 2012, ANAL BIOANAL CHEM, V402, P2089, DOI 10.1007/s00216-011-5686-8; HOUGHTEN RA, 1980, P NATL ACAD SCI-BIOL, V77, P4588, DOI 10.1073/pnas.77.8.4588; Inceoglu B, 2011, P NATL ACAD SCI USA, V108, P5093, DOI 10.1073/pnas.1101073108; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; Jaba IA, 2007, CENT EUR J MED, V2, P417, DOI 10.2478/s11536-007-0036-0; KAROL MD, 1990, BIOPHARM DRUG DISPOS, V11, P179, DOI 10.1002/bdd.2510110210; KAY N, 1987, LIFE SCI, V40, P1083, DOI 10.1016/0024-3205(87)90571-6; LEBOUILLE JLM, 1989, J NEUROCHEM, V52, P1714, DOI 10.1111/j.1471-4159.1989.tb07249.x; LI CH, 1981, INT J PEPT PROT RES, V18, P242; Lin L, 2001, J BIOL CHEM, V276, P2249, DOI 10.1074/jbc.M008562200; MCDONALD JK, 1980, BIOCHIM BIOPHYS ACTA, V616, P68; Miller BC, 1996, IMMUNOPHARMACOLOGY, V31, P151, DOI 10.1016/0162-3109(95)00046-1; Montiel JL, 1997, J NEUROCHEM, V68, P354; Mousa SA, 2001, J NEUROIMMUNOL, V115, P71, DOI 10.1016/S0165-5728(01)00271-5; Noble F, 2007, EXPERT OPIN THER TAR, V11, P145, DOI 10.1517/14728222.11.2.145; Reed B, 2008, J NEUROENDOCRINOL, V20, P606, DOI 10.1111/j.1365-2826.2008.01705.x; Rittner HL, 2001, ANESTHESIOLOGY, V95, P500, DOI 10.1097/00000542-200108000-00036; Roth-Deri I, 2008, PROG NEUROBIOL, V86, P1, DOI 10.1016/j.pneurobio.2008.06.003; Safavi A, 1996, BIOCHEMISTRY-US, V35, P14318, DOI 10.1021/bi960582q; Sakurada C, 2003, BIOCHEM PHARMACOL, V66, P653, DOI 10.1016/S0006-2952(03)00391-5; Sandin J, 1998, REGUL PEPTIDES, V73, P67, DOI 10.1016/S0167-0115(97)01065-3; Sarada B, 1998, J NEUROIMMUNOLOGY, V85, P59; SCARONE S, 1990, PSYCHIAT RES, V32, P159, DOI 10.1016/0165-1781(90)90082-G; Schreiter A, 2012, FASEB J, V26, P5161, DOI 10.1096/fj.12-208678; SHOOK JE, 1988, J PHARMACOL EXP THER, V246, P1018; Steele AD, 2002, CYTOKINE GROWTH F R, V13, P209, DOI 10.1016/S1359-6101(02)00007-2; STEIN C, 1995, NEW ENGL J MED, V332, P1685, DOI 10.1056/NEJM199506223322506; Stein C, 2009, CURR OPIN PHARMACOL, V9, P3, DOI 10.1016/j.coph.2008.12.009; Vetter I, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-22; Yan L, 1997, PEPTIDES, V18, P1399, DOI 10.1016/S0196-9781(97)00207-6; YU VC, 1990, J NEUROCHEM, V55, P1390, DOI 10.1111/j.1471-4159.1990.tb03151.x	47	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90380	10.1371/journal.pone.0090380	http://dx.doi.org/10.1371/journal.pone.0090380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618600	Green Published, gold			2022-12-27	WOS:000332842400015
J	Chen, Q; Zhou, Z; Zhang, L; Xu, SC; Chen, CH; Yu, ZP				Chen, Qian; Zhou, Zhou; Zhang, Lei; Xu, Shangcheng; Chen, Chunhai; Yu, Zhengping			The Cellular Distribution and Ser262 Phosphorylation of Tau Protein Are Regulated by BDNF In Vitro	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; MICROTUBULE DYNAMICS; NEUROBLASTOMA-CELLS; NEUROTROPHIC FACTOR; AXONAL-TRANSPORT; DRUG DISCOVERY; RETINOIC ACID; MOUSE MODEL; NEURONS	The brain-enriched microtubule-associated protein tau, a critical regulator of cytoskeletal dynamics, forms insoluble aggregates in a number of neurodegenerative diseases termed tauopathies, including Alzheimer's disease (AD). Hyperphosphorylation of tau protein is an important mechanism for aggregation, so many studies on the pathogenesis of AD and other tauopathies have focused on regulation of tau phosphorylation by kinases and phosphatases. Less studied are mechanisms of tau transcriptional and post-transcriptional regulation by extracellular signals such as BDNF and how such changes alter neuronal function. Previously, we reported that tau is required for morphological plasticity induced by BDNF. Here, we further explore tau modification during BDNF-induced changes in neuronal cell morphology. In undifferentiated SH-SY5Y cells lacking neurites, tau formed a sphere within the soma as revealed by immunocytochemistry. In contrast, tau was enriched in the neurites and sparse in the soma of SH-SY5Y cells induced to differentiate by retinoic acid (RA). Treatment with RA also increased total tau protein levels but decreased expression of tau phosphorylated at Ser262 as determined by Western blot. Both effects were further enhanced by subsequent BDNF treatment. Upregulation of tau protein and downregulation of p-Ser262 tau were correlated with total neurite length (R = .94 and R = -.98, respectively). When primary E18 hippocampal neurons were treated with nocodazole, a blocker of microtubule polymerization, nascent neurites were lost and tau shifted to the soma. This process of retrograde tau movement away from neurites was reversed by BDNF. These results indicate that tau is redistributed to neurites and dephosphorylated during RA-and BDNF-mediated differentiation.	[Chen, Qian; Zhou, Zhou; Zhang, Lei; Xu, Shangcheng; Chen, Chunhai; Yu, Zhengping] Third Mil Med Univ, Dept Occupat Hlth, Chongqing, Peoples R China	Army Medical University	Yu, ZP (corresponding author), Third Mil Med Univ, Dept Occupat Hlth, Chongqing, Peoples R China.	yuzping_tmmu@126.com		Chen, Chunhai/0000-0002-7549-213X	National Natural Science Foundation of China [31370833, 30900274]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos. 31370833 and 30900274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Buck KB, 2002, J NEUROSCI, V22, P9358; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; Caccamo A, 2010, P NATL ACAD SCI USA, V107, P22687, DOI 10.1073/pnas.1012851108; Chen Q, 2012, NEUROCHEM INT, V60, P233, DOI 10.1016/j.neuint.2011.12.013; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Dawson HN, 2010, NEUROSCIENCE, V169, P516, DOI 10.1016/j.neuroscience.2010.04.037; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; DRUBIN D, 1988, J CELL BIOL, V106, P1583, DOI 10.1083/jcb.106.5.1583; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Fumagalli F, 2006, PHARMACOGENOMICS J, V6, P8, DOI 10.1038/sj.tpj.6500337; Gordon D, 2008, J NEUROSCI RES, V86, P2591, DOI 10.1002/jnr.21719; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Haque N, 1999, BRAIN RES, V838, P69, DOI 10.1016/S0006-8993(99)01622-4; Hoogenraad CC, 2009, TRENDS CELL BIOL, V19, P669, DOI 10.1016/j.tcb.2009.08.006; Jamsa A, 2004, BIOCHEM BIOPH RES CO, V319, P993, DOI 10.1016/j.bbrc.2004.05.075; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Jinwal UK, 2011, J BIOL CHEM, V286, P16976, DOI 10.1074/jbc.M110.182493; KOSIK KS, 1989, ANN MED, V21, P109, DOI 10.3109/07853898909149195; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; Miao YY, 2010, J NEUROSCI RES, V88, P102, DOI 10.1002/jnr.22188; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Niewiadomska G, 2005, ANN NY ACAD SCI, V1048, P287, DOI 10.1196/annals.1342.026; Noble W, 2011, EXPERT OPIN DRUG DIS, V6, P797, DOI 10.1517/17460441.2011.586690; Papanikolopoulou K, 2010, BIOCHEM SOC T, V38, P981, DOI 10.1042/BST0380981; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Post RM, 2007, J PSYCHIATR RES, V41, P979, DOI 10.1016/j.jpsychires.2006.09.009; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; RIEDERER BM, 1994, BRAIN RES BULL, V33, P155, DOI 10.1016/0361-9230(94)90245-3; SHEA TB, 1992, J NEUROSCI RES, V32, P363, DOI 10.1002/jnr.490320308; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; Sultan A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/jbc.M110.199976; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Vega IE, 2006, EXP NEUROL, V202, P152, DOI 10.1016/j.expneurol.2006.05.026; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; Whiteman IT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020878; Wilson L, 1999, CELL STRUCT FUNCT, V24, P329, DOI 10.1247/csf.24.329; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; Yoshizaki C, 2004, NEUROSCI RES, V49, P363, DOI 10.1016/j.neures.2004.04.005; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102	53	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91793	10.1371/journal.pone.0091793	http://dx.doi.org/10.1371/journal.pone.0091793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618580	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400132
J	Giles, EL; Robalino, S; McColl, E; Sniehotta, FF; Adams, J				Giles, Emma L.; Robalino, Shannon; McColl, Elaine; Sniehotta, Falko F.; Adams, Jean			The Effectiveness of Financial Incentives for Health Behaviour Change: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; INCREASE PHYSICAL-ACTIVITY; SMOKING-CESSATION; CONTINGENCY MANAGEMENT; WEIGHT CONTROL; INTERVENTIONS; REINFORCEMENT; MONETARY; OBESITY; WORK	Background: Financial incentive interventions have been suggested as one method of promoting healthy behaviour change. Objectives: To conduct a systematic review of the effectiveness of financial incentive interventions for encouraging healthy behaviour change; to explore whether effects vary according to the type of behaviour incentivised, post-intervention follow-up time, or incentive value. Data Sources: Searches were of relevant electronic databases, research registers, www.google.com, and the reference lists of previous reviews; and requests for information sent to relevant mailing lists. Eligibility Criteria: Controlled evaluations of the effectiveness of financial incentive interventions, compared to no intervention or usual care, to encourage healthy behaviour change, in non-clinical adult populations, living in high-income countries, were included. Study Appraisal and Synthesis: The Cochrane Risk of Bias tool was used to assess all included studies. Meta-analysis was used to explore the effect of financial incentive interventions within groups of similar behaviours and overall. Meta-regression was used to determine if effect varied according to post-intervention follow up time, or incentive value. Results: Seventeen papers reporting on 16 studies on smoking cessation (n = 10), attendance for vaccination or screening (n = 5), and physical activity (n = 1) were included. In meta-analyses, the average effect of incentive interventions was greater than control for short-term (<= six months) smoking cessation (relative risk (95% confidence intervals): 2.48 (1.77 to 3.46); long-term (>six months) smoking cessation (1.50 (1.05 to 2.14)); attendance for vaccination or screening (1.92 (1.46 to 2.53)); and for all behaviours combined (1.62 (1.38 to 1.91)). There was not convincing evidence that effects were different between different groups of behaviours. Meta-regression found some, limited, evidence that effect sizes decreased as post-intervention follow-up period and incentive value increased. However, the latter effect may be confounded by the former. Conclusions: The available evidence suggests that financial incentive interventions are more effective than usual care or no intervention for encouraging healthy behaviour change.	[Giles, Emma L.; Robalino, Shannon; Sniehotta, Falko F.; Adams, Jean] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [McColl, Elaine] Newcastle Univ, Sch Med, Inst Hlth & Soc, Newcastle Clin Trials Unit, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Giles, EL (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	e.l.giles@ncl.ac.uk	Adams, Jean/G-2402-2010; Sniehotta, Falko F/C-5481-2008; McColl, Elaine/V-9906-2019; Robalino, Shannon/N-4113-2015; Robalino, Shannon/GRS-6021-2022; Sniehotta, Falko/ABF-7131-2021; Giles, Emma/AAE-9096-2019	Adams, Jean/0000-0002-5733-7830; Sniehotta, Falko F/0000-0003-1738-4269; McColl, Elaine/0000-0001-8300-3204; Robalino, Shannon/0000-0002-6359-1827; Sniehotta, Falko/0000-0003-1738-4269; Giles, Emma/0000-0002-2166-3300	NIHR; Fuse: the Centre for Translational Research in Public Health, a UKCRC Public Health Research Centre of Excellence; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research under UK Clinical Research Collaboration; Medical Research Council [MR/K02325X/1] Funding Source: researchfish; National Institute for Health Research [CDF-2011-04-001] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); Fuse: the Centre for Translational Research in Public Health, a UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research under UK Clinical Research Collaboration(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work is produced under the terms of a Career Development Fellowship research training fellowship issued by the NIHR to JA. The views expressed are those of the authors and not necessarily those of the NHS, The National Institute for Health Research or the Department of Health. JA & ELG are funded in part, and FFS is funded in full by Fuse: the Centre for Translational Research in Public Health, a UKCRC Public Health Research Centre of Excellence. Funding for Fuse from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; Achat H, 1999, AUST NZ J PUBL HEAL, V23, P285, DOI 10.1111/j.1467-842X.1999.tb01257.x; Adams J, 2013, HLTH PSYCHOL REV; Adams J, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-51; Avenell A, 2004, HEALTH TECHNOL ASSES, V8, P1; Aveyard P, 2011, COCHRANE DB SYST REV; Bryant J, 2011, ADDICTION, V106, P1568, DOI 10.1111/j.1360-0443.2011.03467.x; Cahill K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004307.pub3; Cahill K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004986.pub3; Cochrane Collaboration, 2002, MOD 13 DIV HET; Cookson R, 2008, BMJ, V337; Crockett RA, 2009, PSYCHOL HEALTH, V24, P333, DOI 10.1080/08870440701813030; Debari R, 2007, ONCOL NURS FORUM, V34, P488; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Department of Health, 2004, CHOOS HLTH MAK HLTH; Department of Health, 1998, OUR HTLH NAT CONTR H; Donatelle RJ, 2000, TOB CONTROL, V9, P67; Eastwood P, 2009, HLTH SURVEY ENGLAND; Finkelstein EA, 2008, PREV MED, V47, P182, DOI 10.1016/j.ypmed.2008.05.002; Flodgren G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009255; Gardner B, 2010, PSYCHOL HEALTH MED, V15, P220, DOI 10.1080/13548501003623963; Giuffrida A, 1997, BRIT MED J, V315, P703, DOI 10.1136/bmj.315.7110.703; GLASGOW RE, 1993, ADDICT BEHAV, V18, P455, DOI 10.1016/0306-4603(93)90063-F; Gneezy U, 2011, J ECON PERSPECT, V25, P191, DOI 10.1257/jep.25.4.191; Hey K, 2005, COCHRANE DB SYST REV, V2; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204; Jason LA, 1997, HEALTH EDUC RES, V12, P129, DOI 10.1093/her/12.1.129; JASON LA, 1995, BEHAV THER, V26, P393, DOI 10.1016/S0005-7894(05)80090-5; JEFFERY RW, 1993, AM J PUBLIC HEALTH, V83, P395, DOI 10.2105/AJPH.83.3.395; JEFFERY RW, 1990, HEALTH PSYCHOL, V9, P585, DOI 10.1037/0278-6133.9.5.585; Jochelson K., 2007, PAYING PATIENT IMPRO; Johnston M, 2010, J HEALTH SERV RES PO, V15, P131, DOI 10.1258/jhsrp.2010.010048; Kane RL, 2004, AM J PREV MED, V27, P327, DOI 10.1016/j.amepre.2004.07.002; Kavanagh J, 2009, INCENTIVES IMPROVE S; Kavanagh J, 2011, HEALTH EDUC J, V70, P192, DOI 10.1177/0017896910375878; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Leeks KD, 2010, AM J PREV MED, V38, pS263, DOI 10.1016/j.amepre.2009.10.034; Loewenstein G, 2007, JAMA-J AM MED ASSOC, V298, P2415, DOI 10.1001/jama.298.20.2415; Lussier JP, 2006, ADDICTION, V101, P192, DOI 10.1111/j.1360-0443.2006.01311.x; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Malotte CK, 1999, AM J PREV MED, V16, P182, DOI 10.1016/S0749-3797(98)00093-2; Malotte CK, 1998, AM J PUBLIC HEALTH, V88, P792, DOI 10.2105/AJPH.88.5.792; Matson D M, 1993, Am J Health Promot, V7, P270; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; McEachan RRC, 2010, BRIT J HEALTH PSYCH, V15, P347, DOI 10.1348/135910709X466487; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moher M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003440.pub2; Morgan O, 2005, PUBLIC HEALTH, V119, P361, DOI 10.1016/j.puhe.2004.06.008; National Business Group on Health, 2007, FIN INC HLTH LIF WHO; Nowalk MP, 2010, AM J PREV MED, V38, P237, DOI 10.1016/j.amepre.2009.11.011; O'Malley GC, 2012, COCHRANE DATABASE SY, V1; Ogilvie DEM, 2005, BMJ-BRIT MED J, V329, P1; Oliver A, 2009, J HEALTH SERV RES PO, V14, P1, DOI 10.1258/jhsrp.2008.008132; Parke H, 2013, HEALTH EXPECT, V16, P292, DOI 10.1111/j.1369-7625.2011.00719.x; Paul-Ebhohimhen V, 2008, OBES REV, V9, P355, DOI 10.1111/j.1467-789X.2007.00409.x; Pawson R., 2006, EVIDENCE BASED POLIC, DOI 10.4135/9781849209120; Peersman G., 1998, EFFECTIVENESS HLTH P; Petry NM, 2010, ADDICTION, V105, P1507, DOI 10.1111/j.1360-0443.2009.02879.x; Prendergast M, 2006, ADDICTION, V101, P1546, DOI 10.1111/j.1360-0443.2006.01581.x; Promberger M, 2011, J MED ETHICS, V37, P682, DOI 10.1136/jme.2010.039347; RESNICK JH, 1974, BEHAV THER, V5, P711; Robinow A, 2007, CONSUMER INCENTIVES; Rothman AJ, 2000, HEALTH PSYCHOL, V19, P64, DOI 10.1037/0278-6133.19.Suppl1.64; Roux L, 2008, AM J PREV MED, V35, P578, DOI 10.1016/j.amepre.2008.06.040; Sabatino SA, 2008, AM J PREV MED, V35, pS67, DOI 10.1016/j.amepre.2008.04.008; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Stitzer ML, 2010, DRUG ALCOHOL DEPEN, V107, P76, DOI 10.1016/j.drugalcdep.2009.09.006; STITZER ML, 1983, BEHAV THER, V14, P647, DOI 10.1016/S0005-7894(83)80057-4; STITZER ML, 1985, ADDICT BEHAV, V10, P345, DOI 10.1016/0306-4603(85)90030-9; Stone EG, 2002, ANN INTERN MED, V136, P641, DOI 10.7326/0003-4819-136-9-200205070-00006; Sutherland K, 2008, MED CARE RES REV, V65, p36S, DOI 10.1177/1077558708324235; Thomas B, 2004, WORLDV EVID-BASED NU, V1, P17; Volpp KG, 2009, NEW ENGL J MED, V360, P699, DOI 10.1056/NEJMsa0806819; Volpp KG, 2006, CANCER EPIDEM BIOMAR, V15, P12, DOI 10.1158/1055-9965.EPI-05-0314; Wall J, 2006, NUTR REV, V64, P518, DOI [10.1301/nr.2006.dec.518-531, 10.1111/j.1753-4887.2006.tb00185.x]; White M, 2009, SOCIAL INEQUALITY AND PUBLIC HEALTH, P65; WINDSOR RA, 1988, J BEHAV MED, V11, P407, DOI 10.1007/BF00844939; Yabroff KR, 1999, CANCER EPIDEM BIOMAR, V8, P749	79	244	245	5	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90347	10.1371/journal.pone.0090347	http://dx.doi.org/10.1371/journal.pone.0090347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24618584	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400013
J	Hajrezaie, M; Hassandarvish, P; Moghadamtousi, SZ; Gwaram, NS; Golbabapour, S; NajiHussien, A; Almagrami, AA; Zahedifard, M; Rouhollahi, E; Karimian, H; Fani, S; Kamalidehghan, B; Majid, NA; Ali, HM; Abdulla, MA				Hajrezaie, Maryam; Hassandarvish, Pouya; Moghadamtousi, Soheil Zorofchian; Gwaram, Nura Suleiman; Golbabapour, Shahram; NajiHussien, Abdrabuh; Almagrami, Amel Abdullah; Zahedifard, Maryam; Rouhollahi, Elham; Karimian, Hamed; Fani, Somaye; Kamalidehghan, Behnam; Majid, Nazia Abdul; Ali, Hapipah Mohd; Abdulla, Mahmood Ameen			Chemopreventive Evaluation of a Schiff Base Derived Copper (II) Complex against Azoxymethane-Induced Colorectal Cancer in Rats	PLOS ONE			English	Article							ABERRANT CRYPT FOCI; COLON-CANCER; PROTEASOME INHIBITORS; OXIDATIVE STRESS; APOPTOSIS; INDUCTION; CELLS; CARCINOGENESIS; PROLIFERATION; COMPOUND	Background: Based on the potential of Schiff base compounds to act as sources for the development of cancer chemotherapeutic agents, this in vivo study was performed to investigate the inhibitory properties of the synthetic Schiff base compound Cu(BrHAP)(2) on colonic aberrant crypt foci (ACF). Methodology: This study involved five groups of male rats. The negative control group was injected with normal saline once a week for 2 weeks and fed 10% Tween 20 for 10 weeks, the cancer control group was subcutaneously injected with 15 mg/kg azoxymethane once per week for two consecutive weeks, the positive control group was injected with 15 mg/kg azoxymethane once per week for two consecutive weeks and 35 mg/kg 5-fluorouracil (injected intra-peritoneally) for 4 weeks, and the experimental groups were first injected with 15 mg/kg azoxymethane once per week for two consecutive weeks and then fed 2.5 or 5 mg/kg of the Schiff base compound once a day for 10 weeks. Application of the Schiff base compound suppressed total colonic ACF formation by up to 72% to 74% (P<0.05) when compared with the cancer control group. Analysis of colorectal specimens revealed that treatments with the Schiff base compound decreased the mean crypt scores in azoxymethane-treated rats. Significant elevations of superoxide dismutase, glutathione peroxidase and catalase activities and a reduction in the level of malondialdehyde were also observed. Histologically, all treatment groups exhibited significant decreases in dysplasia compared to the cancer control group (P<0.05). Immunohistochemical staining demonstrated down-regulation of the PCNA protein. Comparative western blot analysis revealed that COX-2 and Bcl2 were up-regulated and Bax was down-regulated compared with the AOM control group. Conclusion: The current study demonstrated that the Cu(BrHAP)(2) compound has promising chemoprotective activities that are evidenced by significant decreases in the numbers of ACFs in azoxymethane-induced colon cancer.	[Hajrezaie, Maryam; Hassandarvish, Pouya; Golbabapour, Shahram; NajiHussien, Abdrabuh; Almagrami, Amel Abdullah; Zahedifard, Maryam; Rouhollahi, Elham; Abdulla, Mahmood Ameen] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Hajrezaie, Maryam; Moghadamtousi, Soheil Zorofchian; Golbabapour, Shahram; Zahedifard, Maryam; Majid, Nazia Abdul] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Gwaram, Nura Suleiman; Ali, Hapipah Mohd] Univ Malaya, Dept Chem, Kuala Lumpur 59100, Malaysia; [Karimian, Hamed; Fani, Somaye; Kamalidehghan, Behnam] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Abdulla, MA (corresponding author), Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia.	ammeen@um.edu.my	MAJID, NAZIA ABDUL/B-9215-2010; Hassandarvish, Pouya/K-8112-2012; Karimian, Hamed/V-2933-2017; Gwaram, Nura Suleiman/AEQ-1882-2022; Karimian, Hamed/A-2324-2014; Kamalidehghan, Behnam/B-5401-2013	MAJID, NAZIA ABDUL/0000-0002-6817-8046; Hassandarvish, Pouya/0000-0003-0364-5587; Karimian, Hamed/0000-0002-8501-9864; Gwaram, Nura Suleiman/0000-0002-8423-6111; Karimian, Hamed/0000-0002-8501-9864; Kamalidehghan, Behnam/0000-0001-8530-8124	University of Malaya [PV069-2012A]	University of Malaya(Universiti Malaya)	The authors would like to thank the University of Malaya for supporting this project PV069-2012A, and HIR-MOHE (F000009-21001) from the Ministry of Higher Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsule S, 2006, J MED CHEM, V49, P7242, DOI 10.1021/jm060712l; Al-Numair NS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S4; Bawa S, 2009, INDIAN J CHEM B, V48, P142; Beaver LM, 2012, TOXICOL APPL PHARM, V263, P345, DOI 10.1016/j.taap.2012.07.007; Bocci V, 2013, ANTIOXID MED SCI, V2, P149; Carrer A, 2013, RECTAL CANC, P41; Carroll RE, 2009, GROWTH HORM IGF RES, V19, P447, DOI 10.1016/j.ghir.2009.02.001; Chakraborty A, 2010, EUR J PHARMACOL, V647, P1, DOI 10.1016/j.ejphar.2010.08.003; Chemicals dofo, 2005, OECD GUID TEST CHEM; da Silveira VC, 2008, J INORG BIOCHEM, V102, P1090, DOI 10.1016/j.jinorgbio.2007.12.033; Datta R, 2012, MAPANA J SCI MJS, V11, P57; DELEON MP, 1988, CANCER RES, V48, P4121; DESCHNER EE, 1983, J NATL CANCER I, V70, P279; Dou QP, 1999, DRUG RESIST UPDATE, V2, P215, DOI 10.1054/drup.1999.0095; Easmon J, 2001, J MED CHEM, V44, P2164, DOI 10.1021/jm000979z; Essa MM, 2012, BIOL TRACE ELEM RES, V147, P25, DOI 10.1007/s12011-011-9280-x; Faris MAIE, 2009, NUTR RES, V29, P355, DOI 10.1016/j.nutres.2009.05.005; Filomeni G, 2007, J BIOL CHEM, V282, P12010, DOI 10.1074/jbc.M610927200; Garber J.C., 2010, COMMITTEE UPDATE GUI, P248; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Ha HL, 2010, WORLD J GASTROENTERO, V16, P6035, DOI 10.3748/wjg.v16.i48.6035; Hajrezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051537; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Illan-Cabeza NA, 2008, J INORG BIOCHEM, V102, P647, DOI 10.1016/j.jinorgbio.2007.10.008; Jaaskelainen M, 2010, MOL CELL ENDOCRINOL, V330, P17, DOI 10.1016/j.mce.2010.07.020; Janakiram NB, 2009, CANCER PREV RES, V2, P52, DOI 10.1158/1940-6207.CAPR-08-0140; Khare S, 2008, NUTR CANCER, V60, P389, DOI 10.1080/01635580701883003; KOHNO H, 1999, J TOXICOL PATHOL, V12, P209; Komiya M, 2013, JPN J CLIN ONCOL; Kostova Irena, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P19, DOI 10.2174/187152006774755500; Kumar VK, 2010, ENVIRON TOXICOL PHAR, V29, P50, DOI 10.1016/j.etap.2009.09.006; Lee JS, 2012, INT J TOXICOL, V31, P70, DOI 10.1177/1091581811423845; Liang F, 2003, BIOORG MED CHEM LETT, V13, P2469, DOI 10.1016/S0960-894X(03)00489-X; LIPKIN M, 1983, CANCER RES, V43, P1899; Ma ZY, 2012, J INORG BIOCHEM, V117, P1, DOI 10.1016/j.jinorgbio.2012.08.007; Majumder A, 2006, POLYHEDRON, V25, P1753, DOI 10.1016/j.poly.2005.11.029; Milacic V, 2006, CANCER RES, V66, P10478, DOI 10.1158/0008-5472.CAN-06-3017; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Paul S, 2010, CARCINOGENESIS, V31, P1272, DOI 10.1093/carcin/bgq004; Poudyal D, 2012, CANCER PREV RES, V5, P685, DOI 10.1158/1940-6207.CAPR-11-0421; Qiao X, 2011, J INORG BIOCHEM, V105, P728, DOI 10.1016/j.jinorgbio.2011.01.004; Rey NA, 2009, J INORG BIOCHEM, V103, P1323, DOI 10.1016/j.jinorgbio.2009.05.008; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; Sheikhshoaie I, 2010, ARAB J SCI ENG, V35, P53; Sondhi SM, 2006, BIOORGAN MED CHEM, V14, P3758, DOI 10.1016/j.bmc.2006.01.054; Sujarania S, 2012, DIG J NANOMATER BIOS, V7, P1843; Suzuki R, 2004, CANCER LETT, V210, P159, DOI 10.1016/j.canlet.2004.01.034; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; Tammali R, 2009, CARCINOGENESIS, V30, P799, DOI 10.1093/carcin/bgn246; Vanco J, 2008, J INORG BIOCHEM, V102, P595, DOI 10.1016/j.jinorgbio.2007.10.003; Velmurugan B, 2010, MOL CARCINOGEN, V49, P641, DOI 10.1002/mc.20643; Xiao Y, 2008, INT J ONCOL, V33, P1073, DOI 10.3892/ijo_00000096; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zhang X, 2008, INT J MOL MED, V22, P677, DOI 10.3892/ijmm_00000072	55	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91246	10.1371/journal.pone.0091246	http://dx.doi.org/10.1371/journal.pone.0091246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618844	Green Published, gold			2022-12-27	WOS:000332842400066
J	Smith-Ryan, AE; Fultz, SN; Melvin, MN; Wingfield, HL; Woessner, MN				Smith-Ryan, Abbie E.; Fultz, Sarah N.; Melvin, Malia N.; Wingfield, Hailee L.; Woessner, Mary N.			Reproducibility and Validity of A-Mode Ultrasound for Body Composition Measurement and Classification in Overweight and Obese Men and Women	PLOS ONE			English	Article							AIR-DISPLACEMENT PLETHYSMOGRAPHY; SUBCUTANEOUS ADIPOSE-TISSUE; FAT-FREE MASS; WEIGHT-LOSS; US ADULTS; RELIABILITY; SKINFOLD; VALIDATION; PREVALENCE; THICKNESS	Identifying portable methods to measure body composition may be more advantageous than using body mass index (BMI) to categorize associated health consequences. Purpose: To compare the validity and reliability of a portable A-mode ultrasound (US) to a criterion three compartment model (3C) for the measurement of body composition. Methods: Forty-seven overweight and obese subjects participated in this study. Body composition was measured once via air displacement plethysmography for body density (Bd) and bioelectrical impedance spectroscopy for total body water (TBW) for the 3C calculations. Ultrasound measurements (BodyMetrix, Intelametrix) were made using an A mode, 2.5- MHz transmitter. All measurements were made on the right side of the body at 7 skinfold sites. The US software calculated percent body fat (%BF), fat mass (FM) and fat free mass (FFM) from the 7-site Jackson and Pollock equation. Results: %BF and FM, respectively, measured by the US (29.1 +/- 6.5%; 27.4 +/- 8.1 kg) was significantly lower compared to the 3C model (33.7 +/- 7.6%; 31.8 +/- 9.8 kg; p<0.0005). Fat free mass was significantly higher for the US (66.7 +/- 13.0 kg) compared to the 3C model (62.3 +/- 12.6; p = 0.001). The US demonstrated respectable reliability for %BF, FM, and FFM with intraclass correlation coefficients (ICC) ranging from 0.84-0.98 and standard error of the measurement (SEM) values and 2.2%BF, 1.9 kg, 1.9 kg, respectively. Discussion: The US was found to under predict %BF and FM with large deviations from the criterion (n = 10>4%BF error). While the US was not valid in this population, it was reliable producing results with minimal error, suggesting this technique may be effective for tracking changes in a weight loss or clinical setting.	[Smith-Ryan, Abbie E.; Fultz, Sarah N.; Melvin, Malia N.; Wingfield, Hailee L.; Woessner, Mary N.] Univ N Carolina, Dept Exercise & Sport Sci, Appl Physiol Lab, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Smith-Ryan, AE (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Appl Physiol Lab, Chapel Hill, NC 27515 USA.	abbsmith@email.unc.edu	Woessner, Mary/O-1050-2015	Woessner, Mary/0000-0001-7001-8407; Smith-Ryan, Abbie/0000-0002-5405-304X	Nutrition Obesity Research Center [P30DK056350]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	Nutrition Obesity Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the Nutrition Obesity Research Center (P30DK056350). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland TR, 2012, SPORTS MED, V42, P227, DOI 10.2165/11597140-000000000-00000; BELLISARI A, 1993, INT J OBESITY, V17, P475; Borrud Lori G, 2010, Vital Health Stat 11, P1; Bosy-Westphal A, 2008, OBESITY FACTS, V1, P319, DOI 10.1159/000176061; BULLEN BA, 1965, HUM BIOL, V37, P375; Da Silva, 2010, INTRO ULTRASOUND BOD; Das SK, 2003, AM J PHYSIOL-ENDOC M, V284, pE1080, DOI 10.1152/ajpendo.00185.2002; Demerath EW, 2002, INT J OBESITY, V26, P389, DOI 10.1038/sj.ijo.0801898; DEMPSTER P, 1995, MED SCI SPORT EXER, V27, P1692; FANELLI MT, 1984, AM J CLIN NUTR, V39, P703, DOI 10.1093/ajcn/39.5.703; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Ginde SR, 2005, OBES RES, V13, P1232, DOI 10.1038/oby.2005.146; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; JACKSON AS, 1978, RES QUART, V49, P546, DOI 10.1080/10671315.1978.10615569; Johnson Kelly E, 2012, Int J Exerc Sci, V5, P205; KUCZMARSKI RJ, 1987, AM J CLIN NUTR, V45, P717, DOI 10.1093/ajcn/45.4.717; Leahy S, 2012, ULTRASOUND MED BIOL, V38, P28, DOI 10.1016/j.ultrasmedbio.2011.10.011; LUKASKI HC, 1985, AM J CLIN NUTR, V41, P810, DOI 10.1093/ajcn/41.4.810; Matthie J, 1998, J APPL PHYSIOL, V84, P1801, DOI 10.1152/jappl.1998.84.5.1801; McCrory MA, 1998, J APPL PHYSIOL, V84, P1475, DOI 10.1152/jappl.1998.84.4.1475; Minderico CS, 2008, BRIT J NUTR, V99, P432, DOI 10.1017/S0007114507815789; Moon JR, 2009, CLIN NUTR, V28, P516, DOI 10.1016/j.clnu.2009.04.025; Moon JR, 2007, J INT SOC SPORT NUTR, V4, DOI 10.1186/1550-2783-4-16; Moon JR, 2009, EUR J APPL PHYSIOL, V105, P119, DOI 10.1007/s00421-008-0881-9; Muller W, 2013, BRIT J SPORT MED, V47, P1028, DOI 10.1136/bjsports-2013-092232; Pateyjohns IR, 2006, OBESITY, V14, P2064, DOI 10.1038/oby.2006.241; Pineau JC, 2007, ANN NUTR METAB, V51, P421, DOI 10.1159/000111161; Pineau JC, 2009, J ATHL TRAINING, V44, P142, DOI 10.4085/1062-6050-44.2.142; Ramsey R, 2012, J NUTR HEALTH AGING, V16, P26, DOI 10.1007/s12603-011-0085-6; Ritz P, 2007, DIABETES RES CLIN PR, V77, P405, DOI 10.1016/j.diabres.2007.01.007; Rolfe ED, 2010, OBESITY, V18, P625, DOI 10.1038/oby.2009.309; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SIRI WE, 1993, NUTRITION, V9, P481; Stolk RP, 2003, AM J CLIN NUTR, V77, P857, DOI 10.1093/ajcn/77.4.857; Stolk RP, 2001, INT J OBESITY, V25, P1346, DOI 10.1038/sj.ijo.0801734; Ulbricht L, 2012, IEEE ENG MED BIO, P1952, DOI 10.1109/EMBC.2012.6346337; Utter AC, 2008, MED SCI SPORT EXER, V40, P943, DOI 10.1249/MSS.0b013e318163f29e; Van der Ploeg GE, 2003, J APPL PHYSIOL, V94, P499, DOI 10.1152/japplphysiol.00436.2002; Verdich C, 2011, DIABETES METAB, V37, P222, DOI 10.1016/j.diabet.2010.10.007; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wang ZM, 1998, INT J OBESITY, V22, P329, DOI 10.1038/sj.ijo.0800590; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; [No title captured], DOI DOI 10.1155/2013/280713	45	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91750	10.1371/journal.pone.0091750	http://dx.doi.org/10.1371/journal.pone.0091750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618841	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000332842400124
J	Vergun, AA; Martirosyan, IA; Semyenova, SK; Omelchenko, AV; Petrosyan, VG; Lazebny, OE; Tokarskaya, ON; Korchagin, VI; Ryskov, AP				Vergun, Andrey A.; Martirosyan, Irena A.; Semyenova, Seraphima K.; Omelchenko, Andrey V.; Petrosyan, Varos G.; Lazebny, Oleg E.; Tokarskaya, Olga N.; Korchagin, Vitaly I.; Ryskov, Alexey P.			Clonal Diversity and Clone Formation in the Parthenogenetic Caucasian Rock Lizard Darevskia dahlia	PLOS ONE			English	Article							HETERONOTIA-BINOEI GEKKONIDAE; CNEMIDOPHORUS-NEOMEXICANUS; MICROSATELLITE LOCI; LACERTA; ORIGIN; AGE; EVOLUTION; POLYMORPHISM; SAURIA	The all-female Caucasian rock lizard species Darevskia dahli and other parthenogenetic species of this genus reproduce normally via true parthenogenesis. Previously, the genetic diversity of this species was analyzed using allozymes, mitochondrial DNA, and DNA fingerprint markers. In the present study, variation at three microsatellite loci was studied in 111 specimens of D. dahli from five populations from Armenia, and new information regarding clonal diversity and clone formation in D. dahli was obtained that suggests a multiple hybridization origin. All individuals but one were heterozygous at the loci studied. Based on specific allele combinations, 11 genotypes were identified among the individuals studied. Individuals with the same genotypes formed distinct clonal lineages: one major clone was represented by 72 individuals, an intermediate clone was represented by 21 individuals, and nine other clones were rare and represented by one or several individuals. A new approach based on the detection and comparison of genotype-specific markers formed by combinations of parental-specific markers was developed and used to identify at least three hybridization founder events that resulted in the initial formation of one major and two rare clones. All other clones, including the intermediate and seven rare clones, probably arose through postformation microsatellite mutations of the major clone. This approach can be used to identify hybridization founder events and to study clone formation in other unisexual taxa.	[Vergun, Andrey A.; Martirosyan, Irena A.; Semyenova, Seraphima K.; Tokarskaya, Olga N.; Korchagin, Vitaly I.; Ryskov, Alexey P.] Russian Acad Sci, Inst Gene Biol, Lab Genome Org, Moscow, Russia; [Vergun, Andrey A.] Moscow State Pedag Univ, Dept Organ & Biol Chem, Moscow 119435, Russia; [Omelchenko, Andrey V.; Petrosyan, Varos G.] Russian Acad Sci, Severtsov Inst Ecol & Evolut, Grp Bioinformat & Modeling Biol Proc, Moscow, Russia; [Lazebny, Oleg E.] Russian Acad Sci, Koltsov Inst Dev Biol, Dept Genet, Moscow, Russia	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Moscow State University of Education; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences	Ryskov, AP (corresponding author), Russian Acad Sci, Inst Gene Biol, Lab Genome Org, Moscow, Russia.	ryskov@mail.ru	Omelchenko, Andrey V/E-8887-2014; Lazebny, Oleg/R-9208-2016; Vergun, Andrey/I-4829-2016; Ryskov, Alexey/F-1179-2016	Omelchenko, Andrey V/0000-0003-4512-4413; Lazebny, Oleg/0000-0003-3136-0415; Vergun, Andrey/0000-0001-5255-7802; Petrosyan, Varos/0000-0002-7483-5102; Ryskov, Alexey/0000-0002-4159-0671	Russian Foundation for Basic Research [11-04-00754-a]; RAS; President RF Program [5233.2012.4, 2501.2014.4, 2349.2014.4]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); RAS(Russian Academy of SciencesRegione Sardegna); President RF Program	This study was partly supported by the Russian Foundation for Basic Research (grant No. 11-04-00754-a), the RAS Programs "Molecular and Cell Biology'' and "Living Nature,'' and the President RF Program (grant Nos. 5233.2012.4; 2501.2014.4; 2349.2014.4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakelyan M.S., 2011, HERPETOFAUNA ARMENIA; Badaeva TN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002730; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cole CJ, 1988, AM MUS NOVIT, V2905, P1; Darevsky I.S., 1967, ROCK LIZARDS CAUCASU, P1; DAREVSKY IS, 1958, DOKL AKAD NAUK SSSR+, V122, P730; Darevsky IS, 1985, BIOL REPTILIA, V15, P413; Davoyan A, 2007, THESIS YEREVAN; Davoyan AG, 2007, RUSS J GENET+, V43, P20, DOI 10.1134/S1022795407010036; DENSMORE LD, 1989, EVOLUTION, V43, P969, DOI 10.1111/j.1558-5646.1989.tb02543.x; DENSMORE LD, 1989, EVOLUTION, V43, P943, DOI 10.1111/j.1558-5646.1989.tb02541.x; Dessauer Herbert C., 1989, New York State Museum Bulletin, V466, P49; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Fu JZ, 2000, AMPHIBIA-REPTILIA, V21, P83, DOI 10.1163/156853800507291; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Kan NG, 1998, MOL BIOL+, V32, P672; Karakhanian A, 2002, J VOLCANOL GEOTH RES, V113, P319, DOI 10.1016/S0377-0273(01)00264-5; Korchagin VI, 2007, GENE, V392, P126, DOI 10.1016/j.gene.2006.11.020; KUPRIYAN.LA, 1974, TSITOLOGIYA+, V16, P1519; Lyapunova EA, 1988, RUSS J GENET, V9, P480; MacCulloch RD, 1997, BIOCHEM SYST ECOL, V25, P33, DOI 10.1016/S0305-1978(96)00085-3; MORITZ C, 1989, EVOLUTION, V43, P994, DOI 10.1111/j.1558-5646.1989.tb02545.x; MORITZ C, 1992, GENETICA, V87, P53, DOI 10.1007/BF00128773; Moritz C., 1989, New York State Museum Bulletin, V466, P87; MORITZ C, 1991, GENETICS, V129, P211; Murphy RW, 1997, GENETICA, V101, P125, DOI 10.1023/A:1018392603062; Parker E. Davis Jr, 1989, New York State Museum Bulletin, V466, P72; PARKER ED, 1984, HERPETOLOGICA, V40, P245; PARKER ED, 1979, AM ZOOL, V19, P753; PARKER ED, 1976, GENETICS, V84, P791; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Ryskov AR, 2008, INT REV CEL MOL BIO, V270, P319, DOI 10.1016/S1937-6448(08)01407-X; SAVIC I, 1979, J BIOGEOGR, V6, P363, DOI 10.2307/3038088; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; Sinclair EA, 2010, EVOLUTION, V64, P1346, DOI 10.1111/j.1558-5646.2009.00893.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarkhnishvili D, 2010, BIOL J LINN SOC, V101, P447, DOI 10.1111/j.1095-8312.2010.01498.x; TEMPLETON AR, 1992, GENETICS, V132, P619; UZZELL T, 1975, COPEIA, P204; Vergun AA, 2007, DOKL BIOCHEM BIOPHYS, V416, P278, DOI 10.1134/S1607672907050146; Vrijenhoek RC, 1989, EVOLUTION ECOLOGY UN, P19; VYAS DK, 1990, EVOLUTION, V44, P922, DOI 10.1111/j.1558-5646.1990.tb03814.x; WAHRMAN J, 1969, SCIENCE, V164, P82, DOI 10.1126/science.164.3875.82	43	18	21	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91674	10.1371/journal.pone.0091674	http://dx.doi.org/10.1371/journal.pone.0091674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618670	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400115
J	Zhou, F; Toivonen, H; King, RD				Zhou, Fang; Toivonen, Hannu; King, Ross D.			The Use of Weighted Graphs for Large-Scale Genome Analysis	PLOS ONE			English	Article							METABOLIC NETWORKS; EVOLUTION; MODEL; SETS	There is an acute need for better tools to extract knowledge from the growing flood of sequence data. For example, thousands of complete genomes have been sequenced, and their metabolic networks inferred. Such data should enable a better understanding of evolution. However, most existing network analysis methods are based on pair-wise comparisons, and these do not scale to thousands of genomes. Here we propose the use of weighted graphs as a data structure to enable large-scale phylogenetic analysis of networks. We have developed three types of weighted graph for enzymes: taxonomic (these summarize phylogenetic importance), isoenzymatic (these summarize enzymatic variety/redundancy), and sequence-similarity (these summarize sequence conservation); and we applied these types of weighted graph to survey prokaryotic metabolism. To demonstrate the utility of this approach we have compared and contrasted the large-scale evolution of metabolism in Archaea and Eubacteria. Our results provide evidence for limits to the contingency of evolution.	[Zhou, Fang] Univ Nottingham, Div Comp Sci, Ningbo, Zhejiang, Peoples R China; [Toivonen, Hannu] Univ Helsinki, Dept Comp Sci, FIN-00014 Helsinki, Finland; [King, Ross D.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England	University of Nottingham Ningbo China; University of Helsinki; University of Manchester	King, RD (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.	ross.king@manchester.ac.uk	Toivonen, Hannu TT/A-3657-2012	Toivonen, Hannu TT/0000-0003-1339-8022; King, Ross/0000-0001-7208-4387	Algorithmic Data Analysis (Algodan) Centre of Excellence of the Academy of Finland [118653]; European Commission; BBSRC [BB/J006955/1]; Bureau of Education; Bureau of Science and Technology, Ningbo Municipality; Biotechnology and Biological Sciences Research Council [BB/F008228/1, BB/J006955/1] Funding Source: researchfish; BBSRC [BB/F008228/1] Funding Source: UKRI	Algorithmic Data Analysis (Algodan) Centre of Excellence of the Academy of Finland(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bureau of Education; Bureau of Science and Technology, Ningbo Municipality; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Algorithmic Data Analysis (Algodan) Centre of Excellence of the Academy of Finland (Grant 118653), by the European Commission under the FP7 Collaborative Programme UNICELLSYS, by the BBSRC (BB/J006955/1), and by the Bureau of Education and Bureau of Science and Technology, Ningbo Municipality, under the IDIC Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, KDD 11 P 17 ACM SIGK; Arita M, 2004, P NATL ACAD SCI USA, V101, P1543, DOI 10.1073/pnas.0306458101; Borenstein E, 2008, P NATL ACAD SCI USA, V105, P14482, DOI 10.1073/pnas.0806162105; Freilich S, 2005, J MOL BIOL, V349, P745, DOI 10.1016/j.jmb.2005.04.027; Gould S. J., 1990, WONDERFUL LIFE BURGE; Holme P, 2009, J R SOC INTERFACE, V6, P1027, DOI 10.1098/rsif.2008.0489; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; King RD, 2009, SCIENCE, V324, P85, DOI 10.1126/science.1165620; Kreimer A, 2008, P NATL ACAD SCI USA, V105, P6976, DOI 10.1073/pnas.0712149105; Lacroix V, 2008, IEEE ACM T COMPUT BI, V5, P594, DOI 10.1109/TCBB.2008.79; Morris S. C., 2000, CRUCIBLE CREATION BU; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Peregrin-Alvarez JM, 2003, GENOME RES, V13, P422, DOI 10.1101/gr.246903; Ridley M., 1993, EVOLUTION; Whelan KE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-97; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787	19	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e89618	10.1371/journal.pone.0089618	http://dx.doi.org/10.1371/journal.pone.0089618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619061	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400007
J	Khurana, P; Aggarwal, A; Mitra, S; Italia, YM; Saraswathy, KN; Chandrasekar, A; Kshatriya, GK				Khurana, Priyanka; Aggarwal, Aastha; Mitra, Siuli; Italia, Yazdi M.; Saraswathy, Kallur N.; Chandrasekar, Adimoolam; Kshatriya, Gautam K.			Y Chromosome Haplogroup Distribution in Indo-European Speaking Tribes of Gujarat, Western India	PLOS ONE			English	Article							CASTE POPULATIONS; DNA; DIVERSITY; PEOPLE; PLEISTOCENE; PERSPECTIVE; AFFINITIES; RESOLUTION; ORIGINS; POLYMORPHISMS	The present study was carried out in the Indo-European speaking tribal population groups of Southern Gujarat, India to investigate and reconstruct their paternal population structure and population histories. The role of language, ethnicity and geography in determining the observed pattern of Y haplogroup clustering in the study populations was also examined. A set of 48 bi-allelic markers on the non-recombining region of Y chromosome (NRY) were analysed in 284 males; representing nine Indo-European speaking tribal populations. The genetic structure of the populations revealed that none of these groups was overtly admixed or completely isolated. However, elevated haplogroup diversity and F-ST value point towards greater diversity and differentiation which suggests the possibility of early demographic expansion of the study groups. The phylogenetic analysis revealed 13 paternal lineages, of which six haplogroups: C5, H1a*, H2, J2, R1a1* and R2 accounted for a major portion of the Y chromosome diversity. The higher frequency of the six haplogroups and the pattern of clustering in the populations indicated overlapping of haplogroups with West and Central Asian populations. Other analyses undertaken on the population affiliations revealed that the Indo-European speaking populations along with the Dravidian speaking groups of southern India have an influence on the tribal groups of Gujarat. The vital role of geography in determining the distribution of Y lineages was also noticed. This implies that although language plays a vital role in determining the distribution of Y lineages, the present day linguistic affiliation of any population in India for reconstructing the demographic history of the country should be considered with caution.	[Khurana, Priyanka] Dr Hari Singh Gour Vishwavidyalaya, Sch Appl Sci, Dept Anthropol, Sagar, Madhya Pradesh, India; [Aggarwal, Aastha] Publ Hlth Fdn India, South Asia Network Chron Dis, Delhi, India; [Mitra, Siuli; Saraswathy, Kallur N.; Kshatriya, Gautam K.] Univ Delhi, Dept Anthropol, Delhi 110007, India; [Italia, Yazdi M.] Valsad Raktdan Kendra, Valsad, Gujarat, India; [Chandrasekar, Adimoolam] Anthropol Survey India, Southern Reg Ctr, Mysore, Karnataka, India	Dr. Hari Singh Gour University; Public Health Foundation of India; University of Delhi	Kshatriya, GK (corresponding author), Univ Delhi, Dept Anthropol, Delhi 110007, India.	g26_51@yahoo.co.in	Aggarwal, Aastha/AAT-1347-2020	Aggarwal, Aastha/0000-0002-8180-8743	Department of Biotechnology (DBT) [BT/PR9840/MED/12/366/2007]	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India)	The work was funded by Department of Biotechnology (DBT) grant (vide letter BT/PR9840/MED/12/366/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Barbujani G, 2000, HUM BIOL, V72, P133; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Brahmachari SK, 2008, J GENET, V87, P3; Cameron D, 2004, INT J OSTEOARCHAEOL, V14, P419, DOI 10.1002/oa.725; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1992, P NATL ACAD SCI USA, V89, P5620, DOI 10.1073/pnas.89.12.5620; Census, 2011, CENS IND WEBS; Census of India, 2001, REG GEN CENS COMM; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Chaubey G, 2008, INT J HUM GENET, V8, P41, DOI 10.1080/09723757.2008.11886018; Chaubey G, 2011, MOL BIOL EVOL, V28, P1013, DOI 10.1093/molbev/msq288; Cordaux R, 2004, CURR BIOL, V14, P231, DOI 10.1016/j.cub.2004.01.024; Cordaux R, 2003, EUR J HUM GENET, V11, P253, DOI 10.1038/sj.ejhg.5200949; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flores C, 2005, J HUM GENET, V50, P435, DOI 10.1007/s10038-005-0274-4; FUCHS S, 1964, TRIBAL LIFE GUJARAT, P263; GADGIL M, 1983, ANN HUM BIOL, V10, P465, DOI 10.1080/03014468300006671; Gadgil M., 1997, INDIAN HUMAN HERITAG, P100; Gadgil M., 1998, INDIAN HUMAN HERITAG, P100; Haber M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034288; Harpending H.C., 1982, BIOCH ASPECTS EVOLUT, P213; JOSHI NV, 1993, CURR SCI INDIA, V64, P10; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karafet TM, 2002, HUM BIOL, V74, P761, DOI 10.1353/hub.2003.0006; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; KENNEDY KAR, 1989, CURR ANTHROPOL, V30, P394, DOI 10.1086/203757; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kshatriya GK, 2011, ANN HUM BIOL, V38, P583, DOI 10.3109/03014460.2011.577455; Kshatriya GK, 2010, GENET TEST MOL BIOMA, V14, P215, DOI 10.1089/gtmb.2009.0166; Kumar V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-47; Majumder PP, 1999, EUR J HUM GENET, V7, P435, DOI 10.1038/sj.ejhg.5200317; Majumder PP, 1998, EVOL ANTHROPOL, V6, P100, DOI 10.1002/(SICI)1520-6505(1998)6:3<100::AID-EVAN4>3.0.CO;2-I; MALHOTRA KC, 1993, HUMAN POPULATION GENETICS, P207; Meenakshi K., 1995, RECENT PERSPECTIVES, P53; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Misra V.N., 1990, MAN ENV, V14, P17; PATTANAYAK DP, 1998, INDIAN HUMAN HERITAG, P95; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Rai N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048477; RATNAGAR S, 1995, RECENT PERSPECTIVES, P1; Ray N., 1973, NATL INDIA; Regueiro M, 2006, HUM HERED, V61, P132, DOI 10.1159/000093774; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Roychoudhury S, 2001, HUM GENET, V109, P339, DOI 10.1007/s004390100577; Sahoo S, 2006, P NATL ACAD SCI USA, V103, P843, DOI 10.1073/pnas.0507714103; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Sharma G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032546; SINGH KS, 1993, CURR SCI INDIA, V64, P5; SONAKIA A, 1985, AM ANTHROPOL, V87, P612, DOI 10.1525/aa.1985.87.3.02a00060; Thangaraj K, 2003, CURR BIOL, V13, P86, DOI 10.1016/S0960-9822(02)01336-2; Thangaraj K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015283; Thapar, 1966, HIST INDIA DISCOVERY; Trivedi R, 2008, INT J HUM GENET, V8, P97, DOI 10.1080/09723757.2008.11886023; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Zhong H, 2010, J HUM GENET, V55, P428, DOI 10.1038/jhg.2010.40	59	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90414	10.1371/journal.pone.0090414	http://dx.doi.org/10.1371/journal.pone.0090414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614885	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300024
J	Evans, MF; Peng, ZH; Clark, KM; Adamson, CSC; Ma, XJ; Wu, XY; Wang, HW; Luo, YL; Cooper, K				Evans, Mark F.; Peng, Zhihua; Clark, Kelli M.; Adamson, Christine S. -C.; Ma, Xiao-Jun; Wu, Xingyong; Wang, Hongwei; Luo, Yuling; Cooper, Kumarasen			HPV E6/E7 RNA In Situ Hybridization Signal Patterns as Biomarkers of Three-Tier Cervical Intraepithelial Neoplasia Grade	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; GENE-EXPRESSION; LIFE-CYCLE; RISK; TRANSCRIPTS; MANAGEMENT; REGRESSION; BIOLOGY; CANCER; SENSE	Cervical lesion grading is critical for effective patient management. A three-tier classification (cervical intraepithelial neoplasia [CIN] grade 1, 2 or 3) based on H&E slide review is widely used. However, for reasons of considerable inter-observer variation in CIN grade assignment and for want of a biomarker validating a three-fold stratification, CAP-ASCCP LAST consensus guidelines recommend a two-tier system: low-or high-grade squamous intraepithelial lesions (LSIL or HSIL). In this study, high-risk HPV E6/E7 and p16 mRNA expression patterns in eighty-six CIN lesions were investigated by RNAscope chromogenic in situ hybridization (CISH). Specimens were also screened by immunohistochemistry for p16(INK4a) (clone E6H4), and by tyramide-based CISH for HPV DNA. HPV genotyping was performed by GP5+/6+ PCR combined with cycle-sequencing. Abundant high-risk HPV RNA CISH signals were detected in 26/32 (81.3%) CIN 1, 22/22 (100%) CIN 2 and in 32/32 (100%) CIN 3 lesions. CIN 1 staining patterns were typified (67.7% specimens) by abundant diffusely staining nuclei in the upper epithelial layers; CIN 2 lesions mostly (66.7%) showed a combination of superficial diffuse-stained nuclei and multiple dot-like nuclear and cytoplasmic signals throughout the epithelium; CIN 3 lesions were characterized (87.5%) by multiple dot-like nuclear and cytoplasmic signals throughout the epithelial thickness and absence/scarcity of diffusely staining nuclei (trend across CIN grades: P<0.0001). These data are consistent with productive phase HPV infections exemplifying CIN 1, transformative phase infections CIN 3, whereas CIN 2 shows both productive and transformative phase elements. Three-tier data correlation was not found for the other assays examined. The dual discernment of diffuse and/or dot-like signals together with the assay's high sensitivity for HPV support the use of HPV E6/E7 RNA CISH as an adjunct test for deciding lesion grade when CIN 2 grading may be beneficial (e.g. among young women) or when 'LSIL vs. HSIL' assignment is equivocal.	[Evans, Mark F.; Peng, Zhihua; Clark, Kelli M.; Adamson, Christine S. -C.; Cooper, Kumarasen] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Clark, Kelli M.; Cooper, Kumarasen] Fletcher Allen Hlth Care, Dept Pathol & Lab Med, Burlington, VT USA; [Ma, Xiao-Jun; Wu, Xingyong; Wang, Hongwei; Luo, Yuling] Adv Cell Diagnost Inc, Hayward, CA USA	University of Vermont; University of Vermont Medical Center	Evans, MF (corresponding author), Univ Vermont, Dept Pathol, Burlington, VT 05405 USA.	mark.evans@med.uvm.edu	Evans, Mark/GYU-3450-2022		University of Vermont Department of Pathology	University of Vermont Department of Pathology	This study was supported by the University of Vermont Department of Pathology. RNAscope in situ hybridization was performed by Advanced Cell Diagnostics (ACD), Hayward, CA at no charge. Authors Xiao-Jun Ma, Xingyong Wu, Hongwei Wang and Yuling Luo are employees and shareholders of ACD. XJM and YL contributed reagents, materials and technical consultancy on the performance of RNAscope assays, which were performed by XW and HW at ACDs facility in Hayward, CA. XJM contributed text for the technical sections of the manuscript. ACD employees had no role in study design, data interpretation, control over manuscript contents or decision to publish.	Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Chaiwongkot A, 2013, INT J CANCER, V132, P2087, DOI 10.1002/ijc.27906; COOPER K, 1991, J CLIN PATHOL, V44, P400, DOI 10.1136/jcp.44.5.400; Crum C, US CAN AC PATH USCAP; Crum CP, 2008, AM J CLIN PATHOL, V130, P162, DOI 10.1309/GCVB5C4KFV7TFC7F; Darragh TM, 2013, INT J GYNECOL PATHOL, V32, P76, DOI 10.1097/PGP.0b013e31826916c7; Doeberitz MV, 2012, EXPERT REV PROTEOMIC, V9, P149, DOI [10.1586/epr.12.13, 10.1586/EPR.12.13]; Doeberitz MV, 2009, ARCH MED RES, V40, P435, DOI 10.1016/j.arcmed.2009.06.002; Doorbar J, 2007, DIS MARKERS, V23, P297, DOI 10.1155/2007/613150; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; DURST M, 1992, VIROLOGY, V189, P132, DOI 10.1016/0042-6822(92)90688-L; Evans MF, 2005, BMC CLIN PATHOL, V5, DOI 10.1186/1472-6890-5-10; Evans MF, 2003, EUR J GYNAECOL ONCOL, V24, P373; Evans MF, 2002, MODERN PATHOL, V15, P1339, DOI 10.1038/modpathol.3880698; Fukuchi E, 2013, J LOW GENIT TRACT DI, V17, P255, DOI 10.1097/LGT.0b013e31826ca4d9; Galgano MT, 2010, AM J SURG PATHOL, V34, P1077, DOI 10.1097/PAS.0b013e3181e8b2c4; HIGGINS GD, 1992, CANCER-AM CANCER SOC, V70, P136, DOI 10.1002/1097-0142(19920701)70:1<136::AID-CNCR2820700123>3.0.CO;2-2; HIGGINS GD, 1991, J GEN VIROL, V72, P885, DOI 10.1099/0022-1317-72-4-885; HIGGINS GD, 1992, J GEN VIROL, V73, P2047, DOI 10.1099/0022-1317-73-8-2047; HIGGINS GD, 1991, CANCER-AM CANCER SOC, V68, P561, DOI 10.1002/1097-0142(19910801)68:3<561::AID-CNCR2820680320>3.0.CO;2-R; HUSMAN AMD, 1995, BRIT J CANCER, V72, P412, DOI 10.1038/bjc.1995.347; McAllum B, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.069; Moscicki AB, 2010, OBSTET GYNECOL, V116, P1373, DOI 10.1097/AOG.0b013e3181fe777f; Noehr B, 2009, OBSTET GYNECOL, V114, P1232, DOI 10.1097/AOG.0b013e3181bf1ef2; Sadler L, 2004, JAMA-J AM MED ASSOC, V291, P2100, DOI 10.1001/jama.291.17.2100; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; STOLER MH, 1992, HUM PATHOL, V23, P117, DOI 10.1016/0046-8177(92)90232-R; STOLER MH, 1986, HUM PATHOL, V17, P1250, DOI 10.1016/S0046-8177(86)80569-X; Stoler MH, US CAN AC PATH USCAP; Syrjanen K, 2012, EUR J GYNAECOL ONCOL, V33, P5; Syrjanen K, 2009, CME J GYNECOL ONCOL, V14, P4; Triglia RD, 2009, GYNECOL ONCOL, V112, P114, DOI 10.1016/j.ygyno.2008.09.047; VORMWALDDOGAN V, 1992, J GEN VIROL, V73, P1833, DOI 10.1099/0022-1317-73-7-1833; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Waxman AG, 2012, OBSTET GYNECOL, V120, P1465, DOI [10.1097/AOG.0b013e31827001d5, http://10.1097/AOG.0b013e31827001d5]; Zeng SY, 2012, EUR J GYNAECOL ONCOL, V33, P257	37	35	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91142	10.1371/journal.pone.0091142	http://dx.doi.org/10.1371/journal.pone.0091142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625757	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300058
J	Sun, SJ; Han, YY; Liu, J; Fang, Y; Tian, Y; Zhou, JF; Ma, D; Wu, P				Sun, Shujuan; Han, Yingyan; Liu, Jia; Fang, Yong; Tian, Yuan; Zhou, Jianfeng; Ma, Ding; Wu, Peng			Trichostatin A Targets the Mitochondrial Respiratory Chain, Increasing Mitochondrial Reactive Oxygen Species Production to Trigger Apoptosis in Human Breast Cancer Cells	PLOS ONE			English	Article							HISTONE-DEACETYLASE INHIBITORS; THIOREDOXIN; THERAPY; DRUGS; TRANSCRIPTION; METABOLISM; INDUCTION; PATHWAY; GROWTH	Aim: Histone deacetylase inhibitors (HDACIs)-based therapies have stimulated interest via their anti-tumor activities, including apoptosis induction, cell cycle arrest, cell differentiation, and autophagy. However, the mechanisms of HDACI-associated anti-tumor activity are not yet clearly defined. The aim of this study was to explore the key events of Trichostatin A (TSA), a classic HDACI agent, against breast cancer cells. Methods: The MCF-7, MDA-MB-231 and MCF-10A cell lines were evaluated with colony-forming and cell viability assays. Apoptosis and cell cycle distribution were detected by flow cytometry. Mitochondrial function was measured with biochemical assays, flow cytometry and transmission electron microscopy. Results: TSA inhibited breast cancer cell viability and proliferation, without affecting MCF-10A cell. TSA-induced breast cancer cell apoptosis was initiated by G2-M arrest and depended on mitochondrial reactive oxygen species (ROS) produced subsequent to reduced mitochondrial respiratory chain activity. The enhanced mitochondrial ROS production and apoptosis in cancer cells were markedly attenuated by antioxidants, such as N-acetyl cysteine (NAC), reduced glutathione (GSH) and Vitamin C. Conclusion: The present study demonstrated that TSA-induced cell death by arresting cell cycle in G2-M phase and was dependent on production of mitochondria-derived ROS, which was derived from impaired mitochondrial respiratory chain.	[Sun, Shujuan; Han, Yingyan; Liu, Jia; Fang, Yong; Tian, Yuan; Zhou, Jianfeng; Ma, Ding; Wu, Peng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Ma, D (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Peoples R China.	dma@tjh.tjmu.edu.cn; pengwu8626@126.com	wu, peng/M-1812-2019	wu, peng/0000-0002-4016-6641	National Science Foundation of China [81372806, 81101962, 81101965, 81202060, 20120142120049]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by Grant Supports: National Science Foundation of China (81372806; 81101962; 81101965; 81202060; 20120142120049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Fischer D, 2011, NAT NEUROSCI, V14, P1260, DOI 10.1038/nn.2916; Bernhard D, 1999, FASEB J, V13, P1991, DOI 10.1096/fasebj.13.14.1991; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; de la Vega L, 2012, MOL CELL, V46, P472, DOI 10.1016/j.molcel.2012.03.003; Frew AJ, 2008, P NATL ACAD SCI USA, V105, P11317, DOI 10.1073/pnas.0801868105; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; Ikeda K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3147; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Johnstone RW, 2003, CANCER CELL, V4, P13, DOI 10.1016/S1535-6108(03)00165-X; Lustberg MB, 2011, CURR BREAST CANCER R, V3, P34, DOI 10.1007/s12609-010-0034-0; Ma XL, 2010, CLIN CANCER RES, V16, P5165, DOI 10.1158/1078-0432.CCR-09-3174; Marks PA, 2005, EXPERT OPIN INV DRUG, V14, P1497, DOI 10.1517/13543784.14.12.1497; Mo QQ, 2013, ACTA PHARMACOL SIN, V34, P541, DOI 10.1038/aps.2012.197; Pandolfi PP, 2001, ONCOGENE, V20, P3116, DOI 10.1038/sj.onc.1204299; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Rajendran P, 2011, CRIT REV BIOCHEM MOL, V46, P181, DOI 10.3109/10409238.2011.557713; Rosato RR, 2003, CANCER RES, V63, P3637; Ruefli AA, 2001, P NATL ACAD SCI USA, V98, P10833, DOI 10.1073/pnas.191208598; Schmidt K, 1999, ARCH PHARM, V332, P353, DOI 10.1002/(SICI)1521-4184(199910)332:10<353::AID-ARDP353>3.0.CO;2-X; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Stearman RS, 2007, MOL CANCER RES, V5, P295, DOI 10.1158/1541-7786.MCR-06-0221; TSUJI N, 1976, J ANTIBIOT, V29, P1, DOI 10.7164/antibiotics.29.1; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Ungerstedt JS, 2005, P NATL ACAD SCI USA, V102, P673, DOI 10.1073/pnas.0408732102; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wu P, 2010, CELL DEATH DIFFER, V17, P109, DOI 10.1038/cdd.2009.142; Xu WS, 2006, P NATL ACAD SCI USA, V103, P15540, DOI 10.1073/pnas.0607518103; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102; Zhu Y, 2013, ONCOGENE IN PRESS	31	31	31	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91610	10.1371/journal.pone.0091610	http://dx.doi.org/10.1371/journal.pone.0091610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626188	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300108
J	Hoffmeister, MC; Briceno, JDC; Nielsen, SN				Chavez Hoffmeister, Martin; Carrillo Briceno, Jorge D.; Nielsen, Sven N.			The Evolution of Seabirds in the Humboldt Current: New Clues from the Pliocene of Central Chile	PLOS ONE			English	Article							FOSSIL PENGUINS; SOUTHERN; MIOCENE; SPHENISCIFORMES; PERU; AVES; BIOGEOGRAPHY; SPHENISCUS; PATTERNS; NORTHERN	Background: During the last decade, new Neogene fossil assemblages from South America have revealed important clues about the evolution of seabird faunas in one of the major upwelling systems of the world: the Humboldt Current. However, most of this record comes from arid Northern Chile and Southern Peru and, in consequence, our knowledge of the evolutionary history of seabirds in the temperate transitional zone is negligible. A new Late Pliocene assemblage of fossil birds from the coastal locality of Horcon in Central Chile offers a unique opportunity to fill this gap. Principal Findings: Isolated bones of a medium-sized penguin are the most abundant bird remains. Morphological and cladistic analyses reveal that these specimens represent a new species of crested penguin, Eudyptes calauina sp. nov. Eudyptes is a penguin genus that inhabit temperate and subantarctic regions and currently absent in central Chile. Additionally, a partial skeleton of a small species of cormorant and a partial tarsometatarsus of a sooty shearwater have been identified. Conclusion/Significance: The Horcon fossils suggest the existence of a mixed avifauna in central Chile during the Pliocene in concordance with the latitudinal thermal gradient. This resembles the current assemblages from the transitional zone, with the presence of species shared with Northern Chile and Southern Peru and a previously unrecorded penguin currently absent from the Humboldt System but present in the Magellanic region. Comparison of Pliocene seabird diversity across the Pacific coast of South America shows that the Horcon avifauna represents a distinctive assemblage linking the living faunas with the Late Miocene ones. A comparison with the fossil record near the Benguela Current (west coast of southern Africa) suggests that the thermic gradient could play an important role in the preservation of a higher diversity of cold/temperate seabirds in the Humboldt Current.	[Chavez Hoffmeister, Martin] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Carrillo Briceno, Jorge D.] Univ Zurich, Palaeontol Inst & Museum, Zurich, Switzerland; [Chavez Hoffmeister, Martin; Nielsen, Sven N.] Univ Austral Chile, Inst Ciencias Ambientales & Evolutivas, Valdivia, Chile	University of Bristol; University of Zurich; Universidad Austral de Chile	Hoffmeister, MC (corresponding author), Univ Bristol, Sch Earth Sci, Bristol, Avon, England.	glmfch@bristol.ac.uk	Nielsen, Sven N/A-2187-2009	Nielsen, Sven N/0000-0003-2064-8050; Chavez Hoffmeister, Martin/0000-0001-5940-5983; Carrillo Briceno, Jorge Domingo/0000-0002-8652-7692	Direccion de Investigacion y Desarrollo (DID) of the Universidad Austral de Chile	Direccion de Investigacion y Desarrollo (DID) of the Universidad Austral de Chile	The Direccion de Investigacion y Desarrollo (DID) of the Universidad Austral de Chile provided funding to cover part of the Publication Fees of the present paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Acosta Hospitaleche C, 2006, REV ESPANOLA PALEONT, V21, P115; Acosta Hospitaleche Carolina, 2005, Revista Espanola de Paleontologia, V20, P1; Alheit J, 2004, PROG OCEANOGR, V60, P201, DOI 10.1016/j.pocean.2004.02.006; Avery Graham, 2011, Transactions of the Royal Society of South Africa, V66, P14, DOI 10.1080/0035919X.2011.564490; Baker AJ, 2006, P ROY SOC B-BIOL SCI, V273, P11, DOI 10.1098/rspb.2005.3260; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Camus PA, 2001, REV CHIL HIST NAT, V74, P587, DOI 10.4067/S0716-078X2001000300008; Carrillo-Briceno JD, 2013, REV CHIL HIST NAT, V86, P191, DOI 10.4067/S0716-078X2013000200008; Chandler RM, 1990, ORNITHOL MONOGR, V44, P73; Chavez M., 2007, B I FRANCAIS ETUDES, V36, P175; Chavez Martin, 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P551; Chavez MF, 2007, REV CHIL HIST NAT, V80, P255; Cheneval Jacques, 1993, Documents des Laboratoires de Geologie Lyon, V125, P85; Crawford RJM, 2006, AFR J MAR SCI, V28, P553, DOI 10.2989/18142320609504205; Davis LS., 2003, PENGUINS; De Muizon C, 2004, J VERTEBR PALEONTOL, V24, P398, DOI 10.1671/2429b; DeFrance SD, 2005, J ARCHAEOL SCI, V32, P1131, DOI 10.1016/j.jas.2005.03.001; DeVries Thomas J., 1997, Tulane Studies in Geology and Paleontology, V30, P125; DeVries TJ, 2005, VELIGER, V47, P277; DeVries TJ, 1997, J PALEONTOL, V71, P610, DOI 10.1017/S0022336000040099; Dowsett HJ, 2009, CLIM PAST, V5, P769, DOI 10.5194/cp-5-769-2009; Dowsett HJ, 2012, NAT CLIM CHANGE, V2, P365, DOI [10.1038/NCLIMATE1455, 10.1038/nclimate1455]; DUFFY DC, 1983, BIOL CONSERV, V26, P227, DOI 10.1016/0006-3207(83)90075-7; Ehret DJ, 2012, PALAEONTOLOGY, V55, P1139, DOI 10.1111/j.1475-4983.2012.01201.x; Emslie SD, 2003, P BIOL SOC WASH, V116, P308; Fedorov AV, 2013, NATURE, V496, P43, DOI 10.1038/nature12003; Forsythe R.D., 1985, Revista Geologica de Chile, V25-26, P3; Frassinetti C. Daniel, 2000, Boletin del Museo Nacional de Historia Natural Chile, V49, P131; Garcia P, 2013, PENGUINS NATURAL HIS; Gohlich UB, 2007, ACTA PALAEONTOL POL, V52, P285; Griffin M, 2008, J SYST PALAEONTOL, V6, P251, DOI 10.1017/S1477201907002374; HARRISON P, 1985, SEABIRDS IDENTIFICAT; Hartmann-Schroder VG, 1962, MITTEILUNGEN HAMBU S, V60, P270; Herm D., 1969, Zitteliana, V2, P1; Hospitaleche CA, 2007, ACTA PALAEONTOL POL, V52, P299; Hospitaleche CA, 2006, REV GEOL CHILE, V33, P327; Howard H., 1971, Contr Sci, VNo. 217, P1; Howard H, 1949, CARNEGIE I WASHINGTO, V584, P179; KNOX GA, 1960, PROC R SOC SER B-BIO, V152, P577, DOI 10.1098/rspb.1960.0068; Ksepka DT, 2006, CLADISTICS, V22, P412, DOI 10.1111/j.1096-0031.2006.00116.x; Ksepka DT, 2012, J VERTEBR PALEONTOL, V32, P235, DOI 10.1080/02724634.2012.652051; Ksepka DT, 2012, P ROY SOC B-BIOL SCI, V279, P1027, DOI 10.1098/rspb.2011.1592; Ksepka DT, 2010, B AM MUS NAT HIST, P1; Ksepka DT., 2011, LIVING DINOSAURS EVO, P155, DOI DOI 10.1002/9781119990475.CH6; Le Roux JP, 2012, SEDIMENT GEOL, V247, P1, DOI 10.1016/j.sedgeo.2011.12.014; LIVEZEY BC, 1989, J ZOOL, V219, P269, DOI 10.1111/j.1469-7998.1989.tb02582.x; Mayr G, 2010, J VERTEBR PALEONTOL, V30, P1313, DOI 10.1080/02724634.2010.501465; Nielsen SN, 2013, PALAEONTOL Z, V87, P33, DOI 10.1007/s12542-012-0146-0; Oehler DA, 2008, WILSON J ORNITHOL, V120, P575, DOI 10.1676/07-108.1; OLSON S L, 1985, Annals of the South African Museum, V95, P123; OLSON SL, 1983, S AFR J SCI, V79, P399; Sallaberry M, 2006, BIOL RES SB, V39, pR; Schlatter Roberto P., 1999, Estudios Oceanologicos, V18, P25; SIMPSON G G, 1972, Records of the Canterbury Museum, V9, P159; STUCCHI M, 2005, B SOC GEOLOGICA PERU, V100, P67; Stucchi M, 2003, B SOC GEOLOGICA PERU, V96, P117; STUCCHI M, 2003, B SOC GEOLOGICA PERU, V95, P75; Stucchi M, 2007, 4 EUR M PAL STRAT LA; Stucchi M., 2002, B SOC GEOL PERU, V94, P19; Subramanian S, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0748; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tavera J, 1960, FACULTAD CIENCIAS FI, V17, P346; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; THOMAS H, 1958, I INVESTIGACIONES GE, V2, P1; Tumarkin-Deratzian AR, 2006, ZOOL J LINN SOC-LOND, V148, P133, DOI 10.1111/j.1096-3642.2006.00232.x; Urbina M, 2005, B SOC GEOLOGICA PERU, V99, P41; Valenzuela-Toro AM, 2013, J VERTEBR PALEONTOL, V33, P216, DOI 10.1080/02724634.2012.710282; Walsh S.A., 2006, HIST BIOL, V18, P119, DOI [DOI 10.1080/08912960600640796, 10.1080/08912960600640796]; Walsh SA, 2001, J VERTEBR PALEONTOL, V21, P484, DOI 10.1671/0272-4634(2001)021[0484:ANNMAA]2.0.CO;2; Warheit Kenneth I., 2002, P17; WARHEIT KI, 1992, SYST BIOL, V41, P345, DOI 10.2307/2992571; WARHEIT KI, 1992, PALEOBIOLOGY, V18, P401, DOI 10.1017/S0094837300010976; Weimerskirch H, 2012, MAR ECOL PROG SER, V458, P231, DOI 10.3354/meps09752; Worthy Trevor H., 1997, New Zealand Natural Sciences, V23, P71	74	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90043	10.1371/journal.pone.0090043	http://dx.doi.org/10.1371/journal.pone.0090043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621560	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000332845300012
J	Dieringer, MA; Deimling, M; Santoro, D; Wuerfel, J; Madai, VI; Sobesky, J; von Knobelsdorff-Brenkenhoff, F; Schulz-Menger, J; Niendorf, T				Dieringer, Matthias A.; Deimling, Michael; Santoro, Davide; Wuerfel, Jens; Madai, Vince I.; Sobesky, Jan; von Knobelsdorff-Brenkenhoff, Florian; Schulz-Menger, Jeanette; Niendorf, Thoralf			Rapid Parametric Mapping of the Longitudinal Relaxation Time T-1 Using Two-Dimensional Variable Flip Angle Magnetic Resonance Imaging at 1.5 Tesla, 3 Tesla, and 7 Tesla	PLOS ONE			English	Article							RF-FIELD INHOMOGENEITIES; SINGLE-PULSE OBSERVATION; MULTIPLE-SCLEROSIS; HUMAN BRAIN; WHITE-MATTER; IN-VIVO; RADIOFREQUENCY FIELD; LESION MORPHOLOGY; T1 RELAXATION; SPIN-LATTICE	Introduction: Visual but subjective reading of longitudinal relaxation time (T-1) weighted magnetic resonance images is commonly used for the detection of brain pathologies. For this non-quantitative measure, diagnostic quality depends on hardware configuration, imaging parameters, radio frequency transmission field (B-1(+)) uniformity, as well as observer experience. Parametric quantification of the tissue T-1 relaxation parameter offsets the propensity for these effects, but is typically time consuming. For this reason, this study examines the feasibility of rapid 2D T-1 quantification using a variable flip angles (VFA) approach at magnetic field strengths of 1.5 Tesla, 3 Tesla, and 7 Tesla. These efforts include validation in phantom experiments and application for brain T-1 mapping. Methods: T-1 quantification included simulations of the Bloch equations to correct for slice profile imperfections, and a correction for B-1(+). Fast gradient echo acquisitions were conducted using three adjusted flip angles for the proposed T-1 quantification approach that was benchmarked against slice profile uncorrected 2D VFA and an inversion-recovery spin-echo based reference method. Brain T-1 mapping was performed in six healthy subjects, one multiple sclerosis patient, and one stroke patient. Results: Phantom experiments showed a mean T-1 estimation error of (-63 +/- 1.5)% for slice profile uncorrected 2D VFA and (0.2 +/- 1.4)% for the proposed approach compared to the reference method. Scan time for single slice T-1 mapping including B-1(+) mapping could be reduced to 5 seconds using an in-plane resolution of (2x2) mm(2), which equals a scan time reduction of more than 99% compared to the reference method. Conclusion: Our results demonstrate that rapid 2D T-1 quantification using a variable flip angle approach is feasible at 1.5T/3T/7T. It represents a valuable alternative for rapid T-1 mapping due to the gain in speed versus conventional approaches. This progress may serve to enhance the capabilities of parametric MR based lesion detection and brain tissue characterization.	[Dieringer, Matthias A.; Deimling, Michael; Santoro, Davide; von Knobelsdorff-Brenkenhoff, Florian; Schulz-Menger, Jeanette; Niendorf, Thoralf] Max Delbruck Ctr Mol Med, BUFF, Berlin, Germany; [Dieringer, Matthias A.; von Knobelsdorff-Brenkenhoff, Florian; Schulz-Menger, Jeanette] HELIOS Clin Berlin Buch, Working Grp Cardiovasc Magnet Resonance, Expt & Clin Res Ctr, Dept Cardiol & Nephrol, Berlin, Germany; [Deimling, Michael] Siemens Healthcare, Erlangen, Germany; [Wuerfel, Jens] Univ Med Gottingen, Inst Neuroradiol, Gottingen, Germany; [Wuerfel, Jens] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Madai, Vince I.; Sobesky, Jan] Charite Med Fac Berlin, Neurol Clin, Berlin, Germany; [Madai, Vince I.; Sobesky, Jan] Charite Med Fac Berlin, Ctr Stroke Res Berlin, Berlin, Germany; [Niendorf, Thoralf] Expt & Clin Res Ctr, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Siemens AG; Siemens Germany; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Dieringer, MA (corresponding author), Max Delbruck Ctr Mol Med, BUFF, Berlin, Germany.	Matthias.dieringer@charite.de	Madai, Vince/GYD-7365-2022; Niendorf, Thoralf/H-7738-2013; Madai, Vince/AAF-5525-2020	Madai, Vince/0000-0002-8552-6954; Niendorf, Thoralf/0000-0001-7584-6527; Madai, Vince/0000-0002-8552-6954; Sobesky, Jan/0000-0001-5459-3655; Schulz-Menger, Jeanette/0000-0003-3100-1092; Wuerfel, Jens/0000-0002-0034-8053	Else Kroner-Fresenius-Stiftung, Bad Homburg, Germany [2010_A70]	Else Kroner-Fresenius-Stiftung, Bad Homburg, Germany	Florian von Knobelsdorff-Brenkenhoff and Matthias A. Dieringer (partly) are supported by a grant of the Else Kroner-Fresenius-Stiftung, Bad Homburg, Germany (2010_A70). Matthias A. Dieringer is employed at the Charite' Berlin, which is a university faculty. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKOKA S, 1993, MAGN RESON IMAGING, V11, P437, DOI 10.1016/0730-725X(93)90078-R; Andreisek G, 2009, RADIOLOGY, V252, P865, DOI 10.1148/radiol.2531081115; BRANTZAWADZKI M, 1992, RADIOLOGY, V182, P769, DOI 10.1148/radiology.182.3.1535892; Carinci F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057982; Cheng HLM, 2006, MAGN RESON MED, V55, P566, DOI 10.1002/mrm.20791; de Graaf WL, 2013, EUR RADIOL, V23, P528, DOI 10.1007/s00330-012-2619-7; Deoni SCL, 2004, MAGNET RESON MED, V51, P194, DOI 10.1002/mrm.10661; Deoni SCL, 2007, J MAGN RESON IMAGING, V26, P1106, DOI 10.1002/jmri.21130; Ethofer T, 2003, MAGN RESON MED, V50, P1296, DOI 10.1002/mrm.10640; FRAHM J, 1986, J COMPUT ASSIST TOMO, V10, P363, DOI 10.1097/00004728-198603000-00046; FRAM EK, 1987, MAGN RESON IMAGING, V5, P201, DOI 10.1016/0730-725X(87)90021-X; Ge Y, 2006, AM J NEURORADIOL, V27, P1165; Gelman N, 2001, MAGNET RESON MED, V45, P71, DOI 10.1002/1522-2594(200101)45:1<71::AID-MRM1011>3.0.CO;2-2; HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6; HAJNAL JV, 1992, J COMPUT ASSIST TOMO, V16, P841, DOI 10.1097/00004728-199211000-00001; Henderson E, 1999, MAGN RESON IMAGING, V17, P1163, DOI 10.1016/S0730-725X(99)00025-9; HOMER J, 1985, J MAGN RESON, V63, P287, DOI 10.1016/0022-2364(85)90318-X; Inglese M, 2006, AM J NEURORADIOL, V27, P954; INSKO EK, 1993, J MAGN RESON SER A, V103, P82, DOI 10.1006/jmra.1993.1133; Jurcoane A, 2013, J MAGN RESON IMAGING; Lancaster JL, 2003, J MAGN RESON IMAGING, V17, P1, DOI 10.1002/jmri.10230; Loader B, 2010, 32 ANN M BIOEL SOC S, P94; Madai VI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037631; Niendorf T, 2006, NMR BIOMED, V19, P325, DOI 10.1002/nbm.1051; Parker GJM, 2001, MAGN RESON MED, V45, P838, DOI 10.1002/mrm.1112; Parry A, 2002, J NEUROL, V249, P1279, DOI 10.1007/s00415-002-0837-7; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; REDPATH TW, 1994, BRIT J RADIOL, V67, P1258, DOI 10.1259/0007-1285-67-804-1258; Rooney WD, 2007, MAGN RESON MED, V57, P308, DOI 10.1002/mrm.21122; Sacolick LI, 2010, MAGN RESON MED, V63, P1315, DOI 10.1002/mrm.22357; SCHNEIDER E, 1991, MAGNET RESON MED, V18, P335, DOI 10.1002/mrm.1910180208; Sinnecker T, 2012, NEUROLOGY, V79, P708, DOI 10.1212/WNL.0b013e3182648bc8; Sinnecker T, 2012, ARCH NEUROL-CHICAGO, V69, P739, DOI 10.1001/archneurol.2011.2450; Sled JG, 2001, MAGNET RESON MED, V46, P923, DOI 10.1002/mrm.1278; Sobesky J, 2012, J CEREBR BLOOD F MET, V32, P1416, DOI 10.1038/jcbfm.2012.54; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Susac JO, 2003, NEUROLOGY, V61, P1783, DOI 10.1212/01.WNL.0000103880.29693.48; Tallantyre EC, 2008, NEUROLOGY, V70, P2076, DOI 10.1212/01.wnl.0000313377.49555.2e; Tannus A, 1997, NMR BIOMED, V10, P423, DOI 10.1002/(SICI)1099-1492(199712)10:8<423::AID-NBM488>3.0.CO;2-X; Venkatesan R, 1998, MAGNET RESON MED, V40, P592, DOI 10.1002/mrm.1910400412; Vrenken H, 2006, RADIOLOGY, V240, P811, DOI 10.1148/radiol.2403050569; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wuerfel J, 2012, MULT SCLER J, V18, P1592, DOI 10.1177/1352458512441270; Zhu YD, 2004, MAGNET RESON MED, V52, P869, DOI 10.1002/mrm.20209	45	29	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91318	10.1371/journal.pone.0091318	http://dx.doi.org/10.1371/journal.pone.0091318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621588	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000332845300074
J	Gao, T; Han, Y; Yu, L; Ao, S; Li, ZY; Ji, JF				Gao, Tian; Han, Yong; Yu, Ling; Ao, Sheng; Li, Ziyu; Ji, Jiafu			CCNA2 Is a Prognostic Biomarker for ER plus Breast Cancer and Tamoxifen Resistance	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; MICROARRAY DATA; CYCLIN A2; SURVIVAL; GENE; OVEREXPRESSION; RECURRENCE	Identification of effective prognostic biomarkers and targets are of crucial importance to the management of estrogen receptor positive (ER+) breast cancer. CCNA2 (also known as CyclinA2) belongs to the highly conserved cyclin family and is significantly overexpressed in various cancer types. In this study, we demonstrated that CCNA2 had significant predictive power in distant metastasis free survival, disease free survival, recurrence free survival and overall survival of ER+ breast cancer patients. We also found that CCNA2 was closely associated with tamoxifen resistance. In addition, gene set enrichment analysis (GSEA) revealed that its expression was positively associated with genes overexpressed in endocrine therapy resistant samples. Finally, though CCNA2-Drug interaction network, we demonstrated the interactions between CCNA2 and several available cancer drugs. Overall, we suggest that CCNA2 is a biomarker for the prognosis of ER+ breast cancer and monitoring of tamoxifen efficacy. It's also a promising target for developing new strategies to prevent or even reverse tamoxifen resistance. Moreover, CCNA2 expression may help monitoring tamoxifen efficacy and directing personalized therapies. Nevertheless, in vivo and in vitro experiments and multi-center randomized controlled clinical trials are still needed before its application in clinical settings.	[Gao, Tian; Ao, Sheng; Li, Ziyu; Ji, Jiafu] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Gastrointestinal Surg, Beijing 100871, Peoples R China; [Han, Yong] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Yu, Ling] Wuhan Univ, Dept Orthoped, Renmin Hosp, Wuhan 430072, Hubei, Peoples R China	Peking University; Peking University; Wuhan University	Ji, JF (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Gastrointestinal Surg, Beijing 100871, Peoples R China.	JiafJi2002@gmail.com		Han, Yong/0000-0001-9935-2978				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 1998, LANCET, V352, P930; Arsic N, 2012, J CELL BIOL, V196, P147, DOI 10.1083/jcb.201102085; Bendris Nawal, 2012, Small GTPases, V3, P225, DOI 10.4161/sgtp.20791; Bergh J, 2000, LANCET, V355, P944, DOI 10.1016/S0140-6736(00)90007-2; Brenner H, 2002, LANCET, V360, P1131, DOI 10.1016/S0140-6736(02)11199-8; Castellano I, 2013, ANN ONCOL, V24, P2292, DOI 10.1093/annonc/mdt183; Clarke M, 1998, LANCET, V351, P1451; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Davis AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058201; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; Gonzalez-Malerva L, 2011, P NATL ACAD SCI USA, V108, P2058, DOI 10.1073/pnas.1018157108; Guo SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052380; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hiscox S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-458; Jansen MPHM, 2005, J CLIN ONCOL, V23, P732, DOI 10.1200/JCO.2005.05.145; Jirstrom K, 2005, CANCER RES, V65, P8009, DOI 10.1158/0008-5472.CAN-05-0746; Johansson HJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3175; Ko E, 2013, ANN SURG ONCOL, V20, P1005, DOI 10.1245/s10434-012-2727-2; Loh YN, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-174; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Osborne CK, 2003, BREAST, V12, P362, DOI 10.1016/S0960-9776(03)00137-1; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Palmieri C, 2013, MOL CELL ENDOCRINOL, V7; Piva M, 2013, EMBO MOL MED, V31; Ruckhaberle E, 2009, CLIMACTERIC, V12, P502, DOI 10.3109/13697130902939913; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taminau J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-335; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Ur-Rehman S, 2013, BREAST CANCER RES TR, V139, P907, DOI 10.1007/s10549-013-2593-z; Vendrell JA, 2007, ONCOGENE, V26, P4656, DOI 10.1038/sj.onc.1210269; Xu XL, 2013, BREAST CANCER RES TR, V139, P329, DOI 10.1007/s10549-013-2563-5; Yamamoto M, 2013, CANCER SCI, V10, P12302	39	75	77	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91771	10.1371/journal.pone.0091771	http://dx.doi.org/10.1371/journal.pone.0091771			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622579	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300127
J	Moreno-Palomo, J; Creus, A; Marcos, R; Hernandez, A				Moreno-Palomo, Jennifer; Creus, Amadeu; Marcos, Ricard; Hernandez, Alba			Genomic Instability in Newborn with Short Telomeres	PLOS ONE			English	Article							PRENATAL STRESS; LENGTH; RISK; DYSFUNCTION; CANCER; BLOOD; INDUCTION; DIET; END	Telomere length is considered to be a risk factor in adults due to its proved association with cancer incidence and mortality. Since newborn present a wide interindividual variation in mean telomere length, it is relevant to demonstrate if these differences in length can act also as an early risk indicator. To answer this question, we have measured the mean telomere length of 74 samples of cord blood from newborns and studied its association with the basal genetic damage, measured as the frequency of binucleated cells carrying micronuclei. In addition, we have challenged the cells of a subgroup of individuals (N = 35) against mitomycin-C (MMC) to establish their sensitivity to induced genomic instability. Results indicate that newborn with shorter telomeres present significantly higher levels of genetic damage when compared to those with longer telomeres. In addition, the cellular response to MMC was also significantly higher among those samples from subjects with shorter telomeres. Independently of the causal mechanisms involved, our results show for the first time that telomere length at delivery influence both the basal and induced genetic damage of the individual. Impact: Individuals born with shorter telomeres may be at increased risk, especially for those biological processes triggered by genomic instability as is the case of cancer and other age-related diseases.	[Moreno-Palomo, Jennifer; Creus, Amadeu; Marcos, Ricard; Hernandez, Alba] Univ Autonoma Barcelona, Fac Biociencies, Dept Genet & Microbiol, Grp Mutagenesi, Cerdanyola Del Valles, Spain; [Creus, Amadeu; Marcos, Ricard; Hernandez, Alba] Inst Salud Carlos III, CIBER Epidemiol & Salud Publ, Madrid, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III	Marcos, R (corresponding author), Univ Autonoma Barcelona, Fac Biociencies, Dept Genet & Microbiol, Grp Mutagenesi, Campus Bellaterra, Cerdanyola Del Valles, Spain.	ricard.marcos@uab.es; alba.hernandez@uab.es	Creus, Amadeu/A-7778-2013; Marcos, Ricard/G-9671-2015; Hernandez, Alba/H-5251-2015	Creus, Amadeu/0000-0003-0848-9448; Marcos, Ricard/0000-0001-7891-357X; Hernandez, Alba/0000-0001-6938-1233	Generalitat de Catalunya (CIRIT) [2009SGR-725]	Generalitat de Catalunya (CIRIT)(Generalitat de Catalunya)	This work was supported by Generalitat de Catalunya (CIRIT, 2009SGR-725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002696; Aviv A, 2008, J GERONTOL A-BIOL, V63, P979, DOI 10.1093/gerona/63.9.979; Ban S, 2004, J RADIAT RES, V45, P535, DOI 10.1269/jrr.45.535; BLACKBURN EH, 1994, CELL, V77, P621, DOI 10.1016/0092-8674(94)90046-9; Bonassi S, 2007, CARCINOGENESIS, V28, P625, DOI 10.1093/carcin/bgl177; Callen E, 2004, MUTAT RES-REV MUTAT, V567, P85, DOI 10.1016/j.mrrev.2004.06.003; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Castella A, 2007, TOXICOL LETT, V172, P29, DOI 10.1016/j.toxlet.2007.05.012; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Duensing A, 2010, ADV EXP MED BIOL, V676, P93; Entringer S, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/632548; Entringer S, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.033; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Feldser DM, 2003, NAT REV CANCER, V3, P623, DOI 10.1038/nrc1142; Gilley D, 2005, INT J BIOCHEM CELL B, V37, P1000, DOI 10.1016/j.biocel.2004.09.003; Gollin SM, 2005, SEMIN CANCER BIOL, V15, P33, DOI 10.1016/j.semcancer.2004.09.004; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Huizink AC, 2004, PSYCHOL BULL, V130, P115, DOI 10.1037/0033-2909.130.1.115; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lin SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060815; Marcon F, 2012, MUTAGENESIS, V27, P49, DOI 10.1093/mutage/ger056; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Muftuoglu M, 2006, CANCER RES, V66, P113, DOI 10.1158/0008-5472.CAN-05-2742; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Orjuela MA, 2010, MUTAT RES-GEN TOX EN, V703, P108, DOI 10.1016/j.mrgentox.2010.08.004; Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893; Prescott J, 2012, MUTAT RES, V730, P73; Prescott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019635; Samassekou O, 2010, ANN ANAT, V192, P284, DOI 10.1016/j.aanat.2010.07.005; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Slyskova J, 2011, ENVIRON MOL MUTAGEN, V52, P511, DOI 10.1002/em.20650; SURRALLES J, 1995, MUTAT RES-GENET TOX, V341, P169, DOI 10.1016/0165-1218(95)90007-1; Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wright WE, 2005, NAT GENET, V37, P116, DOI 10.1038/ng0205-116; Xu Q, 2009, AM J CLIN NUTR, V89, P1857, DOI 10.3945/ajcn.2008.26986	38	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91753	10.1371/journal.pone.0091753	http://dx.doi.org/10.1371/journal.pone.0091753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622247	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300123
J	Uzochukwu, BSC; Onwujekwe, OE; Okwuosa, C; Ibe, OP				Uzochukwu, Benjamin S. C.; Onwujekwe, Obinna E.; Okwuosa, Chinenye; Ibe, Ogochukwu P.			Patent Medicine Dealers and Irrational Use of Medicines in Children: The Economic Cost and Implications for Reducing Childhood Mortality in Southeast Nigeria	PLOS ONE			English	Article							MALARIA; SELLERS; VENDORS; URBAN	This study assessed the economic costs of irrational medicine use by Patent Medicine Dealers (PMDs) for malaria, acute respiratory infection (ARI) and diarrhea diseases (DD) in Nigeria. Exit interviews were conducted with 395 respondents who sought care for their children from 15 PMDs in Abakpa district of Enugu state Nigeria. Of the total respondents, 80.0% received treatment for malaria while 12.0% and 8.0% received treatment for DD and ARI respectively. The average number of drugs dispensed per patient was 6.8, average percentage of patients given injections was 72.5%, average percentage of patients given one or more antibiotics was 59.7%, while the percentage of patients given non essential drugs was 45.9%. The additional costs to the standard treatment in Naira was 255, 350 and 175 for malaria, ARI and DD respectively. The losses attributable to irrational dispensing was 4,500 Naira. However, more than half of the drugs were on essential drug list, implying some cost savings for the consumers, but the high number of drugs (6.8) on average/patient is likely to increase the total cost of drugs cancelling out the cost savings to consumers arising from dispensing essential drugs.	[Uzochukwu, Benjamin S. C.] Univ Nigeria Enugu Campus, Dept Community Med, Coll Med, Enugu, Nigeria; [Uzochukwu, Benjamin S. C.; Onwujekwe, Obinna E.] Univ Nigeria Enugu Campus, Coll Med, Dept Hlth Adm & Management, Enugu, Nigeria; [Uzochukwu, Benjamin S. C.; Onwujekwe, Obinna E.; Okwuosa, Chinenye; Ibe, Ogochukwu P.] Univ Nigeria Enugu Campus, Coll Med, Hlth Policy Res Grp, Enugu, Nigeria	University of Nigeria; University of Nigeria; University of Nigeria	Uzochukwu, BSC (corresponding author), Univ Nigeria Enugu Campus, Dept Community Med, Coll Med, Enugu, Nigeria.	bscuzochukwu@gmail.com	Onwujekwe, Obinna/O-6232-2014	Onwujekwe, Obinna/0000-0002-1214-4285				Abiola AB, 1993, QUALITATIVE ASSESSME; Abuya TO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-57; Aina BA, 2008, J INFECT DEV COUNTR, V2, P68, DOI 10.3855/jidc.325; AKINDE J, 1982, SURVEY PATENT MED ST; Ansari K. U., 1998, Indian Journal of Pharmacology, V30, P43; Biswas Nihar R., 2000, Indian Journal of Physiology and Pharmacology, V44, P109; Brieger WR, 2004, HEALTH POLICY PLANN, V19, P177, DOI 10.1093/heapol/czh021; Brugha R, 2002, HLTH POLICY PLAN, V13, P103; de Jong J, 2008, EUR J CLIN PHARMACOL, V64, P913, DOI 10.1007/s00228-008-0479-5; Erhun WO., 2001, J HLTH POPULATION DE, V4, P23; Federal Government of Nigeria, 2007, OFFICIAL GAZETTE LAG, V24, P94; Federal Ministry of Health, 1999, NIG IMCI POL; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Holloway KA, 2001, HEALTH POLICY PLANN, V16, P421, DOI 10.1093/heapol/16.4.421; IWEZE EA, 1987, URBAN POOR NIGERIA, P317; MASSELE AY, 1993, E AFR MED J, V70, P639; Mirza NY, 2009, BANGL J PHARMACOL, V4, P39, DOI 10.3329/bjp.v4i1.1062; Mohanty BK, 2010, J CLIN DIAGN RES, V4, P2047; National Bureau of Statistics, 2005, POV PROF NIG; Nsimba Stephen Elias Damson, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P206; Nurgozhin T, 2004, DRUG PRESCRIPTION PR; Ojuawo A, 1993, Niger J Paediatr, V20, P41; Okeke TA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-97; Oladepo O, 2008, POLICY BRIEF, V2008, P01; Onwujekwe O, 2000, HEALTH POLICY, V54, P143, DOI 10.1016/S0168-8510(00)00105-6; Osamor PE, 2001, THESIS U IBADAN NIGE; OSHINAME FO, 1992, SOC SCI MED, V35, P1477, DOI 10.1016/0277-9536(92)90050-Z; Qidwai Waris, 2006, J Coll Physicians Surg Pak, V16, P743; Salako LA, 2001, J TROP PEDIATRICS, V47, P230, DOI 10.1093/tropej/47.4.230; Souleymane M, 1994, PUBLIC HLTH MEASURE; TAWFIK Y, 2002, UTILIZING POTENTIAL; Ukwaja KN, 2010, AFR J RESPIR MED, V6, P18; USAID, 2008, MAN SCI HLTH RAT DRU; Uzochukwu BSC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001788; Uzochukwu Benjamin Sc, 2004, Int J Equity Health, V3, P6, DOI 10.1186/1475-9276-3-6; Uzochukwu BS, 2002, HEALTH POLICY PLANN, V17, P378, DOI 10.1093/heapol/17.4.378; VANDERGEEST S, 1991, CULT MED PSYCHIAT, V15, P69, DOI 10.1007/BF00050828; World Bank, 1992, 4 WORLD BANK AFR TEC; World Bank Development Data Group, 2004, DAT COUNTR; World Health Organization, 2006, SEARO TECH PUBL SER	40	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91667	10.1371/journal.pone.0091667	http://dx.doi.org/10.1371/journal.pone.0091667			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24621618	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300116
J	Baho, DL; Drakare, S; Johnson, RK; Allen, CR; Angeler, DG				Baho, Didier L.; Drakare, Stina; Johnson, Richard K.; Allen, Craig R.; Angeler, David G.			Similar Resilience Attributes in Lakes with Different Management Practices	PLOS ONE			English	Article							ACIDIFIED LAKES; BOREAL LAKES; FOOD-WEB; ZOOPLANKTON COMMUNITIES; RELATIVE RESILIENCE; FUNCTIONAL-GROUPS; REGIME SHIFTS; RECOVERY; ACIDIFICATION; DIVERSITY	Liming has been used extensively in Scandinavia and elsewhere since the 1970s to counteract the negative effects of acidification. Communities in limed lakes usually return to acidified conditions once liming is discontinued, suggesting that liming is unlikely to shift acidified lakes to a state equivalent to pre-acidification conditions that requires no further management intervention. While this suggests a low resilience of limed lakes, attributes that confer resilience have not been assessed, limiting our understanding of the efficiency of costly management programs. In this study, we assessed community metrics (diversity, richness, evenness, biovolume), multivariate community structure and the relative resilience of phytoplankton in limed, acidified and circum-neutral lakes from 1997 to 2009, using multivariate time series modeling. We identified dominant temporal frequencies in the data, allowing us to track community change at distinct temporal scales. We assessed two attributes of relative resilience (cross-scale and within-scale structure) of the phytoplankton communities, based on the fluctuation frequency patterns identified. We also assessed species with stochastic temporal dynamics. Liming increased phytoplankton diversity and richness; however, multivariate community structure differed in limed relative to acidified and circum-neutral lakes. Cross-scale and within-scale attributes of resilience were similar across all lakes studied but the contribution of those species exhibiting stochastic dynamics was higher in the acidified and limed compared to circum-neutral lakes. From a resilience perspective, our results suggest that limed lakes comprise a particular condition of an acidified lake state. This explains why liming does not move acidified lakes out of a "degraded'' basin of attraction. In addition, our study demonstrates the potential of time series modeling to assess the efficiency of restoration and management outcomes through quantification of the attributes contributing to resilience in ecosystems.	[Baho, Didier L.; Drakare, Stina; Johnson, Richard K.; Angeler, David G.] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden; [Allen, Craig R.] Univ Nebraska, Sch Nat Resources, Nebraska Cooperat Fish & Wildlife Res Unit, US Geol Survey, Lincoln, NE USA	Swedish University of Agricultural Sciences; United States Department of the Interior; United States Geological Survey; University of Nebraska System; University of Nebraska Lincoln	Baho, DL (corresponding author), Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden.	didier.baho@slu.se	Johnson, Richard K./P-4991-2014; Drakare, Stina/ABF-1259-2020; Drakare, Stina/D-4532-2016	Johnson, Richard K./0000-0001-7979-6563; Drakare, Stina/0000-0002-7389-2105; Drakare, Stina/0000-0002-7389-2105	August T. Larsson Foundation (NL Faculty, Swedish University of Agricultural Sciences); U.S. Geological Survey; Nebraska Game and Parks Commission; University of Nebraska-Lincoln; United States Fish and Wildlife Service; Wildlife Management Institute	August T. Larsson Foundation (NL Faculty, Swedish University of Agricultural Sciences); U.S. Geological Survey(United States Geological Survey); Nebraska Game and Parks Commission; University of Nebraska-Lincoln; United States Fish and Wildlife Service(US Fish & Wildlife Service); Wildlife Management Institute	Financial support was provided by the August T. Larsson Foundation (NL Faculty, Swedish University of Agricultural Sciences). The Nebraska Cooperative Fish and Wildlife Research Unit are jointly supported by a cooperative agreement between the U.S. Geological Survey, the Nebraska Game and Parks Commission, the University of Nebraska-Lincoln, the United States Fish and Wildlife Service, and the Wildlife Management Institute. Reference to trade names does not imply endorsement by the authors or the U.S. government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CR, 2006, ECOL LETT, V9, P630, DOI 10.1111/j.1461-0248.2006.00902.x; Allen CR, 2005, ECOSYSTEMS, V8, P958, DOI 10.1007/s10021-005-0147-x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Angeler DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077338; Angeler DG, 2013, J APPL ECOL, V50, P572, DOI 10.1111/1365-2664.12092; Angeler DG, 2012, ECOL SOC, V17, DOI 10.5751/ES-04928-170232; Angeler DG, 2012, ECOL APPL, V22, P1172, DOI 10.1890/11-1474.1; Angeler DG, 2010, J APPL ECOL, V47, P478, DOI 10.1111/j.1365-2664.2010.01794.x; Angeler DG, 2009, ECOLOGY, V90, P3245, DOI 10.1890/07-0391.1; [Anonymous], 2001, PANARCHY UNDERSTANDI; Appelberg M, 2001, WATER AIR SOIL POLL, V130, P1745, DOI 10.1023/A:1013908003052; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.2307/3868190; Bertills U, 2007, NATURAL ACIDIFICATIO; Binks JA, 2005, ECOL APPL, V15, P2025, DOI 10.1890/04-1726; Bishop K, 2001, WATER AIR SOIL POLL, V130, P1415, DOI 10.1023/A:1013936224549; Blanchet FG, 2008, ECOL MODEL, V215, P325, DOI 10.1016/j.ecolmodel.2008.04.001; Blanchet FG, 2011, OECOLOGIA, V166, P357, DOI 10.1007/s00442-010-1867-y; Blomqvist P, 1998, 4861 SWED ENV PROT 2; Bostedt G, 2010, AMBIO, V39, P40, DOI 10.1007/s13280-009-0004-9; Bradley DC, 2002, FRESHWATER BIOL, V47, P161, DOI 10.1046/j.1365-2427.2002.00770.x; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; CARPENTER SR, 1992, AM NAT, V140, P781, DOI 10.1086/285440; Clair Thomas A., 2005, Environmental Reviews, V13, P91, DOI 10.1139/a05-009; COOKE G. D., 1993, RESTORATION MANAGEME; ERIKSSON F, 1983, HYDROBIOLOGIA, V101, P145, DOI 10.1007/BF00008667; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Gray DK, 2011, ECOL APPL, V21, P2652, DOI 10.1890/10-2067.1; Gray DK, 2011, ECOL APPL, V21, P1241, DOI 10.1890/10-0364.1; Gunn J, 2001, WATER AIR SOIL POLL, V130, P1439, DOI 10.1023/A:1013908913162; Hagley CA, 1996, RESTOR ECOL, V4, P307, DOI 10.1111/j.1526-100X.1996.tb00182.x; Henrikson Lennart, 1995, P1; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holling CS, 1996, CONSERV BIOL, V10, P328, DOI 10.1046/j.1523-1739.1996.10020328.x; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; JACKS G, 1994, AMBIO, V23, P358; Jarvinen M, 1995, WATER AIR SOIL POLL, V85, P943, DOI 10.1007/BF00476951; Jeppesen E, 2007, HYDROBIOLOGIA, V581, P269, DOI 10.1007/s10750-006-0507-3; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Keller W, 1998, RESTOR ECOL, V6, P364, DOI 10.1046/j.1526-100X.1998.06407.x; KopuYek J., 2002, WATER AIR SOIL POLL, V2, P91, DOI DOI 10.1023/A:1020190205652; Kreyling J, 2011, ECOL LETT, V14, P758, DOI 10.1111/j.1461-0248.2011.01637.x; KULLBERG A, 1987, FRESHWATER BIOL, V17, P553, DOI 10.1111/j.1365-2427.1987.tb01076.x; Layer K, 2010, GLOBAL CHANGE BIOL, V16, P3133, DOI 10.1111/j.1365-2486.2010.02195.x; Ledger ME, 2005, ENVIRON POLLUT, V137, P103, DOI 10.1016/j.envpol.2004.12.024; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; LEWIS WM, 1982, LIMNOL OCEANOGR, V27, P167, DOI 10.4319/lo.1982.27.1.0167; MARMOREK DR, 1993, WATER AIR SOIL POLL, V69, P223, DOI 10.1007/BF00478160; McKie BG, 2006, J APPL ECOL, V43, P780, DOI 10.1111/j.1365-2664.2006.01196.x; Mori AS, 2013, BIOL REV, V88, P349, DOI 10.1111/brv.12004; Newbery DM, 2009, PLANT ECOL, V201, P147, DOI 10.1007/s11258-008-9533-8; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Olrik K.P., 1989, METHODS QUANTITATI 1; Ormerod SJ, 2009, J APPL ECOL, V46, P164, DOI 10.1111/j.1365-2664.2008.01587.x; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; R Development Core Team, 2012, R LANG ENV STAT COMP; RAITANIEMI J, 1990, Aqua Fennica, V20, P115; ROSSELAND BO, 1992, ENVIRON POLLUT, V78, P3, DOI 10.1016/0269-7491(92)90003-S; Sandoy S, 1995, WATER AIR SOIL POLL, V85, P997, DOI 10.1007/BF00476960; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Schindler DW, 1997, RESTOR ECOL, V5, P1, DOI 10.1046/j.1526-100X.1997.09701.x; Scott KA, 2010, J LIMNOL, V69, P33, DOI 10.4081/jlimnol.2010.s1.33; Soltero R, 1992, WATERSHED MANAGEMENT, P458; Stendera S, 2008, J N AM BENTHOL SOC, V27, P529, DOI 10.1899/07-125.1; Sundstrom SM, 2012, CONSERV BIOL, V26, P305, DOI 10.1111/j.1523-1739.2011.01822.x; Tuomisto H, 2012, OIKOS, V121, P1203, DOI 10.1111/j.1600-0706.2011.19897.x; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Walker B., 2004, Ecology and Society, V9, P5; Wallstedt T, 2008, SCI TOTAL ENVIRON, V407, P405, DOI 10.1016/j.scitotenv.2008.07.062; Wardwell DA, 2008, ECOL COMPLEX, V5, P165, DOI 10.1016/j.ecocom.2007.11.001; WEATHERLEY NS, 1988, WATER AIR SOIL POLL, V39, P421; Wilander A, 2003, SYNOPTISK STUDIE VAT; Yan ND, 2003, AMBIO, V32, P165, DOI 10.1639/0044-7447(2003)032[0165:DCFFTR]2.0.CO;2; Yan ND, 1996, CAN J FISH AQUAT SCI, V53, P1301, DOI 10.1139/f96-065; Zaccarelli N, 2008, ECOL SOC, V13	77	23	23	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91881	10.1371/journal.pone.0091881	http://dx.doi.org/10.1371/journal.pone.0091881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618720	Green Submitted, gold, Green Published			2022-12-27	WOS:000332842400139
J	Hou, CX; Qin, GX; Liu, T; Geng, T; Gao, K; Pan, ZH; Qian, HY; Guo, XJ				Hou, Chengxiang; Qin, Guangxing; Liu, Ting; Geng, Tao; Gao, Kun; Pan, Zhonghua; Qian, Heying; Guo, Xijie			Transcriptome Analysis of Silkworm, Bombyx mori, during Early Response to Beauveria bassiana Challenges	PLOS ONE			English	Article							GENE-EXPRESSION PROFILE; HEAT-SHOCK PROTEINS; MICROARRAY ANALYSIS; INVOLVEMENT; PROTEASE; RECEPTOR; SYSTEM; NUCLEOPOLYHEDROVIRUS; IDENTIFICATION; RESISTANT	Host-pathogen interactions are complex processes and it is a central challenge to reveal these interactions. Fungal infection of silkworm, Bombyx mori, may induce a variety of responsive reaction. However, little is known about the molecular mechanism of silkworm immune response against the fungal infection. To obtain an overview of the interaction between silkworm and an entomopathogenic fungus Beauveria bassiana, Digital Gene Expression profiling, a tag based high-throughput transcriptome sequencing method, was employed to screen and identify differentially expressed genes (DEGs, FDR <= 0.001, log(2)ratio >= 1) of silkworm larvae during early response against B. bassiana infection. Total 1430 DEGs including 960 up-regulated and 470 down-regulated ones were identified, of which 627 DEGs can be classified into GO categories by Gene Ontology (GO) analysis. KEGG pathways analysis of these DEGs suggested that many biological processes, such as defense and response, signal transduction, phagocytosis, regulation of gene expression, RNA splicing, biosynthesis and metabolism, protein transport etc. were involved in the interaction between the silkworm and B. bassiana. A number of differentially expressed fungal genes were also identified by mapping the sequencing tags to B. bassiana genome. These results provided new insights to the molecular mechanism of silkworm immune response to B. bassiana infection.	[Hou, Chengxiang; Qin, Guangxing; Liu, Ting; Geng, Tao; Gao, Kun; Pan, Zhonghua; Qian, Heying; Guo, Xijie] Jiangsu Univ Sci & Technol, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China; [Hou, Chengxiang; Qin, Guangxing; Liu, Ting; Qian, Heying; Guo, Xijie] Chinese Acad Agr Sci, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University of Science & Technology; Chinese Academy of Agricultural Sciences	Guo, XJ (corresponding author), Jiangsu Univ Sci & Technol, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China.	guoxijie@just.edu.cn	Guo, Xijie/GPX-9247-2022		National Natural Science Foundation of China [31272498]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20123220110003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (Grant No. 31272498) (http://www.nsfc.gov.cn/Portal0/default152.htm) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20123220110003)(http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JW, 2010, MOL BIOL REP, V37, P1657, DOI 10.1007/s11033-009-9580-9; Altincicek B, 2008, DEV COMP IMMUNOL, V32, P585, DOI 10.1016/j.dci.2007.09.005; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Bao YY, 2009, GENOMICS, V94, P138, DOI 10.1016/j.ygeno.2009.04.003; Basu S, 2000, CELL STRESS CHAPERON, V5, P443, DOI 10.1379/1466-1268(2000)005<0443:HSPTFO>2.0.CO;2; Bennett ST, 2005, PHARMACOGENOMICS, V6, P373, DOI 10.1517/14622416.6.4.373; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Charnley AK, 2003, ADV BOT RES, V40, P241, DOI 10.1016/S0065-2296(05)40006-3; Chengxiang H, 2011, GENE, V484, P35, DOI 10.1016/j.gene.2011.05.023; Clarke TE, 2002, J GEN VIROL, V83, P1565, DOI 10.1099/0022-1317-83-7-1565; Clarkson JM, 1996, TRENDS MICROBIOL, V4, P197, DOI 10.1016/0966-842X(96)10022-6; Du MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031045; Du X, 2012, CARBOHYD POLYM, V92, P1302; Erban T, 2008, EXP APPL ACAROL, V44, P199, DOI 10.1007/s10493-008-9138-x; Feyereisen R., 2005, P1; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Grogan GJ, 2000, J MOL CATAL B-ENZYM, V9, P1, DOI 10.1016/S1381-1177(99)00080-6; Gurer C, 2002, J VIROL, V76, P4666, DOI 10.1128/JVI.76.9.4666-4670.2002; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Iordanskiy S, 2004, J VIROL, V78, P9697, DOI 10.1128/JVI.78.18.9697-9704.2004; Ji SJ, 2003, NUCLEIC ACIDS RES, V31, P2534, DOI 10.1093/nar/gkg358; Jiang HB, 2005, INSECT BIOCHEM MOLEC, V35, P931, DOI 10.1016/j.ibmb.2005.03.009; Jin LH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000168; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Le Floc'h N, 2004, LIVEST PROD SCI, V87, P37, DOI 10.1016/j.livprodsci.2003.09.005; Li B, 2006, J INSECT PHYSIOL, V52, P936, DOI 10.1016/j.jinsphys.2006.06.002; Li MW, 2005, GENOME, V48, P802, DOI 10.1139/g05-053; Liu WM, 2010, MOL BIOL REP, V37, P1801, DOI 10.1007/s11033-009-9614-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo M, 2005, PLANT SCI, V169, P695, DOI 10.1016/j.plantsci.2005.05.020; Luo Y, 2010, MOL BIOL REP, V37, P875, DOI 10.1007/s11033-009-9694-0; Maki N, 1997, INSECT BIOCHEM MOLEC, V27, P721, DOI 10.1016/S0965-1748(97)00050-7; Maki N, 2001, INSECT BIOCHEM MOLEC, V31, P407, DOI 10.1016/S0965-1748(00)00135-1; McBride WH, 2003, ONCOGENE, V22, P5755, DOI 10.1038/sj.onc.1206676; Pradeepa MM, 2008, MOL CELL BIOL, V28, P4331, DOI 10.1128/MCB.00519-07; Roh Kyung-Baeg, 2009, J Biol Chem, V284, P19474, DOI 10.1074/jbc.M109.007419; Sagisaka A, 2010, VIRUS RES, V147, P166, DOI 10.1016/j.virusres.2009.10.015; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Tanaka H, 2009, INSECT MOL BIOL, V18, P71, DOI 10.1111/j.1365-2583.2009.00851.x; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Ujita M, 2005, BIOSCI BIOTECH BIOCH, V69, P1178, DOI 10.1271/bbb.69.1178; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Veitch NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-124; Wang JS, 2006, CELL MOL IMMUNOL, V3, P255; Wieten L, 2010, CELL STRESS CHAPERON, V15, P25, DOI 10.1007/s12192-009-0119-8; Williams JHH, 2008, J LEUKOCYTE BIOL, V83, P489, DOI 10.1189/jlb.0607356; Wu P, 2011, MOL BIOL REP, V38, P333, DOI 10.1007/s11033-010-0112-4; Wu S, 2010, DEV COMP IMMUNOL, V34, P93, DOI 10.1016/j.dci.2009.08.010; Xiao Guohua, 2012, Sci Rep, V2, P483, DOI 10.1038/srep00483; Yamamoto K, 2010, PESTIC BIOCHEM PHYS, V97, P1, DOI 10.1016/j.pestbp.2009.11.006; Yao HP, 2006, J ZHEJIANG U SC A S2, V7, P350, DOI DOI 10.1631/JZUS.2006.AS0350; Yasuharaa N, 2009, SEMIN CELL DEV BIOL, V20, P590, DOI 10.1016/j.semcdb.2009.05.003; Zaitseva L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-11; Zhou Y, 2013, GENOMICS, V101, P256, DOI 10.1016/j.ygeno.2013.02.004	59	41	45	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91189	10.1371/journal.pone.0091189	http://dx.doi.org/10.1371/journal.pone.0091189			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618587	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400054
J	Unmack, PJ; Dowling, TE; Laitinen, NJ; Secor, CL; Mayden, RL; Shiozawa, DK; Smith, GR				Unmack, Peter J.; Dowling, Thomas E.; Laitinen, Nina J.; Secor, Carol L.; Mayden, Richard L.; Shiozawa, Dennis K.; Smith, Gerald R.			Influence of Introgression and Geological Processes on Phylogenetic Relationships of Western North American Mountain Suckers (Pantosteus, Catostomidae)	PLOS ONE			English	Article							LOWER COLORADO RIVER; GREAT-BASIN; LAKE BONNEVILLE; BOUSE FORMATION; EVOLUTION; HYBRIDIZATION; TELEOSTEI; MIOCENE; HISTORY; BIOGEOGRAPHY	Intense geological activity caused major topographic changes in Western North America over the past 15 million years. Major rivers here are composites of different ancient rivers, resulting in isolation and mixing episodes between river basins over time. This history influenced the diversification of most of the aquatic fauna. The genus Pantosteus is one of several clades centered in this tectonically active region. The eight recognized Pantosteus species are widespread and common across southwestern Canada, western USA and into northern Mexico. They are typically found in medium gradient, middle-elevation reaches of rivers over rocky substrates. This study (1) compares molecular data with morphological and paleontological data for proposed species of Pantosteus, (2) tests hypotheses of their monophyly, (3) uses these data for phylogenetic inferences of sister-group relationships, and (4) estimates timing of divergence events of identified lineages. Using 8055 base pairs from mitochondrial DNA protein coding genes, Pantosteus and Catostomus are reciprocally monophyletic, in contrast with morphological data. The only exception to a monophyletic Pantosteus is P. columbianus whose mtDNA is closely aligned with C. tahoensis because of introgression. Within Pantosteus, several species have deep genetic divergences among allopatric sister lineages, several of which are diagnosed and elevated to species, bringing the total diversity in the group to 11 species. Conflicting molecular and morphological data may be resolved when patterns of divergence are shown to be correlated with sympatry and evidence of introgression.	[Unmack, Peter J.; Laitinen, Nina J.; Shiozawa, Dennis K.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Unmack, Peter J.] Natl Evolutionary Synth Ctr, Durham, NC USA; [Dowling, Thomas E.; Secor, Carol L.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Dowling, Thomas E.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Mayden, Richard L.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Smith, Gerald R.] Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA	Brigham Young University; The National Evolutionary Synthesis Center; Arizona State University; Arizona State University-Tempe; Wayne State University; Saint Louis University; University of Michigan System; University of Michigan	Unmack, PJ (corresponding author), Brigham Young Univ, Dept Biol, WIDB 401, Provo, UT 84602 USA.	peter.pub@unmack.net	Unmack, Peter J./AAU-3023-2020	Unmack, Peter J./0000-0003-1175-1152	US Bureau of Reclamation; National Evolutionary Synthesis Center (NESCent); NSF [EF-0905606, DEB 0240184, EF 0431326, DEB-0817027, DBI-0956370, DEB-1021840]	US Bureau of Reclamation; National Evolutionary Synthesis Center (NESCent)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NSF(National Science Foundation (NSF))	This work was supported in part by funds from the US Bureau of Reclamation to TED and CLS, by the National Evolutionary Synthesis Center (NESCent) and NSF EF-0905606 to PJU and NSF DEB 0240184, EF 0431326, DEB-0817027, DBI-0956370 and DEB-1021840 to RLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Bart HL, 2010, INT J MOL SCI, V11, P1090, DOI 10.3390/ijms11031090; BENCRABTREE C, 1987, COPEIA, P843; Benson L, 2004, DEV QUA SCI, V1, P185; Beranek LP, 2006, GEOL SOC AM BULL, V118, P1027, DOI 10.1130/B25896.1; Billman EJ, 2010, WEST N AM NATURALIST, V70, P39, DOI 10.3398/064.070.0105; Blackwelder E, 1948, B U UTAH, V38, P1; BLAKEY R., 2008, ANCIENT LANDSCAPES C; Bouchard DP, 1998, PALAEOGEOGR PALAEOCL, V141, P95, DOI 10.1016/S0031-0182(98)00005-4; Bufalino AP, 2010, MOL PHYLOGENET EVOL, V55, P274, DOI 10.1016/j.ympev.2009.12.017; Cavender T.M., 1986, P699; Chamberlain CP, 2012, AM J SCI, V312, P213, DOI 10.2475/02.2012.05; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Cope ED, 1872, US GEOLOGICAL SURV 4, P432; Cummings ML, 2000, GEOL SOC AM BULL, V112, P668, DOI 10.1130/0016-7606(2000)112<0668:SASEOT>2.3.CO;2; CURREY DR, 1990, PALAEOGEOGR PALAEOCL, V76, P189, DOI 10.1016/0031-0182(90)90113-L; Dallegge T.A., 2001, GRAND CANYON ASS MON, V12, P47; Davies OK, 1999, REV PALAEOBOT PALYNO, V107, P249, DOI 10.1016/S0034-6667(99)00020-2; DEMARAIS BD, 1992, P NATL ACAD SCI USA, V89, P2747, DOI 10.1073/pnas.89.7.2747; Doosey MH, 2010, MOL PHYLOGENET EVOL, V54, P1028, DOI 10.1016/j.ympev.2009.06.006; DOWLING TE, 1989, EVOLUTION, V43, P620, DOI 10.1111/j.1558-5646.1989.tb04257.x; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Dowling TE, 2002, COPEIA, P665, DOI 10.1643/0045-8511(2002)002[0665:EROTPT]2.0.CO;2; DOWLING TE, 1984, COPEIA, P617; DOWLING TE, 1992, CONSERV BIOL, V6, P600, DOI 10.1046/j.1523-1739.1992.06040600.x; DOWLING TE, 1992, CONSERV BIOL, V6, P7, DOI 10.1046/j.1523-1739.1992.6100064.x; DOWLING TE, 1993, NATURE, V362, P444, DOI 10.1038/362444a0; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duchene S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027138; Echelle AA, 2005, COPEIA, P320, DOI 10.1643/CG-03-093R3; Estabrook GF, 2007, EVOLUTION, V61, P1176, DOI 10.1111/j.1558-5646.2007.00089.x; Faulds J.E., 1998, GEOLOGICAL SOC AM SP, V323, P1, DOI DOI 10.1130/0-8137-2323-X.1; FERRIS SD, 1982, COPEIA, P444, DOI 10.2307/1444627; Gerber AS, 2001, EVOLUTION, V55, P2028; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hansen W.R., 1985, Mountain Geologist, V22, P192; Harper KT, 1978, GREAT BASIN NAT MEM, V2; Hershler R, 2002, SMITHSON CONTRIB EAR, P255; Ho SYW, 2008, BIOL LETTERS, V4, P370, DOI 10.1098/rsbl.2008.0073; Howard KA, 2008, GEOL SOC AM SPEC PAP, V439, P391, DOI 10.1130/2008.2439(18); Hubbs C. L., 1943, CONTRIB LAB VERT BIO, V22, P1; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Hubbs CL, 1948, B U UTAH, V38, P18; Hunt CB, 1960, US GEOL SURV PROF PA, V279, P1; Johnson JB, 2004, SYST BIOL, V53, P841, DOI 10.1080/10635150490522557; KIMMEL P.G., 1975, U MICHIGAN MUSEUM PA, V14, P69; Kinziger AP, 2005, COPEIA, P303, DOI 10.1643/CI-03-290R1; Kohn MJ, 2008, GEOLOGY, V36, P783, DOI 10.1130/G24928A.1; LUCCHITTA I, 1972, GEOL SOC AM BULL, V83, P1933, DOI 10.1130/0016-7606(1972)83[1933:EHOTCR]2.0.CO;2; Lucchitta I., 2011, GSA TODAY, V21, P4, DOI [10.1130/G119A.1, DOI 10.1130/G119A.1]; MARSHALL CR, 1990, PALEOBIOLOGY, V16, P1, DOI 10.1017/S0094837300009672; NEFF NA, 1979, SYST ZOOL, V28, P176, DOI 10.2307/2412521; Negrini RM, 2002, SMITHSON CONTRIB EAR, P11; NORRIS S. M., 2005, FRESHWATER FISHES ME; Oviatt CG, 2002, SMITHSON CONTRIB EAR, P121; Oviatt CG, 1994, UTAH GEOL ASS PUBL, V23, P97; Parenti LR, 1981, B AM MUS NAT HIST, V168, P335, DOI DOI 10.1080/00222930210135631; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reheis MC, 2002, SMITHSON CONTRIB EAR, P53; Reheis MC, 2008, 439 GEOL SOC AM; Retallack GJ, 2004, PALAEOGEOGR PALAEOCL, V214, P97, DOI 10.1016/j.palaeo.2004.07.024; Roskowski JA, 2010, GEOL SOC AM BULL, V122, P1625, DOI 10.1130/B30186.1; Sack D, 2002, SMITHSON CONTRIB EAR, P129; Smith G.R., 1993, P778; SMITH G.R., 1982, CENOZOIC GEOLOGY IDA, V26, P519; Smith G.R., 2000, U MICHIGAN MUSEUM PA, V32, P1; Smith Gerald R., 2013, Occasional Papers of the Museum of Zoology University of Michigan, V743, P1; Smith GR, 2010, EVOL ECOL RES, V12, P693; SMITH GERALD RAY, 1966, MISC PUBLICATIONS MUS ZOOL UNIV MICH, V129, P1; SMITH GR, 1992, SYST BIOL, V41, P41, DOI 10.2307/2992505; Smith GR, 2002, SMITHSON CONTRIB EAR, P175; SMITH GR, 1983, COPEIA, P37, DOI 10.2307/1444696; SMITH GR, 1971, SYST ZOOL, V20, P282, DOI 10.2307/2412341; Snyder JO, 1924, P US NATL MUS, V64, P1; Spencer JE, 2013, GEOSPHERE, V9, P444, DOI 10.1130/GES00896.1; Spencer JE, 2008, GEOL SOC AM SPEC PAP, V439, P279, DOI 10.1130/2008.2439(12); Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor D.W., 1985, P265; Tibbets CA, 1996, EVOLUTION, V50, P1280, DOI 10.1111/j.1558-5646.1996.tb02368.x; Tolan T. L., 2009, FIELD GUIDES, V15, P645; Webb SA, 2004, MOL PHYLOGENET EVOL, V30, P527, DOI 10.1016/S1055-7903(03)00257-4; Wernicke B, 2011, GEOL SOC AM BULL, V123, P1288, DOI 10.1130/B30274.1; WHEELER HE, 1954, J GEOL, V62, P525, DOI 10.1086/626205; [No title captured]	88	28	29	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90061	10.1371/journal.pone.0090061	http://dx.doi.org/10.1371/journal.pone.0090061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619087	Green Submitted, gold, Green Published			2022-12-27	WOS:000332842400008
J	Ye, CX; Zhang, LC; Liu, TS; Li, H; Liu, Q				Ye, Chaoxiong; Zhang, Lingcong; Liu, Taosheng; Li, Hong; Liu, Qiang			Visual Working Memory Capacity for Color Is Independent of Representation Resolution	PLOS ONE			English	Article							SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; FEATURES; NUMBER; INFORMATION; PRECISION; STORAGE; CONSOLIDATION; ALLOCATION; RESOURCES	Background: The relationship between visual working memory (VWM) capacity and resolution of representation have been extensively investigated. Several recent ERP studies using orientation (or arrow) stimuli suggest that there is an inverse relationship between VWM capacity and representation resolution. However, different results have been obtained in studies using color stimuli. This could be due to important differences in the experimental paradigms used in previous studies. Methodology/Principal Findings: We examined whether the same relationship between capacity and resolution holds for color information. Participants performed a color change detection task while their electroencephalography was recorded. We manipulated representation resolution by asking participants to detect either a salient change (low-resolution) or a subtle change (high-resolution) in color. We used an ERP component known as contralateral delay activity (CDA) to index the amount of information maintained in VWM. The result demonstrated the same pattern for both low- and high-resolution conditions, with no difference between conditions. Conclusions/Significance: This result suggests that VWM always represents a fixed number of approximately 3-4 colors regardless of the resolution of representation.	[Ye, Chaoxiong; Zhang, Lingcong] Minnan Normal Univ, Dept Educ Sci & Technol, Zhangzhou, Peoples R China; [Liu, Taosheng] Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA; [Liu, Taosheng] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Li, Hong; Liu, Qiang] Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China	MinNan Normal University; Michigan State University; Michigan State University; Liaoning Normal University	Liu, Q (corresponding author), Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China.	lq780614@163.com	Ye, Chaoxiong/T-1953-2019; Liu, Qiang/AAA-2260-2020; Liu, Taosheng/K-9148-2013; Ye, Chaoxiong/S-9025-2018	Ye, Chaoxiong/0000-0002-8301-7582; Liu, Taosheng/0000-0002-9768-0393; Ye, Chaoxiong/0000-0002-8301-7582	National Natural Science Foundation of China [NSFC 31170982]; NATIONAL EYE INSTITUTE [R01EY022727] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by awards from the National Natural Science Foundation of China (NSFC 31170982) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2008, PERCEPT PSYCHOPHYS, V70, P346, DOI 10.3758/PP.70.2.346; Anderson DE, 2011, J NEUROSCI, V31, P1128, DOI 10.1523/JNEUROSCI.4125-10.2011; Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x; Baddeley A, 1998, CURR OPIN NEUROBIOL, V8, P234, DOI 10.1016/S0959-4388(98)80145-1; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barton B, 2009, J EXP PSYCHOL HUMAN, V35, P1359, DOI 10.1037/a0015792; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Bays PM, 2009, J VISION, V9, DOI 10.1167/9.10.7; Becker MW, 2013, ATTEN PERCEPT PSYCHO, V75, P415, DOI 10.3758/s13414-012-0410-0; Brouwer AM, 2007, J VISION, V7, DOI 10.1167/7.5.6; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; Cowan N, 2005, COGNITIVE PSYCHOL, V51, P42, DOI 10.1016/j.cogpsych.2004.12.001; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Diamantopoulou S, 2011, EXP BRAIN RES, V209, P501, DOI 10.1007/s00221-011-2536-z; Fukuda K, 2010, CURR OPIN NEUROBIOL, V20, P177, DOI 10.1016/j.conb.2010.03.005; Gao ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057913; Gao ZF, 2011, BRAIN RES, V1406, P30, DOI 10.1016/j.brainres.2011.06.049; Gao ZF, 2011, BIOL PSYCHOL, V87, P296, DOI 10.1016/j.biopsycho.2011.03.013; Gao ZF, 2009, J VISION, V9, DOI 10.1167/9.7.17; Gorgoraptis N, 2011, J NEUROSCI, V31, P8502, DOI 10.1523/JNEUROSCI.0208-11.2011; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Hollingworth A, 2009, ATTEN PERCEPT PSYCHO, V71, P936, DOI 10.3758/APP.71.4.936; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Keshvari S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002927; Klaver P, 1999, NEUROREPORT, V10, P2001, DOI 10.1097/00001756-199907130-00002; Liu T, 2013, PSYCHOL SCI; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Luria R, 2011, NEUROPSYCHOLOGIA, V49, P1632, DOI 10.1016/j.neuropsychologia.2010.11.031; Luria R, 2010, J COGNITIVE NEUROSCI, V22, P496, DOI 10.1162/jocn.2009.21214; Machizawa MG, 2012, PSYCHOL SCI, V23, P554, DOI 10.1177/0956797611431988; Machizawa MG, 2011, NEUROPSYCHOLOGIA, V49, P1518, DOI 10.1016/j.neuropsychologia.2010.11.032; Mance I, 2012, J EXP PSYCHOL HUMAN, V38, P429, DOI 10.1037/a0023925; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Murray AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041223; Oh H, 2010, J COGNITIVE NEUROSCI, V22, P292, DOI 10.1162/jocn.2009.21250; Perron R, 2009, PSYCHOL RES-PSYCH FO, V73, P222, DOI 10.1007/s00426-008-0214-y; Scolari M, 2008, PSYCHON B REV, V15, P215, DOI 10.3758/PBR.15.1.215; Stevanovski B, 2011, ATTEN PERCEPT PSYCHO, V73, P1108, DOI 10.3758/s13414-011-0099-5; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Woodman GF, 2008, PSYCHON B REV, V15, P223, DOI 10.3758/PBR.15.1.223; Woodman GF, 2007, CEREB CORTEX, V17, pI118, DOI 10.1093/cercor/bhm065; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860; Zhang WW, 2009, PSYCHOL SCI, V20, P423, DOI 10.1111/j.1467-9280.2009.02322.x	47	21	24	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91681	10.1371/journal.pone.0091681	http://dx.doi.org/10.1371/journal.pone.0091681			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24618685	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400117
J	Schacht, A; Sommer, W; Shmuilovich, O; Martienz, PC; Martin-Loeches, M				Schacht, Annekathrin; Sommer, Werner; Shmuilovich, Olga; Casado Martienz, Pilar; Martin-Loeches, Manuel			Differential Task Effects on N400 and P600 Elicited by Semantic and Syntactic Violations	PLOS ONE			English	Article							SENTENCE COMPREHENSION; BRAIN POTENTIALS; WORKING-MEMORY; POSITIVE SHIFT; ERP; P300; INDEPENDENCE; SPECIFICITY; LEVEL	Syntactic violations in sentences elicit a P600 component in the event-related potential, which is frequently interpreted as signaling reanalysis or repair of the sentence structure. However, P600 components have been reported also for semantic and combined semantic and syntactic violations, giving rise to still other interpretations. In many of these studies, the violation might be of special significance for the task of the participants; however there is a lack of studies directly targeting task effects on the P600. Here we repeated a previously published study but using a probe verification task, focusing on individual words rather than on sentence correctness and directly compared the results with the previous ones. Although a (somewhat smaller) N400 component occurred also in the present study, we did not observe a parietal P600 component. Instead, we found a late anterior negativity. Possibly, the parietal P600 observed in sentence acceptability paradigms relates to the target value of the violations or to late sentence structure-specific processes that are more task-sensitive than the N400 and which are or not initiated in the probe verification task. In any case the present findings show a strong dependency of P600-eliciting processes from attention to the sentences context whereas the N400 eliciting processes appear relatively robust.	[Schacht, Annekathrin] Univ Gottingen, CRC Text Struct, D-37073 Gottingen, Germany; [Sommer, Werner; Shmuilovich, Olga] Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany; [Casado Martienz, Pilar; Martin-Loeches, Manuel] UCM ISCIII, Ctr Human Evolut & Behav, Madrid, Spain	University of Gottingen; Humboldt University of Berlin	Sommer, W (corresponding author), Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany.	Werner.Sommer@cms.HU-Berlin.de	Sommer, Werner/N-1945-2019; Schacht, Annekathrin/B-2521-2014; Sommer, Werner/H-4672-2011; Martin-Loeches, Manuel/G-4288-2017	Sommer, Werner/0000-0001-5266-3445; Sommer, Werner/0000-0001-5266-3445; Martin-Loeches, Manuel/0000-0002-3487-8423; Schacht, Anne/0000-0001-9471-3842	Erasmus exchange program of the European Union; German Initiative of Excellence	Erasmus exchange program of the European Union; German Initiative of Excellence	This research was supported by a grant of the Erasmus exchange program of the European Union to OS and by the German Initiative of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggio G, 2008, J MEM LANG, V59, P36, DOI 10.1016/j.jml.2008.02.005; Bargh J.A., 1994, HDB SOCIAL COGNITION, P1; CHWILLA DJ, 1995, PSYCHOPHYSIOLOGY, V32, P274, DOI 10.1111/j.1469-8986.1995.tb02956.x; Coulson S, 1998, LANG COGNITIVE PROC, V13, P21, DOI 10.1080/016909698386582; Deacon D, 2000, FRONT BIOSCI, V5, pE82, DOI 10.2741/deacon; Friederici AD, 1999, MEM COGNITION, V27, P438, DOI 10.3758/BF03211539; Friederici AD, 2001, COGNITIVE BRAIN RES, V11, P305, DOI 10.1016/S0926-6410(00)00065-3; Gunter TC, 1999, PSYCHOPHYSIOLOGY, V36, P126, DOI 10.1017/S004857729997155X; Gunter TC, 1997, PSYCHOPHYSIOLOGY, V34, P660, DOI 10.1111/j.1469-8986.1997.tb02142.x; Hagoort P, 2003, J COGNITIVE NEUROSCI, V15, P883, DOI 10.1162/089892903322370807; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hahne A, 1999, J COGNITIVE NEUROSCI, V11, P194, DOI 10.1162/089892999563328; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; Jiang XM, 2009, NEUROPSYCHOLOGIA, V47, P1799, DOI 10.1016/j.neuropsychologia.2009.02.020; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; JONIDES J, 1985, ACTA PSYCHOL, V60, P157, DOI 10.1016/0001-6918(85)90053-8; Kim A, 2005, J MEM LANG, V52, P205, DOI 10.1016/j.jml.2004.10.002; KING JW, 1995, J COGNITIVE NEUROSCI, V7, P376, DOI 10.1162/jocn.1995.7.3.376; Kolk HHJ, 2003, BRAIN LANG, V85, P1, DOI 10.1016/S0093-934X(02)00548-5; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Kuperberg GR, 2003, COGNITIVE BRAIN RES, V17, P117, DOI 10.1016/S0926-6410(03)00086-7; Kutas M., 2006, HDB PSYCHOLINGUISTIC; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Martin-Loeches M, 2006, BRAIN RES, V1093, P178, DOI 10.1016/j.brainres.2006.03.094; Martin-Loeches M, 2009, J COGNITIVE NEUROSCI, V21, P1365, DOI 10.1162/jocn.2009.21106; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; Munte TF, 1998, NEUROPSYCHOLOGIA, V36, P217, DOI 10.1016/S0028-3932(97)00119-X; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Osterhout L, 1999, LANG COGNITIVE PROC, V14, P283, DOI 10.1080/016909699386310; Osterhout L, 1996, J COGNITIVE NEUROSCI, V8, P507, DOI 10.1162/jocn.1996.8.6.507; Osterhout L, 1995, J MEM LANG, V34, P739, DOI 10.1006/jmla.1995.1033; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Schacht A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009742; Sebastian N., 2000, LEXESP LEXICO INFORM; Steinhauer K, 1997, Z EXP PSYCHOL, V44, P305; VANPETTEN C, 1991, MEM COGNITION, V19, P95, DOI 10.3758/BF03198500	39	44	46	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91226	10.1371/journal.pone.0091226	http://dx.doi.org/10.1371/journal.pone.0091226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614675	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300099
J	Bhat, S; Amundsen, PA; Knudsen, R; Gjelland, KO; Fevolden, SE; Bernatchez, L; Praebel, K				Bhat, Shripathi; Amundsen, Per-Arne; Knudsen, Rune; Gjelland, Karl Oystein; Fevolden, Svein-Erik; Bernatchez, Louis; Praebel, Kim			Speciation Reversal in European Whitefish (Coregonus lavaretus (L.)) Caused by Competitor Invasion	PLOS ONE			English	Article							REPRODUCTIVE ISOLATION; ECOLOGICAL SPECIATION; POPULATION-STRUCTURE; SPECIES COMPLEX; GENETIC ARCHITECTURE; DIVERGENT SELECTION; SEXUAL SELECTION; DNA MARKERS; ALBULA L.; HYBRIDIZATION	Invasion of exotic species has caused the loss of biodiversity and imparts evolutionary and ecological changes in the introduced systems. In northern Fennoscandia, European whitefish (Coregonus lavaretus (L.)) is a highly polymorphic species displaying adaptive radiations into partially reproductively isolated and thus genetically differentiated sympatric morphs utilizing the planktivorous and benthivorous food niche in many lakes. In 1993, Lake Skrukkebukta was invaded by vendace (Coregonus albula (L.)) which is a zooplanktivorous specialist. The vendace displaced the densely rakered whitefish from its preferred pelagic niche to the benthic habitat harbouring the large sparsely rakered whitefish. In this study, we investigate the potential influence of the vendace invasion on the breakdown of reproductive isolation between the two whitefish morphs. We inferred the genotypic and phenotypic differentiation between the two morphs collected at the arrival (1993) and 15 years after (2008) the vendace invasion using 16 microsatellite loci and gill raker numbers, the most distinctive adaptive phenotypic trait between them. The comparison of gill raker number distributions revealed two modes growing closer over 15 years following the invasion. Bayesian analyses of genotypes revealed that the two genetically distinct whitefish morphs that existed in 1993 had collapsed into a single population in 2008. The decline in association between the gill raker numbers and admixture values over 15 years corroborates the findings from the Bayesian analysis. Our study thus suggests an apparent decrease of reproductive isolation in a morph-pair of European whitefish within 15 years (. 3 generations) following the invasion of a superior trophic competitor (vendace) in a subarctic lake, reflecting a situation of "speciation in reverse''.	[Bhat, Shripathi; Amundsen, Per-Arne; Knudsen, Rune; Fevolden, Svein-Erik; Praebel, Kim] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Bernatchez, Louis] Univ Laval, IBIS, Quebec City, PQ, Canada; [Gjelland, Karl Oystein] Norwegian Inst Nat Res, Tromso, Norway	UiT The Arctic University of Tromso; Laval University; Norwegian Institute Nature Research	Bhat, S (corresponding author), Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway.	shripathi.bhat@uit.no	Gjelland, Karl/I-7023-2012; Præbel, Kim/A-2844-2014	Gjelland, Karl/0000-0003-4036-4207; Præbel, Kim/0000-0002-0681-1854; Amundsen, Per-Arne/0000-0002-2203-8216; Bernatchez, Louis/0000-0002-8085-9709	Norwegian Research Council [186320/V40]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was financially supported by the Norwegian Research Council (grant no. 186320/V40), www.forskningsradet.no. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Amundsen PA, 2004, ANN ZOOL FENN, V41, P291; Amundsen PA, 1999, BIOL CONSERV, V88, P405, DOI 10.1016/S0006-3207(98)00110-4; Amundsen PA, 2009, FRESHWATER BIOL, V54, P24, DOI 10.1111/j.1365-2427.2008.02088.x; Behm JE, 2010, AM NAT, V175, P11, DOI 10.1086/648559; Bernatchez L, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P175; Bernatchez L, 1996, EVOLUTION, V50, P624, DOI [10.2307/2410836, 10.1111/j.1558-5646.1996.tb03873.x]; Bernatchez L, 2010, PHILOS T R SOC B, V365, P1783, DOI 10.1098/rstb.2009.0274; Bohn T, 2004, OIKOS, V106, P138, DOI 10.1111/j.0030-1299.2004.13022.x; Bohn T, 1998, J PLANKTON RES, V20, P243, DOI 10.1093/plankt/20.2.243; Bohn T, 2008, BIOL INVASIONS, V10, P359, DOI 10.1007/s10530-007-9135-8; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Chouinard A, 1996, CAN J ZOOL, V74, P1989, DOI 10.1139/z96-226; Coyne J.A., 2004, SPECIATION; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; CROWDER LB, 1984, COPEIA, P878, DOI 10.2307/1445332; Filteau M, 2013, MOL BIOL EVOL, V30, P1384, DOI 10.1093/molbev/mst053; FOOTE CJ, 1988, BEHAVIOUR, V106, P63, DOI 10.1163/156853988X00098; Gagnaire PA, 2013, EVOLUTION, V67, P2483, DOI 10.1111/evo.12075; Gilman RT, 2011, EVOLUTION, V65, P2592, DOI 10.1111/j.1558-5646.2011.01320.x; Gjelland KO, 2007, J FISH BIOL, V71, P196, DOI 10.1111/j.1095-8649.2007.01678.x; Grant PR, 1996, PHILOS T ROY SOC B, V351, P765, DOI 10.1098/rstb.1996.0071; GRANT PR, 1993, PHILOS T R SOC B, V340, P127, DOI 10.1098/rstb.1993.0052; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Harrod C, 2010, J ANIM ECOL, V79, P1057, DOI 10.1111/j.1365-2656.2010.01702.x; Hatfield T, 1997, AM NAT, V149, P1009, DOI 10.1086/286036; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; IBM Corp, 2010, IBM SPSS STAT WIND V; Kahilainen K, 2006, J FISH BIOL, V68, P63, DOI 10.1111/j.0022-1112.2006.00876.x; Kahilainen KK, 2011, EVOL ECOL, V25, P573, DOI 10.1007/s10682-010-9411-4; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Klemetsen Anders, 2010, Freshwater Reviews, V3, P49, DOI 10.1608/FRJ-3.1.3; Lu GQ, 1998, P ROY SOC B-BIOL SCI, V265, P1025, DOI 10.1098/rspb.1998.0394; McKinnon JS, 2004, NATURE, V429, P294, DOI 10.1038/nature02556; Mutenia Ahti, 1992, Polskie Archiwum Hydrobiologii, V39, P797; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Ostbye K, 2006, MOL ECOL, V15, P3983, DOI 10.1111/j.1365-294X.2006.03062.x; Ostbye K, 2005, MOL ECOL, V14, P4371, DOI 10.1111/j.1365-294X.2005.02737.x; Ostbye K, 2005, J EVOLUTION BIOL, V18, P683, DOI 10.1111/j.1420-9101.2004.00844.x; Patton JC, 1997, CAN J FISH AQUAT SCI, V54, P1548, DOI 10.1139/cjfas-54-7-1548; Praebel K, 2013, ADV LIMNOL, V64, P247, DOI 10.1127/1612-166X/2013/0064-0026; Praebel K, 2013, ECOL EVOL, V3, P4970, DOI 10.1002/ece3.867; Praebel K, 2013, ECOL EVOL, V3, P1400, DOI 10.1002/ece3.552; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2012, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; RICE WR, 1984, EVOLUTION, V38, P1251, DOI 10.1111/j.1558-5646.1984.tb05647.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Rogers SM, 2007, MOL BIOL EVOL, V24, P1423, DOI 10.1093/molbev/msm066; Rogers SM, 2006, J EVOLUTION BIOL, V19, P1979, DOI 10.1111/j.1420-9101.2006.01150.x; Rogers SM, 2004, MOL ECOL NOTES, V4, P89, DOI 10.1046/j.1471-8286.2003.00578.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Saint-Laurent R, 2003, MOL ECOL, V12, P315, DOI 10.1046/j.1365-294X.2003.01735.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Seehausen O, 2006, CURR BIOL, V16, pR334, DOI 10.1016/j.cub.2006.03.080; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 1999, J EVOLUTION BIOL, V12, P514, DOI 10.1046/j.1420-9101.1999.00055.x; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Senn HV, 2010, MOL ECOL, V19, P910, DOI 10.1111/j.1365-294X.2009.04497.x; Siwertsson A, 2012, ADV LIMNOL, V63, P229; Siwertsson A, 2010, EVOL ECOL RES, V12, P929; Susnik S, 1999, MOL ECOL, V8, P1756, DOI 10.1046/j.1365-294x.1999.00723-2.x; Svardson G., 1979, REP I FRESHWATER RES, V57, P3; SVARDSON G., 1970, BIOL COREGONID FISHE, P33; SVARDSON GUNNAR, 1965, REP INST FRESHWATER RES DROTTNINGHOLM, V46, P95; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; TODD TN, 1989, CAN J ZOOL, V67, P1679, DOI 10.1139/z89-241; Turgeon J, 1999, EVOLUTION, V53, P1857, DOI 10.1111/j.1558-5646.1999.tb04568.x; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VARNAVSKAYA NV, 1994, CAN J FISH AQUAT SCI, V51, P147, DOI 10.1139/f94-301; Velema GJ, 2012, CAN J ZOOL, V90, P1328, DOI 10.1139/z2012-102; Vines TH, 2006, P ROY SOC B-BIOL SCI, V273, P911, DOI 10.1098/rspb.2005.3387; Vonlanthen P, 2012, NATURE, V482, P357, DOI 10.1038/nature10824; Vonlanthen P, 2009, J EVOLUTION BIOL, V22, P498, DOI 10.1111/j.1420-9101.2008.01670.x; WIMBERGER PH, 1994, BEL BAR LIB, P19; Winkler KA, 2008, MOL ECOL RESOUR, V8, P1055, DOI 10.1111/j.1755-0998.2008.02153.x; Woods PJ, 2009, J EVOLUTION BIOL, V22, P2305, DOI 10.1111/j.1420-9101.2009.01846.x; Zimmerman CE, 2000, CAN J FISH AQUAT SCI, V57, P2152, DOI 10.1139/cjfas-57-10-2152	84	40	42	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91208	10.1371/journal.pone.0091208	http://dx.doi.org/10.1371/journal.pone.0091208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626131	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300065
J	Cheng, CY; Lin, JG; Tang, NY; Kao, ST; Hsieh, CL				Cheng, Chin-Yi; Lin, Jaung-Geng; Tang, Nou-Ying; Kao, Shung-Te; Hsieh, Ching-Liang			Electroacupuncture-Like Stimulation at the Baihui (GV20) and Dazhui (GV14) Acupoints Protects Rats against Subacute-Phase Cerebral Ischemia-Reperfusion Injuries by Reducing S100B-Mediated Neurotoxicity	PLOS ONE			English	Article							PERMANENT FOCAL ISCHEMIA; APOPTOTIC CELL-DEATH; BRAIN-DAMAGE; ASTROCYTIC ACTIVATION; ARTERY OCCLUSION; NEONATAL-RAT; EXPRESSION; STROKE; S100B; INFARCTION	Objectives: The purpose of this study was to evaluate the effects of electroacupuncture-like stimulation at the Baihui (GV20) and Dazhui (GV14) acupoints (EA at acupoints) during the subacute phase of cerebral ischemia-reperfusion (I/R) injury and to establish the neuroprotective mechanisms involved in the modulation of the S100B-mediated signaling pathway. Methods: The experimental rats were subjected to middle cerebral artery occlusion (MCAo) for 15 min followed by 1 d or 7 d of reperfusion. EA at acupoints was applied 1 d postreperfusion then once daily for 6 consecutive days. Results: We observed that 15 min of MCAo caused delayed infarct expansion 7 d after reperfusion. EA at acupoints significantly reduced the cerebral infarct and neurological deficit scores. EA at acupoints also downregulated the expression of the glial fibrillary acidic protein (GFAP), S100B, nuclear factor-kappa B (NF-kappa B; p50), and tumor necrosis factor-alpha (TNF-alpha), and reduced the level of inducible nitric oxide synthase (iNOS) and apoptosis in the ischemic cortical penumbra 7 d after reperfusion. Western blot analysis showed that EA at acupoints significantly downregulated the cytosolic expression of phospho-p38 MAP kinase (p-p38 MAP kinase), tumor necrosis factor receptor type 1-associated death domain (TRADD), Fas-associated death domain (FADD), cleaved caspase-8, and cleaved caspase-3 in the ischemic cortical penumbra 7 d after reperfusion. EA at acupoints significantly reduced the numbers of GFAP/S100B and S100B/nitrotyrosine double-labeled cells. Conclusion: Our study results indicate that EA at acupoints initiated 1 d postreperfusion effectively downregulates astrocytic S100B expression to provide neuroprotection against delayed infarct expansion by modulating p38 MAP kinase-mediated NF-kappa B expression. These effects subsequently reduce oxidative/nitrative stress and inhibit the TNF-alpha/TRADD/ FADD/cleaved caspase-8/cleaved caspase-3 apoptotic pathway in the ischemic cortical penumbra 7 d after reperfusion.	[Cheng, Chin-Yi; Lin, Jaung-Geng; Tang, Nou-Ying; Kao, Shung-Te] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Cheng, Chin-Yi] Hui Sheng Hosp, Dept Chinese Med, Taichung, Taiwan; [Hsieh, Ching-Liang] China Med Univ, Acupuncture Res Ctr, Taichung, Taiwan; [Hsieh, Ching-Liang] China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan; [Hsieh, Ching-Liang] China Med Univ, Grad Inst Integrated Med, Coll Chinese Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Hsieh, CL (corresponding author), China Med Univ, Acupuncture Res Ctr, Taichung, Taiwan.	clhsieh@mail.cmuh.org.tw			China Medical University [CMU101-S-07]; Taiwanese Department of Health, Clinical Trials and Research Center of Excellence [DOH102-TD-B-111-004]	China Medical University(China Medical University); Taiwanese Department of Health, Clinical Trials and Research Center of Excellence	This study was supported by grants from China Medical University (CMU101-S-07), and the Taiwanese Department of Health, Clinical Trials and Research Center of Excellence (DOH102-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2005, CNS NEUROL DISORD-DR, V4, P127, DOI 10.2174/1568007053544084; Bianchi R, 2007, J LEUKOCYTE BIOL, V81, P108, DOI 10.1189/jlb.0306198; Buyukuysal RL, 2005, NEUROCHEM INT, V47, P580, DOI 10.1016/j.neuint.2005.06.009; Chao XD, EXP NEUROL, V239, P163; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cheng CY, 2010, ACTA PHARMACOL SIN, V31, P889, DOI 10.1038/aps.2010.66; Clemens JA, 1997, MOL BRAIN RES, V48, P187, DOI 10.1016/S0169-328X(97)00092-2; Coeroli L, 1998, J NEUROCHEM, V70, P2516; Collino M, 2008, SHOCK, V30, P299, DOI 10.1097/SHK.0b013e318164e762; Collino M, 2006, FREE RADICAL BIO MED, V41, P1619, DOI 10.1016/j.freeradbiomed.2006.09.013; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Figiel I, 2008, ACTA NEUROBIOL EXP, V68, P526; Gow AJ, 1996, FEBS LETT, V385, P63, DOI 10.1016/0014-5793(96)00347-X; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Hu JR, 1996, BBA-MOL CELL RES, V1313, P239, DOI 10.1016/0167-4889(96)00095-X; Iadecola C, 1997, J NEUROSCI, V17, P9157; Johansson BB, 2001, STROKE, V32, P707, DOI 10.1161/01.STR.32.3.707; Jung DH, 2009, J ETHNOPHARMACOL, V125, P374, DOI 10.1016/j.jep.2009.08.002; Lee JM, 2002, NEUROSCIENCE, V115, P871, DOI 10.1016/S0306-4522(02)00513-4; Lee SH, 2002, BRAIN RES, V956, P14, DOI 10.1016/S0006-8993(02)03197-9; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Luo Y, 2011, CHIN J INTEGR MED, V17, P750, DOI 10.1007/s11655-011-0754-7; Matsui T, 2002, J CEREBR BLOOD F MET, V22, P711, DOI 10.1097/00004647-200206000-00010; Mori T, 2005, J CEREBR BLOOD F MET, V25, P748, DOI 10.1038/sj.jcbfm.9600063; Mori T., 2010, CARDIOVASC PSYCHIAT; Mori T, 2008, STROKE, V39, P2114, DOI 10.1161/STROKEAHA.107.503821; Park J, 2001, J NEUROL, V248, P558, DOI 10.1007/s004150170132; Pizzi M, 2009, FEBS J, V276, P27, DOI 10.1111/j.1742-4658.2008.06767.x; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Sallstrom S, 1995, Tidsskr Nor Laegeforen, V115, P2884; Tanaka Y, 2007, BRAIN RES, V1137, P140, DOI 10.1016/j.brainres.2006.12.025; Tateishi N, 1998, Nihon Yakurigaku Zasshi, V112 Suppl 1, p103P; Wang Q, 2005, NEUROSCI LETT, V381, P158, DOI 10.1016/j.neulet.2005.02.019; Wang YH, 2006, J BIOMED SCI, V13, P127, DOI 10.1007/s11373-005-9031-0; Xiong L, 2003, CHINESE MED J-PEKING, V116, P108; Yang J, 2011, BRAIN RES, V1398, P94, DOI 10.1016/j.brainres.2011.05.007; Yasuda Y, 2004, BRAIN RES, V1021, P20, DOI 10.1016/j.brainres.2004.06.015; Ye YL, 2007, EUR J PHARMACOL, V557, P23, DOI 10.1016/j.ejphar.2006.11.003; Yu LY, 2006, NEUROCHEM RES, V31, P21, DOI 10.1007/s11064-005-9004-8; Zhai DX, 2008, NEUROSCI LETT, V445, P117, DOI 10.1016/j.neulet.2008.08.077; Zhang F, 2011, BRAIN INJURY, V25, P895, DOI 10.3109/02699052.2011.581639; Zhou Hai-peng, 2011, Zhonghua Yi Xue Za Zhi, V91, P1203; Zhu CL, 2004, J NEUROCHEM, V90, P462, DOI 10.1111/j.1471-4159.2004.02500.x; Zong H, J BIOL CHEM, V285, P23137	44	37	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91426	10.1371/journal.pone.0091426	http://dx.doi.org/10.1371/journal.pone.0091426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626220	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300084
J	Hoeppner, MP; Lundquist, A; Pirun, M; Meadows, JRS; Zamani, N; Johnson, J; Sundstrom, G; Cook, A; FitzGerald, MG; Swofford, R; Mauceli, E; Moghadam, BT; Greka, A; Alfoldi, J; Abouelleil, A; Aftuck, L; Bessette, D; Berlin, A; Brown, A; Gearin, G; Lui, A; Macdonald, JP; Priest, M; Shea, T; Turner-Maier, J; Zimmer, A; Lander, ES; di Palma, F; Lindblad-Toh, K; Grabherr, MG				Hoeppner, Marc P.; Lundquist, Andrew; Pirun, Mono; Meadows, Jennifer R. S.; Zamani, Neda; Johnson, Jeremy; Sundstrom, Gorel; Cook, April; FitzGerald, Michael G.; Swofford, Ross; Mauceli, Evan; Moghadam, Behrooz Torabi; Greka, Anna; Alfoeldi, Jessica; Abouelleil, Amr; Aftuck, Lynne; Bessette, Daniel; Berlin, Aaron; Brown, Adam; Gearin, Gary; Lui, Annie; Macdonald, J. Pendexter; Priest, Margaret; Shea, Terrance; Turner-Maier, Jason; Zimmer, Andrew; Lander, Eric S.; di Palma, Federica; Lindblad-Toh, Kerstin; Grabherr, Manfred G.			An Improved Canine Genome and a Comprehensive Catalogue of Coding Genes and Non-Coding Transcripts	PLOS ONE			English	Article							RNA; SEQUENCE; IDENTIFICATION; DOMESTICATION; LANDSCAPE; LINCRNAS; MUTATION; CIS	The domestic dog, Canis familiaris, is a well-established model system for mapping trait and disease loci. While the original draft sequence was of good quality, gaps were abundant particularly in promoter regions of the genome, negatively impacting the annotation and study of candidate genes. Here, we present an improved genome build, canFam3.1, which includes 85 MB of novel sequence and now covers 99.8% of the euchromatic portion of the genome. We also present multiple RNA-Sequencing data sets from 10 different canine tissues to catalog similar to 175,000 expressed loci. While about 90% of the coding genes previously annotated by EnsEMBL have measurable expression in at least one sample, the number of transcript isoforms detected by our data expands the EnsEMBL annotations by a factor of four. Syntenic comparison with the human genome revealed an additional similar to 3,000 loci that are characterized as protein coding in human and were also expressed in the dog, suggesting that those were previously not annotated in the EnsEMBL canine gene set. In addition to,20,700 high-confidence protein coding loci, we found,4,600 antisense transcripts overlapping exons of protein coding genes, similar to 7,200 intergenic multi-exon transcripts without coding potential, likely candidates for long intergenic non-coding RNAs (lincRNAs) and,11,000 transcripts were reported by two different library construction methods but did not fit any of the above categories. Of the lincRNAs, about 6,000 have no annotated orthologs in human or mouse. Functional analysis of two novel transcripts with shRNA in a mouse kidney cell line altered cell morphology and motility. All in all, we provide a much-improved annotation of the canine genome and suggest regulatory functions for several of the novel non-coding transcripts.	[Hoeppner, Marc P.; Meadows, Jennifer R. S.; Zamani, Neda; Sundstrom, Gorel; Lindblad-Toh, Kerstin; Grabherr, Manfred G.] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Labs, Uppsala, Sweden; [Lundquist, Andrew; Johnson, Jeremy; Cook, April; FitzGerald, Michael G.; Swofford, Ross; Greka, Anna; Alfoeldi, Jessica; Abouelleil, Amr; Aftuck, Lynne; Bessette, Daniel; Berlin, Aaron; Brown, Adam; Gearin, Gary; Lui, Annie; Macdonald, J. Pendexter; Priest, Margaret; Shea, Terrance; Turner-Maier, Jason; Zimmer, Andrew; Lander, Eric S.; di Palma, Federica; Lindblad-Toh, Kerstin; Grabherr, Manfred G.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Lundquist, Andrew] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA USA; [Lundquist, Andrew] Harvard Univ, Sch Med, Charlestown, MA USA; [Pirun, Mono] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Mauceli, Evan] Boston Childrens Hosp, Boston, MA USA; [Moghadam, Behrooz Torabi] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden; [di Palma, Federica] Genome Anal Ctr, Norwich, Norfolk, England	Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Memorial Sloan Kettering Cancer Center; Harvard University; Boston Children's Hospital; Uppsala University; The Genome Analysis Centre (TGAC)	Lindblad-Toh, K (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Labs, Uppsala, Sweden.	kersli@broadinstitute.org; manfred.grabherr@imbim.uu.se	Berlin, Aaron M/AFY-6549-2022	Berlin, Aaron M/0000-0002-0714-2808; Meadows, Jennifer/0000-0002-0850-230X; Swofford, Ross/0000-0003-3676-8479; Grabherr, Manfred/0000-0001-8792-6508; Di-Palma, Federica/0000-0002-4394-0102	NHGRI [U54 HG003067]; Uppsala University; Swedish Medical Research Council; Research Council FORMAS; European Commission [FP7-LUPA, GA-201370]; Science for Life Laboratory; BBSRC [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Uppsala University; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Research Council FORMAS(Swedish Research Council Formas); European Commission(European CommissionEuropean Commission Joint Research Centre); Science for Life Laboratory; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded in part by NHGRI (U54 HG003067), Uppsala University, Swedish Medical Research Council, Research Council FORMAS, and the European Commission (FP7-LUPA, GA-201370), and a start-up grant from the Science for Life Laboratory to MGG. KLT is a recipient of a EURYI from the ESF and received a Consolidator Award from ERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Axelsson E, 2012, GENOME RES, V22, P51, DOI 10.1101/gr.124123.111; Bannasch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009632; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Bogdanov EA, 2010, CURR PROTOC MOL BIOL, V5, P11, DOI DOI 10.1002/0471142727.MB3001S90; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Braidotti G, 2004, COLD SPRING HARB SYM, V69, P55, DOI 10.1101/sqb.2004.69.55; DAVIS SJM, 1978, NATURE, V276, P608, DOI 10.1038/276608a0; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Downs LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021452; Dreger DL, 2013, J HERED, V104, P399, DOI 10.1093/jhered/est012; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Grabherr MG, 2010, BIOINFORMATICS, V26, P1145, DOI 10.1093/bioinformatics/btq102; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hoopes BC, 2012, MAMM GENOME, V23, P780, DOI 10.1007/s00335-012-9417-z; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lequarre AS, 2011, VET J, V189, P155, DOI 10.1016/j.tvjl.2011.06.013; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Olsson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001332; Owczarek-Lipska M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039176; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Pauler FM, 2007, TRENDS GENET, V23, P284, DOI 10.1016/j.tig.2007.03.018; Pielberg GR, 2008, NAT GENET, V40, P1004, DOI 10.1038/ng.185; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Salzberg SL, 2005, BIOINFORMATICS, V21, P4320, DOI 10.1093/bioinformatics/bti769; Schmidt EE, 1996, CURR BIOL, V6, P768, DOI 10.1016/S0960-9822(02)00589-4; Schoenebeck JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002849; Seppala EH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002194; Shearin AL, 2010, DIS MODEL MECH, V3, P27, DOI 10.1242/dmm.004358; Skoglund P, 2011, MOL BIOL EVOL, V28, P1505, DOI 10.1093/molbev/msq342; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Weiss B, 1999, CELL MOL LIFE SCI, V55, P334, DOI 10.1007/s000180050296; Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525; Yanagida-Asanuma E, 2007, AM J PATHOL, V171, P415, DOI 10.2353/ajpath.2007.070075	50	131	132	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91172	10.1371/journal.pone.0091172	http://dx.doi.org/10.1371/journal.pone.0091172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625832	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300061
J	Mandal, M; Mukhopadhyay, A				Mandal, Monalisa; Mukhopadhyay, Anirban			A Graph-Theoretic Approach for Identifying Non-Redundant and Relevant Gene Markers from Microarray Data Using Multiobjective Binary PSO	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; FEATURE-SELECTION; CANCER; CLASSIFICATION	The purpose of feature selection is to identify the relevant and non-redundant features from a dataset. In this article, the feature selection problem is organized as a graph-theoretic problem where a feature-dissimilarity graph is shaped from the data matrix. The nodes represent features and the edges represent their dissimilarity. Both nodes and edges are given weight according to the feature's relevance and dissimilarity among the features, respectively. The problem of finding relevant and non-redundant features is then mapped into densest subgraph finding problem. We have proposed a multiobjective particle swarm optimization (PSO)-based algorithm that optimizes average node-weight and average edge-weight of the candidate subgraph simultaneously. The proposed algorithm is applied for identifying relevant and non-redundant disease-related genes from microarray gene expression data. The performance of the proposed method is compared with that of several other existing feature selection techniques on different real-life microarray gene expression datasets.	[Mandal, Monalisa; Mukhopadhyay, Anirban] Univ Kalyani, Dept Comp Sci & Engn, Kalyani 741235, W Bengal, India	Kalyani University	Mandal, M (corresponding author), Univ Kalyani, Dept Comp Sci & Engn, Kalyani 741235, W Bengal, India.	monalisa@klyuniv.ac.in; anirban@klyuniv.ac.in	Mukhopadhyay, Anirban/H-3220-2012; Mukhopadhyay, Anirban/ABB-5739-2021	Mukhopadhyay, Anirban/0000-0001-8128-3521				Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Bahmani B, 2012, PROC VLDB ENDOW, V5, P454, DOI 10.14778/2140436.2140442; Baya A, 2007, GENE SET ENRICHMENT; Cai D, 2010, KDD10 WASH DC US; Chen LF, 2012, INTELL DATA ANAL, V16, P167, DOI 10.3233/IDA-2012-0517; Cheok M, 2003, OPERATIONS RES LETT, V31; Cheok MH, 2003, NAT GENET, V34, P85, DOI 10.1038/ng1151; Chuang L, 2011, INT C MACH LEARN COM; Coello CAC, 2006, IEEE COMPUT INTELL M, V1, P28, DOI 10.1109/MCI.2006.1597059; Cover T.M., 2006, ELEM INF THEORY, V2nd, P16; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, MULTIOBJECTIVE OPTIM; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Dy JG, 2003, IEEE T PATTERN ANAL, V25, P373, DOI 10.1109/TPAMI.2003.1182100; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fukuta K, 2012, P INT CONTR INN COMP; Gordon GJ, 2002, CANCER RES, V62, P4963; Hall M. A., 1999, P 12 INT FLAIRS C; Hanczar B, 2003, SIGKDD EXPLOR NEWSLE; Iashkargir M, 2009, INT J COMPUTER SCI I, V4; Jaeger J, 2003, PAC S BIOCOMPUT; Jiang S, 2012, NEW FRONTIERS APPL D; Kamandar M, 2009, INT C HYBR ART INT S; Kamandar M, 2011, INT WORKSH GRAPH BAS; Kamandar M., 2011, 19 IR C EL ENG ICEE; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Krause E, ADDISON WESLEY INNOV; Lee I, 2011, J CLIN BIOINFORMATIC, V1; Li Y, 2006, HYBRID METHOD UNSUPE; Liu YN, 2011, J BIONIC ENG, V8, P191, DOI 10.1016/S1672-6529(11)60020-6; M-Cedeno A, 2010, P IEEE IND EL SOC; Mankiewicz R., 2000, STORY MATH; Mao KZ, 2004, IEEE T SYST MAN CY B, V34, P629, DOI 10.1109/TSMCB.2002.804363; Maulik U, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-27; Mitra P, 2002, IEEE T PATTERN ANAL, V24, P301, DOI 10.1109/34.990133; Mohamad MS, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-15; Morita M., 2004, FRONTIERS HANDWRITIN; Parsopoulos KE, 2010, PARTICLE SWARM OPTIMIZATION AND INTELLIGENCE: ADVANCES AND APPLICATIONS, P1, DOI 10.4018/978-1-61520-666-7; Reyes-Sierra M., 2006, INT J COMPUTATIONAL, V2, P287, DOI DOI 10.5019/J.IJCIR.2006.68; Ruiz R, 2006, PATTERN RECOGN, V39, P2383, DOI 10.1016/j.patcog.2005.11.001; Shipp M, 2002, NATURE MED, V8; Tang E, 2005, IEEE S COMP INT BIOI; Troyanskaya OG, 2002, BIOINFORMATICS, V18, P1454, DOI 10.1093/bioinformatics/18.11.1454; Unler A, 2010, EUR J OPER RES, V206, P528, DOI 10.1016/j.ejor.2010.02.032; Wang X, 2009, INT C GEN INF; Xue B, 2013, IEEE T CYBERNETICS, V43, P1656, DOI 10.1109/TSMCB.2012.2227469; Xue B, 2012, CONNECT SCI, V24, P91, DOI 10.1080/09540091.2012.737765; Yoon YR, 2008, INFORM SCIENCES, V178, P88, DOI 10.1016/j.ins.2007.08.013; Zhang Z, 2011, GRAPH BASED APPROACH	49	30	30	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90949	10.1371/journal.pone.0090949	http://dx.doi.org/10.1371/journal.pone.0090949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625895	Green Published, gold			2022-12-27	WOS:000332851300043
J	Wojtalewicz, N; Sadeqzadeh, E; Weiss, JV; Tehrani, MM; Klein-Scory, S; Hahn, S; Schmiegel, W; Warnken, U; Schnolzer, M; de Bock, CE; Thorne, RF; Schwarte-Waldhoff, I				Wojtalewicz, Nathalie; Sadeqzadeh, Elham; Weiss, Jakob V.; Tehrani, Mahnaz Moradian; Klein-Scory, Susanne; Hahn, Stephan; Schmiegel, Wolff; Warnken, Uwe; Schnoelzer, Martina; de Bock, Charles E.; Thorne, Rick F.; Schwarte-Waldhoff, Irmgard			A Soluble Form of the Giant Cadherin Fat1 Is Released from Pancreatic Cancer Cells by ADAM10 Mediated Ectodomain Shedding	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; PROTOCADHERIN FAT1; BETA-CATENIN; DROSOPHILA; EXPRESSION; SERUM; PROTEINS; ADHESION; HOMOLOG; BIOMARKERS	In pancreatic cancer, there is a clear unmet need to identify new serum markers for either early diagnosis, therapeutic stratification or patient monitoring. Proteomic analysis of tumor cell secretomes is a promising approach to indicate proteins released from tumor cells in vitro. Ectodomain shedding of transmembrane proteins has previously been shown to contribute significant fractions the tumor cell secretomes and to generate valuable serum biomarkers. Here we introduce a soluble form of the giant cadherin Fat1 as a novel biomarker candidate. Fat1 expression and proteolytic processing was analyzed by mass spectrometry and Western blotting using pancreatic cancer cell lines as compared to human pancreatic ductal epithelial cells. RNA expression in cancer tissues was assessed by in silico analysis of publically available microarray data. Involvement of ADAM10 (A Disintegrin and metalloproteinase domain-containing protein 10) in Fat1 ectodomain shedding was analyzed by chemical inhibition and knockdown experiments. A sandwich ELISA was developed to determine levels of soluble Fat1 in serum samples. In the present report we describe the release of high levels of the ectodomain of Fat1 cadherin into the secretomes of human pancreatic cancer cells in vitro, a process that is mediated by ADAM10. We confirm the full-length and processed heterodimeric form of Fat1 expressed on the plasma membrane and also show the p60 C-terminal transmembrane remnant fragment corresponding to the shed ectodomain. Fat1 and its sheddase ADAM10 are overexpressed in pancreatic adenocarcinomas and ectodomain shedding is also recapitulated in vivo leading to increased Fat1 serum levels in some pancreatic cancer patients. We suggest that soluble Fat1 may find an application as a marker for patient monitoring complementing carbohydrate antigen 19-9 (CA19-9). In addition, detailed analysis of the diverse processed protein isoforms of the candidate tumor suppressor Fat1 can also contribute to our understanding of cell biology and tumor behavior.	[Wojtalewicz, Nathalie; Weiss, Jakob V.; Klein-Scory, Susanne; Schwarte-Waldhoff, Irmgard] Ruhr Univ Bochum, Knappschaftskrankenhaus, Dept Internal Med, IMBL, Bochum, Germany; [Sadeqzadeh, Elham; Thorne, Rick F.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Tehrani, Mahnaz Moradian; Warnken, Uwe; Schnoelzer, Martina] German Canc Res Ctr, Heidelberg, Germany; [Hahn, Stephan] Ruhr Univ Bochum, Dept Mol Gastrointestinal Oncol, Bochum, Germany; [Schmiegel, Wolff] Ruhr Univ Bochum, Knappschaftskrankenhaus, Dept Internal Med, Bochum, Germany; [de Bock, Charles E.] Vlaams Inst Biotechnol, Ctr Biol Dis, Louvain, Belgium	Ruhr University Bochum; University of Newcastle; Helmholtz Association; German Cancer Research Center (DKFZ); Ruhr University Bochum; Ruhr University Bochum; Flanders Institute for Biotechnology (VIB)	Schwarte-Waldhoff, I (corresponding author), Ruhr Univ Bochum, Knappschaftskrankenhaus, Dept Internal Med, IMBL, Univ Str 150, Bochum, Germany.	Irmgard.Schwarte-Waldhoff@rub.de	de Bock, Charles/H-7699-2019; Hahn, Stephan/E-3880-2010; Hahn, Stephan A./AAV-6062-2021	de Bock, Charles/0000-0001-5182-8535; Hahn, Stephan/0000-0003-0855-9741; Hahn, Stephan A./0000-0003-0855-9741; Thorne, Rick/0000-0001-7882-7081; Wojtalewicz, Nathalie/0000-0002-1977-7931; Klein-Scory, Susanne/0000-0003-1930-3354	Bundesministerium fur Bildung und Forschung, NGFN Plus program [01GS08117, 01GS08118]; Hunter Translational Cancer Research Unit	Bundesministerium fur Bildung und Forschung, NGFN Plus program(Federal Ministry of Education & Research (BMBF)); Hunter Translational Cancer Research Unit	This work was supported by the Bundesministerium fur Bildung und Forschung, NGFN Plus program, 01GS08117 (to MS) and 01GS08118 (to IS-W) and by a grant from the Hunter Translational Cancer Research Unit (to RFT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk KA, 2011, LIFE SCI, V89, P304, DOI 10.1016/j.lfs.2011.06.020; Ballehaninna UK, 2011, INDIA J SURG ONCOL, V2, P88, DOI 10.1007/s13193-011-0042-1; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; Chosdol K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-5; Ciani L, 2003, MOL CELL BIOL, V23, P3575, DOI 10.1128/MCB.23.10.3575-3582.2003; Cox B, 2000, DEV DYNAM, V217, P233, DOI 10.1002/(SICI)1097-0177(200003)217:3<233::AID-DVDY1>3.0.CO;2-O; de Bock CE, 2012, LEUKEMIA, V26, P918, DOI 10.1038/leu.2011.319; Diehl HC, 2007, PROTEOM CLIN APPL, V1, P47, DOI 10.1002/prca.200600491; DUNNE J, 1995, GENOMICS, V30, P207, DOI 10.1006/geno.1995.9884; Faca VM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002425; Feng YQ, 2009, P NATL ACAD SCI USA, V106, P11989, DOI 10.1073/pnas.0811540106; Fong ZV, 2012, CANCER J, V18, P530, DOI 10.1097/PPO.0b013e31827654ea; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004; Gunawardana CG, 2009, J PROTEOME RES, V8, P4705, DOI 10.1021/pr900411g; Humphris JL, 2012, ANN ONCOL, V23, P1713, DOI 10.1093/annonc/mdr561; Hundhausen Christian, 2003, Blood, V102, P1186; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Katoh Y, 2006, INT J MOL MED, V18, P523; Kwaepila N, 2006, PATHOLOGY, V38, P125, DOI 10.1080/00313020600559975; LOHR M, 1994, BRIT J CANCER, V69, P144, DOI 10.1038/bjc.1994.24; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Magg T, 2005, EXP CELL RES, V307, P100, DOI 10.1016/j.yexcr.2005.03.006; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Marrelli D, 2009, AM J SURG, V198, P333, DOI 10.1016/j.amjsurg.2008.12.031; May M, 2009, NAT MED, V15, P828, DOI 10.1038/nm0809-828; Medina M, 2003, CELL SIGNAL, V15, P829, DOI 10.1016/S0898-6568(03)00041-X; Moeller MJ, 2004, EMBO J, V23, P3769, DOI 10.1038/sj.emboj.7600380; Moradian Tehrani M, 2012, THESIS U HEIDELBERG; Moss ML, 2010, COMB CHEM HIGH T SCR, V13, P358; Nakaya K, 2007, ONCOGENE, V26, P5300, DOI 10.1038/sj.onc.1210330; Nawrocki-Raby B, 2003, INT J CANCER, V105, P790, DOI 10.1002/ijc.11168; O'Reilly EM, 2012, CANCER J, V18, P609, DOI 10.1097/PPO.0b013e3182758e27; Ponassi M, 1999, MECH DEVELOP, V80, P207, DOI 10.1016/S0925-4773(98)00217-2; Sadeqzadeh E, 2013, MED RES REV IN PRESS; Sadeqzadeh E, 2011, J BIOL CHEM, V286, P28181, DOI 10.1074/jbc.M111.234419; Settakorn J, 2005, J CLIN PATHOL, V58, P1249, DOI 10.1136/jcp.2005.026575; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Singh S, 2011, DIGEST DIS SCI, V56, P2491, DOI 10.1007/s10620-011-1709-8; Sopko R, 2009, CURR OPIN CELL BIOL, V21, P717, DOI 10.1016/j.ceb.2009.07.001; Symowicz J, 2007, CANCER RES, V67, P2030, DOI 10.1158/0008-5472.CAN-06-2808; Tanoue T, 2005, J CELL SCI, V118, P2347, DOI 10.1242/jcs.02398; TEMPERO MA, 1987, CANCER RES, V47, P5501; Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954; van Kilsdonk JWJ, 2010, EUR J CELL BIOL, V89, P415, DOI 10.1016/j.ejcb.2009.11.026; Vestergaard EM, 1999, CLIN CHEM, V45, P54; Volmer MW, 2005, PROTEOMICS, V5, P2587, DOI 10.1002/pmic.200401188; Weiss JV, 2011, INT J CANCER, V128, P1384, DOI 10.1002/ijc.25438; Xue H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-52	51	20	22	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90461	10.1371/journal.pone.0090461	http://dx.doi.org/10.1371/journal.pone.0090461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625754	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300020
J	Forbes, KM; Stuart, P; Mappes, T; Hoset, KS; Henttonen, H; Huitu, O				Forbes, Kristian M.; Stuart, Peter; Mappes, Tapio; Hoset, Katrine S.; Henttonen, Heikki; Huitu, Otso			Diet Quality Limits Summer Growth of Field Vole Populations	PLOS ONE			English	Article							FOOD SUPPLEMENTATION EXPERIMENTS; RODENT DYNAMICS; CYCLES; PREDATION; CLIMATE; AVAILABILITY; REPRODUCTION; TERRESTRIAL; TEMPERATURE; MECHANISMS	Marked variation occurs in both seasonal and multiannual population density peaks of northern European small mammal species, including voles. The availability of dietary proteins is a key factor limiting the population growth of herbivore species. The objective of this study is to investigate the degree to which protein availability influences the growth of increasing vole populations. We hypothesise that the summer growth of folivorous vole populations is positively associated with dietary protein availability. A field experiment was conducted over a summer reproductive period in 18 vegetated enclosures. Populations of field voles (Microtus agrestis) were randomised amongst three treatment groups: 1) food supplementation with ad libitum high protein (30% dry weight) pellets, 2) food supplementation with ad libitum low protein (1% dry weight; both supplemented foods had equivalent energy content) pellets, and 3) control (no food supplementation), n = 6 per treatment. Vole density, survival, demographic attributes and condition indicators were monitored with live-trapping and blood sampling. Highest final vole densities were attained in populations that received high protein supplementation and lowest in low protein populations. Control populations displayed intermediate densities. The survival rate of voles was similar in all treatment groups. The proportion of females, and of those that were pregnant or lactating, was highest in the high protein supplemented populations. This suggests that variation in reproductive, rather than survival rates of voles, accounted for density differences between the treatment groups. We found no clear association between population demography and individual physiological condition. Our results demonstrate that dietary protein availability limits vole population growth during the summer growing season. This suggests that the nutritional quality of forage may be an underestimated source of interannual variation in the density and growth rates of widely fluctuating populations of herbivorous small mammals.	[Forbes, Kristian M.; Stuart, Peter; Huitu, Otso] Finnish Forest Res Inst, Suonenjoki Res Unit, Suonenjoki, Finland; [Forbes, Kristian M.; Mappes, Tapio] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Stuart, Peter] Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic; [Hoset, Katrine S.] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Henttonen, Heikki] Finnish Forest Res Inst, Vantaa Res Unit, Vantaa, Finland	Natural Resources Institute Finland (Luke); University of Jyvaskyla; Masaryk University Brno; University of Turku; Natural Resources Institute Finland (Luke)	Huitu, O (corresponding author), Finnish Forest Res Inst, Suonenjoki Res Unit, Suonenjoki, Finland.	otso.huitu@metla.fi	Hoset, Katrine S./A-5090-2010; Stuart, Peter/N-1830-2016; Mappes, Tapio/B-9780-2013	Hoset, Katrine S./0000-0002-1371-012X; Mappes, Tapio/0000-0002-5936-7355	Academy of Finland [133495, 132190]	Academy of Finland(Academy of Finland)	The experiment was funded by the Academy of Finland (www.aka.fi/eng: grant 133495 to OH, grant 132190 to TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen HP, 2013, OIKOS, V122, P507, DOI 10.1111/j.1600-0706.2012.00238.x; Beldomenico PM, 2008, J ANIM ECOL, V77, P984, DOI 10.1111/j.1365-2656.2008.01413.x; BOONSTRA R, 1994, EVOL ECOL, V8, P196, DOI 10.1007/BF01238250; BOONSTRA R, 1979, ECOLOGY, V60, P567, DOI 10.2307/1936077; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Burnham K. P., 2002, MODEL SELECTION INTE; Burthe SJ, 2010, OECOLOGIA, V162, P653, DOI 10.1007/s00442-009-1495-6; Cameron GN, 1996, J MAMMAL, V77, P220, DOI 10.2307/1382723; CHAPIN FS, 1980, J ECOL, V68, P189; CHITTY D, 1952, PHILOS T ROY SOC B, V236, P505, DOI 10.1098/rstb.1952.0009; COLE FR, 1979, J ANIM ECOL, V48, P455, DOI 10.2307/4172; Cornulier T, 2013, SCIENCE, V340, P63, DOI 10.1126/science.1228992; Dalkvist T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022834; DESY EA, 1989, ECOLOGY, V70, P411, DOI 10.2307/1937546; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Ergon T, 2001, NATURE, V411, P1043, DOI 10.1038/35082553; FROMMEL TO, 1988, J PARASITOL, V74, P957, DOI 10.2307/3282215; HANSKI I, 1991, J ANIM ECOL, V60, P353, DOI 10.2307/5465; HANSKI I, 1993, NATURE, V364, P232, DOI 10.1038/364232a0; Hanski I, 2001, ECOLOGY, V82, P1505, DOI 10.1890/0012-9658(2001)082[1505:SRDAP]2.0.CO;2; HANSSON L, 1985, OECOLOGIA, V67, P394, DOI 10.1007/BF00384946; HANSSON L, 1979, OECOLOGIA, V37, P297, DOI 10.1007/BF00347907; HANSSON L, 1985, ANN ZOOL FENN, V22, P277; Helle H, 2012, J ANIM ECOL, V81, P573, DOI 10.1111/j.1365-2656.2011.01937.x; HENTTONEN H, 1987, OIKOS, V50, P366, DOI 10.2307/3565497; Hornfeldt B, 2005, P ROY SOC B-BIOL SCI, V272, P2045, DOI 10.1098/rspb.2005.3141; Huitu O, 2003, ECOLOGY, V84, P2108, DOI 10.1890/02-0040; Huitu O, 2007, OIKOS, V116, P565, DOI 10.1111/j.2007.0030-1299.15488.x; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Inchausti P, 1998, J ANIM ECOL, V67, P180, DOI 10.1046/j.1365-2656.1998.00189.x; Jonsdottir IS, 2005, CAN J BOT, V83, P1608, DOI 10.1139/b05-129; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; Kallio ER, 2009, EPIDEMICS-NETH, V1, P101, DOI 10.1016/j.epidem.2009.03.002; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Klemola T, 2000, P ROY SOC B-BIOL SCI, V267, P351, DOI 10.1098/rspb.2000.1008; Korpela K, 2013, GLOBAL CHANGE BIOL, V19, P697, DOI 10.1111/gcb.12099; Korpimaki E, 2005, J ANIM ECOL, V74, P1150, DOI 10.1111/j.1365-2656.2005.01015.x; Koskela E, 1998, P ROY SOC B-BIOL SCI, V265, P1129, DOI 10.1098/rspb.1998.0408; Krebs C.J., 2013, POPULATION FLUCTUATI; KUMMEROW J, 1980, ARCTIC ALPINE RES, V12, P335, DOI 10.2307/1550719; Lack D., 1954, P343; LAINE KM, 1987, OIKOS, V50, P389, DOI 10.2307/3565500; Lambin X, 2006, J ANIM ECOL, V75, P340, DOI 10.1111/j.1365-2656.2006.01051.x; Littell R. C., 2006, SAS SYSTEM MIXED MOD; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mira A, 1994, HYSTRIX, V5, P63; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; MYLLYMAKI A, 1977, OIKOS, V29, P468, DOI 10.2307/3543588; Norrdahl K, 2002, OECOLOGIA, V130, P239, DOI 10.1007/s004420100795; NORRDAHL K, 1995, BIOL REV, V70, P621, DOI 10.1111/j.1469-185X.1995.tb01654.x; OTIS DL, 1978, WILDLIFE MONOGR, P1; POLLOCK KH, 1983, BIOMETRICS, V39, P1035, DOI 10.2307/2531337; Rikalainen K, 2012, ECOL EVOL, V2, P1491, DOI 10.1002/ece3.277; Schetter TA, 1998, J ANIM ECOL, V67, P705, DOI 10.1046/j.1365-2656.1998.00240.x; Schoech SJ, 2009, INTEGR COMP BIOL, V49, P480, DOI 10.1093/icb/icp005; Schulte-Hostedde AI, 2001, CAN J ZOOL, V79, P1021, DOI 10.1139/cjz-79-6-1021; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Sinclair ARE, 2002, PHILOS T ROY SOC B, V357, P1221, DOI 10.1098/rstb.2002.1123; Speakman JR, 2003, P NATL ACAD SCI USA, V100, P14057, DOI 10.1073/pnas.2235671100; Suleiman A, 1999, J RANGE MANAGE, V52, P75, DOI 10.2307/4003495; Tkadlec E, 2001, P ROY SOC B-BIOL SCI, V268, P1547, DOI 10.1098/rspb.2001.1694; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White TCR, 2005, WHY DOES THE WORLD STAY GREEN: NUTRITION AND SURVIVAL OF PLANT-EATERS, P1; WHITE TCR, 1978, OECOLOGIA, V33, P71, DOI 10.1007/BF00376997	65	22	25	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91113	10.1371/journal.pone.0091113	http://dx.doi.org/10.1371/journal.pone.0091113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621513	Green Published, gold			2022-12-27	WOS:000332845300051
J	Glauzy, S; Andre-Schmutz, I; Larghero, J; Ezine, S; de Latour, RP; Moins-Teisserenc, H; Servais, S; Robin, M; Socie, G; Clave, E; Toubert, A				Glauzy, Salome; Andre-Schmutz, Isabelle; Larghero, Jerome; Ezine, Sophie; de Latour, Regis Peffault; Moins-Teisserenc, Helene; Servais, Sophie; Robin, Marie; Socie, Gerard; Clave, Emmanuel; Toubert, Antoine			CXCR4-Related Increase of Circulating Human Lymphoid Progenitors after Allogeneic Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; ADULT THYMUS; GRAFT; MOBILIZATION; RECONSTITUTION; REGENERATION; CHEMOTHERAPY; MAINTENANCE; MACROPHAGES	Immune recovery after profound lymphopenia is a major challenge in many clinical situations, such as allogeneic hematopoietic stem cell transplantation (allo-HSCT). Recovery depends, in a first step, on hematopoietic lymphoid progenitors production in the bone marrow (BM). In this study, we characterized CD34(+) Lin(-)CD10(+) lymphoid progenitors in the peripheral blood of allo-HSCT patients. Our data demonstrate a strong recovery of this population 3 months after transplantation. This rebound was abolished in patients who developed acute graft-versus-host disease (aGVHD). A similar recovery profile was found for both CD24(+) and CD24(-) progenitor subpopulations. CD34(+)lin(-)CD10(+)CD24(-) lymphoid progenitors sorted from allo-HSCT patients preserved their T cell potentiel according to in vitro T-cell differentiation assay and the expression profile of 22 genes involved in T-cell differentiation and homing. CD34(+)lin(-)CD10(+)CD24(-) cells from patients without aGVHD had reduced CXCR4 gene expression, consistent with an enhanced egress from the BM. CCR7 gene expression was reduced in patients after allo-HSCT, as were its ligands CCL21 and CCL19. This reduction was particularly marked in patients with aGVHD, suggesting a possible impact on thymic homing. Thus, the data presented here identify this population as an important early step in T cell reconstitution in humans and so, an important target when seeking to enhance immune reconstitution.	[Glauzy, Salome; Larghero, Jerome; de Latour, Regis Peffault; Moins-Teisserenc, Helene; Robin, Marie; Socie, Gerard; Clave, Emmanuel; Toubert, Antoine] Univ Paris Diderot, Sorbonne Paris Cite, Inst Univ Hematol, Paris, France; [Glauzy, Salome; Larghero, Jerome; Moins-Teisserenc, Helene; Socie, Gerard; Clave, Emmanuel; Toubert, Antoine] INSERM, UMR1160, Paris, France; [Glauzy, Salome; Moins-Teisserenc, Helene; Clave, Emmanuel; Toubert, Antoine] Hop St Louis, AP HP, Lab Immunol & Histocompatibil, Paris, France; [Andre-Schmutz, Isabelle] Univ Paris 05, Sorbonne Paris Cite, INSERM, U768,Inst Imagine, Paris, France; [Larghero, Jerome] Hop St Louis, AP HP, Unite Therapie Cellulaire & CIC Biotherapies, Paris, France; [Ezine, Sophie] INSERM, U1020, Paris, France; [de Latour, Regis Peffault; Servais, Sophie; Robin, Marie; Socie, Gerard] Hop St Louis, AP HP, Serv Hematol Greffe Moelle, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Clave, E (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Inst Univ Hematol, Paris, France.	emmanuel.clave@univ-paris-diderot.fr	Andre, Isabelle/F-6263-2013; Moins-Teisserenc, helene/AAL-1566-2021; Clave, Emmanuel/ABD-8112-2020; Toubert, Antoine/Q-3404-2017; Andre-Schmutz, Isabelle/M-1279-2016	Andre, Isabelle/0000-0002-3905-9910; Moins-Teisserenc, helene/0000-0003-1602-7534; Clave, Emmanuel/0000-0001-8217-5039; Toubert, Antoine/0000-0002-7308-7317; Robin, Marie/0000-0003-1388-9876	Assistance Publique-Hopitaux de Paris [RTB10002]; LABEX Milieu Interieur; LABEX Transplantex; ERA-NET program [TRANSCAN 12-072 HAPLO-IMMUNE]	Assistance Publique-Hopitaux de Paris; LABEX Milieu Interieur; LABEX Transplantex; ERA-NET program	This work was supported by research grants from Assistance Publique-Hopitaux de Paris (#RTB10002), LABEX Milieu Interieur, LABEX Transplantex, ERA-NET program TRANSCAN 12-072 HAPLO-IMMUNE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clave E, 2005, BLOOD, V105, P2608, DOI 10.1182/blood-2004-04-1667; Clave E, 2009, BLOOD, V113, P6477, DOI 10.1182/blood-2008-09-176594; Dar A, 2011, LEUKEMIA, V25, P1286, DOI 10.1038/leu.2011.62; Dean RM, 2008, J CLIN ONCOL, V26, P5735, DOI 10.1200/JCO.2008.17.1314; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Haddad R, 2006, IMMUNITY, V24, P217, DOI 10.1016/j.immuni.2006.01.008; Hakim FT, 2005, J CLIN INVEST, V115, P930, DOI 10.1172/JCI200522492; Hauri-Hohl MM, 2007, BLOOD, V109, P4080, DOI 10.1182/blood-2006-07-034157; Hosoya T, 2009, J EXP MED, V206, P2987, DOI 10.1084/jem.20090934; Kohn LA, 2012, NAT IMMUNOL, V13, P963, DOI 10.1038/ni.2405; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Krenger W, 2000, BLOOD, V96, P347, DOI 10.1182/blood.V96.1.347.013k26_347_354; Krenger W, 2011, BLOOD, V117, P6768, DOI 10.1182/blood-2011-02-334623; Krueger A, 2010, BLOOD, V115, P1906, DOI 10.1182/blood-2009-07-235721; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Ludin A, 2012, NAT IMMUNOL, V13, P1072, DOI 10.1038/ni.2408; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Martins VC, 2012, J EXP MED, V209, P1409, DOI 10.1084/jem.20120846; Mavroudis D, 1996, BLOOD, V88, P3223, DOI 10.1182/blood.V88.8.3223.bloodjournal8883223; Misslitz A, 2004, J EXP MED, V200, P481, DOI 10.1084/jem.20040383; Peaudecerf L, 2012, J EXP MED, V209, P1401, DOI 10.1084/jem.20120845; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Reimann C, 2012, STEM CELLS, V30, P1771, DOI 10.1002/stem.1145; Rettig MP, 2012, LEUKEMIA, V26, P34, DOI 10.1038/leu.2011.197; Rossi FMV, 2005, NAT IMMUNOL, V6, P626, DOI 10.1038/ni1203; Roux E, 2000, BLOOD, V96, P2299; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; SEEMAYER TA, 1977, AM J PATHOL, V88, P119; Shono Y, 2010, BLOOD, V115, P5401, DOI 10.1182/blood-2009-11-253559; Six EM, 2007, J EXP MED, V204, P3085, DOI 10.1084/jem.20071003; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Talvensarri K, 2002, BLOOD, V99, P1458, DOI 10.1182/blood.V99.4.1458; Thiant S, 2011, BONE MARROW TRANSPL, V46, P1374, DOI 10.1038/bmt.2010.300; Tichelli A, 2008, BEST PRACT RES CL HA, V21, P139, DOI 10.1016/j.beha.2008.02.002; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; WEAVER CH, 1995, BLOOD, V86, P3961, DOI 10.1182/blood.V86.10.3961.bloodjournal86103961; Zlotoff DA, 2011, BLOOD, V118, P1962, DOI 10.1182/blood-2010-12-324954; Zlotoff DA, 2011, ANN NY ACAD SCI, V1217, P122, DOI 10.1111/j.1749-6632.2010.05881.x; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	44	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91492	10.1371/journal.pone.0091492	http://dx.doi.org/10.1371/journal.pone.0091492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621606	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300096
J	Henriksen, JR; Etzerodt, T; Gjetting, T; Andresen, TL				Henriksen, Jonas R.; Etzerodt, Thomas; Gjetting, Torben; Andresen, Thomas L.			Side Chain Hydrophobicity Modulates Therapeutic Activity and Membrane Selectivity of Antimicrobial Peptide Mastoparan-X	PLOS ONE			English	Article							MAGAININ 2 AMIDE; TITRATION CALORIMETRY; LIPID-MEMBRANES; ANTIBACTERIAL; BINDING; MODEL; THERMODYNAMICS; ACYLATION	The discovery of new anti-infective compounds is stagnating and multi-resistant bacteria continue to emerge, threatening to end the "antibiotic era''. Antimicrobial peptides (AMPs) and lipo-peptides such as daptomycin offer themselves as a new potential class of antibiotics; however, further optimization is needed if AMPs are to find broad use as antibiotics. In the present work, eight analogues of mastoparan-X (MPX) were investigated, having side chain modifications in position 1, 8 and 14 to modulate peptide hydrophobicity. The self-association properties of the peptides were characterized, and the peptide-membrane interactions in model membranes were compared with the bactericidal and haemolytic properties. Alanine substitution at position 1 and 14 resulted in higher target selectivity (red blood cells versus bacteria), but also decreased bactericidal potency. For these analogues, the gain in target selectivity correlated to biophysical parameters showing an increased effective charge and reduction in the partitioning coefficient for membrane insertion. Introduction of an unnatural amino acid, with an octyl side chain by amino acid substitution, at positions 1, 8 and 14 resulted in increased bactericidal potency at the expense of radically reduced membrane target selectivity. Overall, optimized membrane selectivity or bactericidal potency was achieved by changes in side chain hydrophobicity of MPX. However, enhanced potency was achieved at the expense of selectivity and vice versa in all cases.	[Henriksen, Jonas R.] Tech Univ Denmark, Dept Chem, Ctr Nanomed & Theranost, DTU Chem, DK-2800 Lyngby, Denmark; [Etzerodt, Thomas; Gjetting, Torben; Andresen, Thomas L.] Tech Univ Denmark, Ctr Nanomed & Theranost, DTU Nanotech, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Henriksen, JR (corresponding author), Tech Univ Denmark, Dept Chem, Ctr Nanomed & Theranost, DTU Chem, DK-2800 Lyngby, Denmark.	jonas.henriksen@kemi.dtu.dk	Andresen, Thomas L/B-5324-2012	Andresen, Thomas Lars/0000-0002-1048-127X; Henriksen, Jonas Rosager/0000-0001-9154-6639	Danish Research Council (FSS); Strategic Research Council; Danish Research Council for Technology and Innovation; Technical University of Denmark	Danish Research Council (FSS)(Det Frie Forskningsrad (DFF)Danish Medical Research Council); Strategic Research Council; Danish Research Council for Technology and Innovation; Technical University of Denmark	The Danish Research Council (FSS), the Strategic Research Council, the Danish Research Council for Technology and Innovation, and the Technical University of Denmark have funded the current project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTAFIEVA I, 1993, MACROMOLECULES, V26, P7339, DOI 10.1021/ma00078a034; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P10995, DOI 10.1021/bi00501a018; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Chu-Kung AF, 2010, J COLLOID INTERF SCI, V345, P160, DOI 10.1016/j.jcis.2009.11.057; Dathe M, 1997, FEBS LETT, V403, P208, DOI 10.1016/S0014-5793(97)00055-0; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Epand RF, 2010, BIOCHEMISTRY-US, V49, P4076, DOI 10.1021/bi100378m; Etzerodt T, 2011, BIOPHYS J, V100, P399, DOI 10.1016/j.bpj.2010.11.040; Giuliani A, 2007, CENT EUR J BIOL, V2, P1, DOI 10.2478/s11535-007-0010-5; Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637; Heerklotz H, 2000, BBA-BIOMEMBRANES, V1508, P69, DOI 10.1016/S0304-4157(00)00009-5; Hellmann N, 1998, BBA-BIOMEMBRANES, V1369, P267, DOI 10.1016/S0005-2736(97)00230-7; Henriksen JR, 2011, BIOPHYS J, V101, P100, DOI 10.1016/j.bpj.2011.05.047; Henriksen JR, 2010, BIOPHYS J, V98, P2199, DOI 10.1016/j.bpj.2010.01.037; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Hristova K, 2005, BIOCHEMISTRY-US, V44, P12614, DOI 10.1021/bi051193b; Japelj B, 2007, J AM CHEM SOC, V129, P1022, DOI 10.1021/ja067419v; Jiang Z, 2007, PEPTIDE SCI, V90, P369; Klocek G, 2009, BIOCHEMISTRY-US, V48, P2586, DOI 10.1021/bi802127h; Ladokhin AS, 2001, J MOL BIOL, V309, P543, DOI 10.1006/jmbi.2001.4684; Laverty G, 2010, CHEM BIOL DRUG DES, V75, P563, DOI 10.1111/j.1747-0285.2010.00973.x; Lockwood NA, 2004, BIOCHEM J, V378, P93, DOI 10.1042/BJ20031393; Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103; Malina A, 2005, BIOCHEM J, V390, P695, DOI 10.1042/BJ20050520; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; Murray D, 1999, BIOPHYS J, V77, P3176, DOI 10.1016/S0006-3495(99)77148-1; NAKAJIMA T, 1986, BIOPOLYMERS, V25, pS115; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Song YM, 2004, BIOCHEM BIOPH RES CO, V314, P615, DOI 10.1016/j.bbrc.2003.12.142; Wenk MR, 1998, BIOCHEMISTRY-US, V37, P3909, DOI 10.1021/bi972615n; Wenzel RP, 2004, NEW ENGL J MED, V351, P523, DOI 10.1056/NEJMp048093; Wieprecht T, 2000, BIOCHEMISTRY-US, V39, P442, DOI 10.1021/bi992146k; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P6124, DOI 10.1021/bi9619987; WILHELM M, 1991, MACROMOLECULES, V24, P1033, DOI 10.1021/ma00005a010; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	39	34	34	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91007	10.1371/journal.pone.0091007	http://dx.doi.org/10.1371/journal.pone.0091007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621994	gold, Green Published, Green Submitted			2022-12-27	WOS:000332845300045
J	Legland, D; Devaux, MF; Guillon, F				Legland, David; Devaux, Marie-Francoise; Guillon, Fabienne			Statistical Mapping of Maize Bundle Intensity at the Stem Scale Using Spatial Normalisation of Replicated Images	PLOS ONE			English	Article							CELL-WALL; TOMATO PERICARP; SHAPE; MORPHOLOGY; LIGNIN; MUTANT; TISSUE; SIZE; QUANTIFICATION; DEHYDROGENASES	The cellular structure of plant tissues is a key parameter for determining their properties. While the morphology of cells can easily be described, few studies focus on the spatial distribution of different types of tissues within an organ. As plants have various shapes and sizes, the integration of several individuals for statistical analysis of tissues distribution is a difficult problem. The aim of this study is to propose a method that quantifies the average spatial organisation of vascular bundles within maize stems, by integrating information from replicated images. In order to compare observations made on stems of different sizes and shapes, a spatial normalisation strategy was used. A model of average stem contour was computed from the digitisation of several stem slab images. Point patterns obtained from individual stem slices were projected onto the average stem to normalise them. Group-wise analysis of the spatial distribution of vascular bundles was applied on normalised data through the construction of average intensity maps. A quantitative description of average bundle organisation was obtained, via a 3D model of bundle distribution within a typical maize internode. The proposed method is generic and could easily be extended to other plant organs or organisms.	[Legland, David] INRA, Food Proc Engn & Microbiol UMR782, F-78850 Thiverval Grignon, France; [Legland, David] AgroParisTech, Food Proc Engn & Microbiol UMR782, Thiverval Grignon, France; [Legland, David] INRA, UMR Inst Jean Pierre Bourgin 1318, F-78026 Versailles, France; [Legland, David] AgroParisTech, Inst Jean Pierre Bourgin, Versailles, France; [Devaux, Marie-Francoise; Guillon, Fabienne] INRA, Biopolymers Interact & Assemblies UR1268, F-44026 Nantes, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Legland, D (corresponding author), INRA, Food Proc Engn & Microbiol UMR782, F-78850 Thiverval Grignon, France.	david.legland@grignon.inra.fr	Legland, David/AAI-2455-2020; /U-1825-2018	Legland, David/0000-0001-7456-4632; /0000-0001-7925-3104	Agence Nationale de la Recherche Genoplante programm [ANR-07-GPLA-0018 GrassBioFuel]	Agence Nationale de la Recherche Genoplante programm(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche Genoplante 2007 programm, project ANR-07-GPLA-0018 GrassBioFuel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrey P, 2008, I S BIOMED IMAGING, P1183, DOI 10.1109/ISBI.2008.4541213; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Barriere Y, 2009, EUPHYTICA, V170, P183, DOI 10.1007/s10681-009-9923-6; Barros-Rios J, 2012, ANIM FEED SCI TECH, V172, P226, DOI 10.1016/j.anifeedsci.2012.01.005; Bookstein F L, 1997, Med Image Anal, V1, P225; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Bruce DM, 2003, PHILOS T R SOC B, V358, P1437, DOI 10.1098/rstb.2003.1337; Burguet J, 2011, PATTERN RECOGN LETT, V32, P1894, DOI 10.1016/j.patrec.2011.07.008; Burguet J, 2009, J COMP NEUROL, V513, P483, DOI 10.1002/cne.21954; Casler MD, 2006, ANIM FEED SCI TECH, V125, P151, DOI 10.1016/j.anifeedsci.2005.05.015; Chassagne-Berces S, 2009, FOOD RES INT, V42, P788, DOI 10.1016/j.foodres.2009.03.001; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; Cressie N, 2011, STAT SPATIO TEMPORAL; Devaux MF, 2008, POSTHARVEST BIOL TEC, V47, P199, DOI 10.1016/j.postharvbio.2007.06.017; Devaux MF, 2009, MACROVISION ANAL GRA, P93; DIGGLE P, 1985, J R STAT SOC C-APPL, V34, P138; Douglas D.H., 1973, CARTOGRAPHICA INT J, V10, P112, DOI [10.3138/FM57-6770-U75U-7727, DOI 10.3138/FM57-6770-U75U-7727]; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Fromont L, 2005, 9 EUR C STER IM AN 1, V2, P71; Genard M, 2007, J EXP BOT, V58, P917, DOI 10.1093/jxb/erl287; Grenander U, 1998, Q APPL MATH, V56, P617, DOI 10.1090/qam/1668732; Guillemin F., 2004, Image Analysis & Stereology, V23, P13, DOI 10.5566/ias.v23.p13-22; Guillon F, 2008, J EXP BOT, V59, P273, DOI 10.1093/jxb/erm323; Hahn U, 2003, ADV APPL PROBAB, V35, P319, DOI 10.1239/aap/1051201648; Higashi K, 1999, J EXP BOT, V50, P1593, DOI 10.1093/jexbot/50.339.1593; Iwata H, 1998, EUPHYTICA, V102, P143, DOI 10.1023/A:1018392531226; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Jung HG, 2006, CROP SCI, V46, P1801, DOI 10.2135/cropsci2006.02-0086; Jung HJG, 2012, PLANT SCI, V185, P65, DOI 10.1016/j.plantsci.2011.10.014; Kaack K, 2003, IND CROP PROD, V17, P131, DOI 10.1016/S0926-6690(02)00093-6; Karkonen A, 2006, PLANTA, V223, P858, DOI 10.1007/s00425-005-0207-7; Karkonen A, 2005, BIOCHEM J, V391, P409, DOI 10.1042/BJ20050800; Legland D, 2012, J MICROSC-OXFORD, V247, P78, DOI 10.1111/j.1365-2818.2012.03623.x; Legland D, 2010, ANN BOT-LONDON, V105, P265, DOI 10.1093/aob/mcp283; Lootens P, 2007, COMPUT ELECTRON AGR, V58, P164, DOI 10.1016/j.compag.2007.03.014; Malladi A, 2010, J EXP BOT, V61, P3003, DOI 10.1093/jxb/erq134; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Mebatsion HK, 2006, COMPUT ELECTRON AGR, V52, P36, DOI 10.1016/j.compag.2006.01.002; Mebatsion HK, 2012, COMPUT ELECTRON AGR, V80, P63, DOI 10.1016/j.compag.2011.10.016; Mechin V, 2005, J AGR FOOD CHEM, V53, P5872, DOI 10.1021/jf050722f; Milien M, 2012, SCI HORTIC-AMSTERDAM, V144, P130, DOI 10.1016/j.scienta.2012.06.045; Moller J, 2004, STAT MONOGRAPHS STAT, V100; Ntenga R, 2011, COMP MATER SCI, V50, P1442, DOI 10.1016/j.commatsci.2010.11.032; Pieczywek PM, 2012, COMPUT ELECTRON AGR, V81, P72, DOI 10.1016/j.compag.2011.11.006; Pincus Z, 2007, J MICROSC-OXFORD, V227, P140, DOI 10.1111/j.1365-2818.2007.01799.x; Ripley BD, 1981, SPATIAL STAT PROBABI; Sarath G, 2011, BIORESOURCE TECHNOL, V102, P9579, DOI 10.1016/j.biortech.2011.07.086; Schauer K, 2010, NAT METHODS, V7, P560, DOI [10.1038/NMETH.1462, 10.1038/nmeth.1462]; Soille P., 2004, MORPHOLOGICAL IMAGE, DOI [10.1007/978-3-662-05088-0, DOI 10.1007/978-3-662-05088-0]; WILSON JR, 1993, J SCI FOOD AGR, V63, P407, DOI 10.1002/jsfa.2740630406; Zdunek A, 2005, J TEXTURE STUD, V36, P25, DOI 10.1111/j.1745-4603.2005.00002.x; Zhang Y, 2013, J AGR FOOD CHEM, V61, P3186, DOI 10.1021/jf400912s	53	20	20	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90673	10.1371/journal.pone.0090673	http://dx.doi.org/10.1371/journal.pone.0090673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622152	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300025
J	Polo, P; Hernandez-Lloreda, V; Colmenares, F				Polo, Pablo; Hernandez-Lloreda, Victoria; Colmenares, Fernando			Male Takeovers Are Reproductively Costly to Females in Hamadryas Baboons: A Test of the Sexual Coercion Hypothesis	PLOS ONE			English	Article							MULTILEVEL SOCIETY; HYBRID BABOONS; CONFLICT; COLONY; CLANS; PRIMATES; CHOICE; UNITS	During male takeovers, in addition to fighting off the female's current mating partner, males may exhibit intense aggressive mate guarding of the newly acquired females. Recent studies indicate that coercive sexual aggression by males is an important strategy through which sexual conflict is expressed. Previous tests of the sexual coercion hypothesis in primates have focused on assessing if female mate choice is effectively reduced by male aggression, however, only one recent study has tested a critical prediction of this hypothesis, namely, that male coercion is reproductively costly to victim females. The present study uses 15 years of data on inter-birth intervals from a large multilevel colony of baboons, mostly Papio h. hamadryas, with a mating system based on harem-defence polygyny to examine if male takeovers impact the length of the abducted females' inter-birth intervals. Our analysis of 121 inter-birth intervals from 45 adult females indicates that male takeovers are reproductively costly to abducted females as they are associated with an increase in the time they take to conceive and a lengthening of the inter-birth intervals. We discuss how several factors may contribute to this reproductive cost, including male-female sexual conflict, male-male competition, and female-female competition. Our findings suggest that the male's aggressive herding is the main contributor to the abducted females' immediate reproductive cost. We argue that although some of the male's aggressive herding may be driven by male-male competition, nonetheless, it serves a coercive function as it both constrains the female's mate choice options and hampers her immediate breeding performance. This conclusion is backed up by results obtained in the only other study that has tested the same prediction and which has been carried out in a wild population of hamadryas baboons.	[Polo, Pablo; Hernandez-Lloreda, Victoria; Colmenares, Fernando] Grp UCM Estudio Comportamiento Anim & Humano, Madrid, Spain; [Polo, Pablo; Colmenares, Fernando] Univ Complutense Madrid, Fac Psicol, Dept Psicobiol, Madrid, Spain; [Hernandez-Lloreda, Victoria] Univ Complutense Madrid, Dept Metodol Ciencias Comportamiento, Fac Psicol, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Colmenares, F (corresponding author), Grp UCM Estudio Comportamiento Anim & Humano, Madrid, Spain.	colmenares@psi.ucm.es	Polo, Pablo/E-6878-2016	Polo, Pablo/0000-0002-6366-933X; Hernandez-Lloreda, Maria Victoria/0000-0003-0966-7453	Ministerio de Educacion (Spain); Ministerio de Ciencia e Innovacion (Spain) [PSI2008-00526, PSI2011-29016-C02-01]; Universidad Complutense de Madrid [GR35/10-A-940813]	Ministerio de Educacion (Spain)(Spanish Government); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Universidad Complutense de Madrid	Partly supported by a studentship from the Ministerio de Educacion (Spain) to Pablo Polo and by project grants PSI2008-00526, PSI2011-29016-C02-01 from the Ministerio de Ciencia e Innovacion (Spain) and GR35/10-A-940813 from the Universidad Complutense de Madrid to Fernando Colmenares. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegglen JJ., 1984, SOCIALIZATION HAMADR; ALTMANN J, 1978, SCIENCE, V201, P1028, DOI 10.1126/science.98844; Anaya-Huertas C, 2002, FOLIA PRIMATOL, V73, P291; Arnqvist Goran, 2005, pUnpaginated; BACHMANN C, 1980, BEHAV ECOL SOCIOBIOL, V6, P315, DOI 10.1007/BF00292774; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Clarke Parry, 2009, P42; Clutton-Brock Tim H., 2004, P24, DOI 10.1017/CBO9780511542459.004; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Colmenares F, 2006, AM J PRIMATOL, V68, P21, DOI 10.1002/ajp.20204; Colmenares F, 2004, KINSHIP AND BEHAVIOR IN PRIMATES, P242; COLMENARES F, 1992, BEHAVIOUR, V121, P61, DOI 10.1163/156853992X00444; COLMENARES F, 1988, FOLIA PRIMATOL, V50, P157, DOI 10.1159/000156343; Colmenares F, 1992, BEHAV MECH EVOLUTION, P74; Connor R. C., 2009, SEXUAL COERCION PRIM; Darwin C., 1871, P423; Dixson AF, 2012, PRIMATE SEXUALITY: COMPARATIVE STUDIES OF THE PROSIMIANS, MONKEYS, APES, AND HUMANS, 2ND EDITION, P1, DOI 10.1093/acprof:osobl/9780199544646.001.0001; Dunbar R., 1984, REPROD DECISIONS EC; Harcourt AH, 2007, GORILLA SOC COMPROMI; Hernandez-Lloreda MV, 2003, ANIM BEHAV, V66, P607, DOI 10.1006/anbe.2003.2241; Kappeler Peter M., 2003, P1; Kitchen DM, 2009, SEXUAL COERCION PRIM, P129; Kummer H., 1968, SOCIAL ORG HAMADRYAS; Kummer Hans, 1995, QUEST SACRED BABOON; Mulder MB, 2009, EVOL ANTHROPOL, V18, P201, DOI 10.1002/evan.20226; Muller MN, 2011, BEHAV ECOL SOCIOBIOL, V65, P921, DOI 10.1007/s00265-010-1093-y; Muller MN, 2009, SEXUAL COERCION PRIM, P3, DOI DOI 10.4159/9780674054349-001; Parker G.A., 1979, P123; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; Polo P, 2012, BEHAV PROCESS, V90, P238, DOI 10.1016/j.beproc.2012.02.004; Robbins Martha M., 2009, P112; Robbins MM, 2011, PRIMATES PERSPECTIVE, P326; Schreier AL, 2009, AM J PRIMATOL, V71, P948, DOI 10.1002/ajp.20736; Setchell JM, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P373, DOI 10.1017/CBO9780511542602.016; SHAIKH A A, 1982, Primates, V23, P444, DOI 10.1007/BF02381326; SMUTS BB, 1993, ADV STUD BEHAV, V22, P1, DOI 10.1016/S0065-3454(08)60404-0; Smuts BB, 1989, AM J PRIMATOL, V119, P229; Snijders T. A. B., 2003, MULTILEVEL ANAL INTR; Stumpf R, 2011, PRIMATES PERSPECTIVE, P340; Stumpf RM, 2010, ANIM BEHAV, V79, P333, DOI 10.1016/j.anbehav.2009.11.008; Stumpf RM, 2011, EVOL ANTHROPOL, V20, P62, DOI 10.1002/evan.20297; SWEDELL L, 2006, STRATEGIES SEX SURVI; Swedell L, 2011, PRIMATES PERSPECTIVE, P241; Swedell L, 2014, BEHAV ECOL SOCIOBIOL, V68, P263, DOI 10.1007/s00265-013-1641-3; Swedell L, 2011, AM J PHYS ANTHROPOL, V145, P360, DOI 10.1002/ajpa.21504; Swedell Larissa, 2009, P244; Tregenza T, 2006, PHILOS T R SOC B, V361, P229, DOI 10.1098/rstb.2005.1796; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; van Schaik Carel P., 2000, P27, DOI 10.1017/CBO9780511542312.004; West B. T., 2007, LINEAR MIXED MODELS; Zar JH, 1999, BIOSTATISTICAL ANAL; Zinner D, 2000, AM J PRIMATOL, V52, P157, DOI 10.1002/1098-2345(200012)52:4<157::AID-AJP1>3.0.CO;2-L; Zuckerman S., 1932, SOCIAL LIFE MONKEYS	53	9	9	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90996	10.1371/journal.pone.0090996	http://dx.doi.org/10.1371/journal.pone.0090996			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621865	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300043
J	Tanja-Dijkstra, K; Pahl, S; White, MP; Andrade, J; Qian, C; Bruce, M; May, J; Moles, DR				Tanja-Dijkstra, Karin; Pahl, Sabine; White, Mathew P.; Andrade, Jackie; Qian, Cheng; Bruce, Malcolm; May, Jon; Moles, David R.			Improving Dental Experiences by Using Virtual Reality Distraction: A Simulation Study	PLOS ONE			English	Article							COLD PRESSOR PAIN; AUDIOVISUAL DISTRACTION; ANXIETY; HEALTH; CARE	Dental anxiety creates significant problems for both patients and the dental profession. Some distraction interventions are already used by healthcare professionals to help patients cope with unpleasant procedures. The present study is novel because it a) builds on evidence that natural scenery is beneficial for patients, and b) uses a Virtual Reality (VR) representation of nature to distract participants. Extending previous work that has investigated pain and anxiety during treatment, c) we also consider the longer term effects in terms of more positive memories of the treatment, building on a cognitive theory of memory (Elaborated Intrusions). Participants (n = 69) took part in a simulated dental experience and were randomly assigned to one of three VR conditions (active vs. passive vs. control). In addition, participants were distinguished into high and low dentally anxious according to a median split resulting in a 362 between-subjects design. VR distraction in a simulated dental context affected memories a week later. The VR distraction had effects not only on concurrent experiences, such as perceived control, but longitudinally upon the vividness of memories after the dental experience had ended. Participants with higher dental anxiety (for whom the dental procedures were presumably more aversive) showed a greater reduction in memory vividness than lower dental-anxiety participants. This study thus suggests that VR distractions can be considered as a relevant intervention for cycles of care in which people's previous experiences affect their behaviour for future events.	[Tanja-Dijkstra, Karin; Pahl, Sabine; Andrade, Jackie; May, Jon] Univ Plymouth, Sch Psychol, Plymouth PL4 8AA, Devon, England; [White, Mathew P.] Univ Exeter, Sch Med, European Ctr Environm & Human Hlth, Truro, England; [Qian, Cheng] Univ Birmingham, Sch Elect Elect & Comp Engn, Birmingham, W Midlands, England; [Bruce, Malcolm; Moles, David R.] Univ Plymouth, Peninsula Sch Med, Plymouth PL4 8AA, Devon, England; [Bruce, Malcolm; Moles, David R.] Univ Plymouth, Peninsula Sch Dent, Plymouth PL4 8AA, Devon, England	University of Plymouth; University of Exeter; University of Birmingham; University of Plymouth; University of Plymouth	Tanja-Dijkstra, K (corresponding author), Univ Plymouth, Sch Psychol, Plymouth PL4 8AA, Devon, England.	karin.tanja-dijkstra@plymouth.ac.uk	White, Mathew P/AAZ-4113-2021; Pahl, Sabine/AAT-1829-2021; May, Jon/GLS-6683-2022; May, Jon/C-7750-2009; Andrade, Jackie/H-1215-2013	May, Jon/0000-0001-7439-9200; May, Jon/0000-0001-7439-9200; Moles, David/0000-0001-9797-6226; White, Mathew Philip/0000-0002-4168-7289; Tanja-Dijkstra, Karin/0000-0003-2826-3155; Andrade, Jackie/0000-0002-6626-7192	Plymouth University	Plymouth University	This study is supported by internal funding from Plymouth University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armfield Jason M, 2007, BMC Oral Health, V7, P1, DOI 10.1186/1472-6831-7-1; Banos RM, 2000, CYBERPSYCHOL BEHAV, V3, P327, DOI 10.1089/10949310050078760; Bare Lyndsay C, 2004, J Dent Educ, V68, P1172; Beukeboom CJ, 2012, J ALTERN COMPLEM MED, V18, P329, DOI 10.1089/acm.2011.0488; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Dahlquist LM, 2007, HEALTH PSYCHOL, V26, P794, DOI 10.1037/0278-6133.26.6.794; DEJONGH A, 1995, COMMUNITY DENT ORAL, V23, P170; Derakshan N, 2009, EUR PSYCHOL, V14, P168, DOI 10.1027/1016-9040.14.2.168; Dijkstra K, 2008, PREV MED, V47, P279, DOI 10.1016/j.ypmed.2008.01.013; Frere CL, 2001, J AM DENT ASSOC, V132, P1031, DOI 10.14219/jada.archive.2001.0309; Furman E, 2009, J AM DENT ASSOC, V140, P1508, DOI 10.14219/jada.archive.2009.0102; Gold JI, 2007, CYBERPSYCHOL BEHAV, V10, P536, DOI 10.1089/cpb.2007.9993; Hartig T, 1996, SCAND J PSYCHOL, V37, P378, DOI 10.1111/j.1467-9450.1996.tb00670.x; Hill KB, 2008, BRIT DENT J, V204, DOI 10.1038/sj.bdj.2008.318; Hoffman HG, 2000, PAIN, V85, P305, DOI 10.1016/S0304-3959(99)00275-4; Hoffman HG, 2001, CYBERPSYCHOL BEHAV, V4, P527, DOI 10.1089/109493101750527088; Holmes EA, 2004, J EXP PSYCHOL GEN, V133, P3, DOI 10.1037/0096-3445.133.1.3; Humphris G M, 1995, Community Dent Health, V12, P143; Kavanagh DJ, 2005, PSYCHOL REV, V112, P446, DOI 10.1037/0033-295X.112.2.446; KLEINKNECHT RA, 1978, BEHAV THER, V9, P626, DOI 10.1016/S0005-7894(78)80138-5; Knight JF, 2012, INT J GAMING COMPUTE, V2012, P3; Krans J, 2010, J ANXIETY DISORD, V24, P134, DOI 10.1016/j.janxdis.2009.09.009; Law EF, 2011, J PEDIATR PSYCHOL, V36, P84, DOI 10.1093/jpepsy/jsq063; Leibovici V, 2009, PAIN RES MANAG, V14, P283, DOI 10.1155/2009/178751; LOCKER D, 1991, J DENT RES, V70, P198, DOI 10.1177/00220345910700030801; Maggirias J, 2002, COMMUNITY DENT ORAL, V30, P151, DOI 10.1034/j.1600-0528.2002.300209.x; Mahrer NE, 2009, CURR PAIN HEADACHE R, V13, P100, DOI 10.1007/s11916-009-0019-8; Malloy KM, 2010, CLIN PSYCHOL REV, V30, P1011, DOI 10.1016/j.cpr.2010.07.001; MCCAUL KD, 1992, HEALTH PSYCHOL, V11, P210, DOI 10.1037/0278-6133.11.4.210; Muhlberger A, 2007, CYBERPSYCHOL BEHAV, V10, P516, DOI 10.1089/cpb.2007.9996; Oosterink FMD, 2009, EUR J ORAL SCI, V117, P135, DOI 10.1111/j.1600-0722.2008.00602.x; Redelmeier DA, 2003, PAIN, V104, P187, DOI 10.1016/S0304-3959(03)00003-4; Russell, 1974, APPROACH ENV PSYCHOL; Schmitt YS, 2011, BURNS, V37, P61, DOI 10.1016/j.burns.2010.07.007; Schneider SM, 2003, CYBERPSYCHOL BEHAV, V6, P301, DOI 10.1089/109493103322011605; Schneider SM, 2007, ONCOL NURS FORUM, V34, P39, DOI 10.1188/07.ONF.39-46; Schubert T, 2001, PRESENCE-VIRTUAL AUG, V10, P266, DOI 10.1162/105474601300343603; Statham DJ, 2011, ADDICTION, V106, P1230, DOI 10.1111/j.1360-0443.2011.03442.x; Volker S, 2011, INT J HYG ENVIR HEAL, V214, P449, DOI 10.1016/j.ijheh.2011.05.001; WEGNER DM, 1987, J PERS SOC PSYCHOL, V53, P5, DOI 10.1037/0022-3514.53.1.5; Wheeler BW, 2012, HEALTH PLACE, V18, P1198, DOI 10.1016/j.healthplace.2012.06.015	41	32	33	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91276	10.1371/journal.pone.0091276	http://dx.doi.org/10.1371/journal.pone.0091276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24621518	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300071
J	Morris, JC; Tan, AR; Olencki, TE; Shapiro, GI; Dezube, BJ; Reiss, M; Hsu, FJ; Berzofsky, JA; Lawrence, DP				Morris, John C.; Tan, Antoinette R.; Olencki, Thomas E.; Shapiro, Geoffrey I.; Dezube, Bruce J.; Reiss, Michael; Hsu, Frank J.; Berzofsky, Jay A.; Lawrence, Donald P.			Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGF beta) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSDIFFERENTIATION; METASTATIC BREAST-CANCER; SOLID TUMORS; T-CELLS; PROGRESSION; INHIBITION; EFFICACY; SURVIVAL; VIVO; KERATOACANTHOMAS	Background: In advanced cancers, transforming growth factor-beta (TGFb) promotes tumor growth and metastases and suppresses host antitumor immunity. GC1008 is a human anti-TGFb monoclonal antibody that neutralizes all isoforms of TGFb. Here, the safety and activity of GC1008 was evaluated in patients with advanced malignant melanoma and renal cell carcinoma. Methods: In this multi-center phase I trial, cohorts of patients with previously treated malignant melanoma or renal cell carcinoma received intravenous GC1008 at 0.1, 0.3, 1, 3, 10, or 15 mg/kg on days 0, 28, 42, and 56. Patients achieving at least stable disease were eligible to receive Extended Treatment consisting of 4 doses of GC1008 every 2 weeks for up to 2 additional courses. Pharmacokinetic and exploratory biomarker assessments were performed. Results: Twenty-nine patients, 28 with malignant melanoma and 1 with renal cell carcinoma, were enrolled and treated, 22 in the dose-escalation part and 7 in a safety cohort expansion. No dose-limiting toxicity was observed, and the maximum dose, 15 mg/kg, was determined to be safe. The development of reversible cutaneous keratoacanthomas/squamous-cell carcinomas (4 patients) and hyperkeratosis was the major adverse event observed. One malignant melanoma patient achieved a partial response, and six had stable disease with a median progression-free survival of 24 weeks for these 7 patients (range, 16.4-44.4 weeks). Conclusions: GC1008 had no dose-limiting toxicity up to 15 mg/kg. In patients with advanced malignant melanoma and renal cell carcinoma, multiple doses of GC1008 demonstrated acceptable safety and preliminary evidence of antitumor activity, warranting further studies of single agent and combination treatments.	[Morris, John C.; Berzofsky, Jay A.] NCI, Vaccine Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Morris, John C.; Berzofsky, Jay A.] NCI, Metab Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Tan, Antoinette R.; Reiss, Michael] Canc Inst New Jersey, Dept Med, New Brunswick, NJ USA; [Olencki, Thomas E.] Ohio State Univ, Dept Med, Columbus, OH 43210 USA; [Shapiro, Geoffrey I.] Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; [Dezube, Bruce J.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Hsu, Frank J.] Genzyme Corp, Cambridge, MA USA; [Lawrence, Donald P.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; University System of Ohio; Ohio State University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Sanofi-Aventis; Genzyme Corporation; Harvard University; Massachusetts General Hospital	Morris, JC (corresponding author), Univ Cincinnati, Dept Med, Div Hematol Oncol, Vontz Ctr Mol Studies, ML0562, Cincinnati, OH 45221 USA.	morri2j7@ucmail.uc.edu; berzofsj@mail.nih.gov		Reiss, Michael/0000-0001-8543-8092	Genzyme Corporation; Center for Cancer Research, National Cancer Institute (NCI); Genzyme; NATIONAL CANCER INSTITUTE [ZIASC004020] Funding Source: NIH RePORTER	Genzyme Corporation(Sanofi-AventisGenzyme Corporation); Center for Cancer Research, National Cancer Institute (NCI); Genzyme(Sanofi-AventisGenzyme Corporation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Genzyme Corporation, and in part by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute (NCI). Genzyme provided financial support, the investigational agent GC1008, and supported study design, data collection and analysis, the decision to publish, and preparation of the manuscript.	Arnault JP, 2009, J CLIN ONCOL, V27, pE59, DOI 10.1200/JCO.2009.23.4823; ARTEAGA CL, 1993, J CLIN INVEST, V92, P2569, DOI 10.1172/JCI116871; Bandyopadhyay A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010365; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Biswas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027090; Bouquet F, 2011, CLIN CANCER RES, V17, P6754, DOI 10.1158/1078-0432.CCR-11-0544; CAULIN C, 1995, CELL GROWTH DIFFER, V6, P1027; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cheever AW, 2009, REPORT IMMUNE RESPON; Ellenrieder V, 2001, CANCER RES, V61, P4222; Esser AC, 2004, J AM ACAD DERMATOL, V50, pS75; Ganapathy V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-122; Goudie DR, 2011, NAT GENET, V43, P365, DOI 10.1038/ng.780; Harper JW, 2010, AM ASS CANC RES ANN; Inman GJ, 2011, CURR OPIN GENET DEV, V21, P93, DOI 10.1016/j.gde.2010.12.004; Ivanovic V, 2006, CLIN CHIM ACTA, V371, P191, DOI 10.1016/j.cca.2006.02.027; Kakonen SM, 2002, J BIOL CHEM, V277, P24571, DOI 10.1074/jbc.M202561200; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; Karaa A, 2007, INT J DERMATOL, V46, P671, DOI 10.1111/j.1365-4632.2007.03260.x; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kobie JJ, 2003, CANCER RES, V63, P1860; Korn EL, 2008, J CLIN ONCOL, V26, P527, DOI 10.1200/JCO.2007.12.7837; Liao S, 2011, CLIN CANCER RES, V17, P1415, DOI 10.1158/1078-0432.CCR-10-2429; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Munroe K, 2009, AACR NCI EORTC INT C; Nam JS, 2008, CANCER RES, V68, P3835, DOI 10.1158/0008-5472.CAN-08-0215; Norton L, 2006, NAT MED, V12, P875, DOI 10.1038/nm0806-875; Ohmori T, 1998, EXP CELL RES, V245, P350, DOI 10.1006/excr.1998.4261; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Putti TC, 2004, MODERN PATHOL, V17, P468, DOI 10.1038/modpathol.3800063; ROBERTS AB, 1981, P NATL ACAD SCI-BIOL, V78, P5339, DOI 10.1073/pnas.78.9.5339; RODECK U, 1994, CANCER RES, V54, P575; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Tabe Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062785; Tan AR, 2009, BREAST CANCER RES TR, V115, P453, DOI 10.1007/s10549-008-0184-1; Taniguchi Y, 2010, CANCER SCI, V101, P2207, DOI 10.1111/j.1349-7006.2010.01646.x; Teicher BA, 1997, INT J CANCER, V71, P49, DOI 10.1002/(SICI)1097-0215(19970328)71:1<49::AID-IJC10>3.0.CO;2-4; Teicher BA, 1996, CANCER CHEMOTH PHARM, V37, P601, DOI 10.1007/s002800050435; Terabe M, 2004, CURR OPIN IMMUNOL, V16, P157, DOI 10.1016/j.coi.2004.01.010; Terabe M, 2003, J EXP MED, V198, P1741, DOI 10.1084/jem.20022227; Terabe M, 2009, CLIN CANCER RES, V15, P6560, DOI 10.1158/1078-0432.CCR-09-1066; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Trachtman H, 2011, KIDNEY INT, V79, P1236, DOI 10.1038/ki.2011.33; Ueda R, 2009, CLIN CANCER RES, V15, P6551, DOI 10.1158/1078-0432.CCR-09-1067; Wikstrom P, 1998, PROSTATE, V37, P19, DOI 10.1002/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO;2-3; Wojtowicz-Praga S, 2003, INVEST NEW DRUG, V21, P21, DOI 10.1023/A:1022951824806; WojtowiczPraga S, 1996, J IMMUNOTHER, V19, P169, DOI 10.1097/00002371-199605000-00001; Wrzesinski SH, 2007, CLIN CANCER RES, V13, P5262, DOI 10.1158/1078-0432.CCR-07-1157; Wunderlich H, 1998, UROL INT, V60, P205, DOI 10.1159/000030255; Zhou Y, 2010, 2010 DEC 4 2010 ORL	50	244	261	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90353	10.1371/journal.pone.0090353	http://dx.doi.org/10.1371/journal.pone.0090353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618589	Green Submitted, gold, Green Published			2022-12-27	WOS:000332842400014
J	Yu, SZ; Li, FN; Yan, N; Yuan, CQ; He, SS; Hou, TS				Yu, Shunzhi; Li, Fengning; Yan, Ning; Yuan, Chaoqun; He, Shisheng; Hou, Tiesheng			Anterior Fusion Technique for Multilevel Cervical Spondylotic Myelopathy: A Retrospective Analysis of Surgical Outcome of Patients with Different Number of Levels Fused	PLOS ONE			English	Article							SPINE SURGERY; INTERBODY FUSION; PLATE FIXATION; RISK-FACTORS; NECK PAIN; CORPECTOMY; DISKECTOMY; LAMINOPLASTY; DYSPHAGIA; MANAGEMENT	Objective: The anterior approach for multilevel CSM has been developed and obtained favorable outcomes. However, the operation difficulty, invasiveness and operative risks increase when multi-level involved. This study was to assess surgical parameters, complications, clinical and radiological outcomes in the treatment of 2-, 3- and 4-level CSM. Methods: A total of 248 patients with 2-, 3- or 4-level CSM who underwent anterior decompression and fusion procedures between October 2005 and June 2011 were divided into three groups, the 2-level group (106 patients), the 3-level group (98 patients) and the 4-level group (44 patients). The clinical and Radiographic outcomes including Japanese Orthopedic Association (JOA) score, Neck Disability Index (NDI) score, Odom's Scale, hospital stay, blood loss, operation time, fusion rate, cervical lordosis, cervical range of motion (ROM), and complications were compared. Results: At a minimum of 2-year follow-up, no statistical differences in JOA score, NDI score, Odom's Scale, hospital stay, fusion rate and cervical lordosis were found among the 3 groups. However, the mean postoperative NDI score of the 4-level group was significantly higher than that in the other two groups (P < 0.05), and in terms of postoperative total ROM, the 3-level group was superior to the 4-level group and inferior to 2-level group (P < 0.05). The decrease rate of ROM in the 3-level group was significantly higher than that in the 2-level group, and lower than that in the 4-level group (P < 0.05). Conclusions: As the number of involved levels increased, surgical results become worse in terms of operative time, blood loss, NDI score, cervical ROM and complication rates postoperatively. An appropriate surgical procedure for multilevel CSM should be chosen according to comprehensive clinical evaluation before operation, thus reducing fusion and decompression levels if possible.	[Yu, Shunzhi; Yan, Ning; Yuan, Chaoqun; He, Shisheng; Hou, Tiesheng] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Orthoped, Shanghai 200092, Peoples R China; [Li, Fengning] PLA Second Mil Med Univ, Affiliated Hosp 3, Dept Orthoped, Shanghai, Peoples R China	Tongji University; Naval Medical University	Hou, TS (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Orthoped, Shanghai 200092, Peoples R China.	houzhuren@126.com		Yuan, Chaoqun/0000-0003-4354-422X				Chang SW, 2010, NEUROSURGERY, V66, P639, DOI 10.1227/01.NEU.0000367449.60796.94; Chen Z, 2012, SPINE, V37, P1292, DOI 10.1097/BRS.0b013e3182477f26; CLOWARD RB, 1958, J NEUROSURG, V15, P602, DOI 10.3171/jns.1958.15.6.0602; Danto J, 2012, J NEUROSURG ANESTH, V24, P350, DOI 10.1097/ANA.0b013e3182622843; David KS, 2006, CLIN NEUROL NEUROSUR, V108, P675, DOI 10.1016/j.clineuro.2005.04.005; Grabowski G, 2012, ORTHOP CLIN N AM, V43, P63, DOI 10.1016/j.ocl.2011.08.008; Guo QF, 2011, EUR SPINE J, V20, P1539, DOI 10.1007/s00586-011-1735-4; Ha SM, 2013, J KOREAN NEUROSURG S, V53, P288, DOI 10.3340/jkns.2013.53.5.288; Hacker RJ, 2000, SPINE, V25, P2646, DOI 10.1097/00007632-200010150-00017; Hacker RJ, 2000, J NEUROSURG, V93, P222, DOI 10.3171/spi.2000.93.2.0222; HERKOWITZ HN, 1988, SPINE, V13, P774, DOI 10.1097/00007632-198807000-00011; Jiang JL, 2012, J CLIN NEUROSCI, V19, P804, DOI 10.1016/j.jocn.2011.09.021; Kang SH, 2011, J CLIN NEUROSCI, V18, P1369, DOI 10.1016/j.jocn.2011.02.033; Konya D, 2009, J CLIN NEUROSCI, V16, P404, DOI 10.1016/j.jocn.2008.07.070; Kou J, 2002, SPINE, V27, P1670, DOI 10.1097/00007632-200208010-00016; Lebl Darren R, 2011, HSS J, V7, P170, DOI 10.1007/s11420-011-9208-1; Lee KE, 2004, J NEUROSCI METH, V137, P151, DOI 10.1016/j.jneumeth.2004.02.021; Lin QS, 2012, EUR SPINE J, V21, P474, DOI 10.1007/s00586-011-1961-9; Liu T, 2011, EUR SPINE J, V20, P224, DOI 10.1007/s00586-010-1486-7; Liu Y, 2012, SPINE, V37, pE1450, DOI 10.1097/BRS.0b013e31826c72b4; Liu Y, 2009, J ZHEJIANG UNIV-SC B, V10, P696, DOI 10.1631/jzus.B0960001; Majd ME, 1999, SPINE, V24, P1604, DOI 10.1097/00007632-199908010-00016; Manchikanti L, 2008, SPINE, V33, P1813, DOI 10.1097/BRS.0b013e31817b8f88; Manzano GR, 2012, NEUROSURGERY, V70, P264, DOI 10.1227/NEU.0b013e3182305669; Oh MC, 2009, SPINE, V34, P692, DOI 10.1097/BRS.0b013e318199690a; Panjabi MM, 1999, SPINE, V24, P2383, DOI 10.1097/00007632-199911150-00016; Park Y, 2010, SPINE J, V10, P193, DOI 10.1016/j.spinee.2009.09.006; PENNING L, 1978, AM J ROENTGENOL, V130, P317, DOI 10.2214/ajr.130.2.317; Reitman CA, 2004, SPINE, V29, pE221, DOI 10.1097/00007632-200406010-00022; ROBINSON RA, 1955, B JOHNS HOPKINS HOSP, V96, P223; Sagi HC, 2002, SPINE, V27, P949, DOI 10.1097/00007632-200205010-00013; Sakaura H, 2003, SPINE, V28, P2447, DOI 10.1097/01.BRS.0000090833.96168.3F; Sasso RC, 2003, SPINE, V28, P140, DOI 10.1097/00007632-200301150-00009; Sevki K, 2004, SPINE, V29, P2493, DOI 10.1097/01.brs.0000145412.93407.c3; Stewart TJ, 2007, NEUROSURGERY, V60, P143, DOI 10.1227/01.NEU.0000217015.96212.1B; Vaccaro AR, 1998, J SPINAL DISORD, V11, P410; Winkelstein BA, 2008, SPINE, V33, P856, DOI 10.1097/BRS.0b013e31816b4710; Wu XD, 2012, EUR SPINE J, V21, P1368, DOI 10.1007/s00586-012-2157-7; Yalamanchili PK, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/783762; YONENOBU K, 1992, SPINE, V17, P1281, DOI 10.1097/00007632-199211000-00004; Yu SZ, 2013, ORTHOPEDICS, V36, pE613, DOI 10.3928/01477447-20130426-24; Zeng JH, 2013, ARCH ORTHOP TRAUM SU, V133, P1067, DOI 10.1007/s00402-013-1773-y	42	25	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91329	10.1371/journal.pone.0091329	http://dx.doi.org/10.1371/journal.pone.0091329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618678	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400077
J	Bandholm, T; Thorborg, K; Lunn, TH; Kehlet, H; Jakobsen, TL				Bandholm, Thomas; Thorborg, Kristian; Lunn, Troels Haxholdt; Kehlet, Henrik; Jakobsen, Thomas Linding			Knee Pain during Strength Training Shortly following Fast-Track Total Knee Arthroplasty: A Cross-Sectional Study	PLOS ONE			English	Article							ACUTE POSTOPERATIVE PAIN; QUADRICEPS STRENGTH; EXERCISE; REHABILITATION; ACTIVATION; HIP; FORCES	Background: Loading and contraction failure (muscular exhaustion) are strength training variables known to influence neural activation of the exercising muscle in healthy subjects, which may help reduce neural inhibition of the quadriceps muscle following total knee arthroplasty (TKA). It is unknown how these exercise variables influence knee pain after TKA. Objective: To investigate the effect of loading and contraction failure on knee pain during strength training, shortly following TKA. Design: Cross-sectional study. Setting: Consecutive sample of patients from the Copenhagen area, Denmark, receiving a TKA, between November 2012 and April 2013. Participants: Seventeen patients, no more than 3 weeks after their TKA. Main outcome measures: In a randomized order, the patients performed 1 set of 4 standardized knee extensions, using relative loads of 8, 14, and 20 repetition maximum (RM), and ended with 1 single set to contraction failure (14 RM load). The individual loadings (kilograms) were determined during a familiarization session >72 hours prior. The patients rated their knee pain during each repetition, using a numerical rating scale (0-10). Results: Two patients were lost to follow up. Knee pain increased with increasing load (20 RM: 3.1+/-2.0 points, 14 RM: 3.5+/-1.8 points, 8 RM: 4.3+/-2.5 points, P = 0.006), and repetitions to contraction failure (10% failure: 3.2+/-1.9 points, 100% failure: 5.4+/-1.6 points, P < 0.001). Resting knee pain 60 seconds after the final repetition (2.7+/-2.4 points) was not different from that recorded before strength training (2.7+/-1.8 points, P = 0.88). Conclusion: Both loading and repetitions performed to contraction failure during knee-extension strength-training, increased post-operative knee pain during strength training implemented shortly following TKA. However, only the increase in pain during repetitions to contraction failure exceeded that defined as clinically relevant, and was very short-lived.	[Bandholm, Thomas; Thorborg, Kristian] Univ Copenhagen, Hvidovre Hosp, Dept Phys Therapy, Phys Med & Rehabil Res Copenhagen PMR C, Copenhagen, Denmark; [Bandholm, Thomas; Jakobsen, Thomas Linding] Univ Copenhagen, Clin Res Ctr, Hvidovre Hosp, Copenhagen, Denmark; [Bandholm, Thomas; Thorborg, Kristian] Univ Copenhagen, Dept Orthoped Surg, Hvidovre Hosp, Copenhagen, Denmark; [Thorborg, Kristian] Univ Copenhagen, Amager Hosp, Arthroscop Ctr Amager, Copenhagen, Denmark; [Lunn, Troels Haxholdt] Univ Copenhagen, Dept Anaesthesiol, Hvidovre Hosp, Copenhagen, Denmark; [Lunn, Troels Haxholdt; Kehlet, Henrik; Jakobsen, Thomas Linding] Univ Copenhagen, Lundbeckfdn Ctr Fast Track Hip & Knee Surg, Hvidovre Hosp, Copenhagen, Denmark; [Kehlet, Henrik] Univ Copenhagen, Rigshosp, Sect Surg Pathophysiol, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Bandholm, T (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Phys Therapy, Phys Med & Rehabil Res Copenhagen PMR C, Copenhagen, Denmark.	thomas.bandholm@hvh.regionh.dk	Bandholm, Thomas/AAZ-8632-2020	Bandholm, Thomas/0000-0001-6884-1971; Kehlet, Henrik/0000-0002-2209-1711	Lundbeck Foundation, Hellerup, Denmark	Lundbeck Foundation, Hellerup, Denmark(Lundbeckfonden)	The study was supported partly by a grant from the Lundbeck Foundation, Hellerup, Denmark (www.lundbeckfonden.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LO, 2009, ANAESTHESIA, V64, P508, DOI 10.1111/j.1365-2044.2008.05831.x; Bade MJ, 2012, CURR OPIN RHEUMATOL, V24, P208, DOI 10.1097/BOR.0b013e32834ff26d; Bandholm T, 2012, ARCH PHYS MED REHAB, V93, P1292, DOI 10.1016/j.apmr.2012.02.014; Breivik H, 2008, BRIT J ANAESTH, V101, P17, DOI 10.1093/bja/aen103; Brzycki M., 1993, J PHYS ED REC DANCE, V64, P88, DOI [10.1080/07303084.1993.10606684, DOI 10.1080/07303084.1993.10606684]; Carr AJ, 2012, LANCET, V379, P1331, DOI 10.1016/S0140-6736(11)60752-6; Chan EY, 2013, OSTEOARTHR CARTILAGE, V21, P1257, DOI 10.1016/j.joca.2013.06.011; Chen YW, 2013, REGION ANESTH PAIN M, V38, P282, DOI 10.1097/AAP.0b013e31828df3f9; D'Lima DD, 2008, CLIN ORTHOP RELAT R, V466, P2605, DOI 10.1007/s11999-008-0345-x; HODGES JL, 1962, ANN MATH STAT, V33, P482, DOI 10.1214/aoms/1177704575; Holm B, 2010, ARCH PHYS MED REHAB, V91, P1770, DOI 10.1016/j.apmr.2010.07.229; Holm B, 2010, DISABIL REHABIL, V32, P300, DOI 10.3109/09638280903095965; Jakobsen MD, 2013, HUM MOVEMENT SCI, V32, P65, DOI 10.1016/j.humov.2012.07.002; Jakobsen TL, 2010, PHYSIOTHER RES INT, V15, P126, DOI 10.1002/pri.450; Jakobsen TL, 2012, DISABIL REHABIL, V34, P1034, DOI 10.3109/09638288.2011.629019; Kehlet H, 2013, LANCET, V381, P1600, DOI 10.1016/S0140-6736(13)61003-X; Lin CWC, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-69; Lunn TH, 2012, ACTA ANAESTH SCAND, V56, P1234, DOI 10.1111/j.1399-6576.2012.02744.x; McNair PJ, 1996, ARCH PHYS MED REHAB, V77, P896, DOI 10.1016/S0003-9993(96)90277-4; Mizner RL, 2005, J BONE JOINT SURG AM, V87A, P1047, DOI 10.2106/JBJS.D.01992; Moffet H, 2004, ARCH PHYS MED REHAB, V85, P546, DOI 10.1016/j.apmr.2003.08.080; Naugle KM, 2012, J PAIN, V13, P1139, DOI 10.1016/j.jpain.2012.09.006; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Rice DA, 2010, SEMIN ARTHRITIS RHEU, V40, P250, DOI 10.1016/j.semarthrit.2009.10.001; Stevens JE, 2003, J ORTHOPAED RES, V21, P775, DOI 10.1016/S0736-0266(03)00052-4; Sundstrup E, 2012, J STRENGTH COND RES, V26, P1897, DOI 10.1519/JSC.0b013e318239c38e; Thomas AC, 2012, EXERC SPORT SCI REV, V40, P95, DOI 10.1097/JES.0b013e31824a732b; Thomee R, 1997, PHYS THER, V77, P1690, DOI 10.1093/ptj/77.12.1690; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wilk KE, 1996, AM J SPORT MED, V24, P518, DOI 10.1177/036354659602400418	30	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91107	10.1371/journal.pone.0091107	http://dx.doi.org/10.1371/journal.pone.0091107			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614574	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300076
J	Kim, SH; Kim, DH; Lee, KH; Im, SK; Hur, EM; Chung, KC; Rhim, H				Kim, Soon-Hee; Kim, Dong Hyuk; Lee, Kang Ho; Im, Sun-Kyoung; Hur, Eun-Mi; Chung, Kwang Chul; Rhim, Hyewhon			Direct Interaction and Functional Coupling between Human 5-HT6 Receptor and the Light Chain 1 Subunit of the Microtubule-Associated Protein 1B (MAP1B-LC1)	PLOS ONE			English	Article							SEROTONIN RECEPTORS; MECHANISM; CLONING; CHANNEL; FAMILY; TAU	Serotonin (5-HT) receptors of type 6 (5-HT6R) play important roles in mood, psychosis, and eating disorders. Recently, a growing number of studies support the use of 5-HT6R-targeting compounds as promising drug candidates for treating cognitive dysfunction associated with Alzheimer's disease. However, the mechanistic linkage between 5-HT6R and such functions remains poorly understood. By using yeast two-hybrid, GST pull-down, and co-immunoprecipitation assays, here we show that human 5-HT6R interacts with the light chain 1 (LC1) subunit of MAP1B protein (MAP1B-LC1), a classical microtubule-associated protein highly expressed in the brain. Functionally, we have found that expression of MAP1B-LC1 regulates serotonin signaling in a receptor subtype-specific manner, specifically controlling the activities of 5-HT6(R), but not those of 5-HT4R and 5-HT7R. In addition, we have demonstrated that MAP1B-LC1 increases the surface expression of 5-HT6R and decreases its endocytosis, suggesting that MAP1B-LC1 is involved in the desensitization and trafficking of 5-HT6R via a direct interaction. Together, we suggest that signal transduction pathways downstream of 5-HT6R are regulated by MAP1B, which might play a role in 5-HT6R-mediated signaling in the brain.	[Kim, Soon-Hee; Kim, Dong Hyuk; Lee, Kang Ho; Im, Sun-Kyoung; Hur, Eun-Mi; Rhim, Hyewhon] Korea Inst Sci & Technol, Ctr Neurosci, Brain Sci Inst, Seoul, South Korea; [Lee, Kang Ho; Rhim, Hyewhon] Univ Sci & Technol, Dept Neurosci, Taejon, South Korea; [Chung, Kwang Chul] Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Korea Institute of Science & Technology (KIST); Yonsei University	Rhim, H (corresponding author), Korea Inst Sci & Technol, Ctr Neurosci, Brain Sci Inst, Seoul, South Korea.	hrhim@kist.re.kr	Hur, Eun Mi/AAU-4906-2021		Pioneer Research Program [2013008915]; Korea Institute of Science and Technology, the Republic of Korea [2E24480]	Pioneer Research Program; Korea Institute of Science and Technology, the Republic of Korea	This work was supported by grants from the Pioneer Research Program (No. 2013008915) and Korea Institute of Science and Technology (2E24480), the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Codony X, 2011, CURR OPIN PHARMACOL, V11, P94, DOI 10.1016/j.coph.2011.01.004; East SZ, 2002, SYNAPSE, V45, P191, DOI 10.1002/syn.10097; Filip M, 2009, PHARMACOL REP, V61, P761, DOI 10.1016/S1734-1140(09)70132-X; Fujiwara Y, 2011, BIOCHIMIE, V93, P817, DOI 10.1016/j.biochi.2011.01.008; GARNER CC, 1990, J NEUROCHEM, V55, P146, DOI 10.1111/j.1471-4159.1990.tb08832.x; Gonzalez-Billault C, 2004, J NEUROBIOL, V58, P48, DOI 10.1002/neu.10283; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Henriquez DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053123; Hur EM, 2011, GENE DEV, V25, P1968, DOI 10.1101/gad.17015911; Kim DH, 2010, BIOL PHARM BULL, V33, P2024, DOI 10.1248/bpb.33.2024; Kim HJ, 2008, COMB CHEM HIGH T SCR, V11, P316, DOI 10.2174/138620708784246059; Kim S, 2007, J BIOL CHEM, V282, P32877, DOI 10.1074/jbc.M701418200; Kohen R, 1996, J NEUROCHEM, V66, P47; Lee G, 1998, J CELL SCI, V111, P3167; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Lee SY, 2008, FEBS LETT, V582, P2826, DOI 10.1016/j.febslet.2008.07.021; Marazziti D, 2011, CURR MED CHEM, V18, P2783, DOI 10.2174/092986711796011283; Meffre J, 2012, EMBO MOL MED, V4, P1043, DOI 10.1002/emmm.201201410; Mnie-Filali O, 2010, CELL SIGNAL, V22, P501, DOI 10.1016/j.cellsig.2009.11.004; Moritz A, 2009, BIOCHEM BIOPH RES CO, V390, P82, DOI 10.1016/j.bbrc.2009.09.070; Norum JH, 2003, J BIOL CHEM, V278, P3098, DOI 10.1074/jbc.M206237200; O'Brien JE, 2012, J BIOL CHEM, V287, P18459, DOI 10.1074/jbc.M111.336024; Riccioni T, 2011, EUR J PHARMACOL, V661, P8, DOI 10.1016/j.ejphar.2011.04.028; Sun H, 2008, J PHYSIOL-LONDON, V586, P751, DOI 10.1113/jphysiol.2007.136440; WICHE G, 1991, INT REV CYTOL, V124, P217; Woolley ML, 2004, CNS NEUROL DISORD-DR, V3, P59, DOI 10.2174/1568007043482561; Yun HM, 2007, J BIOL CHEM, V282, P5496, DOI 10.1074/jbc.M606215200; Yun Hyung-Mun, 2011, Exp Neurobiol, V20, P159, DOI 10.5607/en.2011.20.4.159; Yun HM, 2010, J BIOL CHEM, V285, P10016, DOI 10.1074/jbc.M109.068759	29	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91402	10.1371/journal.pone.0091402	http://dx.doi.org/10.1371/journal.pone.0091402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614691	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300120
J	Fan, XF; Zheng, WT; Chen, X; Singh, DJ				Fan, Xiaofeng; Zheng, Weitao; Chen, Xin; Singh, David J.			2DEGs at Perovskite Interfaces between KTaO3 or KNbO3 and Stannates	PLOS ONE			English	Article							POLAR OXIDE ZNSNO3; TRANSPORT-PROPERTIES; LANTHANUM; TRANSITION; MOBILITY; PHONON	We report density functional studies of electron rich interfaces between KTaO3 or KNbO3 and CaSnO3 or ZnSnO3 and in particular the nature of the interfacial electron gasses that can be formed. We find that depending on the details these may occur on either the transition metal or stannate sides of the interface and in the later case can be shifted away from the interface by ferroelectricity. We also present calculations for bulk KNbO3, KTaO3, CaSnO3, BaSnO3 and ZnSnO3, showing the different transport and optical properties that may be expected on the two sides of such interfaces. The results suggest that these interfaces may display a wide range of behaviors depending on conditions, and in particular the interplay with ferroelectricity suggests that electrical control of these properties may be possible.	[Fan, Xiaofeng; Zheng, Weitao] Jilin Univ, Coll Mat Sci & Engn, Changchun 130023, Peoples R China; [Chen, Xin; Singh, David J.] Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37830 USA	Jilin University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Singh, DJ (corresponding author), Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37830 USA.	singhdj@ornl.gov	Fan, Xiaofeng/B-9680-2011; zheng, weitao/HCH-5112-2022	Fan, Xiaofeng/0000-0001-6288-4866; zheng, weitao/0000-0002-9028-278X	Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division	Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE))	Work at ORNL was supported by the Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarzadeh AR, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205104; Bennett JW, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180102; Bevillon E, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/14/145217; Blaha P., 2001, WIEN2K; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; CAVA RJ, 1990, PHYS REV B, V42, P4815, DOI 10.1103/PhysRevB.42.4815; Chen X, 2013, SCI REP-UK, V3, DOI 10.1038/srep03168; Cooper VR, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.235109; Du MH, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.144114; Fang CH, 2009, CHEM COMMUN, P2350, DOI 10.1039/b821459j; Filippetti A, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195301; Hadjarab B, 2007, J PHYS D APPL PHYS, V40, P5833, DOI 10.1088/0022-3727/40/19/006; Hwang HY, 2012, NAT MATER, V11, P103, DOI [10.1038/nmat3223, 10.1038/NMAT3223]; Inaguma Y, 2008, J AM CHEM SOC, V130, P6704, DOI 10.1021/ja801843v; Inaguma Y, 2012, J SOLID STATE CHEM, V195, P115, DOI 10.1016/j.jssc.2012.07.036; Jellison GE, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.155130; Kagimura R, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.012103; Kim HJ, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.061102; Kim YS, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.205212; King PDC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.117602; Koller D, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.195134; KOONCE CS, 1967, PHYS REV, V163, P380, DOI 10.1103/PhysRev.163.380; Kovacheva D, 1998, SOLID STATE IONICS, V109, P327, DOI 10.1016/S0167-2738(97)00507-9; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Liu HR, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4798325; Liu QZ, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4770299; Luo X, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4709415; Madsen GKH, 2006, COMPUT PHYS COMMUN, V175, P67, DOI 10.1016/j.cpc.2006.03.007; Madsen GKH, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.125212; Maekawa T, 2006, J ALLOY COMPD, V416, P214, DOI 10.1016/j.jallcom.2005.08.032; Men H, 2010, CHEM COMMUN, V46, P7581, DOI 10.1039/c0cc02222e; Miyauchi M, 2010, CHEM COMMUN, V46, P1529, DOI 10.1039/b921010e; Nakayama M, 2010, ADV MATER, V22, P2579, DOI 10.1002/adma.200903432; Niranjan MK, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.016804; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Parker D, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.146601; Parker D, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033045; Parker D, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021005; Pentcheva R, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.205106; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; PERRY CH, 1989, PHYS REV B, V39, P8666, DOI 10.1103/PhysRevB.39.8666; PERTOSA P, 1978, PHYS REV B, V17, P2011, DOI 10.1103/PhysRevB.17.2011; Popovic ZS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.256801; Sakai A, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.097002; Siemons W, 2012, ADV MATER, V24, P3965, DOI 10.1002/adma.201104665; SINGH D, 1991, PHYS REV B, V43, P6388, DOI 10.1103/PhysRevB.43.6388; SINGH D, 1991, PHYS REV B, V43, P1441, DOI 10.1103/PhysRevB.43.1441; Singh D. J., 2006, PLANEWAVES PSEUDOPOT, V2nd, DOI DOI 10.1007/978-1-4757-2312-0; Singh DJ, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.205102; Singh DJ, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.155145; Singh DJ, 1996, PHYS REV B, V53, P176, DOI 10.1103/PhysRevB.53.176; SINGH DJ, 1991, PHYS REV B, V44, P9519, DOI 10.1103/PhysRevB.44.9519; Sjostedt E, 2000, SOLID STATE COMMUN, V114, P15, DOI 10.1016/S0038-1098(99)00577-3; Son JY, 2009, J AM CHEM SOC, V131, P8386, DOI 10.1021/ja903133n; Stanislavchuk TN, 2012, J APPL PHYS, V112, DOI 10.1063/1.4748309; Takahashi R, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3481364; Tran F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.226401; Ueno K, 2011, NAT NANOTECHNOL, V6, P408, DOI [10.1038/NNANO.2011.78, 10.1038/nnano.2011.78]; Upadhyay S, 2004, J PHYS D APPL PHYS, V37, P1483, DOI 10.1088/0022-3727/37/10/011; Usui H, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.205121; VEGAS A, 1986, ACTA CRYSTALLOGR B, V42, P167, DOI 10.1107/S0108768186098403; Wang HF, 2007, J APPL PHYS, V101, DOI 10.1063/1.2736629; Wang Y, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165130; WEMPLE SH, 1965, PHYS REV, V137, P1575, DOI 10.1103/PhysRev.137.A1575; WIESENDA.E, 1974, FERROELECTRICS, V6, P263, DOI 10.1080/00150197408243977; Wu JM, 2012, ACS NANO, V6, P4335, DOI 10.1021/nn300951d; Xue XY, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1944204; Zhang J, 2010, PHYS CHEM CHEM PHYS, V12, P9197, DOI 10.1039/b920065g	68	32	32	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91423	10.1371/journal.pone.0091423	http://dx.doi.org/10.1371/journal.pone.0091423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626191	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300083
J	Li, S; Kang, JD; Jin, JX; Hong, Y; Zhu, HY; Jin, L; Gao, QS; Yan, CG; Cui, CD; Li, WX; Yin, XJ				Li, Suo; Kang, Jin-Dan; Jin, Jun-Xue; Hong, Yu; Zhu, Hai-Ying; Jin, Long; Gao, Qing-Shan; Yan, Chang-Guo; Cui, Cheng-Du; Li, Wen-Xue; Yin, Xi-Jun			Effect of Demecolcine-Assisted Enucleation on the MPF Level and Cyclin B1 Distribution in Porcine Oocytes	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; METAPHASE-II ARREST; MOUSE OOCYTES; IN-VITRO; FIBROBLAST CELLS; RAT OOCYTES; CLONED PIGS; MEIOSIS-I; ACTIVATION; EMBRYOS	Demecolcine (DEM) treatment of oocytes induces formation of a membrane protrusion containing a mass of condensed maternal chromosomes, which can be removed with minimal damage prior to somatic cell nuclear transfer (SCNT). However, the effect of this method on the distribution of maturation- promoting factor (MPF) in porcine oocytes has not been reported. Here, the level of MPF and the distribution of cyclin B1 were assessed in porcine oocytes following DEM treatment. In addition, the efficiencies of DEM- assisted and mechanical enucleation were compared, as were the development (in vitro and in vivo) of these oocytes following SCNT. MPF was uniformly distributed in oocytes that had been treated with 0.4 mu g/ml DEM for 1 h. Immunofluorescence microscopy showed that in untreated oocytes, cyclin B1, the regulatory subunit of MPF, accumulated around the spindle, and was lowly detected in the cytoplasm. DEM treatment disrupted spindle microtubules, induced chromosome condensation, and reduced the level of cyclin B1 in the nuclear region. Cyclin B1 was uniformly distributed in DEM- treated oocytes and the level of MPF was increased. The potential of embryos generated from DEM-treated oocytes to develop in vivo was significantly greater than that of embryos generated from mechanically enucleated oocytes. This is the first study to report the effects of DEM- assisted enucleation of porcine oocytes on the distribution of cyclin B1. MPF in mature oocytes is important for the development of reconstructed embryos and for efficient SCNT.	[Li, Suo; Kang, Jin-Dan; Jin, Jun-Xue; Hong, Yu; Zhu, Hai-Ying; Jin, Long; Gao, Qing-Shan; Yan, Chang-Guo; Yin, Xi-Jun] Yanbian Univ, Coll Agr, Dept Anim Sci, Yanji, Peoples R China; [Cui, Cheng-Du; Li, Wen-Xue] Yanbian Univ, Dept Vet Med, Coll Agr, Yanji, Peoples R China	Yanbian University; Yanbian University	Yin, XJ (corresponding author), Yanbian Univ, Coll Agr, Dept Anim Sci, Yanji, Peoples R China.	yinxj33@msn.com			National Natural Science Foundation of China [30960175]; State Key Development Program for Basic Research of China [2012CB526710]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China)	This work was supported by the National Natural Science Foundation of China (grant number 30960175), and the State Key Development Program for Basic Research of China (grant number 2012CB526710). The authors thank XJ Yin and all members of the laboratory for their technical assistance and advice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Costa-Borges N, 2011, THERIOGENOLOGY, V75, P527, DOI 10.1016/j.theriogenology.2010.09.022; D'Angiolella V, 2003, GENE DEV, V17, P2520, DOI 10.1101/gad.267603; Fan NN, 2013, CELL RES, V23, P162, DOI 10.1038/cr.2012.176; Fulka J, 1995, REPROD FERT DEVELOP, V7, P1123, DOI 10.1071/RD9951123; Galat V, 2007, CLONING STEM CELLS, V9, P303, DOI 10.1089/clo.2006.0059; Gasparrini B, 2003, BIOL REPROD, V68, P1259, DOI 10.1095/biolreprod.102.008730; Goto S, 2002, MOL REPROD DEV, V63, P388, DOI 10.1002/mrd.90022; Goudet G, 1998, MOL HUM REPROD, V4, P563, DOI 10.1093/molehr/4.6.563; Homer HA, 2005, REPRODUCTION, V130, P829, DOI 10.1530/rep.1.00856; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Huang TS, 2000, APOPTOSIS, V5, P235, DOI 10.1023/A:1009652412399; Kang JD, 2013, THERIOGENOLOGY, V79, P306, DOI 10.1016/j.theriogenology.2012.08.021; KATO Y, 1992, J REPROD FERTIL, V95, P39, DOI 10.1530/jrf.0.0950039; Kato Y, 2000, J REPROD FERTIL, V120, P231, DOI 10.1530/reprod/120.2.231; Kawakami M, 2003, CLONING STEM CELLS, V5, P379, DOI 10.1089/153623003772032871; KUBIAK JZ, 1993, EMBO J, V12, P3773, DOI 10.1002/j.1460-2075.1993.tb06055.x; Lefebvre C, 2002, J CELL BIOL, V157, P603, DOI 10.1083/jcb.200202052; Ling YH, 1998, INT J CANCER, V75, P925, DOI 10.1002/(SICI)1097-0215(19980316)75:6<925::AID-IJC16>3.0.CO;2-1; Miyara F, 2006, DEV BIOL, V289, P206, DOI 10.1016/j.ydbio.2005.10.030; Miyoshi K, 2008, J REPROD DEVELOP, V54, P117, DOI 10.1262/jrd.19142; Miyoshi K, 2007, MOL REPROD DEV, V74, P1568, DOI 10.1002/mrd.20730; Nixon VL, 2002, CURR BIOL, V12, P746, DOI 10.1016/S0960-9822(02)00811-4; Peura TT, 1998, MOL REPROD DEV, V50, P185, DOI 10.1002/(SICI)1098-2795(199806)50:2&lt;185::AID-MRD9&gt;3.0.CO;2-G; Russell DF, 2005, MOL REPROD DEV, V72, P161, DOI 10.1002/mrd.20356; Sakamoto I, 1998, DEV BIOL, V195, P60, DOI 10.1006/dbio.1997.8835; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Simerly C, 2003, SCIENCE, V300, P297, DOI 10.1126/science.1082091; Tani T, 2006, CLONING STEM CELLS, V8, P61, DOI 10.1089/clo.2006.8.61; Van Thuan N, 2006, BIOL REPROD, V74, P777, DOI 10.1095/biolreprod.105.044677; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1998, ZYGOTE, V6, P341, DOI 10.1017/S096719949800029X; Wang HL, 2011, CELL REPROGRAM, V13, P225, DOI 10.1089/cell.2010.0101; Wu YG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012706; Yin XJ, 2008, THERIOGENOLOGY, V69, P1001, DOI 10.1016/j.theriogenology.2008.01.017; Yin XJ, 2008, BIOL REPROD, V78, P425, DOI 10.1095/biolreprod.107.065185; Yin XJ, 2002, ZYGOTE, V10, P217, DOI 10.1017/S0967199402002289; Yin XJ, 2002, BIOL REPROD, V67, P442, DOI 10.1095/biolreprod67.2.442; Yin XJ, 2002, REPRODUCTION, V124, P41, DOI 10.1530/rep.0.1240041; ZERNICKAGOETZ M, 1993, MOL REPROD DEV, V35, P165, DOI 10.1002/mrd.1080350210	41	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91483	10.1371/journal.pone.0091483	http://dx.doi.org/10.1371/journal.pone.0091483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626152	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300088
J	Maganti, N; Moody, TD; Truax, AD; Thakkar, M; Spring, AM; Germann, MW; Greer, SF				Maganti, Nagini; Moody, Tomika D.; Truax, Agnieszka D.; Thakkar, Meghna; Spring, Alexander M.; Germann, Markus W.; Greer, Susanna F.			Nonproteolytic Roles of 19S ATPases in Transcription of CIITApIV Genes	PLOS ONE			English	Article							RNA-POLYMERASE-II; MAJOR HISTOCOMPATIBILITY COMPLEX; 26S PROTEASOME; P-TEFB; HIV-1 TRANSCRIPTION; REGULATORY PARTICLE; INITIATION-FACTORS; TERMINAL DOMAIN; EXPRESSION; PROMOTER	Accumulating evidence shows the 26S proteasome is involved in the regulation of gene expression. We and others have demonstrated that proteasome components bind to sites of gene transcription, regulate covalent modifications to histones, and are involved in the assembly of activator complexes in mammalian cells. The mechanisms by which the proteasome influences transcription remain unclear, although prior observations suggest both proteolytic and non-proteolytic activities. Here, we define novel, non-proteolytic, roles for each of the three 19S heterodimers, represented by the 19S ATPases Sug1, S7, and S6a, in mammalian gene expression using the inflammatory gene CIITApIV. These 19S ATPases are recruited to induced CIITApIV promoters and also associate with CIITA coding regions. Additionally, these ATPases interact with elongation factor PTEFb complex members CDK9 and Hexim-1 and with Ser5 phosphorylated RNA Pol II. Both the generation of transcripts from CIITApIV and efficient recruitment of RNA Pol II to CIITApIV are negatively impacted by siRNA mediated knockdown of these 19S ATPases. Together, these results define novel roles for 19S ATPases in mammalian gene expression and indicate roles for these ATPases in promoting transcription processes.	[Maganti, Nagini; Moody, Tomika D.; Truax, Agnieszka D.; Thakkar, Meghna; Greer, Susanna F.] Georgia State Univ, Dept Biol, Grad Program Cell Biol & Immunol, Atlanta, GA 30302 USA; [Spring, Alexander M.; Germann, Markus W.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Greer, SF (corresponding author), Georgia State Univ, Dept Biol, Grad Program Cell Biol & Immunol, Atlanta, GA 30302 USA.	sgreer@gsu.edu		Germann, Markus/0000-0002-1674-8166	American Cancer Society [RSG-09-067-01-LB]	American Cancer Society(American Cancer Society)	Research was supported by grant # RSG-09-067-01-LB from the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; Boss JM, 2003, CURR OPIN IMMUNOL, V15, P105, DOI 10.1016/S0952-7915(02)00015-8; Boss JM, 1997, CURR OPIN IMMUNOL, V9, P107, DOI 10.1016/S0952-7915(97)80166-5; BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7; Bush KT, 1997, J BIOL CHEM, V272, P9086; Chaves S, 2010, MOL CELL BIOL, V30, P5284, DOI 10.1128/MCB.00952-10; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Ferdous A, 2002, BIOCHEMISTRY-US, V41, P12798, DOI 10.1021/bi020425t; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Garrido F, 1991, Semin Cancer Biol, V2, P3; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Gorbea C, 1999, MOL BIOL REP, V26, P15, DOI 10.1023/A:1006957802028; GUY K, 1986, BRIT J CANCER, V53, P161, DOI 10.1038/bjc.1986.31; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Ishizuka T, 2001, MOL ENDOCRINOL, V15, P1329, DOI 10.1210/me.15.8.1329; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; KAUFMAN JF, 1984, CELL, V36, P1, DOI 10.1016/0092-8674(84)90068-0; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Koues OI, 2009, BIOCH BIOPHYS ACTA; Koues OI, 2008, MOL CELL BIOL, V28, P5837, DOI 10.1128/MCB.00535-08; Koues OI, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-5; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Masternak K, 2000, GENE DEV, V14, P1156; Masternak K, 1998, NAT GENET, V20, P273, DOI 10.1038/3081; Morris AC, 2002, MOL CELL BIOL, V22, P4781, DOI 10.1128/MCB.22.13.4781-4791.2002; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; NELBOCK P, 1990, SCIENCE, V248, P1650, DOI 10.1126/science.2194290; Pattenden SG, 2002, EMBO J, V21, P1978, DOI 10.1093/emboj/21.8.1978; PETERS JM, 1994, J BIOL CHEM, V269, P7709; Piskurich JF, 2006, MOL IMMUNOL, V43, P519, DOI 10.1016/j.molimm.2005.05.005; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Trowsdale J, 2011, IMMUNOL LETT, V137, P1, DOI 10.1016/j.imlet.2011.01.002; Truax AD, 2010, J MOL BIOL, V395, P254, DOI 10.1016/j.jmb.2009.10.035; Wright KL, 2006, TRENDS IMMUNOL, V27, P405, DOI 10.1016/j.it.2006.07.007; Zhou Q, 1998, EMBO J, V17, P3681, DOI 10.1093/emboj/17.13.3681	64	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91200	10.1371/journal.pone.0091200	http://dx.doi.org/10.1371/journal.pone.0091200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625964	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300063
J	Pentzold, S; Zagrobelny, M; Roelsgaard, PS; Moller, BL; Bak, S				Pentzold, Stefan; Zagrobelny, Mika; Roelsgaard, Pernille Solvhoj; Moller, Birger Lindberg; Bak, Soren			The Multiple Strategies of an Insect Herbivore to Overcome Plant Cyanogenic Glucoside Defence	PLOS ONE			English	Article							GLUCOSINOLATE-MYROSINASE SYSTEM; IRIDOID GLYCOSIDES; LEPIDOPTERAN MIDGUT; LARVAL LEPIDOPTERA; BETA-GLYCOSIDASES; SEQUESTRATION; PURIFICATION; CATERPILLAR; CYANIDE; BIOSYNTHESIS	Cyanogenic glucosides (CNglcs) are widespread plant defence compounds that release toxic hydrogen cyanide by plant beta-glucosidase activity after tissue damage. Specialised insect herbivores have evolved counter strategies and some sequester CNglcs, but the underlying mechanisms to keep CNglcs intact during feeding and digestion are unknown. We show that CNglc-sequestering Zygaena filipendulae larvae combine behavioural, morphological, physiological and biochemical strategies at different time points during feeding and digestion to avoid toxic hydrolysis of the CNglcs present in their Lotus food plant, i.e. cyanogenesis. We found that a high feeding rate limits the time for plant beta-glucosidases to hydrolyse CNglcs. Larvae performed leaf-snipping, a minimal disruptive feeding mode that prevents mixing of plant beta-glucosidases and CNglcs. Saliva extracts did not inhibit plant cyanogenesis. However, a highly alkaline midgut lumen inhibited the activity of ingested plant beta-glucosidases significantly. Moreover, insect b-glucosidases from the saliva and gut tissue did not hydrolyse the CNglcs present in Lotus. The strategies disclosed may also be used by other insect species to overcome CNglc-based plant defence and to sequester these compounds intact.	[Bak, Soren] Univ Copenhagen, Plant Biochem Lab, Copenhagen, Denmark; Univ Copenhagen, Villum Res Ctr Plant Plast, Dept Plant & Environm Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Bak, S (corresponding author), Univ Copenhagen, Plant Biochem Lab, Copenhagen, Denmark.	bak@plen.ku.dk	Bak, Soren/H-4404-2014; Pentzold, Stefan/I-3083-2019; Zagrobelny, Mika/L-8679-2015; Møller, Birger Lindberg/H-2657-2014; Møller, Birger Lindberg/GQI-1792-2022	Bak, Soren/0000-0003-4100-115X; Zagrobelny, Mika/0000-0001-5574-2894; Møller, Birger Lindberg/0000-0002-3252-3119; Møller, Birger Lindberg/0000-0002-3252-3119; Pentzold, Stefan/0000-0003-3101-7465	Villum Foundation; Villum Fonden [00007523] Funding Source: researchfish	Villum Foundation(Villum Fonden); Villum Fonden(Villum Fonden)	This work was supported by Villum Foundation (www.villumfoundation.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar A, 1998, BIORESOURCE TECHNOL, V64, P175, DOI 10.1016/S0960-8524(97)00182-X; Azevedo TR, 2003, INSECT BIOCHEM MOLEC, V33, P81, DOI 10.1016/S0965-1748(02)00179-0; Baden CU, 2012, CHEMOECOLOGY, V22, P113, DOI 10.1007/s00049-012-0103-0; Ballhorn DJ, 2010, ENTOMOL EXP APPL, V134, P245, DOI 10.1111/j.1570-7458.2009.00961.x; Ballhorn DJ, 2010, J ECOL, V98, P226, DOI 10.1111/j.1365-2745.2009.01591.x; Ballhorn DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005450; BARBEHENN RV, 1992, OECOLOGIA, V89, P229, DOI 10.1007/BF00317222; BEREBAUM M, 1980, AM NAT, V115, P138, DOI 10.1086/283551; BERNAYS EA, 1988, ECOLOGY, V69, P1153, DOI 10.2307/1941269; Bjarnholt N, 2008, PHYTOCHEMISTRY, V69, P1507, DOI 10.1016/j.phytochem.2008.01.022; BLAKE JD, 1971, CARBOHYD RES, V16, P49, DOI 10.1016/S0008-6215(00)86097-8; Boeckler GA, 2011, PHYTOCHEMISTRY, V72, P1497, DOI 10.1016/j.phytochem.2011.01.038; Bridges M, 2002, P ROY SOC B-BIOL SCI, V269, P187, DOI 10.1098/rspb.2001.1861; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; CHRISTELLER JT, 1992, INSECT BIOCHEM MOLEC, V22, P735, DOI 10.1016/0965-1748(92)90052-G; DAVIS RH, 1987, INSECT BIOCHEM, V17, P689, DOI 10.1016/0020-1790(87)90037-0; Dobler S, 2001, BASIC APPL ECOL, V2, P15, DOI 10.1078/1439-1791-00032; Dobler S, 2011, PHYTOCHEMISTRY, V72, P1593, DOI 10.1016/j.phytochem.2011.04.015; Dow J. A. T., 1987, ADV INSECT PHYSIOL, V19, P187, DOI [DOI 10.1016/S0065-2806(08)60102-2, 10.1016/S0065-2806(08)60102-2]; DOW JAT, 1992, J EXP BIOL, V172, P355; DOW JAT, 1990, J EXP BIOL, V150, P247; DUFFEY SS, 1980, ANNU REV ENTOMOL, V25, P447, DOI 10.1146/annurev.en.25.010180.002311; Engler HS, 2000, NATURE, V406, P144, DOI 10.1038/35018159; Fanger H, 2001, EUR J ENTOMOL, V98, P201, DOI 10.14411/eje.2001.038; FEIGL F, 1966, ANALYST, V91, P282, DOI 10.1039/an9669100282; FELTON GW, 1991, J CHEM ECOL, V17, P1821, DOI 10.1007/BF00993731; Ferreira C, 1998, COMP BIOCHEM PHYS B, V119, P219, DOI 10.1016/S0305-0491(97)00310-6; Fitzgerald TD, 2008, J CHEM ECOL, V34, P1283, DOI 10.1007/s10886-008-9545-9; Fitzgerald TD, 2008, J EXP BIOL, V211, P671, DOI 10.1242/jeb.013664; Fojan P, 2000, BIOCHIMIE, V82, P1033, DOI 10.1016/S0300-9084(00)01188-3; FRANZL S, 1989, EXPERIENTIA, V45, P712, DOI 10.1007/BF01974565; GRINGORTEN JL, 1993, J EXP BIOL, V183, P353; HALKIER BA, 1989, PLANT PHYSIOL, V90, P1552, DOI 10.1104/pp.90.4.1552; Jensen NB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1271; Jones DA, 1998, PHYTOCHEMISTRY, V47, P155, DOI 10.1016/S0031-9422(97)00425-1; Kuhn J, 2004, P NATL ACAD SCI USA, V101, P13808, DOI 10.1073/pnas.0402576101; LAMBERT JL, 1975, ANAL CHEM, V47, P916, DOI 10.1021/ac60356a036; Marana SR, 2000, INSECT BIOCHEM MOLEC, V30, P1139, DOI 10.1016/S0965-1748(00)00090-4; Moller BL, 2010, CURR OPIN PLANT BIOL, V13, P338, DOI 10.1016/j.pbi.2010.01.009; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Musser RO, 2005, ARCH INSECT BIOCHEM, V58, P128, DOI 10.1002/arch.20039; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; Nishida R, 2002, ANNU REV ENTOMOL, V47, P57, DOI 10.1146/annurev.ento.47.091201.145121; Opitz SEW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033649; Opitz SEW, 2009, CHEMOECOLOGY, V19, P117, DOI 10.1007/s00049-009-0018-6; Pankoke H, 2012, INSECT BIOCHEM MOLEC, V42, P426, DOI 10.1016/j.ibmb.2012.02.004; Peiffer M, 2009, J CHEM ECOL, V35, P326, DOI 10.1007/s10886-009-9604-x; Pentzold S, 2014, BIOL REV, V89, P531, DOI 10.1111/brv.12066; Pytelkova J, 2009, FEBS J, V276, P3531, DOI 10.1111/j.1742-4658.2009.07074.x; Ruuhola T, 2003, J CHEM ECOL, V29, P1083, DOI 10.1023/A:1023821304656; Ruuhola T, 2001, J CHEM ECOL, V27, P1595, DOI 10.1023/A:1010458208335; Strauss AS, 2013, ELIFE, V2, DOI 10.7554/eLife.01096; Takos A, 2010, PLANT CELL, V22, P1605, DOI 10.1105/tpc.109.073502; Terra WR, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P365, DOI 10.1016/B978-0-12-384747-8.10011-X; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; Vegliante F, 2005, ACTA ZOOL-STOCKHOLM, V86, P167, DOI 10.1111/j.1463-6395.2005.00198.x; Vegliante F, 2004, EUR J ENTOMOL, V101, P165, DOI 10.14411/eje.2004.021; Vegliante F, 2012, ANNU REV ENTOMOL, V57, P187, DOI 10.1146/annurev-ento-120710-100646; WATERHOUSE DF, 1949, AUST J SCI RES SER B, V2, P428, DOI 10.1071/BI9490428; Winde I, 2011, PHYTOCHEMISTRY, V72, P1566, DOI 10.1016/j.phytochem.2011.01.016; WITTHOHN K, 1987, J CHEM ECOL, V13, P1789, DOI 10.1007/BF01013229; Zagrobelny M, 2008, PHYTOCHEMISTRY, V69, P1457, DOI 10.1016/j.phytochem.2008.02.019; Zagrobelny M, 2007, INSECT BIOCHEM MOLEC, V37, P10, DOI 10.1016/j.ibmb.2006.09.008; Zagrobelny M, 2014, INSECT BIOCHEM MOLEC, V44, P44, DOI 10.1016/j.ibmb.2013.11.003; Zagrobelny M, 2011, PHYTOCHEMISTRY, V72, P1585, DOI 10.1016/j.phytochem.2011.02.023	66	52	52	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91337	10.1371/journal.pone.0091337	http://dx.doi.org/10.1371/journal.pone.0091337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625698	Green Submitted, gold, Green Published			2022-12-27	WOS:000332851300073
J	Woo, JI; Oh, S; Webster, P; Lee, YJ; Lim, DJ; Moon, SK				Woo, Jeong-Im; Oh, Sejo; Webster, Paul; Lee, Yoo Jin; Lim, David J.; Moon, Sung K.			NOD2/RICK-Dependent beta-Defensin 2 Regulation Is Protective for Nontypeable Haemophilus influenzae-Induced Middle Ear Infection	PLOS ONE			English	Article							NF-KAPPA-B; BRONCHIAL EPITHELIAL-CELLS; NEGATIVE CROSS-TALK; ACUTE OTITIS-MEDIA; UP-REGULATION; SIGNALING PATHWAY; STREPTOCOCCUS-PNEUMONIAE; LISTERIA-MONOCYTOGENES; HUMAN BETA-DEFENSIN-2; GENE-EXPRESSION	Middle ear infection, otitis media (OM), is clinically important due to the high incidence in children and its impact on the development of language and motor coordination. Previously, we have demonstrated that the human middle ear epithelial cells up-regulate beta-defensin 2, a model innate immune molecule, in response to nontypeable Haemophilus influenzae (NTHi), the most common OM pathogen, via TLR2 signaling. NTHi does internalize into the epithelial cells, but its intracellular trafficking and host responses to the internalized NTHi are poorly understood. Here we aimed to determine a role of cytoplasmic pathogen recognition receptors in NTHi-induced beta-defensin 2 regulation and NTHi clearance from the middle ear. Notably, we observed that the internalized NTHi is able to exist freely in the cytoplasm of the human epithelial cells after rupturing the surrounding membrane. The human middle ear epithelial cells inhibited NTHi-induced beta-defensin 2 production by NOD2 silencing but augmented it by NOD2 over-expression. NTHi-induced beta-defensin 2 up-regulation was attenuated by cytochalasin D, an inhibitor of actin polymerization and was enhanced by alpha-hemolysin, a pore-forming toxin. NOD2 silencing was found to block alpha-hemolysin-mediated enhancement of NTHi-induced beta-defensin 2 up-regulation. NOD2 deficiency appeared to reduce inflammatory reactions in response to intratympanic inoculation of NTHi and inhibit NTHi clearance from the middle ear. Taken together, our findings suggest that a cytoplasmic release of internalized NTHi is involved in the pathogenesis of NTHi infections, and NOD2-mediated beta-defensin 2 regulation contributes to the protection against NTHi-induced otitis media.	[Woo, Jeong-Im; Lee, Yoo Jin; Lim, David J.; Moon, Sung K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA; [Oh, Sejo] House Ear Res Inst, Div Clin & Translat Res, Los Angeles, CA 90034 USA; [Webster, Paul] Univ So Calif, Ctr Electron Microscopy & Microanal, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; House Research Institute; University of Southern California	Lim, DJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA.	djlim@mednet.ucla.edu; skmoon@mednet.ucla.edu		Webster, Paul/0000-0002-1980-6931	National Institutes of Health National Institute on Deafness and Other Communication Disorders (NIH-NIDCD) [RO1 DC005025, R21 DC011862]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011862, R01DC005025] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Deafness and Other Communication Disorders (NIH-NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by National Institutes of Health National Institute on Deafness and Other Communication Disorders (NIH-NIDCD) grants RO1 DC005025 and R21 DC011862. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren IL, 2001, J INFECT DIS, V184, P150, DOI 10.1086/322016; Akkerman AE, 2005, J ANTIMICROB CHEMOTH, V56, P569, DOI 10.1093/jac/dki257; ANDREWS NW, 1991, PARASITOL TODAY, V7, P335, DOI 10.1016/0169-4758(91)90212-7; Augustin DK, 2011, INFECT IMMUN, V79, P595, DOI 10.1128/IAI.00854-10; BARENKAMP SJ, 1992, INFECT IMMUN, V60, P1302, DOI 10.1128/IAI.60.4.1302-1313.1992; Berrington WR, 2010, J INFECT DIS, V201, P1422, DOI 10.1086/651559; BLUESTONE CD, 1995, ARCH OTOLARYNGOL, V121, P505; Boughan PK, 2006, J BIOL CHEM, V281, P11637, DOI 10.1074/jbc.M510275200; Chattoraj P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058514; Chun YM, 2002, ANN OTO RHINOL LARYN, V111, P507, DOI 10.1177/000348940211100606; Chung WO, 2004, J IMMUNOL, V173, P5165, DOI 10.4049/jimmunol.173.8.5165; Clementi CF, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00001; COSSART P, 1989, MOL BIOL MED, V6, P463; CROWLE AJ, 1991, INFECT IMMUN, V59, P1823, DOI 10.1128/IAI.59.5.1823-1831.1991; Darrow David H, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P416, DOI 10.1097/00020840-200312000-00002; Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294, DOI 10.1128/MMBR.62.2.294-308.1998; Fritz JH, 2005, EUR J IMMUNOL, V35, P2459, DOI 10.1002/eji.200526286; GIBSON BW, 1993, J BACTERIOL, V175, P2702, DOI 10.1128/JB.175.9.2702-2712.1993; Gilsdorf JR, 1996, PEDIATR RES, V39, P343, DOI 10.1203/00006450-199602000-00025; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Granath A, 2011, J INFECTION, V63, P174, DOI 10.1016/j.jinf.2011.06.006; GROENEVELD K, 1990, J INFECT DIS, V161, P512, DOI 10.1093/infdis/161.3.512; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hernandez M, 2008, J INFECT DIS, V198, P1862, DOI 10.1086/593213; Holmes KA, 1997, MICROB PATHOGENESIS, V23, P157, DOI 10.1006/mpat.1997.0145; Hong WZ, 2007, INFECT IMMUN, V75, P958, DOI 10.1128/IAI.01691-06; HORWITZ MA, 1988, CURR OPIN IMMUNOL, V1, P41, DOI 10.1016/0952-7915(88)90049-0; Hotomi M, 2010, AURIS NASUS LARYNX, V37, P137, DOI 10.1016/j.anl.2009.03.012; Hruz P, 2008, CURR OPIN GASTROEN, V24, P108, DOI 10.1097/MOG.0b013e3282f50fdf; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Jeong YJ, 2012, J MICROBIOL, V50, P489, DOI 10.1007/s12275-012-1534-6; Jia HP, 2000, J BIOL CHEM, V275, P33314, DOI 10.1074/jbc.M006603200; Juhn SK, 2008, CLIN EXP OTORHINOLAR, V1, P117, DOI 10.3342/ceo.2008.1.3.117; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Ketterer MR, 1999, INFECT IMMUN, V67, P4161, DOI 10.1128/IAI.67.8.4161-4170.1999; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Lee HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-87; Lee HY, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-12; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Leibovitz E, 2003, PEDIATR INFECT DIS J, V22, P509, DOI 10.1097/00006454-200306000-00006; Liang XD, 2006, CELL MICROBIOL, V8, P1656, DOI 10.1111/j.1462-5822.2006.00740.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacArthur CJ, 2011, OTOL NEUROTOL, V32, P508, DOI 10.1097/MAO.0b013e31820e6de4; Marti-Lliteras P, 2009, INFECT IMMUN, V77, P4232, DOI 10.1128/IAI.00305-09; MARTIN E, 1995, J LEUKOCYTE BIOL, V58, P128, DOI 10.1002/jlb.58.2.128; Maxson S, 1996, Pediatr Rev, V17, P191, DOI 10.1542/pir.17-6-191; McDermott AM, 2003, INVEST OPHTH VIS SCI, V44, P1859, DOI 10.1167/iovs.02-0787; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Mikami F, 2006, J BIOL CHEM, V281, P22397, DOI 10.1074/jbc.M602124200; Moon SK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-12; Moon SK, 2002, BBA-MOL CELL RES, V1590, P41, DOI 10.1016/S0167-4889(02)00196-9; Moon SK, 2007, INFECT IMMUN, V75, P3361, DOI 10.1128/IAI.01886-06; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Morey P, 2011, MICROBIOL-SGM, V157, P234, DOI 10.1099/mic.0.040451-0; Morrison GM, 1999, FEBS LETT, V442, P112, DOI 10.1016/S0014-5793(98)01630-5; Murphy TF, 2004, AM J RESP CRIT CARE, V170, P266, DOI 10.1164/rccm.200403-354OC; Murphy TF, 2000, PEDIATR INFECT DIS J, V19, pS9, DOI 10.1097/00006454-200005001-00003; Nabatov AA, 2013, BBA-GEN SUBJECTS, V1830, P5277, DOI 10.1016/j.bbagen.2013.07.017; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Oh S, 2012, J IMMUNOL, V188, P3496, DOI 10.4049/jimmunol.1103182; Ratner AJ, 2007, CELL MICROBIOL, V9, P1343, DOI 10.1111/j.1462-5822.2006.00878.x; Ren DB, 2012, EXP BIOL MED, V237, P540, DOI 10.1258/ebm.2012.011377; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Schroder JM, 1999, BIODRUGS, V11, P293, DOI 10.2165/00063030-199911050-00001; Shimada J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-134; Shuto T, 2002, J BIOL CHEM, V277, P17263, DOI 10.1074/jbc.M112190200; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Sinai AP, 1997, J CELL SCI, V110, P2117; Starner TD, 2006, AM J RESP CRIT CARE, V174, P213, DOI 10.1164/rccm.200509-1459OC; Swords WE, 2000, MOL MICROBIOL, V37, P13, DOI 10.1046/j.1365-2958.2000.01952.x; Theivanthiran B, 2012, INFECT IMMUN, V80, P2558, DOI 10.1128/IAI.06230-11; Tong HH, 2001, INFECT IMMUN, V69, P3678, DOI 10.1128/IAI.69.6.3678-3684.2001; Tsai WH, 2011, CELL MICROBIOL, V13, P717, DOI 10.1111/j.1462-5822.2010.01567.x; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; Vadia S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002356; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Wang BN, 2002, J BIOL CHEM, V277, P949, DOI 10.1074/jbc.M107484200; Watanabe T, 2004, P NATL ACAD SCI USA, V101, P3563, DOI 10.1073/pnas.0400557101; Webster P, 2002, J HISTOCHEM CYTOCHEM, V50, P503, DOI 10.1177/002215540205000407; Wilson E, 2008, J INFECT DIS, V197, pS178, DOI 10.1086/522136; Woo JI, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-314; Xu XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028216; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yao QP, 2013, SEMIN ARTHRITIS RHEU, V43, P125, DOI 10.1016/j.semarthrit.2012.12.005	87	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90933	10.1371/journal.pone.0090933	http://dx.doi.org/10.1371/journal.pone.0090933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625812	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300041
J	Connelly, JJ; Golding, J; Gregory, SP; Ring, SM; Davis, JM; Smith, GD; Harris, JC; Carter, CS; Pembrey, M				Connelly, Jessica J.; Golding, Jean; Gregory, Steven P.; Ring, Susan M.; Davis, John M.; Smith, George Davey; Harris, James C.; Carter, C. Sue; Pembrey, Marcus			Personality, Behavior and Environmental Features Associated with OXTR Genetic Variants in British Mothers	PLOS ONE			English	Article							OXYTOCIN RECEPTOR OXTR; EXPOSOME; CHILDREN; PSYCHOPATHOLOGY; VULNERABILITY; VASOPRESSIN; METABOLISM; PARENTS; SCALE	Background: It is assumed that the oxytocin receptor gene (OXTR) is associated with factors that are related to features of reproduction as well as the currently emerging fields of mood and emotional response. Methods: We analysed data from over 8000 mothers who participated in the Avon Longitudinal Study of Parents and Children (ALSPAC). We determined reproductive, emotional and personality differences related to the two SNPs rs53576 and rs2254298 of the oxytocin receptor gene to determine whether there was evidence in this population for: (i) associations with emotional and personality differences, and (ii) behavioural or environmental links with these SNPs using a hypothesis free approach with over 1000 types of exposure. Results: Our analyses of 7723 women showed that there were no differences in 11 mood, social or relationship characteristics associated with the rs2254298, and just one with rs53576 (with emotional loneliness) - one statistically significant out of 22 tests is no more than would be expected by chance. There were no interactions with childhood abuse. Using a hypothesis-free approach we found few indicators of environmental or behavioural differences associated with rs2254298, but there was an excess of associations with eating habits with rs53576. The findings included an association with dieting to lose weight, and habits typical of bulimia for the women with GG. The nutrition of the women also showed negative associations of the GG genotype with 13 nutrients, including vitamins D, B-12 and retinol, and intake of calcium, potassium and iodine. Conclusions: We conclude that this large database of pregnant women was unable to provide confirmation of the types of personality associated with these two OXTR SNPs, but we have shown some evidence of eating differences in those with GG on rs53576. Confirmation of our hypothesis free associations using other data sets is important.	[Connelly, Jessica J.] Univ Virginia, Dept Med, Div Cardiovasc Med, Charlottesville, VA 22903 USA; [Connelly, Jessica J.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA USA; [Golding, Jean; Gregory, Steven P.; Pembrey, Marcus] Univ Bristol, Ctr Child & Adolescent Hlth, Sch Social & Community Med, Bristol, Avon, England; [Ring, Susan M.; Smith, George Davey] Univ Bristol, Sch Social & Community Med, Avon Longitudinal Study Parents & Children, Bristol, Avon, England; [Davis, John M.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Harris, James C.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Carter, C. Sue] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Carter, C. Sue] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Pembrey, Marcus] UCL, Inst Child Hlth, London, England	University of Virginia; University of Virginia; University of Bristol; University of Bristol; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; Northeastern University; University of London; University College London	Connelly, JJ (corresponding author), Univ Virginia, Dept Med, Div Cardiovasc Med, Charlottesville, VA 22903 USA.	jessica.connelly@virginia.edu	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Gregory, Steve/0000-0002-1529-9338; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475; Golding, Jean/0000-0003-2826-3307	Medical Research Council [G1100226]; Fetzer Institute [3091.00]; Medical Research Council [MC_PC_15018, MC_UU_12013/1] Funding Source: researchfish; MRC [G1100226, MC_UU_12013/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fetzer Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The UK Medical Research Council (MRC), the Wellcome Trust and the University of Bristol currently provide core support for ALSPAC. The statistical analyses for this project were undertaken with funding from the Medical Research Council [grant no. G1100226]. Genotyping to confirm imputation of rs2254298 was funded through the Fetzer Institute (Project #3091.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011153; Armitage P., 2002, STAT METHODS MED RES; BACHMAN JG, 1977, J PERS SOC PSYCHOL, V35, P365, DOI 10.1037/0022-3514.35.6.365; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Bath SC, 2013, LANCET, V382, P331, DOI 10.1016/S0140-6736(13)60436-5; BOYCE P, 1989, AUST NZ J PSYCHIAT, V23, P341; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Bradley B, 2011, DEV PSYCHOPATHOL, V23, P439, DOI 10.1017/S0954579411000162; Brune M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-38; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Carter CS, 2008, PROG BRAIN RES, V170, P331, DOI 10.1016/S0079-6123(08)00427-5; Chen FS, 2012, SOC PSYCHOL PERS SCI, V3, P93, DOI 10.1177/1948550611410325; Cornelis MC, 2012, MOL PSYCHIATR, V17, P1157, DOI 10.1038/mp.2011.178; Ebstein RP, 2012, HORM BEHAV, V61, P359, DOI 10.1016/j.yhbeh.2011.12.014; Edenberg HJ, 2007, ALCOHOL RES HEALTH, V30, P5; Feldman R, 2012, BIOL PSYCHIAT, V72, P175, DOI 10.1016/j.biopsych.2011.12.025; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Gillath O, 2008, PERS SOC PSYCHOL B, V34, P1396, DOI 10.1177/0146167208321484; Golding J, 2004, EUR J ENDOCRINOL, V151, pU119, DOI 10.1530/eje.0.151U119; Graustella AJ, 2012, HORM BEHAV, V61, P410, DOI [10.1016/j.yhbeh.2012.01.002, 10.1016/j.yhbeh.2012.04.008]; Jacob S, 2007, NEUROSCI LETT, V417, P6, DOI 10.1016/j.neulet.2007.02.001; Jones R, 2005, PAEDIATR PERINAT EP, V19, P264, DOI 10.1111/j.1365-3016.2005.00664.x; Kogan A, 2011, P NATL ACAD SCI USA, V108, P19189, DOI 10.1073/pnas.1112658108; Lawson EA, 2012, J CLIN ENDOCR METAB, V97, pE1898, DOI 10.1210/jc.2012-1702; Louis GMB, 2012, STAT MED, V31, P2569, DOI 10.1002/sim.5496; Lucht MJ, 2009, PROG NEURO-PSYCHOPH, V33, P860, DOI 10.1016/j.pnpbp.2009.04.004; MacDonald K, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00035; Malik AI, 2012, GENES BRAIN BEHAV, V11, P545, DOI 10.1111/j.1601-183X.2012.00776.x; McQuaid RJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00128; Mwenifumbo Jill C, 2009, Handb Exp Pharmacol, P235, DOI 10.1007/978-3-540-69248-5_9; NOWICKI S, 1974, J PERS ASSESS, V38, P136, DOI 10.1080/00223891.1974.10119950; O'Connor TG, 1999, J CHILD PSYCHOL PSYC, V40, P777, DOI 10.1111/1469-7610.00493; Peters A, 2012, J EPIDEMIOL COMMUN H, V66, P103, DOI 10.1136/jech-2011-200643; Pianezza ML, 1998, NATURE, V393, P750, DOI 10.1038/31623; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Rodriguez S, 2013, J INVEST DERMATOL, V133, P1760, DOI 10.1038/jid.2012.480; Saphire-Bernstein S, 2011, P NATL ACAD SCI USA, V108, P15118, DOI 10.1073/pnas.1113137108; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; Wild CP, 2012, INT J EPIDEMIOL, V41, P24, DOI 10.1093/ije/dyr236; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013	42	23	23	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90465	10.1371/journal.pone.0090465	http://dx.doi.org/10.1371/journal.pone.0090465			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621820	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300021
J	Enama, ME; Ledgerwood, JE; Novik, L; Nason, MC; Gordon, IJ; Holman, L; Bailer, RT; Roederer, M; Koup, RA; Mascola, JR; Nabel, GJ; Graham, BS				Enama, Mary E.; Ledgerwood, Julie E.; Novik, Laura; Nason, Martha C.; Gordon, Ingelise J.; Holman, LaSonji; Bailer, Robert T.; Roederer, Mario; Koup, Richard A.; Mascola, John R.; Nabel, Gary J.; Graham, Barney S.		VRC 011 Study Team	Phase I Randomized Clinical Trial of VRC DNA and rAd5 HIV-1 Vaccine Delivery by Intramuscular (IM), Subcutaneous (SC) and Intradermal (ID) Administration (VRC 011)	PLOS ONE			English	Article							T-CELL RESPONSES; CANDIDATE VACCINE; IMMUNOGENICITY EVALUATION; EFFICACY TRIAL; VIRUS; IMMUNIZATION; INFECTION; ANTIBODY; IMMUNITY; VECTORS	Background: Phase 1 evaluation of the VRC HIV DNA and rAd5 vaccines delivered intramuscularly (IM) supported proceeding to a Phase 2 b efficacy study. Here we report comparison of the IM, subcutaneous (SC) and intradermal (ID) routes of administration. Methods: Sixty subjects were randomized to 6 schedules to evaluate the IM, SC or ID route for prime injections. Three schedules included DNA primes (Wks 0,4,8) and 3 schedules included rAd5 prime (Wk0); all included rAd5 IM boost (Wk24). DNA vaccine dosage was 4 mg IM or SC, but 0.4 mg ID, while all rAd5 vaccinations were 10(10) PU. All injections were administered by needle and syringe. Results: Overall, 27/30 subjects completed 3 DNA primes; 30/30 subjects completed rAd5 primes. Mild local pruritus (itchiness), superficial skin lesions and injection site nodules were associated with ID and SC, but not IM injections. All routes induced T-cell and antibody immune responses after rAd5 boosting. Overall, >95% had Env antibody and >80% had Env T-cell responses. Conclusions: The pattern of local reactogenicity following ID and SC injections differed from IM injections but all routes were well-tolerated. There was no evidence of an immunogenicity advantage following SC or ID delivery, supporting IM delivery as the preferred route of administration.	[Enama, Mary E.; Ledgerwood, Julie E.; Novik, Laura; Gordon, Ingelise J.; Holman, LaSonji; Bailer, Robert T.; Roederer, Mario; Koup, Richard A.; Mascola, John R.; Nabel, Gary J.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Nason, Martha C.] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	bgraham@nih.gov	Roederer, Mario/G-1887-2011; Graham, Barney S./AAC-5898-2019; Mascola, John/AAI-7193-2021	Graham, Barney S./0000-0001-8112-0853; 	U.S. Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005035, ZIAAI005021, ZICAI005123] Funding Source: NIH RePORTER	U.S. Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by U.S. Government funding for the intramural research conducted by the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Churchyard GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021225; De Rosa SC, 2011, J IMMUNOL, V187, P3391, DOI 10.4049/jimmunol.1101421; Freel SA, 2010, J VIROL, V84, P4998, DOI 10.1128/JVI.00138-10; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Graham BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059340; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Jaoko W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012873; Kibuuka H, 2010, J INFECT DIS, V201, P600, DOI 10.1086/650299; Koblin BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024517; Koup RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009015; Koup RA, 2009, J VIROL, V83, P6318, DOI 10.1128/JVI.00384-09; Ledgerwood JE, 2012, CLIN VACCINE IMMUNOL, V19, P1792, DOI 10.1128/CVI.05663-11; Lewis JA, 2006, DEV BIOLOGICALS, V123, P165; Peachman KK, 2003, METHODS, V31, P232, DOI 10.1016/S1046-2023(03)00137-3; Peiperl L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013579; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roozbeh J, 2005, ASAIO J, V51, P242, DOI 10.1097/01.MAT.0000161935.66158.97; Roy MJ, 2000, VACCINE, V19, P764, DOI 10.1016/S0264-410X(00)00302-9; Sugaya M, 2004, J IMMUNOL, V172, P2219, DOI 10.4049/jimmunol.172.4.2219	24	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91366	10.1371/journal.pone.0091366	http://dx.doi.org/10.1371/journal.pone.0091366			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621858	Green Submitted, gold, Green Published			2022-12-27	WOS:000332845300081
J	de Souza, LB; da Silva, LLP; Jamur, MC; Oliver, C				de Souza, Lorena Brito; Pinto da Silva, Luis Lamberti; Jamur, Maria Celia; Oliver, Constance			Phospholipase D Is Involved in the Formation of Golgi Associated Clathrin Coated Vesicles in Human Parotid Duct Cells	PLOS ONE			English	Article							PHOSPHATIDIC-ACID; CYTOSKELETAL REORGANIZATION; MAMMALIAN-CELLS; PLASMA-MEMBRANE; GENE FAMILY; RECEPTOR; ENDOCYTOSIS; APPARATUS; LOCALIZATION; ISOFORM	Phospholipase D (PLD) has been implicated in many cellular functions, such as vesicle trafficking, exocytosis, differentiation, and proliferation. The aim of this study was to characterize the role of PLD in HSY cells, a human cell line originating from the intercalated duct of the parotid gland. As the function and intracellular localization of PLD varies according to cell type, initially, the intracellular localization of PLD1 and PLD2 was determined. By immunofluorescence, PLD1 and PLD2 both showed a punctate cytoplasmic distribution with extensive co-localization with TGN-46. PLD1 was also found in the nucleus, while PLD2 was associated with the plasma membrane. Treatment of cells with the primary alcohol 1-butanol inhibits the hydrolysis of phosphatidylcoline by PLD thereby suppressing phosphatidic acid (PA) production. In untreated HSY cells, there was only a slight co-localization of PLD with the clathrin coated vesicles. When HSY cells were incubated with 1-butanol the total number of clathrin coated vesicles increased, especially in the juxtanuclear region and the co-localization of PLD with the clathrin coated vesicles was augmented. Transmission electron microscopy confirmed that the number of Golgi-associated coated vesicles was greater. Treatment with 1-butanol also affected the Golgi apparatus, increasing the volume of the Golgi saccules. The decrease in PA levels after treatment with 1-butanol likewise resulted in an accumulation of enlarged lysosomes in the perinuclear region. Therefore, in HSY cells PLD appears to be involved in the formation of Golgi associated clathrin coated vesicles as well as in the structural maintenance of the Golgi apparatus.	[de Souza, Lorena Brito; Pinto da Silva, Luis Lamberti; Jamur, Maria Celia; Oliver, Constance] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cell & Mol Biol, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Oliver, C (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cell & Mol Biol, BR-14049 Ribeirao Preto, SP, Brazil.	coliver@fmrp.usp.br	daSilva, Luis LP/AAD-5657-2019; Brito de Souza, Lorena/N-3385-2014; LP daSilva, Luis/A-9949-2010	daSilva, Luis LP/0000-0003-3558-0087; Brito de Souza, Lorena/0000-0002-2462-6759; LP daSilva, Luis/0000-0003-3558-0087	CAPES (Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior) [BEX 4085/09-4]; FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [06/55650-6]	CAPES (Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support was received from the following agencies: CAPES (Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior; http://www.capes.gov.br/-Individual Grant BEX 4085/09-4, FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia; http://www.faepa.br/) and FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; http://www.fapesp.br/-Individual Grant 06/55650-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapuy B, 2008, TRAFFIC, V9, P1157, DOI 10.1111/j.1600-0854.2008.00745.x; Chen YG, 1997, J CELL BIOL, V138, P495, DOI 10.1083/jcb.138.3.495; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Dohke Y, 2002, BIOCHEM BIOPH RES CO, V299, P663, DOI 10.1016/S0006-291X(02)02713-4; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Faugaret D, 2011, BIOCHEM PHARMACOL, V81, P144, DOI 10.1016/j.bcp.2010.09.014; Freyberg Z, 2003, TRENDS CELL BIOL, V13, P540, DOI 10.1016/j.tcb.2003.08.004; Freyberg Z, 2002, MOL BIOL CELL, V13, P3930, DOI 10.1091/mbc.02-04-0059; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Garrido JL, 2009, MOL ENDOCRINOL, V23, P2048, DOI 10.1210/me.2008-0436; Gayral S, 2006, CIRC RES, V99, P132, DOI 10.1161/01.RES.0000232323.86227.8b; Ghosh P, 2003, J CELL BIOL, V163, P755, DOI 10.1083/jcb.200308038; Gibbs TC, 2000, J CELL PHYSIOL, V182, P77, DOI 10.1002/(SICI)1097-4652(200001)182:1<77::AID-JCP9>3.0.CO;2-B; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hitomi T, 2004, BLOOD, V104, P4122, DOI 10.1182/blood-2004-06-2091; Jang JH, 2012, PROG LIPID RES, V51, P71, DOI 10.1016/j.plipres.2011.12.003; Jang YH, 2011, J BIOL CHEM, V286, P4680, DOI 10.1074/jbc.M110.162602; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Koch T, 2006, J NEUROCHEM, V97, P365, DOI 10.1111/j.1471-4159.2006.03736.x; Kooijman EE, 2009, BBA-MOL CELL BIOL L, V1791, P881, DOI 10.1016/j.bbalip.2009.04.001; Lavieri R, 2009, BIOORG MED CHEM LETT, V19, P2240, DOI 10.1016/j.bmcl.2009.02.125; Lee CS, 2006, NAT CELL BIOL, V8, P477, DOI 10.1038/ncb1401; Lewis JA, 2009, BIOORG MED CHEM LETT, V19, P1916, DOI 10.1016/j.bmcl.2009.02.057; Liscovitch M, 1999, BBA-MOL CELL BIOL L, V1439, P245, DOI 10.1016/S1388-1981(99)00098-0; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; LUDWIG T, 1991, J CELL BIOL, V115, P1561, DOI 10.1083/jcb.115.6.1561; Manifava M, 2001, J BIOL CHEM, V276, P8987, DOI 10.1074/jbc.M010308200; Mateos MV, 2010, BBA-BIOMEMBRANES, V1798, P624, DOI 10.1016/j.bbamem.2009.12.008; Marchini-Alves CMM, 2012, J HISTOCHEM CYTOCHEM, V60, P386, DOI 10.1369/0022155412438886; Metcalf DJ, 2008, TRAFFIC, V9, P1905, DOI 10.1111/j.1600-0854.2008.00807.x; Padron D, 2006, MOL BIOL CELL, V17, P598, DOI 10.1091/mbc.E05-05-0389; Park MH, 2009, CARCINOGENESIS, V30, P356, DOI 10.1093/carcin/bgn287; Peng X, 2012, ACTA PHYSIOL, V204, P219, DOI 10.1111/j.1748-1716.2011.02298.x; Perez-Victoria FJ, 2008, MOL BIOL CELL, V19, P2350, DOI 10.1091/mbc.E07-11-1189; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Riebeling C, 2009, BBA-MOL CELL BIOL L, V1791, P876, DOI 10.1016/j.bbalip.2009.04.003; Roach AN, 2012, J LIPID RES, V53, P2598, DOI 10.1194/jlr.M028597; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Siddhanta A, 2000, J BIOL CHEM, V275, P12023, DOI 10.1074/jbc.275.16.12023; Sweeney DA, 2002, J BIOL CHEM, V277, P3030, DOI 10.1074/jbc.M104639200; Vorland M, 2008, PLATELETS, V19, P582, DOI 10.1080/09537100802454992; YANAGAWA T, 1986, VIRCHOWS ARCH B, V51, P187, DOI 10.1007/BF02899028; Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200	47	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91868	10.1371/journal.pone.0091868	http://dx.doi.org/10.1371/journal.pone.0091868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618697	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400138
J	Ma, Q; Zou, Y; Lv, YJ; Song, H; Yuan, YJ				Ma, Qian; Zou, Yang; Lv, Yajin; Song, Hao; Yuan, Ying-Jin			Comparative Proteomic Analysis of Experimental Evolution of the Bacillus cereus-Ketogulonicigenium vulgare Co-Culture	PLOS ONE			English	Article							TERM EXPERIMENTAL EVOLUTION; SYSTEMS BIOLOGY; OLIGOPEPTIDE TRANSPORT; COMMUNITY PROTEOMICS; ESCHERICHIA-COLI; EXOSPORIUM; SPORULATION; EXPRESSION; SPECIFICITY; MEGATERIUM	The microbial co-culture system composing of Ketogulonicigenium vulgare and Bacillus cereus was widely adopted in industry for the production of 2-keto-gulonic acid (2-KGA), the precursor of vitamin C. We found serial subcultivation of the co-culture could enhance the yield of 2-KGA by 16% in comparison to that of the ancestral co-culture. To elucidate the evolutionary dynamics and interaction mechanisms of the two microbes, we performed iTRAQ-based quantitative proteomic analyses of the pure cultures of K. vulgare, B. cereus and their co-culture during serial subcultivation. Hierarchy cluster analyses of the proteomic data showed that the expression level of a number of crucial proteins associated with sorbose conversion and oligopeptide transport was significantly enhanced by the experimental evolution. In particular, the expression level of sorbose/sorbosone dehydrogenase was enhanced in the evolved K. vulgare, while the expression level of InhA and the transport efficiency of oligopeptides were increased in the evolved B. cereus. The decreased sporulating protein expression and increased peptide transporter expression observed in evolved B. cereus, together with the increased amino acids synthesis in evolved K. vulgare suggested that serial subcultivation result in enhanced synergistic cooperation between K. vulgare and B. cereus, enabling an increased production of 2-KGA.	[Yuan, Ying-Jin] Tianjin Univ, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China; Tianjin Univ, Sch Chem Engn & Technol, Collaborat Innovat Ctr Chem Sci & Engn, Dept Pharmaceut Engn, Tianjin 300072, Peoples R China	Tianjin University; Tianjin University	Yuan, YJ (corresponding author), Tianjin Univ, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China.	yjyuan@tju.edu.cn	Song, Hao/G-6207-2010	Song, Hao/0000-0001-5553-2539	National Basic Research Program of China ("973'' Program) [2013CB733600]; National Natural Science Foundation of China; National High Technology Research and Development Program ("863'' Program) [2012AA02A701]	National Basic Research Program of China ("973'' Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program ("863'' Program)(National High Technology Research and Development Program of China)	This work was funded by the National Basic Research Program of China ("973'' Program: 2013CB733600), the National Natural Science Foundation of China, the National High Technology Research and Development Program ("863'' Program: 2012AA02A701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura A, 1999, BIOSCI BIOTECH BIOCH, V63, P46, DOI 10.1271/bbb.63.46; Ball DA, 2008, MOL MICROBIOL, V68, P947, DOI 10.1111/j.1365-2958.2008.06206.x; Barrett RDH, 2005, AM NAT, V166, P470, DOI 10.1086/444440; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang WT, 2007, BIORESOURCE TECHNOL, V98, P1224, DOI 10.1016/j.biortech.2006.05.005; Charlton S, 1999, J APPL MICROBIOL, V87, P241, DOI 10.1046/j.1365-2672.1999.00878.x; de Lorenzo V, 2008, CURR OPIN BIOTECH, V19, P579, DOI 10.1016/j.copbio.2008.10.004; de Vries YP, 2004, APPL ENVIRON MICROB, V70, P2514, DOI 10.1128/AEM.70.4.2514-2519.2004; dos Santos VM, 2010, CURR OPIN BIOTECH, V21, P539, DOI 10.1016/j.copbio.2010.08.003; Fazzini MM, 2010, J BACTERIOL, V192, P4012, DOI 10.1128/JB.00197-10; Gominet M, 2001, MOL MICROBIOL, V40, P963, DOI 10.1046/j.1365-2958.2001.02440.x; Guillemet E, 2010, J BACTERIOL, V192, P286, DOI 10.1128/JB.00264-09; Hillesland KL, 2010, P NATL ACAD SCI USA, V107, P2124, DOI 10.1073/pnas.0908456107; Hillesland KL, 2009, P ROY SOC B-BIOL SCI, V276, P459, DOI 10.1098/rspb.2008.1098; Ma Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032156; Ma Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026108; MATZ LL, 1970, J BACTERIOL, V101, P196, DOI 10.1128/JB.101.1.196-201.1970; Monnet V, 2003, CELL MOL LIFE SCI, V60, P2100, DOI 10.1007/s00018-003-3054-3; PEREGO M, 1991, MOL MICROBIOL, V5, P173, DOI 10.1111/j.1365-2958.1991.tb01838.x; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Roling WFM, 2010, CURR OPIN BIOTECH, V21, P532, DOI 10.1016/j.copbio.2010.06.007; Rozen DE, 2000, AM NAT, V155, P24, DOI 10.1086/303299; Saito Y, 1997, APPL ENVIRON MICROB, V63, P454, DOI 10.1128/AEM.63.2.454-460.1997; Solomon J, 2003, J BACTERIOL, V185, P6425, DOI 10.1128/JB.185.21.6425-6433.2003; Tauveron G, 2006, INT J FOOD MICROBIOL, V110, P254, DOI 10.1016/j.ijfoodmicro.2006.04.027; Travisano M, 1996, GENETICS, V143, P15; VASANTHA N, 1980, J BACTERIOL, V144, P1119, DOI 10.1128/JB.144.3.1119-1125.1980; VerBerkmoes NC, 2009, NAT REV MICROBIOL, V7, P196, DOI 10.1038/nrmicro2080; Wang W, 2006, J BIOTECHNOL, V126, P313, DOI 10.1016/j.jbiotec.2006.05.005; Wilmes P, 2009, CURR OPIN MICROBIOL, V12, P310, DOI 10.1016/j.mib.2009.03.004; Zhang J, 2011, BIORESOURCE TECHNOL, V102, P4807, DOI 10.1016/j.biortech.2010.10.124; Zhou J, 2011, APPL ENVIRON MICROB, V77, P7023, DOI 10.1128/AEM.05123-11; Zhu Y, 2012, PROCESS BIOCH; Zou Y, 2012, BIORESOURCE TECHNOLO	34	15	16	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91789	10.1371/journal.pone.0091789	http://dx.doi.org/10.1371/journal.pone.0091789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619085	Green Submitted, gold, Green Published			2022-12-27	WOS:000332842400130
J	Pan, T; Sun, JF; Hu, JY; Hu, YW; Zhou, J; Chen, ZG; Xu, D; Xu, WH; Zheng, S; Zhang, SZ				Pan, Tao; Sun, Junfeng; Hu, Jiyi; Hu, Yiwang; Zhou, Jun; Chen, Zhigang; Xu, Dong; Xu, Wenhong; Zheng, Shu; Zhang, Suzhan			Cytohesins/ARNO: The Function in Colorectal Cancer Cells	PLOS ONE			English	Article							FACTOR RECEPTOR EGFR; GROWTH-FACTOR SYSTEM; INHIBITION; CETUXIMAB; PATHWAY	Epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I) are critical regulators of cell differentiation, survival, proliferation, and migration in cancers. This study found that ARNO (cytohesin-2), an activator of the EGF and IGF-I pathways, was more highly expressed in colorectal cancer tissue than in benign adjacent colorectal tissue. When ARNO-siRNA or the chemical inhibitor SecinH3 blocked ARNO, the downstream of the EGF and IGF-I pathways decreased in colorectal cell lines HT29 and HCT116. This blocking also weakened cell proliferation, invasion, and migration in vitro. Furthermore, EGF receptor (EGFR)-dependent colorectal tumor xenografts in nude mouse exerted anti-proliferative and growth suppression effects by injecting secineH3. These data suggested that inhibiting cytohesins or ARNO as cytoplasmic activators of EGFR and IGF-I in colorectal cancer resulted in anti-proliferation, reduced invasion, decreased migration, and suppressed growth in vivo and in vitro. Therefore, cytohesins or ARNO may be a potential therapy target for some colorectal cancer.	[Pan, Tao; Hu, Jiyi; Hu, Yiwang; Zhou, Jun; Chen, Zhigang; Zheng, Shu; Zhang, Suzhan] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Tao; Xu, Dong; Xu, Wenhong] Zhejiang Univ, Sch Med, Key Lab Canc Prevent & Intervent, Canc Inst,Natl Minist Educ,Prov Key Lab Mol Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Junfeng] Zhengzhou Univ, Henan Canc Hosp, Dept Gastrointestinal Surg, Zhengzhou 450052, Peoples R China	Zhejiang University; Zhejiang University; Zhengzhou University	Zhang, SZ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	suzhan_zhang@163.com			National High Technology Research and Development Program of China [2012AA02A506]; Zhejiang Provincial Natural Science Foundation of China [LD13H160015]; Zhejiang Provincial Key Scientific and Technological Research Projects of International Cooperation [2009C14010]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Key Scientific and Technological Research Projects of International Cooperation	This research was supported from National High Technology Research and Development Program of China (No. 2012AA02A506), Zhejiang Provincial Natural Science Foundation of China (LD13H160015) and Zhejiang Provincial Key Scientific and Technological Research Projects of International Cooperation (No. 2009C14010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Bill A, 2010, CELL, V143, P201, DOI 10.1016/j.cell.2010.09.011; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Chi F, 2013, MOL BIOL REP, V40, P3583, DOI 10.1007/s11033-012-2432-z; Choi YJ, 2010, CANCER CHEMOTH PHARM, V66, P381, DOI 10.1007/s00280-009-1174-7; Dey BR, 1996, MOL ENDOCRINOL, V10, P631, DOI 10.1210/me.10.6.631; Dutta PR, 2007, CANCER LETT, V254, P165, DOI 10.1016/j.canlet.2007.02.006; Gibson TB, 2006, CLIN COLORECTAL CANC, V6, P29, DOI 10.3816/CCC.2006.n.01; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Heuckmann JM, 2012, J CLIN ONCOL, V30, P3417, DOI 10.1200/JCO.2012.43.1825; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ludovini V, 2009, ANN ONCOL, V20, P842, DOI 10.1093/annonc/mdn727; McLeod HL, 2000, EUR J CANCER, V36, P1706, DOI 10.1016/S0959-8049(00)00150-7; Montagut C, 2012, NAT MED, V18, P221, DOI 10.1038/nm.2609; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Oh SJ, 2010, J BIOL CHEM, V285, P14610, DOI 10.1074/jbc.M109.043935; Pan T, 2013, ONCOL LETT, V5, P521, DOI 10.3892/ol.2012.1064; Park JHY, 2008, ASIA PAC J CLIN NUTR, V17, P257; Rosenzweig SA, 2010, BIOCHEM PHARMACOL, V80, P1115, DOI 10.1016/j.bcp.2010.06.013; Scartozzi M, 2011, ONCOLOGIST, V16, P53, DOI 10.1634/theoncologist.2010-0119; Sung FL, 2006, J PROTEOME RES, V5, P3260, DOI 10.1021/pr050452g; Ullrich RT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003908; Weroha SJ, 2012, ENDOCRIN METAB CLIN, V41, P335, DOI 10.1016/j.ecl.2012.04.014; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Zhang WZ, 2011, BRAZ J MED BIOL RES, V44, P642, DOI [10.1590/S0100-879X2011007500072, 10.1590/S0100-879X2011000700005]; Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603; Zimmer S, 2009, J CANCER RES CLIN, V135, P723, DOI 10.1007/s00432-008-0509-9	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90997	10.1371/journal.pone.0090997	http://dx.doi.org/10.1371/journal.pone.0090997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618737	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400042
J	Wiley, L; Ashok, D; Martin-Ruiz, C; Talbot, DCS; Collerton, J; Kingston, A; Davies, K; Chinnery, PF; Catt, M; Jagger, C; Kirkwood, TBL; von Zglinicki, T				Wiley, Laura; Ashok, Deepthi; Martin-Ruiz, Carmen; Talbot, Duncan C. S.; Collerton, Joanna; Kingston, Andrew; Davies, Karen; Chinnery, Patrick F.; Catt, Michael; Jagger, Carol; Kirkwood, Thomas B. L.; von Zglinicki, Thomas			Reactive Oxygen Species Production and Mitochondrial Dysfunction in White Blood Cells Are Not Valid Biomarkers of Ageing in the Very Old	PLOS ONE			English	Article							PERMEABILITY TRANSITION; OXIDATIVE STRESS; SENESCENCE; DAMAGE; DNA; DISEASE; ONSET; RATS	Reliable and valid biomarkers of ageing (BoA) are needed to understand mechanisms, test interventions and predict the timing of adverse health events associated with ageing. Since increased reactive oxygen species (ROS) production and mitochondrial dysfunction are consequences of cellular senescence and may contribute causally to the ageing of organisms, we focused on these parameters as candidate BoA. Superoxide levels, mitochondrial mass and mitochondrial membrane potential in human peripheral blood mononuclear cells (PBMCs) and subpopulations (lymphocytes and monocytes) were measured in participants from the Newcastle 85+ study, a population-based study of the very old (aged 85 years and older). The intra-and inter-assay precision expressed as coefficient of variation (CV) for all parameters was acceptable (3% to 12% and 5 to 22% respectively). All parameters were stable in the short-term (1 week interval) in a sample of control individuals in the PBMCs and lymphocyte subpopulation, however they were unstable in the monocyte subpopulation; this rendered monocytes unreliable for further analysis. There was a significant association between superoxide levels and mitochondrial mass (positive in lymphocytes, p = 0.01) and between superoxide levels and mitochondrial membrane potential (negative in PBMCs, p = 0.01; positive in lymphocytes, p = 0.05). There were also significant associations between superoxide levels and mitochondrial parameters with other markers of oxidative stress-induced cellular senescence (p <= 0.04), however some were in the opposite direction to expected. No associations were found between the measured parameters and age-related outcomes, including cognitive impairment, disability, co-morbidity and survival - questioning the validity of these parameters as candidate BoA in the very old.	[Wiley, Laura; Ashok, Deepthi; Martin-Ruiz, Carmen; Collerton, Joanna; Kingston, Andrew; Davies, Karen; Catt, Michael; Jagger, Carol; Kirkwood, Thomas B. L.; von Zglinicki, Thomas] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Talbot, Duncan C. S.] Colworth Sci Pk, Unilever Discover, Sharnbrook, Beds, England; [Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Unilever; Newcastle University - UK	von Zglinicki, T (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Campus Ageing & Vital, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	t.vonzglinicki@newcastle.ac.uk		Chinnery, Patrick/0000-0002-7065-6617; Martin-Ruiz, Carmen/0000-0002-3361-6974; von Zglinicki, Thomas/0000-0002-5939-0248; Kingston, Andrew/0000-0003-4211-7007; Catt, Michael/0000-0003-0935-7973; Davies, Karen/0000-0002-2820-9397; Ashok, Deepthi/0000-0003-0252-4716; Jagger, Carol/0000-0002-6377-9926; Wiley, Laura/0000-0001-9619-4484	Medical Research Council [G0500997]; MRC/Unilever grant [G0601333]; Unilever/BBSRC CASE studentship [BH092279]; Dunhill Medical Trust grant [R124/0509]; National Institute for Health Research Newcastle Biomedical Research Centre; Biomedical Research Unit based at Newcastle Hospitals NHS Foundation Trust; Newcastle University; MRC [G0601333, MR/K000608/1, MR/K006312/1, G0500997, MR/J50001X/1] Funding Source: UKRI; Medical Research Council [MR/K006312/1, G0601333, MR/J50001X/1, MR/K000608/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC/Unilever grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Unilever/BBSRC CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dunhill Medical Trust grant(Dunhill Medical Trust); National Institute for Health Research Newcastle Biomedical Research Centre; Biomedical Research Unit based at Newcastle Hospitals NHS Foundation Trust; Newcastle University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Medical Research Council grant G0500997, MRC/Unilever grant G0601333, Unilever/BBSRC CASE studentship BH092279, the Dunhill Medical Trust grant R124/0509 and by the National Institute for Health Research Newcastle Biomedical Research Centre and Biomedical Research Unit based at Newcastle Hospitals NHS Foundation Trust and Newcastle University. The funder provided support in the form of salaries/stipend for authors DCST and LW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ackermann K, 2012, SLEEP, V35, P933, DOI 10.5665/sleep.1954; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Chen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046473; Collerton J, 2012, MECH AGEING DEV; COLLERTON J, 2009, BMJ-BRIT MED J, V399, P1; Collerton J, 2007, BMC GERIATR, V7, P1, DOI DOI 10.1186/1471-2318-7-1; Collerton J, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.04.001; Davies K, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-64; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fleisher TA, 2001, CURR PROTOC IMMUNOL, V7, DOI DOI 10.1002/0471142735.IM0707S08; Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425; Hagen TM, 1999, FASEB J, V13, P411, DOI 10.1096/fasebj.13.2.411; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; Houston DK, 2013, J GERONTOL A-BIOL, V68, P181, DOI 10.1093/gerona/gls136; Kirkwood TBL, 1998, EXP GERONTOL, V33, P135, DOI 10.1016/S0531-5565(97)00114-9; Kirkwood TBL, 2008, NATURE, V451, P644, DOI 10.1038/451644a; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Litwin V, 2001, FLOW CYTOMETRY DRUG; Martin-Ruiz C, 2013, LIFE COURSE IN RPESS; Martin-Ruiz C, 2011, MECH AGEING DEV, V132, P496, DOI 10.1016/j.mad.2011.08.001; Mayeux Richard, 2004, NeuroRx, V1, P182, DOI 10.1007/BF03206601; Meng JE, 2012, CANCER EPIDEM BIOMAR, V21, P916, DOI 10.1158/1055-9965.EPI-12-0026; Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08; Mueller EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052367; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; Nesselroade J. R., 2004, RES HUMAN DEV, V1, P9, DOI [DOI 10.1080/15427609.2004.9683328, 10.1207/s15427617rhd0101&2_3]; Office-for-National-Statistics, 2010, UK HLTH STAT 2010; Office-for-National-Statistics, 2011, UK INT LIF TABL 1980; Passes JF, 2007, BIOESSAYS, V29, P908, DOI 10.1002/bies.20634; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Schwartz LM, 2001, METHOD CELL BIOL, V66, P82; Sprott RL, 2010, EXP GERONTOL, V45, P2, DOI 10.1016/j.exger.2009.07.008; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Wang CF, 2010, AGING-US, V2, P555, DOI 10.18632/aging.100196; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Wolf C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-8; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	46	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91005	10.1371/journal.pone.0091005	http://dx.doi.org/10.1371/journal.pone.0091005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614678	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300062
J	Chipman, PH; Zhang, Y; Rafuse, VF				Chipman, Peter H.; Zhang, Ying; Rafuse, Victor F.			A Stem-Cell Based Bioassay to Critically Assess the Pathology of Dysfunctional Neuromuscular Junctions	PLOS ONE			English	Article							ADHESION MOLECULE; MOTOR-NEURONS; SYNAPSE FORMATION; N-CAM; FUNCTIONAL COMPONENTS; GENETIC DISSECTION; MOUSE MODEL; NERVE; NCAM; MOTONEURONS	Pluripotent stem cells can be directed to differentiate into motor neurons and assessed for functionality in vitro. An emerging application of this technique is to model genetically inherited diseases in differentiated motor neurons and to screen for new therapeutic targets. The neuromuscular junction (NMJ) is essential to the functionality of motor neurons and its dysfunction is a primary hallmark of motor neuron disease. However, mature NMJs that possess the functional and morphological characteristics of those formed in vivo have so far not been obtained in vitro. Here we describe the generation and analysis of mature NMJs formed between embryonic stem cell-derived motor neurons (ESCMNs) and primary myotubes. We compared the formation and maturation of NMJs generated by wild-type (NCAM(+/+)) ESCMNs to those generated by neural cell adhesion molecule null (NCAM(-/-)) ESCMNs in order to definitively test the sensitivity of this assay to identify synaptic pathology. We find that co-cultures using NCAM(-/-) ESCMNs replicate key in vivo NCAM(-/-) phenotypes and reveal that NCAM influences neuromuscular synaptogenesis by controlling the mode of synaptic vesicle endocytosis. Further, we could improve synapse formation and function in NCAM(-/-) co-cultures by chronic treatment with nifedipine, which blocks an immature synaptic vesicle recycling pathway. Together, our results demonstrate that this ESCMN/myofiber co-culture system is a highly sensitive bioassay for examining molecules postulated to regulate synaptic function and for screening therapeutics that will improve the function of compromised NMJs.	[Chipman, Peter H.; Zhang, Ying; Rafuse, Victor F.] Dalhousie Univ, Dept Med Neurosci, Halifax, NS, Canada; [Rafuse, Victor F.] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Zhang, Ying; Rafuse, Victor F.] Life Sci Res Ctr, Brain Repair Ctr, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Rafuse, VF (corresponding author), Dalhousie Univ, Dept Med Neurosci, Halifax, NS, Canada.	vrafuse@dal.ca		Zhang, Ying/0000-0003-4363-5666	Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Canadian Institutes for Health Research (V.F.R.). P.H.C. was funded by Natural Sciences and Engineering Research Council of Canada graduate student scholarship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Chipman PH, 2012, PROG BRAIN RES, V201, P313, DOI 10.1016/B978-0-444-59544-7.00015-9; Chipman PH, 2010, EUR J NEUROSCI, V31, P238, DOI 10.1111/j.1460-9568.2009.07049.x; CHOW I, 1985, J NEUROSCI, V5, P1076; COVAULT J, 1986, J CELL BIOL, V102, P716, DOI 10.1083/jcb.102.3.716; COVAULT J, 1985, P NATL ACAD SCI USA, V82, P4544, DOI 10.1073/pnas.82.13.4544; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Diestel S, 2007, J CELL SCI, V120, P4035, DOI 10.1242/jcs.019729; DUTTON EK, 1995, J NEUROSCI, V15, P7401; FISCHBACH GD, 1970, SCIENCE, V169, P1331, DOI 10.1126/science.169.3952.1331; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Frey D, 2000, J NEUROSCI, V20, P2534; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Guo XF, 2011, BIOMATERIALS, V32, P9602, DOI 10.1016/j.biomaterials.2011.09.014; Hata K, 2007, J NEUROSCI, V27, P14481, DOI 10.1523/JNEUROSCI.3847-07.2007; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Marteyn A, 2011, CELL STEM CELL, V8, P434, DOI 10.1016/j.stem.2011.02.004; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Moscoso LM, 1998, J NEUROSCI, V18, P1465; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Polo-Parada L, 2005, NEURON, V46, P917, DOI 10.1016/j.neuron.2005.05.018; Polo-Parada L, 2004, J NEUROSCI, V24, P1852, DOI 10.1523/JNEUROSCI.4406-03.2004; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Proszynski TJ, 2009, P NATL ACAD SCI USA, V106, P18373, DOI 10.1073/pnas.0910391106; Rafuse VF, 2000, J NEUROSCI, V20, P1056, DOI 10.1523/JNEUROSCI.20-03-01056.2000; Rafuse VF, 1996, J CELL BIOL, V132, P969, DOI 10.1083/jcb.132.5.969; Rafuse VF, 2000, J NEUROSCI, V20, P6529, DOI 10.1523/JNEUROSCI.20-17-06529.2000; Ruiz R, 2010, J NEUROSCI, V30, P849, DOI 10.1523/JNEUROSCI.4496-09.2010; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Serio A, 2013, P NATL ACAD SCI USA, V110, P4697, DOI 10.1073/pnas.1300398110; Shetty A, 2013, J NEUROSCI, V33, P16828, DOI 10.1523/JNEUROSCI.2192-13.2013; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006; Sugiura Y, 1997, J NEUROSCI, V17, P1101; TAKAHASHI T, 1987, J NEUROSCI, V7, P473; Thomson SR, 2012, J ANAT, V220, P122, DOI 10.1111/j.1469-7580.2011.01459.x; Umbach JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036049; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yang YM, 2013, CELL STEM CELL, V12, P713, DOI 10.1016/j.stem.2013.04.003; Zakharenko S, 1999, J CELL BIOL, V144, P507, DOI 10.1083/jcb.144.3.507; Zhang XH, 2002, NEURON, V36, P675, DOI 10.1016/S0896-6273(02)01023-1	52	23	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91643	10.1371/journal.pone.0091643	http://dx.doi.org/10.1371/journal.pone.0091643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626225	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300111
J	Leighton, GM				Leighton, Gavin M.			The Relative Effectiveness of Signaling Systems: Relying on External Items Reduces Signaling Accuracy while Leks Increase Accuracy	PLOS ONE			English	Article							MATE CHOICE; SEXUAL SELECTION; MATING SUCCESS; FEMALE CHOICE; BLACK WHEATEAR; MULTIPLE CUES; EVOLUTION; BEHAVIOR; DISPLAY; NEST	Multiple evolutionary phenomena require individual animals to assess conspecifics based on behaviors, morphology, or both. Both behavior and morphology can provide information about individuals and are often used as signals to convey information about quality, motivation, or energetic output. In certain cases, conspecific receivers of this information must rank these signaling individuals based on specific traits. The efficacy of information transfer associated within a signal is likely related to the type of trait used to signal, though few studies have investigated the relative effectiveness of contrasting signaling systems. I present a set of models that represent a large portion of signaling systems and compare them in terms of the ability of receivers to rank signalers accurately. Receivers more accurately assess signalers if the signalers use traits that do not require non-food resources; similarly, receivers more accurately ranked signalers if all the signalers could be observed simultaneously, similar to leks. Surprisingly, I also found that receivers are only slightly better at ranking signaler effort if the effort results in a cumulative structure. This series of findings suggests that receivers may attend to specific traits because the traits provide more information relative to others; and similarly, these results may explain the preponderance of morphological and behavioral display signals.	Univ Miami, Dept Biol, Coral Gables, FL 33124 USA	University of Miami	Leighton, GM (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33124 USA.	gleighton@bio.miami.edu		Leighton, Gavin/0000-0003-0564-3980	National Science Foundation Doctoral Dissertation Improvement Grant [1210500]	National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF))	This research was supported by an National Science Foundation Doctoral Dissertation Improvement Grant (1210500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktipis CA, 2011, BEHAV ECOL SOCIOBIOL, V65, P1079, DOI 10.1007/s00265-010-1115-9; Andersson Malte, 1994; Backwell PRY, 1996, BEHAV ECOL SOCIOBIOL, V38, P407, DOI 10.1007/s002650050258; Barske J, 2011, P ROY SOC B-BIOL SCI, V278, P3523, DOI 10.1098/rspb.2011.0382; BORGIA G, 1985, BEHAV ECOL SOCIOBIOL, V18, P91, DOI 10.1007/BF00299037; BORGIA G, 1995, EMU, V95, P1, DOI 10.1071/MU9950001; Bshary R, 2002, ANIM BEHAV, V63, P547, DOI 10.1006/anbe.2001.1937; Buchanan KL, 1997, P ROY SOC B-BIOL SCI, V264, P521, DOI 10.1098/rspb.1997.0074; Candolin U, 2000, ANIM BEHAV, V60, P417, DOI 10.1006/anbe.2000.1481; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Candolin U, 2001, BEHAV ECOL, V12, P407, DOI 10.1093/beheco/12.4.407; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; COLLIAS NE, 1978, ANIM BEHAV, V26, P470, DOI 10.1016/0003-3472(78)90064-7; Doutrelant C, 2007, ANIM BEHAV, V74, P739, DOI 10.1016/j.anbehav.2006.11.033; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; Evans MR, 1996, BEHAV ECOL, V7, P101, DOI 10.1093/beheco/7.1.101; Farrell ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018533; Fisher RA, 1930, GENETICAL THEORY NAT; Fiske P, 1998, BEHAV ECOL, V9, P328, DOI 10.1093/beheco/9.4.328; GARSON PJ, 1979, ANIM BEHAV, V27, P309, DOI 10.1016/0003-3472(79)90151-9; GIBSON RM, 1985, BEHAV ECOL SOCIOBIOL, V18, P117, DOI 10.1007/BF00299040; Goodson JL, 2009, SCIENCE, V325, P862, DOI 10.1126/science.1174929; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; IWASA Y, 1994, EVOLUTION, V48, P853, DOI 10.1111/j.1558-5646.1994.tb01367.x; JANETOS AC, 1980, BEHAV ECOL SOCIOBIOL, V7, P107, DOI 10.1007/BF00299515; Jennions MD, 2001, Q REV BIOL, V76, P3, DOI 10.1086/393743; Jovani R, 2008, P ROY SOC B-BIOL SCI, V275, P1557, DOI 10.1098/rspb.2008.0125; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Krams I, 2008, BEHAV ECOL SOCIOBIOL, V62, P599, DOI 10.1007/s00265-007-0484-1; KREBS JR, 1984, BEHAV ECOLOGY; Lawes M, 2002, OSTRICH, V73, P87, DOI 10.1080/00306525.2002.11446735; Lenth R., 2019, Journal of Statistical Software, V60, P1; Luke S, 2005, SIMUL-T SOC MOD SIM, V81, P517, DOI 10.1177/0037549705058073; Luttbeg B, 1996, BEHAV ECOL, V7, P451, DOI 10.1093/beheco/7.4.451; Lynch M, 2007, ORIGINS GENOME ARCHI; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Melis AP, 2008, ANIM BEHAV, V76, P951, DOI 10.1016/j.anbehav.2008.05.014; Meuche I, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-29; Moller AP, 1995, BEHAV ECOL, V6, P368, DOI 10.1093/beheco/6.4.368; MORENO J, 1994, ANIM BEHAV, V47, P1297, DOI 10.1006/anbe.1994.1178; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; PETRIE M, 1994, NATURE, V371, P598, DOI 10.1038/371598a0; PETRIE M, 1991, ANIM BEHAV, V41, P323, DOI 10.1016/S0003-3472(05)80484-1; POMIANKOWSKI A, 1993, P ROY SOC B-BIOL SCI, V253, P173, DOI 10.1098/rspb.1993.0099; Quader S, 2005, ETHOLOGY, V111, P1073, DOI 10.1111/j.1439-0310.2005.01134.x; R Core Team, 2010, R LANG ENV STAT COMP; Raihani NJ, 2012, TRENDS ECOL EVOL, V27, P288, DOI 10.1016/j.tree.2011.12.004; Railsback S.F., 2011, AGENT BASED INDIVIDU; Robson TE, 2005, BIOL LETTERS, V1, P264, DOI 10.1098/rsbl.2005.0325; Rubenstein DR, 2012, PHILOS T R SOC B, V367, P2248, DOI 10.1098/rstb.2011.0278; Schaedelin FC, 2010, BEHAV ECOL SOCIOBIOL, V64, P1437, DOI 10.1007/s00265-010-0959-3; Schaedelin FC, 2009, BIOL REV, V84, P293, DOI 10.1111/j.1469-185X.2008.00075.x; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; SEARCY WA, 1992, AM ZOOL, V32, P71; Shorey L, 2002, BEHAV ECOL SOCIOBIOL, V52, P451, DOI 10.1007/s00265-002-0540-9; Sibly RM, 2013, METHODS ECOL EVOL, V4, P151, DOI 10.1111/2041-210x.12002; Sibly RM, 2012, P NATL ACAD SCI USA, V109, P10937, DOI 10.1073/pnas.1206512109; Smith JE, 2010, BEHAV ECOL, V21, P284, DOI 10.1093/beheco/arp181; Soares MC, 2009, BEHAV ECOL, V20, P1343, DOI 10.1093/beheco/arp138; Sokal RR, 1995, BIOMETRY; Soler JJ, 1998, EVOL ECOL, V12, P427, DOI 10.1023/A:1006520821219; Szekely T., 2010, SOCIAL BEHAV GENES E; Taborsky B, 2012, TRENDS ECOL EVOL, V27, P679, DOI 10.1016/j.tree.2012.09.003; THORNHILL R, 1976, AM NAT, V110, P529, DOI 10.1086/283089; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Uy JAC, 2001, AM NAT, V158, P530, DOI 10.1086/323118; Uy JAC, 2013, BEHAV ECOL SOCIOBIOL, P1; WAAGE JK, 1973, BEHAVIOUR, V47, P240, DOI 10.1163/156853973X00094; Wiegmann DD, 2013, CURR ZOOL, V59, P184, DOI 10.1093/czoolo/59.2.184; Wiegmann DD, 1996, AM NAT, V147, P188, DOI 10.1086/285846; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0	74	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91725	10.1371/journal.pone.0091725	http://dx.doi.org/10.1371/journal.pone.0091725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626221	gold, Green Submitted, Green Published			2022-12-27	WOS:000332851300129
J	Zhang, Y; Sheng, XJ; Meng, XF; Li, Y				Zhang, Yu; Sheng, Xiaojing; Meng, Xiangfei; Li, Yan			The Circular F-Actin Bundles Provide a Track for Turnaround and Bidirectional Movement of Mitochondria in Arabidopsis Root Hair	PLOS ONE			English	Article							FLUORESCENT PROTEIN FUSION; MYOSIN-XI; TIP GROWTH; PLANT; CYTOSKELETON; MORPHOGENESIS; TRAFFICKING; ORGANIZATION; PROFILIN; FAMILY	Background: The movement of organelles in root hairs primarily occurs along the actin cytoskeleton. Circulation and "reverse fountain'' cytoplasmic streaming constitute the typical forms by which most organelles (such as mitochondria and the Golgi apparatus) in plant root hair cells engage in bidirectional movement. However, there remains a lack of in-depth research regarding the relationship between the distribution of the actin cytoskeleton and turnaround organelle movement in plant root hair cells. Results: In this paper, Arabidopsis seedlings that had been stably transformed with a GFP-ABD2-GFP (green fluorescent protein-actin-binding domain 2-green fluorescent protein) construct were utilized to study the distribution of bundles of filamentous (F)-actin and the directed motion of mitochondria along these bundles in root hairs. Observations with a confocal laser scanning microscope revealed that there were widespread circular F-actin bundles in the epidermal cells and root hairs of Arabidopsis roots. In root hairs, these circular bundles primarily start at the sub-apical region, which is the location where the turnaround movement of organelles occurs. MitoTracker probes were used to label mitochondria, and the dynamic observation of root hair cells with a confocal laser scanning microscope indicated that turnaround mitochondrial movement occurred along circular F-actin bundles. Conclusions: Relevant experimental results demonstrated that the circular F-actin bundles provide a track for the turnaround and bidirectional movement of mitochondria.	[Zhang, Yu; Sheng, Xiaojing; Meng, Xiangfei; Li, Yan] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	China Agricultural University	Li, Y (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	liyan@cau.edu.cn			National Natural Science Foundation of China [31270230, 30971435]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant nos. 31270230 and 30971435 to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avisar D, 2008, PLANT PHYSIOL, V146, P1098, DOI 10.1104/pp.107.113647; Baluska F, 2000, DEV BIOL, V227, P618, DOI 10.1006/dbio.2000.9908; Baluska F, 2002, TRENDS CELL BIOL, V12, P14, DOI 10.1016/S0962-8924(01)02208-5; Baluska F, 2001, DEV BIOL, V231, P113, DOI 10.1006/dbio.2000.0115; Bezanilla M, 2003, J MOL EVOL, V57, P229, DOI 10.1007/s00239-003-2469-7; Braun M, 1999, PLANTA, V209, P435, DOI 10.1007/s004250050746; Ditengou FA, 2003, PLANTA, V218, P217, DOI 10.1007/s00425-003-1095-3; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Geitmann A, 2000, J MICROSC-OXFORD, V198, P218, DOI 10.1046/j.1365-2818.2000.00702.x; He X, 2006, ANN BOT-LONDON, V98, P49, DOI 10.1093/aob/mcl084; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Hodge T, 2000, J CELL SCI, V113, P3353; Ketelaar T, 2004, CURR BIOL, V14, P145, DOI 10.1016/j.cub.2004.01.004; KINKEMA M, 1994, PLANT MOL BIOL, V26, P1139, DOI 10.1007/BF00040695; Li Y, 2001, PLANTA, V213, P722, DOI 10.1007/s004250100543; Mathur J, 2002, CURR BIOL, V12, pR669, DOI 10.1016/S0960-9822(02)01164-8; Miller DD, 1999, PLANT J, V17, P141, DOI 10.1046/j.1365-313X.1999.00358.x; Ojangu EL, 2007, PROTOPLASMA, V230, P193, DOI 10.1007/s00709-006-0233-8; Ovecka M, 2005, PROTOPLASMA, V226, P39, DOI 10.1007/s00709-005-0103-9; Peremyslov VV, 2008, PLANT PHYSIOL, V146, P1109, DOI 10.1104/pp.107.113654; Reddy ASN, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-7-research0024; Reisen D, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-6; RIDGE RW, 1988, BOT MAG TOKYO, V101, P427, DOI 10.1007/BF02488086; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Sheahan MB, 2004, PLANT PHYSIOL, V136, P3968, DOI 10.1104/pp.104.049411; Sieberer B, 2000, PROTOPLASMA, V214, P118, DOI 10.1007/BF02524268; Tominaga M, 2000, PLANTA, V210, P836, DOI 10.1007/s004250050687; Tominaga M, 2003, EMBO J, V22, P1263, DOI 10.1093/emboj/cdg130; Walter N, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-74; Wang YS, 2004, CELL MOTIL CYTOSKEL, V59, P79, DOI 10.1002/cm.20024; Wang YS, 2008, NEW PHYTOL, V177, P525, DOI 10.1111/j.1469-8137.2007.02261.x; Yokota E, 1999, PLANT PHYSIOL, V121, P525, DOI 10.1104/pp.121.2.525	32	3	3	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91501	10.1371/journal.pone.0091501	http://dx.doi.org/10.1371/journal.pone.0091501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626218	Green Published, gold			2022-12-27	WOS:000332851300091
J	Birngruber, T; Ghosh, A; Hochmeister, S; Asslaber, M; Kroath, T; Pieber, TR; Sinner, F				Birngruber, Thomas; Ghosh, Arijit; Hochmeister, Sonja; Asslaber, Martin; Kroath, Thomas; Pieber, Thomas R.; Sinner, Frank			Long-Term Implanted cOFM Probe Causes Minimal Tissue Reaction in the Brain	PLOS ONE			English	Article							IN-VIVO; MICRODIALYSIS PROBES; RAT; TRANSPORT; DOPAMINE; ADIPOSE; INJURY; MODEL; FLUID	This study investigated the histological tissue reaction to long-term implanted cerebral open flow microperfusion (cOFM) probes in the frontal lobe of the rat brain. Most probe-based cerebral fluid sampling techniques are limited in application time due to the formation of a glial scar that hinders substance exchange between brain tissue and the probe. A glial scar not only functions as a diffusion barrier but also alters metabolism and signaling in extracellular brain fluid. cOFM is a recently developed probe-based technique to continuously sample extracellular brain fluid with an intact blood-brain barrier. After probe implantation, a 2 week healing period is needed for blood-brain barrier reestablishment. Therefore, cOFM probes need to stay in place and functional for at least 15 days after implantation to ensure functionality. Probe design and probe materials are optimized to evoke minimal tissue reaction even after a long implantation period. Qualitative and quantitative histological tissue analysis revealed no continuous glial scar formation around the cOFM probe 30 days after implantation and only a minor tissue reaction regardless of perfusion of the probe.	[Birngruber, Thomas; Kroath, Thomas; Pieber, Thomas R.; Sinner, Frank] JOANNEUM RES, HLTH Inst Biomed & Hlth Sci, Graz, Austria; [Ghosh, Arijit; Pieber, Thomas R.; Sinner, Frank] Med Univ Graz, Div Endocrinol & Metab, Graz, Austria; [Hochmeister, Sonja] Med Univ Graz, Div Gen Neurol, Graz, Austria; [Asslaber, Martin] Med Univ Graz, Inst Pathol, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Sinner, F (corresponding author), JOANNEUM RES, HLTH Inst Biomed & Hlth Sci, Graz, Austria.	ca.health@joanneum.at		Pieber, Thomas/0000-0003-3554-0405	FFG - Austrian Research Promotion Agency [IDT4Brain]	FFG - Austrian Research Promotion Agency	This project was funded by FFG - Austrian Research Promotion Agency: Programm line: COIN (Cooperation and Inovation) Project: IDT4Brain (Improved Diagnosis and Treatment for neurodegenerative Diseases through direct Tissue Access in Brain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABNET K, 1991, DEV BRAIN RES, V59, P187, DOI 10.1016/0165-3806(91)90099-5; Azemi E, 2011, BIOMATERIALS, V32, P681, DOI 10.1016/j.biomaterials.2010.09.033; BENVENISTE H, 1987, ACTA NEUROPATHOL, V74, P234, DOI 10.1007/BF00688186; Birngruber T, 2013, CLIN EXP PHARMACOL P, V40, P864, DOI 10.1111/1440-1681.12174; Bodenlenz M, 2005, AM J PHYSIOL-ENDOC M, V289, pE296, DOI 10.1152/ajpendo.00431.2004; Bodenlenz M, 2012, EUR J PHARM BIOPHARM, V81, P635, DOI 10.1016/j.ejpb.2012.04.009; Borland LM, 2005, J NEUROSCI METH, V146, P149, DOI 10.1016/j.jneumeth.2005.02.002; Bungay PM, 2003, J NEUROCHEM, V86, P932, DOI 10.1046/j.1471-4159.2003.01904.x; Chefer Vladimir I, 2009, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0701s47; Clapp-Lilly KL, 1999, J NEUROSCI METH, V90, P129, DOI 10.1016/S0165-0270(99)00064-3; Dahlin AP, 2012, ANAL BIOANAL CHEM, V402, P2057, DOI 10.1007/s00216-011-5614-y; deLange ECM, 1997, BRAIN RES REV, V25, P27, DOI 10.1016/S0165-0173(97)00014-3; DELANGE ECM, 1995, BRAIN RES, V702, P261, DOI 10.1016/0006-8993(95)01184-X; Fitch MT, 1999, J NEUROSCI, V19, P8182; Grabb MC, 1998, J NEUROSCI METH, V82, P25, DOI 10.1016/S0165-0270(98)00025-9; Harris JP, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066011; Hascup ER, 2009, BRAIN RES, V1291, P12, DOI 10.1016/j.brainres.2009.06.084; Holmgaard R, 2012, PHARM RES-DORDR, V29, P1808, DOI 10.1007/s11095-012-0705-9; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Kim YT, 2004, BIOMATERIALS, V25, P2229, DOI 10.1016/j.biomaterials.2003.09.010; Kottegoda S, 2002, J NEUROSCI METH, V121, P93, DOI 10.1016/S0165-0270(02)00245-5; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; McNay EC, 2004, J NEUROSCI METH, V132, P35, DOI 10.1016/j.jneumeth.2003.08.014; MYERS RD, 1986, ANN NY ACAD SCI, V473, P21, DOI 10.1111/j.1749-6632.1986.tb23601.x; Myers RD, 1998, NEUROSCI BIOBEHAV R, V22, P371, DOI 10.1016/S0149-7634(97)00025-0; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Schaupp L, 1999, AM J PHYSIOL-ENDOC M, V276, pE401, DOI 10.1152/ajpendo.1999.276.2.E401; Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862; Seymour JP, 2007, BIOMATERIALS, V28, P3594, DOI 10.1016/j.biomaterials.2007.03.024; Thelin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016267; Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983; von Grote EC, 2011, MOL BIOSYST, V7, P150, DOI 10.1039/c0mb00059k; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721; Winslow BD, 2010, BIOMATERIALS, V31, P1558, DOI 10.1016/j.biomaterials.2009.11.049; Wisniewski N, 2001, J BIOMED MATER RES, V57, P513, DOI 10.1002/1097-4636(20011215)57:4<513::AID-JBM1197>3.0.CO;2-E	35	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90221	10.1371/journal.pone.0090221	http://dx.doi.org/10.1371/journal.pone.0090221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621608	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300016
J	Kusza, S; Podgorski, T; Scandura, M; Borowik, T; Javor, A; Sidorovich, VE; Bunevich, AN; Kolesnikov, M; Jedrzejewska, B				Kusza, Szilvia; Podgorski, Tomasz; Scandura, Massimo; Borowik, Tomasz; Javor, Andras; Sidorovich, Vadim E.; Bunevich, Aleksei N.; Kolesnikov, Mikhail; Jedrzejewska, Bogumila			Contemporary Genetic Structure, Phylogeography and Past Demographic Processes of Wild Boar Sus scrofa Population in Central and Eastern Europe	PLOS ONE			English	Article							DOMESTIC PIG; MITOCHONDRIAL-DNA; ANCIENT DNA; DIVERSITY; COLONIZATION; EXPANSION; SOFTWARE; GROWTH; BREEDS	The wild boar (Sus scrofa) is one of the most widely distributed mammals in Europe. Its demography was affected by various events in the past and today populations are increasing throughout Europe. We examined genetic diversity, structure and population dynamics of wild boar in Central and Eastern Europe. MtDNA control region (664 bp) was sequenced in 254 wild boar from six countries (Poland, Hungary, Belarus, Ukraine, Moldova and the European part of Russia). We detected 16 haplotypes, all known from previous studies in Europe; 14 of them belonged to European 1 (E1) clade, including 13 haplotypes from E1-C and one from E1-A lineages. Two haplotypes belonged respectively to the East Asian and the Near Eastern clade. Both haplotypes were found in Russia and most probably originated from the documented translocations of wild boar. The studied populations showed moderate haplotype (0.714 +/- 0.023) and low nucleotide diversity (0.003 +/- 0.002). SAMOVA grouped the genetic structuring of Central and Eastern European wild boar into three subpopulations, comprising of: (1) north-eastern Belarus and the European part of Russia, (2) Poland, Ukraine, Moldova and most of Belarus, and (3) Hungary. The multimodal mismatch distribution, Fu's Fs index, Bayesian skyline plot and the high occurrence of shared haplotypes among populations did not suggest strong demographic fluctuations in wild boar numbers in the Holocene and pre-Holocene times. This study showed relatively weak genetic diversity and structure in Central and Eastern European wild boar populations and underlined gaps in our knowledge on the role of southern refugia and demographic processes shaping genetic diversity of wild boar in this part of Europe.	[Kusza, Szilvia; Javor, Andras] Univ Debrecen, Inst Anim Sci Biotechnol & Nat Conservat, H-4012 Debrecen, Hungary; [Podgorski, Tomasz; Borowik, Tomasz; Jedrzejewska, Bogumila] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Scandura, Massimo] Dept Sci Nat & Environm Resources, Sassari, Italy; [Sidorovich, Vadim E.] Natl Acad Sci Belarus, Inst Zool, Minsk, BELARUS; [Bunevich, Aleksei N.] State Natl Pk Belovezhskaya Pushcha, Kamenec Raion, Kamenyuki, BELARUS; [Kolesnikov, Mikhail] Luhansk Taras Shevchenko Natl Univ, Lugansk, Ukraine	University of Debrecen; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; National Academy of Sciences of Belarus (NASB); Scientific & Practical Center for Bioresources of the National Academy of Sciences of Belarus; National Park "Belovezhskaya Pushcha"; Ministry of Education & Science of Ukraine; Luhansk Taras Shevchenko National University	Kusza, S (corresponding author), Univ Debrecen, Inst Anim Sci Biotechnol & Nat Conservat, H-4012 Debrecen, Hungary.	kusza@agr.unideb.hu	Podgórski, Tomasz/B-4869-2015; Borowik, Tomasz/W-4008-2018	Podgórski, Tomasz/0000-0001-6858-7838; Borowik, Tomasz/0000-0003-0321-8200; Scandura, Massimo/0000-0003-2754-6866	Polish Ministry of Science and Higher Education [NN304-253935]; BIOCONSUS [245737]; BIOGEAST [247652]; Hungarian State Eotvos fellowship	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); BIOCONSUS; BIOGEAST; Hungarian State Eotvos fellowship	This study was funded by the Polish Ministry of Science and Higher Education (grant no. NN304-253935), BIOCONSUS (Research Potential in Conservation and Sustainable Management of Biodiversity, 7th Framework Programme contract no. 245737), BIOGEAST (Biodiversity of East-European and Siberian large mammals on the level of genetic variation of populations, 7th Framework Programme contract no. 247652), and supported by Hungarian State Eotvos fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandri P, 2012, J BIOGEOGR, V39, P713, DOI 10.1111/j.1365-2699.2011.02636.x; Alves E, 2003, ANIM GENET, V34, P319, DOI 10.1046/j.1365-2052.2003.01010.x; Alves PC, 2010, BIOL J LINN SOC, V101, P797, DOI 10.1111/j.1095-8312.2010.01530.x; [Anonymous], 2014, TRACER V1 6; Apollonio M., 2010, EUROPEAN UNGULATES T; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Corbet G.B, 1978, MAMMALS PALAEARCTIC; Danilkin A A, 2001, Dokl Biol Sci, V380, P457, DOI 10.1023/A:1012323421633; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fadeev E. V., 1969, Byulleten Moskovskogo Obshchestva Ispytatelei Prirody, V74, P37; Fang M, 2006, ANIM GENET, V37, P459, DOI 10.1111/j.1365-2052.2006.01498.x; Fang MY, 2006, P R SOC B, V273, P1803, DOI 10.1098/rspb.2006.3514; Farago S, 1997, VADALLOMANY SZABALYO; Fauvelot C, 2003, EVOLUTION, V57, P1571; Feichtner B, 1998, Z JAGDWISS, V44, P140, DOI 10.1007/BF02250741; Frantz AC, 2013, BIOL J LINN SOC, V110, P104, DOI 10.1111/bij.12111; Fu YX, 1997, GENETICS, V147, P915; Giuffra E, 2000, GENETICS, V154, P1785; Gongora J, 2004, MOL PHYLOGENET EVOL, V33, P339, DOI 10.1016/j.ympev.2004.06.004; Gongora J, 2003, ACTA AGR SCAND A-AN, V53, P161, DOI 10.1080/09064710310010602; Gongora J, 2011, ZOOL SCR, V40, P327, DOI 10.1111/j.1463-6409.2011.00480.x; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hajji GE, 2011, EUR J WILDLIFE RES, V57, P449, DOI 10.1007/s10344-010-0452-3; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Jedrzejewska B, 1997, ACTA THERIOL, V42, P399; Kim BW, 2011, GENES GENOM, V33, P111, DOI 10.1007/s13258-010-0129-z; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lucchini V, 2005, J ZOOL, V266, P25, DOI 10.1017/S0952836905006588; Markova AK, 2009, QUATERN INT, V201, P53, DOI 10.1016/j.quaint.2008.05.020; Martel C, 2004, MAR ECOL PROG SER, V273, P163, DOI 10.3354/meps273163; McDevitt AD, 2013, EUR J WILDLIFE RES, V59, P761, DOI 10.1007/s10344-013-0721-z; Melis C, 2006, J BIOGEOGR, V33, P803, DOI 10.1111/j.1365-2699.2006.01434.x; Montiel-Sosa JF, 2000, J AGR FOOD CHEM, V48, P2829, DOI 10.1021/jf9907438; Okumura N, 2001, ANIM GENET, V32, P139, DOI 10.1046/j.1365-2052.2001.00757.x; Ottoni C, 2013, MOL BIOL EVOL, V30, P824, DOI 10.1093/molbev/mss261; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2012, FIGTREE V 1 4 0; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russakov OS, 1984, KABAN EKOLOGIYA RESU, P1; SAEZROYUELA C, 1986, MAMMAL REV, V16, P97; Scandura M, 2008, MOL ECOL, V17, P1745, DOI 10.1111/j.1365-294X.2008.03703.x; Scandura M, 2011, MAMMAL REV, V41, P125, DOI 10.1111/j.1365-2907.2010.00182.x; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; TAJIMA F, 1989, GENETICS, V123, P585; van Asch B, 2012, ANIM GENET, V43, P35, DOI 10.1111/j.1365-2052.2011.02222.x; Vilaca ST, 2014, J BIOGEOGR IN PRESS; Wu GS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r245	55	29	29	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91401	10.1371/journal.pone.0091401	http://dx.doi.org/10.1371/journal.pone.0091401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622149	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300085
J	Saevereid, HA; Schnohr, P; Prescott, E				Saevereid, Hans Askelund; Schnohr, Peter; Prescott, Eva			Speed and Duration of Walking and Other Leisure Time Physical Activity and the Risk of Heart Failure: A Prospective Cohort Study from the Copenhagen City Heart Study	PLOS ONE			English	Article							BODY-MASS INDEX; BLOOD-PRESSURE; WOMEN; MEN; EXERCISE; EPIDEMIOLOGY; ASSOCIATION; PREVENTION; INTENSITY; DISEASE	Aim: Physical activity (PA) confers some protection against development of heart failure (HF) but little is known of the role of intensity and duration of exercise. Methods and Results: In a prospective cohort study of men and women free of previous MI, stroke or HF with one or more examinations in 1976-2003, we studied the association between updated self-assessed leisure-time PA, speed and duration of walking and subsequent hospitalization or death from HF. Light and moderate/high level of leisure-time PA and brisk walking were associated with reduced risk of HF in both genders whereas no consistent association with duration of walking was seen. In 18,209 subjects age 20-80 with 1580 cases of HF, using the lowest activity level as reference, the confounder-adjusted hazard ratios (HR) for light and moderate/high leisure-time physical activity were 0.75 (0.66-0.86) and 0.80 (0.69-0.93), respectively. In 9,937 subjects with information on walking available and 542 cases of HF, moderate and high walking speed were associated with adjusted HRs of 0.53 (0.43-0.66) and 0.30 (0.21-0.44), respectively, and daily walking of 1/2-1 hrs, 1-2 and >2 hrs with HR of 0.80 (0.61-1.06), 0.82 (0.62-1.06), and 0.96 (0.73-1.27), respectively. Results were similar for both genders and remained robust after exclusion of HF related to coronary heart disease and after a series of sensitivity analyses. Conclusions: Speed rather than duration of walking was associated with reduced risk of HF. Walking is the most widespread PA and public health measures to curb the increase in HF may benefit from this information.	[Saevereid, Hans Askelund; Prescott, Eva] Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark; [Schnohr, Peter; Prescott, Eva] Frederiksberg Univ Hosp, Copenhagen City Heart Study, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital	Saevereid, HA (corresponding author), Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark.	hans.saevereid@gmail.com	Prescott, Eva/AAJ-7441-2020; Saevereid, Hans/Q-7747-2019	Prescott, Eva/0000-0002-4134-0349	Danish Council for Independent Research \ Medical Sciences [11-115808]	Danish Council for Independent Research \ Medical Sciences(Det Frie Forskningsrad (DFF))	This work was supported by The Danish Council for Independent Research vertical bar Medical Sciences [grant number 11-115808]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleyard M., 1989, SCAND J SOC MED, V41, P1; Arbab-Zadeh A, 2004, CIRCULATION, V110, P1799, DOI 10.1161/01.CIR.0000142863.71285.74; Australian Bureau of Statistics, 2011, PHYS ACT AUSTR SNAPS; Boone-Heinonen J, 2009, OBES REV, V10, P204, DOI 10.1111/j.1467-789X.2008.00533.x; Djousse L, 2009, JAMA-J AM MED ASSOC, V302, P394, DOI 10.1001/jama.2009.1062; Eyler AA, 2003, MED SCI SPORT EXER, V35, P1529, DOI 10.1249/01.MSS.0000084622.39122.0C; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GORE CJ, 1995, EUR RESPIR J, V8, P773; Hamer M, 2008, BRIT J SPORT MED, V42, P238, DOI 10.1136/bjsm.2007.039974; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Hoevenaar-Blom MP, 2011, EUR J CARDIOV PREV R, V18, P41, DOI 10.1097/HJR.0b013e32833bfc87; Holtermann A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000556; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Hu G, 2010, CIRCULATION, V121, P237, DOI 10.1161/CIRCULATIONAHA.109.887893; Kenchaiah S, 2009, CIRCULATION, V119, P44, DOI 10.1161/CIRCULATIONAHA.108.807289; KOKKINOS PF, 1995, NEW ENGL J MED, V333, P1462, DOI 10.1056/NEJM199511303332204; Kraigher-Krainer E, 2013, EUR J HEART FAIL, V15, P742, DOI 10.1093/eurjhf/hft025; Kraus WE, 2002, NEW ENGL J MED, V347, P1483, DOI 10.1056/NEJMoa020194; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Laursen AH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001711; Lee IM, 2003, CIRCULATION, V107, P1110, DOI 10.1161/01.CIR.0000052626.63602.58; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Molmen HE, 2012, SCAND CARDIOVASC J, V46, P163, DOI 10.3109/14017431.2012.660192; Molmen-Hansen HE, 2012, EUR J PREV CARDIOL, V19, P151, DOI 10.1177/1741826711400512; Patel K, 2013, INT J CARDIOL; Reis JP, 2008, J PHYS ACT HEALTH, V5, P337, DOI 10.1123/jpah.5.3.337; Schnohr P, 2007, EUR J CARDIOV PREV R, V14, P72, DOI 10.1097/HJR.0b013e3280144470; Schnohr P, 2009, DAN MED BULL, V56, P40; Schocken DD, 2008, CIRCULATION, V117, P2544, DOI 10.1161/CIRCULATIONAHA.107.188965; SIEGEL PZ, 1995, AM J PUBLIC HEALTH, V85, P706, DOI 10.2105/AJPH.85.5.706; Slentz CA, 2004, ARCH INTERN MED, V164, P31, DOI 10.1001/archinte.164.1.31; Tanasescu N, 2002, JAMA-J AM MED ASSOC, V288, P1994, DOI 10.1001/jama.288.16.1994; Wang YJ, 2010, J AM COLL CARDIOL, V56, P1140, DOI 10.1016/j.jacc.2010.05.035; Weinstein AR, 2004, JAMA-J AM MED ASSOC, V292, P1188, DOI 10.1001/jama.292.10.1188; Zheng H, 2009, EUR J EPIDEMIOL, V24, P181, DOI 10.1007/s10654-009-9328-9	35	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e89909	10.1371/journal.pone.0089909	http://dx.doi.org/10.1371/journal.pone.0089909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621514	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300011
J	Colangeli, R; Arcus, VL; Cursons, RT; Ruthe, A; Karalus, N; Coley, K; Manning, SD; Kim, S; Marchiano, E; Alland, D				Colangeli, Roberto; Arcus, Vic L.; Cursons, Ray T.; Ruthe, Ali; Karalus, Noel; Coley, Kathy; Manning, Shannon D.; Kim, Soyeon; Marchiano, Emily; Alland, David			Whole Genome Sequencing of Mycobacterium tuberculosis Reveals Slow Growth and Low Mutation Rates during Latent Infections in Humans	PLOS ONE			English	Article							RECOMMENDATIONS	Very little is known about the growth and mutation rates of Mycobacterium tuberculosis during latent infection in humans. However, studies in rhesus macaques have suggested that latent infections have mutation rates that are higher than that observed during active tuberculosis disease. Elevated mutation rates are presumed risk factors for the development of drug resistance. Therefore, the investigation of mutation rates during human latency is of high importance. We performed whole genome mutation analysis of M. tuberculosis isolates from a multi-decade tuberculosis outbreak of the New Zealand Rangipo strain. We used epidemiological and phylogenetic analysis to identify four cases of tuberculosis acquired from the same index case. Two of the tuberculosis cases occurred within two years of exposure and were classified as recently transmitted tuberculosis. Two other cases occurred more than 20 years after exposure and were classified as reactivation of latent M. tuberculosis infections. Mutation rates were compared between the two recently transmitted pairs versus the two latent pairs. Mean mutation rates assuming 20 hour generation times were 5.5X10(-10) mutations/bp/generation for recently transmitted tuberculosis and 7.3X10(-11) mutations/bp/generation for latent tuberculosis. Generation time versus mutation rate curves were also significantly higher for recently transmitted tuberculosis across all replication rates ( p = 0.006). Assuming identical replication and mutation rates among all isolates in the final two years before disease reactivation, the u20hr mutation rate attributable to the remaining latent period was 1.6x10(-11) mutations/bp/generation, or approximately 30 fold less than that calculated during the two years immediately before disease. Mutations attributable to oxidative stress as might be caused by bacterial exposure to the host immune system were not increased in latent infections. In conclusion, we did not find any evidence to suggest elevated mutation rates during tuberculosis latency in humans, unlike the situation in rhesus macaques.	[Colangeli, Roberto; Marchiano, Emily; Alland, David] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ USA; [Arcus, Vic L.; Cursons, Ray T.; Ruthe, Ali] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [Kim, Soyeon] Rutgers New Jersey Med Sch, Dept Prevent Med, Newark, NJ USA; [Manning, Shannon D.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Karalus, Noel] Waikato Hosp, Resp Res Unit, Hamilton, New Zealand; [Coley, Kathy] Waikato Hosp, Dept Pathol, Hamilton, New Zealand	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Waikato; Rutgers State University New Brunswick; Rutgers State University Medical Center; Michigan State University; Waikato Hospital; Waikato Hospital	Alland, D (corresponding author), Rutgers New Jersey Med Sch, Dept Med, Newark, NJ USA.	allandda@njms.rutgers.edu	Manning, Shannon/GXA-0622-2022	Manning, Shannon/0000-0001-9581-0660; ROBERTO, COLANGELI/0000-0003-3263-7404	NIAID [AI49352, AI065663]; University of Waikato Strategic Investment Fund; Waikato Medical Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI065663, R01AI049352] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Waikato Strategic Investment Fund; Waikato Medical Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially funded by NIAID grants AI49352, AI065663 and by the University of Waikato Strategic Investment Fund. The authors also would like to thank the Waikato Medical Research Foundation for funding and the Molecular Microbiology Section, LabPlus, Auckland City Hospital for the MIRU typing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Chin DP, 1996, CLIN CHEST MED, V17, P697, DOI 10.1016/S0272-5231(05)70340-3; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Gupta A, 2012, IMMUNOBIOLOGY, V217, P363, DOI 10.1016/j.imbio.2011.07.008; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; McElnay Caroline, 2004, N Z Med J, V117, pU1019; Namouchi A, 2012, GENOME RES, V22, P721, DOI 10.1101/gr.129544.111; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nei M., 2000, MOL EVOLUTION PHYLOG; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandegren L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016647; Sexton KS, 2008, 5 YEARS MOL TYPING M; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Walker TM, 2012, LANCET INFECT DIS; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291	24	55	56	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91024	10.1371/journal.pone.0091024	http://dx.doi.org/10.1371/journal.pone.0091024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618815	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400044
J	Nakhnikian, A; Rebec, GV; Grasse, LM; Dwiel, LL; Shimono, M; Beggs, JM				Nakhnikian, Alexander; Rebec, George V.; Grasse, Leslie M.; Dwiel, Lucas L.; Shimono, Masanori; Beggs, John M.			Behavior Modulates Effective Connectivity between Cortex and Striatum	PLOS ONE			English	Article							FIELD POTENTIAL OSCILLATIONS; BASAL GANGLIA; INFORMATION-FLOW; CEREBRAL-CORTEX; LARGE-SCALE; HIPPOCAMPUS; TOOLBOX; NEURONS; MODELS; SYNCHRONIZATION	It has been notoriously difficult to understand interactions in the basal ganglia because of multiple recurrent loops. Another complication is that activity there is strongly dependent on behavior, suggesting that directional interactions, or effective connections, can dynamically change. A simplifying approach would be to examine just the direct, monosynaptic projections from cortex to striatum and contrast this with the polysynaptic feedback connections from striatum to cortex. Previous work by others on effective connectivity in this pathway indicated that activity in cortex could be used to predict activity in striatum, but that striatal activity could not predict cortical activity. However, this work was conducted in anesthetized or seizing animals, making it impossible to know how free behavior might influence effective connectivity. To address this issue, we applied Granger causality to local field potential signals from cortex and striatum in freely behaving rats. Consistent with previous results, we found that effective connectivity was largely unidirectional, from cortex to striatum, during anesthetized and resting states. Interestingly, we found that effective connectivity became bidirectional during free behaviors. These results are the first to our knowledge to show that striatal influence on cortex can be as strong as cortical influence on striatum. In addition, these findings highlight how behavioral states can affect basal ganglia interactions. Finally, we suggest that this approach may be useful for studies of Parkinson's or Huntington's diseases, in which effective connectivity may change during movement.	[Nakhnikian, Alexander; Rebec, George V.; Beggs, John M.] Indiana Univ, Program Neurosci, Bloomington, IN 47405 USA; [Rebec, George V.; Grasse, Leslie M.; Dwiel, Lucas L.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Nakhnikian, Alexander] Indiana Univ, Cognit Sci Program, Bloomington, IN USA; [Shimono, Masanori; Beggs, John M.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Shimono, Masanori] Univ Tokyo, Grad Sch Educ, Dept Phys & Hlth Educ, Tokyo, Japan	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Tokyo	Beggs, JM (corresponding author), Indiana Univ, Program Neurosci, Bloomington, IN 47405 USA.	jmbeggs@indiana.edu		shimono, masanori/0000-0003-3549-7697	NIH [R01 DA 12964, P50 DA 05312, R01 NS 35663]; NSF, NSF GRFP [0343636]; Japan Society for the Promotion of Science [8652]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005312, R01DA012964] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF, NSF GRFP; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH R01 DA 12964, P50 DA 05312, R01 NS 35663 (http://www.nih.gov/); and NSF 0343636, the NSF GRFP (http://www.nsf.gov). Masanori Shimono: Japan Society for the Promotion of Science Research Fellowships for Young Scientists #8652 and Research Fellowship for Young Scientists Abroad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Barrett AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029072; Berke JD, 2008, HIPPOCAMPUS, V18, P519, DOI 10.1002/hipo.20435; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Brillinger D.R., 1981, TIME SERIES DATA ANA; Brittain JS, 2007, IEEE T BIO-MED ENG, V54, P854, DOI 10.1109/TBME.2006.889185; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Brown P, 2005, CLIN NEUROPHYSIOL, V116, P2510, DOI 10.1016/j.clinph.2005.05.009; CARELLI RM, 1993, BRAIN RES, V626, P14, DOI 10.1016/0006-8993(93)90557-4; Cohen MX, 2009, BEHAV BRAIN RES, V199, P141, DOI 10.1016/j.bbr.2008.09.029; Courtemanche R, 2003, J NEUROSCIENCE, V23; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Cui J, 2008, NEURAL NETWORKS, V21, P1094, DOI 10.1016/j.neunet.2008.05.007; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; DeCoteau WE, 2007, J NEUROPHYSIOL, V97, P3800, DOI 10.1152/jn.00108.2007; Dhamala M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018701; Ding M., 2006, HDB TIME SERIES ANAL, P437, DOI DOI 10.1002/9783527609970.CH17; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Dorner JL, 2009, BRAIN RES, V1290, P111, DOI 10.1016/j.brainres.2009.07.019; Estrada-Sanchez AM, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00019; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Fujii N, 2005, P NATL ACAD SCI USA, V102, P9032, DOI 10.1073/pnas.0503541102; Gatev P, 2009, CEREB CORTEX, V19, P1330, DOI 10.1093/cercor/bhn171; Gerhard F, SUCCESSFUL RECONSTRU; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; Ghosh S, 2013, J NEUROSCI, V33, P7234, DOI 10.1523/JNEUROSCI.0638-13.2013; Goldberg JA, 2004, J NEUROSCI, V24, P6003, DOI 10.1523/JNEUROSCI.4848-03.2004; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Hermer-Vazquez L, 2008, J COMB OPTIM, V15, P242, DOI 10.1007/s10878-007-9101-5; Hong SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047026; Howe MW, 2011, P NATL ACAD SCI USA, V108, P16801, DOI 10.1073/pnas.1113158108; Joel D, 2001, MOVEMENT DISORD, V16, P407, DOI 10.1002/mds.1096; Kaiser A, 2002, PHYSICA D, V166, P43, DOI 10.1016/S0167-2789(02)00432-3; Kispersky T, 2011, NEURAL SYSTEMS CIRCU; Kopell N, 2010, SPR SER COMPUT NEURO, V5, P423, DOI 10.1007/978-1-4419-0996-1_15; Levy R, 2002, J NEUROSCI, V22, P2855, DOI 10.1523/JNEUROSCI.22-07-02855.2002; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lindner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-119; Lungarella M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056117; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Montgomery EB, 2007, PARKINSONISM RELAT D, V13, P455, DOI 10.1016/j.parkreldis.2007.07.020; Montgomery Jr EB, 2004, NONLINEAR STUDIES, V11, P385; Murphy-Nakhnikian A, 2012, NEUROSCI LETT, V512, P1, DOI 10.1016/j.neulet.2011.12.040; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; Olhede SC, 2002, IEEE T SIGNAL PROCES, V50, P2661, DOI 10.1109/TSP.2002.804066; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sanger TD, 2003, J NEUROL NEUROSUR PS, V74, P1509, DOI 10.1136/jnnp.74.11.1509; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Sharott A, 2005, J PHYSIOL-LONDON, V562, P951, DOI 10.1113/jphysiol.2004.073189; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Walker A, 2008, J NEUROSCIENCE, V28; Walters JR, 2007, NEUROSCIENCE, V144, P762, DOI 10.1016/j.neuroscience.2006.10.006; Wilson GT, 1972, SIAM J APPL MATH, DOI [10.1016/S0167-6911(01)00109-8, DOI 10.1016/S0167-6911(01)00109-8]	63	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e89443	10.1371/journal.pone.0089443	http://dx.doi.org/10.1371/journal.pone.0089443			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618981	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400005
J	Nizza, ST; Campbell, JJ				Nizza, Suzanne T.; Campbell, James J.			CD11b(+) Migratory Dendritic Cells Mediate CD8 T Cell Cross-Priming and Cutaneous Imprinting after Topical Immunization	PLOS ONE			English	Article							EPIDERMAL LANGERHANS CELLS; IN-VIVO; LYMPH-NODE; SELF-ANTIGENS; INFLAMED SKIN; TISSUE; SUBSETS; MICROENVIRONMENT; PROLIFERATION; ACCUMULATION	Topical antigen application is a focus of current vaccine research. This immunization route mimics natural antigen exposure across a barrier tissue and generates T cells imprinted for skin-selective homing. Soluble antigens introduced through this route require cross-presentation by DC to generate CD8 T cell responses. Here we have explored the relative contribution of various skin-derived DC subsets to cross-priming and skin-selective imprinting. In our model, DC acquire soluble Ag in vivo from immunized murine skin for cross-presentation to naive CD8 T cells ex vivo. We find CD11b(+) migratory DC to be the relevant cross-priming DC in this model. Both Langerin(+) and Langerin(-) CD11b(+) migratory DC can cross-present antigen in our system, but only the Langerin(+) subset can induce expression of the skin-selective addressin E-selectin ligand. Thus, the CD11b(+) Langerin(+) migratory DC population, comprised primarily of Langerhans cells, both cross-primes naive CD8 T cells and imprints them with skin-homing capabilities.	[Nizza, Suzanne T.; Campbell, James J.] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Nizza, Suzanne T.] Harvard Univ, Sch Med, Grad Program Biol & Biomed Sci, Boston, MA USA; [Campbell, James J.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Campbell, JJ (corresponding author), Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA.	jcampbell@chemocentryx.com		Campbell, James/0000-0003-4252-5182	NIH [R21AI092388, R21AI097468]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092388, R21AI097468] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH and R21AI092388 & R21AI097468 (to J. J. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Anderson AO, 2005, IMMUNITY, V22, P3, DOI 10.1016/j.immuni.2005.01.003; Baekkevold ES, 2005, J EXP MED, V201, P1045, DOI 10.1084/jem.20041059; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Bursch LS, 2009, J IMMUNOL, V182, P4657, DOI 10.4049/jimmunol.0803656; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Campbell JJ, 2007, J IMMUNOL, V178, P3358, DOI 10.4049/jimmunol.178.6.3358; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Cao T, 2007, EUR J IMMUNOL, V37, P2657, DOI 10.1002/eji.200636499; del Rio ML, 2010, IMMUNOL REV, V234, P268, DOI 10.1111/j.0105-2896.2009.00874.x; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudda JC, 2004, J IMMUNOL, V172, P857, DOI 10.4049/jimmunol.172.2.857; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Edele F, 2008, J IMMUNOL, V181, P3745, DOI 10.4049/jimmunol.181.6.3745; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Geissmann F, 2002, J EXP MED, V196, P417, DOI 10.1084/jem.20020018; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Goldwich A, 2011, J LEUKOCYTE BIOL, V89, P973, DOI 10.1189/jlb.0310180; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kaplan DH, 2008, EUR J IMMUNOL, V38, P2369, DOI 10.1002/eji.200838397; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Lutz MB, 2010, IMMUNOL CELL BIOL, V88, P381, DOI 10.1038/icb.2010.17; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Mora JR, 2005, J EXP MED, V201, P303, DOI 10.1084/jem.20041645; Morelli AE, 2001, SEMIN IMMUNOL, V13, P323, DOI 10.1006/smim.2001.0328; Olvera-Gomez I, 2012, P NATL ACAD SCI USA, V109, P2072, DOI 10.1073/pnas.1105771109; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Shklovskaya E, 2008, J IMMUNOL, V181, P418, DOI 10.4049/jimmunol.181.1.418; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Stoitzner P, 2006, P NATL ACAD SCI USA, V103, P7783, DOI 10.1073/pnas.0509307103; Wang XQ, 2008, J IMMUNOL, V180, P6703, DOI 10.4049/jimmunol.180.10.6703	39	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91054	10.1371/journal.pone.0091054	http://dx.doi.org/10.1371/journal.pone.0091054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618819	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400045
J	Price, GL; Davis, KL; Karve, S; Pohl, G; Walgren, RA				Price, Gregory L.; Davis, Keith L.; Karve, Sudeep; Pohl, Gerhardt; Walgren, Richard A.			Survival Patterns in United States (US) Medicare Enrollees with Non-CML Myeloproliferative Neoplasms (MPN)	PLOS ONE			English	Article							ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; PRIMARY MYELOFIBROSIS; MYELOID MALIGNANCIES; LIFE EXPECTANCY; PROGNOSTIC-FACTORS; OLMSTED COUNTY; DISORDERS; POPULATION; MUTATION	Purpose: Non-CML myeloproliferative neoplasms (MPN) include essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF). Reported median overall survival (OS) ranges from a few to several years for MF, a decade or more for ET and PV. The study objective was to compare US survival rates of ET, PV, and MF patients with matched non-MPN/non-cancer controls in a nationally representative database. Patients and Methods: Data were taken retrospectively from the Survey, Epidemiology, and End Results (SEER)-Medicare linked database. Medicare enrollees with a new SEER MPN diagnosis between Jan 1, 2001 and Dec 31, 2007 were eligible. First MPN diagnosis was required at or after Medicare enrollment to allow for continuous follow-up. Non-MPN/non-cancer control groups were selected from Medicare separately for each MPN subtype and demographically matched to cases at a ratio of 5:1. Survival was determined starting from the case diagnosis date using the Kaplan-Meier method. Results: A total of 3,364 MPN patients (n = 1,217 ET; 1,625 PV; 522 MF) met the inclusion criteria and were matched to controls. Mean age was 78.4, 76.1, and 77.4 years for ET, PV, and MF, respectively, and percent female was 63, 50, and 41. Median OS was significantly (p<0.05) lower for MPN cases vs. controls (ET: 68 vs. 101 months; PV: 65 vs. 104; MF: 24 vs. 106). Conclusions: In the US Medicare population, survival in MF patients was worse than that of patients with ET or PV and significantly worse than matched controls. Survival of patients with ET or PV was substantially inferior to matched controls. These findings have implications for the clinical management of MPN patients and underscore the need for effective therapies in all MPN subtypes.	[Price, Gregory L.; Pohl, Gerhardt; Walgren, Richard A.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Davis, Keith L.; Karve, Sudeep] RTI Hlth Solut, Res Triangle Pk, NC USA	Eli Lilly; Research Triangle Institute	Price, GL (corresponding author), Eli Lilly & Co, Indianapolis, IN 46285 USA.	glp@lilly.com		Davis, Keith/0000-0002-0044-7107	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	Gregory L. Price, Gerhardt Pohl, and Richard A. Walgren are employees of Eli Lilly and Company, whose company funded this study. Keith L. Davis and Sudeep Karve are employees of RTI Health Solutions. Eli Lilly and Company is pursuing innovative drug development in the MPNs. There are no other relevant patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ANIA BJ, 1994, AM J HEMATOL, V47, P89, DOI 10.1002/ajh.2830470205; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Cervantes F, 2012, J CLIN ONCOL, V30, P2981, DOI 10.1200/JCO.2012.42.0240; Craig BM, 2012, CANCER EPIDEM BIOMAR, V21, P474, DOI 10.1158/1055-9965.EPI-11-1087; Gangat N, 2011, J CLIN ONCOL, V29, P392, DOI 10.1200/JCO.2010.32.2446; Hultcrantz M, 2012, J CLIN ONCOL, V30, P2995, DOI 10.1200/JCO.2012.42.1925; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Koopmans SM, 2012, NETH J MED, V70, P159; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Leukemia and Lymphoma Society, DIS INF SUPP MYEL NE; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Maynadie M, 2013, HAEMATOLOGICA, V98, P230, DOI 10.3324/haematol.2012.064014; Maynadie M, 2011, HAEMATOL-HEMATOL J, V96, P55, DOI 10.3324/haematol.2010.026252; Mesa RA, 1999, AM J HEMATOL, V61, P10, DOI 10.1002/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.3.CO;2-9; Murray J, 2005, CLIN MED, V5, P328, DOI 10.7861/clinmedicine.5-4-328; Nattinger AB, 1997, J CLIN EPIDEMIOL, V50, P939, DOI 10.1016/S0895-4356(97)00099-1; Palandri F, 2009, AM J HEMATOL, V84, P215, DOI 10.1002/ajh.21360; Passamonti F, 2004, AM J MED, V117, P755, DOI 10.1016/j.amjmed.2004.06.032; Passamonti F, 2010, BLOOD, V115, P1703, DOI 10.1182/blood-2009-09-245837; Rollison DE, 2008, BLOOD, V112, P45, DOI 10.1182/blood-2008-01-134858; ROZMAN C, 1991, CANCER, V67, P2658, DOI 10.1002/1097-0142(19910515)67:10<2658::AID-CNCR2820671042>3.0.CO;2-C; Silver RT, 2013, BLOOD, V122, P1881, DOI 10.1182/blood-2013-06-508416; Steven H., 2008, WHO CLASSIFICATION T, P40; Tefferi A, 2008, LEUKEMIA, V22, P756, DOI 10.1038/sj.leu.2405097; Thiele J, 1999, LEUKEMIA LYMPHOMA, V33, P207, DOI 10.3109/10428199909058421; Visser O, 2012, EUR J CANCER, V48, P3257, DOI 10.1016/j.ejca.2012.05.024; Warren JL, 2002, MED CARE, V40, P3; Wolanskyj AP, 2006, MAYO CLIN PROC, V81, P159, DOI 10.4065/81.2.159; Xu ZF, 2012, BLOOD, V119, P2469, DOI 10.1182/blood-2011-11-389866	29	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90299	10.1371/journal.pone.0090299	http://dx.doi.org/10.1371/journal.pone.0090299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618579	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400012
J	Tang, DD; Zhao, X; Chen, AT				Tang, Dandan; Zhao, Xiao; Chen, Antao			The Task-Relevant Attribute Representation Can Mediate the Simon Effect	PLOS ONE			English	Article							S-R COMPATIBILITY; WORKING-MEMORY; SPATIAL STIMULUS; IRRELEVANT; INFORMATION; ACTIVATION; ACCOUNT; CUE	Researchers have previously suggested a working memory (WM) account of spatial codes, and based on this suggestion, the present study carries out three experiments to investigate how the task-relevant attribute representation (verbal or visual) in the typical Simon task affects the Simon effect. Experiment 1 compared the Simon effect between the between- and within-category color conditions, which required subjects to discriminate between red and blue stimuli (presumed to be represented by verbal WM codes because it was easy and fast to name the colors verbally) and to discriminate between two similar green stimuli (presumed to be represented by visual WM codes because it was hard and time-consuming to name the colors verbally), respectively. The results revealed a reliable Simon effect that only occurs in the between-category condition. Experiment 2 assessed the Simon effect by requiring subjects to discriminate between two different isosceles trapezoids (within-category shapes) and to discriminate isosceles trapezoid from rectangle (between-category shapes), and the results replicated and expanded the findings of Experiment 1. In Experiment 3, subjects were required to perform both tasks from Experiment 1. Wherein, in Experiment 3A, the between-category task preceded the within-category task; in Experiment 3B, the task order was opposite. The results showed the reliable Simon effect when subjects represented the task-relevant stimulus attributes by verbal WM encoding. In addition, the response times (RTs) distribution analysis for both the between-and within-category conditions of Experiments 3A and 3B showed decreased Simon effect with the RTs lengthened. Altogether, although the present results are consistent with the temporal coding account, we put forth that the Simon effect also depends on the verbal WM representation of task-relevant stimulus attribute.	[Tang, Dandan; Zhao, Xiao; Chen, Antao] Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Chen, Antao] Liaoning Normal Univ, Sch Psychol, Dalian, Liaoning, Peoples R China	Southwest University - China; Liaoning Normal University	Chen, AT (corresponding author), Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	xscat@swu.edu.cn			National Natural Science Foundation of China [31170980, 81271477]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201107]; New Century Excellent Talents in University [NCET-11-0698]; Fundamental Research Funds for the Central Universities [SWU1009001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31170980, 81271477), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201107), the New Century Excellent Talents in University (NCET-11-0698), and the Fundamental Research Funds for the Central Universities (SWU1009001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2007, PSYCHON B REV, V14, P742, DOI 10.3758/BF03196831; Ansorge U, 2004, J EXP PSYCHOL HUMAN, V30, P365, DOI 10.1037/0096-1523.30.2.365; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; DEJONG R, 1994, J EXP PSYCHOL HUMAN, V20, P731, DOI 10.1037/0096-1523.20.4.731; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Franz VH, 2012, PSYCHON B REV, V19, P395, DOI 10.3758/s13423-012-0230-1; HEDGE A, 1975, ACTA PSYCHOL, V39, P427, DOI 10.1016/0001-6918(75)90041-4; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P280, DOI 10.1007/BF00419688; HOMMEL B, 1994, PSYCHOL RES-PSYCH FO, V56, P179, DOI 10.1007/BF00419705; HOMMEL B, 1994, PSYCHOL RES-PSYCH FO, V56, P261, DOI 10.1007/BF00419656; Ikeda T, 2007, NEUROREPORT, V18, P111, DOI 10.1097/WNR.0b013e328010ff3f; Ivanoff J, 2000, PSYCHOL RES-PSYCH FO, V64, P117, DOI 10.1007/s004260000033; Koida K, 2007, NAT NEUROSCI, V10, P108, DOI 10.1038/nn1823; KOMATSU H, 1992, J NEUROSCI, V12, P408; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Lameira AP, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.059.2009; Lammertyn J, 2007, EXP PSYCHOL, V54, P202, DOI 10.1027/1618-3169.54.3.202; Liu X, 2004, NEUROIMAGE, V22, P1097, DOI 10.1016/j.neuroimage.2004.02.033; LU CH, 1995, PSYCHON B REV, V2, P174, DOI 10.3758/BF03210959; LU CH, 1994, J EXP PSYCHOL HUMAN, V20, P286, DOI 10.1037/0096-1523.20.2.286; Peterson BS, 2002, COGNITIVE BRAIN RES, V13, P427, DOI 10.1016/S0926-6410(02)00054-X; Proctor RW, 2011, PSYCHON B REV, V18, P242, DOI 10.3758/s13423-011-0053-5; Proctor RW, 2002, MEM COGNITION, V30, P281, DOI 10.3758/BF03195289; Ridderinkhof KR, 2002, ATTENTION PERFORM, V19, P494; Rothmayr C, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-56; SIMON JR, 1969, J EXP PSYCHOL, V81, P174, DOI 10.1037/h0027448; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; SIMON JR, 1976, PERCEPT PSYCHOPHYS, V19, P16, DOI 10.3758/BF03199380; Simon JR., 1990, ADV PSYCHOL, P31, DOI [10.1016/s0166-4115(08)61218-2, DOI 10.1016/S0166-4115(08)61218-2]; STOFFER TH, 1991, PSYCHOL RES-PSYCH FO, V53, P127, DOI 10.1007/BF01371820; Sturmer B, 2005, EUR J COGN PSYCHOL, V17, P590, DOI 10.1080/09541440540000077; Takechi H, 1997, NEUROSCI LETT, V230, P17, DOI 10.1016/S0304-3940(97)00461-8; Tootell RBH, 2004, CEREB CORTEX, V14, P353, DOI 10.1093/cercor/bhh001; Wascher E, 2001, J EXP PSYCHOL HUMAN, V27, P731, DOI 10.1037//0096-1523.27.3.731; Wuhr P, 2007, PSYCHON B REV, V14, P984, DOI 10.3758/BF03194132; Wuhr P, 2011, J EXP PSYCHOL HUMAN, V37, P442, DOI 10.1037/a0020563; Wuhr P, 2006, ACTA PSYCHOL, V121, P210, DOI 10.1016/j.actpsy.2004.12.003; Zhao XA, 2010, PSYCHON B REV, V17, P687, DOI 10.3758/PBR.17.5.687	39	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90954	10.1371/journal.pone.0090954	http://dx.doi.org/10.1371/journal.pone.0090954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24618692	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400038
J	Velayutham, BRV; Nair, D; Chandrasekaran, V; Raman, B; Sekar, G; Watson, B; Charles, N; Malaisamy, M; Thomas, A; Swaminathan, S				Velayutham, Banu Rekha Vaithilingam; Nair, Dina; Chandrasekaran, Vedachalam; Raman, Balambal; Sekar, Gomathy; Watson, Basilea; Charles, Niruparani; Malaisamy, Muniyandi; Thomas, Aleyamma; Swaminathan, Soumya			Profile and Response to Anti-Tuberculosis Treatment among Elderly Tuberculosis Patients Treated under the TB Control Programme in South India	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RISK-FACTORS	Introduction: The demographic transition in India has resulted in an increase in the elderly population. There is limited data on the profile of elderly tuberculosis (TB) patients and their treatment outcomes in India. Objective: To compare the clinical profile, presentation and response to anti-TB treatment among elderly (>= 60 yrs) and younger (15-59 yrs) TB patients treated under the Revised National TB Control programme. Methodology: Retrospective cohort analysis of TB patients treated from May 1999 to December 2004 in one Tuberculosis Unit of Tiruvallur district, South India. Results: Records of 865 elderly and 4343 younger TB patients were examined: elderly were more likely to be male (84% vs. 71%), smokers (46% vs. 37%), illiterate (63% vs. 45%), identified by active case finding through survey (19% vs. 11%), have pulmonary TB (96% vs. 91%) and initial smear negative disease (46% vs. 36%) compared to younger (for all p<0.001). Among a total of 352 elderly and 1933 younger new smear positive pulmonary TB, the elderly had higher loss to follow-up (15% vs. 11%; p = 0.03) and death rates (9% vs. 4%; p<0.001). Mycobacterium tuberculosis susceptibility to first line anti-TB drugs did not differ (elderly 87% vs. younger 84%) (p = 0.20). Side effects related to anti-TB drugs were reported by a higher proportion of elderly patients (63% vs. 54%) (p = 0.005). Previously treated patients had similar treatment outcomes in both the groups. Conclusion: Elderly TB patients are less likely to have smear positive disease. Newly diagnosed elderly TB patients are more likely to be lost to follow-up or die and report drug side effects. Suitable interventions need to be developed for effective management and better treatment outcomes of TB in the elderly.	[Velayutham, Banu Rekha Vaithilingam; Nair, Dina; Chandrasekaran, Vedachalam; Raman, Balambal; Sekar, Gomathy; Watson, Basilea; Charles, Niruparani; Malaisamy, Muniyandi; Thomas, Aleyamma; Swaminathan, Soumya] Natl Inst Res TB, Chennai, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Swaminathan, S (corresponding author), Natl Inst Res TB, Chennai, Tamil Nadu, India.	doctorsoumya@yahoo.com	Watson, Basilea/AGH-6965-2022		United States Agency for International Development through the World Health Organization; Indian Council of Medical Research, India	United States Agency for International Development through the World Health Organization(United States Agency for International Development (USAID)); Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	This report was funded in part by a grant from the United States Agency for International Development provided through the World Health Organization. Additional funding was from the Indian Council of Medical Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B W, 1968, MYCOBACTERIA ISOLATI; Ananthakrishnan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067288; [Anonymous], 1983, TUBERCLE, V64, P73; Arora V K, 2003, Indian J Chest Dis Allied Sci, V45, P231; Arora V K, 1989, J Assoc Physicians India, V37, P205; Bhushan B, 2012, INT J TUBERC LUNG D, V16, P1210, DOI 10.5588/ijtld.11.0778; Brinkmann B, 2002, DEUT MED WOCHENSCHR, V127, P791, DOI 10.1055/s-2002-25021; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Central Statistics Office Government of India, 2011, SIT AN ELD IND; Central TB Division (CTD) Directorate General of Health Services Ministry of Health and Family Welfare Government of India, 2005, MAN REV NAT TB CONTR, P77; Central TB Division (CTD) Directorate General of Health Services Ministry of Health and Family Welfare Government of India. Revised National Tuberculosis Control Programme (RNTCP), 2010, TRAIN MOD MED PRACT, P27; Gaur S. N., 2004, Indian Journal of Tuberculosis, V51, P83; Geeta Pardeshi, 2007, Indian Journal of Community Medicine, V32, P292; Hauer B, 2011, EUR RESPIR J, V38, P467, DOI 10.1183/09031936.00199910; Holt PR, 2001, GASTROENTEROL CLIN N, V30, P427, DOI 10.1016/S0889-8553(05)70189-8; Ingle Gopal K, 2008, Indian J Community Med, V33, P214, DOI 10.4103/0970-0218.43225; Kolappan C, 2002, THORAX, V57, P964, DOI 10.1136/thorax.57.11.964; Kwon YS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-121; Lee JH, 2005, J KOREAN MED SCI, V20, P784, DOI 10.3346/jkms.2005.20.5.784; Pande JN, 1996, THORAX, V51, P132, DOI 10.1136/thx.51.2.132; Rath SP, 2011, INT J BUSINESS MANAG, V1, P1; Rawat Jagdish, 2008, Indian J Tuberc, V55, P84; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Schaaf HS, 2010, RESPIROLOGY, V15, P747, DOI 10.1111/j.1440-1843.2010.01784.x; Sood R, 2000, J INDIAN ACAD CLIN M, V5, P156; STEAD WW, 1965, AM REV RESPIR DIS, V91, P811; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; TEALE C, 1993, AGE AGEING, V22, P289, DOI 10.1093/ageing/22.4.289; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zhao FZ, 1997, INT J TUBERC LUNG D, V1, P570	30	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e88045	10.1371/journal.pone.0088045	http://dx.doi.org/10.1371/journal.pone.0088045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618888	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000332842400003
J	Korrer, MJ; Routes, JM				Korrer, Michael J.; Routes, John M.			Possible Role of Arginase-1 in Concomitant Tumor Immunity	PLOS ONE			English	Article							ADENOVIRUS E1A ONCOGENE; HUMAN-PAPILLOMAVIRUS E7; L-ARGININE; T-CELLS; CYTOLYTIC SUSCEPTIBILITY; BREAST-CANCER; MOUSE MODEL; TNF-ALPHA; NK-CELL; EXPRESSION	The expression of Adenovirus serotype 2 or serotype 5 (Ad2/5) E1A in tumor cells reduces their tumorigenicity in vivo by enhancing the NK cell mediated and T cell mediated anti-tumor immune response, an activity that correlates with the ability of E1A to bind p300. We determined if E1A could be used as a molecular adjuvant to enhance antigen-specific T cell responses to a model tumor antigen, ovalbumin (OVA). To achieve this goal, we stably expressed a fusion protein of E1A and OVA (MCA-205-E1A-OVA), OVA (MCA-205-OVA) or a mutant version of E1A unable to bind p300 and OVA (E1A-Delta p300-OVA) in the B6-derived, highly tumorigenic MCA-205 tumor cell line. MCA-205-E1A-OVA tumor cells were over 10,000 fold less tumorigenic than MCA-205-OVA, MCA-205-E1A-Delta p300-OVA, or MCA-205 in B6 mice. However, immunization of B6 mice with live MCA-205-OVA, MCA-205-E1A-Delta p300-OVA and MCA-E1A-OVA tumor cells induced nearly equivalent OVA-specific CD4 T cells and CD8 CTL responses. Further studies revealed that mice with primary, enlarging MCA-205-OVA or MCA-205-E1A-Delta p300-OVA tumors on one flank exhibited OVA-specific anti-tumor T cell responses that rejected a tumorigenic dose of MCA-205-OVA cells on the contralateral flank (concomitant tumor immunity). Next we found that tumor associated macrophages (TAMs) in progressive MCA-205-OVA tumors, but not MCA-205-E1A-OVA tumors that expressed high levels of arginase-1, which is known to have local immunosuppressive activities. In summary, immunization of mice with MCA-205 cells expressing OVA, E1A-Delta p300-OVA or E1A-OVA induced equivalent OVA-specific CD4 and CD8 anti-tumor responses. TAMs found in MCA-205-OVA, but not MCA-205-E1A-OVA, tumors expressed high levels of arginase-1. We hypothesize that the production of arginase-1 by TAMs in MCA-205-OVA or MCA-205-E1A-Delta p300-OVA tumor cells leads to an ineffective antitumor immune response in the tumor microenvironment, but does not result in inhibition of a systemic anti-tumor immunity.	[Korrer, Michael J.; Routes, John M.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Korrer, Michael J.; Routes, John M.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Korrer, Michael J.; Routes, John M.] Childrens Res Inst, Milwaukee, WI USA; [Korrer, Michael J.; Routes, John M.] Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Korrer, MJ (corresponding author), Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mjkorrer@gmail.com; jroutes@mcw.edu	Routes, john/AAA-4833-2021	Routes, john/0000-0001-8378-3773; Korrer, Michael/0000-0001-8477-8810	National Institutes of Health [CA125666-05]; NATIONAL CANCER INSTITUTE [R01CA125666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant CA125666-05 to J. M. Routes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; COOK JL, 1984, SCIENCE, V224, P612, DOI 10.1126/science.6710160; COOK JL, 1986, P NATL ACAD SCI USA, V83, P6965, DOI 10.1073/pnas.83.18.6965; Cook JL, 1996, P NATL ACAD SCI USA, V93, P13985, DOI 10.1073/pnas.93.24.13985; COOK JL, 1979, CANCER RES, V39, P3335; COOK JL, 1989, J IMMUNOL, V142, P4527; EGAN C, 1988, MOL CELL BIOL, V8, P3955, DOI 10.1128/MCB.8.9.3955; GALLIMORE PH, 1977, CELL, V10, P669, DOI 10.1016/0092-8674(77)90100-3; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Iyer RK, 2002, MOL CELL BIOL, V22, P4491, DOI 10.1128/MCB.22.13.4491-4498.2002; Kasten J, 2013, MOL GENET METAB, V110, P222, DOI 10.1016/j.ymgme.2013.06.020; KELEKAR A, 1987, MOL CELL BIOL, V7, P3899, DOI 10.1128/MCB.7.11.3899; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Loubaki L, 2013, J IMMUNOL METHODS, V393, P38, DOI 10.1016/j.jim.2013.04.004; Marzo AL, 2000, J IMMUNOL, V165, P6047, DOI 10.4049/jimmunol.165.11.6047; Miura TA, 2003, J IMMUNOL, V170, P4119, DOI 10.4049/jimmunol.170.8.4119; Prati C, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3860; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Rodriguez PC, 2010, J IMMUNOL, V185, P5198, DOI 10.4049/jimmunol.1001224; Rodriguez PC, 2002, J BIOL CHEM, V277, P21123, DOI 10.1074/jbc.M110675200; Routes JM, 2000, VIROLOGY, V277, P48, DOI 10.1006/viro.2000.0571; Routes JM, 2005, J EXP MED, V202, P1477, DOI 10.1084/jem.20050240; Routes JM, 2000, J IMMUNOL, V165, P4522, DOI 10.4049/jimmunol.165.8.4522; SPIESS PJ, 1987, JNCI-J NATL CANCER I, V79, P1067; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Taheri F, 2001, CLIN CANCER RES, V7, p958S; Torisu H, 2000, INT J CANCER, V85, P182, DOI 10.1002/(SICI)1097-0215(20000115)85:2<182::AID-IJC6>3.3.CO;2-D; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; WALKER TA, 1991, P NATL ACAD SCI USA, V88, P6491, DOI 10.1073/pnas.88.15.6491; Wang F, 2013, CELL MOL LIFE SCI, V70, P3989, DOI 10.1007/s00018-012-1254-4	31	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91370	10.1371/journal.pone.0091370	http://dx.doi.org/10.1371/journal.pone.0091370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614600	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300117
J	de Macedo-Soares, LCP; Garcia, CAE; Freire, AS; Muelbert, JH				Pinto de Macedo-Soares, Luis Carlos; Eiras Garcia, Carlos Alberto; Freire, Andrea Santarosa; Muelbert, Jose Henrique			Large-Scale Ichthyoplankton and Water Mass Distribution along the South Brazil Shelf	PLOS ONE			English	Article							LARVAL FISH ASSEMBLAGES; ANCHOVY ENGRAULIS-ANCHOITA; OCEANOGRAPHIC CONDITIONS; REPRODUCTIVE HABITATS; LATITUDINAL GRADIENTS; CONTINENTAL-SHELF; COASTAL LAGOON; PATTERNS; MYCTOPHIDAE; DIVERSITY	Ichthyoplankton is an essential component of pelagic ecosystems, and environmental factors play an important role in determining its distribution. We have investigated simultaneous latitudinal and cross-shelf gradients in ichthyoplankton abundance to test the hypothesis that the large-scale distribution of fish larvae in the South Brazil Shelf is associated with water mass composition. Vertical plankton tows were collected between 21 degrees 27' and 34 degrees 51'S at 107 stations, in austral late spring and early summer seasons. Samples were taken with a conical-cylindrical plankton net from the depth of chlorophyll maxima to the surface in deep stations, or from 10 m from the bottom to the surface in shallow waters. Salinity and temperature were obtained with a CTD/rosette system, which provided seawater for chlorophyll-a and nutrient concentrations. The influence of water mass on larval fish species was studied using Indicator Species Analysis, whereas environmental effects on the distribution of larval fish species were analyzed by Distance-based Redundancy Analysis. Larval fish species were associated with specific water masses: in the north, Sardinella brasiliensis was found in Shelf Water; whereas in the south, Engraulis anchoita inhabited the Plata Plume Water. At the slope, Tropical Water was characterized by the bristlemouth Cyclothone acclinidens. The concurrent analysis showed the importance of both cross-shelf and latitudinal gradients on the large-scale distribution of larval fish species. Our findings reveal that ichthyoplankton composition and large-scale spatial distribution are determined by water mass composition in both latitudinal and cross-shelf gradients.	[Pinto de Macedo-Soares, Luis Carlos; Freire, Andrea Santarosa] Univ Fed Santa Catarina, Dept Ecol & Zool, Lab Crustaceos & Plancton, Programa Posgrad Ecol, Florianopolis, SC, Brazil; [Pinto de Macedo-Soares, Luis Carlos; Muelbert, Jose Henrique] Univ Fed Rio Grande, Inst Oceanog, Lab Ecol Ictioplancton, Rio Grande, RS, Brazil; [Eiras Garcia, Carlos Alberto] Univ Fed Rio Grande, Inst Oceanog, Lab Estudos Oceanos & Clima, Rio Grande, RS, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal do Rio Grande; Universidade Federal do Rio Grande	de Macedo-Soares, LCP (corresponding author), Univ Fed Santa Catarina, Dept Ecol & Zool, Lab Crustaceos & Plancton, Programa Posgrad Ecol, Florianopolis, SC, Brazil.	luismacedosoares@gmail.com	Freire, Andrea/AAQ-9863-2021; de Macedo Soares, Luis Carlos Pinto/R-4883-2019; Freire, Andrea S/J-6226-2018; Muelbert, Jose H/J-5110-2014; Garcia, Carlos A. E./K-7382-2012	de Macedo Soares, Luis Carlos Pinto/0000-0003-4993-2901; Freire, Andrea S/0000-0001-6280-7254; Muelbert, Jose H/0000-0002-2319-2469; 	MCTI; Brazilian Navy; CNPq [482059/2010-9, Proc. 310931/2012-6]; CAPES	MCTI; Brazilian Navy; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study is part of the project "Fronts dynamics in the south and southeast Brazilian shelf and upper slope and its influence on carbon fluxes between ocean and atmosphere", and was supported by MCTI, Brazilian Navy, CNPq (Grant 482059/2010-9) and by a post-graduate fellowship from CAPES. JHM benefited from a CNPq grant (Proc. 310931/2012-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha EM, 2004, J MARINE SYST, V44, P83, DOI 10.1016/j.jmarsys.2003.09.005; Ahlstrom E.H., 1980, California Cooperative Oceanic Fisheries Investigations Reports, V21, P121; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BAKUN A, 1991, ICES J MAR SCI, V48, P343, DOI 10.1093/icesjms/48.3.343; BAKUN A, 1990, J CONSEIL, V46, P269; Berasategui AD, 2004, ESTUAR COAST SHELF S, V60, P599, DOI 10.1016/j.ecss.2004.02.015; BOEHLERT GW, 1994, MAR ECOL PROG SER, V107, P1, DOI 10.3354/meps107001; Bonecker ACT, 2006, SERIE LIVROS DOCUMEN, V19; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Braga ES, 2008, CONT SHELF RES, V28, P1649, DOI 10.1016/j.csr.2007.06.018; Calado L, 2010, CONT SHELF RES, V30, P1181, DOI 10.1016/j.csr.2010.03.007; Campos EJD, 2000, GEOPHYS RES LETT, V27, P751, DOI 10.1029/1999GL010502; Campos PC, 2013, J GEOPHYS RES-OCEANS, V118, P1420, DOI 10.1002/jgrc.20131; Castello JP, 2009, J APPL ICHTHYOL, V25, P287, DOI 10.1111/j.1439-0426.2009.01229.x; Castello L, 2003, FISH RES, V59, P409, DOI 10.1016/S0165-7836(02)00014-0; Castro BM., 2006, AMBIENTE OCEANOGR FI, P11; Ciechomski JD, 1965, B I BIOL MAR, V9, P1; CIOTTI AM, 1995, CONT SHELF RES, V15, P1737, DOI 10.1016/0278-4343(94)00091-Z; Clarke K., 2005, PRIMER 6 COMPUTER PR; de Castro MS, 2005, BRAZ ARCH BIOL TECHN, V48, P121, DOI 10.1590/S1516-89132005000100016; de Freitas WM, 2004, BRAZ ARCH BIOL TECHN, V47, P601, DOI 10.1590/S1516-89132004000400014; Derisio C, 2012, SCI MAR, V76, P29, DOI 10.3989/scimar.2012.76n1029; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Ekau W, 1999, ARCH FISH MAR RES, V47, P183; Fahay M.P., 1983, Journal of Northwest Atlantic Fishery Science, V4, P1; FIELD JG, 1982, MAR ECOL PROG SER, V8, P37, DOI 10.3354/meps008037; Floeter SR, 2004, J FISH BIOL, V64, P1680, DOI 10.1111/j.0022-1112.2004.00428.x; Floeter SR, 2001, GLOBAL ECOL BIOGEOGR, V10, P423, DOI 10.1046/j.1466-822X.2001.00245.x; Franco BC, 2006, FISH OCEANOGR, V15, P37, DOI 10.1111/j.1365-2419.2005.00359.x; Franco-Gordo C, 2008, FISH OCEANOGR, V17, P178, DOI 10.1111/j.1365-2419.2008.00463.x; Franco-Gordo C, 2002, J PLANKTON RES, V24, P775, DOI 10.1093/plankt/24.8.775; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Grasshoff K., 1983, METHODS SEAWATER ANA, V2nd, DOI DOI 10.15359/REVMAR.3.2; Heiberger R, 2013, HH STAT ANAL DATA DI; Hernandez-Miranda E, 2003, ESTUAR COAST SHELF S, V56, P1075, DOI 10.1016/S0272-7714(02)00308-6; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; Katsuragawa M, 2006, AMBIENTE OCEANOGRAFI, P359; LASKER R, 1975, FISH B-NOAA, V73, P453; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Llanos-Rivera A, 2004, FISH B-NOAA, V102, P207; Lopes RM, 2006, SCI MAR, V70, P189, DOI 10.3989/scimar.2006.70n2189; Macedo-Soares LCP, 2012, MAR ECOL PROG SER, V444, P207, DOI 10.3354/meps09436; Macedo-Soares LCP, 2009, NEOTROP ICHTHYOL, V7, P231, DOI 10.1590/S1679-62252009000200015; Mafalda JR PO, 2006, ATLANTICA, V28, P5; Mafalda Jr PO, 2009, BIOMASSA FITOPLANCTO, P103; Martins IM, 2007, J MARINE SYST, V68, P537, DOI 10.1016/j.jmarsys.2007.02.004; MATSUURA Y, 1975, Boletim do Instituto Oceanografico, V24, P17; MATSUURA Y, 1995, ARCH FISH MAR RES, V42, P239; Matsuura Y, 1997, ICHTHYOL RES, V44, P369, DOI 10.1007/BF02671988; Matsuura Y, 1996, S AFR J MARINE SCI, V17, P29; Matsuura Yasunobu, 1992, Boletim do Instituto Oceanografico, V40, P101, DOI 10.1590/S1679-87591992000100009; Moller OO, 2008, CONT SHELF RES, V28, P1607, DOI 10.1016/j.csr.2008.03.012; MOSER HG, 1993, B MAR SCI, V53, P645; Moser HG, 1996, EARLY STAGES FISHES, V33, P1; Moser HG, 1984, ONTOGENY SYSTEMATICS, V1; Muelbert J.H., 1991, Larval Fish Recruitment in the Americas, P43; Muelbert JH, 2008, CONT SHELF RES, V28, P1662, DOI 10.1016/j.csr.2007.08.011; Muhling BA, 2008, FISH OCEANOGR, V17, P16, DOI 10.1111/j.1365-2419.2007.00452.x; Muhling BA, 2013, FISH OCEANOGR, V22, P409, DOI 10.1111/fog.12031; NELSON J S, 1976, P416; Niencheski LFH, 2007, MAR CHEM, V106, P546, DOI 10.1016/j.marchem.2007.06.004; Nonaka RH, 2000, FISH B-NOAA, V98, P767; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olivar MP, 2010, FISH OCEANOGR, V19, P209, DOI 10.1111/j.1365-2419.2010.00538.x; OLIVAR M-P, 1991, Scientia Marina, V55, P1; Olivar MP, 1999, SCI MAR, V63, P101; OLIVAR MP, 1993, B MAR SCI, V53, P450; Olivar MP, 1995, S AFR J MARINE SCI, V16, P129; Olivar MP, 1997, B MAR SCI, V60, P47; OLNEY J E, 1976, Chesapeake Science, V17, P229, DOI 10.2307/1350510; Olney J.E., 2006, EARLY STAGES ATLANTI, P1019; Piola AR, 2008, CONT SHELF RES, V28, P1639, DOI 10.1016/j.csr.2008.03.013; R Core Team, 2021, R LANGUAGE ENV STAT; Rodrigues RR, 2001, CONT SHELF RES, V21, P371, DOI 10.1016/S0278-4343(00)00094-7; Sabates A, 2007, PROG OCEANOGR, V74, P355, DOI 10.1016/j.pocean.2007.04.017; Sanvicente-Anorve L, 1998, B MAR SCI, V62, P17; Sassa C, 2003, ICHTHYOL RES, V50, P94, DOI 10.1007/s102280300015; Schmidt A, 2011, J HYDROL, V406, P66, DOI 10.1016/j.jhydrol.2011.06.001; Schwartzlose RA, 1999, S AFR J MARINE SCI, V21, P289; Silveira I.C.A., 2000, REV BRAS OCEANOGR, V48, P171, DOI [10.1590/S1413-77392000000200008, DOI 10.1590/S1413-77392000000200008]; SMITH P E, 1977, FAO (Food and Agriculture Organization of the United Nations) Fisheries Technical Paper, V175, P1; Strickland J. D. H., 1968, B FISH RES BOARD CAN, V167; VALENTIN JL, 1984, HYDROBIOLOGIA, V113, P183, DOI 10.1007/BF00026607; Vinagre C, 2009, ESTUAR COAST SHELF S, V81, P375, DOI 10.1016/j.ecss.2008.11.015; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Woodd-Walker RS, 2002, MAR ECOL PROG SER, V236, P189, DOI 10.3354/meps236189	88	36	37	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91241	10.1371/journal.pone.0091241	http://dx.doi.org/10.1371/journal.pone.0091241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614798	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300101
J	Rathe, AA; Pilkington, LJ; Hoddle, MS; Spohr, LJ; Daugherty, MP; Gurr, GM				Rathe, Anna A.; Pilkington, Leigh J.; Hoddle, Mark S.; Spohr, Lorraine J.; Daugherty, Matthew P.; Gurr, Geoff M.			Feeding and Development of the Glassy-Winged Sharpshooter, Homalodisca vitripennis, on Australian Native Plant Species and Implications for Australian Biosecurity	PLOS ONE			English	Article							GONATOCERUS-TRIGUTTATUS HYMENOPTERA; HEMIPTERA CICADELLIDAE; HOST PLANTS; XYLEM FLUID; COAGULATA HOMOPTERA; GERMAR HEMIPTERA; FRENCH-POLYNESIA; LEAFHOPPER; MYMARIDAE; ASHMEADI	In any insect invasion the presence or absence of suitable food and oviposition hosts in the invaded range is a key factor determining establishment success. The glassy-winged sharpshooter, Homalodisca vitripennis, is an important insect vector of the xylem-limited bacterial plant pathogen, Xylella fastidiosa, which causes disease in numerous host plants including food and feedstock crops, ornamentals and weeds. Both the pathogen and the vector are native to the Americas and are considered to be highly invasive. Neither has been detected in Australia. Twelve Australian native plant species present in the USA were observed over two years for suitability as H. vitripennis feeding, oviposition and nymph development hosts. Hosts providing evidence of adult or nymph presence were Leptospermum laevigatum, Acacia cowleana, Eremophila divaricata, Eucalyptus wandoo, Hakea laurina, Melaleuca laterita and Swainsona galegifolia. An oviposition-suitability field study was conducted with citrus, a favoured oviposition host, as a positive control. Citrus and L. laevigatum, A. cowleana, B. ericifoliaxB. spinulosa, C. pulchella, E. divaricata, E. wandoo, H. laurina, and S. galegifolia were found to be oviposition hosts. Egg parasitism by the mymarid parasitoid Gonatocerus ashmeadi was observed on all Australian plants. A number of Australian plants that may facilitate H. vitripennis invasion have been identified and categorised as 'high risk' due to their ability to support all three life stages (egg, nymph and adult) of the insect in the field (L. laevigatum, A. cowleana, E. divaricata, H. laurina, and S. galegifolia). The implications of these host status and natural enemy research findings are discussed and placed in an Australian invasion context.	[Rathe, Anna A.; Pilkington, Leigh J.] Plant Biosecur Cooperat Res Ctr, Bruce, ACT, Australia; [Rathe, Anna A.; Pilkington, Leigh J.] NSW Dept Primary Ind, Graham Ctr Agr Innovat, Gosford, NSW, Australia; [Rathe, Anna A.; Pilkington, Leigh J.] Charles Sturt Univ, Cent Coast Primary Ind Ctr, NSW Dept Primary Ind, Gosford, NSW, Australia; [Rathe, Anna A.; Gurr, Geoff M.] NSW Dept Primary Ind, Graham Ctr Agr Innovat, Orange, NSW, Australia; [Rathe, Anna A.; Gurr, Geoff M.] Charles Sturt Univ, Orange, NSW, Australia; [Hoddle, Mark S.; Daugherty, Matthew P.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Spohr, Lorraine J.] NSW Dept Primary Ind, Cent Coast Primary Ind Ctr, Gosford, NSW, Australia	NSW Department of Primary Industries; Charles Sturt University; NSW Department of Primary Industries; NSW Department of Primary Industries; Charles Sturt University; University of California System; University of California Riverside; NSW Department of Primary Industries	Pilkington, LJ (corresponding author), Plant Biosecur Cooperat Res Ctr, Bruce, ACT, Australia.	leigh.pilkington@dpi.nsw.gov.au	Spohr, Lorraine/N-8611-2016; GURR, GEOFFREY M/F-3519-2011	Spohr, Lorraine/0000-0002-0205-6302; Gurr, Geoff/0000-0001-5008-7966	Australian Government's Cooperative Research Centres Program; Grape and Wine Research and Development Corporation; EH Graham Centre for Agricultural Innovation	Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Grape and Wine Research and Development Corporation; EH Graham Centre for Agricultural Innovation	This study was supported by the Australian Government's Cooperative Research Centres Program (http://www.crcplantbiosecurity.com.au), the Grape and Wine Research and Development Corporation (http://www.gwrdc.com.au) and the EH Graham Centre for Agricultural Innovation (http://www.csu.edu.au/research/grahamcentre/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RPP, 2005, ANN ENTOMOL SOC AM, V98, P775, DOI 10.1603/0013-8746(2005)098[0775:VTOXFA]2.0.CO;2; ANDERSEN PC, 1992, J INSECT PHYSIOL, V38, P611, DOI 10.1016/0022-1910(92)90113-R; ANDERSEN PC, 1989, ENTOMOL EXP APPL, V50, P149, DOI 10.1007/BF00365399; Blua M. J., 1999, California Agriculture, V53, P22, DOI 10.3733/ca.v053n02p22; Boyd EA, 2007, SOUTHWEST ENTOMOL, V32, P177, DOI 10.3958/0147-1724-32.3.177; Brodbeck BV, 2007, ENVIRON ENTOMOL, V36, P1512, DOI 10.1603/0046-225X(2007)36[1512:PLOTXF]2.0.CO;2; BRODBECK BV, 1993, J INSECT PHYSIOL, V39, P73, DOI 10.1016/0022-1910(93)90020-R; Butler D, 2011, ASREML R REFERENCE M; California Department of Food and Agriculture, 2005, PLANT QUAR MAN PIERC; Chen WL, 2010, ENVIRON ENTOMOL, V39, P1545, DOI 10.1603/EN10098; Grandgirard J, 2008, BIOL INVASIONS, V10, P135, DOI 10.1007/s10530-007-9116-y; Hoddle MS, 2003, FLA ENTOMOL, V86, P89, DOI 10.1653/0015-4040(2003)086[0089:DAPARF]2.0.CO;2; Hoddle MS, 2009, CDFA PIERC DIS CONTR; Hummel NA, 2006, ENVIRON ENTOMOL, V35, P901, DOI 10.1603/0046-225X-35.4.901; Irvin NA, 2004, FLA ENTOMOL, V87, P504, DOI 10.1653/0015-4040(2004)087[0504:OPOHCF]2.0.CO;2; Johnson MW, 2006, CDFA PIERC DIS CONTR; Krugner R, 2008, BIOL CONTROL, V47, P8, DOI 10.1016/j.biocontrol.2008.06.004; Krugner R, 2009, J ECON ENTOMOL, V102, P960, DOI 10.1603/029.102.0315; Lauziere I, 2009, ANN ENTOMOL SOC AM, V102, P642, DOI 10.1603/008.102.0409; Luck J, 2001, POTENTIAL ESTABLISHM; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mizell RF, 2008, ENVIRON ENTOMOL, V37, P1049, DOI 10.1603/0046-225X(2008)37[1049:BMFHVH]2.0.CO;2; Morse JG, 2005, CDFA PIERC DIS CONTR; Petit JN, 2008, BIOL INVASIONS, V10, P955, DOI 10.1007/s10530-007-9172-3; Pierce's Disease/Riparian Habitat Workgroup, 2000, INF MAN RIP VEG MAN; Pilkington L. J., 2005, California Agriculture, V59, P223, DOI 10.3733/ca.v059n04p223; R Development Core Team, 2012, R LANG ENV STAT COMP; Raven JA, 1983, ADV ECOLOGICAL RES; Setamou M, 2005, ANN ENTOMOL SOC AM, V98, P322, DOI 10.1603/0013-8746(2005)098[0322:BABOSH]2.0.CO;2; Son Y, 2010, ENVIRON ENTOMOL, V39, P1264, DOI 10.1603/EN09367; Tipping C, 2004, FLA ENTOMOL, V87, P372, DOI 10.1653/0015-4040(2004)087[0372:DAOISO]2.0.CO;2; Triapitsyn SV, 2000, FLA ENTOMOL, V83, P200, DOI 10.2307/3496158; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188	33	6	6	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90410	10.1371/journal.pone.0090410	http://dx.doi.org/10.1371/journal.pone.0090410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614821	Green Published, gold			2022-12-27	WOS:000332839300023
J	Silva, JA; Santana, ET; Manchini, MT; Antonio, EL; Bocalini, DS; Krieger, JE; Tucci, PJF; Serra, AJ				Silva, Jose Antonio, Jr.; Santana, Eduardo Tadeu; Manchini, Martha Trindade; Antonio, Ednei Luis; Bocalini, Danilo Sales; Krieger, Jose Eduardo; Ferreira Tucci, Paulo Jose; Serra, Andrey Jorge			Exercise Training Can Prevent Cardiac Hypertrophy Induced by Sympathetic Hyperactivity with Modulation of Kallikrein-Kinin Pathway and Angiogenesis	PLOS ONE			English	Article							TISSUE KALLIKREIN; NITRIC-OXIDE; BLOOD-PRESSURE; HUMAN HEART; ACTIVATION; RECEPTOR; SYSTEM; MUSCLE; ABNORMALITIES; PROGRESSION	Sympathetic hyperactivity induces adverse effects in myocardial. Recent studies have shown that exercise training induces cardioprotection against sympathetic overload; however, relevant mechanisms of this issue remain unclear. We analyzed whether exercise can prevent pathological hypertrophy induced by sympathetic hyperactivity with modulation of the kallikrein-kinin and angiogenesis pathways. Male Wistar rats were assigned to non-trained group that received vehicle; non-trained isoproterenol treated group (Iso, 0.3 mg kg(-1) day(-1)); and trained group (Iso+Exe) which was subjected to sympathetic hyperactivity with isoproterenol. The Iso rats showed hypertrophy and myocardial dysfunction with reduced force development and relaxation of muscle. The isoproterenol induced severe fibrosis, apoptosis and reduced myocardial capillary. Interestingly, exercise blunted hypertrophy, myocardial dysfunction, fibrosis, apoptosis and capillary decreases. The sympathetic hyperactivity was associated with high abundance of ANF mRNA and beta-MHC mRNA, which was significantly attenuated by exercise. The tissue kallikrein was augmented in the Iso+Exe group, and kinin B-1 receptor mRNA was increased in the Iso group. Moreover, exercise induced an increase of kinin B-2 receptor mRNA in myocardial. The myocardial content of eNOS, VEGF, VEGF receptor 2, pAkt and Bcl-2 were increased in the Iso+Exe group. Likewise, increased expression of pro-apoptotic Bad in the Iso rats was prevented by prior exercise. Our results represent the first demonstration that exercise can modulate kallikrein-kinin and angiogenesis pathways in the myocardial on sympathetic hyperactivity. These findings suggest that kallikrein-kinin and angiogenesis may have a key role in protecting the heart.	[Silva, Jose Antonio, Jr.; Santana, Eduardo Tadeu; Manchini, Martha Trindade; Bocalini, Danilo Sales; Serra, Andrey Jorge] Univ Nove Julho Uninove, Programa Posgrad Ciencias Reabilitacao, Sao Paulo, Brazil; [Antonio, Ednei Luis; Ferreira Tucci, Paulo Jose] Univ Fed Sao Paulo Unifesp, Sao Paulo, Brazil; [Krieger, Jose Eduardo] Univ Sao Paulo, Sao Paulo, Brazil; [Silva, Jose Antonio, Jr.; Serra, Andrey Jorge] Univ Nove Julho Uninove, Programa Posgrad Med, Sao Paulo, Brazil	Universidade Nove de Julho; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Nove de Julho	Serra, AJ (corresponding author), Univ Nove Julho Uninove, Programa Posgrad Ciencias Reabilitacao, Rua Vergueiro, Sao Paulo, Brazil.	andreyserra@gmail.com	Silva, Jose Antonio/AAA-8100-2019; Bocalini, Danilo/J-1997-2014; Serra, Andrey Jorge/E-7460-2015; Antonio, Ednei/AGG-9987-2022; Tucci, Paulo/D-1441-2015	Silva, Jose Antonio/0000-0001-6904-9185; Serra, Andrey Jorge/0000-0002-5407-8183; Antonio, Ednei/0000-0002-8254-5762; Krieger, Jose E/0000-0001-5464-1792; Tucci, Paulo/0000-0001-9793-670X; Manchini, Martha/0000-0001-5785-0899	Sao Paulo Research Foundation (FAPESP) [2009/54225-8]; National Council for Scientific and Technological [477458/2009-2, 479395/2012-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological	This work was supported by grant number 2009/54225-8, Sao Paulo Research Foundation (FAPESP) and National Council for Scientific and Technological (grant numbers 477458/2009-2; 479395/2012-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avgeris M, 2010, BIOL CHEM, V391, P505, DOI 10.1515/BC.2010.056; BALLIGAND JL, 1993, P NATL ACAD SCI USA, V90, P347, DOI 10.1073/pnas.90.1.347; Bocalini DS, 2009, INT HEART J, V50, P643, DOI 10.1536/ihj.50.643; Chao JL, 2008, HYPERTENSION, V52, P715, DOI 10.1161/HYPERTENSIONAHA.108.114587; Chao J, 2010, BIOL CHEM, V391, P345, DOI 10.1515/BC.2010.042; Cheng SM, 2013, INT J CARDIOL, V167, P478, DOI 10.1016/j.ijcard.2012.01.031; Concannon LG, 2012, PM&R, V4, P833, DOI 10.1016/j.pmrj.2012.08.007; Crimi E, 2009, NAT REV CARDIOL, V6, P292, DOI 10.1038/nrcardio.2009.8; Downs DS, 2012, RES Q EXERCISE SPORT, V83, P485; Emami N, 2007, CLIN CHIM ACTA, V381, P78, DOI 10.1016/j.cca.2007.02.023; Emanueli C, 2001, TRENDS PHARMACOL SCI, V22, P478, DOI 10.1016/S0165-6147(00)01761-2; Gallego M, 2001, PHARMACOL RES, V44, P311, DOI 10.1006/phrs.2001.0865; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; GERDES AM, 1994, CARDIOSCIENCE, V5, P203; Golbidi S, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/972807; Heather LC, 2009, J PHYSIOL PHARMACOL, V60, P31; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Huang CY, 2012, J APPL PHYSIOL, V112, P883, DOI 10.1152/japplphysiol.00605.2011; Kapakos G, 2010, CURR CARDIOL REV, V6, P247, DOI 10.2174/157340310793566055; Laufs U, 2005, EUR J CARDIOV PREV R, V12, P407, DOI 10.1097/01.hjr.0000174823.87269.2e; Lu FH, 2013, CELL PHYSIOL BIOCHEM, V31, P728, DOI 10.1159/000350091; Mahabeer R, 2000, PHARMACOL THERAPEUT, V88, P77, DOI 10.1016/S0163-7258(00)00080-2; Meneton P, 2001, P NATL ACAD SCI USA, V98, P2634, DOI 10.1073/pnas.051619598; Moreau ME, 2005, J PHARMACOL SCI, V99, P6, DOI 10.1254/jphs.SRJ05001X; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; PACKER M, 1988, CIRCULATION, V77, P721, DOI 10.1161/01.CIR.77.4.721; Piepoli Massimo F, 2006, Curr Heart Fail Rep, V3, P33; Pontes FL, 2008, INT IMMUNOPHARMACOL, V8, P261, DOI 10.1016/j.intimp.2007.09.001; Rankin AJ, 2012, SCOT MED J, V57, P99, DOI 10.1258/smj.2011.011284; Rengo G, 2010, AM J PHYSIOL-HEART C, V298, pH2032, DOI 10.1152/ajpheart.00702.2009; Rundqvist B, 1997, CIRCULATION, V95, P169, DOI 10.1161/01.CIR.95.1.169; Ruzicka M, 2013, CLIN SCI, V124, P589, DOI 10.1042/CS20120437; Salimeh A, 2013, J PHYSIOL BIOCHEM, V69, P255, DOI 10.1007/s13105-012-0208-5; Serra AJ, 2008, EUR J HEART FAIL, V10, P534, DOI 10.1016/j.ejheart.2008.03.016; Serra AJ, 2010, J PHYSIOL-LONDON, V588, P2431, DOI 10.1113/jphysiol.2010.187310; Silva JA, 2000, FASEB J, V14, P1858; Stein B, 1996, AM J PHYSIOL-HEART C, V270, pH2021, DOI 10.1152/ajpheart.1996.270.6.H2021; Su JB, 2013, J RENIN ANG IN PRESS; VASSALLO DV, 1988, PHARMACOL RES, V20, P61, DOI 10.1016/S0031-6989(88)80607-6; Wu D, 2012, PLOS ONE, V7; Xu J, 2013, CLIN SCI, V124, P87, DOI 10.1042/CS20120341; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062373; Yin H, 2008, LIFE SCI, V82, P156, DOI 10.1016/j.lfs.2007.10.021; Zhang KR, 2007, APOPTOSIS, V12, P1579, DOI 10.1007/s10495-007-0090-8	44	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91017	10.1371/journal.pone.0091017	http://dx.doi.org/10.1371/journal.pone.0091017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614810	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300064
J	Shao, F; Wang, XG; Yu, JF; Jiang, HL; Zhu, B; Gu, ZL				Shao, Fang; Wang, Xingguo; Yu, Jianfeng; Jiang, Honglin; Zhu, Bin; Gu, Zhiliang			Expression of miR-33 from an SREBF2 Intron Targets the FTO Gene in the Chicken	PLOS ONE			English	Article							MESSENGER-RNAS; HOST GENES; FAT MASS; CHOLESTEROL; METABOLISM; MICRORNAS; SUBSTRATE	The sterol regulatory element binding transcription factor 2 (SREBF2) gene encodes a transcription factor that activates the expression of many genes involved in the synthesis and uptake of cholesterol, fatty acids, triglycerides, and phospholipids. Through bioinformatics, we found that intron 16 of the chicken SREBF2 gene might encode the chicken miR-33. Using quantitative RT-PCR, we detected the expression of miR-33 in a variety of chicken tissues including skeletal muscle, adipose tissue, and liver. Three hundred and seventy eight genes were predicted to be potential targets of miR-33 in chickens via miRNA target prediction programs "miRanda'' and "TargetScan''. Among these targets, the gene FTO (fat mass and obesity associated) encodes a Fe(II)- and 2-oxoglutarate-dependent nucleic acid demethylase that regulates lipid metabolism, and the possibility that its expression is negatively regulated by miR-33 in the chicken liver was therefore further studied. Co-transfection and dual-luciferase reporter assays showed that the expression of luciferase reporter gene linked to the 3'-untranslated region (3'UTR) of the chicken FTO mRNA was down-regulated by overexpression of the chicken miR-33 in the C2C12 cells (P<0.05). Furthermore, this down-regulation was completely abolished when the predicted miR-33 target site in the FTO 3'UTR was mutated. In contrast, the expression of FTO mRNA in the primary chicken hepatocytes was up-regulated after transfection with the miR-33 inhibitor LNA-anti-miR-33. Using quantitative RT-PCR, we also found that the expression of miR-33 was increased in the chicken liver from day 0 to day 49 of age, whereas that of the FTO mRNA was decreased during the same age period. These data together suggest that miR-33 might play an important role in lipid metabolism in the chicken liver by negatively regulating the expression of the FTO gene.	[Shao, Fang; Wang, Xingguo; Yu, Jianfeng; Gu, Zhiliang] Changshu Inst Technol, Dept Life Sci & Technol, Changshu, Jiangsu, Peoples R China; [Shao, Fang; Zhu, Bin] Soochow Univ, Coll Basic Med & Biol Sci, Suzhou, Jiangsu, Peoples R China; [Jiang, Honglin] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA	Changshu Institute of Technology; Soochow University - China; Virginia Polytechnic Institute & State University	Gu, ZL (corresponding author), Changshu Inst Technol, Dept Life Sci & Technol, Changshu, Jiangsu, Peoples R China.	zhilianggu88@hotmail.com	wang, xingguo/AAF-3020-2020	, Honglin/0000-0001-9540-5788	Natural Science Foundation of China [30871789, 31272438]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by Natural Science Foundation of China (30871789, 31272438). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Cirera-Salinas D, 2012, CELL CYCLE, V11, P922, DOI 10.4161/cc.11.5.19421; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; DOUAIRE M, 1993, J CELL SCI, V104, P713; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Gerin I, 2010, J BIOL CHEM, V285, P33652, DOI 10.1074/jbc.M110.152090; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hermier D, 1997, J NUTR, V127, pS805, DOI 10.1093/jn/127.5.805S; Horie T, 2010, P NATL ACAD SCI USA, V107, P17321, DOI 10.1073/pnas.1008499107; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jia X, 2012, INT J OBESITY, V36, P1054, DOI 10.1038/ijo.2011.221; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Poritsanos NJ, 2010, BIOCHEM BIOPH RES CO, V400, P713, DOI 10.1016/j.bbrc.2010.08.133; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Tiwari A, 2012, DOMEST ANIM ENDOCRIN, V42, P1, DOI 10.1016/j.domaniend.2011.08.001; Wang D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004421; Wang XG, 2013, POULTRY SCI, V92, P1888, DOI 10.3382/ps.2012-02919; Wang YF, 2012, COMP BIOCHEM PHYS A, V163, P246, DOI 10.1016/j.cbpa.2012.08.009	37	21	25	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91236	10.1371/journal.pone.0091236	http://dx.doi.org/10.1371/journal.pone.0091236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626192	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300067
J	Weiterer, S; Schulte, D; Muller, S; Kohlen, T; Uhle, F; Weigand, MA; Henrich, M				Weiterer, Sebastian; Schulte, Dagmar; Mueller, Sabrina; Kohlen, Thomas; Uhle, Florian; Weigand, Markus A.; Henrich, Michael			Tumor Necrosis Factor Alpha Induces a Serotonin Dependent Early Increase in Ciliary Beat Frequency and Epithelial Transport Velocity in Murine Tracheae	PLOS ONE			English	Article							SOLUBLE ADENYLYL-CYCLASE; FACTOR RECEPTOR; TNF-ALPHA; PULMONARY-HYPERTENSION; PATHWAY; CELLS; 5-HYDROXYTRYPTAMINE; ACETYLCHOLINE; STIMULATION; CONTRIBUTES	The tracheal epithelium prevents via its highly effective clearance mechanism the contamination of the lower airways by pathogens. This mechanism is driven by ciliary bearing cells which are not only in contact with the gas phase; in addition they are also influenced by inflammatory mediators. These mediators can alter the protective function of the epithelium. Since the pro-inflammatoric cytokine tumor necrosis factor-alpha (TNF-alpha) plays a pivotal role within the inflammatory cascade, we investigated its effect onto the tracheal epithelium measured by its ciliary beat frequency and the particle transport velocity. In organ explant experiments the ciliary beat frequency and the particle transport velocity were measured under the application of TNF-alpha using tracheae from male C57BL6J mice. We observed a dose dependent TNF-alpha induced increase of both particle transport velocity and ciliary beat frequency. Knock out mice experiments made evident that the increase was depended on the expression of tumor necrosis factor receptor 1 (TNF-R1). The increases in ciliary beat frequency as well as the accelerated particle transport velocity were either inhibited by the unspecific serotonin antagonist methysergide or by cyproheptadine a specific 5-HT2 receptor antagonist. Thus, acetylcholine antagonists or nitric oxide synthase (NOS) inhibitors failed to inhibit the TNF-alpha induced activation. In conclusion, TNF-alpha may play a pivotal role in the protection of lower airways by inducing ciliary activity and increase in particle transport velocity via TNF-R1 and 5-HT2 receptor.	[Weiterer, Sebastian; Schulte, Dagmar; Mueller, Sabrina; Kohlen, Thomas; Uhle, Florian; Weigand, Markus A.; Henrich, Michael] Univ Giessen, Dept Anaesthesiol, D-35390 Giessen, Germany	Justus Liebig University Giessen	Henrich, M (corresponding author), Univ Giessen, Dept Anaesthesiol, D-35390 Giessen, Germany.	michael.henrich@anatomie.med.uni-giessen.de	Uhle, Florian/Q-6191-2019		Fachbereich Medizin der Justus-Liebig-UniversitAt Giessen	Fachbereich Medizin der Justus-Liebig-UniversitAt Giessen	This work was supported from the Fachbereich Medizin der Justus-Liebig-UniversitAt Giessen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani Y, 1996, REV MAL RESPIR, V13, P539; Amrani Y, 2000, MOL PHARMACOL, V58, P237, DOI 10.1124/mol.58.1.237; Aparicio CL, 1996, MOL IMMUNOL, V33, P671, DOI 10.1016/0161-5890(96)00013-2; Arisoy O, 2013, RHEUMATOL INT; BENYO DF, 1992, ENDOCRINOLOGY, V130, P854, DOI 10.1210/en.130.2.854; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Brzezinska-Blaszczyk E, 2007, J INTERF CYTOK RES, V27, P911, DOI 10.1089/jir.2006.0158; Carneiro AMD, 2008, J CLIN INVEST, V118, P1544, DOI 10.1172/JCI33374; Eddahibi S, 1999, CIRC RES, V84, P329, DOI 10.1161/01.RES.84.3.329; Esteve JM, 2007, CELL BIOCHEM BIOPHYS, V47, P33, DOI 10.1385/CBB:47:1:33; Fry DE, 2012, AM SURGEON, V78, P1; Gertsberg I, 2004, J GEN PHYSIOL, V124, P527, DOI 10.1085/jgp.200409153; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; JAIN B, 1995, AM J PHYSIOL-LUNG C, V268, pL911, DOI 10.1152/ajplung.1995.268.6.L911; Kereveur A, 2000, ARTERIOSCL THROM VAS, V20, P2233, DOI 10.1161/01.ATV.20.10.2233; Klein MK, 2009, EUR RESPIR J, V33, P1113, DOI 10.1183/09031936.00015108; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Konig P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004938; Kummer W, 2008, HISTOCHEM CELL BIOL, V130, P219, DOI 10.1007/s00418-008-0455-2; Lee TW, 2012, COCHRANE DB SYST REV, V10; MacLean MR, 2010, ADV EXP MED BIOL, V661, P309, DOI 10.1007/978-1-60761-500-2_20; MARTIN TR, 1989, J CLIN INVEST, V83, P1375, DOI 10.1172/JCI114025; McFarlane SM, 2001, BIOCHEM PHARMACOL, V61, P749, DOI 10.1016/S0006-2952(01)00530-5; Moffatt JD, 2004, BRIT J PHARMACOL, V141, P1159, DOI 10.1038/sj.bjp.0705720; Morse DM, 2001, AM J PHYSIOL-CELL PH, V280, pC1485, DOI 10.1152/ajpcell.2001.280.6.C1485; Ni W, 2006, CLIN EXP PHARMACOL P, V33, P575, DOI 10.1111/j.1440-1681.2006.04410.x; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253; Sangaletti S, 2010, CANCER RES, V70, P7764, DOI 10.1158/0008-5472.CAN-10-0471; Schliemann M, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-204; Schmid A, 2007, J GEN PHYSIOL, V130, P99, DOI 10.1085/jgp.200709784; Schmid A, 2011, SUBCELL BIOCHEM, V55, P95, DOI 10.1007/978-94-007-1217-1_5; Schmid A, 2010, J BIOL CHEM, V285, P29998, DOI 10.1074/jbc.M110.113621; Schulman CI, 2002, SHOCK, V18, P75, DOI 10.1097/00024382-200207000-00014; Shimoda LA, 2013, J MOL MED, V91, P297, DOI 10.1007/s00109-013-0998-0; Sisson JH, 1999, ALCOHOL CLIN EXP RES, V23, P1528, DOI 10.1111/j.1530-0277.1999.tb04677.x; SUTER PM, 1992, AM REV RESPIR DIS, V145, P1016, DOI 10.1164/ajrccm/145.5.1016; Uzlaner N, 1999, J PHYSIOL-LONDON, V516, P179, DOI 10.1111/j.1469-7793.1999.179aa.x; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; Weigand LA, 2009, J PHYSIOL-LONDON, V587, P3355, DOI 10.1113/jphysiol.2009.173054; Wyatt TA, 2008, EUR RESPIR J, V31, P1249, DOI 10.1183/09031936.00015007; Wyatt TA, 1998, AM J PHYSIOL-LUNG C, V275, pL827, DOI 10.1152/ajplung.1998.275.4.L827; Zhang Q, 2013, J MOL CELL BIOL	43	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91705	10.1371/journal.pone.0091705	http://dx.doi.org/10.1371/journal.pone.0091705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626175	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300126
J	Gallace, A; Soravia, G; Cattaneo, Z; Moseley, GL; Vallar, G				Gallace, Alberto; Soravia, Giovanna; Cattaneo, Zaira; Moseley, G. Lorimer; Vallar, Giuseppe			Temporary Interference over the Posterior Parietal Cortices Disrupts Thermoregulatory Control in Humans	PLOS ONE			English	Article							REGIONAL PAIN SYNDROME; TRANSCRANIAL MAGNETIC STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; SOMATOSENSORY CORTEX; SKIN TEMPERATURE; BODY-OWNERSHIP; INTRAPARIETAL SULCUS; RUBBER HAND; STROKE; BRAIN	The suggestion has recently been made that certain higher-order cortical areas involved in supporting multisensory representations of the body, and of the space around it, might also play a role in controlling thermoregulatory functions. Here we demonstrate that temporary interference with the function of one of these areas, the posterior parietal cortex, by repetitive transcranial magnetic stimulation, results in a decrease in limb temperature. By contrast, interference with the activity of a sensory-specific area (the primary somatosensory cortex) had no effect on temperature. The results of this experiment suggest that associative multisensory brain areas might exert a top-down modulation over basic physiological control. Such a function might be part of a larger neural circuit responsible for maintaining the integrity of the body at both a homeostatic and a psychological level.	[Gallace, Alberto; Soravia, Giovanna; Cattaneo, Zaira; Vallar, Giuseppe] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Moseley, G. Lorimer] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Moseley, G. Lorimer] Neurosci Res Australia, Sydney, NSW, Australia; [Vallar, Giuseppe] IRCCS Ist Auxol Italiano, Milan, Italy	University of Milano-Bicocca; University of South Australia; Neuroscience Research Australia; IRCCS Istituto Auxologico Italiano	Gallace, A (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	alberto.gallace1@unimib.it	Gallace, Alberto/L-7276-2015; Moseley, Lorimer/A-7095-2009	Moseley, Lorimer/0000-0002-3750-4945; GALLACE, ALBERTO/0000-0002-4561-8926	National Health & Medical Research Council of Australia [571090]; Ricerca Corrente Grant from the IRCCS Istituto Auxologico Italiano; Futuro in Ricerca grant [RBFR12F0BD_003]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Ricerca Corrente Grant from the IRCCS Istituto Auxologico Italiano; Futuro in Ricerca grant	GLM was supported by the National Health & Medical Research Council of Australia ID 571090. G. V. was supported by a Ricerca Corrente Grant from the IRCCS Istituto Auxologico Italiano. A. G. and Z. C. were supported by a Futuro in Ricerca 2012 grant (RBFR12F0BD_003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerra NE, 2007, J REHABIL MED, V39, P109, DOI 10.2340/16501977-0027; Barnsley N, 2011, CURR BIOL, V21, pR945, DOI 10.1016/j.cub.2011.10.039; BASSETTI C, 1993, NEUROLOGY, V43, P1942, DOI 10.1212/WNL.43.10.1942; Blankenburg F, 2010, CEREB CORTEX, V20, P2702, DOI 10.1093/cercor/bhq015; Blatow M, 2007, NEUROIMAGE, V37, P927, DOI 10.1016/j.neuroimage.2007.05.038; Bottini G, 2005, NEUROLOGY, V65, P1278, DOI 10.1212/01.wnl.0000182398.14088.e8; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Cappelletti M, 2007, EXP BRAIN RES, V179, P631, DOI 10.1007/s00221-006-0820-0; DELUCA B, 1989, BRAIN RES BULL, V22, P1003, DOI 10.1016/0361-9230(89)90012-9; Dijkerman HC, 2007, BEHAV BRAIN SCI, V30, P189, DOI 10.1017/S0140525X07001392; Egan GF, 2005, P NATL ACAD SCI USA, V102, P5262, DOI 10.1073/pnas.0409753102; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ellis LB, 1936, ARCH NEURO PSYCHIATR, V36, P362, DOI 10.1001/archneurpsyc.1936.02260080134008; Ferretti A, 2003, NEUROIMAGE, V20, P1625, DOI 10.1016/j.neuroimage.2003.07.004; Fiorio M, 2005, EUR J NEUROSCI, V22, P773, DOI 10.1111/j.1460-9568.2005.04267.x; Fregni F, 2007, NAT CLIN PRACT NEURO, V3, P383, DOI 10.1038/ncpneuro0530; Freund Hans-Joachim, 2003, Adv Neurol, V93, P179; Gallace A., 2010, PSYCHE INTERDISCIPLI, V16, P30; Gallace A, 2008, CONSCIOUS COGN, V17, P370, DOI 10.1016/j.concog.2007.01.005; Giummarra MJ, 2008, NEUROSCI BIOBEHAV R, V32, P143, DOI 10.1016/j.neubiorev.2007.07.001; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hasselberg MJ, SLEEP MED IN PRESS; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Hung J, 2005, J NEUROSCI, V25, P9602, DOI 10.1523/JNEUROSCI.0879-05.2005; Ishii K, 1996, CLIN NEUROLOGY, V36, P951; Iwamura Y, 2000, PHILOS T R SOC B, V355, P267, DOI 10.1098/rstb.2000.0563; Kammers MPM, 2011, NEUROPSYCHOLOGIA, V49, P1316, DOI 10.1016/j.neuropsychologia.2011.02.039; Kim JS, 2007, NEUROLOGY, V68, P174, DOI 10.1212/01.wnl.0000251298.12763.9b; Kitazawa S, 2002, CONSCIOUS COGN, V11, P475, DOI 10.1016/S1053-8100(02)00031-4; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Marinus J, 2011, LANCET NEUROL, V10, P637, DOI 10.1016/S1474-4422(11)70106-5; MELZACK R, 1990, TRENDS NEUROSCI, V13, P88, DOI 10.1016/0166-2236(90)90179-E; Miniussi C, 2010, CORTEX, V46, P128, DOI 10.1016/j.cortex.2009.03.004; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Moseley GL, 2013, PAIN, V154, P2463, DOI 10.1016/j.pain.2013.07.026; Moseley GL, 2012, BRAIN, V135, P3676, DOI 10.1093/brain/aws297; Moseley GL, 2012, NEUROLOGY, V79, P327, DOI 10.1212/WNL.0b013e318260cba2; Moseley GL, 2012, NEUROSCI BIOBEHAV R, V36, P34, DOI 10.1016/j.neubiorev.2011.03.013; Moseley GL, 2009, BRAIN, V132, P3142, DOI 10.1093/brain/awp224; NAVER H, 1995, STROKE, V26, P1379, DOI 10.1161/01.STR.26.8.1379; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveira FTP, 2010, P NATL ACAD SCI USA, V107, P17751, DOI 10.1073/pnas.1006223107; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Petchkrua W, 2000, NEUROREHAB NEURAL RE, V14, P59, DOI 10.1177/154596830001400107; Reed CL, 1996, BRAIN, V119, P875, DOI 10.1093/brain/119.3.875; Riedl B, 2001, ACTA NEUROL SCAND, V103, P27, DOI 10.1034/j.1600-0404.2001.00139.x; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Salomon R, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00065; Satoh M, 2002, J NEUROL, V249, P1404, DOI 10.1007/S00415-002-0853-7; Smith ADH, 2010, PHYSIOL MEAS, V31, P95, DOI 10.1088/0967-3334/31/1/007; STERZI R, 1993, J NEUROL NEUROSUR PS, V56, P308, DOI 10.1136/jnnp.56.3.308; Tsakiris M, 2008, NEUROPSYCHOLOGIA, V46, P3014, DOI 10.1016/j.neuropsychologia.2008.06.004; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P2740, DOI 10.1016/j.neuropsychologia.2010.05.021; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Vallar G, 1997, HIPPOCAMPAL PARIETAL, P33; Vallar G, 2007, BEHAV BRAIN SCI, V30, P223, DOI 10.1017/S0140525X0700163X; Vallar G, 2009, EXP BRAIN RES, V192, P533, DOI 10.1007/s00221-008-1562-y; Lichtenbelt WDV, 2006, PHYSIOL BEHAV, V88, P489, DOI 10.1016/j.physbeh.2006.04.026; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; WANKLYN P, 1994, STROKE, V25, P1765, DOI 10.1161/01.STR.25.9.1765; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245	67	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e88209	10.1371/journal.pone.0088209	http://dx.doi.org/10.1371/journal.pone.0088209			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622382	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000332845300004
J	Konno, K; Inoue, TA; Nakamura, M				Konno, Kotaro; Inoue, Takashi A.; Nakamura, Masatoshi			Synergistic Defensive Function of Raphides and Protease through the Needle Effect	PLOS ONE			English	Article							CALCIUM-OXALATE CRYSTALS; LATEX; PLANTS; CARCINOGENESIS; INHIBITION; ACTIVATION; EXPRESSION; CHITINASE; INSECTS; ARACEAE	Raphides, needle-shaped calcium oxalate crystals in tissues of many plants, have been thought to play defensive roles against herbivores without detailed bioassays for their defensive roles and modes of function using purified raphides. In order to examine the defensive roles and modes of function of raphides in a clear experimental system, we performed bioassays giving the larvae of the Eri silkmoth, Samia ricini (Saturniidae), leaves of their host plant, the castor oil plant, Ricinus communis (Euphorbiaceae), painted with the raphides purified from kiwifruits, Actinidia deliciosa (Actinidiaceae), in presence or absence of cysteine protease, which often coincide with raphides in plant tissues. Raphides alone or cysteine protease alone showed only weak defensive activities around experimental concentrations. However, when raphides and cysteine protease coexisted, they synergistically showed very strong growth-reducing activities, and the mortality of caterpillars was very high. In contrast, amorphous calcium oxalate did not show synergism with cysteine protease on defensive activities, indicating that the needle-shape of raphides is essential for the synergism. The present study provides the first clear experimental evidence for the synergism between raphides and other defensive factors. Further, the study suggests that "the needle effect", which intensify the bioactivities of other bioactive factors by making holes to the barriers (cell membrane, cuticle, epithelium, the nuclear membrane, etc.) and facilitate the bioactive factors to go through them and reach the targets, is important in the defensive activities of raphides, and possibly in the allergy caused by raphides, and in the carcinogenic activities of other needle-shaped components including asbestos and plant derived silica needles.	[Konno, Kotaro; Inoue, Takashi A.] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Nakamura, Masatoshi] Natl Inst Agrobiol Sci, Hokuto, Yamanashi, Japan	National Institute of Agrobiological Sciences - Japan	Konno, K (corresponding author), Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan.	konno@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan (MAFF)	Ministry of Agriculture, Forestry and Fisheries of Japan (MAFF)(Ministry of Agriculture Forestry & Fisheries - Japan)	This research was supported by a Research Grant Project from the Ministry of Agriculture, Forestry and Fisheries of Japan (MAFF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; Agrawal AA, 2009, ANNU REV ECOL EVOL S, V40, P311, DOI 10.1146/annurev.ecolsys.110308.120307; ARAKI T, 1992, J BIOL CHEM, V267, P19944; Arnott HJ, 2000, INT J PLANT SCI, V161, P133, DOI 10.1086/314230; BHATT T, 1984, INT J CANCER, V34, P519, DOI 10.1002/ijc.2910340415; Bradbury JH, 1998, J SCI FOOD AGR, V76, P608, DOI [10.1002/(SICI)1097-0010(199804)76:4&lt;608::AID-JSFA996&gt;3.0.CO;2-2, 10.1002/(SICI)1097-0010(199804)76:4<608::AID-JSFA996>3.3.CO;2-U]; Carbone M, 2012, J CELL PHYSIOL, V227, P44, DOI 10.1002/jcp.22724; Cote GG, 2012, AM J BOT, V99, P1231, DOI 10.3732/ajb.1100499; DENOUTER RW, 1988, J HORTIC SCI, V63, P645, DOI 10.1080/14620316.1988.11515906; Dussourd David E., 1993, P92; FELTON GW, 1989, J CHEM ECOL, V15, P2667, DOI 10.1007/BF01014725; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; FRANCESCHI VR, 1980, BOT REV, V46, P361, DOI 10.1007/BF02860532; Fukui Akiko, 2002, Entomological Science, V5, P263; GARDNER DG, 1994, ORAL SURG ORAL MED O, V78, P631, DOI 10.1016/0030-4220(94)90177-5; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hartmann T, 2008, P NATL ACAD SCI USA, V105, P4541, DOI 10.1073/pnas.0709231105; Konno K, 2006, P NATL ACAD SCI USA, V103, P1337, DOI 10.1073/pnas.0506944103; Konno K, 2004, PLANT J, V37, P370, DOI 10.1046/j.1365-313X.2003.01968.x; Konno K, 1999, P NATL ACAD SCI USA, V96, P9159, DOI 10.1073/pnas.96.16.9159; Konno K, 2011, PHYTOCHEMISTRY, V72, P1510, DOI 10.1016/j.phytochem.2011.02.016; Lawrence SD, 2006, BIOTECHNOL LETT, V28, P593, DOI 10.1007/s10529-006-0022-7; Lucas JSA, 2003, PEDIAT ALLERG IMM-UK, V14, P420, DOI 10.1046/j.0905-6157.2003.00095.x; Ota E, 2013, PHYTOCHEMISTRY, V89, P15, DOI 10.1016/j.phytochem.2013.01.013; PERERA CO, 1990, J FOOD SCI, V55, P1066, DOI 10.1111/j.1365-2621.1990.tb01599.x; PRAEKELT UM, 1988, PLANT MOL BIOL, V10, P193, DOI 10.1007/BF00027396; Prychid CJ, 1999, ANN BOT-LONDON, V84, P725, DOI 10.1006/anbo.1999.0975; Rinallo C, 2002, BIOL PLANTARUM, V45, P137, DOI 10.1023/A:1015189616477; SAKAI WS, 1972, SCIENCE, V178, P314, DOI 10.1126/science.178.4058.314; Salinas ML, 2001, CONTACT DERMATITIS, V44, P94, DOI 10.1034/j.1600-0536.2001.440208.x; Seigler D. S., 1991, HERBIVORES THEIR INT, VI, P35; Stahl E, 1919, FLORA, V111, P1; Toyokuni S, 2009, NAGOYA J MED SCI, V71, P1; Ward D, 1997, J CHEM ECOL, V23, P333, DOI 10.1023/B:JOEC.0000006363.34360.9d; Wasano N, 2009, PHYTOCHEMISTRY, V70, P880, DOI 10.1016/j.phytochem.2009.04.014; Wen ZM, 2006, J CHEM ECOL, V32, P507, DOI 10.1007/s10886-005-9014-7	36	23	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91341	10.1371/journal.pone.0091341	http://dx.doi.org/10.1371/journal.pone.0091341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621613	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300077
J	Kuo, HC; Hsu, YW; Lo, MH; Huang, YH; Chien, SC; Chang, WC				Kuo, Ho-Chang; Hsu, Yu-Wen; Lo, Mao-Hung; Huang, Ying-Hsien; Chien, Shu-Chen; Chang, Wei-Chiao			Single-Nucleotide Polymorphism rs7251246 in ITPKC Is Associated with Susceptibility and Coronary Artery Lesions in Kawasaki Disease	PLOS ONE			English	Article							IMMUNITY; MODEL	Kawasaki disease (KD) is a multi-systemic vasculitis that preferentially affects children. A single nucleotide polymorphism (SNP) in inositol 1,4,5-trisphosphate 3-kinase C (ITPKC) has been identified to be an important polymorphism in the risk of KD. This study was conducted to comprehensively investigate the associations between all tagging SNPs of ITPKC in the risk of KD in a Taiwanese population. A total of 950 subjects (381 KD patients and 569 controls) were recruited. Seven tagging SNPs (rs11673492, rs7257602, rs7251246, rs890934, rs10420685, rs2607420, rs2290692) were selected for TaqMan allelic discrimination assay. Clinical data of coronary artery lesions (CAL) and aneurysms were collected for analysis. A significant association was found between rs7251246 in ITPKC and CAL formation. Haplotype analysis for ITPKC polymorphisms also confirmed this association in the patients with CAL and aneurysm formation. This is the first study to identify that SNP rs7251246 in ITPKC is associated with the severity of KD.	[Kuo, Ho-Chang; Lo, Mao-Hung; Huang, Ying-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Lo, Mao-Hung; Huang, Ying-Hsien] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Hsu, Yu-Wen; Chien, Shu-Chen; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; Taipei Med Univ Hosp, Dept Pharm, Taipei, Taiwan; Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Wan Fang Hosp, Dept Pharm, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Kaohsiung Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Chang, WC (corresponding author), Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan.	wcc@tmu.edu.tw	Kuo, Ho-Chang/AAQ-6644-2020	Kuo, Ho-Chang/0000-0002-3295-2984; Chang, Wei-Chiao/0000-0002-8573-5924	National Science Council, Taiwan [NSC 102-2314-B-182-053-MY3]; Chang Gung Memorial Hospital, Taiwan [CMRPG8B0211, CMRPG8B0151]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by a grant from the National Science Council, Taiwan (NSC 102-2314-B-182-053-MY3), and grants from Chang Gung Memorial Hospital, Taiwan (CMRPG8B0211 and CMRPG8B0151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown TJ, 2001, J INFECT DIS, V184, P940, DOI 10.1086/323155; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Franco A, 2010, AUTOIMMUNITY, V43, P317, DOI 10.3109/08916930903405891; Huang WC, 2009, PEDIATRICS, V123, pe401, DOI 10.1542/peds.2008-2187; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Kuo HC, 2011, J HUM GENET, V56, P840, DOI 10.1038/jhg.2011.113; Kuo HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017370; Kuo HC, 2010, ACTA PAEDIATR, V99, P1578, DOI 10.1111/j.1651-2227.2010.01875.x; Lee E., 2012, NEURAL NETWORKS TRIC, V1, P1, DOI [10.1007/978-3-642-35289-8_25, DOI 10.1007/978-3-642-35289-8_25]; Liang CD, 2009, AM HEART J, V157, P584, DOI 10.1016/j.ahj.2008.11.020; Lin MT, 2011, PEDIATR INFECT DIS J, V30, P148, DOI 10.1097/INF.0b013e3181f43a4e; Lou J, 2012, MOL BIOL REP, V39, P11137, DOI 10.1007/s11033-012-2022-0; Nakamura Y, 2012, J EPIDEMIOL, V22, P216, DOI 10.2188/jea.JE20110126; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Peng Q, 2012, PEDIATR CARDIOL, V33, P1046, DOI 10.1007/s00246-012-0223-x; Schulte DJ, 2009, J IMMUNOL, V183, P5311, DOI 10.4049/jimmunol.0901395; Takahashi K, 2011, PEDIATR RHEUMATOL, V9, DOI 10.1186/1546-0096-9-30; Tremoulet AH, 2012, J PEDIATR-US, V161, P506, DOI 10.1016/j.jpeds.2012.02.048; Wang CL, 2005, PEDIATR INFECT DIS J, V24, P998, DOI 10.1097/01.inf.0000183786.70519.fa; Wei JCC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020426; Yeter D, 2012, AUTOIMMUN REV, V11, P903, DOI 10.1016/j.autrev.2012.03.006	22	26	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91118	10.1371/journal.pone.0091118	http://dx.doi.org/10.1371/journal.pone.0091118			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621571	gold, Green Published, Green Submitted			2022-12-27	WOS:000332845300053
J	Milder, DA; Sutherland, EJ; Gandevia, SC; McNulty, PA				Milder, David A.; Sutherland, Emily J.; Gandevia, Simon C.; McNulty, Penelope A.			Sustained Maximal Voluntary Contraction Produces Independent Changes in Human Motor Axons and the Muscle They Innervate	PLOS ONE			English	Article							DEPENDENT EXCITABILITY CHANGES; HUMAN PERIPHERAL-NERVE; MYELINATED AXONS; VOLTAGE-DEPENDENCE; NATURAL ACTIVITY; HYPERPOLARIZATION; NEUROPATHY; PUMP; RAT; FATIGUE	The repetitive discharges required to produce a sustained muscle contraction results in activity-dependent hyperpolarization of the motor axons and a reduction in the force-generating capacity of the muscle. We investigated the relationship between these changes in the adductor pollicis muscle and the motor axons of its ulnar nerve supply, and the reproducibility of these changes. Ten subjects performed a 1-min maximal voluntary contraction. Activity-dependent changes in axonal excitability were measured using threshold tracking with electrical stimulation at the wrist; changes in the muscle were assessed as evoked and voluntary electromyography (EMG) and isometric force. Separate components of axonal excitability and muscle properties were tested at 5 min intervals after the sustained contraction in 5 separate sessions. The current threshold required to produce the target muscle action potential increased immediately after the contraction by 14.8% (p<0.05), reflecting decreased axonal excitability secondary to hyperpolarization. This was not correlated with the decline in amplitude of muscle force or evoked EMG. A late reversal in threshold current after the initial recovery from hyperpolarization peaked at -5.9% at similar to 35 min (p<0.05). This pattern was mirrored by other indices of axonal excitability revealing a previously unreported depolarization of motor axons in the late recovery period. Measures of axonal excitability were relatively stable at rest but less so after sustained activity. The coefficient of variation (CoV) for threshold current increase was higher after activity (CoV 0.54, p<0.05) whereas changes in voluntary (CoV 0.12) and evoked twitch (CoV 0.15) force were relatively stable. These results demonstrate that activity-dependent changes in motor axon excitability are unlikely to contribute to concomitant changes in the muscle after sustained activity in healthy people. The variability in axonal excitability after sustained activity suggests that care is needed when using these measures if the integrity of either the muscle or nerve may be compromised.	[McNulty, Penelope A.] Neurosci Res Australia, Sydney, NSW, Australia; Univ New S Wales, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney	McNulty, PA (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	p.mcnulty@neura.edu.au	Gandevia, Simon/D-5009-2011	Gandevia, Simon/0000-0002-1345-3821	National Health and Medical Research Council of Australia; New South Wales Office of Science and Medical Research	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Office of Science and Medical Research	This work was supported by the National Health and Medical Research Council of Australia and the New South Wales Office of Science and Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER M, 1987, J PHYSIOL-LONDON, V383, P45; BELLEMARE F, 1983, J NEUROPHYSIOL, V50, P1380, DOI 10.1152/jn.1983.50.6.1380; BIGLANDRITCHIE B, 1983, J NEUROPHYSIOL, V50, P313, DOI 10.1152/jn.1983.50.1.313; BOSTOCK H, 1985, J PHYSIOL-LONDON, V365, P239, DOI 10.1113/jphysiol.1985.sp015769; Bostock H, 1997, J PHYSIOL-LONDON, V498, P277, DOI 10.1113/jphysiol.1997.sp021857; Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C; BRIGANT JL, 1982, J PHYSIOL-LONDON, V333, P619, DOI 10.1113/jphysiol.1982.sp014472; BULLER AJ, 1960, J PHYSIOL-LONDON, V150, P417, DOI 10.1113/jphysiol.1960.sp006395; Burke D, 2001, CLIN NEUROPHYSIOL, V112, P1575, DOI 10.1016/S1388-2457(01)00595-8; Burke R.E., 1981, HDB PHYSL SECTION 1, VII, P345, DOI 10.1002/cphy.cp010210; Cappelen Smith C, 2000, ANN NEUROL, V48, P826; DAVID G, 1995, J PHYSIOL-LONDON, V489, P141, DOI 10.1113/jphysiol.1995.sp021037; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; DESCHENES M, 1980, BRAIN RES, V191, P538, DOI 10.1016/0006-8993(80)91302-5; EDSTROM L, 1986, MUSCLE NERVE, V9, P104, DOI 10.1002/mus.880090203; ENOKA RM, 1995, J CLIN NEUROPHYSIOL, V12, P538, DOI 10.1097/00004691-199511000-00002; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P581, DOI 10.1152/jn.1965.28.3.581; Howells J, 2013, J PHYSIOL-LONDON, V591, P3063, DOI 10.1113/jphysiol.2012.249060; Howells J, 2012, J PHYSIOL-LONDON, V590, P1625, DOI 10.1113/jphysiol.2011.225573; Ishihara A, 2003, EXERC SPORT SCI REV, V31, P51, DOI 10.1097/00003677-200301000-00010; ITO M, 1965, J PHYSIOL-LONDON, V180, P607, DOI 10.1113/jphysiol.1965.sp007720; Kaji R, 2000, BRAIN, V123, P1602, DOI 10.1093/brain/123.8.1602; KAJI R, 1989, NEUROLOGY, V39, P1364, DOI 10.1212/WNL.39.10.1364; KERNELL D, 1992, ARCH ITAL BIOL, V130, P19; Kiernan MC, 2004, J PHYSIOL-LONDON, V558, P341, DOI 10.1113/jphysiol.2004.063966; Kiernan MC, 2000, MUSCLE NERVE, V23, P399, DOI 10.1002/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G; Kiernan MC, 2000, BRAIN, V123, P2542, DOI 10.1093/brain/123.12.2542; Krishnan AV, 2008, BRAIN, V131, P1209, DOI 10.1093/brain/awn052; Krishnan AV, 2006, CLIN NEUROPHYSIOL, V117, P992, DOI 10.1016/j.clinph.2006.02.002; Krishnan AV, 2009, PROG NEUROBIOL, V89, P288, DOI 10.1016/j.pneurobio.2009.08.002; Kuwabara S, 2002, MUSCLE NERVE, V25, P176, DOI 10.1002/mus.10030.abs; Kuwabara S, 2001, J PHYSIOL-LONDON, V531, P265, DOI 10.1111/j.1469-7793.2001.0265j.x; MAYER ML, 1983, J PHYSIOL-LONDON, V340, P19, DOI 10.1113/jphysiol.1983.sp014747; MCPHEDRA.AM, 1965, J NEUROPHYSIOL, V28, P71, DOI 10.1152/jn.1965.28.1.71; MORITA K, 1993, J NEUROPHYSIOL, V70, P1874, DOI 10.1152/jn.1993.70.5.1874; Murray JE, 2011, CLIN NEUROPHYSIOL, V122, P2290, DOI 10.1016/j.clinph.2011.04.007; Nodera H, 2006, CLIN NEUROPHYSIOL, V117, P1902, DOI 10.1016/j.clinph.2006.01.018; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Park SB, 2011, EXP NEUROL, V227, P120, DOI 10.1016/j.expneurol.2010.10.002; RAKOWSKI RF, 1989, J GEN PHYSIOL, V93, P903, DOI 10.1085/jgp.93.5.903; RITCHIE JM, 1957, J PHYSIOL-LONDON, V136, P80, DOI 10.1113/jphysiol.1957.sp005744; SIMPSON JA, 1969, ELECTROEN CLIN NEURO, V26, P224; Soleng AF, 2003, J PHYSIOL-LONDON, V552, P459, DOI 10.1113/jphysiol.2003.048058; STAMPFLI R, 1954, PHYSIOL REV, V34, P101, DOI 10.1152/physrev.1954.34.1.101; Sutherland E, 2010, DIFFERENT TIME COURS; Tasaki I, 1939, AM J PHYSIOL, V127, P211, DOI 10.1152/ajplegacy.1939.127.2.211; Tomlinson SE, 2010, MUSCLE NERVE, V41, P247, DOI 10.1002/mus.21482; Trevillion L, 2004, MUSCLE NERVE, V30, P437, DOI 10.1002/mus.20134; Vagg R, 1998, J PHYSIOL-LONDON, V507, P919, DOI 10.1111/j.1469-7793.1998.919bs.x; Van Cutsem M, 1998, J PHYSIOL-LONDON, V513, P295, DOI 10.1111/j.1469-7793.1998.295by.x; Vucic S, 2007, J NEUROL NEUROSUR PS, V78, P1202, DOI 10.1136/jnnp.2006.112078; Wood SJ, 2001, PROG NEUROBIOL, V64, P393, DOI 10.1016/S0301-0082(00)00055-1; WUERKER RB, 1965, J NEUROPHYSIOL, V28, P85, DOI 10.1152/jn.1965.28.1.85; Z'Graggen WJ, 2006, BRAIN, V129, P2461, DOI 10.1093/brain/awl191	56	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91754	10.1371/journal.pone.0091754	http://dx.doi.org/10.1371/journal.pone.0091754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622330	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300124
J	Singh, M; Sareen, D				Singh, Mangal; Sareen, Dipti			Novel LanT Associated Lantibiotic Clusters Identified by Genome Database Mining	PLOS ONE			English	Article							LEADER SEQUENCE; PEPTIDE; BIOSYNTHESIS; NISIN; BACTERIOCIN; STREPTOCOCCUS; STRAIN; IMMUNITY; LICHENICIDIN; HALODURACIN	Background: Frequent use of antibiotics has led to the emergence of antibiotic resistance in bacteria. Lantibiotic compounds are ribosomally synthesized antimicrobial peptides against which bacteria are not able to produce resistance, hence making them a good alternative to antibiotics. Nisin is the oldest and the most widely used lantibiotic, in food preservation, without having developed any significant resistance against it. Having their antimicrobial potential and a limited number, there is a need to identify novel lantibiotics. Methodology/Findings: Identification of novel lantibiotic biosynthetic clusters from an ever increasing database of bacterial genomes, can provide a major lead in this direction. In order to achieve this, a strategy was adopted to identify novel lantibiotic biosynthetic clusters by screening the sequenced genomes for LanT homolog, which is a conserved lantibiotic transporter specific to type IB clusters. This strategy resulted in identification of 54 bacterial strains containing the LanT homologs, which are not the known lantibiotic producers. Of these, 24 strains were subjected to a detailed bioinformatic analysis to identify genes encoding for precursor peptides, modification enzyme, immunity and quorum sensing proteins. Eight clusters having two LanM determinants, similar to haloduracin and lichenicidin were identified, along with 13 clusters having a single LanM determinant as in mersacidin biosynthetic cluster. Besides these, orphan LanT homologs were also identified which might be associated with novel bacteriocins, encoded somewhere else in the genome. Three identified gene clusters had a C39 domain containing LanT transporter, associated with the LanBC proteins and double glycine type precursor peptides, the only known example of such a cluster is that of salivaricin. Conclusion: This study led to the identification of 8 novel putative two-component lantibiotic clusters along with 13 having a single LanM and 3 with LanBC genes. Putative lantibiotic clusters identified here hold the potential for the discovery of novel lantibiotic(s).	[Singh, Mangal; Sareen, Dipti] Panjab Univ, Dept Biochem, Chandigarh 160014, India	Panjab University	Sareen, D (corresponding author), Panjab Univ, Dept Biochem, Chandigarh 160014, India.	diptsare@pu.ac.in	Panwar, Mangal Singh/ABD-4791-2020; Singh, Mangal/Y-9283-2018	Panwar, Mangal Singh/0000-0002-2381-2250; Singh, Mangal/0000-0002-2381-2250; Sareen, Dipti/0000-0001-9432-0870	Junior Research Fellowship (JRF) by the Indian Council of Medical Research (ICMR), Government of India (New Delhi) [3/1/3/JRF-2011/HRD-99(11005)]	Junior Research Fellowship (JRF) by the Indian Council of Medical Research (ICMR), Government of India (New Delhi)	M.S. acknowledges the independent Junior Research Fellowship (JRF) No. 3/1/3/JRF-2011/HRD-99(11005), awarded by the Indian Council of Medical Research (ICMR; http://icmr.nic.in/), Government of India (New Delhi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib Z, 2012, J BIOTECHNOL, V159, P145, DOI 10.1016/j.jbiotec.2012.01.032; Altena K, 2000, APPL ENVIRON MICROB, V66, P2565, DOI 10.1128/AEM.66.6.2565-2571.2000; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Begley M, 2009, APPL ENVIRON MICROB, V75, P5451, DOI 10.1128/AEM.00730-09; BROTZ H, 1995, ANTIMICROB AGENTS CH, V39, P714, DOI 10.1128/AAC.39.3.714; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Chang YJ, 2011, STAND GENOMIC SCI, V5, P97, DOI 10.4056/sigs.2114901; Corvey C, 2003, BIOCHEM BIOPH RES CO, V304, P48, DOI 10.1016/S0006-291X(03)00529-1; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Cox CR, 2005, CURR PROTEIN PEPT SC, V6, P77, DOI 10.2174/1389203053027557; de Jong A, 2010, NUCLEIC ACIDS RES, V38, pW647, DOI 10.1093/nar/gkq365; DelvesBroughton J, 1996, ANTON LEEUW INT J G, V69, P193, DOI 10.1007/BF00399424; Dirix G, 2004, PEPTIDES, V25, P1425, DOI 10.1016/j.peptides.2003.10.028; Dischinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006788; Foulston LC, 2010, P NATL ACAD SCI USA, V107, P13461, DOI 10.1073/pnas.1008285107; FREDENHAGEN A, 1990, J ANTIBIOT, V43, P1403, DOI 10.7164/antibiotics.43.1403; Goto Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000339; HAVARSTEIN LS, 1995, MOL MICROBIOL, V16, P229, DOI 10.1111/j.1365-2958.1995.tb02295.x; He ZG, 2008, FEBS LETT, V582, P2787, DOI 10.1016/j.febslet.2008.07.008; Hyink O, 2005, FEMS MICROBIOL LETT, V252, P235, DOI 10.1016/j.femsle.2005.09.003; Izaguirre G, 1997, APPL ENVIRON MICROB, V63, P3965, DOI 10.1128/AEM.63.10.3965-3971.1997; Kataeva IA, 2009, J BACTERIOL, V191, P3760, DOI 10.1128/JB.00256-09; KLAENHAMMER TR, 1993, FEMS MICROBIOL REV, V12, P39, DOI 10.1111/j.1574-6976.1993.tb00012.x; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; Kuipers A, 2004, J BIOL CHEM, V279, P22176, DOI 10.1074/jbc.M312789200; Lawton EM, 2007, FEMS MICROBIOL LETT, V267, P64, DOI 10.1111/j.1574-6968.2006.00539.x; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Li B, 2010, P NATL ACAD SCI USA, V107, P10430, DOI 10.1073/pnas.0913677107; Li XL, 2012, BIOTECHNOL LETT, V34, P2133, DOI 10.1007/s10529-012-1024-2; Lubelski J, 2008, CELL MOL LIFE SCI, V65, P455, DOI 10.1007/s00018-007-7171-2; Marsh AJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-679; Mattick ATR, 1944, NATURE, V154, P551, DOI 10.1038/154551a0; McClerren AL, 2006, P NATL ACAD SCI USA, V103, P17243, DOI 10.1073/pnas.0606088103; Navaratna MADB, 1998, APPL ENVIRON MICROB, V64, P4803; Nes IF, 2007, J BACTERIOL, V189, P1189, DOI 10.1128/JB.01254-06; Nusspaumer G, 2000, EMBO J, V19, P6075, DOI 10.1093/emboj/19.22.6075; Patton GC, 2008, BIOCHEMISTRY-US, V47, P7342, DOI 10.1021/bi800277d; Plat A, 2011, APPL ENVIRON MICROB, V77, P604, DOI 10.1128/AEM.01503-10; Ryan MP, 1996, APPL ENVIRON MICROB, V62, P612, DOI 10.1128/AEM.62.2.612-619.1996; Stein T, 2003, J BIOL CHEM, V278, P89, DOI 10.1074/jbc.M207237200; Stepper J, 2011, FEBS LETT, V585, P645, DOI 10.1016/j.febslet.2011.01.023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOMASZ A, 1994, NEW ENGL J MED, V330, P1247, DOI 10.1056/NEJM199404283301725; Upton M, 2001, J BACTERIOL, V183, P3931, DOI 10.1128/JB.183.13.3931-3938.2001; WAKAMIYA T, 1985, TETRAHEDRON LETT, V26, P665, DOI 10.1016/S0040-4039(00)89174-1; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022384; Wang XJ, 2010, J BACTERIOL, V192, P4526, DOI 10.1128/JB.00596-10; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Xie LL, 2004, SCIENCE, V303, P679, DOI 10.1126/science.1092600; Xiong ZH, 2009, J BACTERIOL, V191, P1120, DOI 10.1128/JB.01629-08; Yonezawa H, 2005, ANTIMICROB AGENTS CH, V49, P541, DOI 10.1128/AAC.49.2.541-548.2005; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018	54	37	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91352	10.1371/journal.pone.0091352	http://dx.doi.org/10.1371/journal.pone.0091352			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621781	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300079
J	Airi, V; Gizzi, F; Falini, G; Levy, O; Dubinsky, Z; Goffredo, S				Airi, Valentina; Gizzi, Francesca; Falini, Giuseppe; Levy, Oren; Dubinsky, Zvy; Goffredo, Stefano			Reproductive Efficiency of a Mediterranean Endemic Zooxanthellate Coral Decreases with Increasing Temperature along a Wide Latitudinal Gradient	PLOS ONE			English	Article							BALANOPHYLLIA-EUROPAEA SCLERACTINIA; LEPTOPSAMMIA-PRUVOTI SCLERACTINIA; SEA-SURFACE TEMPERATURE; SEXUAL REPRODUCTION; MORPHOLOGICAL ASPECTS; THERMAL-STRESS; MORTALITY; GAMETOGENESIS; ANTHOZOA; GROWTH	Investments at the organismal level towards reproduction and growth are often used as indicators of health. Understanding how such energy allocation varies with environmental conditions may, therefore, aid in predicting possible responses to global climatic change in the near future. For example, variations in seawater temperature may alter the physiological functioning, behavior, reproductive output and demographic traits (e.g., productivity) of marine organisms, leading to shifts in the structure, spatial range, and abundance of populations. This study investigated variations in reproductive output associated with local seawater temperature along a wide latitudinal gradient on the western Italian coast, in the zooxanthellate Mediterranean coral, Balanophyllia europaea. Reproductive potential varied significantly among sites, where B. europaea individuals from the warmest site experienced loss of oocytes during gametogenesis. Most of the early oocytes from warmest sites did not reach maturity, possibly due to inhibition of metabolic processes at high temperatures, causing B. europaea to reabsorb the oocytes and utilize them as energy for other vital functions. In a progressively warming Mediterranean, the efficiency of the energy invested in reproduction could be considerably reduced in this species, thereby affecting vital processes. Given the projected increase in seawater temperature as a consequence of global climate change, the present study adds evidence to the threats posed by high temperatures to the survival of B. europaea in the next decades.	[Airi, Valentina; Gizzi, Francesca; Goffredo, Stefano] Alma Mater Studiorum Univ Bologna, Biol Sect, Dept Biol Geol & Environm Sci, Marine Sci Grp, Bologna, Italy; [Falini, Giuseppe] Alma Mater Studiorum Univ Bologna, Dept Chem G Ciamician, Bologna, Italy; [Levy, Oren; Dubinsky, Zvy] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	University of Bologna; University of Bologna; Bar Ilan University	Goffredo, S (corresponding author), Alma Mater Studiorum Univ Bologna, Biol Sect, Dept Biol Geol & Environm Sci, Marine Sci Grp, Bologna, Italy.	stefano.goffredo@marinesciencegroup.org	Gizzi, Francesca/Q-4866-2019; Gizzi, Francesca/K-5469-2015	Gizzi, Francesca/0000-0001-9447-8694; Gizzi, Francesca/0000-0001-9447-8694; goffredo, stefano/0000-0002-5022-9503; Airi, Valentina/0000-0002-6118-7441	European Research Council under the European Union/ERC [249930]	European Research Council under the European Union/ERC(European Research Council (ERC))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 249930 - CoralWarm: Corals and global warming: the Mediterranean versus the Red Sea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2005, SCI MAR, V69, P347, DOI 10.3989/scimar.2005.69n3347; Albright R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056468; Altman D.G., 1991, PRACTICAL STAT MED R, DOI [DOI 10.1002/SIM.4780101015, 10.1002/sim.4780101015]; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX; Bauman AG, 2011, CORAL REEFS, V30, P405, DOI 10.1007/s00338-010-0711-5; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; Caroselli E, 2011, ZOOLOGY, V114, P255, DOI 10.1016/j.zool.2011.04.003; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Cupido R, 2012, MAR ECOL PROG SER, V469, P25, DOI 10.3354/meps09976; de Putron SJ, 2009, INVERTEBR BIOL, V128, P213, DOI 10.1111/j.1744-7410.2009.00170.x; Fadlallah Y.H., 1983, Coral Reefs, V2, P129, DOI 10.1007/BF00336720; Fantazzini P, 2013, ENVIRON SCI TECHNOL, V47, P12679, DOI 10.1021/es402521b; Fischer B, 2011, EVOLUTION, V65, P1221, DOI 10.1111/j.1558-5646.2010.01198.x; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Goffredo S, 2008, CORAL REEFS, V27, P623, DOI 10.1007/s00338-008-0362-y; Goffredo S, 2006, MAR BIOL, V148, P923, DOI 10.1007/s00227-005-0137-8; Goffredo S, 2005, MAR BIOL, V147, P485, DOI 10.1007/s00227-005-1567-z; Goffredo S, 2004, MAR BIOL, V145, P1075, DOI 10.1007/s00227-004-1403-x; Goffredo S, 2004, CORAL REEFS, V23, P433, DOI 10.1007/s00338-004-0395-9; Goffredo S, 2002, MAR ECOL PROG SER, V229, P83, DOI 10.3354/meps229083; Goffredo S, 2007, MAR BIOL, V152, P351, DOI 10.1007/s00227-007-0695-z; Goffredo S, 2012, J MORPHOL, V273, P943, DOI 10.1002/jmor.20039; Goffredo S, 2011, B MAR SCI, V87, P589, DOI 10.5343/bms.2010.1068; Goffredo S, 2010, MAR BIOL RES, V6, P421, DOI 10.1080/17451000903428488; Goffredo S, 2009, LIMNOL OCEANOGR, V54, P930, DOI 10.4319/lo.2009.54.3.0930; Gori A, 2007, MAR BIOL, V151, P1571, DOI 10.1007/s00227-006-0595-7; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Hayward A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016557; Henry LA, 2005, INT REV HYDROBIOL, V90, P125, DOI 10.1002/iroh.200410759; HOEGHGULDBERG O, 1995, AM ZOOL, V35, P415; Kersting DK, 2013, MAR ECOL PROG SER, V486, P165, DOI 10.3354/meps10356; Kipson S, 2012, MAR ECOL PROG SER, V470, P69, DOI 10.3354/meps09982; Korta M, 2010, FISH RES, V104, P56, DOI 10.1016/j.fishres.2010.01.010; Kruzic P, 2008, CORAL REEFS, V27, P337, DOI 10.1007/s00338-007-0334-7; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Lesser MP, 2013, CORAL REEFS, V32, P25, DOI 10.1007/s00338-012-0993-x; Leuzinger S, 2003, OECOLOGIA, V136, P524, DOI 10.1007/s00442-003-1305-5; Leuzinger S, 2012, MAR BIOL, V159, P177, DOI 10.1007/s00227-011-1797-1; Linares C, 2008, CORAL REEFS, V27, P27, DOI 10.1007/s00338-007-0285-z; Llodra ER, 2002, ADV MAR BIOL, V43, P87; Lowerre-Barbieri SK, 2011, MAR COAST FISH, V3, P71, DOI 10.1080/19425120.2011.556932; Lueg JR, 2012, J MAR BIOL, V2012, DOI DOI 10.1155/2012/370247; Maltby L, 1999, ECOL APPL, V9, P431, DOI 10.1890/1051-0761(1999)009[0431:SSTIOO]2.0.CO;2; MCCLINTOCK JB, 1990, J EXP MAR BIOL ECOL, V139, P175, DOI 10.1016/0022-0981(90)90145-3; Michalek-Wagner K, 2001, CORAL REEFS, V19, P231, DOI 10.1007/s003380170003; Muscatine L., 1990, P75; Nakamura E, 2004, PHYCOL RES, V52, P38, DOI 10.1046/j.1322-0829.2003.00323.x; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; Nespolo RF, 2009, EVOLUTION, V63, P2402, DOI 10.1111/j.1558-5646.2009.00706.x; Okubo N, 2007, MAR BIOL, V151, P353, DOI 10.1007/s00227-006-0490-2; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parry ML, 2000, ASSESSMENT POTENTIAL; POTVIN C, 1993, ECOLOGY, V74, P1617, DOI 10.2307/1939920; Ribes M, 2007, INVERTEBR BIOL, V126, P307, DOI 10.1111/j.1744-7410.2007.00101.x; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; RINKEVICH B, 1989, MAR BIOL, V101, P259, DOI 10.1007/BF00391465; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tamelander J, 2002, AMBIO, V31, P551, DOI 10.1639/0044-7447(2002)031[0551:CRFAMM]2.0.CO;2; Torrents O, 2011, MAR BIOL, V158, P1019, DOI 10.1007/s00227-011-1627-5; Weil E, 2009, DIS AQUAT ORGAN, V87, P45, DOI 10.3354/dao02103; Zibrowius H., 1980, MEM I OCEANOGR MONAC, V11, P1	64	20	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91792	10.1371/journal.pone.0091792	http://dx.doi.org/10.1371/journal.pone.0091792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618568	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400131
J	Cornejo-Garcia, JA; Flores, C; Plaza-Seron, MC; Acosta-Herrera, M; Blanca-Lopez, N; Dona, I; Torres, MJ; Mayorga, C; Gueant-Rodriguez, RM; Ayuso, P; Fernandez, J; Laguna, JJ; Agundez, JAG; Garcia-Martin, E; Gueant, JL; Canto, G; Blanca, M				Antonio Cornejo-Garcia, Jose; Flores, Carlos; Plaza-Seron, Maria C.; Acosta-Herrera, Marialbert; Blanca-Lopez, Natalia; Dona, Inmaculada; Torres, Maria J.; Mayorga, Cristobalina; Gueant-Rodriguez, Rosa M.; Ayuso, Pedro; Fernandez, Javier; Laguna, Jose J.; Agundez, Jose A. G.; Garcia-Martin, Elena; Gueant, Jean-Louis; Canto, Gabriela; Blanca, Miguel			Variants of CEP68 Gene Are Associated with Acute Urticaria/Angioedema Induced by Multiple Non-Steroidal Anti-Inflammatory Drugs	PLOS ONE			English	Article							ASPIRIN-INTOLERANT ASTHMA; GENOME-WIDE ASSOCIATION; HYPERSENSITIVITY REACTIONS; CYSTEINYL-LEUKOTRIENES; POLYMORPHISMS; CHALLENGE; URTICARIA; PATTERNS; EICOSANOIDS; CENTROSOME	Non-steroidal anti-inflammatory drugs (NSAIDs) are the most consumed drugs worldwide because of their efficacy and utility in the treatment of pain and inflammatory diseases. However, they are also responsible for an important number of adverse effects including hypersensitivity reactions. The most important group of these reactions is triggered by non-immunological, pharmacological mechanisms catalogued under the denomination of cross-intolerance (CRI), with acute urticaria/angioedema induced by multiple NSAIDs (MNSAID-UA) the most frequently associated clinical entity. A recent genome-wide association study identified the gene encoding the centrosomal protein of 68 KDa (CEP68) as the major locus associated with aspirin intolerance susceptibility in asthmatics. In this study, we aimed to assess the role of this locus in susceptibility to CRI to NSAIDs by examining 53 common gene variants in a total of 635 patients that were classified as MNSAID-UA (n = 399), airway exacerbations (n = 110) or blended pattern (n = 126), and 425 controls. We found in the MNSAID-UA group a number of variants (17) associated (lowest p-value = 1.13 x 10(-6)), including the non-synonymous Gly74Ser variant (rs7572857) previously associated with aspirin intolerance susceptibility in asthmatics. Although not being significant in the context of multiple testing, eight of these variants were also associated with exacerbated respiratory disease or blended reactions. Our results suggest that CEP68 gene variants may play an important role in MNSAID-UA susceptibility and, despite the different regulatory mechanisms involved depending on the specific affected organ, in the development of hypersensitivity reactions to NSAIDs.	[Antonio Cornejo-Garcia, Jose; Plaza-Seron, Maria C.; Mayorga, Cristobalina; Ayuso, Pedro] IBIMA Malaga Univ Gen Hosp, Res Lab, Malaga, Spain; [Flores, Carlos; Acosta-Herrera, Marialbert] Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Enfermedades Resp, Madrid, Spain; [Flores, Carlos; Acosta-Herrera, Marialbert] Hosp Univ NS de Candelaria, Res Unit, Tenerife, Spain; [Flores, Carlos] Univ La Laguna, Appl Genom Grp G2A, Genet Lab, Inst Univ Enfermedades Trop & Salud Publ Canarias, Tenerife, Spain; [Acosta-Herrera, Marialbert; Blanca, Miguel] Hosp Univ Dr Negrin, Res Unit, Las Palmas Gran Canaria, Spain; [Blanca-Lopez, Natalia] Infanta Leonor Hosp, Allergy Serv, Madrid, Spain; [Dona, Inmaculada; Torres, Maria J.; Mayorga, Cristobalina; Canto, Gabriela] Malaga Univ Gen Hosp, Unidad Gest Clin UGC Allergy Inst Invest Biomed I, Malaga, Spain; [Gueant-Rodriguez, Rosa M.; Gueant, Jean-Louis] Univ Nancy, Fac Med, INSERM, Nutr Genet & Exposit Risques Environm U954, Vandoeuvre Les Nancy, France; [Gueant-Rodriguez, Rosa M.; Gueant, Jean-Louis] Univ Hosp Ctr CHU Nancy, Vandoeuvre Les Nancy, France; [Fernandez, Javier] Alicante Hosp, Allergy Serv, Alicante, Spain; [Laguna, Jose J.] Cruz Roja Cent Hosp, Allergy Serv, Madrid, Spain; [Agundez, Jose A. G.] Univ Extremadura, Dept Pharmacol, Caceres, Spain; [Garcia-Martin, Elena] Univ Extremadura, Biochem Mol Biol & Genet Dept, Caceres, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universidad de la Laguna; Hospital Universitario Infanta Leonor; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; General University Hospital of Alicante; Universidad de Extremadura; Universidad de Extremadura	Blanca, M (corresponding author), Hosp Univ Dr Negrin, Res Unit, Las Palmas Gran Canaria, Spain.	mblancago@gmail.com	Fernandez, Javier/B-6425-2018; Mayorga, Cristobalina/D-7167-2018; Flores, Carlos/R-1159-2019; Agúndez, José A. G./A-5503-2008; Torres, Maria/GVU-3391-2022; Torres, María José/T-3518-2017; Mayorga, Lina/FBO-7730-2022; Cornejo-García, Jose Antonio/S-7726-2016; García-Martin, Elena/H-9828-2016; Martinez, Jose Julio Laguna/L-6891-2017	Fernandez, Javier/0000-0003-1065-7199; Mayorga, Cristobalina/0000-0001-8852-8077; Agúndez, José A. G./0000-0001-6895-9160; Torres, María José/0000-0001-5228-471X; Cornejo-García, Jose Antonio/0000-0003-3465-8735; García-Martin, Elena/0000-0002-8094-046X; Martinez, Jose Julio Laguna/0000-0001-5909-8979; Flores, Carlos/0000-0001-5352-069X; Ayuso Parejo, Pedro/0000-0002-9441-4022; Plaza-Seron, Maria del Carmen/0000-0003-4695-5075	Carlos III Institute of the Spanish Health Ministry network Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos (RIRAAF) [RD12/0013/0001]; European Regional Development Funds; European Union; Health Government of Andalucia [PI-0279-2012]; Carlos III Institute [FI11/00074]; Canary Islands Government [EMER07/001];  [PI071220];  [PI10/01598];  [PS09/02419];  [PI11/00623]	Carlos III Institute of the Spanish Health Ministry network Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos (RIRAAF); European Regional Development Funds(European Commission); European Union(European Commission); Health Government of Andalucia; Carlos III Institute(Instituto de Salud Carlos III); Canary Islands Government; ; ; ; 	This study was supported by grants from Carlos III Institute of the Spanish Health Ministry network Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos (RIRAAF, RD12/0013/0001), PI071220, PI10/01598, PS09/02419, PI11/00623, which were co-financed by the European Regional Development Funds, "A way of making Europe'' from the European Union; and from the Health Government of Andalucia, PI-0279-2012. Dr. Cornejo-Garcia is a postdoctoral researcher of the Juan de la Cierva Program (Spanish Ministry of Science and Innovation). Dr. Flores was supported by a specific agreement Carlos III Institute and Canary Islands Government (EMER07/001). M. Acosta-Herrera was supported by a fellowship from Carlos III Institute (FI11/00074). Carlos III website: http://www.isciii.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047571; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Antczak A, 2002, AM J RESP CRIT CARE, V166, P301, DOI 10.1164/rccm.2101021; Carlson CS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001661; Chen Y, 2007, PROTEOMICS, V7, P2384, DOI 10.1002/pmic.200600968; Choi JH, 2004, HUM GENET, V114, P337, DOI 10.1007/s00439-004-1082-1; CHRISTIE PE, 1992, AM REV RESPIR DIS, V146, P1531, DOI 10.1164/ajrccm/146.6.1531; Conaghan PG, 2012, RHEUMATOL INT, V32, P1491, DOI 10.1007/s00296-011-2263-6; Cornejo-Garcia JA, 2012, CLIN EXP ALLERGY, V42, P1772, DOI 10.1111/j.1365-2222.2012.04078.x; Dona I, 2012, J INVEST ALLERG CLIN, V22, P363; Dona I, 2011, CLIN EXP ALLERGY, V41, P86, DOI 10.1111/j.1365-2222.2010.03651.x; Duroudier NP, 2009, ALLERGY, V64, P823, DOI 10.1111/j.1398-9995.2009.02015.x; Flores C, 2007, GENET EPIDEMIOL, V31, P296, DOI 10.1002/gepi.20210; Fosbol EL, 2008, PHARMACOEPIDEM DR S, V17, P822, DOI 10.1002/pds.1592; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gaber F, 2008, THORAX, V63, P1076, DOI 10.1136/thx.2008.101196; Garcia-Closas M, 1999, AM J EPIDEMIOL, V149, P689; Gomes E, 2004, CLIN EXP ALLERGY, V34, P1597, DOI 10.1111/j.1365-2222.2004.02070.x; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Gray PA, 2002, BRIT J PHARMACOL, V137, P1031, DOI 10.1038/sj.bjp.0704927; Higashi N, 2010, J ALLERGY CLIN IMMUN, V125, P1084, DOI 10.1016/j.jaci.2009.12.977; Hirota N, 2012, FASEB J, V26, P1704, DOI 10.1096/fj.11-197061; Jinnai N, 2004, HUM MOL GENET, V13, P3203, DOI 10.1093/hmg/ddh332; Kim JY, 2013, ALLERGY ASTHMA IMMUN, V5, P34, DOI 10.4168/aair.2013.5.1.34; Kim JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013818; Kim SH, 2007, J CLIN IMMUNOL, V27, P613, DOI 10.1007/s10875-007-9115-x; Kim SH, 2010, CURR OPIN ALLERGY CL, V10, P280, DOI 10.1097/ACI.0b013e32833b1eb3; Kim SH, 2006, CLIN EXP ALLERGY, V36, P433, DOI 10.1111/j.1365-2222.2006.02457.x; Kim SH, 2005, J KOREAN MED SCI, V20, P926, DOI 10.3346/jkms.2005.20.6.926; Kowalski ML, 2011, ALLERGY, V66, P818, DOI 10.1111/j.1398-9995.2011.02557.x; Laidlaw TM, 2012, CLIN EXP ALLERGY, V42, P1313, DOI 10.1111/j.1365-2222.2012.03982.x; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Maheshwari R, 2004, J COLLOID INTERF SCI, V277, P79, DOI 10.1016/j.jcis.2004.04.023; Mastalerz L, 2008, THORAX, V63, P27, DOI 10.1136/thx.2007.080903; Mastalerz L, 2004, J ALLERGY CLIN IMMUN, V113, P771, DOI 10.1016/j.jaci.2003.12.323; McGovern T, 2010, AM J PHYSIOL-LUNG C, V299, pL808, DOI 10.1152/ajplung.00438.2009; Motola D, 2004, EUR J CLIN PHARMACOL, V60, P731, DOI 10.1007/s00228-004-0826-0; Park BL, 2013, HUM GENET, V132, P313, DOI 10.1007/s00439-012-1247-2; Park JS, 2005, PHARMACOGENET GENOM, V15, P483, DOI 10.1097/01.fpc.0000166456.84905.a0; Pino-Yanes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018389; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Quiralte J, 2007, J INVEST ALLERG CLIN, V17, P182; Sanak M, 2000, AM J RESP CELL MOL, V23, P290, DOI 10.1165/ajrcmb.23.3.4051; Sanak M, 2004, CLIN EXP ALLERGY, V34, P1899, DOI 10.1111/j.1365-2222.2004.02123.x; Sanak M, 2011, J ALLERGY CLIN IMMUN, V127, P1141, DOI 10.1016/j.jaci.2010.12.1108; Setkowicz M, 2009, J ALLERGY CLIN IMMUN, V123, P174, DOI 10.1016/j.jaci.2008.09.005; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swierczynska M, 2003, J ALLERGY CLIN IMMUN, V112, P995, DOI 10.1016/S0091-6749(03)02015-3; Szczeklik A, 2006, EUR J PHARMACOL, V533, P145, DOI 10.1016/j.ejphar.2005.12.053; SZCZEKLIK A, 1975, BRIT MED J, V1, P67, DOI 10.1136/bmj.1.5949.67; Szczeklik A, 1996, AM J RESP CRIT CARE, V154, P1608, DOI 10.1164/ajrccm.154.6.8970343; Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zambonino MA, 2013, PEDIAT ALLERG IMM-UK, V24, P151, DOI 10.1111/pai.12039	57	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90966	10.1371/journal.pone.0090966	http://dx.doi.org/10.1371/journal.pone.0090966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618698	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400039
J	Bouzid, MA; Hammouda, O; Matran, R; Robin, S; Fabre, C				Bouzid, Mohamed Amine; Hammouda, Omar; Matran, Regis; Robin, Sophie; Fabre, Claudine			Changes in Oxidative Stress Markers and Biological Markers of Muscle Injury with Aging at Rest and in Response to an Exhaustive Exercise	PLOS ONE			English	Article							ANTIOXIDANT STATUS; FREE-RADICALS; ECCENTRIC EXERCISE; YOUNG; BLOOD; OLD; LIPOPROTEINS; INFLAMMATION; BIOMARKERS; ENZYMES	Purpose: The aim of this study was to evaluate whether oxidative stress markers and biomarkers of muscle injury would be affected by aging at rest and in response to an incremental exhaustive exercise. Methods: Fifteen young (20.3 +/- 2.8 years) and fifteen older adults (65.1 +/- 3.5 years) performed an incremental cycle ergometer test to exhaustion. Before and after exercise, oxidative stress [superoxide dismutase (SOD), glutathione peroxidase (GPX), glutathione reductase (GR), ascorbic acid, alpha-Tocopherol, malondialdehyde (MDA)] and muscle injury [creatine kinase (CK), lactate deshydrogenase (LDH)] biomarkers were assessed. Results: At rest, there was no difference in oxidative stress markers and LDH level between the groups, however CK was significantly higher in the young group than the elderly group (p<0.05). During recovery, in comparison with resting values, a significant increase in SOD (1092 +/- 145.9 vs. 1243698 U/g Hb), GPX (67.4 +/- 12.7 vs. 79.2 +/- 15.6 U/g Hb) and GR (6.5 +/- 0.9 vs. 7.7 +/- 0.5 U/g Hb) activities were observed only in the young group (p<0.05). MDA has increased only in the older group (0.54 +/- 0.2 vs. 0.79 +/- 0.2 mu mol/l) (p<0.01). CK increased in both groups (young group: 122.5 +/- 22.2 vs. 161.9 +/- 18.7 UI/l; older group: 88.8 +/- 34.1 vs. 111.1 +/- 25.9 UI/l) (p<0.01), however LDH has increased only in the young group (400.5 +/- 22.2 vs. 485 +/- 18.7 UI/l) (p<0.01) without alteration in the older group (382.8 +/- 34.1 vs. 418.5 +/- 25.9 UI/l). Conclusions: These findings indicate that aging is associated with a decrease in antioxidant efficiency and an increase in oxidative stress damage. Furthermore, older adults would not more susceptible to exercise-induced muscle injury than young people.	[Bouzid, Mohamed Amine; Fabre, Claudine] Univ Lille Nord France, EA 4488, Fac Sci Sport & Educ Phys, Ronchin, France; [Hammouda, Omar] Natl Ctr Medecine & Sci Sports, Res Lab Sport Performance Optimisat, Tunis, Tunisia; [Matran, Regis; Robin, Sophie] CHRU Lille, Serv EFR, F-59037 Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Hammouda, O (corresponding author), Natl Ctr Medecine & Sci Sports, Res Lab Sport Performance Optimisat, Tunis, Tunisia.	omarham007@yahoo.fr	HAMMOUDA, Omar/AGE-5171-2022	HAMMOUDA, Omar/0000-0002-5002-687X				Balkan J, 2002, INT J VITAM NUTR RES, V72, P315, DOI 10.1024/0300-9831.72.5.315; Bar-Shai M, 2008, FREE RADICAL BIO MED, V44, P202, DOI 10.1016/j.freeradbiomed.2007.03.019; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Bejma J, 2000, ACTA PHYSIOL SCAND, V169, P343; Bloomer RJ, 2004, CAN J APPL PHYSIOL, V29, P245, DOI 10.1139/h04-017; Di Massimo C, 1999, CLIN HEMORHEOL MICRO, V20, P105; El Abed K, 2011, J STRENGTH COND RES, V25, P2400, DOI 10.1519/JSC.0b013e3181fc5c35; Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4; Fantini AG, 1993, AM J PHYSIOL, V264, P1953; Farney TM, 2012, MED SCI SPORT EXER, V44, P1855, DOI 10.1249/MSS.0b013e3182592575; Figueiredo PA, 2009, J GERONTOL A-BIOL, V64, P21, DOI 10.1093/gerona/gln048; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; FrankiewiczJozko A, 1996, EUR J APPL PHYSIOL O, V74, P470; Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002; Hammouda O, 2011, CHRONOBIOL INT, V28, P958, DOI 10.3109/07420528.2011.613683; Hou JH, 1996, BIOCHEM J, V318, P1065, DOI 10.1042/bj3181065; JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918; KANTER MM, 1988, EUR J APPL PHYSIOL O, V57, P60, DOI 10.1007/BF00691239; Karaouzene N, 2011, NUTR METAB CARDIOVAS, V21, P792, DOI 10.1016/j.numecd.2010.02.007; Kasapoglu M, 2001, EXP GERONTOL, V36, P209, DOI 10.1016/S0531-5565(00)00198-4; Lavender AP, 2006, APPL PHYSIOL NUTR ME, V31, P218, DOI 10.1139/H05-028; Lavrovsky Y, 2000, EXP GERONTOL, V35, P521, DOI 10.1016/S0531-5565(00)00118-2; Lee HC, 2001, BIOGERONTOLOGY, V2, P231, DOI 10.1023/A:1013270512172; Meng SJ, 2010, INT J MOL SCI, V11, P1509, DOI 10.3390/ijms11041509; MEYDANI M, 1993, AM J PHYSIOL, V264, pR992, DOI 10.1152/ajpregu.1993.264.5.R992; Monemi M, 1998, J NEUROL SCI, V154, P35, DOI 10.1016/S0022-510X(97)00208-6; Mutlu-Turkoglu U, 2003, CLIN BIOCHEM, V36, P397, DOI 10.1016/S0009-9120(03)00035-3; Nikolaidis MG, 2007, MED SCI SPORT EXER, V39, P1080, DOI 10.1249/mss.0b013e31804ca10c; Ohishi S, 1997, CLIN EXP PHARMACOL P, V24, P326, DOI 10.1111/j.1440-1681.1997.tb01196.x; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Prasertsri P, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-13; Rousseau AS, 2006, J NUTR BIOCHEM, V17, P463, DOI 10.1016/j.jnutbio.2005.10.001; Sacheck JM, 2003, FREE RADICAL BIO MED, V34, P1575, DOI 10.1016/S0891-5849(03)00187-4; SCHAFER L, 1989, ANN NUTR METAB, V33, P315, DOI 10.1159/000177552; Schmuck A, 1996, EUR J CLIN NUTR, V50, P473; Shephard RJ, 2009, BRIT J SPORT MED, V43, P342, DOI 10.1136/bjsm.2007.044800; Siu PM, 2008, J APPL PHYSIOL, V105, P1695, DOI 10.1152/japplphysiol.90800.2008; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Toft AD, 2002, AM J PHYSIOL-CELL PH, V283, pC289, DOI 10.1152/ajpcell.00583.2001; Vina J, 2000, IUBMB LIFE, V50, P271, DOI 10.1080/15216540051080994; Wang CH, 2013, EXP BIOL MED, V238, P450, DOI 10.1177/1535370213493069; Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901; Williams CA, 2004, J ANIM SCI, V82, P588; You TJ, 2005, CAN J APPL PHYSIOL, V30, P677, DOI 10.1139/h05-148	44	63	64	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90420	10.1371/journal.pone.0090420	http://dx.doi.org/10.1371/journal.pone.0090420			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618679	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400017
J	Chen, J; Hou, RL; Zhang, X; Ye, Y; Wang, Y; Tian, J				Chen, Jian; Hou, Ruanling; Zhang, Xing; Ye, Yu; Wang, Yong; Tian, Jing			Calycosin Suppresses Breast Cancer Cell Growth via ER beta-Dependent Regulation of IGF-1R, p38 MAPK and PI3K/Akt Pathways	PLOS ONE			English	Article							FACTOR-I RECEPTOR; DOWN-REGULATION; CROSS-TALK; INSULIN; ESTROGEN; ALPHA; TARGET; VITRO; 17-BETA-ESTRADIOL; PHYTOESTROGENS	We previously reported that calycosin, a natural phytoestrogen structurally similar to estrogen, successfully triggered apoptosis of estrogen receptor (ER)-positive breast cancer cell line, MCF-7. To better understand the antitumor activities of calycosin against breast cancer, besides MCF-7 cells, another ER-positive cell line T-47D was analyzed here, with ER-negative cell lines (MDA-231, MDA-435) as control. Notably, calycosin led to inhibited cell proliferation and apoptosis only in ER-positive cells, particularly in MCF-7 cells, whereas no such effect was observed in ER-negative cells. Then we investigated whether regulation of ER beta, a subtype of ER, contributed to calycosin-induced apoptosis in breast cancer cells. The results showed that incubation of calycosin resulted in enhanced expression ER beta in MCF-7 and T-47D cells, rather than MDA-231 and MDA-435 cells. Moreover, with the upregulation of ER beta, successive changes in downstream signaling pathways were found, including inactivation of insulin-like growth factor 1 receptor (IGF-1R), then stimulation of p38 MAPK and suppression of the serine/threonine kinase (Akt), and finally poly(ADP-ribose) polymerase 1 (PARP-1) cleavage. However, the other two members of the mitogen-activated protein kinase (MAPK) family, extracellular signal-regulated kinase (ERK) 1/2 and c-Jun N-terminal kinase (JNK), were not consequently regulated by downregulated IGF-1R, indicating ERK 1/2 and JNK pathways were not necessary to allow proliferation inhibition by calycosin. Taken together, our results indicate that calycosin tends to inhibit growth and induce apoptosis in ER-positive breast cancer cells, which is mediated by ER beta-induced inhibition of IGF-1R, along with the selective regulation of MAPK and phosphatidylinositol 3-kinase (PI3K)/Akt pathways.	[Chen, Jian; Zhang, Xing] Guilin Med Univ, Sch Basic Med Sci, Guilin, Peoples R China; [Hou, Ruanling] Xinxiang Med Univ, Dept Physiol & Neurobiol, Xinxiang, Peoples R China; [Ye, Yu] Guangxi Med Univ, Affiliated Hosp 1, Dept Emergency, Nanning, Peoples R China; [Wang, Yong; Tian, Jing] Guilin Med Univ, Sch Basic Med Sci, Dept Physiol, Guilin, Peoples R China	Guilin Medical University; Xinxiang Medical University; Guangxi Medical University; Guilin Medical University	Tian, J (corresponding author), Guilin Med Univ, Sch Basic Med Sci, Dept Physiol, Guilin, Peoples R China.	glmcchenjian@163.com			National Natural Science Foundation of China [81260343]; Natural Science Foundation of Guangxi [2013GXNSFAA019143, 2013GXNSFBA019185]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province)	This work was supported by National Natural Science Foundation of China (81260343) and Natural Science Foundation of Guangxi (2013GXNSFAA019143 and 2013GXNSFBA019185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2005, J CELL PHYSIOL, V203, P193, DOI 10.1002/jcp.20219; Bartella V, 2012, CELL SIGNAL, V24, P1515, DOI 10.1016/j.cellsig.2012.03.012; Chen J, 2011, HORM METAB RES, V43, P681, DOI 10.1055/s-0031-1286306; Cotrim CZ, 2013, ONCOGENE, V32, P2390, DOI 10.1038/onc.2012.261; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Friedlander TW, 2012, ONCOL REP, V27, P3, DOI 10.3892/or.2011.1487; Grober OMV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-36; Gupta S, 2009, J CELL MOL MED, V13, P1004, DOI 10.1111/j.1582-4934.2009.00697.x; Kang NH, 2013, FOOD CHEM TOXICOL, V59, P373, DOI 10.1016/j.fct.2013.06.029; Krolik M, 2012, ADV CLIN EXP MED, V21, P535; Langelier MF, 2013, CURR OPIN STRUC BIOL, V23, P134, DOI 10.1016/j.sbi.2013.01.003; Liang J, 2013, ANNU REV PHYSIOL, V75, P225, DOI 10.1146/annurev-physiol-030212-183708; Lin AHY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063199; Ma CX, 2013, BREAST CANCER RES TR, V139, P145, DOI 10.1007/s10549-013-2528-8; Ohtani M, 2009, BIOSCI TRENDS, V3, P131; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Renoir JM, 2013, BIOCHEM PHARMACOL, V85, P449, DOI 10.1016/j.bcp.2012.10.018; Renoir JM, 2012, STEROIDS, V77, P1249, DOI 10.1016/j.steroids.2012.07.019; Sabbatini P, 2009, CLIN CANCER RES, V15, P3058, DOI 10.1158/1078-0432.CCR-08-2530; Saxena R, 2013, STEROIDS, V78, P1071, DOI 10.1016/j.steroids.2013.07.004; Serrano ML, 2008, HORM METAB RES, V40, P661, DOI 10.1055/s-0028-1082080; Sukhanova MV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P736, DOI 10.1134/S0006297906070066; Tang HX, 2012, MED ONCOL, V29, P2640, DOI 10.1007/s12032-012-0198-8; Tian J, 2013, HORM METAB RES, V45, P593, DOI 10.1055/s-0033-1341510; Tiong CT, 2012, CARCINOGENESIS, V33, P1089, DOI 10.1093/carcin/bgs110; van der Veeken J, 2009, CURR CANCER DRUG TAR, V9, P748; van Duursen MBM, 2013, TOXICOL APPL PHARM, V269, P132, DOI 10.1016/j.taap.2013.03.014; Varewijck AJ, 2012, ENDOCR-RELAT CANCER, V19, pF63, DOI 10.1530/ERC-12-0026; Wallace JL, 2011, J MEMBRANE BIOL, V242, P53, DOI 10.1007/s00232-011-9376-4; Xu T, 2012, MOL BIOL REP, V39, P7743, DOI 10.1007/s11033-012-1611-2; Yakimchuk K, 2011, LEUKEMIA, V25, P1103, DOI 10.1038/leu.2011.68; Yu ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062642; Zhao Y, 2011, CANCER LETT, V313, P54, DOI 10.1016/j.canlet.2011.08.023	33	54	61	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91245	10.1371/journal.pone.0091245	http://dx.doi.org/10.1371/journal.pone.0091245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618835	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400065
J	Fraisier, C; Koraka, P; Belghazi, M; Bakli, M; Granjeaud, S; Pophillat, M; Lim, SM; Osterhaus, A; Martina, B; Camoin, L; Almeras, L				Fraisier, Christophe; Koraka, Penelope; Belghazi, Maya; Bakli, Mahfoud; Granjeaud, Samuel; Pophillat, Matthieu; Lim, Stephanie M.; Osterhaus, Albert; Martina, Byron; Camoin, Luc; Almeras, Lionel			Kinetic Analysis of Mouse Brain Proteome Alterations Following Chikungunya Virus Infection before and after Appearance of Clinical Symptoms	PLOS ONE			English	Article							WEST-NILE-VIRUS; ALPHA-V-INTEGRINS; PLASMODIUM-FALCIPARUM; REUNION ISLAND; ACTIN CYTOSKELETON; ENDOCYTIC PATHWAY; ARP2/3 COMPLEX; NERVOUS-SYSTEM; SEVERE DISEASE; LATE ENDOSOMES	Recent outbreaks of Chikungunya virus (CHIKV) infection have been characterized by an increasing number of severe cases with atypical manifestations including neurological complications. In parallel, the risk map of CHIKV outbreaks has expanded because of improved vector competence. These features make CHIKV infection a major public health concern that requires a better understanding of the underlying physiopathological processes for the development of antiviral strategies to protect individuals from severe disease. To decipher the mechanisms of CHIKV infection in the nervous system, a kinetic analysis on the host proteome modifications in the brain of CHIKV-infected mice sampled before and after the onset of clinical symptoms was performed. The combination of 2D-DIGE and iTRAQ proteomic approaches, followed by mass spectrometry protein identification revealed 177 significantly differentially expressed proteins. This kinetic analysis revealed a dramatic down-regulation of proteins before the appearance of the clinical symptoms followed by the increased expression of most of these proteins in the acute symptomatic phase. Bioinformatic analyses of the protein datasets enabled the identification of the major biological processes that were altered during the time course of CHIKV infection, such as integrin signaling and cytoskeleton dynamics, endosome machinery and receptor recycling related to virus transport and synapse function, regulation of gene expression, and the ubiquitin-proteasome pathway. These results reveal the putative mechanisms associated with severe CHIKV infection-mediated neurological disease and highlight the potential markers or targets that can be used to develop diagnostic and/or antiviral tools.	[Fraisier, Christophe; Bakli, Mahfoud; Almeras, Lionel] Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, UM63, CNRS 7278,IRD 198,Inserm 1095, Marseille, France; [Koraka, Penelope; Lim, Stephanie M.; Osterhaus, Albert; Martina, Byron] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Belghazi, Maya] Aix Marseille Univ, CNRS, UMR 7286 CRN2M, Marseille, France; [Granjeaud, Samuel; Pophillat, Matthieu; Camoin, Luc] CRCM, Marseille Prote, INSERM, U1068, Marseille, France; [Granjeaud, Samuel; Pophillat, Matthieu; Camoin, Luc] Aix Marseille Univ, UM 105, Marseille, France; [Almeras, Lionel] IRBA, URBEP, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Erasmus University Rotterdam; Erasmus MC; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Almeras, L (corresponding author), Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, UM63, CNRS 7278,IRD 198,Inserm 1095, Marseille, France.	almeras.lionel@gmail.com	Camoin, Luc/AAB-3856-2019; Granjeaud, Samuel/AAE-6488-2022	Camoin, Luc/0000-0002-1230-4787; Granjeaud, Samuel/0000-0001-9245-1535; ALMERAS, Lionel/0000-0003-0490-5774; Martina, Byron/0000-0003-4980-4619; BAKLI, Mahfoud/0000-0002-1427-2985	European Community [261466]; Delegation Generale pour l'Armement (DGA) [ArthroSer 10Ca 401]	European Community(European Commission); Delegation Generale pour l'Armement (DGA)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007 - 2 013) under the project "VECTORIE'', EC grant agreement number 261466. This study was also supported by Delegation Generale pour l'Armement (DGA, ArthroSer 10Ca 401). This manuscript has been reviewed and corrected by American Journal Experts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abere B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034800; Abraham C, 2011, NEUROSCIENCE, V190, P75, DOI 10.1016/j.neuroscience.2011.05.069; Agola JO, 2011, CLIN GENET, V80, P305, DOI 10.1111/j.1399-0004.2011.01724.x; Alla SAO, 2011, BEST PRACT RES CL RH, V25, P337, DOI 10.1016/j.berh.2011.03.005; Allaire PD, 2013, J CELL SCI, V126, P722, DOI 10.1242/jcs.112375; Arpino C, 2009, REV MED VIROL, V19, P121, DOI 10.1002/rmv.606; Belizaire R, 2004, J COMP NEUROL, V470, P266, DOI 10.1002/cne.20008; Bernard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011479; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Bockaert J, 2010, ANNU REV PHARMACOL, V50, P89, DOI 10.1146/annurev.pharmtox.010909.105705; Briolant S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-141; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Caminade C, 2012, J R SOC INTERFACE; Chen YS, 2013, CHIN J CANC; Chevallier J, 2009, FEBS LETT, V583, P1096, DOI 10.1016/j.febslet.2009.03.012; Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004; Chua CEL, 2010, FEBS LETT, V584, P1, DOI 10.1016/j.febslet.2009.11.051; Clague MJ, 1998, BIOCHEM J, V336, P271, DOI 10.1042/bj3360271; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Das T, 2010, PROG NEUROBIOL, V91, P121, DOI 10.1016/j.pneurobio.2009.12.006; Dhanwani R, 2011, PROTEOMICS, V11, P1936, DOI 10.1002/pmic.201000500; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446; Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167; Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187; Fontaine A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-276; Fraisier C, 2013, VIRUS RES IN PRESS; Fraisier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068318; Fuchs SY, 2012, GROWTH FACTORS, V30, P141, DOI 10.3109/08977194.2012.669382; Garmashova N, 2007, J VIROL, V81, P2472, DOI 10.1128/JVI.02073-06; Garmashova N, 2006, J VIROL, V80, P5686, DOI 10.1128/JVI.02739-05; Garrison AR, 2013, VIROLOGY; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Grande E, 2012, EXPERT REV ANTICANC, V12, P457, DOI [10.1586/era.12.26, 10.1586/ERA.12.26]; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Greenfield LJ, 2013, SEIZURE-EUR J EPILEP, V22, P589, DOI 10.1016/j.seizure.2013.04.015; Grieve Adam G, 2012, Int J Cell Biol, V2012, P852430, DOI 10.1155/2012/852430; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hoogenraad Casper C, 2010, Commun Integr Biol, V3, P433, DOI 10.4161/cib.3.5.12209; Jurado S, 2010, EMBO J, V29, P2827, DOI 10.1038/emboj.2010.160; Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; La Linn M, 2005, VIROLOGY, V336, P229, DOI 10.1016/j.virol.2005.03.015; Lee RCH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002050; Lei WL, 2012, CELL RES, V22, P954, DOI 10.1038/cr.2012.40; Li E, 2001, J VIROL, V75, P5405, DOI 10.1128/JVI.75.11.5405-5409.2001; Li G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011371; Liu BS, 2010, STROKE, V41, P1018, DOI 10.1161/STROKEAHA.110.579011; Mainou BA, 2012, J VIROL, V86, P8346, DOI 10.1128/JVI.00100-12; Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652; Masliah E, 2004, J NEUROIMMUNOL, V157, P163, DOI 10.1016/j.jneuroim.2004.08.026; MATHIAS P, 1994, J VIROL, V68, P6811, DOI 10.1128/JVI.68.10.6811-6814.1994; Nakamura T, 1999, J BIOL CHEM, V274, P13322, DOI 10.1074/jbc.274.19.13322; Nakamura Y, 2011, EMBO J, V30, P719, DOI 10.1038/emboj.2010.357; NIMMANNITYA S, 1969, AM J TROP MED HYG, V18, P954, DOI 10.4269/ajtmh.1969.18.954; Pastorino B, 2009, MOL CELL PROTEOMICS, V8, P1623, DOI 10.1074/mcp.M800565-MCP200; Pattanakitsakul S, 2007, J PROTEOME RES, V6, P4592, DOI 10.1021/pr070366b; Queyriaux B, 2008, LANCET, V371, P723, DOI 10.1016/S0140-6736(08)60337-2; Renault P, 2007, AM J TROP MED HYG, V77, P727; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Robinson LJ, 1997, J CELL SCI, V110, P2079; ROBINSON M. C., 1955, TANGANYIKA TERRITORY IN 1952 53 I TRANS ROY SOC TROP MED AND HYG, V49, P28, DOI 10.1016/0035-9203(55)90080-8; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; ROSS R. W., 1956, JOUR HYG, V54, P177; Schaffner Florence, 2013, Cancers (Basel), V5, P27, DOI 10.3390/cancers5010027; Schmidt K, 2013, J GEN VIROL; Scholte FEM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071047; Sheppard D, 2004, CURR OPIN CELL BIOL, V16, P552, DOI 10.1016/j.ceb.2004.06.017; Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Thio CLP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061444; THIRUVENGADAM KV, 1965, INDIAN J MED RES, V53, P729; Torrentino-Madamet M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-4; Tournebize P, 2009, REV NEUROL-FRANCE, V165, P48, DOI 10.1016/j.neurol.2008.06.009; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; Viswanathan K, 2010, CURR OPIN MICROBIOL, V13, P517, DOI 10.1016/j.mib.2010.05.012; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Werneke SW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002322; White LK, 2011, J VIROL, V85, P606, DOI 10.1128/JVI.00767-10; Wintachai P, 2012, J MED VIROL, V84, P1757, DOI 10.1002/jmv.23403; Yamashiro K, 2007, INT J BIOCHEM CELL B, V39, P910, DOI 10.1016/j.biocel.2007.01.015	87	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91397	10.1371/journal.pone.0091397	http://dx.doi.org/10.1371/journal.pone.0091397			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618821	gold, Green Published, Green Submitted			2022-12-27	WOS:000332842400086
J	Gressette, M; Verillaud, B; Jimenez-Pailhes, AS; Lelievre, H; Lo, KW; Ferrand, FR; Gattolliat, CH; Jacquet-Bescond, A; Kraus-Berthier, L; Depil, S; Busson, P				Gressette, Melanie; Verillaud, Benjamin; Jimenez-Pailhes, Anne-Sophie; Lelievre, Helene; Lo, Kwok-Wai; Ferrand, Francois-Regis; Gattolliat, Charles-Henry; Jacquet-Bescond, Anne; Kraus-Berthier, Laurence; Depil, Stephane; Busson, Pierre			Treatment of Nasopharyngeal Carcinoma Cells with the Histone-Deacetylase Inhibitor Abexinostat: Cooperative Effects with Cis-platin and Radiotherapy on Patient-Derived Xenografts	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; SUBEROYLANILIDE HYDROXAMIC ACID; PHASE-II; CONCURRENT CHEMORADIOTHERAPY; RANDOMIZED-TRIALS; INDUCED APOPTOSIS; GROWTH-FACTOR; P53 GENE; CHEMOTHERAPY; EXPRESSION	EBV-related nasopharyngeal carcinomas (NPCs) still raise serious therapeutic problems. The therapeutic potential of the histone-deacetylase (HDAC) inhibitor Abexinostat was investigated using 5 preclinical NPC models including 2 patient-derived xenografts (C15 and C17). The cytotoxicity of Abexinostat used either alone or in combination with cis-platin or irradiation was assessed in vitro by MTT and clonogenic assays using 2 EBV-negative (CNE1 and HONE1) and 3 EBV-positive NPC models (C15, C17 and C666-1). Subsequently, the 3 EBV-positive models were used under the form of xenografts to assess the impact of systemic treatments by Abexinostat or combinations of Abexinostat with cis-platin or irradiation. Several cell proteins known to be affected by HDAC inhibitors and the small viral non-coding RNA EBER1 were investigated in the treated tumors. Synergistic cytotoxic effects of Abexinostat combined with cis-platin or irradiation were demonstrated in vitro for each NPC model. When using xenografts, Abexinostat by itself (12.5 mg/kg, BID, 4 days a week for 3 weeks) had significant anti-tumor effects against C17. Cooperative effects with cis-platin (2 mg/kg, IP, at days 3, 10 and 17) and irradiation (1Gy) were observed for the C15 and C17 xenografts. Simultaneously two types of biological alterations were induced in the tumor tissue, especially in the C17 model: a depletion of the DNA-repair protein RAD51 and a stronger in situ detection of the small viral RNA EBER1. Overall, these results support implementation of phase I/II clinical trials of Abexinostat for the treatment of NPC. A depletion of RAD51 is likely to contribute to the cooperation of Abexinostat with DNA damaging agents. Reduction of RAD51 combined to enhanced detection of EBER 1 might be helpful for early assessment of tumor response.	[Gressette, Melanie; Verillaud, Benjamin; Jimenez-Pailhes, Anne-Sophie; Gattolliat, Charles-Henry; Busson, Pierre] Univ Paris 11, CNRS, UMR 8126, Villejuif, France; [Gressette, Melanie; Verillaud, Benjamin; Jimenez-Pailhes, Anne-Sophie; Gattolliat, Charles-Henry; Busson, Pierre] Gustave Roussy, Villejuif, France; [Lelievre, Helene; Jacquet-Bescond, Anne; Kraus-Berthier, Laurence; Depil, Stephane] Inst Rech Int Servier, Suresnes, France; [Lo, Kwok-Wai] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Ferrand, Francois-Regis] Hop Val de Grace, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Servier; Institut de Recherches Internationales Servier; Chinese University of Hong Kong; Val-de-Grace Hospital	Busson, P (corresponding author), Univ Paris 11, CNRS, UMR 8126, Villejuif, France.	pbusson@igr.fr	Verillaud, Benjamin/AAM-5105-2020	Busson, Pierre/0000-0003-1027-3400; Verillaud, Benjamin/0000-0003-0611-4570	Servier, a company developing Abexinostat; Institut Gustave Roussy; Institut National du Cancer [FOR - 2010-INCa_3113]; APHP-CNRS [RAFCNR11]	Servier, a company developing Abexinostat; Institut Gustave Roussy; Institut National du Cancer(Institut National du Cancer (INCA) France); APHP-CNRS(Centre National de la Recherche Scientifique (CNRS))	Research carried by Pierre Busson's group has been supported by a contract linking Servier, a company developing Abexinostat, and Institut Gustave Roussy. Benjamin Verillaud was the recipient of a fellowship from the Institut National du Cancer (FOR - 2010-INCa_3113) and from the APHP-CNRS (RAFCNR11). Helene Lelievre, Anne Jacquet-Bescond, Laurence Kraus-Berthier, and Stephane Depil are employed by Servier, and had a role in study design, data analysis, decision to publish, and preparation of the manuscript.	Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Ali A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.260; Balluff B, 2011, AM J PATHOL, V179, P2720, DOI 10.1016/j.ajpath.2011.08.032; Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; BERENBAUM MC, 1981, ADV CANCER RES, V35, P269, DOI 10.1016/S0065-230X(08)60912-4; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; BUSSON P, 1988, INT J CANCER, V42, P599, DOI 10.1002/ijc.2910420422; Chan ATC, 2005, J CLIN ONCOL, V23, P3568, DOI 10.1200/JCO.2005.02.147; Chan SYY, 2008, INT J CANCER, V122, P2169, DOI 10.1002/ijc.23374; Chen L, 2012, LANCET ONCOL, V13, P163, DOI 10.1016/S1470-2045(11)70320-5; Chen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079781; Chen XF, 2012, MOL CANCER RES, V10, P1052, DOI 10.1158/1541-7786.MCR-11-0587; Cheng Y, 2000, GENE CHROMOSOME CANC, V28, P82, DOI 10.1002/(SICI)1098-2264(200005)28:1<82::AID-GCC10>3.0.CO;2-8; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Chua DTT, 2004, INT J RADIAT ONCOL, V59, P11, DOI 10.1016/j.ijrobp.2003.10.038; EFFERT P, 1992, J VIROL, V66, P3768, DOI 10.1128/JVI.66.6.3768-3775.1992; Feng BJ, 2013, ADV EXP MED BIOL, V778, P23; Fotheringham S, 2009, CANCER CELL, V15, P57, DOI 10.1016/j.ccr.2008.12.001; Friboulet L, 2008, NEOPLASIA, V10, P1183, DOI 10.1593/neo.08590; Gourzones C, 2013, ADV EXP MED BIOL, V778, P42; Hui EP, 2011, ANN ONCOL, V22, P1280, DOI 10.1093/annonc/mdq629; Hui EP, 2013, ADV EXP MED BIOL, V778, P149; Hui EP, 2002, CLIN CANCER RES, V8, P2595; Hui KF, 2012, INT J CANCER, V131, P1930, DOI 10.1002/ijc.27439; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Jin Y, 2013, EUR J CANCER, V49, P1619, DOI 10.1016/j.ejca.2012.11.032; Kerr E, 2012, CELL DEATH DIFFER, V19, P1317, DOI 10.1038/cdd.2012.8; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Lee N, 2012, RNA, V18, P2073, DOI 10.1261/rna.034900.112; Lim WT, 2011, CLIN CANCER RES, V17, P5481, DOI 10.1158/1078-0432.CCR-10-3409; Pow EHN, 2006, INT J RADIAT ONCOL, V66, P981, DOI 10.1016/j.ijrobp.2006.06.013; Salvador MA, 2013, CLIN CANCER RES, V19, P6520, DOI 10.1158/1078-0432.CCR-13-0877; Sbih-Lammali F, 1999, CANCER RES, V59, P924; Su Sheng-Fa, 2011, Chin J Cancer, V30, P565, DOI 10.5732/cjc.010.10547; Takada K, 2012, SEMIN CANCER BIOL, V22, P162, DOI 10.1016/j.semcancer.2011.12.007; TOCZYSKI DP, 1994, P NATL ACAD SCI USA, V91, P3463, DOI 10.1073/pnas.91.8.3463; Weinrib L, 2001, CANCER GENE THER, V8, P352, DOI 10.1038/sj.cgt.7700319; Xiao X, 2007, INT J CANCER, V121, P2095, DOI 10.1002/ijc.22955; Zhang L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-558	39	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91325	10.1371/journal.pone.0091325	http://dx.doi.org/10.1371/journal.pone.0091325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618637	gold, Green Published, Green Submitted			2022-12-27	WOS:000332842400075
J	Jia, JY; Jin, YX; Bian, T; Wu, DH; Yang, LJ; Terada, N; Wu, WH; Jin, SG				Jia, Jingyue; Jin, Yongxin; Bian, Ting; Wu, Donghai; Yang, Lijun; Terada, Naohiro; Wu, Weihui; Jin, Shouguang			Bacterial Delivery of TALEN Proteins for Human Genome Editing	PLOS ONE			English	Article							DNA-BINDING SPECIFICITY; DOUBLE-STRAND BREAKS; PSEUDOMONAS-AERUGINOSA; EFFECTOR NUCLEASES; III EFFECTORS; SECRETION; FIBROBLASTS; GENERATION; INJECTION; KNOCKOUT	Transcription Activator-Like Effector Nucleases (TALENs) are a novel class of sequence-specific nucleases that have recently gained prominence for its ease of production and high efficiency in genome editing. A TALEN pair recognizes specific DNA sequences and introduce double-strand break in the target site, triggering non-homologous end joining and homologous recombination. Current methods of TALEN delivery involves introduction of foreign genetic materials, such as plasmid DNA or mRNA, through transfection. Here, we show an alternative way of TALEN delivery, bacterial type III secretion system (T3SS) mediated direct injection of the TALEN proteins into human cells. Bacterially injected TALEN was shown to efficiently target host cell nucleus where it persists for almost 12 hours. Using a pair of TALENs targeting venus gene, such injected nuclear TALENs were shown functional in introducing DNA mutation in the target site. Interestingly, S-phase cells seem to show greater sensitivity to the TALEN mediated target gene modification. Accordingly, efficiency of such genome editing can easily be manipulated by the infection dose, number of repeated infections as well as enrichment of S phase cells. This work further extends the utility of T3SS in the delivery of functional proteins into mammalian cells to alter their characters for biomedical applications.	[Jia, Jingyue; Jin, Yongxin; Bian, Ting; Wu, Weihui; Jin, Shouguang] Nankai Univ, Dept Microbiol, Minist Educ, Key Lab, Tianjin 300071, Peoples R China; [Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Guangdong, Peoples R China; [Yang, Lijun; Terada, Naohiro] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Jin, Shouguang] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	Nankai University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Wu, WH (corresponding author), Nankai Univ, Dept Microbiol, Minist Educ, Key Lab, Tianjin 300071, Peoples R China.	wuweihui@nankai.edu.cn; sjin@ufl.edu	Jin, Shouguang/N-5548-2016	jia, jingyue/0000-0002-1522-9612	National Science Foundation of China [31170128]; National Basic Research Program of China (973 Program) [2012CB518700, 2010CB945500]; National Institutes of Health [RC1GM091238]; Bankhead-Coley Cancer Research Program [FLDH 09BW-12]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091238] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bankhead-Coley Cancer Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Science Foundation of China (31170128), National Basic Research Program of China (973 Program, 2012CB518700 and 2010CB945500), National Institutes of Health (RC1GM091238) and Bankhead-Coley Cancer Research Program (FLDH 09BW-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bichsel C, 2013, CELL REPROGRAM, V15, P117, DOI 10.1089/cell.2012.0058; Bichsel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016465; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Buttner D, 2004, MOL MICROBIOL, V54, P755, DOI 10.1111/j.1365-2958.2004.04302.x; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Grau J, 2013, BIOINFORMATICS, V29, P2931, DOI 10.1093/bioinformatics/btt501; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Khan M, 2013, BIOMATERIALS, V34, P5336, DOI 10.1016/j.biomaterials.2013.03.072; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mukherjee S, 2013, GENE, V525, P174, DOI 10.1016/j.gene.2013.03.098; Pastor A, 2005, FEMS MICROBIOL LETT, V253, P95, DOI 10.1016/j.femsle.2005.09.028; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Wolff Jon A., 1992, Human Molecular Genetics, V1, P363, DOI 10.1093/hmg/1.6.363; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	26	23	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91547	10.1371/journal.pone.0091547	http://dx.doi.org/10.1371/journal.pone.0091547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618838	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400103
J	Liu, D; Wu, AD; Cui, L; Hao, RD; Wang, Y; He, J; Guo, DY				Liu, Dan; Wu, An'dong; Cui, Lei; Hao, Ruidong; Wang, Yuan; He, Jing; Guo, Deyin			Hepatitis B Virus Polymerase Suppresses NF-kappa B Signaling by Inhibiting the Activity of IKKs via Interaction with Hsp90 beta	PLOS ONE			English	Article							X-PROTEIN; GENE-EXPRESSION; KINASE-ACTIVITY; ALPHA; TRANSCRIPTION; BINDING; ACTIVATION; PHOSPHORYLATION; INFECTION; SUBUNIT	Nuclear factor-kappa B (NF-kappa B) plays a central role in the regulation of diverse biological processes, including immune responses, development, cell growth, and cell survival. To establish persistent infection, many viruses have evolved strategies to evade the host's antiviral immune defenses. In the case of hepatitis B virus (HBV), which can cause chronic infection in the liver, immune evasion strategies used by the virus are not fully understood. It has recently been reported that the polymerase of HBV (Pol) inhibits interferon-beta (IFN-beta) activity by disrupting the interaction between IKK epsilon and the DDX3. In the current study, we found that HBV Pol suppressed NF-kB signaling, which can also contribute to IFN-beta production. HBV Pol did not alter the level of NF-kappa B expression, but it prevented NF-kappa B subunits involved in both the canonical and non-canonical NF-kappa B pathways from entering the nucleus. Further experiments demonstrated that HBV Pol preferentially suppressed the activity of the I kappa B kinase (IKK) complex by disrupting the association of IKK/NEMO with Cdc37/Hsp90, which is critical for the assembly of the IKK complex and recruitment of the IKK complex to the tumor necrosis factor type 1 receptor (TNF-R1). Furthermore, we found that HBV Pol inhibited the NF-kappa B-mediated transcription of target genes. Taken together, it is suggested that HBV Pol could counteract host innate immune responses by interfering with two distinct signaling pathways required for IFN-beta activation. Our studies therefore shed light on a potential therapeutic target for persistent infection with HBV.	[Guo, Deyin] Wuhan Univ, Natl Key Lab Virol, Wuhan 430072, Peoples R China; Wuhan Univ, Modern Virol Res Ctr, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Guo, DY (corresponding author), Wuhan Univ, Natl Key Lab Virol, Wuhan 430072, Peoples R China.	dguo@whu.edu.cn			China "973'' Basic Research Program [2010CB911800]; China NSFC [31221061]; Hubei Provincial Science & Technology Innovation Team [2012FFA043]; Hubei Province's Outstanding Medical Academic Leader Program	China "973'' Basic Research Program(National Basic Research Program of China); China NSFC(National Natural Science Foundation of China (NSFC)); Hubei Provincial Science & Technology Innovation Team; Hubei Province's Outstanding Medical Academic Leader Program	This study was supported by China "973'' Basic Research Program (#2010CB911800), China NSFC (grant 31221061) and Hubei Provincial Science & Technology Innovation Team grant (#2012FFA043). D.G. is also supported by Hubei Province's Outstanding Medical Academic Leader Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; BARTENSCHLAGER R, 1992, EMBO J, V11, P3413, DOI 10.1002/j.1460-2075.1992.tb05420.x; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Cho G, 2000, BIOCHEM BIOPH RES CO, V269, P191, DOI 10.1006/bbrc.2000.2240; Cho GA, 2000, BIOCHEM BIOPH RES CO, V274, P203, DOI 10.1006/bbrc.2000.3119; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Harling-McNabb L, 1999, INT IMMUNOL, V11, P1431, DOI 10.1093/intimm/11.9.1431; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hildt E, 1996, VIROLOGY, V225, P235, DOI 10.1006/viro.1996.0594; Hinz M, 2007, J BIOL CHEM, V282, P32311, DOI 10.1074/jbc.M705785200; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Lara-Pezzi E, 1998, HEPATOLOGY, V28, P1013, DOI 10.1002/hep.510280416; Lee Y, 1998, CLIN CANCER RES, V4, P1711; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; MAHE Y, 1991, J BIOL CHEM, V266, P13759; Nam NH, 2006, MINI-REV MED CHEM, V6, P945, DOI 10.2174/138955706777934937; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Park SG, 2002, ARCH BIOCHEM BIOPHYS, V401, P99, DOI 10.1016/S0003-9861(02)00004-8; POLLACK JR, 1994, J VIROL, V68, P5579, DOI 10.1128/JVI.68.9.5579-5587.1994; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Rodriguez CI, 2002, J VIROL, V76, P3936, DOI 10.1128/JVI.76.8.3936-3942.2002; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Su F, 1996, J VIROL, V70, P4558, DOI 10.1128/JVI.70.7.4558-4566.1996; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Tait SWG, 2000, J BIOL CHEM, V275, P34656, DOI 10.1074/jbc.M000320200; Wang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000986; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wu M, 2007, J GEN VIROL, V88, P3260, DOI 10.1099/vir.0.82959-0	43	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91658	10.1371/journal.pone.0091658	http://dx.doi.org/10.1371/journal.pone.0091658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618592	gold, Green Published, Green Submitted			2022-12-27	WOS:000332842400113
J	Monsey, MS; Boyle, LM; Zhang, ML; Nguyen, CP; Kronman, HG; Ota, KT; Duman, RS; Taylor, JR; Schafe, GE				Monsey, Melissa S.; Boyle, Lara M.; Zhang, Melinda L.; Nguyen, Caroline P.; Kronman, Hope G.; Ota, Kristie T.; Duman, Ronald S.; Taylor, Jane R.; Schafe, Glenn E.			Chronic Corticosterone Exposure Persistently Elevates the Expression of Memory-Related Genes in the Lateral Amygdala and Enhances the Consolidation of a Pavlovian Fear Memory	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; EPIGENETIC MECHANISMS; CONTRASTING PATTERNS; CELL-PROLIFERATION; DORSAL HIPPOCAMPUS; PROTEIN ARC/ARG3.1; SPATIAL MEMORY; MAP KINASE; STRESS; BRAIN	Chronic exposure to stress has been widely implicated in the development of anxiety disorders, yet relatively little is known about the long-term effects of chronic stress on amygdala-dependent memory formation. Here, we examined the effects of a history of chronic exposure to the stress-associated adrenal steroid corticosterone (CORT) on the consolidation of a fear memory and the expression of memory-related immediate early genes (IEGs) in the lateral nucleus of the amygdala (LA). Rats received chronic exposure to CORT (50 mu g/ml) in their drinking water for 2 weeks and were then titrated off the CORT for an additional 6 days followed by a 2 week 'wash-out' period consisting of access to plain water. Rats were then either sacrificed to examine the expression of memory-related IEG expression in the LA or given auditory Pavlovian fear conditioning. We show that chronic exposure to CORT leads to a persistent elevation in the expression of the IEGs Arc/Arg3.1 and Egr-1 in the LA. Further, we show that rats with a history of chronic CORT exposure exhibit enhanced consolidation of a fear memory; short-term memory (STM) is not affected, while long-term memory (LTM) is significantly enhanced. Treatment with the selective serotonin reuptake inhibitor (SSRI) fluoxetine following the chronic CORT exposure period was observed to effectively reverse both the persistent CORT-related increases in memory-related IEG expression in the LA and the CORT-related enhancement in fear memory consolidation. Our findings suggest that chronic exposure to CORT can regulate memory-related IEG expression and fear memory consolidation processes in the LA in a long-lasting manner and that treatment with fluoxetine can reverse these effects.	[Monsey, Melissa S.; Boyle, Lara M.; Zhang, Melinda L.; Nguyen, Caroline P.; Kronman, Hope G.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Duman, Ronald S.; Taylor, Jane R.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA; [Ota, Kristie T.; Duman, Ronald S.; Taylor, Jane R.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Schafe, Glenn E.] CUNY, Dept Psychol, New York, NY 10021 USA; [Schafe, Glenn E.] CUNY, Hunter Coll, Ctr Study Gene Struct & Funct, New York, NY 10021 USA; [Schafe, Glenn E.] CUNY, Grad Ctr, New York, NY 10021 USA	Yale University; Yale University; Yale University; City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System	Schafe, GE (corresponding author), CUNY, Dept Psychol, New York, NY 10021 USA.	glenn.schafe@hunter.cuny.edu		Kronman, Hope/0000-0002-2828-723X	National Institutes of Health [MH 073949]; Yale University; Hunter Gene Center; American Psychological Association Dissertation Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; Hunter Gene Center; American Psychological Association Dissertation Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institutes of Health Grant MH 073949 (to GES), Yale University and The Hunter Gene Center. MSM is supported by an American Psychological Association Dissertation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBEL I, 1994, BRAIN RES, V657, P227, DOI 10.1016/0006-8993(94)90972-5; Barrett RM, 2008, LEARN MEMORY, V15, P460, DOI 10.1101/lm.917508; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P299, DOI 10.1016/S0166-4328(02)00045-1; Birmaher B, 2003, J AM ACAD CHILD PSY, V42, P415, DOI 10.1097/01.CHI.0000037049.04952.9F; BODNOFF SR, 1995, J NEUROSCI, V15, P61; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; Burghardt NS, 2013, NEUROSCIENCE, V247, P253, DOI 10.1016/j.neuroscience.2013.05.050; Burghardt NS, 2013, BIOL PSYCHIAT, V73, P1078, DOI 10.1016/j.biopsych.2012.10.012; Burghardt NS, 2004, BIOL PSYCHIAT, V55, P1171, DOI 10.1016/j.biopsych.2004.02.029; Conrad CD, 1999, BEHAV NEUROSCI, V113, P902, DOI 10.1037/0735-7044.113.5.902; Conrad CD, 2004, NEUROBIOL LEARN MEM, V81, P185, DOI 10.1016/j.nlm.2004.01.002; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; DACHIR S, 1993, BEHAV NEURAL BIOL, V60, P103, DOI 10.1016/0163-1047(93)90173-F; Dagyte G, 2009, NEUROSCIENCE, V162, P904, DOI 10.1016/j.neuroscience.2009.05.053; Gourley SL, 2008, BIOL PSYCHIAT, V64, P884, DOI 10.1016/j.biopsych.2008.06.016; Gourley SL, 2008, BIOL PSYCHIAT, V63, P353, DOI 10.1016/j.biopsych.2007.07.016; Gourley SL, 2013, J NEUROSCI, V33, P3107, DOI 10.1523/JNEUROSCI.2138-12.2013; Gourley Shannon L, 2009, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0932s49; Gourley SL, 2009, NEUROPSYCHOPHARMACOL, V34, P707, DOI 10.1038/npp.2008.123; Gourley SL, 2008, ANN NY ACAD SCI, V1148, P509, DOI 10.1196/annals.1410.076; Johnson LR, 2005, NEUROSCIENCE, V136, P289, DOI 10.1016/j.neuroscience.2005.06.050; Kent JM, 1998, BIOL PSYCHIAT, V44, P812, DOI 10.1016/S0006-3223(98)00210-8; Lakshminarasimhan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030481; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; LUINE V, 1994, BRAIN RES, V639, P167, DOI 10.1016/0006-8993(94)91778-7; Maddox SA, 2013, LEARN MEMORY, V20, P109, DOI 10.1101/lm.029157.112; Maddox SA, 2011, J NEUROSCI, V31, P7073, DOI 10.1523/JNEUROSCI.1120-11.2011; Maddox SA, 2011, LEARN MEMORY, V18, P24, DOI 10.1101/lm.1980211; Magarinos AM, 1998, BRAIN RES, V809, P314, DOI 10.1016/S0006-8993(98)00882-8; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Matus-Amat P, 2004, J NEUROSCI, V24, P2431, DOI 10.1523/JNEUROSCI.1598-03.2004; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Monsey MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019958; Newport DJ, 2000, CURR OPIN NEUROBIOL, V10, P211, DOI 10.1016/S0959-4388(00)00080-5; Ou LC, 2006, NEUROPSYCHOPHARMACOL, V31, P287, DOI 10.1038/sj.npp.1300830; Ou LC, 2007, MOL PHARMACOL, V72, P350, DOI 10.1124/mol.107.034934; PAVLIDES C, 1993, HIPPOCAMPUS, V3, P183, DOI 10.1002/hipo.450030210; Pillai AG, 2012, NEUROPSYCHOPHARMACOL, V37, P2702, DOI 10.1038/npp.2012.135; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; Rattiner LM, 2004, LEARN MEMORY, V11, P727, DOI 10.1101/lm.83304; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Rudy JW, 2002, BEHAV NEUROSCI, V116, P530, DOI 10.1037//0735-7044.116.4.530; Schafe GE, 2000, J NEUROSCI, V20, P8177; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Vyas A, 2006, NEUROSCIENCE, V143, P387, DOI 10.1016/j.neuroscience.2006.08.003; Vyas A, 2004, BEHAV NEUROSCI, V118, P1450, DOI 10.1037/0735-7044.118.6.1450; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Vyas A, 2002, J NEUROSCI, V22, P6810; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A; Xu JJ, 2011, NEUROSCIENCES, V16, P257; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006	63	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91530	10.1371/journal.pone.0091530	http://dx.doi.org/10.1371/journal.pone.0091530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618807	Green Published, gold			2022-12-27	WOS:000332842400101
J	Perlman, S; Wamai, RG; Bain, PA; Welty, T; Welty, E; Ogembo, JG				Perlman, Stacey; Wamai, Richard G.; Bain, Paul A.; Welty, Thomas; Welty, Edith; Ogembo, Javier Gordon			Knowledge and Awareness of HPV Vaccine and Acceptability to Vaccinate in Sub-Saharan Africa: A Systematic Review	PLOS ONE			English	Review							PAPILLOMA-VIRUS VACCINE; CERVICAL-CANCER PREVENTION; WOMENS KNOWLEDGE; HIGH COVERAGE; HEALTH; ATTITUDES; ACCEPTANCE; INFECTION; BELIEFS; PROGRAM	Objectives: We assessed the knowledge and awareness of cervical cancer, HPV and HPV vaccine, and willingness and acceptability to vaccinate in sub-Saharan African (SSA) countries. We further identified countries that fulfill the two GAVI Alliance eligibility criteria to support nationwide HPV vaccination. Methods: We conducted a systematic review of peer-reviewed studies on the knowledge and awareness of cervical cancer, HPV and HPV vaccine, and willingness and acceptability to vaccinate. Trends in Diphtheria-tetanus-pertussis (DTP3) vaccine coverage in SSA countries from 1990-2011 were extracted from the World Health Organization database. Findings: The review revealed high levels of willingness and acceptability of HPV vaccine but low levels of knowledge and awareness of cervical cancer, HPV or HPV vaccine. We identified only six countries to have met the two GAVI Alliance requirements for supporting introduction of HPV vaccine: 1) the ability to deliver multi-dose vaccines for no less than 50% of the target vaccination cohort in an average size district, and 2) achieving over 70% coverage of DTP3 vaccine nationally. From 2008 through 2011 all SSA countries, with the exception of Mauritania and Nigeria, have reached or maintained DTP3 coverage at 70% or above. Conclusion: There is an urgent need for more education to inform the public about HPV, HPV vaccine, and cervical cancer, particularly to key demographics, (adolescents, parents and healthcare professionals), to leverage high levels of willingness and acceptability of HPV vaccine towards successful implementation of HPV vaccination programs. There is unpreparedness in most SSA countries to roll out national HPV vaccination as per the GAVI Alliance eligibility criteria for supporting introduction of the vaccine. In countries that have met 70% DTP3 coverage, pilot programs need to be rolled out to identify the best practice and strategies for delivering HPV vaccines to adolescents and also to qualify for GAVI Alliance support.	[Perlman, Stacey] Pathfinder Int, Watertown, MA USA; [Wamai, Richard G.] Northeastern Univ, Boston, MA 02115 USA; [Bain, Paul A.] Harvard Univ, Sch Med, Countway Lib Med, Boston, MA USA; [Welty, Thomas; Welty, Edith] Cameroon Baptist Convent Hlth Serv, Bamenda, Cameroon; [Ogembo, Javier Gordon] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA	Northeastern University; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester	Ogembo, JG (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01605 USA.	javier.ogembo@umassmed.edu	Bain, Paul A./P-3641-2016	Bain, Paul A./0000-0002-4257-2467; Ogembo, Javier Gordon/0000-0001-6949-8693				Agosti JM, 2007, NEW ENGL J MED, V356, P1908, DOI 10.1056/NEJMp078053; Allen JD, 2010, VACCINE, V28, P4027, DOI 10.1016/j.vaccine.2010.03.063; [Anonymous], 2013, LANCET, V381, P1688, DOI 10.1016/S0140-6736(13)61058-2; Anorlu RI, 2008, REPROD HEALTH MATTER, V16, P41, DOI 10.1016/S0968-8080(08)32415-X; Ayissi CA, 2012, J COMMUN HEALTH, V37, P1127, DOI 10.1007/s10900-012-9554-z; Banura C, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-24; Bean SJ, 2011, VACCINE, V29, P1874, DOI 10.1016/j.vaccine.2011.01.003; Becker-Dreps S, 2010, VACCINE, V28, P4864, DOI 10.1016/j.vaccine.2010.05.034; Binagwaho A, 2012, B WORLD HEALTH ORGAN, V90, P623, DOI 10.2471/BLT.11.097253; Binagwaho A, 2011, LANCET, V378, P1916, DOI 10.1016/S0140-6736(11)61837-0; Chan ZCY, 2012, PUBLIC HEALTH NURS, V29, P481, DOI 10.1111/j.1525-1446.2012.01022.x; Chauke-Moagi BE, 2012, VACCINE, V30, pC3, DOI 10.1016/j.vaccine.2012.05.086; Coleman MA, 2011, VACCINE, V29, P3945, DOI 10.1016/j.vaccine.2011.03.093; Crowcroft NS, 2013, LANCET INFECT DIS, V13, P564, DOI 10.1016/S1473-3099(13)70131-2; DiAngi YT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025481; Ebosse Y, 2010, LE SOIR HEBD; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Francis SA, 2011, VACCINE, V29, P8760, DOI 10.1016/j.vaccine.2011.07.116; Francis SA, 2010, VACCINE, V28, P8026, DOI 10.1016/j.vaccine.2010.08.090; Friedrich MJ, 2013, JAMA-J AM MED ASSOC, V309, P1101, DOI 10.1001/jama.2013.2400; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Galagan SR, 2013, VACCINE; Gilmour S, 2013, LANCET, V382, P768, DOI 10.1016/S0140-6736(13)61831-0; Iliyasu Z, 2010, J OBSTET GYNAECOL, V30, P857, DOI 10.3109/01443615.2010.511724; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khan K.S., 2001, UNDERTAKING SYSTEMAT; Knaul FM, 2011, GLOBAL TASK FORCES E; Ladner J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-370; LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.089862, 10.2471/BLT.11.08986]; Larson HJ, 2013, LANCET INFECT DIS, V13, P606, DOI 10.1016/S1473-3099(13)70108-7; Larson HJ, 2010, LANCET, V376, P572, DOI 10.1016/S0140-6736(10)60881-1; Larson HJ, 2010, JAMA-J AM MED ASSOC, V303, P271, DOI 10.1001/jama.2009.2023; Levine OS, 2011, LANCET, V378, P439, DOI 10.1016/S0140-6736(11)60406-6; Liu FW, 2012, J VACCINES VACCINATI; Louie KS, 2009, TROP MED INT HEALTH, V14, P1287, DOI 10.1111/j.1365-3156.2009.02372.x; Machingaidze S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001405; Maher D, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-14; Makwe CC, 2011, INT J WOMENS HEALTH, V3, P313, DOI 10.2147/IJWH.S22792; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Mbamara SU, 2011, J REPROD MED, V56, P491; McCarey C, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-45; Mingo AM, 2012, INT J GYNECOL CANCER, V22, P638, DOI 10.1097/IGC.0b013e318249470a; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moodley I, 2013, SAMJ S AFR MED J, V103, P318, DOI 10.7196/SAMJ.6414; Morhason-Bello I, 2009, INT J GYNECOL OBSTET, V107, pS274; Mupepi SC, 2011, J WOMENS HEALTH, V20, P943, DOI 10.1089/jwh.2010.2062; Nelson JA, 2010, SEX REPROD HEALTHC, V1, P195, DOI 10.1016/j.srhc.2010.07.004; Omer SB, 2013, NEW ENGL J MED, V368, P1374, DOI 10.1056/NEJMp1300765; Ovedraogo N, 2011, LANCET, V378, P315, DOI 10.1016/S0140-6736(11)61164-1; Ozawa S, 2011, HEALTH AFFAIR, V30, P1010, DOI 10.1377/hlthaff.2011.0381; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Paterson P, 2012, HEALTH POLICY PLANN, V27, pII77, DOI 10.1093/heapol/czs038; Petticrew M, 2006, SYSTEMATIC REVIEWS IN THE SOCIAL SCIENCES: A PRACTICAL GUIDE, P1, DOI 10.1002/9780470754887; Poole D, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S2-O27; Remes P, 2012, VACCINE; Rositch AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040766; Sitas F, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P289; Tan TPY, 2009, INT J EVID-BASED HEA, V7, P169, DOI 10.1111/j.1744-1609.2009.00135.x; Ugwu EO, 2013, NIGER J CLIN PRACT, V16, P249, DOI 10.4103/1119-3077.110141; Urasa M, 2011, AFRICAN HLTH SCI, V11; Wamai RG, 2013, INT J NURSING STUDIE; Wamai RG, 2013, INT J NURS STUD, V50, P1399, DOI 10.1016/j.ijnurstu.2012.12.020; Wamai RG, 2012, J COMMUN HEALTH, V37, P917, DOI 10.1007/s10900-012-9540-5; Watson-Jones D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045231; Watson-Jones D, 2012, J INFECT DIS, V206, P678, DOI 10.1093/infdis/jis407; WHO, 2009, HUM PAP VACC; WHO, 2012, PROGR GLOB IMM GOALS; Wigle J, 2013, VACCINE	68	105	105	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90912	10.1371/journal.pone.0090912	http://dx.doi.org/10.1371/journal.pone.0090912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24618636	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400035
J	Ren, JP; Liu, GL; Go, J; Kolli, D; Zhang, GP; Bao, XY				Ren, Junping; Liu, Guangliang; Go, Jonathan; Kolli, Deepthi; Zhang, Guanping; Bao, Xiaoyong			Human Metapneumovirus M2-2 Protein Inhibits Innate Immune Response in Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; TOLL-LIKE RECEPTORS; INDUCIBLE GENE-I; YOUNG-CHILDREN; RIG-I; INFECTION; INTERFERON; INDUCTION; TRAFFICKING; RECOGNITION	Human metapneumovirus (hMPV) is a leading cause of lower respiratory infection in young children, the elderly and immunocompromised patients. Repeated hMPV infections occur throughout life. However, immune evasion mechanisms of hMPV infection are largely unknown. Recently, our group has demonstrated that hMPV M2-2 protein, an important virulence factor, contributes to immune evasion in airway epithelial cells by targeting the mitochondrial antiviral-signaling protein (MAVS). Whether M2-2 regulates the innate immunity in human dendritic cells (DC), an important family of immune cells controlling antigen presenting, is currently unknown. We found that human DC infected with a virus lacking M2-2 protein expression (rhMPV-Delta M2-2) produced higher levels of cytokines, chemokines and IFNs, compared to cells infected with wild-type virus (rhMPV-WT), suggesting that M2-2 protein inhibits innate immunity in human DC. In parallel, we found that myeloid differentiation primary response gene 88 (MyD88), an essential adaptor for Toll-like receptors (TLRs), plays a critical role in inducing immune response of human DC, as downregulation of MyD88 by siRNA blocked the induction of immune regulatory molecules by hMPV. Since M2-2 is a cytoplasmic protein, we investigated whether M2-2 interferes with MyD88-mediated antiviral signaling. We found that indeed M2-2 protein associated with MyD88 and inhibited MyD88-dependent gene transcription. In this study, we also identified the domains of M2-2 responsible for its immune inhibitory function in human DC. In summary, our results demonstrate that M2-2 contributes to hMPV immune evasion by inhibiting MyD88-dependent cellular responses in human DC.	[Ren, Junping; Liu, Guangliang; Go, Jonathan; Kolli, Deepthi; Bao, Xiaoyong] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Liu, Guangliang; Zhang, Guanping] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Otorhinolaryngol, Guangzhou 510275, Guangdong, Peoples R China; [Bao, Xiaoyong] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; Sun Yat Sen University; University of Texas System; University of Texas Medical Branch Galveston	Bao, XY (corresponding author), Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.	xibao@utmb.edu			National Institutes of Health-National Institute of Allergy and Infectious Diseases [KAI074829A]; American Lung Association [RG232529N]; American Heart Association [12BGIA12060008]; Sun Yat-Sen University, Guangzhou, China; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Lung Association; American Heart Association(American Heart Association); Sun Yat-Sen University, Guangzhou, China; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants from the National Institutes of Health-National Institute of Allergy and Infectious Diseases KAI074829A, the American Lung Association RG232529N, and American Heart Association 12BGIA12060008 to X.B. G.L. was supported by a student scholarship from Sun Yat-Sen University, Guangzhou, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banos-Lara MD, 2013, J VIROL, V87, P1242, DOI 10.1128/JVI.01213-12; Bao XY, 2008, J VIROL, V82, P8224, DOI 10.1128/JVI.02584-07; Bao XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062568; Bao XY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000077; Boogaard I, 2007, IMMUNOLOGY, V122, P65, DOI 10.1111/j.1365-2567.2007.02613.x; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Chen S, 2007, J ENDOTOXIN RES, V13, P281, DOI 10.1177/0968051907085096; Davidson S, 2011, J IMMUNOL, V186, P5938, DOI 10.4049/jimmunol.1002635; de Graaff PAA, 2005, J IMMUNOL, V175, P5904, DOI 10.4049/jimmunol.175.9.5904; Edwards KM, 2013, NEW ENGL J MED, V368, P633, DOI 10.1056/NEJMoa1204630; Englund JA, 2006, ANN INTERN MED, V144, P344, DOI 10.7326/0003-4819-144-5-200603070-00010; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Goutagny N, 2010, J IMMUNOL, V184, P1168, DOI 10.4049/jimmunol.0902750; Guerrero-Plata A, 2006, AM J RESP CELL MOL, V34, P320, DOI 10.1165/rcmb.2005-0287OC; Guerrero-Plata A, 2005, J VIROL, V79, P10190, DOI 10.1128/JVI.79.16.10190-10199.2005; Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Jakubzick C, 2006, J IMMUNOL, V176, P3578, DOI 10.4049/jimmunol.176.6.3578; Jartti T, 2002, LANCET, V360, P1393, DOI 10.1016/S0140-6736(02)11391-2; Juarez E, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-2; Kawai T, 2005, ARTHRITIS RES THER, V7, P12, DOI 10.1186/ar1469; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2006, J BIOCH TOKYO; Kolli D, 2011, J IMMUNOL, V187, P47, DOI 10.4049/jimmunol.1002589; Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Liao S, 2008, J GEN VIROL, V89, P1978, DOI 10.1099/vir.0.2008/000778-0; Malmgaard L, 2004, J IMMUNOL, V173, P6890, DOI 10.4049/jimmunol.173.11.6890; Melchjorsen J, 2005, J VIROL, V79, P12944, DOI 10.1128/JVI.79.20.12944-12951.2005; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Ren J, 2013, VIRUS RES, DOI [10.1016/j.virusres.2013.06.014, DOI 10.1016/J.VIR-USRES.2013.06.014]; Ren JP, 2012, J VIROL, V86, P13049, DOI 10.1128/JVI.01248-12; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schreibelt G, 2010, CANCER IMMUNOL IMMUN, V59, P1573, DOI 10.1007/s00262-010-0833-1; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; van den Hoogen BG, 2007, CLIN INFECT DIS, V44, P1159, DOI 10.1086/513295; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; von Bernuth H, 2012, EUR J IMMUNOL, V42, P3126, DOI 10.1002/eji.201242683; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577	43	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91865	10.1371/journal.pone.0091865	http://dx.doi.org/10.1371/journal.pone.0091865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618691	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400137
J	Shen, HT; Cao, JS; Zhang, WJ; Zeng, XH; Wang, HR				Shen, Huitao; Cao, Jiansheng; Zhang, Wanjun; Zeng, Xinhua; Wang, Huaru			Winter Soil CO2 Flux from Different Mid-Latitude Sites from Middle Taihang Mountain in North China	PLOS ONE			English	Article							ECOSYSTEM RESPIRATION; WATER-CONTENT; TEMPERATURE; FOREST; PRECIPITATION; PLANTATION; DEPENDENCE; CLIMATE; LITTER; REGION	Winter soil respiration is a very important component of the annual soil carbon flux in some ecosystems. We hypothesized that, with all other factors being equal, shorter winter SR result in reduced contribution to annual soil C flux. In this study, the contribution of winter soil respiration to annual soil respiration was measured for three sites (grassland: dominated by Artemisia sacrorum, Bothriochloa ischaemum and Themeda japonica; shrubland: dominated by Vitex negundo var. heterophylla; plantation: dominated by Populus tomatosa) in a mountainous area of north China. Diurnal and intra-annual soil CO2 flux patterns were consistent among different sites, with the maximum soil respiration rates at 12:00 or 14:00, and in July or August. The lowest respiration rates were seen in February. Mean soil respiration rates ranged from 0.26 to 0.45 mu mol m(-2) s(-1) in the winter (December to February), and between 2.38 to 3.16 mu mol m(-2) s(-1) during the growing season (May-September). The winter soil carbon flux was 24.6 to 42.8 g C m(-2), which contributed 4.8 to 7.1% of the annual soil carbon flux. Based on exponential functions, soil temperature explained 73.8 to 91.8% of the within year variability in soil respiration rates. The Q(10) values of SR against ST at 10 cm ranged from 3.60 to 4.90 among different sites. In addition, the equation between soil respiration and soil temperature for the growing season was used to calculate the "modeled'' annual soil carbon flux based on the actual measured soil temperature. The "measured'' annual value was significantly higher than the "modeled'' annual value. Our results suggest that winter soil respiration plays a significant role in annual soil carbon balance, and should not be neglected when soil ecosystems are assessed as either sinks or sources of atmospheric CO2.	[Shen, Huitao; Cao, Jiansheng; Zhang, Wanjun; Zeng, Xinhua] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Key Lab Agr Water Resources,Hebei Key Lab Agr Wat, Shijiazhuang, Hebei, Peoples R China; [Wang, Huaru] Yellow River Water Resources Protect Inst, Zhengzhou, Henan, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Yangtze River Water Resources Protection Bureau	Zhang, WJ (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Key Lab Agr Water Resources,Hebei Key Lab Agr Wat, Shijiazhuang, Hebei, Peoples R China.	zhangwj@sjziam.ac.cn			Chinese Academy of Sciences [XDA05060600]; National Science and Technology Project in Rural Areas [2011BAD31B02]; CFERN & GENE Awards Funds on Ecological Paper	Chinese Academy of Sciences(Chinese Academy of Sciences); National Science and Technology Project in Rural Areas; CFERN & GENE Awards Funds on Ecological Paper	This work was supported by the "Strategic Priority Research Progam'' of Chinese Academy of Sciences (XDA05060600), the Twelfth Five-Year Plan of National Science and Technology Project in Rural Areas (2011BAD31B02), and CFERN & GENE Awards Funds on Ecological Paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, EOS T; Arevalo CBM, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001006; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Brooks PD, 2005, GLOBAL CHANGE BIOL, V11, P231, DOI 10.1111/j.1365-2486.2004.00877.x; Cao JS, 2013, HYDROL PROCESS, V27, P360, DOI 10.1002/hyp.9231; Chen QS, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003538; Cook FJ, 2008, SOIL BIOL BIOCHEM, V40, P1013, DOI 10.1016/j.soilbio.2007.12.012; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P230, DOI 10.1111/j.1365-2486.2005.01062.x; Dorrepaal E, 2009, NATURE, V460, P616, DOI 10.1038/nature08216; Du EZ, 2013, J PLANT ECOL, V6, P349, DOI 10.1093/jpe/rtt012; Elberling B, 2007, SOIL BIOL BIOCHEM, V39, P646, DOI 10.1016/j.soilbio.2006.09.017; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P220, DOI 10.1016/j.agrformet.2006.08.003; Grogan P, 2006, GLOBAL CHANGE BIOL, V12, P1479, DOI 10.1111/j.1365-2486.2006.01184.x; Han GX, 2012, ENVIRON MANAGE, V50, P39, DOI 10.1007/s00267-012-9869-7; Han SM, 2012, HYDROL PROCESS, V26, P1332, DOI 10.1002/hyp.8233; Jiang H, 2013, BIOGEOSCIENCES, V10, P3963, DOI 10.5194/bg-10-3963-2013; Kellman L, 2007, BIOGEOCHEMISTRY, V82, P101, DOI 10.1007/s10533-006-9056-0; Lellei-Kovacs E, 2011, EUR J SOIL BIOL, V47, P247, DOI 10.1016/j.ejsobi.2011.05.004; Li HJ, 2008, AGR FOREST METEOROL, V148, P490, DOI 10.1016/j.agrformet.2007.10.009; Li LJ, 2013, EUR J SOIL BIOL, V55, P83, DOI 10.1016/j.ejsobi.2012.12.009; Liu X.P., 2013, BIOGEOSCIENCES DISCU, V10, P11037; Luan JW, 2012, SOIL BIOL BIOCHEM, V44, P143, DOI 10.1016/j.soilbio.2011.08.012; Luo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042354; Mariko S, 2000, ECOL RES, V15, P363, DOI 10.1046/j.1440-1703.2000.00357.x; McDowell NG, 2000, TREE PHYSIOL, V20, P745; Michaelson GJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000920; Mo W, 2005, AGR FOREST METEOROL, V134, P81, DOI 10.1016/j.agrformet.2005.08.015; Monson RK, 2005, OECOLOGIA, V146, P130, DOI 10.1007/s00442-005-0169-2; Pavelka M, 2007, PLANT SOIL, V292, P171, DOI 10.1007/s11104-007-9213-9; Peng SS, 2009, SOIL BIOL BIOCHEM, V41, P1008, DOI 10.1016/j.soilbio.2008.10.023; Schindlbacher A, 2007, AGR FOREST METEOROL, V146, P205, DOI 10.1016/j.agrformet.2007.06.001; Shi XH, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004054; Song XZ, 2013, SCI TOTAL ENVIRON, V444, P363, DOI 10.1016/j.scitotenv.2012.12.006; Tang JW, 2008, AGR FOREST METEOROL, V148, P171, DOI 10.1016/j.agrformet.2007.08.008; Uchida M, 2005, AGR FOREST METEOROL, V134, P102, DOI 10.1016/j.agrformet.2005.11.003; Vargas R, 2008, NEW PHYTOL, V179, P460, DOI 10.1111/j.1469-8137.2008.02481.x; Wang T, 2011, BIOGEOSCIENCES, V8, P2009, DOI 10.5194/bg-8-2009-2011; Wang W, 2010, SOIL BIOL BIOCHEM, V42, P451, DOI 10.1016/j.soilbio.2009.11.028; Wu X, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003616; You WZ, 2013, TREES-STRUCT FUNCT, V27, P1417, DOI 10.1007/s00468-013-0889-6; Zhang LH, 2010, J ARID ENVIRON, V74, P1200, DOI 10.1016/j.jaridenv.2010.05.031; Zhou ZY, 2013, SOIL BIOL BIOCHEM, V57, P135, DOI 10.1016/j.soilbio.2012.08.010; Zimmermann M, 2009, SOIL BIOL BIOCHEM, V41, P1338, DOI 10.1016/j.soilbio.2009.02.023	43	6	7	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91589	10.1371/journal.pone.0091589	http://dx.doi.org/10.1371/journal.pone.0091589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614868	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300142
J	Silberberg, Y; Kupiec, M; Sharan, R				Silberberg, Yael; Kupiec, Martin; Sharan, Roded			A Method for Predicting Protein-Protein Interaction Types	PLOS ONE			English	Article							APOPTOSIS; COMPLEX; GENES; RNA	Protein-protein interactions (PPIs) govern basic cellular processes through signal transduction and complex formation. The diversity of those processes gives rise to a remarkable diversity of interactions types, ranging from transient phosphorylation interactions to stable covalent bonding. Despite our increasing knowledge on PPIs in humans and other species, their types remain relatively unexplored and few annotations of types exist in public databases. Here, we propose the first method for systematic prediction of PPI type based solely on the techniques by which the interaction was detected. We show that different detection methods are better suited for detecting specific types. We apply our method to ten interaction types on a large scale human PPI dataset. We evaluate the performance of the method using both internal cross validation and external data sources. In cross validation, we obtain an area under receiver operating characteristic (ROC) curve ranging from 0.65 to 0.97 with an average of 0.84 across the predicted types. Comparing the predicted interaction types to external data sources, we obtained significant agreements for phosphorylation and ubiquitination interactions, with hypergeometric p-value = 2.3e(-54) and 5.6e(-28) respectively. We examine the biological relevance of our predictions using known signaling pathways and chart the abundance of interaction types in cell processes. Finally, we investigate the cross-relations between different interaction types within the network and characterize the discovered patterns, or motifs. We expect the resulting annotated network to facilitate the reconstruction of process-specific subnetworks and assist in predicting protein function or interaction.	[Silberberg, Yael; Kupiec, Martin] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Sharan, Roded] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Sharan, R (corresponding author), Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.	roded@post.tau.ac.il			Edmond J. Safra Center for Bioinformatics at Tel Aviv University; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [757/12]; Israel Science Foundation; Israel Cancer Research Fund; Israel Cancer Association	Edmond J. Safra Center for Bioinformatics at Tel Aviv University; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; Israel Cancer Association	YS was supported in part by a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel Aviv University. RS was supported by an I-CORE Program of the Planning and Budgeting Committee and The Israel Science Foundation (grant no. 757/12). MK was supported by the Israel Science Foundation, the Israel Cancer Research Fund and the Israel Cancer Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy P, 2004, NAT BIOTECHNOL, V22, P1317, DOI 10.1038/nbt1018; Aranda B, 2011, NAT METHODS, V8, P528, DOI 10.1038/nmeth.1637; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Du Y, 2011, DATABASE J BIOL DATA, V2011; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Friedrich MG, 2004, CLIN CANCER RES, V10, P7457, DOI 10.1158/1078-0432.CCR-04-0930; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawashima S, 2003, GENOME INFORMATICS, V14, P673; Lundell MJ, 2003, DEVELOPMENT, V130, P4109, DOI 10.1242/dev.00593; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; Moll UM, 2003, MOL CANCER RES, V1, P1001; Neubauer G, 1997, P NATL ACAD SCI USA, V94, P385, DOI 10.1073/pnas.94.2.385; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Ponstingl H, 2000, PROTEINS, V41, P47; Pryor A, 2004, NUCLEIC ACIDS RES, V32, P1857, DOI 10.1093/nar/gkh347; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Van de Craen M, 1999, CELL DEATH DIFFER, V6, P1117, DOI 10.1038/sj.cdd.4400589; Zhang Lan V, 2005, J Biol, V4, P6, DOI 10.1186/jbiol23; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27	29	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90904	10.1371/journal.pone.0090904	http://dx.doi.org/10.1371/journal.pone.0090904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625764	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300040
J	Zhang, XX; Cao, RS; Liu, RP; Zhao, RP; Huang, Y; Gurley, EC; Hylemon, PB; Pandak, WM; Wang, GJ; Zhang, LY; Li, XK; Zhou, HP				Zhang, Xiaoxuan; Cao, Risheng; Liu, Runping; Zhao, Renping; Huang, Yi; Gurley, Emily C.; Hylemon, Phillip B.; Pandak, William M.; Wang, Guangji; Zhang, Luyong; Li, Xiaokun; Zhou, Huiping			Reduction of the HIV Protease Inhibitor-Induced ER Stress and Inflammatory Response by Raltegravir in Macrophages	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FATTY-ACID; OXIDATIVE STRESS; LIPID-METABOLISM; LIVER; HYPERLIPIDEMIA; EXPRESSION; PREVENTION; ACTIVATE; THERAPY	Background: HIV protease inhibitor (PI), the core component of highly active antiretroviral treatment (HAART) for HIV infection, has been implicated in HAART-associated cardiovascular complications. Our previous studies have demonstrated that activation of endoplasmic reticulum (ER) stress is linked to HIV PI-induced inflammation and foam cell formation in macrophages. Raltegravir is a first-in-its-class HIV integrase inhibitor, the newest class of anti-HIV agents. We have recently reported that raltegravir has less hepatic toxicity and could prevent HIV PI-induced dysregulation of hepatic lipid metabolism by inhibiting ER stress. However, little information is available as to whether raltegravir would also prevent HIV PI-induced inflammatory response and foam cell formation in macrophages. Methodology and Principal Findings: In this study, we examined the effect of raltegravir on ER stress activation and lipid accumulation in cultured mouse macrophages (J774A.1), primary mouse macrophages, and human THP-1-derived macrophages, and further determined whether the combination of raltegravir with existing HIV PIs would potentially exacerbate or prevent the previously observed activation of inflammatory response and foam cell formation. The results indicated that raltegravir did not induce ER stress and inflammatory response in macrophages. Even more interestingly, HIV PI-induced ER stress, oxidative stress, inflammatory response and foam cell formation were significantly reduced by raltegravir. High performance liquid chromatography (HPLC) analysis further demonstrated that raltegravir did not affect the uptake of HIV PIs in macrophages. Conclusion and Significance: Raltegravir could prevent HIV PI-induced inflammatory response and foam cell formation by inhibiting ER stress. These results suggest that incorporation of this HIV integrase inhibitor may reduce the cardiovascular complications associated with current HAART.	[Zhang, Xiaoxuan; Liu, Runping; Zhao, Renping; Huang, Yi; Wang, Guangji; Zhang, Luyong] China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiaoxuan; Cao, Risheng; Liu, Runping; Gurley, Emily C.; Hylemon, Phillip B.; Zhou, Huiping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Huang, Yi; Li, Xiaokun; Zhou, Huiping] Wenzhou Med Univ, Sch Pharm, Wenzhou, Peoples R China; [Hylemon, Phillip B.; Pandak, William M.; Zhou, Huiping] Dept Internal Med Gastroenterol, Richmond, VA USA; [Hylemon, Phillip B.; Pandak, William M.; Zhou, Huiping] McGuire Vet Affairs Med Ctr, Richmond, VA USA	China Pharmaceutical University; Virginia Commonwealth University; Wenzhou Medical University; Hunter Holmes McGuire Veterinary Affairs Medical Center	Wang, GJ (corresponding author), China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China.	wangguangji01@gmail.com; hzhou@vcu.edu	Zhao, Renping/C-8175-2014; Stefanadis, Christodoulos/ABH-2232-2020; Zhou, Huiping/H-6875-2019; Zhou, Huiping/J-3639-2015	Stefanadis, Christodoulos/0000-0001-5974-6454; Zhou, Huiping/0000-0002-0050-372X; 	Merck Research Fund; National Institute of Allergy and Infectious Diseases [AI06843, AI057189]; National Institute of Complementary and Alternative Medicine [AT004148]; VA Merit Award [1I01BX001390]; National Science Foundation of China [81070245, 81270489]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057189] Funding Source: NIH RePORTER	Merck Research Fund; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Complementary and Alternative Medicine; VA Merit Award(US Department of Veterans Affairs); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study is supported by Merck Research Fund; the National Institute of Allergy and Infectious Diseases [Grants AI06843 and AI057189]; the National Institute of Complementary and Alternative Medicine [Grant AT004148]; VA Merit Award (1I01BX001390) and National Science Foundation of China (Grants 81070245 and 81270489). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg K, 2005, FREE RADICAL RES, V39, P629, DOI 10.1080/10715760400028027; Cao RS, 2010, J PHARMACOL EXP THER, V334, P530, DOI 10.1124/jpet.110.168484; Chen L, 2009, BIOCHEM PHARMACOL, V78, P70, DOI 10.1016/j.bcp.2009.03.022; Cnop M, 2008, BIOCHEM SOC T, V36, P909, DOI 10.1042/BST0360909; Cocohoba J, 2008, CLIN THER, V30, P1747, DOI 10.1016/j.clinthera.2008.10.012; Deng W, 2010, J MOL CELL CARDIOL, V49, P746, DOI 10.1016/j.yjmcc.2010.08.013; Fan Jianglin, 2003, J Atheroscler Thromb, V10, P63; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Hughes CA, 2009, EXPERT OPIN PHARMACO, V10, P2445, DOI 10.1517/14656560903176446; Imaz A, 2009, JAIDS-J ACQ IMM DEF, V52, P382, DOI 10.1097/QAI.0b013e3181b17f53; Jacob A, 2007, BBA-MOL BASIS DIS, V1772, P766, DOI 10.1016/j.bbadis.2007.03.010; Jager R, 2012, BIOL CELL; Kaplowitz N, 2007, SEMIN LIVER DIS, V27, P367, DOI 10.1055/s-2007-991513; Kaplowitz N, 2006, J GASTROEN HEPATOL, V21, pS7, DOI 10.1111/j.1440-1746.2006.04581.x; Kobayasi R, 2010, J HYPERTENS, V28, P2111, DOI 10.1097/HJH.0b013e32833ca68c; Koster JC, 2003, DIABETES, V52, P1695, DOI 10.2337/diabetes.52.7.1695; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mooser V, 2001, CURR OPIN LIPIDOL, V12, P313, DOI 10.1097/00041433-200106000-00011; Moyle Graeme, 2002, HIV Clin Trials, V3, P89; Nair V, 2007, REV MED VIROL, V17, P277, DOI 10.1002/rmv.539; Poirier JM, 2008, J CHROMATOGR B, V867, P277, DOI 10.1016/j.jchromb.2008.03.026; Riddle TM, 2001, J BIOL CHEM, V276, P37514, DOI 10.1074/jbc.M104557200; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Spector AA, 2006, ARTERIOSCL THROM VAS, V26, P7, DOI 10.1161/01.ATV.0000198749.28422.29; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Tousoulis D, 2009, INT J CARDIOL, V136, P258, DOI 10.1016/j.ijcard.2008.04.087; Vlahakis SR, 2007, APOPTOSIS, V12, P969, DOI 10.1007/s10495-007-0755-3; Wu XD, 2008, HEPATOLOGY, V47, P1905, DOI 10.1002/hep.22239; Wu XD, 2010, GASTROENTEROLOGY, V138, P197, DOI 10.1053/j.gastro.2009.08.054; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhou H, 2007, ATHEROSCLEROSIS; Zhou HP, 2005, MOL PHARMACOL, V68, P690, DOI 10.1124/mol.105.012898; Zhou HP, 2006, AM J PHYSIOL-GASTR L, V291, pG1071, DOI 10.1152/ajpgi.00182.2006	34	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90856	10.1371/journal.pone.0090856	http://dx.doi.org/10.1371/journal.pone.0090856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625618	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300036
J	Hao, WR; Friedman, A				Hao, Wenrui; Friedman, Avner			The LDL-HDL Profile Determines the Risk of Atherosclerosis: A Mathematical Model	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; LYMPHOCYTES-T; MYCOBACTERIUM-TUBERCULOSIS; ANTIOXIDANT VITAMINS; TISSUE INHIBITOR; PARTICLE-SIZE; GROWTH; CELL; MACROPHAGES; EXPRESSION	Atherosclerosis, the leading death in the United State, is a disease in which a plaque builds up inside the arteries. As the plaque continues to grow, the shear force of the blood flow through the decreasing cross section of the lumen increases. This force may eventually cause rupture of the plaque, resulting in the formation of thrombus, and possibly heart attack. It has long been recognized that the formation of a plaque relates to the cholesterol concentration in the blood. For example, individuals with LDL above 190 mg/dL and HDL below 40 mg/dL are at high risk, while individuals with LDL below 100 mg/dL and HDL above 50 mg/dL are at no risk. In this paper, we developed a mathematical model of the formation of a plaque, which includes the following key variables: LDL and HDL, free radicals and oxidized LDL, MMP and TIMP, cytockines: MCP-1, IFN-gamma, IL-12 and PDGF, and cells: macrophages, foam cells, T cells and smooth muscle cells. The model is given by a system of partial differential equations with in evolving plaque. Simulations of the model show how the combination of the concentrations of LDL and HDL in the blood determine whether a plaque will grow or disappear. More precisely, we create a map, showing the risk of plaque development for any pair of values (LDL, HDL).	[Hao, Wenrui; Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hao, WR (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	hao.50@mbi.osu.edu		HAO, WENRUI/0000-0002-6925-7424	Mathematical Biosciences Institute; National Science Foundation [DMS 0931642]	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF))	This research has been supported by the Mathematical Biosciences Institute and the National Science Foundation under grant DMS 0931642 (http://nsf.gov/awardsearch/showAward?AWD_ID = 0931642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberty J, 1999, NUMER ALGORITHMS, V20, P117, DOI 10.1023/A:1019155918070; ANTONIADES HN, 1981, P NATL ACAD SCI-BIOL, V78, P7314, DOI 10.1073/pnas.78.12.7314; Arsenault BJ, 2009, J AM COLL CARDIOL, V55, P35, DOI 10.1016/j.jacc.2009.07.057; BARRETT TB, 1988, P NATL ACAD SCI USA, V85, P2810, DOI 10.1073/pnas.85.8.2810; Barter P, 2005, EUR HEART J SUPPL, V7, pF4, DOI 10.1093/eurheartj/sui036; Barter PJ, 2010, J LIPID RES, V51, P1546, DOI 10.1194/jlr.P002816; BOFILL M, 1992, CLIN EXP IMMUNOL, V88, P243, DOI 10.1111/j.1365-2249.1992.tb03068.x; BOWENPOPE DF, 1984, BLOOD, V64, P458; Byrne HM, 1999, J MATH BIOL, V39, P59, DOI 10.1007/s002850050163; Byrne HM, 1997, IMA J MATH APPL MED, V14, P305; Byrne HM, 1996, MATH COMPUT MODEL, V24, P1, DOI 10.1016/S0895-7177(96)00174-4; Calvez V, 2009, CEMRACS 2008 MODELLI, V28, P1; Chen D, 2012, B MATH BIOL, V74, P2752, DOI 10.1007/s11538-012-9776-3; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Cobbold CA, 2002, B MATH BIOL, V64, P65, DOI 10.1006/bulm.2001.0267; Cohen A, 2012, PREPRINT; Day J, 2009, P NATL ACAD SCI USA, V106, P11246, DOI 10.1073/pnas.0904846106; Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003; Fabunmi RP, 1998, CIRC RES, V83, P270, DOI 10.1161/01.RES.83.3.270; Friedman A, 2008, EXP GERONTOL, V43, P275, DOI 10.1016/j.exger.2007.12.004; Frink R., 2002, INFLAMMATORY ATHEROS; Garcia-Tunon I, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-158; Gattorno M, 1998, ANN RHEUM DIS, V57, P425, DOI 10.1136/ard.57.7.425; Gui T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/693083; Hamza T, 2010, INT J MOL SCI, V11, P789, DOI 10.3390/ijms11030789; HANSSON GK, 1989, AM J PATHOL, V135, P169; Harrington JR, 2000, STEM CELLS, V18, P65, DOI 10.1634/stemcells.18-1-65; HOKLAND B, 1992, J LIPID RES, V33, P1335; Hoyert D. L., 2012, NATL VITAL STAT REPO, V61; INGOLD KU, 1993, P NATL ACAD SCI USA, V90, P45, DOI 10.1073/pnas.90.1.45; Ishigaki Y, 2009, CURR OPIN LIPIDOL, V20, P363, DOI 10.1097/MOL.0b013e32832fa58d; JANIN J, 1978, BIOCHEMISTRY-US, V17, P2943, DOI 10.1021/bi00608a001; Johnson JL, 2009, CURR OPIN LIPIDOL, V20, P370, DOI 10.1097/MOL.0b013e3283309848; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028293; Kim Y, 2010, B MATH BIOL, V72, P1029, DOI 10.1007/s11538-009-9481-z; Kim Y, 2009, J THEOR BIOL, V260, P359, DOI 10.1016/j.jtbi.2009.06.025; King IL, 2005, J IMMUNOL, V175, P641, DOI 10.4049/jimmunol.175.2.641; KOSAKA C, 1992, ATHEROSCLEROSIS, V97, P75, DOI 10.1016/0021-9150(92)90053-J; Levonen AL, 2008, CIRCULATION, V117, P2142, DOI 10.1161/CIRCULATIONAHA.107.718585; Li Z, FINITE ELEMENT METHO; Liao KL, 2013, J THEOR BIOL, V328, P65, DOI 10.1016/j.jtbi.2013.03.017; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Little MP, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000539; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Mayo Clinic Staff, IMP IS CHOL RAT; Mckay C., 2005, MODEL ATHEROSCLEROSI; Mercapide J, 2003, INT J CANCER, V106, P676, DOI 10.1002/ijc.11286; Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X; Mitsuhashi T, 2013, FISHERIES SCI, V79, P495, DOI 10.1007/s12562-013-0616-7; Moreno Pedro R, 2010, Cardiol Clin, V28, P1, DOI 10.1016/j.ccl.2009.09.008; O'Keefe JH, 2004, J AM COLL CARDIOL, V43, P2142, DOI 10.1016/j.jacc.2004.03.046; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Orbe J, 2003, ATHEROSCLEROSIS, V167, P45, DOI 10.1016/S0021-9150(02)00392-1; ORME IM, 1987, J IMMUNOL, V138, P4414; Osterud B, 2003, PHYSIOL REV, V83, P1069, DOI 10.1152/physrev.00005.2003; Otani H, 2013, OXID MED CELL LONGEV; Ozkanlar S, 2012, ADV CLIN EXP MED, V21, P115; Palosaari H, 2003, MATRIX METALLOPROTEI; Persson PO, 2004, SIAM REV, V46, P329, DOI 10.1137/S0036144503429121; Rahdert D A, 1999, Cardiovasc Radiat Med, V1, P358; RAINES EW, 1993, BRIT HEART J, V69, pS30; Rajman I, 1999, BRIT J CLIN PHARMACO, V48, P125, DOI 10.1046/j.1365-2125.1999.00991.x; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Rhodes J, 2009, J TRAUMA, V66, P1591, DOI 10.1097/TA.0b013e31819a0344; Rodriguez JA, 2007, REV ESP CARDIOL, V60, P959, DOI 10.1157/13109649; ROSS R, 1990, SCIENCE, V248, P1009, DOI 10.1126/science.2343305; Ryu B.H., 2000, BIOTECHNOL BIOPROC E, V5, P313, DOI [10.1007/BF02942205, DOI 10.1007/BF02942205]; Tardif Jean-Claude, 2005, Curr Atheroscler Rep, V7, P71, DOI 10.1007/s11883-005-0078-1; Tietz NW, 1999, CLIN GUIDE LAB TESTS; Tsimikas S, 2001, CIRCULATION, V103, P1930; TSUKAGUCHI K, 1995, J IMMUNOL, V154, P1786; Xue C, 2009, P NATL ACAD SCI USA, V106, P16782, DOI 10.1073/pnas.0909115106; Yamamoto S, 2006, J SURG RES, V134, P307, DOI 10.1016/j.jss.2005.11.588; Yokochi S, 2001, J INTERF CYTOK RES, V21, P389, DOI 10.1089/107999001750277862	74	48	50	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90497	10.1371/journal.pone.0090497	http://dx.doi.org/10.1371/journal.pone.0090497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621857	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300022
J	Liu, JH; Zhang, ZK; Chen, LJ; Liu, C; Yang, CC; Wang, XQ				Liu, Jin-Hu; Zhang, Zi-Ke; Chen, Lingjiao; Liu, Chuang; Yang, Chengcheng; Wang, Xueqi			Gravity Effects on Information Filtering and Network Evolving	PLOS ONE			English	Article							COMPLEX NETWORKS; MODEL; EVOLUTION	In this paper, based on the gravity principle of classical physics, we propose a tunable gravity-based model, which considers tag usage pattern to weigh both the mass and distance of network nodes. We then apply this model in solving the problems of information filtering and network evolving. Experimental results on two real-world data sets, Del.icio.us and MovieLens, show that it can not only enhance the algorithmic performance, but can also better characterize the properties of real networks. This work may shed some light on the in-depth understanding of the effect of gravity model.	[Liu, Jin-Hu; Chen, Lingjiao; Yang, Chengcheng] Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China; [Liu, Jin-Hu; Zhang, Zi-Ke; Chen, Lingjiao; Liu, Chuang] Hangzhou Normal Univ, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China; [Liu, Jin-Hu; Zhang, Zi-Ke; Chen, Lingjiao; Liu, Chuang] Hangzhou Normal Univ, Alibaba Res Ctr Complex Sci, Hangzhou, Peoples R China; [Wang, Xueqi] Second Mil Med Univ, Shanghai Changzheng Hosp, Div Translat Med, Shanghai, Peoples R China	University of Electronic Science & Technology of China; Hangzhou Normal University; Hangzhou Normal University; Naval Medical University	Zhang, ZK (corresponding author), Hangzhou Normal Univ, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China.	zhangzike@gmail.com; xueqiniu.wang@gmail.com	chuang, liu/AAH-1377-2021		Zhejiang Provincial Natural Science Foundation of China [LY12A05003, LQ13F030015];  [NSFC: 11105024];  [11205040];  [11301490];  [11305043]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); ; ; ; 	NSFC: 11105024, 11205040, 11301490 and 11305043. Zhejiang Provincial Natural Science Foundation of China: Grant Nos. LY12A05003 and LQ13F030015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BERGSTRAND JH, 1985, REV ECON STAT, V67, P474, DOI 10.2307/1925976; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bouttier J, 2002, NUCL PHYS B, V645, P477, DOI 10.1016/S0550-3213(02)00813-1; Casey HJ, 1955, TRAFFIC Q, V9, P313; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Cui AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050702; Dorogovtsev SN, 2000, EUROPHYS LETT, V52, P33, DOI 10.1209/epl/i2000-00400-0; Dorogovtsev SN, 2000, PHYS REV E, V62, P1842, DOI 10.1103/PhysRevE.62.1842; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; Galileo G., 1914, DIALOGUES 2 NEW SCI; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hu F, 2013, ACTA PHYS SIN-CH ED, V62, DOI 10.7498/aps.62.198901; Jin EM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046132; Jung WS, 2008, EUR PHYS J B, V62, P113, DOI 10.1140/epjb/e2008-00123-0; Liu JG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037101; Liu WP, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/58007; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lu LY, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066119; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Newton I., 1999, MATH PRINCIPLES NATU; Qiu T, 2014, COMPUT PHYS COMMUN, V185, P489, DOI 10.1016/j.cpc.2013.10.003; Qiu T, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/48007; Qiu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063531; Qiu T, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/58003; Reilly W.J, 1929, METHODS STUDY RETAIL; Reilly WJ, 1931, LAWS RETAIL GRAVITAT; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; RIETVELD P, 1989, ANN REGIONAL SCI, V23, P255, DOI 10.1007/BF01579778; Rodrigue J.-P., 2013, GEOGRAPHY TRANSPORT; Rose AK, 2004, AM ECON REV, V94, P98, DOI 10.1257/000282804322970724; Salton G, 1983, INTRO MODEL INFORM R; Sarwar B., 2001, P 10 INT C WORLD WID, P285, DOI [DOI 10.1145/371920.372071, 10.1145/371920.372071]; STEWART JQ, 1950, AM J PHYS, V18, P239, DOI 10.1119/1.1932559; Tinbergen J., 1962, SHAPING WORLD EC SUG; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westerlund J, 2011, APPL ECON, V43, P641, DOI 10.1080/00036840802599784; Willumsen LG, 2011, MOD TRANSP 4 ED; Zhang CX, 2013, PHYSICA A, V392, P6100, DOI 10.1016/j.physa.2013.07.027; Zhang ZK, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S0218127412501660; Zhang ZK, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/10/P10005; Zhang ZK, 2011, J COMPUT SCI TECH-CH, V26, P767, DOI 10.1007/s11390-011-0176-1; Zhang ZK, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/28002; Zhang ZK, 2010, PHYSICA A, V389, P179, DOI 10.1016/j.physa.2009.08.036; Zhou S, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/173; Zhou T, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/58004; Zhou T, 2009, EUR PHYS J B, V71, P623, DOI 10.1140/epjb/e2009-00335-8	55	8	10	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91070	10.1371/journal.pone.0091070	http://dx.doi.org/10.1371/journal.pone.0091070			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622162	gold, Green Published, Green Submitted			2022-12-27	WOS:000332845300047
J	McAleer, P; Todorov, A; Belin, P				McAleer, Phil; Todorov, Alexander; Belin, Pascal			How Do You Say 'Hello'? Personality Impressions from Brief Novel Voices	PLOS ONE			English	Article							FORMANT FREQUENCIES INFLUENCE; VOCAL ATTRACTIVENESS; 1ST IMPRESSIONS; SPEAKER HEIGHT; FACIAL ATTRACTIVENESS; WEIGHT IDENTIFICATION; JUDGING PERSONALITY; MENS VOICES; BODY-SIZE; FACES	On hearing a novel voice, listeners readily form personality impressions of that speaker. Accurate or not, these impressions are known to affect subsequent interactions; yet the underlying psychological and acoustical bases remain poorly understood. Furthermore, hitherto studies have focussed on extended speech as opposed to analysing the instantaneous impressions we obtain from first experience. In this paper, through a mass online rating experiment, 320 participants rated 64 sub-second vocal utterances of the word 'hello' on one of 10 personality traits. We show that: (1) personality judgements of brief utterances from unfamiliar speakers are consistent across listeners; (2) a two-dimensional 'social voice space' with axes mapping Valence (Trust, Likeability) and Dominance, each driven by differing combinations of vocal acoustics, adequately summarises ratings in both male and female voices; and (3) a positive combination of Valence and Dominance results in increased perceived male vocal Attractiveness, whereas perceived female vocal Attractiveness is largely controlled by increasing Valence. Results are discussed in relation to the rapid evaluation of personality and, in turn, the intent of others, as being driven by survival mechanisms via approach or avoidance behaviours. These findings provide empirical bases for predicting personality impressions from acoustical analyses of short utterances and for generating desired personality impressions in artificial voices.	[McAleer, Phil; Belin, Pascal] Univ Glasgow, Sch Psychol, Coll Sci & Engn, Glasgow, Lanark, Scotland; [Todorov, Alexander] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Belin, Pascal] Univ Glasgow, Coll Med Vet & Life Sci, Voice Neurocognit Lab, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Belin, Pascal] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Belin, Pascal] Univ Aix Marseille, Inst Neurosci La Timone, Marseille, France	University of Glasgow; Princeton University; University of Glasgow; Universite de Montreal; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	McAleer, P (corresponding author), Univ Glasgow, Sch Psychol, Coll Sci & Engn, Glasgow, Lanark, Scotland.	Philip.McAleer@glasgow.ac.uk	Belin, Pascal/C-6247-2009; McAleer, Phil/A-8178-2011	Belin, Pascal/0000-0002-7578-6365; McAleer, Phil/0000-0002-4523-2097	ESRC/MRC [RES-060-25-0010]; ESRC [ES/E020933/1] Funding Source: UKRI; Economic and Social Research Council [ES/E020933/1] Funding Source: researchfish	ESRC/MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This project was funded by an ESRC/MRC large grant RES-060-25-0010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport GW, 1934, J SOC PSYCHOL, V5, P37, DOI 10.1080/00224545.1934.9921582; Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; Apicella CL, 2009, P ROY SOC B-BIOL SCI, V276, P1077, DOI 10.1098/rspb.2008.1542; ARONOVITCH CD, 1976, J SOC PSYCHOL, V99, P207, DOI 10.1080/00224545.1976.9924774; Baumann O, 2010, PSYCHOL RES-PSYCH FO, V74, P110, DOI 10.1007/s00426-008-0185-z; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2011, BRIT J PSYCHOL, V102, P711, DOI 10.1111/j.2044-8295.2011.02041.x; BERRY DS, 1989, PERS SOC PSYCHOL B, V15, P266, DOI 10.1177/0146167289152013; BERRY DS, 1991, J PERS SOC PSYCHOL, V61, P298, DOI 10.1037/0022-3514.61.2.298; BERRY DS, 1990, J NONVERBAL BEHAV, V14, P141, DOI 10.1007/BF00996223; Berry DS, 1992, J NONVERBAL BEHAV, V14, P141; Bestelmeyer PEG, 2012, CEREB CORTEX, V22, P1263, DOI 10.1093/cercor/bhr204; Bestelmeyer PEG, 2010, COGNITION, V117, P217, DOI 10.1016/j.cognition.2010.08.008; Boersma Paul, 2002, GLOT INT, V5, P341; BORKENAU P, 1993, J PERS, V61, P477, DOI 10.1111/j.1467-6494.1993.tb00779.x; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Bruckert L, 2006, P ROY SOC B-BIOL SCI, V273, P83, DOI 10.1098/rspb.2005.3265; Bruckert L, 2010, CURR BIOL, V20, P116, DOI 10.1016/j.cub.2009.11.034; Collins SA, 2000, ANIM BEHAV, V60, P773, DOI 10.1006/anbe.2000.1523; Evans S, 2006, BIOL PSYCHOL, V72, P160, DOI 10.1016/j.biopsycho.2005.09.003; Feinberg DR, 2012, BEHAV ECOL SOCIOBIOL, V66, P413, DOI 10.1007/s00265-011-1287-y; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Ferdenzi C, 2013, BEHAV RES METHODS, V45, P405, DOI 10.3758/s13428-012-0275-0; Ferrand CT, 2002, J VOICE, V16, P480, DOI 10.1016/S0892-1997(02)00123-6; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Funder DC, 2012, CURR DIR PSYCHOL SCI, V21, P177, DOI 10.1177/0963721412445309; Germine L, 2012, PSYCHON B REV, V19, P847, DOI 10.3758/s13423-012-0296-9; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; Hassin R, 2000, J PERS SOC PSYCHOL, V78, P837, DOI 10.1037/0022-3514.78.5.837; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Hughes S. M., 2009, J SOCIAL EVOLUTIONAR, V3, P343, DOI DOI 10.1037/H0099311); Hughes SM, 2004, EVOL HUM BEHAV, V25, P295, DOI 10.1016/j.evolhumbehav.2004.06.001; Hughes SM, 2010, J SOC EVOL CULT PSYC, V4, P290, DOI DOI 10.1037/H0099282; Jones BC, 2007, PERCEPT PSYCHOPHYS, V69, P1273, DOI 10.3758/BF03192944; Kawahara H, 2003, 2003 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL I, PROCEEDINGS, P256; KENNY DA, 1992, J PERS SOC PSYCHOL, V62, P88, DOI 10.1037/0022-3514.62.1.88; Klofstad CA, 2012, P ROY SOC B-BIOL SCI, V279, P2698, DOI 10.1098/rspb.2012.0311; Ko SJ, 2006, PERS SOC PSYCHOL B, V32, P806, DOI 10.1177/0146167206286627; Kramer RSS, 2010, Q J EXP PSYCHOL, V63, P2273, DOI 10.1080/17470211003770912; Krauss RM, 2002, J EXP SOC PSYCHOL, V38, P618, DOI 10.1016/S0022-1031(02)00510-3; KREIMAN J, 1993, J SPEECH HEAR RES, V36, P21, DOI 10.1044/jshr.3601.21; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; LASS NJ, 1978, J ACOUST SOC AM, V63, P1218, DOI 10.1121/1.381808; LASS NJ, 1980, J PHONETICS, V8, P277, DOI 10.1016/S0095-4470(19)31477-9; Latinus M, 2013, CURR BIOL, V23, P1075, DOI 10.1016/j.cub.2013.04.055; Latinus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041384; Latinus M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00175; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Lewis JW, 2009, J NEUROSCI, V29, P2283, DOI 10.1523/JNEUROSCI.4145-08.2009; Little AC, 2013, ARCH SEX BEHAV; Little AC, 2007, BRIT J PSYCHOL, V98, P111, DOI 10.1348/000712606X109648; Little AC, 2012, Q J EXP PSYCHOL, V65, P2018, DOI 10.1080/17470218.2012.677048; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Luevano V.X., 2007, EVOL PSYCHOL-US, V5, P15, DOI [10.1177/147470490700500102, DOI 10.1177/147470490700500102]; MCARTHUR LZ, 1983, PSYCHOL REV, V90, P215, DOI 10.1037/0033-295X.90.3.215; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; MIYAKE K, 1993, J PERS, V61, P411, DOI 10.1111/j.1467-6494.1993.tb00287.x; MONTEPARE JM, 1987, J EXP SOC PSYCHOL, V23, P331, DOI 10.1016/0022-1031(87)90045-X; Nass C, 2001, J EXP PSYCHOL-APPL, V7, P171, DOI 10.1037//1076-898X.7.3.171; NORMAN WT, 1963, J ABNORM PSYCHOL, V66, P574, DOI 10.1037/h0040291; OHALA JJ, 1984, PHONETICA, V41, P1, DOI 10.1159/000261706; Olivola CY, 2010, J EXP SOC PSYCHOL, V46, P315, DOI 10.1016/j.jesp.2009.12.002; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; PAGE RA, 1978, J SOC PSYCHOL, V105, P65, DOI 10.1080/00224545.1978.9924091; PASSINI FT, 1966, J PERS SOC PSYCHOL, V4, P44, DOI 10.1037/h0023519; Patel S, 2011, BIOL PSYCHOL, V87, P93, DOI 10.1016/j.biopsycho.2011.02.010; Penton-Voak IS, 2006, SOC COGNITION, V24, P607, DOI 10.1521/soco.2006.24.5.607; Perrachione TK, 2011, SCIENCE, V333, P595, DOI 10.1126/science.1207327; Pivonkova V, 2011, ARCH SEX BEHAV, V40, P1137, DOI 10.1007/s10508-011-9821-6; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Rendall D, 2007, J EXP PSYCHOL HUMAN, V33, P1208, DOI 10.1037/0096-1523.33.5.1208; Rhodes G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026653; ROSENBER.S, 1968, J PERS SOC PSYCHOL, V9, P283, DOI 10.1037/h0026086; Said CP, 2009, EMOTION, V9, P260, DOI 10.1037/a0014681; Scherer K.R., 1979, LANGUAGE SOCIAL PSYC, P88; SCHERER KR, 1972, J PERS, V40, P191, DOI 10.1111/j.1467-6494.1972.tb00998.x; Schotz Susanne, 2007, Speaker Classification I. Fundamentals, Features, and Methods. (Lecture Notes in Artificial Intelligence vol. 4343), P88, DOI 10.1007/978-3-540-74200-5_5; Secord PF., 1958, PERSON PERCEPTION IN, P300; Shevlin M, 2003, PERS INDIV DIFFER, V35, P1373, DOI 10.1016/S0191-8869(02)00356-2; Sutherland CAM, 2013, COGNITION, V127, P105, DOI 10.1016/j.cognition.2012.12.001; Tigue CC, 2012, EVOL HUM BEHAV, V33, P210, DOI 10.1016/j.evolhumbehav.2011.09.004; TITZE IR, 1989, J ACOUST SOC AM, V85, P1699, DOI 10.1121/1.397959; Todorov A, 2009, SOC COGNITION, V27, P813, DOI 10.1521/soco.2009.27.6.813; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; vanDommelen WA, 1995, LANG SPEECH, V38, P267, DOI 10.1177/002383099503800304; VANDOMMELEN WA, 1993, J PHONETICS, V21, P337, DOI 10.1016/S0095-4470(19)31343-9; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; Verosky SC, 2010, PSYCHOL SCI, V21, P779, DOI 10.1177/0956797610371965; WIGGINS JS, 1979, J PERS SOC PSYCHOL, V37, P395, DOI 10.1037/0022-3514.37.3.395; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Yao B, 2012, NEUROIMAGE, V60, P1832, DOI 10.1016/j.neuroimage.2012.01.111; Yao B, 2011, COGNITION, V121, P447, DOI 10.1016/j.cognition.2011.08.007; Young AW, 2011, BRIT J PSYCHOL, V102, P959, DOI 10.1111/j.2044-8295.2011.02045.x; Zebrowitz L A, 1997, Pers Soc Psychol Rev, V1, P204, DOI 10.1207/s15327957pspr0103_2; Zebrowitz LA, 1996, FDN STEREOTYPES STER; Zebrowitz LA, 2008, SOC PERSONAL PSYCHOL, V2, P1497, DOI 10.1111/j.1751-9004.2008.00109.x; Zebrowitz LA, 2012, J CROSS CULT PSYCHOL, V43, P119, DOI 10.1177/0022022111411386; Zebrowitz LA, 2010, J PERS SOC PSYCHOL, V98, P175, DOI 10.1037/a0017990; ZEBROWITZMCARTHUR L, 1989, J NONVERBAL BEHAV, V13, P189, DOI 10.1007/BF00987049; ZUCKERMAN M, 1995, J RES PERS, V29, P253, DOI 10.1006/jrpe.1995.1015; ZUCKERMAN M, 1990, J NONVERBAL BEHAV, V14, P97, DOI 10.1007/BF01670437; ZUCKERMAN M, 1989, J NONVERBAL BEHAV, V13, P67	105	133	137	6	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90779	10.1371/journal.pone.0090779	http://dx.doi.org/10.1371/journal.pone.0090779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24622283	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000332845300027
J	Weinandy, S; Babczyk, P; Dreier, A; Unger, RE; Flanagan, TC; Kirkpatrick, CJ; Zenke, M; Klee, D; Jockenhoevel, S				Weinandy, Stefan; Babczyk, Patrick; Dreier, Agnieszka; Unger, Ronald E.; Flanagan, Thomas C.; Kirkpatrick, C. James; Zenke, Martin; Klee, Doris; Jockenhoevel, Stefan			Ovine Carotid Artery-Derived Cells as an Optimized Supportive Cell Layer in 2-D Capillary Network Assays	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; ANGIOGENESIS; VEGF; INHIBITION; DELIVERY; ANTIBODY; SCAFFOLD; SYSTEM	Background: Endothelial cell co-culture assays are differentiation assays which simulate the formation of capillary-like tubules with the aid of a supportive cell layer. Different cell types have been employed as a supportive cell layer, including human pulmonary artery smooth muscle cells (PASMCs) and human mammary fibroblasts. However, these sources of human tissue-derived cells are limited, and more readily accessible human or animal tissue-derived cell sources would simplify the endothelial cell co-culture assay. In the present study, we investigated the potential use of alternative, accessible supportive cells for endothelial cell co-culture assay, including human umbilical cord and ovine carotid artery. Methods and Results: Human umbilical artery SMCs (HUASMCs) and ovine carotid artery-derived cells were seeded into 96-well plates, followed by addition of human umbilical vein endothelial cells (HUVECs). Nine days after co-culture, cells were fixed, immunostained and analysed using an in vitro angiogenesis quantification tool. Capillary-like structures were detected on ovine carotid artery-derived supportive cell layers. The initial cell number, as well as pro-and anti-angiogenic factors (VEGF, PDGF-BB and Bevacizumab), had a positive or negative influence on the number of capillary-like structures. Furthermore, HUVECs from different donors showed distinct levels of VEGF receptor-2, which correlated with the amount of capillary-like structures. In the case of HUASMC supportive cell layers, HUVECs detached almost completely from the surface. Conclusions: Cells of different origin have a varying applicability regarding the endothelial cell co-culture assay: under the conditions described here, ovine carotid artery-derived cells seem to be more suitable than HUASMCs for an endothelial co-culture assay. Furthermore, the ovine carotid artery-derived cells are easier to obtain and are in more abundant supply than the currently used dermal or breast tissue cells. The use of ovine carotid artery-derived cells simplifies the endothelial co-culture assay with respect to testing large amounts of pro-and anti-angiogenic factors.	[Weinandy, Stefan; Babczyk, Patrick; Jockenhoevel, Stefan] Rhein Westfal TH Aachen, AME Helmholtz Inst Biomed Engn, Dept Tissue Engn & Text Implants, Aachen, Germany; [Dreier, Agnieszka] Rhein Westfal TH Aachen, Fac Med, Dept Neurosurg, Aachen, Germany; [Unger, Ronald E.; Kirkpatrick, C. James] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathol, D-55122 Mainz, Germany; [Flanagan, Thomas C.] Univ Coll Dublin, Hlth Sci Ctr, Sch Med & Med Sci, Dublin 2, Ireland; [Zenke, Martin] Rhein Westfal TH Aachen, Inst Biomed Engn, Dept Cell Biol, Aachen, Germany; [Klee, Doris] Rhein Westfal TH Aachen, ITMC, Aachen, Germany	RWTH Aachen University; RWTH Aachen University; Johannes Gutenberg University of Mainz; University College Dublin; RWTH Aachen University; RWTH Aachen University	Jockenhoevel, S (corresponding author), Rhein Westfal TH Aachen, AME Helmholtz Inst Biomed Engn, Dept Tissue Engn & Text Implants, Aachen, Germany.	jockenhoevel@hia.rwth-aachen.de		Kirkpatrick, Charles James/0000-0002-0088-418X; Jockenhoevel, Stefan/0000-0003-0584-9444	DFG graduate school Biointerface [1035]	DFG graduate school Biointerface	The published work is funded by DFG graduate school Biointerface 1035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Davies NH, 2012, TISSUE ENG PT A, V18, P26, DOI 10.1089/ten.tea.2011.0192; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Dreier A, 2012, TUMOR BIOL, V33, P85, DOI 10.1007/s13277-011-0248-4; Ekaputra AK, 2011, BIOMATERIALS, V32, P8108, DOI 10.1016/j.biomaterials.2011.07.022; Ennett AB, 2006, J BIOMED MATER RES A, V79A, P176, DOI 10.1002/jbm.a.30771; Evensen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005798; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FINKENZELLER G, 1992, CANCER RES, V52, P4821; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; LAWLEY TJ, 1989, J INVEST DERMATOL, V93, pS59, DOI 10.1111/1523-1747.ep12581070; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Mabry R, 2010, MABS-AUSTIN, V2, P20, DOI 10.4161/mabs.2.1.10498; Nakatsu MN, 2003, LAB INVEST, V83, P1873, DOI 10.1097/01.LAB.0000107160.81875.33; Newman AC, 2011, MOL BIOL CELL, V22, P3791, DOI 10.1091/mbc.E11-05-0393; NICOSIA RF, 1990, LAB INVEST, V63, P115; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; OREILLY MS, 1994, COLD SPRING HARB SYM, V59, P471, DOI 10.1101/SQB.1994.059.01.052; Presta LG, 1997, CANCER RES, V57, P4593; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; SATO N, 1993, AM J PATHOL, V142, P1119; Semela D, 2008, GASTROENTEROLOGY, V135, P671, DOI 10.1053/j.gastro.2008.04.010; Senger DR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005090; Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x; Sorrell JM, 2007, CELLS TISSUES ORGANS, V186, P157, DOI 10.1159/000106670; Staton CA, 2009, INT J EXP PATHOL, V90, P195, DOI 10.1111/j.1365-2613.2008.00633.x; STAVRI GT, 1995, FEBS LETT, V358, P311, DOI 10.1016/0014-5793(94)01458-D	32	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91664	10.1371/journal.pone.0091664	http://dx.doi.org/10.1371/journal.pone.0091664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621607	Green Submitted, gold, Green Published			2022-12-27	WOS:000332845300115
J	Causer, LM; Kaldor, JM; Fairley, CK; Donovan, B; Karapanagiotidis, T; Leslie, DE; Robertson, PW; McNulty, AM; Anderson, D; Wand, H; Conway, DP; Denham, I; Ryan, C; Guy, RJ				Causer, Louise M.; Kaldor, John M.; Fairley, Christopher K.; Donovan, Basil; Karapanagiotidis, Theo; Leslie, David E.; Robertson, Peter W.; McNulty, Anna M.; Anderson, David; Wand, Handan; Conway, Damian P.; Denham, Ian; Ryan, Claire; Guy, Rebecca J.			A Laboratory-Based Evaluation of Four Rapid Point-of-Care Tests for Syphilis	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; COST-EFFECTIVENESS; TREPONEMAL ANTIBODIES; CONGENITAL-SYPHILIS; DIAGNOSTIC-ACCURACY; PLASMA REAGIN; HIV; PERFORMANCE; AFRICA; TANZANIA	Background: Syphilis point-of-care tests may reduce morbidity and ongoing transmission by increasing the proportion of people rapidly treated. Syphilis stage and co-infection with HIV may influence test performance. We evaluated four commercially available syphilis point-of-care devices in a head-to-head comparison using sera from laboratories in Australia. Methods: Point-of-care tests were evaluated using sera stored at Sydney and Melbourne laboratories. Sensitivity and specificity were calculated by standard methods, comparing point-of-care results to treponemal immunoassay (IA) reference test results. Additional analyses by clinical syphilis stage, HIV status, and non-treponemal antibody titre were performed. Non-overlapping 95% confidence intervals (CI) were considered statistically significant differences in estimates. Results: In total 1203 specimens were tested (736 IA-reactive, 467 IA-nonreactive). Point-of-care test sensitivities were: Determine 97.3%(95% CI: 95.8-98.3), Onsite 92.5%(90.3-94.3), DPP 89.8%(87.3-91.9) and Bioline 87.8%(85.1-90.0). Specificities were: Determine 96.4%(94.1-97.8), Onsite 92.5%(90.3-94.3), DPP 98.3%(96.5-99.2), and Bioline 98.5%(96.8-99.3). Sensitivity of the Determine test was 100% for primary and 100% for secondary syphilis. The three other tests had reduced sensitivity among primary (80.4-90.2%) compared to secondary syphilis (94.3-98.6%). No significant differences in sensitivity were observed by HIV status. Test sensitivities were significantly higher among high-RPR titre (RPR >= 8) (range: 94.6-99.5%) than RPR non-reactive infections (range: 76.3-92.9%). Conclusions: The Determine test had the highest sensitivity overall. All tests were most sensitive among high-RPR titre infections. Point-of-care tests have a role in syphilis control programs however in developed countries with established laboratory infrastructures, the lower sensitivities of some tests observed in primary syphilis suggest these would need to be supplemented with additional tests among populations where syphilis incidence is high to avoid missing early syphilis cases.	[Causer, Louise M.; Kaldor, John M.; Donovan, Basil; Wand, Handan; Conway, Damian P.; Guy, Rebecca J.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Fairley, Christopher K.] Univ Melbourne, Sch Populat & Global Hlth, Carlton, Vic 3053, Australia; [Karapanagiotidis, Theo; Leslie, David E.] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Robertson, Peter W.] Prince Wales Hosp, SEALS Area Serol Lab, Randwick, NSW 2031, Australia; [McNulty, Anna M.] Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [Anderson, David; Ryan, Claire] Burnet Inst, Melbourne, Vic, Australia; [Denham, Ian] Melbourne Sexual Hlth Ctr, Carlton, Vic, Australia	University of New South Wales Sydney; Kirby Institute; University of Melbourne; Victorian Infectious Diseases Reference Laboratory; Burnet Institute	Causer, LM (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	lcauser@kirby.unsw.edu.au	Donovan, Basil J/K-1246-2012; Nightingale, Claire Elizabeth/K-1667-2019; Conway, Damian Patrick/F-2789-2012	Donovan, Basil J/0000-0001-8851-4126; Nightingale, Claire Elizabeth/0000-0002-4103-6240; Conway, Damian Patrick/0000-0003-3316-2199; Causer, Louise/0000-0002-8814-0678; Christopher, Fairley/0000-0001-9081-1664; Anderson, David/0000-0002-9969-3905; Guy, Rebecca/0000-0002-2929-4634	Nation Health and Medical Research Council, Australia [568971]	Nation Health and Medical Research Council, Australia	This work was supported by the Nation Health and Medical Research Council, Australia [application # 568971; http://www.nhmrc.gov.au/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blandford JM, 2007, SEX TRANSM DIS, V34, pS61, DOI 10.1097/01.olq.0000258314.20752.5f; Bronzan RN, 2007, SEX TRANSM DIS, V34, pS55, DOI 10.1097/01.olq.0000245987.78067.0c; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; Burgess C, 2008, EVALUATION ABBOTT AR, P1; Castro AR, 2010, J CLIN MICROBIOL, V48, P4615, DOI 10.1128/JCM.00624-10; Cole M, 2004, 10 SYPHILIS EIAS MED, P1; Diaz T, 2004, CLIN DIAGN LAB IMMUN, V11, P98, DOI 10.1128/CDLI.11.1.98-101.2004; Donovan B, 2010, OXFORD TXB MED, P885; Guy RJ, 2005, MED J AUSTRALIA, V183, P218, DOI 10.5694/j.1326-5377.2005.tb07004.x; Hernandez-Trejo M, 2006, REV INVEST CLIN, V58, P119; Herring AJ, 2006, SEX TRANSM INFECT, V82, pV7, DOI 10.1136/sti.2006.022707; Herring A, 2006, NAT REV MICROBIOL, pS33, DOI 10.1038/nrmicro1563; Hunter MG, 2013, J INFECT DIS, V207, P1416, DOI 10.1093/infdis/jis459; Jafari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054695; Jin FY, 2007, SEX TRANSM INFECT, V83, P397, DOI 10.1136/sti.2007.025684; Jin FY, 2005, MED J AUSTRALIA, V183, P179, DOI 10.5694/j.1326-5377.2005.tb06989.x; Lien TX, 2000, AM J TROP MED HYG, V62, P301, DOI 10.4269/ajtmh.2000.62.301; Lowry R., 1998, VASSARSTATS WEBSITE; Lynn WA, 2004, LANCET INFECT DIS, V4, P456, DOI 10.1016/S1473-3099(04)01061-8; Mabey D, 2006, SEX TRANSM INFECT, V82, pV13, DOI 10.1136/sti.2006.022467; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; Mamoojee Y, 2012, TROP MED INT HEALTH, V17, P1521, DOI 10.1111/j.1365-3156.2012.03090.x; Montoya PJ, 2006, B WORLD HEALTH ORGAN, V84, P97, DOI 10.2471/BLT.04.018663; Nessa K, 2008, INT J STD AIDS, V19, P316, DOI 10.1258/ijsa.2007.007280; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; Peterman TA, 2005, SEX TRANSM DIS, V32, pS4, DOI 10.1097/01.olq.0000180455.79024.e9; Read PJ, 2012, INTERN MED J, V42, P614, DOI 10.1111/j.1445-5994.2012.02814.x; Rydzak CE, 2008, SEX TRANSM DIS, V35, P775, DOI 10.1097/OLQ.0b013e318176196d; Sexual Health Society of Victoria, 2008, NAT MAN GUID SEX TRA, P1; Siedner M, 2004, SEX TRANSM DIS, V31, P557, DOI 10.1097/01.olq.0000137903.48413.5e; STI's in Gay Men Action Group (STIGMA), 2010, SEX TRANSM INF TEST; Tinajeros F, 2006, SEX TRANSM INFECT, V82, pV17, DOI 10.1136/sti.2006.022640; Tucker JD, 2010, LANCET INFECT DIS, V10, P381, DOI 10.1016/S1473-3099(10)70092-X; Vickerman P, 2006, SEX TRANSM INFECT, V82, pV38, DOI 10.1136/sti.2006.021824; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; Watson-Jones D, 2002, J INFECT DIS, V186, P948, DOI 10.1086/342951; West B, 2002, SEX TRANSM INFECT, V78, P282, DOI 10.1136/sti.78.4.282; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; World Health Organisation, 2007, GLOB EL SYPH RAT STR; Yin YP, 2013, CLIN INFECT DIS, V56, P659, DOI 10.1093/cid/cis928	40	30	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91504	10.1371/journal.pone.0091504	http://dx.doi.org/10.1371/journal.pone.0091504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618681	Green Published, gold			2022-12-27	WOS:000332842400097
J	Cesari, P; Camponogara, I; Papetti, S; Rocchesso, D; Fontana, F				Cesari, Paola; Camponogara, Ivan; Papetti, Stefano; Rocchesso, Davide; Fontana, Federico			Might as Well Jump: Sound Affects Muscle Activation in Skateboarding	PLOS ONE			English	Article							ANTICIPATORY POSTURAL ADJUSTMENTS; AUDITORY MIRROR SYSTEM; ACTION REPRESENTATION; FUNCTIONAL-ANATOMY; SPEECH PRODUCTION; MUSIC PERCEPTION; GAIT INITIATION; VENTRAL STREAMS; ARM MOVEMENTS; OLDER-ADULTS	The aim of the study is to reveal the role of sound in action anticipation and performance, and to test whether the level of precision in action planning and execution is related to the level of sensorimotor skills and experience that listeners possess about a specific action. Individuals ranging from 18 to 75 years of age - some of them without any skills in skateboarding and others experts in this sport - were compared in their ability to anticipate and simulate a skateboarding jump by listening to the sound it produces. Only skaters were able to modulate the forces underfoot and to apply muscle synergies that closely resembled the ones that a skater would use if actually jumping on a skateboard. More importantly we showed that only skaters were able to plan the action by activating anticipatory postural adjustments about 200 ms after the jump event. We conclude that expert patterns are guided by auditory events that trigger proper anticipations of the corresponding patterns of movements.	[Cesari, Paola; Camponogara, Ivan] Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy; [Fontana, Federico] Univ Udine, Dept Math & Comp Sci, I-33100 Udine, Italy; [Rocchesso, Davide] Iuav Univ Venice, Dept Architecture & Arts, Venice, Italy; [Papetti, Stefano] Zurich Univ Arts, Inst Comp Mus & Sound Technol, Zurich, Switzerland	University of Verona; University of Udine; IUAV University Venice	Cesari, P (corresponding author), Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy.	paola.cesari@univr.it	Camponogara, Ivan/AAW-6596-2020; Rocchesso, Davide/H-4711-2019; Papetti, Stefano/ABC-9182-2020	Camponogara, Ivan/0000-0001-5140-3449; Rocchesso, Davide/0000-0002-0849-7766; Papetti, Stefano/0000-0002-7490-3574; Cesari, Paola/0000-0002-1705-6065	European Community [222107]; European Commission [618067]	European Community(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	Funding for the experimental activities leading to this research was received from the European Community's Seventh Framework Programme under FET-Open grant agreement 222107 NIW - Natural Interactive Walking. Author DR acknowledges the financial support of the Future and EmergingTechnologies (FET) program within the Seventh Framework Programme for Research of the European Commission, under FET-Open grant number 618067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Aglioti SM, 2011, TRENDS COGN SCI, V15, P47, DOI 10.1016/j.tics.2010.12.003; ARUIN AS, 1995, EXP BRAIN RES, V103, P323; Aziz-Zadeh L, 2004, EUR J NEUROSCI, V19, P2609, DOI 10.1111/j.0953-816X.2004.03348.x; Belinkiy VE, 1967, BIOFIZIKA, V12, P135; Benvenuti F, 1997, BRAIN RES, V761, P59, DOI 10.1016/S0006-8993(97)00260-6; Bertucco M, 2010, NEUROSCIENCE, V171, P205, DOI 10.1016/j.neuroscience.2010.08.023; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Castiello U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012240; Chen JL, 2008, CEREB CORTEX, V18, P2844, DOI 10.1093/cercor/bhn042; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cusumano JP, 2006, BIOL CYBERN, V94, P367, DOI 10.1007/s00422-006-0052-1; D'Ausillo A, 2009, CURR BIOL, V19, P381, DOI 10.1016/j.cub.2009.01.017; De Wolf S, 1998, EXP BRAIN RES, V121, P7, DOI 10.1007/s002210050431; Elsner B, 2001, J EXP PSYCHOL HUMAN, V27, P229, DOI 10.1037/0096-1523.27.1.229; Frederick EC, 2006, J APPL BIOMECH, V22, P33, DOI 10.1123/jab.22.1.33; Freriks B, 1999, EUROPEAN RECOMMENDAT, P1; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Goodale MA, 2005, PROG BRAIN RES, V149, P269, DOI 10.1016/S0079-6123(05)49019-6; Haueisen J, 2001, J COGNITIVE NEUROSCI, V13, P786, DOI 10.1162/08989290152541449; Hesse S, 1997, ARCH PHYS MED REHAB, V78, P719, DOI 10.1016/S0003-9993(97)90079-4; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2001, J PSYCHOLINGUIST RES, V30, P225, DOI 10.1023/A:1010486816667; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hyodo M, 2012, GAIT POSTURE, V36, P625, DOI 10.1016/j.gaitpost.2012.06.018; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Kunde W, 2004, Q J EXP PSYCHOL-A, V57, P87, DOI 10.1080/02724980343000143; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Lemaitre G, 2012, J ACOUST SOC AM, V131, P1337, DOI 10.1121/1.3675946; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; Muller H, 2003, BIOL CYBERN, V89, P22, DOI 10.1007/s00422-003-0399-5; Murray MM, 2006, J NEUROSCI, V26, P1293, DOI 10.1523/JNEUROSCI.4511-05.2006; Pezzulo G, 2011, MIND LANG, V26, P78, DOI 10.1111/j.1468-0017.2010.01411.x; Pizzamiglio L, 2005, NEUROIMAGE, V24, P852, DOI 10.1016/j.neuroimage.2004.09.025; Pulvermuller F, 2006, P NATL ACAD SCI USA, V103, P7865, DOI 10.1073/pnas.0509989103; Rath M, 2005, IEEE MULTIMEDIA, V12, P60, DOI 10.1109/MMUL.2005.24; Rogers MW, 2001, ARCH PHYS MED REHAB, V82, P619, DOI 10.1053/apmr.2001.20833; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Sedda A, 2011, EXP BRAIN RES, V209, P365, DOI 10.1007/s00221-011-2559-5; Shiratori T, 2001, CLIN NEUROPHYSIOL, V112, P1250, DOI 10.1016/S1388-2457(01)00553-3; Shiratori T, 2000, CLIN NEUROPHYSIOL, V111, P613, DOI 10.1016/S1388-2457(99)00300-4; Slijper H, 2002, BRAIN RES, V924, P184, DOI 10.1016/S0006-8993(01)03233-4; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Turchet L, 2013, T APPL PRCE IN PRESS; Uemura K, 2012, GAIT POSTURE, V35, P282, DOI 10.1016/j.gaitpost.2011.09.100; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263; Young W, 2013, J EXP PSYCHOL HUMAN, V39, P464, DOI 10.1037/a0029402; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	53	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90156	10.1371/journal.pone.0090156	http://dx.doi.org/10.1371/journal.pone.0090156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24619134	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400010
J	Golan, M; Hagay, N; Tamir, S				Golan, Moria; Hagay, Noa; Tamir, Snait			Gender Related Differences in Response to "In Favor of Myself'' Wellness Program to Enhance Positive Self & Body Image among Adolescents	PLOS ONE			English	Article							FEMALE ADOLESCENTS; EATING ATTITUDES; PREVENTION; ESTEEM; BEHAVIORS; DISSATISFACTION; GIRLS; BOYS; RISK	Background: Physical, neurological and psychological changes are often experienced differently by male and female adolescents. Positive self-esteem, emotional well-being, school achievements, and family connectedness are considered as protective factors against health-compromising behaviors. This study examines the gender differences in respect to the effect of a school-based interactive wellness program - "In Favor of Myself'' - on self-image, body image, eating attitudes and behaviors of young adolescents. Methods: Two hundred and ten adolescents (mean age 13.5) participated in the intervention group, 55% were girls and 45% boys. Program consisted of eight 90-minutes structured sessions integrated into a regular school coping skills curriculum. The program focused on self-esteem, self-image, body image, media literacy and cognitive dissonance. The overall impact of the program and the study protocol were previously published. Results: Overall, there are gender related differences in respect to body image and self-image in young adolescents in response to "In Favor of Myself''. Compared to boys, girls reported at baseline higher self-esteem, being more contingent by appearance, and their self-image was more influenced by popularity, appearance, interpersonal communication and admired people. Furthermore girls presented greater gap between current body figure and perceived ideal figure. Not only were girls more dissatisfied with their body, but they were more active in attempts to become and/or remain "thin''. At program termination, gender x time effect was detected in reduction of self-worth contingent by others, change in importance given to achievements at schools, parents' perceptions, as well as the impact of comparisons to friends and family members on self-image. Conclusions: Girls exhibited more gains than boys from 'In Favor of Myself' which raise the questions about how effective would be the program when delivered in mixed gender groups vs. mono-gender groups.	[Golan, Moria] Shahaf, Community Serv Management Weight Related Problems, Tel Aviv, Israel; [Golan, Moria; Tamir, Snait] Tel Hai Coll, Sch Nutr Sci, Upper Galilee, Israel; [Golan, Moria; Hagay, Noa] Hebrew Univ Jerusalem, Sch Nutr Sci, IL-76100 Rehovot, Israel	Tel Hai Academy College; Hebrew University of Jerusalem	Golan, M (corresponding author), Shahaf, Community Serv Management Weight Related Problems, Tel Aviv, Israel.	moria.golan@mail.huji.ac.il			Dove Self Esteem Fund; Unilever Israel	Dove Self Esteem Fund; Unilever Israel(Unilever)	The program was initiated and is sponsored by "The Dove Self Esteem Fund" and "Unilever Israel." The funding support does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barker ET, 2003, J EARLY ADOLESCENCE, V23, P141, DOI 10.1177/0272431603023002002; Bhardwaj A, 2013, INT J SOC SCI INTERD, V8, P114, DOI DOI 10.15406/JPCPY.2015.02.00092; Brown J. D., 1993, PSYCHOL PERSPECTIVES, V4, P27; Brown JD, 2001, COGNITION EMOTION, V15, P615; CASH TF, 1986, PSYCHOL TODAY, V20, P30; Cohen J.E., 1988, STAT POWER ANAL BEHA; COLLINS ME, 1991, INT J EAT DISORDER, V10, P199, DOI 10.1002/1098-108X(199103)10:2&lt;199::AID-EAT2260100209&gt;3.0.CO;2-D; Cororve Fingeret Michelle, 2006, Eat Disord, V14, P191, DOI 10.1080/10640260600638899; Dalle Grave R, 2001, Eat Disord, V9, P327; Fairburn CG, 1993, BINGE EATING; Flament MF, 2012, BODY IMAGE, V9, P68, DOI 10.1016/j.bodyim.2011.07.007; Florack A, 2005, SWISS J PSYCHOL, V64, P87, DOI 10.1024/1421-0185.64.2.87; Golan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078223; Gonzalez M, 2011, EUR EAT DISORD REV, V19, P349, DOI 10.1002/erv.1102; Hargreaves DA, 2006, J HEALTH PSYCHOL, V11, P567, DOI 10.1177/1359105306065017; Harter S, 1997, DEV PSYCHOPATHOL, V9, P835, DOI 10.1017/S0954579497001466; Jauregui-Lobera I, INT J GEN MED, V3, P263; Larson NI, 2009, J AM DIET ASSOC, V109, P1869, DOI 10.1016/j.jada.2009.08.016; McArthur LH, 2005, ADOLESCENCE, V40, P801; McCabe MP, 2004, J PSYCHOSOM RES, V56, P675, DOI 10.1016/S0022-3999(03)00129-6; McCabe MP, 2001, EUR EAT DISORD REV, V9, P335, DOI 10.1002/erv.389; McCabe MP, 2004, ADOLESCENCE, V35, P145; McVey GL, 2004, INT J EAT DISORDER, V36, P1, DOI 10.1002/eat.20006; Mullie P, 2006, NUTR FOOD SCI, V36, P315, DOI 10.1108/00346650610703162; O'Dea JA, 2000, INT J EAT DISORDER, V28, P43, DOI 10.1002/(SICI)1098-108X(200007)28:1<43::AID-EAT6>3.0.CO;2-D; Oliva P, 1999, SCH YEARS YOUNG WOME; Olivardia R., 2004, PSYCHOL MEN MASCULIN, V5, P112, DOI [10.1037/1524-9220.5.2.112, DOI 10.1037/1524-9220.5.2.112]; Paxton S. J., 2000, HEALTH PROMOT J AUST, V10, P15; Phares V, 2004, J YOUTH ADOLESCENCE, V33, P421, DOI 10.1023/B:JOYO.0000037634.18749.20; Richardson SM, 2009, BODY IMAGE, V6, P75, DOI 10.1016/j.bodyim.2008.11.001; Scime M, 2008, INT J EAT DISORDER, V41, P134, DOI 10.1002/eat.20480; Sira N, 2011, FAM SCI REV, V16, P157; Stice E, 2007, ANNU REV CLIN PSYCHO, V3, P207, DOI 10.1146/annurev.clinpsy.3.022806.091447; Stice E, 2013, INT J EAT DISORDER, V46, P478, DOI 10.1002/eat.22105; Usmiani S, 1997, J YOUTH ADOLESCENCE, V26, P45, DOI 10.1023/A:1024588112108; Varnado-Sullivan PJ, 2006, J CLIN PSYCHOL, V62, P687, DOI 10.1002/jclp.20258; Vereecken C, 2009, INT J PUBLIC HEALTH, V54, P180, DOI 10.1007/s00038-009-5409-5; Wade TD, 2003, INT J EAT DISORDER, V33, P371, DOI 10.1002/eat.10136; Williamson S, 2001, INT J EAT DISORDER, V29, P80, DOI 10.1002/1098-108X(200101)29:1<80::AID-EAT13>3.0.CO;2-O; Yager Z, 2009, HEALTH EDUC RES, V24, P472, DOI 10.1093/her/cyn044	40	26	26	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91778	10.1371/journal.pone.0091778	http://dx.doi.org/10.1371/journal.pone.0091778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24618996	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400128
J	Guzzetta, G; Faustini, L; Panatto, D; Gasparini, R; Manfredi, P				Guzzetta, Giorgio; Faustini, Luca; Panatto, Donatella; Gasparini, Roberto; Manfredi, Piero			The Impact of HPV Female Immunization in Italy: Model Based Predictions	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; CERVICAL-CANCER; PARTICLE VACCINE; NATURAL-HISTORY; SEXUAL-ACTIVITY; PREVALENCE; RISK; EPIDEMIOLOGY; TRANSMISSION; POPULATION	The Human Papillomavirus (HPV) is a sexually transmitted virus that causes cervical cancer. Since 2008 a vaccination program targeting 12-year-old girls has been initiated in Italy, backing up the cervical screening program already active since 1996. We propose a mathematical model of HPV transmission dynamics with the aim of evaluating the impact of these prevention strategies. The model considers heterosexual transmission of HPV types 16 and 18, structured by sex, age and sexual activity level, where transition to sexual activity is explicitly modeled from recent survey data. The epidemiological structure is a hybrid SIS/SIR, where a fraction of individuals recovering from infection develops permanent immunity against reinfection. Infections may progress to cervical lesions and cancer and heal spontaneously or upon treatment. Women undergoing hysterectomy (either after treatment of HPV lesions or by other causes) also transmit HPV infection. The model fits well both the age-specific prevalence of HPV infections and the incidence of cervical cancers in Italy, and accurately reproduces the decreasing trend in cancer incidence due to the introduction of the screening program. The model predicts that if the screening coverage is maintained at current levels, even in the absence of vaccination, such trend will continue in the next few decades, eventually plateauing at 25% below the current level. The additional initiation of routine vaccination targeting 12-year-old girls will further reduce cervical cancer incidence by two thirds at equilibrium, under realistic assumptions of 70% coverage and a duration of protective immunity of 50 years. If catch-up immunization of 25-year-old women at first cervical screening is also introduced, about 3,000 cervical cancer cases overall can be averted, corresponding to 9.6% of all cases expected in the scenario without catch-up. We conclude that HPV vaccination in addition to cervical screening will significantly reduce the burden of cervical cancer in Italy.	[Guzzetta, Giorgio] Trento Rise, Trento, Italy; [Guzzetta, Giorgio] Fdn Bruno Kessler, Trento, Italy; [Faustini, Luca] Istat Toscana, Florence, Italy; [Panatto, Donatella; Gasparini, Roberto] Univ Genoa, Dipartimento Sci Salute, Genoa, Italy; [Manfredi, Piero] Univ Pisa, Dipartimento Econ Management, Pisa, Italy	Fondazione Bruno Kessler; University of Genoa; University of Pisa	Guzzetta, G (corresponding author), Trento Rise, Trento, Italy.	g.guzzetta@trentorise.eu	Bragazzi, Nicola Luigi/G-1672-2011	Bragazzi, Nicola Luigi/0000-0001-8409-868X; Guzzetta, Giorgio/0000-0002-9296-9470; Panatto, Donatella/0000-0002-2677-0551; Gasparini, Roberto/0000-0002-1012-6913	Italian Ministry of Research [2009ZPM4X4]	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR))	The study was funded by the Italian Ministry of Research under project grant 2009ZPM4X4 titled "I vaccini tra nuove tecnologie e nuove applicazioni. Valutazione dell'impatto dei vaccini recentemente introdotti nei piani di prevenzione regionali e prospettive future.'', awarded to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accetta G, 2010, J MED SCREEN, V00, P1; AIRTUM (Italian Association of Cancer Registries), IT PROJ; Barnabas RV, 2006, PLOS MED, V3, P624, DOI 10.1371/journal.pmed.0030138; Baussano I, 2011, VACCINE, V29, P1270, DOI 10.1016/j.vaccine.2010.11.082; Baussano I, 2010, EPIDEMICS-NETH, V2, P21, DOI 10.1016/j.epidem.2010.02.002; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Burchell AN, 2006, VACCINE, V24, P52, DOI 10.1016/j.vaccine.2006.05.031; Capri S, 2011, GYNECOL ONCOL, V121, P514, DOI 10.1016/j.ygyno.2011.01.029; Carozzi FM, 2010, CANCER EPIDEM BIOMAR, V19, P2389, DOI 10.1158/1055-9965.EPI-10-0131; Castellsague X, 2008, GYNECOL ONCOL, V110, pS4, DOI 10.1016/j.ygyno.2008.07.045; Castle PE, 2004, J INFECT DIS, V190, P458, DOI 10.1086/421916; Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125; Dalla Zuanna G, 2010, COMPORTAMENTO SESSUA; David MP, 2009, GYNECOL ONCOL, V115, pS1, DOI 10.1016/j.ygyno.2009.01.011; Dona MG, 2012, J CLIN VIROL, V54, P185, DOI 10.1016/j.jcv.2012.02.014; Durham DP, 2012, J INFECT DIS, V206, P1291, DOI 10.1093/infdis/jis494; Elbasha EH, 2008, B MATH BIOL, V70, P2126, DOI 10.1007/s11538-008-9338-x; Fraser C, 2007, VACCINE, V25, P4324, DOI 10.1016/j.vaccine.2007.02.069; GARNETT GP, 1993, PHILOS T R SOC B, V342, P137, DOI 10.1098/rstb.1993.0143; Giambi C., 2012, STATO AVANZAMENTO CA; Giambi C, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-74; Gravitt PE, 2011, J CLIN INVEST, V121, P4593, DOI 10.1172/JCI57149; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Harper DM, 2009, EXPERT REV VACCINES, V8, P1663, DOI [10.1586/erv.09.123, 10.1586/ERV.09.123]; HERNES G, 1972, AM SOCIOL REV, V37, P173, DOI 10.2307/2094025; Hethcote H., 1996, MODELING HETEROGENEO; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Ho GYF, 2002, J INFECT DIS, V186, P737, DOI 10.1086/342972; International Agency for Research on Cancer, 2011, IARC MON EV CARC R B, V100B, P261; JACQUEZ JA, 1988, MATH BIOSCI, V92, P119, DOI 10.1016/0025-5564(88)90031-4; Kjellgren O, 1995, ACTA ONCOL, V34, P1017, DOI 10.3109/02841869509127228; Koulova A, 2008, VACCINE, V26, P6529, DOI 10.1016/j.vaccine.2008.08.067; La Torre G, 2010, VACCINE, V28, P3379, DOI 10.1016/j.vaccine.2010.02.080; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; LYNGE E, 1989, WORLD J SURG, V13, P71, DOI 10.1007/BF01671157; Malik ZA, 2009, VIRAL IMMUNOL, V22, P445, DOI 10.1089/vim.2009.0055; Mariani L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-259; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marra F, 2009, PHARMACOECONOMICS, V27, P127, DOI 10.2165/00019053-200927020-00004; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Materia E, 2002, J EPIDEMIOL COMMUN H, V56, P461, DOI 10.1136/jech.56.6.461; Mennini FS, 2009, GYNECOL ONCOL, V112, P370, DOI 10.1016/j.ygyno.2008.09.031; Moscicki AB, 2006, VACCINE, V24, P42, DOI 10.1016/j.vaccine.2006.06.018; National Observatory on Screening, YEARL REP; Panatto D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-623; Park H, 1998, STAT PROBABIL LETT, V40, P227, DOI 10.1016/S0167-7152(98)00088-1; Raybould R, 2011, OPEN CLIN CANC J, V5, P1; Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Ronco G, 2008, J NATL CANCER I, V100, P492, DOI 10.1093/jnci/djn065; Rossi PG, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-26; Rossi PG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-214; Rowhani-Rahbar A, 2012, J CLIN VIROL, V53, P239, DOI 10.1016/j.jcv.2011.12.009; Safaeian M, 2010, JNCI-J NATL CANCER I, V102, P1653, DOI 10.1093/jnci/djq384; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Smith JS, 2008, J ADOLESCENT HEALTH, V43, pS5, DOI 10.1016/j.jadohealth.2008.07.009; Stang A, 2013, EUR J PUBLIC HEALTH, V23, P879, DOI 10.1093/eurpub/cks080; Stanley M, 2010, GYNECOL ONCOL, V117, pS5, DOI [10.1016/j.ygyno.2010.01.024, 10.1016/j.ygyno.2010.04.002]; Trottier H, 2010, CANCER RES, V70, P8569, DOI 10.1158/0008-5472.CAN-10-0621; Vaccarella S, 2013, EUR J CANCER, V49, P3262, DOI 10.1016/j.ejca.2013.04.024; Van de Velde N, 2012, JNCI-J NATL CANCER I, V104, P1712, DOI 10.1093/jnci/djs395; Van de Velde N, 2010, VACCINE, V28, P5473, DOI 10.1016/j.vaccine.2010.05.056; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Viscidi RP, 2004, CANCER EPIDEM BIOMAR, V13, P324, DOI 10.1158/1055-9965.EPI-03-0166	63	8	8	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91698	10.1371/journal.pone.0091698	http://dx.doi.org/10.1371/journal.pone.0091698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618824	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400122
J	Montalvo, NF; Davis, J; Vicente, J; Pittiglio, R; Ravel, J; Hill, RT				Montalvo, Naomi F.; Davis, Jeanette; Vicente, Jan; Pittiglio, Raquel; Ravel, Jacques; Hill, Russell T.			Integration of Culture-Based and Molecular Analysis of a Complex Sponge-Associated Bacterial Community	PLOS ONE			English	Article							MARINE SPONGES; MICROTHRIX-PARVICELLA; MICROMONOSPORA SP; SEQUENCE DATA; DIVERSITY; PCR; MICROORGANISMS; SYMBIONTS; GENES; SOIL	The bacterial communities of sponges have been studied using molecular techniques as well as culture-based techniques, but the communities described by these two methods are remarkably distinct. Culture-based methods describe communities dominated by Proteobacteria, and Actinomycetes while molecular methods describe communities dominated by predominantly uncultivated groups such as the Chloroflexi, Acidobacteria, and Acidimicrobidae. In this study, we used a wide range of culture media to increase the diversity of cultivable bacteria from the closely related giant barrel sponges, Xestospongia muta collected from the Florida Keys, Atlantic Ocean and Xestospongia testudinaria, collected from Indonesia, Pacific Ocean. Over 400 pure cultures were isolated and identified from X. muta and X. testudinaria and over 90 bacterial species were represented. Over 16,000 pyrosequences were analyzed and assigned to 976 OTUs. We employed both cultured-based methods and pyrosequencing to look for patterns of overlap between the culturable and molecular communities. Only one OTU was found in both the molecular and culturable communities, revealing limitations inherent in both approaches.	[Montalvo, Naomi F.; Davis, Jeanette; Vicente, Jan; Pittiglio, Raquel; Hill, Russell T.] Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA; [Ravel, Jacques] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; University System of Maryland; University of Maryland Baltimore	Hill, RT (corresponding author), Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA.	hill@umces.edu	Ravel, Jacques/D-2530-2009; Hill, Russell/AAF-4190-2019	Hill, Russell/0000-0002-9832-1851; Ravel, Jacques/0000-0002-0851-2233	National Science Foundation Microbial Observatories Program [MCB-0238515]; Microbial Interactions and Processes Program [MCB-0703467]; BIO/IOS Program [IOS-0919728]; ASM Robert D. Watkins Fellowship Program; NOAA Living Marine Resources Cooperative Science Center (LMRCSC) (NOAA Award) [NA11SEC4810002]	National Science Foundation Microbial Observatories Program(National Science Foundation (NSF)); Microbial Interactions and Processes Program; BIO/IOS Program; ASM Robert D. Watkins Fellowship Program; NOAA Living Marine Resources Cooperative Science Center (LMRCSC) (NOAA Award)	This study was supported by grants from the National Science Foundation Microbial Observatories Program (MCB-0238515), the Microbial Interactions and Processes Program (MCB-0703467) and BIO/IOS Program (IOS-0919728). NM was supported by the ASM Robert D. Watkins Fellowship Program. NM, JD and JV were supported by the NOAA Living Marine Resources Cooperative Science Center (LMRCSC) (NOAA Award No. NA11SEC4810002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Cassler M, 2008, MICROB ECOL, V55, P384, DOI 10.1007/s00248-007-9283-5; Devi P, 2010, MAR DRUGS, V8, P1203, DOI 10.3390/md8041203; Enticknap JJ, 2006, APPL ENVIRON MICROB, V72, P3724, DOI 10.1128/AEM.72.5.3724-3732.2006; Esteves AIS, 2013, FEMS MICROBIOL ECOL, V85, P519, DOI 10.1111/1574-6941.12140; GIOVANNONI SJ, 2000, MICROBIAL ECOLOGY OC, P47; GRIMES DJ, 1986, MICROBIOL SCI, V3, P324; Gurgui C, 2010, METHODS MOL BIOL, V668, P247, DOI 10.1007/978-1-60761-823-2_17; Gutierrez-Lugo MT, 2005, NAT PROD RES, V19, P645, DOI 10.1080/14786410412331272040; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hansson L, 2009, MAR ECOL PROG SER, V397, P89, DOI 10.3354/meps08429; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Hoffmann M, 2010, ISME J, V4, P1608, DOI 10.1038/ismej.2010.85; Janssen PH, 1997, APPL ENVIRON MICROB, V63, P1382, DOI 10.1128/AEM.63.4.1382-1388.1997; KOCIANOVA E, 1994, J APPL BACTERIOL, V76, P301, DOI 10.1111/j.1365-2672.1994.tb01632.x; Lafi FF, 2005, MICROB ECOL, V50, P213, DOI 10.1007/s00248-004-0202-8; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lui M, 2012, ISME J, V6, P1515; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P2910, DOI 10.1111/j.1462-2920.2008.01704.x; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P75, DOI 10.1111/j.1462-2920.2007.01431.x; Mohamed NM, 2010, ISME J, V4, P38, DOI 10.1038/ismej.2009.84; Montalvo NF, 2011, APPL ENVIRON MICROB, V77, P7207, DOI 10.1128/AEM.05285-11; Montalvo NF, 2005, ANTON LEEUW INT J G, V87, P29, DOI 10.1007/s10482-004-6536-x; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; RAVEL J, 2010, P NATL ACAD SCI US; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Sait M, 2002, ENVIRON MICROBIOL, V4, P654, DOI 10.1046/j.1462-2920.2002.00352.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Sfanos K, 2005, SYST APPL MICROBIOL, V28, P242, DOI 10.1016/j.syapm.2004.12.002; Shade A, 2012, ENVIRON MICROBIOL, V14, P2247, DOI 10.1111/j.1462-2920.2012.02817.x; Siegl A, 2011, ISME J, V5, P61, DOI 10.1038/ismej.2010.95; Simpson TL, 1984, CELL BIOL SPONGES, P662; Sipkema D, 2011, APPL ENVIRON MICROB, V77, P2130, DOI 10.1128/AEM.01203-10; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; SLIJKHUIS H, 1983, APPL ENVIRON MICROB, V46, P832, DOI 10.1128/AEM.46.4.832-839.1983; Sousa TD, 2012, J NAT PROD, V75, P489, DOI 10.1021/np200795p; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2011, MAR BIOTECHNOL, V13, P1057, DOI 10.1007/s10126-011-9397-0; Thiel V, 2007, MICROB ECOL, V54, P101, DOI 10.1007/s00248-006-9177-y; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Webster NS, 2001, MAR BIOL, V138, P843, DOI 10.1007/s002270000503; White JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038204; Wicke C, 2000, J NAT PROD, V63, P621, DOI 10.1021/np990313b; WILKINSON CR, 1981, MICROBIAL ECOL, V7, P13, DOI 10.1007/BF02010474; Zan JD, 2012, MOL MICROBIOL, V85, P916, DOI 10.1111/j.1365-2958.2012.08149.x; Zan JD, 2011, ISME J, V5, P1505, DOI 10.1038/ismej.2011.31	54	40	40	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90517	10.1371/journal.pone.0090517	http://dx.doi.org/10.1371/journal.pone.0090517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618773	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400020
J	Parikh, I; Fardo, DW; Estus, S				Parikh, Ishita; Fardo, David W.; Estus, Steven			Genetics of PICALM Expression and Alzheimer's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; COMMON VARIANTS; CLATHRIN; PROTEIN; CD33; CLU; CD2AP; EPHA1; CALM	Novel Alzheimer's disease (AD) risk factors have been identified by genome-wide association studies. Elucidating the mechanism underlying these factors is critical to the validation process and, by identifying rate-limiting steps in AD risk, may yield novel therapeutic targets. Here, we evaluated the association between the AD-associated polymorphism rs3851179 near PICALM, which encodes a clathrin-coated pit accessory protein. Immunostaining established that PICALM is expressed predominately in microvessels in human brain. Consistent with this finding, PICALM mRNA expression correlated with expression of the endothelial genes vWF and CD31. Additionally, we found that PICALM expression was modestly increased with the rs3851179A AD-protective allele. Analysis of PICALM isoforms found several isoforms lacking exons encoding elements previously identified as critical to PICALM function. Increased expression of the common isoform lacking exon 13 was also associated with the rs3851179A protective allele; this association was not apparent when this isoform was compared with total PICALM expression, indicating that the SNP is associated with total PICALM expression and not this isoform per se. Interestingly, PICALM lacking exons 2-4 was not associated with rs3851179 but was associated with rs592297, which is located in exon 5. Thus, our primary findings are that multiple PICALM isoforms are expressed in the human brain, that PICALM is robustly expressed in microvessels, and that expression of total PICALM is modestly correlated with the AD-associated SNP rs3851179. We interpret these results as suggesting that increased PICALM expression in the microvasculature may reduce AD risk.	[Parikh, Ishita; Estus, Steven] Univ Kentucky, Dept Physiol, Sanders Brown Ctr Aging, Lexington, KY 40506 USA; [Fardo, David W.] Univ Kentucky, Sanders Brown Ctr Aging, Dept Biostat, Lexington, KY USA	University of Kentucky; University of Kentucky	Estus, S (corresponding author), Univ Kentucky, Dept Physiol, Sanders Brown Ctr Aging, Lexington, KY 40506 USA.	steve.estus@uky.edu		Parikh, Ishita/0000-0001-9335-733X; Fardo, David/0000-0002-7207-4696	National Institute on Aging [P01-AG030128, K25-AG043546]; NATIONAL INSTITUTE ON AGING [P01AG030128, R01AG045775, K25AG043546, P30AG028383] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors acknowledge the National Institute on Aging for funding (P01-AG030128 (Estus) and K25-AG043546 (Fardo)), the University of Kentucky Alzheimer's Center for tissue (P30-AG028383) and James Simpson for technical assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2012, NEUROLOGY, V79, P221, DOI 10.1212/WNL.0b013e3182605801; Ando K, 2013, ACTA NEUROPATHOL, V125, P861, DOI 10.1007/s00401-013-1111-z; Avramopoulos D, 2009, GENOME MED, V1, DOI 10.1186/gm34; Baig S, 2010, J NEUROPATH EXP NEUR, V69, P1071, DOI 10.1097/NEN.0b013e3181f52e01; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Harel A, 2011, NEUROMOL MED, V13, P88, DOI 10.1007/s12017-010-8142-6; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Jackson DE, 2003, FEBS LETT, V540, P7, DOI 10.1016/S0014-5793(03)00224-2; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976; Lambert JC, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.11.022; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Ling IF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033923; Malik M, 2013, J NEUROSCI, V33, P13320, DOI 10.1523/JNEUROSCI.1224-13.2013; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Morgan K, 2011, NEUROPATH APPL NEURO, V37, P353, DOI 10.1111/j.1365-2990.2011.01181.x; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Ramanan V, 2011, INTEGR BIOL-UK, V3, P803, DOI 10.1039/c1ib00036e; Rosenbloom KR, 2012, NUCL ACIDS RES; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sagare AP, 2012, COLD SPRING HARB PER, V2; Schnetz-Boutaud NC, 2012, ANN HUM GENET, V76, P448, DOI 10.1111/j.1469-1809.2012.00727.x; Scotland PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044252; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Xiao QL, 2012, J BIOL CHEM, V287, P21279, DOI 10.1074/jbc.M111.338376	31	48	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91242	10.1371/journal.pone.0091242	http://dx.doi.org/10.1371/journal.pone.0091242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618820	gold, Green Published, Green Submitted			2022-12-27	WOS:000332842400063
J	Shimizu, E; Glaspy, K; Witt, MD; Poon, K; Black, S; Schwartz, S; Bholat, T; Diaz, N; Kuo, A; Spellberg, B				Shimizu, Eri; Glaspy, Kathleen; Witt, Mallory D.; Poon, Kimble; Black, Susan; Schwartz, Shelley; Bholat, Tasneem; Diaz, Norma; Kuo, Allen; Spellberg, Brad			Readmissions at a Public Safety Net Hospital	PLOS ONE			English	Article							POTENTIALLY PREVENTABLE READMISSIONS; HEALTH LITERACY; MEDICARE BENEFICIARIES; INPATIENT CARE; DISCHARGE; QUALITY; PROGRAM; REHOSPITALIZATION; ASSOCIATION; EVENTS	Objective: We aimed to determine factors related to avoidability of 30-day readmissions at our public, safety net hospital in the United States (US). Methods: We prospectively reviewed medical records of adult internal medicine patients with scheduled and unscheduled 30-day readmissions. We also interviewed patients if they were available. An independent panel used pre-specified, objective criteria to adjudicate potential avoidability. Results: Of 153 readmissions evaluated, 68% were unscheduled. Among these, 67% were unavoidable, primarily due to disease progression and development of new diagnoses. Scheduled readmissions accounted for 32% of readmissions and most (69%) were clinically appropriate and unavoidable. The scheduled but avoidable readmissions (31%) were attributed largely to limited resources in our healthcare system. Conclusions: Most readmissions at our public, safety net hospital were unavoidable, even among our unscheduled readmissions. Surprisingly, one-third of our overall readmissions were scheduled, the majority reflecting appropriate management strategies designed to reduce unnecessary hospital days. The scheduled but avoidable readmissions were due to constrained access to non-emergent, expensive procedures that are typically not reimbursed given our system's payor mix, a problem which likely plague other safety net systems. These findings suggest that readmissions do not necessarily reflect inadequate medical care, may reflect resource constraints that are unlikely to be addressable in systems caring for a large burden of uninsured patients, and merit individualized review.	[Shimizu, Eri; Glaspy, Kathleen; Schwartz, Shelley; Bholat, Tasneem; Kuo, Allen; Spellberg, Brad] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Gen Internal Med, Torrance, CA 90509 USA; [Shimizu, Eri] Hawaii Permanente Med Grp, Dept Med, Wailuku, HI USA; [Shimizu, Eri; Poon, Kimble] Maui Mem Med Ctr, Dept Med, Wailuku, HI USA; [Glaspy, Kathleen; Witt, Mallory D.; Spellberg, Brad] Univ Calif Los Angeles, David Geffen Sch Med, Torrance, CA USA; [Witt, Mallory D.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div HIV Med, Torrance, CA 90509 USA; [Black, Susan; Diaz, Norma] Harbor UCLA Med Ctr, Dept Qual, Torrance, CA 90509 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Permanente Medical Groups; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Shimizu, E (corresponding author), Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Gen Internal Med, Torrance, CA 90509 USA.	eshimizu37@gmail.com						[Anonymous], 2007, MED PAYM ADV COMM RE, P107; Arbaje AI, 2008, GERONTOLOGIST, V48, P495, DOI 10.1093/geront/48.4.495; ASHTON CM, 1995, ANN INTERN MED, V122, P415, DOI 10.7326/0003-4819-122-6-199503150-00003; ASHTON CM, 1994, MED CARE, V32, P755, DOI 10.1097/00005650-199408000-00001; Ashton CM, 1997, MED CARE, V35, P1044, DOI 10.1097/00005650-199710000-00006; Berenson Julia, 2012, Issue Brief (Commonw Fund), V34, P1; Calvillo-King L, 2013, J GEN INTERN MED, V28, P269, DOI 10.1007/s11606-012-2235-x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chew LD, 2004, FAM MED, V36, P588; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Dudas V, 2001, AM J MED, V111, P26, DOI 10.1016/S0002-9343(01)00966-4; Forster AJ, 2005, J GEN INTERN MED, V20, P317, DOI 10.1111/j.1525-1497.2005.30390.x; Forster AJ, 2004, CAN MED ASSOC J, V170, P345; Goldfield NI, 2008, HEALTH CARE FINANC R, V30, P75; Horwitz LI, 2013, JAMA INTERN MED, V173, P1715, DOI 10.1001/jamainternmed.2013.9318; Hughes M R, 2000, Top Health Inf Manage, V20, P65; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jiang HJ, 2005, AM J PUBLIC HEALTH, V95, P1561, DOI 10.2105/AJPH.2004.044222; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Joynt KE, 2012, NEW ENGL J MED, V366, P1366, DOI 10.1056/NEJMp1201598; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Makaryus AN, 2005, MAYO CLIN PROC, V80, P991, DOI 10.4065/80.8.991; Maniaci MJ, 2008, MAYO CLIN PROC, V83, P554, DOI 10.4065/83.5.554; Mitchell SE, 2012, J HEALTH COMMUN, V17, P325, DOI 10.1080/10810730.2012.715233; Oddone EZ, 1996, J GEN INTERN MED, V11, P597, DOI 10.1007/BF02599027; Rodriguez F, 2011, AM HEART J, V162, P254, DOI 10.1016/j.ahj.2011.05.009; Strunin L, 2007, J HOSP MED, V2, P297, DOI 10.1002/jhm.206; van Walraven C, 2011, CAN MED ASSOC J, V183, pE391, DOI 10.1503/cmaj.101860; Weissman JS, 1999, MED CARE, V37, P490, DOI 10.1097/00005650-199905000-00008; WEISSMAN JS, 1994, INQUIRY-J HEALTH CAR, V31, P163	31	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91244	10.1371/journal.pone.0091244	http://dx.doi.org/10.1371/journal.pone.0091244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618829	gold, Green Submitted, Green Published			2022-12-27	WOS:000332842400064
J	Tsai, JR; Liu, PL; Chen, YH; Chou, SH; Yang, MC; Cheng, YJ; Hwang, JJ; Yin, WH; Chong, IW				Tsai, Jong-Rung; Liu, Po-Len; Chen, Yung-Hsiang; Chou, Shah-Hwa; Yang, Ming-Chan; Cheng, Yu-Jen; Hwang, Jhi-Jhu; Yin, Wei-Hsian; Chong, Inn-Wen			Ginkgo biloba Extract Decreases Non-Small Cell Lung Cancer Cell Migration by Downregulating Metastasis-Associated Factor Heat-Shock Protein 27	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; ESTROGEN-RECEPTOR; STRESS-PROTEINS; EXPRESSION; HSP27; ACTIVATION; CHEMOTHERAPY; APOPTOSIS; SURVIVAL; ADENOCARCINOMA	Heat-shock proteins (HSPs) are molecular chaperones that protect proteins from damage. HSP27 expression is associated with cancer transformation and invasion. Ginkgo biloba extract (EGb761), the most widely sold herbal supplement, has antiangiogenic effects and induces tumor apoptosis. Data regarding the effect of EGb761 on HSP expression is limited, particularly in cancer. HSP27 expression in paired tumors and normal lung tissues of 64 patients with non-small cell lung cancer (NSCLC) were detected by real-time PCR, western blotting, and immunohistochemistry. NSCLC cell lines (A549/H441) were used to examine the migratory abilities in vitro. NSCLC tissue showed higher HSP27 expression than normal lung tissue. Kaplan-Meier survival analysis showed that NSCLC patients with low HSP27 expression ratio (<1) had significantly longer survival time than those with a high expression ratio (>1) (p = 0.04). EGb761 inhibited HSP27 expression and migratory ability of A549/H441 cells, which is the same as HSP27-siRNA transfection effect. Moreover, EGb761 treatment activated the AKT and p38 pathways and did not affect the expression of PI3K, ERK, and JNK pathways. HSP27 is a poor prognostic indicator of NSCLC. EGb761 can decrease the migration ability of A549/H441 by inhibiting HSP27 expression most likely through AKT and p38 MAPK pathways activation.	[Tsai, Jong-Rung; Liu, Po-Len; Chou, Shah-Hwa; Hwang, Jhi-Jhu; Chong, Inn-Wen] Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung, Taiwan; [Tsai, Jong-Rung; Hwang, Jhi-Jhu; Chong, Inn-Wen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Yung-Hsiang] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Chou, Shah-Hwa] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Chest Surg, Dept Surg, Kaohsiung, Taiwan; [Yang, Ming-Chan] Yuans Gen Hosp, Dept Surg, Kaohsiung, Taiwan; [Cheng, Yu-Jen] I Shou Univ, E Da Hosp, Dept Surg, Dept Hlth Management,Div Thorac Surg, Kaohsiung, Taiwan; [Yin, Wei-Hsian] Natl Yang Ming Univ, Fac Med, Cheng Hsin Gen Hosp, Div Cardiol, Taipei 112, Taiwan; [Yin, Wei-Hsian] Natl Yang Ming Univ, Sch Med, Cardiovasc Res Ctr, Taipei 112, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; E-Da Hospital; I Shou University; Cheng Hsin General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chong, IW (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung, Taiwan.	chong@kmu.edu.tw	Chen, Yung-Hsiang/K-6766-2015	Chen, Yung-Hsiang/0000-0002-8756-5113; Tsai, Jong rung/0000-0002-3222-0409	Kaohsiung Medical University [KMU-Q098022]; National Science Council, Taiwan [NSC102-2314-B-037-067]	Kaohsiung Medical University; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by grant KMU-Q098022 from the Kaohsiung Medical University, and grant NSC102-2314-B-037-067 from National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrian S, 2002, CELL STRESS CHAPERON, V7, P177, DOI 10.1379/1466-1268(2002)007<0177:OOHATM>2.0.CO;2; Arts HJG, 1999, INT J CANCER, V84, P234, DOI 10.1002/(SICI)1097-0215(19990621)84:3<234::AID-IJC6>3.0.CO;2-9; Atkins D, 2005, CONTRIB NEPHROL, V148, P35, DOI 10.1159/000086042; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bausero MA, 2004, TUMOR BIOL, V25, P243, DOI 10.1159/000081387; Berrieman HK, 2006, ONCOL REP, V15, P283; Bubendorf L, 1999, J NATL CANCER I, V91, P1758, DOI 10.1093/jnci/91.20.1758; Chao JCJ, 2004, WORLD J GASTROENTERO, V10, P37; Chen XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059314; Chen XH, 2011, CELL PHYSIOL BIOCHEM, V27, P227, DOI 10.1159/000327948; CHRETIEN P, 1988, J CELL PHYSIOL, V137, P157, DOI 10.1002/jcp.1041370119; CIOCCA DR, 1989, CANCER RES, V49, P4298; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Conroy SE, 1998, BRIT J CANCER, V77, P1875, DOI 10.1038/bjc.1998.312; Cornford PA, 2000, CANCER RES, V60, P7099; DeFeudis FV, 2003, FUND CLIN PHARMACOL, V17, P405, DOI 10.1046/j.1472-8206.2003.00156.x; Dorion S, 2002, CELL STRESS CHAPERON, V7, P200, DOI 10.1379/1466-1268(2002)007<0200:AOTMAP>2.0.CO;2; Erkizan O, 2004, UROLOGY, V64, P474, DOI 10.1016/j.urology.2004.04.017; Eskenazi AE, 1998, CLIN EXP METASTAS, V16, P283, DOI 10.1023/A:1006553127695; Fukaya H, 1999, Nihon Jibiinkoka Gakkai Kaiho, V102, P907; Gandour-Edwards R, 1998, OTOLARYNG HEAD NECK, V118, P610, DOI 10.1016/S0194-5998(98)70229-3; Ghosh A, 2013, EXP MOL PATHOL, V94, P103, DOI 10.1016/j.yexmp.2012.09.001; Grabinski N, 2011, CELL SIGNAL; Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027; Hadchity E, 2009, MOL THER, V17, P1387, DOI 10.1038/mt.2009.90; Hauns B, 1999, ARZNEIMITTEL-FORSCH, V49, P1030; HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2; Hsu HS, 2011, CANCER; KANITAKIS J, 1989, J CUTAN PATHOL, V16, P272, DOI 10.1111/j.1600-0560.1989.tb00051.x; Kapranos N, 2002, J CANCER RES CLIN, V128, P426, DOI 10.1007/s00432-002-0357-y; Kim KS, 2005, ORAL ONCOL, V41, P383, DOI 10.1016/j.oraloncology.2004.09.013; King KL, 2000, CANCER, V88, P2464, DOI 10.1002/1097-0142(20000601)88:11<2464::AID-CNCR6>3.0.CO;2-W; Lemieux P., 1997, BIOL DELAY SYSTEMS L, V17, P113; Malusecka E, 2008, ANTICANCER RES, V28, P501; Mansi L, 2011, B CANC; Moon A, 2010, PATHOLOGY, V42, P421, DOI 10.3109/00313025.2010.493866; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Nano M, 2000, Chir Ital, V52, P313; Oken BS, 1998, ARCH NEUROL-CHICAGO, V55, P1409, DOI 10.1001/archneur.55.11.1409; Onen A, 1999, ACTA GASTRO-ENT BELG, V62, P386; Pietri S, 1997, CARDIOVASC DRUG THER, V11, P121, DOI 10.1023/A:1007728729844; PUY LA, 1989, CANCER, V64, P1067, DOI 10.1002/1097-0142(19890901)64:5<1067::AID-CNCR2820640518>3.0.CO;2-H; Rozsas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077459; Sarhadi V, 2006, J PATHOL, V209, P206, DOI 10.1002/path.1960; Soldes OS, 1999, BRIT J CANCER, V79, P595, DOI 10.1038/sj.bjc.6690094; Storm FK, 1996, ANN SURG ONCOL, V3, P570, DOI 10.1007/BF02306091; Takeno S, 2001, DIS ESOPHAGUS, V14, P149, DOI 10.1046/j.1442-2050.2001.00174.x; Takeno S, 2001, ANN SURG ONCOL, V8, P215, DOI 10.1245/aso.2001.8.3.215; Tang SQ, 1997, J BIOL CHEM, V272, P28704, DOI 10.1074/jbc.272.45.28704; Tian T, 2007, CANCER SCI, V98, P1265, DOI 10.1111/j.1349-7006.2007.00514.x; Tsuruta M, 2008, ONCOL REP, V20, P1165, DOI 10.3892/or_00000125; Wang GD, 2004, ONCOL REP, V12, P955; Wang W, 2011, TUMOR BIOL, V32, P1199, DOI 10.1007/s13277-011-0223-0; WEISS A, 1984, J IMMUNOL, V133, P123; Wikman H, 2002, ONCOGENE, V21, P5804, DOI 10.1038/sj.onc.1205726; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yao HX, 2009, LUNG CANCER, V65, P41, DOI 10.1016/j.lungcan.2008.10.024; Zhang Y, 2007, CLIN CANCER RES, V13, P2855, DOI 10.1158/1078-0432.CCR-06-2090; Zimmermann M, 2012, CLIN CHIM ACTA, V413, P1115, DOI 10.1016/j.cca.2012.03.008	59	24	31	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91331	10.1371/journal.pone.0091331	http://dx.doi.org/10.1371/journal.pone.0091331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618684	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400078
J	do Amaral, DN; Cavalcanti, BC; Bezerra, DP; Ferreira, PMP; Castro, RD; Sabino, JR; Machado, CML; Chammas, R; Pessoa, C; Sant'Anna, CMR; Barreiro, EJ; Lima, LM				do Amaral, Daniel Nascimento; Cavalcanti, Bruno C.; Bezerra, Daniel P.; Ferreira, Paulo Michel P.; Castro, Rosane de Paula; Sabino, Jose Ricardo; Longo Machado, Camila Maria; Chammas, Roger; Pessoa, Claudia; Sant'Anna, Carlos M. R.; Barreiro, Eliezer J.; Lima, Lidia Moreira			Docking, Synthesis and Antiproliferative Activity of N-Acylhydrazone Derivatives Designed as Combretastatin A4 Analogues	PLOS ONE			English	Article							HOLLOW-FIBER ASSAY; BETA-TUBULIN; TARGET; GROWTH; SERIES; TUMOR; MODEL	Cancer is the second most common cause of death in the USA. Among the known classes of anticancer agents, the microtubule-targeted antimitotic drugs are considered to be one of the most important. They are usually classified into microtubule-destabilizing (e. g., Vinca alkaloids) and microtubule-stabilizing (e. g., paclitaxel) agents. Combretastatin A4 (CA-4), which is a natural stilbene isolated from Combretum caffrum, is a microtubule-destabilizing agent that binds to the colchicine domain on beta-tubulin and exhibits a lower toxicity profile than paclitaxel or the Vinca alkaloids. In this paper, we describe the docking study, synthesis, antiproliferative activity and selectivity index of the N-acylhydrazone derivatives (5a-r) designed as CA-4 analogues. The essential structural requirements for molecular recognition by the colchicine binding site of beta-tubulin were recognized, and several compounds with moderate to high antiproliferative potency (IC50 values <= 18 mu M and >= 4 nM) were identified. Among these active compounds, LASSBio-1586 (5b) emerged as a simple antitumor drug candidate, which is capable of inhibiting microtubule polymerization and possesses a broad in vitro and in vivo antiproliferative profile, as well as a better selectivity index than the prototype CA-4, indicating improved selective cytotoxicity toward cancer cells.	[do Amaral, Daniel Nascimento; Barreiro, Eliezer J.; Lima, Lidia Moreira] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Farmacos & Medicamento, Lab Avaliacao & Sintese Subst Bioat LASSBio, Rio De Janeiro, Brazil; [do Amaral, Daniel Nascimento; Barreiro, Eliezer J.; Lima, Lidia Moreira] Univ Fed Rio de Janeiro, Inst Quim, Programa Posgrad Quim, Rio De Janeiro, Brazil; [Cavalcanti, Bruno C.; Bezerra, Daniel P.; Pessoa, Claudia] Univ Fed Ceara, Fac Med, Dept Fisiol & Farmacol, Fortaleza, Ceara, Brazil; [Ferreira, Paulo Michel P.] Univ Fed Piaui, Dept Ciencias Biol, Picos, Brazil; [Castro, Rosane de Paula; Sabino, Jose Ricardo] Univ Fed Goias, Inst Fis, Goiania, Go, Brazil; [Longo Machado, Camila Maria; Chammas, Roger] Univ Sao Paulo, Fac Med, Dept Radiol, Sao Paulo, Brazil; [Sant'Anna, Carlos M. R.] Univ Fed Rural Rio de Janeiro, Dept Quim, Seropedica, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Ceara; Universidade Federal do Piaui; Universidade Federal de Goias; Universidade de Sao Paulo; Universidade Federal Rural do Rio de Janeiro (UFRRJ)	Lima, LM (corresponding author), Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Farmacos & Medicamento, Lab Avaliacao & Sintese Subst Bioat LASSBio, Rio De Janeiro, Brazil.	lidia@lassbio.icb.ufrj.br	SABINO, JOSE RICARDO/AAB-5846-2021; Bezerra, Daniel P/K-7889-2017; Amaral, Daniel/V-5658-2019; Fapesp, Biota/F-8655-2017; Lima, Lidia M/D-9587-2015; Chammas, Roger/A-8004-2011; Ferreira, Paulo Michel Pinheiro/J-6783-2012; Sant'Anna, Carlos Mauricio Rabello de/G-3879-2012; Machado, Camila/C-4077-2012; Barreiro, Eliezer J/B-1131-2011; Coêlho Cavalcanti, Bruno/F-1555-2015	Bezerra, Daniel P/0000-0002-6774-2063; Amaral, Daniel/0000-0002-6800-0248; Fapesp, Biota/0000-0002-9887-8449; Lima, Lidia M/0000-0002-8625-6351; Chammas, Roger/0000-0003-0342-8726; Ferreira, Paulo Michel Pinheiro/0000-0001-6862-6497; Sant'Anna, Carlos Mauricio Rabello de/0000-0003-1989-5038; Barreiro, Eliezer J/0000-0003-1759-0038; 	CNPq; FAPERJ; INCT-INOFAR [573.564/2008-6, E-26/170.020/2008]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); INCT-INOFAR	This work was supported by CNPq (BR), FAPERJ (BR) and INCT-INOFAR (BR, 573.564/2008-6 and E-26/170.020/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MM, 2010, J COMB CHEM, V12, P245, DOI 10.1021/cc9001444; Bai RL, 2000, J BIOL CHEM, V275, P40443, DOI 10.1074/jbc.M005299200; Baxter CA, 1998, PROTEINS, V33, P367, DOI 10.1002/(SICI)1097-0134(19981115)33:3<367::AID-PROT6>3.3.CO;2-N; BONNE D, 1985, J BIOL CHEM, V260, P2819; Borchhardt DM, 2010, J BRAZIL CHEM SOC, V21, P142, DOI 10.1590/S0103-50532010000100021; Cao XF, 2011, J CHIN CHEM SOC-TAIP, V58, P35, DOI 10.1002/jccs.201190055; Combes S, 2011, J MED CHEM, V54, P3153, DOI 10.1021/jm901826e; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Dorleans A, 2009, P NATL ACAD SCI USA, V106, P13775, DOI 10.1073/pnas.0904223106; Ducki S, 1998, BIOORG MED CHEM LETT, V8, P1051, DOI 10.1016/S0960-894X(98)00162-0; Ducki S, 2009, BIOORGAN MED CHEM, V17, P7698, DOI 10.1016/j.bmc.2009.09.039; Ducki S, 2009, BIOORGAN MED CHEM, V17, P7711, DOI 10.1016/j.bmc.2009.09.044; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Farrugia L.J., 1997, J APPL CRYSTALLOGR, V30, P565, DOI 10.1107/S0021889897003117; Farrugia L.J., 1999, J APPL CRYSTALLOGR, V32, P837, DOI [DOI 10.1107/S0021889812029111, 10.1107/S0021889899006020, DOI 10.1107/S0021889899006020, 10.1107/S0021889812029111]; Furst R, 2009, BIOORG MED CHEM LETT, V19, P6948, DOI 10.1016/j.bmcl.2009.10.064; Hall LM, 2000, ANTICANCER RES, V20, P903; HOLLINGSHEAD MG, 1995, LIFE SCI, V57, P131, DOI 10.1016/0024-3205(95)00254-4; HORWITZ JP, 1954, J ORG CHEM, V19, P194, DOI 10.1021/jo01367a007; Jin LH, 2006, BIOORG MED CHEM LETT, V16, P5036, DOI 10.1016/j.bmcl.2006.07.048; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kummerle AE, 2009, EUR J MED CHEM, V44, P4004, DOI 10.1016/j.ejmech.2009.04.044; Lee L, 2010, J MED CHEM, V53, P325, DOI 10.1021/jm901268n; Lima PC, 2000, EUR J MED CHEM, V35, P187, DOI 10.1016/S0223-5234(00)00120-3; MACK CH, 1969, J CHEM ENG DATA, V14, P258, DOI 10.1021/je60041a042; MAZZONE G, 1978, FARMACO-ED SCI, V33, P963; Mazzone G, 1991, B SEDUTE ACAD GIONIA, V8, P689; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Prise VE, 2002, INT J ONCOL, V21, P717; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Sadar MD, 2002, MOL CANCER THER, V1, P629; Schneider P, 2009, PHYTOCHEM LETT, V2, P85, DOI 10.1016/j.phytol.2008.12.004; Shan Y, 2011, CURR MED CHEM, V18, P523, DOI 10.2174/092986711794480221; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Singh P, 2008, IUBMB LIFE, V60, P368, DOI 10.1002/iub.42; Snyder JP, 2001, P NATL ACAD SCI USA, V98, P5312, DOI 10.1073/pnas.051309398; Suggitt M, 2004, CLIN CANCER RES, V10, P6677, DOI 10.1158/1078-0432.CCR-04-0855; Tron GC, 2006, J MED CHEM, V49, P3033, DOI 10.1021/jm0512903; Wermuth GC, 2008, PRACTICE MED CHEM, P448; Workman P, 1998, BRIT J CANCER, V77, P1; Yogeeswari P, 2005, J MED CHEM, V48, P6202, DOI 10.1021/jm050283b	43	38	38	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e85380	10.1371/journal.pone.0085380	http://dx.doi.org/10.1371/journal.pone.0085380			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614859	Green Published, gold			2022-12-27	WOS:000332839300002
J	Helin-Salmivaara, A; Lavikainen, P; Aarnio, E; Huupponen, R; Korhonen, MJ				Helin-Salmivaara, Arja; Lavikainen, Piia; Aarnio, Emma; Huupponen, Risto; Korhonen, Maarit Jaana			Sequential Cohort Design Applying Propensity Score Matching to Analyze the Comparative Effectiveness of Atorvastatin and Simvastatin in Preventing Cardiovascular Events	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; HOSPITAL DISCHARGE REGISTER; OUTCOMES; THERAPY; STATINS; DISEASE; STROKE	Background: Sequential cohort design (SCD) applying matching for propensity scores (PS) in accrual periods has been proposed to mitigate bias caused by channeling when calendar time is a proxy for strong confounders. We studied the channeling of patients according to atorvastatin and simvastatin initiation in Finland, starting from the market introduction of atorvastatin in 1998, and explored the SCD PS approach to analyzing the comparative effectiveness of atorvastatin versus simvastatin in the prevention of cardiovascular events (CVE). Methods: Initiators of atorvastatin or simvastatin use in the 45-75-year age range in 1998-2006 were characterized by their propensity of receiving atorvastatin over simvastatin, as estimated for 17 six-month periods. Atorvastatin (10 mg) and simvastatin (20 mg) initiators were matched 1: 1 on the PS, as estimated for the whole cohort and within each period. Cox regression models were fitted conventionally, and also for the PS matched cohort and the periodically PS matched cohort, to estimate the hazard ratios (HR) for CVEs. Findings: Atorvastatin (10 mg) was associated with a 11%-12% lower incidence of CVE in comparison with simvastatin (20 mg). The HR estimates were the same for a conventional Cox model (0.88, 95% confidence interval 0.85-0.91), for the analysis in which the PS was used to match across all periods and the Cox model was adjusted for strong confounders (0.89, 0.85-0.92), and for the analysis in which PS matching was applied within sequential periods (0.88, 0.84-0.92). The HR from a traditional PS matched analysis was 0.80 (0.77-0.83). Conclusions: The SCD PS approach produced effect estimates similar to those obtained in matching for PS within the whole cohort and adjusting the outcome model for strong confounders, but at the cost of efficiency. A traditional PS matched analysis without further adjustment in the outcome model produced estimates further away from unity.	[Helin-Salmivaara, Arja; Lavikainen, Piia; Huupponen, Risto; Korhonen, Maarit Jaana] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Helin-Salmivaara, Arja] Hosp Dist Helsinki, Unit Primary Hlth Care, Helsinki, Finland; [Helin-Salmivaara, Arja] Uusimaa, Helsinki, Finland; [Aarnio, Emma; Huupponen, Risto] Turku Univ Hosp, Tykslab, Dept Clin Pharmacol, FIN-20520 Turku, Finland; [Aarnio, Emma] Univ Eastern Finland, Sch Pharm, Kuopio, Finland; [Korhonen, Maarit Jaana] Univ Turku, Dept Publ Hlth, Turku, Finland	University of Turku; University of Turku; University of Eastern Finland; University of Turku	Helin-Salmivaara, A (corresponding author), Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland.	arja.helin-salmivaara@utu.fi		Lavikainen, Piia/0000-0003-3560-8860; Aarnio, Emma/0000-0002-6555-7833; Korhonen, Maarit/0000-0002-2953-4757	Academy of Finland [138255]	Academy of Finland(Academy of Finland)	This study was funded by the Academy of Finland (www.aka.fi, decision number 138255). The Academy of Finland had no role in the design, analyses, interpretation of data, writing the report, or in the decision to submit the manuscript.	Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Dilokthornsakul P, 2012, 28 INT C PHARM THER; Dusetzina SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063973; European Medicines Agency, CER; Foody JM, 2008, CLIN THER, V30, P195, DOI 10.1016/j.clinthera.2008.01.003; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Gagne JJ, 2012, EPIDEMIOLOGY, V23, P238, DOI 10.1097/EDE.0b013e3182459d7d; Halava H, 2009, EUR J CLIN PHARMACOL, V65, P927, DOI 10.1007/s00228-009-0664-1; Jacobson TA, 2008, MAYO CLIN PROC, V83, P1316, DOI 10.1016/S0025-6196(11)60779-9; Korhonen MJ, 2009, EUR J CLIN PHARMACOL, V65, P1167, DOI 10.1007/s00228-009-0701-0; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Mack CD, 2013, PHARMACOEPIDEM DR S, V22, P810, DOI 10.1002/pds.3386; Martikainen JE, 2010, MED CARE, V48, P761, DOI 10.1097/MLR.0b013e3181e41bcb; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Parsons LS, USING SAS SOFTWARE P; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P697, DOI 10.1002/pds.2256; Schneeweiss S, 2011, CLIN PHARMACOL THER, V90, P777, DOI 10.1038/clpt.2011.235; Seeger JD, 2005, PHARMACOEPIDEM DR S, V14, P465, DOI 10.1002/pds.1062; Simpson RJ, 2009, MAYO CLIN PROC, V84, P1065, DOI 10.4065/mcp.2009.0298; Tolonen H, 2007, EUR J CARDIOV PREV R, V14, P380, DOI 10.1097/01.hjr.0000239466.26132.f2; Wahl PM, 2012, DRUG SAFETY, V35, P407, DOI 10.2165/11594770-000000000-00000; Weng TC, 2010, J CLIN PHARM THER, V35, P139, DOI 10.1111/j.1365-2710.2009.01085.x; WHO, ATC DDD SYST; Wilke RA, 2008, BASIC CLIN PHARMACOL, V103, P354, DOI 10.1111/j.1742-7843.2008.00291.x	25	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90325	10.1371/journal.pone.0090325	http://dx.doi.org/10.1371/journal.pone.0090325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614626	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300020
J	McGlade, D; McClenahan, C; Pierscionek, B				McGlade, Donal; McClenahan, Carol; Pierscionek, Barbara			Pro-Donation Behaviours of Nursing Students from the Four Countries of the UK	PLOS ONE			English	Article							ORGAN DONATION; TISSUE DONATION; DONOR CARD; ATTITUDES; KNOWLEDGE; RATES; CONSENT; COMMUNICATION; INCENTIVES; SCOTLAND	Background: The effectiveness of the organ donation system depends on the health professionals involved in procurement and in dealing with donors and their families. Concerns about lack of knowledge and experience of organ donation have been expressed among such professionals but there is a paucity of literature to indicate the basis of such concerns and where knowledge may be lacking. Given that regional variations in organ donation rates exist in the UK, this study investigates knowledge about and attitudes towards organ donation among student nurses in different countries of the UK and examines regional variations. Methods: A questionnaire was distributed to 667 student nurses (female: male = 582: 85) aged 18 to 50 years (mean [SD] 25.4 [7.1] years) recruited from a total of five Universities (Scotland, Wales, Northern Ireland, England) during the period of January to September 2011. Results: Registration behaviour among participants was shown to vary depending upon many different factors that include birthplace, residency, fear of death and concerns of medical distrust. Conclusions: Regional variations in organ donation behaviour in the UK were found in the cohorts of student nurses who participated in this study. These variations include willingness to register and to donate specific body parts and not others. The relationship between attitude and behaviour and how this may influence the decision making process of organ donation, as well as the underlying factors that result in regional variations, require further investigation.	[McGlade, Donal; Pierscionek, Barbara] Kingston Univ London, Fac Sci Engn & Comp, Kingston Upon Thames, Surrey, England; [McClenahan, Carol] Univ Ulster, Sch Psychol, Coleraine BT52 1SA, Londonderry, North Ireland	Kingston University; Ulster University	Pierscionek, B (corresponding author), Kingston Univ London, Fac Sci Engn & Comp, Kingston Upon Thames, Surrey, England.	b.pierscionek@kingston.ac.uk	Pierscionek, Barbara/AAK-5760-2021					Akgun HS, 2003, TRANSPLANT P, V35, P1273, DOI 10.1016/S0041-1345(03)00437-8; Anker AE, 2009, PROG TRANSPLANT, V19, P343; Benabou R, 2006, AM ECON REV, V96, P1652, DOI 10.1257/aer.96.5.1652; Bener A, 2008, EXP CLIN TRANSPLANT, V6, P249; Besser A, 2004, PERS INDIV DIFFER, V36, P1709, DOI 10.1016/j.paid.2003.07.012; Bleich SN, 2012, OBESITY, V20, P999, DOI 10.1038/oby.2011.402; Boyle DK, 2005, CRIT CARE NURS Q, V28, P302, DOI 10.1097/00002727-200510000-00002; Cantwell M, 2000, J ADV NURS, V32, P961, DOI 10.1046/j.1365-2648.2000.01562.x; Cohen J, 1998, STAT POWER ANAL BEHA, P215; Collins Timothy J, 2005, Intensive Crit Care Nurs, V21, P226; Ertin H, 2010, NURS ETHICS, V17, P705, DOI 10.1177/0969733010378933; Floden Anne, 2009, Intensive Crit Care Nurs, V25, P306, DOI 10.1016/j.iccn.2009.06.002; Goz F, 2006, J CLIN NURS, V15, P1371, DOI 10.1111/j.1365-2702.2006.01431.x; Haddow G, 2006, J MED ETHICS, V32, P324, DOI 10.1136/jme.2005.013805; Hanlon P, 2005, J PUBLIC HEALTH, V27, P199, DOI 10.1093/pubmed/fdi002; Hayward C, 2003, SOC SCI MED, V57, P389, DOI 10.1016/S0277-9536(02)00364-7; Heyes A, 2005, J HEALTH ECON, V24, P561, DOI 10.1016/j.jhealeco.2004.09.002; HORTON RL, 1991, SOC SCI MED, V33, P1037, DOI 10.1016/0277-9536(91)90009-2; Jones-Riffell A J, 1998, J Contin Educ Nurs, V29, P274; KENT B, 1995, INT J NURS STUD, V32, P484, DOI 10.1016/0020-7489(95)00009-M; Kinnear PR, 2010, PASW STAT 17 MADE SI, P1; Lester D, 2005, PSYCHOL REP, V96, P769; MATTEN MR, 1991, PUBLIC HEALTH REP, V106, P155; McCabe C, 2004, J CLIN NURS, V13, P41, DOI 10.1111/j.1365-2702.2004.00817.x; McGlade D, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000055; Muraine M, 2000, CORNEA, V19, P12, DOI 10.1097/00003226-200001000-00003; Murphy F, 2009, ANAESTHESIA, V64, P822, DOI 10.1111/j.1365-2044.2009.05932.x; New B, 1994, 18 KINGS FUND I; NHSBT, 2012, ORG DON TRANSPL ACT; Nursing and Midwifery Council, 2008, STAT AN REG 1 APR 20; Organ Donation Taskforce Implementation Programme, 2011, WORK TOG SAV LIV ORG; Ozdag N, 2001, EDTNA ERCA J, V27, P201; Pickersgall Francis, 2011, Emerg Nurse, V19, P7; Pipe A, 2009, PATIENT EDUC COUNS, V74, P118, DOI 10.1016/j.pec.2008.07.042; Raffe D, 1999, COMP EDUC, V35, P9, DOI 10.1080/03050069928044; Zambudio AR, 2009, PROG TRANSPLANT, V19, P371; ROBBINS RA, 1990, DEATH STUD, V14, P219, DOI 10.1080/07481189008252363; Rodrigue JR, 2006, TRANSPLANTATION, V81, P1249, DOI 10.1097/01.tp.0000203165.49905.4a; Saleem T, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-5; Salim A, 2007, J TRAUMA, V62, P1411, DOI 10.1097/TA.0b013e3180479876; Salim A, 2011, J TRAUMA, V71, P733, DOI 10.1097/TA.0b013e31820500e6; Shafer Teresa J, 2004, Prog Transplant, V14, P250; SIMINOFF LA, 1995, J TRAUMA, V39, P553; Smith M, 2004, ORGAN DONATION SERVI; Verble M, 1997, J Transpl Coord, V7, P72; Verble M, 1997, J Transpl Coord, V7, P111; Vincent A, 2012, BRIT J ANAESTH, V108, pI80, DOI 10.1093/bja/aer353; Wight C, 1998, TRANSPLANT P, V30, P2253, DOI 10.1016/S0041-1345(98)00609-5; Wight J, 2004, NEPHROL DIAL TRANSPL, V19, P963, DOI 10.1093/ndt/gfg618; Young Harriet, 2010, Popul Trends, P11, DOI 10.1057/pt.2010.3; Zampieron A, 2010, INT NURS REV, V57, P370, DOI 10.1111/j.1466-7657.2010.00806.x	51	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91405	10.1371/journal.pone.0091405	http://dx.doi.org/10.1371/journal.pone.0091405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614807	Green Accepted, gold, Green Published			2022-12-27	WOS:000332839300121
J	Tajiri, N; Quach, DM; Kaneko, Y; Wu, S; Lee, D; Lam, T; Hayama, KL; Hazel, TG; Johe, K; Wu, MC; Borlongan, CV				Tajiri, Naoki; Quach, David M.; Kaneko, Yuji; Wu, Stephanie; Lee, David; Lam, Tina; Hayama, Ken L.; Hazel, Thomas G.; Johe, Karl; Wu, Michael C.; Borlongan, Cesar V.			Behavioral and Histopathological Assessment of Adult Ischemic Rat Brains after Intracerebral Transplantation of NSI-566RSC Cell Lines	PLOS ONE			English	Article							NEURAL STEM-CELLS; SPINAL-CORD; FUNCTIONAL RECOVERY; STROKE THERAPY; CYCLOSPORINE-A; GRAFTS; DISEASE; NEUROPROTECTION; TRANSLATION; DISORDERS	Stroke is a major cause of death and disability, with very limited treatment option. Cell-based therapies have emerged as potential treatments for stroke. Indeed, studies have shown that transplantation of neural stem cells (NSCs) exerts functional benefits in stroke models. However, graft survival and integration with the host remain pressing concerns with cell-based treatments. The current study set out to investigate those very issues using a human NSC line, NSI-566RSC, in a rat model of ischemic stroke induced by transient occlusion of the middle cerebral artery. Seven days after stroke surgery, those animals that showed significant motor and neurological impairments were randomly assigned to receive NSI-566RSC intracerebral transplants at two sites within the striatum at three different doses: group A (0 cells/mu l), group B (5,000 cells/mu l), group C (10,000 cells/mu l), and group D (20,000 cells/mu l). Weekly behavioral tests, starting at seven days and continued up to 8 weeks after transplantation, revealed dose-dependent recovery from both motor and neurological deficits in transplanted stroke animals. Eight weeks after cell transplantation, immunohistochemical investigations via hematoxylin and eosin staining revealed infarct size was similar across all groups. To identify the cell graft, and estimate volume, immunohistochemistry was performed using two human-specific antibodies: one to detect all human nuclei (HuNu), and another to detect human neuron-specific enolase (hNSE). Surviving cell grafts were confirmed in 10/10 animals of group B, 9/10 group C, and 9/10 in group D. hNSE and HuNu staining revealed similar graft volume estimates in transplanted stroke animals. hNSE-immunoreactive fibers were also present within the corpus callosum, coursing in parallel with host tracts, suggesting a propensity to follow established neuroanatomical features. Despite absence of reduction in infarct volume, NSI-566RSC transplantation produced behavioral improvements possibly via robust engraftment and neuronal differentiation, supporting the use of this NSC line for stroke therapy.	[Tajiri, Naoki; Kaneko, Yuji; Borlongan, Cesar V.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA; [Quach, David M.; Wu, Stephanie; Lee, David; Lam, Tina; Hayama, Ken L.; Hazel, Thomas G.; Johe, Karl] Neuralstem Inc, Rockville, MD USA; [Wu, Michael C.] Neurodigitech LLC, San Diego, CA USA	State University System of Florida; University of South Florida	Borlongan, CV (corresponding author), Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA.	cborlong@health.usf.edu	Tajiri, Naoki/K-1230-2012; Borlongan, Cesar/I-5696-2012; Wu, Michael/AAP-2829-2021	Tajiri, Naoki/0000-0003-2189-662X; Borlongan, Cesar/0000-0002-2966-9782; 	Neuralstem Inc; National Institutes of Health; National Institute of Neurological Disorders and Stroke [1R01NS071956-01]; James and Esther King Foundation for Biomedical Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071956] Funding Source: NIH RePORTER	Neuralstem Inc; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); James and Esther King Foundation for Biomedical Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	CVB received research support from Neuralstem Inc for this study. DMQ, SW, DL, TL, KLH, TGH and KJ are employed by the funder of this study, Neuralstem Inc. CVB is supported by National Institutes of Health, National Institute of Neurological Disorders and Stroke 1R01NS071956-01 and James and Esther King Foundation for Biomedical Research Program. The funder provided support in the form of salaries for authors DMQ, SW, DL, TL, KLH, TGH and KJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Borlongan CV, 2011, LEUKEMIA, V25, P1674, DOI 10.1038/leu.2011.167; Borlongan CV, 2008, REGEN MED, V3, P249, DOI 10.2217/17460751.3.3.249; Borlongan CV, 2011, PROG NEUROBIOL, V95, P213, DOI 10.1016/j.pneurobio.2011.08.005; Borlongan CV, 2010, STEM CELLS DEV, V19, P439, DOI 10.1089/scd.2009.0340; Borlongan CV, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-31; Borlongan CV, 2009, STROKE, V40, pS146, DOI 10.1161/STROKEAHA.108.533091; Borlongan CV, 2005, LIFE SCI, V76, P1503, DOI 10.1016/j.lfs.2004.09.022; Borlongan CV, 1998, EXP NEUROL, V149, P310, DOI 10.1006/exnr.1997.6730; Chen JL, 2013, CELL TRANSPLANT, V22, P871, DOI 10.3727/096368911X637380; Chopp M, 2009, CELL TRANSPLANT, V18, P691, DOI 10.3727/096368909X470883; Cizkova D, 2007, NEUROSCIENCE, V147, P546, DOI 10.1016/j.neuroscience.2007.02.065; Dailey T., 2013, CELL BASED THERAPIES, P29; Fisher M, 2013, ANN NEUROL, V73, P4, DOI 10.1002/ana.23744; Garbuzova-Davis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063553; Glass JD, 2012, STEM CELLS, V30, P1144, DOI 10.1002/stem.1079; Guo XF, 2010, J TISSUE ENG REGEN M, V4, P181, DOI 10.1002/term.223; Guzman R, 2008, STROKE, V39, P1300, DOI 10.1161/STROKEAHA.107.500470; Hefferan MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042614; Hess DC, 2008, CELL PROLIFERAT, V41, P94, DOI 10.1111/j.1365-2184.2008.00486.x; Hess David C, 2008, Expert Rev Neurother, V8, P1193, DOI 10.1586/14737175.8.8.1193; Kaneko Y, 2013, CNS NEUROL DISORD-DR, V12, P405, DOI 10.2174/1871527311312030013; Kaneko Y, 2012, CURR PHARM DESIGN, V18, P3731, DOI 10.2174/138161212802002733; Lunn JS, 2010, STEM CELLS DEV, V19, P1983, DOI 10.1089/scd.2010.0003; Matsukawa N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-126; Mays R. W., 2010, J EXP STROKE TRANSL, V3, P34; Nelson PT, 2002, AM J PATHOL, V160, P1201, DOI 10.1016/S0002-9440(10)62546-1; Rodrigues MCO, 2012, NEUROSCI BIOBEHAV R, V36, P177, DOI 10.1016/j.neubiorev.2011.05.010; Osman MM, 2011, NEUROPEPTIDES, V45, P359, DOI 10.1016/j.npep.2011.04.002; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pollock K, 2006, EXP NEUROL, V199, P143, DOI 10.1016/j.expneurol.2005.12.011; Raore B, 2011, SPINE, V36, pE164, DOI 10.1097/BRS.0b013e3181d77a47; Sanberg PR, 2012, PROG BRAIN RES, V201, P99, DOI 10.1016/B978-0-444-59544-7.00006-8; Sanberg PR, 2012, BRIT MED BULL, V101, P163, DOI 10.1093/bmb/lds001; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Savitz SI, 2013, STROKE, V44, pS107, DOI 10.1161/STROKEAHA.112.679605; Sinden JD, 2012, PROG BRAIN RES, V201, P119, DOI 10.1016/B978-0-444-59544-7.00007-X; Sinden JD, 2012, INT J STROKE, V7, P426, DOI 10.1111/j.1747-4949.2012.00840.x; Stroemer P, 2009, NEUROREHAB NEURAL RE, V23, P895, DOI 10.1177/1545968309335978; Tajiri N, 2013, TRANSL STROKE RES, V4, P308, DOI 10.1007/s12975-012-0241-2; Tajiri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043779; Tanny SPT, 2013, STROKE, V44, P2269, DOI 10.1161/STROKEAHA.113.001295; Teng YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004579; Teng YD, 2011, CURR NEUROPHARMACOL, V9, P574, DOI 10.2174/157015911798376299; Usvald D, 2010, CELL TRANSPLANT, V19, P1103, DOI 10.3727/096368910X503406; van Gorp S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt209; Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a; Xu LY, 2011, NEUROSCI LETT, V494, P222, DOI 10.1016/j.neulet.2011.03.017; Xu LY, 2009, J COMP NEUROL, V514, P297, DOI 10.1002/cne.22022; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Yan J, 2006, STEM CELLS, V24, P1976, DOI 10.1634/stemcells.2005-0518; Yang B, 2012, STEM CELLS DEV, V21, P3332, DOI 10.1089/scd.2012.0037; Yasuhara T, 2009, STEM CELLS DEV, V18, P1501, DOI 10.1089/scd.2009.0011	53	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91408	10.1371/journal.pone.0091408	http://dx.doi.org/10.1371/journal.pone.0091408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614895	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300123
J	Wang, JZ; Zhang, YW; Xu, K; Mao, XB; Xue, LJ; Liu, XB; Yu, HJ; Chen, LB; Chu, XY				Wang, Jingzi; Zhang, Youwei; Xu, Kai; Mao, Xiaobei; Xue, Lijun; Liu, Xiaobei; Yu, Hongjun; Chen, Longbang; Chu, Xiaoyuan			Genome-Wide Screen of DNA Methylation Changes Induced by Low Dose X-Ray Radiation in Mice	PLOS ONE			English	Article							CHROMOSOMAL INSTABILITY; EXCISION-REPAIR; CELLS; DAMAGE; GENE; HYPOMETHYLATION; CARCINOGENESIS; IRRADIATION; PATTERNS; EXPOSURE	Epigenetic mechanisms play a key role in non-targeted effects of radiation. The purpose of this study was to investigate global hypomethylation and promoter hypermethylation of particular genes induced by low dose radiation (LDR). Thirty male BALB/c mice were divided into 3 groups: control, acutely exposed (0.5Gy X-rays), and chronic exposure for 10 days (0.05Gy/d610d). High-performance liquid chromatography (HPLC) and MeDIP-quantitative polymerase chain reaction (qPCR) were used to study methylation profiles. DNMT1 and MBD2 expression was determined by qPCR and western blot assays. Methylation and expression of Rad23b and Ddit3 were determined by bisulfate sequencing primers (BSP) and qPCR, respectively. The results show that LDR induced genomic hypomethylation in blood 2 h postirraditaion, but was not retained at 1-month. DNMT1 and MBD2 were downregulated in a tissue-specific manner but did not persist. Specific hypermethylation was observed for 811 regions in the group receiving chronic exposure, which covered almost all key biological processes as indicated by GO and KEGG pathway analysis. Eight hypermethylated genes (Rad23b, Tdg, Ccnd1, Ddit3, Llgl1, Rasl11a, Tbx2, Scl6a15) were verified by MeDIP-qPCR. Among them, Rad23b and Ddit3 gene displayed tissue-specific methylation and downregulation, which persisted for 1-month postirradiation. Thus, LDR induced global hypomethylation and tissue-specific promoter hypermethylation of particular genes. Promoter hypermethylation, rather than global hypomethylation, was relatively stable. Dysregulation of methylation might be correlated with down-regulation of DNMT1 and MBD2, but much better understanding the molecular mechanisms involved in this process will require further study.	[Wang, Jingzi; Zhang, Youwei; Xu, Kai; Mao, Xiaobei; Xue, Lijun; Liu, Xiaobei; Yu, Hongjun; Chen, Longbang; Chu, Xiaoyuan] Southern Med Univ, Nanjing Clin Sch, Jinling Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China; [Zhang, Youwei] Yangzhou Univ, Clin Sch 2, Yangzhou Peoples Hosp 1, Dept Med Oncol, Yangzhou, Peoples R China	Southern Medical University - China; Yangzhou University	Chu, XY (corresponding author), Southern Med Univ, Nanjing Clin Sch, Jinling Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China.	chuxiaoyuan6906@gmail.com		Liu, Zhi-Hong/0000-0001-6093-0726	National Natural Science Foundation of China [81272394]; Medical and Health Research Fund of Nanjing Military, PLA [11MA092]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical and Health Research Fund of Nanjing Military, PLA	This work was supported by the National Natural Science Foundation of China (No. 81272394) and Medical and Health Research Fund of Nanjing Military, PLA (No. 11MA092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong CA, 2012, EPIGENETICS-US, V7, P892, DOI 10.4161/epi.21094; Aypar U, 2011, INT J RADIAT BIOL, V87, P179, DOI 10.3109/09553002.2010.522686; Aypar U, 2011, MUTAT RES-FUND MOL M, V707, P24, DOI 10.1016/j.mrfmmm.2010.12.003; Bernal AJ, 2013, FASEB J, V27, P665, DOI 10.1096/fj.12-220350; Duthie SJ, 2000, NUTR CANCER, V37, P245, DOI 10.1207/S15327914NC372_18; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Friso S, 2002, ANAL CHEM, V74, P4526, DOI 10.1021/ac020050h; Huang L, 2003, ONCOGENE, V22, P5848, DOI 10.1038/sj.onc.1206697; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KALINICH JF, 1989, RADIAT RES, V117, P185, DOI 10.2307/3577319; Kang KA, 2012, TUMOR BIOL, V33, P403, DOI 10.1007/s13277-012-0322-6; Karotki AV, 2012, CELL MOL LIFE SCI, V69, P3351, DOI 10.1007/s00018-012-1148-5; Kaup S, 2006, MUTAT RES-FUND MOL M, V597, P87, DOI 10.1016/j.mrfmmm.2005.06.032; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Kovalchuk O, 2004, MUTAT RES-FUND MOL M, V548, P75, DOI 10.1016/j.mrfmmm.2003.12.016; Kuhmann C, 2011, RADIOTHER ONCOL, V101, P116, DOI 10.1016/j.radonc.2011.05.048; Limoli CL, 1997, CANCER RES, V57, P5557; Lin J, 2010, LEUKEMIA RES, V34, P991, DOI 10.1016/j.leukres.2010.01.003; Nandakumar V, 2011, CARCINOGENESIS, V32, P597, DOI 10.1093/carcin/bgq282; Panayiotidis MI, 2004, ANTIOXID REDOX SIGN, V6, P129, DOI 10.1089/152308604771978435; Pengt B, 2005, J BIOL CHEM, V280, P4182, DOI 10.1074/jbc.M412566200; Pogribny I, 2004, BIOCHEM BIOPH RES CO, V320, P1253, DOI 10.1016/j.bbrc.2004.06.081; Pogrlbny I, 2005, MOL CANCER RES, V3, P553, DOI 10.1158/1541-7786.MCR-05-0074; Ponnaluri VKC, 2013, BIOCHEM BIOPH RES CO, V436, P115, DOI 10.1016/j.bbrc.2013.05.077; Snyder AR, 2005, DNA REPAIR, V4, P958, DOI 10.1016/j.dnarep.2005.04.003; Suzuki K, 2012, JPN J CLIN ONCOL, V42, P563, DOI 10.1093/jjco/hys078; Tawa R, 1998, J RADIAT RES, V39, P271, DOI 10.1269/jrr.39.271; THU KL, 2009, JOVE-J VIS EXP, V23, P935; Wang YL, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-54; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011	30	23	32	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90804	10.1371/journal.pone.0090804	http://dx.doi.org/10.1371/journal.pone.0090804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614869	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300043
J	Atwoli, L; Ayuku, D; Hogan, J; Koech, J; Vreeman, RC; Ayaya, S; Braitstein, P				Atwoli, Lukoye; Ayuku, David; Hogan, Joseph; Koech, Julius; Vreeman, Rachel Christine; Ayaya, Samuel; Braitstein, Paula			Impact of Domestic Care Environment on Trauma and Posttraumatic Stress Disorder among Orphans in Western Kenya	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SOUTH-AFRICA; VIOLENCE; CHILDREN; VICTIMIZATION; ADOLESCENTS; AGGRESSION; HOMELESS; FOSTER; HEALTH	Objective: The aim of this study was to determine the impact of the domestic care environment on the prevalence of potentially traumatic events (PTEs) and posttraumatic stress disorder (PTSD) among orphaned and separated children in Uasin Gishu County, western Kenya. Methods: A total of 1565 (55.5% male) orphaned and separated adolescents aged 10-18 years (mean 13.8 years, sd 2.2), were assessed for PTSD and PTEs including bullying, physical abuse and sexual abuse. In this sample, 746 lived in extended family households, 746 in Charitable Children's Institutions (CCIs), and 73 on the street. Posttraumatic stress symptom (PTSS) scores and PTSD were assessed using the Child PTSD Checklist. Results: Bullying was the commonest PTE in all domestic care environments, followed by physical and sexual abuse. All PTEs were commonest among the street youth followed by CCIs. However, sexual abuse was more prevalent in households than in CCIs. Prevalence of PTSD was highest among street youth (28.8%), then households (15.0%) and CCIs (11.5%). PTSS scores were also highest among street youth, followed by CCIs and households. Bullying was associated with higher PTSS scores and PTSD odds than either sexual or physical abuse. Conclusion: This study demonstrated differences in distribution of trauma and PTSD among orphaned and separated children in different domestic care environments, with street youth suffering more than those in CCIs or households. Interventions are needed to address bullying and sexual abuse, especially in extended family households. Street youth, a heretofore neglected population, are urgently in need of dedicated mental health services and support.	[Atwoli, Lukoye] Moi Univ, Coll Hlth Sci, Sch Med, Dept Mental Hlth, Eldoret, Kenya; [Ayuku, David] Moi Univ, Coll Hlth Sci, Sch Med, Dept Behav Sci, Eldoret, Kenya; [Hogan, Joseph] Brown Univ, Sch Publ Hlth, Dept Biostat, Providence, RI 02912 USA; [Hogan, Joseph; Koech, Julius; Vreeman, Rachel Christine; Braitstein, Paula] USAID Acad Model Providing Access Healthcare AMPA, Eldoret, Kenya; [Vreeman, Rachel Christine] Indiana Univ Sch Med, Dept Childrens Hlth Serv Res, Indianapolis, IN 46202 USA; [Ayaya, Samuel] Moi Univ, Coll Hlth Sci, Sch Med, Dept Child Hlth & Pediat, Eldoret, Kenya; [Braitstein, Paula] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Braitstein, Paula] Moi Univ, Coll Hlth Sci, Sch Med, Dept Med, Eldoret, Kenya; [Braitstein, Paula] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Braitstein, Paula] Regenstrief Inst Inc, Indianapolis, IN USA	Moi University; Moi University; Brown University; United States Agency for International Development (USAID); Indiana University System; Indiana University Bloomington; Moi University; Indiana University System; Indiana University Bloomington; Moi University; University of Toronto; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Atwoli, L (corresponding author), Moi Univ, Coll Hlth Sci, Sch Med, Dept Mental Hlth, Eldoret, Kenya.	Lukoye@gmail.com	Ayuku, David/AAB-8485-2019; Hogan, Joseph/J-4579-2014	Atwoli, Lukoye/0000-0001-7710-9723; Hogan, Joseph/0000-0001-7959-7361	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD060478]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041020, R01HD060478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Award Number R01HD060478 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 1996, CHILD ABUSE NEGLECT, V20, P1161, DOI 10.1016/S0145-2134(96)00067-1; Atwoli L, 2010, East Afr Med J, V87, P465; Boyes ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046905; Cluver Lucie, 2006, Ann Gen Psychiatry, V5, P8, DOI 10.1186/1744-859X-5-8; Cluver L, 2007, J CHILD PSYCHOL PSYC, V48, P755, DOI 10.1111/j.1469-7610.2007.01757.x; Cluver L, 2011, JAIDS-J ACQ IMM DEF, V58, P336, DOI 10.1097/QAI.0b013e31822f0d82; Cluver L, 2010, CHILD ABUSE NEGLECT, V34, P793, DOI 10.1016/j.chiabu.2010.04.002; Harder VS, 2012, J TRAUMA STRESS, V25, P64, DOI 10.1002/jts.21660; Hasanovic M, 2006, CROAT MED J, V47, P85; Kamanda A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-91; Karsberg Sidsel H, 2012, Clin Pract Epidemiol Ment Health, V8, P91, DOI 10.2174/1745017901208010091; Kettrey HH, 2006, J FAM VIOLENCE, V21, P407, DOI 10.1007/s10896-006-9036-0; Lombe M, 2008, INT SOC WORK, V51, P682, DOI 10.1177/0020872808093345; Morantz G, 2013, CHILD ABUSE NEGL, DOI 00210.01016/j.chiabu.02012.00210.00007; NORTH CS, 1994, J TRAUMA STRESS, V7, P95, DOI 10.1007/BF02111915; NORTH CS, 1992, HOSP COMMUNITY PSYCH, V43, P1010; Schaal S, 2006, J TRAUMA STRESS, V19, P95, DOI 10.1002/jts.20104; Seedat S, 2004, BRIT J PSYCHIAT, V184, P169, DOI 10.1192/bjp.184.2.169; Tucker CJ, 2013, PEDIATRICS, V132, P79, DOI 10.1542/peds.2012-3801; Uasin Gishu County Government, 2013, WELC COUNT CHAMP ELD; UNICEF, 2013, AFR ORPH VULN GEN CH; Zolotor AJ, 2009, CHILD ABUSE NEGLECT, V33, P833, DOI 10.1016/j.chiabu.2009.09.004	22	33	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e89937	10.1371/journal.pone.0089937	http://dx.doi.org/10.1371/journal.pone.0089937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9JS	24625395	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300011
J	Hesse, C; Ball, K; Schenk, T				Hesse, Constanze; Ball, Keira; Schenk, Thomas			Pointing in Visual Periphery: Is DF's Dorsal Stream Intact?	PLOS ONE			English	Article							UNILATERAL OPTIC ATAXIA; FORM AGNOSIA; PSYCHOPHYSICS TOOLBOX; PATIENT DF; VISUOMOTOR; PERCEPTION; DEFICIT; EYE; DISSOCIATION; HANDEDNESS	Observations of the visual form agnosic patient DF have been highly influential in establishing the hypothesis that separate processing streams deal with vision for perception (ventral stream) and vision for action (dorsal stream). In this context, DF's preserved ability to perform visually-guided actions has been contrasted with the selective impairment of visuomotor performance in optic ataxia patients suffering from damage to dorsal stream areas. However, the recent finding that DF shows a thinning of the grey matter in the dorsal stream regions of both hemispheres in combination with the observation that her right-handed movements are impaired when they are performed in visual periphery has opened up the possibility that patient DF may potentially also be suffering from optic ataxia. If lesions to the posterior parietal cortex (dorsal stream) are bilateral, pointing and reaching deficits should be observed in both visual hemifields and for both hands when targets are viewed in visual periphery. Here, we tested DF's visuomotor performance when pointing with her left and her right hand toward targets presented in the left and the right visual field at three different visual eccentricities. Our results indicate that DF shows large and consistent impairments in all conditions. These findings imply that DF's dorsal stream atrophies are functionally relevant and hence challenge the idea that patient DF's seemingly normal visuomotor behaviour can be attributed to her intact dorsal stream. Instead, DF seems to be a patient who suffers from combined ventral and dorsal stream damage meaning that a new account is needed to explain why she shows such remarkably normal visuomotor behaviour in a number of tasks and conditions.	[Hesse, Constanze] Univ Aberdeen, Sch Psychol, Aberdeen AB24 3FX, Scotland; [Ball, Keira] Univ Durham, Dept Psychol, Stockton On Tees, England; [Schenk, Thomas] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany	University of Aberdeen; Durham University; University of Erlangen Nuremberg	Hesse, C (corresponding author), Univ Aberdeen, Sch Psychol, Aberdeen AB24 3FX, Scotland.	c.hesse@abdn.ac.uk	Hesse, Constanze/H-2941-2016; S, T/GRY-0013-2022; S, T/GXF-0648-2022	Hesse, Constanze/0000-0002-4395-0781; 				Adamovich SV, 1998, J NEUROPHYSIOL, V79, P2833, DOI 10.1152/jn.1998.79.6.2833; Blangero A, 2008, CORTEX, V44, P560, DOI 10.1016/j.cortex.2007.09.004; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bridge H, 2013, J NEUROSCI, V33, P12779, DOI 10.1523/JNEUROSCI.4853-12.2013; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Crawford JR, 2005, NEUROPSYCHOLOGY, V19, P318, DOI 10.1037/0894-4105.19.3.318; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Desmurget M, 1997, J NEUROPHYSIOL, V77, P1644, DOI 10.1152/jn.1997.77.3.1644; Fiehler K, 2011, VISION RES, V51, P890, DOI 10.1016/j.visres.2010.12.015; GAUTHIER GM, 1994, VISION RES, V34, P2613, DOI 10.1016/0042-6989(94)90247-X; Glover S, 2003, NEUROSCI BIOBEHAV R, V27, P447, DOI 10.1016/S0149-7634(03)00072-1; Gonzalez CLR, 2006, J NEUROPHYSIOL, V95, P3496, DOI 10.1152/jn.01187.2005; Gonzalez CLR, 2007, EXP BRAIN RES, V182, P275, DOI 10.1007/s00221-007-1090-1; Goodale M, 2013, SIGHT UNSEEN EXPLORA; GOODALE MA, 1994, CURR BIOL, V4, P604, DOI 10.1016/S0960-9822(00)00132-9; Goodale MA, 2005, PROG BRAIN RES, V149, P269, DOI 10.1016/S0079-6123(05)49019-6; Goodale Melvyn A., 2004, SIGHT UNSEEN EXPLORA; Henriques DYP, 2002, J NEUROPHYSIOL, V87, P1677, DOI 10.1152/jn.00509.2001; Hesse C, 2012, NEUROPSYCHOLOGIA, V50, P90, DOI 10.1016/j.neuropsychologia.2011.11.002; Himmelbach M, 2012, NEUROPSYCHOLOGIA, V50, P139, DOI 10.1016/j.neuropsychologia.2011.11.011; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; Karnath HO, 2005, CEREB CORTEX, V15, P1561, DOI 10.1093/cercor/bhi034; Kleiner M, 2010, PERCEPTION, V39, P189; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Milner A. D., 1995, VISUAL BRAIN ACTION; Milner AD, 1999, P ROY SOC B-BIOL SCI, V266, P2225, DOI 10.1098/rspb.1999.0912; MILNER AD, 1991, BRAIN, V114, P405, DOI 10.1093/brain/114.1.405; Milner AD, 2006, VISUAL BRAIN ACTION, DOI 10.1093/acprof:oso/9780198524724.001.0001; Mon-Williams M, 2001, EXP BRAIN RES, V139, P137, DOI 10.1007/s002210000658; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Perenin M.-T., 1997, PARIETAL LOBE CONTRI, P289; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Rice NJ, 2008, NEUROPSYCHOLOGIA, V46, P1549, DOI 10.1016/j.neuropsychologia.2008.01.012; Riddoch G, 1917, BRAIN, V40, P15, DOI 10.1093/brain/40.1.15; RONDOT P, 1977, BRAIN, V100, P355, DOI 10.1093/brain/100.2.355; Rossetti Y, 2005, NEUROPSYCHOLOGIA, V43, P162, DOI 10.1016/j.neuropsychologia.2004.11.004; Rossetti Y, 2003, EXP BRAIN RES, V153, P171, DOI 10.1007/s00221-003-1590-6; Schenk T, 2012, J NEUROSCI, V32, P2013, DOI 10.1523/JNEUROSCI.3413-11.2012; Schenk T, 2010, VISION RES, V50, P2627, DOI 10.1016/j.visres.2010.08.013	39	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91420	10.1371/journal.pone.0091420	http://dx.doi.org/10.1371/journal.pone.0091420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626162	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000332851300082
J	Kojima, T; Van Deusen, M; Jerome, WG; Garrett, CG; Sivasankar, MP; Novaleski, CK; Rousseau, B				Kojima, Tsuyoshi; Van Deusen, Mark; Jerome, W. Gray; Garrett, C. Gaelyn; Sivasankar, M. Preeti; Novaleski, Carolyn K.; Rousseau, Bernard			Quantification of Acute Vocal Fold Epithelial Surface Damage with Increasing Time and Magnitude Doses of Vibration Exposure	PLOS ONE			English	Article							EVOKED RABBIT PHONATION; VOICE DISORDERS; DESQUAMATION; IMPACT; MICROPROJECTIONS; VERTEBRATES; POPULATION; CELLS; MODEL; IMAGE	Because the vocal folds undergo repeated trauma during continuous cycles of vibration, the epithelium is routinely susceptible to damage during phonation. Excessive and prolonged vibration exposure is considered a significant predisposing factor in the development of vocal fold pathology. The purpose of the present study was to quantify the extent of epithelial surface damage following increased time and magnitude doses of vibration exposure using an in vivo rabbit phonation model. Forty-five New Zealand white breeder rabbits were randomized to nine groups and received varying phonation time-doses (30, 60, or 120 minutes) and magnitude-doses (control, modal intensity phonation, or raised intensity phonation) of vibration exposure. Scanning electron microscopy and transmission electron microscopy was used to quantify the degree of epithelial surface damage. Results revealed a significant reduction in microprojection density, microprojection height, and depth of the epithelial surface with increasing time and phonation magnitudes doses, signifying increased epithelial surface damage risk with excessive and prolonged vibration exposure. Destruction to the epithelial cell surface may provide significant insight into the disruption of cell function following prolonged vibration exposure. One important goal achieved in the present study was the quantification of epithelial surface damage using objective imaging criteria. These data provide an important foundation for future studies of long-term tissue recovery from excessive and prolonged vibration exposure.	[Kojima, Tsuyoshi; Van Deusen, Mark; Garrett, C. Gaelyn; Rousseau, Bernard] Vanderbilt Univ, Sch Med, Dept Otolaryngol, Nashville, TN 37212 USA; [Novaleski, Carolyn K.; Rousseau, Bernard] Vanderbilt Univ, Sch Med, Dept Hearing & Speech Sci, Nashville, TN 37212 USA; [Jerome, W. Gray] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Sivasankar, M. Preeti] Purdue Univ, Dept Speech Language & Hearing Sci, W Lafayette, IN 47907 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rousseau, B (corresponding author), Vanderbilt Univ, Sch Med, Dept Otolaryngol, Nashville, TN 37212 USA.	bernard.rousseau@vanderbilt.edu		Garrett, Catherine Gaelyn/0000-0002-3434-8844	NIH from the National Institute on Deafness and Other Communication Disorders [R01 DC 011338]; NIH [CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, U24DK059637, U2CDK059637, P30DK020593, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011338] Funding Source: NIH RePORTER	NIH from the National Institute on Deafness and Other Communication Disorders; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grant R01 DC 011338 from the National Institute on Deafness and Other Communication Disorders. Electron microscopy was performed in part through the use of the VUMC Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637 and EY08126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P M, 1981, Prog Clin Biol Res, V59B, P21; Bouwers F, 2009, J VOICE, V23, P218, DOI 10.1016/j.jvoice.2007.08.007; Chan RW, 1999, J ACOUST SOC AM, V106, P2008, DOI 10.1121/1.427947; Cohen SM, 2012, LARYNGOSCOPE, V122, P1582, DOI 10.1002/lary.23189; Cohen SM, 2010, LARYNGOSCOPE, V120, P2022, DOI 10.1002/lary.21058; Collin HB, 2000, PHILOS T ROY SOC B, V355, P1171, DOI 10.1098/rstb.2000.0661; Collin SP, 2006, J MORPHOL, V267, P273, DOI 10.1002/jmor.10400; Egelrud T, 2000, ACTA DERM-VENEREOL, P44; Fisher KV, 2001, J APPL PHYSIOL, V91, P1401, DOI 10.1152/jappl.2001.91.3.1401; Fisher KV, 2001, J SPEECH LANG HEAR R, V44, P354, DOI 10.1044/1092-4388(2001/029); Ge PJ, 2009, ANN OTO RHINOL LARYN, V118, P51, DOI 10.1177/000348940911800109; GRAY S, 1988, ANN OTO RHINOL LARYN, V97, P381, DOI 10.1177/000348948809700410; Gray SD, 2000, OTOLARYNG CLIN N AM, V33, P679, DOI 10.1016/S0030-6665(05)70237-1; HAURI HP, 1985, J CELL BIOL, V101, P838, DOI 10.1083/jcb.101.3.838; HAZLETT LD, 1980, OPHTHALMIC RES, V12, P315, DOI 10.1159/000265095; HIRANO M, 1974, FOLIA PHONIATR, V26, P89, DOI 10.1159/000263771; Jacobson BH, 1997, AM J SPEECH LANGUAGE, V6, P66, DOI DOI 10.1044/1058-0360.0603.66; JEROME WG, 1983, SCAN ELECTRON MICROS, P1453; Julio G, 2008, J ANAT, V212, P879, DOI 10.1111/j.1469-7580.2008.00898.x; Leydon C, 2009, J VOICE, V23, P658, DOI 10.1016/j.jvoice.2008.03.010; Ling CY, 2011, CELLS TISSUES ORGANS, V193, P158, DOI 10.1159/000318605; Milstone LM, 2004, J DERMATOL SCI, V36, P131, DOI 10.1016/j.jdermsci.2004.05.004; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Rousseau B, 2011, LARYNGOSCOPE, V121, P346, DOI 10.1002/lary.21364; Roy N, 2005, LARYNGOSCOPE, V115, P1988, DOI 10.1097/01.mlg.0000179174.32345.41; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sivasankar M, 2010, OTOLARYNG HEAD NECK, V142, P79, DOI 10.1016/j.otohns.2009.09.011; SOKOL JL, 1990, INVEST OPHTH VIS SCI, V31, P294; Swanson ER, 2010, OTOLARYNG HEAD NECK, V143, P567, DOI 10.1016/j.otohns.2010.04.264; Swanson ER, 2009, LARYNGOSCOPE, V119, P1439, DOI 10.1002/lary.20532; Talbot C, 2012, J COMP PHYSIOL A, V198, P849, DOI 10.1007/s00359-012-0755-9; TILLMANN B, 1977, CELL TISSUE RES, V185, P279; TITZE IR, 1994, J VOICE, V8, P99, DOI 10.1016/S0892-1997(05)80302-9	33	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91615	10.1371/journal.pone.0091615	http://dx.doi.org/10.1371/journal.pone.0091615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626217	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300109
J	Neamat-Allah, J; Wald, D; Husing, A; Teucher, B; Wendt, A; Delorme, S; Dinkel, J; Vigl, M; Bergmann, MM; Feller, S; Hierholzer, J; Boeing, H; Kaaks, R				Neamat-Allah, Jasmine; Wald, Diana; Huesing, Anika; Teucher, Birgit; Wendt, Andrea; Delorme, Stefan; Dinkel, Julien; Vigl, Matthaeus; Bergmann, Manuela M.; Feller, Silke; Hierholzer, Johannes; Boeing, Heiner; Kaaks, Rudolf			Validation of Anthropometric Indices of Adiposity against Whole-Body Magnetic Resonance Imaging - A Study within the German European Prospective Investigation into Cancer and Nutrition (EPIC) Cohorts	PLOS ONE			English	Article							MASS INDEX; WAIST CIRCUMFERENCE; VISCERAL FAT; CARDIOVASCULAR RISK; TISSUE DISTRIBUTION; METABOLIC SYNDROME; ABDOMINAL OBESITY; MRI; QUANTIFICATION; MECHANISMS	Background: In epidemiological studies, measures of body fat generally are obtained through anthropometric indices such as the body mass index (BMI), waist (WC), and hip circumferences (HC). Such indices, however, can only provide estimates of a person's true body fat content, overall or by adipose compartment, and may have limited accuracy, especially for the visceral adipose compartment (VAT). Objective: To determine the extent to which different body adipose tissue compartments are adequately predicted by anthropometry, and to identify anthropometric measures alone, or in combination to predict overall adiposity and specific adipose tissue compartments, independently of age and body size (height). Methods: In a sub-study of 1,192 participants of the German EPIC (European Prospective Investigation into Cancer and Nutrition) cohorts, whole-body MRI was performed to determine adipose and muscle tissue compartments. Additional anthropometric measurements of BMI, WC and HC were taken. Results: After adjusting for age and height, BMI, WC and HC were better predictors of total body volume (TBV), total adipose tissue (TAT) and subcutaneous adipose tissue (SAT) than for VAT, coronary adipose tissue (CAT) and skeletal muscle tissue (SMT). In both sexes, BMI was the best predictor for TBV (men: r = 0.72 [0.68-0.76], women: r = 0.80 [0.77-0.83]) and SMT (men: r = 0.52 [0.45-0.57], women: r = 0.48 [0.41-0.54]). WC was the best predictor variable for TAT (r = 0.48 [0.41-0.54]), VAT (r = 0.44 [0.37-0.50]) and CAT (r = 0.34 [0.26-0.41]) (men), and for VAT (r = 0.42 [0.35-0.49]) and CAT (r = 0.29 [0.22-0.37]) (women). BMI was the best predictor for TAT (r = 0.49 [0.43-0.55]) (women). HC was the best predictor for SAT (men (r = 0.39 [0.32-0.45]) and women (r = 0.52 [0.46-0.58])). Conclusions: Especially the volumes of internal body fat compartments are poorly predicted by anthropometry. A possible implication may be that associations of chronic disease risks with the sizes of internal body fat as measured by BMI, WC and HC may be strongly underestimated.	[Neamat-Allah, Jasmine; Huesing, Anika; Teucher, Birgit; Wendt, Andrea; Kaaks, Rudolf] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Wald, Diana] German Canc Res Ctr, Div Med & Biol Informat, Heidelberg, Germany; [Teucher, Birgit] Translat Lung Res Ctr, Dept Translat Pulmonol, Heidelberg, Germany; [Delorme, Stefan; Dinkel, Julien] German Canc Res Ctr, Div Radiol, Heidelberg, Germany; [Dinkel, Julien] Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Vigl, Matthaeus; Bergmann, Manuela M.; Feller, Silke; Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Hierholzer, Johannes] Clin Ernst von Bergmann, Dept Diagnost & Intervent Radiol, Potsdam, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Klinikum Ernst von Bergmann	Kaaks, R (corresponding author), German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany.	r.kaaks@dkfz.de	Delorme, Stefan/AAM-7271-2021; Teucher, Birgit/J-6380-2015; Hüsing, Anika/U-1296-2019	Delorme, Stefan/0000-0002-1000-2582; Husing, Anika/0000-0002-2685-9732	"Kompetenznetz Adipositas" (Competence Network Obesity); German Federal Ministry of Education and Research (BMBF) [01GI1121B]; German Federal Ministry of Education and Research [01ER0808, 01ER0809]	"Kompetenznetz Adipositas" (Competence Network Obesity); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The first author was supported by the "Kompetenznetz Adipositas" (Competence Network Obesity) funded by the German Federal Ministry of Education and Research (BMBF, http://www.bmbf.de/en/index.php), grant number: 01GI1121B. The sub-studies in Potsdam and Heidelberg were supported by the German Federal Ministry of Education and Research (grant numbers: 01ER0808, 01ER0809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENN RT, 1971, BRIT J PREV SOC MED, V25, P42; Bergman RN, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2006.11.012; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; Bonekamp S, 2008, INT J OBESITY, V32, P100, DOI 10.1038/sj.ijo.0803696; Bonora E, 1995, METABOLISM, V44, P1617, DOI 10.1016/0026-0495(95)90084-5; Brambilla P, 2006, INT J OBESITY, V30, P23, DOI 10.1038/sj.ijo.0803163; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Carmienke S, 2013, EUR J CLIN NUTR, V67, P573, DOI 10.1038/ejcn.2013.61; Demerath EW, 2007, AM J CLIN NUTR, V85, P362, DOI 10.1093/ajcn/85.2.362; Donohoe CL, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-12; Duvnjak L, 2009, J PHYSIOL PHARMACOL, V60, P19; Heymsfield SB, 2007, AM J CLIN NUTR, V86, P82, DOI 10.1093/ajcn/86.1.82; Heymsfield SB, 2011, AM J CLIN NUTR, V93, P736, DOI 10.3945/ajcn.110.007161; Iacobellis G, 2011, TRENDS ENDOCRIN MET, V22, P450, DOI 10.1016/j.tem.2011.07.003; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Jensen MD, 2008, J CLIN ENDOCR METAB, V93, pS57, DOI 10.1210/jc.2008-1585; Kullberg J, 2010, J MAGN RESON IMAGING, V32, P204, DOI 10.1002/jmri.22193; Li X, 2012, BIOMED ENVIRON SCI, V25, P141, DOI 10.3967/0895-3988.2012.02.003; Ludescher B, 2009, INVEST RADIOL, V44, P712, DOI 10.1097/RLI.0b013e3181afbb1e; Matsuzawa Y, 2010, P JPN ACAD B-PHYS, V86, P131, DOI 10.2183/pjab.86.131; Nakamura K, 2011, ONCOL REP, V26, P65, DOI 10.3892/or.2011.1259; Ness-Abramof R, 2008, NUTR CLIN PRACT, V23, P397, DOI 10.1177/0884533608321700; Poll LudgerWilhelm, 2004, Diabetes Technol Ther, V6, P844; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Renehan AG, 2012, AM J EPIDEMIOL, V176, P1130, DOI 10.1093/aje/kws192; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; ROSS R, 1992, J APPL PHYSIOL, V72, P787, DOI 10.1152/jappl.1992.72.2.787; Ross RJI., 2005, HUMAN BODY COMPOSITI, P89; Rothman K.J., 2008, MODERN EPIDEMIOLOGY, P128; Schwenzer NF, 2010, INVEST RADIOL, V45, P788, DOI 10.1097/RLI.0b013e3181f10fe1; Sowers JR, 2003, AM J MED, V115, P37, DOI 10.1016/j.amjmed.2003.08.012; Springer F, 2012, EUR J RADIOL, V81, P1488, DOI 10.1016/j.ejrad.2011.04.006; Thomas EL, 2012, NUTR RES REV, V25, P150, DOI 10.1017/S0954422412000054; Thomas EL, 2012, OBESITY, V20, P76, DOI 10.1038/oby.2011.142; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vrieling A, 2010, BREAST CANCER RES TR, V123, P641, DOI 10.1007/s10549-010-1116-4; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wald D, 2012, J MAGN RESON IMAGING, V36, P1421, DOI 10.1002/jmri.23775; Wald D, 2012, PROC SPIE, V8315, DOI 10.1117/12.911290; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S	41	62	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91586	10.1371/journal.pone.0091586	http://dx.doi.org/10.1371/journal.pone.0091586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626110	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300106
J	van Vugt, MK; Simen, P; Nystrom, L; Holmes, P; Cohen, JD				van Vugt, Marieke K.; Simen, Patrick; Nystrom, Leigh; Holmes, Philip; Cohen, Jonathan D.			Lateralized Readiness Potentials Reveal Properties of a Neural Mechanism for Implementing a Decision Threshold	PLOS ONE			English	Article							REACTION-TIME TASKS; DORSOLATERAL PREFRONTAL CORTEX; PERCEPTUAL DECISION; ELECTROPHYSIOLOGICAL EVIDENCE; PRIOR PROBABILITY; DIFFUSION-MODEL; CHOICE TASKS; HUMAN BRAIN; REWARD RATE; COMPUTATIONS	Many perceptual decision making models posit that participants accumulate noisy evidence over time to improve the accuracy of their decisions, and that in free response tasks, participants respond when the accumulated evidence reaches a decision threshold. Research on the neural correlates of these models' components focuses primarily on evidence accumulation. Far less attention has been paid to the neural correlates of decision thresholds, reflecting the final commitment to a decision. Inspired by a model of bistable neural activity that implements a decision threshold, we reinterpret human lateralized readiness potentials (LRPs) as reflecting the crossing of a decision threshold. Interestingly, this threshold crossing preserves signatures of a drift-diffusion process of evidence accumulation that feeds in to the threshold mechanism. We show that, as our model predicts, LRP amplitudes and growth rates recorded while participants performed a motion discrimination task correlate with individual differences in behaviorally-estimated prior beliefs, decision thresholds and evidence accumulation rates. As such LRPs provide a useful measure to test dynamical models of both evidence accumulation and decision commitment processes non-invasively.	[van Vugt, Marieke K.] Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands; [Simen, Patrick] Oberlin Coll, Dept Neurosci, Oberlin, OH 44074 USA; [Nystrom, Leigh; Holmes, Philip; Cohen, Jonathan D.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Holmes, Philip] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA	University of Groningen; Oberlin College; Princeton University; Princeton University	van Vugt, MK (corresponding author), Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands.	m.k.van.vugt@rug.nl	van Vugt, Marieke/A-8159-2011	van Vugt, Marieke/0000-0003-3200-0059	AFOSR Multi-University Research Initiative [FA9550-07-1-0537]; Conte Center [MH062196]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH062196] Funding Source: NIH RePORTER	AFOSR Multi-University Research Initiative(MURI); Conte Center; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors gratefully acknowledge funding from the AFOSR Multi-University Research Initiative FA9550-07-1-0537, and Conte Center MH062196 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balci F, 2011, ATTEN PERCEPT PSYCHO, V73, P640, DOI 10.3758/s13414-010-0049-7; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; Boucher L, 2007, PSYCHOL REV, V114, P376, DOI 10.1037/0033-295X.114.2.376; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Cohen JY, 2009, J NEUROPHYSIOL, V101, P1699, DOI 10.1152/jn.00035.2009; COLES MGH, 1989, PSYCHOPHYSIOLOGY, V26, P251, DOI 10.1111/j.1469-8986.1989.tb01916.x; DEJONG R, 1988, J EXP PSYCHOL HUMAN, V14, P682, DOI 10.1037/0096-1523.14.4.682; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Ding L, 2010, J NEUROSCI, V30, P15747, DOI 10.1523/JNEUROSCI.2894-10.2010; Domenech P, 2010, J NEUROSCI, V30, P14305, DOI 10.1523/JNEUROSCI.2371-10.2010; Donner TH, 2009, CURR BIOL, V19, P1581, DOI 10.1016/j.cub.2009.07.066; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Friederici AD, 2000, HUM BRAIN MAPP, V11, P1, DOI 10.1002/1097-0193(200009)11:1<1::AID-HBM10>3.0.CO;2-B; Gao JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016749; Gao J, 2009, NEURAL COMPUT, V21, P2407, DOI 10.1162/neco.2009.09-08-866; Gluth S, 2013, NEUROIMAGE, V79, P394, DOI 10.1016/j.neuroimage.2013.05.005; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldfarb S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00213; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Hanks TD, 2011, J NEUROSCI, V31, P6339, DOI 10.1523/JNEUROSCI.5613-10.2011; HARTH EM, 1970, J THEOR BIOL, V26, P93, DOI 10.1016/S0022-5193(70)80035-2; Heekeren HR, 2006, P NATL ACAD SCI USA, V103, P10023, DOI 10.1073/pnas.0603949103; Heitz RP, 2012, NEURON, V76, P616, DOI 10.1016/j.neuron.2012.08.030; Hestvik A, 2007, BRAIN LANG, V100, P301, DOI 10.1016/j.bandl.2006.07.007; Ho TC, 2009, J NEUROSCI, V29, P8675, DOI 10.1523/JNEUROSCI.5984-08.2009; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; Hsieh S, 2003, COGNITIVE BRAIN RES, V17, P228, DOI 10.1016/S0926-6410(03)00110-1; Jentzsch I, 2002, ACTA PSYCHOL, V111, P265, DOI 10.1016/S0001-6918(02)00053-7; Jentzsch I, 2002, PERCEPT PSYCHOPHYS, V64, P1169, DOI 10.3758/BF03194765; Kelly SP, 2013, J NEUROSCI, V33, P19434, DOI 10.1523/JNEUROSCI.3355-13.2013; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; KRISTEVA R, 1991, ELECTROEN CLIN NEURO, V81, P284, DOI 10.1016/0168-5597(91)90015-P; Leuthold H, 2003, ACTA PSYCHOL, V114, P83, DOI 10.1016/S0001-6918(03)00051-9; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Luce R. D., 1986, RESPONSE TIMES; Luck S.J., 2005, INTRO EVENT RELATED; MILLER J, 1992, J EXP PSYCHOL GEN, V121, P195, DOI 10.1037/0096-3445.121.2.195; MILLER J, 1992, J EXP PSYCHOL HUMAN, V18, P1121, DOI 10.1037/0096-1523.18.4.1121; Mordkoff JT, 2000, PSYCHOPHYSIOLOGY, V37, P347; O'Connell RG, 2012, NAT NEUROSCI, V15, P1729, DOI 10.1038/nn.3248; Philiastides MG, 2006, J NEUROSCI, V26, P8965, DOI 10.1523/JNEUROSCI.1655-06.2006; Pouget P, 2011, J NEUROSCI, V31, P12604, DOI 10.1523/JNEUROSCI.1868-11.2011; Purcell BA, 2010, PSYCHOL REV, V117, P1113, DOI 10.1037/a0020311; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Rinkenauer G, 2004, J EXP PSYCHOL GEN, V133, P261, DOI 10.1037/0096-3445.133.2.261; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Sangals J, 2004, ACTA PSYCHOL, V117, P275, DOI 10.1016/j.actpsy.2004.07.001; Scheibe C, 2009, PSYCHOPHYSIOLOGY, V46, P758, DOI 10.1111/j.1469-8986.2009.00825.x; Schwarzenau P, 1998, BEHAV RES METH INSTR, V30, P100; Shadlen MN, 2013, NEURON, V80, P791, DOI 10.1016/j.neuron.2013.10.047; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Simen P, 2006, NEURAL NETWORKS, V19, P1013, DOI 10.1016/j.neunet.2006.05.038; Simen P, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00183; Simen P, 2009, J EXP PSYCHOL HUMAN, V35, P1865, DOI 10.1037/a0016926; Simen P, 2009, BRAIN RES, V1299, P95, DOI 10.1016/j.brainres.2009.07.017; Snyder LH, 2006, J NEUROSCI, V26, P10091, DOI 10.1523/JNEUROSCI.0513-06.2006; Spencer KM, 1999, PSYCHOPHYSIOLOGY, V36, P364, DOI 10.1017/S0048577299970749; Tollner T, 2008, J EXP PSYCHOL HUMAN, V34, P531, DOI 10.1037/0096-1523.34.3.531; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; van Veen V, 2008, J COGNITIVE NEUROSCI, V20, P1952, DOI 10.1162/jocn.2008.20146; van Vugt MK, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00106; Vandekerckhove J, 2008, BEHAV RES METHODS, V40, P61, DOI 10.3758/BRM.40.1.61; Vandekerckhove J, 2007, PSYCHON B REV, V14, P1011, DOI 10.3758/BF03193087; Vidal F, 2003, PSYCHOPHYSIOLOGY, V40, P796, DOI 10.1111/1469-8986.00080; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5	71	28	28	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90943	10.1371/journal.pone.0090943	http://dx.doi.org/10.1371/journal.pone.0090943			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625827	gold, Green Published			2022-12-27	WOS:000332851300042
J	Buttigieg, KR; Dowall, SD; Findlay-Wilson, S; Miloszewska, A; Rayner, E; Hewson, R; Carroll, MW				Buttigieg, Karen R.; Dowall, Stuart D.; Findlay-Wilson, Stephen; Miloszewska, Aleksandra; Rayner, Emma; Hewson, Roger; Carroll, Miles W.			A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model	PLOS ONE			English	Article							VIRUS GLYCOPROTEIN; IMMUNE-RESPONSE; DNA VACCINES; VIRAL LOAD; MVA; INFECTION; IMMUNOGENICITY; LOCALIZATION; ANTIBODY; IDENTIFICATION	Crimean-Congo Haemorrhagic Fever (CCHF) is a severe tick-borne disease, endemic in many countries in Africa, the Middle East, Eastern Europe and Asia. Between 15-70% of reported cases are fatal. There is no approved vaccine available, and preclinical protection in vivo by an experimental vaccine has not been demonstrated previously. In the present study, the attenuated poxvirus vector, Modified Vaccinia virus Ankara, was used to develop a recombinant candidate vaccine expressing the CCHF virus glycoproteins. Cellular and humoral immunogenicity was confirmed in two mouse strains, including type I interferon receptor knockout mice, which are susceptible to CCHF disease. This vaccine protected all recipient animals from lethal disease in a challenge model adapted to represent infection via a tick bite. Histopathology and viral load analysis of protected animals confirmed that they had been exposed to challenge virus, even though they did not exhibit clinical signs. This is the first demonstration of efficacy of a CCHF vaccine.	[Buttigieg, Karen R.; Dowall, Stuart D.; Findlay-Wilson, Stephen; Miloszewska, Aleksandra; Rayner, Emma; Hewson, Roger; Carroll, Miles W.] Publ Hlth England, Microbiol Serv Res, Porton Down, Wilts, England	Public Health England	Hewson, R (corresponding author), Publ Hlth England, Microbiol Serv Res, Porton Down, Wilts, England.	Roger.Hewson@phe.gov.uk			Health Protection Agency (subsequently part of Public Health England) of the United Kingdom	Health Protection Agency (subsequently part of Public Health England) of the United Kingdom	This work was funded by the Health Protection Agency (subsequently part of Public Health England) of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2005, J GEN VIROL, V86, P3327, DOI 10.1099/vir.0.81175-0; Akinci E, 2009, INT J INFECT DIS, V13, P560, DOI 10.1016/j.ijid.2008.08.027; Alcock R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000490; Altamura LA, 2007, J VIROL, V81, P6632, DOI 10.1128/JVI.02730-06; Amato RJ, 2010, CLIN CANCER RES, V16, P5539, DOI 10.1158/1078-0432.CCR-10-2082; Atkinson B, 2012, EUROSURVEILLANCE, P17; Atkinson B, 2012, VECTOR-BORNE ZOONOT, V12, P786, DOI 10.1089/vbz.2011.0770; Bente DA, 2010, J VIROL, V84, P11089, DOI 10.1128/JVI.01383-10; Bereczky S, 2010, J GEN VIROL, V91, P1473, DOI 10.1099/vir.0.019034-0; Bergeron E, 2007, J VIROL, V81, P13271, DOI 10.1128/JVI.01647-07; Bertolotti-Ciarlet A, 2005, J VIROL, V79, P6152, DOI 10.1128/JVI.79.10.6152-6161.2005; Bisht H, 2004, P NATL ACAD SCI USA, V101, P6641, DOI 10.1073/pnas.0401939101; Boukhebza H, 2012, HUM VACC IMMUNOTHER, V8, P1746, DOI 10.4161/hv.21689; CASALS J, 1969, P SOC EXP BIOL MED, V131, P233; Centers for Disease Control (CDC), 1988, MMWR Suppl, V37, P1; Chumakov M., 1945, NEW TICK BORNE VIRUS, P13; Clark TR, 2011, INFECT IMMUN, V79, P1631, DOI 10.1128/IAI.00048-11; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Cottingham MG, 2013, VACCINE, V31, P4247, DOI 10.1016/j.vaccine.2013.03.021; Dowall SD, 2012, J VIROL METHODS, V179, P335, DOI 10.1016/j.jviromet.2011.11.020; Draper SJ, 2013, VACCINE, V31, P4223, DOI 10.1016/j.vaccine.2013.05.091; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Duh D, 2007, EMERG INFECT DIS, V13, P1769, DOI 10.3201/eid1311.070222; Earl PL, 1998, CURR PROTOC PROTEI S, V13; Gomez CE, 2013, EXPERT REV VACCINES, V12, P1395, DOI 10.1586/14760584.2013.845531; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Erickson BR, 2007, VIROLOGY, V361, P348, DOI 10.1016/j.virol.2006.11.023; Garcia F, 2011, VACCINE, V29, P8309, DOI 10.1016/j.vaccine.2011.08.098; Garcia S, 2006, J CLIN VIROL, V35, P154, DOI 10.1016/j.jcv.2005.02.016; Ghiasi SM, 2011, CLIN VACCINE IMMUNOL, V18, P2031, DOI 10.1128/CVI.05352-11; Haferkamp S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-42; HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653; Hawkridge T, 2008, J INFECT DIS, V198, P544, DOI 10.1086/590185; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Katzen F, 2007, EXPERT OPIN DRUG DIS, V2, P571, DOI 10.1517/17460441.2.4.571; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luo MC, 2008, J VIROL METHODS, V154, P121, DOI 10.1016/j.jviromet.2008.08.011; Maltezou HC, 2010, EUROSURVEILLANCE, V15, P48; McCurdy LH, 2004, CLIN INFECT DIS, V38, P1749, DOI 10.1086/421266; Meisinger-Henschel C, 2007, J GEN VIROL, V88, P3249, DOI 10.1099/vir.0.83156-0; MEYER H, 1991, J GEN VIROL, V72, P1031, DOI 10.1099/0022-1317-72-5-1031; Mousavi-Jazi M, 2012, VACCINE, V30, P6225, DOI 10.1016/j.vaccine.2012.08.003; Nabeth P, 2004, EMERG INFECT DIS, V10, P2143, DOI 10.3201/eid1012.040535; Ozturk B, 2012, INT J INFECT DIS, V16, pE89, DOI 10.1016/j.ijid.2011.06.005; Powell TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062778; Saksida A, 2010, CLIN VACCINE IMMUNOL, V17, P1086, DOI 10.1128/CVI.00530-09; Sanchez AJ, 2006, J VIROL, V80, P514, DOI 10.1128/JVI.80.1.514-525.2006; Sanchez AJ, 2002, J VIROL, V76, P7263, DOI 10.1128/JVI.76.14.7263-7275.2002; Shih CM, 1996, J CLIN MICROBIOL, V34, P2297, DOI 10.1128/JCM.34.9.2297-2299.1996; SMITH GL, 1983, GENE, V25, P21, DOI 10.1016/0378-1119(83)90163-4; Spik K, 2006, VACCINE, V24, P4657, DOI 10.1016/j.vaccine.2005.08.034; STICKL H, 1974, DEUT MED WOCHENSCHR, V99, P2386, DOI 10.1055/s-0028-1108143; SWANEPOEL R, 1987, AM J TROP MED HYG, V36, P120, DOI 10.4269/ajtmh.1987.36.120; SWANEPOEL R, 1989, REV INFECT DIS, V11, pS794; Tezer H, 2009, J INFECTION, V59, P291, DOI 10.1016/j.jinf.2009.07.011; Thomas S, 2012, VECTOR-BORNE ZOONOT, V12, P800, DOI 10.1089/vbz.2011.0776; TIGNOR GH, 1993, ANTIVIR RES, V22, P309, DOI 10.1016/0166-3542(93)90040-P; Tobery TW, 2001, J IMMUNOL METHODS, V254, P59, DOI 10.1016/S0022-1759(01)00397-0; Varela AS, 2003, J WILDLIFE DIS, V39, P881, DOI 10.7589/0090-3558-39.4.881; Vincent MJ, 2003, J VIROL, V77, P8640, DOI 10.1128/JVI.77.16.8640-8649.2003; Vipond J, 2006, VACCINE, V24, P6340, DOI 10.1016/j.vaccine.2006.05.025; Wang ZD, 2010, VACCINE, V28, P1547, DOI 10.1016/j.vaccine.2009.11.056; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2; Xiao XD, 2011, BIOCHEM BIOPH RES CO, V411, P253, DOI 10.1016/j.bbrc.2011.06.109; Zivcec M, 2013, J INFECT DIS, V207, P1909, DOI 10.1093/infdis/jit061	66	79	86	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91516	10.1371/journal.pone.0091516	http://dx.doi.org/10.1371/journal.pone.0091516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621656	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300098
J	Hu, WC; Liu, YT; Yan, J				Hu, Wenchao; Liu, Yuting; Yan, Jun			Microarray Meta-Analysis of RNA-Binding Protein Functions in Alternative Polyadenylation	PLOS ONE			English	Article							PRE-MESSENGER-RNA; 3' UNTRANSLATED REGIONS; COMPUTATIONAL ANALYSIS; WIDE ANALYSIS; CLEAVAGE; DATABASE; SITES; EXPRESSION; IDENTIFY; NETWORKS	Alternative polyadenylation (APA) is a post-transcriptional mechanism to generate diverse mRNA transcripts with different 3'UTRs from the same gene. In this study, we systematically searched for the APA events with differential expression in public mouse microarray data. Hundreds of genes with over-represented differential APA events and the corresponding experiments were identified. We further revealed that global APA differential expression occurred prevalently in tissues such as brain comparing to peripheral tissues, and biological processes such as development, differentiation and immune responses. Interestingly, we also observed widespread differential APA events in RNA-binding protein (RBP) genes such as Rbm3, Eif4e2 and Elavl1. Given the fact that RBPs are considered as the main regulators of differential APA expression, we constructed a co-expression network between APAs and RBPs using the microarray data. Further incorporation of CLIP-seq data of selected RBPs showed that Nova2 represses and Mbnl1 promotes the polyadenylation of closest poly(A) sites respectively. Altogether, our study is the first microarray meta-analysis in a mammal on the regulation of APA by RBPs that integrated massive mRNA expression data under a wide-range of biological conditions. Finally, we present our results as a comprehensive resource in an online website for the research community.	[Hu, Wenchao; Liu, Yuting; Yan, Jun] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Yan, J (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China.	junyan@picb.ac.cn	Hu, Wencheng/K-2380-2014		Chinese Academy of Sciences; German Max-Planck Society	Chinese Academy of Sciences(Chinese Academy of Sciences); German Max-Planck Society(Max Planck Society)	This research was supported by Chinese Academy of Sciences and German Max-Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avendano-Vazquez SE, 2012, GENE DEV, V26, P1679, DOI 10.1101/gad.194829.112; Bava FA, 2013, NATURE, V495, P121, DOI 10.1038/nature11901; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Cowley M, 2012, NUCLEIC ACIDS RES, V40, P8917, DOI 10.1093/nar/gks654; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Filteau M, 2013, MOL BIOL EVOL, V30, P1384, DOI 10.1093/molbev/mst053; Gawande B, 2006, EMBO J, V25, P1263, DOI 10.1038/sj.emboj.7601022; Hilgers V, 2012, GENE DEV, V26, P2259, DOI 10.1101/gad.199653.112; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022; Ji Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.69; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Li YX, 2012, GENOME RES, V22, P1899, DOI 10.1101/gr.128488.111; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Liu YT, 2013, SCI REP-UK, V3, DOI 10.1038/srep02054; Lutz CS, 2011, WIRES RNA, V2, P22, DOI 10.1002/wrna.47; Mansfield KD, 2012, NUCLEIC ACIDS RES, V40, P2734, DOI 10.1093/nar/gkr1114; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Martins R, 2012, PLOS ONE, V7; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Miura P, 2013, GENOME RES; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Naipauer J, 2013, BIOCHEM J, V454, P345, DOI 10.1042/BJ20130062; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Uren PJ, 2011, J BIOL CHEM, V286, P37063, DOI 10.1074/jbc.C111.266882; van Dam S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-535; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Wang HF, 2010, PHYSIOL GENOMICS, V42, P427, DOI 10.1152/physiolgenomics.00205.2009; Wren JD, 2009, BIOINFORMATICS, V25, P1694, DOI 10.1093/bioinformatics/btp290; Yan J, 2005, GENOME RES, V15, P369, DOI 10.1101/gr.3109605; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yao P, 2012, CELL, V149, P88, DOI 10.1016/j.cell.2012.02.018; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	48	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90774	10.1371/journal.pone.0090774	http://dx.doi.org/10.1371/journal.pone.0090774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622240	gold, Green Published, Green Submitted			2022-12-27	WOS:000332845300026
J	Huang, JC; Tang, XJ; Liang, XM; Wen, QW; Zhang, SJ; Xuan, FF; Jian, J; Lin, X; Huang, RB				Huang, Jianchun; Tang, XiaoJun; Liang, Xingmei; Wen, Qingwei; Zhang, Shijun; Xuan, Feifei; Jian, Jie; Lin, Xing; Huang, Renbin			The Effects of 17-Methoxyl-7-Hydroxy-Benzene-Furanchalcone on the Pressure Overload-Induced Progression of Cardiac Hypertrophy to Cardiac Failure	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; LEFT-VENTRICULAR HYPERTROPHY; ANGIOTENSIN RECEPTOR ANTAGONIST; MYOCARDIAL-INFARCTION; ENDOTHELIAL DYSFUNCTION; ESSENTIAL-HYPERTENSION; HEART; DISEASE; RATS; PERFORMANCE	We investigated the effects of 17-methoxyl-7-hydroxy-benzene-furanchalcone (MHBFC), which was isolated from the roots of Millettia pulchra (Benth.) Kurz var. Laxior (Dunn) Z. Wei (Papilionaceae) (MKL), on the progression of cardiac hypertrophy to failure in a rat model of abdominal aortic banding (AAB)-induced pressure overloading. Endothelial dysfunction is central to pressure overload-induced cardiac hypertrophy and failure. It would be useful to clarify whether MHBFC could prevent this dysfunction. The effects of pressure overload were assessed in male Sprague-Dawley rats 6 weeks after AAB using the progression of cardiac hypertrophy to heart failure as the endpoint. The AAB-treated rats exhibited a greater progression to heart failure and had significantly elevated blood pressure, systolic and diastolic cardiac dysfunction, and evidence of left ventricular hypertrophy (LVH). LVH was characterized by increases in the ratios of heart and left ventricular weights to body weight, increased myocyte cross-sectional areas, myocardial and perivascular fibrosis, and elevated cardiac hydroxyproline. These symptoms could be prevented by treatment with MHBFC at daily oral doses of 6 and 12 mg/kg for 6 weeks. The progression to cardiac failure, which was demonstrated by increases in relative lung and right ventricular weights, cardiac function disorders and overexpression of atrial natriuretic peptide (ANP) mRNA, could also be prevented. Furthermore, MHBFC partialy rescued the downregulated nitric oxide signaling system, whereas inhibited the upregulated endothelin signaling system, normalizing the balance between these two systems. MHBFC protected the endothelium and prevented the pressure overload-induced progression of cardiac hypertrophy to cardiac failure.	[Huang, Jianchun; Liang, Xingmei; Wen, Qingwei; Zhang, Shijun; Xuan, Feifei; Jian, Jie; Lin, Xing; Huang, Renbin] Guangxi Med Univ, Pharmaceut Coll, Nanning, Guangxi, Peoples R China; [Tang, XiaoJun] Guangxi Med Coll, Dept Lab Med, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Huang, RB (corresponding author), Guangxi Med Univ, Pharmaceut Coll, Nanning, Guangxi, Peoples R China.	huangrenbin518@163.com			Guangxi Scientific Research and Technology Development Research Projects [0630002-2A]; Guangxi Natural Science Foundation [2013GXNSFAA019175]; Fund of Guangxi Key Laboratory of Functional Phytochemicals Research and Utilization [FPRU2013-3]; Outstanding Doctoral Dissertation Breeding Program in the Guangxi Zhuang Autonomous Region [YCBZ2012013]	Guangxi Scientific Research and Technology Development Research Projects; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Fund of Guangxi Key Laboratory of Functional Phytochemicals Research and Utilization; Outstanding Doctoral Dissertation Breeding Program in the Guangxi Zhuang Autonomous Region	This work was supported by the Guangxi Scientific Research and Technology Development Research Projects (No. 0630002-2A); the Guangxi Natural Science Foundation (No. 2013GXNSFAA019175); the Fund of Guangxi Key Laboratory of Functional Phytochemicals Research and Utilization (No. FPRU2013-3); and the Outstanding Doctoral Dissertation Breeding Program in the Guangxi Zhuang Autonomous Region (No. YCBZ2012013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin EJ, 1999, AM J MED SCI, V317, P168, DOI 10.1097/00000441-199903000-00006; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Bohm F, 2007, CARDIOVASC RES, V76, P8, DOI 10.1016/j.cardiores.2007.06.004; Chen X, 2001, HYPERTENSION, V38, P606, DOI 10.1161/hy09t1.094005; Clozel M, 2005, ANN MED, V37, P2, DOI 10.1080/07853890410018925; Dhalla NS, 1999, ANN NY ACAD SCI, V874, P100, DOI 10.1111/j.1749-6632.1999.tb09228.x; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Fraccarollo D, 1997, CIRCULATION, V96, P3963; Fraccarollo D, 2008, CIRCULATION, V118, P818, DOI 10.1161/CIRCULATIONAHA.107.717702; FRIBERG P, 1990, J HYPERTENS, V8, P879, DOI 10.1097/00004872-199010000-00001; Frohlich ED, 2001, HYPERTENSION, V38, P1388, DOI 10.1161/hy1201.098768; Gao S, 2009, CARDIOVASC RES, V83, P444, DOI 10.1093/cvr/cvp099; Grantham JA, 1997, CIRCULATION, V96, P388; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Huang RB, 2003, CHINESE J HOSP PHARM, V6, P726; [黄仁彬 Huang Renbin], 2010, [华西药学杂志, West China Journal of Pharmaceutical Sciences], V25, P287; [黄媛恒 HUANG Yuan-heng], 2008, [中国新药杂志, Chinese Journal New Drugs], V17, P1764; Janssens S, 2004, CIRC RES, V94, P1256, DOI 10.1161/01.RES.0000126497.38281.23; Jian J, 2009, CHIN J GERONTOL, V29, P73; Jian J, 2012, PLANTA MED, V78, P1324, DOI 10.1055/s-0032-1314964; Jian Jie, 2011, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V42, P1313; Jian Jie, 2009, Zhongguo Yaolixue Tongbao, V25, P942; Jiao Y., 2004, ACTA ACADEMIAE MEDIC, V21, P22; Kobayashi N, 2001, J HYPERTENS, V19, P795, DOI 10.1097/00004872-200104000-00017; Mc Murray A, 2008, REV ARGENT CARDIOL, V76, P295; OWENS GK, 1985, CIRC RES, V57, P695, DOI 10.1161/01.RES.57.5.695; Pfisterer L, 2012, CARDIOVASC RES, V96, P120, DOI 10.1093/cvr/cvs247; SAVAGE DD, 1987, CIRCULATION, V75, P26; Scherrer-Crosbie M, 2001, CIRCULATION, V104, P1286, DOI 10.1161/hc3601.094298; Schiffrin EL, 2000, CIRCULATION, V101, P1653; Schiffrin EL, 2002, J HYPERTENS, V20, P71, DOI 10.1097/00004872-200201000-00011; Schiffrin EL, 1996, J CARDIOVASC PHAR S2, V27, P13; STEPHENSON TJ, 1990, ARCH DIS CHILD, V65, P1293, DOI 10.1136/adc.65.12.1293; Taddei S, 1998, CIRCULATION, V97, P2222, DOI 10.1161/01.CIR.97.22.2222; van Zwieten PA, 2000, CARDIOVASC RES, V45, P82, DOI 10.1016/S0008-6363(99)00291-6; Woodard GE, 2008, INT REV CEL MOL BIO, V268, P59, DOI 10.1016/S1937-6448(08)00803-4; Zhang YX, 2011, AM J PHYSIOL-HEART C, V301, pH634, DOI 10.1152/ajpheart.01315.2010	37	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91834	10.1371/journal.pone.0091834	http://dx.doi.org/10.1371/journal.pone.0091834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622486	Green Submitted, gold, Green Published			2022-12-27	WOS:000332845300133
J	Li, LS; Zhang, PP; Zheng, TF; Zhang, HY; Jiang, ZC; Huang, DG				Li, Lishuang; Zhang, Panpan; Zheng, Tianfu; Zhang, Hongying; Jiang, Zhenchao; Huang, Degen			Integrating Semantic Information into Multiple Kernels for Protein-Protein Interaction Extraction from Biomedical Literatures	PLOS ONE			English	Article								Protein-Protein Interaction (PPI) extraction is an important task in the biomedical information extraction. Presently, many machine learning methods for PPI extraction have achieved promising results. However, the performance is still not satisfactory. One reason is that the semantic resources were basically ignored. In this paper, we propose a multiple-kernel learning-based approach to extract PPIs, combining the feature-based kernel, tree kernel and semantic kernel. Particularly, we extend the shortest path-enclosed tree kernel (SPT) by a dynamic extended strategy to retrieve the richer syntactic information. Our semantic kernel calculates the protein-protein pair similarity and the context similarity based on two semantic resources: WordNet and Medical Subject Heading (MeSH). We evaluate our method with Support Vector Machine (SVM) and achieve an F-score of 69.40% and an AUC of 92.00%, which show that our method outperforms most of the state-of-the-art systems by integrating semantic information.	[Li, Lishuang; Zhang, Panpan; Jiang, Zhenchao; Huang, Degen] Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Peoples R China; [Zheng, Tianfu] Dalian Univ Technol, Fac Chem Environm & Biol Sci & Technol, Dalian, Peoples R China; [Zhang, Hongying] Dalian Med Univ, Dept Pathol, Dalian, Peoples R China	Dalian University of Technology; Dalian University of Technology; Dalian Medical University	Li, LS (corresponding author), Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Peoples R China.	lilishuang314@163.com			National Natural Science Foundation of China [61173101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China NO. 61173101 (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airola A., 2008, P WORKSH CURR TRENDS, P1, DOI [DOI 10.3115/1572306.1572308, 10.3115/ 1572306.1572308]; [Anonymous], THESIS; [Anonymous], 2006, P LREC; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Bunescu R, 2005, ARTIF INTELL MED, V33, P139, DOI 10.1016/j.artmed.2004.07.016; Collins M, 2002, ADV NEUR IN, V14, P625; Fellbaum C, 2010, THEORY AND APPLICATIONS OF ONTOLOGY: COMPUTER APPLICATIONS, P231, DOI 10.1007/978-90-481-8847-5_10; Fundel K, 2007, BIOINFORMATICS, V23, P365, DOI 10.1093/bioinformatics/btl616; Huang M, 2004, P INT JOINT WORKSH N, P22; Li YP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S2-S7; Li YH, 2003, IEEE T KNOWL DATA EN, V15, P871, DOI 10.1109/TKDE.2003.1209005; Lin Dekang, 1993, P 31 ANN M ASS COMP, P112, DOI [10.3115/981574.981590, DOI 10.3115/981574.981590]; [刘兵 Liu Bing], 2011, [中文信息学报, Journal of Chinese Information Processing], V25, P21; LOWE HJ, 1994, JAMA-J AM MED ASSOC, V271, P1103, DOI 10.1001/jama.271.14.1103; MIWA M, 2008, P 3 INT S SEM MIN BI, P101; Miwa M, 2009, INT J MED INFORM, V78, pE39, DOI 10.1016/j.ijmedinf.2009.04.010; Moschitti A., 2004, P 42 ANN M ASS COMP; Ono T, 2001, BIOINFORMATICS, V17, P155, DOI 10.1093/bioinformatics/17.2.155; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Xia JF, 2010, AMINO ACIDS, V39, P1595, DOI 10.1007/s00726-010-0588-1; Yang ZH, 2011, ARTIF INTELL MED, V51, P163, DOI 10.1016/j.artmed.2010.12.002; You ZH, 2010, BIOINFORMATICS, V26, P2744, DOI 10.1093/bioinformatics/btq510; Zhang M, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P825	24	14	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91898	10.1371/journal.pone.0091898	http://dx.doi.org/10.1371/journal.pone.0091898			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622773	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300138
J	Rodrigues, APD; Farias, LHS; Carvalho, ASC; Santos, AS; do Nascimento, JLM; Silva, EO				Rodrigues, Ana Paula D.; Farias, Luis Henrique S.; Carvalho, Antonio Sergio C.; Santos, Alberdan S.; do Nascimento, Jose Luiz M.; Silva, Edilene O.			A Novel Function for Kojic Acid, a Secondary Metabolite from Aspergillus Fungi, as Antileishmanial Agent	PLOS ONE			English	Article							CUTANEOUS LEISHMANIASIS; DRUG-RESISTANCE; ABSENCE	Kojic acid (KA) is a fungal metabolite used as a topical treatment skin-whitening cosmetic agent for melasma in humans; however its potential as an anti-leishmanial agent is unknown. Chemotherapy is one of the most effective treatments for Leishmaniasis. However, the drugs available are expensive, invasive, require long-term treatment and have severe side effects. Thus, the development of new effective leishmanicidal agents is a necessity. In this study we investigated the anti-leishmanial effect of KA on L. amazonensis, following in vitro and in vivo infections. KA (50 mu g/mL) was found to decrease the growth by 62% (IC50 34 mu g/mL) and 79% (IC50 27.84 mu g/mL) of promastigotes and amastigotes in vitro, respectively. Ultrastructural analysis of KA-treated amastigotes showed the presence of vesicles bodies into the flagellar pocket, and an intense intracellular vacuolization and swelling of the mitochondrion. During the in vitro interaction of parasites and the host cell, KA reverses the superoxide anions (O-2(-)) inhibitory mechanism promoted by parasite. In addition, 4 weeks after KA-topical formulation treatment of infected animals, a healing process was observed with a high production of collagen fibers and a decrease in parasite burden. Thus, these results demonstrated the great potential of KA as an anti-leishmanial compound.	[Rodrigues, Ana Paula D.; Farias, Luis Henrique S.; Silva, Edilene O.] Fed Univ Para, Inst Ciencias Biol, Lab Biol Estrutural, BR-66059 Belem, Para, Brazil; [Carvalho, Antonio Sergio C.; Santos, Alberdan S.] Fed Univ Para, Inst Ciencias Exactas & Nat, Lab Invest Sistemat Biotecnol & Biodiversidade Mo, BR-66059 Belem, Para, Brazil; [do Nascimento, Jose Luiz M.] Fed Univ Para, Inst Ciencias Biol, Lab Neuroquim Mol & Celular, BR-66059 Belem, Para, Brazil; [Rodrigues, Ana Paula D.; Farias, Luis Henrique S.; Silva, Edilene O.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil; [Rodrigues, Ana Paula D.] Minist Saude, Secretaria Vigilancia Saude, Inst Evandro Chagas, Lab Microscopia Eletron, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Rio de Janeiro; Instituto Evandro Chagas	Silva, EO (corresponding author), Fed Univ Para, Inst Ciencias Biol, Lab Biol Estrutural, BR-66059 Belem, Para, Brazil.	edilene@ufpa.br	Santos, Alberdan Silva/AAY-7861-2020; Silva, Edilene O/B-8239-2015; Farias, Ana Paula Paula/AAW-7164-2021	Farias, Ana Paula Paula/0000-0002-5016-392X; do Nascimento, jose/0000-0003-3647-9124; Silva, Edilene/0000-0001-6555-6868	Programa Nacional de Cooperacao Academica (PROCAD) [620179/2008-2]; Programa Nacional de Cooperacao Academica (Novas Fronteiras) [630/2010]; Instituto Nacional de Biologia Estrutural e Bioimagem (CNPq) [573767/2008-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Universal) [482922/2010-9]; Fundacao de Amparo a Pesquisa do Estado do Para; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Fundacao de Amparo e Desenvolvimento da Pesquisa; Universidade Federal do Para/PROPESP	Programa Nacional de Cooperacao Academica (PROCAD); Programa Nacional de Cooperacao Academica (Novas Fronteiras); Instituto Nacional de Biologia Estrutural e Bioimagem (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Universal); Fundacao de Amparo a Pesquisa do Estado do Para(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo e Desenvolvimento da Pesquisa; Universidade Federal do Para/PROPESP	The work was supported by Programa Nacional de Cooperacao Academica (PROCAD - grant number 620179/2008-2 and Novas Fronteiras - grant number 630/2010), Instituto Nacional de Biologia Estrutural e Bioimagem (CNPq - grant number 573767/2008-4), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Universal - grant number 482922/2010-9), Fundacao de Amparo a Pesquisa do Estado do Para, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, Fundacao de Amparo e Desenvolvimento da Pesquisa and Universidade Federal do Para/PROPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Silva AL, 2004, PARASITOLOGY, V128, P385, DOI 10.1017/S0031182003004621; Adade C.M., 2010, OPEN PARASITOL J, V4, P178, DOI [https://doi.org/10.2174/1874421401004010178, DOI 10.2174/1874421401004010178, 10.2174/1874421401004010178]; Alavi-Naini R, 2012, Prague Med Rep, V113, P105; Baldwin T, 2007, PARASITE IMMUNOL, V29, P501, DOI 10.1111/j.1365-3024.2007.00969.x; Bentley R, 2006, NAT PROD REP, V23, P1046, DOI 10.1039/b603758p; Blumenthal CZ, 2004, REGUL TOXICOL PHARM, V39, P214, DOI 10.1016/j.yrtph.2003.09.002; Burdock FA, 2001, REGUL TOXICOL PHARM, V33, P80, DOI 10.1006/rtph.2000.1442; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; Croft SL, 2006, INDIAN J MED RES, V123, P399; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Emami S, 2007, BIOORG MED CHEM LETT, V17, P45, DOI 10.1016/j.bmcl.2006.09.097; Ferreira NR, 2010, AN ACAD BRAS CIENC, V82, P569, DOI 10.1590/S0001-37652010000300004; Fitzpatrick JM, 2007, FASEB J, V21, P823, DOI 10.1096/fj.06-7314com; Gomes AJ, 2001, BRAZ J MED BIOL RES, V34, P1487, DOI 10.1590/S0100-879X2001001100018; Guimaraes LRC, 2010, PARASITOL RES, V107, P1075, DOI 10.1007/s00436-010-1973-0; Ha YM, 2007, BIOL PHARM BULL, V30, P1711, DOI 10.1248/bpb.30.1711; HAGGIS GH, 1977, J MICROSC-OXFORD, V111, P193, DOI 10.1111/j.1365-2818.1977.tb00059.x; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lainson Ralph, 2010, Revista Pan-Amazonica de Saude, V1, P13; Lecoeur H, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000034; Lim JTE, 1999, DERMATOL SURG, V25, P282, DOI 10.1046/j.1524-4725.1999.08236.x; Lin CH, 2007, ANAL CHIM ACTA, V581, P102, DOI 10.1016/j.aca.2006.08.002; Miller MC, 2005, BIODRUGS, V19, P363, DOI 10.2165/00063030-200519060-00004; Mohammadpour M, 2013, INT WOUND J, V10, P260, DOI 10.1111/j.1742-481X.2012.00971.x; Moto M, 2006, ARCH TOXICOL, V80, P299, DOI 10.1007/s00204-005-0034-4; Mukbel RM, 2007, AM J TROP MED HYG, V76, P669, DOI 10.4269/ajtmh.2007.76.669; Nohynek GJ, 2004, FOOD CHEM TOXICOL, V42, P93, DOI 10.1016/j.fct.2003.08.008; Nurden AT, 2011, THROMB HAEMOSTASIS, V105, pS13, DOI 10.1160/THS10-11-0720; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Polonio T, 2008, INT J MOL MED, V22, P277, DOI 10.3892/ijmm_00000020; Rocha-Vieira E, 2003, IMMUNOLOGY, V108, P401, DOI 10.1046/j.1365-2567.2003.01582.x; Rodrigues APD, 2011, CELL BIOL INT, V35, P335, DOI 10.1042/CBI20100083; Rodrigues JCF, 2002, ANTIMICROB AGENTS CH, V46, P487, DOI 10.1128/AAC.46.2.487-499.2002; Sakthianandeswaren A, 2005, P NATL ACAD SCI USA, V102, P15551, DOI 10.1073/pnas.0505630102; Santos AS, 2011, U.S. Patent, Patent No. [2011/0178169 A1, 20110178169]; Santos AS, 2011, Brazilian patent PI, Patent No. [0817954-9, 08179549]; Santos AS, 2010, European patent WO, Patent No. 2010017613; Silveira FT, 2004, MEM I OSWALDO CRUZ, V99, P239, DOI 10.1590/S0074-02762004000300001; Silveira FT, 2009, GAZ MED BAHIA, V79, P25; Tamura T, 2006, TOXICOLOGY, V222, P213, DOI 10.1016/j.tox.2006.02.023; Valadares DG, 2011, PARASITOL INT, V60, P357, DOI 10.1016/j.parint.2011.06.001; Vendrametto MC, 2010, PARASITOL INT, V59, P154, DOI 10.1016/j.parint.2009.12.009	43	58	59	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91259	10.1371/journal.pone.0091259	http://dx.doi.org/10.1371/journal.pone.0091259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621481	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300070
J	Sicoli, MA; Holton, G				Sicoli, Mark A.; Holton, Gary			Linguistic Phylogenies Support Back-Migration from Beringia to Asia	PLOS ONE			English	Article							LANGUAGE EVOLUTION; NETWORKS; HISTORY; EXPANSION; ORIGINS; TREES; SHAPE	Recent arguments connecting Na-Dene languages of North America with Yeniseian languages of Siberia have been used to assert proof for the origin of Native Americans in central or western Asia. We apply phylogenetic methods to test support for this hypothesis against an alternative hypothesis that Yeniseian represents a back-migration to Asia from a Beringian ancestral population. We coded a linguistic dataset of typological features and used neighbor-joining network algorithms and Bayesian model comparison based on Bayes factors to test the fit between the data and the linguistic phylogenies modeling two dispersal hypotheses. Our results support that a Dene-Yeniseian connection more likely represents radiation out of Beringia with back-migration into central Asia than a migration from central or western Asia to North America.	[Sicoli, Mark A.] Georgetown Univ, Dept Linguist, Washington, DC 20057 USA; [Holton, Gary] Univ Alaska Fairbanks, Alaska Native Language Ctr, Fairbanks, AK USA	Georgetown University; University of Alaska System; University of Alaska Fairbanks	Sicoli, MA (corresponding author), Georgetown Univ, Dept Linguist, Washington, DC 20057 USA.	mas498@georgetown.edu			Alaska EPSCoR; Direct For Social, Behav & Economic Scie [0936887] Funding Source: National Science Foundation; Directorate For Geosciences [1642783, 1003160] Funding Source: National Science Foundation	Alaska EPSCoR; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Financial support was provided by Alaska EPSCoR for an RA in Mark Sicoli's lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; Bowern C, 2012, LANGUAGE, V88, P817, DOI 10.1353/lan.2012.0081; Campbell L, 2011, INT J AM LINGUIST, V77, P445, DOI 10.1086/660977; Castren M. Alexander, 1858, VERSUCH JENISSEI OST; Diamond J, 2011, NATURE, V476, P291, DOI 10.1038/476291a; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dunn M, 2005, SCIENCE, V309, P2072, DOI 10.1126/science.1114615; Dunn M, 2011, NATURE, V473, P79, DOI 10.1038/nature09923; Dunn M, 2009, LINGUA, V119, P1664, DOI 10.1016/j.lingua.2007.10.026; Georg S, 2007, LANG ASIA, V1, P1; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; Gray RD, 2010, PHILOS T R SOC B, V365, P3923, DOI 10.1098/rstb.2010.0162; Greenhill SJ, 2010, P ROY SOC B-BIOL SCI, V277, P2443, DOI 10.1098/rspb.2010.0051; GREENHILL SJ, 2005, EVOLUTION CULTURAL D, P31; Holland BR, 2005, SYST BIOL, V54, P66, DOI 10.1080/10635150590906055; Holman EW, 2011, CURR ANTHROPOL, V52, P841, DOI 10.1086/662127; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Krauss ME, 1973, LINGUISTICS N AM, P903; Krauss Michael E., 1981, HDB N AM INDIANS, V6, P67; Levinson SC, 2012, TRENDS COGN SCI, V16, P167, DOI 10.1016/j.tics.2012.01.007; Nelson-Sathi S, 2011, P ROY SOC B-BIOL SCI, V278, P1794, DOI 10.1098/rspb.2010.1917; Nichols Johanna, 1992, LINGUISTIC DIVERSITY; Potter Ben, 2010, ANTHR PAPERS U ALASK, V5, P138; Reesink G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000241; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Robinson LC, 2012, LANG DYN CHANG, V2, P123, DOI 10.1163/22105832-20120201; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruhlen M, 1998, P NATL ACAD SCI USA, V95, P13994, DOI 10.1073/pnas.95.23.13994; Sapir E, 1916, CANADA DEP MINES MEM, V13; Sherzer J, 1976, N HOLLAND LINGUISTIC, V20; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Trombetti Alfredo, 1923, ELEMENTI GLOTTOLOGIA; VAJDA EJ, 2010, ANTHR PAPERS U ALASK, V5, P100; Wichmann S, 2011, LANG DYN CHANG, V1, P205, DOI 10.1163/221058212X648072; Wichmann Soren, 2007, DIACHRONICA, V24, P373, DOI DOI 10.1075/DIA.24.2.06WIC; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102	39	26	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91722	10.1371/journal.pone.0091722	http://dx.doi.org/10.1371/journal.pone.0091722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AC9HN	24621925	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300120
J	Morcillo, F; Gonzalez-Munoz, MT; Reitz, T; Romero-Gonzalez, ME; Arias, JM; Merroun, ML				Morcillo, Fernando; Gonzalez-Munoz, Maria T.; Reitz, Thomas; Romero-Gonzalez, Maria E.; Arias, Jose M.; Merroun, Mohamed L.			Biosorption and Biomineralization of U(VI) by the Marine Bacterium Idiomarina loihiensis MAH1: Effect of Background Electrolyte and pH	PLOS ONE			English	Article							LASER-INDUCED FLUORESCENCE; 3 ECO-TYPES; COMPLEX-FORMATION; URANIUM; SPECTROSCOPY; PRECIPITATION; ADSORPTION; MINERALS; SEAWATER; STRAINS	The main goal of this study is to compare the effects of pH, uranium concentration, and background electrolyte (seawater and NaClO4 solution) on the speciation of uranium(VI) associated with the marine bacterium Idiomarina loihiensis MAH1. This was done at the molecular level using a multidisciplinary approach combining X-ray Absorption Spectroscopy (XAS), Time-Resolved Laser-Induced Fluorescence Spectroscopy (TRLFS), and High Resolution Transmission Electron Microscopy (HRTEM). We showed that the U(VI)/bacterium interaction mechanism is highly dependent upon pH but also the nature of the used background electrolyte played a role. At neutral conditions and a U concentration ranging from 5-10(-4) to 10(-5) M (environmentally relevant concentrations), XAS analysis revealed that uranyl phosphate mineral phases, structurally resembling meta-autunite [Ca(UO2)(2)(PO4)(2) 2-6H(2)O] are precipitated at the cell surfaces of the strain MAH1. The formation of this mineral phase is independent of the background solution but U(VI) luminescence lifetime analyses demonstrated that the U(VI) speciation in seawater samples is more intricate, i. e., different complexes were formed under natural conditions. At acidic conditions, pH 2, 3 and 4.3 ([U] = 5 . 10(-4) M, background electrolyte = 0.1 M NaClO4), the removal of U from solution was due to biosorption to Extracellular Polysaccharides (EPS) and cell wall components as evident from TEM analysis. The LIII-edge XAS and TRLFS studies showed that the biosorption process observed is dependent of pH. The bacterial cell forms a complex with U through organic phosphate groups at pH 2 and via phosphate and carboxyl groups at pH 3 and 4.3, respectively. The differences in the complexes formed between uranium and bacteria on seawater compared to NaClO4 solution demonstrates that the actinide/microbe interactions are influenced by the three studied factors, i.e., the pH, the uranium concentration and the chemical composition of the solution.	[Morcillo, Fernando; Gonzalez-Munoz, Maria T.; Arias, Jose M.; Merroun, Mohamed L.] Univ Granada, Dept Microbiol, Granada, Spain; [Reitz, Thomas] Helmholtz Zentrum Dresden Rossendorf, Inst Resource Ecol, Dresden, Germany; [Romero-Gonzalez, Maria E.] Univ Sheffield, Struct & Civil Engn Dept, Sheffield, S Yorkshire, England	University of Granada; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); University of Sheffield	Merroun, ML (corresponding author), Univ Granada, Dept Microbiol, Granada, Spain.	merroun@ugr.es	Reitz, Thomas/AFP-6355-2022; Merroun, Mohamed/L-4514-2014; González-Muñoz, Maria Teresa/N-1160-2014	Merroun, Mohamed/0000-0003-4553-5976; González-Muñoz, Maria Teresa/0000-0001-5170-4604; Romero-Gonzalez, Maria/0000-0001-5808-5383	Ministerio de Ciencia e Innovacion [CGL2009-09760, CGL2012-36505]; Junta de Andalucia, Spain [RNM 3943]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission)	This work was funded by the grants CGL2009-09760 and CGL2012-36505 (Ministerio de Ciencia e Innovacion), and RNM 3943 (Junta de Andalucia), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amayri S, 2005, J SOLID STATE CHEM, V178, P567, DOI 10.1016/j.jssc.2004.07.050; Ankudinov AL, 1998, PHYS REV B, V58, P7565, DOI 10.1103/PhysRevB.58.7565; Appukuttan D, 2011, J BIOTECHNOL, V154, P285, DOI 10.1016/j.jbiotec.2011.05.002; Baik MH, 2004, RADIOCHIM ACTA, V92, P663, DOI 10.1524/ract.92.9.663.54980; Barkleit A, 2008, DALTON T, P2879, DOI 10.1039/b715669c; Barkleit A, 2009, DALTON T, P5379, DOI 10.1039/b818702a; Barnett MO, 2002, ENVIRON SCI TECHNOL, V36, P937, DOI 10.1021/es010846i; Bernhard G, 2001, RADIOCHIM ACTA, V89, P511, DOI 10.1524/ract.2001.89.8.511; Bleise A, 2003, J ENVIRON RADIOACTIV, V64, P93, DOI 10.1016/S0265-931X(02)00041-3; Bonhoure I, 2007, RADIOCHIM ACTA, V95, P165, DOI 10.1524/ract.2007.95.3.165; Bowler C, 2009, NATURE, V459, P180, DOI 10.1038/nature08056; Brendler V, 1996, RADIOCHIM ACTA, V74, P75; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; Denecke MA, 1998, J ALLOY COMPD, V271, P123, DOI 10.1016/S0925-8388(98)00038-3; ELIET V, 1995, J CHEM SOC FARADAY T, V91, P2275, DOI 10.1039/ft9959102275; Fein JB, 1997, GEOCHIM COSMOCHIM AC, V61, P3319, DOI 10.1016/S0016-7037(97)00166-X; Geipel G, 2000, RADIOCHIM ACTA, V88, P757, DOI 10.1524/ract.2000.88.9-11.757; Geipel G, 1996, RADIOCHIM ACTA, V75, P199; Geissler A, 2009, GEOBIOLOGY, V7, P282, DOI 10.1111/j.1472-4669.2009.00199.x; George G.N., 1995, EXAFSPAK SUITE COMPU; Gilat E, 1975, P IAEA 30 JUN 4 JUL; Gonzalez-Munoz MT, 2012, GEOLOGY, V40, P675, DOI 10.1130/G33006.1; Gunther A, 2011, RADIOCHIM ACTA, V99, P535, DOI 10.1524/ract.2011.1847; Gustafsson JP, 2009, APPL GEOCHEM, V24, P454, DOI 10.1016/j.apgeochem.2008.12.032; Henderson GM, 2003, REV MINERAL GEOCHEM, V52, P493, DOI 10.2113/0520493; Hudson EA, 1996, PHYS REV B, V54, P156, DOI 10.1103/PhysRevB.54.156; Iyer A, 2005, MAR POLLUT BULL, V50, P340, DOI 10.1016/j.marpolbul.2004.11.012; Kelly SD, 2002, GEOCHIM COSMOCHIM AC, V66, P3855, DOI 10.1016/S0016-7037(02)00947-X; Koban A, 2004, RADIOCHIM ACTA, V92, P903, DOI 10.1524/ract.92.12.903.55114; Konstantinou M., 2004, MEDITERR MAR SCI, V5, P55, DOI [10.12681/mms.210, DOI 10.12681/MMS.210]; Krawczyk-Barsch E, 2012, GEOCHIM COSMOCHIM AC, V96, P94, DOI 10.1016/j.gca.2012.08.012; Macaskie LE, 2000, MICROBIOL-SGM, V146, P1855, DOI 10.1099/00221287-146-8-1855; MAKAROV ES, 1960, DOKL AKAD NAUK SSSR+, V132, P673; Matz W, 1999, J SYNCHROTRON RADIAT, V6, P1076, DOI 10.1107/S0909049599010663; Merroun M, 2006, RADIOCHIM ACTA, V94, P723, DOI 10.1524/ract.2006.94.9.723; Merroun M, 2003, RADIOCHIM ACTA, V91, P583, DOI 10.1524/ract.91.10.583.22477; Merroun M, 2002, BIOCHEM SOC T, V30, P669, DOI 10.1042/BST0300669; Merroun ML, 2005, APPL ENVIRON MICROB, V71, P5532, DOI 10.1128/AEM.71.9.5532-5543.2005; Merroun ML, 2003, BIOMETALS, V16, P331, DOI 10.1023/A:1020612600726; Merroun ML, 2011, J HAZARD MATER, V197, P1, DOI 10.1016/j.jhazmat.2011.09.049; Merroun ML, 2008, J CONTAM HYDROL, V102, P285, DOI 10.1016/j.jconhyd.2008.09.019; Morcillo De Amuedo F, 2010, THESIS U GRANADA SPA; Moulin C, 1998, APPL SPECTROSC, V52, P528, DOI 10.1366/0003702981944076; Nedelkova M, 2007, FEMS MICROBIOL ECOL, V59, P694, DOI 10.1111/j.1574-6941.2006.00261.x; OECD Uranium, 2009, OECD NEA PUBL; Panak PJ, 2000, RADIOCHIM ACTA, V88, P71, DOI 10.1524/ract.2000.88.2.071; Reitz T, 2011, RADIOCHIM ACTA, V99, P543, DOI 10.1524/ract.2011.1848; Reitz T, 2010, RADIOCHIM ACTA, V98, P249, DOI 10.1524/ract.2010.1716; Sakamoto N, 2008, BIOINORG CHEM APPL, V2008, DOI 10.1155/2008/706240; Siokou-Frangou I, 2010, BIOGEOSCIENCES, V7, P1543, DOI 10.5194/bg-7-1543-2010; Takata H, 2011, J RADIOANAL NUCL CH, V287, P795, DOI 10.1007/s10967-010-0827-7; Gonzalez-Munoz MT, 2008, CHEMOSPHERE, V72, P465, DOI 10.1016/j.chemosphere.2008.02.010; Vogel M, 2010, SCI TOTAL ENVIRON, V409, P384, DOI 10.1016/j.scitotenv.2010.10.011; YONG P, 1995, B ENVIRON CONTAM TOX, V54, P892, DOI 10.1007/BF00197975	54	34	36	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91305	10.1371/journal.pone.0091305	http://dx.doi.org/10.1371/journal.pone.0091305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618567	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400071
J	Toth, E; Huszar, K; Bencsura, P; Kulcsar, PI; Vodicska, B; Nyeste, A; Welker, Z; Toth, S; Welker, E				Toth, Eszter; Huszar, Krisztina; Bencsura, Petra; Kulcsar, Peter Istvan; Vodicska, Barbara; Nyeste, Antal; Welker, Zsombor; Toth, Szilvia; Welker, Ervin			Restriction Enzyme Body Doubles and PCR Cloning: On the General Use of Type IIS Restriction Enzymes for Cloning	PLOS ONE			English	Article							LIGATION-INDEPENDENT CLONING; ONE-STEP; ONE-POT; DNA; SITES; ENDONUCLEASES; MUTAGENESIS; DELETIONS; CLEAVAGE; VECTORS	The procedure described here allows the cloning of PCR fragments containing a recognition site of the restriction endonuclease ( Type IIP) used for cloning in the sequence of the insert. A Type IIS endonuclease - a Body Double of the Type IIP enzyme - is used to generate the same protruding palindrome. Thus, the insert can be cloned to the Type IIP site of the vector without digesting the PCR product with the same Type IIP enzyme. We achieve this by incorporating the recognition site of a Type IIS restriction enzyme that cleaves the DNA outside of its recognition site in the PCR primer in such a way that the cutting positions straddle the desired overhang sequence. Digestion of the PCR product by the Body Double generates the required overhang. Hitherto the use of Type IIS restriction enzymes in cloning reactions has only been used for special applications, the approach presented here makes Type IIS enzymes as useful as Type IIP enzymes for general cloning purposes. To assist in finding Body Double enzymes, we summarised the available Type IIS enzymes which are potentially useful for Body Double cloning and created an online program ( http://group.szbk.u-szeged.hu/welkergr/body_double/index.html) for the selection of suitable Body Double enzymes and the design of the appropriate primers.	[Toth, Eszter; Kulcsar, Peter Istvan; Vodicska, Barbara; Nyeste, Antal; Welker, Ervin] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Huszar, Krisztina; Bencsura, Petra; Welker, Zsombor; Toth, Szilvia; Welker, Ervin] Hungarian Acad Sci, Inst Mol Pharmacol, Res Ctr Nat Sci, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Welker, E (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary.	welker@brc.hu	Vodicska, Barbara/AGY-8745-2022; Kulcsár, Péter István/AAD-8175-2021; Welker, Ervin/AAC-6493-2022	Kulcsár, Péter István/0000-0002-7783-5108; Vodicska, Barbara/0000-0003-1191-234X	Hungarian Scientific Research Fund [K-82090]; Hungarian National Development Agency [TAMOP-4.2.2.A-11/1/2012-0052]; National Excellence Program - "Elaborating and operating an inland student and researcher personal support system convergence program'' [TAMOP 4.2.4. A/2-11-1-2012-0001, TAMOP 4.2.4. A/1-11-1-2012-0001]; European Union; European Social Fund	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian National Development Agency; National Excellence Program - "Elaborating and operating an inland student and researcher personal support system convergence program''; European Union(European Commission); European Social Fund(European Social Fund (ESF))	This work was supported by the Hungarian Scientific Research Fund [K-82090]; the Hungarian National Development Agency [TAMOP-4.2.2.A-11/1/2012-0052]; and the National Excellence Program - "Elaborating and operating an inland student and researcher personal support system convergence program'' [TAMOP 4.2.4.A/2-11-1-2012-0001 to Eszter Toth and TAMOP 4.2.4. A/1-11-1-2012-0001 to Barbara Vodicska]. The project was subsidized by the European Union and co-financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BECK R, 1994, NUCLEIC ACIDS RES, V22, P886, DOI 10.1093/nar/22.5.886; BERGER SL, 1993, ANAL BIOCHEM, V214, P571, DOI 10.1006/abio.1993.1540; Berlin Y A, 1999, Curr Issues Mol Biol, V1, P21; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Fromme Tobias, 2007, J Biol Eng, V1, P7, DOI 10.1186/1754-1611-1-7; GAYLE RB, 1987, GENE, V54, P221, DOI 10.1016/0378-1119(87)90490-2; GILMARTIN PM, 1989, NUCLEIC ACIDS RES, V17, P4901, DOI 10.1093/nar/17.12.4901; HASAN N, 1989, GENE, V82, P305, DOI 10.1016/0378-1119(89)90055-3; HASAN N, 1986, GENE, V50, P55, DOI 10.1016/0378-1119(86)90309-4; HAYDEN MA, 1988, DNA-J MOLEC CELL BIO, V7, P571, DOI 10.1089/dna.1.1988.7.571; Ivics Z, 2007, MOL THER, V15, P1137, DOI 10.1038/sj.mt.6300169; Kuzuya A, 2012, MOLECULES, V17, P328, DOI 10.3390/molecules17010328; LEBEDENKO EN, 1991, NUCLEIC ACIDS RES, V19, P6757, DOI 10.1093/nar/19.24.6757; Lu Q, 2005, TRENDS BIOTECHNOL, V23, P199, DOI 10.1016/j.tibtech.2005.02.008; MORMENEO S, 1987, GENE, V61, P21, DOI 10.1016/0378-1119(87)90361-1; Padgett KA, 1996, GENE, V168, P31, DOI 10.1016/0378-1119(95)00731-8; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; PODHAJSKA AJ, 1985, GENE, V40, P175, DOI 10.1016/0378-1119(85)90040-X; Prabhakara R, 2013, INFECT IMMUN, V81, P1306, DOI 10.1128/IAI.01304-12; Rebatchouk D, 1996, P NATL ACAD SCI USA, V93, P10891, DOI 10.1073/pnas.93.20.10891; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; SCARPULLA RC, 1982, ANAL BIOCHEM, V121, P356, DOI 10.1016/0003-2697(82)90493-6; STEMMER WPC, 1992, BIOTECHNIQUES, V13, P214; SZYBALSKI W, 1991, GENE, V100, P13, DOI 10.1016/0378-1119(91)90345-C; SZYBALSKI W, 1985, GENE, V40, P169, DOI 10.1016/0378-1119(85)90039-3; Tillett D, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e26; Toth E, 2013, BBA-MOL CELL RES, V1833, P1199, DOI 10.1016/j.bbamcr.2013.01.020; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Welker E, 2000, BIOCHEM BIOPH RES CO, V271, P534, DOI 10.1006/bbrc.2000.2668	33	7	8	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90896	10.1371/journal.pone.0090896	http://dx.doi.org/10.1371/journal.pone.0090896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618593	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400034
J	Zhang, HJ; Jiang, XJ; Xiao, WF; Lu, LP				Zhang, Hangjun; Jiang, Xiaojun; Xiao, Wenfeng; Lu, Liping			Proteomic Strategy for the Analysis of the Polychlorobiphenyl-Degrading Cyanobacterium Anabaena PD-1 Exposed to Aroclor 1254	PLOS ONE			English	Article							POLYCHLORINATED-BIPHENYLS; PSEUDOMONAS-PUTIDA; STRESS-RESPONSE; DEGRADATION; PROTEINS; BIODEGRADATION; BIOREMEDIATION; DIOXYGENASES; METABOLITES; POLLUTANTS	The cyanobacterium Anabaena PD-1, which was originally isolated from polychlorobiphenyl (PCB)-contaminated paddy soils, has capabilities for dechlorinatin and for degrading the commercial PCB mixture Aroclor 1254. In this study, 25 upregulated proteins were identified using 2D electrophoresis (2-DE) coupled with matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS). These proteins were involved in (i) PCB degradation (i.e., 3-chlorobenzoate-3,4-dioxygenase); (ii) transport processes [e. g., ATP-binding cassette (ABC) transporter substrate-binding protein, amino acid ABC transporter substrate-binding protein, peptide ABC transporter substrate-binding protein, putrescine-binding protein, periplasmic solute-binding protein, branched-chain amino acid uptake periplasmic solutebinding protein, periplasmic phosphate-binding protein, phosphonate ABC transporter substrate-binding protein, and xylose ABC transporter substrate-binding protein]; (iii) energetic metabolism (e. g., methanol/ethanol family pyrroloquinoline quinone (PQQ)-dependent dehydrogenase, malate-CoA ligase subunit beta, enolase, ATP synthase beta subunit, FOF1 ATP synthase subunit beta, ATP synthase a subunit, and IMP cyclohydrolase); (iv) electron transport (cytochrome b(6)f complex FeS protein); (v) general stress response (e. g., molecular chaperone DnaK, elongation factor G, and translation elongation factor thermostable); (vi) carbon metabolism (methanol dehydrogenase and malate-CoA ligase subunit beta); and (vii) nitrogen reductase (nitrous oxide reductase). The results of real-time polymerase chain reaction showed that the genes encoding for dioxygenase, ABC transporters, transmembrane proteins, electron transporter, and energetic metabolism proteins were significantly upregulated during PCB degradation. These genes upregulated by 1.26- to 8.98-fold. These findings reveal the resistance and adaptation of cyanobacterium to the presence of PCBs, shedding light on the complexity of PCB catabolism by Anabaena PD-1.	[Zhang, Hangjun; Jiang, Xiaojun; Xiao, Wenfeng; Lu, Liping] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University	Zhang, HJ (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	zhanghangjun@gmail.com		zhang, hangjun/0000-0002-3281-6093	Natural Science Foundation of China [21077030]; Program for Excellent Young Teachers in Hangzhou Normal University [JTAS 2011-01-012]; Program for talents in Hangzhou City; Undergraduates innovation ability promotion project in Hangzhou Normal University [CX2013078]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Excellent Young Teachers in Hangzhou Normal University; Program for talents in Hangzhou City; Undergraduates innovation ability promotion project in Hangzhou Normal University	This work was supported by the Natural Science Foundation of China (21077030), the Program for Excellent Young Teachers in Hangzhou Normal University (JTAS 2011-01-012), the Program for talents in Hangzhou City, and the Undergraduates innovation ability promotion project in Hangzhou Normal University (CX2013078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agullo L, 2007, FEMS MICROBIOL LETT, V267, P167, DOI 10.1111/j.1574-6968.2006.00554.x; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Baniulis D, 2009, J BIOL CHEM, V284, P9861, DOI 10.1074/jbc.M809196200; Barriault D, 2001, CAN J MICROBIOL, V47, P1025, DOI 10.1139/cjm-47-11-1025; Ben Hassine S, 2012, CHEMOSPHERE, V89, P369, DOI 10.1016/j.chemosphere.2012.05.035; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breugelmans P, 2010, RES MICROBIOL, V161, P208, DOI 10.1016/j.resmic.2010.01.010; Cao B, 2008, BIOTECHNOL BIOENG, V101, P1297, DOI 10.1002/bit.21997; Cao B, 2009, J CHEM TECHNOL BIOT, V84, P1178, DOI 10.1002/jctb.2155; Colbert CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052550; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Cvancarova M, 2012, CHEMOSPHERE, V88, P1317, DOI 10.1016/j.chemosphere.2012.03.107; Dominguez-Cuevas P, 2006, J BIOL CHEM, V281, P11981, DOI 10.1074/jbc.M509848200; Eixarch H, 2010, PROCESS BIOCHEM, V45, P794, DOI 10.1016/j.procbio.2009.12.015; Endo R, 2007, J BACTERIOL, V189, P3712, DOI 10.1128/JB.01883-06; Fanous A, 2007, CHEMOSPHERE, V69, P25, DOI 10.1016/j.chemosphere.2007.04.075; Field JA, 2008, ENVIRON POLLUT, V155, P1, DOI 10.1016/j.envpol.2007.10.016; Furukawa K, 2000, CURR OPIN BIOTECH, V11, P244, DOI 10.1016/S0958-1669(00)00091-4; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; Giuffrida MG, 2001, ELECTROPHORESIS, V22, P1705, DOI 10.1002/1522-2683(200105)22:9<1705::AID-ELPS1705>3.0.CO;2-0; Hong CY, 2012, J ENVIRON SCI HEAL A, V47, P1878, DOI 10.1080/03601234.2012.676432; Huang F, 2006, PROTEOMICS, V6, P910, DOI 10.1002/pmic.200500114; Jones KC, 1999, ENVIRON POLLUT, V100, P209, DOI 10.1016/S0269-7491(99)00098-6; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Kim SJ, 2009, CURR OPIN MICROBIOL, V12, P301, DOI 10.1016/j.mib.2009.03.006; Kumamaru T, 1998, NAT BIOTECHNOL, V16, P663, DOI 10.1038/nbt0798-663; Kurian D, 2006, PROTEOMICS, V6, P3614, DOI 10.1002/pmic.200600033; Lambo AJ, 2007, J APPL MICROBIOL, V102, P1318, DOI 10.1111/j.1365-2672.2006.03268.x; Li ZM, 2009, SOIL BIOL BIOCHEM, V41, P984, DOI 10.1016/j.soilbio.2008.10.026; Liu Y, 2013, J ENVIRON SCI, V25, P1662, DOI 10.1016/S1001-0742(12)60182-X; Lund PA, 2001, ADV MICROB PHYSIOL, V44, P93, DOI 10.1016/S0065-2911(01)44012-4; NAKATSU CH, 1995, MICROBIOL-UK, V141, P485, DOI 10.1099/13500872-141-2-485; Nam JW, 2001, BIOSCI BIOTECH BIOCH, V65, P254, DOI 10.1271/bbb.65.254; Ohtsubo Y, 2004, APPL MICROBIOL BIOT, V65, P250, DOI 10.1007/s00253-004-1654-y; Pandey S, 2012, J PROTEOMICS, V75, P921, DOI 10.1016/j.jprot.2011.10.011; Papazi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061682; Papazi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049037; Park SH, 2001, CURR MICROBIOL, V43, P176, DOI 10.1007/s002840010283; Perez-Pantoja D., 2009, HDB HYDROCARBON LIPI, P1356; Ren NQ, 2007, ENVIRON SCI TECHNOL, V41, P3871, DOI 10.1021/es063004y; RIESKE JS, 1964, BIOCHEM BIOPH RES CO, V15, P338, DOI 10.1016/0006-291X(64)90171-8; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Robinson GK, 1998, BIOCHEM SOC T, V26, P686, DOI 10.1042/bst0260686; Rodrigues JLM, 2006, APPL ENVIRON MICROB, V72, P2476, DOI 10.1128/AEM.72.4.2476-2482.2006; Samanta SK, 2002, TRENDS BIOTECHNOL, V20, P243, DOI 10.1016/S0167-7799(02)01943-1; Santos PM, 2004, PROTEOMICS, V4, P2640, DOI 10.1002/pmic.200300793; Schultze M, 2009, BBA-BIOENERGETICS, V1787, P1479, DOI 10.1016/j.bbabio.2009.06.010; Segura A, 1999, ENVIRON MICROBIOL, V1, P191, DOI 10.1046/j.1462-2920.1999.00033.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singer AC, 2000, APPL MICROBIOL BIOT, V54, P838, DOI 10.1007/s002530000472; Subashchandrabose SR, 2013, ENVIRON INT, V51, P59, DOI 10.1016/j.envint.2012.10.007; Tsuji N, 2003, BIOTECHNOL LETT, V25, P241, DOI 10.1023/A:1022333406348; Tu C, 2011, J HAZARD MATER, V186, P1438, DOI 10.1016/j.jhazmat.2010.12.008; Waid John S., 1986, PCBS ENV; Yun SH, 2011, J PROTEOMICS, V74, P620, DOI 10.1016/j.jprot.2011.01.020; Zhang HJ, 2012, J APPL PHYCOL, V24, P221, DOI 10.1007/s10811-011-9670-7; Zhang Y, 2009, BIODEGRADATION, V20, P55, DOI 10.1007/s10532-008-9199-x	58	9	9	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91162	10.1371/journal.pone.0091162	http://dx.doi.org/10.1371/journal.pone.0091162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618583	gold, Green Submitted, Green Published			2022-12-27	WOS:000332842400053
J	Zimmer, U; Koschutnig, K; Ebner, F; Ischebeck, A				Zimmer, Ulrike; Koschutnig, Karl; Ebner, Franz; Ischebeck, Anja			Successful Contextual Integration of Loose Mental Associations As Evidenced by Emotional Conflict-Processing	PLOS ONE			English	Article							EVENT-RELATED FMRI; FUNCTIONAL CONNECTIVITY; FACIAL EXPRESSIONS; VOCAL EXPRESSION; ANTERIOR INSULA; BASIC EMOTIONS; HUMAN BRAIN; ATTENTION; DISGUST; AMYGDALA	Often we cannot resist emotional distraction, because emotions capture our attention. For example, in TV-commercials, tempting emotional voices add an emotional expression to a formerly neutral product. Here, we used a Stroop-like conflict paradigm as a tool to investigate whether emotional capture results in contextual integration of loose mental associations. Specifically, we tested whether the associatively connected meaning of an ignored auditory emotion with a non-emotional neutral visual target would yield a modulation of activation sensitive to emotional conflict in the brain. In an fMRI-study, nineteen participants detected the presence or absence of a little worm hidden in the picture of an apple, while ignoring a voice with an emotional sound of taste (delicious/disgusting). Our results indicate a modulation due to emotional conflict, pronounced most strongly when processing conflict in the context of disgust (conflict: disgust/no-worm vs. no conflict: disgust/worm). For conflict in the context of disgust, insula activity was increased, with activity correlating positively with reaction time in the conflict case. Conflict in the context of deliciousness resulted in increased amygdala activation, possibly due to the resulting "negative'' emotion in incongruent versus congruent combinations. These results indicate that our associative stimulus-combinations showed a conflict-dependent modulation of activity in emotional brain areas. This shows that the emotional sounds were successfully contextually integrated with the loosely associated neutral pictures.	[Zimmer, Ulrike; Ischebeck, Anja] Graz Univ, Dept Psychol, Graz, Austria; [Koschutnig, Karl; Ebner, Franz] Med Univ Graz, Dept Radiol, Graz, Austria	University of Graz; Medical University of Graz	Zimmer, U (corresponding author), Graz Univ, Dept Psychol, Graz, Austria.		Koschutnig, Karl/W-3106-2019	Koschutnig, Karl/0000-0001-6234-0498; Ischebeck, Anja/0000-0002-3493-2848; Zimmer, Ulrike/0000-0002-4232-0550				Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Brown S, 2011, NEUROIMAGE, V58, P250, DOI 10.1016/j.neuroimage.2011.06.012; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; Ethofer T, 2006, HUM BRAIN MAPP, V27, P707, DOI 10.1002/hbm.20212; Ethofer T, 2012, CEREB CORTEX, V22, P191, DOI 10.1093/cercor/bhr113; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Fecteau S, 2007, NEUROIMAGE, V36, P480, DOI 10.1016/j.neuroimage.2007.02.043; Fichtenholtz HM, 2004, COGNITIVE BRAIN RES, V20, P67, DOI 10.1016/j.cogbrainres.2004.01.006; Focker J, 2011, ACTA PSYCHOL, V137, P36, DOI 10.1016/j.actpsy.2011.02.004; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; Isenberg N, 1999, P NATL ACAD SCI USA, V96, P10456, DOI 10.1073/pnas.96.18.10456; Jabbi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002939; Juslin PN, 2001, EMOTION, V1, P381, DOI 10.1037//1528-3542.1.4.381; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Klasen M, 2011, J NEUROSCI, V31, P13635, DOI 10.1523/JNEUROSCI.2833-11.2011; Krolak-Salmon P, 2003, ANN NEUROL, V53, P446, DOI 10.1002/ana.10502; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Bispo RFM, 2010, INT J MORPHOL, V28, P439, DOI 10.4067/S0717-95022010000200018; Muller VI, 2011, NEUROIMAGE, V54, P2257, DOI 10.1016/j.neuroimage.2010.10.047; Paulmann S, 2010, COGN AFFECT BEHAV NE, V10, P230, DOI 10.3758/CABN.10.2.230; Pessoa L, 2005, NEUROIMAGE, V28, P249, DOI 10.1016/j.neuroimage.2005.05.048; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Pinkham AE, 2010, EMOTION, V10, P141, DOI 10.1037/a0017387; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Pourtois G, 2006, PROG BRAIN RES, V156, P67, DOI 10.1016/S0079-6123(06)56004-2; Royet JP, 2003, NEUROIMAGE, V20, P713, DOI 10.1016/S1053-8119(03)00388-4; Sambataro F, 2006, EUR J NEUROSCI, V24, P2355, DOI 10.1111/j.1460-9568.2006.05120.x; Schienle A, 2002, NEUROREPORT, V13, P2023, DOI 10.1097/00001756-200211150-00006; Shafer AT, 2012, J COGNITIVE NEUROSCI, V24, P1233, DOI 10.1162/jocn_a_00206; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Stark R, 2007, NEUROIMAGE, V37, P663, DOI 10.1016/j.neuroimage.2007.05.005; Tettamanti M, 2012, NEUROIMAGE, V59, P1804, DOI 10.1016/j.neuroimage.2011.08.018; van Atteveldt NM, 2007, CEREB CORTEX, V17, P962, DOI 10.1093/cercor/bhl007; van Atteveldt NM, 2013, HUM BRAIN MAPP; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wiethoff S, 2009, NEUROREPORT, V20, P1356, DOI 10.1097/WNR.0b013e328330eb83; Wittfoth M, 2010, CEREB CORTEX, V20, P383, DOI 10.1093/cercor/bhp106; Zald DH, 1998, J CEREBR BLOOD F MET, V18, P896, DOI 10.1097/00004647-199808000-00010; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5; Zimmer U, 2010, EUR J NEUROSCI, V31, P1744, DOI 10.1111/j.1460-9568.2010.07229.x; Zimmer U, 2010, NEUROIMAGE, V52, P606, DOI 10.1016/j.neuroimage.2010.04.245	49	3	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91470	10.1371/journal.pone.0091470	http://dx.doi.org/10.1371/journal.pone.0091470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24618674	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400096
J	Criscuoli, I; Alberti, G; Baronti, S; Favilli, F; Martinez, C; Calzolari, C; Pusceddu, E; Rumpel, C; Viola, R; Miglietta, F				Criscuoli, Irene; Alberti, Giorgio; Baronti, Silvia; Favilli, Filippo; Martinez, Cristina; Calzolari, Costanza; Pusceddu, Emanuela; Rumpel, Cornelia; Viola, Roberto; Miglietta, Franco			Carbon Sequestration and Fertility after Centennial Time Scale Incorporation of Charcoal into Soil	PLOS ONE			English	Article							CHEMICAL-PROPERTIES; ORGANIC-CARBON; BLACK CARBON; LAND-USE; BIOCHAR; PHOSPHORUS; FRACTIONATION; PROPAGATION; TERRAMARA; ISOTOPES	The addition of pyrogenic carbon (C) in the soil is considered a potential strategy to achieve direct C sequestration and potential reduction of non-CO2 greenhouse gas emissions. In this paper, we investigated the long term effects of charcoal addition on C sequestration and soil physico-chemical properties by studying a series of abandoned charcoal hearths in the Eastern Alps of Italy established in the XIX century. This natural setting can be seen as an analogue of a deliberate experiment with replications. Carbon sequestration was assessed indirectly by comparing the amount of pyrogenic C present in the hearths (23.3+/-4.7 kg C m(-2)) with the estimated amount of charcoal that was left on the soil after the carbonization (29.3+/-5.1 kg C m(-2)). After taking into account uncertainty associated with parameters' estimation, we were able to conclude that 80+/-21% of the C originally added to the soil via charcoal can still be found there and that charcoal has an overall Mean Residence Time of 650+/-139 years, thus supporting the view that charcoal incorporation is an effective way to sequester atmospheric CO2. We also observed an overall change in the physical properties (hydrophobicity and bulk density) of charcoal hearth soils and an accumulation of nutrients compared to the adjacent soil without charcoal. We caution, however, that our site-specific results should not be generalized without further study.	[Criscuoli, Irene; Martinez, Cristina; Miglietta, Franco] Fdn E Mach, FoxLab, San Michele All Adige, Trento, Italy; [Alberti, Giorgio] European Forest Inst, MountFor Project Ctr, San Michele All Adige, Trento, Italy; [Alberti, Giorgio] Univ Udine, Dept Agr & Environm Sci, I-33100 Udine, Italy; [Baronti, Silvia; Martinez, Cristina; Pusceddu, Emanuela; Miglietta, Franco] CNR, Inst Biometeorol, Florence, Italy; [Favilli, Filippo] European Acad Bolzano, Bolzano, Italy; [Calzolari, Costanza] CNR, Inst Res Hydrogeol Protect, Sesto Fiorentino, FI, Italy; [Criscuoli, Irene; Rumpel, Cornelia] CNRS INRA ENS Paris 6, Biogeochim & Ecol Milieux Continentaux, Thiverval Grignon, France; [Viola, Roberto] Fdn E Mach, Ctr Res & Innovat, San Michele All Adige, Trento, Italy	Fondazione Edmund Mach; University of Udine; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); European Academy of Bozen-Bolzano; Consiglio Nazionale delle Ricerche (CNR); INRAE; UDICE-French Research Universities; Sorbonne Universite; Fondazione Edmund Mach	Criscuoli, I (corresponding author), Fdn E Mach, FoxLab, San Michele All Adige, Trento, Italy.	irene.criscuoli@fmach.it	Baronti, Silvia/AAD-5339-2019; Calzolari, Maria/AAV-9538-2020; Pusceddu, Emanuela/P-1620-2018; Favilli, Filippo/AAA-8738-2022; Baronti, Silvia/D-2828-2011; Rumpel, Cornelia/A-2001-2015; Martinez, Cristina/F-3251-2017; Baronti, Silvia/AAX-7952-2020; Miglietta, Franco/B-6137-2008; Viola, Roberto/F-3657-2014	Baronti, Silvia/0000-0002-0986-0723; Calzolari, Maria/0000-0002-2126-9290; Pusceddu, Emanuela/0000-0002-1325-6932; Favilli, Filippo/0000-0001-8101-0689; Baronti, Silvia/0000-0002-0986-0723; Rumpel, Cornelia/0000-0003-2131-9451; Martinez, Cristina/0000-0003-1592-9149; Miglietta, Franco/0000-0003-1474-8143; Viola, Roberto/0000-0002-8202-8503; Alberti, Giorgio/0000-0003-2422-3009	European Commission [FP7-ENV-478 2010ID-265179]; Regione Toscana, Italy; Fondazione Edmund Mach, Trento	European Commission(European CommissionEuropean Commission Joint Research Centre); Regione Toscana, Italy(Regione Toscana); Fondazione Edmund Mach, Trento	This study was financially supported by the European Commission through the EuroChar project (FP7-ENV-478 2010ID-265179) and AgroPyroGas funded by Regione Toscana, Italy. I. C. was supported by a Ph.D. grant from Fondazione Edmund Mach, Trento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ASACSSA SSSA INT ANN; BACKMEROFF C. E., 2013, MIN CULT LANDSC 8 IN, P218; Badeck FW, 2005, RAPID COMMUN MASS SP, V19, P1381, DOI 10.1002/rcm.1912; Ball DF, 1964, LOSS ON IGNITION EST, V15; Basso Andres S., 2013, GCB Bioenergy, V5, P132, DOI 10.1111/gcbb.12026; BERGAMETTI G, 1992, J ATMOS CHEM, V14, P501, DOI 10.1007/BF00115254; Bird MI, 2012, ORG GEOCHEM, V42, P1529, DOI 10.1016/j.orggeochem.2010.09.005; Carcaillet C, 2001, HOLOCENE, V11, P231, DOI 10.1191/095968301674071040; Cheng CH, 2008, GEOCHIM COSMOCHIM AC, V72, P1598, DOI 10.1016/j.gca.2008.01.010; Cremaschi M, 2006, QUATERN INT, V151, P87, DOI 10.1016/j.quaint.2006.01.020; Del Galdo I, 2003, GLOBAL CHANGE BIOL, V9, P1204, DOI 10.1046/j.1365-2486.2003.00657.x; Di Piazza A., 2012, ANALISI SERIE GIORNA; Eckmeier E, 2007, BIOGEOSCIENCES, V4, P377, DOI 10.5194/bg-4-377-2007; Favilli F, 2010, HOLOCENE, V20, P67, DOI 10.1177/0959683609348850; Flueck Werner T., 2009, Sustainability, V1, P104, DOI 10.3390/su1020104; Food and Agriculture Organization of the United Nation (FAO), 1987, SIMPL TECHN CHARC MA; FRIEDLI H, 1986, NATURE, V324, P237, DOI 10.1038/324237a0; Genesio L, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014025; Glaser B, 2001, NATURWISSENSCHAFTEN, V88, P37, DOI 10.1007/s001140000193; Glaser B, 2002, BIOL FERT SOILS, V35, P219, DOI 10.1007/s00374-002-0466-4; Graber ER, 2010, PLANT SOIL, V337, P481, DOI 10.1007/s11104-010-0544-6; Gurwick NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075932; Hesketh N, 2000, J ENVIRON QUAL, V29, P105, DOI 10.2134/jeq2000.00472425002900010013x; Jaffe R, 2013, SCIENCE, V340, P345, DOI 10.1126/science.1231476; Joseph SD, 2007, BIOCHAR CARBON SEQUE, P130; Kaal J, 2008, J ARCHAEOL SCI, V35, P2133, DOI 10.1016/j.jas.2008.01.013; Keeling CD, 2011, CONCENTRATION ISOTOP; Kinney TJ, 2012, BIOMASS BIOENERG, V41, P34, DOI 10.1016/j.biombioe.2012.01.033; Knicker H, 2011, QUATERN INT, V243, P251, DOI 10.1016/j.quaint.2011.02.037; Laird DA, 2008, CHARCOAL VISION WIN, DOI [10.2134/agronj2007.0161, DOI 10.2134/AGR0NJ2007.0161]; Lane PNJ, 2004, HYDROL PROCESS, V18, P879, DOI 10.1002/hyp.1316; Lehmann J., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P403, DOI 10.1007/s11027-005-9006-5; Lehmann J, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002435; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; LETEY J., 1969, Water-repellent soils. Proceedings of the symposium on water-repellent soils held at the University of California, Riverside, May 6-10, 1968., P43; Lo E, 2005, ECOL MONOGR, V75, P451, DOI 10.1890/05-0030; Mahowald N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2008GB003240; Mantovani P, 2006, RICORDI CARBONER BON; Masiello CA, 2004, MAR CHEM, V92, P201, DOI 10.1016/j.marchem.2004.06.043; Mencuccini M, 2005, ECOL LETT, V8, P1183, DOI 10.1111/j.1461-0248.2005.00819.x; Mercuri AM, 2006, VEG HIST ARCHAEOBOT, V16, P43, DOI 10.1007/s00334-006-0034-1; Naisse C, 2013, ORG GEOCHEM, V60, P40, DOI 10.1016/j.orggeochem.2013.04.011; Oguntunde PG, 2004, BIOL FERT SOILS, V39, P295, DOI 10.1007/s00374-003-0707-1; Oguntunde PG, 2008, J PLANT NUTR SOIL SC, V171, P591, DOI 10.1002/jpln.200625185; Peng X, 2011, SOIL TILL RES, V112, P159, DOI 10.1016/j.still.2011.01.002; Poda A, 1963, TAVOLE STEREOMETRICH, P780; Pusceddu E, 2013, J PHYS CONF SER, V470, DOI 10.1088/1742-6596/470/1/012003; Quilliam RS, 2013, SOIL BIOL BIOCHEM, V65, P287, DOI 10.1016/j.soilbio.2013.06.004; Reynolds WD, 2009, GEODERMA, V152, P252, DOI 10.1016/j.geoderma.2009.06.009; Rizzi G, 2010, SENTIERO VAL SOLE SF; Saurer M, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000689; Schenkel Y, 1998, BIOMASS BIOENERG, V14, P505, DOI 10.1016/S0961-9534(97)10033-2; Schmidt MWI, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001939; Schutz M, 2006, ECOSYSTEMS, V9, P624, DOI 10.1007/s10021-006-0091-4; SCOTT DF, 1990, J HYDROL, V121, P239, DOI 10.1016/0022-1694(90)90234-O; Singh N, 2012, BIOGEOSCIENCES, V9, P2847, DOI 10.5194/bg-9-2847-2012; SMITH NJH, 1980, ANN ASSOC AM GEOGR, V70, P553, DOI 10.1111/j.1467-8306.1980.tb01332.x; Smith R.T, 1975, TECHNIQUES PEDOLOGY; Sonna R, STUDI RICERCHE, P1; Tait D., 2000, J LIMNOL, V59, DOI [10.4081/jlimnol.2000.61, DOI 10.4081/JLIMNOL.2000.61]; Tonolli S, 2011, EUR J FOREST RES, V130, P569, DOI 10.1007/s10342-010-0445-5; USEPA Method 3052, 1996, 3052 USEPA; Vendrell P, 1990, COMMUNICATIONS SOIL, V21; Willis RB, 1993, COMMUNICATIONS SOIL, V24; Woolf D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1053; Yanai Y, 2007, SOIL SCI PLANT NUTR, V53, P181, DOI 10.1111/j.1747-0765.2007.00123.x; Zimmermann M, 2012, GLOBAL CHANGE BIOL, V18, P3306, DOI 10.1111/j.1365-2486.2012.02796.x	68	47	47	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91114	10.1371/journal.pone.0091114	http://dx.doi.org/10.1371/journal.pone.0091114			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614647	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300078
J	Wielders, CCH; Wuister, AMH; de Visser, VL; de Jager-Leclercq, MG; Groot, CAR; Dijkstra, F; van Gageldonk-Lafeber, AB; van Leuken, JPG; Wever, PC; van der Hoek, W; Schneeberger, PM				Wielders, Cornelia C. H.; Wuister, Annemarie M. H.; de Visser, Veerle L.; de Jager-Leclercq, Monique G.; Groot, Cornelis A. R.; Dijkstra, Frederika; van Gageldonk-Lafeber, Arianne B.; van Leuken, Jeroen P. G.; Wever, Peter C.; van der Hoek, Wim; Schneeberger, Peter M.			Characteristics of Hospitalized Acute Q Fever Patients during a Large Epidemic, The Netherlands	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; OUTBREAK; MORTALITY; HYPONATREMIA; ASSOCIATION; MANAGEMENT; IDENTIFY; FEATURES	Background: From 2007 to 2009, the Netherlands experienced a major Q fever epidemic, with higher hospitalization rates than the 2-5% reported in the literature for acute Q fever pneumonia and hepatitis. We describe epidemiological and clinical features of hospitalized acute Q fever patients and compared patients presenting with Q fever pneumonia with patients admitted for other forms of community-acquired pneumonia (CAP). We also examined whether proximity to infected ruminant farms was a risk factor for hospitalization. Methods: A retrospective cohort study was conducted for all patients diagnosed and hospitalized with acute Q fever between 2007 and 2009 in one general hospital situated in the high incidence area in the south of the Netherlands. Pneumonia severity scores (PSI and CURB-65) of acute Q fever pneumonia patients (defined as infiltrate on a chest x-ray) were compared with data from CAP patients. Hepatitis was defined as a. twofold the reference value for alanine aminotransferase and for bilirubin. Results: Among the 183 hospitalized acute Q fever patients, 86.0% had pneumonia. Elevated liver enzymes (alanine aminotransferase) were found in 32.3% of patients, although hepatitis was not observed in any of them. The most frequent clinical signs upon presentation were fever, cough and dyspnoea. The median duration of admission was five days. Acute Q fever pneumonia patients were younger, had less co-morbidity, and lower PSI and CURB-65 scores than other CAP patients. Anecdotal information from attending physicians suggests that some patients were admitted because of severe subjective dyspnoea, which was not included in the scoring systems. Proximity to an infected ruminant farm was not associated with hospitalization. Conclusion: Hospitalized Dutch acute Q fever patients mostly presented with fever and pneumonia. Patients with acute Q fever pneumonia were hospitalized despite low PSI and CURB-65 scores, presumably because subjective dyspnoea was not included in the scoring systems.	[Wielders, Cornelia C. H.; Wever, Peter C.; Schneeberger, Peter M.] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands; [Wielders, Cornelia C. H.; Wuister, Annemarie M. H.; Dijkstra, Frederika; van Gageldonk-Lafeber, Arianne B.; van Leuken, Jeroen P. G.; van der Hoek, Wim; Schneeberger, Peter M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Wuister, Annemarie M. H.; de Jager-Leclercq, Monique G.] Bernhoven Hosp, Dept Internal Med, Uden, Netherlands; [de Visser, Veerle L.] Jeroen Bosch Hosp, Dept Pulm Dis, Shertogenbosch, Netherlands; [Groot, Cornelis A. R.] Bernhoven Hosp, Dept Pulm Dis, Uden, Netherlands; [van Leuken, Jeroen P. G.] Univ Utrecht, Fac Vet Sci, Inst Risk Assessment Sci, Utrecht, Netherlands	Jeroen Bosch Ziekenhuis; Netherlands National Institute for Public Health & the Environment; Jeroen Bosch Ziekenhuis; Utrecht University	Wielders, CCH (corresponding author), Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands.	l.wielders@jbz.nl	Wielders, Cornelia CH/I-1970-2019; Dijkstra, Frederika/ABF-3865-2021	Wielders, Cornelia CH/0000-0002-2413-9088; Dijkstra, Frederika/0000-0003-0012-740X	Netherlands Organisation for Health Research and Development (ZonMw) [205520006]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by the Netherlands Organisation for Health Research and Development (ZonMw)(http://www.zonmw.nl/), grant number 205520006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; BERNARD E, 1994, EUR J CLIN MICROBIOL, V13, P658, DOI 10.1007/BF01973993; Bernit E, 2002, ARCH INTERN MED, V162, P693, DOI 10.1001/archinte.162.6.693; Caron F, 1998, CHEST, V114, P808, DOI 10.1378/chest.114.3.808; Comprehensive Cancer Centre the Netherlands, 2011, NETH CANC REG COMPR; Cunha BA, 2000, CLIN MICROBIOL INFEC, V6, P633, DOI 10.1046/j.1469-0691.2000.0194f.x; de Alarcon A, 2003, J INFECTION, V47, P110, DOI 10.1016/S0163-4453(03)00013-6; de Wit NCJ, 2009, CLIN CHEM LAB MED, V47, P1407, DOI 10.1515/CCLM.2009.307; Dijkstra F, 2011, EPIDEMIOL INFECT, V139, P1332, DOI 10.1017/S0950268810002621; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; DUPONT HT, 1992, AM J MED, V93, P427, DOI 10.1016/0002-9343(92)90173-9; Ergas D, 2006, ISR MED ASSOC J, V8, P337; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Fournier PE, 1998, J CLIN MICROBIOL, V36, P1823, DOI 10.1128/JCM.36.7.1823-1834.1998; Gilsdorf A, 2008, EPIDEMIOL INFECT, V136, P1084, DOI 10.1017/S0950268807009533; Gommer AM, 2011, BETTER HLTH DUTCH 20; Kampschreur LM, 2010, NETH J MED, V68, P408; Kampschreur LM, 2012, EMERG INFECT DIS, V18, P563, DOI 10.3201/eid1804.111478; Karagiannis I, 2009, EPIDEMIOL INFECT, V137, P1283, DOI 10.1017/S0950268808001908; Lai CH, 2008, SCAND J INFECT DIS, V40, P105, DOI 10.1080/00365540701558722; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Marrie TJ, 1996, J INFECT DIS, V173, P484, DOI 10.1093/infdis/173.2.484; MARRIE TJ, 1990, CAN VET J, V31, P555; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Medic S, 2012, EUROSURVEILLANCE, V17, P2; Nair V, 2007, AM J NEPHROL, V27, P184, DOI 10.1159/000100866; Oyston PCF, 2011, J MED MICROBIOL, V60, P9, DOI 10.1099/jmm.0.024778-0; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; Porten K, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-147; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Raoult D, 2000, MEDICINE, V79, P109, DOI 10.1097/00005792-200003000-00005; Schimmer B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-69; SMITH DL, 1993, RESP MED, V87, P509, DOI 10.1016/0954-6111(93)90006-L; Snijders BEP, 2013, PRIM CARE RESP J, V22, P400, DOI 10.4104/pcrj.2013.00085; SOBRADILLO V, 1989, EUR RESPIR J, V2, P263; Statistics Netherlands, 2013, HLTH LIF MED CONT RE; TIGERTT WD, 1961, BACTERIOL REV, V25, P285, DOI 10.1128/MMBR.25.3.285-293.1961; Van den Brom R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054021; van der Hoek W, 2010, EURO SURVEILL, P15; van der Hoek W, 2012, ADV EXP MED BIOL, V984, P329, DOI 10.1007/978-94-007-4315-1_17; van Gageldonk-Lafeber AB, 2013, NETH J MED, V71, P418; Vardi M, 2011, EUR J CLIN MICROBIOL, V30, P1527, DOI 10.1007/s10096-011-1255-5; Waikar SS, 2009, AM J MED, V122, P857, DOI 10.1016/j.amjmed.2009.01.027; Wald R, 2010, ARCH INTERN MED, V170, P294, DOI 10.1001/archinternmed.2009.513; Wegdam-Blans MCA, 2012, J INFECTION, V64, P247, DOI 10.1016/j.jinf.2011.12.014; Wielders CCH, 2013, J CLIN MICROBIOL, V51, P3192, DOI 10.1128/JCM.00993-13; Wielders CCH, 2013, EUR J CLIN INVEST, V43, P616, DOI 10.1111/eci.12073; Wiersinga WJ, 2012, NETH J MED, V70, P90; Zilberberg Marya D, 2008, BMC Pulm Med, V8, P16, DOI 10.1186/1471-2466-8-16	49	24	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91764	10.1371/journal.pone.0091764	http://dx.doi.org/10.1371/journal.pone.0091764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614585	gold, Green Published, Green Submitted			2022-12-27	WOS:000332839300155
J	Bantubani, N; Kabera, G; Connolly, C; Rustomjee, R; Reddy, T; Cohen, T; Pym, AS				Bantubani, Nonkqubela; Kabera, Gaetan; Connolly, Catherine; Rustomjee, Roxana; Reddy, Tarylee; Cohen, Ted; Pym, Alexander S.			High Rates of Potentially Infectious Tuberculosis and Multidrug-Resistant Tuberculosis (MDR-TB) among Hospital Inpatients in KwaZulu Natal, South Africa Indicate Risk of Nosocomial Transmission	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; OUTBREAK; AEROSOLS	Background: Nosocomial transmission has been implicated as a key factor in the outbreak of extensively drug resistant (XDR) and multidrug-resistant (MDR-TB) tuberculosis at Church of Scotland Hospital (CoSH), in KwaZulu-Natal (KZN), South Africa. The aim of this study was to quantify the burden of potentially infectious tuberculosis and the proportion of drug resistance among hospital inpatients throughout the province of KZN. Methods: Inpatients with current cough, capable of producing sputum were selected from 19 public hospitals in KZN. After informed consent, demographic and clinical data, and sputum samples were collected. Samples were processed for fluorescent microscopy, liquid culture and first and second-line anti-tuberculosis drug susceptibility testing. Results: There were a total of 2,964 inpatients where sampling was done. About 1,585 inpatients (53%) had a current cough and sufficient microbiological and clinical data for inclusion. Mycobacterium tuberculosis was isolated from 543 inpatients (34% of those tested and 18% of all inpatients). Eighty-four (15%) inpatients with TB were found to be MDR-TB infected and 16 (3%) had XDR-TB. There was no association between the prevalence of MDR-TB and proximity to CoSH. Among patients with microbiologically confirmed TB, MDR/XDR-TB was associated with male sex, a longer length of stay between hospital admission and date of sample collection, and current or previous TB treatment. Conclusions: One in five inpatients had potentially infectious TB. This is an underestimate since patients without current cough were not tested. MDR-TB was frequently observed and was found in nearly one in six active TB inpatients. While present at lower levels than the original outbreak report at CoSH, XDR-TB was detected in hospitals throughout KZN. The high burden of potentially infectious TB and confirmed MDR-TB, much of it undiagnosed, indicates a serious risk for nosocomial transmission and the need for intensified infection control within the inpatient setting.	[Bantubani, Nonkqubela; Kabera, Gaetan; Connolly, Catherine; Rustomjee, Roxana; Reddy, Tarylee; Pym, Alexander S.] MRC, TBRU, Durban, Kwazulu Natal, South Africa; [Cohen, Ted] Harvard Univ, Brigham & Womens Hosp, Div Global Hlth Equ, Sch Med, Boston, MA 02115 USA; [Pym, Alexander S.] KwaZulu Natal Res Inst TB & HIV Res K RITH, Nelson Mandela Sch Med, Durban, Kwazulu Natal, South Africa	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kwazulu Natal	Pym, AS (corresponding author), MRC, TBRU, Durban, Kwazulu Natal, South Africa.	alex.pym@k-rith.org		Cohen, Ted/0000-0002-8091-7198; Reddy, Tarylee/0000-0002-9521-2692; Pym, Alexander/0000-0002-6260-8180; Kabera, Gaetan/0000-0001-9320-1896	Centre for Diseases Control and Prevention through a cooperative agreement to the Medical Research Council of South Africa	Centre for Diseases Control and Prevention through a cooperative agreement to the Medical Research Council of South Africa	This study was funded by The Centre for Diseases Control and Prevention (www.cdc.gov) through a cooperative agreement to the Medical Research Council of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Africa NDoHS, 2009, NAT TUB MAN GUID; Alvarez GG, 2004, INT J TUBERC LUNG D, V8, P1472; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; Bradshaw D, 2003, SAMJ S AFR MED J, V93, P682; Breathnach AS, 1998, J HOSP INFECT, V39, P111, DOI 10.1016/S0195-6701(98)90324-3; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Fennelly KP, 2012, AM J RESP CRIT CARE, V186, P450, DOI 10.1164/rccm.201203-0444OC; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gullans C, 1992, CLIN MICROBIOLOGY PR; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, UNAIDSJC25021E; Jones-Lopez EC, 2013, AM J RESP CRIT CARE, V187, P1007, DOI 10.1164/rccm.201208-1422OC; Menzies D, 1997, INFECT CONT HOSP EP, V18, P582; National Department of Health Republic of South Africa, 2012, ANT SURV 2011 NAT AN; O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008; ROUILLON A, 1976, TUBERCLE, V57, P275, DOI 10.1016/S0041-3879(76)80006-2; Rullan JV, 1996, EMERG INFECT DIS, V2, P125, DOI 10.3201/eid0202.960208; Sacks LV, 1999, CLIN INFECT DIS, V29, P96, DOI 10.1086/520189; SHAW JB, 1954, AM REV TUBERC PULM, V69, P724; STROUD LA, 1995, INFECT CONT HOSP EP, V16, P141; Weyer K, 2007, SAMJ S AFR MED J, V97, P1120; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2009, WHO POL TB INF CONTR	24	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90868	10.1371/journal.pone.0090868	http://dx.doi.org/10.1371/journal.pone.0090868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625669	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300037
J	Boessenecker, RW; Perry, FA; Schmitt, JG				Boessenecker, Robert W.; Perry, Frank A.; Schmitt, James G.			Comparative Taphonomy, Taphofacies, and Bonebeds of the Mio-Pliocene Purisima Formation, Central California: Strong Physical Control on Marine Vertebrate Preservation in Shallow Marine Settings	PLOS ONE			English	Article							HELL-CREEK-FORMATION; SEQUENCE STRATIGRAPHY; CROSS-STRATIFICATION; WHALE; SEA; BONES; ASSEMBLAGE; TRANSPORT; DINOSAUR; ANATOMY	Background: Taphonomic study of marine vertebrate remains has traditionally focused on single skeletons, lagerstatten, or bonebed genesis with few attempts to document environmental gradients in preservation. As such, establishment of a concrete taphonomic model for shallow marine vertebrate assemblages is lacking. The Neogene Purisima Formation of Northern California, a richly fossiliferous unit recording nearshore to offshore depositional settings, offers a unique opportunity to examine preservational trends across these settings. Methodology/Principal Findings: Lithofacies analysis was conducted to place vertebrate fossils within a hydrodynamic and depositional environmental context. Taphonomic data including abrasion, fragmentation, phosphatization, articulation, polish, and biogenic bone modification were recorded for over 1000 vertebrate fossils of sharks, bony fish, birds, pinnipeds, odontocetes, mysticetes, sirenians, and land mammals. These data were used to compare both preservation of multiple taxa within a single lithofacies and preservation of individual taxa across lithofacies to document environmental gradients in preservation. Differential preservation between taxa indicates strong preservational bias within the Purisima Formation. Varying levels of abrasion, fragmentation, phosphatization, and articulation are strongly correlative with physical processes of sediment transport and sedimentation rate. Preservational characteristics were used to delineate four taphofacies corresponding to inner, middle, and outer shelf settings, and bonebeds. Application of sequence stratigraphic methods shows that bonebeds mark major stratigraphic discontinuities, while packages of rock between discontinuities consistently exhibit onshore-offshore changes in taphofacies. Conclusions/Significance: Changes in vertebrate preservation and bonebed character between lithofacies closely correspond to onshore-offshore changes in depositional setting, indicating that the dominant control of preservation is exerted by physical processes. The strong physical control on marine vertebrate preservation and preservational bias within the Purisima Formation has implications for paleoecologic and paleobiologic studies of marine vertebrates. Evidence of preservational bias among marine vertebrates suggests that careful consideration of taphonomic overprint must be undertaken before meaningful paleoecologic interpretations of shallow marine vertebrates is attempted.	[Boessenecker, Robert W.; Schmitt, James G.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Boessenecker, Robert W.] Univ Calif Berkeley, Univ Calif Museum Paleontol, Berkeley, CA 94720 USA; [Perry, Frank A.] Santa Cruz Museum Nat Hist, Santa Cruz, CA USA	Montana State University System; Montana State University Bozeman; University of California System; University of California Berkeley	Boessenecker, RW (corresponding author), Univ Otago, Dept Geol, Dunedin, New Zealand.	boessenecker@gmail.com			Geological Society of America; Sigma Xi; U. Otago doctoral scholarship	Geological Society of America; Sigma Xi; U. Otago doctoral scholarship	Funding sources included a graduate research grant from the Geological Society of America, and a Grant-in-aid of research from Sigma Xi. The lead author is currently supported by a U. Otago doctoral scholarship, which supported the writing of this paper (although the research was carried out beforehand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello IW, 2001, GEOLOGY, V29, P1111, DOI 10.1130/0091-7613(2001)029<1111:AAOOCS>2.0.CO;2; Aigner T., 1982, SENCKENB MARIT, V14, P183; ALLISON PA, 1988, PALAEONTOLOGY, V31, P1079; ALLISON PA, 1991, PALEOBIOLOGY, V17, P78, DOI 10.1017/S0094837300010368; Allulee JL, 2005, PALAIOS, V20, P518, DOI 10.2110/palo.2003.p03-120; Anderson GS, 2010, CURRENT CONCEPTS IN FORENSIC ENTOMOLOGY, P223, DOI 10.1007/978-1-4020-9684-6_12; Anderson GS, 2004, INT J LEGAL MED, V118, P206, DOI 10.1007/s00414-004-0447-2; [Anonymous], 2006, REEXAMINATION FACIES, DOI DOI 10.2110/PEC.06.84.0293; Antia D.D.J., 1979, Mercian Geologist, V7, P93; ARGAST S, 1987, GEOLOGY, V15, P927, DOI 10.1130/0091-7613(1987)15<927:TAOFRT>2.0.CO;2; AUBRY MP, 1991, J GEOPHYS RES-SOLID, V96, P6641, DOI 10.1029/90JB01204; BANDY O. L., 1955, CONTR CUSHMAN FOUND FORAMINIFERAL RES, V6, P77; Barnes L.G., 1985, Contributions in Science (Los Angeles), P1; BARNES LG, 1976, SYST ZOOL, V25, P321, DOI 10.2307/2412508; BARRON JA, 1986, PALAEOGEOGR PALAEOCL, V53, P27, DOI 10.1016/0031-0182(86)90037-4; Becker MA., 1998, SOUTHEAST GEOL, V37, P205; Becker MA, 2012, GEOSCIENCES, V2, P109, DOI 10.3390/geosciences2020109; Becker Martin A., 2002, Northeastern Geology and Environmental Sciences, V24, P282; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; Behrensmeyer Anna K., 1992, P15; Behrensmeyer Anna K., 2007, P65; Belaustegui Z, 2012, PALAEOGEOGR PALAEOCL, V323, P68, DOI 10.1016/j.palaeo.2012.01.031; Bentley SJ, 2003, SILTSTONES MUDSTONES, P35; Blob RW, 1996, PALEOBIOLOGY, V22, P422, DOI 10.1017/S0094837300016377; Boessenecker R, 2006, J VERTEBR PALEONTOL, V26, p43A; Boessenecker R, 2009, J VERTEBR PALEONTOL, V29, p66A; Boessenecker R, 2008, J VERTEBR PALEONTOL, V28, p54A; Boessenecker RW, 2013, GEODIVERSITAS, V35, P815, DOI 10.5252/g2013n4a5; Boessenecker RW, 2013, J PALEONTOL, V87, P657, DOI 10.1666/13-005; Boessenecker Robert W., 2011, PalArch's Journal of Vertebrate Palaeontology, V8, P1; Boessenecker RW, 2011, J VERTEBR PALEONTOL, V31, P652, DOI 10.1080/02724634.2011.562268; Boessenecker RW, 2011, PALAIOS, V26, P115, DOI 10.2110/palo.2010.p10-088r; Boessenecker RW, 2013, ACTA PALAEONTOLOGICA, P1; BOYLE S, 1997, FORENSIC TAPHONOMY P; BRETT C E, 1986, Palaios, V1, P207, DOI 10.2307/3514686; Brett Carlton E., 2003, Courier Forschungsinstitut Senckenberg, V242, P125; Brett CE, 1995, PALAIOS, V10, P597, DOI 10.2307/3515097; Cappetta H., 1987, HDB PALEOICHTHYOLO B, V3B; Clark J.C., 1978, CALIF DIV MINES GEOL, V136, P3; CLARK JC, 1981, US GEOLOGICAL SURVEY, V1168, P1; Cloud P.E., 1955, AAPG BULL, V39, P484; Cummings J. C., 1962, CALIFORNIA DIVISION, V181, P179; Dahlgren TG, 2006, CAH BIOL MAR, V47, P385; Danise S, 2014, RECORD FOSS IN PRESS; Davis PG, 1998, PALAIOS, V13, P3, DOI 10.2307/3515277; DEMERE TA, 1982, J PALEONTOL, V56, P1480; Dickinson W.R., 1987, CENOZOIC BASIN DEV C, VVI, P2; Domning DP., 1978, U CALIFORNIA PUBLICA, V118, P1; Dornbos SQ, 2011, TOP GEOBIOL, V32, P435, DOI 10.1007/978-90-481-8643-3_12; Dorsey RJ, 2000, GEOL SOC AM BULL, V112, P177, DOI 10.1130/0016-7606(2000)112<177:TAECOS>2.0.CO;2; DROSER M L, 1989, Palaios, V4, P598, DOI 10.2307/3514750; DUKE WL, 1991, GEOLOGY, V19, P625, DOI 10.1130/0091-7613(1991)019<0625:SSAHCS>2.3.CO;2; Dumas S, 2006, GEOLOGY, V34, P1073, DOI 10.1130/G22930A.1; DUMONT MP, 1986, MICROPALEONTOLOGY, V32, P372, DOI 10.2307/1485728; DURHAM J W, 1978, Proceedings of the California Academy of Sciences, V41, P297; EBBESMEYER CC, 1994, J FORENSIC SCI, V39, P231; Ekdale A.A., 1984, SOC EC PALEONTOL MIN; Everhart Michael J., 2006, Transactions of the Kansas Academy of Science, V109, P27, DOI 10.1660/0022-8443(2006)109[27:SDHCVF]2.0.CO;2; Everhart Michael J., 2003, Transactions of the Kansas Academy of Science, V106, P139, DOI 10.1660/0022-8443(2003)106[0139:FROPRI]2.0.CO;2; Everhart Michael J., 2004, Mosasaur, V7, P41; Fahlke JM, 2012, PALAEONTOL ELECTRON, V15, P1, DOI DOI 10.26879/341; FIORILLO A R, 1988, Contributions to Geology University of Wyoming, V26, P57; Follmi KB, 1996, EARTH-SCI REV, V40, P55, DOI 10.1016/0012-8252(95)00049-6; Friede K, 1987, FORMATION DEPOSITION; Galloway A.J., 1977, CALIFORNIA DIVISION, V202, P1; Glen W., 1959, Publications Dep Geol University California, V36, P147; Haehl HL, 1904, AM PHIL SOC P, V43, P16; HAGLUND WD, 1993, J FORENSIC SCI, V38, P806; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Higgs ND, 2012, HIST BIOL, V24, P269, DOI 10.1080/08912963.2011.621167; Ingle JC, 1979, GUIDEBOOK MIOCENE LI, P53; Irmis RB, 2006, PALAIOS, V21, P466, DOI 10.2110/palo.2005.P05-105R; Jacobsen AR, 2009, GEOL Q, V53, P373; Jones EG, 1998, P ROY SOC B-BIOL SCI, V265, P1119, DOI 10.1098/rspb.1998.0407; Jordan T.E., 1995, TECTONICS SEDIMENTAR, P331; KIDWELL S M, 1986, Palaios, V1, P228, DOI 10.2307/3514687; KIDWELL S M, 1991, Palaios, V6, P426, DOI 10.2307/3514967; KIDWELL SM, 1985, NATURE, V318, P457, DOI 10.1038/318457a0; KIDWELL SM, 1993, J GEOL SOC LONDON, V150, P165, DOI 10.1144/gsjgs.150.1.0165; KIDWELL SM, 1988, PALAEOGEOGR PALAEOCL, V63, P201, DOI 10.1016/0031-0182(88)90097-1; KIDWELL SM, 1993, GEOL RUNDSCH, V82, P189; Kiel S, 2013, PALAEONTOL Z, V87, P161, DOI 10.1007/s12542-012-0158-9; Koretsky IA, 2002, SM C PALEOB, P179; Laudet F, 2005, CR PALEVOL, V4, P203, DOI 10.1016/j.crpv.2004.11.010; Liebig PM, 2007, PALAIOS, V22, P384, DOI 10.2110/palo.2005.p05-052r; Liebig PM, 2003, PALAIOS, V18, P168, DOI 10.1669/0883-1351(2003)18<168:BOTBMM>2.0.CO;2; LONG DJ, 1995, EXPERIENTIA, V51, P85, DOI 10.1007/BF01964926; Lundsten L, 2010, DEEP-SEA RES PT I, V57, P1573, DOI 10.1016/j.dsr.2010.09.003; Macquaker J. H. S., 1996, GEOL SOC LOND SPEC P, V103, P97, DOI DOI 10.1144/GSL.SP.1996.103.01.07; MACQUAKER JHS, 1994, ZOOL J LINN SOC-LOND, V112, P285, DOI 10.1006/zjls.1994.1043; Macquaker JHS, 2010, GEOLOGY, V38, P947, DOI 10.1130/G31093.1; MADRID VM, 1986, EARTH PLANET SC LETT, V79, P431, DOI 10.1016/0012-821X(86)90198-6; Martill David M., 1993, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V2, P77; MARTILL DM, 1985, PHILOS T ROY SOC B, V311, P155, DOI 10.1098/rstb.1985.0147; MARTILL DM, 1999, FOSSILS RHAETIAN PEN, V9, P49; MEYER C A, 1991, Palaios, V6, P89, DOI 10.2307/3514956; Mikulas Radek, 2006, Ichnos, V13, P113, DOI 10.1080/10420940600850729; Morton R.A., 1988, GEOLOGICAL SOC AM SP, P7; MULLINS HT, 1985, ECON GEOL, V80, P696, DOI 10.2113/gsecongeo.80.3.696; Myrow PM, 2002, J SEDIMENT RES, V72, P641, DOI 10.1306/022102720641; Nations J.D., 1975, NATURAL HIST MUSEUM, V23, P1, DOI DOI 10.1080/14772000.2011.554457; Nilsen TH., 1995, TECTONICS SEDIMENTAR, P425; NORRIS R D, 1986, Palaios, V1, P256, DOI 10.2307/3514689; Perry F.A., 1977, FOSSILS SANTA CRUZ C; Perry FA, 1977, THESIS U CALIFORNIA; Perry I, 1989, THESIS U BRISTOL; Peters SE, 2009, PALAIOS, V24, P290, DOI 10.2110/palo.2008.p08-080r; Pobiner Briana, 2008, Journal of Taphonomy, V6, P373; Powell Charles L. II, 2007, U S Geological Survey Professional Paper, V1740, P1; POWELL II C. L., 1998, US GEOLOGIAL SURVEY, V98-594, P1; Pyenson ND, 2013, BIOL J LINN SOC, V108, P586, DOI 10.1111/j.1095-8312.2012.02032.x; Pyenson ND, 2009, GEOLOGY, V37, P519, DOI 10.1130/G25509A.1; Reif W.-E., 1976, ZENTRALBLATT GEOLOGI, V5, P252; Reif WE, 1982, CYCLIC EVENT STRATIF, P299; Repenning C. A., 1977, UNITED STATE GEOLOGI, V992, P1; RINE JM, 1985, J SEDIMENT PETROL, V55, P633; Rogers RM, 2007, AIAA EDUC SER, P1; Rogers RR, 2000, J GEOL, V108, P131, DOI 10.1086/314399; Rutty Guy N, 2007, Forensic Sci Med Pathol, V3, P57, DOI 10.1385/FSMP:3:1:57; SCHAFER W, 1972, ECOLOGY PALEOECOLOGY; Schroder-Adams CJ, 2001, PALAEOGEOGR PALAEOCL, V170, P261, DOI 10.1016/S0031-0182(01)00259-0; Seilacher A., 2007, TRACE FOSSIL ANAL; Shimada K, 1997, J PALEONTOL, V71, P926, DOI 10.1017/S002233600003585X; Smith CR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P286; Soares M. B., 2003, Geologica Acta, V1, P349; Sorg M. H., 1997, FORENSIC TAPHONOMY P; Spennemann D.H.R., 1992, INT J ANTHR, V7, P1, DOI [10.1007/BF02444991, DOI 10.1007/BF02444991]; SPEYER S E, 1986, Palaios, V1, P312, DOI 10.2307/3514694; SPEYER SE, 1988, PALAEOGEOGR PALAEOCL, V63, P225, DOI 10.1016/0031-0182(88)90098-3; Staron RM, 2001, PALAIOS, V16, P255, DOI 10.2307/3515603; Stojanowski CM, 2002, INT J OSTEOARCHAEOL, V12, P259, DOI 10.1002/oa.620; Suter J.R., 2006, SPECIAL PUBLICATION, V84, P339, DOI DOI 10.2110/PEC.06.84.0339; Tapanila L, 2008, PALAIOS, V23, P139, DOI 10.2110/palo.2006.p06-113r; Traykovski P, 2000, CONT SHELF RES, V20, P2113, DOI 10.1016/S0278-4343(00)00071-6; Trueman CN, 1997, GEOLOGY, V25, P263, DOI 10.1130/0091-7613(1997)025<0263:AGMTTT>2.3.CO;2; Uhen MD., 2004, U MICHIGAN PAP PALEO, V34, P1; Underwood CJ, 1999, P YORKS GEOL SOC, V52, P269, DOI 10.1144/pygs.52.3.269; Van Wagoner JC., 1990, AAPG METHODS EXPLORA, V7, P1; Varricchio DJ, 2001, J PALEONTOL, V75, P401, DOI 10.1666/0022-3360(2001)075<0401:GCFACT>2.0.CO;2; Walker R G, 1992, FACIES MODELS RESPON, P219; Walsh SA, 2006, J GEOL SOC LONDON, V163, P697, DOI 10.1144/0016-764920-135; Whitmore Frank C. Jr, 2008, Virginia Museum of Natural History Special Publication, V14, P141; Wilson LE, 2008, PALAIOS, V23, P289, DOI 10.2110/palo.2007.p07-006r	144	52	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91419	10.1371/journal.pone.0091419	http://dx.doi.org/10.1371/journal.pone.0091419			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626134	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300081
J	Caceres-Gorriti, KY; Carmona, E; Barres, V; Rahimi, K; Letourneau, IJ; Tonin, PN; Provencher, D; Mes-Masson, AM				Caceres-Gorriti, Katia Y.; Carmona, Euridice; Barres, Veronique; Rahimi, Kurosh; Letourneau, Isabelle J.; Tonin, Patricia N.; Provencher, Diane; Mes-Masson, Anne-Marie			RAN Nucleo-Cytoplasmic Transport and Mitotic Spindle Assembly Partners XPO7 and TPX2 Are New Prognostic Biomarkers in Serous Epithelial Ovarian Cancer	PLOS ONE			English	Article							BINDING PROTEIN; IMPORTIN-ALPHA; IDENTIFICATION; GTPASE; EXPRESSION; MITOSIS; CHROMOSOME; PACLITAXEL; APOPTOSIS; BIOLOGY	Purpose: Epithelial ovarian cancer has the highest mortality rate of all gynecological malignancies. We have shown that high RAN expression strongly correlates with high-grade and poor patient survival in epithelial ovarian cancer. However, as RAN is a small GTPase involved in two main biological functions, nucleo-cytoplasmic transport and mitosis, it is still unknown which of these functions associate with poor prognosis. Methods: To examine the biomarker value of RAN network components in serous epithelial ovarian cancer, protein expression of six specific RAN partners was analyzed by immunohistochemistry using a tissue microarray representing 143 patients associated with clinical parameters. The RAN GDP/GTP cycle was evaluated by the expression of RANBP1 and RCC1, the mitotic function by TPX2 and IMP beta, and the nucleo-cytoplasmic trafficking function by XPO7, XPOT and IMP beta. Results: Based on Kaplan-Meier analyses, RAN, cytoplasmic XPO7 and TPX2 were significantly associated with poor overall patient survival, and RAN and TPX2 were associated with lower disease free survival in patients with high-grade serous carcinoma. Cox regression analysis revealed that RAN and TPX2 expression were independent prognostic factors for both overall and disease free survival, and that cytoplasmic XPO7 expression was a prognostic factor for overall patient survival. Conclusions: In this systematic study, we show that RAN and two protein partners involved in its nucleo-cytoplasmic and mitotic functions (XPO7 and TPX2, respectively) can be used as biomarkers to stratify patients based on prognosis. In particular, we reported for the first time the clinical relevance of the exportin XPO7 and showed that TPX2 expression had the strongest prognostic value. These findings suggest that protein partners in each of RAN's functions can discriminate between different outcomes in high-grade serous epithelial ovarian cancer patients. Furthermore, these proteins point to cellular processes that may ultimately be targeted to improve the survival in serous epithelial ovarian cancer.	[Caceres-Gorriti, Katia Y.; Carmona, Euridice; Barres, Veronique; Letourneau, Isabelle J.; Provencher, Diane; Mes-Masson, Anne-Marie] CRCHUM, Montreal, PQ, Canada; [Caceres-Gorriti, Katia Y.; Carmona, Euridice; Barres, Veronique; Letourneau, Isabelle J.; Provencher, Diane; Mes-Masson, Anne-Marie] Inst Canc Montreal, Montreal, PQ, Canada; [Rahimi, Kurosh] CHUM, Dept Pathol, Montreal, PQ, Canada; [Tonin, Patricia N.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Tonin, Patricia N.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Tonin, Patricia N.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Provencher, Diane] Univ Montreal, Dept Obstet Gynecol, Montreal, PQ, Canada; [Provencher, Diane; Mes-Masson, Anne-Marie] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal	Mes-Masson, AM (corresponding author), CRCHUM, Montreal, PQ, Canada.	anne-marie.mes-masson@umontreal.ca		Mes-Masson, Anne-Marie/0000-0002-6498-266X	Canadian Institutes of Health Research (CIHR) (MOP) [36056]; Banque de tissus et donnees of the Reseau de recherche sur le cancer of the Fond de recherche du Quebec - Sante (FRQS); Carole Epstein Foundation; Canderel fund of the Institut du cancer de Montreal; FRQS postdoctoral training award; FRQS	Canadian Institutes of Health Research (CIHR) (MOP)(Canadian Institutes of Health Research (CIHR)); Banque de tissus et donnees of the Reseau de recherche sur le cancer of the Fond de recherche du Quebec - Sante (FRQS); Carole Epstein Foundation; Canderel fund of the Institut du cancer de Montreal; FRQS postdoctoral training award; FRQS	This work was supported by a grant (MOP #36056) from the Canadian Institutes of Health Research (CIHR) to A-MM-M, PNT and DP. Tumor banking was supported by the Banque de tissus et donnees of the Reseau de recherche sur le cancer of the Fond de recherche du Quebec - Sante (FRQS), associated with the Canadian Tumor Repository Network (CTRNet). KYC-G was supported in part by studentships from the Carole Epstein Foundation and the Canderel fund of the Institut du cancer de Montreal. IJL was supported by a FRQS postdoctoral training award. A-MM-M and DMP are researchers of the Centre de recherche du Centre hospitalier de l'Universite de Montreal (CRCHUM) and PNT is a researcher at the Research Institute of the McGill University Health Centre (MUHC), both of which receive support from the FRQS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Portoles C, 2012, CANCER RES, V72, P1518, DOI 10.1158/0008-5472.CAN-11-1971; Arts GJ, 1998, CURR BIOL, V8, P305, DOI 10.1016/S0960-9822(98)70130-7; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Azuma K, 2004, CLIN CANCER RES, V10, P6695, DOI 10.1158/1078-0432.CCR-04-0818; Barres V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-272; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Chen VW, 2003, CANCER, V97, P2631, DOI 10.1002/cncr.11345; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Colombo N, 2006, CRIT REV ONCOL HEMAT, V60, P159, DOI 10.1016/j.critrevonc.2006.03.004; Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5; DESOUZA PL, 1992, HEMATOL ONCOL CLIN N, V6, P761; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Etemadmoghadam D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015498; Fan H, 2012, INT J CLIN ONCOL; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Koch P, 2000, BIOCHEM BIOPH RES CO, V278, P241, DOI 10.1006/bbrc.2000.3788; Kurisetty VV, 2008, ONCOGENE, V27, P7139, DOI 10.1038/onc.2008.325; Kutay U, 1998, MOL CELL, V1, P359, DOI 10.1016/S1097-2765(00)80036-2; Kutay U, 2000, J BIOL CHEM, V275, P40163, DOI 10.1074/jbc.M006242200; Li H, 2006, ACTA BIOCH BIOPH SIN, V38, P900, DOI 10.1111/j.1745-7270.2006.00235.x; Ly TK, 2010, J BIOL CHEM, V285, P5815, DOI 10.1074/jbc.M109.071886; Ma Y, 2006, CLIN CANCER RES, V12, P1121, DOI 10.1158/1078-0432.CCR-05-1766; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Malpica A, 2008, INT J GYNECOL PATHOL, V27, P175, DOI 10.1097/PGP.0b013e31816085e0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; McGuire WP, 2009, J CLIN ONCOL, V27, P4633, DOI 10.1200/JCO.2009.23.6653; Mingot JM, 2004, EMBO J, V23, P3227, DOI 10.1038/sj.emboj.7600338; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; Ouellet V, 2005, ONCOGENE, V24, P4672, DOI 10.1038/sj.onc.1208214; Ouellet V, 2006, INT J CANCER, V119, P599, DOI 10.1002/ijc.21902; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Rensen WM, 2008, FRONT BIOSCI-LANDMRK, V13, P4097, DOI 10.2741/2996; Roscioli E, 2010, BIOCHEM SOC T, V38, P1709, DOI 10.1042/BST0381709; Scharer CD, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-79; Seidman JD, 2000, HUM PATHOL, V31, P539, DOI 10.1053/hp.2000.8048; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singer G, 2002, AM J PATHOL, V160, P1223, DOI 10.1016/S0002-9440(10)62549-7; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strom AC, 2001, GENOME BIOL, V2; Vainio P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039801; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Winter SF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002735; Woo IS, 2008, APOPTOSIS, V13, P1223, DOI 10.1007/s10495-008-0247-0; Xia F, 2008, CANCER RES, V68, P1826, DOI 10.1158/0008-5472.CAN-07-5279	50	32	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91000	10.1371/journal.pone.0091000	http://dx.doi.org/10.1371/journal.pone.0091000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625450	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300049
J	Rogers, SM; Turner, CF; Hobbs, M; Miller, WC; Tan, S; Roman, AM; Eggleston, E; Villarroel, MA; Ganapathi, L; Chromy, JR; Erbelding, E				Rogers, Susan M.; Turner, Charles F.; Hobbs, Marcia; Miller, William C.; Tan, Sylvia; Roman, Anthony M.; Eggleston, Elizabeth; Villarroel, Maria A.; Ganapathi, Laxminarayana; Chromy, James R.; Erbelding, Emily			Epidemiology of Undiagnosed Trichomoniasis in a Probability Sample of Urban Young Adults	PLOS ONE			English	Article							VAGINALIS INFECTION; T-ACASI; CHLAMYDIAL INFECTION; UNITED-STATES; DRUG-USE; PREVALENCE; RISK; HEALTH; IMPACT; WOMEN	T. vaginalis infection (trichomoniasis) is the most common curable sexually transmitted infection (STI) in the U. S. It is associated with increased HIV risk and adverse pregnancy outcomes. Trichomoniasis surveillance data do not exist for either national or local populations. The Monitoring STIs Survey Program (MSSP) collected survey data and specimens which were tested using nucleic acid amplification tests to monitor trichomoniasis and other STIs in 2006-09 among a probability sample of young adults (N = 2,936) in Baltimore, Maryland - an urban area with high rates of reported STIs. The estimated prevalence of trichomoniasis was 7.5% (95% CI 6.3, 9.1) in the overall population and 16.1% (95% CI 13.0, 19.8) among Black women. The overwhelming majority of infected men (98.5%) and women (73.3%) were asymptomatic. Infections were more common in both women (OR = 3.6, 95% CI 1.6, 8.2) and men (OR = 9.0, 95% CI 1.8, 44.3) with concurrent chlamydial infection. Trichomoniasis did not vary significantly by age for either men or women. Women with two or more partners in the past year and women with a history of personal or partner incarceration were more likely to have an infection. Overall, these results suggest that routine T vaginalis screening in populations at elevated risk of infection should be considered.	[Rogers, Susan M.; Turner, Charles F.; Tan, Sylvia; Eggleston, Elizabeth; Villarroel, Maria A.] Res Triangle Inst, Washington, DC 20037 USA; [Turner, Charles F.] CUNY Queens Coll, Program Data Analyt & Appl Social Res, Flushing, NY 11367 USA; [Turner, Charles F.] Grad Ctr, Flushing, NY USA; [Hobbs, Marcia; Miller, William C.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Hobbs, Marcia; Miller, William C.] Univ N Carolina, Gillings Sch Publ Hlth, Chapel Hill, NC USA; [Roman, Anthony M.] Univ Massachusetts, Survey Res Ctr, Boston, MA 02125 USA; [Villarroel, Maria A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Ganapathi, Laxminarayana] Res Triangle Inst, Res Comp Div, Res Triangle Pk, NC 27709 USA; [Chromy, James R.] Res Triangle Inst, Stat & Epidemiol Div, Res Triangle Pk, NC 27709 USA; [Erbelding, Emily] Johns Hopkins Bayview Med Ctr, Div Infect Dis, Baltimore, MD USA	Research Triangle Institute; City University of New York (CUNY) System; Queens College NY (CUNY); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Massachusetts System; University of Massachusetts Boston; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Research Triangle Institute; Research Triangle Institute; Johns Hopkins University; Johns Hopkins Medicine	Rogers, SM (corresponding author), Res Triangle Inst, Washington, DC 20037 USA.	smr@rti.org	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827; Tan, Sylvia Margaret/0000-0002-2987-0072; Ganapathi, Laxminarayana/0000-0001-8751-3797	National Institute of Child Health and Human Development [HD047163]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047163] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from the National Institute of Child Health and Human Development [HD047163]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsworth JE, 2009, SEX TRANSM DIS, V36, P738, DOI 10.1097/OLQ.0b013e3181b38a4b; [Anonymous], ASS REPR PUBL OP SUR; Bachmann LH, 2011, CLIN INFECT DIS, V53, pS160, DOI 10.1093/cid/cir705; Biener L, 2004, AM J PREV MED, V27, P254, DOI 10.1016/j.amepre.2004.05.006; *CDCP, 2007, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention, 2011, SEX TRANSM DIS SURV; Cooley PC, 1998, COMPUT HUM BEHAV, V14, P195, DOI 10.1016/S0747-5632(98)00001-6; Cooley PC, 2000, COMPUT HUM BEHAV, V16, P1, DOI 10.1016/S0747-5632(99)00048-5; Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008; Field N, 2012, J MED ETHICS, V38, P380, DOI 10.1136/medethics-2011-100068; Genesys, 1996, METH NOT LIST HOUS S; Gribble JN, 2000, SUBST USE MISUSE, V35, P869, DOI 10.3109/10826080009148425; Helms DJ, 2008, SEX TRANSM DIS, V35, P484, DOI 10.1097/OLQ.0b013e3181644b9c; Huppert JS, 2007, CLIN INFECT DIS, V45, P194, DOI 10.1086/518851; Ku L, 2002, AM J PUBLIC HEALTH, V92, P1140, DOI 10.2105/AJPH.92.7.1140; Mavedzenge SN, 2010, SEX TRANSM DIS, V37, P460, DOI 10.1097/OLQ.0b013e3181cfcc4b; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; Miller WC, 2005, SEX TRANSM DIS, V32, P593, DOI 10.1097/01.olq.0000179874.76360.ad; Roman AM, 2008, P 2008 JOINT STAT M; Roth AM, 2011, SEX TRANSM DIS, V38, P398, DOI 10.1097/OLQ.0b013e318203e3ce; Schwebke JR, 2002, SEX TRANSM INFECT, V78, P378, DOI 10.1136/sti.78.5.378; StataCorp, 2011, STAT STAT SOFTW REL; Stekler J, 2005, CLIN INFECT DIS, V40, P787, DOI 10.1086/428043; Sutton M, 2007, CLIN INFECT DIS, V45, P1319, DOI 10.1086/522532; Turner CF, 2005, ADDICTION, V100, P1432, DOI 10.1111/j.1360-0443.2005.01196.x; Turner CF, 2002, JAMA-J AM MED ASSOC, V287, P726, DOI 10.1001/jama.287.6.726; U.S. Bureau of the Census, 2006, AM COMM SURV; Van Der Pol B, 2005, J INFECT DIS, V192, P2039, DOI 10.1086/498217; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496; Van der Pol B, 2007, CLIN INFECT DIS, V44, P23, DOI 10.1086/509934; Villarroel MA, 2008, SEX TRANSM DIS, V35, P499, DOI 10.1097/OLQ.0b013e318165925a; Villarroel MA, 2006, PUBLIC OPIN QUART, V70, P166, DOI 10.1093/poq/nfj023; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x; Zenilman JM, 2003, SEX TRANSM INFECT, V79, P94, DOI 10.1136/sti.79.2.94	34	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90548	10.1371/journal.pone.0090548	http://dx.doi.org/10.1371/journal.pone.0090548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9JS	24626058	Green Published, gold			2022-12-27	WOS:000332851300025
J	Carvalho, R; Buzna, L; Bono, F; Masera, M; Arrowsmith, DK; Helbing, D				Carvalho, Rui; Buzna, Lubos; Bono, Flavio; Masera, Marcelo; Arrowsmith, David K.; Helbing, Dirk			Resilience of Natural Gas Networks during Conflicts, Crises and Disruptions	PLOS ONE			English	Article							INTERDEPENDENT NETWORKS; SYSTEMS; SCIENCE	Human conflict, geopolitical crises, terrorist attacks, and natural disasters can turn large parts of energy distribution networks offline. Europe's current gas supply network is largely dependent on deliveries from Russia and North Africa, creating vulnerabilities to social and political instabilities. During crises, less delivery may mean greater congestion, as the pipeline network is used in ways it has not been designed for. Given the importance of the security of natural gas supply, we develop a model to handle network congestion on various geographical scales. We offer a resilient response strategy to energy shortages and quantify its effectiveness for a variety of relevant scenarios. In essence, Europe's gas supply can be made robust even to major supply disruptions, if a fair distribution strategy is applied.	[Carvalho, Rui; Arrowsmith, David K.] Queen Mary Univ London, Sch Math Sci, London, England; [Buzna, Lubos] Univ Zilina, Zilina, Slovakia; [Bono, Flavio] Commiss European Communities, Joint Res Ctr, IPSC, European Lab Struct Assessment, I-21020 Ispra, VA, Italy; [Masera, Marcelo] Joint Res Ctr, Inst Energy & Transport, Energy Secur Unit, Petten, Netherlands; [Helbing, Dirk] ETH, Zurich, Switzerland; [Helbing, Dirk] ETH, Swiss Fed Inst Technol, Risk Ctr, Zurich, Switzerland	University of London; Queen Mary University London; University of Zilina; European Commission Joint Research Centre; EC JRC ISPRA Site; European Commission Joint Research Centre; EC JRC Institute for Energy & Transport (IET); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Carvalho, R (corresponding author), Queen Mary Univ London, Sch Math Sci, London, England.	r.carvalho@qmul.ac.uk	Carvalho, Rui/C-4095-2009; Buzna, Lubos/A-1147-2010	Buzna, Lubos/0000-0002-5410-6762; Carvalho, Rui/0000-0002-3279-4218	Engineering and Physical Sciences Research Council [EP/H04812X/1]; APVV [APVV-0760-11]; VEGA [1/0339/13]; EPSRC [EP/H04812X/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); APVV(Slovak Research and Development Agency); VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council under grant number EP/H04812X/1, by APVV (project APVV-0760-11) and by VEGA (project 1/0339/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmone-Marsan M, 2012, EUR PHYS J-SPEC TOP, V214, P547, DOI 10.1140/epjst/e2012-01705-1; [Anonymous], 2009, ECONOMIST; Bertsimas D, 2011, OPER RES, V59, P17, DOI 10.1287/opre.1100.0865; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Brummitt CD, 2012, P NATL ACAD SCI USA, V109, pE680, DOI 10.1073/pnas.1110586109; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Carvalho R, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046101; Chiang M, 2007, P IEEE, V95, P255, DOI 10.1109/JPROC.2006.887322; Chrisafis Angelique, 2013, GUARDIAN; Clark WC, 2003, P NATL ACAD SCI USA, V100, P8059, DOI 10.1073/pnas.1231333100; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Energy and Environmental Analysis, 2005, TECHNICAL REPORT; Frischmann Brett, 2012, INFRASTRUCTURE SOCIA; Havlin S, 2012, EUR PHYS J-SPEC TOP, V214, P273, DOI 10.1140/epjst/e2012-01695-x; Helbing D, 2013, NATURE, V497, P51, DOI 10.1038/nature12047; Hunt S., 2002, MAKING COMPETITION W; International Energy Agency, 2012, NAT GAS INF; Kelly F, 1997, EUR T TELECOMMUN, V8, P33, DOI 10.1002/ett.4460080106; Kelly F, 2011, NEXT GENERATION INTE; Kelly FP, 1998, J OPER RES SOC, V49, P237, DOI 10.2307/3010473; Kirschen D., 2018, FUNDAMENTALS POWER S, V2nd ed.; Lempert RJ, 2002, P NATL ACAD SCI USA, V99, P7309, DOI 10.1073/pnas.082081699; Levi M., 2013, POWER SURGE ENERGY O; Levin S., 2013, NOT AM MATH SOC, V60, P392; Lochner S, 2011, ENERGY, V36, P2483, DOI 10.1016/j.energy.2011.01.040; Moniz E., 2011, TECHNICAL REPORT; Mouawad J., 2005, NY TIMES; Plimmer G, 2013, FINANCIAL TIMES; Quattrociocchi W, 2013, ARXIV13053450; Schiermeier Q, 2013, NATURE, V496, P156, DOI 10.1038/496156a; Srikant R., 2004, MATH INTERNET CONGES; Voropai NI, 2012, ENERGY, V42, P3, DOI 10.1016/j.energy.2011.07.038; Wright S, 2012, ECONOMIST; Yergin D., 2012, FOREIGN POLICY	36	38	40	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90265	10.1371/journal.pone.0090265	http://dx.doi.org/10.1371/journal.pone.0090265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621655	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000332845300018
J	Shen, TC; Lin, CL; Chen, CH; Tu, CY; Hsia, TC; Shih, CM; Hsu, WH; Chang, YJ				Shen, Te-Chun; Lin, Cheng-Li; Chen, Chia-Hung; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei; Chang, Yen-Jung			Increased Risk of Chronic Obstructive Pulmonary Disease in Patients with Systemic Lupus Erythematosus: A Population-Based Cohort Study	PLOS ONE			English	Article							CIGARETTE-SMOKE; RHEUMATOID-ARTHRITIS; INDUCED EMPHYSEMA; COPD PATIENTS; AUTOIMMUNITY; AUTOANTIBODIES; INFLAMMATION; ASSOCIATION; NONSMOKERS; EXPRESSION	Background: There is increasing evidence that autoimmune disease is associated with development of chronic obstructive pulmonary disease (COPD). We aim to assess the relationship between systemic lupus erythematosus (SLE) and COPD risk in a nationwide population. Methods: We conducted a retrospective cohort study using the catastrophic illness registry of the Taiwan National Health Insurance Research Database (NHIRD). We identified 10,623 patients with SLE newly diagnosed between 2000 and 2010. Each patient was randomly frequency-matched with four people without SLE on age, sex, and index year from the general population. Both cohorts were followed up until the end of 2010 to measure the incidence of COPD. The risk of COPD was analyzed using Cox proportional hazards regression models including age, sex, index year and comorbidities. Results: The overall incidence rate of COPD was 1.73-fold higher in the SLE cohort than in the control cohort (17.4 vs. 10.1 per 10,000 person-years, 95% CI = 1.62-1.84). Age related analysis showed increased incidence of COPD with age in both SLE and control cohorts. However, adjusted HR maximum was observed in the youngest age group (adjusted HR: 4.33, 95% CI, 2.39-7.85) while adjusted HR minimum was witnessed in the oldest age group (adjusted HR: 1.19, 95% CI, 0.85-1.22). Conclusion: Patients with SLE have a significant risk of developing COPD than the control population. Based on the findings from this study, it can be hypothesized that in addition to cigarette smoke SLE may be a determining factor for COPD incidence. However, further investigation is needed to corroborate this hypothesis.	[Shen, Te-Chun; Chen, Chia-Hung; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei] China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan; [Shen, Te-Chun; Chen, Chia-Hung; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei] China Med Univ, Taichung, Taiwan; [Shen, Te-Chun] Chu Shang Show Chwan Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Nantou, Taiwan; [Lin, Cheng-Li] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chang, Yen-Jung] Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Taiwan Normal University	Hsia, TC (corresponding author), China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan.	derrick.hsia@msa.hinet.net; yjchang2012@gmail.com		Shen, Te-Chun/0000-0002-9427-1068	Taiwan Department of Health Clinical Trial and Research Center and for Excellence [DOH102-TD-B-111-004]; Taiwan Department of Health Cancer Research Center for Excellence [DOH102-TD-C-111-005]	Taiwan Department of Health Clinical Trial and Research Center and for Excellence; Taiwan Department of Health Cancer Research Center for Excellence	This work was supported by Taiwan Department of Health Clinical Trial and Research Center and for Excellence (DOH102-TD-B-111-004) and Taiwan Department of Health Cancer Research Center for Excellence (DOH102-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Bengtsson AA, 2002, RHEUMATOLOGY, V41, P563, DOI 10.1093/rheumatology/41.5.563; Bieber V, 2013, IMMUNOL RES, V56, P261, DOI 10.1007/s12026-013-8395-x; Birring SS, 2002, AM J RESP CRIT CARE, V166, P1078, DOI 10.1164/rccm.200203-245OC; Carmi G, 2011, ISR MED ASSOC J, V13, P121; Cheng TM, 2009, 6 COUNTRIES 6 REFORM, P171, DOI [10.1142/9789814261593_000710, 1142/9789814261593_0007, DOI 10.1142/9789814261593_0007]; Cooper GS, 2001, J RHEUMATOL, V28, P2653; Drenkard C, 2013, SEMIN ARTHRITIS RHEU, V43, P209, DOI 10.1016/j.semarthrit.2013.04.003; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; FESSEL WJ, 1988, RHEUM DIS CLIN N AM, V14, P15; Freemer MM, 2006, ANN RHEUM DIS, V65, P581, DOI 10.1136/ard.2005.039438; Hagstad S, 2012, RESP MED, V106, P980, DOI 10.1016/j.rmed.2012.03.010; Karayama M, 2010, CHEST, V138, P1303, DOI 10.1378/chest.10-0863; Kirkham PA, 2011, AM J RESP CRIT CARE, V184, P796, DOI 10.1164/rccm.201010-1605OC; Kuo YB, 2010, IMMUNOL LETT, V128, P131, DOI 10.1016/j.imlet.2009.12.017; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Leidinger P, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-20; MacRedmond RE, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-84; Majka DS, 2006, ANN RHEUM DIS, V65, P561, DOI 10.1136/ard.2005.046052; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Nunez B, 2011, AM J RESP CRIT CARE, V183, P1025, DOI 10.1164/rccm.201001-0029OC; Packard TA, 2013, IMMUNOL RES, V55, P48, DOI 10.1007/s12026-012-8347-x; Petri M, 2001, ARTHRITIS RHEUM, V44, pS331; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Rajendrasozhan S, 2008, ANTIOXID REDOX SIGN, V10, P799, DOI 10.1089/ars.2007.1938; REIDENBERG MM, 1993, ARTHRITIS RHEUM, V36, P971, DOI 10.1002/art.1780360714; Shen TC, 2014, QJM; Shen TC, 2014, AM J RESP CRIT CARE, V189, P496, DOI 10.1164/rccm.201310-1792LE; Suzuki M, 2008, INHAL TOXICOL, V20, P349, DOI 10.1080/08958370701866412 ; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; VERMEULEN A, 1993, ENVIRON HEALTH PERSP, V101, P91, DOI 10.2307/3431381; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Yeh KW, 2013, RHEUMATOL INT, V33, P1805, DOI 10.1007/s00296-012-2643-6; Zifman E, 2008, AUTOIMMUN REV, V8, P165, DOI 10.1016/j.autrev.2008.06.011	34	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91821	10.1371/journal.pone.0091821	http://dx.doi.org/10.1371/journal.pone.0091821			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622340	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300131
J	Lu, WZ; Yang, SC; Chen, LZ; Wang, WQ; Du, XN; Wang, CM; Ma, Y; Lin, GX; Lin, GH				Lu, Weizhi; Yang, Shengchang; Chen, Luzhen; Wang, Wenqing; Du, Xiaona; Wang, Canmou; Ma, Yan; Lin, Guangxuan; Lin, Guanghui			Changes in Carbon Pool and Stand Structure of a Native Subtropical Mangrove Forest after Inter-Planting with Exotic Species Sonneratia apetala	PLOS ONE			English	Article							INVASION; SEQUESTRATION; CONSERVATION; PLANTATIONS; RESTORATION; LITTERFALL; WORLD	In this study, we compared stand structure, biomass and soil carbon pools, and litterfall production between a mixed mangrove forest consisting of Aegiceras corniculatum inter-planted with the exotic Sonneratia apetala and a native monospecific forest dominated by A. corniculatum in the intertidal area of Zhanjiang, Guangdong Province, southeast China. The goal of this study was to test the hypothesis that inter-planting fast growing exotic mangrove S. apetala into subtropical native mangrove forests will significantly increase C sequestration. Although the tree heights and basal diameters of S. apetala were significantly higher than those of A. corniculatum, the density of the 12-year-old S. apetala trees in the mixed forest was much smaller than that of A. corniculatum in the monospecific forest. In contrast to several previous studies on S. apetala forests planted directly on mangrove-free mudflats, the mixed mangrove forest showed no significant difference in either standing biomass or soil carbon pools from the native monospecific mangrove forest (p = 0.294 and 0.073, respectively) twelve years after inter-planting with S. apetala. Moreover, carbon cycling was likely speeded up after inter-planting S. apetala due to higher litterfall input and lower C/N ratio. Thus, inter-planting fast-growing S. apetala into native mangrove forest is not an effective way to increase carbon sequestration in this subtropical mangrove forest. Given that exotic plant species may exert negative impact on native mangrove species and related epifauna, this fast-growing mangrove species is not suitable for mangrove plantation projects aiming mainly at enhancing carbon sequestration.	[Lu, Weizhi; Yang, Shengchang; Chen, Luzhen; Wang, Wenqing; Du, Xiaona; Wang, Canmou; Ma, Yan] Xiamen Univ, Sch Life Sci, Minist Educ Coastal & Wetland Ecosyst, Key Lab, Xiamen, Fujian, Peoples R China; [Lu, Weizhi; Lin, Guanghui] Tsinghua Univ, Grad Sch Shenzhen, Div Marine Sci & Technol, Shenzhen 518057, Guangdong, Peoples R China; [Lin, Guangxuan] Adm Bur Zhanjiang Natl Mangrove Nat Reserve, Zhanjiang, Guangdong, Peoples R China; [Lin, Guanghui] Tsinghua Univ, Ctr Earth Syst Sci, Key Lab Earth Syst Modeling, Minist Educ, Beijing 100084, Peoples R China	Xiamen University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Tsinghua University	Lin, GH (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Div Marine Sci & Technol, Shenzhen 518057, Guangdong, Peoples R China.	lingh@mail.tsinghua.edu.cn			National Natural Science Foundation of China [30930017]; Ministry of Science and Techology, China [2013CB556601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Techology, China	This study was supported financially by National Natural Science Foundation of China (30930017) and by National Key Basic Research Program (or 973 program) of Ministry of Science and Techology, China (2013CB556601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2012, CARBON MANAG, V3, P313, DOI [10.4155/CMT.12.20, 10.4155/cmt.12.20]; Alongi DM, 2011, ENVIRON SCI POLICY, V14, P462, DOI 10.1016/j.envsci.2011.02.004; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Barbier EB, 2006, FRONT ECOL ENVIRON, V4, P124, DOI 10.1890/1540-9295(2006)004[0124:NBTNDR]2.0.CO;2; Bosire JO, 2008, AQUAT BOT, V89, P251, DOI 10.1016/j.aquabot.2008.03.010; Bouillon S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003052; Cai Li-zhe, 2012, Yingyong Shengtai Xuebao, V23, P965; Chang SE, 2006, EARTHQ SPECTRA, V22, pS863, DOI 10.1193/1.2201971; Chen LZ, 2012, FOREST ECOL MANAG, V284, P222, DOI 10.1016/j.foreco.2012.06.058; Chen LZ, 2009, J PLANT ECOL, V2, P45, DOI 10.1093/jpe/rtp009; CLARKE PJ, 1994, AUST J BOT, V42, P37, DOI 10.1071/BT9940037; Craft C, 2003, ECOL APPL, V13, P1417, DOI 10.1890/02-5086; Dassonville N, 2007, ECOSCIENCE, V14, P230, DOI 10.2980/1195-6860(2007)14[230:IBFJIT]2.0.CO;2; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Finzi AC, 2006, ECOLOGY, V87, P15, DOI 10.1890/04-1748; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Gong P, 2010, SCI CHINA EARTH SCI, V53, P1036, DOI 10.1007/s11430-010-4002-3; Han WeiDong, 2001, Journal of Forestry Research, V12, P229, DOI 10.1007/BF02856712; Irving AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018311; Larson DL, 2001, ECOL APPL, V11, P128, DOI 10.1890/1051-0761(2001)011[0128:APIIMG]2.0.CO;2; Li DJ, 2012, NEW PHYTOL, V195, P172, DOI 10.1111/j.1469-8137.2012.04150.x; Liao W.B., 1990, J FOREST RES, P47; Lin P, 1990, J XIAMEN U NATURAL S, V29, P209; Lin P, 1985, J XIAMEN U NATURAL S, V24, P508; Lin P, 1990, ACTA PHYTOECOLOGICA, V14, P69; Lindsay EA, 2005, J APPL ECOL, V42, P556, DOI 10.1111/j.1365-2664.2005.01036.x; Lu C.Y., 1988, J XIAMEN UNIV-NAT SC, V27, P459; Luo YQ, 2006, ECOLOGY, V87, P3, DOI 10.1890/05-0923; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Metz ORDB, 2007, CLIMATE CHANGE 2007; Miao S.Y., 1998, GUIHAIA, V18, P16; Moriya H, 1986, BIOL SYSTEM MANGROVE, P123; Ordonez A, 2010, FUNCT ECOL, V24, P1353, DOI 10.1111/j.1365-2435.2010.01739.x; Ren H, 2008, ECOL RES, V23, P401, DOI 10.1007/s11284-007-0393-9; Ren H, 2010, PLANT SOIL, V327, P279, DOI 10.1007/s11104-009-0053-7; Ren H, 2009, ECOL ENG, V35, P1243, DOI 10.1016/j.ecoleng.2009.05.008; Sathirathai S, 2001, CONTEMP ECON POLICY, V19, P109, DOI 10.1093/cep/19.2.109; Walters BB, 2008, AQUAT BOT, V89, P220, DOI 10.1016/j.aquabot.2008.02.009; Yee S, 2010, REDD BLUE CARBON CAR; ZAN QJ, 2001, J WUHAN BOT RES, V15, P391; [张乔民 Zhang Qiaomin], 2003, [生态学报, Acta Ecologica Sinica], V23, P1977; ZHENG FZ, 2000, J XIAMEN U, V39, P693	44	27	28	10	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91238	10.1371/journal.pone.0091238	http://dx.doi.org/10.1371/journal.pone.0091238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618793	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400062
J	Ong, KJ; MacCormack, TJ; Clark, RJ; Ede, JD; Ortega, VA; Felix, LC; Dang, MKM; Ma, GB; Fenniri, H; Veinot, JGC; Goss, GG				Ong, Kimberly J.; MacCormack, Tyson J.; Clark, Rhett J.; Ede, James D.; Ortega, Van A.; Felix, Lindsey C.; Dang, Michael K. M.; Ma, Guibin; Fenniri, Hicham; Veinot, Jonathan G. C.; Goss, Greg G.			Widespread Nanoparticle-Assay Interference: Implications for Nanotoxicity Testing	PLOS ONE			English	Article							WALLED CARBON NANOTUBES; A549 LUNG-CELLS; IN-VITRO; OPTICAL-PROPERTIES; VIABILITY ASSAYS; TOXICITY; SIZE; NANOMATERIALS; CYTOTOXICITY; ACID	The evaluation of engineered nanomaterial safety has been hindered by conflicting reports demonstrating differential degrees of toxicity with the same nanoparticles. The unique properties of these materials increase the likelihood that they will interfere with analytical techniques, which may contribute to this phenomenon. We tested the potential for: 1) nanoparticle intrinsic fluorescence/absorbance, 2) interactions between nanoparticles and assay components, and 3) the effects of adding both nanoparticles and analytes to an assay, to interfere with the accurate assessment of toxicity. Silicon, cadmium selenide, titanium dioxide, and helical rosette nanotubes each affected at least one of the six assays tested, resulting in either substantial over-or under-estimations of toxicity. Simulation of realistic assay conditions revealed that interference could not be predicted solely by interactions between nanoparticles and assay components. Moreover, the nature and degree of interference cannot be predicted solely based on our current understanding of nanomaterial behaviour. A literature survey indicated that ca. 95% of papers from 2010 using biochemical techniques to assess nanotoxicity did not account for potential interference of nanoparticles, and this number had not substantially improved in 2012. We provide guidance on avoiding and/or controlling for such interference to improve the accuracy of nanotoxicity assessments.	[Ong, Kimberly J.; MacCormack, Tyson J.; Ede, James D.; Ortega, Van A.; Felix, Lindsey C.; Goss, Greg G.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [MacCormack, Tyson J.] Mt Allison Univ, Dept Chem & Biochem, Sackville, NB E0A 3C0, Canada; [Clark, Rhett J.; Dang, Michael K. M.; Ma, Guibin; Fenniri, Hicham; Veinot, Jonathan G. C.] Univ Alberta, Dept Chem, Edmonton, AB, Canada; [Fenniri, Hicham] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada; [Fenniri, Hicham] Natl Inst Nanotechnol, Edmonton, AB, Canada	University of Alberta; Mount Allison University; University of Alberta; University of Alberta; National Research Council Canada	Ong, KJ (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	kjong@ualberta.ca; greg.goss@ualberta.ca	MacCormack, Tyson/AAJ-8920-2021; Goss, Greg/D-2723-2015; Felix, Lindsey/O-5638-2016	Goss, Greg/0000-0003-0786-8868; Felix, Lindsey/0000-0001-7335-9792; MacCormack, Tyson/0000-0002-6080-9413	NNBNI Initiative [RES0002319]; Environment Canada; NRC; NSERC; NSERC PDF	NNBNI Initiative; Environment Canada(CGIAR); NRC(National Research Centre (NRC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC PDF(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the NNBNI Initiative (Grant #RES0002319), Environment Canada, and NRC. K.J.O. and J.D.E. were supported by both NSERC Vanier and Alberta Innovates Graduate Student Scholarships, V.A.O. was supported by an NSERC graduate student scholarship, and T.J.M. was supported by an NSERC PDF scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asuri P, 2006, CURR OPIN BIOTECH, V17, P562, DOI 10.1016/j.copbio.2006.09.002; Bailey RE, 2003, J AM CHEM SOC, V125, P7100, DOI 10.1021/ja035000o; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Casals E, 2010, ACS NANO, V4, P3623, DOI 10.1021/nn901372t; Casey A, 2008, TOXICOL LETT, V179, P78, DOI 10.1016/j.toxlet.2008.04.006; Casey A, 2007, CARBON, V45, P1425, DOI 10.1016/j.carbon.2007.03.033; Clark RJ, 2010, LANGMUIR, V26, P15657, DOI 10.1021/la102983c; Davoren M, 2007, TOXICOL IN VITRO, V21, P438, DOI 10.1016/j.tiv.2006.10.007; Doak SH, 2009, MUTAGENESIS, V24, P285, DOI 10.1093/mutage/gep010; Dobrovoiskaia MA, 2008, NANO LETT, V8, P2180, DOI 10.1021/nl0805615; Fei L, 2009, INT J MOL SCI, V10, P646, DOI 10.3390/ijms10020646; Fenniri H, 2002, P NATL ACAD SCI USA, V99, P6487, DOI 10.1073/pnas.032527099; Han XL, 2011, TOXICOLOGY, V287, P99, DOI 10.1016/j.tox.2011.06.011; Hedderman TG, 2004, J PHYS CHEM B, V108, P18860, DOI 10.1021/jp0491481; Hessel CM, 2007, J PHYS CHEM C, V111, P6956, DOI 10.1021/jp070908c; Hikosaka K, 2008, COLLOID SURFACE B, V66, P195, DOI 10.1016/j.colsurfb.2008.06.008; Hoet PH, 2013, NANO TODAY, V8, P223, DOI 10.1016/j.nantod.2013.01.001; Holder AL, 2012, CHEM RES TOXICOL, V25, P1885, DOI 10.1021/tx3001708; Huang XH, 2005, J PHOTOCH PHOTOBIO B, V81, P76, DOI 10.1016/j.jphotobiol.2005.05.010; Kane RS, 2007, BIOTECHNOL PROGR, V23, P316, DOI 10.1021/bp060388n; Karajanagi SS, 2004, LANGMUIR, V20, P11594, DOI 10.1021/la047994h; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Kroll A, 2012, ARCH TOXICOL, V86, P1123, DOI 10.1007/s00204-012-0837-z; Kuhnel D, 2009, AQUAT TOXICOL, V93, P91, DOI 10.1016/j.aquatox.2009.04.003; Lim SI, 2009, ACCOUNTS CHEM RES, V42, P798, DOI 10.1021/ar8002688; Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001; Love SA, 2012, ANNU REV ANAL CHEM, V5, P181, DOI 10.1146/annurev-anchem-062011-143134; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I, 2008, NANO TODAY, V3, P40, DOI 10.1016/S1748-0132(08)70014-8; Ma S, 2013, ENVIRON SCI-PROC IMP, V15, P145, DOI 10.1039/c2em30637a; Maccormack TJ, 2012, NANOTOXICOLOGY, V6, P514, DOI 10.3109/17435390.2011.587904; Mallick K, 2006, MATER CHEM PHYS, V97, P283, DOI 10.1016/j.matchemphys.2005.08.011; Manokaran S, 2010, BBA-PROTEINS PROTEOM, V1804, P1376, DOI 10.1016/j.bbapap.2010.02.014; Marquis BJ, 2009, ANALYST, V134, P425, DOI 10.1039/b818082b; Monteiro-Riviere NA, 2009, TOXICOL APPL PHARM, V234, P222, DOI 10.1016/j.taap.2008.09.030; Monteiro-Riviere NA, 2006, CARBON, V44, P1070, DOI 10.1016/j.carbon.2005.11.004; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Pfaller T, 2010, NANOTOXICOLOGY, V4, P52, DOI 10.3109/17435390903374001; Ramakrishna G, 2001, J PHYS CHEM B, V105, P7000, DOI 10.1021/jp011291g; Stone V, 2009, CRIT REV TOXICOL, V39, P613, DOI 10.1080/10408440903120975; Stueker O, 2014, SMALL IN PRESS, DOI [10.1002/smll.201303639, DOI 10.1002/SMLL.201303639]; Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c; Yang SK, 2009, J PHYS CHEM C, V113, P6480, DOI 10.1021/jp810787d; Zhong P, 2006, TALANTA, V70, P902, DOI 10.1016/j.talanta.2006.03.015; Zhong WW, 2009, ANAL BIOANAL CHEM, V394, P47, DOI 10.1007/s00216-009-2643-x; Zhu Y, 2009, CARBON, V47, P1351, DOI 10.1016/j.carbon.2009.01.026	46	191	191	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90650	10.1371/journal.pone.0090650	http://dx.doi.org/10.1371/journal.pone.0090650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618833	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400023
J	Purves-Tyson, TD; Owens, SJ; Double, KL; Desai, R; Handelsman, DJ; Weickert, CS				Purves-Tyson, Tertia D.; Owens, Samantha J.; Double, Kay L.; Desai, Reena; Handelsman, David J.; Weickert, Cynthia Shannon			Testosterone Induces Molecular Changes in Dopamine Signaling Pathway Molecules in the Adolescent Male Rat Nigrostriatal Pathway	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; MALE SPRAGUE-DAWLEY; SUBSTANTIA-NIGRA; SEX-DIFFERENCES; BRAIN-FUNCTION; MESSENGER-RNA; SCHIZOPHRENIA; ANDROGEN; NEURONS; TRANSPORTER	Adolescent males have an increased risk of developing schizophrenia, implicating testosterone in the precipitation of dopamine-related psychopathology. Evidence from adult rodent brain indicates that testosterone can modulate nigrostriatal dopamine. However, studies are required to understand the role testosterone plays in maturation of dopamine pathways during adolescence and to elucidate the molecular mechanism(s) by which testosterone exerts its effects. We hypothesized that molecular indices of dopamine neurotransmission [synthesis (tyrosine hydroxylase), breakdown (catechol-O-methyl transferase; monoamine oxygenase), transport [vesicular monoamine transporter (VMAT), dopamine transporter (DAT)] and receptors (DRD1-D5)] would be changed by testosterone or its metabolites, dihydrotestosterone and 17 beta-estradiol, in the nigrostriatal pathway of adolescent male rats. We found that testosterone and dihydrotestosterone increased DAT and VMAT mRNAs in the substantia nigra and that testosterone increased DAT protein at the region of the cell bodies, but not in target regions in the striatum. Dopamine receptor D2 mRNA was increased and D3 mRNA was decreased in substantia nigra and/or striatum by androgens. These data suggest that increased testosterone at adolescence may change dopamine responsivity of the nigrostriatal pathway by modulating, at a molecular level, the capacity of neurons to transport and respond to dopamine. Further, dopamine turnover was increased in the dorsal striatum following gonadectomy and this was prevented by testosterone replacement. Gene expression changes in the dopaminergic cell body region may serve to modulate both dendritic dopamine feedback inhibition and reuptake in the dopaminergic somatodendritic field as well as dopamine release and re-uptake dynamics at the presynaptic terminals in the striatum. These testosterone-induced changes of molecular indices of dopamine neurotransmission in males are primarily androgen receptor-driven events as estradiol had minimal effect. We conclude that nigrostriatal responsivity to dopamine may be modulated by testosterone acting via androgen receptors to alter gene expression of molecules involved in dopamine signaling during adolescence.	[Purves-Tyson, Tertia D.; Owens, Samantha J.; Weickert, Cynthia Shannon] Schizophrenia Res Inst, Sydney, NSW, Australia; [Purves-Tyson, Tertia D.; Owens, Samantha J.; Weickert, Cynthia Shannon] Neurosci Res Australia, Schizophrenia Res Lab, Sydney, NSW, Australia; [Double, Kay L.] Univ Sydney, Sydney Med Sch, Sch Med Sci, Discipline Biomed Sci, Sydney, NSW 2006, Australia; [Purves-Tyson, Tertia D.; Owens, Samantha J.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Desai, Reena; Handelsman, David J.] Univ Sydney, Concord Hosp, ANZAC Res Inst, Concord, NSW, Australia; [Weickert, Cynthia Shannon] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia	Neuroscience Research Australia; University of Sydney; University of New South Wales Sydney; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of New South Wales Sydney	Weickert, CS (corresponding author), Schizophrenia Res Inst, Sydney, NSW, Australia.	c.weickert@neura.edu.au	Purves-Tyson, Tertia D/C-9799-2011; Research Institute, ANZAC/CAE-9030-2022; Double, Kay/AAX-7902-2021; Ekanayake, Kanchana/P-8817-2016; Handelsman, David/AAR-9580-2021	Purves-Tyson, Tertia D/0000-0003-2401-4266; Double, Kay/0000-0001-8712-7781; Handelsman, David/0000-0002-4200-7476; Shannon Weickert, Cynthia/0000-0002-4560-0259	Schizophrenia Research Institute; NSW Ministry of Health; Macquarie Group Foundation; University of New South Wales; Neuroscience Research Australia; NHMRC [1020981]; NHMRC (Australia) [1021970, 401101]	Schizophrenia Research Institute; NSW Ministry of Health; Macquarie Group Foundation; University of New South Wales; Neuroscience Research Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	CSW and the Schizophrenia Research Laboratory are supported by the Schizophrenia Research Institute (utilizing infrastructure funding from the NSW Ministry of Health and the Macquarie Group Foundation), the University of New South Wales, and Neuroscience Research Australia. This study was supported by an NH&MRC Project Grant to CSW and KLD (#1020981). CSW is the recipient of a NH&MRC (Australia) Research Fellowship (#1021970). KLD is the recipient of a NH&MRC (Australia) Senior Research Fellowship (#401101). (http://www.nhmrc.gov.au/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; ABREU P, 1988, NEUROSCI LETT, V95, P213, DOI 10.1016/0304-3940(88)90659-3; Akil M, 2003, J NEUROSCI, V23, P2008; ALBURGES ME, 1993, BIOMED CHROMATOGR, V7, P306, DOI 10.1002/bmc.1130070605; Aleman A, 2003, ARCH GEN PSYCHIAT, V60, P565, DOI 10.1001/archpsyc.60.6.565; Allan CM, 2010, ENDOCRINOLOGY, V151, P2800, DOI 10.1210/en.2009-1477; Aubele T, 2011, CEREB CORTEX, V21, P222, DOI 10.1093/cercor/bhq083; Bai YY, 2011, ENDOCRINOLOGY, V152, P1562, DOI 10.1210/en.2010-1042; BEATTY WW, 1982, PHARMACOL BIOCHEM BE, V16, P565, DOI 10.1016/0091-3057(82)90416-6; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; Birgner C, 2008, BRAIN RES, V1219, P103, DOI 10.1016/j.brainres.2008.05.014; Blystone CR, 2007, TOXICOL SCI, V97, P65, DOI 10.1093/toxsci/kfm004; CELOTTI F, 1992, FRONT NEUROENDOCRIN, V13, P163; Ciliax BJ, 1999, J COMP NEUROL, V409, P38, DOI 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1; DLUZEN DE, 1989, J NEUROENDOCRINOL, V1, P285, DOI 10.1111/j.1365-2826.1989.tb00117.x; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Glatt SJ, 2006, AM J MED GENET B, V141B, P149, DOI 10.1002/ajmg.b.30273; Glatt SJ, 2003, MOL PSYCHIATR, V8, P911, DOI 10.1038/sj.mp.4001321; Handa RJ, 2008, HORM BEHAV, V53, P741, DOI 10.1016/j.yhbeh.2007.09.012; Harwood DT, 2009, CLIN CHIM ACTA, V409, P78, DOI 10.1016/j.cca.2009.09.003; Hermans EJ, 2010, NEUROIMAGE, V52, P277, DOI 10.1016/j.neuroimage.2010.04.019; Hersch SM, 1997, J COMP NEUROL, V388, P211; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Huck S.W., 2009, STAT MISCONCEPTIONS; Johnson ML, 2010, J NEUROENDOCRINOL, V22, P238, DOI 10.1111/j.1365-2826.2010.01965.x; Kegeles LS, 2010, ARCH GEN PSYCHIAT, V67, P231, DOI 10.1001/archgenpsychiatry.2010.10; Kindlundh AMS, 2004, NEUROSCI LETT, V356, P131, DOI 10.1016/j.neulet.2003.11.040; KONTUR P, 1984, J NEUROSCI METH, V11, P5, DOI 10.1016/0165-0270(84)90003-7; KORENBROT CC, 1977, BIOL REPROD, V17, P298, DOI 10.1095/biolreprod17.2.298; Kritzer MF, 2008, J NEUROSCI, V28, P9525, DOI 10.1523/JNEUROSCI.2637-08.2008; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; Laruelle M, 1999, BIOL PSYCHIAT, V46, P56, DOI 10.1016/S0006-3223(99)00067-0; Leung A, 2000, ACTA PSYCHIAT SCAND, V101, P3; Lewis EM, 2002, DRUG CHEM TOXICOL, V25, P437, DOI 10.1081/DCT-120014794; Markham JA, 2012, REV ENDOCR METAB DIS, V13, P187, DOI 10.1007/s11154-011-9184-2; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; McGrath J, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-13; McNamara KM, 2010, J STEROID BIOCHEM, V121, P611, DOI 10.1016/j.jsbmb.2010.02.001; Meyers B, 2010, NEUROSCIENCE, V165, P850, DOI 10.1016/j.neuroscience.2009.11.013; Morris RW, 2010, PSYCHONEUROENDOCRINO, V35, P896, DOI 10.1016/j.psyneuen.2009.12.002; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; Nirenberg MJ, 1996, J NEUROSCI, V16, P4135; Noriega NC, 2009, TOXICOL SCI, V111, P163, DOI 10.1093/toxsci/kfp129; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Perez SE, 2003, DEV BRAIN RES, V145, P117, DOI 10.1016/S0165-3806(03)00223-2; Purves-Tyson TD, 2007, NEUROSCIENCE, V148, P92, DOI 10.1016/j.neuroscience.2007.05.043; Purves-Tyson TD, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-95; Ravizza T, 2003, NEUROSCI LETT, V338, P57, DOI 10.1016/S0304-3940(02)01317-4; SAKSENA SK, 1979, EXP AGING RES, V5, P179, DOI 10.1080/03610737908257197; Seeman P, 2006, EXPERT OPIN THER TAR, V10, P515, DOI 10.1517/14728222.10.4.515; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Silva MAD, 2009, EUR NEUROPSYCHOPHARM, V19, P53, DOI 10.1016/j.euroneuro.2008.08.003; Simons CJ, 2012, SCHIZOPHR B; SINGH J, 1995, ENDOCRINOLOGY, V136, P5311, DOI 10.1210/en.136.12.5311; Thiblin I, 1999, BRIT J PHARMACOL, V126, P1301, DOI 10.1038/sj.bjp.0702412; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walker DM, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102798; Walker QD, 2001, NEUROPSYCHOPHARMACOL, V25, P118, DOI 10.1016/S0893-133X(00)00248-7; Weickert CS, 2008, HUM MOL GENET, V17, P2293, DOI 10.1093/hmg/ddn130; Weickert CS, 2010, AUST NZ J PSYCHIAT, V44, P59, DOI 10.3109/00048670903393662; Wood RI, 2008, FRONT NEUROENDOCRIN, V29, P490, DOI 10.1016/j.yfrne.2007.12.002	63	55	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91151	10.1371/journal.pone.0091151	http://dx.doi.org/10.1371/journal.pone.0091151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618531	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400051
J	Wang, X; Wang, XH; Liu, T; He, QW; Wang, YP; Zhang, XH				Wang, Xiao; Wang, Xinghuan; Liu, Tao; He, Qianwen; Wang, Yipeng; Zhang, Xinhua			Systematic Review and Meta-Analysis of the Use of Phosphodiesterase Type 5 Inhibitors for Treatment of Erectile Dysfunction following Bilateral Nerve-Sparing Radical Prostatectomy	PLOS ONE			English	Review							RETROPUBIC PROSTATECTOMY; PENILE REHABILITATION; SILDENAFIL CITRATE; POSTRADICAL PROSTATECTOMY; SEXUAL FUNCTION; DOUBLE-BLIND; EFFICACY; CANCER; RECOVERY; SAFETY	Prostate cancer is relatively common cancer occurring in males. Radical prostatectomy (RP) is the most effective treatment for a localized tumor but erectile dysfunction (ED) is common complication, even when bilateral nerve-sparing RP (BNSRP) is performed. Clinical trials have shown varied effectiveness of phosphodiesterase type-5 inhibitors (PDE5-Is) for treatment of post-BNSRP ED, but there remains controversy over the application of this treatment and no formal systematic review and meta-analysis for the use of PDE5-Is for this condition has been conducted. This review was to systematically assess the efficacy and safety of oral PDE5-Is for post-BNSRP ED. A database search was conducted to identify randomized controlled trials (RCTs). The comparative efficacy of treatments was analyzed by fixed or random effect modeling. Erectile function was measured using the International Index of Erectile Function (IIEF), Sexual Encounter Profile (SEP) question-2, 3 and the Global Assessment Question (GAQ). The rate and incidence of adverse events (AEs) were determined. The quality of included studies was appraised using the Cochrane Collaboration bias appraisal tool. Eight RCTs were included in the analyses. PDE5-Is were effective for treating post-BNSRP ED compared to placebo when erectile function was determined using the IIEF score [mean difference (MD) 5.63, 95% confidence interval (CI) (4.26-6.99)], SEP-2 [relative risk (RR) 1.63, 95% CI (1.18-2.25)], SEP-3 [RR 2.00, 95% CI (1.27-3.15)] and GAQ [RR 3.35, 95% CI (2.68-4.67)]. The subgroup analysis could find a trend that longer treatment duration, higher dosage, on-demand dosing, sildenafil and mild ED are associated with more responsiveness to PDE5-Is. PDE5-Is were overall well tolerated with headache being the most commonly reported AE. Our data provides compelling evidence for the use of PDE5-Is as a primary treatment for post-BNSRP ED. However, further studies are required to optomize usage parameters (such as dosage and duration of treatment).	[Wang, Xiao; Wang, Xinghuan; Liu, Tao; Zhang, Xinhua] Wuhan Univ, Zhongnan Hosp, Dept Urol, Wuhan, Hubei Province, Peoples R China; [He, Qianwen] Wuhan Univ, Zhongnan Hosp, Dept Cardiol, Wuhan, Hubei Province, Peoples R China; [Wang, Yipeng] Wuhan Univ, Zhongnan Hosp, Dept Anesthesiol, Wuhan, Hubei Province, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Wang, XH (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Urol, Wuhan, Hubei Province, Peoples R China.	wangxinhuan1965@gmail.com; zxhmd2000@yahoo.com	Wang, Xinghuan/AAB-3192-2021	Wang, Xinghuan/0000-0003-3497-0024	National Natural Science Foundation of China [81270843]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	X.H.Z. is supported by National Natural Science Foundation of China (N.81270843). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydogdu O, 2011, INT BRAZ J UROL, V37, P336, DOI 10.1590/S1677-55382011000300007; Bannowsky A, 2008, BJU INT, V101, P1279, DOI 10.1111/j.1464-410X.2008.07515.x; Borlaug BA, 2005, CIRCULATION, V112, P2642, DOI 10.1161/CIRCULATIONAHA.105.540500; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Briganti A, 2006, NAT CLIN PRACT UROL, V3, P400, DOI 10.1038/ncpuro0555; Brock G, 2003, J UROLOGY, V170, P1278, DOI 10.1097/01.ju.0000086947.00547.49; Burnett AL, 2007, J UROLOGY, V178, P597, DOI 10.1016/j.juro.2007.03.140; Candy B, 2008, BJU INT, V102, P426, DOI 10.1111/j.1464-410X.2008.07668.x; CATALONA WJ, 1993, J UROLOGY, V150, P905, DOI 10.1016/S0022-5347(17)35645-8; Cavallini G, 2005, UROLOGY, V66, P1080, DOI 10.1016/j.urology.2005.05.014; GEARY ES, 1995, J UROLOGY, V154, P145, DOI 10.1016/S0022-5347(01)67251-3; Giuliano F, 2008, J SEX MED, V5, P448, DOI 10.1111/j.1743-6109.2007.00670.x; Hatzichristou D, 2004, EUR UROL, V45, P634, DOI 10.1016/j.eururo.2004.01.014; Hatzimouratidis K, 2007, EUR UROL, V51, P75, DOI 10.1016/j.eururo.2006.07.020; Jackson G, 2004, J SEX MED, V1, P161, DOI 10.1111/j.1743-6109.2004.04024.x; Klein LT, 1997, J UROLOGY, V158, P626, DOI 10.1016/S0022-5347(01)64572-5; Kundu SD, 2004, J UROLOGY, V172, P2227, DOI 10.1097/01.ju.0000145222.94455.73; Lee Richard, 2002, Semin Urol Oncol, V20, P63, DOI 10.1053/suro.2002.30400; Magheli A, 2009, NAT REV UROL, V6, P415, DOI 10.1038/nrurol.2009.126; Montorsi F, 2005, J SEX MED, V2, P658, DOI 10.1111/j.1743-6109.2005.00117.x; Montorsi F, 2004, J UROLOGY, V172, P1036, DOI 10.1097/01.ju.0000136448.71773.2b; Montorsi F, 1997, J UROLOGY, V158, P1408, DOI 10.1016/S0022-5347(01)64227-7; Montorsi F, 2008, EUR UROL, V54, P924, DOI 10.1016/j.eururo.2008.06.083; Mulhall J P, 1996, Int J Impot Res, V8, P91; Mulhall JP, 2013, J UROLOGY, V189, P2229, DOI 10.1016/j.juro.2012.11.177; Mulhall John P, 2009, Curr Urol Rep, V10, P219; Padma-Nathan H, 2008, INT J IMPOT RES, V20, P479, DOI 10.1038/ijir.2008.33; Padma-Nathan H, 2002, UROLOGY, V60, P67, DOI 10.1016/S0090-4295(02)01752-1; QUINLAN DM, 1991, J UROLOGY, V145, P998, DOI 10.1016/S0022-5347(17)38512-9; Rabbani F, 2000, J UROLOGY, V164, P1929, DOI 10.1016/S0022-5347(05)66921-2; Raina R, 2008, INT J IMPOT RES, V20, P121, DOI 10.1038/sj.ijir.3901573; Rambhatla A, 2008, INT J IMPOT RES, V20, P30, DOI 10.1038/sj.ijir.3901588; Stephenson RA, 2005, J UROLOGY, V174, P646, DOI 10.1097/01.ju.0000165342.85300.14; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Tutolo M, 2012, THER ADV UROL, V4, P347, DOI 10.1177/1756287212450063; User HM, 2003, J UROLOGY, V169, P1175, DOI 10.1097/01.ju.0000048974.47461.50; WALSH PC, 1987, UROL CLIN N AM, V14, P663; Wang R, 2007, J SEX MED, V4, P1085, DOI 10.1111/j.1743-6109.2007.00482.x; Zippe C D, 2001, Curr Urol Rep, V2, P495, DOI 10.1007/s11934-001-0045-5; Zippe CD, 2007, UROL CLIN N AM, V34, P601, DOI 10.1016/j.ucl.2007.08.012	40	27	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91327	10.1371/journal.pone.0091327	http://dx.doi.org/10.1371/journal.pone.0091327			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618671	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400076
J	Yoshimura, H; Iwasaki, S; Nishio, S; Kumakawa, K; Tono, T; Kobayashi, Y; Sato, H; Nagai, K; Ishikawa, K; Ikezono, T; Naito, Y; Fukushima, K; Oshikawa, C; Kimitsuki, T; Nakanishi, H; Usami, S				Yoshimura, Hidekane; Iwasaki, Satoshi; Nishio, Shin-ya; Kumakawa, Kozo; Tono, Tetsuya; Kobayashi, Yumiko; Sato, Hiroaki; Nagai, Kyoko; Ishikawa, Kotaro; Ikezono, Tetsuo; Naito, Yasushi; Fukushima, Kunihiro; Oshikawa, Chie; Kimitsuki, Takashi; Nakanishi, Hiroshi; Usami, Shin-ichi			Massively Parallel DNA Sequencing Facilitates Diagnosis of Patients with Usher Syndrome Type 1	PLOS ONE			English	Article							SYNDROME TYPE-I; GENE; MUTATIONS; JAPANESE; VARIANTS; PCDH15; LOCUS; MAPS	Usher syndrome is an autosomal recessive disorder manifesting hearing loss, retinitis pigmentosa and vestibular dysfunction, and having three clinical subtypes. Usher syndrome type 1 is the most severe subtype due to its profound hearing loss, lack of vestibular responses, and retinitis pigmentosa that appears in prepuberty. Six of the corresponding genes have been identified, making early diagnosis through DNA testing possible, with many immediate and several long-term advantages for patients and their families. However, the conventional genetic techniques, such as direct sequence analysis, are both time-consuming and expensive. Targeted exon sequencing of selected genes using the massively parallel DNA sequencing technology will potentially enable us to systematically tackle previously intractable monogenic disorders and improve molecular diagnosis. Using this technique combined with direct sequence analysis, we screened 17 unrelated Usher syndrome type 1 patients and detected probable pathogenic variants in the 16 of them (94.1%) who carried at least one mutation. Seven patients had the MYO7A mutation (41.2%), which is the most common type in Japanese. Most of the mutations were detected by only the massively parallel DNA sequencing. We report here four patients, who had probable pathogenic mutations in two different Usher syndrome type 1 genes, and one case of MYO7A/PCDH15 digenic inheritance. This is the first report of Usher syndrome mutation analysis using massively parallel DNA sequencing and the frequency of Usher syndrome type 1 genes in Japanese. Mutation screening using this technique has the power to quickly identify mutations of many causative genes while maintaining cost-benefit performance. In addition, the simultaneous mutation analysis of large numbers of genes is useful for detecting mutations in different genes that are possibly disease modifiers or of digenic inheritance.	[Yoshimura, Hidekane; Nishio, Shin-ya; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan; [Iwasaki, Satoshi] Shinshu Univ, Sch Med, Dept Hearing Implant Sci, Matsumoto, Nagano 390, Japan; [Iwasaki, Satoshi] Int Univ Hlth & Welf, Mita Hosp, Dept Otorhinolaryngol, Minato Ku, Tokyo, Japan; [Kumakawa, Kozo] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Dept Otolaryngol, Minato Ku, Tokyo, Japan; [Tono, Tetsuya] Miyazaki Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Miyazaki, Japan; [Kobayashi, Yumiko; Sato, Hiroaki] Iwate Med Univ, Dept Otolaryngol Head & Neck Surg, Morioka, Iwate 020, Japan; [Nagai, Kyoko] Gunma Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Maebashi, Gunma 371, Japan; [Ishikawa, Kotaro] Natl Rehabil Ctr Persons Disabil, Dept Otolaryngol, Tokorozawa, Saitama, Japan; [Ikezono, Tetsuo] Saitama Med Univ, Dept Otolaryngol, Moroyama, Saitama, Japan; [Naito, Yasushi] Gen Hosp, Kobe City Med Ctr, Dept Otolaryngol, Kobe, Hyougo, Japan; [Fukushima, Kunihiro] Okayama Univ, Postgrad Sch Med Dent & Pharmaceut Sci, Dept Otorhinolaryngol Head & Neck Surg, Okayama 7008530, Japan; [Oshikawa, Chie] Kyushu Univ, Grad Sch Med Sci, Dept Otorhinolaryngol, Fukuoka 812, Japan; [Kimitsuki, Takashi] Kyushu Cent Hosp, Dept Otorhinolaryngol, Fukuoka, Japan; [Nakanishi, Hiroshi] Hamamatsu Univ Sch Med, Dept Otorhinolaryngol, Hamamatsu, Shizuoka 4313192, Japan	Shinshu University; Shinshu University; International University of Health & Welfare; Toranomon Hospital; University of Miyazaki; Iwate Medical University; Gunma University; Saitama Medical University; Kobe City Medical Center General Hospital; Okayama University; Kyushu University; Hamamatsu University School of Medicine	Usami, S (corresponding author), Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan.	usami@shinshu-u.ac.jp		Nishio, Shin-ya/0000-0001-6640-2297	Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Science and Culture of Japan	Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare of Japan (S. U.), and by a Grant-in-Aid for Scientific Research from the (then) Ministry of Education, Science and Culture of Japan (http://www.mext.go.jp/english/) (S. U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Aller E, 2010, MOL VIS, V16, P495; Ben-Yosef T, 2003, NEW ENGL J MED, V348, P1664, DOI 10.1056/NEJMoa021502; Bonnet C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-21; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Ebermann I, 2010, J CLIN INVEST, V120, P1812, DOI 10.1172/JCI39715; Eudy JD, 1998, GENOMICS, V50, P382, DOI 10.1006/geno.1998.5345; Jaworek TJ, 2012, J HUM GENET, V57, P633, DOI 10.1038/jhg.2012.79; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; Kimberling WJ, 2010, GENET MED, V12, P512, DOI 10.1097/GIM.0b013e3181e5afb8; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Miyagawa M, 2013, PLOS ONE; Mustapha M, 2002, HUM GENET, V110, P348, DOI 10.1007/s00439-002-0690-x; Nakanishi H, 2011, J HUM GENET, V56, P484, DOI 10.1038/jhg.2011.45; Nakanishi H, 2010, J HUM GENET, V55, P796, DOI 10.1038/jhg.2010.115; Ouyang XM, 2005, HUM GENET, V116, P292, DOI 10.1007/s00439-004-1227-2; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Stabej PL, 2012, J MED GENET, V49, P27, DOI 10.1136/jmedgenet-2011-100468; Usami SI, 2008, ACTA OTO-LARYNGOL, V128, P446, DOI 10.1080/00016480701785046; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Yan D, 2010, J HUM GENET, V55, P327, DOI 10.1038/jhg.2010.29	26	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90688	10.1371/journal.pone.0090688	http://dx.doi.org/10.1371/journal.pone.0090688			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618850	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400025
J	Li, ZH; Li, W; Shi, JL; Tang, MK				Li, Ze-Hui; Li, Wei; Shi, Jin-Li; Tang, Min-Ke			Nardosinone Improves the Proliferation, Migration and Selective Differentiation of Mouse Embryonic Neural Stem Cells	PLOS ONE			English	Article							PROGENITOR PROLIFERATION; PROTEIN; SURVIVAL; ASSAY	In this study, we investigated the impact of Nardosinone, a bioactive component in Nardostachys root, on the proliferation and differentiation of neural stem cells. The neural stem cells were isolated from cerebrums of embryonic day 14 CD1 mice. The proliferation of cells was monitored using the cell counting kit-8 assay, bromodeoxyuridine incorporation and cell cycle analysis. Cell migration and differentiation were investigated with the neurosphere assay and cell specific markers, respectively. The results showed that Nardosinone promotes cells proliferation and increases cells migration distance in a dose-dependent manner. Nardosinone also induces the selective differentiation of neural stem cells to neurons and oligodendrocytes, as indicated by the expression of microtubule-associated protein-2 and myelin basic protein, respectively. Nardosinone also increases the expression of phospho-extracellular signal-regulated kinase and phospho-cAMP response element binding protein during proliferation and differentiation. In conclusion, this study reveals the regulatory effects of Nardosinone on neural stem cells, which may have significant implications for the treatment of brain injury and neurodegenerative diseases.	[Li, Ze-Hui] Univ Toledo, Coll Med, Dept Biomed Sci, Toledo, OH 43606 USA; [Li, Ze-Hui; Li, Wei; Shi, Jin-Li; Tang, Min-Ke] Beijing Univ Chinese Med, Dept Pharmacol, Beijing, Peoples R China	University System of Ohio; University of Toledo; Beijing University of Chinese Medicine	Tang, MK (corresponding author), Beijing Univ Chinese Med, Dept Pharmacol, Beijing, Peoples R China.	tangmk@bucm.edu.cn			Program for New Century Excellent Talents of the Ministry of Education of China; National Natural Science Foundation of China [30772763]	Program for New Century Excellent Talents of the Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Program for New Century Excellent Talents of the Ministry of Education of China (2010) and the National Natural Science Foundation of China (30772763). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boscia F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006486; Dworkin S, 2009, STEM CELLS, V27, P1347, DOI 10.1002/stem.56; Gampe K, 2011, BRAIN RES, V1376, P31, DOI 10.1016/j.brainres.2010.11.040; Herold S, 2011, MOL CELL NEUROSCI, V46, P79, DOI 10.1016/j.mcn.2010.08.008; Ishido M, 2010, J HEALTH SCI, V56, P175, DOI 10.1248/jhs.56.175; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Ladiwala U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038613; Li P, 2003, J PHARMACOL SCI, V93, P122, DOI 10.1254/jphs.93.122; Li Wei, 2013, Yaoxue Xuebao, V48, P1422; Liu SS, 1963, TRADITIONAL CHINESE, P155; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Metkar Bharat, 1999, Indian Journal of Natural Products, V15, P10; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Pucilowska J, 2012, J NEUROSCI, V32, P8663, DOI 10.1523/JNEUROSCI.1107-12.2012; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174	18	15	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91260	10.1371/journal.pone.0091260	http://dx.doi.org/10.1371/journal.pone.0091260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614893	Green Submitted, gold, Green Published			2022-12-27	WOS:000332839300103
J	Lopez-Lopez, E; Gutierrez-Camino, A; Pinan, MA; Sanchez-Toledo, J; Uriz, JJ; Ballesteros, J; Garcia-Miguel, P; Navajas, A; Garcia-Orad, A				Lopez-Lopez, Elixabet; Gutierrez-Camino, Angela; Angeles Pinan, Maria; Sanchez-Toledo, Jose; Javier Uriz, Jose; Ballesteros, Javier; Garcia-Miguel, Purificacion; Navajas, Aurora; Garcia-Orad, Africa			Pharmacogenetics of MicroRNAs and MicroRNAs Biogenesis Machinery in Pediatric Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; LINKING POLYMORPHISMS; POLYMIRTS DATABASE; DRUG-RESISTANCE; COMPLEX TRAITS; TARGET SITES; CANCER; METHOTREXATE; CHILDHOOD; TOXICITY	Despite the clinical success of acute lymphoblastic leukemia (ALL) therapy, toxicity is frequent. Therefore, it would be useful to identify predictors of adverse effects. In the last years, several studies have investigated the relationship between genetic variation and treatment-related toxicity. However, most of these studies are focused in coding regions. Nowadays, it is known that regions that do not codify proteins, such as microRNAs (miRNAs), may have an important regulatory function. MiRNAs can regulate the expression of genes affecting drug response. In fact, the expression of some of those miRNAs has been associated with drug response. Genetic variations affecting miRNAs can modify their function, which may lead to drug sensitivity. The aim of this study was to detect new toxicity markers in pediatric B-ALL, studying miRNA-related polymorphisms, which can affect miRNA levels and function. We analyzed 118 SNPs in pre-miRNAs and miRNA processing genes in association with toxicity in 152 pediatric B-ALL patients all treated with the same protocol (LAL/SHOP). Among the results found, we detected for the first time an association between rs639174 in DROSHA and vomits that remained statistically significant after FDR correction. DROSHA had been associated with alterations in miRNAs expression, which could affect genes involved in drug transport. This suggests that miRNA-related SNPs could be a useful tool for toxicity prediction in pediatric B-ALL.	[Lopez-Lopez, Elixabet; Gutierrez-Camino, Angela; Garcia-Orad, Africa] Univ Basque Country UPV EHU, Fac Med & Odontol, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Angeles Pinan, Maria] Univ Hosp Cruces, Serv Hematol & Hemotherapy, Bilbao, Spain; [Sanchez-Toledo, Jose] VHIR, Univ Hosp Vall dHebron, Serv Pediat Oncol & Hematol, Barcelona, Spain; [Javier Uriz, Jose] Univ Hosp Donostia, Unit Pediat Oncohematol, San Sebastian, Spain; [Ballesteros, Javier] Univ Basque Country UPV EHU, Fac Med & Odontol, Dept Neurosci, Leioa, Spain; [Garcia-Miguel, Purificacion] Univ Hosp La Paz, Serv Pediat Oncohematol, Madrid, Spain; [Navajas, Aurora] Univ Hosp Cruces, Unit Pediat Hematol Oncol, Bilbao, Spain	University of Basque Country; Hospital Universitario Cruces; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University Hospital Donostia; University of Basque Country; Hospital Universitario La Paz; Hospital Universitario Cruces	Garcia-Orad, A (corresponding author), Univ Basque Country UPV EHU, Fac Med & Odontol, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain.	africa.garciaorad@ehu.es	Gutierrez-Camino, Angela/AAM-2032-2020; Ballesteros, Javier/O-8267-2015; López-López, Elixabet/T-4607-2019	Gutierrez-Camino, Angela/0000-0002-8679-6868; Ballesteros, Javier/0000-0002-6713-1916; Garcia.Orad, Africa/0000-0002-5575-3080; Lopez-Lopez, Elixabet/0000-0002-5309-3031	Spanish Thematic Network for Cooperative Investigation in Cancer RTICC [RD/06/0020/0048]; Basque Government [GIC10/71, SAI11/75]; University of the Basque Country UPV/EHU [UFI11/35, GIU10/24]; Investigation Vice-rector's office of the University of the Basque Country UPV/EHU	Spanish Thematic Network for Cooperative Investigation in Cancer RTICC; Basque Government(Basque Government); University of the Basque Country UPV/EHU; Investigation Vice-rector's office of the University of the Basque Country UPV/EHU	This project was supported by the Spanish Thematic Network for Cooperative Investigation in Cancer RTICC (RD/06/0020/0048), Basque Government (GIC10/71, SAI11/75), and University of the Basque Country UPV/EHU (UFI11/35 and GIU10/24). ELL was supported by a predoctoral grant from the Basque Government and by a "Fellowship for recent doctors until their integration in postdoctoral programs" by the Investigation Vice-rector's office of the University of the Basque Country UPV/EHU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Han BW, 2011, HUM MOL GENET, V20, P4903, DOI 10.1093/hmg/ddr428; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Hochberg Y, 1995, J ROYAL STAT SOC B; Huang L, 2008, LEUKEMIA, V22, P1798, DOI 10.1038/leu.2008.66; Johnston WT, 2010, CANCER EPIDEMIOL, V34, P659, DOI 10.1016/j.canep.2010.06.020; Kishi S, 2007, BLOOD, V109, P4151, DOI 10.1182/blood-2006-10-054528; Kotnik BF, 2011, EUR J CLIN PHARMACOL, V67, P993, DOI 10.1007/s00228-011-1046-z; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu SG, 2011, LEUKEMIA LYMPHOMA, V52, P1030, DOI 10.3109/10428194.2011.563883; Lopez-Lopez Elixabet, 2013, Pharmacogenet Genomics, V23, P53, DOI 10.1097/FPC.0b013e32835c3b24; Lopez-Lopez E, 2011, PEDIATR BLOOD CANCER, V57, P612, DOI 10.1002/pbc.23074; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Munker R, 2011, CLIN SCI, V121, P141, DOI 10.1042/CS20110005; Phua SLC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025689; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Pui CH, 2012, BLOOD, V120, P1165, DOI 10.1182/blood-2012-05-378943; Rosalina WRW, 2012, J CLIN PHARM THER, V37, P237, DOI 10.1111/j.1365-2710.2011.01272.x; Rotunno M, 2010, BRIT J CANCER, V103, P1870, DOI 10.1038/sj.bjc.6605976; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Schotte D, 2011, HAEMATOL-HEMATOL J, V96, P703, DOI 10.3324/haematol.2010.026138; Slaby O, 2012, J CELL MOL MED, V16, P8, DOI 10.1111/j.1582-4934.2011.01359.x; Trevin LR, 2009, J CLIN ONCOL, V27, P5972, DOI 10.1200/JCO.2008.20.4156; Yokoi T, 2013, ANNU REV PHARMACOL, V53, P377, DOI 10.1146/annurev-pharmtox-011112-140250; Zhang XF, 2010, CARCINOGENESIS, V31, P2118, DOI 10.1093/carcin/bgq177; Ziebarth JD, 2012, NUCLEIC ACIDS RES, V40, pD216, DOI 10.1093/nar/gkr1026	29	30	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91261	10.1371/journal.pone.0091261	http://dx.doi.org/10.1371/journal.pone.0091261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614921	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300104
J	Selokar, NL; Saini, M; Palta, P; Chauhan, MS; Manik, R; Singla, SK				Selokar, Naresh L.; Saini, Monika; Palta, Prabhat; Chauhan, Manmohan S.; Manik, Radheysham; Singla, Suresh K.			Hope for Restoration of Dead Valuable Bulls through Cloning Using Donor Somatic Cells Isolated from Cryopreserved Semen	PLOS ONE			English	Article							EPITHELIAL-CELLS; NUCLEAR TRANSFER; CLONED EMBRYOS; METHYLATION; PROLIFERATION; CULTURE; TIME	Somatic cells were isolated from cryopreserved semen of 4 buffalo bulls, 3 of which had died over 10 years earlier, and were established in culture. The cells expressed cytokeratin-18, keratin and vimentin indicating that they were of epithelial origin. The cells were used as nuclear donors for hand-made cloning for producing buffalo embryos. The blastocyst rate and quality, as indicated by apoptotic index, were comparable among embryos produced using cells obtained from fresh or frozen-thawed semen or those obtained from conventional cell sources such as skin. Examination of the epigenetic status revealed that the global level of H3K27me3 but not that of H3K9/14ac and H4K5ac differed significantly (P<0.05) among cloned embryos from different bulls. The relative mRNA abundance of HDAC1, DNMT1, P53 and CASPASE 3 but not that of DNMT3a differed in cells and in cloned embryos. Following transfer of 24 cloned embryos produced from fresh semen-derived cells to 12 recipients, one calf weighing 55 kg, which is now 6 months of age and is normal, was born through normal parturition. Following transfer of 20 embryos produced from frozen-thawed semen-derived cells to 10 recipients, 2 became pregnant, one of which aborted in the first trimester; the calf born was severely underweight (17 kg), and died 12 h after birth. The ability of cells derived from fresh and frozen-thawed semen to produce live offspring confirms the ability of these cells to be reprogrammed. Our findings pave the way for restoration of highly precious progeny-tested bulls, which has immense economic importance, and can also be used for restoration of endangered species.	[Selokar, Naresh L.; Saini, Monika; Palta, Prabhat; Chauhan, Manmohan S.; Manik, Radheysham; Singla, Suresh K.] Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal, India; [Selokar, Naresh L.] Cent Inst Res Buffaloes, Dept Anim Physiol & Reprod, Cellular Reprogramming Lab, Hisar, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Central Institute for Research on Buffaloes	Singla, SK (corresponding author), Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal, India.	singlasuresh@yahoo.com	Selokar, Naresh/D-6526-2015; Saini, Monika/R-6753-2019	Selokar, Naresh/0000-0003-3687-3914; Saini, Monika/0000-0003-1357-3679	National Agriculture Innovative Project (NAIP) [C 2-1-(5)/2007, C-2067, 075]; CSIR-SRF	National Agriculture Innovative Project (NAIP); CSIR-SRF(Council of Scientific & Industrial Research (CSIR) - India)	The present work was funded by National Agriculture Innovative Project (NAIP) grant to SKS (C 2-1-(5)/2007) and MSC (C-2067 and 075. NLS and MS are recipients of CSIR-SRF fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.naip.icar.org.in	Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Iuso D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051317; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kim MK, 2007, CLONING STEM CELLS, V9, P130, DOI 10.1089/clo.2006.0034; Leland GD, 2002, CULTURE EPITHELIAL C, Vsecond, P277; Liu J, 2010, THERIOGENOLOGY, V74, P1629, DOI 10.1016/j.theriogenology.2010.06.035; Liu J, 2009, ANIM REPROD SCI, V115, P49, DOI 10.1016/j.anireprosci.2008.11.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loi P, 2001, NAT BIOTECHNOL, V19, P962, DOI 10.1038/nbt1001-962; Nel-Themaat L, 2007, REPROD FERT DEVELOP, V19, P576, DOI 10.1071/RD06153; Nel-Themaat L, 2008, CLONING STEM CELLS, V10, P143, DOI 10.1089/clo.2007.0067; Rybouchkin A, 2006, BIOL REPROD, V74, P1083, DOI 10.1095/biolreprod.105.047456; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Selokar NL, 2012, THERIOGENOLOGY, V78, P930, DOI 10.1016/j.theriogenology.2012.03.018; Selokar NL, 2012, CELL REPROGRAM, V14, P146, DOI 10.1089/cell.2011.0076; Sirisha K, 2013, REPROD DOMEST ANIM, V48, P538, DOI 10.1111/rda.12122; Vajta G, 1998, MOL REPROD DEV, V51, P53, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;53::AID-MRD6&gt;3.0.CO;2-V; Vajta G, 2001, Cloning, V3, P89, DOI 10.1089/15204550152475590; Williams JB, 2006, METH MOL B, V348, P169; Yanxin LX, 2006, MOL REPROD DEV, V73, P189, DOI 10.1002/mrd.20405	21	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90755	10.1371/journal.pone.0090755	http://dx.doi.org/10.1371/journal.pone.0090755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614586	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300037
J	Wang, T; Zeng, X; Li, WY; Zhu, HJ; Wang, G; Liu, X; Lv, YG; Wu, JH; Zhuang, XH; Zhang, JL; Zhao, Y; Huang, HD; Fan, J; Yao, Q; He, CY; Zhang, XQ; Huang, C; Chen, JH; Wang, L				Wang, Ting; Zeng, Xi; Li, Weiyang; Zhu, Haijun; Wang, Guan; Liu, Xiao; Lv, Yonggang; Wu, Jinghua; Zhuang, Xuehan; Zhang, Juliang; Zhao, Yi; Huang, Haodong; Fan, Jing; Yao, Qing; He, Chenyang; Zhang, Xiuqing; Huang, Chen; Chen, Jianghao; Wang, Ling			Detection and Analysis of Human Papillomavirus (HPV) DNA in Breast Cancer Patients by an Effective Method of HPV Capture	PLOS ONE			English	Article							VARIANT LINEAGES; TISSUE SAMPLES; NO EVIDENCE; ASSOCIATION; PROTEIN; PERSISTENCE; CARCINOMAS; EVOLUTION; INFECTION; SEQUENCES	Despite an increase in the number of molecular epidemiological studies conducted in recent years to evaluate the association between human papillomavirus (HPV) and the risk of breast carcinoma, these studies remain inconclusive. Here we aim to detect HPV DNA in various tissues from patients with breast carcinoma using the method of HPV capture combined with massive paralleled sequencing (MPS). To validate the confidence of our methods, 15 cervical cancer samples were tested by PCR and the new method. Results showed that there was 100% consistence between the two methods. DNA from peripheral blood, tumor tissue, adjacent lymph nodes and adjacent normal tissue were collected from seven malignant breast cancer patients, and HPV type 16(HPV16) was detected in 1/7, 1/7, 1/7and 1/7 of patients respectively. Peripheral blood, tumor tissue and adjacent normal tissue were also collected from two patients with benign breast tumor, and 1/2, 2/2 and 2/2 was detected to have HPV16 DNA respectively. MPS metrics including mapping ratio, coverage, depth and SNVs were provided to characterize HPV in samples. The average coverage was 69% and 61.2% for malignant and benign samples respectively. 126 SNVs were identified in all 9 samples. The maximum number of SNVs was located in the gene of E2 and E4 among all samples. Our study not only provided an efficient method to capture HPV DNA, but detected the SNVS, coverage, SNV type and depth. The finding has provided further clue of association between HPV16 and breast cancer.	[Wang, Ting; Zhu, Haijun; Lv, Yonggang; Zhang, Juliang; Fan, Jing; Yao, Qing; He, Chenyang; Chen, Jianghao; Wang, Ling] Fourth Mil Med Univ, Xijing Hosp, Dept Vasc & Endocrine Surg, Xian 710032, Peoples R China; [Zeng, Xi; Li, Weiyang; Wang, Guan; Liu, Xiao; Wu, Jinghua; Zhuang, Xuehan; Zhao, Yi; Huang, Haodong; Zhang, Xiuqing] BGI Shenzhen, Shenzhen, Peoples R China; [Huang, Chen] Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Peoples R China; [Li, Weiyang; Zhao, Yi; Huang, Haodong] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Chinah, Peoples R China; [Zeng, Xi] Chinese Univ Hong Kong, CUHK BGI Innovat Inst Transom, Div Genom & Bioinformat, Hong Kong, Hong Kong, Peoples R China; [Liu, Xiao] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Air Force Military Medical University; Beijing Genomics Institute (BGI); Air Force Military Medical University; South China University of Technology; Chinese University of Hong Kong; University of Copenhagen	Huang, C (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Peoples R China.	huangchen@fmmu.edu.cn; jhchen@fmmu.edu.cn; vascular@fmmu.edu	Liu, Xiao/P-2732-2015; Li, Weiyang/GRO-0563-2022	Liu, Xiao/0000-0002-8073-0534; 	National Natural Science Fund [81272899, 81172510]; Discipline booster plan of Xi Jing Hospital [XJZT12Z07]; Chinese 863 program [2012AA02A201]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Discipline booster plan of Xi Jing Hospital; Chinese 863 program(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Fund (81272899 & 81172510) and Discipline booster plan of Xi Jing Hospital (XJZT12Z07). The study is also sponsored by Chinese 863 program (no. 2012AA02A201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Nuno E, 2004, ANTICANCER RES, V24, P1319; Antonsson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039842; ARMSTRONG B, 1975, INT J CANCER, V15, P617, DOI 10.1002/ijc.2910150411; Blakaj DM, FRONT BIOSCI, V14, P900; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Campeau PM, 2008, HUM GENET, V124, P31, DOI 10.1007/s00439-008-0529-1; Chen AC, J MED VIROL, V81, P1792; Damin APS, 2004, BREAST CANCER RES TR, V84, P131, DOI 10.1023/B:BREA.0000018411.89667.0d; de Cremoux P, BREAST CANC RES TREA, V109, P55; de Villiers EM, 2005, BREAST CANCER RES, V7, pR1, DOI 10.1186/bcr940; DILONARDO A, 1992, BREAST CANCER RES TR, V21, P95, DOI 10.1007/BF01836955; Gheit T, 2011, CANCER EPIDEM BIOMAR, V20, P1315, DOI 10.1158/1055-9965.EPI-10-1187; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Gumus M, 2006, J EXP CLIN CANC RES, V25, P515; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Kroupis C, 2006, CLIN BIOCHEM, V39, P727, DOI 10.1016/j.clinbiochem.2006.03.005; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li WY, 2013, GENOMICS, V102, P338, DOI 10.1016/j.ygeno.2013.07.002; Lindel K, 2007, BREAST, V16, P172, DOI 10.1016/j.breast.2006.09.001; Liu Xin, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P1272; Masterson PJ, 1998, J VIROL, V72, P7407, DOI 10.1128/JVI.72.9.7407-7419.1998; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; Shang QL, 2011, J CLIN MICROBIOL, V49, P2656, DOI 10.1128/JCM.02203-10; Silva RG, 2011, BREAST CANCER RES TR, V125, P261, DOI 10.1007/s10549-010-1129-z; Smith B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021375; Sun M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036577; Wang T, 2012, MED ONCOL, V29, P48, DOI 10.1007/s12032-010-9812-9; Widschwendter A, 2004, J CLIN VIROL, V31, P292, DOI 10.1016/j.jcv.2004.06.009; WREDE D, 1992, BRIT J CANCER, V65, P891, DOI 10.1038/bjc.1992.186; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	34	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90343	10.1371/journal.pone.0090343	http://dx.doi.org/10.1371/journal.pone.0090343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614680	gold, Green Submitted, Green Published			2022-12-27	WOS:000332839300021
J	Bao, L; Chen, D; Ding, L; Ling, WH; Xu, F				Bao, Long; Chen, Du; Ding, Li; Ling, Weihua; Xu, Feng			Fever Burden Is an Independent Predictor for Prognosis of Traumatic Brain Injury	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; BODY-TEMPERATURE; CLINICAL-TRIAL; IMPACT; MORTALITY; OUTCOMES; DESIGN; STROKE; COMA; AGE	Objective: To evaluate fever burden as an independent predictor for prognosis of traumatic brain injury (TBI). Methods: This retrospective study involved 355 TBI patients with Glasgow Coma Scale (GCS) <= 14, who presented at the emergency department of our hospital between November 2010 and October 2012. At 6 months follow-up, patients were divided into 5 groups based on Glasgow Outcome Scale (GOS) and dichotomized to GOS score (high (4 to 5) vs. low (1 to 3)). The relationship between fever burden and GOS was assessed. Results: Fever burden increased as GOS scores decreased from 5 to 2, except for score 1 of GOS, which corresponded to a significant lower fever burden. Following dichotomization, patients in the high GOS group were younger, and showed less abnormal pupil reactivity (P < 0.001), a higher median GCS score (P < 0.001), and a lower median fever burden (P < 0.001), compared with patients in the low GOS group. Univariate logistic regression analysis revealed that poor TBI prognosis was related to age, GCS, pupil reactivity, and fever burden (OR: 1.166 [95% CI: 1.117-1.217] P < 0.0001). Multivariate logistic regression analysis identified fever burden as an independent predictor of poor prognosis after TBI (OR 1.098; 95% CI: 1.031-1.169; P = 0.003). These observations were confirmed by evaluation of the receiver operating characteristic (ROC) curve for fever burden (area under the curve [AUC] 0.73 [95% CI: 0.663-0.760]). Conclusion: Fever burden might be an independent predictor for prognosis of TBI. High fever burden in the early stage of the disease course associated with TBI could increase the risk of poor prognosis.	[Bao, Long; Chen, Du; Ding, Li; Ling, Weihua; Xu, Feng] Soochow Univ, Affiliated Hosp 1, Dept Emergency Med, Suzhou, Peoples R China	Soochow University - China	Xu, F (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Emergency Med, Suzhou, Peoples R China.	xufengmedsci@163.com	Chen, Du/AAM-8789-2021	Chen, Du/0000-0001-6990-3310				Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Mayer SA, 2004, CRIT CARE MED, V32, P2508, DOI 10.1097/01.CCM.0000147441.39670.37; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Naidech AM, 2008, NEUROSURGERY, V63, P212, DOI 10.1227/01.NEU.0000320453.61270.0F; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Phipps MS, 2011, STROKE, V42, P3357, DOI 10.1161/STROKEAHA.111.621425; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; TEASDALE G, 1974, LANCET, V2, P81; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577	21	33	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90956	10.1371/journal.pone.0090956	http://dx.doi.org/10.1371/journal.pone.0090956			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626046	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300044
J	Watanabe, H				Watanabe, Hayafumi			Mean Field Approximation for Biased Diffusion on Japanese Inter-Firm Trading Network	PLOS ONE			English	Article							COMPLEX NETWORKS	By analysing the financial data of firms across Japan, a nonlinear power law with an exponent of 1.3 was observed between the number of business partners (i.e. the degree of the inter-firm trading network) and sales. In a previous study using numerical simulations, we found that this scaling can be explained by both the money-transport model, where a firm (i.e. customer) distributes money to its out-edges (suppliers) in proportion to the in-degree of destinations, and by the correlations among the Japanese inter-firm trading network. However, in this previous study, we could not specifically identify what types of structure properties (or correlations) of the network determine the 1.3 exponent. In the present study, we more clearly elucidate the relationship between this nonlinear scaling and the network structure by applying mean-field approximation of the diffusion in a complex network to this money-transport model. Using theoretical analysis, we obtained the mean-field solution of the model and found that, in the case of the Japanese firms, the scaling exponent of 1.3 can be determined from the power law of the average degree of the nearest neighbours of the network with an exponent of -0.7.	Hottolink Inc, Chiyoda Ku, Tokyo, Japan		Watanabe, H (corresponding author), Hottolink Inc, Chiyoda Ku, Tokyo, Japan.	h.watanabe@hottolink.co.jp						Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Baronchelli A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011111; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Chmiel A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066122; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Fronczak A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016107; Glattfelder JB, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036104; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Iino T., 2010, Journal of Physics: Conference Series, V221, DOI 10.1088/1742-6596/221/1/012012; Litvak N, 2009, LECT NOTES COMPUT SC, V5427, P90, DOI 10.1007/978-3-540-95995-3_8; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Milo R, 2003, CONDMAT0312028 ARXIV; Miura W, 2012, EUR PHYS J-SPEC TOP, V212, P65, DOI 10.1140/epjst/e2012-01654-7; Miura W, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.168701; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; Ohnishi T, 2009, PROG THEOR PHYS SUPP, P157, DOI 10.1143/PTPS.179.157; Sen P, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.036106; Tamura Koutarou, 2012, International Journal of Modern Physics: Conference Series, V16, P93, DOI 10.1142/S2010194512007805; Tamura K, 2012, P AS PAC S INT EV SY; Vitali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025995; Vitali S, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/6/063021; Watanabe H, 2013, PHYSICA A, V392, P741, DOI 10.1016/j.physa.2012.10.020; Watanabe H, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/4/043034	25	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91704	10.1371/journal.pone.0091704	http://dx.doi.org/10.1371/journal.pone.0091704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626149	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300125
J	Tsuda, T; Mochizuki, E; Kishida, S; Iwasaki, K; Tsunashima, K; Kuwabata, S				Tsuda, Tetsuya; Mochizuki, Eiko; Kishida, Shoko; Iwasaki, Kazuki; Tsunashima, Katsuhiko; Kuwabata, Susumu			SEM Observation of Hydrous Superabsorbent Polymer Pretreated with Room-Temperature Ionic Liquids	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; PHYSICOCHEMICAL PROPERTIES; CELLS; ELECTROCHEMISTRY; VACUUM	Room-temperature ionic liquid (RTIL), which is a liquid salt at or below room temperature, shows peculiar physicochemical properties such as negligible vapor pressure and relatively-high ionic conductivity. In this investigation, we used six types of RTILs as a liquid material in the pretreatment process for scanning electron microscope (SEM) observation of hydrous superabsorbent polymer (SAP) particles. Very clear SEM images of the hydrous SAP particles were obtained if the neat RTILs were used for the pretreatment process. Of them, tri-n-butylmethylphosphonium dimethylphosphate ([P-4,P- 4,P- 4,P- 1][DMP]) provided the best result. On the other hand, the surface morphology of the hydrous SAP particles pretreated with 1-ethyl-3-methylimidazolium tetrafluoroborate ([C(2)mim][BF4]) and 1-butyl-3-methylimidazolium tetrafluoroborate ([C(4)mim][BF4]) was damaged. The results of SEM observation and thermogravimetry analysis of the hydrous SAP pretreated with the RTILs strongly suggested that most water in the SAP particles are replaced with RTIL during the pretreatment process.	[Tsuda, Tetsuya; Mochizuki, Eiko; Kishida, Shoko; Iwasaki, Kazuki; Kuwabata, Susumu] Osaka Univ, Dept Appl Chem, Grad Sch Engn, Suita, Osaka, Japan; [Tsunashima, Katsuhiko] Wakayama Natl Coll Technol, Dept Mat Sci, Gobo, Wakayama, Japan	Osaka University	Tsuda, T (corresponding author), Osaka Univ, Dept Appl Chem, Grad Sch Engn, Suita, Osaka, Japan.	ttsuda@chem.eng.osaka-u.ac.jp; kuwabata@chem.eng.osaka-u.ac.jp	Kuwabata, Susumu/N-3492-2018; Tsuda, Tetsuya/F-7234-2014	Kuwabata, Susumu/0000-0002-4606-964X; Tsuda, Tetsuya/0000-0001-9462-8066	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24350071]; Advanced Low Carbon Technology Research and Development Program (ALCA), Japan Science and Technology Agency (JST); Japanese Ministry of Economy, Trade and Industry (METI)	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Advanced Low Carbon Technology Research and Development Program (ALCA), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japanese Ministry of Economy, Trade and Industry (METI)	Part of this research was supported by Grant-in-Aid for Scientific Research B, Grant No. 24350071, from Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), from Advanced Low Carbon Technology Research and Development Program (ALCA), Japan Science and Technology Agency (JST), and from Japanese Ministry of Economy, Trade and Industry (METI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto S, 2008, ELECTROCHIM ACTA, V53, P6228, DOI 10.1016/j.electacta.2008.01.001; Dupont J, 2010, CHEM SOC REV, V39, P1780, DOI 10.1039/b822551f; Dwiranti A, 2012, MICROSC RES TECHNIQ, V75, P1113, DOI 10.1002/jemt.22038; Dykstra MJ, 2003, BIOL ELECT MICROSCOP; Freire MG, 2011, J CHEM ENG DATA, V56, P4813, DOI 10.1021/je200790q; Goldstein J., 2018, SCANNING ELECT MICRO, V4th ed.; Ishigaki Y, 2011, MICROSC RES TECHNIQ, V74, P1024, DOI 10.1002/jemt.20989; Ishigaki Y, 2011, MICROSC RES TECHNIQ, V74, P415, DOI 10.1002/jemt.20924; Johnston M, 2005, J PHYS CHEM B, V109, P11296, DOI 10.1021/jp051243m; Kawai K, 2011, LANGMUIR, V27, P9671, DOI 10.1021/la201914h; Kuwabata S, 2006, CHEM LETT, V35, P600, DOI 10.1246/cl.2006.600; Kuwabata S, 2010, J PHYS CHEM LETT, V1, P3177, DOI 10.1021/jz100876m; Lovelock KRJ, 2010, CHEM REV, V110, P5158, DOI 10.1021/cr100114t; RADOSAVLJEVIC S, 1979, J FLUORINE CHEM, V13, P465, DOI 10.1016/S0022-1139(00)83094-8; Rilo E, 2010, J CHEM ENG DATA, V55, P639, DOI 10.1021/je900600c; Shima F, 2013, B CHEM SOC JPN, V86, P153, DOI 10.1246/bcsj.20120227; Takahashi C, 2013, MATER CHEM PHYS, V141, P657, DOI 10.1016/j.matchemphys.2013.05.051; Tokuda H, 2006, J PHYS CHEM B, V110, P19593, DOI 10.1021/jp064159v; Torimoto T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2404975; Torimoto T, 2010, ADV MATER, V22, P1196, DOI 10.1002/adma.200902184; Tsuda T, 2013, ELECTROCHIM ACTA, V100, P285, DOI 10.1016/j.electacta.2012.05.156; Tsuda T, 2012, ELECTROCHEMISTRY, V80, P308, DOI 10.5796/electrochemistry.80.308; Tsuda T, 2011, CHEMBIOCHEM, V12, P2547, DOI 10.1002/cbic.201100476; Tsuda T, 2011, ANGEW CHEM INT EDIT, V50, P1310, DOI 10.1002/anie.201005208; Tsuda T, 2009, MOD ASP ELECTROCHEM, P63, DOI 10.1007/978-1-4419-0655-7_2; Wasserscheid P., 2008, IONIC LIQUIDS SYNTHE, V1; Yanaga K, 2012, MYCOL PROG, V11, P343, DOI 10.1007/s11557-011-0794-6; Yoshii K, 2013, J PHYS CHEM B, V117, P15051, DOI 10.1021/jp406791a	28	17	17	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91193	10.1371/journal.pone.0091193	http://dx.doi.org/10.1371/journal.pone.0091193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621609	gold, Green Submitted, Green Published			2022-12-27	WOS:000332845300060
J	Davenport, ER; Mizrahi-Man, O; Michelini, K; Barreiro, LB; Ober, C; Gilad, Y				Davenport, Emily R.; Mizrahi-Man, Orna; Michelini, Katelyn; Barreiro, Luis B.; Ober, Carole; Gilad, Yoav			Seasonal Variation in Human Gut Microbiome Composition	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; DIET; OBESITY; ASSOCIATIONS; COMMUNITIES; METABOLISM; PATTERNS; NUTRIENT; DELIVERY	The composition of the human gut microbiome is influenced by many environmental factors. Diet is thought to be one of the most important determinants, though we have limited understanding of the extent to which dietary fluctuations alter variation in the gut microbiome between individuals. In this study, we examined variation in gut microbiome composition between winter and summer over the course of one year in 60 members of a founder population, the Hutterites. Because of their communal lifestyle, Hutterite diets are similar across individuals and remarkably stable throughout the year, with the exception that fresh produce is primarily served during the summer and autumn months. Our data indicate that despite overall gut microbiome stability within individuals over time, there are consistent and significant population-wide shifts in microbiome composition across seasons. We found seasonal differences in both (i) the abundance of particular taxa (false discovery rate <0.05), including highly abundant phyla Bacteroidetes and Firmicutes, and (ii) overall gut microbiome diversity (by Shannon diversity; P = 0.001). It is likely that the dietary fluctuations between seasons with respect to produce availability explain, at least in part, these differences in microbiome composition. For example, high levels of produce containing complex carbohydrates consumed during the summer months might explain increased abundance of Bacteroidetes, which contain complex carbohydrate digesters, and decreased levels of Actinobacteria, which have been negatively correlated to fiber content in food questionnaires. Our observations demonstrate the plastic nature of the human gut microbiome in response to variation in diet.	[Davenport, Emily R.; Mizrahi-Man, Orna; Michelini, Katelyn; Barreiro, Luis B.; Ober, Carole; Gilad, Yoav] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	carole@genetics.uchicago.edu; gilad@uchicago.edu	Barreiro, Luis/I-7772-2015	Davenport, Emily R./0000-0002-6938-4933; Barreiro, Luis/0000-0001-9456-367X; Ober, Carole/0000-0003-4626-9809	NIH [HG006123, HL085197]; Digestive Disease Research Core Center [P30-DK42086]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085197] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Disease Research Core Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by NIH grants HG006123 to YG and HL085197 to CO, and the Digestive Disease Research Core Center grant P30-DK42086 (through a P&F grant to YG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bailey MT, 2010, BRAIN BEHAV IMMUN, V24, P577, DOI 10.1016/j.bbi.2009.12.010; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; da Silva S, 2011, P NATL ACAD SCI USA, V108, P3395, DOI 10.1073/pnas.1014411108; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Fava F., 2012, INT J OBESITY; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; HOSTETLER JA, 1985, AM J MED GENET, V22, P453, DOI 10.1002/ajmg.1320220303; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Leff JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059310; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li F, 2009, J NUTR, V139, P1685, DOI 10.3945/jn.109.108191; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Mai V, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-49; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; Marques TM, 2010, CURR OPIN BIOTECH, V21, P149, DOI 10.1016/j.copbio.2010.03.020; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; Mizrahi-Man O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053608; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; MULLEN BJ, 1984, AM J CLIN NUTR, V39, P136, DOI 10.1093/ajcn/39.1.136; Oksanen J., 2008, COMMUNITY ECOLOGY PA, V190, P254, DOI 10.4135/9781412971874.n145; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; R Development Core Team, 2011, R LANG ENV STAT COMP; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Van den Abbeele P, 2011, ENVIRON MICROBIOL, V13, P2667, DOI 10.1111/j.1462-2920.2011.02533.x; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112	55	181	185	6	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90731	10.1371/journal.pone.0090731	http://dx.doi.org/10.1371/journal.pone.0090731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618913	gold, Green Published, Green Submitted			2022-12-27	WOS:000332842400027
J	Rungrassamee, W; Klanchui, A; Maibunkaew, S; Chaiyapechara, S; Jiravanichpaisal, P; Karoonuthaisiri, N				Rungrassamee, Wanilada; Klanchui, Amornpan; Maibunkaew, Sawarot; Chaiyapechara, Sage; Jiravanichpaisal, Pikul; Karoonuthaisiri, Nitsara			Characterization of Intestinal Bacteria in Wild and Domesticated Adult Black Tiger Shrimp (Penaeus monodon)	PLOS ONE			English	Article							SP-NOV.; GUT MICROBIOTA; DIGESTIVE-TRACT; GEN. NOV.; LITOPENAEUS-VANNAMEI; MOLECULAR ANALYSIS; MARINE BACTERIUM; WHITE SHRIMP; DEEP-SEA; DIVERSITY	The black tiger shrimp (Penaeus monodon) is a marine crustacean of economic importance in the world market. To ensure sustainability of the shrimp industry, production capacity and disease outbreak prevention must be improved. Understanding healthy microbial balance inside the shrimp intestine can provide an initial step toward better farming practice and probiotic applications. In this study, we employed a barcode pyrosequencing analysis of V3-4 regions of 16S rRNA genes to examine intestinal bacteria communities in wild-caught and domesticated P. monodon broodstock. Shrimp faeces were removed from intestines prior to further analysis in attempt to identify mucosal bacterial population. Five phyla, Actinobacteria, Fusobacteria, Proteobacteria, Firmicutes and Bacteroidetes, were found in all shrimp from both wild and domesticated environments. The operational taxonomic unit (OTU) was assigned at 97% sequence identity, and our pyrosequencing results identified 18 OTUs commonly found in both groups. Sequences of the shared OTUs were similar to bacteria in three phyla, namely i) Proteobacteria (Vibrio, Photobacterium, Novosphingobium, Pseudomonas, Sphingomonas and Undibacterium), ii) Firmicutes (Fusibacter), and iii) Bacteroidetes (Cloacibacterium). The shared bacterial members in P. monodon from two different habitats provide evidence that the internal environments within the host shrimp also exerts selective pressure on bacterial members. Intestinal bacterial profiles were compared using denaturing gradient gel electrophoresis (DGGE). The sequences from DGGE bands were similar to those of Vibrio and Photobacterium in all shrimp, consistent with pyrosequencing results. This work provides the first comprehensive report on bacterial populations in the intestine of adult black tiger shrimp and reveals some similar bacterial members between the intestine of wild-caught and domesticated shrimp.	[Rungrassamee, Wanilada; Klanchui, Amornpan; Maibunkaew, Sawarot; Karoonuthaisiri, Nitsara] Natl Ctr Genet Engn & Biotechnol BIOTEC, Microarray Lab, Khlong Luang, Pathum Thani, Thailand; [Chaiyapechara, Sage; Jiravanichpaisal, Pikul] Natl Ctr Genet Engn & Biotechnol BIOTEC, Aquat Mol Genet & Biotechnol Lab, Khlong Luang, Pathum Thani, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Karoonuthaisiri, N (corresponding author), Natl Ctr Genet Engn & Biotechnol BIOTEC, Microarray Lab, Khlong Luang, Pathum Thani, Thailand.	nitsara.kar@biotec.or.th	Rungrassamee, Wanilada/E-1718-2011	Rungrassamee, Wanilada/0000-0002-5802-4342; Chaiyapechara, Sage/0000-0002-6836-2759	Thailand Research Fund [DBG5380030]; National Center for Genetic Engineering and Biotechnology (BIOTEC) [P-10-10722]	Thailand Research Fund(Thailand Research Fund (TRF)); National Center for Genetic Engineering and Biotechnology (BIOTEC)	The project received funding support from the Thailand Research Fund (grant number DBG5380030) and the National Center for Genetic Engineering and Biotechnology (BIOTEC, grant number P-10-10722). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Hania W, 2012, INT J SYST EVOL MICR, V62, P1365, DOI 10.1099/ijs.0.034603-0; Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S; Briggs M, 2005, FAO FISHERIES TECHNI; Browdy CL, 1998, AQUACULTURE, V164, P3, DOI 10.1016/S0044-8486(98)00174-4; Brune A, 2000, CURR OPIN MICROBIOL, V3, P263, DOI 10.1016/S1369-5274(00)00087-4; Cai L., 2013, PLOS ONE, V8; Chaiyapechara S, 2012, MICROB ECOL, V63, P938, DOI 10.1007/s00248-011-9936-2; Cleary DFR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029380; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Desriac F, 2010, MAR DRUGS, V8, P1153, DOI 10.3390/md8041153; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dhanasiri AKS, 2011, MICROB ECOL, V61, P20, DOI 10.1007/s00248-010-9673-y; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Gaggia F, 2010, INT J FOOD MICROBIOL, V141, pS15, DOI 10.1016/j.ijfoodmicro.2010.02.031; Ghyselinck J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071360; Gillilland MG, 2012, APPL ENVIRON MICROB, V78, P2359, DOI 10.1128/AEM.05239-11; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Holben WE, 2002, MICROB ECOL, V44, P175, DOI 10.1007/s00248-002-1011-6; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; Jarchum I, 2011, CURR OPIN IMMUNOL, V23, P353, DOI 10.1016/j.coi.2011.03.001; Johnson CN, 2008, J WORLD AQUACULT SOC, V39, P251, DOI 10.1111/j.1749-7345.2008.00155.x; Khan ST, 2007, INT J SYST EVOL MICR, V57, P265, DOI 10.1099/ijs.0.64628-0; Kongnum K, 2012, FISH SHELLFISH IMMUN, V32, P170, DOI 10.1016/j.fsi.2011.11.008; KRAXBERGERBEATTY T, 1990, J FISH DIS, V13, P557, DOI 10.1111/j.1365-2761.1990.tb00819.x; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lebel L, 2010, ENVIRON SCI POLICY, V13, P291, DOI 10.1016/j.envsci.2010.03.005; Lee HI, 2010, ANAEROBE, V16, P522, DOI 10.1016/j.anaerobe.2010.07.002; Lee K, 2007, INT J SYST EVOL MICR, V57, P1653, DOI 10.1099/ijs.0.64960-0; Lee YS, 2009, INT J SYST EVOL MICR, V59, P1609, DOI 10.1099/ijs.0.006866-0; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Liu HD, 2011, AQUACULTURE, V317, P32, DOI 10.1016/j.aquaculture.2011.04.008; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARTE CL, 1980, CRUSTACEANA, V38, P225, DOI 10.1163/156854080X00139; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Meziti A, 2012, SYST APPL MICROBIOL, V35, P473, DOI 10.1016/j.syapm.2012.07.004; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Navarrete P, 2009, MICROB ECOL, V57, P550, DOI 10.1007/s00248-008-9448-x; ORTIGOSA M, 1994, SYST APPL MICROBIOL, V17, P216, DOI 10.1016/S0723-2020(11)80011-1; OSULLIVAN J, 1990, J ANTIBIOT, V43, P913, DOI 10.7164/antibiotics.43.913; Oxley APA, 2002, J APPL MICROBIOL, V93, P214, DOI 10.1046/j.1365-2672.2002.01673.x; Ravot G, 1999, INT J SYST BACTERIOL, V49, P1141, DOI 10.1099/00207713-49-3-1141; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Rengpipat S, 1998, AQUACULTURE, V167, P301, DOI 10.1016/S0044-8486(98)00305-6; Rengpipat S, 2003, DIS AQUAT ORGAN, V55, P169, DOI 10.3354/dao055169; Ringo E, 1998, AQUACULTURE, V160, P177, DOI 10.1016/S0044-8486(97)00299-8; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Rosenberry B., 2001, WORLD SHRIMP FARMING; Rungrassamee W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060802; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schluter J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001424; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Soonthornchai W, 2010, DEV COMP IMMUNOL, V34, P19, DOI 10.1016/j.dci.2009.07.007; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; Tan TF, 2009, INT J SYST EVOL MICR, V59, P1143, DOI 10.1099/ijs.0.000901-0; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Vaseeharan B, 2003, MICROBIOL RES, V158, P299, DOI 10.1078/0944-5013-00208; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Wang BJ, 2009, INT J SYST EVOL MICR, V59, P1116, DOI 10.1099/ijs.0.002477-0; Wang CS, 2009, INT J SYST EVOL MICR, V59, P545, DOI 10.1099/ijs.0.004531-0; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2010, INT J SYST EVOL MICR, V60, P2517, DOI 10.1099/ijs.0.016915-0; Waqairatu SS, 2012, ECOL EVOL, V2, P2057, DOI 10.1002/ece3.316; Wilson KH, 2006, ANAEROBE, V12, P249, DOI 10.1016/j.anaerobe.2006.09.002; Wongwilaiwalin S, 2010, ENZYME MICROB TECH, V47, P283, DOI 10.1016/j.enzmictec.2010.07.013; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yoon JH, 2007, INT J SYST EVOL MICR, V57, P856, DOI 10.1099/ijs.0.64779-0; Zou Z, 2008, INSECT BIOCHEM MOLEC, V38, P677, DOI 10.1016/j.ibmb.2008.03.009	81	178	202	5	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91853	10.1371/journal.pone.0091853	http://dx.doi.org/10.1371/journal.pone.0091853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618668	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400135
J	Subhi, Y; Henningsen, GO; Larsen, CT; Sorensen, MS; Sorensen, TL				Subhi, Yousif; Henningsen, Gitte O.; Larsen, Charlotte T.; Sorensen, Mette S.; Sorensen, Torben L.			Foveal Morphology Affects Self-Perceived Visual Function and Treatment Response in Neovascular Age-Related Macular Degeneration: A Cohort Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; VISION-RELATED FUNCTION; QUESTIONNAIRE NEI-VFQ; RANIBIZUMAB TREATMENT; PHOTORECEPTOR INTEGRITY; SUBGROUP ANALYSIS; CLINICAL-TRIAL; ACUITY; PREDICTORS; EYES	Objectives: To investigate the relationship between foveal morphology and self-perceived visual function in patients with neovascular age-related macular degeneration (AMD) and whether foveal characteristics are associated with Ranibizumab treatment response on the self-perceived visual function. Methods: This prospective cohort study included patients with newly diagnosed neovascular AMD found eligible for treatment with Ranibizumab. Foveal morphology of both eyes was assessed using spectral-domain optical coherence tomography and all patients were interviewed using the 39-item National Eye Institute Visual Function Questionnaire (VFQ). Patients were re-interviewed 3 and 12 months after initiation of treatment with Ranibizumab. We evaluated foveal morphology at baseline in relation to VFQ scores at baseline and clinically meaningful changes in VFQ after 3 and 12 months. Results: VFQ scores correlated with central foveal thickness, central foveal thickness of neuroretina (CFN), foveal RPE elevation, foveal integrity of the photoreceptor inner segment/outer segment junction (IS/OS), and external limiting membrane. In a multiple linear regression model, only best-corrected visual acuity of the better eye (p<0.001) and the IS/OS status in the better eye (p = 0.012) remained significant (Adjusted R-2 = 0.418). Lower baseline VFQ and a baseline CFN within 170-270 mu m in the better eye were both associated with a clinically meaningful increase in the VFQ scores after 3 and 12 months. An absent foveal IS/OS band in the better eye was associated with a clinically meaningful decrease in the VFQ scores at 12 months. Conclusions: Foveal morphology in the better eye influences the self-perceived visual function in patients with neovascular AMD and possesses a predictive value for change in the self-perceived visual function at 3 and 12 months after initiation of treatment. These findings may help clinicians provide patients more individualized information of their disease and treatment prognosis from a patient-perceived point-of-view.	[Subhi, Yousif; Henningsen, Gitte O.; Larsen, Charlotte T.; Sorensen, Mette S.; Sorensen, Torben L.] Copenhagen Univ Hosp Roskilde, Dept Ophthalmol, Clin Eye Res Unit, Roskilde, Denmark; [Subhi, Yousif; Sorensen, Torben L.] Univ Copenhagen, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Sorensen, TL (corresponding author), Copenhagen Univ Hosp Roskilde, Dept Ophthalmol, Clin Eye Res Unit, Roskilde, Denmark.	torbenls@dadlnet.dk	Sørensen, Torben Lykke L/N-1417-2014; Subhi, Yousif/ABG-6330-2020	Sørensen, Torben Lykke L/0000-0002-6790-0199; Subhi, Yousif/0000-0001-6620-5365	Region Zealand Research Foundation	Region Zealand Research Foundation	This work is supported by the Region Zealand Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi-Kurashige Y, 2012, GRAEF ARCH CLIN EXP, V250, P1129, DOI 10.1007/s00417-012-1928-5; Bauer P, 2008, KLIN MONATSBL AUGENH, V225, P376, DOI 10.1055/s-2008-1027264; Boyer DS, 2007, OPHTHALMOLOGY, V114, P246, DOI 10.1016/j.ophtha.2006.10.045; Bressler NM, 2010, OPHTHALMOLOGY, V117, P747, DOI 10.1016/j.ophtha.2009.09.002; Brundage M, 2011, QUAL LIFE RES, V20, P653, DOI 10.1007/s11136-010-9793-3; Chang TS, 2007, ARCH OPHTHALMOL-CHIC, V125, P1460, DOI 10.1001/archopht.125.11.1460; Chhablani J, 2013, INT J OPHTHALMOL-CHI, V6, P62, DOI 10.3980/j.issn.2222-3959.2013.01.13; Clemons TE, 2003, ARCH OPHTHALMOL-CHIC, V121, P211; Falk MK, 2013, AM J OPHTHALMOL, V155, P89, DOI 10.1016/j.ajo.2012.06.031; Finger RP, 2013, ACTA OPHTHALMOL, V91, P540, DOI 10.1111/j.1755-3768.2012.02493.x; Gomi F, 2008, CURR OPIN OPHTHALMOL, V19, P208, DOI 10.1097/ICU.0b013e3282fb7c33; Hayashi H, 2009, AM J OPHTHALMOL, V148, P83, DOI 10.1016/j.ajo.2009.01.017; Kaiser PK, 2007, AM J OPHTHALMOL, V144, P850, DOI 10.1016/j.ajo.2007.08.012; Kurashige Y, 2012, RETINA-J RET VIT DIS, V32, P792, DOI 10.1097/IAE.0b013e3182278b98; Leys A, 2008, EYE, V22, P792, DOI 10.1038/sj.eye.6702900; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P1496, DOI 10.1001/archopht.116.11.1496; Marella M, 2010, INVEST OPHTH VIS SCI, V51, P2878, DOI 10.1167/iovs.09-4494; Margolis MK, 2002, PHARMACOECONOMICS, V20, P791, DOI 10.2165/00019053-200220120-00001; Marques IR, 2013, OPHTHALMOLOGICA, V229, P158, DOI 10.1159/000343709; Miskala PH, 2007, OPHTHAL EPIDEMIOL, V14, P205, DOI 10.1080/09286580701502970; Oishi A, 2010, AM J OPHTHALMOL, V150, P27, DOI 10.1016/j.ajo.2010.02.012; Orr P, 2011, INVEST OPHTH VIS SCI, V52, P3354, DOI 10.1167/iovs.10-5645; Pappuru RR, 2011, INVEST OPHTH VIS SCI, V52, P6743, DOI 10.1167/iovs.10-6723; Pesudovs K, 2010, J CATARACT REFR SURG, V36, P718, DOI 10.1016/j.jcrs.2009.11.019; Rein DB, 2009, ARCH OPHTHALMOL-CHIC, V127, P533, DOI 10.1001/archophthalmol.2009.58; Revicki DA, 2010, INVEST OPHTH VIS SCI, V51, P712, DOI 10.1167/iovs.09-3766; Richter-Mueksch S, 2006, GRAEF ARCH CLIN EXP, V244, P154, DOI 10.1007/s00417-005-0063-y; Rubin GS, 2000, INVEST OPHTH VIS SCI, V41, P3327; Sabour-Pickett S, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/268438; Shin HJ, 2012, GRAEF ARCH CLIN EXP, V250, P61, DOI 10.1007/s00417-011-1774-x; Shin HJ, 2011, RETINA-J RET VIT DIS, V31, P1627, DOI 10.1097/IAE.0b013e31820d3d01; Sorensen MS, 2011, DAN MED BULL, V58; Sorensen TL, 2011, ACTA OPHTHALMOL, V89, pE97, DOI 10.1111/j.1755-3768.2010.01899.x; Suner IJ, 2009, INVEST OPHTH VIS SCI, V50, P3629, DOI 10.1167/iovs.08-3225; Tuulonen A, 2009, ACTA OPHTHALMOL, V87, P820, DOI 10.1111/j.1755-3768.2009.01532.x; Watanabe K, 2013, JAMA OPHTHALMOL, V131, P172, DOI 10.1001/jamaophthalmol.2013.686; Wiliams RA, 1998, ARCH OPHTHALMOL-CHIC, V116, P514; Ying GS, 2013, OPHTHALMOLOGY, V120, P122, DOI 10.1016/j.ophtha.2012.07.042	39	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91227	10.1371/journal.pone.0091227	http://dx.doi.org/10.1371/journal.pone.0091227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618706	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400059
J	Schouten, HJ; Koek, HL; Kruisman-Ebbers, M; Geersing, GJ; Oudega, R; Kars, MC; Moons, KGM; van Delden, JJM				Schouten, Henrike J.; Koek, Huiberdina L.; Kruisman-Ebbers, Marije; Geersing, Geert-Jan; Oudega, Ruud; Kars, Marijke C.; Moons, Karel G. M.; van Delden, Johannes J. M.			Decisions to Withhold Diagnostic Investigations in Nursing Home Patients with a Clinical Suspicion of Venous Thromboembolism	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; ELDERLY-PATIENTS; CARE; HOSPITALIZATION; ANTICOAGULANT; TRANSITIONS; RESIDENTS; PHYSICIAN; ACCURACY	Background: This study aimed to gather insights in physicians' considerations for decisions to either refer for-or to withhold additional diagnostic investigations in nursing home patients with a suspicion of venous thromboembolism. Methods: Our study was nested in an observational study on diagnostic strategies for suspected venous thromboembolism in nursing home patients. Patient characteristics, bleeding-complications and mortality were related to the decision to withhold investigations. For a better understanding of the physicians' decisions, 21 individual face-to-face in-depth interviews were performed and analysed using the grounded theory approach. Results: Referal for additional diagnostic investigations was forgone in 126/322 (39.1%) patients with an indication for diagnostic work-up. 'Blind' anticoagulant treatment was initiated in 95 (75.4%) of these patients. The 3month mortality rates were higher for patients in whom investigations were withheld than in the referred patients, irrespective of anticoagulant treatment (odds ratio 2.45; 95% confidence interval 1.40 to 4.29) but when adjusted for the probability of being referred (i.e. the propensity score), there was no relation of non-diagnosis decisions to mortality (odds ratio 1.75; 0.98 to 3.11). In their decisions to forgo diagnostic investigations, physicians incorporated the estimated relative impact of the potential disease; the potential net-benefits of diagnostic investigations and whether performing investigations agreed with established management goals in advance care planning. Conclusion: Referral for additional diagnostic investigations is withheld in almost 40% of Dutch nursing home patients with suspected venous thromboembolism and an indication for diagnostic work-up. We propose that, given the complexity of these decisions and the uncertainty regarding their indirect effects on patient outcome, more attention should be focused on the decision to either use or withhold additional diagnostic tests.	[Schouten, Henrike J.; Kruisman-Ebbers, Marije; Geersing, Geert-Jan; Oudega, Ruud; Kars, Marijke C.; Moons, Karel G. M.; van Delden, Johannes J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Schouten, Henrike J.; Koek, Huiberdina L.] Univ Med Ctr Utrecht, Dept Geriatr, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Schouten, HJ (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	h.j.schouten@umcutrecht.nl	Geersing, Geert-Jan/AAY-1119-2021; Kars, Marijke C/M-4301-2015		Netherlands Organization for Scientific Research (ZonMw) [17088-2502]	Netherlands Organization for Scientific Research (ZonMw)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	Financial support was provided by the Netherlands Organization for Scientific Research (ZonMw project number 17088-2502). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, CODE CONDUCT MED RES; AVVV NVVA Sting, 2006, BEGR ZORGV BETR BESL; BARRITT DW, 1960, LANCET, V1, P1309; Boeije H., 2009, ANAL QUALITATIVE RES; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; de Casterle BD, 2012, INT J NURS STUD, V49, P360, DOI 10.1016/j.ijnurstu.2011.09.012; Di Nisio M, 2007, J THROMB HAEMOST, V5, P296, DOI 10.1111/j.1538-7836.2007.02328.x; Ferrante di Ruffano L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e686; Fried TR, 1997, J AM GERIATR SOC, V45, P265, DOI 10.1111/j.1532-5415.1997.tb00938.x; Gill TM, 2011, J GERONTOL A-BIOL, V66, P1238, DOI 10.1093/gerona/glr142; GILLICK MR, 1982, SOC SCI MED, V16, P1033, DOI 10.1016/0277-9536(82)90175-7; Givens JL, 2012, J AM GERIATR SOC, V60, P905, DOI 10.1111/j.1532-5415.2012.03919.x; Glaser B.G., 1968, DISCOV GROUNDED THEO; Goldfeld KS, 2013, J PAIN SYMPTOM MANAG, V10; Goodacre S, 2005, ANN INTERN MED, V143, P129, DOI 10.7326/0003-4819-143-2-200507190-00012; Gozalo P, 2011, NEW ENGL J MED, V365, P1212, DOI 10.1056/NEJMsa1100347; Hamaker ME, 2012, J AM MED DIR ASSOC, V13, P464, DOI 10.1016/j.jamda.2012.01.002; Helton MR, 2006, ANN FAM MED, V4, P221, DOI 10.1370/afm.536; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Khreizat HS, 2012, DRUG AGING, V29, P307, DOI 10.2165/11599060-000000000-00000; Koopmans RTCM, 2010, J AM GERIATR SOC, V58, P1807, DOI 10.1111/j.1532-5415.2010.03043.x; Ling J, 2000, EUR J CANCER, V36, P621, DOI 10.1016/S0959-8049(99)00330-5; Lingard L, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.39602.690162.47; Masotti L, 2008, VASC HEALTH RISK MAN, V4, P629, DOI 10.2147/VHRM.S2605; Mitchell AM, 2012, ACAD EMERG MED, V19, P618, DOI 10.1111/j.1553-2712.2012.01374.x; Oudega R, 2005, THROMB HAEMOSTASIS, V94, P200, DOI 10.1160/TH04-12-0829; Oudega R, 2005, FAM PRACT, V22, P86, DOI 10.1093/fampra/cmh718; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Prasad V, 2012, ARCH INTERN MED, V172, P955, DOI 10.1001/archinternmed.2012.195; Righini M, 2005, J AM GERIATR SOC, V53, P1039, DOI 10.1111/j.1532-5415.2005.53309.x; Schouten HJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2492; Schouten HJ, 2012, J AM MED DIR ASSOC, V13, P682, DOI 10.1016/j.jamda.2012.05.010; Schulman S, 2008, CHEST, V133, p257S, DOI 10.1378/chest.08-0674; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Wells PS, 2007, J THROMB HAEMOST, V5, P41, DOI 10.1111/j.1538-7836.2007.02493.x; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; Wiener RS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3368	39	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90395	10.1371/journal.pone.0090395	http://dx.doi.org/10.1371/journal.pone.0090395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614754	gold, Green Submitted, Green Published			2022-12-27	WOS:000332839300022
J	Gao, ZB; Wang, W; Wang, ZF; Zhao, XL; Shang, YC; Guo, Y; Gong, M; Yang, LJ; Shi, XB; Xu, X; An, NY; Wu, WP				Gao, Zhongbao; Wang, Wei; Wang, Zhenfu; Zhao, Xingli; Shang, Yanchang; Guo, Yaner; Gong, Mei; Yang, Lijuan; Shi, Xiaobing; Xu, Xian; An, Ningyu; Wu, Weiping			Cerebral Microbleeds Are Associated with Deep White Matter Hyperintensities, but Only in Hypertensive Patients	PLOS ONE			English	Article							RISK-FACTORS; ISCHEMIC-STROKE; ARTERIAL STIFFNESS; HEALTHY-SUBJECTS; ROTTERDAM SCAN; PREVALENCE; LESIONS; LEUKOARAIOSIS; BRAIN; AGE	Cerebral microbleeds (CMBs) and white matter hyperintensities (WMH) are the most common manifestations of small vessel disease, and often co-occur in patients with cerebral vascular disease. Hypertension is widely accepted as a risk factor for both CMBs and WMH. However, the effect of hypertension on the association between CMBs and WMH remains unclear. We hypothesized that the relationship between CMBs and WMH is determined by hypertension. One hundred forty-eight patients with acute cerebrovascular disease who were admitted to PLA general hospital in Beijing, China from February 2010 to May 2011 were recruited in this study. CMBs on T2*-weighted angiography (SWAN) were assessed using the Brain Observer Microbleed Rating Scale criteria. The severity of the WMH was separately assessed as either peri-ventricular hyperintensities (PVH) or deep white matter hyperintensities (DWMH). The association among CMBs and the severity of WMH, and hypertension were determined. CMBs were found in 65 (43.9%) patients. The frequency of CMBs was related to the severity of DWMH and PVH. CMBs were more frequently observed in patients with hypertension compared to patients without hypertension (51.3% vs. 20.0%, p = 0.001). Hypertension was an independent risk factor for CMBs (odds ratio 5.239, p = 0.001) and DWMH (odds ratio 2.373, p = 0.040). Furthermore, the relationship between the presence of CMBs and the severity of DWMH was only found in patients with hypertension (r = 0.298, p<0.01). However, CMBs were associated with PVH independently of hypertension. This study demonstrated that hypertension determined the association between CMBs and DWMH.	[Gao, Zhongbao; Wang, Wei; Wang, Zhenfu; Zhao, Xingli; Shang, Yanchang; Guo, Yaner; Gong, Mei; Yang, Lijuan; Shi, Xiaobing; Wu, Weiping] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Neurol, Beijing, Peoples R China; [Xu, Xian; An, Ningyu] Chinese Peoples Liberat Army Gen Hosp, Dept Radiol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Wang, ZF (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Neurol, Beijing, Peoples R China.	zhenfuw@sina.com; wuwp@vip.sina.com		Gao, Zhongbao/0000-0001-6376-9659	Chinese Central Healthcare Committee Foundation [B2009B104]; PLA general hospital [2013FC-TSYS-2008]	Chinese Central Healthcare Committee Foundation; PLA general hospital	This work was supported by Chinese Central Healthcare Committee Foundation (#B2009B104) and supportive grant for clinical research of PLA general hospital (#2013FC-TSYS-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Boeckh-Behrens T, 2012, EUR J RADIOL, V81, P1238, DOI 10.1016/j.ejrad.2011.02.057; Chowdhury MH, 2011, J STROKE CEREBROVASC, V20, P302, DOI 10.1016/j.jstrokecerebrovasdis.2009.12.010; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; Cordonnier C, 2009, STROKE, V40, P94, DOI 10.1161/STROKEAHA.108.526996; Fan YH, 2004, J NEUROL, V251, P537, DOI 10.1007/s00415-004-0359-6; Fazekas F, 1998, DEMENT GERIATR COGN, V9, P2, DOI 10.1159/000051182; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Gao TL, 2008, NEUROL RES, V30, P272, DOI 10.1179/016164107X251556; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Hatanaka R, 2011, CEREBROVASC DIS, V31, P329, DOI 10.1159/000322599; Igase M, 2009, CIRC J, V73, P530, DOI 10.1253/circj.CJ-08-0764; Jeerakathil T, 2004, STROKE, V35, P1831, DOI 10.1161/01.STR.0000131809.35202.1b; Kato H, 2002, STROKE, V33, P1536, DOI 10.1161/01.STR.0000018012.65108.86; Lee HK, 2013, INT J GERIATR PSYCHI; Lee SH, 2004, J NEUROL NEUROSUR PS, V75, P423, DOI 10.1136/jnnp.2003.015990; Liu PF, 2010, CHINESE MED J-PEKING, V123, P286, DOI 10.3760/cma.j.issn.0366-6999.2010.03.006; Liu WH, 2012, STROKE, V43, P2916, DOI 10.1161/STROKEAHA.112.658369; Murray AD, 2005, RADIOLOGY, V237, P251, DOI 10.1148/radiol.2371041496; Naganuma T, 2011, CLIN NEPHROL, V75, P346, DOI 10.5414/CNP75346; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; Seo WK, 2008, CEREBROVASC DIS, V26, P618, DOI 10.1159/000166837; Stehling C, 2008, ACAD RADIOL, V15, P895, DOI 10.1016/j.acra.2008.01.013; van Es ACGM, 2008, CEREBROVASC DIS, V26, P397, DOI 10.1159/000151680; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Vernooij MW, 2008, RADIOLOGY, V248, P272, DOI 10.1148/radiol.2481071158; Wardlaw JM, 2006, STROKE, V37, P2633, DOI 10.1161/01.STR.0000240513.00579.bf; Werring DJ, 2005, NEUROLOGY, V65, P1914, DOI 10.1212/01.wnl.0000188874.48592.f7; Yamada S, 2012, EUR J NEUROL, V19, P98, DOI 10.1111/j.1468-1331.2011.03451.x	31	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91637	10.1371/journal.pone.0091637	http://dx.doi.org/10.1371/journal.pone.0091637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626222	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300110
J	Krouchev, NI; Danner, SM; Vinet, A; Rattay, F; Sawan, M				Krouchev, Nedialko I.; Danner, Simon M.; Vinet, Alain; Rattay, Frank; Sawan, Mohamad			Energy-Optimal Electrical-Stimulation Pulses Shaped by the Least-Action Principle	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXCITABILITY; EXCITATION; CHRONAXIE; FEEDBACK; ELEMENTS	Electrical stimulation (ES) devices interact with excitable neural tissue toward eliciting action potentials (AP's) by specific current patterns. Low-energy ES prevents tissue damage and loss of specificity. Hence to identify optimal stimulation-current waveforms is a relevant problem, whose solution may have significant impact on the related medical (e. g. minimized side-effects) and engineering (e. g. maximized battery-life) efficiency. This has typically been addressed by simulation (of a given excitable-tissue model) and iterative numerical optimization with hard discontinuous constraints - e.g. AP's are all-or-none phenomena. Such approach is computationally expensive, while the solution is uncertain - e. g. may converge to local-only energy-minima and be model-specific. We exploit the Least-Action Principle (LAP). First, we derive in closed form the general template of the membrane-potential's temporal trajectory, which minimizes the ES energy integral over time and over any space-clamp ionic current model. From the given model we then obtain the specific energy-efficient current waveform, which is demonstrated to be globally optimal. The solution is model-independent by construction. We illustrate the approach by a broad set of example situations with some of the most popular ionic current models from the literature. The proposed approach may result in the significant improvement of solution efficiency: cumbersome and uncertain iteration is replaced by a single quadrature of a system of ordinary differential equations. The approach is further validated by enabling a general comparison to the conventional simulation and optimization results from the literature, including one of our own, based on finite-horizon optimal control. Applying the LAP also resulted in a number of general ES optimality principles. One such succinct observation is that ES with long pulse durations is much more sensitive to the pulse's shape whereas a rectangular pulse is most frequently optimal for short pulse durations.	[Krouchev, Nedialko I.; Sawan, Mohamad] Ecole Polytech, Montreal, PQ H3C 3A7, Canada; [Danner, Simon M.; Rattay, Frank] Univ Technol, Inst Anal & Sci Comp, Vienna, Austria; [Danner, Simon M.] Med Univ, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Vinet, Alain] Univ Montreal, Inst Genie Biomed, Montreal, PQ, Canada	Universite de Montreal; Polytechnique Montreal; Technische Universitat Wien; Universite de Montreal	Krouchev, NI (corresponding author), Ecole Polytech, Montreal, PQ H3C 3A7, Canada.	Nedialko.Krouchev@polymtl.ca	Danner, Simon M./I-7944-2012; Rattay, Frank/A-2231-2015	Danner, Simon M./0000-0002-4642-7064; Rattay, Frank/0000-0002-2819-8827	Fonds de recherche du Quebec - Nature et technologies; Natural Sciences and Engineering Research Council of Canada; Vienna Science and Technology Fund (WWTF) [LS11-057]	Fonds de recherche du Quebec - Nature et technologies; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Vienna Science and Technology Fund (WWTF)	The Fonds de recherche du Quebec - Nature et technologies and the Natural Sciences and Engineering Research Council of Canada provided funding for this work. S.D. was supported by the Vienna Science and Technology Fund (WWTF), Proj.Nr. LS11-057. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], 1901, ARCH ITAL BIOL; Danner S, 2010, J AGROQUAL, V8, P2; Danner SM, 2011, ARTIF ORGANS, V35, P257, DOI 10.1111/j.1525-1594.2011.01213.x; Dhillon GS, 2005, IEEE T NEUR SYS REH, V13, P468, DOI 10.1109/TNSRE.2005.856072; Fetz EE, 2007, J PHYSIOL-LONDON, V579, P571, DOI 10.1113/jphysiol.2006.127142; Feynman R. P., 1964, FEYNMAN LECT PHYS, V2; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Foutz TJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066008; Geddes LA, 2004, IEEE T BIO-MED ENG, V51, P176, DOI 10.1109/TBME.2003.820340; Grill W, 2010, COMMUNICATION; Hofmann Lorenz, 2011, Front Neuroeng, V4, P9, DOI 10.3389/fneng.2011.00009; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Jezernik S, 2005, IEEE T BIO-MED ENG, V52, P740, DOI 10.1109/TBME.2005.844050; kandel, 1977, NERVOUS SYSTEM, V1; Katz B, 1937, PROC R SOC SER B-BIO, V124, P244, DOI 10.1098/rspb.1937.0084; Lapicque L, 1931, J PHYSIOL-LONDON, V73, P189, DOI 10.1113/jphysiol.1931.sp002806; Lapicque L, 1907, J PHYSIOL-PARIS, V9, P622; LIBERSON W T, 1961, Arch Phys Med Rehabil, V42, P101; Lucas TH, 2013, J NEUROSCI, V33, P5261, DOI 10.1523/JNEUROSCI.4683-12.2013; Lykknes A, 2012, SCI NETWORKS HIST ST, V44; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; O'Doherty JE, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.020.2009; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Rattay F, 1999, NEUROSCIENCE, V89, P335, DOI 10.1016/S0306-4522(98)00330-3; Rattay F, 1998, IEEE T BIO-MED ENG, V45, P766, DOI 10.1109/10.678611; Rattay F, 2012, NEUROSCIENCE, V214, P1, DOI 10.1016/j.neuroscience.2012.04.004; Rattay F, 2010, NEUROSCIENCE, V170, P399, DOI 10.1016/j.neuroscience.2010.07.032; Rattay F, 1990, ELECT NERVE STIMULAT; Sage AP, 1971, MATH SCI ENG, V80; Sahin M, 2007, J NEURAL ENG, V4, P227, DOI 10.1088/1741-2560/4/3/008; Shaw RM, 1997, CIRC RES, V81, P727; Wongsarnpigoon A, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046009; Wongsarnpigoon A, 2010, IEEE T NEUR SYS REH, V18, P319, DOI 10.1109/TNSRE.2010.2047610	36	20	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90480	10.1371/journal.pone.0090480	http://dx.doi.org/10.1371/journal.pone.0090480			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625822	Green Accepted, gold, Green Published			2022-12-27	WOS:000332851300022
J	Zivadinov, R; Dwyer, MG; Markovic-Plese, S; Kennedy, C; Bergsland, N; Ramasamy, DP; Durfee, J; Hojnacki, D; Hayward, B; Dangond, F; Weinstock-Guttman, B				Zivadinov, Robert; Dwyer, Michael G.; Markovic-Plese, Silva; Kennedy, Cheryl; Bergsland, Niels; Ramasamy, Deepa P.; Durfee, Jacqueline; Hojnacki, David; Hayward, Brooke; Dangond, Fernando; Weinstock-Guttman, Bianca			Effect of Treatment with Interferon Beta-1a on Changes in Voxel-Wise Magnetization Transfer Ratio in Normal Appearing Brain Tissue and Lesions of Patients with Relapsing-Remitting Multiple Sclerosis: A 24-Week, Controlled Pilot Study	PLOS ONE			English	Article							MULTIEXPONENTIAL T-2; IN-VIVO; REMYELINATION; DEMYELINATION; REEXPRESSION; EVOLUTION; MODEL; MRI; MS	Background: This pilot study investigated changes in remyelinating and demyelinating activity in normal appearing brain tissue (NABT) and lesions, by using voxel-wise magnetization transfer ratio (VW-MTR), in patients with relapsing-remitting multiple sclerosis (RRMS) receiving interferon beta-1a 44 mcg subcutaneously (IFN beta-1a SC) three times weekly versus healthy controls (HCs) (NCT01085318). Methods: Increasing (suggestive of remyelination) and decreasing (suggestive of demyelination) VW-MTR changes in NABT and in T2, T1 and gadolinium (Gd)-enhancing lesion volume were measured over 24 weeks in 23 patients treated with IFN beta-1a SC and in 15 HCs (where applicable). VW-MTR changes were tested using the Wilcoxon signed-rank or Wilcoxon rank-sum test. Results: A trend for greater volume of NABT with increasing VW-MTR at 24 weeks was observed for patients versus HCs (median [range] 1206 [0-15278]; 342 [0-951] mm(3); p = 0.061). NABT volume with increasing VW-MTR at 12 weeks was significantly greater in patients than in HCs (852 [6-11577]; 360 [0-1755] mm(3); p = 0.028). Similar findings were detected for lesion volumes. Two patients with notably high numbers of Gd-enhancing lesions at baseline had a markedly greater volume of tissue with increasing VW-MTR compared with other patients. Volume of NABT tissue with decreasing VW-MTR was significantly greater in patients versus HCs at 24 weeks (942 [0-6141]; 297 [0-852] mm(3); p<0.001). Conclusions: The significant change in NABT volume with increasing VW-MTR at 12 weeks suggests that active remyelination in patients with RRMS may occur during treatment with IFN b-1a SC. Findings from two patients with the highest number of Gd-enhancing lesions at baseline suggest that extensive remyelination in NABT may occur in patients with high disease activity. Tissue volume with decreasing VW-MTR was greater in patients than in HCs, despite treatment, validating the sensitivity of this technique for detecting MS disease activity.	[Zivadinov, Robert; Dwyer, Michael G.; Kennedy, Cheryl; Bergsland, Niels; Ramasamy, Deepa P.; Durfee, Jacqueline] SUNY Buffalo, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA; [Zivadinov, Robert; Hojnacki, David; Weinstock-Guttman, Bianca] SUNY Buffalo, Dept Neurol, Buffalo, NY 14260 USA; [Markovic-Plese, Silva] Univ N Carolina, Dept Neurol Microbiol & Immunol, Chapel Hill, NC USA; [Hayward, Brooke; Dangond, Fernando] EMD Serono Inc, Rockland, MA USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of North Carolina; University of North Carolina Chapel Hill; Merck KGaA; EMD Serono Inc.	Zivadinov, R (corresponding author), SUNY Buffalo, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA.	rzivadinov@bnac.net	Bergsland, Niels/H-3077-2019; Weinstock-Guttman, Bianca/AAI-4694-2021; Zivadinov, Robert/Q-2054-2019; Ramasamy, Deepa/X-5780-2019	Bergsland, Niels/0000-0002-7792-0433; Weinstock-Guttman, Bianca/0000-0001-6732-151X; Zivadinov, Robert/0000-0002-7799-1485; Dwyer, Michael/0000-0003-4684-4658; Hayward, Brooke/0000-0002-1234-7445	EMD Serono, Inc., Rockland, MA a subsidiary of Merck KGaA, Darmstadt, Germany; Pfizer, Inc, New York, NY	EMD Serono, Inc., Rockland, MA a subsidiary of Merck KGaA, Darmstadt, Germany; Pfizer, Inc, New York, NY(Pfizer)	This study was sponsored by EMD Serono, Inc., Rockland, MA (www.emdserono.com/), a subsidiary of Merck KGaA, Darmstadt, Germany, and by Pfizer, Inc, New York, NY (www.pfizer.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Esther Law and Chris Grantham of Caudex Medical, who assisted in preparing the initial draft of the manuscript, collating the comments of authors and other named contributors, as well as assembling tables and figures, were supported by EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany.	Audoin B, 2007, MULT SCLER J, V13, P483, DOI 10.1177/1352458506070450; Barkhof F, 2003, ARCH NEUROL-CHICAGO, V60, P1073, DOI 10.1001/archneur.60.8.1073; Bramow S, 2010, BRAIN, V133, P2983, DOI 10.1093/brain/awq250; Brown RA, 2013, NEUROIMAGE, V66, P103, DOI 10.1016/j.neuroimage.2012.10.059; Charles P, 2002, BRAIN, V125, P1972, DOI 10.1093/brain/awf216; Chen JT, 2007, NEUROIMAGE, V36, P1152, DOI 10.1016/j.neuroimage.2007.03.073; Chen JT, 2008, ANN NEUROL, V63, P254, DOI 10.1002/ana.21302; Chen JTH, 2013, NEUROLOGY, V80, P246, DOI 10.1212/WNL.0b013e31827deb99; Deloire-Grassin MSA, 2000, J NEUROL SCI, V178, P10, DOI 10.1016/S0022-510X(00)00331-2; DOUSSET V, 1995, AM J NEURORADIOL, V16, P225; Dula AN, 2010, MAGN RESON MED, V63, P902, DOI 10.1002/mrm.22267; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Dwyer M, 2009, J NEUROL SCI, V282, P86, DOI 10.1016/j.jns.2009.03.016; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Fox RJ, 2011, NEUROL CLIN, V29, P357, DOI 10.1016/j.ncl.2010.12.011; Francis G, 2001, NEUROLOGY, V56, P1628; Gareau PJ, 2000, J MAGN RESON IMAGING, V11, P586, DOI 10.1002/1522-2586(200006)11:6<586::AID-JMRI3>3.0.CO;2-V; Giacomini PS, 2009, ARCH NEUROL-CHICAGO, V66, P375, DOI 10.1001/archneurol.2008.578; Goldschmidt T, 2009, NEUROLOGY, V72, P1914, DOI 10.1212/WNL.0b013e3181a8260a; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; McCreary CR, 2009, NEUROIMAGE, V45, P1173, DOI 10.1016/j.neuroimage.2008.12.071; Njenga MK, 2000, J NEUROSCI RES, V59, P661, DOI 10.1002/(SICI)1097-4547(20000301)59:5<661::AID-JNR9>3.0.CO;2-E; Panitch H, 2002, NEUROLOGY, V59, P1496, DOI 10.1212/01.WNL.0000034080.43681.DA; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; PRINEAS JW, 1993, BRAIN, V116, P681, DOI 10.1093/brain/116.3.681; Tjoa CW, 2008, J NEUROIMAGING, V18, P130, DOI 10.1111/j.1552-6569.2007.00198.x; Vavasour IM, 2011, J MAGN RESON IMAGING, V33, P713, DOI 10.1002/jmri.22441; Zaaraoui W, 2008, MAGN RESON MATER PHY, V21, P357, DOI 10.1007/s10334-008-0141-3; Zivadinov R, 2012, MULT SCLER J, V18, P1125, DOI 10.1177/1352458511433304; Zivadinov R, 2007, NEUROLOGY, V68, pS72, DOI 10.1212/01.wnl.0000275236.51129.d2; Zivadinov R, 2012, NEUROIMAGE, V59, P331, DOI 10.1016/j.neuroimage.2011.07.045	33	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91098	10.1371/journal.pone.0091098	http://dx.doi.org/10.1371/journal.pone.0091098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625687	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300056
J	Halley, YA; Dowd, SE; Decker, JE; Seabury, PM; Bhattarai, E; Johnson, CD; Rollins, D; Tizard, IR; Brightsmith, DJ; Peterson, MJ; Taylor, JF; Seabury, CM				Halley, Yvette A.; Dowd, Scot E.; Decker, Jared E.; Seabury, Paul M.; Bhattarai, Eric; Johnson, Charles D.; Rollins, Dale; Tizard, Ian R.; Brightsmith, Donald J.; Peterson, Markus J.; Taylor, Jeremy F.; Seabury, Christopher M.			A Draft De Novo Genome Assembly for the Northern Bobwhite (Colinus virginianus) Reveals Evidence for a Rapid Decline in Effective Population Size Beginning in the Late Pleistocene	PLOS ONE			English	Article							QT INTERVAL DURATION; ZEBRA FINCH; WIDE ASSOCIATION; QUAIL ABUNDANCE; COMMON VARIANTS; ARA-MACAO; MICROSATELLITE LOCI; SPECIES DIVERGENCE; GENETIC-VARIATION; BLOOD-PRESSURE	Wild populations of northern bobwhites (Colinus virginianus; hereafter bobwhite) have declined across nearly all of their U. S. range, and despite their importance as an experimental wildlife model for ecotoxicology studies, no bobwhite draft genome assembly currently exists. Herein, we present a bobwhite draft de novo genome assembly with annotation, comparative analyses including genome-wide analyses of divergence with the chicken (Gallus gallus) and zebra finch (Taeniopygia guttata) genomes, and coalescent modeling to reconstruct the demographic history of the bobwhite for comparison to other birds currently in decline (i.e., scarlet macaw; Ara macao). More than 90% of the assembled bobwhite genome was captured within <40,000 final scaffolds (N50 = 45.4 Kb) despite evidence for approximately 3.22 heterozygous polymorphisms per Kb, and three annotation analyses produced evidence for >14,000 unique genes and proteins. Bobwhite analyses of divergence with the chicken and zebra finch genomes revealed many extremely conserved gene sequences, and evidence for lineage-specific divergence of noncoding regions. Coalescent models for reconstructing the demographic history of the bobwhite and the scarlet macaw provided evidence for population bottlenecks which were temporally coincident with human colonization of the New World, the late Pleistocene collapse of the megafauna, and the last glacial maximum. Demographic trends predicted for the bobwhite and the scarlet macaw also were concordant with how opposing natural selection strategies (i.e., skewness in the r-/K-selection continuum) would be expected to shape genome diversity and the effective population sizes in these species, which is directly relevant to future conservation efforts.	[Halley, Yvette A.; Bhattarai, Eric; Tizard, Ian R.; Brightsmith, Donald J.; Seabury, Christopher M.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Dowd, Scot E.] Mol Res LP, Shallowater, TX USA; [Decker, Jared E.; Taylor, Jeremy F.] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Seabury, Paul M.] ElanTech Inc, Greenbelt, MD USA; [Johnson, Charles D.] Texas A&M AgriLife Res, Genom & Bioinformat Core, College Stn, TX USA; [Rollins, Dale] Rolling Plains Quail Res Ranch, Rotan, TX USA; [Peterson, Markus J.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; University of Missouri System; University of Missouri Columbia; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas A&M University System; Texas A&M University College Station	Seabury, CM (corresponding author), Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA.	cseabury@cvm.tamu.edu	Dowd, Scot E/M-5386-2017; Decker, Jared E./H-2730-2019; Peterson, Markus J/C-3303-2008	Dowd, Scot E/0000-0002-6296-1427; Decker, Jared E./0000-0001-5685-7343; Peterson, Markus J/0000-0001-6145-0134; Halley-Schultz, Yvette/0000-0002-5159-6137; Johnson, Charles/0000-0003-3892-7082; Brightsmith, Donald/0000-0002-3306-6490	Park Cities Quail; Rolling Plains Quail Research Ranch	Park Cities Quail; Rolling Plains Quail Research Ranch	The funders had no role in study design, data collection, data analysis, interpretation of the data or analyses, decision to publish, or drafting of the manuscript. This study was funded by private donations to CMS from Mr. Joe Crafton, members of Park Cities Quail, and the Rolling Plains Quail Research Ranch. DR directs the Rolling Plains Quail Research Ranch, which funded this study in part, but DR had no role in the primary analysis or interpretation of the data or analyses. DR provided reagents/materials/analysis tools and did make editorial comments and suggestions related to the final manuscript.	Allen CR, 2000, J AGR URBAN ENTOMOL, V17, P43; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; [Anonymous], 1995, SE ARCHAEOLOGY; Balakrishnan CN, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-29; Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; Baumgartner F. M., 1944, JOUR WILDLIFE MANAGEMENT, V8, P112, DOI 10.2307/3796443; BECAK ML, 1971, CHROMOSOME ATLAS FIS, V1; Blom J, 2005, ZOOLOGY, V108, P81, DOI 10.1016/j.zool.2005.02.001; Brady S.J., 1998, Gibier Faune Sauvage, V15, P413; Brausch JM, 2010, J TOXICOL ENV HEAL A, V73, P540, DOI 10.1080/15287390903566559; BRENNAN L. A., 2007, TEXAS QUAILS ECOLOGY; BRENNAN LA, 1991, WILDLIFE SOC B, V19, P544; Bridges AS, 2001, J WILDLIFE MANAGE, V65, P10, DOI 10.2307/3803270; Brightsmith D, 2005, BIOL CONSERV, V121, P465, DOI 10.1016/j.biocon.2004.05.016; BUECHNER HK, 1950, J WILDLIFE MANAGE, V14, P363, DOI 10.2307/3797265; Caparroz R, 2001, BIOL CONSERV, V99, P307, DOI 10.1016/S0006-3207(00)00196-8; Casinos A, 2001, COMP BIOCHEM PHYS A, V131, P159, DOI 10.1016/S1095-6433(01)00463-9; Church K. E., 1993, P NATL QUAIL S, V3, P44; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Companioni O, 2011, REV ESP CARDIOL, V64, P509, DOI [10.1016/j.recesp.2011.01.010, 10.1016/j.rec.2011.01.011]; DACKE CG, 1993, J EXP BIOL, V184, P63; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; del Hoyo J., 2010, HDB BIRDS WORLD, V15; Del Hoyo J., 1997, HDB BIRDS WORLD, Vthe World, Vol. 2; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Deng FY, 2010, OSTEOPOROSIS INT, V21, P579, DOI 10.1007/s00198-009-0998-7; DEVOS T, 1995, WILDLIFE SOC B, V23, P267; Dobzhansky T., 1950, American Scientist, V38, P209; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Droege S, 1990, PERDIX, P2; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Eijgelsheim M, 2010, HUM MOL GENET, V19, P3885, DOI 10.1093/hmg/ddq303; Ekblom R, 2011, IMMUNOGENETICS, V63, P523, DOI [10.1007/s00251-011-0525-9, 10.1007/s00251-011-0528-6]; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Errington PL, 1936, IOWA STATE COLL AGR, V201, P305; Ersland KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031687; Eshleman JA, 2003, EVOL ANTHROPOL, V12, P7, DOI 10.1002/evan.10048; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Evans KO, 2006, GAMEBIRD, P121; Faircloth BC, 2009, CONSERV GENET, V10, P535, DOI 10.1007/s10592-008-9559-4; Firestone RB, 2007, P NATL ACAD SCI USA, V104, P16016, DOI 10.1073/pnas.0706977104; Folk TH, 2007, POPUL ECOL, V49, P211, DOI 10.1007/s10144-007-0037-5; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Gu XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021872; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Guthery FS, 2004, WILDLIFE SOC B, V32, P194, DOI 10.2193/0091-7648(2004)32[194:RSAWRN]2.0.CO;2; Guthery FS, 2006, BOBWHITES NO 27, P213; Guthery FS, 2000, NATL QUAIL S P, P198; Hagg S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000754; HALE DW, 1988, AUK, V105, P776; Hancock DB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003098; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hemmings N, 2012, BIOL LETTERS, V8, P964, DOI 10.1098/rsbl.2012.0655; Hernandez F, 2005, WILDLIFE SOC B, V33, P1071, DOI 10.2193/0091-7648(2005)33[1071:IOPODO]2.0.CO;2; Hernandez F, 2007, TEXAS QUAILS BOOK, P40; Hernandez F, 2013, WILDLIFE SOC B, V37, P177, DOI 10.1002/wsb.223; Higgins PJ, 2006, HDB AUSTR NZ ANTARTI, V6; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hughes CR, 2008, IMMUNOGENETICS, V60, P219, DOI 10.1007/s00251-008-0287-1; Johnson MS, 2005, INT J TOXICOL, V24, P265, DOI 10.1080/10915810591007247; Johnson R, 2009, MOL BIOL EVOL, V26, P1491, DOI 10.1093/molbev/msp058; Kabat C, 1963, TECH B WIS CONSERV D, V30; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; Kitulagodage M, 2011, CHEMOSPHERE, V83, P524, DOI 10.1016/j.chemosphere.2010.12.057; Kramer PL, 2011, NEUROBIOL AGING, V32, P2113, DOI 10.1016/j.neurobiolaging.2010.01.010; Kricher J.C., 1999, NEOTROPICAL COMPANIO; Kumar S, 2011, BIOINFORMATICS, V27, P2023, DOI 10.1093/bioinformatics/btr315; Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014; Lande R., 2003, OXFORD SERIES ECOLOG; Lebeau G, 2011, LEARN MEMORY, V18, P314, DOI 10.1101/lm.2100611; Lehmann VW, 1937, INCREASE QUAIL IMPRO; Leopold A, 1931, REPORT GAME SURVEY N; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Lusk JJ, 2002, J WILDLIFE MANAGE, V66, P1040, DOI 10.2307/3802936; MAC ARTHUR ROBERT H., 1967; Madge S, 2002, PLATE 59 BOBWHITE PH; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; MARSDEN HALSEY M., 1958, JOUR WILDLIFE MANAGEMENT, V22, P414, DOI 10.2307/3796828; Mayer C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-277; McClay JL, 2011, NEUROPSYCHOPHARMACOL, V36, P616, DOI 10.1038/npp.2010.193; Meisler MH, 2001, GENOME RES, V11, P1617, DOI 10.1101/gr.211401; Menzaghi C, 2008, J INTERN MED, V263, P653, DOI 10.1111/j.1365-2796.2008.01924.x; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Middelberg RPS, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-123; Mitchell GF, 2012, CIRC-CARDIOVASC GENE, V5, P81, DOI 10.1161/CIRCGENETICS.111.959817; Mitgutsch C, 2011, ZOOL SCI, V28, P491, DOI 10.2108/zsj.28.491; Monson MS, 2013, POULTRY SCI, V92, P1523, DOI 10.3382/ps.2012-02951; Mueller JM, 1999, J WILDLIFE MANAGE, V63, P1291, DOI 10.2307/3802847; Murray JR, 2013, J MORPHOL, V274, P1090, DOI 10.1002/jmor.20165; Nachman MW, 2000, GENETICS, V156, P297; Nager R. G., 2010, The UFAW handbook on the care and management of laboratory and other research animals, P674, DOI 10.1002/9781444318777.ch43; Nei M., 2000, MOL EVOLUTION PHYLOG; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Nolan DP, 2012, SAFETY AND SECURITY REVIEW FOR THE PROCESS INDUSTRIES: APPLICATION OF HAZOP, PHA, WHAT-IF AND SVA REVIEWS, 3RD EDITION, P5, DOI 10.1016/B978-1-4377-3518-5.00002-5; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Oleksyk TK, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-14; Ottinger MA, 2005, DOMEST ANIM ENDOCRIN, V29, P411, DOI 10.1016/j.domaniend.2005.02.038; Peterson MJ, 2001, J WILDLIFE MANAGE, V65, P828, DOI 10.2307/3803032; Peterson MJ, 2002, P NATL QUAIL S, V5, P35; Peterson MJ, 2000, P NATL QUAIL S, V4, P85, DOI DOI 10.2307/3803032; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Polasek O, 2010, CROAT MED J, V50, P7; POLLOCK KH, 1989, J WILDLIFE MANAGE, V53, P1, DOI 10.2307/3801295; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Pushkina D, 2008, J HUM EVOL, V54, P769, DOI 10.1016/j.jhevol.2007.09.024; Quinn MJ, 2007, ENVIRON TOXICOL CHEM, V26, P2202, DOI 10.1897/07-123R.1; Quinn MJ, 2009, J IMMUNOTOXICOL, V6, P171, DOI 10.1080/15476910903023060; Quinn MJ, 2012, ECOTOXICOLOGY, V22, P231; Rawat A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S13; Rawat A, 2010, PHYSIOL GENOMICS, V42, P219, DOI 10.1152/physiolgenomics.00022.2010; REDFORD KH, 1987, AM ANTHROPOL, V89, P650, DOI 10.1525/aa.1987.89.3.02a00070; Reyna KS, 2012, POULTRY SCI, V91, P41, DOI 10.3382/ps.2011-01676; Reynolds SJ, 1997, AUK, V114, P562, DOI 10.2307/4089275; RINGOEN AR, 1945, J MORPHOL, V77, P265, DOI 10.1002/jmor.1050770208; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Roseberry J.L., 1984, POPULATION ECOLOGY B; Rosenberg MS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-102; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Sauer JR, 2005, J WILDLIFE MANAGE, V69, P1321, DOI 10.2193/0022-541X(2005)69[1321:UTNABB]2.0.CO;2; Sauer JR, 2012, N AM BREEDING BIRD S; Schable NA, 2004, MOL ECOL NOTES, V4, P415, DOI 10.1111/j.1471-8286.2004.00670.x; Scott JL, 2013, WILDLIFE SOC B, V37, P168, DOI 10.1002/wsb.239; Seabury CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015811; Seabury CM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pbio.1000475, DOI 10.1371/J0URNAL.PBI0.1000475]; Sheehan S, 2013, GENETICS, V194, P647, DOI 10.1534/genetics.112.149096; Shetty PB, 2012, J HYPERTENS, V30, P1970, DOI 10.1097/HJH.0b013e3283578c80; Smith EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001094; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Speake DW, 1967, THESIS AUBURN U ALAB; Starck J. Matthias, 1998, Oxford Ornithology Series, V8, P3; Stein JL, 2010, NEUROIMAGE, V53, P1160, DOI 10.1016/j.neuroimage.2010.02.032; Strem Rosa I., 2012, Open Conservation Biology Journal, V6, P12, DOI 10.2174/1874839201206010012; Terhune TM, 2010, ECOL APPL, V20, P1040, DOI 10.1890/09-1106.1; TIERSCH TR, 1991, J HERED, V82, P363, DOI 10.1093/oxfordjournals.jhered.a111105; Van Sligtenhorst I, 2012, VET PATHOL, V49, P131, DOI 10.1177/0300985811402841; Vaughan C, 2005, BIRD CONSERV INT, V15, P119; Vigo G, 2011, ORNITOL NEOTROP, V22, P143; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Waters MR, 2011, SCIENCE, V334, P351, DOI 10.1126/science.1207663; Waters MR, 2011, SCIENCE, V331, P1599, DOI 10.1126/science.1201855; Williams CK, 2004, WILDLIFE SOC B, V32, P861, DOI 10.2193/0091-7648(2004)032<0861:TNBDSO>2.0.CO;2; Williams CK, 2004, J WILDLIFE MANAGE, V68, P94, DOI 10.2193/0022-541X(2004)068[0094:WSAAHI]2.0.CO;2; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035; Zhan XJ, 2013, NAT GENET, V45, P563, DOI 10.1038/ng.2588; Zhang J, 2011, TISSUE ENG PT A, V17, P1767, DOI 10.1089/ten.tea.2010.0503	155	26	26	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90240	10.1371/journal.pone.0090240	http://dx.doi.org/10.1371/journal.pone.0090240			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621616	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300017
J	Kaltenborn, A; Bourg, CM; Gutzeit, A; Kalberer, F				Kaltenborn, Alexander; Bourg, Catherine M.; Gutzeit, Andreas; Kalberer, Fabian			The Hip Lag Sign - Prospective Blinded Trial of a New Clinical Sign to Predict Hip Abductor Damage	PLOS ONE			English	Article							GLUTEUS MEDIUS; TROCHANTERIC PAIN; TEARS; DIAGNOSIS; RUPTURE	This study introduces and validates the Hip Lag Sign, a new clinical parameter to determine hip abductor damage, which appears to be one major cause for greater trochanteric pain syndrome. 26 patients who underwent standardized MRI-examination were prospectively enrolled between October 2009 and March 2012. A standard physical examination of the hip was performed, including the Hip Lag Sign as it is defined for the first time in this work. Hip Lag Sign results were statistically compared to MR images, to pain levels measured with the visual analogue scale and to results of the modified Harris Hip Score as a universal and well established diagnostic tool for the hip. Chi(2)- and Mann-Whitney-U-analysis were applied. Diagnostic accuracy was tested with 262-table-calculations. Kappa statistics were used to analyze inter-observer variability. A positive Hip Lag Sign is significantly associated with MRI-proven hip abductor damage (p<0.001). The Hip Lag Sign has a sensitivity of 89.47% and a specificity of 96.55%. The positive and negative predictive values are 94.44%, resp. 93.33%. Its diagnostic Odds Ratio is 239.000 (p<0.001; 95%-CI: 20.031-2827.819). The number needed to diagnose was 1.16. Inter-observer consistency was 98.1% and kappa statistics for inter-observer variability were 0.911. The Hip Lag Sign is specific and sensitive, easy and fast to perform and allows a reliable assessment on the hip abductors' status, especially when there is no access to further diagnostic devices such as MRI for example due to restricted resources like in developing countries. Thus, we recommend the inclusion of the Hip Lag Sign into everyday hip examinations, especially dealing with patients suffering from greater trochanteric pain syndrome.	[Kaltenborn, Alexander; Bourg, Catherine M.; Kalberer, Fabian] Kantonsspital Winterthur, Dept Orthoped Surg, Winterthur, Switzerland; [Kaltenborn, Alexander] Fed Armed Forces Hosp Westerstede, Dept Trauma & Orthoped Surg, Westerstede, Germany; [Kaltenborn, Alexander] Hannover Med Sch, Dept Gen Visceral & Transplant Surg, Hannover, Germany; [Gutzeit, Andreas] Kantonsspital Winterthur, Dept Radiol, Winterthur, Switzerland; [Gutzeit, Andreas] Paracelsus Med Univ Salzburg, Dept Radiol, Salzburg, Austria	Hannover Medical School; Paracelsus Private Medical University	Kaltenborn, A (corresponding author), Kantonsspital Winterthur, Dept Orthoped Surg, Winterthur, Switzerland.	alexander.kaltenborn@gmail.com						Aepli-Schneider N, 2012, Z RHEUMATOL, V71, P68, DOI 10.1007/s00393-011-0919-y; Bard Herve, 2009, Rev Prat, V59, P463; Bird PA, 2001, ARTHRITIS RHEUM, V44, P2138, DOI 10.1002/1529-0131(200109)44:9<2138::AID-ART367>3.0.CO;2-M; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Bunker TD, 1997, J BONE JOINT SURG BR, V79B, P618, DOI 10.1302/0301-620X.79B4.7033; Cormier G, 2006, JOINT BONE SPINE, V73, P411, DOI 10.1016/j.jbspin.2006.01.021; Cvitanic O, 2004, AM J ROENTGENOL, V182, P137, DOI 10.2214/ajr.182.1.1820137; Domb BG, 2010, ARTHROSCOPY, V26, P1697, DOI 10.1016/j.arthro.2010.06.002; GOTTSCHALK F, 1989, J ANAT, V166, P179; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; Jeanneret Luc, 2008, Rev Med Suisse, V4, P1226; Kaltenborn A, 2013, MIL MED, V178, P937, DOI 10.7205/MILMED-D-13-00242; Kingzett-Taylor A, 1999, AM J ROENTGENOL, V173, P1123, DOI 10.2214/ajr.173.4.10511191; Klauser AS, 2013, SEMIN MUSCULOSKEL R, V17, P43, DOI 10.1055/s-0033-1333913; Lachiewicz PF, 2011, J AM ACAD ORTHOP SUR, V19, P385, DOI 10.5435/00124635-201107000-00001; Marchetti P, 2005, J ARTHROPLASTY, V20, P730, DOI 10.1016/j.arth.2004.11.019; Strauss EJ, 2010, SPORTS MED ARTHROSC, V18, P113, DOI 10.1097/JSA.0b013e3181e0b2ff; Sutter R, 2013, SKELETAL RADIOL, V42, P627, DOI 10.1007/s00256-012-1514-2; Voos JE, 2007, ARTHROSCOPY, V23, DOI 10.1016/j.arthro.2006.12.014	19	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91560	10.1371/journal.pone.0091560	http://dx.doi.org/10.1371/journal.pone.0091560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622208	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300105
J	Mejean, C; Macouillard, P; Peneau, S; Lassale, C; Hercberg, S; Castetbon, K				Mejean, Caroline; Macouillard, Pauline; Peneau, Sandrine; Lassale, Camille; Hercberg, Serge; Castetbon, Katia			Association of Perception of Front-of-Pack Labels with Dietary, Lifestyle and Health Characteristics	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; NUTRITION INFORMATION; NATIONAL NUTRITION; FRENCH NUTRITION; FOOD LABELS; CONSUMERS; PROGRAM; IMPACT; RECOMMENDATIONS; ACCEPTABILITY	Objective: To identify patterns of perception of front-of-pack (FOP) nutrition labels and determine dietary, lifestyle and health profiles related to such patterns. Design: Cross-sectional. Participants/Setting: 28,952 French adults participating in the web-based Nutrinet-Sante cohort. Outcome measures: Perception was measured using indicators of understanding and acceptability for three simple FOP labels ("green tick'', the logo of the French Nutrition and Health Program and "simple traffic lights'' (STL)), and two detailed FOP formats ("multiple traffic lights'' (MTL) and "color range'' logo (CR)), placed on ready-to-eat soup packages. Dietary intake data were collected using three web-based 24 h records. Statistical analyses: Associations of perception patterns with individual characteristics, including diet, lifestyle and health status, were examined using analysis of covariance and logistic regression, adjusted for socio-demographic and economic factors. Results: No clear trend emerged concerning differences in dietary intake between perception groups. Low physical activity and obesity were more frequent in the 'favorable to STL' group (respectively, 20.7% and 10.7%). The 'favorable to MTL' group included the highest percentage of individuals who declared type 2 diabetes (2.2%). Persons with hypertension were proportionally more numerous in the 'favorable to MTL' and the 'favorable to CR logo' groups (respectively, 9.5% and 9.3%). Conclusions: After adjustment for socio-demographic and economic factors, no FOP label stood out as being more suitable than another for reaching populations with poor diet. However, both STL and MTL may be most appropriate for increasing awareness of healthy eating among groups at higher risk of nutrition-related chronic diseases.	[Mejean, Caroline; Macouillard, Pauline; Peneau, Sandrine; Lassale, Camille; Hercberg, Serge] Univ Paris 07, Univ Paris 05, Ctr Rech Epidemiol & Biostat, Inserm U1153,Inra U1125,Cnam,Univ Paris 13,Sorbon, Bobigny, France; [Hercberg, Serge; Castetbon, Katia] Univ Paris 13, Unite Surveillance & Epidemiol Nutr USEN, Sorbonne Paris Cite, Ctr Rech Epidemiol & Biostat, Bobigny, France; [Hercberg, Serge] Hop Avicenne, Dept Publ Hlth, F-93009 Bobigny, France; [Castetbon, Katia] Inst Veille Sanit InVS, Dept Maladies Chron & Traumatisme, Unite Surveillance & Epidemiol Nutr USEN, St Maurice, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Institute of Public Health Surveillance	Mejean, C (corresponding author), Univ Paris 07, Univ Paris 05, Ctr Rech Epidemiol & Biostat, Inserm U1153,Inra U1125,Cnam,Univ Paris 13,Sorbon, Bobigny, France.	c.mejean@uren.smbh.univ-paris13.fr	Castetbon, Katia/F-2686-2017; Serge, Hercberg/F-3038-2017; Lassale, Camille/ABE-7813-2020; HERCBERG, Serge/B-4429-2008; Mejean, Caroline/F-2792-2017; Peneau, Sandrine/F-2701-2017	Serge, Hercberg/0000-0002-3168-1350; Lassale, Camille/0000-0002-9340-2708; HERCBERG, Serge/0000-0002-3168-1350; Mejean, Caroline/0000-0001-6467-5056; Peneau, Sandrine/0000-0002-3463-0989; CASTETBON, Katia/0000-0002-1207-6729; Macouillard, Pauline/0000-0003-0110-2415	French National Research Agency (Agence Nationale de la Recherche) [ANR-07-PNRA-018]; Ministere de la Sante (DGS); Ministere de la Sante (French Ministry of Health); Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM); Institut de Recherche en Sante Publique (IRESP); Institut National de la Sante et de la Recherche Medicale (INSERM); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13	French National Research Agency (Agence Nationale de la Recherche)(French National Research Agency (ANR)); Ministere de la Sante (DGS); Ministere de la Sante (French Ministry of Health); Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut de Recherche en Sante Publique (IRESP); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13	This work was supported by the French National Research Agency (Agence Nationale de la Recherche; http://www.agence-nationale-recherche.fr/en/project-based-funding-to-advance-french-research/) within the PNRA 2007 program (ANR-07-PNRA-018). The Nutrinet-Sante study is supported by the following institutions: Ministere de la Sante (DGS; French Ministry of Health), Institut de Veille Sanitaire (InVS; http://www.invs.sante.fr/en), Institut National de la Prevention et de l'Education pour la Sante (INPES; http://www.inpes.sante.fr), Fondation pour la Recherche Medicale (FRM; http://www.frm.org/), Institut de Recherche en Sante Publique (IRESP; http://www.iresp.net/organisation/presentation-in-english/), Institut National de la Sante et de la Recherche Medicale (INSERM; http://english.inserm.fr/), Institut National de la Recherche Agronomique (INRA; http://www.inra.fr/en/), Conservatoire National des Arts et Metiers (CNAM; http://the.cnam.eu/) and Universite Paris 13 (http://www.univ-paris13.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anses/ CIQUAL (Agence nationale de securite sanitaire de l'alimentation de l'environnement et du travail/ Centre d'information sur la qualite des aliments), 2012, FRENCH FOOD COMP TAB; Bittmann RM, 2007, EXPERT SYST, V24, P171, DOI 10.1111/j.1468-0394.2007.00428.x; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Bonsmann SSG, 2010, EUR J CLIN NUTR, V64, P1379, DOI 10.1038/ejcn.2010.179; Bonsmann SSG, 2010, EUR J CLIN NUTR, V64, pS14, DOI 10.1038/ejcn.2010.204; Bonsmann SSG, 2012, CURR OBES REP, V1, P134, DOI 10.1007/s13679-012-0020-0; Borgmeier I, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-184; Brussaard JH, 2002, EUR J CLIN NUTR, V56, pS89, DOI 10.1038/sj.ejcn.1601432; Campos S, 2011, PUBLIC HEALTH NUTR, V14, P1496, DOI 10.1017/S1368980010003290; Castetbon K, 2009, BRIT J NUTR, V102, P733, DOI 10.1017/S0007114509274745; Cowburn G, 2005, PUBLIC HEALTH NUTR, V8, P21, DOI [10.1079/PHN2005666, 10.1079/PHN2004666]; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Darmon N, 2009, AM J CLIN NUTR, V89, P1227, DOI 10.3945/ajcn.2008.26465; Estaquio C, 2009, J AM DIET ASSOC, V109, P1031, DOI 10.1016/j.jada.2009.03.012; Everitt B. S., 2001, CLUSTER ANAL; Feunekes GI, 2008, APPETITE, V50, P57, DOI 10.1016/j.appet.2007.05.009; Food Standards Agency, 2005, QUANT EV ALT FOOD SI; Gorton D, 2009, PUBLIC HEALTH NUTR, V12, P1359, DOI 10.1017/S1368980008004059; Grunert K. G., 2009, PAN EUROPEAN CONSUME; Grunert KG, 2007, J PUBLIC HEALTH-HEID, V15, P385, DOI 10.1007/s10389-007-0101-9; Grunert KG, 2010, APPETITE, V55, P177, DOI 10.1016/j.appet.2010.05.045; Hawley K.L., 2012, PUBLIC HEALTH NUTR, V1, P1; Hercberg S, 2005, TABLE COMPOSITION SU; Hercberg S, 2008, INT J PUBLIC HEALTH, V53, P68, DOI 10.1007/s00038-008-7016-2; Hersey JC, 2013, NUTR REV, V71, P1, DOI 10.1111/nure.12000; Hodgkins C, 2012, APPETITE, V59, P806, DOI 10.1016/j.appet.2012.08.014; INSEE, 2011, FRENCH NAT CENS DAT; Kelly B, 2009, HEALTH PROMOT INT, V24, P120, DOI 10.1093/heapro/dap012; Keppel G., 2004, DESIGN ANAL RES HDB; Kessler H, 1999, DIABETES EDUCATOR, V25, P549, DOI 10.1177/014572179902500407; Kim WK, 2009, NUTR RES PRACT, V3, P300, DOI 10.4162/nrp.2009.3.4.300; Kreuter MW, 1997, AM J PREV MED, V13, P277, DOI 10.1016/S0749-3797(18)30175-2; Lang JE, 2000, J AM DIET ASSOC, V100, P804, DOI 10.1016/S0002-8223(00)00234-0; Larsson I, 1999, EUR J CLIN NUTR, V53, P776, DOI 10.1038/sj.ejcn.1600839; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Lewis JE, 2009, AM J CLIN NUTR, V90, P1351, DOI 10.3945/ajcn.2009.27684; Malon A, 2010, J AM DIET ASSOC, V110, P848, DOI 10.1016/j.jada.2010.03.027; Mejean C, 2013, J HUM NUTR DIET, V26, P494, DOI 10.1111/jhn.12039; Mejean C, 2013, PUBLIC HEALTH NUTR, V16, P392, DOI 10.1017/S1368980012003515; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Moser A, 2010, J VERBRAUCH LEBENSM, V5, P169, DOI 10.1007/s00003-009-0531-0; Moullec N. le, 1996, Cahiers de Nutrition et de Dietetique, V31, P158; Nielsen J., 1993, USABILITY ENG; Rayner M, 2001, J NUTR EDUC, V33, P24, DOI 10.1016/S1499-4046(06)60006-7; Sacks G, 2009, HEALTH PROMOT INT, V24, P344, DOI 10.1093/heapro/dap032; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Touvier M, 2011, BRIT J NUTR, V105, P1055, DOI 10.1017/S0007114510004617; Visschers VHM, 2010, PUBLIC HEALTH NUTR, V13, P1099, DOI 10.1017/S1368980009993235; Vyth EL, 2010, PUBLIC HEALTH NUTR, V13, P1882, DOI 10.1017/S1368980010000637; Vyth EL, 2009, J HEALTH COMMUN, V14, P631, DOI 10.1080/10810730903204247; Which?, 2006, HLTH SIGNS; Willett W., 2012, NUTR EPIDEMIOLOGY; World Health Organization, 1995, PHYS STAT US INT ANT; Young L, 2002, HEALTH PROMOT INT, V17, P13, DOI 10.1093/heapro/17.1.13	54	19	20	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90971	10.1371/journal.pone.0090971	http://dx.doi.org/10.1371/journal.pone.0090971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24621617	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300039
J	Shukrun, R; Vivante, A; Pleniceanu, O; Vax, E; Anikster, Y; Dekel, B; Lotan, D				Shukrun, Rachel; Vivante, Asaf; Pleniceanu, Oren; Vax, Einav; Anikster, Yair; Dekel, Benjamin; Lotan, Danny			A Human Integrin-alpha 3 Mutation Confers Major Renal Developmental Defects	PLOS ONE			English	Article							STEM/PROGENITOR CELLS; EXTRACELLULAR-MATRIX; KIDNEY DEVELOPMENT; DISEASE; RECEPTORS; LUNG; EXPRESSION; UPDATE	The development of the mammalian kidney is a highly complex process dependent upon the interplay of various cell types, secreted morphogens, and the extra-cellular matrix (ECM). Although integrins are the most important receptors for ECM proteins and are ubiquitously expressed during kidney development, mice lacking expression of integrin alpha 3 (Itga3) do not demonstrate a reduced number of nephrons, but mostly a disorganized GBM (glomerular basement membrane) leading to proteinuria. Thus, ITGA3 is considered mostly a passive GBM stabilizer and not an active player in nephrogenesis. Recently, mutations in the human ITGA3 were shown to cause congenital nephrotic syndrome, epidermolysis bullosa and interstitial lung disease, otherwise termed NEP syndrome (Nephrotic syndrome, Epidermolysis bullosa and Pulmonary disease). Herein, we performed histological and molecular analysis on the kidneys of a single patient from the initial cohort harboring an ITGA3 mutation, to illuminate the role of ITGA3 in human renal development. We show the patient to harbor a unique phenotype at birth, including severe unilateral renal hypodysplasia. Interrogation of global gene expression in the hypodysplastic kidney versus three controls (fetal, child and adult kidneys) revealed perturbed expression in several renal developmental pathways implicated in hypodysplasia, including the Wnt, BMP (bone morphogenetic protein) and TGF (transforming growth factor) pathways. Moreover, the affected kidney showed upregulation of early embryonic genes (e. g. OCT4 and PAX8) concomitant with downregulated kidney differentiation markers, implying a defect in proper renal differentiation. In conclusion, we show for the first time that ITGA3 is not merely a passive anchor for renal ECM proteins, as predicted by mouse models. Instead, our results may suggest it plays a central role in the interplay of cells, morphogens and ECM, required for proper nephrogenesis, thus adding ITGA3 to the list of CAKUT (congenital anomalies of the kidney and urinary tract)-causing genes.	[Shukrun, Rachel; Vivante, Asaf; Pleniceanu, Oren; Vax, Einav; Dekel, Benjamin; Lotan, Danny] Edmond & Lili Safra Childrens Hosp, Sheba Med Ctr, Pediat Stem Cell Res Inst, Ramat Gan, Israel; [Shukrun, Rachel; Vivante, Asaf; Pleniceanu, Oren; Vax, Einav; Anikster, Yair; Dekel, Benjamin; Lotan, Danny] Sheba Med Ctr, Sheba Ctr Regenerat Med & Canc Res, Ramat Gan, Israel; [Anikster, Yair; Dekel, Benjamin; Lotan, Danny] Safra Childrens Hosp, Sheba Med Ctr, Dept Pediat & Pediat Nephrol, Ramat Gan, Israel; [Shukrun, Rachel; Vivante, Asaf; Pleniceanu, Oren; Vax, Einav; Dekel, Benjamin; Lotan, Danny] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Dekel, B (corresponding author), Edmond & Lili Safra Childrens Hosp, Sheba Med Ctr, Pediat Stem Cell Res Inst, Ramat Gan, Israel.	benjamin.dekel@gmail.com		/0000-0003-0537-4469	Israeli Society of Clinical Pediatrics; Bretler Foundation; Sackler School of Medicine, Tel-Aviv University; Israeli Ministry of Health	Israeli Society of Clinical Pediatrics; Bretler Foundation; Sackler School of Medicine, Tel-Aviv University; Israeli Ministry of Health	This work was supported in part by the Israeli Society of Clinical Pediatrics, The Bretler Foundation, Sackler School of Medicine, Tel-Aviv University and the Israeli Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER S, 1992, AM J PATHOL, V141, P571; Avni EF, 2011, PEDIATR RADIOL, V41, P76, DOI 10.1007/s00247-010-1793-5; Benoit G, 2010, PEDIATR NEPHROL, V25, P1621, DOI 10.1007/s00467-010-1495-0; Bertram JF, 2011, PEDIATR NEPHROL, V26, P1529, DOI 10.1007/s00467-011-1843-8; Dekel B, 2006, J AM SOC NEPHROL, V17, P3300, DOI 10.1681/ASN.2005020195; EKBLOM P, 1991, AM J KIDNEY DIS, V17, P603, DOI 10.1016/S0272-6386(12)80329-5; Has C, 2012, NEW ENGL J MED, V366, P1508, DOI 10.1056/NEJMoa1110813; Jain S, 2007, PEDIATR NEPHROL, V22, P962, DOI 10.1007/s00467-007-0466-6; Kanwar YS, 2004, AM J PHYSIOL-RENAL, V286, pF202, DOI 10.1152/ajprenal.00157.2003; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Kreidberg JA, 2000, AM J PHYSIOL-RENAL, V279, pF233, DOI 10.1152/ajprenal.2000.279.2.F233; Lelongt B, 2003, PEDIATR NEPHROL, V18, P731, DOI 10.1007/s00467-003-1153-x; Little MH, 2012, COLD SPRING HARB PER, V4; Liu YJ, 2009, DEVELOPMENT, V136, P843, DOI 10.1242/dev.027805; Mathew S, 2012, PEDIATR NEPHROL, V27, P891, DOI 10.1007/s00467-011-1890-1; Miner JH, 2000, DEV BIOL, V217, P278, DOI 10.1006/dbio.1999.9546; Nicolaou N, 2012, J CLIN INVEST, V122, P4375, DOI 10.1172/JCI64100; Pleniceanu O, 2010, STEM CELLS, V28, P1649, DOI 10.1002/stem.486; RAHILLY MA, 1992, J PATHOL, V167, P327, DOI 10.1002/path.1711670311; Sachs N, 2006, J CELL BIOL, V175, P33, DOI 10.1083/jcb.200603073; Vivante A, 2013, J AM SOC NEPHROL, V24, P550, DOI 10.1681/ASN.2012010097	21	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90879	10.1371/journal.pone.0090879	http://dx.doi.org/10.1371/journal.pone.0090879			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621570	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300033
J	Ho, HN; Van Doorn, GH; Kawabe, T; Watanabe, J; Spence, C				Ho, Hsin-Ni; Van Doorn, George H.; Kawabe, Takahiro; Watanabe, Junji; Spence, Charles			Colour-Temperature Correspondences: When Reactions to Thermal Stimuli Are Influenced by Colour	PLOS ONE			English	Article							APPARENT WARMTH; IMPLICIT; COOL; HUE	In our daily lives, information concerning temperature is often provided by means of colour cues, with red typically being associated with warm/hot, and blue with cold. While such correspondences have been known about for many years, they have primarily been studied using subjective report measures. Here we examined this correspondence using two more objective response measures. First, we used the Implicit Association Test (IAT), a test designed to assess the strength of automatic associations between different concepts in a given individual. Second, we used a priming task that involved speeded target discrimination in order to assess whether priming colour or thermal information could invoke the crossmodal association. The results of the IAT confirmed that the association exists at the level of response selection, thus indicating that a participant's responses to colour or thermal stimuli are influenced by the colour-temperature correspondence. The results of the priming experiment revealed that priming a colour affected thermal discrimination reaction times (RTs), but thermal cues did not influence colour discrimination responses. These results may therefore provide important clues as to the level of processing at which such colour-temperature correspondences are represented.	[Ho, Hsin-Ni; Kawabe, Takahiro; Watanabe, Junji] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan; [Van Doorn, George H.] Federat Univ, Sch Appl Media & Social Sci, Churchill, Vic, Australia; [Spence, Charles] Univ Oxford, Dept Expt Psychol, Crossmodal Res Lab, Oxford OX1 3UD, England	Nippon Telegraph & Telephone Corporation; Federation University Australia; University of Oxford	Ho, HN (corresponding author), NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan.	ho.hsinni@lab.ntt.co.jp	Ho, Hsin-Ni/AAV-5590-2021	Ho, Hsin-Ni/0000-0002-9940-9089; Van Doorn, George/0000-0001-7311-7099				Ballesteros S, 2008, EXP BRAIN RES, V189, P473, DOI 10.1007/s00221-008-1441-6; BENNETT CA, 1972, HUM FACTORS, V14, P149, DOI 10.1177/001872087201400204; BERRY PC, 1961, J APPL PSYCHOL, V45, P248, DOI 10.1037/h0040221; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Deroy O, 2013, PSYCHON B REV, V20, P643, DOI 10.3758/s13423-013-0387-2; Ernst MO, 2007, J VISION, V7, DOI 10.1167/7.5.7; Evans KK, 2010, J VISION, V10, DOI 10.1167/10.1.6; Fenko A, 2010, MATER DESIGN, V31, P1325, DOI 10.1016/j.matdes.2009.09.008; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hardin CL, 2000, J CONSCIOUSNESS STUD, V7, P113; KEARNEY GE, 1966, AUST J PSYCHOL, V18, P271, DOI 10.1080/00049536608255549; Kim SH, 1998, BIOL RHYTHM RES, V29, P151, DOI 10.1076/brhm.29.2.151.1449; Kumakura E, 2013, OPAM 21 ANN M TOR CA; Liu B, 2012, NEUROSCIENCE, V223, P21, DOI 10.1016/j.neuroscience.2012.06.009; Marks L. E., 2004, HDB MULTISENSORY PRO, P85; Marks LE, 2000, VARIETIES OF ANOMALOUS EXPERIENCE: EXAMINING THE SCIENTIFIC EVIDENCE, P121, DOI 10.1037/10371-004; Michael GA, 2008, NEUROSCI LETT, V436, P141, DOI 10.1016/j.neulet.2008.03.007; Michael GA, 2010, BEHAV BRAIN RES, V207, P418, DOI 10.1016/j.bbr.2009.10.027; MORGAN GA, 1975, AM J PSYCHOL, V88, P125, DOI 10.2307/1421671; Neely J. H., 1991, BASIC PROCESSES READ, P264, DOI DOI 10.1016/J.BRAINRES.2007.05.058; Parise CV, 2012, EXP BRAIN RES, V220, P319, DOI 10.1007/s00221-012-3140-6; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Piqueras-Fiszman B, 2012, FOOD QUAL PREFER, V25, P148, DOI 10.1016/j.foodqual.2012.02.010; Rossell SL, 2004, EMOTION, V4, P354, DOI 10.1037/1528-3542.4.4.354; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Stone NJ, 2001, J ENVIRON PSYCHOL, V21, P179, DOI 10.1006/jevp.2000.0193; Taft C, 1992, CROSS NATL COMP COLO; Tinker MA, 1938, AM J PSYCHOL, V51, P532, DOI 10.2307/1416154; Tomaselli KG., 2001, CULTURAL STUDIES CRI, V1, P283; Walker P, 2012, PERCEPTION, V41, P620, DOI 10.1068/p7195; Ward J, 2006, CORTEX, V42, P264, DOI 10.1016/S0010-9452(08)70352-6; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; WRIGHT B, 1962, AM J PSYCHOL, V75, P232, DOI 10.2307/1419606	34	53	53	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91854	10.1371/journal.pone.0091854	http://dx.doi.org/10.1371/journal.pone.0091854			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24618675	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400136
J	Xie, P; Guo, F; Ma, YY; Zhu, HL; Wang, FD; Xue, BZ; Shi, H; Yang, J; Yu, LQ				Xie, Ping; Guo, Feng; Ma, Yinyan; Zhu, Hongling; Wang, Freddy; Xue, Bingzhong; Shi, Hang; Yang, Jian; Yu, Liqing			Intestinal Cgi-58 Deficiency Reduces Postprandial Lipid Absorption	PLOS ONE			English	Article							CHANARIN-DORFMAN-SYNDROME; PICK C1-LIKE 1; STORAGE DISEASE; FAT-ABSORPTION; HEPATIC STEATOSIS; TRIGLYCERIDE; MICE; CHOLESTEROL; DROPLETS; LIVER	Comparative Gene Identification-58 (CGI-58), a lipid droplet (LD)-associated protein, promotes intracellular triglyceride (TG) hydrolysis in vitro. Mutations in human CGI-58 cause TG accumulation in numerous tissues including intestine. Enterocytes are thought not to store TG-rich LDs, but a fatty meal does induce temporary cytosolic accumulation of LDs. Accumulated LDs are eventually cleared out, implying existence of TG hydrolytic machinery in enterocytes. However, identities of proteins responsible for LD-TG hydrolysis remain unknown. Here we report that intestine-specific inactivation of CGI-58 in mice significantly reduces postprandial plasma TG concentrations and intestinal TG hydrolase activity, which is associated with a 4-fold increase in intestinal TG content and large cytosolic LD accumulation in absorptive enterocytes during the fasting state. Intestine-specific CGI-58 knockout mice also display mild yet significant decreases in intestinal fatty acid absorption and oxidation. Surprisingly, inactivation of CGI-58 in intestine significantly raises plasma and intestinal cholesterol, and reduces hepatic cholesterol, without altering intestinal cholesterol absorption and fecal neutral sterol excretion. In conclusion, intestinal CGI-58 is required for efficient postprandial lipoprotein-TG secretion and for maintaining hepatic and plasma lipid homeostasis. Our animal model will serve as a valuable tool to further define how intestinal fat metabolism influences the pathogenesis of metabolic disorders, such as obesity and type 2 diabetes.	[Xie, Ping; Guo, Feng; Ma, Yinyan; Wang, Freddy; Yu, Liqing] Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27109 USA; [Xie, Ping] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Xie, Ping] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ma, Yinyan; Zhu, Hongling; Yu, Liqing] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Xue, Bingzhong; Shi, Hang] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Yang, Jian] Univ S Alabama, Coll Med, Dept Physiol, Mobile, GA USA	Wake Forest University; Wake Forest University School of Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University System of Maryland; University of Maryland College Park; University System of Georgia; Georgia State University	Yu, LQ (corresponding author), Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27109 USA.	Lyu123@Umd.Edu		Zhu, Hongling/0000-0003-0612-009X	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK085176, R01DK084172]; National Heart, Lung and Blood Institute [R01HL107500]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085176, R01DK084172] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Award Numbers R01DK085176 (LY) and R01DK084172 (HS) from the National Institute of Diabetes and Digestive and Kidney Diseases, and R01HL107500 (BX) from the National Heart, Lung and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JM, 2007, J LIPID RES, V48, P2295, DOI 10.1194/jlr.M700279-JLR200; Brown JM, 2010, J LIPID RES, V51, P3306, DOI 10.1194/jlr.M010256; Bruno C, 2008, BIOCHEM BIOPH RES CO, V369, P1125, DOI 10.1016/j.bbrc.2008.03.010; Cartwright IJ, 2000, J LIPID RES, V41, P1728; CHANARIN I, 1975, BRIT MED J, V1, P553, DOI 10.1136/bmj.1.5957.553; DORFMAN ML, 1974, ARCH DERMATOL, V110, P261, DOI 10.1001/archderm.110.2.261; FILER LJ, 1969, J NUTR, V99, P293, DOI 10.1093/jn/99.3.293; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Guo F, 2013, J LIPID RES, V54, P2109, DOI 10.1194/jlr.M035519; Igal RA, 1997, J PEDIATR GASTR NUTR, V25, P541, DOI 10.1097/00005176-199711000-00011; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; Jia L, 2010, J LIPID RES, V51, P3135, DOI 10.1194/jlr.M006353; Jia L, 2010, J LIPID RES, V51, P3024, DOI 10.1194/jlr.M008599; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; MIRANDA A, 1979, MUSCLE NERVE, V2, P1, DOI 10.1002/mus.880020102; Petit V, 2007, J LIPID RES, V48, P278, DOI 10.1194/jlr.M600283-JLR200; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; Robertson MD, 2003, GUT, V52, P834, DOI 10.1136/gut.52.6.834; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Tang WQ, 2008, ARTERIOSCL THROM VAS, V28, P448, DOI 10.1161/ATVBAHA.107.160465; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Turley SD, 2003, CURR OPIN LIPIDOL, V14, P233, DOI 10.1097/00041433-200306000-00002; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Zhu JB, 2009, J LIPID RES, V50, P1080, DOI 10.1194/jlr.M800555-JLR200	31	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91652	10.1371/journal.pone.0091652	http://dx.doi.org/10.1371/journal.pone.0091652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618586	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400112
J	Lindberg, AS; Oksa, J; Malm, C				Lindberg, Ann-Sofie; Oksa, Juha; Malm, Christer			Laboratory or Field Tests for Evaluating Firefighters' Work Capacity?	PLOS ONE			English	Article							CONTAINED BREATHING APPARATUS; PHYSICAL-FITNESS; PHYSIOLOGICAL DEMANDS; MUSCLE STRENGTH; ABILITY TEST; PERFORMANCE; FIRE; RESPONSES; GENDER; TASK	Muscle strength is important for firefighters work capacity. Laboratory tests used for measurements of muscle strength, however, are complicated, expensive and time consuming. The aims of the present study were to investigate correlations between physical capacity within commonly occurring and physically demanding firefighting work tasks and both laboratory and field tests in full time (N = 8) and part-time (N = 10) male firefighters and civilian men (N = 8) and women (N = 12), and also to give recommendations as to which field tests might be useful for evaluating firefighters' physical work capacity. Laboratory tests of isokinetic maximal (IM) and endurance (IE) muscle power and dynamic balance, field tests including maximal and endurance muscle performance, and simulated firefighting work tasks were performed. Correlations with work capacity were analyzed with Spearman's rank correlation coefficient (r(s)). The highest significant (p<0.01) correlations with laboratory and field tests were for Cutting: IE trunk extension (r(s) = 0.72) and maximal hand grip strength (r(s) = 0.67), for Stairs: IE shoulder flexion (r(s) = -0.81) and barbell shoulder press (r(s) = -0.77), for Pulling: IE shoulder extension (r(s) = -0.82) and bench press (r(s) = -0.85), for Demolition: IE knee extension (r(s) = 0.75) and bench press (r(s) = 0.83), for Rescue: IE shoulder flexion (r(s) = -0.83) and bench press (r(s) = -0.82), and for the Terrain work task: IE trunk flexion (r(s) = -0.58) and upright barbell row (r(s) = -0.70). In conclusion, field tests may be used instead of laboratory tests. Maximal hand grip strength, bench press, chin ups, dips, upright barbell row, standing broad jump, and barbell shoulder press were strongly correlated (r(s)>= 0.7) with work capacity and are therefore recommended for evaluating firefighters work capacity.	[Lindberg, Ann-Sofie; Malm, Christer] Umea Univ, Sports Med Unit, Umea, Sweden; [Lindberg, Ann-Sofie; Malm, Christer] Winternet, Boden, Sweden; [Oksa, Juha] Finnish Inst Occupat Hlth, Phys Work Capac Team, Oulu, Finland	Umea University; Finnish Institute of Occupational Health	Lindberg, AS (corresponding author), Umea Univ, Sports Med Unit, Umea, Sweden.	ann-sofie.lindberg@winter-net.se	Malm, Christer B/O-3458-2014	Malm, Christer B/0000-0002-8436-2476	Swedish Civil Contingencies Agency (SCCA)	Swedish Civil Contingencies Agency (SCCA)	This work was supported by the Swedish Civil Contingencies Agency (SCCA) (https://www.msb.se/). The funder had no role in study design, data	Adams GM, 2002, EXERCISE PHYSL LAB M, P62; [Anonymous], 2013, WORK CAPACITY EVALUA; Arbetsmiljoverket, 2005, MED KONTROLLER ARBET, P18; Attenborough AS, 2012, J SPORT SCI, V30, P449, DOI 10.1080/02640414.2011.616949; Bakri I, 2012, ERGONOMICS, V55, P782, DOI 10.1080/00140139.2012.663506; Barnekow-Bergkvist M, 2004, ERGONOMICS, V47, P1238, DOI 10.1080/00140130410001714751; Barr D, 2010, APPL ERGON, V41, P161, DOI 10.1016/j.apergo.2009.07.001; Bergkvist M, 1992, UTVARDERING TEST BED; Bilzon JLJ, 2001, ERGONOMICS, V44, P766, DOI 10.1080/00140130118253; Brown LE, 2001, J EXERC PHYSL ONLINE, V4; Carlsson M, 2012, J STRENGTH COND RES, V26, P1496, DOI 10.1519/JSC.0b013e318231a799; Cruz-Gomez NS, 2011, OBESITY FACTS, V4, P212, DOI 10.1159/000329408; Greve JMD, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/850424; DAVIS PO, 1982, MED SCI SPORT EXER, V14, P65, DOI 10.1249/00005768-198201000-00013; Dreger RW, 2007, APPL PHYSIOL NUTR ME, V32, P454, DOI 10.1139/H07-020; Dreger RW, 2006, ERGONOMICS, V49, P911, DOI 10.1080/00140130600667451; Dusick D, 2011, SPEARMAN RANK CORREL; Flanagan SD, 2014, J STRENGTH COND RES, V28, P2437, DOI 10.1519/JSC.0000000000000337; Garver JN, 2005, J STRENGTH COND RES, V19, P310; Gavhed D, 2001, BRANDMANNENS FYSISKA; GAVHED DCE, 1989, EUR J APPL PHYSIOL O, V59, P115, DOI 10.1007/BF02396588; Gentzler M, 2010, WORK, V37, P227, DOI 10.3233/WOR-2010-1075; GLEDHILL N, 1992, CAN J SPORT SCI, V17, P207; GLEDHILL N, 1992, CAN J SPORT SCI, V17, P199; Henderson ND, 2007, PERS PSYCHOL, V60, P431, DOI 10.1111/j.1744-6570.2007.00079.x; Hooper AJ, 2001, APPL ERGON, V32, P399, DOI 10.1016/S0003-6870(01)00007-2; Horn GP, 2013, ERGONOMICS, V56, P1465, DOI 10.1080/00140139.2013.818719; Huang CJ, 2010, INT J PSYCHOPHYSIOL, V75, P312, DOI 10.1016/j.ijpsycho.2009.12.013; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Kluth K, 2004, OCCUPATIONAL ERGONOM, V4, P89; Kumar S, 2004, MUSCLE STRENGTH, P65; Lawton TW, 2011, SPORTS MED, V41, P413, DOI 10.2165/11588540-000000000-00000; Lindberg A-S, 2014, JOSE IN PRESS; Lindberg AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068047; Lund A, 2013, TESTING NORMALITY LA; LUSA S, 1994, J OCCUP ENVIRON MED, V36, P70; Michaelides MA, 2011, J STRENGTH COND RES, V25, P956, DOI 10.1519/JSC.0b013e3181cc23ea; Michaelides MA, 2008, RES Q EXERCISE SPORT, V79, P468, DOI 10.1080/02701367.2008.10599513; OCONNELL ER, 1986, J OCCUP ENVIRON MED, V28, P282; Oksa J, 2013, APPL PHYSIOL NUTR ME, V38, P292, DOI 10.1139/apnm-2012-0180; Perroni F, 2014, APPL ERGON, V45, P456, DOI 10.1016/j.apergo.2013.06.005; Perroni F, 2010, J STRENGTH COND RES, V24, P3457, DOI 10.1519/JSC.0b013e3181b2c7ff; Phillips M, 2011, APPL ERGON, V42, P411, DOI 10.1016/j.apergo.2010.08.020; Phillips M, 2012, APPL ERGON, V43, P435, DOI 10.1016/j.apergo.2011.06.018; Punakallio A, 2005, J SPORT SCI MED, V4, P1; Punakallio A, 2005, SAFETY SCI, V43, P14; Rhea MR, 2004, J STRENGTH COND RES, V18, P348; Ryder JW, 2013, EUR J APPL PHYSIOL, V113, P911, DOI 10.1007/s00421-012-2500-z; Segerstrom AB, 2011, J STRENGTH COND RES, V25, P16, DOI 10.1519/JSC.0b013e31820238c5; Sharkey BJ., 2008, HARD WORK DEFINING P; Sharkey BJ, 2007, FITNESS HLTH, P173; Sheaff AK, 2010, J STRENGTH COND RES, V24, P3112, DOI 10.1519/JSC.0b013e3181f0a8d5; Sheskin DJ, 2003, HDB PARAMETRIC NONPA, P73; Sonnentag S., 2002, PSYCHOL MANAGEMENT I, V23, P3, DOI DOI 10.1002/0470013419; Sothmann MS, 2004, ERGONOMICS, V47, P864, DOI 10.1080/00140130410001670372; Stefani RT, 2006, J SPORT SCI, V24, P1329, DOI 10.1080/02640410500520559; TAYLOR NAS, 1991, EUR J APPL PHYSIOL O, V62, P180, DOI 10.1007/BF00643739; Taylor NAS, 2012, EUR J APPL PHYSIOL, V112, P2913, DOI 10.1007/s00421-011-2267-7; von Heimburg ED, 2006, ERGONOMICS, V49, P111, DOI 10.1080/00140130500435793; Whitley E, 2002, CRIT CARE, V6, P66; Williams-Bell FM, 2009, MED SCI SPORT EXER, V41, P653, DOI 10.1249/MSS.0b013e31818ad117	61	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91215	10.1371/journal.pone.0091215	http://dx.doi.org/10.1371/journal.pone.0091215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614596	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300097
J	McCracken, A; Locke, J				McCracken, Allen; Locke, John			Mutations in CG8878, a Novel Putative Protein Kinase, Enhance P Element Dependent Silencing (PDS) and Position Effect Variegation (PEV) in Drosophila melanogaster	PLOS ONE			English	Article							ARCHITECTURE; ASSOCIATION; CHROMOSOME; HOMOLOG; NHK-1; GENE; PIWI	Genes in multicellular organisms are expressed as part of a developmental program that is largely dependent on self-perpetuating higher-order chromatin states. The mechanism of establishing and maintaining these epigenetic events is well studied in Drosophila. The first known example of an epigenetic effect was that of (PEV) in Drosophila, which has been shown to be due to gene silencing via heterochromatin formation. We are investigating a process similar to Position Effect Variegation (PEV) using a mini-w transgene, called Pci, inserted in the upstream regulatory region of ci. The mini-white(+) transgene in Pci is expressed throughout the adult eye; however, when other P or KP elements are present, a variegated eye phenotype results indicating random w(+) silencing during development. This P element dependent silencing (PDS) can be modified by the haplo-suppressors/triplo-enhancers, Su(var)205 and Su(var)3-7, indicating that these heterochromatic modifiers also act dose dependently in PDS. Here we use a spontaneous derivative mutation of Pci called Pci(E1) (E1) that variegates like PDS in the absence of P elements, presumably due to an adjacent gypsy element insertion, to screen for second-site modifier mutations that enhance variable silencing of white(+) in E1. We isolated 7 mutations in CG8878, an essential gene, that enhance the E1 variegated phenotype. CG8878, a previously uncharacterized gene, potentially encodes a serine/threonine kinase whose closest Drosophila paralogue, ballchen (nhk-1), phosphorylates histones. These mutant alleles enhance both PDS at E1 and Position Effect Variegation (PEV) at w(m4), indicating a previously unknown common silencing mechanism between the two.	[McCracken, Allen; Locke, John] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Locke, J (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	john.locke@ualberta.ca			Natural Sciences and Engineering Research Council (NESRC) of Canada	Natural Sciences and Engineering Research Council (NESRC) of Canada	This work was supported by funding from a Discovery Grant from the Natural Sciences and Engineering Research Council (NESRC) of Canada (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 2004, GENE DEV, V18, P877, DOI 10.1101/gad.1184604; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Belyaeva ES, 1997, CHROMOSOMA, V106, P124, DOI 10.1007/s004120050232; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Brodie R, 2004, BIOINFORMATICS, V20, P279, DOI 10.1093/bioinformatics/btg406; Bushey D, 2004, GENETICS, V168, P1395, DOI 10.1534/genetics.104.026914; Chetverina D, 2008, NUCLEIC ACIDS RES, V36, P929, DOI 10.1093/nar/gkm992; Csink AK, 1996, NATURE, V381, P529, DOI 10.1038/381529a0; Dernburg AF, 1996, CELL, V85, P745, DOI 10.1016/S0092-8674(00)81240-4; EATON S, 1990, GENE DEV, V4, P1068, DOI 10.1101/gad.4.6.1068; Ephrussi B, 1944, GENETICS, V29, P148; Gelbart WM, 2011, FLYBASE ANAL; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Ivanovska I, 2005, GENE DEV, V19, P2571, DOI 10.1101/gad.1348905; Lancaster OM, 2007, J CELL BIOL, V179, P817, DOI 10.1083/jcb.200706067; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Qi HY, 2009, DEV DYNAM, V238, P3248, DOI 10.1002/dvdy.22150; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sameny A, 2011, GENOME, V54, P752, DOI [10.1139/G11-023, 10.1139/g11-023]; Shin J, 2011, J BIOL CHEM, V286, P22131, DOI 10.1074/jbc.M110.200162; Sun FL, 2000, P NATL ACAD SCI USA, V97, P5340, DOI 10.1073/pnas.090530797; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; Zhang WG, 2006, DEVELOPMENT, V133, P229, DOI 10.1242/dev.02199	26	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e71695	10.1371/journal.pone.0071695	http://dx.doi.org/10.1371/journal.pone.0071695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614804	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300001
J	Rosa, G; Majorin, F; Boisson, S; Barstow, C; Johnson, M; Kirby, M; Ngabo, F; Thomas, E; Clasen, T				Rosa, Ghislaine; Majorin, Fiona; Boisson, Sophie; Barstow, Christina; Johnson, Michael; Kirby, Miles; Ngabo, Fidele; Thomas, Evan; Clasen, Thomas			Assessing the Impact of Water Filters and Improved Cook Stoves on Drinking Water Quality and Household Air Pollution: A Randomised Controlled Trial in Rwanda	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; IMPROVED COOKSTOVES; SYSTEMATIC ANALYSIS; PARTICLE MONITOR; CARBON-MONOXIDE; INTERVENTIONS; REDUCTION; EXPOSURE; ADOPTION; HEALTH	Diarrhoea and respiratory infections remain the biggest killers of children under 5 years in developing countries. We conducted a 5-month household randomised controlled trial among 566 households in rural Rwanda to assess uptake, compliance and impact on environmental exposures of a combined intervention delivering high-performance water filters and improved stoves for free. Compliance was measured monthly by self-report and spot-check observations. Semi-continuous 24-h PM2.5 monitoring of the cooking area was conducted in a random subsample of 121 households to assess household air pollution, while samples of drinking water from all households were collected monthly to assess the levels of thermotolerant coliforms. Adoption was generally high, with most householders reporting the filters as their primary source of drinking water and the intervention stoves as their primary cooking stove. However, some householders continued to drink untreated water and most continued to cook on traditional stoves. The intervention was associated with a 97.5% reduction in mean faecal indicator bacteria (Williams means 0.5 vs. 20.2 TTC/100 mL, p<0.001) and a median reduction of 48% of 24-h PM2.5 concentrations in the cooking area (p = 0.005). Further studies to increase compliance should be undertaken to better inform large-scale interventions.	[Rosa, Ghislaine; Majorin, Fiona; Boisson, Sophie; Kirby, Miles; Clasen, Thomas] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Barstow, Christina] Univ Colorado, Dept Civil Environm & Architectural Engn, Boulder, CO 80309 USA; [Johnson, Michael] Berkeley Air Monitoring Grp, Berkeley, CA USA; [Ngabo, Fidele] Govt Rwanda, Minist Hlth, Kigali, Rwanda; [Thomas, Evan] Portland State Univ, Dept Mech & Mat Engn, Portland, OR 97207 USA; [Clasen, Thomas] Emory Univ, Dept Environm Hlth, Atlanta, GA 30322 USA	University of London; London School of Hygiene & Tropical Medicine; University of Colorado System; University of Colorado Boulder; Portland State University; Emory University	Rosa, G (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	ghislaine.rosa@lshtm.ac.uk		Majorin, Fiona/0000-0002-4697-2679; Kirby, Miles/0000-0003-3468-9793; Thomas, Evan/0000-0003-3095-8407; Johnson, Michael/0000-0002-4886-1534	DelAgua Health; Rwanda Ministry of Health	DelAgua Health; Rwanda Ministry of Health	This study was funded by DelAgua Health, a for-profit company that implements the intervention in Rwanda in conjunction with the Rwanda Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins E, 2010, ENERGY SUSTAIN DEV, V14, P172, DOI 10.1016/j.esd.2010.07.003; Air Quality Guidelines, 2006, GLOB UPD 2005 PART M; Alexander N, 2012, TROP MED INT HEALTH, V17, P684, DOI 10.1111/j.1365-3156.2012.02987.x; [Anonymous], 2012, UNICEF PROGR REPORT; APHA, 2001, STANDARD METHODS EXA; Barnes D. F., 1994, WHAT MAKES PEOPLE CO; Barstow CK, 2013, ENV HLTH PRODU UNPUB; Boisson S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012613; Bond TC, 2013, J GEOPHYS RES-ATMOS, V118, P5380, DOI 10.1002/jgrd.50171; Bonjour S, 2013, ENVIRON HEALTH PERSP, V121, P784, DOI 10.1289/ehp.1205987; Brown JC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030955, 10.1371/journal.pone.0036735]; Burwen J, 2012, ENERGY SUSTAIN DEV, V16, P328, DOI 10.1016/j.esd.2012.04.001; Chowdhury Z, 2007, J ENVIRON MONITOR, V9, P1099, DOI 10.1039/b709329m; Clasen T, 2009, AM J TROP MED HYG, V80, P819, DOI 10.4269/ajtmh.2009.80.819; Cynthia AA, 2008, INDOOR AIR, V18, P93, DOI 10.1111/j.1600-0668.2007.00509.x; Dutta K, 2007, ENERGY SUSTAIN DEV, V11, P19, DOI DOI 10.1016/S0973-0826(08)60397-X; Edwards RD, 2007, INDOOR AIR, V17, P189, DOI 10.1111/j.1600-0668.2007.00465.x; Edwards R, 2006, J AIR WASTE MANAGE, V56, P789, DOI 10.1080/10473289.2006.10464491; Enger KS, 2013, WATER RES, V47, P1181, DOI 10.1016/j.watres.2012.11.034; Ezzati M, 2001, ENVIRON HEALTH PERSP, V109, P481, DOI 10.2307/3454706; Fitzgerald C, 2012, SCI TOTAL ENVIRON, V420, P54, DOI 10.1016/j.scitotenv.2011.10.059; Greenstone M., 2012, 18033 NBER; Hunter PR, 2009, ENVIRON SCI TECHNOL, V43, P8991, DOI 10.1021/es9028217; Hunter PR, 2009, SCI TOTAL ENVIRON, V407, P2621, DOI 10.1016/j.scitotenv.2009.01.018; Johnson M, 2009, ENVIRON SCI TECHNOL, V43, P2456, DOI 10.1021/es801564u; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; MANIBOG FR, 1984, ANNU REV ENERGY, V9, P199, DOI 10.1146/annurev.eg.09.110184.001215; Masera OR, 2000, WORLD DEV, V28, P2083, DOI 10.1016/S0305-750X(00)00076-0; McElduff F, 2010, ADV PHYSIOL EDUC, V34, P128, DOI 10.1152/advan.00017.2010; Naeher LP, 2007, INHAL TOXICOL, V19, P67, DOI 10.1080/08958370600985875; Naranjo J., 2011, ASSESSMENT LIFESTRAW; National Institute of Statistics of Rwanda (NISR) MoHMR ICF International, 2012, RWAND DEM HLTH SURV; NISR, 2008, RWAND STAT FIG 2008; NISR, 2012, RWAND MIN HLTH ANN H; Ochieng CA, 2013, INDOOR AIR, V23, P14, DOI 10.1111/j.1600-0668.2012.00786.x; Peletz R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046548; Pennise D, 2009, ENERGY SUSTAIN DEV, V13, P71, DOI 10.1016/j.esd.2009.04.003; Pine K, 2011, ENERGY SUSTAIN DEV, V15, P176, DOI 10.1016/j.esd.2011.04.001; Rehfuess E, 2006, ENV HLTH PERSPECT, V114; RMOH, 2011, RWAND HLTH STAT BOOK; Ruiz-Mercado I, 2011, ENERG POLICY, V39, P7557, DOI 10.1016/j.enpol.2011.03.028; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Thomas EA, 2013, ENVIRON SCI TECHNOL, V47, P13602, DOI 10.1021/es403412x; USAID Berkeley Air Monitoring Group, 2011, IN HOM EM GREENH POL; WHO, 2011, EV HOUS WAT TREATM O; WHO UNICEF, 2012, PROGR DRINK WAT SAN; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x; Zwane AP, 2011, P NATL ACAD SCI US	50	68	68	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91011	10.1371/journal.pone.0091011	http://dx.doi.org/10.1371/journal.pone.0091011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614750	Green Accepted, Green Published, gold			2022-12-27	WOS:000332839300063
J	Tala; Sun, XO; Chen, J; Zhang, LL; Liu, NN; Zhou, J; Li, DW; Liu, M				Tala; Sun, Xiaoou; Chen, Jie; Zhang, Linlin; Liu, Ningning; Zhou, Jun; Li, Dengwen; Liu, Min			Microtubule Stabilization by Mdp3 Is Partially Attributed to Its Modulation of HDAC6 in Addition to Its Association with Tubulin and Microtubules	PLOS ONE			English	Article							DEACETYLASE HDAC6; ACETYLATION; CYTOSKELETON; PROTEINS	Microtubule-mediated cellular events such as intracellular transport and the maintenance of cell polarity are highly dependent upon microtubule stability, which is controlled by a repertoire of microtubule-associated proteins (MAPs) in the cell. MAP7 domain-containing protein 3 (Mdp3) has recently been identified as a critical regulator of microtubule stability. However, it remains elusive how Mdp3 carries out this function. In this study, by examination of tubulin partitioning between the polymer and soluble dimer forms, we found that Mdp3 could protect microtubules from cold-or nocodazole-induced depolymerization. Immunoblotting and immunofluorescence microscopy showed that knockdown of Mdp3 expression significantly reduced the level of tubulin acetylation. In vitro tubulin polymerization assays revealed that the amino-terminal region of Mdp3 was necessary for its ability to stabilize microtubules. Immunoprecipitation and pulldown experiments showed that the amino-terminal region mediated the interaction of Mdp3 with histone deacetylase 6 (HDAC6), in addition to its association with tubulin and microtubules. Immunofluorescence microscopy further demonstrated that endogenous Mdp3 and HDAC6 colocalized in the cytoplasm. Moreover, depletion of Mdp3 dramatically increased the activity of HDAC6 toward tubulin deacetylation. These findings suggest that Mdp3 controls microtubule stability through its binding to tubulin and microtubules as well as its regulation of HDAC6 activity.	[Tala; Sun, Xiaoou; Chen, Jie; Zhang, Linlin; Liu, Ningning; Zhou, Jun; Li, Dengwen] Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Tianjin 300071, Peoples R China; [Liu, Min] Tianjin Med Univ, Dept Biochem, Sch Basic Med Sci, Tianjin, Peoples R China	Nankai University; Tianjin Medical University	Liu, M (corresponding author), Tianjin Med Univ, Dept Biochem, Sch Basic Med Sci, Tianjin, Peoples R China.	minliu@tijmu.edu.cn	Zhou, Jun/D-4654-2017; Zhang, Linlin/J-6639-2019	Zhou, Jun/0000-0001-7858-8260; Zhang, Linlin/0000-0003-3240-1215	National Natural Science Foundation of China [31171334, 31170820, 31271437, 31371382]; Tianjin Natural Science Foundation [13JCZDJC30300]; 111 project of the Ministry of Education of China [B08011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin); 111 project of the Ministry of Education of China(Ministry of Education, China - 111 Project)	This work was supported by grants from the National Natural Science Foundation of China (31171334, 31170820, 31271437, and 31371382), the Tianjin Natural Science Foundation (13JCZDJC30300), and the 111 project of the Ministry of Education of China (B08011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Cassimeris L, 2001, INT REV CYTOL, V210, P163; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Delacourte A, 1997, INT REV CYTOL, V171, P167; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Joshi HC, 1998, CURR OPIN CELL BIOL, V10, P35, DOI 10.1016/S0955-0674(98)80084-7; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; SCHOENFELD TA, 1994, INT REV CYTOL, V151, P67, DOI 10.1016/S0074-7696(08)62631-5; Simoes-Pires C, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-7; Sun XO, 2011, CELL CYCLE, V10, P3929, DOI 10.4161/cc.10.22.18106; VALE RD, 1987, ANNU REV CELL BIOL, V3, P347, DOI 10.1146/annurev.cb.03.110187.002023; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	26	4	5	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90932	10.1371/journal.pone.0090932	http://dx.doi.org/10.1371/journal.pone.0090932			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614595	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300059
J	Skorvaga, M; Nikitina, E; Kubes, M; Kosik, P; Gajdosechova, B; Leitnerova, M; Copakova, L; Belyaev, I				Skorvaga, Milan; Nikitina, Ekaterina; Kubes, Miroslav; Kosik, Pavol; Gajdosechova, Beata; Leitnerova, Michaela; Copakova, Lucia; Belyaev, Igor			Incidence of Common Preleukemic Gene Fusions in Umbilical Cord Blood in Slovak Population	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MINIMAL-RESIDUAL-DISEASE; CHILDHOOD LEUKEMIA; RT-PCR; CHROMOSOME TRANSLOCATIONS; TRANSCRIPTS; CELLS; INDIVIDUALS; ABERRATIONS; EXPRESSION	The first event in origination of many childhood leukemias is likely the presence of preleukemic clone (transformed hematopoietic stem/progenitor cells with preleukemic gene fusions (PGF)) in newborn. Thus, the screening of umbilical cord blood (UCB) for PGF may be of high importance for developing strategies for childhood leukemia prevention and treatment. However, the data on incidence of PGF in UCB are contradictive. We have compared multiplex polymerase chain reaction (PCR) and real-time quantitative PCR (RT qPCR) in neonates from Slovak National Birth Cohort. According to multiplex PCR, all 135 screened samples were negative for the most frequent PGF of B-lineage acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). To explore the prevalence of prognostically important TEL-AML1, MLL-AF4 and BCR-ABL (p190), 200 UCB were screened using RT qPCR. The initial screening showed an unexpectedly high incidence of studied PGF. The validation of selected samples in two laboratories confirmed approximately 1/4 of UCB positive, resulting in similar to 4% incidence of TEL-AML1, similar to 6.25% incidence of BCR-ABL1 p190, and similar to 0.75% frequency of MLL-AF4. In most cases, the PGF presented at very low level, about 1-5 copies per 10(5) cells. We hypothesize that low PGF numbers reflect their relatively late origin and are likely to be eliminated in further development while higher number of PGF reflects earlier origination and may represent higher risk for leukemia.	[Skorvaga, Milan; Nikitina, Ekaterina; Kosik, Pavol; Gajdosechova, Beata; Belyaev, Igor] Slovak Acad Sci, Canc Res Inst, Dept Mol Genet, Bratislava, Slovakia; [Nikitina, Ekaterina] Russian Acad Med Sci, Lab Oncovirol, Canc Res Inst, Siberian Branch, Tomsk, Russia; [Kubes, Miroslav] Eurocord Slovakia, Lab R&D, Bratislava, Slovakia; [Leitnerova, Michaela; Copakova, Lucia] Natl Canc Inst, Dept Clin Oncol, Bratislava, Slovakia	Slovak Academy of Sciences; Russian Academy of Medical Sciences; Russian Academy of Sciences; Tomsk National Research Medical Center; Cancer Research Institute of the RAS; National Institute of Oncology (NOU)	Belyaev, I (corresponding author), Slovak Acad Sci, Canc Res Inst, Dept Mol Genet, Bratislava, Slovakia.	Igor.Beliaev@savba.sk	Skorvaga, Milan/AAO-2360-2021; Belyaev, Igor Y/I-4029-2018	Belyaev, Igor/0000-0002-7963-2240	Slovak Research and Development Agency [APVV 0669-10]; National Scholarship Program of the Slovak Republic (SAIA); Slovak Academy of Sciences (SAS); Russian Academy of Medical Sciences (RAMS); VEGA Grant Agency of the Slovak Republic [2/0150/11]	Slovak Research and Development Agency(Slovak Research and Development Agency); National Scholarship Program of the Slovak Republic (SAIA); Slovak Academy of Sciences (SAS); Russian Academy of Medical Sciences (RAMS); VEGA Grant Agency of the Slovak Republic(Vedecka grantova agentura MSVVaS SR a SAV (VEGA))	This study was supported by the Slovak Research and Development Agency (APVV 0669-10); the National Scholarship Program of the Slovak Republic (SAIA); the Joint Research Project "Cancer diagnostics and assesment of cancer risks" between Slovak Academy of Sciences (SAS) and Russian Academy of Medical Sciences (RAMS), and the VEGA Grant Agency (2/0150/11) of the Slovak Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bose S, 1998, BLOOD, V92, P3362, DOI 10.1182/blood.V92.9.3362; Brown P, 2011, BLOOD, V117, P2, DOI 10.1182/blood-2010-09-304337; Bueno C, 2011, LEUKEMIA, V25, P400, DOI 10.1038/leu.2010.284; Bueno C, 2012, CELL RES, V22, P986, DOI 10.1038/cr.2012.4; Bueno C, 2009, CARCINOGENESIS, V30, P1628, DOI 10.1093/carcin/bgp169; Dickinson HO, 2005, BRIT MED J, V330, P1279, DOI 10.1136/bmj.330.7503.1279; Eguchi-Ishimae M, 2001, BLOOD, V97, P737, DOI 10.1182/blood.V97.3.737; Fischer S, 2007, BLOOD, V110, P3036, DOI 10.1182/blood-2007-03-077339; Ford AM, 1998, P NATL ACAD SCI USA, V95, P4584, DOI 10.1073/pnas.95.8.4584; Ford AM, 2009, J CLIN INVEST, V119, P826, DOI 10.1172/JCI36428; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Gaynon PS, 2005, BRIT J HAEMATOL, V131, P579, DOI 10.1111/j.1365-2141.2005.05773.x; Greaves M, 2011, BLOOD, V117, P369, DOI 10.1182/blood-2010-09-309351; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Greaves MF, 2003, BLOOD, V102, P2321, DOI 10.1182/blood-2002-12-3817; Kaatsch P, 2008, RADIAT PROT DOSIM, V132, P107, DOI 10.1093/rpd/ncn259; Kim-Rouille MH, 1999, BLOOD, V93, P1107, DOI 10.1182/blood.V93.3.1107; Kowarz E, 2011, AM J BLOOD RES, V1, P1; Lausten-Thomsen U, 2011, BLOOD, V117, P186, DOI 10.1182/blood-2010-05-282764; Mannhalter C, 2000, CLIN CHEM LAB MED, V38, P171, DOI 10.1515/CCLM.2000.026; McHale CM, 2004, AM J HEMATOL, V75, P254, DOI 10.1002/ajh.20030; Menendez P, 2009, J EXP MED, V206, P3131, DOI 10.1084/jem.20091050; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Montes R, 2011, BLOOD, V117, P4746, DOI 10.1182/blood-2010-12-322230; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; Olsen M, 2012, J PEDIAT HEMATOL ONC, V34, P301, DOI 10.1097/MPH.0b013e3182332268; Pakakasama S, 2008, INT J LAB HEMATOL, V30, P286, DOI 10.1111/j.1751-553X.2007.00954.x; Portier C, 2008, RADIAT PROT DOSIM, V132, P273, DOI 10.1093/rpd/ncn282; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Rossig C, 2008, RADIAT PROT DOSIM, V132, P114, DOI 10.1093/rpd/ncn269; Shiozaki H, 2014, BONE MARROW TRANSPL, V49, P102, DOI 10.1038/bmt.2013.127; Song JB, 2011, J MOL DIAGN, V13, P213, DOI 10.1016/j.jmoldx.2010.10.009; Trka J, 1999, BLOOD, V93, P1106, DOI 10.1182/blood.V93.3.1106.403a38a_1106_1107; Uckun FM, 1998, BLOOD, V92, P810; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011; Wiemels Joseph, 2008, J Natl Cancer Inst Monogr, P87, DOI 10.1093/jncimonographs/lgn006; Wiseman DH, 2011, BIOL BLOOD MARROW TR, V17, P771, DOI 10.1016/j.bbmt.2010.10.010; Yang GY, 2009, J VIROL METHODS, V162, P288, DOI 10.1016/j.jviromet.2009.08.004; Zuna J, 2011, BLOOD, V117, P368, DOI 10.1182/blood-2010-09-309070	42	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91116	10.1371/journal.pone.0091116	http://dx.doi.org/10.1371/journal.pone.0091116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621554	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300052
J	Yao, Y; Wang, C; Wei, W; Shen, C; Deng, XH; Chen, LJ; Ma, LY; Hao, SG				Yao, Ye; Wang, Chun; Wei, Wei; Shen, Chang; Deng, Xiaohui; Chen, Linjun; Ma, Liyuan; Hao, Siguo			Dendritic Cells Pulsed with Leukemia Cell-Derived Exosomes More Efficiently Induce Antileukemic Immunities	PLOS ONE			English	Article							T-LYMPHOCYTE RESPONSES; CD8(+) CTL RESPONSES; WT1 PEPTIDE; CLASS-I; IMMUNOTHERAPY; VACCINATION; EPITOPES; ANTIGENS	Dendritic cells (DCs) and tumor cell-derived exosomes have been used to develop antitumor vaccines. However, the biological properties and antileukemic effects of leukemia cell-derived exosomes (LEXs) are not well described. In this study, the biological properties and induction of antileukemic immunity of LEXs were investigated using transmission electron microscopy, western blot analysis, cytotoxicity assays, and animal studies. Similar to other tumor cells, leukemia cells release exosomes. Exosomes derived from K562 leukemia cells (LEXK562) are membrane-bound vesicles with diameters of approximately 50-100 mu m and harbor adhesion molecules (e.g., intercellular adhesion molecule-1) and immunologically associated molecules (e.g., heat shock protein 70). In cytotoxicity assays and animal studies, LEXs-pulsed DCs induced an antileukemic cytotoxic T-lymphocyte immune response and antileukemic immunity more effectively than did LEXs and non-pulsed DCs (P<0.05). Therefore, LEXs may harbor antigens and immunological molecules associated with leukemia cells. As such, LEX-based vaccines may be a promising strategy for prolonging disease-free survival in patients with leukemia after chemotherapy or hematopoietic stem cell transplantation.	[Yao, Ye; Wei, Wei; Deng, Xiaohui; Chen, Linjun; Hao, Siguo] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Hematol, Shanghai 200030, Peoples R China; [Wang, Chun; Shen, Chang] Shanghai Jiao Tong Univ, Dept Hematol, Peoples Hosp Shanghai 1, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Hao, SG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Hematol, Shanghai 200030, Peoples R China.	haosghj88@hotmail.com	Wei, Weijun/AAZ-3551-2021	Multhoff, Gabriele/0000-0002-2616-3137	National Natural Science Foundation of China [81070432]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (grant No. 81070432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abache T, 2007, J CELL BIOCHEM, V102, P650, DOI 10.1002/jcb.21318; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Altieri SL, 2004, J IMMUNOTHER, V27, P282, DOI 10.1097/00002371-200407000-00004; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Andre F, 2002, VACCINE, V20, pA28, DOI 10.1016/S0264-410X(02)00384-5; Avigan D, 2004, CLIN CANCER RES, V10, P4699, DOI 10.1158/1078-0432.CCR-04-0347; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barrett AJ, 2010, CLIN EXP IMMUNOL, V161, P223, DOI 10.1111/j.1365-2249.2010.04197.x; Chaput N, 2003, ADV EXP MED BIOL, V532, P215; Chaput N, 2004, J IMMUNOL, V172, P2137, DOI 10.4049/jimmunol.172.4.2137; Delluc S, 2005, HAEMATOLOGICA, V90, P1050; Denzer K, 2000, J CELL SCI, V113, P3365; Dorfel D, 2005, BLOOD, V105, P3199, DOI 10.1182/blood-2004-09-3556; Fukui M, 2004, TUMOR BIOL, V25, P252, DOI 10.1159/000081388; Hao SG, 2006, CELL MOL IMMUNOL, V3, P205; Hao SG, 2007, IMMUNOLOGY, V120, P90, DOI 10.1111/j.1365-2567.2006.02483.x; Kim JV, 2004, NAT BIOTECHNOL, V22, P403, DOI 10.1038/nbt955; Knight SC, 1998, EUR J IMMUNOL, V28, P1636; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Mailander V, 2004, LEUKEMIA, V18, P165, DOI 10.1038/sj.leu.2403186; Merchant ML, 2010, PROTEOM CLIN APPL, V4, P84, DOI 10.1002/prca.200800093; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; Ostankovitch M, 1998, BLOOD, V92, P19, DOI 10.1182/blood.V92.1.19.413a40_19_24; Parkhurst MR, 2003, J IMMUNOL, V170, P5317, DOI 10.4049/jimmunol.170.10.5317; Prasad SJ, 2005, J IMMUNOL, V174, P90, DOI 10.4049/jimmunol.174.1.90; SanMiguel JF, 1997, BLOOD, V90, P2465, DOI 10.1182/blood.V90.6.2465.2465_2465_2470; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Shen C, 2011, J INT MED RES, V39, P740, DOI 10.1177/147323001103900305; Taylor DD, 2003, CLIN CANCER RES, V9, P5113; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Yao Y, 2013, BIOCHEM BIOPH RES CO, V436, P60, DOI 10.1016/j.bbrc.2013.05.058	34	57	64	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91463	10.1371/journal.pone.0091463	http://dx.doi.org/10.1371/journal.pone.0091463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622345	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300088
J	Ehrlich, ES; Chmura, JC; Smith, JC; Kalu, NN; Hayward, GS				Ehrlich, Elana S.; Chmura, Jennifer C.; Smith, John C.; Kalu, Nene N.; Hayward, Gary S.			KSHV RTA Abolishes NFkB Responsive Gene Expression during Lytic Reactivation by Targeting vFLIP for Degradation via the Proteasome	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPPA-B ACTIVATION; E3 LIGASE; PROMOTES DEGRADATION; NUCLEAR ANTIGEN; LYMPHOMA-CELLS; KINASE COMPLEX; PROTEIN; REPLICATION; PATHWAY	Kaposi's sarcoma herpesvirus (KSHV) is a gamma-2 herpesvirus present in all cases of Kaposi's sarcoma, primary effusion lymphoma (PEL), and some cases of multicentric Castleman's disease. Viral FLICE inhibitory protein (vFLIP) is a latently expressed gene that has been shown to be essential for survival of latently infected PEL cells by activating the NFkB pathway. Inhibitors of either vFLIP expression or the NF kappa B pathway result in enhanced lytic reactivation and apoptosis. We have observed a decrease in vFLIP protein levels and of NF kappa B activation in the presence of the KSHV lytic switch protein RTA. Whereas vFLIP alone induced expression of the NF kappa B responsive genes ICAM1 and TNF alpha, inclusion of RTA decreased vFLIP induced ICAM1 and TNF alpha expression in both co-transfected 293T cells and in doxycycline induced TREx BCBL1 cells. RTA expression resulted in proteasome dependent destabilization of vFLIP. Neither RTA ubiquitin E3 ligase domain mutants nor a dominant-negative RAUL mutant abrogated this effect, while RTA truncation mutants did, suggesting that RTA recruits a novel cellular ubiquitin E3 ligase to target vFLIP for proteasomal degradation, allowing for inhibition of NF B responsive gene expression early during lytic reactivation.	[Ehrlich, Elana S.; Kalu, Nene N.; Hayward, Gary S.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Viral Oncol Program, Baltimore, MD USA; [Ehrlich, Elana S.; Chmura, Jennifer C.; Smith, John C.] Towson Univ, Dept Biol Sci, Towson, MD 21252 USA	Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; Towson University	Ehrlich, ES (corresponding author), Towson Univ, Dept Biol Sci, Towson, MD 21252 USA.	eehrlich@towson.edu; ghayward@jhmi.edu			Anti-Cancer Drug Development (ACDD) Training Program [T32 CA009243-35]; National Institutes of Health NCI [R01 CA073585-15]; NATIONAL CANCER INSTITUTE [T32CA009243, R01CA073585] Funding Source: NIH RePORTER	Anti-Cancer Drug Development (ACDD) Training Program; National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by a Post-Doctoral stipend to Elana Ehrlich from the Anti-Cancer Drug Development (ACDD) Training Program Grant T32 CA009243-35 and by National Institutes of Health NCI Research Grant R01 CA073585-15 to GSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JB, 2003, ONCOGENE, V22, P3371, DOI 10.1038/sj.onc.1206407; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Brown HJ, 2003, J VIROL, V77, P8532, DOI 10.1128/JVI.77.15.8532-8540.2003; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Cotter MA, 1999, VIROLOGY, V264, P254, DOI 10.1006/viro.1999.9999; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Gould F, 2009, J VIROL, V83, P6727, DOI 10.1128/JVI.00351-09; Grossmann C, 2008, VIROLOGY, V375, P94, DOI 10.1016/j.virol.2007.12.044; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; Matta H, 2007, J BIOL CHEM, V282, P24858, DOI 10.1074/jbc.M700118200; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; Punj V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037498; Punj V, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-50; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Sgarbanti M, 2004, ONCOGENE, V23, P5770, DOI 10.1038/sj.onc.1207707; Sun Q, 2003, BLOOD, V101, P1956, DOI 10.1182/blood-2002-07-2072; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; Wang SE, 2003, J VIROL, V77, P600, DOI 10.1128/JVI.77.1.600-623.2003; Yang ZL, 2008, J VIROL, V82, P3590, DOI 10.1128/JVI.02229-07; Ye FC, 2008, J VIROL, V82, P4235, DOI 10.1128/JVI.02370-07; You JX, 2003, J BIOL CHEM, V278, P23369, DOI 10.1074/jbc.M212887200; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011	27	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91359	10.1371/journal.pone.0091359	http://dx.doi.org/10.1371/journal.pone.0091359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614587	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300116
J	Inoue, A; Kawakami, N; Tsutsumi, A; Shimazu, A; Miyaki, K; Takahashi, M; Kurioka, S; Eguchi, H; Tsuchiya, M; Enta, K; Kosugi, Y; Sakata, T; Totsuzaki, T				Inoue, Akiomi; Kawakami, Norito; Tsutsumi, Akizumi; Shimazu, Akihito; Miyaki, Koichi; Takahashi, Masaya; Kurioka, Sumiko; Eguchi, Hisashi; Tsuchiya, Masao; Enta, Kazuhiko; Kosugi, Yuki; Sakata, Tomoko; Totsuzaki, Takafumi			Association of Job Demands with Work Engagement of Japanese Employees: Comparison of Challenges with Hindrances (J-HOPE)	PLOS ONE			English	Article							EFFORT-REWARD IMBALANCE; RESOURCES MODEL; BURNOUT; STRESS; STRAIN; QUESTIONNAIRE; VERSION; DIARY	Objectives: Recent epidemiological research in Europe has reported that two groups of job demands, i.e., challenges and hindrances, are differently associated with work engagement. The purpose of the present study was to replicate the cross-sectional association of workload and time pressure (as a challenge) and role ambiguity (as a hindrance) with work engagement among Japanese employees. Methods: Between October 2010 and December 2011, a total of 9,134 employees (7,101 men and 1,673 women) from 12 companies in Japan were surveyed using a self-administered questionnaire comprising the Job Content Questionnaire, National Institute for Occupational Safety and Health Generic Job Stress Questionnaire, short 10-item version of the Effort-Reward Imbalance Questionnaire, short nine-item version of the Utrecht Work Engagement Scale, and demographic characteristics. Multilevel regression analyses with a random intercept model were conducted. Results: After adjusting for demographic characteristics, workload and time pressure showed a positive association with work engagement with a small effect size (standardized coefficient [beta] = 0.102, Cohen's d [d] = 0.240) while role ambiguity showed a negative association with a large effect size (beta = -0.429, d = 1.011). After additionally adjusting for job resources (i.e., decision latitude, supervisor support, co-worker support, and extrinsic reward), the effect size of workload and time pressure was not attenuated (beta = 0.093, d = 0.234) while that of role ambiguity was attenuated but still medium (beta = -0.242, d = 0.609). Conclusions: Among Japanese employees, challenges such as having higher levels of workload and time pressure may enhance work engagement but hindrances, such as role ambiguity, may reduce it.	[Inoue, Akiomi] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Mental Hlth, Kitakyushu, Fukuoka 807, Japan; [Kawakami, Norito; Shimazu, Akihito] Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Tokyo, Japan; [Tsutsumi, Akizumi; Eguchi, Hisashi] Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa 228, Japan; [Miyaki, Koichi] Natl Ctr Global Hlth & Med, Dept Clin Res & Informat, Div Clin Epidemiol, Tokyo, Japan; [Takahashi, Masaya; Tsuchiya, Masao] Natl Inst Occupat Safety & Hlth, Hlth Adm & Psychosocial Factor Res Grp, Kawasaki, Kanagawa, Japan; [Kurioka, Sumiko] Univ Occupat & Environm Hlth, Grad Sch Med Sci, Dept Hlth Policy & Management, Kitakyushu, Fukuoka 807, Japan; [Enta, Kazuhiko] Cent Japan Railway Co, Hlth Care Ctr, Nagoya, Aichi, Japan; [Kosugi, Yuki] Kosugi Hlth Management Off, Toyama, Japan; [Sakata, Tomoko] Fukuoka Tokushukai Med Ctr, Dept Lab Med, Kasuga, Fukuoka, Japan; [Totsuzaki, Takafumi] Mizuho Hlth Insurance Soc, Uchisaiwaicho Med Ctr, Tokyo, Japan	University of Occupational & Environmental Health - Japan; University of Tokyo; Kitasato University; National Center for Global Health & Medicine - Japan; University of Occupational & Environmental Health - Japan	Inoue, A (corresponding author), Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Mental Hlth, Kitakyushu, Fukuoka 807, Japan.	akiomi@med.uoeh-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [4102-21119001]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The present study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Research Area) 2009-2013 (No. 4102-21119001) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker AB, 2005, HUM RELAT, V58, P661, DOI 10.1177/0018726705055967; Bakker A, 2009, ROUTL RES ORGAN BEH, P50; Bakker AB, 2007, J EDUC PSYCHOL, V99, P274, DOI 10.1037/0022-0663.99.2.274; Cavanaugh MA, 2000, J APPL PSYCHOL, V85, P65, DOI 10.1037/0021-9010.85.1.65; Cho SI, 2008, SCAND J WORK ENV HEA, P60; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; de Jonge J, 2006, J APPL PSYCHOL, V91, P1359, DOI 10.1037/0021-9010.91.5.1359; de Lange AH, 2008, WORK STRESS, V22, P201, DOI 10.1080/02678370802390132; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Demerouti E, 2001, SCAND J WORK ENV HEA, V27, P279, DOI 10.5271/sjweh.615; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gurbuz A, 2007, DOGUS U DERGISI, V8; Hakanen JJ, 2008, WORK STRESS, V22, P224, DOI 10.1080/02678370802379432; Hakanen JJ, 2008, J VOCAT BEHAV, V73, P78, DOI 10.1016/j.jvb.2008.01.003; Hakanen JJ, 2006, J SCHOOL PSYCHOL, V43, P495, DOI 10.1016/j.jsp.2005.11.001; Haratani T, 1996, 25 INT C OCC HLTH 2, P393; HURRELL JJ, 1988, SCAND J WORK ENV HEA, V14, P27; Inoue A, 2013, INT ARCH OCC ENV HEA, V86, P441, DOI 10.1007/s00420-012-0777-1; JOHNSON JV, 1988, AM J PUBLIC HEALTH, V78, P1336, DOI 10.2105/AJPH.78.10.1336; Karasek R., 1985, JOB CONTENT QUESTION; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kawakami N, 1995, INT J BEHAV MED, V2, P358, DOI 10.1207/s15327558ijbm0204_5; Koyuncu M, 2006, EQUAL OPPOR INT, V25, P299, DOI [10.1108/02610150610706276, DOI 10.1108/02610150610706276]; Kurioka S, 2013, J OCCUP HEALTH, V55, P340, DOI 10.1539/joh.12-0235-OA; Lepine JA, 2005, ACAD MANAGE J, V48, P764, DOI 10.2307/20159696; Llorens S., 2006, INT J STRESS MANAG, V13, P378, DOI [DOI 10.1037/1072-5245.13.3.378, 10.1037/1072-5245.13.3.378]; Prieto LL, 2008, PSICOTHEMA, V20, P354; Mauno S, 2007, J VOCAT BEHAV, V70, P149, DOI 10.1016/j.jvb.2006.09.002; Ministry of Internal Affairs and Communications, 2011, SUMM RES 2009 EC CEN; Nakane C., 1970, JAPANESE SOC; Podsakoff NP, 2007, J APPL PSYCHOL, V92, P438, DOI 10.1037/0021-9010.92.2.438; Ren Y, 2000, INT REV ENV STRATEGI, V1, P79; Salancik G.R., 1977, NEW DIRECTIONS ORG B, P1; Schaufeli W., 2003, UTRECHT WORK ENGAGEM; Schaufeli W.B., 2002, J HAPPINESS STUD, V3, P72, DOI [10.1023/A:1015630930326, DOI 10.1023/A:1015630930326]; Schaufeli WB, 2004, J ORGAN BEHAV, V25, P293, DOI 10.1002/job.248; Schaufeli WB, 2006, EDUC PSYCHOL MEAS, V66, P701, DOI 10.1177/0013164405282471; Schaufeli WB, 2009, J ORGAN BEHAV, V30, P893, DOI 10.1002/job.595; Shimazu A, 2008, APPL PSYCHOL-INT REV, V57, P510, DOI 10.1111/j.1464-0597.2008.00333.x; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; Siegrist J, 2009, INT ARCH OCC ENV HEA, V82, P1005, DOI 10.1007/s00420-008-0384-3; Spector PE, 2006, ORGAN RES METHODS, V9, P221, DOI 10.1177/1094428105284955; Tymms P., 2004, WHAT DOES IT MEAN US, P55; Van den Broeck A, 2010, EUR J WORK ORGAN PSY, V19, P735, DOI 10.1080/13594320903223839; Verbruggen A, 2009, EXTENDING JOB DEMAND; Widmer PS, 2012, J VOCAT BEHAV, V80, P422, DOI 10.1016/j.jvb.2011.09.006; Xanthopoulou D, 2007, J MANAGE PSYCHOL, V22, P766; Xanthopoulou D., 2007, INT J STRESS MANAGE, V14, P121, DOI [10.1037/1072-5245.14.2.121, DOI 10.1037/10725245.14.2.121, DOI 10.1037/1072-5245.14.2.121]; Xanthopoulou D, 2008, J OCCUP HEALTH PSYCH, V13, P345, DOI 10.1037/1076-8998.13.4.345; Xanthopoulou D, 2009, J OCCUP ORGAN PSYCH, V82, P183, DOI 10.1348/096317908X285633; Xanthopoulou D, 2009, J VOCAT BEHAV, V74, P235, DOI 10.1016/j.jvb.2008.11.003	51	23	23	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91583	10.1371/journal.pone.0091583	http://dx.doi.org/10.1371/journal.pone.0091583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614682	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300139
J	Nakasugi, K; Crowhurst, R; Bally, J; Waterhouse, P				Nakasugi, Kenlee; Crowhurst, Ross; Bally, Julia; Waterhouse, Peter			Combining Transcriptome Assemblies from Multiple De Novo Assemblers in the Allo-Tetraploid Plant Nicotiana benthamiana	PLOS ONE			English	Article							RNA-SEQ DATA; READ ALIGNMENT; PROTEIN; WHEAT; GENES; ARABIDOPSIS; UNIPROT; SPACE	Background: Nicotiana benthamiana is an allo-tetraploid plant, which can be challenging for de novo transcriptome assemblies due to homeologous and duplicated gene copies. Transcripts generated from such genes can be distinct yet highly similar in sequence, with markedly differing expression levels. This can lead to unassembled, partially assembled or mis-assembled contigs. Due to the different properties of de novo assemblers, no one assembler with any one given parameter space can re-assemble all possible transcripts from a transcriptome. Results: In an effort to maximise the diversity and completeness of de novo assembled transcripts, we utilised four de novo transcriptome assemblers, TransAbyss, Trinity, SOAPdenovo-Trans, and Oases, using a range of k-mer sizes and different input RNA-seq read counts. We complemented the parameter space biologically by using RNA from 10 plant tissues. We then combined the output of all assemblies into a large super-set of sequences. Using a method from the EvidentialGene pipeline, the combined assembly was reduced from 9.9 million de novo assembled transcripts to about 235,000 of which about 50,000 were classified as primary. Metrics such as average bit-scores, feature response curves and the ability to distinguish paralogous or homeologous transcripts, indicated that the EvidentialGene processed assembly was of high quality. Of 35 RNA silencing gene transcripts, 34 were identified as assembled to full length, whereas in a previous assembly using only one assembler, 9 of these were partially assembled. Conclusions: To achieve a high quality transcriptome, it is advantageous to implement and combine the output from as many different de novo assemblers as possible. We have in essence taking the 'best' output from each assembler while minimising sequence redundancy. We have also shown that simultaneous assessment of a variety of metrics, not just focused on contig length, is necessary to gauge the quality of assemblies.	[Nakasugi, Kenlee; Bally, Julia; Waterhouse, Peter] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Crowhurst, Ross] Mt Albert Res Ctr, Auckland, New Zealand; [Waterhouse, Peter] Queensland Univ Technol, Ctr Trop Crops & Biocommod, Brisbane, Qld 4001, Australia	University of Sydney; New Zealand Institute for Plant & Food Research Ltd; Queensland University of Technology (QUT)	Nakasugi, K (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	kenlee.nakasugi@sydney.edu.au; peter.waterhouse@qut.edu.au	Crowhurst, Ross N/N-8892-2017	Crowhurst, Ross N/0000-0003-0608-2134; Bally, Julia/0000-0003-0692-280X; Waterhouse, Peter/0000-0002-2812-3753	ARC Federation Fellowship [FF0776510]	ARC Federation Fellowship(Australian Research Council)	PMW is funded by the ARC Federation Fellowship FF0776510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Bombarely A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-406; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Duan JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-392; Gilbert D., 2013, P 7 ANN ARTHR GEN S; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gruenheit N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-92; Haznedaroglu BZ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-170; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Jones L, 2006, PLANT PHYSIOL, V141, P598, DOI 10.1104/pp.105.076109; Krasileva KV, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r66; Krzywinski MI, 2009, GENOME RES; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CX, 2008, PLANT J, V55, P543, DOI 10.1111/j.1365-313X.2008.03526.x; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Oono Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-77; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; R Core Team, 2012, R LANG ENV STAT COMP; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ranwez V, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S15-S15; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Schreiber AW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-492; Schulz M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-18; Sierro N, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r60; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vezzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052210; Vezzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031002; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xie Y, 2013, ARXIV13056760; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Yang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-328; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	46	103	103	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91776	10.1371/journal.pone.0091776	http://dx.doi.org/10.1371/journal.pone.0091776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614631	Green Published, gold			2022-12-27	WOS:000332839300157
J	Tauro, F; Grimaldi, S; Porfiri, M				Tauro, Flavia; Grimaldi, Salvatore; Porfiri, Maurizio			Unraveling Flow Patterns through Nonlinear Manifold Learning	PLOS ONE			English	Article							OF-THE-ART; VORTEX; IDENTIFICATION; VISUALIZATION; VALIDATION; TURBULENCE; REDUCTION; MODEL; WAKE	From climatology to biofluidics, the characterization of complex flows relies on computationally expensive kinematic and kinetic measurements. In addition, such big data are difficult to handle in real time, thereby hampering advancements in the area of flow control and distributed sensing. Here, we propose a novel framework for unsupervised characterization of flow patterns through nonlinear manifold learning. Specifically, we apply the isometric feature mapping (Isomap) to experimental video data of the wake past a circular cylinder from steady to turbulent flows. Without direct velocity measurements, we show that manifold topology is intrinsically related to flow regime and that Isomap global coordinates can unravel salient flow features.	[Tauro, Flavia; Grimaldi, Salvatore; Porfiri, Maurizio] NYU, Polytech Sch Engn, Dept Mech & Aerosp Engn, Brooklyn, NY 11201 USA; [Tauro, Flavia] Univ Roma La Sapienza, Dipartimento Ingn Civile Edile & Ambientale, I-00185 Rome, Italy; [Grimaldi, Salvatore] Univ Tuscia, Dipartimento Innovaz Nei Sistemi Biol Agroaliment, Viterbo, Italy	New York University; New York University Tandon School of Engineering; Sapienza University Rome; Tuscia University	Porfiri, M (corresponding author), NYU, Polytech Sch Engn, Dept Mech & Aerosp Engn, Brooklyn, NY 11201 USA.	mporfiri@nyu.edu	Tauro, Flavia/AAA-6086-2020	TAURO, Flavia/0000-0002-5176-3492; Porfiri, Maurizio/0000-0002-1480-3539	Italian Ministry of Research; Honors Center of Italian Universities; MIUR project PRIN [2009CA4A4A]; National Science Foundation [CMMI-1129820]	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); Honors Center of Italian Universities; MIUR project PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); National Science Foundation(National Science Foundation (NSF))	This work was supported by the Italian Ministry of Research, the Honors Center of Italian Universities, the MIUR project PRIN 2009 N. 2009CA4A4A, and the National Science Foundation under Grant No. CMMI-1129820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaid N, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.041907; Abdelkefi A, 2013, NONLINEAR DYNAM, V71, P159, DOI 10.1007/s11071-012-0648-z; ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; Agui JH, 2003, EXP FLUIDS, V34, P192, DOI [10.1007/S00348-002-0547-z, 10.1007/S00348-002-0547-Z]; BENZI R, 1992, PHYS REP, V222, P145, DOI 10.1016/0370-1573(92)90090-M; Beymer D, 1996, SCIENCE, V272, P1905, DOI 10.1126/science.272.5270.1905; Blackburn J, 2007, LECT NOTES COMPUT SC, V4814, P285; Bollt E, 2007, INT J BIFURCAT CHAOS, V17, P1199, DOI 10.1142/S021812740701777X; Boric K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069574; Cattafesta LN, 2011, ANNU REV FLUID MECH, V43, P247, DOI 10.1146/annurev-fluid-122109-160634; Chakraborty P, 2005, J FLUID MECH, V535, P189, DOI 10.1017/S0022112005004726; Cox T. F, 1994, MULTIDIMENSIONAL SCA; Daqaq MF, 2008, NONLINEAR DYNAM, V54, P167, DOI 10.1007/s11071-007-9246-x; DeLellis P, 2014, SCI REP-UK, V4, DOI 10.1038/srep03723; DeLellis P, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022818; Depardon S, 2007, EXP FLUIDS, V42, P697, DOI 10.1007/s00348-007-0277-3; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Foss JF, 2004, EXP FLUIDS, V37, P883, DOI 10.1007/s00348-004-0877-0; Green MA, 2010, CHAOS, V20, DOI 10.1063/1.3270045; HAMMACHE M, 1991, J FLUID MECH, V232, P567, DOI 10.1017/S0022112091003804; Hess D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077120; Jadaliha M, 2013, IEEE T CONTR SYST T, V21, P899, DOI 10.1109/TCST.2012.2190070; Kasagi N, 2009, ANNU REV FLUID MECH, V41, P231, DOI 10.1146/annurev.fluid.010908.165221; Macias D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030436; Manzo M, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4757569; Marcos, 2011, P NATL ACAD SCI USA, V108, P3860, DOI 10.1073/pnas.1014576108; Michelin S, 2008, J FLUID MECH, V617, P1, DOI 10.1017/S0022112008004321; Morton C, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3459157; Naguib A, 2001, MEMS AUTONOMOUS CONT, V3; OLINGER DJ, 1988, PHYS REV LETT, V60, P797, DOI 10.1103/PhysRevLett.60.797; Pedersen LM, 2010, EUR J CARDIO-THORAC, V37, P658, DOI 10.1016/j.ejcts.2009.07.041; PERRY AE, 1982, J FLUID MECH, V116, P77, DOI 10.1017/S0022112082000378; Pobitzer A, 2011, COMPUT GRAPH FORUM, V30, P1789, DOI 10.1111/j.1467-8659.2011.01901.x; Poelma C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045247; Post FH, 2003, COMPUT GRAPH FORUM, V22, P775, DOI 10.1111/j.1467-8659.2003.00723.x; Quenot GM, 1998, EXP FLUIDS, V25, P177, DOI 10.1007/s003480050222; Raffel M, 2007, EXP FLUID MECH, P1, DOI 10.1007/978-3-540-72308-0; Reinders F, 2002, COMPUT GRAPH FORUM, V21, P675, DOI 10.1111/1467-8659.00625; Roshko A., 1954, 1191 NAT ADV COMM AE; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Rulli MC, 2013, P NATL ACAD SCI US; Sadarjoen IA, 2000, COMPUT GRAPH-UK, V24, P333, DOI 10.1016/S0097-8493(00)00029-7; Schaepman ME, 2009, REMOTE SENS ENVIRON, V113, pS123, DOI 10.1016/j.rse.2009.03.001; Schlichting H., 2017, BOUNDARY LAYER THEOR, VNinth, DOI DOI 10.1007/978-3-642-85829-1; STRYKOWSKI PJ, 1990, J FLUID MECH, V218, P71, DOI 10.1017/S0022112090000933; Sumner D, 2000, J FLUID MECH, V411, P263, DOI 10.1017/S0022112099008137; Szymczak A, 2006, MED IMAGE ANAL, V10, P548, DOI 10.1016/j.media.2006.05.002; Tauro F, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011610; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; TRITTON DJ, 1959, J FLUID MECH, V6, P547, DOI 10.1017/S0022112059000829; Wolochuk MC, 1996, J FLUID ENG-T ASME, V118, P18, DOI 10.1115/1.2817501; Wong KKL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004747; Yang XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047406; Young GS, 2006, MON WEATHER REV, V134, P2285, DOI 10.1175/MWR3186.1	54	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91131	10.1371/journal.pone.0091131	http://dx.doi.org/10.1371/journal.pone.0091131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614890	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300082
J	Ye, SD; Yin, L; Amico, KR; Simoni, JM; Vermund, SH; Ruan, YH; Shao, YM; Qian, HZ				Ye, Shaodong; Yin, Lu; Amico, K. Rivet; Simoni, Jane M.; Vermund, Sten H.; Ruan, Yuhua; Shao, Yiming; Qian, Han-Zhu			Efficacy of Peer-Led Interventions to Reduce Unprotected Anal Intercourse among Men Who Have Sex with Men: A Meta-Analysis	PLOS ONE			English	Article							HIV-PREVENTION INTERVENTION; RANDOMIZED CONTROLLED-TRIAL; RISK BEHAVIOR; BISEXUAL MEN; GAY MEN; DEVELOPING-COUNTRIES; HOMOSEXUAL-MEN; YOUNG GAY; EDUCATION; LEVEL	Objective: To conduct a systematic review and meta-analysis to evaluate the efficacy of peer-led interventions in reducing unprotected anal intercourse (UAI) among men who have sex with men (MSM). Methods: Randomized clinical trials (RCTs), quasi-experimental studies, pre- and post-intervention studies without control groups, and serial cross-sectional assessments involving peers delivering interventions among MSM and published as of February 2012 were identified by systematically searching 13 electronic databases and cross-referencing. Effect sizes (ES) were calculated as the changes of standardized mean difference (SMD) in UAI between groups or pre-post intervention. Results: A total of 22 studies met the eligibility criteria, including five RCTs, six quasi-experimental studies, six pre-and-post intervention studies, and five serial cross-sectional intervention studies. We used 15 individual studies including 17 interventions for overall ES calculation; peer-led interventions reduced UAI with any sexual partners in meta-analysis (mean ES: -0.27; 95% confidence interval [CI]: -0.41, -0.13; P<0.01). Subgroup analyses demonstrated a statistically significant reduction on UAI in quasi-experimental studies (mean ES: -0.30; 95% CI: -0.50, -0.09; P = 0.01) and serial cross-sectional intervention studies (mean ES: -0.33; 95% CI: -0.57, -0.09; P = 0.01), but non-significant reduction in RCTs (mean ES: -0.15; 95% CI: -0.36, 0.07; P = 0.18) or pre- and post-intervention studies (mean ES: -0.29; 95% CI: -0.69, 0.11; P = 0.15). Heterogeneity was large across these 15 studies (I-2 = 77.5%; P<0.01), largely due to pre-and-post intervention studies and serial cross-sectional intervention studies. Conclusions: Peer-led HIV prevention interventions reduced the overall UAI among MSM, but the efficacy varied by study design. More RCTs are needed to evaluate the effect of peer-led interventions while minimizing potential bias.	[Ye, Shaodong; Yin, Lu; Vermund, Sten H.; Qian, Han-Zhu] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Ye, Shaodong; Ruan, Yuhua; Shao, Yiming] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent, Beijing, Peoples R China; [Ye, Shaodong; Ruan, Yuhua; Shao, Yiming] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Amico, K. Rivet] Univ Connecticut, Ctr Hlth Intervent & Prevent, Storrs, CT USA; [Simoni, Jane M.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Vermund, Sten H.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Qian, Han-Zhu] Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37212 USA	Vanderbilt University; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; University of Connecticut; University of Washington; University of Washington Seattle; Vanderbilt University; Vanderbilt University	Qian, HZ (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA.	han-zhu.qian@vanderbilt.edu	/AAE-4700-2020; Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698; Yin, Lu/0000-0001-9596-3325; Simoni, Jane/0000-0002-8711-1576; Amico, K Rivet/0000-0002-4458-6934	National Institute of Allergy And Infectious Diseases of the National Institutes of Health [R01AI09462, R34AI091446]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094562, R34AI091446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH093243] Funding Source: NIH RePORTER	National Institute of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this study was provided by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under award numbers R01AI09462 and R34AI091446. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirkhanian YA, 2003, AIDS EDUC PREV, V15, P205, DOI 10.1521/aeap.15.4.205.23832; Bastos FI, 2008, INT J EPIDEMIOL, V37, P729, DOI 10.1093/ije/dyn127; BECKER BJ, 1988, BRIT J MATH STAT PSY, V41, P257, DOI 10.1111/j.2044-8317.1988.tb00901.x; Berg R, 2009, EURO SURVEILL, V14; Bradford JB, 2007, AIDS PATIENT CARE ST, V21, pS49, DOI 10.1089/apc.2007.9987; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; Crepaz N, 2009, AIDS, V23, P1617, DOI 10.1097/QAD.0b013e32832effae; DEEKS J, 2002, SYSTEMATIC REV HLTH, P285; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eaton LA, 2011, AM J PUBLIC HEALTH, V101, P539, DOI 10.2105/AJPH.2010.191791; Elford J, 2001, AIDS, V15, P535, DOI 10.1097/00002030-200103090-00018; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2010, HIV AIDS SURV EUR 20; Flowers P, 2002, INT J STD AIDS, V13, P102, DOI 10.1258/0956462021924721; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hart GJ, 1998, SEX TRANSM INFECT, V74, P87; He J, 2010, SHI JIE GAN RAN ZA Z, V10, P32; Herbst JH, 2007, AM J PREV MED, V32, pS38, DOI 10.1016/j.amepre.2006.12.006; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; Johnson WD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001230.pub2; Johnson WD, 2005, AIDS EDUC PREV, V17, P568, DOI 10.1521/aeap.2005.17.6.568; Johnson WD, 2002, J ACQ IMMUN DEF SYND, V30, pS118, DOI 10.1097/01.QAI.0000018918.84759.19; Jones KT, 2008, AM J PUBLIC HEALTH, V98, P1043, DOI 10.2105/AJPH.2007.120337; Kang M, 2009, PEDIATR EXERC SCI, V21, P148, DOI 10.1123/pes.21.2.148; Kegeles SM, 1999, AIDS, V13, P1753, DOI 10.1097/00002030-199909100-00020; Kegeles SM, 1996, AM J PUBLIC HEALTH, V86, P1129, DOI 10.2105/AJPH.86.8_Pt_1.1129; Kelly JA, 1997, LANCET, V350, P1500, DOI 10.1016/S0140-6736(97)07439-4; KELLY JA, 1991, AM J PUBLIC HEALTH, V81, P168, DOI 10.2105/AJPH.81.2.168; Kennedy CE, 2010, B WORLD HEALTH ORGAN, V88, P615, DOI 10.2471/BLT.09.068213; Liang ZM, 2011, J MED PEST CONTROL, V27, P348; Lipsey M. W., 2001, PRACTICAL METAANALYS, V49; McKirnan DJ, 2010, J CONSULT CLIN PSYCH, V78, P952, DOI 10.1037/a0020759; Medley A, 2009, AIDS EDUC PREV, V21, P181, DOI 10.1521/aeap.2009.21.3.181; Miller RL, 1998, AM J COMMUN PSYCHOL, V26, P97, DOI 10.1023/A:1021886208524; National Center for HIV/AIDS Viral Hepatitis STD & TB Prevention, 2010, EP HIV INF 2009; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Paul-Ebhohimhen V, 2009, OBESITY FACTS, V2, P17, DOI 10.1159/000186144; Peterson JL, 1996, AIDS, V10, P319, DOI 10.1097/00002030-199603000-00011; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; REMAFEDI G, 1994, J ADOLESCENT HEALTH, V15, P142, DOI 10.1016/1054-139X(94)90541-X; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Safren SA, 2011, AIDS BEHAV, V15, P949, DOI 10.1007/s10461-010-9807-8; Sanchez-Meca J, 2003, PSYCHOL METHODS, V8, P448, DOI 10.1037/1082-989X.8.4.448; Shiner M, 1999, J ADOLESCENCE, V22, P555, DOI 10.1006/jado.1999.0248; Simoni JM, 2011, AIDS BEHAV, V15, P376, DOI 10.1007/s10461-010-9836-3; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; STLAWRENCE JS, 1994, AM J PUBLIC HEALTH, V84, P2027, DOI 10.2105/AJPH.84.12.2027; TUDIVER F, 1992, EVAL HEALTH PROF, V15, P26, DOI 10.1177/016327879201500102; van den Boom W, 2012, AIDS CARE, V24, P167, DOI 10.1080/09540121.2011.603285; van Griensven F, 2010, AIDS, V24, pS30, DOI 10.1097/01.aids.0000390087.22565.b4; Vergidis PI, 2009, INFECT DIS CLIN N AM, V23, P309, DOI 10.1016/j.idc.2009.02.001; Vermund SH, 2008, JAMA-J AM MED ASSOC, V300, P1698, DOI 10.1001/jama.300.14.1698; Webel AR, 2010, AM J PUBLIC HEALTH, V100, P247, DOI 10.2105/AJPH.2008.149419; Wolitski RJ, 2005, AIDS, V19, pS99, DOI 10.1097/01.aids.0000167356.94664.59; Zhang Hong-bo, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P970; Zhang Z, 2010, YU FANG YI XUE QING, V26, P784; Zhu Jun-li, 2008, Zhonghua Yufang Yixue Zazhi, V42, P895	56	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90788	10.1371/journal.pone.0090788	http://dx.doi.org/10.1371/journal.pone.0090788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9FH	24614809	Green Submitted, gold, Green Published			2022-12-27	WOS:000332839300042
J	Han, L; Gao, Y; Li, DY				Han, Lei; Gao, Yang; Li, Deying			Ion Uptake in Tall Fescue as Affected by Carbonate, Chloride, and Sulfate Salinity	PLOS ONE			English	Article							MG; IRRIGATION; TOLERANCE; ALFALFA; GROWTH; WATER; CA	Turfgrass nutrient uptake may be differentially affected by different salts. The objective of this study was to compare nutrient uptake in tall fescue (Festuca arundinacea Schreb.) as affected by carbonate, chloride, and sulfate under isoosmotic, iso-Na+ strength conditions. 'Tar Heel II' and 'Wolfpack' cultivars were subjected to NaCl, Na2CO3, Na2SO4, CaCl2, NaCl+ CaCl2, Na2CO3+ CaCl2, and Na2SO4+ CaCl2, in the range of 0 to 225 mM. There was no cultivar difference regarding K, Na, Mg, and Mn content in shoots. 'Tar Heel II' had higher shoot Ca content than 'Wolfpack', which were 6.9 and 5.7 g kg 21, respectively. In general, K+/Na+ ratio decreased with increasing salt concentrations, which reached <1 at about 87.5 mM in Na2CO3 treatment. All salt treatments decreased Mg content in shoot tissues, especially in Na2CO3 and treatments containing CaCl2. Both Ca and Mg content in shoot were higher in the NaCl treatment than the Na2SO4 and Na2CO3 treatments. All salt treatments except Na2CO3 had higher Mn content in shoots compared to the control. In conclusion, nutrient uptake was differently affected by carbonate, chloride, and sulfate which are different in pH, electrical conductivity (EC), and osmotic potential at the same concentration. Adding Ca to the sodium salts increased Ca content and balanced K+/Na+ in shoots, but did not increase Mg content, which was below sufficient level. Maintaining Mg content in shoots under salinity stress was recommended. The physiological impact of elevated Mn content in shoot under salinity stress requires further study.	[Han, Lei] State Forestry Adm, Res Inst Forestry, Key Lab Forest Cultivat, Beijing, Peoples R China; [Gao, Yang; Li, Deying] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA	North Dakota State University Fargo	Li, DY (corresponding author), N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA.	deying.li@ndsu.edu			National Natural Science Foundation of China [30500396]; National High Technology Research and Development Program of China [2009AA10Z109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The project was funded by the National Natural Science Foundation of China (Project No. 30500396), and the National High Technology Research and Development Program of China (Project No. 2009AA10Z109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshammary SF, 2004, AGR WATER MANAGE, V66, P97, DOI 10.1016/j.agwat.2003.11.002; Baldwin CM, 2006, HORTSCIENCE, V41, P808, DOI 10.21273/HORTSCI.41.3.808; Barnes R. F., 1990, Biotechnology in tall fescue improvement., P1; Bowman DC, 2006, J PLANT NUTR, V29, P1481, DOI 10.1080/01904160600837584; Carrow R.N., 2001, TURFGRASS SOIL FERTI; Carrow RN, 2003, CROP SCI, V43, P978, DOI 10.2135/cropsci2003.0978; Chen LM, 2010, J PLANT NUTR, V33, P1040, DOI 10.1080/01904161003728701; Clark RB, 2003, COMMUN SOIL SCI PLAN, V34, P1681, DOI 10.1081/CSS-120021306; Dudeck A. E., 1993, INT TURF SOC RES, V7, P680; ElSamad HMA, 1996, J PLANT NUTR, V19, P717, DOI 10.1080/01904169609365155; Gao Y, 2012, SCI HORTIC-AMSTERDAM, V139, P1, DOI 10.1016/j.scienta.2012.02.035; Greweling T, 1976, SEARCH, V6, P1; Hameed M, 2008, FLORA, V203, P683, DOI 10.1016/j.flora.2007.11.005; Hothem SD, 2003, J PLANT NUTR; Jones J.B., 1991, PLANT ANAL HDB PRACT; Jones R. G. W., 1979, Laidman, D. L.; Jones, R. G. W. [Editors]: Recent advances in the biochemistry of cereals., P63; Lee GJ, 2007, CROP SCI, V47, P2504, DOI 10.2135/cropsci2006.10.0639; Leskys AM, 1999, AGRON J, V91, P409, DOI 10.2134/agronj1999.00021962009100030009x; MacAdam JW, 1997, J PLANT NUTR, V20, P1137, DOI 10.1080/01904169709365323; Marcum KB, 2006, AGR WATER MANAGE, V80, P132, DOI 10.1016/j.agwat.2005.07.009; McLean E., 1983, METHODS SOIL ANAL PA, V9, P199, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C12; Qian YL, 2005, HORTSCIENCE, V40, P2170, DOI 10.21273/HORTSCI.40.7.2170; Rhoades JD, 1982, AGRONOMY, V9, P167, DOI DOI 10.2134/AGR0NM0N0GR9.2.2ED.C10; RICHARDS L. A., 1954, Diagnosis and Improvement of Saline and Alkali Soils.; SAS Institute Inc, 2008, SAS 9 1 3 SAS US GUI; SHANNON MC, 1978, AGRON J, V70, P719, DOI 10.2134/agronj1978.00021962007000050006x; Shewmaker GE, 2008, PLANT SOIL, V302, P283, DOI 10.1007/s11104-007-9482-3; SIMSON CR, 1979, COMMUN SOIL SCI PLAN, V10, P153, DOI 10.1080/00103627909366885; SLEPER DA, 1977, CROP SCI, V17, P433, DOI 10.2135/cropsci1977.0011183X001700030023x; USDA-NRCS, 2006, NAT RANG PAST HDB; Wilkinson S. R., 1979, Tall Fescue (Buckner, R.C.; Bush, L.P., Editors)., P41; Wipff JK, 2003, 2003 ANN M ASA CSSSA	32	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91908	10.1371/journal.pone.0091908	http://dx.doi.org/10.1371/journal.pone.0091908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626173	gold, Green Submitted, Green Published			2022-12-27	WOS:000332851300145
J	Jung, S; Bang, M; Kim, BS; Lee, S; Kotov, NA; Kim, B; Jeon, D				Jung, Seungmoon; Bang, Minji; Kim, Byung Sun; Lee, Sungmun; Kotov, Nicholas A.; Kim, Bongsoo; Jeon, Daejong			Intracellular Gold Nanoparticles Increase Neuronal Excitability and Aggravate Seizure Activity in the Mouse Brain	PLOS ONE			English	Article							TUNGSTEN CARBIDE NANOPARTICLES; CA2+-ACTIVATED K+ CHANNELS; TEMPORAL-LOBE EPILEPSY; CENTRAL-NERVOUS-SYSTEM; CA1 PYRAMIDAL NEURONS; POTASSIUM CHANNEL; RAT HIPPOCAMPUS; ZINC-OXIDE; DELIVERY; MEMBRANE	Due to their inert property, gold nanoparticles (AuNPs) have drawn considerable attention; their biological application has recently expanded to include nanomedicine and neuroscience. However, the effect of AuNPs on the bioelectrical properties of a single neuron remains unknown. Here we present the effect of AuNPs on a single neuron under physiological and pathological conditions in vitro. AuNPs were intracellularly applied to hippocampal CA1 neurons from the mouse brain. The electrophysiological property of CA1 neurons treated with 5- or 40-nm AuNPs was assessed using the whole-cell patch-clamp technique. Intracellular application of AuNPs increased both the number of action potentials (APs) and input resistance. The threshold and duration of APs and the after hyperpolarization (AHP) were decreased by the intracellular AuNPs. In addition, intracellular AuNPs elicited paroxysmal depolarizing shift-like firing patterns during sustained repetitive firings (SRF) induced by prolonged depolarization (10 sec). Furthermore, low Mg2+-induced epileptiform activity was aggravated by the intracellular AuNPs. In this study, we demonstrated that intracellular AuNPs alter the intrinsic properties of neurons toward increasing their excitability, and may have deleterious effects on neurons under pathological conditions, such as seizure. These results provide some considerable direction on application of AuNPs into central nervous system (CNS).	[Jung, Seungmoon; Bang, Minji; Kim, Byung Sun; Jeon, Daejong] Korea Adv Inst Sci & Technol KAIST, Dept Bio & Brain Engn, Taejon, South Korea; [Lee, Sungmun] Khalifa Univ Sci Technol & Res, Dept Biomed Engn, Abu Dhabi, U Arab Emirates; [Kotov, Nicholas A.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Kim, Bongsoo] Korea Adv Inst Sci & Technol KAIST, Dept Chem, Taejon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Khalifa University of Science & Technology; University of Michigan System; University of Michigan; Korea Advanced Institute of Science & Technology (KAIST)	Jeon, D (corresponding author), Korea Adv Inst Sci & Technol KAIST, Dept Bio & Brain Engn, Taejon, South Korea.	clark@kaist.ac.kr	Kotov, Nicholas/AAZ-4204-2021; Jeon, Daejong/C-1814-2011; Kim, Bongsoo/C-1545-2011	Kotov, Nicholas/0000-0002-6864-5804; Jeon, Daejong/0000-0002-6998-7603; Lee, Sungmun/0000-0002-1699-8376	Korea Health 21 RD grant [A120051]; Ministry of Health and Welfare; KUSTAR-KAIST Institute, Korea	Korea Health 21 RD grant; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); KUSTAR-KAIST Institute, Korea	This work was supported by the Korea Health 21 R&D grant (A120051) funded by Ministry of Health and Welfare, and also supported by the KUSTAR-KAIST Institute, Korea, under the R&D program supervised by the KAIST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Begley DJ, 2004, PHARMACOL THERAPEUT, V104, P29, DOI 10.1016/j.pharmthera.2004.08.001; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; Boisselier E, 2009, CHEM SOC REV, V38, P1759, DOI 10.1039/b806051g; Chen YS, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/48/485102; Chin C, 2010, INT J NANOMED, V5, P315; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; Chou LYT, 2011, CHEM SOC REV, V40, P233, DOI 10.1039/c0cs00003e; Crosera M, 2009, INT ARCH OCC ENV HEA, V82, P1043, DOI 10.1007/s00420-009-0458-x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Errington AC, 2008, MOL PHARMACOL, V73, P157, DOI 10.1124/mol.107.039867; Etame AB, 2012, NANOMED-NANOTECHNOL, V8, P1133, DOI 10.1016/j.nano.2012.02.003; Garcia-Garcia E, 2005, INT J PHARMACEUT, V298, P274, DOI 10.1016/j.ijpharm.2005.03.031; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hartkoorn RC, 2007, TUBERCULOSIS, V87, P248, DOI 10.1016/j.tube.2006.12.001; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Igelstrom KM, 2011, J NEUROPHYSIOL, V106, P2593, DOI 10.1152/jn.00601.2011; Jeon D, 2008, J BIOL CHEM, V283, P12093, DOI 10.1074/jbc.M800816200; JOHNSTON D, 1984, ANN NEUROL, V16, pS65, DOI 10.1002/ana.410160711; Jung S, 2012, NEUROSCI LETT, V529, P133, DOI 10.1016/j.neulet.2012.08.087; Khlebtsov N, 2011, CHEM SOC REV, V40, P1647, DOI 10.1039/c0cs00018c; Koziara JM, 2003, PHARM RES-DORDR, V20, P1772, DOI 10.1023/B:PHAM.0000003374.58641.62; Kress GJ, 2009, NEUROSCIENCE, V158, P211, DOI 10.1016/j.neuroscience.2008.03.021; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; Leifert A, 2013, P NATL ACAD SCI USA, V110, P8004, DOI 10.1073/pnas.1220143110; Liu ZW, 2012, NANOTOXICOLOGY, V6, P414, DOI 10.3109/17435390.2011.583996; Liu ZW, 2009, TOXICOLOGY, V264, P179, DOI 10.1016/j.tox.2009.08.005; Marquis BJ, 2009, ANALYST, V134, P425, DOI 10.1039/b818082b; Martina M, 1998, J NEUROSCI, V18, P8111; Morin F, 1996, J NEUROPHYSIOL, V76, P1; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Paulo CSO, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494002; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Prades R, 2012, BIOMATERIALS, V33, P7194, DOI 10.1016/j.biomaterials.2012.06.063; Sachdev PS, 2007, SCHIZOPHRENIA BULL, V33, P1029, DOI 10.1093/schbul/sbm012; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Schulz DJ, 2006, J NEUROSCI, V26, P10362, DOI 10.1523/JNEUROSCI.3194-06.2006; Selvan ST, 2010, LANGMUIR, V26, P11631, DOI 10.1021/la903512m; Shan DH, 2013, TOXICOL IN VITRO, V27, P299, DOI 10.1016/j.tiv.2012.08.025; Shan DH, 2012, TOXICOL LETT, V209, P129, DOI 10.1016/j.toxlet.2011.12.001; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Taverna S, 2005, J NEUROSCI, V25, P9162, DOI 10.1523/JNEUROSCI.2454-05.2005; Torchilin VP, 2006, ANNU REV BIOMED ENG, V8, P343, DOI 10.1146/annurev.bioeng.8.061505.095735; Wang TT, 2012, ACS NANO, V6, P1251, DOI 10.1021/nn203892h; Xi LJ, 2009, ENVIRON TOXICOL, V24, P211, DOI 10.1002/tox.20418; Xie YL, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-14; Yang Z, 2010, J R SOC INTERFACE, V7, pS411, DOI 10.1098/rsif.2010.0158.focus; Zhang XF, 2010, NAT NEUROSCI, V13, P1056, DOI 10.1038/nn.2610; Zhang Y, 2002, BIOMATERIALS, V23, P1553, DOI 10.1016/S0142-9612(01)00267-8; Zhao JX, 2009, NEUROTOXICOLOGY, V30, P220, DOI 10.1016/j.neuro.2008.12.005	54	37	40	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91360	10.1371/journal.pone.0091360	http://dx.doi.org/10.1371/journal.pone.0091360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625829	Green Submitted, gold, Green Published			2022-12-27	WOS:000332851300077
J	Ran, S; Liu, YJ; Zhang, L; Pei, YF; Yang, TL; Hai, R; Han, YY; Lin, Y; Tian, Q; Deng, HW				Ran, Shu; Liu, Yong-Jun; Zhang, Lei; Pei, Yufang; Yang, Tie-Lin; Hai, Rong; Han, Ying-Ying; Lin, Yong; Tian, Qing; Deng, Hong-Wen			Genome-Wide Association Study Identified Copy Number Variants Important for Appendicular Lean Mass	PLOS ONE			English	Article							ALTERNATIVE DEFINITIONS; STRUCTURAL VARIANTS; MUSCLE STRENGTH; GENES; POLYMORPHISMS; EXPRESSION; SARCOPENIA; FAMILY; RISK	Skeletal muscle is a major component of the human body. Age-related loss of muscle mass and function contributes to some public health problems such as sarcopenia and osteoporosis. Skeletal muscle, mainly composed of appendicular lean mass (ALM), is a heritable trait. Copy number variation (CNV) is a common type of human genome variant which may play an important role in the etiology of many human diseases. In this study, we performed genome-wide association analyses of CNV for ALM in 2,286 Caucasian subjects. We then replicated the major findings in 1,627 Chinese subjects. Two CNVs, CNV1191 and CNV2580, were detected to be associated with ALM (p = 2.26x10(-2) and 3.34x10(-3), respectively). In the Chinese replication sample, the two CNVs achieved p-values of 3.26x10(-2) and 0.107, respectively. CNV1191 covers a gene, GTPase of the immunity-associated protein family (GIMAP1), which is important for skeletal muscle cell survival/death in humans. CNV2580 is located in the Serine hydrolase-like protein (SERHL) gene, which plays an important role in normal peroxisome function and skeletal muscle growth in response to mechanical stimuli. In summary, our study suggested two novel CNVs and the related genes that may contribute to variation in ALM.	[Ran, Shu; Zhang, Lei; Pei, Yufang; Han, Ying-Ying; Lin, Yong; Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China; [Yang, Tie-Lin] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Minist Educ,Inst Mol Genet, Xian 710049, Peoples R China; [Hai, Rong] Inner Mongolia Peoples Hosp, Geriatr Hlth Clin, Inner Mongolia, Peoples R China; [Liu, Yong-Jun; Tian, Qing; Deng, Hong-Wen] Tulane Univ, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA	University of Shanghai for Science & Technology; Xi'an Jiaotong University; Tulane University	Deng, HW (corresponding author), Shanghai Univ Sci & Technol, Ctr Syst Biomed Sci, Shanghai 201800, Peoples R China.	hdeng2@tulane.edu	Zhang, Lei/L-1016-2016; Yang, Tie-Lin/G-8365-2014; Liu, Yong/GWQ-6163-2022	Zhang, Lei/0000-0002-1007-4834; Yang, Tie-Lin/0000-0001-7062-3025; Deng, Hong-Wen/0000-0002-0387-8818	Shanghai University of Science and Technology; Shanghai Leading Academic Discipline Project [S30501]; National Institutes of Health [R01AG026564, RC2DE020756, R01AR057049, R01AR050496, R03TW008221]; SCOR (Specialized Center of Research) [P50AR055081]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Office of Research on Women's Health (ORWH); Edward G. Schlieder Endowment; Franklin D. Dickson/Missouri Endowment; National Natural Science Foundation of China [31100902]; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR050496, R01AR057049, R01AR059781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564] Funding Source: NIH RePORTER	Shanghai University of Science and Technology; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SCOR (Specialized Center of Research); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Office of Research on Women's Health (ORWH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Edward G. Schlieder Endowment; Franklin D. Dickson/Missouri Endowment; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was partially supported by startup funding from Shanghai University of Science and Technology and Shanghai Leading Academic Discipline Project (S30501). The investigators of this work were partially supported by grants from the National Institutes of Health (R01AG026564, RC2DE020756, R01AR057049, R01AR050496 and R03TW008221), a SCOR (Specialized Center of Research) grant (P50AR055081) supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the Office of Research on Women's Health (ORWH), and the Edward G. Schlieder Endowment and the Franklin D. Dickson/Missouri Endowment. Lei Zhang was also supported by the National Natural Science Foundation of China project (31100902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden NK, 1997, J BONE MINER RES, V12, P2076, DOI 10.1359/jbmr.1997.12.12.2076; Baumgartner RN, 2000, ANN NY ACAD SCI, V904, P437; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; Delmonico MJ, 2007, J AM GERIATR SOC, V55, P769, DOI 10.1111/j.1532-5415.2007.01140.x; Deng HW, 2002, AM J HUM GENET, V70, P1138, DOI 10.1086/339934; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fisher KA, 2008, J ACOUST SOC AM, V123, P1862, DOI 10.1121/1.2839140; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hai R, 2012, J HUM GENET, V57, P33, DOI 10.1038/jhg.2011.125; Han YY, 2012, BONE, V51, P1000, DOI 10.1016/j.bone.2012.08.127; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Karakelides H, 2005, CURR TOP DEV BIOL, V68, P123, DOI 10.1016/S0070-2153(05)68005-2; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Liaubet L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-548; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Newman AB, 2003, J AM GERIATR SOC, V51, P1602, DOI 10.1046/j.1532-5415.2003.51534.x; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; R Development Core Team, 2010, R LANG ENV STAT COMP; Ravnik-Glavac M, 2012, CONSCIOUS COGN, V21, P1322, DOI 10.1016/j.concog.2012.06.003; Raymond F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-125; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Sadusky TJ, 2001, GENOMICS, V73, P38, DOI 10.1006/geno.2000.6483; Saunders A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-53; Schwefel David, 2011, Small GTPases, V2, P27; Sipila S, 2006, J GERONTOL A-BIOL, V61, P92, DOI 10.1093/gerona/61.1.92; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sun L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027325; Thomis MAI, 2004, EUR J APPL PHYSIOL, V92, P267, DOI 10.1007/s00421-004-1093-6; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174	37	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e89776	10.1371/journal.pone.0089776	http://dx.doi.org/10.1371/journal.pone.0089776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626161	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300009
J	Leisnham, PT; LaDeau, SL; Juliano, SA				Leisnham, Paul T.; LaDeau, Shannon L.; Juliano, Steven A.			Spatial and Temporal Habitat Segregation of Mosquitoes in Urban Florida	PLOS ONE			English	Article							QUINQUEFASCIATUS DIPTERA-CULICIDAE; CONDITION-SPECIFIC COMPETITION; AEDES-ALBOPICTUS DIPTERA; CULEX-PIPIENS DIPTERA; CONTAINER MOSQUITOS; SEASONAL-VARIATION; AGGREGATION MODEL; AEGYPTI DIPTERA; OVIPOSITION; COEXISTENCE	Understanding mechanisms fostering coexistence between invasive and resident species is important in predicting ecological, economic, or health impacts of invasive species. The non-native mosquitoes Aedes aegypti and Culex quinquefasciatus have been resident in the southeastern United States for over a century. They coexist at some urban sites with the more recent invasive Aedes albopictus, which is usually superior in interspecific competition. We tested predictions of temporal and spatial habitat segregation that foster coexistence of these resident species with the superior invasive competitor. We measured spatial and temporal patterns of site occupancy and abundance for all three species among standard oviposition traps in metropolitan Tampa, Florida. Consistent with the condition-specific competition hypothesis, A. albopictus and A. aegypti abundances were greater and C. quinquefasciatus abundance was lower late (September) versus early (June) in the rainy season, and the proportional increase of A. albopictus abundance was greater than that of A. aegypti. These results are postulated to result from greater dry-season egg mortality and associated greater rainy-season competitive superiority of larvae of A. albopictus, followed by A. aegypti, and C. quinquefasciatus. Spatial partitioning among landscape variables was also evident among species, with A. albopictus more likely to oviposit across a range of open grass landscapes whereas A. aegypti were mostly restricted to cemeteries. Culex quinquefasciatus showed a shift in abundance from cemeteries early in the rainy season to developed areas characterized by built environments with large proportions of impervious surfaces late in the rainy season, where A. albopictus was not in its highest abundance. These results suggest that both temporal and spatial variation, and their interaction, may contribute to local coexistence between Aedes and Culex mosquito species in urban areas.	[Leisnham, Paul T.] Univ Maryland, Dept Environm Sci & Technol, College Pk, MD 20742 USA; [LaDeau, Shannon L.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Juliano, Steven A.] Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA	University System of Maryland; University of Maryland College Park; Cary Institute of Ecosystem Studies; Illinois State University	Leisnham, PT (corresponding author), Univ Maryland, Dept Environm Sci & Technol, College Pk, MD 20742 USA.	leisnham@umd.edu		Juliano, Steven/0000-0002-6178-4553; LaDeau, Shannon/0000-0003-4825-5435; Leisnham, Paul T./0000-0003-3527-8435	NIAID [R01-AI-44793]; Illinois State University; University of Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044793] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Illinois State University; University of Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Field work was funded by NIAID grant R01-AI-44793 (Illinois State University subaward) and by a grant to SAJ from Illinois State University. Time for analyses and authorship for PTL was funded by the University of Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2001, J THEOR BIOL, V209, P333, DOI 10.1006/jtbi.2001.2269; Barrera R, 2006, J MED ENTOMOL, V43, P484, DOI 10.1603/0022-2585(2006)43[484:EFIAAD]2.0.CO;2; BLAUSTEIN L, 1993, ECOL ENTOMOL, V18, P104, DOI 10.1111/j.1365-2311.1993.tb01190.x; Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785; Calcagno V, 2006, ECOL LETT, V9, P897, DOI 10.1111/j.1461-0248.2006.00930.x; Carbajo AE, 2006, MED VET ENTOMOL, V20, P209, DOI 10.1111/j.1365-2915.2006.00625.x; Carrieri M, 2003, ENVIRON ENTOMOL, V32, P1313, DOI 10.1603/0046-225X-32.6.1313; CHADEE DD, 2002, ENTOMOL EXP APPL, V57, P1990; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Costanzo KS, 2005, ECOLOGY, V86, P3289, DOI 10.1890/05-0583; Costanzo KS, 2005, J MED ENTOMOL, V42, P559, DOI 10.1603/0022-2585(2005)042[0559:ACAPOA]2.0.CO;2; Dibo MR, 2008, MEM I OSWALDO CRUZ, V103, P554, DOI 10.1590/S0074-02762008000600008; Fader JE, 2013, ECOLOGY, V94, P478, DOI 10.1890/12-0123.1; Focks D.A., 2004, REV ENTOMOLOGICAL SA; Geographic Mapping Section, 1999, FLOR LAND US COV FOR; Gerhardt RR, 2001, EMERG INFECT DIS, V7, P807; Ghosh SK, 2006, J STAT PLAN INFER, V136, P1360, DOI 10.1016/j.jspi.2004.10.008; Harbison JE, 2010, J MED ENTOMOL, V47, P67, DOI 10.1603/033.047.0109; Hartley S, 2002, J ANIM ECOL, V71, P651, DOI 10.1046/j.1365-2656.2002.00628.x; Hoeck PAE, 2003, J VECTOR ECOL, V28, P65; Ibanez-Bernal S, 1997, MED VET ENTOMOL, V11, P305, DOI 10.1111/j.1365-2915.1997.tb00413.x; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4; Juliano SA, 2008, ANN REV ENTOMOLOGY, V54; Juliano SA, 2010, ISR J ECOL EVOL, V56, P325, DOI 10.1560/IJEE.55.3-4.325; Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611; Kery M., 2010, INTRO WINBUGS ECOLOG; Lee JH, 2004, J AM MOSQUITO CONTR, V20, P248; Leisnham PT, 2009, OECOLOGIA, V160, P343, DOI 10.1007/s00442-009-1305-1; Lounibos LP, 2002, J VECTOR ECOL, V27, P86; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mokany A, 2003, AUSTRAL ECOL, V28, P33, DOI 10.1046/j.1442-9993.2003.01239.x; Morato VCG, 2005, REV SAUDE PUBL, V39, P553, DOI 10.1590/S0034-89102005000400006; Murrell EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043458; Murrell EG, 2011, ANN ENTOMOL SOC AM, V104, P688, DOI 10.1603/AN10158; Serpa LLN, 2006, REV SAUDE PUBL, V40, P1101, DOI 10.1590/S0034-89102006005000008; O'Neal PA, 2013, J ANIM ECOL, V82, P256, DOI 10.1111/j.1365-2656.2012.02017.x; OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554; Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005; PETERS TM, 1969, MOSQ NEWS, V29, P435; Rawlins SC, 1998, J AM MOSQUITO CONTR, V14, P131; Reiter ME, 2009, J VECTOR ECOL, V34, P208, DOI [10.3376/038.034.0206, 10.1111/j.1948-7134.2009.00028.x]; Rey JR, 2006, J MED ENTOMOL, V43, P1134, DOI 10.1603/0022-2585(2006)43[1134:HSOMAV]2.0.CO;2; Richards SL, 2006, J MED ENTOMOL, V43, P976, DOI 10.1603/0022-2585(2006)43[976:SAOAAD]2.0.CO;2; Romero-Vivas CME, 2005, J AM MOSQUITO CONTR, V21, P15, DOI 10.2987/8756-971X(2005)21[15:IORBAA]2.0.CO;2; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Schultz George W., 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P369; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Taniguchi Y, 2000, ECOLOGY, V81, P2027, DOI 10.2307/177290; Tilman D., 1982, Monographs in Population Biology, pi; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]; Workman PD, 2003, J VECTOR ECOL, V28, P213	56	44	46	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91655	10.1371/journal.pone.0091655	http://dx.doi.org/10.1371/journal.pone.0091655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621592	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300113
J	Sanchez-Lopez, J; Fernandez, T; Silva-Pereyra, J; Mesa, JAM; Di Russo, F				Sanchez-Lopez, Javier; Fernandez, Thalia; Silva-Pereyra, Juan; Mesa, Juan A. Martinez; Di Russo, Francesco			Differences in Visuo-Motor Control in Skilled vs. Novice Martial Arts Athletes during Sustained and Transient Attention Tasks: A Motor-Related Cortical Potential Study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ALPHA RHYTHMS; MOVEMENT; REACTIVITY; BRAIN; TESTS	Cognitive and motor processes are essential for optimal athletic performance. Individuals trained in different skills and sports may have specialized cognitive abilities and motor strategies related to the characteristics of the activity and the effects of training and expertise. Most studies have investigated differences in motor-related cortical potential (MRCP) during self-paced tasks in athletes but not in stimulus-related tasks. The aim of the present study was to identify the differences in performance and MRCP between skilled and novice martial arts athletes during two different types of tasks: a sustained attention task and a transient attention task. Behavioral and electrophysiological data from twenty-two martial arts athletes were obtained while they performed a continuous performance task (CPT) to measure sustained attention and a cued continuous performance task (c-CPT) to measure transient attention. MRCP components were analyzed and compared between groups. Electrophysiological data in the CPT task indicated larger prefrontal positive activity and greater posterior negativity distribution prior to a motor response in the skilled athletes, while novices showed a significantly larger response-related P3 after a motor response in centro-parietal areas. A different effect occurred in the c-CPT task in which the novice athletes showed strong prefrontal positive activity before a motor response and a large response-related P3, while in skilled athletes, the prefrontal activity was absent. We propose that during the CPT, skilled athletes were able to allocate two different but related processes simultaneously according to CPT demand, which requires controlled attention and controlled motor responses. On the other hand, in the c-CPT, skilled athletes showed better cue facilitation, which permitted a major economy of resources and "automatic'' or less controlled responses to relevant stimuli. In conclusion, the present data suggest that motor expertise enhances neural flexibility and allows better adaptation of cognitive control to the requested task.	[Sanchez-Lopez, Javier; Fernandez, Thalia] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Conductual & Cognit, Juriquilla, Queretaro, Mexico; [Silva-Pereyra, Juan] Univ Nacl Autonoma Mexico, Proyecto Neurociencias, Fac Estudios Super Iztacala, Tlalnepantla, Estado De Mexic, Mexico; [Mesa, Juan A. Martinez] Inst Med Deporte Cuba, Dept Psicol Deporte, Cerro, Ciudad De La Ha, Cuba; [Di Russo, Francesco] Univ Roma Foro Italico, Dipartimento Sci Motorie Umane & Salute, Rome, Lazio, Italy; [Di Russo, Francesco] IRCCS Fdn Santa Lucia, Unita Neuropsicol, Rome, Lazio, Italy	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Foro Italico University of Rome; IRCCS Santa Lucia	Fernandez, T (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Conductual & Cognit, Juriquilla, Queretaro, Mexico.	thaliafh@yahoo.com.mx	Sanchez-Lopez, Javier/AAD-2006-2019; Di Russo, Francesco/N-6686-2015; Fernandez, Thalia/AGI-6073-2022	Sanchez-Lopez, Javier/0000-0002-4291-0315; Di Russo, Francesco/0000-0002-3127-9433; Silva-Pereyra, Juan/0000-0002-2982-1457	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [PAPIIT IN205212]	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This research was supported by the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT IN205212). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNETHY B, 1987, J SPORT EXERCISE PSY, V9, P326, DOI 10.1123/jsp.9.4.326; Anshel MH, 2006, SPORT PSYCHOLOGIST'S HANDBOOK: A GUIDE FOR SPORT-SPECIFIC PERFORMANCE ENHANCEMENT, P353; Babiloni C, 2010, BEHAV BRAIN RES, V207, P466, DOI 10.1016/j.bbr.2009.10.034; Babiloni C, 2010, BRAIN RES BULL, V81, P149, DOI 10.1016/j.brainresbull.2009.10.014; Berchicci M, 2013, J GERONTOLOGY A; Berchicci M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00135; Berchicci M, 2012, NEUROIMAGE, V62, P1750, DOI 10.1016/j.neuroimage.2012.06.031; Blumenstaein B, 2002, BRAIN BODY SPORT EXE; BRUNIA CHM, 1993, PSYCHOPHYSIOLOGY, V30, P327, DOI 10.1111/j.1469-8986.1993.tb02054.x; Del Percio C, 2011, INT J PSYCHOPHYSIOL, V82, P240, DOI 10.1016/j.ijpsycho.2011.09.005; Del Percio C, 2010, CLIN NEUROPHYSIOL, V121, P482, DOI 10.1016/j.clinph.2009.12.004; Del Percio C, 2009, BRAIN RES BULL, V79, P193, DOI 10.1016/j.brainresbull.2009.02.001; del-Monte L, 2005, EF DEPORTES, V87, P1; Di Russo F, 2005, MED SCI SPORT EXER, V37, P1586, DOI 10.1249/01.mss.0000177458.71676.0d; Di Russo F, 2006, NEUROSCI LETT, V408, P113, DOI 10.1016/j.neulet.2006.08.085; Fattapposta F, 1996, ELECTROEN CLIN NEURO, V99, P495, DOI 10.1016/S0013-4694(96)96560-8; Fontani G, 1999, EUR J APPL PHYSIOL O, V80, P308, DOI 10.1007/s004210050597; Fontani G, 2002, PERCEPT MOTOR SKILL, V94, P817, DOI 10.2466/pms.2002.94.3.817; Fontani G, 2006, PERCEPT MOTOR SKILL, V102, P791, DOI 10.2466/PMS.102.3.791-805; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hack Johannes, 2009, Res Q Exerc Sport, V80, P727; HAMON J F, 1989, Neurophysiologie Clinique, V19, P109; Hatta A, 2009, NEUROSCI LETT, V459, P105, DOI 10.1016/j.neulet.2009.05.005; Hung T-M, 2004, J SPORT EXERCISE PSY, P26; Jennings J. R., 1991, HDB COGNITIVE PSYCHO; Kita Y, 2001, NEUROREPORT, V12, P2221, DOI 10.1097/00001756-200107200-00035; LAVALLE D, 2004, SPORT PSYCHOL CONT T; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; Nougier V, 1999, INT J SPORT PSYCHOL, V30, P246; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Radlo SJ, 2001, RES Q EXERCISE SPORT, V72, P22, DOI 10.1080/02701367.2001.10608928; ROSENBAUM DA, 1980, J EXP PSYCHOL GEN, V109, P444, DOI 10.1037/0096-3445.109.4.444; Rushall BS, 2006, SPORT PSYCHOLOGIST'S HANDBOOK: A GUIDE FOR SPORT-SPECIFIC PERFORMANCE ENHANCEMENT, P375; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Smid HGOM, 2006, J CLIN EXP NEUROPSYC, V28, P859, DOI 10.1080/13803390591001025; Squire L., 1999, NEW COGNITIVE NEUROS, V2nd ed., P765; Taddei F, 2012, MED SCI SPORT EXER, V44, P1057, DOI 10.1249/MSS.0b013e31824529c2; Williams AM, 1999, INT J SPORT PSYCHOL, V30, P194; Wright DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051886; Wright DJ, 2012, HUM MOVEMENT SCI, V31, P567, DOI 10.1016/j.humov.2011.07.001; Wright DJ, 2011, J MOTOR BEHAV, V43, P193, DOI 10.1080/00222895.2011.557751	43	28	28	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91112	10.1371/journal.pone.0091112	http://dx.doi.org/10.1371/journal.pone.0091112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24621480	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300050
J	Shibata, M; Ninomiya, T; Jensen, MP; Anno, K; Yonemoto, K; Makino, S; Iwaki, R; Yamashiro, K; Yoshida, T; Imada, Y; Kubo, C; Kiyohara, Y; Sudo, N; Hosoi, M				Shibata, Mao; Ninomiya, Toshiharu; Jensen, Mark P.; Anno, Kozo; Yonemoto, Koji; Makino, Seiko; Iwaki, Rie; Yamashiro, Koji; Yoshida, Toshiyuki; Imada, Yuko; Kubo, Chiharu; Kiyohara, Yutaka; Sudo, Nobuyuki; Hosoi, Masako			Alexithymia Is Associated with Greater Risk of Chronic Pain and Negative Affect and with Lower Life Satisfaction in a General Population: The Hisayama Study	PLOS ONE			English	Article							VISUAL ANALOG SCALE; LOW-BACK-PAIN; PREVALENCE; DISEASE; COMORBIDITY; RELIABILITY; DEPRESSION; VALIDITY; GENDER; HEALTH	Introduction: Chronic pain is a significant health problem worldwide, with a prevalence in the general population of approximately 40%. Alexithymia - the personality trait of having difficulties with emotional awareness and self-regulation - has been reported to contribute to an increased risk of several chronic diseases and health conditions, and limited research indicates a potential role for alexithymia in the development and maintenance of chronic pain. However, no study has yet examined the associations between alexithymia and chronic pain in the general population. Methods: We administered measures assessing alexithymia, pain, disability, anxiety, depression, and life satisfaction to 927 adults in Hisayama, Japan. We classified the participants into four groups (low-normal alexithymia, middle-normal alexithymia, high-normal alexithymia, and alexithymic) based on their responses to the alexithymia measure. We calculated the risk estimates for the criterion measures by a logistic regression analysis. Results: Controlling for demographic variables, the odds ratio (OR) for having chronic pain was significantly higher in the high-normal (OR: 1.49, 95% CI: 1.07-2.09) and alexithymic groups (OR: 2.56, 95% CI: 1.47-4.45) compared to the low-normal group. Approximately 40% of the participants belonged to these two high-risk groups. In the subanalyses of the 439 participants with chronic pain, the levels of pain intensity, disability, depression, and anxiety were significantly increased and the degree of life satisfaction was decreased with elevating alexithymia categories. Conclusions: The findings demonstrate that, in the general population, higher levels of alexithymia are associated with a higher risk of having chronic pain. The early identification and treatment of alexithymia and negative affect may be beneficial in preventing chronic pain and reducing the clinical and economic burdens of chronic pain. Further research is needed to determine if this association is due to a causal effect of alexithymia on the prevalence and severity of chronic pain.	[Shibata, Mao; Anno, Kozo; Makino, Seiko; Iwaki, Rie; Yamashiro, Koji; Imada, Yuko; Sudo, Nobuyuki] Kyushu Univ, Grad Sch Med Sci, Dept Psychosomat Med, Fukuoka 812, Japan; [Shibata, Mao; Kubo, Chiharu; Sudo, Nobuyuki; Hosoi, Masako] Kyushu Univ Hosp, Dept Psychosomat Med, Fukuoka 812, Japan; [Shibata, Mao; Ninomiya, Toshiharu; Kiyohara, Yutaka] Kyushu Univ, Grad Sch Med Sci, Dept Environm Med, Fukuoka 812, Japan; [Ninomiya, Toshiharu] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Jensen, Mark P.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Yonemoto, Koji] Kurume Univ, Biostat Ctr, Fukuoka, Japan; [Yoshida, Toshiyuki] Int Univ Hlth & Welf, Dept Speech & Hearing Sci, Sch Hlth Sci Fukuoka, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University; University of Washington; University of Washington Seattle; Kurume University; International University of Health & Welfare	Hosoi, M (corresponding author), Kyushu Univ Hosp, Dept Psychosomat Med, Fukuoka 812, Japan.	hosoi@cephal.med.kyushu-u.ac.jp		Hosoi, Masako/0000-0001-8880-5847; Sudo, Nobuyuki/0000-0002-7935-878X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21590766]; Ministry of Health, Labor and Welfare of Japan [H23-Pain-Shitei-005]; Grants-in-Aid for Scientific Research [25253048] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MH was supported in part by Grants-in-Aid for Scientific Research C (number 21590766) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and for the Health and Labor Sciences Research from the Ministry of Health, Labor and Welfare of Japan (H23-Pain-Shitei-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Bagby RM, 1997, DISORDERS AFFECT REG, P30; Boonstra AM, 2008, INT J REHABIL RES, V31, P165, DOI 10.1097/MRR.0b013e3282fc0f93; CELIKEL F, 2006, ANN GEN PSYCHIATR, V15, P5; Cheng YH, 2002, SOC SCI MED, V55, P1415, DOI 10.1016/S0277-9536(01)00271-4; Committee on Advancing Pain Research Care and Education Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Dworkin RH, 2010, PAIN, V149, P177, DOI 10.1016/j.pain.2010.02.018; Franz M, 2008, SOC PSYCH PSYCH EPID, V43, P54, DOI 10.1007/s00127-007-0265-1; Gregory Robert J, 2005, Ann Clin Psychiatry, V17, P59, DOI 10.1080/10401230590932317; Group TITW, 2011, CLASS CHRON PAIN D 1; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Hosoi M, 2010, PAIN, V149, P273, DOI 10.1016/j.pain.2010.02.012; Huber A, 2009, J PSYCHOSOM RES, V66, P425, DOI 10.1016/j.jpsychores.2008.11.009; Kano M, 2007, PAIN, V132, P252, DOI 10.1016/j.pain.2007.01.032; Kano M, 2013, BIOPSYCHOSOC MED, V7, DOI 10.1186/1751-0759-7-1; Kooiman CG, 2002, J PSYCHOSOM RES, V53, P1083, DOI 10.1016/S0022-3999(02)00348-3; Kosturek A, 1998, PSYCHOSOMATICS, V39, P399, DOI 10.1016/S0033-3182(98)71298-8; Kroenke K, 1998, PSYCHOSOM MED, V60, P150, DOI 10.1097/00006842-199803000-00006; Lumley MA, 2005, PAIN MED, V6, P251, DOI 10.1111/j.1526-4637.2005.05036.x; Lumley MA, 1997, PSYCHOSOMATICS, V38, P497, DOI 10.1016/S0033-3182(97)71427-0; Lumley MA, 1996, J PSYCHOSOM RES, V41, P505, DOI 10.1016/S0022-3999(96)00222-X; Lumley MA, 1997, COMPR PSYCHIAT, V38, P160, DOI 10.1016/S0010-440X(97)90069-9; Lumley MA, 2007, J PERS ASSESS, V89, P230, DOI 10.1080/00223890701629698; Makino S, 2013, CLIN J PAIN, V29, P354, DOI 10.1097/AJP.0b013e3182579c63; Manchikanti Laxmaiah, 2002, Pain Physician, V5, P57; Matsubayashi Kozo, 1994, Japanese Journal of Geriatrics, V31, P790; Mattila AK, 2006, J PSYCHOSOM RES, V61, P629, DOI 10.1016/j.jpsychores.2006.04.013; Mehling WE, 2005, J PSYCHOSOM RES, V58, P73, DOI 10.1016/j.jpsychores.2004.05.007; Mehling WE, 2007, J PSYCHOSOM RES, V62, P667, DOI 10.1016/j.jpsychores.2007.03.002; Messina A, 2011, ANN CLIN PSYCHIATRY, V23, P125; Mico JA, 2006, TRENDS PHARMACOL SCI, V27, P348, DOI 10.1016/j.tips.2006.05.004; Moriguchi Y, 2007, BIOPSYCHOSOC MED, V1, DOI 10.1186/1751-0759-1-7; OHMURA T, 1993, DIABETOLOGIA, V36, P1198, DOI 10.1007/BF00401066; Pecukonis EV, 2009, PAIN MANAG NURS, V10, P116, DOI 10.1016/j.pmn.2008.11.001; Phillips Ceri J, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P591, DOI 10.1586/14737167.6.5.591; Porcelli P, 2007, PSYCHO-ONCOLOGY, V16, P644, DOI 10.1002/pon.1115; Saariaho AS, 2013, GEN HOSP PSYCHIAT, V35, P239, DOI 10.1016/j.genhosppsych.2012.11.011; Sharp John, 2005, Curr Psychiatry Rep, V7, P213, DOI 10.1007/s11920-005-0056-x; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Spek V, 2008, ACTA PSYCHIAT SCAND, V118, P164, DOI 10.1111/j.1600-0447.2008.01199.x; Tolmunen T, 2011, COMPR PSYCHIAT, V52, P536, DOI 10.1016/j.comppsych.2010.09.007; Tomioka M, 2008, BIOPSYCHOSOC MED, V2, DOI 10.1186/1751-0759-2-19; Tsang A, 2008, J PAIN, V9, P883, DOI 10.1016/j.jpain.2008.05.005; Tulipani C, 2010, PSYCHOTHER PSYCHOSOM, V79, P156, DOI 10.1159/000286960; Tunks ER, 2008, CAN J PSYCHIAT, V53, P224, DOI 10.1177/070674370805300403; Valkamo M, 2001, ACTA PSYCHIAT SCAND, V104, P391, DOI 10.1034/j.1600-0447.2001.00165.x; WISE TN, 1994, HEADACHE, V34, P362, DOI 10.1111/j.1526-4610.1994.hed3406362.x	47	64	67	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90984	10.1371/journal.pone.0090984	http://dx.doi.org/10.1371/journal.pone.0090984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24621785	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000332845300041
J	Galvao, BPGV; Weber, BW; Rafudeen, MS; Ferreira, EO; Patrick, S; Abratt, VR				Galvao, Bruna P. G. V.; Weber, Brandon W.; Rafudeen, Mohamed S.; Ferreira, Eliane O.; Patrick, Sheila; Abratt, Valerie R.			Identification of a Collagen Type I Adhesin of Bacteroides fragilis	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; EXTRACELLULAR-MATRIX PROTEINS; EXTENSIVE DNA INVERSIONS; BINDING PROTEIN; SURFACE; SYSTEM; GLYCOSYLATION; EXPRESSION; PREDICTION; SEQUENCES	Bacteroides fragilis is an opportunistic pathogen which can cause life threatening infections in humans and animals. The ability to adhere to components of the extracellular matrix, including collagen, is related to bacterial host colonisation. Collagen Far Western analysis of the B. fragilis outer membrane protein (OMP) fraction revealed the presence two collagen adhesin bands of similar to 31 and similar to 34 kDa. The collagen adhesins in the OMP fraction were separated and isolated by two-dimensional SDS-PAGE and also purified by collagen affinity chromatography. The collagen binding proteins isolated by both these independent methods were subjected to tandem mass spectroscopy for peptide identification and matched to a single hypothetical protein encoded by B. fragilis NCTC 9343 (BF0586), conserved in YCH46 (BF0662) and 638R (BF0633) and which is designated in this study as cbp1 (collagen binding protein). Functionality of the protein was confirmed by targeted insertional mutagenesis of the cbp1 gene in B. fragilis GSH18 which resulted in the specific loss of both the similar to 31 kDa and the similar to 34 kDa adhesin bands. Purified his-tagged Cbp1, expressed in a B. fragilis wild-type and a glycosylation deficient mutant, confirmed that the cbp1 gene encoded the observed collagen adhesin, and showed that the 34 kDa band represents a glycosylated version of the similar to 31 kDa protein. Glycosylation did not appear to be required for binding collagen. This study is the first to report the presence of collagen type I adhesin proteins in B. fragilis and to functionally identify a gene encoding a collagen binding protein.	[Galvao, Bruna P. G. V.; Rafudeen, Mohamed S.; Abratt, Valerie R.] Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, South Africa; [Weber, Brandon W.] Univ Cape Town, Dept Clin Lab Sci, Div Med Biochem, Struct Biol Res Unit, Observatory, Western Cape, South Africa; [Ferreira, Eliane O.] Univ Fed Rio de Janeiro, Ilha Fundao, Inst Microbiol Prof Paulo de Goes, Dept Microbiol Med, Rio de Janeiro, Brazil; [Ferreira, Eliane O.] Univ Fed Rio de Janeiro Polo Xerem, Rio De Janeiro, Brazil; [Patrick, Sheila] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast, Antrim, North Ireland	University of Cape Town; University of Cape Town; Universidade Federal do Rio de Janeiro; Queens University Belfast	Abratt, VR (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, South Africa.	valerie.abratt@uct.ac.za	de Oliveira Ferreira, Eliane/E-4272-2019	de Oliveira Ferreira, Eliane/0000-0002-9977-6460; RAFUDEEN, MOHAMED SUHAIL/0000-0002-0364-6646	Medical Research Council of South Africa; South African National Research Foundation (NRF); NRF Africa Scholarship program; NRF Innovation Scholarship program; University of Cape Town Research Scholarship; Claude Leon Foundation	Medical Research Council of South Africa(South African Medical Research Council); South African National Research Foundation (NRF)(National Research Foundation - South Africa); NRF Africa Scholarship program; NRF Innovation Scholarship program; University of Cape Town Research Scholarship; Claude Leon Foundation	This study was supported by grants from the Medical Research Council of South Africa and the South African National Research Foundation (NRF). BPGVG acknowledges financial support from NRF Africa and Innovation Scholarship programs, University of Cape Town Research Scholarship and the Claude Leon Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 1991, CELL BIOL EXTRACELLU; Barczak AK, 2009, CURR OPIN MICROBIOL, V12, P490, DOI 10.1016/j.mib.2009.06.012; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Chauhan JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040155; Ferreira ED, 2006, RES MICROBIOL, V157, P960, DOI 10.1016/j.resmic.2006.09.005; Ferreira ED, 2008, MEM I OSWALDO CRUZ, V103, P683, DOI 10.1590/S0074-02762008000700010; Dobrindt U, 2008, CURR OPIN MICROBIOL, V11, P409, DOI 10.1016/j.mib.2008.09.005; El Tahir Y, 2001, INT J MED MICROBIOL, V291, P209, DOI 10.1078/1438-4221-00119; Esmay PA, 2003, INFECT IMMUN, V71, P4368, DOI 10.1128/IAI.71.8.4368-4374.2003; Fletcher CM, 2011, J BIOL CHEM, V286, P3219, DOI 10.1074/jbc.M110.194506; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Galvao BPGV, 2011, ANAEROBE, V17, P142, DOI 10.1016/j.anaerobe.2011.02.009; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Houston S, 2010, MICROBIOL-SGM, V156, P2516, DOI 10.1099/mic.0.038588-0; Isaacson T, 2006, NAT PROTOC, V1, P769, DOI 10.1038/nprot.2006.102; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kuwahara T, 2004, P NATL ACAD SCI USA, V101, P14919, DOI 10.1073/pnas.0404172101; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maniatis T., 1982, MOL CLONING; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; Patrick S, 1996, MICROB PATHOGENESIS, V20, P191, DOI 10.1006/mpat.1996.0018; Patrick S, 2010, MICROBIOL-SGM, V156, P3255, DOI 10.1099/mic.0.042978-0; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Pauer H, 2009, FEMS IMMUNOL MED MIC, V55, P388, DOI 10.1111/j.1574-695X.2009.00532.x; Power PM, 2003, FEMS MICROBIOL LETT, V218, P211, DOI 10.1111/j.1574-6968.2003.tb11520.x; Pumbwe L, 2006, ANAEROBE, V12, P211, DOI 10.1016/j.anaerobe.2006.09.004; Shoemaker NB, 2000, J BACTERIOL, V182, P928, DOI 10.1128/JB.182.4.928-936.2000; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Snydman DR, 2010, CLIN INFECT DIS, V50, pS26, DOI 10.1086/647940; Steffens LS, 2010, RES MICROBIOL, V161, P346, DOI 10.1016/j.resmic.2010.04.003; Szoke I, 1996, J MED MICROBIOL, V45, P338, DOI 10.1099/00222615-45-5-338; Szoke I, 1997, ANAEROBE, V3, P91, DOI 10.1006/anae.1997.0079; Watanabe K, 2004, APPL MICROBIOL BIOT, V63, P520, DOI 10.1007/s00253-003-1442-0; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	38	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91141	10.1371/journal.pone.0091141	http://dx.doi.org/10.1371/journal.pone.0091141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618940	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400050
J	Pan, JS; Wang, TL; Wang, L; Chen, WT; Song, M				Pan, Jinsong; Wang, Tingle; Wang, Li; Chen, Wantao; Song, Meng			Cyclic Strain-Induced Cytoskeletal Rearrangement of Human Periodontal Ligament Cells via the Rho Signaling Pathway	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; DISSOCIATION-INHIBITOR-ALPHA; KINASE PATHWAY; IN-VITRO; MIGRATION; APOPTOSIS; REORGANIZATION; PROLIFERATION; PROTEIN; GTPASES	Background: Although mechanical stimulations are known have a significant impact on cytoskeletal rearrangement, little is known regarding the behavioral alteration of human periodontal ligament cells (hPDLCs) under cyclic strain. The aim of this study was to elucidate the role of the Rho signaling pathway on cyclic strain-induced cytoskeletal rearrangement of hPDLCs. Methods: Healthy hPDLCs obtained from teeth extracted for orthodontic purposes were subjected to cyclic strain with physiological loading (10%) at a frequency of 0.1 Hz for 6 h or 24 h using a FX-5000T system. Changes in cell morphology were examined by phase-contrast microscopy, while F-actin reorganization was observed by phalloidin staining and confocal microscopy. Protein expression was analyzed through western blot analysis. Results: Significant enhancement of cytoskeletal reorganization was observed following exposure to the cyclic strain. In addition, a significant increase was noted in the expression levels of GTP-Rho, Rho-associated protein kinase (ROCK) and p-cofilin, whereas the expression levels of Rho GDP dissociation inhibitors alpha (Rho-GDIa) were reduced in the hPDLCs, compared with the static control cells. More importantly, the Rock inhibitor Y-27632 suppressed cyclic strain-induced cytoskeletal rearrangement of hPDLCs. Additionally, Y-27632 and overexpression of Rho-GDIa were found to lower p-cofilin protein expressions under cyclic strain, while Rho-GDIa siRNA transfection had the opposite effect on the hPDLCs. Conclusion: Cyclic strain promotes cytoskeletal rearrangement of hPDLCs by downregulating the expression levels of Rho-GDIa and upregulating the expression levels of GTP-Rho, Rock and p-cofilin. These observations may provide valuable insight into understanding orthodontic tooth movement as well as alveolar bone remodeling.	[Pan, Jinsong; Chen, Wantao] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol, Dept Oral & Maxillofacial Surg,Peoples Hosp 9, Shanghai 200030, Peoples R China; [Pan, Jinsong; Chen, Wantao] Shanghai Res Inst Stomatol, Shanghai 200030, Peoples R China; [Wang, Tingle] Cent Hosp Minhang Dist, Dept Stomatol, Shanghai, Peoples R China; [Wang, Li; Song, Meng] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 1, Dept Stomatol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, WT (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol, Dept Oral & Maxillofacial Surg,Peoples Hosp 9, Shanghai 200030, Peoples R China.	chenwantao2002@hotmail.com; smgjzh160@sohu.com			National Natural Science Foundation of China [11172177, 30973343]; projects of the Shanghai Science and Technology Committee [11DZ2291800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); projects of the Shanghai Science and Technology Committee	This research was supported by grants from the National Natural Science Foundation of China (No. 11172177 and 30973343) and projects of the Shanghai Science and Technology Committee (Grant No. 11DZ2291800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen GPV, 2001, ARTERIOSCL THROM VAS, V21, P300, DOI 10.1161/01.ATV.21.3.300; Archambault J, 2002, J ORTHOPAED RES, V20, P36, DOI 10.1016/S0736-0266(01)00075-4; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bristow JM, 2009, J CELL SCI, V122, P4535, DOI 10.1242/jcs.053728; Dhaliwal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035046; Gros R, 2006, CIRC RES, V99, P845, DOI 10.1161/01.RES.0000245189.21703.c0; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hao Y, 2009, ARCH ORAL BIOL, V54, P864, DOI 10.1016/j.archoralbio.2009.05.012; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Lee J, 2008, J CELL PHYSIOL, V216, P520, DOI 10.1002/jcp.21424; Li CH, 2007, CELL SIGNAL, V19, P881, DOI 10.1016/j.cellsig.2007.01.004; Mayr M, 2002, FASEB J, V16, P1423, DOI 10.1096/fj.02-0042fje; NARAYANAN AS, 1983, COLLAGEN REL RES, V3, P33; Ohtsu H, 2005, ARTERIOSCL THROM VAS, V25, P1831, DOI 10.1161/01.ATV.0000175749.41799.9b; Onoue N, 2008, J CARDIOVASC PHARM, V51, P55, DOI 10.1097/FJC.0b013e31815b9d26; Pan Jin-song, 2010, Zhonghua Kou Qiang Yi Xue Za Zhi, V45, P80; Qi YX, 2008, CARDIOVASC RES, V80, P114, DOI 10.1093/cvr/cvn158; Qi YX, 2010, J CELL BIOCHEM, V109, P906, DOI 10.1002/jcb.22465; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Rolli-Derkinderen M, 2010, MOL CELL BIOL, V30, P4786, DOI 10.1128/MCB.00381-10; Sato R, 2002, J PERIODONTAL RES, V37, P15, DOI 10.1034/j.1600-0765.2002.90770.x; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Yamamoto M, 2012, MOL VIS, V18, P1727; Yano Y, 1997, J CELL BIOCHEM, V64, P505, DOI 10.1002/(SICI)1097-4644(19970301)64:3<505::AID-JCB17>3.0.CO;2-E; Zeichen J, 2000, AM J SPORT MED, V28, P888, DOI 10.1177/03635465000280061901; Zhang J, 2013, ONCOGENE, V32, P61, DOI 10.1038/onc.2012.28; Zhong W, 2008, ORAL DIS, V14, P270, DOI 10.1111/j.1601-0825.2007.01375.x	29	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91580	10.1371/journal.pone.0091580	http://dx.doi.org/10.1371/journal.pone.0091580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619024	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400108
J	Ye, YC; Xie, HZ; Zeng, Y; Zhao, XL; Tian, Z; Zhang, SY				Ye, Yicong; Xie, Hongzhi; Zeng, Yong; Zhao, Xiliang; Tian, Zhuang; Zhang, Shuyang			Optimal Oral Antithrombotic Regimes for Patients with Acute Coronary Syndrome: A Network Meta-Analysis	PLOS ONE			English	Article							ANTIPLATELET THERAPY; MYOCARDIAL-INFARCTION; RANDOMIZED ASSESSMENT; CLOPIDOGREL; PRASUGREL; TICAGRELOR; INTERVENTION; BIVALIRUDIN; RIVAROXABAN; COMBINATION	Objective: We performed a network meta-analysis to investigate the optimal antithrombotic regime by indirectly comparing new antithrombotic regimes (new P2Y12 inhibitors plus aspirin or novel oral anticoagulants on top of traditional dual antiplatelet therapy [DAPT]) in patients with acute coronary syndrome (ACS). Methods: A systematic search of MEDLINE, EMBASE, and the Cochrane databases was performed to identify all phase 3 randomized controlled trials (RCTs) involving novel oral anticoagulants or oral P2Y(12) inhibitors in patients with ACS. Major adverse cardiac events (MACE) were regarded as the efficacy endpoint, and thrombolysis in myocardial infarction (TIMI) major bleeding events were used as the safety endpoint. The net clinical benefit was calculated as the sum of MACE and TIMI major bleeding events. Results: Five phase 3 RCTs with 64,476 ACS patients were included. Although there were no significant differences among new antithrombotic regimes, rivaroxaban 5 mg twice daily plus traditional DAPT might be the most effective in reducing the incidence of MACE, accompanying the highest risk of TIMI major bleeding. Ticagrelor plus aspirin presented slight advantage on the net clinical benefit over other new antithrombotic regimes, with the highest probability of being the best regimes for net clinical benefit (35.0%), followed by prasugrel plus aspirin (28.0%), and rivaroxaban 2.5 mg twice daily plus traditional DAPT (19.5%). Conclusion: Novel antithrombotic regime with ticagrelor plus aspirin brings a larger clinical benefit in comparison with other regimes, suggesting that it may be the optimal antithrombotic regime for patients with ACS.	[Ye, Yicong] Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Cardiol, Beijing, Peoples R China; Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College	Ye, YC (corresponding author), Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Cardiol, Beijing, Peoples R China.	Zhangebmg@gmail.com	Ye, Yicong/AFV-8932-2022	zhao, xiliang/0000-0001-5290-7155; Zhang, Shuyang/0000-0002-1532-0029; Ye, Yicong/0000-0002-9433-6140				Alexander JH, 2011, NEW ENGL J MED, V365, P699, DOI 10.1056/NEJMoa1105819; Alexander JH, 2009, CIRCULATION, V119, P2877, DOI 10.1161/CIRCULATIONAHA.108.832139; Alexopoulos D, 2013, DIABETES CARE, V36, P2211, DOI 10.2337/dc12-2510; Alexopoulos D, 2012, CIRC-CARDIOVASC INTE, V5, P797, DOI 10.1161/CIRCINTERVENTIONS.112.972323; Alexopoulos D, 2012, J AM COLL CARDIOL, V60, P193, DOI 10.1016/j.jacc.2012.03.050; Bellemain-Appaix A, 2010, J AM COLL CARDIOL, V56, P1542, DOI 10.1016/j.jacc.2010.07.012; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Cannon CP, 2007, J AM COLL CARDIOL, V50, P1844, DOI 10.1016/j.jacc.2007.07.053; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Dickson M, 2008, AM J CARDIOVASC DRUG, V8, P45, DOI 10.2165/00129784-200808010-00006; Ferreiro JL, 2010, THROMB HAEMOSTASIS, V103, P1128, DOI 10.1160/TH09-11-0799; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Komocsi A, 2012, ARCH INTERN MED, V172, P1537, DOI 10.1001/archinternmed.2012.4026; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mega JL, 2009, LANCET, V374, P29, DOI 10.1016/S0140-6736(09)60738-8; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Oldgren J, 2013, EUR HEART J, V34, P1670, DOI 10.1093/eurheartj/eht049; Parodi G, 2013, J AM COLL CARDIOL, V61, P1601, DOI 10.1016/j.jacc.2013.01.024; Robert C.P., 2000, TECHNOMETRICS, V42, P430, DOI [10.2307/1270959, DOI 10.2307/1270959]; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Subherwal S, 2013, AM HEART J, V165, P644, DOI 10.1016/j.ahj.2012.11.012; Taylor Addison A, 2003, Congest Heart Fail, V9, P324, DOI 10.1111/j.1527-5299.2003.03269.x; Verheugt FWA, 2013, EUR HEART J, V34, P1618, DOI 10.1093/eurheartj/eht075; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2005, CIRCULATION, V111, P3366, DOI 10.1161/CIRCULATIONAHA.104.502815; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2006, NEW ENGL J MED, V354, P1464; Yusuf S, 2001, NEW ENGL J MED, V345, P494	33	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e90986	10.1371/journal.pone.0090986	http://dx.doi.org/10.1371/journal.pone.0090986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614630	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300061
J	Celton, JM; Kelner, JJ; Martinez, S; Bechti, A; Touhami, AK; James, MJ; Durel, CE; Laurens, F; Costes, E				Celton, Jean-Marc; Kelner, Jean-Jacques; Martinez, Sebastien; Bechti, Abdel; Touhami, Amina Khelifi; James, Marie Jose; Durel, Charles-Eric; Laurens, Francois; Costes, Evelyne			Fruit Self-Thinning: A Trait to Consider for Genetic Improvement of Apple Tree	PLOS ONE			English	Article							X DOMESTICA BORKH.; QTL ANALYSIS; ABSCISSION ZONE; WOOD FORMATION; CROP LOAD; MALUS; GROWTH; REVEALS; EXPRESSION; SIZE	In apple (Malusxdomestica Borkh), as in many fruiting crops, fruit maintenance vs abscission is a major criteria for production profitability. Growers routinely make use of chemical thinning agents to control total fruit load. However, serious threats for the environment lead to the demand for new apple cultivars with self-thinning properties. In this project, we studied the genetic determinism of this trait using a F-1 progeny derived from the cross between the hybrid INRA X3263, assumed to possess the self-thinning trait, and the cultivar 'Belrene'. Both counting and percentage variables were considered to capture the fruiting behaviour on different shoot types and over three consecutive years. Besides low to moderate but significant genetic effects, mixed models showed considerable effects of the year and the shoot type, as well as an interaction effect. Year effect resulted mainly from biennial fruiting. Eight Quantitative Trait Locus (QTL) were detected on several linkage groups (LG), either independent or specific of the year of observation or the shoot type. The QTL with highest LOD value was located on the top third of LG10. The screening of three QTL zones for candidate genes revealed a list of transcription factors and genes involved in fruit nutrition, xylem differentiation, plant responses to starvation and organ abscission that open new avenues for further molecular investigations. The detailed phenotyping performed revealed the dependency between the self-thinning trait and the fruiting status of the trees. Despite a moderate genetic control of the self-thinning trait, QTL and candidate genes were identified which will need further analyses involving other progenies and molecular investigations.	[Celton, Jean-Marc; Kelner, Jean-Jacques; Martinez, Sebastien; Touhami, Amina Khelifi; Costes, Evelyne] INRA, Montpellier SupAgro Team Architecture & Fonctionn, UMR 1334, AGAP,CIRAD, Montpellier, France; [Bechti, Abdel; James, Marie Jose] Pepinieres & Roseraies G Delbard, Commentry, France; [Celton, Jean-Marc; Durel, Charles-Eric; Laurens, Francois] Univ Angers, INRA, UMR1345, IRHS,AgroCampus Ouest,QUASAV,SFR 4207, Beaucouze, France	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; INRAE; Institut Agro; Agrocampus Ouest; Universite d'Angers	Costes, E (corresponding author), INRA, Montpellier SupAgro Team Architecture & Fonctionn, UMR 1334, AGAP,CIRAD, Montpellier, France.	costes@supagro.inra.fr	Kelner, Jean-Jacques/AAE-6210-2020	Kelner, Jean-Jacques/0000-0003-4694-6662; Celton, Jean-Marc/0000-0002-1452-4812	INRA (National Institute for Agronomical Research); department BAP (Plant Biology and Breeding)	INRA (National Institute for Agronomical Research); department BAP (Plant Biology and Breeding)	Funding was provided by INRA (National Institute for Agronomical Research), department BAP (Plant Biology and Breeding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DL, 1960, ANN APPL BIOL, V48, P434, DOI 10.1111/j.1744-7348.1960.tb03546.x; Agusti J, 2008, J EXP BOT, V59, P2717, DOI 10.1093/jxb/ern138; Agusti J, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-127; Alonso-Cantabrana H, 2007, DEVELOPMENT, V134, P2663, DOI 10.1242/DEV.02864; Baldi P, 2013, MOL BREEDING, V31, P429, DOI 10.1007/s11032-012-9800-1; Bangerth F, 2000, PLANT GROWTH REGUL, V31, P43, DOI 10.1023/A:1006398513703; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; BERUTER J, 1991, SCI HORTIC-AMSTERDAM, V46, P201, DOI 10.1016/0304-4238(91)90043-X; Botton A, 2011, PLANT PHYSIOL, V155, P185, DOI 10.1104/pp.110.165779; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Butler DG, 2009, TRAINING SERIES; Cai SQ, 2008, PLANT PHYSIOL, V146, P1305, DOI 10.1104/pp.107.110908; Calenge F, 2006, MOL BREEDING, V17, P329, DOI 10.1007/s11032-006-9004-7; Calenge F, 2004, PHYTOPATHOLOGY, V94, P370, DOI 10.1094/PHYTO.2004.94.4.370; Celton JM, 2011, NEW PHYTOL, V192, P378, DOI 10.1111/j.1469-8137.2011.03823.x; Conner PJ, 1998, THEOR APPL GENET, V96, P1027, DOI 10.1007/s001220050835; Contento AL, 2004, PLANT PHYSIOL, V135, P2330, DOI 10.1104/pp.104.044362; Costes E, 2003, ANN BOT-LONDON, V91, P91, DOI 10.1093/aob/mcg010; Curaba J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-6; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dal Cin V, 2009, GENE, V442, P26, DOI 10.1016/j.gene.2009.04.009; Davey MW, 2006, PLANT PHYSIOL, V142, P343, DOI 10.1104/pp.106.083279; Dennis FG, 2000, PLANT GROWTH REGUL, V31, P1, DOI 10.1023/A:1006330009160; Durand JB, 2013, J EXP BOT, V64, P5099, DOI 10.1093/jxb/ert297; Eccher G, 2013, PLANT PHYSIOL, V161, P1952, DOI 10.1104/pp.112.208470; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Estornell LH, 2013, PLANT SCI, V199, P48, DOI 10.1016/j.plantsci.2012.10.008; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Gallais A, 1989, THEORIE SELECTION AM, P45; Gould N, 2012, PLANT SCI, V188, P97, DOI 10.1016/j.plantsci.2011.12.018; GREENE DW, 1992, J AM SOC HORTIC SCI, V117, P775, DOI 10.21273/JASHS.117.5.775; Guitton B, 2012, J EXP BOT, V63, P131, DOI 10.1093/jxb/err261; Ireland HS, 2013, PLANT J, V73, P1044, DOI 10.1111/tpj.12094; Jarvis MC, 2003, PLANT CELL ENVIRON, V26, P977, DOI 10.1046/j.1365-3040.2003.01034.x; Ji HS, 2006, GENETICS, V173, P995, DOI 10.1534/genetics.105.054031; Kenis K, 2007, MOL BREEDING, V19, P193, DOI 10.1007/s11032-006-9022-5; Krost C, 2013, PLANT MOL BIOL, V81, P211, DOI 10.1007/s11103-012-9992-0; Lakso AN, 2008, ACTA HORTIC, V903, P733; Lauri PE, 1995, SCI HORTIC-AMSTERDAM, V64, P265, DOI 10.1016/0304-4238(95)00836-5; Lauri PE, 1997, J HORTIC SCI, V72, P519, DOI 10.1080/14620316.1997.11515539; Lauri PE, 2004, NEW PHYTOL, V163, P533, DOI 10.1111/j.1469-8137.2004.01136.x; LESPINASSE JM, 1977, CONDUITE POMMIER TYP; Lespinasse Y., 1992, Amelioration des especes vegetales cultivees: objectifs et criteres de selection., P579; Liebhard R, 2002, MOL BREEDING, V10, P217, DOI 10.1023/A:1020525906332; Liebhard R, 2003, PLANT MOL BIOL, V52, P511, DOI 10.1023/A:1024886500979; Looney NE., 1984, ACTA HORTIC, P31, DOI DOI 10.17660/ACTAH0RTIC.1984.146.2; Luckwill LC, 1969, PHYSL TREE CROPS, P123; Luckwill LC, 1970, PHYSL TREE CROPS, P237; Makowsky R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002051; Maliepaard C, 1998, THEOR APPL GENET, V97, P60, DOI 10.1007/s001220050867; Miller S. S., 1988, Horticultural Reviews, V10, P309, DOI 10.1002/9781118060834.ch9; Monselise S. P., 1984, Horticultural Reviews, V4, P128, DOI 10.1002/9781118060773.ch5; Moriya S, 2012, PLANT BREEDING, V131, P641, DOI 10.1111/j.1439-0523.2012.01985.x; Ohtani M, 2011, PLANT J, V67, P499, DOI 10.1111/j.1365-313X.2011.04614.x; Paul S, 2007, ENVIRONMETRICS, V18, P421, DOI 10.1002/env.849; Pourtau N, 2006, PLANTA, V224, P556, DOI 10.1007/s00425-006-0243-y; R Core Team, 2020, R LANG ENV STAT COMP; ROBERTS JA, 2009, STEWART POSTHARVEST, V5, P1, DOI DOI 10.2212/spr.2009.1.2; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Segura V, 2007, GENOME, V50, P159, DOI 10.1139/G07-002; Segura V, 2009, TREE GENET GENOMES, V5, P165, DOI 10.1007/s11295-008-0181-x; Segura V, 2008, NEW PHYTOL, V178, P302, DOI 10.1111/j.1469-8137.2007.02374.x; Silfverberg-Dilworth E, 2006, TREE GENET GENOMES, V2, P202, DOI 10.1007/s11295-006-0045-1; Sun LX, 2009, EUPHYTICA, V165, P55, DOI 10.1007/s10681-008-9754-x; Tapia-Lopez R, 2008, PLANT PHYSIOL, V146, P1182, DOI 10.1104/pp.107.108647; Torres-Galea P, 2013, PLANT PHYSIOL, V161, P291, DOI 10.1104/pp.112.206607; Tustin DS, 2012, ACTA HORTIC, V932, P195, DOI 10.17660/ActaHortic.2012.932.28; Untiedt R, 2001, PLANT GROWTH REGUL, V35, P1, DOI 10.1023/A:1013894901621; van Dyk MM, 2010, TREE GENET GENOMES, V6, P489, DOI 10.1007/s11295-009-0266-1; Van Ooijen J.W., 2009, MAPQTL 6 SOFTWARE MA; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Voorrips R.E., 2001, MAPCHART VERSION 2 0; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055238; WESTWOOD MN, 1967, P AM SOC HORTIC SCI, V91, P51; Williams M. W., 1979, Horticultural Reviews, V1, P270; Wu BH, 2005, J HORTIC SCI BIOTECH, V80, P340, DOI 10.1080/14620316.2005.11511941; Wunsche JN, 2000, J AM SOC HORTIC SCI, V125, P93, DOI 10.21273/JASHS.125.1.93; Zheng XY, 2002, THEOR APPL GENET, V105, P397, DOI 10.1007/s00122-002-0880-x; Zhong RQ, 2011, PLANT PHYSIOL, V157, P1452, DOI 10.1104/pp.111.181354; Zhu H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-138	80	22	23	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91016	10.1371/journal.pone.0091016	http://dx.doi.org/10.1371/journal.pone.0091016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625529	Green Published, gold			2022-12-27	WOS:000332851300051
J	Chen, G; Hou, F; Yan, FF; Zhang, P; Xi, J; Zhou, YF; Lu, ZL; Huang, CB				Chen, Ge; Hou, Fang; Yan, Fang-Fang; Zhang, Pan; Xi, Jie; Zhou, Yifeng; Lu, Zhong-Lin; Huang, Chang-Bing			Noise Provides New Insights on Contrast Sensitivity Function	PLOS ONE			English	Article							VISUAL SIGNAL-DETECTION; SPATIAL-FREQUENCY; LETTER IDENTIFICATION; PSYCHOMETRIC FUNCTION; AMBLYOPIA; VISION; ORIENTATION; MECHANISMS; LUMINANCE; GRATINGS	Sensitivity to luminance difference, or contrast sensitivity, is critical for animals to survive in and interact with the external world. The contrast sensitivity function (CSF), which measures visual sensitivity to spatial patterns over a wide range of spatial frequencies, provides a comprehensive characterization of the visual system. Despite its popularity and significance in both basic research and clinical practice, it hasn't been clear what determines the CSF and how the factors underlying the CSF change in different conditions. In the current study, we applied the external noise method and perceptual template model to a wide range of external noise and spatial frequency (SF) conditions, and evaluated how the various sources of observer inefficiency changed with SF and determined the limiting factors underlying the CSF. We found that only internal additive noise and template gain changed significantly with SF, while the transducer non-linearity and coefficient for multiplicative noise were constant. The 12-parameter model provided a very good account of all the data in the 200 tested conditions (86.5%, 86.2%, 89.5%, and 96.4% for the four subjects, respectively). Our results suggest a re-consideration of the popular spatial vision model that employs the CSF as the front-end filter and constant internal additive noise across spatial frequencies. The study will also be of interest to scientists and clinicians engaged in characterizing spatial vision deficits and/or developing rehabilitation methods to restore spatial vision in clinical populations.	[Chen, Ge; Yan, Fang-Fang; Zhang, Pan; Xi, Jie; Huang, Chang-Bing] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Chen, Ge] Univ Chinese Acad Sci, Beijing, Peoples R China; [Hou, Fang; Lu, Zhong-Lin] Ohio State Univ, Dept Psychol, Ctr Cognit & Brain Sci, Columbus, OH 43210 USA; [Zhou, Yifeng] Chinese Acad Sci, Key Lab Brain Funct & Dis, Hefei, Anhui, Peoples R China; [Zhou, Yifeng] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University System of Ohio; Ohio State University; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Huang, CB (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	huangcb@psych.ac.cn	Huang, Chang-Bing/AAE-2909-2020	huang, chang bing/0000-0003-4694-0834; Hou, Fang/0000-0003-4811-5918; Lu, Zhong-Lin/0000-0002-7295-727X	National Natural Science Foundation of China [NSFC 31230032]; Knowledge Innovation Program of the Chinese Academy of Sciences [Y3CX102003]; Institute of Psychology [Y1CX201006]; National Eye Institute [EY021553]; NATIONAL EYE INSTITUTE [R01EY021553] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Institute of Psychology; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Natural Science Foundation of China (NSFC 31230032 to YZ), the Knowledge Innovation Program of the Chinese Academy of Sciences (Y3CX102003 to CBH), Institute of Psychology (Y1CX201006 to CBH), and the National Eye Institute (EY021553 to ZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANKS MS, 1988, J OPT SOC AM A, V5, P2059, DOI 10.1364/JOSAA.5.002059; BANKS MS, 1987, VISION RES, V27, P1915, DOI 10.1016/0042-6989(87)90057-5; BARLOW HB, 1956, J OPT SOC AM, V46, P634, DOI 10.1364/JOSA.46.000634; Bednarek DB, 2002, NEUROREPORT, V13, P2521, DOI 10.1097/00001756-200212200-00028; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bubl E, 2010, BIOL PSYCHIAT, V68, P205, DOI 10.1016/j.biopsych.2010.02.009; Burgess A.E., 1979, P SPIE, V0173, P34, DOI [10.1117/12.957121, DOI 10.1117/12.957121]; BURGESS AE, 1988, J OPT SOC AM A, V5, P617, DOI 10.1364/JOSAA.5.000617; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; CAMPBELL FW, 1965, J PHYSIOL-LONDON, V181, P576, DOI 10.1113/jphysiol.1965.sp007784; Chung STL, 2002, VISION RES, V42, P1571, DOI 10.1016/S0042-6989(02)00065-2; Chung STL, 2002, VISION RES, V42, P2137, DOI 10.1016/S0042-6989(02)00092-5; Chung STL, 2009, J VISION, V9, DOI 10.1167/9.9.16; Dao DY, 2006, J VISION, V6, P739, DOI 10.1167/6.7.6; Eckstein MP, 1997, J OPT SOC AM A, V14, P2406, DOI 10.1364/JOSAA.14.002406; ELLIOTT DB, 1990, EYE, V4, P712, DOI 10.1038/eye.1990.100; GEORGESON MA, 1975, J PHYSIOL-LONDON, V252, P627, DOI 10.1113/jphysiol.1975.sp011162; Golomb JD, 2009, J NEUROSCI, V29, P9072, DOI 10.1523/JNEUROSCI.1003-09.2009; GREEN DM, 1990, J ACOUST SOC AM, V87, P2662, DOI 10.1121/1.399058; Griffiths JWR, 1963, RADIO ELECT ENG, V25, P225; Hallum LE, 2011, J NEUROPHYSIOL, V105, P2121, DOI 10.1152/jn.01007.2010; Hawkins AS, 2003, J GLAUCOMA, V12, P134, DOI 10.1097/00061198-200304000-00008; HESS RF, 1978, PFLUG ARCH EUR J PHY, V377, P201, DOI 10.1007/BF00584273; Hou F, 2010, INVEST OPHTH VIS SCI, V51, P5365, DOI 10.1167/iovs.10-5468; HOWELL ER, 1983, INVEST OPHTH VIS SCI, V24, P782; Huang CB, 2008, P NATL ACAD SCI USA, V105, P4068, DOI 10.1073/pnas.0800824105; Huang CB, 2009, J VISION, V9, DOI 10.1167/9.3.17; KERSTEN D, 1988, CLIN VISION SCI, V2, P143; Kornowski JA, 2003, J GEN PSYCHOL, V130, P229, DOI 10.1080/00221300309601156; Kwon M, 2007, VISION RES, V47, P2889, DOI 10.1016/j.visres.2007.08.002; Lesmes LA, 2010, J VISION, V10, DOI 10.1167/10.3.17; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; Li XR, 2003, J NEUROSCI METH, V130, P9, DOI 10.1016/S0165-0270(03)00174-2; LOVEGROVE WJ, 1980, SCIENCE, V210, P439, DOI 10.1126/science.7433985; Lu ZL, 2008, PSYCHOL REV, V115, P44, DOI 10.1037/0033-295X.115.1.44; Lu ZL, 1999, J OPT SOC AM A, V16, P764, DOI 10.1364/JOSAA.16.000764; Lu ZL, 2014, VISUAL PSYCHOPHYSICS: FROM LABORATORY TO THEORY, P1; McAnany JJ, 2010, VISION RES, V50, P1957, DOI 10.1016/j.visres.2010.07.006; MOVSHON JA, 1988, J OPT SOC AM A, V5, P2166, DOI 10.1364/JOSAA.5.002166; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; NACHMIAS J, 1981, VISION RES, V21, P215, DOI 10.1016/0042-6989(81)90115-2; NAVARRO R, 1993, J OPT SOC AM A, V10, P201, DOI 10.1364/JOSAA.10.000201; Oruc I, 2009, J VISION, V9, DOI 10.1167/9.9.4; Pelli DG, 1999, J OPT SOC AM A, V16, P647, DOI 10.1364/JOSAA.16.000647; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Pelli DG, 1981, THESIS CAMBRIDGE; Pestilli F, 2005, VISION RES, V45, P1867, DOI 10.1016/j.visres.2005.01.019; Polat U, 2004, P NATL ACAD SCI USA, V101, P6692, DOI 10.1073/pnas.0401200101; REGAN D, 1983, OPHTHALMOLOGY, V90, P1192; Regan David, 2000, HUMAN PERCEPTION OBJ; ROVAMO J, 1992, VISION RES, V32, P631, DOI 10.1016/0042-6989(92)90179-M; SAMPLE PA, 1991, AM J OPHTHALMOL, V112, P308, DOI 10.1016/S0002-9394(14)76732-7; Slaghuis WL, 1999, VISION RES, V39, P651, DOI 10.1016/S0042-6989(98)00151-5; Souza Givago da Silva, 2011, Psychol. Neurosci., V4, P29, DOI 10.3922/j.psns.2011.1.005; Sperling AJ, 2005, NAT NEUROSCI, V8, P862, DOI 10.1038/nn1474; Stuart GW, 2001, VISION RES, V41, P3205, DOI 10.1016/S0042-6989(01)00176-6; Tjan BS, 2002, J VISION, V2, P31, DOI DOI 10.1167/2.7.31; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Watson AB, 2005, J VISION, V5, P717, DOI 10.1167/5.9.6; WILSON HR, 1988, VISION RES, V28, P611; Xu P, 2006, VISION RES, V46, P3748, DOI 10.1016/j.visres.2006.06.013; Zhou YF, 2006, VISION RES, V46, P739, DOI 10.1016/j.visres.2005.07.031	64	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90579	10.1371/journal.pone.0090579	http://dx.doi.org/10.1371/journal.pone.0090579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626135	gold, Green Submitted, Green Published			2022-12-27	WOS:000332851300026
J	Chi, PD; Liu, W; Chen, H; Zhang, JP; Lin, YH; Zheng, X; Liu, WL; Dai, SQ				Chi, Pei-Dong; Liu, Wen; Chen, Hao; Zhang, Jing-Ping; Lin, Yuehao; Zheng, Xin; Liu, Wanli; Dai, Shuqin			High-Density Lipoprotein Cholesterol Is a Favorable Prognostic Factor and Negatively Correlated with C-Reactive Protein Level in Non-Small Cell Lung Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; INHIBIT TUMOR-DEVELOPMENT; HDL-CHOLESTEROL; METABOLIC SYNDROME; APOA-I; CANCER; SERUM; RISK; INFLAMMATION; BIOMARKER	Background: Although the alterations of lipid profile in lung cancer have been documented, the prognostic value of serum HDL-C level and its correlation with inflammation in NSCLC remain unknown. Subjects and Methods: Levels of preoperative serum lipid concentrations (including HDL-C, LDL-C, TC, and TG) and the inflammatory biomarker C-reactive protein level (CRP) were retrospectively analyzed in 228 patients with NSCLC and in 300 healthy controls. The serum lipid levels in these two populations were compared. Univariate and multivariate cox hazards analyses were performed to investigate the prognostic value of serum lipid levels in NSCLC. The correlation between CRP and lipid profile were also analyzed. Results: Compared with those in normal controls, the serum HDL-C, LDL-C, and TC levels were statistically decreased and the TG levels were significantly increased in 228 NSCLC patients. The patients with decreased levels of HDL-C had significantly lower 5-year survival rates than those with normal HDL-C, not only in the whole NSCLC cohort but also in the subgroups stratified according to the disease T, N classifications, and metastasis, whereas the other lipid components were not independent prognostic factors for NSCLC. Of the lipid components, a lower HDL-C level was observed more often in patients with a high CRP level than in those with a normal CRP level. Spearman's rank correlation analysis revealed that the HDL-C level presented a negative correlation with the CRP level (r = -0.360, p<0.001). Conclusions: A decreased level of preoperative HDL-C was found to be associated with poor survival in patients with NSCLC. Serum HDL-C level may be a clinical prognosis factor for NSCLC patients. In addition, a negative correlation was present between the levels of HDL-C and CRP, the well-known inflammation biomarker.	[Chi, Pei-Dong; Liu, Wen; Chen, Hao; Zhang, Jing-Ping; Lin, Yuehao; Zheng, Xin; Liu, Wanli; Dai, Shuqin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Chi, Pei-Dong; Liu, Wen; Chen, Hao; Zhang, Jing-Ping; Lin, Yuehao; Zheng, Xin; Liu, Wanli; Dai, Shuqin] Sun Yat Sen Univ, Ctr Canc, Dept Clin Lab Med, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Dai, SQ (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China.	daisq@sysucc.org.cn	ZHANG, JINGPING/AAT-8229-2021; zhang, jingping/AAM-2751-2021	zhang, jingping/0000-0003-0090-6710				Ahn J, 2009, CANCER EPIDEM BIOMAR, V18, P2814, DOI 10.1158/1055-9965.EPI-08-1248; ALEXOPOULOS CG, 1987, CANCER-AM CANCER SOC, V60, P3065, DOI 10.1002/1097-0142(19871215)60:12<3065::AID-CNCR2820601234>3.0.CO;2-Q; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Baker M, 2004, NAT BIOTECHNOL, V22, P641, DOI 10.1038/nbt0604-641; Boutsikou E, 2013, ONCOTARGETS THER, V6, P125, DOI 10.2147/OTT.S42245; Brower V, 2009, J NATL CANCER I, V101, P11, DOI 10.1093/jnci/djn483; Cheng Xiansheng, 1998, Zhonghua Jiehe He Huxi Zazhi, V21, P749; Cohen MH, 2005, ONCOLOGIST, V10, P461, DOI 10.1634/theoncologist.10-7-461; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cruz PMR, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00119; DESSI S, 1994, CANCER, V73, P253, DOI 10.1002/1097-0142(19940115)73:2<253::AID-CNCR2820730204>3.0.CO;2-F; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Engels EA, 2008, EXPERT REV ANTICANC, V8, P605, DOI 10.1586/14737140.8.4.605; Esteve E, 2005, CLIN NUTR, V24, P16, DOI 10.1016/j.clnu.2004.08.004; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Fiorenza AM, 2000, INT J CLIN LAB RES, V30, P141, DOI 10.1007/s005990070013; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Gazdar AF, 2010, CANCER METAST REV, V29, P37, DOI 10.1007/s10555-010-9201-z; Giusti RM, 2008, CLIN CANCER RES, V14, P1296, DOI 10.1158/1078-0432.CCR-07-1354; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; GRUNFELD C, 1992, J CLIN ENDOCR METAB, V74, P1045, DOI 10.1210/jc.74.5.1045; Guo EQ, 2007, ANN SURG ONCOL, V14, P2528, DOI 10.1245/s10434-007-9401-0; Irwin ME, 2011, J CELL PHYSIOL, V226, P2316, DOI 10.1002/jcp.22570; Italiano A, 2007, B CANCER, V94, pF177; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jeon JH, 2010, LUNG CANCER, V69, P165, DOI 10.1016/j.lungcan.2009.10.014; Jeppesen J, 1998, CIRCULATION, V97, P1029, DOI 10.1161/01.CIR.97.11.1029; Kotani K, 2013, J EPIDEMIOL, V23, P313, DOI 10.2188/jea.JE20130006; Kucharska-Newton AM, 2008, LUNG CANCER, V61, P292, DOI 10.1016/j.lungcan.2008.01.015; LEVY E, 1993, PEDIATR RES, V34, P162, DOI 10.1203/00006450-199308000-00011; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Lim U, 2007, CANCER RES, V67, P5569, DOI 10.1158/0008-5472.CAN-07-0212; Mizia-Stec K, 2003, ACTA CARDIOL, V58, P9, DOI 10.2143/AC.58.1.2005253; Moorman PG, 1998, CANCER EPIDEM BIOMAR, V7, P483; Navab M, 2005, ANN MED, V37, P173, DOI 10.1080/07853890510007322; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Siemes C, 2006, J CLIN ONCOL, V24, P5216, DOI 10.1200/JCO.2006.07.1381; Siemianowicz K, 2000, INT J MOL MED, V6, P307; Su F, 2012, MOL CANCER THER, V11, P1311, DOI 10.1158/1535-7163.MCT-11-0905; Su F, 2010, P NATL ACAD SCI USA, V107, P19997, DOI 10.1073/pnas.1009010107; Tietge UJF, 2002, ARTERIOSCL THROM VAS, V22, P1213, DOI 10.1161/01.ATV.0000023228.90866.29; UMEKI S, 1993, RESPIRATION, V60, P178; van Exel E, 2002, DIABETES, V51, P1088, DOI 10.2337/diabetes.51.4.1088; von Eckardstein A, 2005, CURR OPIN CLIN NUTR, V8, P147, DOI 10.1097/00075197-200503000-00007; WallbergJonsson S, 1996, J INTERN MED, V240, P373, DOI 10.1046/j.1365-2796.1996.53873000.x	47	49	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91080	10.1371/journal.pone.0091080	http://dx.doi.org/10.1371/journal.pone.0091080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625581	gold, Green Submitted, Green Published			2022-12-27	WOS:000332851300054
J	Cheng, JS; Gao, PP; Zhou, IY; Chan, RW; Chan, QN; Mak, HK; Khong, PL; Wu, EX				Cheng, Joe S.; Gao, Patrick P.; Zhou, Iris Y.; Chan, Russell W.; Chan, Queenie; Mak, Henry K.; Khong, Pek L.; Wu, Ed X.			Resting-State fMRI Using Passband Balanced Steady-State Free Precession	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; BOLD FMRI; RAT-BRAIN; SSFP FMRI; NETWORKS; RESOLUTION; MRI; CORTEX	Objective: Resting-state functional MRI (rsfMRI) has been increasingly used for understanding brain functional architecture. To date, most rsfMRI studies have exploited blood oxygenation level-dependent (BOLD) contrast using gradient-echo (GE) echo planar imaging (EPI), which can suffer from image distortion and signal dropout due to magnetic susceptibility and inherent long echo time. In this study, the feasibility of passband balanced steady-state free precession (bSSFP) imaging for distortion-free and high-resolution rsfMRI was investigated. Methods: rsfMRI was performed in humans at 3 T and in rats at 7 T using bSSFP with short repetition time (TR = 4/2.5 ms respectively) in comparison with conventional GE-EPI. Resting-state networks (RSNs) were detected using independent component analysis. Results and Significance: RSNs derived from bSSFP images were shown to be spatially and spectrally comparable to those derived from GE-EPI images with considerable intra-and inter-subject reproducibility. High-resolution bSSFP images corresponded well to the anatomical images, with RSNs exquisitely co-localized to the gray matter. Furthermore, RSNs at areas of severe susceptibility such as human anterior prefrontal cortex and rat piriform cortex were proved accessible. These findings demonstrated for the first time that passband bSSFP approach can be a promising alternative to GE-EPI for rsfMRI. It offers distortion-free and high-resolution RSNs and is potentially suited for high field studies.	[Cheng, Joe S.; Gao, Patrick P.; Zhou, Iris Y.; Chan, Russell W.; Wu, Ed X.] Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Hong Kong, Hong Kong, Peoples R China; [Cheng, Joe S.; Gao, Patrick P.; Zhou, Iris Y.; Chan, Russell W.; Wu, Ed X.] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Hong Kong, Peoples R China; [Wu, Ed X.] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Wu, Ed X.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Mak, Henry K.; Khong, Pek L.] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Chan, Queenie] Philips Healthcare, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Philips; Philips Healthcare	Wu, EX (corresponding author), Univ Hong Kong, Lab Biomed Imaging & Signal Proc, Hong Kong, Hong Kong, Peoples R China.	ewu@eee.hku.hk	Zhou, Iris Yuwen/A-2089-2017; Wu, Ed Xuekui/C-1579-2009	Zhou, Iris Yuwen/0000-0002-4351-7398; Chan, Russell/0000-0002-7680-9231; Wu, Ed Xuekui/0000-0001-5581-1546	Hong Kong Research Grants Council [HKU7837/11M]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported in part by Hong Kong Research Grants Council (HKU7837/11M). The authors have declared that no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert Kir ABM, 2013, P INT SOC MAGN RES M, P2280; BANICH MT, 1990, CORTEX, V26, P77, DOI 10.1016/S0010-9452(13)80076-7; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bowen CV., 2005, P 13 ANN M ISMRM MIA, P119; Bullmore E, 1996, MAGN RESON MED, V35, P261, DOI 10.1002/mrm.1910350219; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chan KC, 2010, NEUROIMAGE, V49, P2013, DOI 10.1016/j.neuroimage.2009.10.069; Chappell M, 2011, MAGN RESON IMAGING, V29, P1, DOI 10.1016/j.mri.2010.07.007; Cheung MM, 2012, NEUROIMAGE, V61, P978, DOI 10.1016/j.neuroimage.2012.03.031; Cheung MM, 2012, NEUROIMAGE, V60, P1205, DOI 10.1016/j.neuroimage.2012.01.087; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; de Zwart JA, 2006, NMR BIOMED, V19, P342, DOI 10.1002/nbm.1043; Dharmakumar R, 2005, MAGN RESON MED, V53, P574, DOI 10.1002/mrm.20393; Duong TQ, 2008, NMR BIOMED, V21, P978, DOI 10.1002/nbm.1311; FARZANEH F, 1990, MAGNET RESON MED, V14, P123, DOI 10.1002/mrm.1910140112; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Foxall DL, 2002, MAGN RESON MED, V48, P502, DOI 10.1002/mrm.10225; Glover GH, 1999, MAGNET RESON MED, V42, P290, DOI 10.1002/(SICI)1522-2594(199908)42:2<290::AID-MRM11>3.0.CO;2-N; Glover GH, 2004, MAGN RESON MED, V51, P863, DOI 10.1002/mrm.20016; GOLANOV EV, 1994, AM J PHYSIOL, V266, pR204, DOI 10.1152/ajpregu.1994.266.1.R204; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jezzard P, 1999, HUM BRAIN MAPP, V8, P80, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<80::AID-HBM2>3.0.CO;2-C; JOHNSON G, 1985, J MAGN RESON, V63, P14, DOI 10.1016/0022-2364(85)90149-0; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Kim TS, 2012, INT J IMAG SYST TECH, V22, P23, DOI 10.1002/ima.21296; Koopmans PJ, 2012, NEUROIMAGE, V62, P1939, DOI 10.1016/j.neuroimage.2012.05.080; Lau C, 2011, NEUROIMAGE, V58, P878, DOI 10.1016/j.neuroimage.2011.06.055; Lee JH, 2008, MAGN RESON MED, V59, P1099, DOI 10.1002/mrm.21576; Lee J, 2007, MAGN RESON MED, V57, P905, DOI 10.1002/mrm.21195; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Miller KL, 2008, MAGN RESON MED, V60, P661, DOI 10.1002/mrm.21690; Miller KL, 2007, NEUROIMAGE, V37, P1227, DOI 10.1016/j.neuroimage.2007.06.024; Miller KL, 2012, NEUROIMAGE, V62, P713, DOI 10.1016/j.neuroimage.2011.10.040; Miller KL, 2006, MAGN RESON MED, V55, P161, DOI 10.1002/mrm.20753; Miller KL, 2003, MAGNET RESON MED, V50, P675, DOI 10.1002/mrm.10602; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Parrish T, 2008, P INT SOC MAGN RES M, P3567; Patterson S, 2011, P INT SOC MAGN RES M, P1630; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peltier SJ, 2002, NEUROIMAGE, V16, P985, DOI 10.1006/nimg.2002.1141; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Scheffler K, 2003, EUR RADIOL, V13, P2409, DOI 10.1007/s00330-003-1957-x; Scheffler K, 2001, NMR BIOMED, V14, P490, DOI 10.1002/nbm.726; Scremin O. U., 2004, RAT NERVOUS SYSTEM, P1167; Shipley M. T., 2004, RAT NERVOUS SYSTEM, P923; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; WEBB P, 1991, MAGNET RESON MED, V20, P113, DOI 10.1002/mrm.1910200112; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhong K, 2007, MAGN RESON MED, V57, P67, DOI 10.1002/mrm.21103; Zhou IY, 2012, MAGN RESON MED, V68, P65, DOI 10.1002/mrm.23202	69	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91075	10.1371/journal.pone.0091075	http://dx.doi.org/10.1371/journal.pone.0091075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622278	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300048
J	Ge, XX; Chen, HW; Wang, HL; Shi, AP; Liu, KF				Ge, Xiuxiu; Chen, Hongwei; Wang, Hongli; Shi, Aiping; Liu, Kefeng			De Novo Assembly and Annotation of Salvia splendens Transcriptome Using the Illumina Platform	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; SSR-MARKERS; RNA-SEQ; GENES; MICROSATELLITES; STRIGOLACTONE; TOOL; ARABIDOPSIS; GENERATION; DISCOVERY	Background: As an important perennial herbaceous flower, Salvia splendens possesses high ornamental value. Understanding its branching processes may help scientists select the best plant type. Although Salvia splendens is a frequently-used horticultural flower, only limited transcriptomic or genomic research is available in public databases. In the present study, we, for the first time, constructed a comprehensive dataset for Salvia splendens through de novo high-throughput transcriptome sequencing. Methodology/Principal Findings: We performed de novo transcriptome sequencing on two different branching type plants (Strain 35 and Cailinghong) using the Illumina paired-end sequencing technology. For Strain 35, a total of 16,488,829 reads were generated and assembled into 38,498 unigenes, with a mean length of approximately 779 bp. For Cailinghong, 16,464,713 reads were generated and assembled into 34,302 unigenes, with a mean length of approximately 812 bp. Moreover, a total of 49,310 unigenes for Salvia splendens were identified, among them 33,925 (68.80%) were annotated in the non-redundant NCBI database, 25,371 (51.45%) were annotated in the Swiss-Prot database, while 24,888 (50.47%) and 9,896 (20.07%) unigenes were assigned to gene ontology categories and clusters of orthologous groups, respectively. Using the Kyoto Encyclopedia of Genes and Genomes pathway database, we identified 134 differently expressed unigenes between Strain 35 and Cailinghong, and then these unigenes were mapped to 79 pathways. In addition, we detected 2,453 simple sequence repeats (SSRs). Conclusions: We obtained a comprehensive transcriptomic information from this work and provided a valuable resource of transcript sequences of Salvia splendens in public databases. Moreover, some candidate genes potentially involved in branching were identified. Furthermore, numerous obtained SSRs might contribute to marker-assisted selection. These data could be further utilized in functional genomics studies on Salvia splendens.	[Ge, Xiuxiu] Beijing Agr Univ, Coll Biol Sci & Engn, Beijing 100094, Peoples R China; [Chen, Hongwei; Liu, Kefeng] Beijing Agr Univ, Coll Urban & Rural Dev, Beijing 100094, Peoples R China; [Wang, Hongli; Shi, Aiping] Beijing Agr Univ, Coll Hort, Beijing 100094, Peoples R China	Beijing University of Agriculture; Beijing University of Agriculture; Beijing University of Agriculture	Ge, XX (corresponding author), Beijing Agr Univ, Coll Biol Sci & Engn, Beijing 100094, Peoples R China.	liukefeng@sohu.com			National Science Foundation for Distinguished Young Scholars of China [31100509]; Science and Technology Development Project of Beijing Municipal Institutions [KM 201210020005]; Beijing Gardening and Greening Bureau [YLHH201200202, YLHH201200120]; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [PXM201010]	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Science and Technology Development Project of Beijing Municipal Institutions; Beijing Gardening and Greening Bureau; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions	This study was supported by the National Science Foundation for Distinguished Young Scholars of China (Grant No. 31100509), Science and Technology Development Project of Beijing Municipal Institutions (KM 201210020005), Beijing Gardening and Greening Bureau (YLHH201200202 and YLHH201200120) and the Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (PXM201010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 2011, P NATL ACAD SCI USA, V108, P20242, DOI 10.1073/pnas.1111902108; ArguelloAstorga GR, 1996, PLANT PHYSIOL, V112, P1151, DOI 10.1104/pp.112.3.1151; Bombarely A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-503; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Costa GGL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-462; Dun EA, 2012, PLANT PHYSIOL, V158, P487, DOI 10.1104/pp.111.186783; Eckert KA, 2002, BIOCHEMISTRY-US, V41, P10490, DOI 10.1021/bi025918c; Gao ZM, 2011, PLANT CELL REP, V30, P2045, DOI 10.1007/s00299-011-1112-0; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Johnson X, 2006, PLANT PHYSIOL, V142, P1014, DOI 10.1104/pp.106.087676; Lawson MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r14; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Lokanathan Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-76; Luo HM, 2010, PHYSIOL PLANTARUM, V139, P1, DOI 10.1111/j.1399-3054.2009.01339.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matusova R, 2005, PLANT PHYSIOL, V139, P920, DOI 10.1104/pp.105.061382; McSteen P, 2000, TRENDS PLANT SCI, V5, P61, DOI 10.1016/S1360-1385(99)01541-1; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Park S, 2006, PLANT PHYSIOL, V141, P811, DOI 10.1104/pp.106.080994; Pauli S, 2004, J VIROL, V78, P12120, DOI 10.1128/JVI.78.22.12120-12128.2004; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Yu JK, 2004, MOL GENET GENOMICS, V271, P742, DOI 10.1007/s00438-004-1027-3; Zhang LD, 2006, BMC GENOMICS, V7, DOI [10.1186/1471-2164-7-323, 10.1186/1471-2164-7-153]	44	28	28	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e87693	10.1371/journal.pone.0087693	http://dx.doi.org/10.1371/journal.pone.0087693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622329	gold, Green Submitted, Green Published			2022-12-27	WOS:000332845300003
J	Gorniak, T; Haraszti, T; Garamus, VM; Buck, AR; Senkbeil, T; Priebe, M; Hedberg-Buenz, A; Koehn, D; Salditt, T; Grunze, M; Anderson, MG; Rosenhahn, A				Gorniak, Thomas; Haraszti, Tamas; Garamus, Vasyl M.; Buck, Andreas R.; Senkbeil, Tobias; Priebe, Marius; Hedberg-Buenz, Adam; Koehn, Demelza; Salditt, Tim; Grunze, Michael; Anderson, Michael G.; Rosenhahn, Axel			Nano-Scale Morphology of Melanosomes Revealed by Small-Angle X-Ray Scattering	PLOS ONE			English	Article							CHEMICAL-PROPERTIES; BROWN LOCUS; MELANIN; HAIR; MELANOGENESIS; DIFFRACTION; MICROSCOPY; INSIGHTS; POWER; BONE	Melanosomes are highly specialized organelles that produce and store the pigment melanin, thereby fulfilling essential functions within their host organism. Besides having obvious cosmetic consequences-determining the color of skin, hair and the iris-they contribute to photochemical protection from ultraviolet radiation, as well as to vision (by defining how much light enters the eye). Though melanosomes can be beneficial for health, abnormalities in their structure can lead to adverse effects. Knowledge of their ultrastructure will be crucial to gaining insight into the mechanisms that ultimately lead to melanosome-related diseases. However, due to their small size and electron-dense content, physiologically intact melanosomes are recalcitrant to study by common imaging techniques such as light and transmission electron microscopy. In contrast, X-ray-based methodologies offer both high spatial resolution and powerful penetrating capabilities, and thus are well suited to study the ultrastructure of electron-dense organelles in their natural, hydrated form. Here, we report on the application of small-angle X-ray scattering-a method effective in determining the three-dimensional structures of biomolecules - to whole, hydrated murine melanosomes. The use of complementary information from the scattering signal of a large ensemble of suspended organelles and from single, vitrified specimens revealed a melanosomal sub-structure whose surface and bulk properties differ in two commonly used inbred strains of laboratory mice. Whereas melanosomes in C57BL/6J mice have a well-defined surface and are densely packed with 40-nm units, their counterparts in DBA/2J mice feature a rough surface, are more granular and consist of 60-nm building blocks. The fact that these strains have different coat colors and distinct susceptibilities to pigment-related eye disease suggest that these differences in size and packing are of biological significance.	[Gorniak, Thomas; Buck, Andreas R.; Senkbeil, Tobias; Grunze, Michael; Rosenhahn, Axel] Karlsruhe Inst Technol KIT, Inst Funct Interfaces IFG, Eggenstein Leopoldshafen, Germany; [Gorniak, Thomas; Haraszti, Tamas; Buck, Andreas R.; Senkbeil, Tobias; Grunze, Michael; Rosenhahn, Axel] Heidelberg Univ, Heidelberg, Germany; [Gorniak, Thomas; Buck, Andreas R.; Rosenhahn, Axel] Ruhr Univ Bochum, Bochum, Germany; [Haraszti, Tamas] Max Planck Inst Intelligent Syst, Stuttgart, Germany; [Garamus, Vasyl M.] Zentrum Mat & Kustenforsch GmbH, Helmholtz Zentrum Geesthacht, Geesthacht, Germany; [Priebe, Marius; Salditt, Tim] Univ Gottingen, Inst Xray Phys, D-37073 Gottingen, Germany; [Hedberg-Buenz, Adam; Koehn, Demelza; Anderson, Michael G.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA; [Hedberg-Buenz, Adam; Anderson, Michael G.] Iowa City Vet Affairs VA Hlth Care Syst, Ctr Prevent & Treatment Visual Loss, Iowa City, IA USA	Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg; Ruhr University Bochum; Max Planck Society; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; University of Gottingen; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Gorniak, T (corresponding author), Karlsruhe Inst Technol KIT, Inst Funct Interfaces IFG, Eggenstein Leopoldshafen, Germany.	thomas.gorniak@kit.edu	Grunze, Michael/O-2912-2019; Grunze, Michael H/H-1600-2013; Rosenhahn, Axel/F-7319-2011; Anderson, Michael/B-4580-2009	Rosenhahn, Axel/0000-0001-9393-7190; Anderson, Michael/0000-0001-5730-6105; Haraszti, Tamas/0000-0002-7095-4358; Salditt, Tim/0000-0003-4636-0813	Helmholtz society, under the virtual institute [VH-VI-403]; BMBF [05K10VH4, FSP 301 FLASH]; National Eye Institute [EY017673]; NATIONAL EYE INSTITUTE [R01EY017673] Funding Source: NIH RePORTER	Helmholtz society, under the virtual institute; BMBF(Federal Ministry of Education & Research (BMBF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors gratefully acknowledge the funding of this work by the Helmholtz society, under the virtual institute VH-VI-403 and by the BMBF (05K10VH4, FSP 301 FLASH). Contributions of MGA were supported by National Eye Institute Grant EY017673. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Anderson MG, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-20; Anderson MG, 2006, MICRON, V37, P689, DOI 10.1016/j.micron.2006.03.008; Avdeev MV, 2009, J PHYS CHEM C, V113, P9473, DOI 10.1021/jp900424p; Avdeev MV, 2006, CARBON, V44, P954, DOI 10.1016/j.carbon.2005.10.010; Beaucage G, 1995, J APPL CRYSTALLOGR, V28, P717, DOI 10.1107/S0021889895005292; Beaucage G, 1996, J APPL CRYSTALLOGR, V29, P134, DOI 10.1107/S0021889895011605; Beaucage G, 2004, J APPL CRYSTALLOGR, V37, P523, DOI 10.1107/S0021889804008969; BIRBECK MSC, 1963, ANN NY ACAD SCI, V100, P540, DOI 10.1111/j.1749-6632.1963.tb42871.x; Blanton TN, 2000, J APPL CRYSTALLOGR, V33, P172, DOI 10.1107/S0021889899012388; BOROVANSKY J, 1991, NEOPLASMA, V38, P393; Borovansky J, 2011, MELANINS AND MELANOSOMES: BIOSYNTHESIS, BIOGENESIS, PHYSIOLOGICAL, AND PATHOLOGICAL FUNCTIONS, P1; Borovansky J, 2011, MELANINS AND MELANOSOMES: BIOSYNTHESIS, BIOGENESIS, PHYSIOLOGICAL, AND PATHOLOGICAL FUNCTIONS, P343; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Burger C, 2012, POLYM SCI COMPREHENS, P363; CHENG J, 1994, PIGM CELL RES, V7, P255, DOI 10.1111/j.1600-0749.1994.tb00060.x; CHENG J, 1994, PIGM CELL RES, V7, P263, DOI 10.1111/j.1600-0749.1994.tb00061.x; Clancy CMR, 2000, J PHYS CHEM B, V104, P7871, DOI 10.1021/jp001630q; Clancy CMR, 2001, BIOCHEMISTRY-US, V40, P13353, DOI 10.1021/bi010786t; Dell'Angelica EC, 2003, TRENDS CELL BIOL, V13, P503, DOI 10.1016/j.tcb.2003.08.001; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; Gallas JM, 1999, BIOPHYS J, V77, P1135, DOI 10.1016/S0006-3495(99)76964-X; Giewekemeyer K, 2013, J SYNCHROTRON RADIAT, V20, P490, DOI 10.1107/S0909049513005372; Granke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058043; Guo SL, 2008, PHOTOCHEM PHOTOBIOL, V84, P671, DOI 10.1111/j.1751-1097.2008.00331.x; Gupta HS, 2006, P NATL ACAD SCI USA, V103, P17741, DOI 10.1073/pnas.0604237103; Haraszti T, 2011, PIGM CELL MELANOMA R, V24, P187, DOI 10.1111/j.1755-148X.2010.00788.x; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; JACKSON IJ, 1988, P NATL ACAD SCI USA, V85, P4392, DOI 10.1073/pnas.85.12.4392; JENKINS NA, 1981, NATURE, V293, P370, DOI 10.1038/293370a0; Kalbfleisch S, 2011, AIP CONF PROC, V1365, P96, DOI 10.1063/1.3625313; Kasas S, 2003, J MICROSC-OXFORD, V211, P48, DOI 10.1046/j.1365-2818.2003.01193.x; Kaulich B, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/8/083002; Krauss S, 2011, J STRUCT BIOL, V175, P457, DOI 10.1016/j.jsb.2011.06.005; Kumagai K, 2009, ULTRAMICROSCOPY, V109, P368, DOI 10.1016/j.ultramic.2009.01.005; Lamoreux ML, 2010, INTRO MUTANT PIGMENT, P51; Littrell KC, 2003, PHOTOCHEM PHOTOBIOL, V77, P115, DOI 10.1562/0031-8655(2003)077<0115:SSOBMB>2.0.CO;2; Liu Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P135, DOI 10.1562/2004-08-03-RA-259.1; Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x; Okulicz JF, 2003, J EUR ACAD DERMATOL, V17, P251, DOI 10.1046/j.1468-3083.2003.00767.x; PAWELEK JM, 1978, NATURE, V276, P627, DOI 10.1038/276627a0; Peles DN, 2009, J PHYS CHEM B, V113, P11346, DOI 10.1021/jp904138n; Petoukhov MV, 2013, INT J BIOCHEM CELL B, V45, P429, DOI 10.1016/j.biocel.2012.10.017; POROD G, 1951, KOLLOID Z Z POLYM, V124, P83, DOI 10.1007/BF01512792; Prem P, 2003, J COSMET SCI, V54, P395; Riley PA, 2003, PIGM CELL RES, V16, P548, DOI 10.1034/j.1600-0749.2003.00069.x; SCHMIDT PW, 1982, J APPL CRYSTALLOGR, V15, P567, DOI 10.1107/S002188988201259X; SCHMIDT PW, 1991, J APPL CRYSTALLOGR, V24, P414, DOI 10.1107/S0021889891003400; SCHMIDT PW, 1986, PHYS REV A, V33, P560, DOI 10.1103/PhysRevA.33.560; Schraermeyer U, 1996, PIGM CELL RES, V9, P248, DOI 10.1111/j.1600-0749.1996.tb00114.x; Simon JD, 2008, J PHYS CHEM B, V112, P13201, DOI 10.1021/jp804248h; SMIT NPM, 2000, ROLE CATECHOL QUINON, P191; Steingrimsson E, 2006, DEV DYNAM, V235, P2401, DOI 10.1002/dvdy.20840; Tello C, 2010, GLAUCOMA BOOK: A PRACTICAL, EVIDENCE-BASED APPROACH TO PATIENT CARE, P499, DOI 10.1007/978-0-387-76700-0_38; Tivol WF, 2008, IMPROVED CRYOGEN PLU, P14; VIJAYASARADHI S, 1990, J EXP MED, V171, P1375, DOI 10.1084/jem.171.4.1375; Wilke RN, 2012, OPT EXPRESS, V20, P19232, DOI 10.1364/OE.20.019232; Zecca L, 2008, P NATL ACAD SCI USA, V105, P17567, DOI 10.1073/pnas.0808768105	58	11	11	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90884	10.1371/journal.pone.0090884	http://dx.doi.org/10.1371/journal.pone.0090884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621581	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300034
J	Barnieh, L; Clement, F; Harris, A; Blom, M; Donaldson, C; Klarenbach, S; Husereau, D; Lorenzetti, D; Manns, B				Barnieh, Lianne; Clement, Fiona; Harris, Anthony; Blom, Marja; Donaldson, Cam; Klarenbach, Scott; Husereau, Don; Lorenzetti, Diane; Manns, Braden			A Systematic Review of Cost-Sharing Strategies Used within Publicly-Funded Drug Plans in Member Countries of the Organisation for Economic Co-Operation and Development	PLOS ONE			English	Review							HEALTH TECHNOLOGY-ASSESSMENT; POSITIVE LIST SYSTEM; DECISION-MAKING; SOUTH-KOREA; PRACTICE GUIDELINES; MANDATORY PRACTICE; CARE-SYSTEMS; REIMBURSEMENT; IMPACT; THAILAND	Background: Publicly-funded drug plans vary in strategies used and policies employed to reduce continually increasing pharmaceutical expenditures. We systematically reviewed the utilization of cost-sharing strategies and physician-directed prescribing regulations in publicly-funded formularies within member nations of the Organization of Economic Cooperation and Development (OECD). Methods & Findings: Using the OECD nations as the sampling frame, a search for cost-sharing strategies and physician-directed prescribing regulations was done using published and grey literature. Collected data was verified by a system expert within the prescription drug insurance plan in each country, to ensure the accuracy of key data elements across plans. Significant variation in the use of cost-sharing mechanisms was seen. Copayments were the most commonly used cost-containment measure, though their use and amount varied for those with certain conditions, most often chronic diseases (in 17 countries), and by socio-economic status (either income or employment status), or with age (in 15 countries). Caps and deductibles were only used by five systems. Drug cost-containment strategies targeting physicians were also identified in 24 countries, including guideline-based prescribing, prescription monitoring and incentive structures. Conclusions: There was variable use of cost-containment strategies to limit pharmaceutical expenditures in publicly funded formularies within OECD countries. Further research is needed to determine the best approach to constrain costs while maintaining access to pharmaceutical drugs.	[Barnieh, Lianne; Manns, Braden] Univ Calgary, Dept Med, Calgary, AB, Canada; [Clement, Fiona; Lorenzetti, Diane] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Harris, Anthony] Monash Univ, Ctr Hlth Econ, Melbourne, Vic 3004, Australia; [Blom, Marja] Univ Helsinki, Fac Pharm, Helsinki, Finland; [Donaldson, Cam] Glasgow Caledonian Univ, Yunus Ctr Social Business & Hlth, Glasgow G4 0BA, Lanark, Scotland; [Klarenbach, Scott] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Husereau, Don] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada	University of Calgary; University of Calgary; Monash University; University of Helsinki; Glasgow Caledonian University; University of Alberta; University of Ottawa	Manns, B (corresponding author), Univ Calgary, Dept Med, Calgary, AB, Canada.	Braden.manns@albertahealthservices.ca	Husereau, Don/AAJ-7722-2021	Husereau, Don/0000-0002-4416-6876; Donaldson, Cam/0000-0003-4670-5340; Lorenzetti, Diane L./0000-0001-8423-3458; Harris, Anthony/0000-0003-1641-3320				Anell A, 2005, EUR J HEALTH ECON, V50, P274; Austvoll-Dahlgren A, 2009, COCHRANE DB SYST REV; Bae EY, 2009, VALUE HEALTH, V12, pS36, DOI 10.1111/j.1524-4733.2009.00625.x; Balfour DC, 2009, J MANAGE CARE PHARM, V15, pS3, DOI 10.18553/jmcp.2009.15.s1.3; Barrett P., 2007, HLTH SYSTEMS TRANSIT, P1; Barry M, 2008, EC DRUG USAGE IRISH; Barry M, 2010, EXPERT REV PHARM OUT, V10, P239, DOI [10.1586/erp.10.23, 10.1586/ERP.10.23]; Barry Michael, 2007, Expert Rev Pharmacoecon Outcomes Res, V7, P605, DOI 10.1586/14737167.7.6.605; Bekkering GE, 2008, EUR J HEALTH ECON, V9, pS5, DOI 10.1007/s10198-008-0122-5; BROOK RH, 1983, NEW ENGL J MED, V309, P1426, DOI 10.1056/NEJM198312083092305; Bryndova L, 2009, HLTH SYSTEMS TRANSIT, V11, P1; Caisse Nationale de la Sante, 2011, FORM INSCR LIST POS; Canadian Agency for Drugs and Technologies in Health, 2010, PROC COMM DRUG REV; Canadian Agency for Drugs and Technologies in Health (CADTH), 2017, GUID EC EV HLTH TECH; Canadian Institute for Health Information, 2007, CAN I HLTH INF DRUG; Canadian Treatment Action Council, 2007, GEN DRUGS CAN POL PA; Chalkidou Kalipso, 2009, Issue Brief (Commonw Fund), V59, P1; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Chun CB, 2009, HLTH SYST TRANSIT, V11, P1; Cleemput I, 2006, GUIDELINES PHARMACOE; Cleemput I, 2009, VALUE HEALTH, V12, P441, DOI 10.1111/j.1524-4733.2008.00469.x; Cumming Jacqueline, 2010, BMJ, V340, pc2441, DOI 10.1136/bmj.c2441; Dasbach Erik J, 2010, J Med Econ, V13, P110, DOI 10.3111/13696990903546013; Davidova J, 2008, PHARM WORLD SCI, V30, P57, DOI 10.1007/s11096-007-9141-z; Daw JR, 2012, HEALTH POLICY, V104, P19, DOI 10.1016/j.healthpol.2011.08.015; Decollogny A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-17; Demers V, 2008, CAN MED ASSOC J, V178, P405, DOI 10.1503/cmaj.070587; Department of Health and Aged Care, 2000, AUSTR HLTH CAR SYST; Department of Health and Ageing, 2008, GUID PREP SUBM PHARM; DeSwaef A., 2008, PHARM PRICING REIMBU; Dormuth CR, 2006, CLIN THER, V28, P964, DOI 10.1016/j.clinthera.2006.06.007; Dormuth CR, 2009, MED CARE, V47, P508, DOI 10.1097/MLR.0b013e318190d482; Doshi JA, 2009, CIRCULATION, V119, P390, DOI 10.1161/CIRCULATIONAHA.108.783944; Drummond M, 2012, EUR J HEALTH ECON, V13, P1, DOI 10.1007/s10198-011-0353-8; Duerden Martin, 2004, J Ambul Care Manage, V27, P132; Duran A, 2006, HLTH SYSTEMS TRANSIT, V8, P1; DurandZaleski I, 1997, BRIT MED J, V315, P943; Durieux P, 2000, INT J TECHNOL ASSESS, V16, P969, DOI 10.1017/S0266462300103046; Elliott D, 2007, PHARM PRICING REIMBU; Ess SM, 2003, PHARMACOECONOMICS, V21, P89, DOI 10.2165/00019053-200321020-00002; Festoy H, 2008, PHARM PRICING REIMBU; Finnish Medicines Agency and Social Insurance Institution, 2011, FINN STAT MED 2010; Folino-Gallo P, 2008, EUR J HEALTH ECON, V9, P305, DOI 10.1007/s10198-008-0114-5; Fretheim A, 2007, PLOS MED, V4, P1178, DOI 10.1371/journal.pmed.0040232; Fricke FU, 2009, VALUE HEALTH, V12, pS20, DOI 10.1111/j.1524-4733.2009.00555.x; Garattini L, 2007, HEALTH POLICY, V82, P330, DOI 10.1016/j.healthpol.2006.11.004; Gerkens S, 2010, HEALT SYST TRANSIT, V12, P1; Gibson TB, 2006, AM J MANAG CARE, V12, pSP11; Glenngard AH., 2005, HLTH SYSTEMS TRANSIT; Godman Brian, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P357, DOI 10.1586/14737167.8.4.357; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Goldman DP, 2006, AM J MANAG CARE, V12, P21; Greenberg D, 2009, INT J TECHNOL ASSESS, V25, P255, DOI 10.1017/S026646230999016X; Habl C, 2006, SURVEYING ASSESSING; Halldorsson M, 2003, HLTH CARE SYSTEMS TR; Hynd A, 2008, PHARMACOEPIDEM DR S, V17, P1091, DOI 10.1002/pds.1670; Iizuka T, 2008, EC PHARM PRICING PHY; Janiszewski R, 2007, PHARM PRICING REIMBU; Jirawattanapisal T, 2009, VALUE HEALTH, V12, pS4, DOI 10.1111/j.1524-4733.2009.00620.x; Joyce GF, 2007, HEALTH AFFAIR, V26, P1333, DOI 10.1377/hlthaff.26.5.1333; Joyce GF, 2002, JAMA-J AM MED ASSOC, V288, P1733, DOI 10.1001/jama.288.14.1733; Kalo Z, 2008, PHARM PRICING REIMBU; Kamae I, 2010, PHARMACOECONOMICS, V28, P831, DOI 10.2165/11538360-000000000-00000; Kanavos P, 2009, REV ESTONIAN PHARM S; Kaypa hoito, 2012, CURR CAR GUID; Kazakov R, 2007, J GEN MED, V4, P249, DOI DOI 10.1057/PALGRAVE.JGM.4950068; Kovacs T, 2007, PHARM PRICING REIMBU; Kuszewski K, 2005, HLTH SYSTEMS TRANSIT; Leopold C, 2008, PHARM PRICING REIMBU; Liu GG, 2009, VALUE HEALTH, V12, pS12, DOI 10.1111/j.1524-4733.2009.00621.x; Liu SZ, 2004, HEALTH POLICY, V68, P277, DOI 10.1016/j.healthpol.2003.12.013; Lopert Ruth, 2009, Issue Brief (Commonw Fund), V60, P1; Lu M, 2008, FINANCING HLTH CARE; Martini N, 2007, PHARM PRICING REIMBU; Mazag J, 2007, PHARM PRICING REIMBU; McDaid D, 2009, HEALT SYST TRANSIT, V11, P1; Mencin D, 2009, VALUE HEALTH, V12, pS14, DOI 10.1111/j.1524-4733.2009.00554.x; Moise P., 2007, OECD HLTH WORKING PA, V28, DOI [10.2139/ssrn.1329310, DOI 10.2139/SSRN.1329310]; Nakao S, 2010, YAKUGAKU ZASSHI, V130, P1347, DOI 10.1248/yakushi.130.1347; Nasser Mona, 2009, Issue Brief (Commonw Fund), V57, P1; National Institute for Health and Clinical Excellence, 2008, GUID METH TECHN APPR; Ngorsuraches S, 2012, VALUE HEALTH, V15, pS120, DOI 10.1016/j.jval.2011.11.002; Oortwijn W, 2010, HEALTH POLICY, V95, P174, DOI 10.1016/j.healthpol.2009.12.008; Organisation of Economic Cooperation and Development, 2012, OECD HLTH DAT 2012 F; Palnoch D., 2007, PHARM PRICING REIMBU; Paris V, 2006, PHARM PRICING REIMBU; Paris V, 2007, PHARM PRICING REIMBU; Park SE, 2012, HEALTH POLICY, V104, P32, DOI 10.1016/j.healthpol.2011.09.006; Peura S., 2007, PHARM PRICING REIMBU; Pharmaceutical Benefits Board L, 2007, SWED PHARM REIMB SYS; PPRI secretariat, 2007, PHARM PRIC REIMB INF; Profili S., 2009, HLTH SYST TRANSIT, V11, P1; Pudersell K, 2007, PHARM PRICING REIMBU; Raftery JP, 2008, MED J AUSTRALIA, V188, P26, DOI 10.5694/j.1326-5377.2008.tb01500.x; Rapoport J, 2009, COST CONTAINMENT EFF; Rawlins M, 2010, BRIT J CLIN PHARMACO, V70, P346, DOI 10.1111/j.1365-2125.2009.03589.x; Redman T, 2007, PHARM PRICING REIMBU; Rochaix Lise, 2009, Issue Brief (Commonw Fund), V58, P1; Sch?fer, 2009, HLTH SYST TRANSIT, V11, P1; Schafer Willemijn, 2010, Health Syst Transit, V12, pv; Sermet C, 2010, APPL HEALTH ECON HEA, V8, P7, DOI 10.2165/11313900-000000000-00000; Shani S, 2000, HEALTH POLICY, V54, P169, DOI 10.1016/S0168-8510(00)00109-3; Solomon MD, 2009, ARCH INTERN MED, V169, P740, DOI 10.1001/archinternmed.2009.62; Stargardt T., 2008, PHARM PRICING REIMBU; Strandberg-Larsen M., 2007, HLTH SYST TRANSIT, V9, P1; Streat S, 2012, CRIT CARE CLIN, V28, P125, DOI 10.1016/j.ccc.2011.10.008; Sundakov A, 2005, NZ PHARM POLICIES TI; Sweeny K, 2009, AUST HEALTH REV, V33, P215, DOI 10.1071/AH090215; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Tatar M, 2007, PHARM PRICING REIMBU; Tatara K, 2009, HEALT SYST TRANSIT, V11, P1; Teixeira I, 2008, PHARM PRICING REIMBU; Thomsen E., 2008, PHARM PRICING REIMBU; Tilson L, 2010, EXPERT REV PHARM OUT, V10, P221, DOI [10.1586/erp.10.33, 10.1586/ERP.10.33]; Van Ganse E, 2008, PHARM PRICING REIMBU; Vardica A, 2007, PHARM PRICING REIMBU; Vogler Sabine, 2009, Pharmaceuticals Policy and Law, V11, P213, DOI 10.3233/PPL-2009-0222; Vogler Sabine, 2011, South Med Rev, V4, P69, DOI 10.5655/smr.v4i2.1004; von der Schulenburg JM, 2010, EUR J HEALTH ECON, V10, P21, DOI 10.1007/s10198-009-0194-x; Vuorenkoski L, 2008, FINLAND HLTH SYSTEM, V10, P1; Walter E, 2006, GUIDELINES HLTH EC E; Wild C, 2009, INT J TECHNOL ASSESS, V25, P74, DOI 10.1017/S026646230909045X; Yang BM, 2008, HEALTH AFFAIR, V27, P179, DOI 10.1377/hlthaff.27.1.179; Yfantopoulos J, 2008, EUR J HEALTH ECON, V9, P87, DOI 10.1007/s10198-007-0061-6; Yoongthong W, 2012, VALUE HEALTH, V15, pS126, DOI 10.1016/j.jval.2011.11.003	125	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90434	10.1371/journal.pone.0090434	http://dx.doi.org/10.1371/journal.pone.0090434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24618721	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400019
J	Froslie, KF; Roislien, J; Qvigstad, E; Godang, K; Bollerslev, J; Henriksen, T; Veierod, MB				Froslie, Kathrine Frey; Roislien, Jo; Qvigstad, Elisabeth; Godang, Kristin; Bollerslev, Jens; Henriksen, Tore; Veierod, Marit B.			Shape Information in Repeated Glucose Curves during Pregnancy Provided Significant Physiological Information for Neonatal Outcomes	PLOS ONE			English	Article							AMERICAN-DIABETES-ASSOCIATION; STUDY-GROUPS RECOMMENDATIONS; INTERNATIONAL ASSOCIATION; POSTPRANDIAL GLUCOSE; CARBOHYDRATE-METABOLISM; FETAL MACROSOMIA; BIRTH-WEIGHT; INSULIN; WOMEN; TOLERANCE	Objective: To use multilevel functional principal component analysis to exploit the information inherent in the shape of longitudinally sampled glucose curves during pregnancy, and to analyse the impact of glucose curve characteristics on neonatal birth weight, percentage fat and cord blood C-peptide. Study Design and Setting: A cohort study of healthy, pregnant women (n = 884). They underwent two oral glucose tolerance tests (gestational weeks 14-16 and 30-32), which gave two glucose curves per woman. Results: Glucose values were higher, and peaked later in third trimester than in early pregnancy. The curve characteristic "general glucose level'' accounted for 91% of the variation across visits, and 72% within visits. The curve characteristics "timing of postprandial peak'', and "oscillating glucose levels'' accounted for a larger part of the variation within visits (15% and 8%), than across visits (7% and <2%). A late postprandial peak during pregnancy, and high general glucose levels in third trimester had significant, positive effects on birth weight (p<0.05). Generally high glucose levels during pregnancy had a significant, positive impact on neonatal percentage fat (p = 0.04). High general glucose level in third trimester had a significant, positive impact on cord blood C-peptide (p = 0.004). Conclusion: Shape information in entire OGTT curves provides significant physiological information of importance for several outcomes, and may contribute to the understanding of the metabolic changes during pregnancy.	[Froslie, Kathrine Frey; Roislien, Jo; Veierod, Marit B.] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Froslie, Kathrine Frey] Univ Oslo, Rikshosp, Norwegian Resource Ctr Womens Hlth, Div Obstet & Gynaecol,Oslo Univ Hosp, N-0027 Oslo, Norway; [Qvigstad, Elisabeth; Godang, Kristin; Bollerslev, Jens] Oslo Univ Hosp, Dept Med, Sect Specialised Endocrinol, Oslo, Norway; [Bollerslev, Jens; Henriksen, Tore] Univ Oslo, Fac Clin Med, Oslo, Norway; [Henriksen, Tore] Univ Oslo, Rikshosp, Oslo Univ Hosp, Div Obstet & Gynaecol, N-0027 Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway	Froslie, KF (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway.	k.f.froslie@medisin.uio.no	Røislien, Jo/AAF-2265-2020; Veierød, Marit B/J-8229-2019	Røislien, Jo/0000-0002-7168-2833; Veierød, Marit B/0000-0002-2083-2758; Qvigstad, Elisabeth/0000-0002-9119-9187	Norwegian Health Association; Faculty of Medicine, University of Oslo; Department of Obstetrics and Gynaecology, Oslo University Hospital Rikshospitalet; National Resource Centre for Women's Health, Oslo University Hospital Rikshospitalet	Norwegian Health Association; Faculty of Medicine, University of Oslo; Department of Obstetrics and Gynaecology, Oslo University Hospital Rikshospitalet; National Resource Centre for Women's Health, Oslo University Hospital Rikshospitalet	Funding for the study was provided by the Norwegian Health Association; Faculty of Medicine, University of Oslo; Department of Obstetrics and Gynaecology and the National Resource Centre for Women's Health, Oslo University Hospital Rikshospitalet. Roche Diagnostics, Norway supplied glucometers and test strips free of charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 2013, R FDN STAT COMPUTING; Aparicio NJ, 1998, AM J OBSTET GYNECOL, V178, P1059, DOI 10.1016/S0002-9378(98)70548-4; Beardsall K, 2008, BEST PRACT RES CL EN, V22, P41, DOI 10.1016/j.beem.2007.10.001; Buhling KJ, 2005, J PERINAT MED, V33, P125, DOI 10.1515/JPM.2005.024; CATALANO PM, 1993, AM J PHYSIOL, V264, pE60, DOI 10.1152/ajpendo.1993.264.1.E60; Chitayat L, 2009, DIABETES TECHNOL THE, V11, pS105, DOI 10.1089/dia.2008.0136; Clapp JF, 1998, DIABETES CARE, V21, pB107; COUSINS L, 1980, AM J OBSTET GYNECOL, V136, P483, DOI 10.1016/0002-9378(80)90675-4; Coustan DR, 2012, CLIN CHEM, V58, P1094, DOI 10.1373/clinchem.2012.186239; Coustan DR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.04.006; Crainiceanu C, 2010, J STAT SOFTW, V32, P1; Di CZ, 2009, ANN APPL STAT, V3, P458, DOI 10.1214/08-AOAS206; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Ferrara A, 2007, DIABETOLOGIA, V50, P298, DOI 10.1007/s00125-006-0517-8; Froslie KF, 2011, CLIN BIOCHEM, V44, P1483, DOI 10.1016/j.clinbiochem.2011.08.1150; Froslie KF, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-6; Godang K, 2013, EUR J ENDOCRINOL, V168, P371, DOI 10.1530/EJE-12-0531; Godang K, 2010, J CLIN DENSITOM, V13, P151, DOI 10.1016/j.jocd.2010.01.121; Gumbiner B, 1996, J CLIN ENDOCR METAB, V81, P2061, DOI 10.1210/jc.81.6.2061; Hadden DR, 2009, SEMIN FETAL NEONAT M, V14, P66, DOI 10.1016/j.siny.2008.09.004; Hernandez TL, 2011, DIABETES CARE, V34, P1660, DOI 10.2337/dc11-0241; Hod M., 2008, TXB DIABETES PREGNAN; Jeffery AN, 2004, MIDWIFERY, V20, P281, DOI 10.1016/j.midw.2004.01.002; JOVANOVICPETERSON L, 1991, AM J OBSTET GYNECOL, V164, P103, DOI 10.1016/0002-9378(91)90637-7; Katon J, 2011, PAEDIATR PERINAT EP, V25, P265, DOI 10.1111/j.1365-3016.2011.01195.x; Langer O, 2013, J MATERN-FETAL NEO M, V26, P111, DOI 10.3109/14767058.2012.734874; Li JX, 2006, J THEOR BIOL, V242, P722, DOI 10.1016/j.jtbi.2006.04.002; LIND T, 1973, J OBSTET GYN BR COMM, V80, P1033; Long H, 2013, CURR DIABETES REP, V13, P43, DOI 10.1007/s11892-012-0330-3; McGowan CA, 2010, BRIT J NUTR, V104, P153, DOI 10.1017/S0007114510000425; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Mills JL, 1998, METABOLISM, V47, P1140, DOI 10.1016/S0026-0495(98)90290-6; Ong KK, 2008, DIABETES CARE, V31, P2193, DOI 10.2337/dc08-1111; Parretti E, 2001, DIABETES CARE, V24, P1319, DOI 10.2337/diacare.24.8.1319; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Ramsay J.O., 2006, FUNCTIONAL DATA ANAL; Scholl TO, 2001, AM J EPIDEMIOL, V154, P514, DOI 10.1093/aje/154.6.514; Siegmund T, 2008, EUR J OBSTET GYN R B, V139, P46, DOI 10.1016/j.ejogrb.2007.12.006; Sivan E, 1997, DIABETES CARE, V20, P1470, DOI 10.2337/diacare.20.9.1470; Stotland NE, 2004, INT J GYNECOL OBSTET, V87, P220, DOI 10.1016/j.ijgo.2004.08.010; Trujillo-Arriaga HM, 2008, COMPUT BIOL MED, V38, P185, DOI 10.1016/j.compbiomed.2007.09.004; Voldner N, 2010, THESIS U OSLO OSLO; Voldner N, 2008, ACTA OBSTET GYN SCAN, V87, P423, DOI 10.1080/00016340801989825; Voldner N, 2010, J MATERN-FETAL NEO M, V23, P74, DOI 10.3109/14767050903121472; Wendland EM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-23; World Health Organization, 2006, DEF DIAGN DIAB MELL; Young BC, 2013, CURR DIABETES REP, V13, P12, DOI 10.1007/s11892-012-0338-8	50	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90798	10.1371/journal.pone.0090798	http://dx.doi.org/10.1371/journal.pone.0090798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619030	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400030
J	Zhang, RY; Li, X; Shi, YN; Shao, YF; Sun, KX; Wang, AP; Sun, FY; Liu, WH; Wang, D; Jin, JJ; Li, YX				Zhang, Renyu; Li, Xiang; Shi, Yanan; Shao, Yufeng; Sun, Kaoxiang; Wang, Aiping; Sun, Fengying; Liu, Wanhui; Wang, Di; Jin, Jingji; Li, Youxin			The Effects of LPM570065, a Novel Triple Reuptake Inhibitor, on Extracellular Serotonin, Dopamine and Norepinephrine Levels in Rats	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; DETECTION FOLLOWING DERIVATIZATION; TREATMENT-RESISTANT DEPRESSION; COLUMN LIQUID-CHROMATOGRAPHY; DORSAL RAPHE NUCLEUS; 5-HT1A RECEPTORS; FRONTAL-CORTEX; IN-VIVO; DESVENLAFAXINE SUCCINATE; ANTIDEPRESSANT TREATMENT	Triple reuptake inhibitors (TRIs) are currently being developed as a new class of promising antidepressants that block serotonin (5-HT), dopamine (DA) and norepinephrine (NE) transporters, thereby increasing extracellular monoamine concentrations. The purpose of this study was to investigate the effects of LPM570065, a novel TRI and a desvenlafaxine prodrug, on extracellular 5-HT, DA and NE levels in the rat striatum after acute and chronic administration relative to desvenlafaxine, using High Performance Liquid Chromatography (HPLC) and microdialysis. Acute administration was performed by providing rodents with oral solutions (0.06 mmol.kg(-1) p.o.), oral suspensions (0.06 mmol.kg(-1) p.o.) and intravenous solutions (0.04 mmol.kg(-1) i.v.) of LPM570065 and desvenlafaxine. Oral suspensions (0.06 mmol.kg(-1).day(-1)) of the two drugs were also administered for a 14-day chronic period. HPLC analysis revealed that LPM570065 rapidly penetrated the rat striatum, converted into desvenlafaxine and exhibited larger total exposure compared with the administration of desvenlafaxine. Microdialysis revealed that acute and chronic administration of oral suspension of LPM570065 increased the 5-HT, DA and NE levels more than the relative administration of desvenlafaxine. Unlike desvenlafaxine, acute administration of an intravenous LPM570065 solution did not induce the undesirable 90% decrease in extracellular 5-HT levels. In contrast to the fully dose-dependent elevation of 5-HT induced by desvenlafaxine, the acute administration of LPM570065 showed a capped increase in extracellular 5-HT levels when combined with WAY-100635. Additionally, forced swim test demonstrated that acute and chronic administration of LPM570065 reduced the immobility time more than the relative administration of desvenlafaxine. These data suggest that LPM570065 may have greater efficacy and/or a more rapid onset of antidepressant action than desvenlafaxine and also counterbalance the harmful effects of desvenlafaxine on 5-HT neurotransmission related to 5-HT1A autoreceptors. Thus, this new class of drugs, TRIs has the potential to provide a new therapeutic mechanism for treating depression.	[Zhang, Renyu; Li, Xiang; Shi, Yanan; Sun, Fengying; Wang, Di; Jin, Jingji; Li, Youxin] Jilin Univ, Sch Life Sci, Changchun 130023, Jilin Province, Peoples R China; [Zhang, Renyu; Li, Xiang; Shi, Yanan; Shao, Yufeng; Sun, Kaoxiang; Wang, Aiping; Liu, Wanhui; Li, Youxin] Luye Pharmaceut Co Ltd, State Key Lab Long Acting & Targeting Drug Delive, Yantai, Shandong, Peoples R China; [Sun, Kaoxiang; Wang, Aiping; Liu, Wanhui; Li, Youxin] Yantai Univ, Sch Pharm, Yantai, Shandong, Peoples R China	Jilin University; Yantai University	Jin, JJ (corresponding author), Jilin Univ, Sch Life Sci, Changchun 130023, Jilin Province, Peoples R China.	jjjin@jlu.edu.cn; liyouxin@jlu.edu.cn			National Major Scientific and Technological Special Project for "Significant New Drugs Development'' [2013ZX09402201-002]; National Basic Research Program of China [2012CB724003]	National Major Scientific and Technological Special Project for "Significant New Drugs Development''; National Basic Research Program of China(National Basic Research Program of China)	This research was supported by the National Major Scientific and Technological Special Project for "Significant New Drugs Development'' during the Twelfth Five-year Plan Period (2013ZX09402201-002, http://www.nmp.gov.cn/) and the National Basic Research Program of China (No 2012CB724003, http://www.cas.cn/ky/kyxm/973xm/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Alfinito PD, 2006, BRAIN RES, V1098, P71, DOI 10.1016/j.brainres.2006.04.057; Aman TK, 2007, J PHARMACOL EXP THER, V320, P376, DOI 10.1124/jpet.106.111690; Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; Baldwin DS, 2006, J CLIN PSYCHIAT, V67, P9; Barr JL, 2011, NEUROSCIENCE, V182, P105, DOI 10.1016/j.neuroscience.2011.03.020; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Beyer CE, 2002, J PSYCHOPHARMACOL, V16, P297, DOI 10.1177/026988110201600403; Breuer ME, 2008, EUR NEUROPSYCHOPHARM, V18, P908, DOI 10.1016/j.euroneuro.2008.07.011; Ceglia I, 2004, BRIT J PHARMACOL, V142, P469, DOI 10.1038/sj.bjp.0705800; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Dawson LA, 2002, J PSYCHOPHARMACOL, V16, P145, DOI 10.1177/026988110201600205; Deecher DC, 2006, J PHARMACOL EXP THER, V318, P657, DOI 10.1124/jpet.106.103382; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Fava M, 2002, J CLIN PSYCHIAT, V63, P13; Fava M, 2006, J CLIN PSYCHIAT, V67, P1754, DOI 10.4088/JCP.v67n1113; Geisler S, 2008, CNS SPECTRUMS, V13, P484, DOI 10.1017/S1092852900016710; Golembiowska K, 2012, SYNAPSE, V66, P435, DOI 10.1002/syn.21531; Gorwood Philip, 2008, Dialogues Clin Neurosci, V10, P291; Guiard BP, 2008, INT J NEUROPSYCHOPH, V11, P625, DOI 10.1017/S1461145707008383; Guiard BP, 2011, INT J NEUROPSYCHOPH, V14, P211, DOI 10.1017/S1461145710000076; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Haj-Dahmane S, 2001, EUR J NEUROSCI, V14, P125, DOI 10.1046/j.0953-816x.2001.01616.x; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; JOLAS T, 1994, J PHARMACOL EXP THER, V268, P1432; Kehr J, 2011, BRIT J PHARMACOL, V164, P1949, DOI 10.1111/j.1476-5381.2011.01499.x; Klimek V, 2002, BIOL PSYCHIAT, V52, P740, DOI 10.1016/S0006-3223(02)01383-5; KREISS DS, 1995, J PHARMACOL EXP THER, V274, P866; Lam RW, 2004, J CLIN PSYCHIAT, V65, P337; Lavretsky H, 2003, J CLIN PSYCHIAT, V64, P1410, DOI 10.4088/JCP.v64n1202; Lavretsky H, 2001, AM J GERIAT PSYCHIAT, V9, P298, DOI 10.1176/appi.ajgp.9.3.298; Le Poul E, 2000, NEUROPHARMACOLOGY, V39, P110, DOI 10.1016/S0028-3908(99)00088-X; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; Li K, 2013, SCIENCE, V341, P1016, DOI 10.1126/science.1240729; Liederer BM, 2006, J PHARM SCI-US, V95, P1177, DOI 10.1002/jps.20542; Mann JJ, 2005, NEW ENGL J MED, V353, P1819, DOI 10.1056/NEJMra050730; Martin-Ruiz R, 2001, J NEUROCHEM, V77, P762, DOI 10.1046/j.1471-4159.2001.00275.x; Mendlin A, 1998, EUR J PHARMACOL, V351, P291, DOI 10.1016/S0014-2999(98)00321-5; Millan MJ, 2009, NEUROTHERAPEUTICS, V6, P53, DOI 10.1016/j.nurt.2008.10.039; Millan MJ, 2000, J PSYCHOPHARMACOL, V14, P114, DOI 10.1177/026988110001400202; Morissette MC, 2008, BEHAV BRAIN RES, V187, P17, DOI 10.1016/j.bbr.2007.08.021; Parent M, 2001, J COMP NEUROL, V439, P162, DOI 10.1002/cne.1340; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Prins J, 2011, EXPERT OPIN INV DRUG, V20, P1107, DOI 10.1517/13543784.2011.594039; ROY A, 1992, ARCH GEN PSYCHIAT, V49, P447; Scorza MC, 2012, BRIT J PHARMACOL, V167, P1021, DOI 10.1111/j.1476-5381.2011.01770.x; Shelton RC, 2005, J CLIN PSYCHIAT, V66, P1289, DOI 10.4088/JCP.v66n1012; Skolnick P, 2003, EUR J PHARMACOL, V461, P99, DOI 10.1016/S0014-2999(03)01310-4; Skolnick P, 2006, CNS DRUG REV, V12, P123, DOI 10.1111/j.1527-3458.2006.00123.x; Spina E, 2012, CNS DRUGS, V26, P39, DOI 10.2165/11594710-000000000-00000; Tian JW, 2011, NEUROSCIENCE, V196, P124, DOI 10.1016/j.neuroscience.2011.08.064; Tizzano JP, 2008, J PHARMACOL EXP THER, V324, P1111, DOI 10.1124/jpet.107.133132; Tran P, 2012, J PSYCHIATR RES, V46, P64, DOI 10.1016/j.jpsychires.2011.09.003; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Weikop P, 2007, J PSYCHOPHARMACOL, V21, P795, DOI 10.1177/0269881107077347; Yamada J, 2004, EUR J PHARMACOL, V504, P207, DOI 10.1016/j.ejphar.2004.09.057; Yoshitake T, 2004, J CHROMATOGR B, V807, P177, DOI 10.1016/j.jchromb.2004.03.069; Yoshitake T, 2003, ANAL BIOCHEM, V312, P125, DOI 10.1016/S0003-2697(02)00435-9; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069934	60	13	15	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91775	10.1371/journal.pone.0091775	http://dx.doi.org/10.1371/journal.pone.0091775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614602	Green Published, gold, Green Submitted			2022-12-27	WOS:000332839300156
J	Kato, N; Sejima, H; Ueda, Y; Mori, K; Satoh, S; Dansako, H; Ikeda, M				Kato, Nobuyuki; Sejima, Hiroe; Ueda, Youki; Mori, Kyoko; Satoh, Shinya; Dansako, Hiromichi; Ikeda, Masanori			Genetic Characterization of Hepatitis C Virus in Long-Term RNA Replication Using Li23 Cell Culture Systems	PLOS ONE			English	Article							ADAPTIVE MUTATIONS; IN-VITRO; SEQUENCE VARIATION; MOLECULAR-CLONING; GENOME; INFECTION; PERSISTENT; STRAIN; IDENTIFICATION; RESISTANCE	Background: The most distinguishing genetic feature of hepatitis C virus (HCV) is its remarkable diversity and variation. To understand this feature, we previously performed genetic analysis of HCV in the long-term culture of human hepatoma HuH-7-derived HCV RNA-replicating cell lines. On the other hand, we newly established HCV RNA-replicating cell lines using human hepatoma Li23 cells, which were distinct from HuH-7 cells. Methodology/Principal Findings: Li23-derived HCV RNA-replicating cells were cultured for 4 years. We performed genetic analysis of HCVs recovered from these cells at 0, 2, and 4 years in culture. Most analysis was performed in two separate parts: one part covered from the 5'-terminus to NS2, which is mostly nonessential for RNA replication, and the other part covered from NS3 to NS5B, which is essential for RNA replication. Genetic mutations in both regions accumulated in a timedependent manner, and the mutation rates in the 5'-terminus-NS2 and NS3-NS5B regions were 4.0-9.0x10(-3) and 2.7-4.0x10(-3) base substitutions/site/year, respectively. These results suggest that the variation in the NS3-NS5B regions is affected by the pressure of RNA replication. Several in-frame deletions (3-105 nucleotides) were detected in the structural regions of HCV RNAs obtained from 2-year or 4-year cultured cells. Phylogenetic tree analyses clearly showed that the genetic diversity of HCV was expanded in a time-dependent manner. The GC content of HCV RNA was significantly increased in a time-dependent manner, as previously observed in HuH-7-derived cell systems. This phenomenon was partially due to the alterations in codon usages for codon optimization in human cells. Furthermore, we demonstrated that these long-term cultured cells were useful as a source for the selection of HCV clones showing resistance to anti-HCV agents. Conclusions/Significance: Long-term cultured HCV RNA-replicating cells are useful for the analysis of evolutionary dynamics and variations of HCV and for drug-resistance analysis.	[Kato, Nobuyuki; Sejima, Hiroe; Ueda, Youki; Mori, Kyoko; Satoh, Shinya; Dansako, Hiromichi; Ikeda, Masanori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Tumor Virol, Shikata, Okayama, Japan	Okayama University	Kato, N (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Tumor Virol, Shikata, Okayama, Japan.	nkato@md.okayama-u.ac.jp	Ueda, Youki/J-3529-2015; DANSAKO, Hiromichi/B-2025-2011; Dansako, Hiromichi/M-1421-2019; Dansako, Hiromichi/N-3109-2019	Ueda, Youki/0000-0002-2627-8524; DANSAKO, Hiromichi/0000-0002-2353-3024; Dansako, Hiromichi/0000-0002-2353-3024	Ministry of Health, Labor, and Welfare of Japan; Japan Society for the Promotion of Science (JSPS); Japan Society for the Promotion of Science	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for research on hepatitis from the Ministry of Health, Labor, and Welfare of Japan; and by a grant-in-aid for Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS). Y.U. was supported by a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartenschlager R, 2005, J HEPATOL, V43, P210, DOI 10.1016/j.jhep.2005.05.013; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Bungyoku Y, 2009, J GEN VIROL, V90, P1681, DOI 10.1099/vir.0.010983-0; Coelmont L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013687; El-Shamy A, 2008, HEPATOLOGY, V48, P38, DOI 10.1002/hep.22339; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Fridell RA, 2010, ANTIMICROB AGENTS CH, V54, P3641, DOI 10.1128/AAC.00556-10; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Goto K, 2009, CANCER SCI, V100, P1943, DOI 10.1111/j.1349-7006.2009.01263.x; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138; Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12; Kang JI, 2009, VIRUS RES, V144, P107, DOI 10.1016/j.virusres.2009.04.002; Kato N, 2005, J GEN VIROL, V86, P645, DOI 10.1099/vir.0.80479-0; KATO N, 1993, J VIROL, V67, P3923, DOI 10.1128/JVI.67.7.3923-3930.1993; Kato N, 2003, BIOCHEM BIOPH RES CO, V306, P756, DOI 10.1016/S0006-291X(03)01047-7; Kato N, 2001, ACTA MED OKAYAMA, V55, P133; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; Kato N, 2009, ARCH VIROL, V154, P77, DOI 10.1007/s00705-008-0282-8; Kato N, 2009, VIRUS RES, V146, P41, DOI 10.1016/j.virusres.2009.08.006; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Kliman RM, 2005, GENE, V352, P92, DOI 10.1016/j.gene.2005.04.001; Koutsoudakis G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052651; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu SY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036406, 10.1371/journal.pone.0030349]; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Major ME, 1999, J VIROL, V73, P3317, DOI 10.1128/JVI.73.4.3317-3325.1999; Mori K, 2013, HEPATOLOGY, V58, P1236, DOI 10.1002/hep.26421; Mori K, 2011, VIRUS RES, V157, P61, DOI 10.1016/j.virusres.2011.02.005; Mori K, 2010, HEPATOL RES, V40, P1248, DOI 10.1111/j.1872-034X.2010.00730.x; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; OKAMOTO H, 1992, VIROLOGY, V190, P894, DOI 10.1016/0042-6822(92)90933-G; Pacini L, 2009, J VIROL, V83, P9079, DOI 10.1128/JVI.00308-09; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Sejima H, 2012, VIRUS RES, V167, P74, DOI 10.1016/j.virusres.2012.04.008; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Suzuki T, 2007, J GASTROENTEROL, V42, P411, DOI 10.1007/s00535-007-2030-3; Takeda M, 2012, J GEN VIROL, V93, P1422, DOI 10.1099/vir.0.040725-0; Tan S. L., 2006, HEPATITIS C VIRUSES; TANAKA T, 1992, VIRUS RES, V23, P39; Thomas DL, 2000, CURR TOP MICROBIOL, V242, P25; Thompson AJ, 2011, CURR OPIN VIROL, V1, P599, DOI 10.1016/j.coviro.2011.10.001; Ueda Y, 2011, BIOCHEM BIOPH RES CO, V409, P663, DOI 10.1016/j.bbrc.2011.05.061; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WEINER A, 1995, P NATL ACAD SCI USA, V92, P2755, DOI 10.1073/pnas.92.7.2755; Zhao Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084346; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	47	9	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91156	10.1371/journal.pone.0091156	http://dx.doi.org/10.1371/journal.pone.0091156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625789	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300059
J	Rauer, C; Ringseis, R; Rothe, S; Wen, GP; Eder, K				Rauer, Christine; Ringseis, Robert; Rothe, Susanne; Wen, Gaiping; Eder, Klaus			Sterol Regulatory Element-Binding Proteins Are Regulators of the Rat Thyroid Peroxidase Gene in Thyroid Cells	PLOS ONE			English	Article							LEUCINE ZIPPER PROTEIN; COENZYME-A REDUCTASE; PROMOTER ANALYSIS; NA+/I-SYMPORTER; EXPRESSION; TRANSCRIPTION; IDENTIFICATION; THYROTROPIN; RECEPTOR; CHOLESTEROL	Sterol regulatory element-binding proteins (SREBPs)-1c and -2, which were initially discovered as master transcriptional regulators of lipid biosynthesis and uptake, were recently identified as novel transcriptional regulators of the sodium-iodide symporter gene in the thyroid, which is essential for thyroid hormone synthesis. Based on this observation that SREBPs play a role for thyroid hormone synthesis, we hypothesized that another gene involved in thyroid hormone synthesis, the thyroid peroxidase (TPO) gene, is also a target of SREBP-1c and -2. Thyroid epithelial cells treated with 25-hydroxycholesterol, which is known to inhibit SREBP activation, had about 50% decreased mRNA levels of TPO. Similarly, the mRNA level of TPO was reduced by about 50% in response to siRNA mediated knockdown of both, SREBP-1 and SREBP-2. Reporter gene assays revealed that overexpression of active SREBP-1c and -2 causes a strong transcriptional activation of the rat TPO gene, which was localized to an approximately 80 bp region in the intron 1 of the rat TPO gene. In vitro-and in vivo-binding of both, SREBP-1c and SREBP-2, to this region in the rat TPO gene could be demonstrated using gel-shift assays and chromatin immunoprecipitation. Mutation analysis of the 80 bp region of rat TPO intron 1 revealed two isolated and two overlapping SREBP-binding elements from which one, the overlapping SRE+609/InvSRE+614, was shown to be functional in reporter gene assays. In connection with recent findings that the rat NIS gene is also a SREBP target gene in the thyroid, the present findings suggest that SREBPs may be possible novel targets for pharmacological modulation of thyroid hormone synthesis.	[Rauer, Christine; Ringseis, Robert; Rothe, Susanne; Wen, Gaiping; Eder, Klaus] Univ Giessen, Inst Anim Nutr & Nutr Physiol, D-35390 Giessen, Germany	Justus Liebig University Giessen	Ringseis, R (corresponding author), Univ Giessen, Inst Anim Nutr & Nutr Physiol, D-35390 Giessen, Germany.	robert.ringseis@ernaehrung.uni-giessen.de	Ringseis, Robert/AAH-1509-2021		Deutsche Forschungsgemeinschaft [RI 1537/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (Grant. no. RI 1537/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOJ SM, 1990, MOL ENDOCRINOL, V4, P611, DOI 10.1210/mend-4-4-611; Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; BIFULCO M, 1995, J BIOL CHEM, V270, P15231, DOI 10.1074/jbc.270.25.15231; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Colin IM, 2013, ENDOCR REV, V34, P209, DOI 10.1210/er.2012-1015; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Ericsson J, 1997, J BIOL CHEM, V272, P7298, DOI 10.1074/jbc.272.11.7298; Espenshade PJ, 2002, P NATL ACAD SCI USA, V99, P11694, DOI 10.1073/pnas.182412799; Gerard AC, 2002, J CLIN ENDOCR METAB, V87, P1291, DOI 10.1210/jc.87.3.1291; Goldstein JL, 2002, ARCH BIOCHEM BIOPHYS, V397, P139, DOI 10.1006/abbi.2001.2615; GRIECO D, 1990, J BIOL CHEM, V265, P19343; Guan GM, 1997, J BIOL CHEM, V272, P10295; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Inoue SI, 2011, MOL PHARMACOL, V79, P148, DOI 10.1124/mol.110.068577; Laglia G, 1996, ENDOCRINOLOGY, V137, P3170, DOI 10.1210/en.137.8.3170; Levy O, 1997, P NATL ACAD SCI USA, V94, P5568, DOI 10.1073/pnas.94.11.5568; Nara TY, 2002, BIOCHEM BIOPH RES CO, V296, P111, DOI 10.1016/S0006-291X(02)00851-3; Nazar M, 2012, ENDOCRINOLOGY, V153, P6114, DOI 10.1210/en.2012-1567; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Nicola JP, 2010, MOL ENDOCRINOL, V24, P1846, DOI 10.1210/me.2010-0102; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Ringseis R, 2013, MOL ENDOCRINOL, V27, P781, DOI 10.1210/me.2012-1269; Rozman D, 1999, MOL ENDOCRINOL, V13, P1951, DOI 10.1210/me.13.11.1951; Ruf J, 2006, ARCH BIOCHEM BIOPHYS, V445, P269, DOI 10.1016/j.abb.2005.06.023; Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Tabor DE, 1999, J BIOL CHEM, V274, P20603, DOI 10.1074/jbc.274.29.20603; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Wen GP, 2010, BIOCHEM PHARMACOL, V79, P768, DOI 10.1016/j.bcp.2009.10.002; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	36	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91265	10.1371/journal.pone.0091265	http://dx.doi.org/10.1371/journal.pone.0091265			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625548	Green Submitted, Green Published, gold			2022-12-27	WOS:000332851300069
J	Tucker, K; Hodges, PW; Van den Hoorn, W; Nordez, A; Hug, F				Tucker, Kylie; Hodges, Paul W.; Van den Hoorn, Wolbert; Nordez, Antoine; Hug, Francois			Does Stress within a Muscle Change in Response to an Acute Noxious Stimulus?	PLOS ONE			English	Article							MOTOR UNIT RECRUITMENT; SHEAR ELASTIC-MODULUS; FIRING RATE; PAIN; CONTRACTIONS; STRATEGIES; FATIGUE; FORCE; ELASTOGRAPHY; STIMULATION	Background: Altered muscle activation during pain is thought to redistribute stress within muscles and ultimately decrease the load on painful structures. However, change in muscle stress during pain has not been directly tested. The aim of the present study is to determine whether stress within muscle tissue is reduced during local acute experimental pain. Methods and Results: Ten participants attended 2 experimental sessions that each involved isometric knee extension tasks in 2 series of control trials and 1 series of test trials at similar to 10%MVC. Shear elastic modulus was measured from vastus lateralis using a shear wave elastographic technique (Supersonic Shear Imaging). Prior to the test contractions, a bolus of hypertonic (Pain) or isotonic saline (No-pain) was injected into vastus lateralis. Pain intensity was 5.2+/-1.0 during the painful contractions. The intra-session repeatability of the shear elastic modulus determined between control trials was good (ICC: 0.95 and 0.99; SEM: 5.1 and 9.3 kPa for No-pain and Pain, respectively). Muscle shear elastic modulus did not change systematically during Pain or No-pain contractions (all main effects and interaction P>0.14). Examination of data for individual participants showed that stress either increased or decreased. If the absolute change in modulus is considered between the control and the test trials, the change during Pain (16.2+/-9.5 kPa) was double that observed with No pain (7.9+/-5.9 kPa; P = 0.046). Conclusion: This is the first study to directly determine the change in stress within a muscle (change in shear elastic modulus) during pain. We conclude that experimental pain induced by hypertonic saline does not induce a systematic reduction in muscle stress during a single-joint isometric task. Therefore, the changes in muscle activity reported previously during similar tasks are unlikely to systematically reduce load in the painful region. Whether the individual-specific increase and decrease are physiologically relevant or purposeful requires further investigation.	[Tucker, Kylie; Hodges, Paul W.; Van den Hoorn, Wolbert; Hug, Francois] Univ Queensland, Sch Hlth & Rehabil Sci, NHMRC, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Brisbane, Qld, Australia; [Tucker, Kylie] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Nordez, Antoine; Hug, Francois] Univ Nantes, Lab Motricite Interact Performance EA 4334, Nantes, France	University of Queensland; University of Queensland; Nantes Universite	Hug, F (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, NHMRC, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Brisbane, Qld, Australia.	f.hug@uq.edu.au	Hug, François/AAV-2415-2020; Tucker, Kylie/M-4887-2013; van den Hoorn, Wolbert/F-6894-2010; Hodges, Paul W/B-6578-2008	Hug, François/0000-0002-6432-558X; Tucker, Kylie/0000-0003-4976-7483; van den Hoorn, Wolbert/0000-0002-9658-2388; Hodges, Paul W/0000-0002-1206-9107	National Health and Medical Research Council [ID401599, ID1009410]; Queensland Government Research Travel Fellowship; European Regional Development Fund (FEDER) [37400]; NHMRC Program grant [ID631717]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Queensland Government Research Travel Fellowship; European Regional Development Fund (FEDER)(European Commission); NHMRC Program grant(National Health and Medical Research Council (NHMRC) of Australia)	National Health and Medical Research Council provided research fellowships for PH: ID401599 and KT: ID1009410. Financial support for KT was also provided by a Queensland Government Research Travel Fellowship, 2012; Project support was provided by a grant from the European Regional Development Fund (FH and AN, FEDER No 37400), and NHMRC Program grant (PH: ID631717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akima H, 2002, J APPL PHYSIOL, V92, P679, DOI 10.1152/japplphysiol.00267.2001; Bank PJM, 2013, EUR J PAIN, V17, P145, DOI 10.1002/j.1532-2149.2012.00186.x; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bouillard K, 2012, J APPL PHYSIOL, V113, P1353, DOI 10.1152/japplphysiol.00858.2012; Bouillard K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029261; Catheline S, 2004, J ACOUST SOC AM, V116, P3734, DOI 10.1121/1.1815075; Ciubotariu A, 2004, EUR J APPL PHYSIOL, V91, P604, DOI 10.1007/s00421-003-1026-9; Del Santo F, 2007, BRAIN RES, V1128, P91, DOI 10.1016/j.brainres.2006.09.039; Dresner MA, 2001, J MAGN RESON IMAGING, V13, P269, DOI 10.1002/1522-2586(200102)13:2<269::AID-JMRI1039>3.3.CO;2-T; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Fadiga L, 2004, NEUROSCI LETT, V361, P250, DOI 10.1016/j.neulet.2003.12.016; Falla D, 2009, CLIN NEUROPHYSIOL, V120, P150, DOI 10.1016/j.clinph.2008.10.148; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Farina D, 2004, J NEUROPHYSIOL, V91, P1250, DOI 10.1152/jn.00620.2003; GravenNielsen T, 1997, ELECTROMYOGR MOTOR C, V105, P156, DOI 10.1016/S0924-980X(96)96554-6; Hirata RP, 2010, CLIN BIOMECH, V25, P931, DOI 10.1016/j.clinbiomech.2010.06.001; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Hodges PW, 2008, J PAIN, V9, P1169, DOI 10.1016/j.jpain.2008.06.012; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hug F, 2013, J ELECTROMY IN PRESS; Hug F, 2014, EUR J APPL IN PRESS; Hug F, 2011, J ELECTROMYOGR KINES, V21, P1, DOI 10.1016/j.jelekin.2010.08.009; Kouzaki M, 2006, J APPL PHYSIOL, V101, P715, DOI 10.1152/japplphysiol.01309.2005; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Madeleine P, 2005, J ELECTROMYOGR KINES, V15, P27, DOI 10.1016/j.jelekin.2004.06.006; Madeleine P, 2006, CLIN NEUROPHYSIOL, V117, P2436, DOI 10.1016/j.clinph.2006.06.753; Minami I, 2013, J DENT RES, V92, P143, DOI 10.1177/0022034512470832; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Peck CC, 2008, AUST DENT J, V53, P201, DOI 10.1111/j.1834-7819.2008.00050.x; RIEK S, 1992, J NEUROPHYSIOL, V68, P100, DOI 10.1152/jn.1992.68.1.100; ROMENY BMT, 1982, EXP NEUROL, V78, P360, DOI 10.1016/0014-4886(82)90054-1; Smith M, 2005, EXP BRAIN RES, V166, P109, DOI 10.1007/s00221-005-2352-4; Svensson P, 1996, PAIN, V64, P241, DOI 10.1016/0304-3959(95)00133-6; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; THOMAS JS, 1978, EXP NEUROL, V59, P384, DOI 10.1016/0014-4886(78)90230-3; Tucker K J, 2013, CHIN J PAIN IN PRESS; Tucker K, 2012, PAIN, V153, P636, DOI 10.1016/j.pain.2011.11.024; Tucker K, 2009, J NEUROSCI, V29, P10820, DOI 10.1523/JNEUROSCI.5211-08.2009; Tucker KJ, 2010, EUR J PAIN, V14, P932, DOI 10.1016/j.ejpain.2010.03.006; Tucker KJ, 2009, PAIN, V141, P151, DOI 10.1016/j.pain.2008.10.029; Yang D, 1998, SURG RADIOL ANAT, V20, P307, DOI 10.1007/BF01630610	41	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91899	10.1371/journal.pone.0091899	http://dx.doi.org/10.1371/journal.pone.0091899			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626150	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300144
J	Zhang, FB; Hao, WW; Zhao, WG; Zheng, C; Chu, YJ; Xu, F				Zhang Fangbin; Hao Weiwei; Zhao Wugan; Zheng Cong; Chu Yanjun; Xu Feng			The Analysis of Factors Associated with Progression of Isolated Terminal Ileal Lesions	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; C-REACTIVE PROTEIN; FECAL CALPROTECTIN; ASYMPTOMATIC ILEITIS; CLINICAL-ASSESSMENT; DIAGNOSTIC-VALUE; CHRONIC DIARRHEA; CROHNS-DISEASE; FOLLOW-UP; SYMPTOMS	Objective: To assess the factors associated with the progression of isolated terminal ileal lesions (ITILs) at colonoscopy in Chinese patients. Methods: Patients diagnosed with ITILs were enrolled. The ileoscopy was performed by two experienced gastroenterologists every 52 weeks. A logistic regression analysis was used to elucidate the factors associated with Crohn's disease (CD) and mucosal healing. A log rank test was used to assess the differences of the cumulative proportion of CD and mucosal healing in different groups at different times. Results: (1) A total of 34 patients were included and no patient had taken nonsteroidal anti-inflammatory drug in the last 6 months; eight (23.5%) patients had a clinical diagnosis of CD, 14 (41.2%) patients achieved mucosal healing, and 12 (35.3%) patients showed no significant changes in the lesions at last follow-up. (2) The logistic regression analysis showed that only abdominal pain was a factor in the ITIL disease outcomes. (3) The cumulative proportion of CD in the abdominal pain group after 3 years was statistically higher than that in the non-abdominal pain group (42.7% vs. 6.2%, chi(2) = 10.129, P = 0.001). However, the cumulative proportion of mucosal healing in the non-abdominal pain group was statistically higher than that in the abdominal pain group (73.3% vs. 5.6%, chi(2) = 5.225, P = 0.022). (4) The numbers of lesions observed on the initial colonoscopy exams and the initial histologic findings were not related to the ITIL disease outcomes. Conclusions: Clinical symptoms may be related to ITIL disease outcomes. Patients with abdominal pain had a high likelihood of CD, whereas those without abdominal pain had a high likelihood of mucosal healing.	[Zhang Fangbin; Hao Weiwei; Zheng Cong; Chu Yanjun; Xu Feng] Zhengzhou Univ, Affiliated Hosp 1, Dept Gastroenterol, Zhengzhou 450052, Peoples R China; [Zhao Wugan] Zhengzhou Univ, Affiliated Hosp 1, Dept Pathol, Zhengzhou 450052, Peoples R China	Zhengzhou University; Zhengzhou University	Zhang, FB (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Gastroenterol, Zhengzhou 450052, Peoples R China.	dr_mingren@163.com			research funding for the doctoral program of higher education of China; Youth Innovation Fund of the First Affiliated Hospital of Zhengzhou University	research funding for the doctoral program of higher education of China; Youth Innovation Fund of the First Affiliated Hospital of Zhengzhou University	This study was sponsored by research funding for the doctoral program of higher education of China and the Youth Innovation Fund of the First Affiliated Hospital of Zhengzhou University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar A, 2010, GUT, V59, P767, DOI 10.1136/gut.2009.194449; Berrill JW, 2013, ALIMENT PHARM THER, V38, P44, DOI 10.1111/apt.12335; BJERKE K, 1993, GUT, V34, P1357, DOI 10.1136/gut.34.10.1357; Canani RB, 2004, DIGEST LIVER DIS, V36, P467, DOI 10.1016/j.dld.2004.02.009; Carroccio A, 2003, CLIN CHEM, V49, P861, DOI 10.1373/49.6.861; Chang HS, 2010, GASTROINTEST ENDOSC, V72, P1226, DOI 10.1016/j.gie.2010.08.029; Courville EL, 2009, AM J SURG PATHOL, V33, P1341, DOI 10.1097/PAS.0b013e3181ad25b6; Geboes K, 1998, AM J GASTROENTEROL, V93, P201, DOI 10.1111/j.1572-0241.1998.00201.x; Geboes K, 2007, AM J GASTROENTEROL, V102, P1090, DOI 10.1111/j.1572-0241.2007.01190.x; Gisbert JP, 2009, DIGEST LIVER DIS, V41, P56, DOI 10.1016/j.dld.2008.05.008; Goldstein NS, 2006, AM J CLIN PATHOL, V125, P838, DOI 10.1309/4PK0G68M2G1L6X47; Greaves ML, 2006, J CLIN GASTROENTEROL, V40, P281, DOI 10.1097/01.mcg.0000210104.59370.66; Halpin SJ, 2012, AM J GASTROENTEROL, V107, P1474, DOI 10.1038/ajg.2012.260; HIZAWA K, 1994, RADIOLOGY, V190, P451, DOI 10.1148/radiology.190.2.8284398; Keohane J, 2010, AM J GASTROENTEROL, V105, P1789, DOI 10.1038/ajg.2010.156; Lengeling RW, 2003, CLIN GASTROENTEROL H, V1, P160, DOI 10.1053/jcgh.2003.50024; Limburg PJ, 2000, AM J GASTROENTEROL, V95, P2831, DOI 10.1016/S0002-9270(00)01987-0; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Matsumoto T, 2000, BRIT J RADIOL, V73, P1046, DOI 10.1259/bjr.73.874.11271896; McHugh JB, 2007, AM J GASTROENTEROL, V102, P1084, DOI 10.1111/j.1572-0241.2007.01194.x; ODONNELL LJD, 1990, BMJ-BRIT MED J, V300, P439, DOI 10.1136/bmj.300.6722.439; Porter CK, 2011, DIGEST DIS SCI, V56, P3262, DOI 10.1007/s10620-011-1762-3; Singh S, 2009, AM J GASTROENTEROL, V104, P1298, DOI 10.1038/ajg.2009.15; Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074; Stavlo PL, 2003, J PEDIATR SURG, V38, P935, DOI 10.1016/S0022-3468(03)00127-1; Tibble J, 2000, GUT, V47, P506, DOI 10.1136/gut.47.4.506; Tibble JA, 2002, GASTROENTEROLOGY, V123, P450, DOI 10.1053/gast.2002.34755; Vermeire S, 2006, GUT, V55, P426, DOI 10.1136/gut.2005.069476; Vermeire S, 2005, NAT CLIN PRACT GASTR, V2, P580, DOI 10.1038/ncpgasthep0359; Vermeire S, 2004, INFLAMM BOWEL DIS, V10, P661, DOI 10.1097/00054725-200409000-00026; Villani AC, 2010, GASTROENTEROLOGY, V138, P1502, DOI 10.1053/j.gastro.2009.12.049; Vivinus-Nebot M, 2013, GUT; Zhou QQ, 2009, PAIN, V146, P41, DOI 10.1016/j.pain.2009.06.017; Zucchelli M, 2011, GUT, V60, P1671, DOI 10.1136/gut.2011.241877	34	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e90797	10.1371/journal.pone.0090797	http://dx.doi.org/10.1371/journal.pone.0090797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625578	gold, Green Submitted, Green Published			2022-12-27	WOS:000332851300035
J	Barnea, O; Huppert, A; Katriel, G; Stone, L				Barnea, Oren; Huppert, Amit; Katriel, Guy; Stone, Lewi			Spatio-Temporal Synchrony of Influenza in Cities across Israel: The "Israel Is One City'' Hypothesis	PLOS ONE			English	Article							SEASONAL INFLUENZA; UNITED-STATES; TRANSMISSION; EPIDEMIC; SPREAD; AUSTRALIA; FRANCE; TRENDS	We analysed an 11-year dataset (1998-2009) of Influenza-Like Illness (ILI) that was based on surveillance of (similar to)23% of Israel's population. We examined whether the level of synchrony of ILI epidemics in Israel's 12 largest cities is high enough to view Israel as a single epidemiological unit. Two methods were developed to assess the synchrony: (1) City-specific attack rates were fitted to a simple model in order to estimate the temporal differences in attack rates and spatial differences in reporting rates of ILI. The model showed good fit to the data (R-2 = 0.76) and revealed considerable differences in reporting rates of ILI in different cities (up to a factor of 2.2). (2) A statistical test was developed to examine the null hypothesis (H0) that ILI incidence curves in two cities are essentially identical, and was tested using ILI data. Upon examining all possible pairs of incidence curves, 77.4% of pairs were found not to be different (H0 was not rejected). It was concluded that all cities generally have the same attack rate and follow the same epidemic curve each season, although the attack rate changes from season to season, providing strong support for the "Israel is one city'' hypothesis. The cities which were the most out of synchronization were Bnei Brak, Beersheba and Haifa, the latter two being geographically remote from all other cities in the dataset and the former geographically very close to several other cities but socially separate due to being populated almost exclusively by ultra-orthodox Jews. Further evidence of assortative mixing of the ultra-orthodox population can be found in the 2001-2002 season, when ultra-orthodox cities and neighborhoods showed distinctly different incidence curves compared to the general population.	[Barnea, Oren; Stone, Lewi] Tel Aviv Univ, Dept Zool, Biomath Unit, Fac Life Sci, IL-69978 Tel Aviv, Israel; [Huppert, Amit] Chaim Sheba Med Ctr, Gertner Inst, IL-52621 Tel Hashomer, Israel; [Katriel, Guy] ORT Braude Coll, Dept Math, Karmiel, Israel; [Stone, Lewi] RMIT Univ, Sch Math & Geospatial Sci, Melbourne, Vic, Australia	Tel Aviv University; Chaim Sheba Medical Center; Royal Melbourne Institute of Technology (RMIT)	Stone, L (corresponding author), Tel Aviv Univ, Dept Zool, Biomath Unit, Fac Life Sci, IL-69978 Tel Aviv, Israel.	lewi@post.tau.ac.il		Stone, Lewi/0000-0002-6465-579X; Katriel, Guy/0000-0001-7411-4789	EU-FP7 Epiwork grant; Israel science Foundation; Israel National Institute for Health Policy and Health Services Research [91168]; Israeli Ministry of Health	EU-FP7 Epiwork grant; Israel science Foundation(Israel Science Foundation); Israel National Institute for Health Policy and Health Services Research; Israeli Ministry of Health	EU-FP7 Epiwork grant; The Israel science Foundation; The Israel National Institute for Health Policy and Health Services Research, http://www.israelhpr.org.il/e/, Grant number: 91168; The Israeli Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Barnea O, 2011, MATH BIOSCI ENG, V8, P561, DOI 10.3934/mbe.2011.8.561; Bonabeau E, 1998, P ROY SOC B-BIOL SCI, V265, P2421, DOI 10.1098/rspb.1998.0593; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Centeral Bureau of Statistics, 2013, STAT ABSTR ISR; Charland KM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017207, 10.1371/journal.pone.0024047]; Choshen M., 2012, JERUSALEM FACTS TREN; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Girard MP, 2005, VACCINE, V23, P5708, DOI 10.1016/j.vaccine.2005.07.046; Gurovich N., 2004, ULTRAORTHODOX JEWS G; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Huppert A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045107; Israel Center for Disease Control, 2013, SURV INFL LIK ILLN I; Lipsitch M, 2009, P NATL ACAD SCI USA, V106, P3645, DOI 10.1073/pnas.0900933106; LONDON WP, 1973, AM J EPIDEMIOL, V98, P453, DOI 10.1093/oxfordjournals.aje.a121575; Paget J, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-141; Rizzo C, 2007, EMERG INFECT DIS, V13, P694, DOI 10.3201/eid1305.061309; Roll U, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-92; Sakai T, 2004, EMERG INFECT DIS, V10, P1822, DOI 10.3201/eid1010.040147; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; Stein-Zamir C, 2009, EUROSURVEILLANCE, V14, P12; Stein-Zamir C, 2008, EURO SURVEILLANCE, V13; Truscott J, 2011, J ROYAL SOC INTERFAC, DOI DOI 10.1098/RSIF.2011.0309.ACCESSED; van Noort SP, 2012, J THEOR BIOL, V298, P131, DOI 10.1016/j.jtbi.2011.12.020; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2004, EMERG INFECT DIS, V10, P32, DOI 10.3201/eid1001.020705; Yaari R, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0298	31	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91909	10.1371/journal.pone.0091909	http://dx.doi.org/10.1371/journal.pone.0091909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622820	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300139
J	Davis, KE; Fox, S; Gigg, J				Davis, Katherine E.; Fox, Sarah; Gigg, John			Increased Hippocampal Excitability in the 3xTgAD Mouse Model for Alzheimer's Disease In Vivo	PLOS ONE			English	Article							EPISODIC-LIKE MEMORY; DENTATE GYRUS; SYNAPTIC PLASTICITY; AMYLOID-BETA; ENTORHINAL CORTEX; ELECTROPHYSIOLOGICAL CHARACTERIZATION; TRANSGENIC MODEL; A-BETA; RAT; ORGANIZATION	Mouse Alzheimer's disease (AD) models develop age-and region-specific pathology throughout the hippocampal formation. One recently established pathological correlate is an increase in hippocampal excitability in vivo. Hippocampal pathology also produces episodic memory decline in human AD and we have shown a similar episodic deficit in 3xTg AD model mice aged 3-6 months. Here, we tested whether hippocampal synaptic dysfunction accompanies this cognitive deficit by probing dorsal CA1 and DG synaptic responses in anaesthetized, 4-6 month-old 3xTgAD mice. As our previous reports highlighted a decline in episodic performance in aged control mice, we included aged cohorts for comparison. CA1 and DG responses to low-frequency perforant path stimulation were comparable between 3xTgAD and controls at both age ranges. As expected, DG recordings in controls showed paired-pulse depression; however, paired-pulse facilitation was observed in DG and CA1 of young and old 3xTgAD mice. During stimulus trains both short-latency (presumably monosynaptic: 'direct') and long-latency (presumably polysynaptic: 're-entrant') responses were observed. Facilitation of direct responses was modest in 3xTgAD animals. However, re-entrant responses in DG and CA1 of young 3xTgAD mice developed earlier in the stimulus train and with larger amplitude when compared to controls. Old mice showed less DG paired-pulse depression and no evidence for re-entrance. In summary, DG and CA1 responses to low-frequency stimulation in all groups were comparable, suggesting no loss of synaptic connectivity in 3xTgAD mice. However, higher-frequency activation revealed complex change in synaptic excitability in DG and CA1 of 3xTgAD mice. In particular, short-term plasticity in DG and CA1 was facilitated in 3xTgAD mice, most evidently in younger animals. In addition, re-entrance was facilitated in young 3xTgAD mice. Overall, these data suggest that the episodic-like memory deficit in 3xTgAD mice could be due to the development of an abnormal hyper-excitable state in the hippocampal formation.	[Davis, Katherine E.; Fox, Sarah; Gigg, John] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Gigg, J (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	j.gigg@manchester.ac.uk		Gigg, John/0000-0001-8253-1582	BBSRC [BB/D011159/1]; Royal Society [RSRG 24519]; Biotechnology and Biological Sciences Research Council [BB/D011159/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful for RCUK funding to KED (BBSRC PhD studentship), SF (BBSRC CASE PhD studentship) and JG (BBSRC grant BB/D011159/1; Royal Society grant RSRG 24519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Backman L, 2001, BRAIN, V124, P96, DOI 10.1093/brain/124.1.96; Baglietto-Vargas D, 2010, J ALZHEIMERS DIS, V21, P119, DOI 10.3233/JAD-2010-100066; Bampton ETW, 1999, BRAIN RES, V841, P123, DOI 10.1016/S0006-8993(99)01811-9; Berg L, 1998, ARCH NEUROL-CHICAGO, V55, P326, DOI 10.1001/archneur.55.3.326; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Blaise JH, 2000, ANN BIOMED ENG, V28, P128, DOI 10.1114/1.261; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BROWN RE, 1995, NEUROSCI LETT, V196, P17, DOI 10.1016/0304-3940(95)11825-H; Buckmaster CA, 2004, J NEUROSCI, V24, P9811, DOI 10.1523/JNEUROSCI.1532-04.2004; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chevaleyre V, 2010, NEURON, V66, P560, DOI 10.1016/j.neuron.2010.04.013; Davis KE, 2013, BEHAV BRAIN RES, V254, P73, DOI 10.1016/j.bbr.2013.03.009; Davis KE, 2013, J ALZHEIMERS DIS, V33, P681, DOI 10.3233/JAD-2012-121543; Desai MK, 2009, GLIA, V57, P54, DOI 10.1002/glia.20734; Disterhoft JF, 2007, AGING CELL, V6, P327, DOI 10.1111/j.1474-9726.2007.00297.x; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Fitzjohn SM, 2001, J NEUROSCI, V21, P4691, DOI 10.1523/JNEUROSCI.21-13-04691.2001; FREEMAN JA, 1975, J NEUROPHYSIOL, V38, P369, DOI 10.1152/jn.1975.38.2.369; Gengler S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009764; Gerrard JL, 2008, J NEUROSCI, V28, P7883, DOI 10.1523/JNEUROSCI.1265-08.2008; Golby A, 2005, BRAIN, V128, P773, DOI 10.1093/brain/awh400; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Guo Q, 1999, J NEUROCHEM, V72, P1019, DOI 10.1046/j.1471-4159.1999.0721019.x; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Hwang DY, 2006, EPILEPSY BEHAV, V8, P115, DOI 10.1016/j.yebeh.2005.09.009; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Kloosterman F, 2003, EUR J NEUROSCI, V18, P3037, DOI 10.1111/j.1460-9568.2003.03046.x; Kloosterman F, 2004, HIPPOCAMPUS, V14, P1026, DOI 10.1002/hipo.20022; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; LAMBERT NA, 1994, J NEUROPHYSIOL, V72, P121, DOI 10.1152/jn.1994.72.1.121; Lee H, 2004, ACTA NEUROBIOL EXP, V64, P89; LEUNG LS, 1995, J NEUROPHYSIOL, V73, P2392, DOI 10.1152/jn.1995.73.6.2392; Loreth D, 2012, NEUROBIOL DIS, V47, P1, DOI 10.1016/j.nbd.2012.03.011; Mastrangelo MA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-81; MCNAUGHTON BL, 1977, J COMP NEUROL, V175, P439, DOI 10.1002/cne.901750404; Naber PA, 2000, ANN NY ACAD SCI, V911, P392; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2005, P NATL ACAD SCI USA, V102, P3046, DOI 10.1073/pnas.0408500102; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Paxinos G, 2001, MOUSE BRAIN INSTEREO; Phillips T, 2000, NEUROSCIENCE, V95, P1139; Reed JM, 1997, BEHAV NEUROSCI, V111, P667, DOI 10.1037/0735-7044.111.4.667; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Sloviter R S, 1991, Hippocampus, V1, P31, DOI 10.1002/hipo.450010105; Smith IF, 2005, J NEUROCHEM, V94, P1711, DOI 10.1111/j.1471-4159.2005.03332.x; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; Takahashi H, 2010, BRAIN STRUCT FUNCT, V214, P145, DOI 10.1007/s00429-010-0242-4; Tamamaki N, 1997, EXP BRAIN RES, V116, P250, DOI 10.1007/PL00005753; Townsend G, 2002, BRAIN RES PROTOC, V9, P122, DOI 10.1016/S1385-299X(02)00139-3; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; VANHOESEN GW, 1990, PROG BRAIN RES, V83, P445; Wang Y, 2009, NEUROBIOL AGING, V30, P1061, DOI 10.1016/j.neurobiolaging.2007.10.009; Witter MP, 2003, INT CONGR SER, V1250, P131, DOI 10.1016/S0531-5131(03)01014-8; Yan XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048782; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006; Ziyatdinova S, 2011, EPILEPSY RES, V94, P75, DOI 10.1016/j.eplepsyres.2011.01.003; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	62	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91203	10.1371/journal.pone.0091203	http://dx.doi.org/10.1371/journal.pone.0091203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621690	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300062
J	Du, YC; Zhang, Q; Zhang, JX				Du, Yingchun; Zhang, Qin; Zhang, John X.			Does N200 Reflect Semantic Processing?-An ERP Study on Chinese Visual Word Recognition	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; TIME-COURSE; NEUROPHYSIOLOGICAL EVIDENCE; REPETITION; MEMORY; IDENTIFICATION; ACTIVATION; FACE; REPRESENTATIONS; CATEGORIZATION	Recent event-related potential research has reported a N200 response or a negative deflection peaking around 200 ms following the visual presentation of two-character Chinese words. This N200 shows amplitude enhancement upon immediate repetition and there has been preliminary evidence that it reflects orthographic processing but not semantic processing. The present study tested whether this N200 is indeed unrelated to semantic processing with more sensitive measures, including the use of two tasks engaging semantic processing either implicitly or explicitly and the adoption of a within-trial priming paradigm. In Exp. 1, participants viewed repeated, semantically related and unrelated prime-target word pairs as they performed a lexical decision task judging whether or not each target was a real word. In Exp. 2, participants viewed high-related, low-related and unrelated word pairs as they performed a semantic task judging whether each word pair was related in meaning. In both tasks, semantic priming was found from both the behavioral data and the N400 ERP responses. Critically, while repetition priming elicited a clear and large enhancement on the N200 response, semantic priming did not show any modulation effect on the same response. The results indicate that the N200 repetition enhancement effect cannot be explained with semantic priming and that this specific N200 response is unlikely to reflect semantic processing.	[Du, Yingchun] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Zhang, Qin] Capital Normal Univ, Dept Psychol, Beijing, Peoples R China; [Zhang, John X.] Fudan Univ, Dept Psychol, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Capital Normal University; Fudan University	Zhang, JX (corresponding author), Fudan Univ, Dept Psychol, Shanghai 200433, Peoples R China.	zhangxuexinjohn@gmail.com			National Nature Science Foundation of China (NSFC) [31100815, 30670702, 31271110]	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Nature Science Foundation of China (NSFC #31100815, #30670702, and #31271110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RP, 2003, BRAIN LANG, V87, P290, DOI 10.1016/S0093-934X(03)00108-1; Badecker W, 2007, BRAIN LANG, V103, P16, DOI 10.1016/j.bandl.2007.07.008; BENTIN S, 1985, ELECTROEN CLIN NEURO, V60, P343, DOI 10.1016/0013-4694(85)90008-2; BENTIN S, 1990, Q J EXP PSYCHOL-A, V42, P693, DOI 10.1080/14640749008401245; Besner D, 1991, BASIC PROCESSES READ, P264; BESSON M, 1992, J COGNITIVE NEUROSCI, V4, P132, DOI 10.1162/jocn.1992.4.2.132; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; Czigler I, 1996, BIOL PSYCHOL, V43, P27, DOI 10.1016/0301-0511(95)05173-2; Douglas LM, 2000, PSYCHOL LEARN MOTIV, P121; Evans KM, 2007, NEUROPSYCHOLOGIA, V45, P1777, DOI 10.1016/j.neuropsychologia.2006.12.014; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Folstein JR, 2004, J EXP PSYCHOL LEARN, V30, P1026, DOI 10.1037/0278-7393.30.5.1026; Gagnepain P, 2008, J NEUROSCI, V28, P5281, DOI 10.1523/JNEUROSCI.0565-08.2008; Ganis G, 2008, NEUROIMAGE, V42, P1714, DOI 10.1016/j.neuroimage.2008.07.004; Guillaume C, 2009, BRAIN RES, V1248, P149, DOI 10.1016/j.brainres.2008.10.069; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P1, DOI 10.1016/0928-4257(94)90092-2; Heinze HJ, 1994, COGNITIVE ELECTROPHY, P124; Henson RN, 2004, NEUROIMAGE, V21, P1674, DOI 10.1016/j.neuroimage.2003.12.020; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Holcomb PJ, 2007, BRAIN RES, V1180, P39, DOI 10.1016/j.brainres.2007.06.110; Holcomb PJ, 2006, J COGNITIVE NEUROSCI, V18, P1631, DOI 10.1162/jocn.2006.18.10.1631; HOLCOMB PJ, 1988, BRAIN LANG, V35, P66, DOI 10.1016/0093-934X(88)90101-0; Hu W, 2013, NEUROSCI LETT, V552, P151, DOI 10.1016/j.neulet.2013.07.041; Itier RJ, 2004, NEUROIMAGE, V21, P1518, DOI 10.1016/j.neuroimage.2003.12.016; Jemel B, 2003, COGNITIVE BRAIN RES, V17, P431, DOI 10.1016/S0926-6410(03)00145-9; Jia XF, 2013, NEUROPSYCHOLOGIA, V51, P1296, DOI 10.1016/j.neuropsychologia.2013.03.024; Kuperberg GR, 2008, HUM BRAIN MAPP, V29, P544, DOI 10.1002/hbm.20419; Lebreton K, 2001, J COGNITIVE NEUROSCI, V13, P670, DOI 10.1162/089892901750363226; Libben G., 2006, REPRESENTATION PROCE; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; McNamara T. P., 2005, SEMANTIC PRIMING PER, DOI DOI 10.4324/9780203338001; MUSEN G, 1990, J EXP PSYCHOL LEARN, V16, P127, DOI 10.1037/0278-7393.16.1.127; Naatanen R, 1997, AUDIOL NEURO-OTOL, V2, P341; NAGY ME, 1989, PSYCHOPHYSIOLOGY, V26, P431, DOI 10.1111/j.1469-8986.1989.tb01946.x; NOBRE AC, 1995, J NEUROSCI, V15, P1090; Olichney JM, 2000, BRAIN, V123, P1948, DOI 10.1093/brain/123.9.1948; Pesciarelli F, 2007, BIOL PSYCHOL, V76, P21, DOI 10.1016/j.biopsycho.2007.05.003; Pylkkanen L, 2003, TRENDS COGN SCI, V7, P187, DOI 10.1016/S1364-6613(03)00092-5; RUGG MD, 1987, Q J EXP PSYCHOL-A, V39, P123, DOI 10.1080/02724988743000060; Rugg MD, 1997, PSYCHOPHYSIOLOGY, V34, P572, DOI 10.1111/j.1469-8986.1997.tb01744.x; Schendan HE, 2007, J COGNITIVE NEUROSCI, V19, P734, DOI 10.1162/jocn.2007.19.5.734; Schendan HE, 2009, NEUROIMAGE, V44, P1423, DOI 10.1016/j.neuroimage.2008.09.061; Schendan HE, 2003, J COGNITIVE NEUROSCI, V15, P111, DOI 10.1162/089892903321107864; Schendan HE, 2002, NEUROPSYCHOLOGIA, V40, P931, DOI 10.1016/S0028-3932(01)00176-2; Segaert K, 2013, NEUROPSYCHOLOGIA, V51, P59, DOI 10.1016/j.neuropsychologia.2012.11.006; Segalowitz SJ, 2009, BIOL PSYCHOL, V80, P122, DOI 10.1016/j.biopsycho.2008.04.009; Sereno SC, 2003, PSYCHOL SCI, V14, P328, DOI 10.1111/1467-9280.14471; Sitnikova T, 2008, J COGNITIVE NEUROSCI, V20, P2037, DOI 10.1162/jocn.2008.20143; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; Swick D, 1998, COGNITIVE BRAIN RES, V7, P143, DOI 10.1016/S0926-6410(98)00019-6; Trenner MU, 2004, COGNITIVE BRAIN RES, V21, P388, DOI 10.1016/j.cogbrainres.2004.06.017; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Van Petten C, 2006, BRAIN LANG, V97, P279, DOI 10.1016/j.bandl.2005.11.003; VANPETTEN C, 1991, J COGNITIVE NEUROSCI, V3, P131, DOI 10.1162/jocn.1991.3.2.131; Xu GF, 2008, THESIS TIANJIN NORMA; Zhang J. X., 2011, J S CHINA NORMAL U S, V4, P5; Zhang JX, 2012, CHINESE SCI BULL, V57, P1516, DOI 10.1007/s11434-011-4932-y	57	20	20	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90794	10.1371/journal.pone.0090794	http://dx.doi.org/10.1371/journal.pone.0090794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24622389	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300029
J	King, DT; Barnes, M; Thomsen, D; Lee, CH				King, Dustin T.; Barnes, Mark; Thomsen, Dana; Lee, Chow H.			Assessing Specific Oligonucleotides and Small Molecule Antibiotics for the Ability to Inhibit the CRD-BP-CD44 RNA Interaction	PLOS ONE			English	Article							PROTEIN CRD-BP; MYC MESSENGER-RNA; NUCLEIC-ACID BINDING; C-MYC; CODING REGION; CELL-PROLIFERATION; EXPRESSION; CANCER; GROWTH; IMP1	Studies on Coding Region Determinant-Binding Protein (CRD-BP) and its orthologs have confirmed their functional role in mRNA stability and localization. CRD-BP is present in extremely low levels in normal adult tissues, but it is over-expressed in many types of aggressive human cancers and in neonatal tissues. Although the exact role of CRD-BP in tumour progression is unclear, cumulative evidence suggests that its ability to physically associate with target mRNAs is an important criterion for its oncogenic role. CRD-BP has high affinity for the 3'UTR of the oncogenic CD44 mRNA and depletion of CRD-BP in cells led to destabilization of CD44 mRNA, decreased CD44 expression, reduced adhesion and disruption of invadopodia formation. Here, we further characterize the CRD-BP-CD44 RNA interaction and assess specific antisense oligonucleotides and small molecule antibiotics for their ability to inhibit the CRD-BP-CD44 RNA interaction. CRD-BP has a high affinity for binding to CD44 RNA nts 2862-3055 with a K-d of 645 nM. Out of ten antisense oligonucleotides spanning nts 2862-3055, only three antisense oligonucleotides (DD4, DD7 and DD10) were effective in competing with CRD-BP for binding to P-32-labeled CD44 RNA. The potency of DD4, DD7 and DD10 in inhibiting the CRD-BP-CD44 RNA interaction in vitro correlated with their ability to specifically reduce the steady-state level of CD44 mRNA in cells. The aminoglycoside antibiotics neomycin, paramomycin, kanamycin and streptomycin effectively inhibited the CRD-BP-CD44 RNA interaction in vitro. Assessing the potential inhibitory effect of aminoglycoside antibiotics including neomycin on the CRD-BP-CD44 mRNA interaction in cells proved difficult, likely due to their propensity to non-specifically bind nucleic acids. Our results have important implications for future studies in finding small molecules and nucleic acid-based inhibitors that interfere with protein-RNA interactions.	[King, Dustin T.; Barnes, Mark; Thomsen, Dana; Lee, Chow H.] Univ No British Columbia, Chem Program, Prince George, BC V2L 5P2, Canada	University of Northern British Columbia	Lee, CH (corresponding author), Univ No British Columbia, Chem Program, Prince George, BC V2L 5P2, Canada.	chow.lee@unbc.ca		King, Dustin/0000-0003-1775-2885	Natural Sciences & Engineering Research Council (NSERC) [227158]; NSERC; BC Cancer Agency Summer Studentship	Natural Sciences & Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); BC Cancer Agency Summer Studentship	This work was supported by a Discovery Grant (grant number 227158) from Natural Sciences & Engineering Research Council (NSERC) to C. H. L. D. T. K. was a recipient of NSERC Undergraduate Student Research Awards and a BC Cancer Agency Summer Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya DP, 2003, J AM CHEM SOC, V125, P8070, DOI 10.1021/ja034241t; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Bergstrom K, 2006, J CELL BIOCHEM, V98, P519, DOI 10.1002/jcb.20726; Boyerinas B, 2012, INT J CANCER, V130, P1787, DOI 10.1002/ijc.26190; Chao JA, 2010, GENE DEV, V24, P148, DOI 10.1101/gad.1862910; Coulis CM, 2000, MOL PHARMACOL, V57, P485, DOI 10.1124/mol.57.3.485; Craig EA, 2012, J CELL SCI, V125, P5950, DOI 10.1242/jcs.115204; Dimitriadis E, 2007, INT J CANCER, V121, P486, DOI 10.1002/ijc.22716; Dinesh CU, 2003, SMALL MOL DNA RNA BI, P58; Doyle GAR, 1998, NUCLEIC ACIDS RES, V26, P5036, DOI 10.1093/nar/26.22.5036; Elcheva I, 2008, ONCOGENE, V27, P5069, DOI 10.1038/onc.2008.141; Goswami S, 2010, J BIOL CHEM, V285, P20532, DOI 10.1074/jbc.M110.109298; Gu W, 2012, J CELL SCI, V125, P81, DOI 10.1242/jcs.086132; Gu W, 2009, J CELL SCI, V122, P1895, DOI 10.1242/jcs.045278; Hamilton KE, 2013, CARCINOGENESIS, V34, P2647, DOI 10.1093/carcin/bgt217; Hammer NA, 2005, REPRODUCTION, V130, P203, DOI 10.1530/rep.1.00664; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Hollingworth D, 2012, NUCLEIC ACIDS RES, V40, P6873, DOI 10.1093/nar/gks368; Hsieh YT, 2013, GYNECOL ONCOL, V131, P182, DOI 10.1016/j.ygyno.2013.07.106; Hwang S, 1999, P NATL ACAD SCI USA, V96, P12997, DOI 10.1073/pnas.96.23.12997; Ioannidis P, 2005, J BIOL CHEM, V280, P20086, DOI 10.1074/jbc.M410036200; Ioannidis P, 2004, CANCER LETT, V209, P245, DOI 10.1016/j.canlet.2003.12.015; Ioannidis P, 2003, INT J CANCER, V104, P54, DOI 10.1002/ijc.10794; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kato T, 2007, CLIN CANCER RES, V13, P434, DOI 10.1158/1078-0432.CCR-06-1297; Kobel M, 2007, ONCOGENE, V26, P7584, DOI 10.1038/sj.onc.1210563; Leeds P, 1997, ONCOGENE, V14, P1279, DOI 10.1038/sj.onc.1201093; Liao BS, 2004, J BIOL CHEM, V279, P48716, DOI 10.1074/jbc.M405853200; Lopez-Novoa JM, 2011, KIDNEY INT, V79, P33, DOI 10.1038/ki.2010.337; LUEDTKE NW, 2003, SMALL MOL DNA RNA BI, P18; Mao CJ, 2006, ANAL BIOCHEM, V350, P222, DOI 10.1016/j.ab.2005.12.010; McCoy LS, 2011, WIRES RNA, V2, P209, DOI 10.1002/wrna.60; Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14; Mongroo PS, 2011, CANCER RES, V71, P2172, DOI 10.1158/0008-5472.CAN-10-3295; Nielsen FC, 2002, J CELL SCI, V115, P2087; Nielsen J, 2004, NUCLEIC ACIDS RES, V32, P4368, DOI 10.1093/nar/gkh754; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; Patel VL, 2012, GENE DEV, V26, P43, DOI 10.1101/gad.177428.111; Prayle A, 2010, THORAX, V65, P654, DOI 10.1136/thx.2009.131532; PROKIPCAK RD, 1994, J BIOL CHEM, V269, P9261; Ross J, 2001, ONCOGENE, V20, P6544, DOI 10.1038/sj.onc.1204838; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider PN, 2011, GENESIS, V49, P117, DOI 10.1002/dvg.20689; Sparanese D, 2007, NUCLEIC ACIDS RES, V35, P1209, DOI 10.1093/nar/gkl1148; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Tok JBH, 2003, CURR TOP MED CHEM, V3, P1001, DOI 10.2174/1568026033452131; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Xue LA, 2011, BIOCHEMISTRY-US, V50, P2838, DOI 10.1021/bi1017304; Xue LA, 2010, BIOCHEMISTRY-US, V49, P5540, DOI 10.1021/bi100071j; Yang G, 2006, J MED CHEM, V49, P5478, DOI 10.1021/jm060288o; Yisraeli JK, 2005, BIOL CELL, V97, P87; Zuker M, 2003, NUCLEIC ACIDS RES, V15, P3046	55	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91585	10.1371/journal.pone.0091585	http://dx.doi.org/10.1371/journal.pone.0091585			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622399	gold, Green Published, Green Submitted			2022-12-27	WOS:000332845300108
J	Scheumann, M; Hasting, AS; Kotz, SA; Zimmermann, E				Scheumann, Marina; Hasting, Anna S.; Kotz, Sonja A.; Zimmermann, Elke			The Voice of Emotion across Species: How Do Human Listeners Recognize Animals' Affective States?	PLOS ONE			English	Article							MOTIVATION-STRUCTURAL RULES; VOCAL EXPRESSION; ACOUSTIC PARAMETERS; DOG BARKS; VOCALIZATIONS; CALLS; PERCEPTION; PRIMATE; AROUSAL; CLASSIFICATION	Voice-induced cross-taxa emotional recognition is the ability to understand the emotional state of another species based on its voice. In the past, induced affective states, experience-dependent higher cognitive processes or cross-taxa universal acoustic coding and processing mechanisms have been discussed to underlie this ability in humans. The present study sets out to distinguish the influence of familiarity and phylogeny on voice-induced cross-taxa emotional perception in humans. For the first time, two perspectives are taken into account: the self-(i.e. emotional valence induced in the listener) versus the others-perspective (i.e. correct recognition of the emotional valence of the recording context). Twenty-eight male participants listened to 192 vocalizations of four different species (human infant, dog, chimpanzee and tree shrew). Stimuli were recorded either in an agonistic (negative emotional valence) or affiliative (positive emotional valence) context. Participants rated the emotional valence of the stimuli adopting self-and others-perspective by using a 5-point version of the Self-Assessment Manikin (SAM). Familiarity was assessed based on subjective rating, objective labelling of the respective stimuli and interaction time with the respective species. Participants reliably recognized the emotional valence of human voices, whereas the results for animal voices were mixed. The correct classification of animal voices depended on the listener's familiarity with the species and the call type/recording context, whereas there was less influence of induced emotional states and phylogeny. Our results provide first evidence that explicit voice-induced cross-taxa emotional recognition in humans is shaped more by experience-dependent cognitive mechanisms than by induced affective states or cross-taxa universal acoustic coding and processing mechanisms.	[Scheumann, Marina; Zimmermann, Elke] Univ Vet Med Hannover, Inst Zool, Hannover, Germany; [Hasting, Anna S.; Kotz, Sonja A.] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany; [Hasting, Anna S.] Univ Hosp Leipzig, Day Clin Cognit Neurol, Leipzig, Germany; [Kotz, Sonja A.] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England	University of Veterinary Medicine Hannover, Foundation; Max Planck Society; Leipzig University; University of Manchester	Scheumann, M (corresponding author), Univ Vet Med Hannover, Inst Zool, Hannover, Germany.	marina.scheumann@tiho-hannover.de		Scheumann, Marina/0000-0002-4091-9500	Deutsche Forschungsgemeinschaft [FOR 499]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was financially supported from the Deutsche Forschungsgemeinschaft (FOR 499; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGUST PV, 1987, J MAMMAL, V68, P1, DOI 10.2307/1381039; Bastian A, 2008, J ACOUST SOC AM, V124, P598, DOI 10.1121/1.2924123; Belin P, 2008, P ROY SOC B-BIOL SCI, V275, P473, DOI 10.1098/rspb.2007.1460; Boersma Paul, 2002, GLOT INT, V5, P341; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; Darwin C., 1872, EXPRESSION EMOTION M; Drolet M, 2012, COGN AFFECT BEHAV NE, V12, P140, DOI 10.3758/s13415-011-0069-3; Ehret Guenter, 2006, P85; Fallow PM, 2011, BEHAV ECOL, V22, P401, DOI 10.1093/beheco/arq221; Fecteau S, 2005, APPL NEUROPSYCHOL, V12, P40, DOI 10.1207/s15324826an1201_7; Feddersen-Petersen DU, 2000, ARCH TIERZUCHT, V43, P387, DOI 10.5194/aab-43-387-2000; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Flom R, 2009, DEV PSYCHOL, V45, P1143, DOI 10.1037/a0015367; Fritz T, 2009, CURR BIOL, V19, P573, DOI 10.1016/j.cub.2009.02.058; Gogoleva SS, 2010, ACTA ETHOL, V13, P75, DOI 10.1007/s10211-010-0076-3; Harnmerschmidt K, 2007, J VOICE, V21, P531, DOI 10.1016/j.jvoice.2006.03.002; Herlyn A, 2009, PRIMATE REPORT, P22; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Jurgens R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00180; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Kitchen DM, 2010, ANIM COGN, V13, P861, DOI 10.1007/s10071-010-0334-9; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Laukka P, 2005, COGNITION EMOTION, V19, P633, DOI 10.1080/02699930441000445; LINNANKOSKI I, 1994, LANG COMMUN, V14, P183, DOI 10.1016/0271-5309(94)90012-4; Magrath RD, 2009, P ROY SOC B-BIOL SCI, V276, P769, DOI 10.1098/rspb.2008.1368; MARTIN GB, 1982, DEV PSYCHOL, V18, P3, DOI 10.1037/0012-1649.18.1.3; Molnar C, 2006, BEHAV PROCESS, V73, P76, DOI 10.1016/j.beproc.2006.03.014; Molnar C, 2010, Q J EXP PSYCHOL, V63, P1004, DOI 10.1080/17470210903168243; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; Nicastro N, 2003, J COMP PSYCHOL, V117, P44, DOI 10.1037/0735-7036.117.1.44; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; PAPOUSEK M, 1989, INFANT BEHAV DEV, V12, P507, DOI 10.1016/0163-6383(89)90030-1; Pell MD, 2009, J PHONETICS, V37, P417, DOI 10.1016/j.wocn.2009.07.005; Pongracz P, 2005, J COMP PSYCHOL, V119, P136, DOI 10.1037/0735-7036.119.2.136; Pongracz P, 2006, APPL ANIM BEHAV SCI, V100, P228, DOI 10.1016/j.applanim.2005.12.004; Pongracz P, 2011, APPL ANIM BEHAV SCI, V135, P95, DOI 10.1016/j.applanim.2011.09.005; Pongracz P, 2010, VET J, V183, P141, DOI 10.1016/j.tvjl.2008.12.010; Ross MD, 2009, CURR BIOL, V19, P1106, DOI 10.1016/j.cub.2009.05.028; Sander K, 2007, HUM BRAIN MAPP, V28, P1007, DOI 10.1002/hbm.20333; Sauter DA, 2010, P NATL ACAD SCI USA, V107, P2408, DOI 10.1073/pnas.0908239106; Schehka S, 2007, J COMP PHYSIOL A, V193, P845, DOI 10.1007/s00359-007-0236-8; Schehka S, 2009, BEHAV BRAIN RES, V203, P223, DOI 10.1016/j.bbr.2009.05.007; Scheiner E, 2002, J VOICE, V16, P509, DOI 10.1016/S0892-1997(02)00127-3; Scherer KR, 2003, SER AFFECTIVE SCI, P433; Scherer KR, 2001, J CROSS CULT PSYCHOL, V32, P76, DOI 10.1177/0022022101032001009; Scheumann M, 2007, DEV PSYCHOBIOL, V49, P708, DOI 10.1002/dev.20234; Scheumann M, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-36; Schirmer A, 2005, NEUROREPORT, V16, P635, DOI 10.1097/00001756-200504250-00024; Schirmer A, 2004, NEUROIMAGE, V21, P1114, DOI 10.1016/j.neuroimage.2003.10.048; Schirmer A, 2002, COGNITIVE BRAIN RES, V14, P228, DOI 10.1016/S0926-6410(02)00108-8; Soltis J, 2005, ANIM BEHAV, V70, P579, DOI 10.1016/j.anbehav.2004.11.015; Tallet C, 2010, J COMP PSYCHOL, V124, P81, DOI 10.1037/a0017354; Taylor AM, 2009, ETHOLOGY, V115, P905, DOI 10.1111/j.1439-0310.2009.01681.x; Vettin J, 2005, BEHAVIOUR, V142, P217, DOI 10.1163/1568539053627640; Yin S, 2004, ANIM BEHAV, V68, P343, DOI 10.1016/j.anbehav.2003.07.016; ZESKIND PS, 1988, CHILD DEV, V59, P193; Zimmermann E., 2013, EVOLUTION EMOTIONAL, P117, DOI 10.1093/acprof:oso/9780199583560.001.0001; Zimmermann E, 2010, HBK BEHAV NEUROSCI, V19, P215, DOI 10.1016/B978-0-12-374593-4.00022-X	58	25	25	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91192	10.1371/journal.pone.0091192	http://dx.doi.org/10.1371/journal.pone.0091192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9HN	24621604	Green Published, gold			2022-12-27	WOS:000332845300059
J	Veronez, CL; Nascimento, FD; Melo, KRB; Nader, HB; Tersariol, ILS; Motta, G				Veronez, Camila Lopes; Nascimento, Fabio D.; Melo, Katia R. B.; Nader, Helena B.; Tersariol, Ivarne L. S.; Motta, Guacyara			The Involvement of Proteoglycans in the Human Plasma Prekallikrein Interaction with the Cell Surface	PLOS ONE			English	Article							MOLECULAR-WEIGHT KININOGEN; HEPARAN-SULFATE PROTEOGLYCANS; HEPATOCYTE GROWTH-FACTOR; VASCULAR SMOOTH-MUSCLE; ENDOTHELIAL-CELLS; ADIPOCYTE DIFFERENTIATION; BRADYKININ FORMATION; CONTACT ACTIVATION; H-KININOGEN; MAST-CELLS	Introduction: The aim of this work was to evaluate the role of human plasma prekallikrein assembly and processing in cells and to determine whether proteoglycans, along with high molecular weight kininogen (H-kininogen), influence this interaction. Methods: We used the endothelial cell line ECV304 and the epithelial cell lines CHO-K1 (wild type) and CHO-745 (deficient in proteoglycans). Prekallikrein endocytosis was studied using confocal microscopy, and prekallikrein cleavage/activation was determined by immunoblotting using an antibody directed to the prekallikrein sequence C364TTKTSTR371 and an antibody directed to the entire H-kininogen molecule. Results: At 37 degrees C, prekallikrein endocytosis was assessed in the absence and presence of exogenously applied H-kininogen and found to be 1,418.4 +/- 0.010 and 1,070.3 +/- 0.001 pixels/cell, respectively, for ECV304 and 1,319.1 +/- 0.003 and 631.3 +/- 0.001 pixels/cell, respectively, for CHO-K1. No prekallikrein internalization was observed in CHO-745 in either condition. Prekallikrein colocalized with LysoTracker in the absence and presence of exogenous H-kininogen at levels of 76.0% and 88.5%, respectively, for ECV304 and at levels of 40.7% and 57.0%, respectively, for CHO-K1. After assembly on the cell surface, a plasma kallikrein fragment of 53 kDa was predominant in the incubation buffer of all the cell lines studied, indicating specific proteolysis; plasma kallikrein fragments of 48-44 kDa and 34-32 kDa were also detected in the incubation buffer, indicating non-specific cleavage. Bradykinin free H-kininogen internalization was not detected in CHO-K1 or CHO-745 cells at 37 degrees C. Conclusion: The prekallikrein interaction with the cell surface is temperature-dependent and independent of exogenously applied H-kininogen, which results in prekallikrein endocytosis promoted by proteoglycans. Prekallikrein proteolysis/activation is influenced by H-kininogen/glycosaminoglycans assembly and controls plasma kallikrein activity.	[Veronez, Camila Lopes; Melo, Katia R. B.; Nader, Helena B.; Tersariol, Ivarne L. S.; Motta, Guacyara] Univ Fed Sao Paulo, Escola Paulista Med, Dept Bioquim, Sao Paulo, Brazil; [Nascimento, Fabio D.] Univ Bandeirante Sao Paulo, Biomat & Biotechnol Res Grp, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Bandeirante de Sao Paulo	Tersariol, ILS (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Bioquim, Sao Paulo, Brazil.	ivarne.tersariol@gmail.com; guacyara.motta05@unifesp.br	Veronez, Camila Lopes/O-6134-2015; Nascimento, Fabio Dupart/ABB-8295-2020; Nascimento, Fabio D/A-5115-2010; Dos Santos Tersariol, Ivarne Luis/G-4042-2012; MOTTA, GUACYARA/C-4429-2015; Nader, Helena Bonciani/D-9253-2012	Veronez, Camila Lopes/0000-0001-9565-1911; Nascimento, Fabio Dupart/0000-0001-6672-3373; Nascimento, Fabio D/0000-0001-6672-3373; Dos Santos Tersariol, Ivarne Luis/0000-0002-8399-4535; MOTTA, GUACYARA/0000-0001-5427-1795; NADER, HELENA/0000-0002-7569-2166	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP 09/51319-1, 09/13160-0, FAPESP 13/05822-9, FAPESP 2012/50219-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq 472403/2007-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Apoio a Universidade Federal de Sao Paulo-FAP/UNIFESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Universidade Federal de Sao Paulo-FAP/UNIFESP	Funding was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: fellowship to C. L. Veronez(FAPESP 09/51319-1 and 09/13160-0), grant to F. D. Nascimento(FAPESP 13/05822-9) and grant to I. L. S. Tersariol (FAPESP 2012/50219-6); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grant to G. Motta(CNPq 472403/2007-9); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Apoio a Universidade Federal de Sao Paulo-FAP/UNIFESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah RT, 2010, J BIOL CHEM, V285, P35206, DOI 10.1074/jbc.M110.171769; Akita K, 2002, GASTROENTEROLOGY, V123, P352, DOI 10.1053/gast.2002.34234; Andrezza JG, 2002, INT IMMUNOPHARMACOL, V2, P1861, DOI 10.1016/S1567-5769(02)00145-5; Bryant J. W., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P234; Buchstein N, 2009, AM J PATHOL, V174, P2116, DOI 10.2353/ajpath.2009.080597; BURGER D, 1986, J BIOL CHEM, V261, P324; Cerf M, 1999, IMMUNOPHARMACOLOGY, V44, P75, DOI 10.1016/S0162-3109(99)00112-5; Chee J, 2007, BIOL CHEM, V388, P1235, DOI 10.1515/BC.2007.139; Colman RW, 2006, CURR PHARM DESIGN, V12, P2599, DOI 10.2174/138161206777698710; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; della Vergiliana JFV, 2010, BIOL CHEM, V391, P1067, DOI 10.1515/BC.2010.102; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; ESKO JD, 1988, SCIENCE, V241, P1092, DOI 10.1126/science.3137658; Fernando AN, 2005, AM J PHYSIOL-HEART C, V289, pH251, DOI 10.1152/ajpheart.00206.2004; Fink E, 2007, BIOL CHEM, V388, P957, DOI 10.1515/BC.2007.104; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Gozzo AJ, 2006, BIOL CHEM, V387, P1129, DOI 10.1515/BC.2006.139; Gozzo AJ, 2011, BIOCHIMIE, V93, P1839, DOI 10.1016/j.biochi.2011.07.003; Guo YL, 2005, J THROMB HAEMOST, V3, P670, DOI 10.1111/j.1538-7836.2005.01218.x; Hughes SE, 1996, EXP CELL RES, V225, P171, DOI 10.1006/excr.1996.0168; Lamorte S, 2012, LEUKEMIA, V26, P1081, DOI 10.1038/leu.2011.290; Le Jan S, 2012, ARTERIOSCL THROM VAS, V32, P1255, DOI 10.1161/ATVBAHA.111.240622; Lilla JN, 2009, J BIOL CHEM, V284, P13792, DOI 10.1074/jbc.M900508200; Melo KRB, 2009, BIOL CHEM, V390, P145, DOI 10.1515/BC.2009.016; Motta G, 1992, Agents Actions Suppl, V36, P200; Motta G, 1992, Agents Actions Suppl, V38 ( Pt 2), P265; Motta G, 1989, Adv Exp Med Biol, V247B, P239; Motta G, 2001, THROMB HAEMOSTASIS, V86, P840; Motta G, 1998, BLOOD, V91, P516, DOI 10.1182/blood.V91.2.516.516_516_528; Oliva M.L.V., 1982, AGENTS ACTIONS S, V9, P52; Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008; Peek M, 2002, J BIOL CHEM, V277, P47804, DOI 10.1074/jbc.M209778200; Renne T, 2000, J BIOL CHEM, V275, P33688, DOI 10.1074/jbc.M000313200; Renne T, 2005, J IMMUNOL, V175, P3377, DOI 10.4049/jimmunol.175.5.3377; Renne T, 2002, INT IMMUNOPHARMACOL, V2, P1867, DOI 10.1016/S1567-5769(02)00170-4; Renne T, 2001, FEBS LETT, V500, P36, DOI 10.1016/S0014-5793(01)02570-4; Schmaier AH, 2007, J THROMB HAEMOST, V5, P2323, DOI 10.1111/j.1538-7836.2007.02770.x; Selvarajan S, 2001, NAT CELL BIOL, V3, P267, DOI 10.1038/35060059; TAKAHASHI K, 1990, IN VITRO CELL DEV B, V26, P265; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Zhao YQ, 2001, AM J PHYSIOL-HEART C, V280, pH1821, DOI 10.1152/ajpheart.2001.280.4.H1821	42	6	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91280	10.1371/journal.pone.0091280	http://dx.doi.org/10.1371/journal.pone.0091280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621563	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300072
J	Fu, SL; Pang, H; Xu, JZ; Wu, XH				Fu, Sheng-Long; Pang, Hao; Xu, Jian-Zhong; Wu, Xue-Hui			C/EBP beta Mediates Osteoclast Recruitment by Regulating Endothelial Progenitor Cell Expression of SDF-1 alpha	PLOS ONE			English	Article							BONE-MARROW; FACTOR-I; OSTEOPROTEGERIN LIGAND; TRANSCRIPTION FACTORS; CHEMOKINE SDF-1; RAW264.7 CELLS; DIFFERENTIATION; CXCR4; PRECURSORS; RECEPTOR	Integration of tissue-engineered bone grafts with the host bone is vital for the healing of critical-size bone defects. An important aspect of this process is bone resorption, which must be carried out by osteoclasts derived from the host. However, the mechanism underlying recruitment of host osteoclast precursors to graft sites remains unclear. Endothelial progenitor cells (EPCs) mobilize from the bone marrow into the circulation and home to sites of angiogenesis such as tissue remodeling. Since EPCs express SDF-1, and C/EBP beta is known to regulate SDF-1 alpha expression, we hypothesized that EPCs may recruit CXCR4-expressing host osteoclast precursors to the repair area and that this recruitment may be mediated through C/EBP beta signaling. Using an inflammatory EPC model we showed that EPCs upregulate protein levels of both SDF-1 alpha and C/EBP beta. A luciferase assay confirmed that C/EBP beta acts on the SDF-1 alpha promoter in these cells, and that binding is increased under conditions of inflammation, while silencing of C/EBP beta reduces expression of SDF-1 alpha and C/EBP beta. Using RAW264.7 cells as a model of osteoclastic monocyte precursors, we investigated their responses to migratory factors in EPC conditioned medium. We showed that RAW264.7 cells migrate towards conditioned medium from EPCs treated with IL-1 beta, an effect which could be abolished by silencing C/EBP beta in EPCs, and was almost completely blocked by silencing CXCR4 in RAW264.7 cells. These findings show that EPCs respond to inflammatory stimuli by signaling to osteoclast precursors via SDF-1, and that C/EBP beta mediates this response.	[Fu, Sheng-Long; Pang, Hao; Xu, Jian-Zhong; Wu, Xue-Hui] Third Mil Med Univ, Southwest Hosp, Dept Orthopaed, Natl & Reg Engn Lab Tissue Engn, Chongqing, Peoples R China	Army Medical University	Xu, JZ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Orthopaed, Natl & Reg Engn Lab Tissue Engn, Chongqing, Peoples R China.	xujz3jd@163.com; rrrranx@yeah.net	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Xu, Jianzhong/0000-0003-0434-5148	National Natural Science Foundation of China [81071465]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (No. 81071465). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; ALAM T, 1992, J BIOL CHEM, V267, P5021; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Benameur T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012392; Cackowski FC, 2010, BLOOD, V115, P140, DOI 10.1182/blood-2009-08-237628; Calonge E, 2010, J MOL BIOL, V396, P463, DOI 10.1016/j.jmb.2009.11.064; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I; Collin-Osdoby P, 2012, METHODS MOL BIOL, V816, P187, DOI 10.1007/978-1-61779-415-5_13; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; De Falco E, 2009, J CELL MOL MED, V13, P3405, DOI 10.1111/j.1582-4934.2009.00655.x; Dong F, 2010, CHINESE MED J-PEKING, V123, P2454, DOI 10.3760/cma.j.issn.0366-6999.2010.17.030; Fan JA, 2010, CANCER BIOTHER RADIO, V25, P521, DOI 10.1089/cbr.2010.0784; Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; George AL, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-24; Hirata M, 2012, HUM MOL GENET, V21, P1111, DOI 10.1093/hmg/ddr540; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Hunger C, 2012, EXP CELL RES, V318, P2178, DOI 10.1016/j.yexcr.2012.06.020; Hungness ES, 2002, INT J BIOCHEM CELL B, V34, P382, DOI 10.1016/S1357-2725(01)00129-7; Jie W, 2010, INT J EXP PATHOL, V91, P436, DOI 10.1111/j.1365-2613.2010.00720.x; Kamio N, 2013, CONNECT TISSUE RES, V54, P147, DOI 10.3109/03008207.2012.761978; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Kim K, 2007, J LEUKOCYTE BIOL, V82, P1332, DOI 10.1189/jlb.1106697; Kubarek L, 2009, BIOMED PHARMACOTHER, V63, P586, DOI 10.1016/j.biopha.2008.10.007; Lacey DL, 2000, AM J PATHOL, V157, P435, DOI 10.1016/S0002-9440(10)64556-7; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Miller RJ, 2008, J NEUROIMMUNOL, V198, P31, DOI 10.1016/j.jneuroim.2008.04.008; Murdoch C, 2000, IMMUNOL REV, V177, P175, DOI 10.1034/j.1600-065X.2000.17715.x; Pang H, 2013, BIOCHEM BIOPH RES CO, V430, P729, DOI 10.1016/j.bbrc.2012.11.081; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Przybylski M, 2010, BIOMED PHARMACOTHER, V64, P254, DOI 10.1016/j.biopha.2009.06.008; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424, DOI 10.1210/endo.139.10.6331; Ribatti D, 2004, J CELL MOL MED, V8, P294, DOI 10.1111/j.1582-4934.2004.tb00319.x; Shalhoub V, 2000, BRIT J HAEMATOL, V111, P501, DOI 10.1046/j.1365-2141.2000.02379.x; Smink JJ, 2012, GENE, V497, P10, DOI 10.1016/j.gene.2012.01.043; Song E, 2010, INT J OPHTHALMOL-CHI, V3, P49, DOI 10.3980/j.issn.2222-3959.2010.01.11; Takagi Y, 2009, AM J PHYSIOL-LUNG C, V297, pL420, DOI 10.1152/ajplung.90477.2008; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tousoulis D, 2008, ATHEROSCLEROSIS, V201, P236, DOI 10.1016/j.atherosclerosis.2008.05.034; Vincent C, 2009, J BONE MINER METAB, V27, P114, DOI 10.1007/s00774-008-0018-6; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Wright LM, 2005, BONE, V36, P840, DOI 10.1016/j.bone.2005.01.021; Wu SH, 2012, INT J MED SCI, V9, P801, DOI 10.7150/ijms.4838; Wu X, 2005, J IMMUNOL, V175, P61, DOI 10.4049/jimmunol.175.1.61; Yamanaka R, 1998, INT J MOL MED, V1, P213; Yu HY, 2008, J ORTHOP RES, V26, P1147, DOI 10.1002/jor.20609; Yu XF, 2003, J BONE MINER RES, V18, P1404, DOI 10.1359/jbmr.2003.18.8.1404; Zwingenberger S, 2013, TISSUE ENG A	50	9	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91217	10.1371/journal.pone.0091217	http://dx.doi.org/10.1371/journal.pone.0091217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618682	Green Submitted, Green Published, gold			2022-12-27	WOS:000332842400057
J	Galimov, ER; Chernyak, BV; Sidorenko, AS; Tereshkova, AV; Chumakov, PM				Galimov, Evgeny R.; Chernyak, Boris V.; Sidorenko, Alena S.; Tereshkova, Alesya V.; Chumakov, Peter M.			Prooxidant Properties of p66shc Are Mediated by Mitochondria in Human Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; LIFE-SPAN; HYDROGEN-PEROXIDE; SERUM DEPRIVATION; ADAPTER PROTEIN; CYTOCHROME-C; NEURODEGENERATIVE DISORDERS; ENDOTHELIAL DYSFUNCTION; FORKHEAD PROTEINS; INDUCED APOPTOSIS	p66shc is a protein product of an mRNA isoform of SHC1 gene that has a pro-oxidant and pro-apoptotic activity and is implicated in the aging process. Mitochondria were suggested as a major source of the p66shc-mediated production of reactive oxygen species (ROS), although the underlying mechanisms are poorly understood. We studied effects of p66shc on oxidative stress induced by hydrogen peroxide or by serum deprivation in human colon carcinoma cell line RKO and in diploid human dermal fibroblasts (HDFs). An shRNA-mediated knockdown of p66shc suppressed and an overexpression of a recombinant p66shc stimulated the production of ROS in the both models. This effect was not detected in the mitochondrial DNA-depleted rho 0-RKO cells that do not have the mitochondrial electron transport chain (ETC). The p66shc-dependent accumulation of mitochondrial ROS was detected with HyPer-mito, a mitochondria-targeted fluorescent protein sensor for hydrogen peroxide. The fragmentation of mitochondria induced by mitochondrial ROS was significantly reduced in the p66shc deficient RKO cells. Mitochondria-targeted antioxidants SkQ1 and SkQR1 also decreased the oxidative stress induced by hydrogen peroxide or by serum deprivation. Together the data indicate that the p66shc-dependant ROS production during oxidative stress has mitochondrial origin in human normal and cancer cells.	[Galimov, Evgeny R.; Chernyak, Boris V.] Moscow MV Lomonosov State Univ, Belozersky Inst Phys & Chem Biol, Moscow, Russia; [Galimov, Evgeny R.; Sidorenko, Alena S.; Tereshkova, Alesya V.; Chumakov, Peter M.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Chumakov, Peter M.] Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; [Chumakov, Peter M.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Cleveland Clinic Foundation; Novosibirsk State University	Chumakov, PM (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia.	peterchumakov@gmail.com	Chernyak, Boris V/D-9917-2012; Chumakov, Peter M/E-7731-2014	Chernyak, Boris V/0000-0003-1523-0864; Galimov, Evgeniy/0000-0001-8891-3362; Chumakov, Peter/0000-0002-8078-2908	Russian Fund for Basic Research [11-04-00410, 11-04-92697, 12-04-00538]; Mitotech LLC.	Russian Fund for Basic Research(Russian Foundation for Basic Research (RFBR)); Mitotech LLC.	The study was supported by grants 11-04-00410, 11-04-92697, and 12-04-00538 from the Russian Fund for Basic Research (www.rfbr.ru) and a grant from Mitotech LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2010, FASEB J, V24, P5033, DOI 10.1096/fj.10-166934; Antonenko YN, 2008, J MEMBRANE BIOL, V222, P141, DOI 10.1007/s00232-008-9108-6; Antonenko YN, 2011, J BIOL CHEM, V286, P17831, DOI 10.1074/jbc.M110.212837; Arany I, 2008, J BIOL CHEM, V283, P6110, DOI 10.1074/jbc.M708799200; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Berniakovich I, 2008, J BIOL CHEM, V283, P34283, DOI 10.1074/jbc.M804362200; Borkowska A, 2011, FREE RADICAL BIO MED, V51, P658, DOI 10.1016/j.freeradbiomed.2011.04.045; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Camici GG, 2007, P NATL ACAD SCI USA, V104, P5217, DOI 10.1073/pnas.0609656104; Chahdi A, 2008, MOL BIOL CELL, V19, P2609, DOI 10.1091/mbc.E07-05-0424; Chernyak BV, 2006, BBA-BIOENERGETICS, V1757, P525, DOI 10.1016/j.bbabio.2006.02.019; Chumakov S P, 2008, Mol Biol (Mosk), V42, P1004; Chumakov SP, 2010, PLASMID, V63, P143, DOI 10.1016/j.plasmid.2009.12.003; Chung YM, 2006, BIOCHEM BIOPH RES CO, V347, P649, DOI 10.1016/j.bbrc.2006.06.140; Chung YM, 2008, J BIOL CHEM, V283, P33763, DOI 10.1074/jbc.M805334200; Dumont A, 1999, ONCOGENE, V18, P747, DOI 10.1038/sj.onc.1202325; Egorov E E, 2007, Ontogenez, V38, P105; FERRARI G, 1995, J NEUROSCI, V15, P2857; Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Fukuyama R, 2002, J BIOL CHEM, V277, P41455, DOI 10.1074/jbc.M204176200; Gertz M, 2008, P NATL ACAD SCI USA, V105, P5705, DOI 10.1073/pnas.0800691105; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Haga S, 2008, J HEPATOL, V48, P422, DOI 10.1016/j.jhep.2007.11.018; Kakhlon O, 2001, BIOCHEM J, V356, P311, DOI 10.1042/0264-6021:3560311; Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2; Khanday FA, 2006, J CELL BIOL, V172, P817, DOI 10.1083/jcb.200506001; Khanday FA, 2006, MOL BIOL CELL, V17, P122, DOI 10.1091/mbc.e05-06-0570; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KITAGAWA T, 1993, BIOL REPROD, V49, P730, DOI 10.1095/biolreprod49.4.730; Koch OR, 2008, LAB INVEST, V88, P750, DOI 10.1038/labinvest.2008.44; Kowaltowski AJ, 2000, BRAZ J MED BIOL RES, V33, P241, DOI 10.1590/S0100-879X2000000200014; Kravchenko JE, 2005, NATURE, V436, P735, DOI 10.1038/nature03848; KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q; Kuznetsov AV, 2011, ANAL BIOANAL CHEM, V400, P2383, DOI 10.1007/s00216-011-4764-2; Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002; Lee SB, 2011, ONCOL REP, V25, P1337, DOI 10.3892/or.2011.1210; Lee SB, 2010, APOPTOSIS, V15, P204, DOI 10.1007/s10495-009-0411-1; Lenaz G, 2012, ADV EXP MED BIOL, V942, P93, DOI 10.1007/978-94-007-2869-1_5; Leonard JV, 2000, LANCET, V355, P389, DOI 10.1016/S0140-6736(99)05226-5; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; Mailloux RJ, 2012, TRENDS ENDOCRIN MET, V23, P451, DOI 10.1016/j.tem.2012.04.004; Markova OV, 2003, BBA-BIOENERGETICS, V1557, P109, DOI 10.1016/S0005-2728(03)00003-3; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; Orsini F, 2006, BIOL CHEM, V387, P1405, DOI 10.1515/BC.2006.176; Pandey S, 2003, APOPTOSIS, V8, P497, DOI 10.1023/A:1025542424986; PETERSEN LC, 1980, BIOCHEM J, V192, P687, DOI 10.1042/bj1920687; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Pletjushkina OY, 2006, BBA-BIOENERGETICS, V1757, P518, DOI 10.1016/j.bbabio.2006.03.018; Pletjushkina OY, 2005, CELL DEATH DIFFER, V12, P1442, DOI 10.1038/sj.cdd.4401685; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Razorenova OV, 2005, GENE, V350, P89, DOI 10.1016/j.gene.2005.02.006; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Satoh T, 1996, BRAIN RES, V733, P9, DOI 10.1016/0006-8993(96)00527-6; SCHEJTER A, 1963, Biochim Biophys Acta, V73, P641; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Skulachev VP, 2009, BBA-BIOENERGETICS, V1787, P437, DOI 10.1016/j.bbabio.2008.12.008; Skulachev VP, 2004, MOL CELL BIOCHEM, V256, P341, DOI 10.1023/B:MCBI.0000009880.94044.49; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Smith WW, 2005, J CELL BIOL, V169, P331, DOI 10.1083/jcb.200410041; SUGANUMA N, 1993, HORM RES, V39, P16, DOI 10.1159/000182752; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901; Wu ZH, 2006, J CELL PHYSIOL, V209, P996, DOI 10.1002/jcp.20819; Zhuge J, 2006, FREE RADICAL BIO MED, V40, P63, DOI 10.1016/j.freeradbiomed.2005.08.012; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	71	22	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e86521	10.1371/journal.pone.0086521	http://dx.doi.org/10.1371/journal.pone.0086521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618848	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400002
J	Herrando-Perez, S; Delean, S; Brook, BW; Cassey, P; Bradshaw, CJA				Herrando-Perez, Salvador; Delean, Steven; Brook, Barry W.; Cassey, Phillip; Bradshaw, Corey J. A.			Spatial Climate Patterns Explain Negligible Variation in Strength of Compensatory Density Feedbacks in Birds and Mammals	PLOS ONE			English	Article							POPULATION-DYNAMICS; TIME-SERIES; LARGE-SCALE; ENVIRONMENTAL-FACTORS; DEPENDENCE; FLUCTUATIONS; VARIABILITY; PREDATION; WEATHER; STOCHASTICITY	The use of long-term population data to separate the demographic role of climate from density-modified demographic processes has become a major topic of ecological investigation over the last two decades. Although the ecological and evolutionary mechanisms that determine the strength of density feedbacks are now well understood, the degree to which climate gradients shape those processes across taxa and broad spatial scales remains unclear. Intuitively, harsh or highly variable environmental conditions should weaken compensatory density feedbacks because populations are hypothetically unable to achieve or maintain densities at which social and trophic interactions (e.g., competition, parasitism, predation, disease) might systematically reduce population growth. Here we investigate variation in the strength of compensatory density feedback, from long-term time series of abundance over 146 species of birds and mammals, in response to spatial gradients of broad-scale temperature precipitation variables covering 97 localities in 28 countries. We use information-theoretic metrics to rank phylogenetic generalized least-squares regression models that control for sample size (time-series length) and phylogenetic non-independence. Climatic factors explained < 1% of the remaining variation in density-feedback strength across species, with the highest non-control, model-averaged effect sizes related to extreme precipitation variables. We could not link our results directly to other published studies, because ecologists use contrasting responses, predictors and statistical approaches to correlate density feedback and climate - at the expense of comparability in a macroecological context. Censuses of multiple populations within a given species, and a priori knowledge of the spatial scales at which density feedbacks interact with climate, seem to be necessary to determine cross-taxa variation in this phenomenon. Despite the availability of robust modelling tools, the appropriate data have not yet been gathered for most species, meaning that we cannot yet make any robust generalisations about how demographic feedbacks interact with climate.	[Herrando-Perez, Salvador; Delean, Steven; Brook, Barry W.; Cassey, Phillip; Bradshaw, Corey J. A.] Univ Adelaide, Inst Environm, Adelaide, SA 5005, Australia; [Herrando-Perez, Salvador; Delean, Steven; Brook, Barry W.; Cassey, Phillip; Bradshaw, Corey J. A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Herrando-Perez, Salvador] Spanish Res Council CSIC, Natl Museum Nat Sci, Dept Biogeog & Global Change, Madrid, Spain	University of Adelaide; University of Adelaide; Consejo Superior de Investigaciones Cientificas (CSIC)	Herrando-Perez, S (corresponding author), Univ Adelaide, Inst Environm, Adelaide, SA 5005, Australia.	salvador.herrando-perez@adelaide.edu.au	Bradshaw, Corey J.A./A-1311-2008; Brook, Barry W./G-2686-2011	Bradshaw, Corey J.A./0000-0002-5328-7741; Brook, Barry W./0000-0002-2491-1517; Cassey, Phillip/0000-0002-2626-0172; Herrando-Perez, Salvador/0000-0001-6052-6854	Endeavour International Postgraduate Scholarship (University of Adelaide); Australian Research Council Discovery Project [DP0878582]	Endeavour International Postgraduate Scholarship (University of Adelaide); Australian Research Council Discovery Project(Australian Research Council)	Funding provided by an Endeavour International Postgraduate Scholarship (University of Adelaide, www.adelaide.edu.au) to SHP, and by an Australian Research Council (http://www.arc.gov.au) Discovery Project grant (DP0878582) to CJAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes R, 2000, ECOGRAPHY, V23, P437, DOI 10.1034/j.1600-0587.2000.230406.x; Bassar RD, 2010, ANN NY ACAD SCI, V1206, P17, DOI 10.1111/j.1749-6632.2010.05706.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Belovsky GE, 2004, BIOSCIENCE, V54, P345, DOI 10.1641/0006-3568(2004)054[0345:TSTSTS]2.0.CO;2; Berryman A., 1999, PRINCIPLES POPULATIO; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BJORNSTAD ON, 1995, P ROY SOC B-BIOL SCI, V262, P127, DOI 10.1098/rspb.1995.0186; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Brook BW, 2006, ECOLOGY, V87, P1445, DOI 10.1890/0012-9658(2006)87[1445:SOEFDD]2.0.CO;2; Brouwer L, 2006, J ANIM ECOL, V75, P1321, DOI 10.1111/j.1365-2656.2006.01155.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bull JC, 2008, J ANIM ECOL, V77, P1296, DOI 10.1111/j.1365-2656.2008.01449.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chamaille-Jammes S, 2008, J ANIM ECOL, V77, P135, DOI 10.1111/j.1365-2656.2007.01307.x; Clark F, 2010, METHODS ECOL EVOL, V1, P253, DOI 10.1111/j.2041-210X.2010.00029.x; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; De Valpine P, 2008, ECOLOGY, V89, P532, DOI 10.1890/06-1996.1; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; Doncaster CP, 2008, THEOR POPUL BIOL, V73, P483, DOI 10.1016/j.tpb.2008.02.003; Driscoll DA, 2012, ECOL MONOGR, V82, P129, DOI 10.1890/11-0916.1; Fagan WF, 2001, ECOL LETT, V4, P132, DOI 10.1046/j.1461-0248.2001.00206.x; FOLEY P, 1994, CONSERV BIOL, V8, P124, DOI 10.1046/j.1523-1739.1994.08010124.x; FOWLER CW, 1981, ECOLOGY, V62, P602, DOI 10.2307/1937727; Fox JW, 2001, J ANIM ECOL, V70, P80; Freckleton RP, 2011, AM NAT, V178, pE10, DOI 10.1086/660272; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fryxell JM, 2005, OIKOS, V111, P143, DOI 10.1111/j.0030-1299.2005.13840.x; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hallett TB, 2004, NATURE, V430, P71, DOI 10.1038/nature02708; Hart EM, 2011, OIKOS, V120, P1227, DOI 10.1111/j.1600-0706.2011.18707.x; Helms SE, 2005, OECOLOGIA, V145, P197, DOI 10.1007/s00442-005-0060-1; Herrando-Perez S, 2012, RESOLVING CONCEPTUAL; Herrando-Perez S, 2012, OECOLOGIA, V170, P585, DOI 10.1007/s00442-012-2347-3; Herrando-Perez S, 2012, ECOL EVOL, V2, P1922, DOI 10.1002/ece3.298; Herrando-Perez S, 2012, ECOLOGY, V93, P1728, DOI 10.1890/11-1415.1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Inchausti P, 2001, SCIENCE, V293, P655, DOI 10.1126/science.293.5530.655; Ives AR, 2010, ECOLOGY, V91, P858, DOI 10.1890/09-0442.1; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jetz W, 2011, CURR BIOL, V21, P72, DOI 10.1016/j.cub.2010.11.075; Johnson DW, 2006, ECOLOGY, V87, P1179, DOI 10.1890/0012-9658(2006)87[1179:PHCAVI]2.0.CO;2; Knape J, 2011, P ROY SOC B-BIOL SCI, V278, P985, DOI 10.1098/rspb.2010.1333; Knape J, 2008, ECOLOGY, V89, P2994, DOI 10.1890/08-0071.1; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Krebs CJ, 2002, PHILOS T ROY SOC B, V357, P1211, DOI 10.1098/rstb.2002.1122; Kruger O, 2002, J ANIM ECOL, V71, P603, DOI 10.1046/j.1365-2656.2002.00626.x; Lima M, 2002, ECOL LETT, V5, P273, DOI 10.1046/j.1461-0248.2002.00312.x; Lima M, 2006, OIKOS, V112, P555, DOI 10.1111/j.0030-1299.2006.14439.x; Mansson L, 2007, POPUL ECOL, V49, P287, DOI 10.1007/s10144-007-0053-5; Martin LJ, 2012, FRONT ECOL ENVIRON, V10, P195, DOI 10.1890/110154; McMahon CR, 2009, OECOLOGIA, V159, P69, DOI 10.1007/s00442-008-1205-9; Medawar PB, 1940, PROC R SOC SER B-BIO, V129, P332, DOI 10.1098/rspb.1940.0042; Mutshinda CM, 2011, J ANIM ECOL, V80, P101, DOI 10.1111/j.1365-2656.2010.01743.x; NELDER JA, 1961, BIOMETRICS, V17, P89, DOI 10.2307/2527498; NICHOLSON AJ, 1950, NATURE, V165, P476, DOI 10.1038/165476a0; NICHOLSON AJ, 1954, AUST J ZOOL, V2, P9, DOI 10.1071/ZO9540009; NICHOLSON AJ, 1954, NATURE, V173, P862, DOI 10.1038/173862a0; Osenberg CW, 2002, ECOL LETT, V5, P715, DOI 10.1046/j.1461-0248.2002.00377.x; Pasinelli G, 2011, J ANIM ECOL, V80, P225, DOI 10.1111/j.1365-2656.2010.01754.x; Pfister CA, 2006, ECOLOGY, V87, P2905, DOI 10.1890/0012-9658(2006)87[2905:CBSEAL]2.0.CO;2; Polansky L, 2009, ECOLOGY, V90, P2313, DOI 10.1890/08-1461.1; Post E, 2005, ECOLOGY, V86, P2320, DOI 10.1890/04-0823; Ritchie ME, 1996, FRONTIERS OF POPULATION ECOLOGY, P79; Saether BE, 2005, NATURE, V436, P99, DOI 10.1038/nature03666; Saether BE, 2008, J ANIM ECOL, V77, P869, DOI 10.1111/j.1365-2656.2008.01424.x; Saitoh T, 1997, J ANIM ECOL, V66, P14, DOI 10.2307/5960; Saitoh T, 1999, ECOLOGY, V80, P638, DOI 10.2307/176641; Saitoh T, 2008, POPUL ECOL, V50, P159, DOI 10.1007/s10144-008-0076-6; Seavy NE, 2009, J WILDLIFE MANAGE, V73, P414, DOI 10.2193/2007-420; Sibly RM, 2007, ECOL LETT, V10, P970, DOI 10.1111/j.1461-0248.2007.01092.x; Sinclair ARE, 1996, OIKOS, V75, P164, DOI 10.2307/3546240; Spencer PD, 2008, FISH OCEANOGR, V17, P396, DOI 10.1111/j.1365-2419.2008.00486.x; Steele MA, 2005, P NATL ACAD SCI USA, V102, P13513, DOI 10.1073/pnas.0504306102; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Stige LC, 2010, P ROY SOC B-BIOL SCI, V277, P3411, DOI 10.1098/rspb.2010.0602; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; TURCHIN P, 1990, NATURE, V344, P660, DOI 10.1038/344660a0; WallisDeVries MF, 2011, OECOLOGIA, V167, P559, DOI 10.1007/s00442-011-2007-z; Wang GM, 2006, ECOLOGY, V87, P95, DOI 10.1890/05-0355; Wang GM, 2002, INT J BIOMETEOROL, V46, P197, DOI 10.1007/s00484-002-0134-2; Wang GM, 2009, POPUL ECOL, V51, P123, DOI 10.1007/s10144-008-0095-3; White PJ, 2007, ECOL APPL, V17, P1598, DOI 10.1890/06-2032.1; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Wilkerson MS, 2010, KOEPPEN GEIGER GE KM; Wilmers CC, 2007, AM NAT, V169, P673, DOI 10.1086/513484; Zeng Z, 1998, ECOLOGY, V79, P2193, DOI 10.1890/0012-9658(1998)079[2193:CPDITR]2.0.CO;2; Ziebarth NL, 2010, ECOL LETT, V13, P21, DOI 10.1111/j.1461-0248.2009.01393.x	90	9	9	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91536	10.1371/journal.pone.0091536	http://dx.doi.org/10.1371/journal.pone.0091536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618822	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400102
J	Hong, LB; Walz, JM; Sajda, P				Hong, Linbi; Walz, Jennifer M.; Sajda, Paul			Your Eyes Give You Away: Prestimulus Changes in Pupil Diameter Correlate with Poststimulus Task-Related EEG Dynamics	PLOS ONE			English	Article							TEMPORAL EVOLUTION; LOCUS-COERULEUS; ALPHA-BAND; ERP; DISCRIMINATION; ORIGINS	Pupillary measures have been linked to arousal and attention as well as activity in the brainstem's locus coeruleus norepinephrine (LC-NE) system. Similarly, there is evidence that evoked EEG responses, such as the P3, might have LC-NE activity as their basis. Since it is not feasible to record electrophysiological data directly from the LC in humans due to its location in the brainstem, an open question has been whether pupillary measures and EEG variability can be linked in a meaningful way to shed light on the nature of the LC-NE role in attention and arousal. We used an auditory oddball task with a data-driven approach to learn task-relevant projections of the EEG, for windows of data spanning the entire trial. We investigated linear and quadratic relationships between the evoked EEG along these projections and both prestimulus (baseline) and poststimulus (evoked dilation) pupil diameter measurements. We found that baseline pupil diameter correlates with early (175-200 ms) and late (350-400 ms) EEG component variability, suggesting a linear relationship between baseline (tonic) LC-NE activity and evoked EEG. We found no relationships between evoked EEG and evoked pupil dilation, which is often associated with evoked (phasic) LC activity. After regressing out reaction time (RT), the correlation between EEG variability and baseline pupil diameter remained, suggesting that such correlation is not explainable by RT variability. We also investigated the relationship between these pupil measures and prestimulus EEG alpha activity, which has been reported as a marker of attentional state, and found a negative linear relationship with evoked pupil dilation. In summary, our results demonstrate significant relationships between prestimulus and poststimulus neural and pupillary measures, and they provide further evidence for tight coupling between attentional state and evoked neural activity and for the role of cortical and subcortical networks underlying the process of target detection.	[Hong, Linbi; Walz, Jennifer M.; Sajda, Paul] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA	Columbia University	Sajda, P (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.	psajda@columbia.edu	Walz, Jennifer/J-7052-2015	Walz, Jennifer/0000-0003-3578-7264; Hong, Linbi/0000-0003-3630-9125	NIH [R01-MH085092]; Army Research Office [W911NF-11-1-0219]; NSF GRFP; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085092] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by NIH (R01-MH085092), Army Research Office (W911NF-11-1-0219), and a NSF GRFP awarded to JMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE ED, 1988, NEUROSCIENCE, V27, P897, DOI 10.1016/0306-4522(88)90192-3; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Babiloni C, 2006, CEREB CORTEX, V16, P1690, DOI 10.1093/cercor/bhj104; Benarroch EE, 2009, NEUROLOGY, V73, P1699, DOI 10.1212/WNL.0b013e3181c2937c; Critchley HD, 2005, NEUROIMAGE, V27, P885, DOI 10.1016/j.neuroimage.2005.05.047; de Gee JW, 2014, P NATL ACAD SCI US; Duoandikoetxea J, 2000, FOURIER ANAL; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gajewski PD, 2008, BRAIN RES, V1189, P127, DOI 10.1016/j.brainres.2007.10.076; Gerson AD, 2005, NEUROIMAGE, V28, P342, DOI 10.1016/j.neuroimage.2005.06.026; Goldman RI, 2009, NEUROIMAGE, V47, P136, DOI 10.1016/j.neuroimage.2009.03.062; Kothe CA, 2011, ANN JOINT S NEUR COM, V1, P16; Lou B, 2012, ORG HUM BRAIN MAPP A, V18, P1080; Marrufo MV, 2001, COGNITIVE BRAIN RES, V12, P315; Murphy PR, 2011, PSYCHOPHYSIOLOGY, V48, P1531, DOI 10.1111/j.1469-8986.2011.01226.x; Nieuwenhuis S, 2010, PSYCHOPHYSIOLOGY; Parra L, 2002, NEUROIMAGE, V17, P223, DOI 10.1006/nimg.2002.1212; Parra LC, 2005, NEUROIMAGE, V28, P326, DOI 10.1016/j.neuroimage.2005.05.032; Rajkowski J., 1993, Society for Neuroscience Abstracts, V19, P974; RAY WJ, 1985, SCIENCE, V228, P750, DOI 10.1126/science.3992243; Robertson SD, 2013, NAT NEUROSCI, V16, P1016, DOI 10.1038/nn.3458; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; STEINHAUER SR, 1992, ANN NY ACAD SCI, V658, P182, DOI 10.1111/j.1749-6632.1992.tb22845.x; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; Walz JM, 2013, J NEUROSCI, V33, P19212, DOI 10.1523/JNEUROSCI.2649-13.2013; Warren CM, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00043	27	58	58	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91321	10.1371/journal.pone.0091321	http://dx.doi.org/10.1371/journal.pone.0091321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618591	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400074
J	Mavrommatis, B; Offord, V; Patterson, R; Watson, M; Kanellos, T; Steinbach, F; Grierson, S; Werling, D				Mavrommatis, Bettina; Offord, Victoria; Patterson, Robert; Watson, Mick; Kanellos, Theo; Steinbach, Falko; Grierson, Sylvia; Werling, Dirk			Global Gene Expression Profiling of Myeloid Immune Cell Subsets in Response to In Vitro Challenge with Porcine Circovirus 2b	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; COMPLETE GENOME SEQUENCE; SWINE ALVEOLAR MACROPHAGES; TUMOR-NECROSIS-FACTOR; DENDRITIC CELLS; TYPE-2 PCV2; GENOTYPE DEFINITION; MICROARRAY ANALYSIS; VIRAL-INFECTION; SYNDROME PMWS	Compelling evidence suggests that the early interaction between porcine circovirus 2 (PCV-2) and the innate immune system is the key event in the pathogenesis of Post-Weaning Multisystemic Wasting Syndrome (PMWS). Furthermore, PCV2 has been detected in bone-marrow samples, potentially enabling an easy spread and reservoir for the virus. To assess the gene-expression differences induced by an in-vitro PCV2b infection in different three different myeloid innate immune cell subsets generated from the same animal, we used the Agilent Porcine Gene Expression Microarray (V2). Alveolar macrophages (AMOs), monocyte-derived dendritic cells (MoDCs) and bone-marrow cells (BMCs) were generated from each animal, and challenged with a UK-isolate of a PCV2 genotype b-strain at a MOI of 0.5. Remarkably, analysis showed a highly distinct and cell-type dependent response to PCV2b challenge. Overall, MoDCs showed the most marked response to PCV2b challenge in vitro and revealed a key role for TNF in the interaction with PCV2b, whereas only few genes were affected in BMCs and AMOs. These observations were further supported by an enrichment of genes in the downstream NF-kappa B Signalling pathway as well as an up regulation of genes with pro-apoptotic functions post-challenge. PCV2b challenge increases the expression of a large number of immune-related and pro-apoptotic genes mainly in MoDC, which possibly explain the increased inflammation, granulomatous inflammation and lymphocyte depletion seen in PMWS-affected pigs.	[Mavrommatis, Bettina; Offord, Victoria; Patterson, Robert; Werling, Dirk] Univ London Royal Vet Coll, Hatfield, Herts, England; [Watson, Mick] Univ Edinburgh, Roslin Inst, ARK Genom, Edinburgh, Midlothian, Scotland; [Watson, Mick] Univ Edinburgh, R D SVS, Edinburgh, Midlothian, Scotland; [Kanellos, Theo] Zoetis Anim Hlth, Paris, France; [Steinbach, Falko; Grierson, Sylvia] Anim Hlth & Vet Labs Agcy, Dept Virol, Addlestone, Surrey, England	University of London; University of London Royal Veterinary College; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Zoetis; Veterinary Laboratories Agency	Werling, D (corresponding author), Univ London Royal Vet Coll, Hatfield, Herts, England.	Dwerling@RVC.AC.UK	Grierson, S/D-9587-2011; Werling, Dirk/F-5555-2013; Steinbach, Falko/V-1682-2019	Werling, Dirk/0000-0001-5411-4044; Steinbach, Falko/0000-0003-1236-2837; Watson, Mick/0000-0003-4211-0358	BBSRC 'Combating Endemic Diseases of Farmed Animals for Sustainability' (CEDFAS) initiative [BB/FO18394/1]; Zoetis Animal Health; BBSRC [BB/E018394/1, BBS/E/D/20231759, BBS/E/D/20211552, BBS/E/D/20310000] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E018394/1, BBS/E/D/20310000, BBS/E/D/20211552, BBS/E/D/20231759] Funding Source: researchfish	BBSRC 'Combating Endemic Diseases of Farmed Animals for Sustainability' (CEDFAS) initiative; Zoetis Animal Health; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a grant (BB/FO18394/1) from the BBSRC 'Combating Endemic Diseases of Farmed Animals for Sustainability' (CEDFAS) initiative, with contributions from BPEX, Biobest Laboratories and Zoetis Animal Health. The funder Zoetis Animal Health provided support in the form of salaries for author TK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GM, 2000, J VET DIAGN INVEST, V12, P3, DOI 10.1177/104063870001200102; Allan GM, 1999, VET MICROBIOL, V66, P115, DOI 10.1016/S0378-1135(99)00004-8; Balmelli C, 2011, IMMUNOLOGY, V132, P57, DOI 10.1111/j.1365-2567.2010.03339.x; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Benedict CA, 2003, CYTOKINE GROWTH F R, V14, P349, DOI 10.1016/S1359-6101(03)00030-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolin SR, 2001, J VET DIAGN INVEST, V13, P185, DOI 10.1177/104063870101300301; Bruckner M, 2012, CELL IMMUNOL, V276, P52, DOI 10.1016/j.cellimm.2012.03.008; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carman S, 2008, CAN J VET RES, V72, P259; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Chae JS, 2011, RES VET SCI, V90, P321, DOI 10.1016/j.rvsc.2010.05.024; Chang HW, 2006, VET IMMUNOL IMMUNOP, V110, P207, DOI 10.1016/j.vetimm.2005.09.016; Chang HW, 2005, VET MICROBIOL, V108, P167, DOI 10.1016/j.vetmic.2005.03.010; Cheng S, 2012, J PROTEOMICS, V75, P3258, DOI 10.1016/j.jprot.2012.03.039; Cheung AK, 2007, ARCH VIROL, V152, P1035, DOI 10.1007/s00705-006-0909-6; Coussens PM, 2002, INFECT IMMUN, V70, P5494, DOI 10.1128/IAI.70.10.5494-5502.2002; de BC, 2004, J GEN VIROL, V85, P293; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Dupont K, 2008, VET MICROBIOL, V128, P56, DOI 10.1016/j.vetmic.2007.09.016; Fernandes LT, 2012, VIRUS RES, V165, P134, DOI 10.1016/j.virusres.2012.02.006; Fernandes LT, 2009, ANIM BIOTECHNOL, V20, P96, DOI 10.1080/10495390902885785; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gillespie J, 2009, J VET INTERN MED, V23, P1151, DOI 10.1111/j.1939-1676.2009.0389.x; Gilpin DF, 2003, VET IMMUNOL IMMUNOP, V94, P149, DOI 10.1016/S0165-2427(03)00087-4; Gordon SB, 2002, BRIT MED BULL, V61, P45, DOI 10.1093/bmb/61.1.45; Grau-Roma L, 2008, VET MICROBIOL, V128, P23, DOI 10.1016/j.vetmic.2007.09.007; Grierson SS, 2004, ARCH VIROL, V149, P1171, DOI 10.1007/s00705-003-0288-1; Hansen MS, 2013, VET PATHOL; Harding JCS, 2004, VET MICROBIOL, V98, P131, DOI 10.1016/j.vetmic.2003.10.013; Hasslung FC, 2003, J GEN VIROL, V84, P2937, DOI 10.1099/vir.0.19362-0; Huang YW, 2009, DEV COMP IMMUNOL, V33, P464, DOI 10.1016/j.dci.2008.09.010; Huang Z, 2012, J VIROL, V86, P10895, DOI 10.1128/JVI.01817-12; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jacobsen B, 2009, VET MICROBIOL, V138, P27, DOI 10.1016/j.vetmic.2009.02.005; Kalim KW, 2013, MOL IMMUNOL, V53, P274, DOI 10.1016/j.molimm.2012.08.014; Kim J, 2006, VET PATHOL, V43, P718, DOI 10.1354/vp.43-5-718; Krakowka S, 2002, VIRAL IMMUNOL, V15, P567, DOI 10.1089/088282402320914511; Larochelle R, 2003, CAN J VET RES, V67, P114; Lee G, 2010, J GEN VIROL, V91, P2585, DOI 10.1099/vir.0.022608-0; Li B, 2012, J VIROL, V86, P4716, DOI 10.1128/JVI.00268-12; Li WT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-353; Lin SQ, 2012, ARCH VIROL, V157, P1821, DOI 10.1007/s00705-012-1328-5; Liu J, 2007, J VIROL, V81, P9560, DOI 10.1128/JVI.00681-07; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; O'Brien V, 1998, J GEN VIROL, V79, P1833, DOI 10.1099/0022-1317-79-8-1833; Obermajer N, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-15; Perez-Martin E, 2007, J VIROL METHODS, V146, P86, DOI 10.1016/j.jviromet.2007.06.005; Rahman Masmudur M, 2006, PLoS Pathog, V2, pe4; Resendes AR, 2004, VET IMMUNOL IMMUNOP, V99, P203, DOI 10.1016/j.vetimm.2004.02.001; Rosell C, 1999, J COMP PATHOL, V120, P59, DOI 10.1053/jcpa.1998.0258; Segales J, 2008, VET REC, V162, P867, DOI 10.1136/vr.162.26.867; Segales J, 2004, VET MICROBIOL, V98, P151, DOI 10.1016/j.vetmic.2003.10.007; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Sinha A, 2012, VET MICROBIOL, V158, P95, DOI 10.1016/j.vetmic.2012.02.013; Sorden SD, 1999, J VET DIAGN INVEST, V11, P528, DOI 10.1177/104063879901100607; Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283; Steiner E, 2008, VIROLOGY, V378, P311, DOI 10.1016/j.virol.2008.06.009; Summerfield A, 1997, J LEUKOCYTE BIOL, V62, P176, DOI 10.1002/jlb.62.2.176; Tomas A, 2008, VET MICROBIOL, V132, P260, DOI 10.1016/j.vetmic.2008.05.023; Tomas A, 2010, VET RES, V41, DOI 10.1051/vetres/2009060; Vincent IE, 2005, IMMUNOLOGY, V115, P388, DOI 10.1111/j.1365-2567.2005.02165.x; Vincent IE, 2003, J VIROL, V77, P13288, DOI 10.1128/JVI.77.24.13288-13300.2003; Vincent IE, 2007, IMMUNOLOGY, V120, P47, DOI 10.1111/j.1365-2567.2006.02476.x; Wen LB, 2012, J VIROL, V86, P5963, DOI 10.1128/JVI.00494-12; Wen LB, 2012, J VIROL, V86, P639, DOI 10.1128/JVI.06469-11; Wieland B, 2012, VET REC, V170, P596, DOI 10.1136/vr.100276; Yang IV, 2002, GENOME BIOL, V3; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Yuan LH, 2005, INFECT IMMUN, V73, P4146, DOI 10.1128/IAI.73.7.4146-4154.2005	74	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91081	10.1371/journal.pone.0091081	http://dx.doi.org/10.1371/journal.pone.0091081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618842	Green Published, gold			2022-12-27	WOS:000332842400047
J	Shero, MR; Pearson, LE; Costa, DP; Burns, JM				Shero, Michelle R.; Pearson, Linnea E.; Costa, Daniel P.; Burns, Jennifer M.			Improving the Precision of Our Ecosystem Calipers: A Modified Morphometric Technique for Estimating Marine Mammal Mass and Body Composition	PLOS ONE			English	Article							SOUTHERN ELEPHANT SEAL; ANTARCTIC FUR SEALS; ATLANTIC HARP SEAL; MIROUNGA-LEONINA; WATER FLUX; NUTRIENT DEPOSITION; FORAGING SUCCESS; DIVING BEHAVIOR; HOODED SEALS; BLUBBER	Mass and body composition are indices of overall animal health and energetic balance and are often used as indicators of resource availability in the environment. This study used morphometric models and isotopic dilution techniques, two commonly used methods in the marine mammal field, to assess body composition of Weddell seals (Leptonychotes weddellii, N = 111). Findings indicated that traditional morphometric models that use a series of circular, truncated cones to calculate marine mammal blubber volume and mass overestimated the animal's measured body mass by 26.9+/-1.5% SE. However, we developed a new morphometric model that uses elliptical truncated cones, and estimates mass with only 22.8+/-1.7% error (N = 10). Because this elliptical truncated cone model can estimate body mass without the need for additional correction factors, it has the potential to be a broadly applicable method in marine mammal species. While using elliptical truncated cones yielded significantly smaller blubber mass estimates than circular cones (10.2+/-0.8% difference; or 3.5+/-0.3% total body mass), both truncated cone models significantly underestimated total body lipid content as compared to isotopic dilution results, suggesting that animals have substantial internal lipid stores (N = 76). Multiple linear regressions were used to determine the minimum number of morphometric measurements needed to reliably estimate animal mass and body composition so that future animal handling times could be reduced. Reduced models estimated body mass and lipid mass with reasonable accuracy using fewer than five morphometric measurements (root-mean-square-error: 4.91% for body mass, 10.90% for lipid mass, and 10.43% for % lipid). This indicates that when test datasets are available to create calibration coefficients, regression models also offer a way to improve body mass and condition estimates in situations where animal handling times must be short and efficient.	[Shero, Michelle R.; Pearson, Linnea E.; Burns, Jennifer M.] Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK 99508 USA; [Shero, Michelle R.; Pearson, Linnea E.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Costa, Daniel P.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of Alaska System; University of Alaska Anchorage; University of Alaska System; University of Alaska Fairbanks; University of California System; University of California Santa Cruz	Shero, MR (corresponding author), Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK 99508 USA.	mrshero@alaska.edu	Burns, Jennifer/AAC-8243-2019; Costa, Daniel/E-2616-2013	Burns, Jennifer/0000-0001-9652-2943; Costa, Daniel/0000-0002-0233-5782; Shero, Michelle/0000-0003-4633-5351	NSF [ANT-0838892, ANT-0838937]; National Science Foundation Graduate Research Fellowship [DGE-1242789]; Cooperative Institute for Alaska Research; Alaska Climate Science Center; UAF Center for Global Change Student Research Grant	NSF(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Cooperative Institute for Alaska Research; Alaska Climate Science Center; UAF Center for Global Change Student Research Grant	This research was conducted with support from NSF ANT-0838892 to D. P. C. and ANT-0838937 to J.M.B. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1242789. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. M. R. S. and this research were supported in part by a UAF Center for Global Change Student Research Grant with funds from the Cooperative Institute for Alaska Research and the Alaska Climate Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAR A, 1990, J MAMMAL, V71, P544, DOI 10.2307/1381793; Aoki K, 2011, J EXP BIOL, V214, P2973, DOI 10.1242/jeb.055137; Arnould JPY, 1996, PHYSIOL ZOOL, V69, P93, DOI 10.1086/physzool.69.1.30164202; Beck CA, 2000, J EXP BIOL, V203, P2323; BECK GG, 1993, CAN J FISH AQUAT SCI, V50, P1372, DOI 10.1139/f93-157; Beck GG, 1995, CAN J ZOOL, V73, P1991, DOI 10.1139/z95-234; Bell CM, 1997, MAR MAMMAL SCI, V13, P669, DOI 10.1111/j.1748-7692.1997.tb00090.x; Bowen WD, 1998, PHYSIOL ZOOL, V71, P329, DOI 10.1086/515921; Boyd IL, 2001, J ANIM ECOL, V70, P747, DOI 10.1046/j.0021-8790.2001.00534.x; Bryden MM, 1967, THESIS U SYDNEY; Budge SM, 2006, MAR MAMMAL SCI, V22, P759, DOI 10.1111/j.1748-7692.2006.00079.x; Burek KA, 2008, ECOL APPL, V18, pS126, DOI 10.1890/06-0553.1; Burns JM, 2007, J COMP PHYSIOL B, V177, P687, DOI 10.1007/s00360-007-0167-2; CASTELLINI MA, 1990, MAR MAMMAL SCI, V6, P75, DOI 10.1111/j.1748-7692.1990.tb00227.x; Costa D. P., 1987, APPROACHES MARINE MA, P43; COSTA DP, 1986, J ZOOL, V209, P21, DOI 10.1111/j.1469-7998.1986.tb03563.x; COSTA DP, 1989, ECOLOGY, V70, P596, DOI 10.2307/1940211; Crocker DE, 2012, PHYSIOL BIOCHEM ZOOL, V85, P11, DOI 10.1086/663634; Crocker DE, 2001, ECOLOGY, V82, P3541, DOI 10.2307/2680171; de Bruyn PJN, 2009, AQUAT BIOL, V5, P31, DOI 10.3354/ab00135; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; Dunkin RC, 2005, J EXP BIOL, V208, P1469, DOI 10.1242/jeb.01559; FOLCH J, 1957, J BIOL CHEM, V226, P497; GALES NJ, 1987, AUST J ZOOL, V35, P207, DOI 10.1071/ZO9870207; GALES R, 1994, POLAR BIOL, V14, P381; GALES R, 1994, CAN J ZOOL, V72, P545, DOI 10.1139/z94-073; Hofman RJ., 1975, DISSERTATION; Koopman HN, 2007, MAR BIOL, V151, P277, DOI 10.1007/s00227-006-0489-8; Koopman HN, 2002, PHYSIOL BIOCHEM ZOOL, V75, P498, DOI 10.1086/342799; Liwanag HEM, 2012, BIOL J LINN SOC, V107, P774, DOI 10.1111/j.1095-8312.2012.01992.x; LOCKYER CH, 1984, CAN J ZOOL, V62, P2553, DOI 10.1139/z84-373; LYDERSEN C, 1992, J ZOOL, V228, P361, DOI 10.1111/j.1469-7998.1992.tb04441.x; McDonald BI, 2008, DEEP-SEA RES PT II, V55, P515, DOI 10.1016/j.dsr2.2007.11.002; Meyers L. S., 2006, APPL MULTIVARIATE RE; Miller PJO, 2012, J EXP BIOL, V215, P3622, DOI 10.1242/jeb.070128; Moore FD, 1963, BODY CELL MASS ITS S; NAGY KA, 1980, AM J PHYSIOL, V238, pR454, DOI 10.1152/ajpregu.1980.238.5.R454; NORDOY ES, 1985, AM J PHYSIOL, V249, pR471, DOI 10.1152/ajpregu.1985.249.4.R471; Noren SR, 2009, J MAMMAL, V90, P629, DOI 10.1644/08-MAMM-A-138R.1; Noren SR, 2008, PHYS BIOCH ZOOL, V81, P868; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Oftedal OT, 1996, PHYSIOL ZOOL, V69, P635, DOI 10.1086/physzool.69.3.30164220; OFTEDAL OT, 1993, PHYSIOL ZOOL, V66, P412, DOI 10.1086/physzool.66.3.30163701; ORTIZ CL, 1978, PHYSIOL ZOOL, V51, P166, DOI 10.1086/physzool.51.2.30157864; POND CM, 1978, ANNU REV ECOL SYST, V9, P519, DOI 10.1146/annurev.es.09.110178.002511; Reid K, 2001, P ROY SOC B-BIOL SCI, V268, P377, DOI 10.1098/rspb.2000.1371; REILLY JJ, 1990, J APPL PHYSIOL, V69, P885, DOI 10.1152/jappl.1990.69.3.885; Rice D. W. W., 1971, AM SOC MAMMAL, DOI DOI 10.5962/BHL.TITLE.39537; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; SCHEFFER VB, 1967, J MAMMAL, V48, P459; Schick RS, 2013, J ANIM ECOL; SHENG HP, 1979, AM J CLIN NUTR, V32, P630, DOI 10.1093/ajcn/32.3.630; SLIP DJ, 1992, AUST J ZOOL, V40, P143, DOI 10.1071/ZO9920143; Speakman J.R., 2001, BODY COMPOSITION ANA; STIRLING I, 1969, ECOLOGY, V50, P573, DOI 10.2307/1936247; Struntz DJ, 2004, J MORPHOL, V259, P7, DOI 10.1002/jmor.10154; Tierney M, 2001, WILDLIFE RES, V28, P581, DOI 10.1071/WR00066; Waite JN, 2007, CAN J FISH AQUAT SCI, V64, P296, DOI 10.1139/F07-014; Webb PM, 1998, J EXP BIOL, V201, P2349; WORTHY GAJ, 1983, J MAMMAL, V64, P89, DOI 10.2307/1380753; WORTHY GAJ, 1992, J ZOOL, V227, P257, DOI 10.1111/j.1469-7998.1992.tb04821.x	61	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91233	10.1371/journal.pone.0091233	http://dx.doi.org/10.1371/journal.pone.0091233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614685	Green Published, Green Submitted, gold			2022-12-27	WOS:000332839300100
J	Dasgupta, B; Kasahara, K; Kamiya, N; Nakamura, H; Kinjo, AR				Dasgupta, Bhaskar; Kasahara, Kota; Kamiya, Narutoshi; Nakamura, Haruki; Kinjo, Akira R.			Specific Non-Local Interactions Are Not Necessary for Recovering Native Protein Dynamics	PLOS ONE			English	Article							NORMAL-MODE ANALYSIS; DISULFIDE-BOND ISOMERASE; CARBONIC-ANHYDRASE-II; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; 1-DEOXY-D-XYLULOSE-5-PHOSPHATE REDUCTOISOMERASE; CONFORMATIONAL-CHANGE; ADENYLATE KINASE; GLOBULAR PROTEIN	The elastic network model (ENM) is a widely used method to study native protein dynamics by normal mode analysis (NMA). In ENM we need information about all pairwise distances, and the distance between contacting atoms is restrained to the native value. Therefore ENM requires O(N-2) information to realize its dynamics for a protein consisting of N amino acid residues. To see if (or to what extent) such a large amount of specific structural information is required to realize native protein dynamics, here we introduce a novel model based on only O(N) restraints. This model, named the ` contact number diffusion' model (CND), includes specific distance restraints for only local (along the amino acid sequence) atom pairs, and semi-specific non-local restraints imposed on each atom, rather than atom pairs. The semi-specific non-local restraints are defined in terms of the non-local contact numbers of atoms. The CND model exhibits the dynamic characteristics comparable to ENM and more correlated with the explicit-solvent molecular dynamics simulation than ENM. Moreover, unrealistic surface fluctuations often observed in ENM were suppressed in CND. On the other hand, in some ligand-bound structures CND showed larger fluctuations of buried protein atoms interacting with the ligand compared to ENM. In addition, fluctuations from CND and ENM show comparable correlations with the experimental B-factor. Although there are some indications of the importance of some specific non-local interactions, the semi-specific non-local interactions are mostly sufficient for reproducing the native protein dynamics.	[Dasgupta, Bhaskar; Kasahara, Kota; Kamiya, Narutoshi; Nakamura, Haruki; Kinjo, Akira R.] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan	Osaka University	Kinjo, AR (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan.	akinjo@protein.osaka-u.ac.jp	Kamiya, Narutoshi/C-4548-2016; Dasgupta, Bhaskar/AAY-4599-2020	Kamiya, Narutoshi/0000-0002-0527-6968; Dasgupta, Bhaskar/0000-0003-0630-4593; Kinjo, Akira/0000-0002-4006-8208; Kasahara, Kota/0000-0003-0207-6271	JSPS [23370071, 25440070]; Grants-in-Aid for Scientific Research [25440070] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research (B) (23370071) and Grant-in-Aid for Scientific Research (C) (25440070) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2010, PROTEINS, V78, P3341, DOI 10.1002/prot.22841; Anderson E., 1999, LAPACK USERS GUIDE; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Atilgan C, 2010, PROTEINS, V78, P3363, DOI 10.1002/prot.22843; Bahar I, 1998, J MOL BIOL, V281, P871, DOI 10.1006/jmbi.1998.1978; Banaszak K, 2004, ACTA CRYSTALLOGR D, V60, P1747, DOI 10.1107/S0907444904018359; Beattie JF, 2003, BIOORG MED CHEM LETT, V13, P2955, DOI 10.1016/S0960-894X(03)00202-6; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; Brylinski M, 2008, PROTEINS, V70, P363, DOI 10.1002/prot.21510; Chaudhuri BN, 1999, J MOL BIOL, V286, P1519, DOI 10.1006/jmbi.1999.2571; Chikenji G, 2006, P NATL ACAD SCI USA, V103, P3141, DOI 10.1073/pnas.0508195103; Choe JY, 1999, BIOCHEMISTRY-US, V38, P6953, DOI 10.1021/bi990159s; Dasgupta B, 2014, PROTEINS, V82, P77, DOI 10.1002/prot.24371; Dasgupta B, 2013, PROTEIN SCI, V22, P168, DOI 10.1002/pro.2195; DIAMOND R, 1988, ACTA CRYSTALLOGR A, V44, P211, DOI 10.1107/S0108767387010535; ERIKSSON AE, 1988, PROTEINS, V4, P274, DOI 10.1002/prot.340040406; GO N, 1983, P NATL ACAD SCI-BIOL, V80, P3696, DOI 10.1073/pnas.80.12.3696; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Halle B, 2002, P NATL ACAD SCI USA, V99, P1274, DOI 10.1073/pnas.032522499; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hinsen K, 1999, J CHEM PHYS, V111, P10766, DOI 10.1063/1.480441; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang JW, 2004, BIOCHEMISTRY-US, V43, P6415, DOI 10.1021/bi030213b; Hubbard S. J., 1993, NACCESS; Ikeguchi M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.078102; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabakcioglu A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041904; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kinjo AR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-401; Kinjo AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001963; Kinjo AR, 2005, BIOINFORMATICS, V21, P2167, DOI 10.1093/bioinformatics/bti330; Kinjo AR, 2005, PROTEINS, V58, P158, DOI 10.1002/prot.20300; Kinoshita K, 2004, BIOINFORMATICS, V20, P1329, DOI 10.1093/bioinformatics/bth073; KITAO A, 1991, CHEM PHYS, V158, P447, DOI 10.1016/0301-0104(91)87082-7; Kondrashov DA, 2006, BIOPHYS J, V91, P2760, DOI 10.1529/biophysj.106.085894; Li DW, 2009, BIOPHYS J, V96, P3074, DOI 10.1016/j.bpj.2009.01.011; Lima CD, 1996, P NATL ACAD SCI USA, V93, P5357, DOI 10.1073/pnas.93.11.5357; Lima CD, 1997, SCIENCE, V278, P286, DOI 10.1126/science.278.5336.286; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; Mac Sweeney A, 2005, J MOL BIOL, V345, P115, DOI 10.1016/j.jmb.2004.10.030; Magnusson U, 2004, J BIOL CHEM, V279, P8747, DOI 10.1074/jbc.M311890200; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Ming DM, 2006, BIOPHYS J, V90, P3382, DOI 10.1529/biophysj.105.071902; Momma K, 2005, BIOCHEMISTRY-US, V44, P5053, DOI 10.1021/bi047781r; Morera S, 2001, J MOL BIOL, V311, P569, DOI 10.1006/jmbi.2001.4905; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Najmanovich R, 2000, PROTEINS, V39, P261, DOI 10.1002/(SICI)1097-0134(20000515)39:3<261::AID-PROT90>3.0.CO;2-4; NISHIKAWA K, 1986, J BIOCHEM-TOKYO, V100, P1043, DOI 10.1093/oxfordjournals.jbchem.a121783; NISHIKAWA K, 1980, INT J PEPT PROT RES, V16, P19; Park H, 2004, MOL MICROBIOL, V51, P963, DOI 10.1046/j.1365-2958.2003.03885.x; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; R Core Team, 2016, R FDN STAT COMP; Reuter K, 2002, J BIOL CHEM, V277, P5378, DOI 10.1074/jbc.M109500200; Schiefner A, 2004, J BIOL CHEM, V279, P48270, DOI 10.1074/jbc.M403540200; Seeliger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000634; Selvaraj S, 2003, BIOPHYS J, V84, P1919, DOI 10.1016/S0006-3495(03)75000-0; Skjaerven L, 2011, PROTEINS, V79, P232, DOI 10.1002/prot.22875; SMITH GM, 1994, PROTEIN SCI, V3, P118, DOI 10.1002/pro.5560030115; Standley DM, 2008, BRIEF BIOINFORM, V9, P276, DOI 10.1093/bib/bbn015; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wako H, 2011, BIOPHYS CHEM, V159, P257, DOI 10.1016/j.bpc.2011.07.004; Wang J, 2005, P NATL ACAD SCI USA, V102, P8881, DOI 10.1073/pnas.0503742102	66	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91347	10.1371/journal.pone.0091347	http://dx.doi.org/10.1371/journal.pone.0091347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625758	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300075
J	Reckhenrich, AK; Kirsch, BM; Wahl, EA; Schenck, TL; Rezaeian, F; Harder, Y; Foehr, P; Machens, HG; Egana, JT				Reckhenrich, Ann Katharin; Kirsch, Bianca Manuela; Wahl, Elizabeth Ann; Schenck, Thilo Ludwig; Rezaeian, Farid; Harder, Yves; Foehr, Peter; Machens, Hans-Guenther; Tomas Egana, Jose			Surgical Sutures Filled with Adipose-Derived Stem Cells Promote Wound Healing	PLOS ONE			English	Article							GROWTH-FACTORS; TENDON REPAIR; DIFFERENTIATION; MARROW; PROLIFERATION; INFLAMMATION; MECHANISMS; DELIVERY; MURINE; MODEL	Delayed wound healing and scar formation are among the most frequent complications after surgical interventions. Although biodegradable surgical sutures present an excellent drug delivery opportunity, their primary function is tissue fixation. Mesenchymal stem cells (MSC) act as trophic mediators and are successful in activating biomaterials. Here biodegradable sutures were filled with adipose-derived mesenchymal stem cells (ASC) to provide a pro-regenerative environment at the injured site. Results showed that after filling, ASCs attach to the suture material, distribute equally throughout the filaments, and remain viable in the suture. Among a broad panel of cytokines, cell-filled sutures constantly release vascular endothelial growth factor to supernatants. Such conditioned media was evaluated in an in vitro wound healing assay and showed a significant decrease in the open wound area compared to controls. After suturing in an ex vivo wound model, cells remained in the suture and maintained their metabolic activity. Furthermore, cell-filled sutures can be cryopreserved without losing their viability. This study presents an innovative approach to equip surgical sutures with pro-regenerative features and allows the treatment and fixation of wounds in one step, therefore representing a promising tool to promote wound healing after injury.	[Reckhenrich, Ann Katharin; Kirsch, Bianca Manuela; Wahl, Elizabeth Ann; Schenck, Thilo Ludwig; Rezaeian, Farid; Harder, Yves; Machens, Hans-Guenther; Tomas Egana, Jose] Tech Univ Munich, Klinikum Rechts Isar, Dept Plast Surg & Hand Surg, D-80290 Munich, Germany; [Tomas Egana, Jose] Univ Chile, Fac Ciencias, FONDAP Ctr Genome Regulat, Santiago, Chile; [Foehr, Peter] Tech Univ Munich, Klinikum Rechts Isar, Chair Orthopaed & Sport Orthopaed, D-80290 Munich, Germany	Technical University of Munich; Universidad de Chile; Technical University of Munich	Egana, JT (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Plast Surg & Hand Surg, D-80290 Munich, Germany.	tomasega@gmail.com		Wahl, Elizabeth/0000-0002-1367-7921; Foehr, Peter/0000-0003-1042-546X; Harder, Yves/0000-0002-2557-249X; Egana, Jose Tomas/0000-0003-2624-6992	CIRM-BMBF Early Translational II Award; Hans und Klementia Langmatz Stiftung	CIRM-BMBF Early Translational II Award; Hans und Klementia Langmatz Stiftung	This work was supported by the CIRM-BMBF Early Translational II Award and the Hans und Klementia Langmatz Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; Braun S, 2004, PHILOS T R SOC B, V359, P753, DOI 10.1098/rstb.2004.1464; Brower J, 2011, ADV SKIN WOUND CARE, V24, P524, DOI 10.1097/01.ASW.0000407648.89961.a6; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Choi KH, 2010, BIOMATERIALS, V31, P5355, DOI 10.1016/j.biomaterials.2010.03.053; Dines JS, 2007, J SHOULDER ELB SURG, V16, p215S, DOI 10.1016/j.jse.2007.03.001; ETHICON, 2008, GES NAHTM IMPL; Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278; Fuchs TF, 2012, SCI WORLD J, DOI 10.1100/2012/109216; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Georgiev-Hristov T, 2012, EUR J CARDIO-THORAC, V42, pE40, DOI 10.1093/ejcts/ezs357; Gir P, 2012, PLAST RECONSTR SURG, V129, P1277, DOI 10.1097/PRS.0b013e31824ecae6; Guyette JP, 2012, J BIOMED MAT RES A; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Jones E, 2011, INJURY, V42, P562, DOI 10.1016/j.injury.2011.03.030; Justinger C, 2012, SURGERY, V151, P398, DOI 10.1016/j.surg.2011.08.004; Li HH, 2012, CELL TISSUE RES, V348, P371, DOI 10.1007/s00441-012-1393-9; Li Y, 2012, LANGMUIR, V28, P12134, DOI 10.1021/la302732w; Low QEH, 2001, AM J PATHOL, V159, P457, DOI 10.1016/S0002-9440(10)61717-8; Mantovani C, 2012, EXP CELL RES, V318, P2034, DOI 10.1016/j.yexcr.2012.05.008; Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018; Newman Robert E., 2009, Inflammation & Allergy Drug Targets, V8, P110; Nozaki K, 2012, CLIN BIOMECH, V27, P506, DOI 10.1016/j.clinbiomech.2011.11.005; Riekstina U, 2008, CYTOTECHNOLOGY, V58, P153, DOI 10.1007/s10616-009-9183-2; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Siggers K, 2010, J BIOMED MATER RES A, V94A, P877, DOI 10.1002/jbm.a.32766; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Sorrell JM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt30; Tobita M, 2011, DISCOV MED, V11, P160; Tziotzios C, 2012, J AM ACAD DERMATOL, V66, P13, DOI 10.1016/j.jaad.2011.08.035; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835	34	28	28	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e91169	10.1371/journal.pone.0091169	http://dx.doi.org/10.1371/journal.pone.0091169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24625821	Green Published, Green Submitted, gold			2022-12-27	WOS:000332851300060
J	Wong, HR; Weiss, SL; Giuliano, JS; Wainwright, MS; Cvijanovich, NZ; Thomas, NJ; Allen, GL; Anas, N; Bigham, MT; Hall, M; Freishtat, RJ; Sen, A; Meyer, K; Checchia, PA; Shanley, TP; Nowak, J; Quasney, M; Chopra, A; Fitzgerald, JC; Gedeit, R; Banschbach, S; Beckman, E; Harmon, K; Lahni, P; Lindsell, CJ				Wong, Hector R.; Weiss, Scott L.; Giuliano, John S., Jr.; Wainwright, Mark S.; Cvijanovich, Natalie Z.; Thomas, Neal J.; Allen, Geoffrey L.; Anas, Nick; Bigham, Michael T.; Hall, Mark; Freishtat, Robert J.; Sen, Anita; Meyer, Keith; Checchia, Paul A.; Shanley, Thomas P.; Nowak, Jeffrey; Quasney, Michael; Chopra, Arun; Fitzgerald, Julie C.; Gedeit, Rainer; Banschbach, Sharon; Beckman, Eileen; Harmon, Kelli; Lahni, Patrick; Lindsell, Christopher J.			The Temporal Version of the Pediatric Sepsis Biomarker Risk Model	PLOS ONE			English	Article							SEPTIC SHOCK; EXPRESSION PROFILES; IDENTIFICATION; MORTALITY	Background: PERSEVERE is a risk model for estimating mortality probability in pediatric septic shock, using five biomarkers measured within 24 hours of clinical presentation. Objective: Here, we derive and test a temporal version of PERSEVERE (tPERSEVERE) that considers biomarker values at the first and third day following presentation to estimate the probability of a "complicated course'', defined as persistence of >= 2 organ failures at seven days after meeting criteria for septic shock, or death within 28 days. Methods: Biomarkers were measured in the derivation cohort (n = 225) using serum samples obtained during days 1 and 3 of septic shock. Classification and Regression Tree (CART) analysis was used to derive a model to estimate the risk of a complicated course. The derived model was validated in the test cohort (n = 74), and subsequently updated using the combined derivation and test cohorts. Results: A complicated course occurred in 23% of the derivation cohort subjects. The derived model had a sensitivity for a complicated course of 90% (95% CI 78-96), specificity was 70% (62-77), positive predictive value was 47% (37-58), and negative predictive value was 96% (91-99). The area under the receiver operating characteristic curve was 0.85 (0.79-0.90). Similar test characteristics were observed in the test cohort. The updated model had a sensitivity of 91% (81-96), a specificity of 70% (64-76), a positive predictive value of 47% (39-56), and a negative predictive value of 96% (92-99). Conclusions: tPERSEVERE reasonably estimates the probability of a complicated course in children with septic shock. tPERSEVERE could potentially serve as an adjunct to physiological assessments for monitoring how risk for poor outcomes changes during early interventions in pediatric septic shock.	[Wong, Hector R.; Banschbach, Sharon; Beckman, Eileen; Harmon, Kelli; Lahni, Patrick] Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA; [Wong, Hector R.; Banschbach, Sharon; Beckman, Eileen; Harmon, Kelli; Lahni, Patrick] Cincinnati Childrens Res Fdn, Cincinnati, OH USA; [Wong, Hector R.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Weiss, Scott L.; Fitzgerald, Julie C.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Giuliano, John S., Jr.] Yale Univ, Sch Med, Dept Pediat, Div Crit Care Med, New Haven, CT 06510 USA; [Wainwright, Mark S.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL USA; [Cvijanovich, Natalie Z.] Childrens Hosp & Res Ctr Oakland, Oakland, CA USA; [Thomas, Neal J.] Penn State Hershey Childrens Hosp, Hershey, PA USA; [Allen, Geoffrey L.] Childrens Mercy Hosp, Kansas City, MO 64108 USA; [Anas, Nick] Childrens Hosp Orange Cty, Orange, CA 92668 USA; [Bigham, Michael T.] Akron Childrens Hosp, Akron, OH USA; [Hall, Mark] Nationwide Childrens Hosp, Columbus, OH USA; [Freishtat, Robert J.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Sen, Anita] Columbia Univ, Med Ctr, Morgan Stanley Childrens Hosp, New York, NY USA; [Meyer, Keith] Miami Childrens Hosp, Miami, FL USA; [Checchia, Paul A.] Texas Childrens Hosp, Houston, TX 77030 USA; [Shanley, Thomas P.; Quasney, Michael] Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA; [Nowak, Jeffrey] Childrens Hosp & Clin Minnesota, Minneapolis, MN USA; [Chopra, Arun] St Christophers Hosp Children, Philadelphia, PA 19133 USA; [Gedeit, Rainer] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA; [Lindsell, Christopher J.] Univ Cincinnati, Coll Med, Dept Emergency Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Yale University; Ann & Robert H. Lurie Children's Hospital of Chicago; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Children's Mercy Hospital; Childrens Hospital of Orange County; Akron Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Children's National Health System; Columbia University; NewYork-Presbyterian Hospital; Morgan Stanley Children's Hospital; Baylor College of Medicine; University of Michigan System; University of Michigan; Children's Hospitals & Clinics of Minnesota; Children's Hospital of Wisconsin; University System of Ohio; University of Cincinnati	Wong, HR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA.	hector.wong@cchmc.org	Chopra, Arun/AAA-6983-2019; Hall, Mark/E-3193-2011	Giuliano, John/0000-0003-2753-8460; Freishtat, Robert/0000-0002-7411-2342; Meyer, Keith/0000-0001-7354-5552; Chopra, Arun/0000-0002-1418-6470; Shanley, Thomas/0000-0001-8936-377X; Gedeit, Rainer/0000-0003-2420-9493; Thomas, Neal/0000-0002-7991-7510; Weiss, Scott/0000-0002-7040-3281; Wong, Hector/0000-0001-7989-1173; Fitzgerald, Julie/0000-0001-9936-9569	National Institutes of Health [RC1HL100474, RO1GM064619, RO1GM099773]; Center for Technology Commercialization at the Cincinnati Children's Hospital Research Foundation; Institutional Clinical and Translational Science Award, NIH/NCRR [8UL1 TR000077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD047349] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099773, R01GM064619, T32GM008478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Technology Commercialization at the Cincinnati Children's Hospital Research Foundation; Institutional Clinical and Translational Science Award, NIH/NCRR; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grants RC1HL100474, RO1GM064619, RO1GM099773, and an Innovation Award from the Center for Technology Commercialization at the Cincinnati Children's Hospital Research Foundation. Supported in part by an Institutional Clinical and Translational Science Award, NIH/NCRR 8UL1 TR000077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulebda K, 2014, CRIT CARE MED, V42, P397, DOI 10.1097/CCM.0b013e3182a64607; Basu RK, 2011, CRIT CARE, V15, DOI 10.1186/cc10554; Che DS, 2011, ADV EXP MED BIOL, V696, P191, DOI 10.1007/978-1-4419-7046-6_19; Cvijanovich N, 2008, PHYSIOL GENOMICS, V34, P127, DOI 10.1152/physiolgenomics.00025.2008; Giuliano Jr JS, 2013, PEDIAT CRIT CARE MED; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Hanna W, 2013, CRIT CARE CLIN, V29, P203, DOI 10.1016/j.ccc.2012.11.003; Kaplan JM, 2011, PEDIATR CRIT CARE ME, V12, P165, DOI 10.1097/PCC.0b013e3181e28876; Mickiewicz B, 2013, AM J RESP CRIT CARE, V187, P967, DOI 10.1164/rccm.201209-1726OC; Muller R, 2008, CLIN CHIM ACTA, V394, P1, DOI 10.1016/j.cca.2008.04.007; Pollack MM, 1997, J PEDIATR-US, V131, P575, DOI 10.1016/S0022-3476(97)70065-9; Shanley TP, 2007, MOL MED, V13, P495, DOI 10.2119/2007-00065.Shanley; Typpo KV, 2009, PEDIATR CRIT CARE ME, V10, P562, DOI 10.1097/PCC.0b013e3181a64be1; Weiss SL, 2012, PEDIATR CRIT CARE ME, V13, pE210, DOI 10.1097/PCC.0b013e318238b5cd; Wong HR, 2008, AM J RESP CRIT CARE, V178, P276, DOI 10.1164/rccm.200801-131OC; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Wong HR, 2013, PEDIATR RES, V73, P564, DOI 10.1038/pr.2013.11; Wong HR, 2012, CRIT CARE, V16, DOI 10.1186/cc11652; Wong HR, 2011, CRIT CARE MED, V39, P2511, DOI 10.1097/CCM.0b013e3182257675; Wong HR, 2010, PEDIATR CRIT CARE ME, V11, P349, DOI 10.1097/PCC.0b013e3181c519b4; Wong HR, 2009, CRIT CARE MED, V37, P1558, DOI 10.1097/CCM.0b013e31819fcc08; Wong HR, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-34; Wong HR, 2014, PLOS ONE IN PRESS, DOI [10.1371/journal.pone.0086242, DOI 10.1371/J0URNAL.P0NE.0086242)]; Wong HR, 2013, CRIT CARE MED; Wynn J, 2010, PEDIATRICS, V125, P1031, DOI 10.1542/peds.2009-3301; Wynn JL, 2011, MOL MED, V17, P1146, DOI 10.2119/molmed.2011.00169; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	27	36	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2014	9	3							e92121	10.1371/journal.pone.0092121	http://dx.doi.org/10.1371/journal.pone.0092121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9JS	24626215	Green Published, gold, Green Submitted			2022-12-27	WOS:000332851300146
J	Bose, U; Hewavitharana, AK; Vidgen, ME; Ng, YK; Shaw, PN; Fuerst, JA; Hodson, MP				Bose, Utpal; Hewavitharana, Amitha K.; Vidgen, Miranda E.; Ng, Yi Kai; Shaw, P. Nicholas; Fuerst, John A.; Hodson, Mark P.			Discovering the Recondite Secondary Metabolome Spectrum of Salinispora Species: A Study of Inter-Species Diversity	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; MASS-SPECTROMETRY; MARINE BACTERIUM; DRUG DISCOVERY; SP NOV.; ACTINOMYCETE; GENOME; RIFAMYCINS; ARENICOLA; EVOLUTION	Patterns of inter-species secondary metabolite production by bacteria can provide valuable information relating to species ecology and evolution. The complex nature of this chemical diversity has previously been probed via directed analyses of a small number of compounds, identified through targeted assays rather than more comprehensive biochemical profiling approaches such as metabolomics. Insights into ecological and evolutionary relationships within bacterial genera can be derived through comparative analysis of broader secondary metabolite patterns, and this can also eventually assist biodiscovery search strategies for new natural products. Here, we investigated the species-level chemical diversity of the two marine actinobacterial species Salinispora arenicola and Salinispora pacifica, isolated from sponges distributed across the Great Barrier Reef (GBR), via their secondary metabolite profiles using LC-MS-based metabolomics. The chemical profiles of these two species were obtained by UHPLC-QToF-MS based metabolic profiling. The resultant data were interrogated using multivariate data analysis methods to compare their (bio)chemical profiles. We found a high level of inter-species diversity in strains from these two bacterial species. We also found rifamycins and saliniketals were produced exclusively by S. arenicola species, as the main secondary metabolites differentiating the two species. Furthermore, the discovery of 57 candidate compounds greatly increases the small number of secondary metabolites previously known to be produced by these species. In addition, we report the production of rifamycin O and W, a key group of ansamycin compounds, in S. arenicola for the first time. Species of the marine actinobacteria harbour a much wider spectrum of secondary metabolites than suspected, and this knowledge may prove a rich field for biodiscovery as well as a database for understanding relationships between speciation, evolution and chemical ecology.	[Bose, Utpal; Hewavitharana, Amitha K.; Shaw, P. Nicholas] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Vidgen, Miranda E.; Ng, Yi Kai; Fuerst, John A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Hodson, Mark P.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Metabol Australia, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Hodson, MP (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Metabol Australia, Brisbane, Qld, Australia.	m.hodson1@uq.edu.au	Bose, Utpal/A-1785-2019; Hewavitharana, Amitha K/A-5533-2008; Bose, Utpal/AAU-5241-2020; Hodson, Mark P/J-7609-2013; Fuerst, John/I-8649-2012; Shaw, Paul N/G-4418-2010; Shaw, Paul/Q-8454-2019	Bose, Utpal/0000-0003-1156-6504; Hewavitharana, Amitha K/0000-0003-2935-9941; Bose, Utpal/0000-0003-1156-6504; Hodson, Mark P/0000-0002-5436-1886; Fuerst, John/0000-0002-6451-8533; Shaw, Paul N/0000-0001-7154-592X; Shaw, Paul/0000-0001-7154-592X; Vidgen, Miranda/0000-0003-4131-0390	CRC Reef Research Centre; Fisheries Research and Development Corporation; National Oceans Office; University of Queensland International Scholarship; University of Queensland Research Scholarship; Australian Research Council	CRC Reef Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Fisheries Research and Development Corporation; National Oceans Office; University of Queensland International Scholarship; University of Queensland Research Scholarship(University of Queensland); Australian Research Council(Australian Research Council)	This paper is an output from the Great Barrier Reef Seabed Biodiversity Project, a collaboration between the Australian Institute of Marine Science (AIMS), the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Queensland Department of Primary Industries & Fisheries (QDPIF), and the Queensland Museum (QM); funded by the CRC Reef Research Centre, the Fisheries Research and Development Corporation, and the National Oceans Office; and led by R. Pitcher (Principal Investigator, CSIRO), P. Doherty (AIMS), J. Hooper (QM) and N. Gribble (QDPIF). Utpal Bose was supported by a University of Queensland International Scholarship. Yi Kai Ng was supported by the University of Queensland Research Scholarship. Miranda Vidgen was supported by an Australian Research Council Linkage Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed L, 2013, ANTON LEEUW INT J G, V103, P1069, DOI 10.1007/s10482-013-9886-4; Aristoff PA, 2010, TUBERCULOSIS, V90, P94, DOI 10.1016/j.tube.2010.02.001; BANERJEE UC, 1992, BIOTECHNOL ADV, V10, P577, DOI 10.1016/0734-9750(92)91454-M; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Doolittle WF, 1999, TRENDS BIOCHEM SCI, V24, pM5, DOI 10.1016/S0968-0004(99)01471-1; Dunn WB, 2011, BIOANALYSIS, V3, P2205, DOI [10.4155/BIO.11.223, 10.4155/bio.11.223]; Edlund A, 2011, APPL ENVIRON MICROB, V77, P5916, DOI 10.1128/AEM.00611-11; Ejje N, 2013, METALLOMICS, V5, P1519, DOI 10.1039/c3mt00230f; Eustaquio AS, 2011, CHEMBIOCHEM, V12, P61, DOI 10.1002/cbic.201000564; Feling RH, 2003, ANGEW CHEM INT EDIT, V42, P355, DOI 10.1002/anie.200390115; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; Fenical W, 2009, BIOORGAN MED CHEM, V17, P2175, DOI 10.1016/j.bmc.2008.10.075; Freel KC, 2011, APPL ENVIRON MICROB, V77, P7261, DOI 10.1128/AEM.05943-11; Hewavitharana AK, 2007, J CHROMATOGR B, V852, P362, DOI 10.1016/j.jchromb.2007.01.042; Hodson MP, 2007, ANAL BIOCHEM, V362, P182, DOI 10.1016/j.ab.2006.12.037; Hornung A, 2007, CHEMBIOCHEM, V8, P757, DOI 10.1002/cbic.200600375; Jensen PR, 2007, APPL ENVIRON MICROB, V73, P1146, DOI 10.1128/AEM.01891-06; Jensen PR, 2005, ANTON LEEUW INT J G, V87, P43, DOI 10.1007/s10482-004-6540-1; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kim TK, 2006, ENVIRON MICROBIOL, V8, P1460, DOI 10.1111/j.1462-2920.2006.01040.x; Kim TK, 2006, APPL ENVIRON MICROB, V72, P2118, DOI 10.1128/AEM.72.3.2118-2125.2006; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Krug D, 2008, ANAL CHIM ACTA, V624, P97, DOI 10.1016/j.aca.2008.06.036; Krug D, 2008, APPL ENVIRON MICROB, V74, P3058, DOI 10.1128/AEM.02863-07; Larsen TO, 2005, NAT PROD REP, V22, P672, DOI 10.1039/b404943h; Macel M, 2010, MOL ECOL RESOUR, V10, P583, DOI 10.1111/j.1755-0998.2010.02854.x; Maldonado LA, 2005, INT J SYST EVOL MICR, V55, P1759, DOI 10.1099/ijs.0.63625-0; Mincer TJ, 2002, APPL ENVIRON MICROB, V68, P5005, DOI 10.1128/AEM.68.10.5005-5011.2002; Ng YK, 2013, APPL MICROBIOL BIOT, V97, P3097, DOI 10.1007/s00253-012-4479-0; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Oliver SG, 1998, TRENDS BIOTECHNOL, V16, P373, DOI 10.1016/S0167-7799(98)01214-1; Paul VJ, 2006, NAT PROD REP, V23, P153, DOI 10.1039/b404735b; Penn K, 2009, ISME J, V3, P1193, DOI 10.1038/ismej.2009.58; Phelan VV, 2012, NAT CHEM BIOL, V8, P26, DOI 10.1038/nchembio.739; Ricard G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-22; SCHUPP T, 1981, J ANTIBIOT, V34, P965, DOI 10.7164/antibiotics.34.965; Udwary DW, 2007, P NATL ACAD SCI USA, V104, P10376, DOI 10.1073/pnas.0700962104; Vidgen M, 2011, ANTON LEEUW INT J G, V101, P603; Wilson MC, 2010, J AM CHEM SOC, V132, P12757, DOI 10.1021/ja105891a; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044; Yu TW, 1999, P NATL ACAD SCI USA, V96, P9051, DOI 10.1073/pnas.96.16.9051; Zhao W, 2010, CELL RES, V20, P1096, DOI 10.1038/cr.2010.87; Zhou JZ, 2008, P NATL ACAD SCI USA, V105, P7768, DOI 10.1073/pnas.0709016105	44	23	23	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91488	10.1371/journal.pone.0091488	http://dx.doi.org/10.1371/journal.pone.0091488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621594	gold, Green Published, Green Submitted			2022-12-27	WOS:000332845300095
J	Hasan, S; Singh, K; Danisuddin, M; Verma, PK; Khan, AU				Hasan, Sadaf; Singh, Kunal; Danisuddin, Mohd; Verma, Praveen K.; Khan, Asad U.			Inhibition of Major Virulence Pathways of Streptococcus mutans by Quercitrin and Deoxynojirimycin: A Synergistic Approach of Infection Control	PLOS ONE			English	Article							VITRO ANTIMICROBIAL ACTIVITY; IN-VITRO; BIOFILM FORMATION; BINDING-SITES; ADHERENCE; ANTIBIOTICS; PROTEIN; GENES; DEHYDROGENASE; ADAPTATION	Objectives: To evaluate the synergistic effect of Quercitrin and Deoxynojirimycin (DNJ) together with their individual inhibitory effect against virulence pathways of Streptococcus mutans. Methodology: MICs of both the compounds were determined by the microdilution method, followed by their in vitrosynergy using checkerboard and time kill assay. The nature of interaction was classified as synergistic on the basis of fractional inhibitory concentration index (FICI) value of <= 0.5. Furthermore, the activity of Quercitrin and DNJ was evaluated individually and in combination against various cariogenic properties of S. mutans UA159 such as acidogenesis, aciduracity, glucan production, hydrophobicity, biofilm and adherence. Moreover, expression of virulent genes in S. mutans was analysed by quantitative RT-PCR (qRT-PCR) and inhibition of F1F0-ATPase, lactate dehydrogenase and enolase was also evaluated. Finally, scanning electron microscopy (SEM) was used to investigate structural obliteration of biofilm. Results: The in vitro synergism between Quercitrin and DNJ was observed, with a FICI of 0.313. Their MIC values were found to be 64 mu g/ml and 16 mu g/ml respectively. The synergistic combination consistently showed best activity against all the virulence factors as compared to Quercitrin and DNJ individually. A reduction in glucan synthesis and biofilm formation was observed at different phases of growth. The qRT-PCR revealed significant downregulation of various virulent genes. Electron micrographs depicted the obliteration of biofilm as compared to control and the activity of cariogenic enzymes was also inhibited. Conclusions: The whole study reflects a prospective role of Quercitrin and DNJ in combination as a potent anticariogenic agent against S. mutans.	[Hasan, Sadaf; Danisuddin, Mohd; Khan, Asad U.] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Med Microbiol & Mol Biol Lab, Aligarh, Uttar Pradesh, India; [Singh, Kunal; Verma, Praveen K.] Natl Inst Plant Genome Res, New Delhi, India	Aligarh Muslim University; Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Khan, AU (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Med Microbiol & Mol Biol Lab, Aligarh, Uttar Pradesh, India.	asad.k@rediffmail.com	hasan, sadaf/J-4050-2019; Singh, Kunal/AAS-1975-2021; Khan, Asad U/K-8157-2013	Singh, Kunal/0000-0001-9375-1070; Khan, Asad U/0000-0001-9191-9423	Interdisciplinary Biotechnology Unit, Aligarh Muslim University; Indian Councel of Medical Research [59/6/2009/BMS/TRM]	Interdisciplinary Biotechnology Unit, Aligarh Muslim University; Indian Councel of Medical Research	This study was supported by internal funds of Interdisciplinary Biotechnology Unit, Aligarh Muslim University and Indian Councel of Medical Research grant no. 59/6/2009/BMS/TRM to AUK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban SH, 2012, MOLECULES, V17, P9231, DOI 10.3390/molecules17089231; BELLI WA, 1995, CAN J MICROBIOL, V41, P785, DOI 10.1139/m95-108; BENCINI DA, 1983, ANAL BIOCHEM, V132, P259, DOI 10.1016/0003-2697(83)90005-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Celenza G, 2012, PHYTOMEDICINE, V19, P596, DOI 10.1016/j.phymed.2012.02.010; CHEN AP, 1994, J BACTERIOL, V176, P1542, DOI 10.1128/jb.176.5.1542-1545.1994; Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778; CROW VL, 1977, J BACTERIOL, V131, P82, DOI 10.1128/JB.131.1.82-91.1977; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Gregoire S, 2007, J APPL MICROBIOL, V103, P1960, DOI 10.1111/j.1365-2672.2007.03441.x; HAMADA S, 1978, INFECT IMMUN, V20, P592, DOI 10.1128/IAI.20.3.592-599.1978; HAMILTON IR, 1991, ORAL MICROBIOL IMMUN, V6, P65, DOI 10.1111/j.1399-302X.1991.tb00453.x; Hasan S, 2013, FUTURE MICROBIOL, V8, P939, DOI 10.2217/fmb.13.54; Hasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040319; Hong CO, 2013, BIOSCI BIOTECH BIOCH, V77, P58, DOI 10.1271/bbb.120562; Islam B, 2008, J ANTIMICROB CHEMOTH, V62, P751, DOI 10.1093/jac/dkn253; Jeon JG, 2011, CARIES RES, V45, P243, DOI 10.1159/000327250; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; KOBAYASHI H, 1986, J BIOL CHEM, V261, P627; Koo H, 2000, ARCH ORAL BIOL, V45, P141, DOI 10.1016/S0003-9969(99)00117-X; KURAMITSU HK, 1993, CRIT REV ORAL BIOL M, V4, P159, DOI 10.1177/10454411930040020201; Larson MR, 2011, J BIOL CHEM, V286, P21657, DOI 10.1074/jbc.M111.231100; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lemos JAC, 2005, CURR ISSUES MOL BIOL, V7, P95; Levesque CM, 2005, INFECT IMMUN, V73, P3773, DOI 10.1128/IAI.73.6.3773-3777.2005; Li Y., 2013, INT J ANTENN PROPAG, V2013; Liu C, 2011, ANTIMICROB AGENTS CH, V55, P2679, DOI 10.1128/AAC.01496-10; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; MCBRIDE BC, 1984, INFECT IMMUN, V44, P68, DOI 10.1128/IAI.44.1.68-75.1984; Miller-Torbert TA, 2008, MICROB PATHOGENESIS, V45, P53, DOI 10.1016/j.micpath.2008.02.001; Muller P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057679; Muzitano MF, 2006, PLANTA MED, V72, P81, DOI 10.1055/s-2005-873183; Nakano K, 2007, J MED MICROBIOL, V56, P1413, DOI 10.1099/jmm.0.47335-0; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Quivey RG, 2000, ADV MICROB PHYSIOL, V42, P239, DOI 10.1016/S0065-2911(00)42004-7; SCHILLING KM, 1992, INFECT IMMUN, V60, P284, DOI 10.1128/IAI.60.1.284-295.1992; SERVICE RF, 1995, SCIENCE, V270, P724, DOI 10.1126/science.270.5237.724; Stipp RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058271; Timokhova A V, 2012, Mol Biol (Mosk), V46, P644; Tsuduki T, 2013, FOOD CHEM, V139, P16, DOI 10.1016/j.foodchem.2013.02.025; Wagner C, 2006, BRAIN RES, V1107, P192, DOI 10.1016/j.brainres.2006.05.084; Wen ZT, 2002, APPL ENVIRON MICROB, V68, P1196, DOI 10.1128/AEM.68.3.1196-1203.2002; Xu X, 2011, ANTIMICROB AGENTS CH, V55, P1229, DOI 10.1128/AAC.01016-10; YAMASHITA Y, 1993, INFECT IMMUN, V61, P3811, DOI 10.1128/IAI.61.9.3811-3817.1993; Yin YQ, 2013, TOXICOL APPL PHARM, V269, P89, DOI 10.1016/j.taap.2013.03.015	45	42	45	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91736	10.1371/journal.pone.0091736	http://dx.doi.org/10.1371/journal.pone.0091736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622055	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300122
J	Jia, ZJ; Hong, B; Chen, DM; Huang, QH; Yang, ZG; Yin, C; Deng, XQ; Liu, JM				Jia, Ze-jun; Hong, Bo; Chen, Da-ming; Huang, Qing-hai; Yang, Zhi-gang; Yin, Cha; Deng, Xiao-qun; Liu, Jian-min			China's Growing Contribution to Global Intracranial Aneurysm Research (1991-2012): A Bibliometric Study	PLOS ONE			English	Article							ENDOVASCULAR APPROACH; SACCULAR ANEURYSMS; ELECTROTHROMBOSIS; INDEX	Background: We sought to analyze the growing worldwide trends of intracranial aneurysm research, investigate China's recent contribution, and compare the contributions of mainland China, Taiwan, and Hong Kong. Methods: Global and China intracranial aneurysm-related publications were retrieved from the Web of Science database from 1991 to 2012. Excel 2007, Matlab, and Thomson Data Analyzer (TDA) software were used to analyze the search results for number of publications, cited frequency, h-index, and organization contributions. Results: 16468 global papers were identified that were cited 273500 times until 2013-08-15. The United States accounted for 31.497% of the articles, 58.64% of the citations, and the highest h-index (127). Japan and Germany followed in frequency. China's articles ranked eighth (third in 2012) in total number, with most of the contributions occurring since 2002 (91.33%). China was at the early stage of the logic growth curve (exponential growth), with the citation frequency and h-index per year increasing. The quality of the publications was low. The main research centers were located in Beijing, Shanghai, Taiwan, and Hong Kong. The main Asian funding body was the National Natural Science Foundation of China. The number of publications and frequency of citations of papers from mainland China was greater than that of Taiwan or Hong Kong. Conclusion: Global intracranial aneurysm research has been developing swiftly since 1991, with the United States making the largest contribution. Research in China started later, in 2002. Since then, China has increased its rate of publication, and became the third largest contributor by 2012.	[Jia, Ze-jun; Hong, Bo; Huang, Qing-hai; Yang, Zhi-gang; Liu, Jian-min] Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Jia, Ze-jun; Yin, Cha; Deng, Xiao-qun] Second Mil Med Univ, Dept Res, Editorial Dept Acad Journal, Shanghai, Peoples R China; [Chen, Da-ming] Chinese Acad Sci, SIBS, Shanghai Informat Ctr Life Sci, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences	Deng, XQ (corresponding author), Second Mil Med Univ, Dept Res, Editorial Dept Acad Journal, Shanghai, Peoples R China.	xqdeng_jane@163.com; chstroke@163.com			National Natural Science Foundation of China [31370810]; Foundation of General Administration of Press and Publication of the People's Republic of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of General Administration of Press and Publication of the People's Republic of China	This work was supported by the National Natural Science Foundation of China (31370810) at http://www.nsfc.gov.cn, and Foundation of General Administration of Press and Publication of the People's Republic of China (2013) at http://www.gapp.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam D, 2002, NATURE, V415, P726, DOI 10.1038/415726a; Asplund K, 2012, STROKE, V43, P830, DOI 10.1161/STROKEAHA.111.637249; Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9; Bornmann L, 2009, EMBO REP, V10, P2, DOI 10.1038/embor.2008.233; BROOKES BC, 1969, NATURE, V224, P953, DOI 10.1038/224953a0; Elango B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081094; Glynn RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013902; GUGLIELMI G, 1991, J NEUROSURG, V75, P1, DOI 10.3171/jns.1991.75.1.0001; GUGLIELMI G, 1991, J NEUROSURG, V75, P8, DOI 10.3171/jns.1991.75.1.0008; Haeffner-Cavaillon N, 2009, ARCH IMMUNOL THER EX, V57, P33, DOI 10.1007/s00005-009-0004-2; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Lai DYF, 2011, NATURE, V476, P152, DOI 10.1038/476152b; Lenoir T, 2009, J BIOMED DISCOV COLL, V4; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042200; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Mori H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057371; Nalimov VV, 1974, SYNTHESE, V27, P211; Peng J, 2011, INT NURS REV, V58, P21, DOI 10.1111/j.1466-7657.2010.00873.x; Rosas SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017428; Shi YG, 2010, SCIENCE, V329, P1128, DOI 10.1126/science.1196916; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Vioque J, 2010, OBES REV, V11, P603, DOI 10.1111/j.1467-789X.2009.00647.x; Xu GL, 2013, STROKE, V44, P1775, DOI 10.1161/STROKEAHA.113.001238; Yao XB, 2013, NAT REV MOL CELL BIO, V14, P600, DOI 10.1038/nrm3638; Zhang JF, 2013, STROKE, V44, P2891, DOI 10.1161/STROKEAHA.113.002599; Zhang WJ, 2012, ANN PLAS SURG, V68, P328, DOI 10.1097/SAP.0b013e318214e6dd	26	19	20	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91594	10.1371/journal.pone.0091594	http://dx.doi.org/10.1371/journal.pone.0091594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622581	Green Submitted, Green Published, gold			2022-12-27	WOS:000332845300109
J	Lada, H; Thomson, JR; Cunningham, SC; Mac Nally, R				Lada, Hania; Thomson, James R.; Cunningham, Shaun C.; Mac Nally, Ralph			Relating Demographic Characteristics of a Small Mammal to Remotely Sensed Forest-Stand Condition	PLOS ONE			English	Article							MARSUPIAL ANTECHINUS-FLAVIPES; SOUTH-EASTERN AUSTRALIA; CLIMATE-CHANGE; RIVER; FLOW; BIODIVERSITY; LANDSCAPE; IMPACTS; STRESS	Many ecological systems around the world are changing rapidly in response to direct (land-use change) and indirect (climate change) human actions. We need tools to assess dynamically, and over appropriate management scales, condition of ecosystems and their responses to potential mitigation of pressures. Using a validated model, we determined whether stand condition of floodplain forests is related to densities of a small mammal (a carnivorous marsupial, Antechinus flavipes) in 60 000 ha of extant river red gum (Eucalyptus camaldulensis) forests in south-eastern Australia in 2004, 2005 and 2011. Stand condition was assessed remotely using models built from ground assessments of stand condition and satellite-derived reflectance. Other covariates, such as volumes of fallen timber, distances to floods, rainfall and life stages were included in the model. Trapping of animals was conducted at 272 plots (0.25 ha) across the region. Densities of second-year females (i.e. females that had survived to a second breeding year) and of second-year females with suckled teats (i.e. inferred to have been successful mothers) were higher in stands with the highest condition. There was no evidence of a relationship with stand condition for males or all females. These outcomes show that remotely-sensed estimates of stand condition (here floodplain forests) are relatable to some demographic characteristics of a small mammal species, and may provide useful information about the capacity of ecosystems to support animal populations. Over-regulation of large, lowland rivers has led to declines in many facets of floodplain function. If management of water resources continues as it has in recent decades, then our results suggest that there will be further deterioration in stand condition and a decreased capacity for female yellow-footed antechinuses to breed multiple times.	[Lada, Hania; Thomson, James R.; Cunningham, Shaun C.; Mac Nally, Ralph] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia	Monash University	Lada, H (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	hania.lada@monash.edu	Cunningham, Shaun/J-7669-2015; Thomson, Jim/W-2950-2019; Cunningham, Shaun/I-1116-2012	Cunningham, Shaun/0000-0002-1447-312X; Cunningham, Shaun/0000-0002-1447-312X	Australian Research Council [DP0984170, DP120100797]	Australian Research Council(Australian Research Council)	The Australian Research Council supported this research (DP0984170, DP120100797); http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballinger A, 2005, FRESHWATER BIOL, V50, P1190, DOI 10.1111/j.1365-2427.2005.01391.x; BREN LJ, 1987, AUST FOREST RES, V17, P127; Buehler DA, 2006, J WILDLIFE MANAGE, V70, P1763, DOI 10.2193/0022-541X(2006)70[1763:PCWHUI]2.0.CO;2; Bureau of Meteorology, 2011, CLIM DAT ONL; Chisholm RA, 2007, ECOL APPL, V17, P317, DOI 10.1890/05-1580; Close A., 1990, MURRAY, P61; COATES T, 1995, REPROD ECOLOGY YELLO; Cunningham SC, 2009, ECOSYSTEMS, V12, P207, DOI 10.1007/s10021-008-9218-0; Cunningham SC, 2011, MAPPING CONDITION RI; Cunningham SC, 2007, AUST J BOT, V55, P692, DOI 10.1071/BT07031; Cunningham SC, 2011, FRESHWATER BIOL, V56, P1494, DOI 10.1111/j.1365-2427.2011.02585.x; DEXTER B D, 1978, Proceedings of the Royal Society of Victoria, V90, P175; Fahey C, 1988, BARMAH FOREST HIST; Gelman A., 1006, BAYESIAN ANAL, V1, P515, DOI [10.1214/06-BA117AQ6, DOI 10.1214/06-BA117AQ6]; Gillespie TW, 2008, PROG PHYS GEOG, V32, P203, DOI 10.1177/0309133308093606; Gonzalez E, 2010, ENVIRON MANAGE, V45, P669, DOI 10.1007/s00267-010-9441-2; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kingsford RT, 2009, CONSERV BIOL, V23, P834, DOI 10.1111/j.1523-1739.2009.01287.x; Klein C, 2009, ECOL APPL, V19, P206, DOI 10.1890/07-1684.1; Lada H, 2008, J APPL ECOL, V45, P1732, DOI 10.1111/j.1365-2664.2008.01563.x; Lada H, 2008, BIOL J LINN SOC, V94, P303, DOI 10.1111/j.1095-8312.2008.00970.x; Lada H, 2008, J MAMMAL, V89, P398, DOI 10.1644/07-MAMM-A-080R.1; Lada H, 2007, MOL ECOL, V16, P2934, DOI 10.1111/j.1365-294X.2007.03327.x; Lada H, 2007, BIOL CONSERV, V134, P527, DOI 10.1016/j.biocon.2006.09.003; Lada H, 2013, AUSTRAL ECOL, V38, P581, DOI 10.1111/aec.12002; Lee A.K., 1982, P1; LUNN DJ, 2005, GENERIC REVERSIBLE J; Mac Nally R, 2008, BASIC APPL ECOL, V9, P458, DOI 10.1016/j.baae.2007.05.003; Mac Nally R, 2007, J ANIM ECOL, V76, P643, DOI 10.1111/j.1365-2656.2007.01247.x; Mac Nally R, 2014, GLOBAL ECOL BIOGEOGR, V23, P191, DOI 10.1111/geb.12091; Mac Nally R, 2011, WATER RESOUR RES, V47, DOI 10.1029/2011WR010383; Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x; Marchesan D, 2004, WILDLIFE RES, V31, P273, DOI 10.1071/WR02038; Margules, 1990, RIP VEG RIV MURR; Mcalpine CA, 2009, GLOBAL CHANGE BIOL, V15, P2206, DOI 10.1111/j.1365-2486.2009.01939.x; Menkhorst P., 1995, MAMMALS VICTORIA DIS; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nicholls N, 2004, CLIMATIC CHANGE, V63, P323, DOI 10.1023/B:CLIM.0000018515.46344.6d; Page K, 2005, RIVER RES APPL, V21, P567, DOI 10.1002/rra.828; Palmer MA, 2008, FRONT ECOL ENVIRON, V6, P81, DOI 10.1890/060148; Pillay D, 2010, MAR ECOL PROG SER, V415, P35, DOI 10.3354/meps08733; Rood SB, 2003, TREE PHYSIOL, V23, P1113, DOI 10.1093/treephys/23.16.1113; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Specht R.L., 1981, ECOLOGICAL BIOGEOGRA, P163; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Treitz PM, 1999, PROG PHYS GEOG, V23, P359, DOI 10.1177/030913339902300303; VEAC, 2008, RIV RED GUM FOR INV	47	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91731	10.1371/journal.pone.0091731	http://dx.doi.org/10.1371/journal.pone.0091731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621967	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300121
J	Shahaf, G; Shweiki, D				Shahaf, Guy; Shweiki, Dorit			Nonsense-Mediated mRNA Decay Immunity Can Help Identify Human Polycistronic Transcripts	PLOS ONE			English	Article							INTERNAL RIBOSOME ENTRY; OPEN READING FRAMES; EXON JUNCTION COMPLEX; TRANSLATION INITIATION; MAMMALIAN-CELLS; NUCLEOTIDE RESOLUTION; UPF1 PHOSPHORYLATION; EXPRESSION; SURVEILLANCE; SEQUENCES	Eukaryotic polycistronic transcription units are rare and only a few examples are known, mostly being the outcome of serendipitous discovery. We claim that nonsense-mediated mRNA decay (NMD) immune structure is a common characteristic of polycistronic transcripts, and that this immunity is an emergent property derived from all functional CDSs. The human RefSeq transcriptome was computationally screened for transcripts capable of eliciting NMD, and which contain an additional ORF(s) potentially capable of rescuing the transcript from NMD. Transcripts were further analyzed implementing domain-based strategies in order to estimate the potential of the candidate ORF to encode a functional protein. Consequently, we predict the existence of forty nine novel polycistronic transcripts. Experimental verification was carried out utilizing two different types of analyses. First, five Gene Expression Omnibus (GEO) datasets from published NMD-inhibition studies were used, aiming to explore whether a given mRNA is indeed insensitive to NMD. All known bicistronic transcripts and eleven out of the twelve predicted genes that were analyzed, displayed NMD insensitivity using various NMD inhibitors. For three genes, a mixed expression pattern was observed presenting both NMD sensitivity and insensitivity in different cell types. Second, we used published global translation initiation sequencing data from HEK293 cells to verify the existence of translation initiation sites in our predicted polycistronic genes. In five of our genes, the predicted rescuing uORFs are indeed identified as translation initiation sites, and in two additional genes, one of two predicted rescuing uORF is verified. These results validate our computational analysis and reinforce the possibility that NMD-immune architecture is a parameter by which polycistronic genes can be identified. Moreover, we present evidence for NMD-mediated regulation controlling the production of one or more proteins encoded in the polycistronic transcript.	[Shahaf, Guy; Shweiki, Dorit] Acad Coll Tel Aviv Yaffo, Sch Comp Sci, Bioinformat Program, Tel Aviv, Israel		Shweiki, D (corresponding author), Acad Coll Tel Aviv Yaffo, Sch Comp Sci, Bioinformat Program, Tel Aviv, Israel.	dorits@mta.ac.il						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anczukow O, 2008, HUM MUTAT, V29, P65, DOI 10.1002/humu.20590; Bailleul B, 1997, NUCLEIC ACIDS RES, V25, P2752, DOI 10.1093/nar/25.14.2752; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; Buisson M, 2006, HUM MUTAT, V27, P1024, DOI 10.1002/humu.20384; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369; Churbanov A, 2005, NUCLEIC ACIDS RES, V33, P5512, DOI 10.1093/nar/gki847; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Durand S, 2013, NAT STRUCT MOL BIOL, V20, P702, DOI 10.1038/nsmb.2575; Filbin ME, 2009, CURR OPIN STRUC BIOL, V19, P267, DOI 10.1016/j.sbi.2009.03.005; Gilat R, 2007, BIOCHEM BIOPH RES CO, V353, P487, DOI 10.1016/j.bbrc.2006.12.052; Gilbert WV, 2010, J BIOL CHEM, V285, P29033, DOI 10.1074/jbc.R110.150532; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Green RE, 2003, BIOINFORMATICS, V19, pi118, DOI 10.1093/bioinformatics/btg1015; Han A, 2007, BIOINFORMATICS, V23, P397, DOI 10.1093/bioinformatics/btl593; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hosoda N, 2005, NAT STRUCT MOL BIOL, V12, P893, DOI 10.1038/nsmb995; Iacono M, 2005, GENE, V349, P97, DOI 10.1016/j.gene.2004.11.041; Imai K, 2010, PROTEOMICS, V10, P3970, DOI 10.1002/pmic.201000274; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Katoh M, 2001, BIOCHEM BIOPH RES CO, V282, P116, DOI 10.1006/bbrc.2001.4551; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Kozak M, 2005, NUCLEIC ACIDS RES, V33, P6593, DOI 10.1093/nar/gki958; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Matsui M, 2007, FEBS LETT, V581, P4184, DOI 10.1016/j.febslet.2007.07.057; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; MILLER PF, 1989, GENE DEV, V3, P1217, DOI 10.1101/gad.3.8.1217; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Mort M, 2008, HUM MUTAT, V29, P1037, DOI 10.1002/humu.20763; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Pesole G, 2002, NUCLEIC ACIDS RES, V30, P335, DOI 10.1093/nar/30.1.335; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Prakash T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013284; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Resch AM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-162; Rufener SC, 2013, NAT STRUCT MOL BIOL, V20, P710, DOI 10.1038/nsmb.2576; Sato H, 2009, GENE DEV, V23, P2537, DOI 10.1101/gad.1817109; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stockklausner C, 2006, NUCLEIC ACIDS RES, V34, P2355, DOI 10.1093/nar/gkl277; Suzuki Y, 2000, GENOMICS, V64, P286, DOI 10.1006/geno.2000.6076; Wu TY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-160; Xiong Z, 2006, J IMMUNOL, V177, P4907, DOI 10.4049/jimmunol.177.7.4907; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang J, 1997, EMBO J, V16, P826, DOI 10.1093/emboj/16.4.826	64	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91535	10.1371/journal.pone.0091535	http://dx.doi.org/10.1371/journal.pone.0091535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24621851	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300101
J	Cerchio, S; Strindberg, S; Collins, T; Bennett, C; Rosenbaum, H				Cerchio, Salvatore; Strindberg, Samantha; Collins, Tim; Bennett, Chanda; Rosenbaum, Howard			Seismic Surveys Negatively Affect Humpback Whale Singing Activity off Northern Angola	PLOS ONE			English	Article							MEGAPTERA-NOVAEANGLIAE; BALAENA-MYSTICETUS; SAKHALIN ISLAND; BOWHEAD WHALES; SONGS; HAWAIIAN; WATERS; EXPLORATION; RESPONSES; TRENDS	Passive acoustic monitoring was used to document the presence of singing humpback whales off the coast of Northern Angola, and opportunistically test for the effect of seismic survey activity in the vicinity on the number of singing whales. Two Marine Autonomous Recording Units (MARUs) were deployed between March and December 2008 in the offshore environment. Song was first heard in mid June and continued through the remaining duration of the study. Seismic survey activity was heard regularly during two separate periods, consistently throughout July and intermittently in mid-October/ November. Numbers of singers were counted during the first ten minutes of every hour for the period from 24 May to 1 December, and Generalized Additive Mixed Models (GAMMs) were used to assess the effect of survey day (seasonality), hour (diel variation), moon phase and received levels of seismic survey pulses (measured from a single pulse during each ten-minute sampled period) on singer number. Application of GAMMs indicated significant seasonal variation, which was the most pronounced effect when assessing the full dataset across the entire season (p<0.001); however seasonality almost entirely dropped out of top-ranked models when applied to a reduced dataset during the July period of seismic survey activity. Diel variation was significant in both the full and reduced datasets (from p<0.01 to p<0.05) and often included in the top-ranked models. The number of singers significantly decreased with increasing received level of seismic survey pulses (from p<0.01 to p<0.05); this explanatory variable was included among the top ranked models for one MARU in the full dataset and both MARUs in the reduced dataset. This suggests that the breeding display of humpback whales is disrupted by seismic survey activity, and thus merits further attention and study, and potentially conservation action in the case of sensitive breeding populations.	[Cerchio, Salvatore; Strindberg, Samantha; Collins, Tim; Bennett, Chanda; Rosenbaum, Howard] Wildlife Conservat Soc, Global Conservat Program, Bronx, NY USA; [Cerchio, Salvatore; Bennett, Chanda; Rosenbaum, Howard] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Bennett, Chanda] New York Aquarium, Brooklyn, NY USA	Wildlife Conservation Society; American Museum of Natural History (AMNH)	Cerchio, S (corresponding author), Wildlife Conservat Soc, Global Conservat Program, Bronx, NY USA.	scerchio@wcs.org		Collins, Tim/0000-0002-7124-4876; Cerchio, Salvatore/0000-0001-5880-5969	Angola Liquefied Natural Gas (ALNG)	Angola Liquefied Natural Gas (ALNG)	Funding for the cost and deployment of equipment used by WCS was provided by Angola Liquefied Natural Gas (ALNG). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The interpretation of results does not reflect the views of ALNG.	Andrew RK, 2011, J ACOUST SOC AM, V129, P642, DOI 10.1121/1.3518770; [Anonymous], 2010, R LANG ENV STAT COMP; Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; Au WWL, 2000, MAR MAMMAL SCI, V16, P530, DOI 10.1111/j.1748-7692.2000.tb00949.x; Barkaszi M. J., 2012, SEISMIC SURVEY MITIG; Blackwell SB, 2013, MAR MAMMAL SCI, V29, pE342, DOI 10.1111/mms.12001; BUREAU OF OCEAN ENERGY MANAGEMENT (BOEM), 2012, IMPL SEISM SUR MIT M; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Castellote M, 2012, BIOL CONSERV, V147, P115, DOI 10.1016/j.biocon.2011.12.021; Cerchio S, 2005, ANIM BEHAV, V70, P267, DOI 10.1016/j.anbehav.2004.10.028; Cerchio S, 2001, ANIM BEHAV, V62, P313, DOI 10.1006/anbe.2001.1747; Cerchio S, 2010, SC62SH12 INT WHAL CO; Cerchio S, 2003, THESIS U MICHIGAN AN; Charif R, 2010, RAVEN PRO 1 4 USERS, P367; Cholewiak DM, 2013, MAR MAMMAL SCI, V29, pE312, DOI 10.1111/mms.12005; Cholewiak DM, 2008, THESIS CORNELL U; CLAPHAM PJ, 1990, MAR MAMMAL SCI, V6, P155, DOI 10.1111/j.1748-7692.1990.tb00238.x; Clark CW, 2009, MAR ECOL PROG SER, V395, P201, DOI 10.3354/meps08402; Clark CW, 2004, P ROY SOC B-BIOL SCI, V271, P1051, DOI 10.1098/rspb.2004.2699; Di Iorio L, 2010, BIOL LETTERS, V6, P51, DOI 10.1098/rsbl.2009.0651; Findlay KP., 2000, MEM QUEENSL MUSEUM, V47, P411; Gailey G, 2007, ENVIRON MONIT ASSESS, V134, P75, DOI 10.1007/s10661-007-9812-1; GAMBELL R, 1976, Mammal Review, V6, P41, DOI 10.1111/j.1365-2907.1976.tb00200.x; Gordon J, 2003, MAR TECHNOL SOC J, V37, P16, DOI 10.4031/002533203787536998; Guinee LN., 1983, COMMUNICATION BEHAV; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; International Association of Oil and Gas Producers, 2008, 206 INT ASS OIL GAS; IUCN, 2012, WORLD CONS C JEJ KOR; Johnson SR, 2007, ENVIRON MONIT ASSESS, V134, P1, DOI 10.1007/s10661-007-9813-0; LJUNGBLAD DK, 1988, ARCTIC, V41, P183; Madsen PT, 2005, J ACOUST SOC AM, V117, P3952, DOI 10.1121/1.1921508; Matthews L. H., 1937, Discovery Reports Cambridge, V17, P7; MATTILA DK, 1987, J MAMMAL, V68, P880, DOI 10.2307/1381574; McCauley R.D., 2000, APPEA J, V40, P692, DOI DOI 10.1071/AJ99048; McCauley RD, 1998, APPEA J, V38, P692; MCDONALD MA, 1995, J ACOUST SOC AM, V98, P712, DOI 10.1121/1.413565; MCSWEENEY DJ, 1989, MAR MAMMAL SCI, V5, P139, DOI 10.1111/j.1748-7692.1989.tb00328.x; Melcon ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032681; Miller PJO, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Payne K., 1983, COMMUNICATION BEHAV, P9; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Pinheiro J, 2001, MIXED EFFECTS MODELS; Richardson W.J., 1999, J ACOUST SOC AM, V106, P2281, DOI [10.1121/1.427801, DOI 10.1121/1.427801]; RICHARDSON WJ, 1986, J ACOUST SOC AM, V79, P1117, DOI 10.1121/1.393384; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Risch D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029741; Rosenbaum Howard, 2006, Bulletin of the Biological Society of Washington, V12, P425; Smith JN, 2008, ANIM BEHAV, V76, P467, DOI 10.1016/j.anbehav.2008.02.013; Sousa-lima RS, 2008, CANADIAN ACOUSTICS, V36, P175; Southall B. L., 2008, AQUAT MAMM, V17, P273, DOI [DOI 10.1578/AM.33.4.2007.411, 10.1578/AM, DOI 10.1578/AM]; TYACK P, 1981, BEHAV ECOL SOCIOBIOL, V8, P105, DOI 10.1007/BF00300822; Venables WN., 2002, MODERN APPL STAT S 4; Weir CR, 2011, AFR J MAR SCI, V33, P1, DOI 10.2989/1814232X.2011.572333; Weir CR, 2013, MAMMAL REV, V43, P258, DOI 10.1111/j.1365-2907.2012.00222.x; Weir CR, 2010, MAMMAL REV, V40, P2, DOI 10.1111/j.1365-2907.2009.00153.x; Weir Caroline R., 2008, Aquatic Mammals, V34, P71, DOI 10.1578/AM.34.1.2008.71; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur Alain F., 2009, P1	59	54	55	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e86464	10.1371/journal.pone.0086464	http://dx.doi.org/10.1371/journal.pone.0086464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618836	Green Submitted, gold, Green Published			2022-12-27	WOS:000332842400001
J	Guo, MJ; Cai, CK; Zhao, GY; Qiu, XC; Zhao, HE; Ma, Q; Tian, LY; Li, XL; Hu, YS; Liao, B; Ma, BA; Fan, QY				Guo, Mingjun; Cai, Chengkui; Zhao, Guangyi; Qiu, Xiuchun; Zhao, Haien; Ma, Qiong; Tian, Liying; Li, Xuelian; Hu, Yunsheng; Liao, Bo; Ma, Baoan; Fan, Qingyu			Hypoxia Promotes Migration and Induces CXCR4 Expression via HIF-1 alpha Activation in Human Osteosarcoma	PLOS ONE			English	Article							INDUCIBLE FACTOR 1-ALPHA; CHEMOKINE RECEPTOR CXCR4; BREAST-CANCER; EWINGS-SARCOMA; CELL INVASION; IN-VIVO; METASTASIS; FACTOR-1; HIF-1; OVEREXPRESSION	Background: Cellular adaptation to a hypoxic microenvironment is essential for tumor progression and is largely mediated by HIF-1 alpha through coordinated regulation of hypoxia-responsive genes. The chemokine SDF-1 alpha and its unique receptor CXCR4 have been implicated in organ-specific metastases of many cancers. In this study, we investigated the response of osteosarcoma cells to hypoxia and the expression of CXCR4 and HIF-1 alpha in human osteosarcoma specimens and explored the roles of CXCR4 and HIF-1 alpha in the cell migration process. Methodology/Principal Findings: We performed immunohistochemistry, immunocytochemistry, quantitative real-time PCR, Western blots and fluorescent reporter assays to evaluate the correlation between CXCR4 and HIF-1 alpha expression in human osteosarcoma specimens or SOSP-9607 cells under normoxic and hypoxic conditions. Transwell assays were used to assess cell migration under different conditions. Exposure of SOSP-9607 cells to hypoxic conditions resulted in significantly increased migration. When SOSP-9607 cells were subjected to hypoxic conditions, the mRNA and protein levels of CXCR4 were significantly increased in a time-dependent manner. Moreover, siHIF-1 alpha significantly decreased the mRNA and protein levels of CXCR4 under hypoxia, whereas pcDNA-HIF-1 alpha significantly increased the mRNA and protein levels of CXCR4 under normoxia. A luciferase reporter gene study showed that siHIF-1 alpha reduced pGL3-CXCR4 luciferase activity. Furthermore, coexpression of HIF-1 alpha and CXCR4 was significantly higher in patients with distant metastasis compared with those without metastasis. Conclusions/Significance: The hypoxia-HIF-1 alpha-CXCR4 pathway plays a crucial role during the migration of human osteosarcoma cells, and targeting this pathway might represent a novel therapeutic strategy for patients suffering from osteosarcoma.	[Guo, Mingjun; Cai, Chengkui; Qiu, Xiuchun; Zhao, Haien; Ma, Qiong; Hu, Yunsheng; Liao, Bo; Ma, Baoan; Fan, Qingyu] Fourth Mil Med Univ, Tangdu Hosp, Dept Orthopaed, Xian 710032, Shaanxi, Peoples R China; [Zhao, Guangyi] Bethune Int Peace Hosp, Dept Orthopaed, Shijiazhuang, Hebei, Peoples R China; [Tian, Liying] Fourth Mil Med Univ, Tangdu Hosp, Dept Anesthesiol, Xian 710032, Shaanxi, Peoples R China; [Li, Xuelian] Xian Hosp TCM, Dept Surg, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Ma, BA (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Orthopaed, Xian 710032, Shaanxi, Peoples R China.	gukemba@fmmu.edu.cn; bonetm@fmmu.edu.cn			National Natural Science Foundation of China [81072194]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (NO. 81072194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Kosei, 2012, Sarcoma, V2012, P523432, DOI 10.1155/2012/523432; Arvidsson Y, 2010, ENDOCR-RELAT CANCER, V17, P303, DOI 10.1677/ERC-09-0085; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chen CW, 2009, IEEE T CIRC SYST VID, V19, P1, DOI 10.1109/TCSVT.2009.2012413; Chen XA, 2011, CANCER BIOL THER, V11, P287, DOI 10.4161/cbt.11.2.13966; Chen X, 2009, CYTOTECHNOLOGY, V61, P37, DOI 10.1007/s10616-009-9239-3; Cronin PA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-225; Damron TA, 2007, CLIN ORTHOP RELAT R, P40, DOI 10.1097/BLO.0b013e318059b8c9; Munoz-Guerra MF, 2009, ANN SURG ONCOL, V16, P2351, DOI 10.1245/s10434-009-0503-8; Gallagher R, 2012, ANN DIAGN PATHOL, V16, P323, DOI 10.1016/j.anndiagpath.2012.01.001; Gruber G, 2004, BREAST CANCER RES, V6, pR191, DOI 10.1186/bcr775; Hartmann TN, 2005, ONCOGENE, V24, P4462, DOI 10.1038/sj.onc.1208621; Huang CY, 2009, J CELL PHYSIOL, V221, P204, DOI 10.1002/jcp.21846; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ishikawa T, 2009, ONCOL REP, V21, P707, DOI 10.3892/or_00000275; Isobe T, 2013, INT J CLIN ONCOL, V18, P293, DOI 10.1007/s10147-012-0378-8; Jubb A, 2005, J CLIN PATHOL, V58, P1344; Knowles HJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-372; Krishnamachary B, 2003, CANCER RES, V63, P1138; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Lu X, 2010, CANCER RES, V70, P3905, DOI 10.1158/0008-5472.CAN-09-3739; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Rivard A, 2000, J BIOL CHEM, V275, P29643, DOI 10.1074/jbc.M001029200; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Sowter HM, 2003, CANCER RES, V63, P6130; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wang Xubu, 2008, BIOCH BIOPHYSICAL RE, V371, P283; Yang QC, 2007, JPN J CLIN ONCOL, V37, P127, DOI 10.1093/jjco/hyl137; Yasui H, 2008, BRIT J CANCER, V99, P1442, DOI 10.1038/sj.bjc.6604720; Zagzag D, 2006, LAB INVEST, V86, P1221, DOI 10.1038/labinvest.3700482; Zhong H, 1999, CANCER RES, V59, P5830	36	68	69	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e90518	10.1371/journal.pone.0090518	http://dx.doi.org/10.1371/journal.pone.0090518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24618817	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400021
J	Magdoom, KN; Pishko, GL; Rice, L; Pampo, C; Siemann, DW; Sarntinoranont, M				Magdoom, Kulam Najmudeen; Pishko, Gregory L.; Rice, Lori; Pampo, Chris; Siemann, Dietmar W.; Sarntinoranont, Malisa			MRI-Based Computational Model of Heterogeneous Tracer Transport following Local Infusion into a Mouse Hind Limb Tumor	PLOS ONE			English	Article							CONVECTION-ENHANCED DELIVERY; INTERSTITIAL FLUID PRESSURE; INTRATUMORAL INFUSION; DRUG-DELIVERY; HYDRAULIC CONDUCTIVITY; THERAPEUTIC AGENTS; BRAIN-TUMORS; SOLID TUMOR; VASCULATURE; MICROENVIRONMENT	Systemic drug delivery to solid tumors involving macromolecular therapeutic agents is challenging for many reasons. Amongst them is their chaotic microvasculature which often leads to inadequate and uneven uptake of the drug. Localized drug delivery can circumvent such obstacles and convection-enhanced delivery (CED) - controlled infusion of the drug directly into the tissue - has emerged as a promising delivery method for distributing macromolecules over larger tissue volumes. In this study, a three-dimensional MR image-based computational porous media transport model accounting for realistic anatomical geometry and tumor leakiness was developed for predicting the interstitial flow field and distribution of albumin tracer following CED into the hind-limb tumor (KHT sarcoma) in a mouse. Sensitivity of the model to changes in infusion flow rate, catheter placement and tissue hydraulic conductivity were investigated. The model predictions suggest that 1) tracer distribution is asymmetric due to heterogeneous porosity; 2) tracer distribution volume varies linearly with infusion volume within the whole leg, and exponentially within the tumor reaching a maximum steady-state value; 3) infusion at the center of the tumor with high flow rates leads to maximum tracer coverage in the tumor with minimal leakage outside; and 4) increasing the tissue hydraulic conductivity lowers the tumor interstitial fluid pressure and decreases the tracer distribution volume within the whole leg and tumor. The model thus predicts that the interstitial fluid flow and drug transport is sensitive to porosity and changes in extracellular space. This image-based model thus serves as a potential tool for exploring the effects of transport heterogeneity in tumors.	[Magdoom, Kulam Najmudeen; Pishko, Gregory L.; Sarntinoranont, Malisa] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA; [Rice, Lori; Pampo, Chris; Siemann, Dietmar W.] Univ Florida, Dept Radiat Oncol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Sarntinoranont, M (corresponding author), Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA.	msarnt@ufl.edu		Siemann, Dietmar/0000-0002-5190-5761	National Institutes of Health [R21NS05270, R01NS063360]; National Cancer Institute (Public Health Service Grant) [CA084408]; NATIONAL CANCER INSTITUTE [R01CA084408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (Public Health Service Grant); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was partly funded by grants from the National Institutes of Health (Grant Nos. R21NS05270 and R01NS063360; http://www.nih.gov/) and National Cancer Institute (Public Health Service Grant CA084408; http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard E, 2009, BIOMATERIALS, V30, P2302, DOI 10.1016/j.biomaterials.2009.01.003; ARUNYAWONGSAKORN U, 1985, ANAL BIOCHEM, V146, P265, DOI 10.1016/0003-2697(85)90425-7; Baish JW, 1996, MICROVASC RES, V51, P327, DOI 10.1006/mvre.1996.0031; BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Boucher Y, 1998, BRIT J CANCER, V78, P1442, DOI 10.1038/bjc.1998.705; BOUCHER Y, 1990, CANCER RES, V50, P4478; BOUCHER Y, 1991, CANCER RES, V51, P6691; Debinski W, 2009, EXPERT REV NEUROTHER, V9, P1519, DOI 10.1586/ERN.09.99; Dickinson PJ, 2010, NEURO-ONCOLOGY, V12, P928, DOI 10.1093/neuonc/noq046; Engebraaten O, 2002, INT J CANCER, V97, P846, DOI 10.1002/ijc.10137; Fu N.J.A., 2008, ANTIANGIOGENIC AGENT, P205; Fukumura D, 2010, MICROCIRCULATION, V17, P206, DOI 10.1111/j.1549-8719.2010.00029.x; Grathwohl P, 1998, DIFFUSION NATURAL PO, P31; Guerin C, 2004, INVEST NEW DRUG, V22, P27, DOI 10.1023/B:DRUG.0000006172.65135.3e; GUTMANN R, 1992, CANCER RES, V52, P1993; Hadaczek P, 2006, MOL THER, V14, P69, DOI 10.1016/j.ymthe.2006.02.018; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Huang GC, 2008, CANCER BIOTHER RADIO, V23, P661, DOI 10.1089/cbr.2008.0492; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; JAIN RK, 1988, CANCER RES, V48, P2641; Kim JH, 2010, MED BIOL ENG COMPUT, V48, P203, DOI 10.1007/s11517-009-0564-7; Kim JH, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3169248; Krauze MT, 2005, J NEUROSURG, V103, P923, DOI 10.3171/jns.2005.103.5.0923; Linninger AA, 2008, J THEOR BIOL, V250, P125, DOI 10.1016/j.jtbi.2007.09.009; MacKay JA, 2005, BRAIN RES, V1035, P139, DOI 10.1016/j.brainres.2004.12.007; Magdoom KN, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007096; McGuire S, 2001, AM J PHYSIOL-HEART C, V281, pH715, DOI 10.1152/ajpheart.2001.281.2.H715; Mow VC., 2004, BASIC ORTHOPAEDIC BI; NATHANSON SD, 1994, ANN SURG ONCOL, V1, P333, DOI 10.1007/BF03187139; Nield D.A., 2006, CONVECTION POROUS ME; Perlstein B, 2008, NEURO-ONCOLOGY, V10, P153, DOI 10.1215/15228517-2008-002; Pishko GL, 2011, ANN BIOMED ENG, V39, P2360, DOI 10.1007/s10439-011-0349-7; Saito R, 2004, CANCER RES, V64, P2572, DOI 10.1158/0008-5472.CAN-03-3631; Sampson JH, 2007, NEURO-ONCOLOGY, V9, P343, DOI 10.1215/15228517-2007-007; Sampson JH, 2007, NEUROSURGERY, V60, P89, DOI 10.1227/01.NEU.0000249256.09289.5F; Secomb TW, 2012, BASIC CLIN PHARMACOL, V110, P63, DOI 10.1111/j.1742-7843.2011.00815.x; Smith JH, 2007, MICROVASC RES, V73, P58, DOI 10.1016/j.mvr.2006.07.001; Soltani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067025; Soltani M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020344; Szerlip NJ, 2007, J NEUROSURG, V107, P560, DOI 10.3171/JNS-07/09/0560; Truskey GA, 2004, TRANSPORT PHENOMENA, P473; Vazquez L, 2012, J MATER SCI-MATER M, P1; WALTER KA, 1995, NEUROSURGERY, V37, P1129, DOI 10.1227/00006123-199512000-00013; Wang Y, 2006, MOL CANCER THER, V5, P362, DOI 10.1158/1535-7163.MCT-05-0266; Wang Y, 2003, MOL CANCER THER, V2, P1233; Welter M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070395; YOUNG JS, 1950, J PATHOL BACTERIOL, V62, P313, DOI 10.1002/path.1700620303; Zhang XY, 2000, AM J PHYSIOL-HEART C, V279, pH2726, DOI 10.1152/ajpheart.2000.279.6.H2726; Zhao JB, 2007, MICROVASC RES, V73, P224, DOI 10.1016/j.mvr.2006.12.003	50	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e89594	10.1371/journal.pone.0089594	http://dx.doi.org/10.1371/journal.pone.0089594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24619021	gold, Green Published			2022-12-27	WOS:000332842400006
J	Mayr, U; LaRoux, C; Rolheiser, T; Osternig, L; Chou, LS; van Donkelaar, P				Mayr, Ulrich; LaRoux, Charlene; Rolheiser, Tyler; Osternig, Louis; Chou, Li-Shan; van Donkelaar, Paul			Executive Dysfunction Assessed with a Task-Switching Task following Concussion	PLOS ONE			English	Article							INJURY SURVEILLANCE SYSTEM; DESCRIPTIVE EPIDEMIOLOGY; ATTENTION; DEFICITS	Concussion frequently results in executive function deficits that can be specifically probed using task-switching tasks. The current study examined in detail the influence of concussion on task switching performance using both spatial and numerical stimuli. Individuals with concussion (n = 16) were tested within 48 hours of injury and 7, 14, and 28 days later. Healthy sex-, age-, height-, weight- and activity-matched controls (n = 16) were also tested at the same intervals. Switch costs were significantly greater in the participants with concussion than in the controls for both types of stimuli. By contrast, the global costs on non-switching trials were unaffected by concussion. We conclude that concussion has pronounced negative effects on the ability to switch task sets that generalize across task combinations (spatial or numerical) and that persist across at least a month after injury.	[Mayr, Ulrich] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [LaRoux, Charlene; Rolheiser, Tyler; Osternig, Louis; Chou, Li-Shan] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; [van Donkelaar, Paul] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada	University of Oregon; University of Oregon; University of British Columbia; University of British Columbia Okanagan	van Donkelaar, P (corresponding author), Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada.	paul.vandonkelaar@ubc.ca			VA [A4842C8, A4843C]; University of Oregon; Peace Health Oregon Region; DoD-TATRC [W81XWH-11-1-0717]	VA(US Department of Veterans Affairs); University of Oregon; Peace Health Oregon Region; DoD-TATRC(United States Department of Defense)	This work was supported by VA (A4842C8, A4843C), University of Oregon, Peace Health Oregon Region, DoD-TATRC (W81XWH-11-1-0717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agel J, 2007, J ATHL TRAINING, V42, P249; Arrington CM, 2005, J EXP PSYCHOL LEARN, V31, P683, DOI 10.1037/0278-7393.31.4.683; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Cantu R., 2009, J ATHL TRAINING, V44, P434, DOI [DOI 10.4085/1062-6050-44.4.434, 10.4085/1062-6050-44.4.434]; DeHaan A, 2007, NEUROPSYCHOLOGIA, V45, P406, DOI 10.1016/j.neuropsychologia.2006.06.008; Dick R, 2007, J ATHL TRAINING, V42, P221; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Mayr U, 2006, PSYCHOL SCI, V17, P774, DOI 10.1111/j.1467-9280.2006.01781.x; McIntire A, 2006, EXP BRAIN RES, V174, P361, DOI 10.1007/s00221-006-0469-8; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Rushworth MFS, 2005, EXP PSYCHOL, V52, P83, DOI 10.1027/1618-3169.52.2.83; Rushworth MFS, 2003, J COGNITIVE NEUROSCI, V15, P338, DOI 10.1162/089892903321593072; Schmitter-Edgecombe M, 2006, NEUROPSYCHOLOGY, V20, P675, DOI 10.1037/0894-4105.20.6.675; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363	17	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91379	10.1371/journal.pone.0091379	http://dx.doi.org/10.1371/journal.pone.0091379			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC9GM	24618717	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400082
J	Li, X; Sun, R; Chen, WP; Lu, BM; Li, XY; Wang, ZJ; Bao, JK				Li, Xin; Sun, Rong; Chen, Wanpeng; Lu, Bangmin; Li, Xiaoyu; Wang, Zijie; Bao, Jinku			A Systematic In Silico Mining of the Mechanistic Implications and Therapeutic Potentials of Estrogen Receptor (ER)-alpha in Breast Cancer	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; INTERACTION DATABASE; DRUG DISCOVERY; ER-ALPHA; PREDICTION; TOOL; IDENTIFICATION; MODULATORS; MICRORNAS; TARGETS	Estrogen receptor (ER)-alpha has long been a potential target in ER-alpha-positive breast cancer therapeutics. In this study, we integrated ER-alpha-related bioinformatic data at different levels to systematically explore the mechanistic and therapeutic implications of ER-alpha. Firstly, we identified ER-alpha-interacting proteins and target genes of ER-alpha-regulating microRNAs (miRNAs), and analyzed their functional gene ontology (GO) annotations of those ER-alpha-associated proteins. In addition, we predicted ten consensus miRNAs that could target ER-alpha, and screened candidate traditional Chinese medicine (TCM) compounds that might hit diverse conformations of ER-alpha ligand binding domain (LBD). These findings may help to uncover the mechanistic implications of ER-alpha in breast cancer at a systematic level, and provide clues of miRNAs- and small molecule modulators-based strategies for future ER-alpha-positive breast cancer therapeutics.	[Bao, Jinku] Sichuan Univ, Sch Life Sci, Chengdu 610064, Peoples R China; Sichuan Univ, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Bao, JK (corresponding author), Sichuan Univ, Sch Life Sci, Chengdu 610064, Peoples R China.	baojinku@scu.edu.cn			National Natural Science Foundation of China [81173093, 30970643, J1103518]; Special Program for Youth Science and the Technology Innovative Research Group of Sichuan Province, China [2011JTD0026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Program for Youth Science and the Technology Innovative Research Group of Sichuan Province, China	This study was supported in part by the National Natural Science Foundation of China (No. 81173093, No. 30970643, and No. J1103518), the Special Program for Youth Science and the Technology Innovative Research Group of Sichuan Province, China (No. 2011JTD0026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragues R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-172; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banerjee S, 2011, J CELL COMMUN SIGNAL, V5, P317, DOI 10.1007/s12079-011-0138-y; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Butler D, 2004, NATURE, V432, P423, DOI 10.1038/432423a; CAO X, 2013, BIOORG MED CHEMLETT, DOI DOI 10.1016/J.BMCL.2013.03.105.PUBMED:23608764; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; Chen JQ, 2004, J CELL BIOCHEM, V93, P358, DOI 10.1002/jcb.20178; Chen JQ, 2003, TOXICOL SCI, V75, P271, DOI 10.1093/toxsci/kfg183; Cheng LS, 2008, J MED CHEM, V51, P3878, DOI 10.1021/jm8001197; Cirillo F, 2013, J PROTEOME RES, V12, P421, DOI 10.1021/pr300753u; Corcoran C, 2011, CLIN CHEM, V57, P18, DOI 10.1373/clinchem.2010.150730; Cuzick J, 2013, LANCET, V381, P1827, DOI 10.1016/S0140-6736(13)60140-3; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Gadaleta E, 2011, BRIEF BIOINFORM, V12, P52, DOI 10.1093/bib/bbq010; Giacinti L, 2006, ONCOLOGIST, V11, P1, DOI 10.1634/theoncologist.11-1-1; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hendriks BS, 2008, BIOTECHNOL PROGR, V24, P96, DOI 10.1021/bp070084g; Howell A, 2013, LANCET, V381, P1795, DOI 10.1016/S0140-6736(13)60443-2; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; Kar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000601; Katchy A, 2012, J STEROID BIOCHEM, V128, P145, DOI 10.1016/j.jsbmb.2011.10.008; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Klinge CM, 2012, TRENDS ENDOCRIN MET, V23, P223, DOI 10.1016/j.tem.2012.03.002; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Manavathi B, 2013, ENDOCR REV, V34, P1, DOI 10.1210/er.2011-1057; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; McDonnell DP, 2010, CURR OPIN PHARMACOL, V10, P620, DOI 10.1016/j.coph.2010.09.007; NANASINKAM S, 2012, CLIN PHARMACOL THER, DOI DOI 10.1038/CLPT.2012.192.PUBMED:23212103; Ostlund G, 2010, MOL CELL PROTEOMICS, V9, P648, DOI 10.1074/mcp.M900227-MCP200; PANG YP, 1994, J COMPUT AID MOL DES, V8, P669, DOI 10.1007/BF00124014; Park WC, 2002, TRENDS MOL MED, V8, P82, DOI 10.1016/S1471-4914(02)02282-7; Persico M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S21; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Prat A, 2008, NAT CLIN PRACT ONCOL, V5, P531, DOI 10.1038/ncponc1179; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schmidt C, 2010, J NATL CANCER I, V102, P1690, DOI 10.1093/jnci/djq477; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; TANRIKULU Y, 2013, DRUG DISCOV TODAY, DOI DOI 10.1016/J.DRUDIS.2013.01.007.PUBMED:23340112; Tenette C, 1996, BIOCHEM SOC T, V24, P268, DOI 10.1042/bst0240268; Tian W, 2013, CLIN TRANSL ONCOL, V15, P335, DOI 10.1007/s12094-012-0929-5; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Witkos TM, 2011, CURR MOL MED, V11, P93; Wuchty S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014681; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yang YD, 2010, MOL INFORM, V29, P421, DOI 10.1002/minf.201000034; Yau C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2120; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang YS, 2012, J BIOL CHEM, V287, P41514, DOI 10.1074/jbc.M112.404871	71	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91894	10.1371/journal.pone.0091894	http://dx.doi.org/10.1371/journal.pone.0091894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614816	Green Published, gold			2022-12-27	WOS:000332839300160
J	Zhao, Y; Zhou, W; Xue, LY; Zhang, WM; Zhan, QM				Zhao, Yue; Zhou, Wei; Xue, Liyan; Zhang, Weimin; Zhan, Qimin			Nicotine Activates YAP1 through nAChRs Mediated Signaling in Esophageal Squamous Cell Cancer (ESCC)	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; DUCT EPITHELIAL-CELLS; ACETYLCHOLINE-RECEPTOR; CANDIDATE ONCOGENE; STEM-LIKE; KINASE-C; POPULATION; CARCINOMA; PATHWAY; CATENIN	Cigarette smoking is an established risk factor for esophageal cancers. Yes-associated protein 1 (YAP1), the key transcription factor of the mammalian Hippo pathway, has been reported to be an oncogenic factor for many cancers. In this study, we find nicotine administration can induce nuclear translocation and activation of YAP1 in ESCC. Consistently, we observed nuclear translocation and activation of YAP1 by knockdown of CHRNA3, which is a negative regulator of nicotine signaling in bronchial and esophageal cancer cells. Nicotine administration or CHRNA3 depletion substantially increased proliferation and migration in esophageal cancer cells. Interestingly, we find that YAP1 physically interacts with nAChRs, and nAChRs-signaling dissociates YAP1 from its negative regulatory complex composed with alpha-catenin, beta-catenin and 14-3-3 in the cytoplasm, leading to upregulation and nuclear translocation of YAP1. This process likely requires PKC activation, as PKC specific inhibitor Enzastaurin can block nicotine induced YAP1 activation. In addition, we find nicotine signaling also inhibits the interaction of YAP1 with P63, which contributes to the inhibitory effect of nicotine on apoptosis. Using immunohistochemistry analysis we observed upregulation of YAP1 in a significant portion of esophageal cancer samples. Consistently, we have found a significant association between YAP1 upregulation and cigarette smoking in the clinical esophageal cancer samples. Together, these findings suggest that the nicotine activated nAChRs signaling pathway which further activates YAP1 plays an important role in the development of esophageal cancer, and this mechanism may be of a general significance for the carcinogenesis of smoking related cancers.	[Zhao, Yue; Zhou, Wei; Zhang, Weimin; Zhan, Qimin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Zhao, Yue; Zhou, Wei; Xue, Liyan; Zhang, Weimin; Zhan, Qimin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xue, Liyan] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Zhan, QM (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	zhanqimin@pumc.edu.cn			973 National Key Fundamental Research Program of China [2009CB521801]; National Natural Science Foundation of China [81021061]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study has been supported by the funds from the 973 National Key Fundamental Research Program of China (2009CB521801) and the National Natural Science Foundation of China (81021061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Wadei HAN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029915; Al-Wadei MH, 2012, CARCINOGENESIS, V33, P1745, DOI 10.1093/carcin/bgs229; Al-Wadei MH, 2012, MOL CANCER RES, V10, P239, DOI 10.1158/1541-7786.MCR-11-0332; An Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047919; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Brown EN, 2003, AM J PHYSIOL-GASTR L, V285, pG37, DOI 10.1152/ajpgi.00053.2003; Brown LM, 2001, AM J EPIDEMIOL, V153, P114, DOI 10.1093/aje/153.2.114; Chen CL, 2013, J CLIN INVEST, V123, P2832, DOI 10.1172/JCI65859; Chernyavsky AI, 2007, EXP CELL RES, V313, P3542, DOI 10.1016/j.yexcr.2007.07.011; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Densham RM, 2009, MOL CELL BIOL, V29, P6380, DOI 10.1128/MCB.00116-09; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Greka A, 2012, SEMIN NEPHROL, V32, P319, DOI 10.1016/j.semnephrol.2012.06.003; He JQ, 2000, J PHYSIOL-LONDON, V524, P807, DOI 10.1111/j.1469-7793.2000.00807.x; Hirata N, 2010, BIOCHEM BIOPH RES CO, V403, P138, DOI 10.1016/j.bbrc.2010.10.134; Kabbani N, 2007, P NATL ACAD SCI USA, V104, P20570, DOI 10.1073/pnas.0710314104; Krais AM, 2011, CARCINOGENESIS, V32, P1388, DOI 10.1093/carcin/bgr090; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Nakamura T, 2010, J BIOL CHEM, V285, P16145, DOI 10.1074/jbc.M109.081315; Nallet-Staub F, 2013, J INVEST DERMATOL; Onoda N, 2001, HEAD NECK-J SCI SPEC, V23, P860, DOI 10.1002/hed.1125; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Ramarao MK, 1998, P NATL ACAD SCI USA, V95, P4007, DOI 10.1073/pnas.95.7.4007; Rosenberg MM, 2008, MOL CELL NEUROSCI, V38, P138, DOI 10.1016/j.mcn.2008.02.006; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Takeuchi H, 2010, J DENT RES, V89, P34, DOI 10.1177/0022034509353403; Tomlinson V, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.7; Wu AH, 2001, CANCER CAUSE CONTROL, V12, P721, DOI 10.1023/A:1011290704728; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yamada K, 2010, CELL PHYSIOL BIOCHEM, V26, P247, DOI 10.1159/000320524; Yeo MK, 2012, ANTICANCER RES, V32, P3835; Yu CC, 2013, TOXICOL APPL PHARM, V266, P459, DOI 10.1016/j.taap.2012.11.023; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051967; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	41	56	56	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90836	10.1371/journal.pone.0090836	http://dx.doi.org/10.1371/journal.pone.0090836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	25093675	Green Published, gold, Green Submitted			2022-12-27	WOS:000332845300031
J	Wang, AT; Fan, JQ; Van Houten, HK; Tilburt, JC; Stout, NK; Montori, VM; Shah, ND				Wang, Amy T.; Fan, Jiaquan; Van Houten, Holly K.; Tilburt, Jon C.; Stout, Natasha K.; Montori, Victor M.; Shah, Nilay D.			Impact of the 2009 US Preventive Services Task Force Guidelines on Screening Mammography Rates on Women in Their 40s	PLOS ONE			English	Article							BREAST-CANCER; RECOMMENDATIONS; OLDER	Background: The 2009 US Preventive Services Task Force breast cancer screening update recommended against routine screening mammography for women aged 40-49; confusion and release of conflicting guidelines followed. We examined the impact of the USPSTF update on population-level screening mammography rates in women ages 40-49. Methods and Findings: We conducted a retrospective, interrupted time-series analysis using a nationally representative, privately-insured population from 1/1/2006-12/31/2011. Women ages 40-64 enrolled for >= 1 month were included. The primary outcome was receipt of screening mammography, identified using administrative claims-based algorithms. Time-series regression models were estimated to determine the effect of the guideline change on screening mammography rates. 5.5 million women ages 40-64 were included. A 1.8 per 1,000 women (p = 0.003) decrease in monthly screening mammography rates for 40-49 year-old women was observed two months following the guideline change; no initial effect was seen for 50-64 year-old women. However, two years following the guideline change, a slight increase in screening mammography rates above expected was observed in both age groups. Conclusions: We detected a modest initial drop in screening mammography rates in women ages 40-49 immediately after the 2009 USPSTF guideline followed by an increase in screening rates. Unfavorable public reactions and release of conflicting statements may have tempered the initial impact. Renewal of the screening debate may have brought mammography to the forefront of women's minds, contributing to the observed increase in mammography rates two years after the guideline change. This pattern is unlikely to reflect informed choice and underscores the need for improved translation of evidence-based care and guidelines into practice.	[Wang, Amy T.; Tilburt, Jon C.] Mayo Clin, Div Gen Internal Med, Rochester, MN USA; [Wang, Amy T.; Tilburt, Jon C.; Montori, Victor M.; Shah, Nilay D.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA; [Fan, Jiaquan; Van Houten, Holly K.; Montori, Victor M.; Shah, Nilay D.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA; [Stout, Natasha K.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Stout, Natasha K.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Montori, Victor M.] Mayo Clin, Div Endocrinol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Mayo Clinic	Shah, ND (corresponding author), Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA.	shah.nilay@mayo.edu	amy.tu.wang, amy.tu.wang/F-8331-2014	amy.tu.wang, amy.tu.wang/0000-0002-0929-1399; Montori, Victor/0000-0003-0595-2898	Small Grants Program; Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota	Small Grants Program; Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota	This work was supported by the Small Grants Program sponsored by the Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM COLL OBST GYN, 2009, OBSTET GYNECOL, V114, P1409; American College of Obstetricians and Gynecologists, 2012, OBSTET GYNECOL, V120, P1222, DOI DOI 10.1097/AOG.1220B1013-318277C318292A; American College of Surgeons, 2010, B AM COLL SURG, V95, P51; Bevers TB, 2009, J NATL COMPR CANC NE, V7, P1060, DOI 10.6004/jnccn.2009.0070; Block LD, 2013, J GEN INTERNAL MED; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Dorn SD, 2012, CLIN GASTROENTEROL H, V10, P278, DOI 10.1016/j.cgh.2011.11.020; Fenton JJ, 2012, MED CARE; IMS Health, 2012, IMS RXBENCHMARK PHAR; Institute KPCM, 2010, BREAST CANC SCREEN C; Lee CH, 2010, J AM COLL RADIOL, V7, P18, DOI 10.1016/j.jacr.2009.09.022; Pace LE, 2013, CANCER-AM CANCER SOC, V119, P2518, DOI 10.1002/cncr.28105; Qaseem A, 2007, ANN INTERN MED, V146, P511, DOI 10.7326/0003-4819-146-7-200704030-00007; Randolph WM, 2002, HEALTH SERV RES, V37, P1643, DOI 10.1111/1475-6773.10912; Smith-Bindman R, 2006, MED CARE, V44, P463, DOI 10.1097/01.mlr.0000207436.07513.79; Squiers LB, 2011, AM J PREV MED, V40, P497, DOI 10.1016/j.amepre.2010.12.027; Stempel DA, 2001, RESP MED, V95, P227, DOI 10.1053/rmed.2000.1027; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x	18	127	128	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91399	10.1371/journal.pone.0091399	http://dx.doi.org/10.1371/journal.pone.0091399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	25343354	Green Published, Green Submitted, gold			2022-12-27	WOS:000332842400087
J	Wang, H; Sun, W; Ma, JQ; Pan, YC; Wang, L; Zhang, WB				Wang, Hua; Sun, Wen; Ma, Junqing; Pan, Yongchu; Wang, Lin; Zhang, Weibing			Polycystin-1 Mediates Mechanical Strain-Induced Osteoblastic Mechanoresponses via Potentiation of Intracellular Calcium and Akt/beta-Catenin Pathway	PLOS ONE			English	Article							FOCAL ADHESION KINASE; KIDNEY-DISEASE; PROTEIN-KINASE; OSTEOGENIC DIFFERENTIATION; FLUID-FLOW; BONE-CELLS; PKD1 GENE; SKELETAL; ACTIVATION; MECHANOTRANSDUCTION	Mechanical regulation of bone formation involves a complex biophysical process, yet the underlying mechanisms remain poorly understood. Polycystin-1 (PC1) is postulated to function as a mechanosensory molecule mediating mechanical signal transduction in renal epithelial cells. To investigate the involvement of PC1 in mechanical strain-induced signaling cascades controlling osteogenesis, PKD1 gene was stably silenced in osteoblastic cell line MC3T3-E1 by using lentivirus-mediated shRNA technology. Here, our findings showed that mechanical tensile strain sufficiently enhanced osteogenic gene expressions and osteoblastic proliferation. However, PC1 deficiency resulted in the loss of the ability to sense external mechanical stimuli thereby promoting osteoblastic osteogenesis and proliferation. The signal pathways implicated in this process were intracellular calcium and Akt/beta-catenin pathway. The basal levels of intracellular calcium, phospho-Akt, phospho-GSK-3 beta and nuclear accumulation of active beta-catenin were significantly attenuated in PC1 deficient osteoblasts. In addition, PC1 deficiency impaired mechanical strain-induced potentiation of intracellular calcium, and activation of Akt-dependent and Wnt/beta-catenin pathways, which was able to be partially reversed by calcium ionophore A23187 treatment. Furthermore, applications of LiCl or A23187 in PC1 deficient osteoblasts could promote osteoblastic differentiation and proliferation under mechanical strain conditions. Therefore, our results demonstrated that osteoblasts require mechanosensory molecule PC1 to adapt to external mechanical tensile strain thereby inducing osteoblastic mechanoresponse, partially through the potentiation of intracellular calcium and downstream Akt/b-catenin signaling pathway.	[Wang, Hua; Ma, Junqing; Pan, Yongchu; Wang, Lin; Zhang, Weibing] Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China; [Sun, Wen] Nanjing Med Univ, Res Ctr Bone & Stem Cells, Dept Anat Histol & Embryol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, L (corresponding author), Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China.	nydwlktz@gmail.com; weibingzhang.njmu@gmail.com		wang, wei/0000-0002-0440-0859	National Natural Science Foundation of China [30973361, 81170981]; Natural Science Foundation for Colleges and Universities in JiangSu Province [10kJB320004]; Jiangsu Province Innovation Project for Graduate Student of China [CXZZ12_0589]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for Colleges and Universities in JiangSu Province; Jiangsu Province Innovation Project for Graduate Student of China	This study was supported in part by the National Natural Science Foundation of China (30973361, 81170981) and Natural Science Foundation for Colleges and Universities in JiangSu Province (10kJB320004) and by the Jiangsu Province Innovation Project for Graduate Student of China (CXZZ12_0589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Boletta Alessandra, 2009, Pathogenetics, V2, P6, DOI 10.1186/1755-8417-2-6; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Boutahar N, 2004, J BIOL CHEM, V279, P30588, DOI 10.1074/jbc.M313244200; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Case N, 2010, J CELL BIOCHEM, V110, P545, DOI 10.1002/jcb.22574; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dalagiorgou G, 2013, CELL MOL LIFE SCI, V70, P167, DOI 10.1007/s00018-012-1164-5; Danciu TE, 2003, FEBS LETT, V536, P193, DOI 10.1016/S0014-5793(03)00055-3; Distefano G, 2009, MOL CELL BIOL, V29, P2359, DOI 10.1128/MCB.01259-08; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Faibish D, 2006, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000200241.14684.4e; Forman JR, 2005, J MOL BIOL, V349, P861, DOI 10.1016/j.jmb.2005.04.008; Gao JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063084; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gay IC, 2007, ORTHOD CRANIOFAC RES, V10, P149, DOI 10.1111/j.1601-6343.2007.00399.x; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Hoey DA, 2012, STEM CELLS, V30, P2561, DOI 10.1002/stem.1235; Hou B, 2009, BONE, V44, P1121, DOI 10.1016/j.bone.2009.02.018; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Khan KM, 2009, BRIT J SPORT MED, V43, P247, DOI 10.1136/bjsm.2008.054239; Koike M, 2005, J BONE MINER METAB, V23, P219, DOI 10.1007/s00774-004-0587-y; Kolpakova-Hart E, 2008, DEV BIOL, V321, P407, DOI 10.1016/j.ydbio.2008.07.005; Kreja L, 2008, BIOCHEM BIOPH RES CO, V368, P582, DOI 10.1016/j.bbrc.2008.01.106; Lei G, 2011, BIOL CELL, V103, P185, DOI 10.1042/BC20100134; Liu DW, 2008, BONE, V42, P644, DOI 10.1016/j.bone.2007.09.058; Liu F, 2008, CELL SIGNAL, V20, P999, DOI 10.1016/j.cellsig.2007.11.011; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2006, J AM SOC NEPHROL, V17, P1015, DOI 10.1681/ASN.2005080830; Papachristou DJ, 2009, BIOESSAYS, V31, P794, DOI 10.1002/bies.200800223; Qiu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046038; Qiu N, 2012, J CELL BIOCHEM, V113, P967, DOI 10.1002/jcb.23426; Raisz LG, 1999, CLIN CHEM, V45, P1353; Rangaswami H, 2012, J BIOL CHEM, V287, P21509, DOI 10.1074/jbc.M112.347245; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; Walker LM, 2000, J CELL BIOCHEM, V79, P648, DOI 10.1002/1097-4644(20001215)79:4<648::AID-JCB130>3.0.CO;2-Q; Weimbs T, 2007, AM J PHYSIOL-RENAL, V293, pF1423, DOI 10.1152/ajprenal.00275.2007; Weimbs T, 2006, CELL CYCLE, V5, P2425, DOI 10.4161/cc.5.21.3408; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Xiao ZS, 2008, J BIOL CHEM, V283, P12624, DOI 10.1074/jbc.M710407200; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Xiao ZS, 2011, FASEB J, V25, P2418, DOI 10.1096/fj.10-180299; Xiao ZS, 2010, J BIOL CHEM, V285, P1177, DOI 10.1074/jbc.M109.050906; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Yu Y, 2012, HISTOCHEM CELL BIOL, V137, P513, DOI 10.1007/s00418-011-0908-x; Zhang WB, 2009, J CELL BIOCHEM, V108, P600, DOI 10.1002/jcb.22291	58	93	98	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91730	10.1371/journal.pone.0091730	http://dx.doi.org/10.1371/journal.pone.0091730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24586557	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400123
J	Wang, H; Zhou, L; Guo, JM; Sun, L; Long, QL; Ma, Y; Zhang, L; Lin, ZM; Zhu, TY; Wang, GM				Wang, Hang; Zhou, Lin; Guo, Jianming; Sun, Li'an; Long, Qilai; Ma, Yong; Zhang, Li; Lin, Zongming; Zhu, Tongyu; Wang, Guomin			Mini-Flank Supra-12th Rib Incision for Open Partial Nephrectomy Compared with Laparoscopic Partial Nephrectomy and Traditional Open Partial Nephrectomy	PLOS ONE			English	Article							RADICAL NEPHRECTOMY; COMPLICATIONS; OUTCOMES; SURGERY; TUMORS	Purpose: The purpose of this study was to report our approach of partial nephrectomy (PN) using a supra-12th rib mini-flank incision. We compared mini-incision open partial nephrectomy (MI-OPN) with open partial nephrectomy (OPN) and laparoscopic partial nephrectomy (LPN) to verify whether MI-OPN can be an alternative to OPN and LPN. Methods: This was a retrospective single-center study including 194 patients who underwent partial nephrectomy (PN) between February 2005 and December 2010. Demographic, perioperative, and complication data were compared among the MI-OPN group, OPN group and LPN group. Results: No statistical differences were reported in either group for age, sex, BMI, tumour side (right or left kidney), RENAL nephrometry scores, PADUA score and preoperative eGFR. The operative time was longer in LPN group when compared with MI-OPN and OPN group (all P < 0.001). The warm ischemia time of LPN group was longer than MI-OPN group (P = 0.032) and OPN group (P = 0.005). The length of stay of LPN group was shorter than OPN group (P = 0.018), but was similar to MI-OPN group (P = 0.094). The incidence of renal artery clamping was lower in OPN group when compared with MI-OPN and LPN group (all P, 0.001). More estimated blood loss was found in OPN group when compared with MI-OPN group (p = 0.003) and LPN group (P = 0.014). The overall incidence of postoperative complications was similar. Conclusions: The approach of MI-OPN can couple the benefits of both minimally invasive and open partial nephrectomy techniques with less estimated blood loss, shorter operative time, shorter length of stay, less postoperative complications, and a smaller incision. MI-OPN may be an effective alternative to laparoscopic or traditional open approaches, which maybe more suitable for the tumors with high RENAL nephrometry score or PADUA score.	[Wang, Hang; Zhou, Lin; Guo, Jianming; Sun, Li'an; Long, Qilai; Ma, Yong; Zhang, Li; Lin, Zongming; Zhu, Tongyu; Wang, Guomin] Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200433, Peoples R China	Fudan University	Wang, H (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200433, Peoples R China.	wang.hang@zs-hospital.sh.cn; guo.jianming@zs-hospital.sh.cn		wang, wei/0000-0002-0440-0859				Breda A, 2007, J UROLOGY, V178, P47, DOI 10.1016/j.juro.2007.03.045; Chatterjee S, 2004, UROL ONCOL-SEMIN ORI, V22, P36, DOI 10.1016/S1078-1439(03)00099-1; DiBlasio CJ, 2006, BJU INT, V97, P149, DOI 10.1111/j.1464-410X.2006.05882.x; Ficarra V, 2009, EUR UROL, V56, P786, DOI 10.1016/j.eururo.2009.07.040; Frank I, 2006, J UROLOGY, V175, P849, DOI 10.1016/S0022-5347(05)00346-0; Gill IS, 2000, J UROLOGY, V163, P1665, DOI 10.1016/S0022-5347(05)67516-7; GILL IS, 1995, J UROLOGY, V154, P479, DOI 10.1016/S0022-5347(01)67078-2; Huang WC, 2007, NAT CLIN PRACT UROL, V4, P444, DOI 10.1038/ncpuro0855; Jain S, 2013, J UROLOGY, V189, P1643, DOI 10.1016/j.juro.2012.11.170; Kenney Chad Wotkowicz, 2012, CAMPBELL WALSH UROLO, V2, P1567; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Marszalek M, 2009, EUR UROL, V55, P1171, DOI 10.1016/j.eururo.2009.01.042; Mitropoulos D, 2012, EUR UROL, V61, P341, DOI 10.1016/j.eururo.2011.10.033; Nadu A, 2009, J UROLOGY, V181, P42, DOI 10.1016/j.juro.2008.09.014; Permpongkosol S, 2007, J UROLOGY, V177, P580, DOI 10.1016/j.juro.2006.09.031; Peycelon M, 2009, J UROLOGY, V181, P35, DOI 10.1016/j.juro.2008.09.025; Ramani AP, 2005, J UROLOGY, V173, P42, DOI 10.1097/01.ju.0000147177.20458.73; Russo P, 2010, BJU INT, V105, P1494, DOI 10.1111/j.1464-410X.2010.09388.x; Ward J N, 1974, Urology, V3, P163, DOI 10.1016/S0090-4295(74)80006-3	20	93	98	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89155	10.1371/journal.pone.0089155	http://dx.doi.org/10.1371/journal.pone.0089155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586557	Green Submitted, gold, Green Published			2022-12-27	WOS:000331717900058
J	Wang, HB; Fang, G; Yu, WZ; Du, F; Fan, CX; Liu, QL; Hao, LX; Liu, Y; Zheng, JS; Qin, ZY; Xia, W; Zhang, SY; Yin, ZD; Jing, Q; Zhang, YX; Huang, RN; Yang, RP; Tong, WB; Qi, Q; Guan, XJ; Jing, YL; Ma, QL; Wang, J; Ma, XZ; Chen, N; Zheng, HR; Li, YQ; Ma, C; Su, QR; Reilly, KH; Luo, HM; Wu, XP; Wen, N; Yang, WZ				Wang, Hai-Bo; Fang, Gang; Yu, Wen-Zhou; Du, Fei; Fan, Chun-Xiang; Liu, Qing-Lian; Hao, Li-Xin; Liu, Yu; Zheng, Jing-Shan; Qin, Zhi-Ying; Xia, Wei; Zhang, Shi-Yue; Yin, Zun-Dong; Jing, Qiong; Zhang, Yan-Xia; Huang, Rong-Na; Yang, Ru-Pei; Tong, Wen-Bin; Qi, Qi; Guan, Xu-Jing; Jing, Yu-Lin; Ma, Qian-Li; Wang, Jin; Ma, Xiao-Zhen; Chen, Na; Zheng, Hong-Ru; Li, Yin-Qiao; Ma, Chao; Su, Qi-Ru; Reilly, Kathleen H.; Luo, Hui-Ming; Wu, Xian-Ping; Wen, Ning; Yang, Wei-Zhong			An Outbreak of Type Pi Vaccine- Derived Poliovirus in Sichuan Province, China: Emergence and Circulation in an Under-Immunized Population	PLOS ONE			English	Article							POLIOMYELITIS	Background: During August 2011-February 2012, an outbreak of type P circulating vaccine-derived poliovirus (cVDPVs) occurred in Sichuan Province, China. Methods: A field investigation of the outbreak was conducted to characterize outbreak isolates and to guide emergency response. Sequence analysis of poliovirus capsid protein VP1 was performed to determine the viral propagation, and a coverage survey was carried out for risk assessment. Results: One clinical compatible polio case and three VDPV cases were determined in Ngawa County, Ngawa Tibetan and Qiang Autonomous Prefecture, Sichuan Province. Case patients were unimmunized children, 0.8-1 years old. Genetic sequencing showed that the isolates diverged from the VP1 region of the type P Sabin strain by 5-12 nucleotides (nt) and shared the same 5 nt VP1 substitutions, which indicate single lineage of cVDPVs. Of the 7 acute flaccid paralysis cases (all. 6 months) reported in Ngawa Prefecture in 2011, 4 (57.1%) cases (including 2 polio cases) did not receive oral attenuated poliovirus vaccine. Supplementary immunization activities (SIAs) were conducted in February-May, 2012, and the strain has not been isolated since. Conclusion: High coverage of routine immunization should be maintained among children until WPV transmission is globally eradicated. Risk assessments should be conducted regularly to pinpoint high risk areas or subpopulations, with SIAs developed if necessary.	[Wang, Hai-Bo; Yu, Wen-Zhou; Fan, Chun-Xiang; Hao, Li-Xin; Zheng, Jing-Shan; Xia, Wei; Yin, Zun-Dong; Zhang, Yan-Xia; Ma, Chao; Su, Qi-Ru; Luo, Hui-Ming; Wen, Ning; Yang, Wei-Zhong] Chinese Ctr Dis Control & Prevent, Beijing 100050, Peoples R China; [Wang, Hai-Bo] Peking Univ, Clin Res Inst, Beijing 100191, Peoples R China; [Fang, Gang; Du, Fei; Liu, Qing-Lian; Liu, Yu; Qin, Zhi-Ying; Tong, Wen-Bin; Qi, Qi; Guan, Xu-Jing; Jing, Yu-Lin; Ma, Qian-Li; Wang, Jin; Ma, Xiao-Zhen; Chen, Na; Zheng, Hong-Ru; Li, Yin-Qiao; Wu, Xian-Ping] Sichuan Prov Ctr Dis Control & Prevent, Chengdu 610041, Sichuan Provinc, Peoples R China; [Zhang, Shi-Yue; Jing, Qiong] Ngawa Tibetan & Qiang Autonomous Prefectural Ctr, Chengdu 624000, Sichuan Provinc, Peoples R China; [Huang, Rong-Na; Yang, Ru-Pei] Chengdu City Ctr Dis Control & Prevent, Chengdu 610041, Sichuan Provinc, Peoples R China; [Reilly, Kathleen H.] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing 100050, Peoples R China	Chinese Center for Disease Control & Prevention; Peking University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Luo, HM (corresponding author), Chinese Ctr Dis Control & Prevent, Nanwei Rd 27, Beijing 100050, Peoples R China.	Hmluo@vip.sina.com; wwwuxp@163.com; ning_wen@163.com; yangwz@chinacdc.cn		wang, wei/0000-0002-0440-0859				Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P545; [Anonymous], 1999, MMWR MORB MORTAL WKL, V48, P747; Bahta L., 2005, Morbidity and Mortality Weekly Report, V54, P1053; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1002; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P967; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P145; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P113; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P357; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P736; Estivariz CF, 2008, J INFECT DIS, V197, P347, DOI 10.1086/525049; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; Lowther SA, 2013, MMWR-MORBID MORTAL W, V62, P335; Luo HM, 2013, NEW ENGL J MED, V369, P1981, DOI 10.1056/NEJMoa1303368; Mundel T, 2013, NEW ENGL J MED, V369, P2045, DOI 10.1056/NEJMe1311591; *NAT COMM CERT POL, 2000, DOC CERT POL ER; NATHANSON N, 1979, AM J EPIDEMIOL, V110, P672, DOI 10.1093/oxfordjournals.aje.a112848; Patriarca PA, 1997, J INFECT DIS, V175, pS165, DOI 10.1093/infdis/175.Supplement_1.S165; Rakoto-Andrianarivelo M, 2008, J INFECT DIS, V197, P1427, DOI 10.1086/587694; Tao WJ, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20343; Wassilak Steve, 2012, Morbidity and Mortality Weekly Report, V61, P353; Wassilak S, 2011, J INFECT DIS, V203, P898, DOI 10.1093/infdis/jiq140; World Health Organization Advisory Committee on Poliomyelitis Eradication, 2005, Wkly Epidemiol Rec, V80, P410; Yoshida H, 2002, J GEN VIROL, V83, P1107, DOI 10.1099/0022-1317-83-5-1107	26	93	98	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e113880	10.1371/journal.pone.0113880	http://dx.doi.org/10.1371/journal.pone.0113880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	24586557	gold, Green Submitted, Green Published			2022-12-27	WOS:000347146700011
J	Jiang, YH; Liu, HT; Kuo, HC				Jiang, Yuan-Hong; Liu, Hsin-Tzu; Kuo, Hann-Chorng			Decrease of Urinary Nerve Growth Factor but Not Brain-Derived Neurotrophic Factor in Patients with Interstitial Cystitis/Bladder Pain Syndrome Treated with Hyaluronic Acid	PLOS ONE			English	Article							DYSFUNCTION; THERAPY	Aims: To investigate urinary nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) levels in interstitial cystitis/bladder pain syndrome (IC/BPS) patients after hyaluronic acid (HA) therapy. Methods: Thirty-three patients with IC/BPS were prospectively studied; a group of 45 age-matched healthy subjects served as controls. All IC/BPS patients received nine intravesical HA instillations during the 6-month treatment regimen. Urine samples were collected for measuring urinary NGF and BDNF levels at baseline and 2 weeks after the last HA treatment. The clinical parameters including visual analog scale (VAS) of pain, daily frequency nocturia episodes, functional bladder capacity (FBC) and global response assessment (GRA) were recorded. Urinary NGF and BDNF levels were compared between IC/BPS patients and controls at baseline and after HA treatment. Results: Urinary NGF, NGF/Cr, BDNF, and BDNF/Cr levels were significantly higher in IC/BPS patients compared to controls. Both NGF and NGF/Cr levels significantly decreased after HA treatment. Urinary NGF and NGF/Cr levels significantly decreased in the responders with a VAS pain reduction by 2 (both p < 0.05) and the GRA improved by 2 (both p < 0.05), but not in non-responders. Urinary BDNF and BDNF/Cr did not decrease in responders or non-responders after HA therapy. Conclusions: Urinary NGF, but not BDNF, levels decreased significantly after HA therapy; both of these factors remained higher than in controls even after HA treatment. HA had a beneficial effect on IC/BPS, but it was limited. The reduction of urinary NGF levels was significant in responders, with a reduction of pain and improved GRA.	[Jiang, Yuan-Hong; Liu, Hsin-Tzu; Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Jiang, Yuan-Hong; Liu, Hsin-Tzu; Kuo, Hann-Chorng] Tzu Chi Univ, Hualien, Taiwan; [Liu, Hsin-Tzu] Tzu Chi Univ, Inst Pharmacol & Toxicol, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Tzu Chi University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.	hck@tzuchi.com.tw		Chen, Peisong/0000-0003-0640-3663; Liao, Chun-Hou/0000-0002-7340-110X				Antunes-Lopes T, 2013, J UROLOGY, V189, P359, DOI 10.1016/j.juro.2012.08.187; Chung SD, 2012, PAIN PHYSICIAN, V15, P197; Daha LK, 2005, EUR UROL, V47, P393, DOI 10.1016/j.eururo.2004.10.022; Daha LK, 2008, SCAND J UROL NEPHROL, V42, P369, DOI 10.1080/00365590701871518; Engelhardt PF, 2011, INT UROGYNECOL J, V22, P401, DOI 10.1007/s00192-010-1294-y; Frias B, 2011, CURR NEUROPHARMACOL, V9, P553, DOI 10.2174/157015911798376253; Ho DR, 2011, INT J UROL, V18, P525, DOI 10.1111/j.1442-2042.2011.02779.x; Homma Y, 2009, INT J UROL, V16, P597, DOI 10.1111/j.1442-2042.2009.02326.x; Hurst RE, 1996, UROLOGY, V48, P817, DOI 10.1016/S0090-4295(96)00322-6; HURST RE, 1987, J UROLOGY, V138, P433, DOI 10.1016/S0022-5347(17)43180-6; Iavazzo C, 2007, EUR UROL, V51, P1534, DOI 10.1016/j.eururo.2007.03.020; Kallestrup EB, 2005, SCAND J UROL NEPHROL, V39, P143, DOI 10.1080/00365590410015876-1; Kuo HannChorng, 2012, Clinical Investigation, V2, P1085; Lai MC, 2013, INT J UROL, V20, P203, DOI 10.1111/j.1442-2042.2012.03135.x; Liu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044687; Liu HT, 2009, BJU INT, V104, P1476, DOI 10.1111/j.1464-410X.2009.08675.x; Lokeshwar VB, 2006, J UROLOGY, V176, P1001, DOI 10.1016/j.juro.2006.04.012; Morales A, 1996, J UROLOGY, V156, P45, DOI 10.1016/S0022-5347(01)65933-0; Nickel JC, 2005, UROLOGY, V65, P654, DOI 10.1016/j.urology.2004.10.071; Nickel JC, 2004, MED CLIN N AM, V88, P467, DOI 10.1016/S0025-7125(03)00151-2; Ochodnicky P, 2012, NAT REV UROL, V9, P628, DOI 10.1038/nrurol.2012.178; Ochodnicky P, 2011, NEUROUROL URODYNAM, V30, P1227, DOI 10.1002/nau.21022; Parsons CL, 2007, UROLOGY, V69, P9, DOI 10.1016/j.urology.2006.03.084; PARSONS CL, 1991, J UROLOGY, V145, P732, DOI 10.1016/S0022-5347(17)38437-9; Pezet S, 2002, BRAIN RES REV, V40, P240, DOI 10.1016/S0165-0173(02)00206-0; Pinto R, 2010, NEUROSCIENCE, V166, P907, DOI 10.1016/j.neuroscience.2010.01.015; Pinto R, 2010, EUR UROL, V58, P360, DOI 10.1016/j.eururo.2010.02.031; Porru D, 1997, UROL INT, V59, P26, DOI 10.1159/000283012; Riedl CR, 2008, INT UROGYNECOL J, V19, P717, DOI 10.1007/s00192-007-0515-5; Shie JH, 2011, BJU INT, V108, pE136, DOI 10.1111/j.1464-410X.2010.09911.x; Steers WD, 2006, NAT CLIN PRACT UROL, V3, P101, DOI 10.1038/ncpuro0408; Tyagi P, 2012, J UROLOGY, V187, P2243, DOI 10.1016/j.juro.2012.01.034; Vizzard MA, 2000, EXP NEUROL, V161, P273, DOI 10.1006/exnr.1999.7254	33	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91609	10.1371/journal.pone.0091609	http://dx.doi.org/10.1371/journal.pone.0091609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614892	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300143
J	Liu, J; Gaj, T; Patterson, JT; Sirk, SJ; Barbas, CF				Liu, Jia; Gaj, Thomas; Patterson, James T.; Sirk, Shannon J.; Barbas, Carlos F., III			Cell-Penetrating Peptide-Mediated Delivery of TALEN Proteins via Bioconjugation for Genome Engineering	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; EMBRYO MICROINJECTION; VECTOR TOOLKIT; KNOCKOUT RATS; GENE-TRANSFER; BASIC DOMAIN; IN-VIVO; DNA; RECOGNITION; EFFECTORS	Transcription activator-like (TAL) effector nucleases (TALENs) have enabled the introduction of targeted genetic alterations into a broad range of cell lines and organisms. These customizable nucleases are comprised of programmable sequence-specific DNA-binding modules derived from TAL effector proteins fused to the non-specific FokI cleavage domain. Delivery of these nucleases into cells has proven challenging as the large size and highly repetitive nature of the TAL effector DNA-binding domain precludes their incorporation into many types of viral vectors. Furthermore, viral and non-viral gene delivery methods carry the risk of insertional mutagenesis and have been shown to increase the off-target activity of site-specific nucleases. We previously demonstrated that direct delivery of zinc-finger nuclease proteins enables highly efficient gene knockout in a variety of mammalian cell types with reduced off-target effects. Here we show that conjugation of cell-penetrating poly-Arg peptides to a surface-exposed Cys residue present on each TAL effector repeat imparted cell-penetrating activity to purified TALEN proteins. These modifications are reversible under reducing conditions and enabled TALEN-mediated gene knockout of the human CCR5 and BMPR1A genes at rates comparable to those achieved with transient transfection of TALEN expression vectors. These findings demonstrate that direct protein delivery, facilitated by conjugation of chemical functionalities onto the TALEN protein surface, is a promising alternative to current non-viral and viral-based methods for TALEN delivery into mammalian cells.	[Barbas, Carlos F., III] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell & Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Barbas, CF (corresponding author), Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	carlos@scripps.edu	Liu, Jia/E-5758-2014	Patterson, James/0000-0001-6006-7184; liu, juanjuan/0000-0001-6941-0372; Ma, Leina/0000-0003-3964-632X; Lin, Xiukun/0000-0002-0306-4953; Spincemaille, Pascal/0000-0002-8821-1341; Prince, Martin/0000-0002-9883-0584; Saloner, David/0000-0002-6989-8547	US National Institutes for Health [DP1CA174426]; NATIONAL CANCER INSTITUTE [DP1CA174426] Funding Source: NIH RePORTER	US National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US National Institutes for Health (DP1CA174426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen Z, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt710; Choi JM, 2006, NAT MED, V12, P574, DOI 10.1038/nm1385; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jin LH, 2001, FREE RADICAL BIO MED, V31, P1509, DOI 10.1016/S0891-5849(01)00734-1; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Kim SS, 2011, METHODS MOL BIOL, V721, P339, DOI 10.1007/978-1-61779-037-9_21; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056633; Mitsui H, 2006, J INVEST DERMATOL, V126, P1804, DOI 10.1038/sj.jid.5700335; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pooga M, 1998, FASEB J, V12, P67, DOI 10.1096/fasebj.12.1.67; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Ru Renli, 2013, Cell Regen, V2, P5, DOI 10.1186/2045-9769-2-5; Segal DJ, 2013, ANNU REV GENOM HUM G, V14, P135, DOI 10.1146/annurev-genom-091212-153435; Stella S, 2013, ACTA CRYSTALLOGR D, V69, P1707, DOI 10.1107/S0907444913016429; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Van Tendeloo VFI, 2000, GENE THER, V7, P1431, DOI 10.1038/sj.gt.3301252; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009	48	200	240	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85755	10.1371/journal.pone.0085755	http://dx.doi.org/10.1371/journal.pone.0085755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24626155	gold, Green Published			2022-12-27	WOS:000330240500068
J	Chen, XX; Shi, Y; Chai, WM; Feng, HL; Zhuang, JX; Chen, QX				Chen, Xiao-Xin; Shi, Yan; Chai, Wei-Ming; Feng, Hui-Ling; Zhuang, Jiang-Xing; Chen, Qing-Xi			Condensed Tannins from Ficus virens as Tyrosinase Inhibitors: Structure, Inhibitory Activity and Molecular Mechanism	PLOS ONE			English	Article							TOF MS ANALYSIS; MUSHROOM TYROSINASE; SKIN; PIGMENTATION; DOPAMINE; KINETICS; LEAVES; IONS; HPLC; NMR	Condensed tannins from Ficus virens leaves, fruit, and stem bark were isolated and their structures characterized by C-13 nuclear magnetic resonance spectrometry, high performance liquid chromatography electrospray ionization mass spectrometry, and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. The results showed that the leaves, fruit, and stem bark condensed tannins were complex mixtures of homo-and heteropolymers of B-type procyanidins and prodelphinidins with degrees of polymerization up to hexamer, dodecamer, and pentadecamer, respectively. Antityrosinase activities of the condensed tannins were studied. The results indicated that the condensed tannins were potent tyrosinase inhibitors. The concentrations for the leaves, fruit, and stem bark condensed tannins leading to 50% enzyme activity were determined to be 131.67, 99.89, and 106.22 mu g/ml on monophenolase activity, and 128.42, 43.07, and 74.27 mu g/ml on diphenolase activity. The inhibition mechanism, type, and constants of the condensed tannins on the diphenolase activity were further investigated. The results indicated that the condensed tannins were reversible and mixed type inhibitors. Fluorescence quenching, copper interacting, and molecular docking techniques were utilized to unravel the molecular mechanisms of the inhibition. The results showed that the hydroxyl group on the B ring of the condensed tannins could chelate the dicopper irons of the enzyme. Moreover, the condensed tannins could reduce the enzyme product o-quinones into colourless compounds. These results would contribute to the development and design of antityrosinase agents.	[Chen, Xiao-Xin; Shi, Yan; Chai, Wei-Ming; Feng, Hui-Ling; Chen, Qing-Xi] Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ Coastal & Wetland Ecosyst, Xiamen, Peoples R China; [Zhuang, Jiang-Xing] Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China	Xiamen University; Xiamen University	Zhuang, JX (corresponding author), Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China.	jiangxingzhuang@xmu.edu.cn; chenqx@xmu.edu.cn	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	Natural Science Foundation of China [31071611, 31070522]; National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China [J1310027/J0106]; Science and Technology Foundation of Fujian Province [2010N5013]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China; Science and Technology Foundation of Fujian Province(Natural Science Foundation of Fujian Province); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The present investigation was supported by the Natural Science Foundation of China (No. 31071611; No. 31070522), the National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China (Grant No. J1310027/J0106) and by the Science and Technology Foundation of Fujian Province (No. 2010N5013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hameed ESS, 2009, FOOD CHEM, V114, P1271, DOI 10.1016/j.foodchem.2008.11.005; Anandjiwala S, 2008, INDIAN J PHARM SCI, V70, P31, DOI 10.4103/0250-474X.40328; Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137; Baby Joseph, 2010, International Journal of Pharma and Bio Sciences, V1, pP; Bawadi HA, 2005, CANCER LETT, V218, P153, DOI 10.1016/j.canlet.2004.06.021; Chai WM, 2012, J AGR FOOD CHEM, V60, P5013, DOI 10.1021/jf300740d; Chauhan S, 2013, J MED PLANTS STUD, V1, P3846; Chen QX, 2005, FOOD CHEM, V91, P269, DOI 10.1016/j.foodchem.2004.01.078; Chen XX, 2014, FOOD CHEM, V155, P1, DOI 10.1016/j.foodchem.2014.01.011; Chen XX, 2013, INT J BIOL MACROMOL, V62, P726, DOI 10.1016/j.ijbiomac.2013.09.052; Chen XX, 2013, J ZHEJIANG UNIV-SC B, V14, P903, DOI 10.1631/jzus.B1200365; Choi H, 2005, PIGM CELL RES, V18, P439, DOI 10.1111/j.1600-0749.2005.00266.x; Espin JC, 2001, BBA-PROTEIN STRUCT M, V1544, P289, DOI 10.1016/S0167-4838(00)00230-2; Chiari ME, 2011, BIOORGAN MED CHEM, V19, P3474, DOI 10.1016/j.bmc.2011.04.025; Haslam E., 1989, Plant polyphenols: vegetable tannins revisited.; Hummer W, 2008, MOL NUTR FOOD RES, V52, P1381, DOI 10.1002/mnfr.200700463; Jimenez M, 2001, J AGR FOOD CHEM, V49, P4060, DOI 10.1021/jf010194h; Khatib S, 2007, J MED CHEM, V50, P2676, DOI 10.1021/jm061361d; Kim D, 2006, J AGR FOOD CHEM, V54, P935, DOI 10.1021/jf0521855; Kim YJ, 2005, CELL MOL LIFE SCI, V62, P1707, DOI 10.1007/s00018-005-5054-y; Kubo I, 1999, J AGR FOOD CHEM, V47, P4121, DOI 10.1021/jf990201q; Lee N, 2012, ACS CHEM BIOL, V7, P1687, DOI 10.1021/cb300222b; Lim YY, 2007, LWT-FOOD SCI TECHNOL, V40, P1664, DOI 10.1016/j.lwt.2006.12.013; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; McDonald M, 1996, J AGR FOOD CHEM, V44, P599, DOI 10.1021/jf950459q; Niranjan S, 2012, GLOBAL J PHARM RES, V1, P318; Sanjust E, 2003, ARCH BIOCHEM BIOPHYS, V412, P272, DOI 10.1016/S0003-9861(03)00053-5; Santos-Buelga C, 2000, J SCI FOOD AGR, V80, P1094, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1094::AID-JSFA569&gt;3.0.CO;2-1, 10.1002/(SICI)1097-0010(20000515)80:7<1094::AID-JSFA569>3.3.CO;2-T]; Sisti M, 2008, LWT-FOOD SCI TECHNOL, V41, P946, DOI 10.1016/j.lwt.2007.05.012; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Takahashi S, 2010, BIOORGAN MED CHEM, V18, P8112, DOI 10.1016/j.bmc.2010.08.056; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Xiang P, 2006, CHINESE J ANAL CHEM, V34, P1019, DOI 10.1016/S1872-2040(06)60047-9; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Zhang LL, 2008, MOLECULES, V13, P2986, DOI 10.3390/molecules13122986; Zhuang JX, 2010, J AGR FOOD CHEM, V58, P12993, DOI 10.1021/jf103723k	38	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91809	10.1371/journal.pone.0091809	http://dx.doi.org/10.1371/journal.pone.0091809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24622390	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100063
J	Chen, XH; Scholl, TO				Chen, Xinhua; Scholl, Theresa O.			Maternal Biomarkers of Endothelial Dysfunction and Preterm Delivery	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ADHESION MOLECULE-1; RETROSPECTIVE COHORT; HEART-DISEASE; UNITED-STATES; SE-SELECTIN; PREECLAMPSIA; RISK; WOMEN; INFLAMMATION	Background: Endothelial dysfunction is key to the development of atherosclerosis. Preterm delivery foreshadows later maternal cardiovascular disease (CVD), but it is not known if endothelial dysfunction also occurs. We prospectively measured circulating biomarkers of endothelial dysfunction in pregnant women with preterm or term delivery. Methods: We conducted a case-control study nested within a large prospective epidemiological study of young, generally healthy pregnant women. Women who delivered preterm (, 37 completed weeks gestation, n = 240) and controls who delivered at term (n = 439) were included. Pregnancies complicated by preeclampsia were analyzed separately. Circulating endothelial dysfunction biomarkers included soluble intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin). Results: Elevated levels of sICAM-1 and sVCAM-1 were positively associated with preterm delivery independent of usual risk factors. At entry (similar to 16 wks), the adjusted odds ratio (AOR) was 1.73 (95% confidence interval (CI) 1.09-2.74) for the highest quartile of sICAM-1 versus the lowest quartile and for sVCAM-1 the AOR was 2.17 (95% CI 1.36-3.46). When analysis was limited to cases with a spontaneous preterm delivery, the results were unchanged. Similar results were obtained for the 3rd trimester (similar to 30 wks). Elevated sE-selectin was increased only in preterm delivery complicated by preeclampsia; risk was increased at entry (AOR 2.32, 95% CI 1.22-4.40) and in the 3rd trimester (AOR 3.37, 95% CI 1.78-6.39). Conclusions: Impaired endothelial function as indicated by increased levels of soluble molecules commonly secreted by endothelial cells is a pathogenic precursor to CVD that is also present in women with preterm delivery. Our findings underscore the need for follow-up studies to determine if improving endothelial function prevents later CVD risk in women.	[Chen, Xinhua; Scholl, Theresa O.] Rowan Univ, Sch Osteopath Med, Dept Obstet & Gynecol, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine	Chen, XH (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Obstet & Gynecol, Stratford, NJ 08084 USA.	chenx1@rowan.edu	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	National Institute of Child Health and Human Development [HD061763, HD18269, HD38329]; National Institute on Minority Health and Health Disparities [1R01MD007828]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by research grants from the National Institute of Child Health and Human Development (HD061763 to Chen; HD18269 and HD38329 to Scholl) and the National Institute on Minority Health and Health Disparities (1R01MD007828 to Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatisa PK, 2004, AM J PHYSIOL-HEART C, V286, pH1389, DOI 10.1152/ajpheart.00298.2003; [Anonymous], 2006, INCOME EARNINGS POVE; Bartha JL, 2012, J WOMENS HEALTH, V21, P643, DOI 10.1089/jwh.2011.3013; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Bonamy AKE, 2011, CIRCULATION, V124, P2839, DOI 10.1161/CIRCULATIONAHA.111.034884; Caughey AB, 2005, OBSTET GYNECOL, V106, P156, DOI 10.1097/01.AOG.0000164478.91731.06; Chaiworapongsa T, 2002, J Matern Fetal Neonatal Med, V12, P19; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; Clapp BR, 2004, CARDIOVASC RES, V64, P172, DOI 10.1016/j.cardiores.2004.06.020; Frieden Thomas R, 2011, MMWR Suppl, V60, P1; Glowinska B, 2005, METABOLISM, V54, P1020, DOI 10.1016/j.metabol.2005.03.004; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gong J, 2012, PAEDIATR PERINAT EP, V26, P45, DOI 10.1111/j.1365-3016.2011.01222.x; Hamilton SJ, 2009, DIABETES CARE, V32, P810, DOI 10.2337/dc08-1736; Hastie CE, 2011, INT J EPIDEMIOL, V40, P914, DOI 10.1093/ije/dyq270; Hediger ML, 1997, ANN EPIDEMIOL, V7, P400, DOI 10.1016/S1047-2797(97)00046-X; Jenny NS, 2006, J THROMB HAEMOST, V4, P107, DOI 10.1111/j.1538-7836.2005.01678.x; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kim SY, 2004, J KOREAN MED SCI, V19, P688, DOI 10.3346/jkms.2004.19.5.688; Magnussen EB, 2007, BRIT MED J, V335, P978, DOI 10.1136/bmj.39366.416817.BE; Martin Joyce A., 2011, Morbidity and Mortality Weekly Report, V60, P78; Marvin KW, 2000, AM J REPROD IMMUNOL, V43, P264, DOI 10.1111/j.8755-8920.2000.430504.x; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Pell JP, 2004, AM J EPIDEMIOL, V159, P336, DOI 10.1093/aje/kwh064; Pina IL, 2011, CARDIOL REV, V19, P71, DOI 10.1097/CRD.0b013e318209c233; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Steinborn A, 2000, OBSTET GYNECOL, V95, P671, DOI 10.1016/S0029-7844(99)00604-3; Stewart FM, 2007, J CLIN ENDOCR METAB, V92, P969, DOI 10.1210/jc.2006-2083; Veas CJ, 2011, J MATERN-FETAL NEO M, V24, P1371, DOI 10.3109/14767058.2011.556204; Velez DR, 2009, AJOG, V200; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Wolf M, 2004, J CLIN ENDOCR METAB, V89, P6239, DOI 10.1210/jc.2004-0548	33	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85716	10.1371/journal.pone.0085716	http://dx.doi.org/10.1371/journal.pone.0085716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24622390	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100065
J	Chen, XK; May, B; Di, YM; Zhang, AL; Lu, CJ; Xue, CC; Lin, L				Chen, Xiankun; May, Brian; Di, Yuan Ming; Zhang, Anthony Lin; Lu, Chuanjian; Xue, Charlie Changli; Lin, Lin			Oral Chinese Herbal Medicine Combined with Pharmacotherapy for Stable COPD: A Systematic Review of Effect on BODE Index and Six Minute Walk Test	PLOS ONE			English	Review							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; CORDYCEPS-SINENSIS; ASTRAGALUS-MEMBRANACEUS; DISTANCE; COMPLEMENTARY; MANAGEMENT; PREDICTOR; CAPACITY; OUTCOMES	This systematic review evaluated the effects of Chinese herbal medicine (CHM) plus routine pharmacotherapy (RP) on the objective outcome measures BODE index, 6-minute walk test (6MWT), and 6-minute walk distance (6MWD) in individuals with stable chronic obstructive pulmonary disease (COPD). Searches were conducted of six English and Chinese databases (PubMed, EMBASE, CENTRAL, CINAHL, CNKI and CQVIP) from their inceptions until 18th November 2013 for randomized controlled trials involving oral administration of CHM plus RP compared to the same RP, with BODE Index and/or 6MWT/D as outcomes. Twenty-five studies were identified. BODE Index was used in nine studies and 6MWT/D was used in 22 studies. Methodological quality was assessed using the Cochrane Risk of Bias tool. Weaknesses were identified in most studies. Six studies were judged as 'low' risk of bias for randomisation sequence generation. Twenty-two studies involving 1,834 participants were included in the meta-analyses. The main meta-analysis results showed relative benefits for BODE Index in nine studies (mean difference [MD] -0.71, 95% confidence interval [CI] -0.94, -0.47) and 6MWT/D in 17 studies (MD 54.61 meters, 95% CI 33.30, 75.92) in favour of the CHM plus RP groups. The principal plants used were Astragalus membranaceus, Panax ginseng and Cordyceps sinensis. A. membranaceus was used in combination with other herbs in 18 formulae in 16 studies. Detailed sub-group and sensitivity analyses were conducted. Clinically meaningful benefits for BODE Index and 6MWT were found in multiple studies. These therapeutic effects were promising but need to be interpreted with caution due to variations in the CHMs and RPs used and methodological weakness in the studies. These issues should be addressed in future trials.	[Chen, Xiankun] Guangdong Prov Acad Chinese Med Sci, Evidence Based Med & Clin Res Serv Grp, Guangzhou, Guangdong, Peoples R China; [Chen, Xiankun; Lu, Chuanjian; Xue, Charlie Changli] Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China; [May, Brian; Di, Yuan Ming; Zhang, Anthony Lin; Xue, Charlie Changli] RMIT Univ, Sch Hlth Sci, Hlth Innovat Res Inst, Tradit & Complementary Med Res Program, Melbourne, Vic, Australia; [Lu, Chuanjian; Xue, Charlie Changli] Guangdong Prov Acad Chinese Med Sci, Guangzhou, Guangdong, Peoples R China; [Lin, Lin] Guangdong Prov Hosp Chinese Med, Dept Resp Med, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Royal Melbourne Institute of Technology (RMIT); Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Lin, L (corresponding author), Guangdong Prov Hosp Chinese Med, Dept Resp Med, Guangzhou, Guangdong, Peoples R China.	drlinlin620@163.com	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	International Science & Technology Cooperation Project of the Ministry of Science and Technology of China [2012DFA31760]; China-Australia International Research Centre for Chinese Medicine; Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS GPHCM); Guangdong China; RMIT University, Australia; GPHCM; School of Health Sciences, RMIT University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	International Science & Technology Cooperation Project of the Ministry of Science and Technology of China; China-Australia International Research Centre for Chinese Medicine; Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS GPHCM); Guangdong China; RMIT University, Australia; GPHCM; School of Health Sciences, RMIT University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study is funded by a project grant from the International Science & Technology Cooperation Project of the Ministry of Science and Technology of China (Project Grant Number: 2012DFA31760, Project Title: Evaluation of Traditional and Scientific Evidence of Chinese Medicine). The project is partially supported by the China-Australia International Research Centre for Chinese Medicine, funded by Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS & GPHCM), Guangdong China, and RMIT University, Australia. The authors also acknowledge the support provided by the GPHCM and the School of Health Sciences, RMIT University to the first author (XKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 1999, AM J RESP CRIT CARE, V159, P1666; An XD, 2012, J ALTERN COMPLEM MED, V18, P731, DOI 10.1089/acm.2011.0389; An XD, 2011, RESP MED, V105, P165, DOI 10.1016/j.rmed.2010.11.007; Brown Cynthia D, 2007, COPD, V4, P217; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Chen GC, 2012, SHANGHAI J TRADITION, V46, P42; Chen Ning, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P105, DOI 10.3736/jcim20090202; Chen Q, 2009, J FUJIAN U TRAD CHIN, V19, P12; Cote CG, 2008, EUR RESPIR J, V31, P571, DOI 10.1183/09031936.00104507; Cote CG, 2005, EUR RESPIR J, V26, P630, DOI 10.1183/09031936.05.00045505; CSRD, 2007, CHIN J INRERN MED, V46, P254; Cui Peng, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3451; Cui Zhao-bo, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P885; Denzler KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012561; Faganello MM, 2010, AM J MED SCI, V339, P10, DOI 10.1097/MAJ.0b013e3181bb8111; Fan BD, 2012, J SICHUAN TRADITIONA, P83; George J, 2004, MED J AUSTRALIA, V181, P248, DOI 10.5694/j.1326-5377.2004.tb06262.x; Glaab T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-79; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Guo WX, 2008, HEBEI J TRADITIONAL, V30, P121; Holland AE, 2010, ARCH PHYS MED REHAB, V91, P221, DOI 10.1016/j.apmr.2009.10.017; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028696; Hu QG, 2012, J GUIYANG COLLAGE TR, V34, P135; [黄东晖 Huang Donghui], 2005, [第四军医大学学报, Journal of the Fourth Military Medical University], V26, P1611; Imfeld S, 2006, CHEST, V129, P873, DOI 10.1378/chest.129.4.873; Jian XY, 2012, J BEIJING U TRADITIO, V19, P32; Jones PW, 2001, THORAX, V56, P880, DOI 10.1136/thorax.56.11.880; Kim HG, 2006, EUR J PHARMACOL, V545, P192, DOI 10.1016/j.ejphar.2006.06.047; Koh JH, 2002, BIOSCI BIOTECH BIOCH, V66, P407, DOI 10.1271/bbb.66.407; Kumar R, 2011, J ETHNOPHARMACOL, V136, P260, DOI 10.1016/j.jep.2011.04.040; Kuo YH, 2009, J ETHNOPHARMACOL, V122, P28, DOI 10.1016/j.jep.2008.11.025; Kuo YC, 1996, AM J CHINESE MED, V24, P111, DOI 10.1142/S0192415X96000165; Kuo YC, 2001, LIFE SCI, V68, P1067, DOI 10.1016/S0024-3205(00)01011-0; Li CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040824; Li SY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-197; Liang AW, 2013, J EMERGENCY TRADITIO, P1125; Liao Y.L., 2011, HERALD MED, V30, P63; Lin YZ, 2013, CHINESE MANIPULATION, P103; Liu CS, 2009, GUIDING J TRADITIONA, V11, P10; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mansori F, 2010, CLIN RESPIR J, V4, P241, DOI 10.1111/j.1752-699X.2010.00185.x; Marin JM, 2011, RESP MED, V105, P916, DOI 10.1016/j.rmed.2011.01.007; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Ong KC, 2005, CHEST, V128, P3810, DOI 10.1378/chest.128.6.3810; Peng ZQ, 2013, THESIS FUJIAN U TRAD; Pinto-Plata V, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-71; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Rao YK, 2007, J ETHNOPHARMACOL, V114, P78, DOI 10.1016/j.jep.2007.07.028; Shahed AR, 2001, TRANSPL P, V33, P2986, DOI 10.1016/S0041-1345(01)02282-5; Shan LN, 2011, J GUANGZHOU U TRADIT, V28, P590; Shang QH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/716459; Shao BM, 2004, BIOCHEM BIOPH RES CO, V320, P1103, DOI 10.1016/j.bbrc.2004.06.065; Shergis JL, 2013, PHYTOTHER RES, V27, P949, DOI 10.1002/ptr.4832; Shin IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045734; Spruit MA, 2012, J AM MED DIR ASSOC, V13, P291, DOI 10.1016/j.jamda.2011.06.009; Vickers A, 1999, BRIT MED J, V319, P1050, DOI 10.1136/bmj.319.7216.1050; Wise Robert A, 2005, COPD, V2, P125; Wu L, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/705315; Xu JZ, 2012, YUNNAN J TRADITIONAL, V33, P31; Xu TingZhen, 2012, Chinese Archives of Traditional Chinese Medicine, V30, P570; Yang CM, 2013, MODERN J INTEGRATED, P729; Yu JY, 2011, J MED INFORM, P4019; Zeng JQ, 2013, J NEW CHINESE MED, P32; Zhang FY, 2007, SHANXI ZHONGYI J, V28, P1594; Zhang FY, 2007, J EMERGENCY TRADITIO, V19, P198; Zhang R.Z., 2011, CHINA PRACTICAL MED, V6, P118; Zhao YL, 2012, J TRADIT CHIN MED, V32, P203, DOI 10.1016/S0254-6272(13)60012-6; 茅蓉, 2009, [中国中西医结合杂志, Chinese Journal of Integrated Traditional and Western Medicine], V29, P362	70	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91830	10.1371/journal.pone.0091830	http://dx.doi.org/10.1371/journal.pone.0091830			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622390	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300132
J	Chen, XF; Li, LZ; Zhou, T; Li, ZZ				Chen, Xiaofang; Li, Lezhi; Zhou, Tao; Li, Zhanzhan			Prevalence of Hypertension in Rural Areas of China: A Meta-Analysis of Published Studies	PLOS ONE			English	Article							STAGE RENAL-DISEASE; BLOOD-PRESSURE; RISK-FACTORS; MEN; AWARENESS; MORTALITY	Background: Hypertension is one of the leading causes of disease burden across the world. In China, the latest nationwide survey of prevalence of hypertension was ten year ago, and data in rural areas is little known. More information about hypertension prevalence could help to improve overall antihypertensive health care. We aimed to estimate the pooled prevalence of hypertension in rural areas of China. Methods: Comprehensive electronic searches of PubMed, Web of Knowledge, Chinese Web of Knowledge, Wangfang, Weipu and SinoMed databases were conducted to identify any study in each database published from January 1, 2004 to December 31, 2013, reporting the prevalence of hypertension in Chinese rural areas. Prevalence estimates were stratified by age, area, sex, publication year, and sample size. All statistical calculations were made using the Stata Version 11.0 (College Station, Texas) and Statsdirect Version 2.7.9. Results: We identified 124 studies with a total population of 3,735,534 in the present meta-analysis. Among people aged 18 years old in Chinese rural areas, the summarized prevalence is 22.81% (19.41%-26.41%). Subgroup analysis shows the following results: for male 24.46% (21.19%-27.89%, for female 22.17% (18.25%-26.35%). For 2004-2006: 18.94% (14.41%-23.94%), for 2007-2009, 21.24% (15.98%-27.01%) for 2010-2013: 26.68%, (20.79%-33.02%). For Northern region 25.76% (22.36%-29.32%), for Southern region 19.30%, (15.48%-24.08%). Conclusions: The last decade witnessed the growth in prevalence of hypertension in rural areas of China compared with the fourth national investigation, which has climbed the same level as the urban area. Guidelines for screening and treatment of hypertension in rural areas need to be given enough attention.	[Chen, Xiaofang] Cent South Univ, Xiangya Nursing Sch, Changsha, Hunan, Peoples R China; [Chen, Xiaofang] Southern Med Univ, Affiliated Hostipal 3, Dept Nursing, Guangzhou, Guangdong, Peoples R China; [Li, Lezhi] Cent South Univ, Dept Nursing, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Zhou, Tao] Southern Med Univ, Dept Cardiol, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Li, Zhanzhan] Cent South Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China	Central South University; Southern Medical University - China; Central South University; Southern Medical University - China; Central South University	Li, LZ (corresponding author), Cent South Univ, Dept Nursing, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	lilz1988@126.com	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Chen B, 2008, MOEDERN PREV MED, V35, P2823; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Department of Disease Control and Prevention Ministry of Health, 2006, REP CHRON DIS CHIN; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diaz AA, 2014, RURAL REMOTE HEALTH, V14; Dong CX, 2013, J INT MED RES, V41, P1291, DOI 10.1177/0300060513488498; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; FLACK JM, 1995, CIRCULATION, V92, P2437, DOI 10.1161/01.CIR.92.9.2437; Gong Jie, 2011, Chinese Preventive Medicine, V12, P227; Han B, 2009, J ZHENGZHOU U MED SC, V44, P337; He F, 2012, CHIN J DIS CONTROL P, V16, P560; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu HH, 2008, PREV TREATMENT CARDI, V8, P195; Hu XJ, 2013, CHIN HLTH SERVICE MA, V5, P391; Hu Y, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P177; Huang JP, 2011, KIDNEY BLOOD PRESS R, V34, P69, DOI 10.1159/000323164; Kannel WB, 1996, JAMA-J AM MED ASSOC, V276, P1269, DOI 10.1001/jama.276.15.1269; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Kokiwar Prashant R, 2012, J Assoc Physicians India, V60, P26; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Li LM, 2008, CHINESE REDIDENTS NU; Li Y, 2011, J SHENYANG MED COLL, V13, P228; Lin Kang, 2014, Wuhan Daxue Xuebao (Yixue Ban), V35, P114; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Ma YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058302; Ministry of Health of the People's Republic of China, 2005, CHIN PREV CONTR HYP; Mittal BV, 2010, AM J KIDNEY DIS, V55, P590, DOI 10.1053/j.ajkd.2009.06.044; Ni GH, 2013, FOOD NUTR CHIN, V19, P70; O'Brien E, 2000, BMJ-BRIT MED J, V320, P1128, DOI 10.1136/bmj.320.7242.1128; O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964; PRC National Blood Pressure Survey Cooperative Group, 1995, CHIN J HYPERTENS, V3, P1; Reynolds K, 2003, J HYPERTENS, V21, P1273, DOI 10.1097/00004872-200307000-00014; Rostom A, 2004, Evid Rep Technol Assess (Summ), P1; Stuart A, 1996, KENDALLS ADV THEORY; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; [王克伟 Wang Kewei], 2011, [中国公共卫生, China Public Health], V27, P1291; Wang YM., 2013, J BENBU MED COLL, V38, P321; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z; Xia YiYin, 2013, Journal of Tropical Medicine (Guangzhou), V13, P350; Xin RB, 2011, GUANGXI MED, V33, P963; Yang HJ, 2010, CHIN J GEN PRAC, V8, P896; Ye HaoFeng, 2005, China Tropical Medicine, V5, P1114; Ye ZW, 2011, ANHUI J PREV MED, V17, P190; Yin CG, 2009, PREV TREATMENT CARDI, V9, P137; Yu QH, 2011, WORLD HLTH DIG MED P, V8, P13; Yu YX, 2009, MED J CHIN PEOPLE HL, V21, P2364; Zhang AH, 2009, PREV MED TRIB, V15, P720; Zhang G, 2009, GONG GONG WEI SHENG, V20, P24; Zhang LJ, 2010, OCCUP HLTH, V26, P1872; Zhang Y., 2011, NINGXIA MED J, V33, P1222; Zhao JiQing, 2013, Bulletin of Disease Control and Prevention, V28, P27; Zheng YT, 2011, CHIN MED J METALL IN, V28, P573; Zheng ZH, 2010, CHINA CHLIN PRAC MED, V4, P219; Zhong DC, 2009, SICHUAN MED J, V30, P1056; Zhou YX, 2011, PRE MED TRIB, V17, P909	59	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115462	10.1371/journal.pone.0115462	http://dx.doi.org/10.1371/journal.pone.0115462			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	24622390	Green Submitted, gold, Green Published			2022-12-27	WOS:000348845600050
J	Chen, XL; Chen, XZ; Lu, ZH; Wang, L; Yang, K; Hu, JK; Zhang, B; Chen, ZX; Chen, JP; Zhou, ZG				Chen, Xiao-Long; Chen, Xin-Zu; Lu, Zheng-Hao; Wang, Li; Yang, Kun; Hu, Jian-Kun; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang			Comparison of Ultrasonic Scalpel versus Conventional Techniques in Open Gastrectomy for Gastric Carcinoma Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ACTIVATED SHEARS; CANCER; LYMPHADENECTOMY	Objectives: To compare surgical efficacy and postoperative recovery of ultrasonic scalpel (USS) with conventional techniques for the resection of gastric carcinoma. Methods: A systematic search of major medical databases (PubMed, Embase, CCRT and CNKI) was conducted. Both randomized and non-randomized controlled trials (RCTs and nRCTs) were considered eligible. Operation time (OT), intraoperative blood loss (BL) and postoperative complications (POC) rates as well as postoperative hospitalization days, number of dissected lymph nodes, abdominal drainage volume and time for recovery of gastrointestinal functions were synthesized and compared. Results: Nineteen studies were included (7 RCTs and 12 nRCTs), in which 1930 patients were enrolled totally (946 in the USS group and 984 in the conventional group). Monopolar electrocautery and ligation were used as the conventional methods. Comparative meta-analysis showed perioperative outcomes were significantly improved using USS compared with conventional surgical instrumentation. OT was reduced from a weighted mean of 185.3 min in the conventional group to 151.0 min in the USS group (MD = -33.30, 95% CI [-41.75, -24.86], p<0.001) and intraoperative BL was decreased from a weighted mean of 217.9 ml in the conventional group to 111.6 ml in the USS group (MD = -113.42, 95% CI [-142.05, -84.79], p<0.001). Results from RCTs subgroup were consistent with those from nRCTs subgroup. The weighted cumulative risk of POC accounted for 8.9% (0%-25%) and 12.9% (5.5%-45%) in the USS and conventional groups, respectively. Pooled estimated results from nRCTs (OR = 0.54, 95% CI [0.27, 1.06], p = 0.07) and RCTs (RR = 0.75, 95% CI [0.44, 1.26], p = 0.27) showed no significant difference between the USS and control groups. Analysis of secondary outcomes showed the improvements of the USS group over control group regarding the number of dissected lymph nodes, postoperative hospitalization days, abdominal drainage volume and time for recovery of gastrointestinal functions. Conclusion: Compared with conventional electrosurgery, the USS is a safe and effective technique with more short-term advantages in open surgery for gastric cancer.	[Chen, Xiao-Long; Chen, Xin-Zu; Lu, Zheng-Hao; Yang, Kun; Hu, Jian-Kun; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang] Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China; [Wang, Li] Sichuan Univ, West China Hosp, Chinese Cochrane Ctr, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University	Hu, JK (corresponding author), Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China.	hujkwch@126.com	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	Outstanding Young Scientific Scholarship Foundation of Sichuan University; Fundamental Research Funds for the Central Universities of China [2011SCU04B19]; Ministry of Education of China [2012SCU-NCET-11-0343]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	Outstanding Young Scientific Scholarship Foundation of Sichuan University; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Ministry of Education of China(Ministry of Education, China); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Domestic support from (1) Outstanding Young Scientific Scholarship Foundation of Sichuan University, from the Fundamental Research Funds for the Central Universities of China (No. 2011SCU04B19); and (2) New Century Excellent Talents in University support program, Ministry of Education of China (2012SCU-NCET-11-0343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 1998, ONCOLOGY-NY, V12, P44; Ajani JA, 2010, J NATL COMPR CANC NE, V8, P378, DOI 10.6004/jnccn.2010.0030; Chen CP, 2012, GUID CHIN MED, V10, P345; Chen XZ, 2010, J AM COLL SURGEONS, V210, P100, DOI 10.1016/j.jamcollsurg.2009.09.033; Chen Z, 2009, CHIN J MOD OPER SURG, V13, P257; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Fu YM, 2011, CONT MED, V17, P104; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hu JK, 2009, SURG TODAY, V39, P207, DOI 10.1007/s00595-008-3856-x; Hu JK, 2008, CHIN J BASES CLIN GE, V15, P718; Inoue K, 2012, J GASTROINTEST SURG, V16, P1840, DOI 10.1007/s11605-012-1970-y; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Li G, 2010, J MED POSTGRA, V23, P1050; Li P, 2011, CHIN MED HERALD, V8, P177; Li ZR, 2009, CHIN ARCH GEN SURG E, V3, P510; Lin YH, 2011, CHIN J CLIN ELECT ED, V5, P975; [陆维祺 LU Weiqi], 2008, [中国实用外科杂志, Chinese Journal of Practical Surgery], V28, P203; Mahabaleshwar V, 2012, CAN J SURG, V55, P307, DOI 10.1503/cjs.000411; McCarus SD, 1996, J AM ASSOC GYN LAP, V3, P601, DOI 10.1016/S1074-3804(05)80174-4; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mohri Y, 2007, SURG TODAY, V37, P1060, DOI 10.1007/s00595-007-3551-3; Pons Y, 2009, HEAD NECK ONCOL, V24, P1; Shi YF, 2012, GUID CHIN MED, V10, P154; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Tou S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007886.pub2; Tsimoyiannis EC, 2002, WORLD J SURG, V26, P158; Tu JC, 2010, MED J COMMUN, V24, P60; Tu XH, 2009, CHIN J MOD OPER SURG, V13, P407; Van Cutsem E, 2008, EUR J CANCER, V44, P182, DOI 10.1016/j.ejca.2007.11.001; Wei ZM, 2010, J MINI INVA MED, V5, P445; Wells G, 2009, OTTAWA HOSP RES I NE; Xu L, 2010, PEOPLES MIL SURG, V53, P490; Yang K, 2009, WORLD J GASTROENTERO, V15, P5352, DOI 10.3748/wjg.15.5352; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhang ZY, 2012, CHIN J MOD DRUG APPL, V6, P3; Zhong L, 2012, ANN ACAD MED SINGAP, V41, P161; 尹蓓, 2011, [江苏医药, Jiangsu Medical Journal], V37, P2877; 宋小平, 2011, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V31, P590; 刘磊, 2010, [中国癌症杂志, China Oncology], V20, P799	41	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103330	10.1371/journal.pone.0103330	http://dx.doi.org/10.1371/journal.pone.0103330			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	24622390	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800038
